<SEC-DOCUMENT>0001628280-23-014190.txt : 20230428
<SEC-HEADER>0001628280-23-014190.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428161630
ACCESSION NUMBER:		0001628280-23-014190
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHPEAK PROPERTIES, INC.
		CENTRAL INDEX KEY:			0000765880
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				330091377
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08895
		FILM NUMBER:		23866471

	BUSINESS ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237
		BUSINESS PHONE:		949-407-0700

	MAIL ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCP, INC.
		DATE OF NAME CHANGE:	20070911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH CARE PROPERTY INVESTORS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>peak-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc,d:d2287c84385e40afa1133fb5d1fa8206--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:peak="http://www.healthpeak.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>peak-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl80LTEtMS0xLTIyNTI3MQ_13e36c76-5f39-4d12-8cf4-c418f682e440">0000765880</ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl81LTEtMS0xLTIyNTI3MQ_f9dc247d-1226-4fc2-bd77-a85521be96f4">false</ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl82LTEtMS0xLTIyNTI3MQ_97f375a3-f513-4566-8d0b-45c96733d25e">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl83LTEtMS0xLTIyNTI3MQ_d9de996b-85df-4a1c-b9c4-e6331b33318b">2023</ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl84LTEtMS0xLTIyNTI3MQ_f29e78ff-d6c1-466d-8ae2-ffd244e4e63b">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i8a25e7b5d67943c7b2f4785d0bbd801e_D20230101-20230331" name="peak:OptionIndexedToIssuersEquityTerm" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTUwMw_5ce2ccbc-5900-4089-b403-cb14df27b311">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="peak-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7b47f0a1b274852999d6d4b2ead62d8_I20230426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="if4882bfad4354d8ea1cac4348c817159_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iaecb36bec2724a3594acf3e81eca36dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacdd5f56e1a64a2f909772d23fa79232_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db6d623777a4436baf821bd0afcff29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0f6cf1f29914223a101cf9dfaee1c2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf4d0c742ae47a892216777fa79e08b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530e671af080458e9ba7b21a10d74180_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de8610900b8400ea338f115550cc75e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0563220fc3204262b0a60fd550eae320_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia08b165391414939958c319482d7e2da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6c895598a3c42b7afdb9ff3193e487c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i807e77a17a3d456481946b1b5c29dc29_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f56515023941089672801d0df27438_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57bcf974abc44e3d904f70df65e9044d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83ebcfd7fc764a069ccd0143794750e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i252b5f72bd3f474cb0b445240f777230_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30bf6bfeb0434265ba52f1329cc43b46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5eba404d7984f2bb0b0aebd3dd90f27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fecc3b0cc14458b9cad2f8b45fe191_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94947a66a6b4b0db78654d659d35ae7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00fa5f4d9ca644438e3562b42ba2334c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i503ad2df9c9240088b9e5481b385a0f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabf59758b312417ebb52a26e8b708bf1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bc82cfb90b4179b30ea0df867d1278_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804d4f9d03a04437bc94e9a064ca876a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib15aeabd34c04dab92eb0fdb03950e0c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980ff73125e2448f9c1841abc88ec5cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8fb31decab14836989f7e62f5d94e60_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f15128c31ab488daa41c96893b79122_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic773135133e649b9a40e6c2ae0098c47_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3673bf0bac0c46438f86bb54a2b7a090_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife363d16c20b4fb4829cc5fa5e166ebd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04bb152d3876442882602d59cb9257bd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d70f4026c6041ec8a4ea17cbea56b52_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c2dda1ede5c4d58a46ce9579d6b92e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1bf5123a8b41479133b782e5100a18_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i118359ae91b74e62812988bfeaa797c8_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f045cefde3045ae8996ee15bbb51550_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ffe53bede314b11a85ecb20ec8a6694_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>peak:property</xbrli:measure></xbrli:unit><xbrli:context id="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0492c2ebf6054f6ebe312755f471116e_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44e261bd07684db7946bf96652492c6f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58508407aa974ce7ae2dd7d111863709_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MOBLandParcelsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b93e6524fd44e6ac71b8975be978f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa2335d07c3144528793163232dd5d77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f86893d4664360ad004f5222f209e3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i868c4fb89cf748b39a591564a160cb85_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864dd3fa811448b2b9b318a07f46f343_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">peak:PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a54d5ef01f84069a21614fb6b5703d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">peak:SorrentoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35fc9183f82c46689dc6c8c571bb0698_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3251deb01d7f43a6b36fce8fe3b868bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299419585a7445608813f122905f9277_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if29b037c8ce04a23a923956f784473ee_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>peak:facility</xbrli:measure></xbrli:unit><xbrli:context id="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec94601e6824a438f9ff0bea83f0c4c_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2528dacab94d72ab3e440848edce92_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc764c876dea4bdf9388495cb2847238_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab5284915b80459fb6366e3a5528172e_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e598ee158714864ac7ec8e1b7c6c04e_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7401311f5444a7a6418fa19740da6b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic385c6dfa277429bad7b41a2a38a66fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib206c24e874f495eb33a7ef79724c812_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95535d107b84adab248bbffe4d73975_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a002d72b97442b5b2b389ad5a9d16ce_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa149a31fb1486581279cc115c490b8_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03330e2036c04219b1af6523e1deca30_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a09c60ade2547478c8bde3119807cfa_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>peak:loan</xbrli:measure></xbrli:unit><xbrli:context id="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292c0d5f96754ad2a296029a917f95b0_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0139f5e9be640a2abe77bf91136f1bb_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63393f69a85548b18409a036fee2f946_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ab4619f5bc4ffb844448dc2ded4d10_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684b88fb97554f22a37f1cbb5a4be09a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e0f4ebc4c1547e5913529941dba4cd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if21dc8e101854dcebeae8d48af75b96d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d00bf264b354d8e9bd17bbbec9cc3db_D20230101-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ecc95ec04841c1b95be484ffd8add8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c1609203464ecf8a00b2af5447978d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7022374097c345abbd7b9628054b8bb1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b8336de4304e599fe3da77c86692a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodGrossWriteOffsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia778bdabbe2148a785c9999be7828073_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodNetWriteOffsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia427c7d52bef42c28adc94497ec593ae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ddbb42639d468984faade1da6bb948_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffec5e441b44bef86395108ef570821_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859ad1c33bde4dffb72acaca2240e037_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05931c32871345c2953b6bc7e9725803_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodGrossWriteOffsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec83876e1875415480e127f2f8ee5341_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodNetWriteOffsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie53bcb07504e4ad99f3ade31d660d86a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a30f0743e84f25b4365b13befe7543_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3eb325105c4a489d9e072e95831f43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8966c32afeb843069c788fcb7d555ba1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893e14a7026040f8939a46fc89d040eb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49856b1a6b744d32850fd6e75896a354_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i563440407d4441eb91bd164b5748f220_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188028ed6c334da79242d89eee8a840e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd9427916f174bbb8f0807aa0d989019_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdf3a793faf4597a6b092e7c936f32a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i164fcc3a8c7b43fab61c0b736e5ce0ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bdefa6de9c94ded98445df17bde5304_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1a0b550fcf40a994feb853ca29945f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea45485ef014df9bcb3a328007f3a5a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d045a82e5d472cab0e50a49b069fc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2addaafadeb048608bb19144472ba521_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cdb1d5067b4c20abc45e5a6b15b490_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf0c3be361842da924660620a57f737_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>peak:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="idcb7ea32456048788d35e1f70da8c6f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i609a39bba39341cca8d2aa1fcce48d99_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ebf93813b04ee98f19d52880e6b227_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SuburbanPropertiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21dc87df2f2b491c818391833acfbe83_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98f2b1c68dfd4ec0b6cfe198f9aa7452_D20230401-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13ba81585eef4986833dfbc887a0e2d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7242708209774688bf6a0fa92eee7c92_I20190523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>peak:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="ic4babd7df1364a05a31daf2030f872a8_D20190523-20190523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-23</xbrli:startDate><xbrli:endDate>2019-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1d4050de8b24d7499a2da8155770c96_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2627cf08414f8db5d11bcfa2e103c2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72eb05af2cbe4e208706e4b57decdb88_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7305c3d00995417db4dbb2b7d6c583a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae753d2f2bb4df0934278cf9eff53e5_D20220822-20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506c4e4d75c74d20b91a42ee338b3511_I20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44957565290418193123188bc3f9a29_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5093505d5344e8bba4c2389265a3a7b_I20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33fc45189ac34f818a512f00fc01253e_I20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i543d187d7c2f422fb35ffbea57ea780b_D20220822-20220822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-22</xbrli:startDate><xbrli:endDate>2022-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6cf8ab3e074c468afa71e272d04f7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000be30d07554d05a5d03c3a41a8a60e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ebc102c23049bb9221a3b5b00a8855_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a237e0795d475c9e344be93e2de478_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative_held"><xbrli:measure>peak:derivative_held</xbrli:measure></xbrli:unit><xbrli:context id="iddbba9ecd72f4daa98c9e47aeddc18e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ef959dde734cdeb101f4075ab3a223_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i581333276c1c4e509b4209a5ef42ea34_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a9825d537dc48a1ace8af19b8cf7906_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idef8861b7d7c4e5fbfc001ae1cebeb57_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac90e17281a0408ebc19a4dd60bf5da8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29765404aa624d6d99bc3534f881b7a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife87565ec58448679511f93e16e05495_I20230117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote525PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i827939e6039a4e69bd555a798b90b6f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb7af8f09e474a1d9f0d3752ba17b366_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id56cce58abda458d9545374c913aac55_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i195c53570e3d4baa8827ffa006124262_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd48946bcbc149b6ba3884e2e5f54793_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cdd8357aeaf42e990fca8f3111eee5f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906008fbc48340908eb765f2c3dc8cd1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08425abe3e614e6d9a9b28ec8e60b022_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea247eaec89041d2888fa7256233e2b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i469ae1eef4044e5f895df14e6080d08a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f5e6ae23fa4d63a3b7da9463495857_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ab24ba7b7534ef3b931937c49723e05_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9776df6071649b4a36a68b2c62e8753_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e46551b1814379a1653a9d1284593d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2038eb8ce7646699de4006ca1c495d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd1122ff910845e8b7d84749fcb941af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic734fa1ccf034c29a212f61c7f547e08_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f077c3935347968dfccf4e35e46bc8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2253586656694cfe961e9fd10a8da88a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9765a57b7623473f9f941b33ccfde3f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb996687cada4f59931cae009c110517_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ddb72c0e5024725b2aacf24463019d1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56bcb722a57e4a5eb514929d2ed3a154_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c875874da304c448ab2b679d2ced02a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie33b9cb06a4a42afbb61346e750be99c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b4bc2e6a6546b1a01836e0851863d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd23299bf615464e91aa88b816387e2f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae86f1b07b148be8f4de81f938ee842_D20230427-20230427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-27</xbrli:startDate><xbrli:endDate>2023-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie980168387e14a51a49837fe74a3b54e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a25e7b5d67943c7b2f4785d0bbd801e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22723edd392546a88d01e90f6ec4ae55_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b96d988a94d4b5ca66cf68c72e38da9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2023AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8051818203c34f2692f50e33f9538046_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37deeeb2d4054785a004587600392cdb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38c0299b9e346949730c17e3fc40429_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c46ce3b6194ec8a6f4bdaad32eab03_I20220801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan_participant"><xbrli:measure>peak:plan_participant</xbrli:measure></xbrli:unit><xbrli:unit id="interest"><xbrli:measure>peak:interest</xbrli:measure></xbrli:unit><xbrli:context id="i6f249757fb504a429bb6dd03fb8bb2be_D20230101-20241231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d31221783254ce6bc6a96ffefb649d9_I20230210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">peak:HealthpeakOPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5a31f73d324958966392fee1b98bb2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">peak:HealthpeakOPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="entity"><xbrli:measure>peak:entity</xbrli:measure></xbrli:unit><xbrli:context id="i89007938f53d4ab597b1694f0b7aa3a3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:ForwardEquitySalesAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b23f95c9490405980d3b3ccc448589e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:ForwardEquitySalesAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4a87426c744c7ab4128e461f3c1dce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc3bbec47ce44e14b11efe8fe8b782a7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic264575fc36449f5a87c5ea91360a740_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fff501744fd4e71876ffa2b83de611a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79f95a47fff3441784d37b2c5a1ae4f7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0777696340044807b047c951cc6b7e89_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="hospital"><xbrli:measure>peak:hospital</xbrli:measure></xbrli:unit><xbrli:context id="if2e661c65de049509e99f61fdd2bd048_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64a9401fe4ee4e0b9e32826d28b5b1b0_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314fcd2c5dec445098b327482f3a7818_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb8e43d445e14ad1b15a9092e886d068_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VenturesVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2003f5627c1f4bf4a0e07c23f54283a8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic426b90826724d11a95dfb86709ed7fe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:MorganStanleyRealEstateInvestmentJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83e29cc8fc7747e8908fa487a0e9cd8f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:DownreitPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11644f24761048e48bf148bb3be4cf35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c865e06411947d296af7de408e5f4ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7ba3154c774008b8363208076ad8ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62e1f932c1974d209acc82e118a8b04e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2a162e312664e3e87e4b7cc4e443e3b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4741bac17c174ed8a6000db9741edd7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e50d56667947df8e6c0aeaf1a3d0c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c7e47c923043719f6f4a0f3ca6bd4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic507fe90dbae43d6b7714fb76376f6c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ce9db3b727c4f4e8d642580044e31cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibff3d7194cc8421785dba30cb9b0f782_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6930d3833b24489bf10582929fa4f52_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf5ac7cd40be471fb36b2da5759371f7_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">peak:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap499PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed735a3625541e0b0040bbdb3d6ff39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap499PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b4be37081f42648c653212038f8710_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap454PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7607072d8464af1a07831fe55ae7d49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap454PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4af01407e54b35b8771e2572ef8748_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap260PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4ed4d0a4ede45839d5ff5d4cde250f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap260PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442974227f63407a813cccaa74ab1313_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap254PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef18c30916344f1bc92844528563a35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap254PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap508PayRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i654b6eb550f645f58b5769d07a3beabd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap463PayRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id2287c84385e40afa1133fb5d1fa8206_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgx_9fddc342-96af-43d8-9c81-340362aeac5b">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6OWY1ZDg3MjRmMDY5NDBmYTg3ZjcwYzAxYjE1NDY1ZGYvdGFibGVyYW5nZTo5ZjVkODcyNGYwNjk0MGZhODdmNzBjMDFiMTU0NjVkZl8wLTAtMS0xLTIyNTI3MQ_c4cd12f6-3f4c-45f6-8f2a-2a9ee5c3ba40">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8xMzg_19418ca3-17d6-4349-957e-5c2115295192">March 31, 2023</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDA2NmRhNTBjMjFkNGNjM2I2Yjc3MmViNDgzMjU4NzEvdGFibGVyYW5nZTpkMDY2ZGE1MGMyMWQ0Y2MzYjZiNzcyZWI0ODMyNTg3MV8wLTAtMS0xLTIyNTI3MQ_b36cc286-eee5-420e-a632-153ffda81adc">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgy_7febe987-6c67-43f6-96b9-ae75cc489c8b">001-08895</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgz_fc14bbda-8409-4ad4-8d6d-846ad00d0086"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">.</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6MDA1NGFiNDU5MGM3NGVjMzg3YThmYTQ5MDY2MGI2MWIvdGFibGVyYW5nZTowMDU0YWI0NTkwYzc0ZWMzODdhOGZhNDkwNjYwYjYxYl8xLTAtMS0xLTIyNTI3MQ_0c610f0c-11c2-45c3-af9f-cfcc00d8ffc8">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6MDA1NGFiNDU5MGM3NGVjMzg3YThmYTQ5MDY2MGI2MWIvdGFibGVyYW5nZTowMDU0YWI0NTkwYzc0ZWMzODdhOGZhNDkwNjYwYjYxYl8xLTItMS0xLTIyNTI3MQ_126c0228-3306-4b80-9733-6a8e2fcee164">33-0091377</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDcz_f9d89f35-9af3-4f61-8b8d-773946b966c4">4600 South Syracuse Street</ix:nonNumeric>, <ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc0_13b3838d-ec33-41dc-ac8c-ac244f97be3f">Suite 500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc1_3806ed21-c484-446e-940c-c8ab9df98f72">Denver</ix:nonNumeric>, <ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDg0_5daedcda-1ae4-4d10-8e6b-69bd8a3feb52">CO</ix:nonNumeric> <ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc2_c1005ccf-0e8f-491f-938e-6cae376b2832">80237</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc3_7ac0c693-7290-42c3-9c09-74fed1341dbb">720</ix:nonNumeric>) <ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc4_8897674c-ee6c-4532-96f5-bbbf0fcf5282">428-5050</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTAtMS0xLTIyNTI3MQ_6566b5ca-49e7-472a-ba7f-d97b0650281b">Common Stock, $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTEtMS0xLTIyNTI3MQ_ac464144-7768-4241-8b74-0e3bb90491a6">PEAK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTItMS0xLTIyNTI3MQ_2a1f646b-83e1-4c91-badb-35e4cc2c1e1b">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc5_6b636467-3007-4cd0-8a2b-03dfaa1027c6">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDcy_362e4224-1623-4725-b302-a8460caa6f9d">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8wLTAtMS0xLTIyNTI3MQ_8182ccad-0365-49a8-a0ee-93df3052a36f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8xLTMtMS0xLTIyNTI3MQ_f1fb42ba-891c-4f4f-a8e2-3db406c68cec">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8yLTMtMS0xLTIyNTI3MQ_9abf3ce6-7413-44f1-98ac-2420f42d0da4">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgw_170eb5ec-5145-4fb7-a91a-25ced6ebd4f0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">April&#160;26, 2023, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if7b47f0a1b274852999d6d4b2ead62d8_I20230426" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDAw_1d3e3421-9c13-4ffe-b53b-01b04373569b">546,995,686</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">shares of the registrant&#8217;s $1.00 par value common stock outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_1358"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, Healthpeak Properties, Inc. announced its intent to implement a corporate reorganization into a new holding company structure commonly referred to as an umbrella partnership real estate investment trust (&#8220;UPREIT&#8221; and, such reorganization, the &#8220;Reorganization&#8221;). Through February 9, 2023, the business of the registrant was conducted by an entity known as Healthpeak Properties, Inc., a Maryland corporation (&#8220;Old Healthpeak&#8221;). As part of the Reorganization, Old Healthpeak formed New Healthpeak, Inc., a Maryland corporation (&#8220;New Healthpeak&#8221;), as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc., a Maryland corporation (&#8220;Merger Sub&#8221;), as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the &#8220;Merger&#8221;). As a result, New Healthpeak became the publicly traded parent company of Old Healthpeak and Old Healthpeak&#8217;s subsidiaries, and New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the Reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (&#8220;Healthpeak OP&#8221;). At the effective time of the Merger, each outstanding share of Old Healthpeak common stock was converted into one equivalent share of New Healthpeak common stock. Following the Reorganization, New Healthpeak&#8217;s business is conducted through Healthpeak OP and New Healthpeak does not have substantial assets or liabilities, other than through its investment in Healthpeak OP.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Merger, New Healthpeak became the successor issuer to Old Healthpeak pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and as a result, shares of New Healthpeak common stock were deemed registered under Section 12(b) of the Exchange Act. This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023, for the quarter ended March 31, 2023, and all data, discussions or references to other periods prior to the effectiveness of the Merger pertain to Old Healthpeak. For additional information on our UPREIT Reorganization, please see our Current Report on Form 8-K12B filed with the Securities and Exchange Commission on February 10, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this Quarterly Report on Form 10-Q, unless the context requires otherwise, &#8220;Healthpeak,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Old Healthpeak through February 9, 2023 and to New Healthpeak from and including February 10, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTHPEAK PROPERTIES, INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_10">PART&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_13">Financial Statements (Unaudited):</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_13">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_16">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_16">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_19">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_19">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_22">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_22">6</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_25">Consolidated Statements of Equity and Redeemable Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_25">7</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_28">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_28">8</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_31">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_31">9</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_88">32</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_148">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_148">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_148">51</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_151">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_151">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_151">52</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_154">PART&#160;II. OTHER INFORMATION&#160;</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_157">Item 1A.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_157">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_157">53</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_160">Item 2.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_160">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_160">53</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_1389">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_1389">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_1389">54</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_163">Item 6.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_163">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_163">55</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_166">Signatures&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id2287c84385e40afa1133fb5d1fa8206_166">57</a></span></div></td></tr></table></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I. FINANCIAL INFORMATION</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_13"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;Financial Statements (Unaudited)</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_16"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMy0xLTEtMS0yMjUyNzE_da7904bd-1da0-4d73-87f7-9b03ccc1e7b2">12,889,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMy0zLTEtMS0yMjUyNzE_9c936741-f303-46c0-9bb8-a96cec13031c">12,784,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNC0xLTEtMS0yMjUyNzE_0699e1ef-ecfd-4f02-9d2c-636d16bb354c">819,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNC0zLTEtMS0yMjUyNzE_51e3d574-d1d2-461c-b5bc-dd98a8388486">760,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNS0xLTEtMS0yMjUyNzE_93a5df16-1d78-4180-b6e5-32df821d64f7">2,674,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNS0zLTEtMS0yMjUyNzE_ddaf6dc7-0bcf-438c-ad4c-8305871b4de4">2,667,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNi0xLTEtMS0yMjUyNzE_5313f716-ba0b-48c7-afe2-9d22ce3f29f6">3,296,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNi0zLTEtMS0yMjUyNzE_fcebd4a4-8c15-482e-8064-65df6a2e683c">3,188,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNy0xLTEtMS0yMjUyNzE_8a549c83-6a8a-4295-8a2a-0ea720ca0cbe">13,087,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNy0zLTEtMS0yMjUyNzE_55d6c698-81cc-4b89-adac-42554c0f6695">13,023,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loans receivable, net of reserves of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0wLTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjoxYjRlMjMzYmM3NGI0N2E2ODU1ZTVlN2YwZjg5MjE0Yl80MQ_ab50e8dc-43c7-4afc-b137-6dc93186141a">6,152</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0wLTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjoxYjRlMjMzYmM3NGI0N2E2ODU1ZTVlN2YwZjg5MjE0Yl80OA_a71e1f25-42e2-4a43-ba25-de7b6db36e85">8,280</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0xLTEtMS0yMjUyNzE_1dcb6061-2bbe-4615-ac5d-8074516bf6e9">243,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0zLTEtMS0yMjUyNzE_501a8f28-9b68-4809-b2a0-9fda64e12119">374,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTAtMS0xLTEtMjI1Mjcx_000d12c8-f742-4aff-8019-3f6090b56d44">714,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTAtMy0xLTEtMjI1Mjcx_53956029-fac8-4bf7-951e-d626b48068a1">706,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMC0xLTEtMjI1MjcxL3RleHRyZWdpb246NGE1MTAwZDVlZDQ5NDFiNGJiMTNjMWJkNmY5YzVkZmFfNDU_8bd1979a-b54d-4468-8e0a-3a6fe4b0eafa">2,413</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMC0xLTEtMjI1MjcxL3RleHRyZWdpb246NGE1MTAwZDVlZDQ5NDFiNGJiMTNjMWJkNmY5YzVkZmFfNTI_defba5be-77dc-45fd-8df8-1e8c5ed05c26">2,399</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMS0xLTEtMjI1Mjcx_4e3ba901-e45d-4c44-9f6e-9c7cd9cf7ce1">57,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMy0xLTEtMjI1Mjcx_bd7e9852-05cd-459f-ba3c-941e00c5b7ba">53,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTItMS0xLTEtMjI1Mjcx_7e073e28-aead-4ea6-abbe-79aa309d57dd">59,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTItMy0xLTEtMjI1Mjcx_35ea21b1-164b-4b8c-938d-9a7b3ca06d78">72,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTMtMS0xLTEtMjI1Mjcx_e8c7859d-fac0-44b2-ab7f-53bd674c56f9">57,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTMtMy0xLTEtMjI1Mjcx_cb7453d2-c740-4f72-8161-fe7148e9b5d8">54,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTQtMS0xLTEtMjI1Mjcx_c0a67723-4b82-4584-b1f1-1804017df48e">391,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTQtMy0xLTEtMjI1Mjcx_21d59b29-735d-4a32-8195-db2c2d1b9b10">418,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTUtMS0xLTEtMjI1Mjcx_a6c6ed85-55f5-4047-9ce4-795bddd99348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTUtMy0xLTEtMjI1Mjcx_3a48a3ca-2dce-473f-9a7a-26a2639bf00d">49,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTYtMS0xLTEtMjI1Mjcx_2d52c3bd-9b83-4cb4-bd0d-c8f53cc005d2">235,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTYtMy0xLTEtMjI1Mjcx_b0d79bef-9871-4551-b783-84ddcb0cfd9f">237,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTctMS0xLTEtMjI1Mjcx_e1388cc1-22b7-4c27-b6d3-a6c56dd4e66e">754,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTctMy0xLTEtMjI1Mjcx_1208d977-8085-4450-ae0c-ea69824de76d">780,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTgtMS0xLTEtMjI1Mjcx_193de18b-57c2-4de4-868c-da126e885023">15,602,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTgtMy0xLTEtMjI1Mjcx_2d06e327-c7a2-4f55-a1d8-106f4f5fb0a8">15,771,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjEtMS0xLTEtMjI1Mjcx_3246bf75-76c8-479a-a28c-66072d69af72">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjEtMy0xLTEtMjI1Mjcx_a2fe2b6c-9490-430c-9853-594364c863f3">995,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LoansPayableToBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjItMS0xLTEtMjI1Mjcx_74b55132-ca73-4515-9f13-d38b93422eb5">496,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:LoansPayableToBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjItMy0xLTEtMjI1Mjcx_26fbf5ea-713a-46c3-8124-c9e089ed9c30">495,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Senior unsecured notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjMtMS0xLTEtMjI1Mjcx_4af2f99f-711f-428a-ac56-976e983b348d">5,056,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjMtMy0xLTEtMjI1Mjcx_540d96c3-bb2c-4c18-a5b5-ab70365a57bd">4,659,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjQtMS0xLTEtMjI1Mjcx_1ff873d9-957b-4625-862a-d52ab2f4fb9b">345,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjQtMy0xLTEtMjI1Mjcx_80a56c0f-8b92-49f0-b83d-dea1d8e1c0ae">346,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjUtMS0xLTEtMjI1Mjcx_cb803ce4-4f08-4a83-8076-878d8a6eabe1">149,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjUtMy0xLTEtMjI1Mjcx_f8aed826-ea70-4cb3-80d8-7b304f92149d">156,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:LiabilitiesRelatedToAssetsHeldForSaleNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjYtMS0xLTEtMjI1Mjcx_88386d4d-4933-43fa-9e6b-13707506fd2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:LiabilitiesRelatedToAssetsHeldForSaleNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjYtMy0xLTEtMjI1Mjcx_06efa2c6-797a-4970-ac0d-58be538dde5f">4,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjctMS0xLTEtMjI1Mjcx_1cfb5197-6fcc-49d4-9fe9-210421e6a068">207,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjctMy0xLTEtMjI1Mjcx_b51fe850-7983-462b-9320-f9668bc0e118">208,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjgtMS0xLTEtMjI1Mjcx_4733c290-f8e0-4077-b12d-a0b222eba4e6">688,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjgtMy0xLTEtMjI1Mjcx_56352194-25d3-4bb0-9848-8f83a9985216">772,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjktMS0xLTEtMjI1Mjcx_2cdcf7b6-851b-4306-8b00-5cdae297fbfd">878,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjktMy0xLTEtMjI1Mjcx_0c3e9c04-d034-4ed3-936c-202614e1007b">844,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzAtMS0xLTEtMjI1Mjcx_207b15b8-88d2-4efa-af71-7baf85c4e91a">8,378,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzAtMy0xLTEtMjI1Mjcx_58ab84a2-2745-4036-be8a-dcd97bb9f401">8,482,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzItMS0xLTEtMjI1Mjcx_18493664-5e08-40e4-83a2-701d0658fd7d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzItMy0xLTEtMjI1Mjcx_7e81fed1-6223-4690-9f91-bafe73e11d61"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzQtMS0xLTEtMjI1Mjcx_e743f5b1-deef-4047-9c0a-c3dbdbdfe2a3">85,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzQtMy0xLTEtMjI1Mjcx_e223ea43-4df6-4ccd-b223-215fa801265d">105,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDE2_8508108d-6ca6-4cda-bd5d-011068d2b22a"><ix:nonFraction unitRef="usdPerShare" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDE2_d91f62f9-507a-4cc4-ab7a-ed1c52579d43">1.00</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDMy_30d1da3c-0d99-4cbc-812c-72d25825f093"><ix:nonFraction unitRef="shares" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDMy_a473cd96-0752-40e7-b43d-86e863932fc3">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDQ2_37e9f338-68a6-4c72-8a87-098cd8c12a5a"><ix:nonFraction unitRef="shares" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDQ2_8b7a2ee7-6d87-4425-9020-bdf7069fa88d">546,994,803</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDYw_a88f6edf-493d-471d-8360-8056ebaf65d5"><ix:nonFraction unitRef="shares" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDYw_d0a8bc52-928e-49fb-b6c8-fec3b43494ce">546,641,973</ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMS0xLTEtMjI1Mjcx_2242607f-a8d9-41fa-9982-72f829625ba7">546,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMy0xLTEtMjI1Mjcx_7b6a9dad-eff4-4e4a-8eb6-8a62299054ed">546,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzgtMS0xLTEtMjI1Mjcx_f41cc173-dc82-4721-957e-e0f24d97a5c7">10,360,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzgtMy0xLTEtMjI1Mjcx_77cfb1de-eeb6-40aa-b7b2-1c8274ad3308">10,349,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative dividends in excess of earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccumulatedDistributionsInExcessOfNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzktMS0xLTEtMjI1Mjcx_7297920d-626d-499e-a147-f0c8176c0955">4,316,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccumulatedDistributionsInExcessOfNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzktMy0xLTEtMjI1Mjcx_f0872735-6d12-4e41-a4ff-65b2a60bf21f">4,269,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDAtMS0xLTEtMjI1Mjcx_419d7131-7862-49e8-bd72-b284ec2608e9">18,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDAtMy0xLTEtMjI1Mjcx_736b1336-0b3a-43f1-a7fe-2282fb5d317b">28,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDEtMS0xLTEtMjI1Mjcx_d1ce1f38-fd6c-4430-bb4f-5f44f8b44af1">6,609,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDEtMy0xLTEtMjI1Mjcx_c830b39d-fcca-418b-9c71-dba5b084c35a">6,654,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Joint venture partners</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:MinorityInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDItMS0xLTEtMjI1Mjcx_522ad3dc-47fa-4980-b1af-8fd60b2db369">320,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:MinorityInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDItMy0xLTEtMjI1Mjcx_f9980450-28f0-4777-afde-e700244dc61f">327,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-managing member unitholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDMtMS0xLTEtMjI1Mjcx_fa7a376d-330e-4006-aa01-fe1cbbcc83af">207,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDMtMy0xLTEtMjI1Mjcx_e20fbaac-bc30-4243-9d8a-284e4390f39a">200,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDQtMS0xLTEtMjI1Mjcx_7d2d9691-54a1-4d26-b47b-38dbbdecafcd">527,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDQtMy0xLTEtMjI1Mjcx_fdd4f47b-fc3f-45b2-9e19-f4706d3dc71a">527,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDUtMS0xLTEtMjI1Mjcx_83eadce5-e299-4886-8b24-060c438d0fab">7,137,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDUtMy0xLTEtMjI1Mjcx_a07b99b0-6b8b-4744-9009-99732d99d908">7,182,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDYtMS0xLTEtMjI1Mjcx_7c348286-67b5-46ce-b285-fef540024b8d">15,602,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDYtMy0xLTEtMjI1Mjcx_4567c9e4-7113-4e14-a226-8c14df349b04">15,771,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:justify;text-indent:63pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMy0xLTEtMS0yMjUyNzE_2c8dc726-eaea-4975-81f6-15690c9110b2">392,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMy0zLTEtMS0yMjUyNzE_fa66ddea-b30e-4d94-b5ee-ef5cf61de50b">370,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Resident fees and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNC0xLTEtMS0yMjUyNzE_0b1e13b5-366c-497e-93de-bf2d6a362beb">127,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNC0zLTEtMS0yMjUyNzE_18f1200e-ee3e-4941-ae10-2238bee8d450">121,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0xLTEtMS0yMjcxOTg_c882a88e-f646-4f8f-99ab-40c7ca9700ef">6,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0zLTEtMS0yMjcxOTg_18f5d2b8-6770-4768-a358-78f13d0c381f">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:DirectFinancingLeaseRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0xLTEtMS0yMjUyNzE_66eeafdb-e335-4eb2-aa4a-97dd64f91331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0zLTEtMS0yMjUyNzE_d45349c5-429a-49c7-ad8d-df87048bd8fa">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNy0xLTEtMS0yMjUyNzE_4afd793d-8ab3-49f3-94da-e93e8c613204">525,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNy0zLTEtMS0yMjUyNzE_83fd5374-7d39-4045-9c78-f251789b09f2">498,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfOS0xLTEtMS0yMjUyNzE_c5d5bdb3-a493-47b3-a4a9-aa7bbeaec38b">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfOS0zLTEtMS0yMjUyNzE_b54a1456-f807-4142-9b5f-8e34877f0087">37,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTAtMS0xLTEtMjI1Mjcx_0b2f70b8-2a7a-47ce-b388-7cbdc2d13ef2">179,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTAtMy0xLTEtMjI1Mjcx_47403f38-bf5b-49d8-8697-244da2a99ee3">177,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTEtMS0xLTEtMjI1Mjcx_e643642e-798a-4d2b-a0b0-74cd1e7d7658">223,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTEtMy0xLTEtMjI1Mjcx_70bb28b0-d65f-4ecb-9c37-6571c38aa0ad">207,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTItMS0xLTEtMjI1Mjcx_4dfd803c-064e-407c-ab6c-4be3a0a7eb1d">24,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTItMy0xLTEtMjI1Mjcx_26942a0a-40bd-4fb5-b09e-3526585963b9">23,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTMtMS0xLTEtMjI1Mjcx_d07e0b48-67be-4f5f-96ec-0295223c61a3">2,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTMtMy0xLTEtMjI1Mjcx_11942c81-3278-4f2e-a49f-710353d2d475">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTUtMS0xLTEtMjI1Mjcx_4bcd6190-4be1-4377-9bc4-8f95e2527fcf">2,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTUtMy0xLTEtMjI1Mjcx_09c690d9-dba3-4cfe-8d71-3eb66dfb1897">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTYtMS0xLTEtMjI1Mjcx_8e9333d6-3734-4d04-8988-181aca84bcf9">475,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTYtMy0xLTEtMjI1Mjcx_424d4268-eb09-47d7-b149-a17e69181fd6">446,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTgtMS0xLTEtMjI1Mjcx_88aea79a-b9d0-4254-98ea-483ef1accbf4">81,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTgtMy0xLTEtMjI1Mjcx_f16c6cfe-2728-4d2a-a90f-26bfa55d41ca">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjAtMS0xLTEtMjI1Mjcx_efbe22db-72fa-4012-8b5a-0882f90cd8f6">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjAtMy0xLTEtMjI1Mjcx_10d501fb-b1d6-47f6-8183-2ce4290b0a4f">18,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjEtMS0xLTEtMjI1Mjcx_2efd5be4-e436-4d54-99d7-fc214e0909a4">82,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjEtMy0xLTEtMjI1Mjcx_2824c176-136b-4420-ae6f-e93b56c339ce">22,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjItMS0xLTEtMjI1Mjcx_a795054a-bfea-4396-ac34-1b2adf3ececf">132,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjItMy0xLTEtMjI1Mjcx_5c5273c3-54ef-4fbf-96fb-77520a2ef6b4">73,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjMtMS0xLTEtMjI1Mjcx_4329368d-aec7-4e71-b97c-2f85327f303b">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjMtMy0xLTEtMjI1Mjcx_78f86c02-df40-42f7-be39-15ee11c79726">777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjQtMS0xLTEtMjI1Mjcx_87a2484a-3b70-40ad-a3ad-fcf10ce42355">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjQtMy0xLTEtMjI1Mjcx_078c74f7-2e61-41c2-9e70-18e68a6b8ba3">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjUtMS0xLTEtMjI1Mjcx_ee771099-fa26-42fe-a376-ffef4c8dca07">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjUtMy0xLTEtMjI1Mjcx_7f0519da-19ef-40c3-a51a-8205d42057db">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjYtMS0xLTEtMjI1Mjcx_60e9027b-bde0-45c9-9a50-a2402512de17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjYtMy0xLTEtMjI1Mjcx_28944e3c-6769-4437-81f4-0e86c4751127">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjctMS0xLTEtMjI1Mjcx_42d1569d-4fc2-449d-9624-3768ced25d45">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjctMy0xLTEtMjI1Mjcx_81861c2f-defd-4391-b9ca-7910d2da5758">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjgtMS0xLTEtMjI1Mjcx_ee2a5210-c58c-4bfe-bca4-310d43537007">15,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjgtMy0xLTEtMjI1Mjcx_2f612666-5aba-4ace-92d9-7b2b263e45be">3,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss) attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzAtMS0xLTEtMjI1Mjcx_f984ddad-82f2-4110-bec9-fbe6e282e0eb">118,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzAtMy0xLTEtMjI1Mjcx_e10408fb-6a07-4aff-b913-f7ead5b7d249">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities&#8217; share in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzItMS0xLTEtMjI1Mjcx_21787eae-3254-45ba-98b5-9883587d9a5b">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzItMy0xLTEtMjI1Mjcx_d933c25f-5ed5-4d98-bd7e-06666f2ef9a8">1,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzMtMS0xLTEtMjI1Mjcx_ed5af48e-d6a2-4ddd-b413-9c45f0f2190d">117,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzMtMy0xLTEtMjI1Mjcx_cc2b334f-4c45-4409-83c2-662018fc20be">69,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzYtMS0xLTEtMjI1Mjcx_97c738ab-6bfb-43ed-b093-024064fef7d3">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzYtMy0xLTEtMjI1Mjcx_fde2b991-8881-488e-81e5-7170c22d1d25">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzctMS0xLTEtMjI1Mjcx_22a6bfbe-d95d-462b-a947-8001671e1d48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzctMy0xLTEtMjI1Mjcx_cce1feec-19c4-44be-b88f-c231f225af4c">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzgtMS0xLTEtMjI1Mjcx_94f237b6-4eba-4797-859a-0d03be4a8c1d">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzgtMy0xLTEtMjI1Mjcx_3d49dc99-6ae0-4fb3-a872-ab62b6d9e0a3">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDAtMS0xLTEtMjI1Mjcx_84743f27-7f1b-4fdf-a1f9-f03becdf058d">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDAtMy0xLTEtMjI1Mjcx_fe22a28b-c3e1-4636-b2b3-f741995a1d0c">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDEtMS0xLTEtMjI1Mjcx_cfa61f09-ae36-4484-b151-9ed6710d810a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDEtMy0xLTEtMjI1Mjcx_2b679823-df55-48f4-91ed-10c75b51fc08">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDItMS0xLTEtMjI1Mjcx_6df91f04-c181-4e4f-8af3-002793efd865">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDItMy0xLTEtMjI1Mjcx_cbc66233-1e31-4e19-80e5-435d680b0e49">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDctMS0xLTEtMjI1Mjcx_ab52d8b2-5637-4ce8-866c-0fa763d1e689">546,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDctMy0xLTEtMjI1Mjcx_218f2ea1-2d06-46c2-8f19-fb44b3a78e97">539,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDgtMS0xLTEtMjI1Mjcx_344948b4-b756-4d61-9003-fd64cda126cc">547,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDgtMy0xLTEtMjI1Mjcx_9d7b7199-91ea-492e-b2fe-1c35b44f8c1b">539,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMi0xLTEtMS0yMjUyNzE_1d8df4f6-4f9b-436e-9ba4-1d936b2e5384">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMi0zLTEtMS0yMjUyNzE_bd9222b1-7f41-4744-adb2-4b88109e034e">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNC0xLTEtMS0yMjUyNzE_061869bb-4683-4b37-8136-66a542fb4e9e">9,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNC0zLTEtMS0yMjUyNzE_5e3e73bf-2584-42b6-bfc2-596c431acf00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Supplemental Executive Retirement Plan obligation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNS0xLTEtMS0yMjUyNzE_6573b88c-3976-458c-8f76-7e396651924f">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNS0zLTEtMS0yMjUyNzE_54cab68b-ae79-409c-82d8-8e41a8c292ff">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNy0xLTEtMS0yMjUyNzE_36d497a9-de54-4f8b-a348-587f00aa88bc">9,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNy0zLTEtMS0yMjUyNzE_8a7f756a-6e29-4cf8-8d97-e81b99923eb1">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOC0xLTEtMS0yMjUyNzE_45d5b1a8-6a13-4baf-b6a3-c4f8bfe4867e">125,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOC0zLTEtMS0yMjUyNzE_7d3b3fef-74bd-459c-8cf9-302105f5e193">75,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive (income) loss attributable to noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOS0xLTEtMS0yMjUyNzE_ca5a0328-6e58-4384-859f-9edaeaf03ed8">15,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOS0zLTEtMS0yMjUyNzE_58af3077-d9d4-49a1-a9d6-972b6f681399">3,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMTEtMS0xLTEtMjI1Mjcx_5779e784-5a70-452d-94a8-4cb98f0fcc43">109,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMTEtMy0xLTEtMjI1Mjcx_7b763f84-4d65-45e8-a112-bb13cdc01531">71,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.483%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Dividends In&#160;Excess Of&#160;Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xLTEtMS0yMjUyNzE_453ea1e6-438e-4f43-b327-0c051f785508">546,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0zLTEtMS0yMjUyNzE_ade23c9b-a4f0-4bb2-a9de-9f7e8949f1c3">546,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdd5f56e1a64a2f909772d23fa79232_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC01LTEtMS0yMjUyNzE_78792364-5a45-4a71-8dfe-a8fe39e97162">10,349,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db6d623777a4436baf821bd0afcff29_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC03LTEtMS0yMjUyNzE_640cb6b4-1d35-43b2-a9f2-edcc1fb037aa">4,269,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0f6cf1f29914223a101cf9dfaee1c2b_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC05LTEtMS0yMjUyNzE_81d98170-39aa-458b-896e-aeaa7b9c43ae">28,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf4d0c742ae47a892216777fa79e08b_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xMS0xLTEtMjI1Mjcx_7ae2dec0-f9e3-4fa0-a07b-e158bacb89b8">6,654,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530e671af080458e9ba7b21a10d74180_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xMy0xLTEtMjI1Mjcx_f9252049-9fb5-497f-9dea-ad0e9c35e62b">527,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xNS0xLTEtMjI1Mjcx_a8a195b0-b5d4-4654-a5ef-88738f380bee">7,182,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xNy0xLTEtMjI1Mjcx_b0524dbb-9f9e-4090-8eb8-db47b96cb750">105,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de8610900b8400ea338f115550cc75e_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS03LTEtMS0yMjUyNzE_2754fa17-9870-4d9b-9823-20ef17cdb599">118,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xMS0xLTEtMjI1Mjcx_0441d21f-f86a-4d2f-914b-07fa3b146a17">118,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xMy0xLTEtMjI1Mjcx_040445ff-3719-481c-a24b-d38bd8d8322a">15,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xNS0xLTEtMjI1Mjcx_b584b987-3c35-4ffc-901c-42b12a028f17">134,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xNy0xLTEtMjI1Mjcx_4f4cf55e-a154-4be6-8783-9ee5bebe9caa">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0563220fc3204262b0a60fd550eae320_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi05LTEtMS0yMjUyNzE_821ea5dd-979a-43a1-a7e2-45828f2714fc">9,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi0xMS0xLTEtMjI1Mjcx_a311b1e1-515f-44b9-a9df-88f52d8ffc1e">9,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi0xNS0xLTEtMjI1Mjcx_8bd5e480-7b2b-41f4-825f-6eb15a02d3a0">9,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xLTEtMS0yMjUyNzE_e9e451fb-980f-49d6-80b3-caf2ec12ea62">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0zLTEtMS0yMjUyNzE_526058ec-36c4-4a71-863d-72f584b6913b">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy01LTEtMS0yMjUyNzE_2e9b439d-79f3-4ab5-82be-8b3bf86606dc">417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xMS0xLTEtMjI1Mjcx_b8b3e95e-d96d-4fc4-a869-0fe08ea337d5">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xNS0xLTEtMjI1Mjcx_e039a593-c92f-4e7a-a6a6-03809b75670d">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xLTEtMS0yMjUyNzE_20bf4e72-5f1e-4ad2-836b-2d024ab08243">238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0zLTEtMS0yMjUyNzE_09cc78e0-b54e-4965-8abd-4451082d2d91">238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS01LTEtMS0yMjUyNzE_07ea5e21-be1b-431e-984b-9fc9dfce6571">6,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xMS0xLTEtMjI1Mjcx_91d54119-e6b4-4193-8628-c662c7bb2e2d">6,467</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xNS0xLTEtMjI1Mjcx_d40703c2-7e6e-4256-b8b7-a5b9f644c5d7">6,467</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtNS0xLTEtMjI1Mjcx_5a4f621b-2d99-4cca-a29c-6076cc31c7f3">2,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTEtMS0xLTIyNTI3MQ_ee75a6e4-6076-4aba-b970-2c5393e2f123">2,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTMtMS0xLTIyNTI3MQ_f07e5ede-10fa-4ded-b86d-3adf1ca16899">7,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTUtMS0xLTIyNTI3MQ_6d83bc5f-bdc0-457e-9604-a0564e2e2975">4,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMC0xLTEtMjI1MjcxL3RleHRyZWdpb246ZWI5YjMwM2UzNWQ2NDQxMGI2ZTE5Nzc2OWIwYTg4ODBfMjI_ecc511f1-6bf0-41cb-b3e0-b4f815c93ca6">0.30</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7de8610900b8400ea338f115550cc75e_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItNy0xLTEtMjI1Mjcx_2528ddef-6a5d-4f25-be47-01ccbb33e3a2">165,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMTEtMS0xLTIyNTI3MQ_708acdde-a0e2-4553-af73-de0c2e879508">165,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMTUtMS0xLTIyNTI3MQ_dcfba858-eb7a-422b-85c8-271ef03f398f">165,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTMtMS0xLTIyNTI3MQ_5aa1320f-fbec-4203-bf5d-112c94287c36">22,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTUtMS0xLTIyNTI3MQ_0d294520-f66f-441d-8fb8-8e3756dc7deb">22,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTctMS0xLTIyNTI3MQ_dd8d91ba-cb60-4257-93f5-5f09c2bdd0eb">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTQtMTctMS0xLTIyNTI3MQ_e6cca0f5-3d19-436b-b52c-db301acbfdfe">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331" decimals="-3" sign="-" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtNS0xLTEtMjI1Mjcx_e47770f8-7b63-48bd-9453-c0110e6f2533">19,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331" decimals="-3" sign="-" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTEtMS0xLTIyNTI3MQ_5261393a-9adc-49cd-9bfa-45293702bd90">19,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTUtMS0xLTIyNTI3MQ_a658b13c-b55e-44aa-86b1-80bd367c88d6">19,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTctMS0xLTIyNTI3MQ_013f8fd6-975e-4ae5-8a45-caab03060a0f">19,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6c895598a3c42b7afdb9ff3193e487c_I20230331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMS0xLTEtMjI1Mjcx_b94ac234-20fb-463d-aace-f07a365fd6bf">546,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c895598a3c42b7afdb9ff3193e487c_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMy0xLTEtMjI1Mjcx_02b9d656-8981-4d80-b6b8-331c12ac9a29">546,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807e77a17a3d456481946b1b5c29dc29_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktNS0xLTEtMjI1Mjcx_3c23847b-1080-4e91-890f-5b2ea957e231">10,360,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99f56515023941089672801d0df27438_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktNy0xLTEtMjI1Mjcx_55b582b5-405f-4440-8c1b-b1a775b3ee58">4,316,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57bcf974abc44e3d904f70df65e9044d_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktOS0xLTEtMjI1Mjcx_9b1b31ef-4ab0-4527-846b-e576c0d6e18d">18,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ebcfd7fc764a069ccd0143794750e6_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTEtMS0xLTIyNTI3MQ_f0b43c12-707e-40e5-ac28-18f55c92c127">6,609,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTMtMS0xLTIyNTI3MQ_aa6a28e6-5f0b-423f-8317-03ab242979ef">527,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTUtMS0xLTIyNTI3MQ_d82fd655-b011-479e-ab54-2a998a6b3937">7,137,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTctMS0xLTIyNTI3MQ_693b6dfd-8a56-4144-bd49-6807d0612ddf">85,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Dividends In&#160;Excess Of&#160;Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30bf6bfeb0434265ba52f1329cc43b46_I20211231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xLTEtMS0yMjUyNzE_c2687390-3e40-47f1-8bba-e891688ae1db">539,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bf6bfeb0434265ba52f1329cc43b46_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0zLTEtMS0yMjUyNzE_65cdd59d-9633-4feb-9741-44fbe2143a66">539,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5eba404d7984f2bb0b0aebd3dd90f27_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC01LTEtMS0yMjUyNzE_f2d0d1d3-d21f-48f1-9ced-eb8265498e9e">10,100,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2fecc3b0cc14458b9cad2f8b45fe191_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC03LTEtMS0yMjUyNzE_c7d253c9-0f09-4a1f-9234-9b5fb6600c9f">4,120,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie94947a66a6b4b0db78654d659d35ae7_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC05LTEtMS0yMjUyNzE_d5283661-7411-4e32-952e-1eeb698fd9dd">3,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00fa5f4d9ca644438e3562b42ba2334c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xMS0xLTEtMjI1Mjcx_89d1d1eb-c870-4341-a9fe-684bf37fb462">6,515,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503ad2df9c9240088b9e5481b385a0f9_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xMy0xLTEtMjI1Mjcx_ae4377a1-0989-46fa-bc30-446dccb25651">543,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xNS0xLTEtMjI1Mjcx_1086a19d-e147-472b-bce6-2cd0d40e04e0">7,058,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xNy0xLTEtMjI1Mjcx_b6994495-26cd-4e3a-a616-c5b5b780c2b3">87,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS03LTEtMS0yMjUyNzE_08f0c37f-9749-4986-bf05-d7a407788e76">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xMS0xLTEtMjI1Mjcx_0661f88c-4f80-4844-92d0-d641896036af">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xMy0xLTEtMjI1Mjcx_13fed783-e8c0-4d05-9ff9-d9a59e4f84c8">3,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xNS0xLTEtMjI1Mjcx_7b9e04f5-22a1-4639-969f-0d08502e0123">75,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xNy0xLTEtMjI1Mjcx_d04c012a-187c-4e38-b8d1-4fe558abfe1c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf59758b312417ebb52a26e8b708bf1_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi05LTEtMS0yMjUyNzE_e67d6db1-71a2-4f90-a07e-01d026079f3c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi0xMS0xLTEtMjI1Mjcx_010051cd-4f35-41d8-b576-57c30b406829">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi0xNS0xLTEtMjI1Mjcx_718c6130-652b-4e48-a852-c19c0b7d5f17">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xLTEtMS0yMjUyNzE_567d5313-ced9-4f5f-84a1-77478dd29eb8">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0zLTEtMS0yMjUyNzE_61028990-bcbe-4399-acca-d4895b282e5a">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy01LTEtMS0yMjUyNzE_8f29310b-01b1-4149-b64d-165db00ab596">437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xMS0xLTEtMjI1Mjcx_68b68819-9b4c-41fd-a446-a6cbbff9657b">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xNS0xLTEtMjI1Mjcx_c3f7d29e-352c-4ee9-bdc5-69cd8bca403c">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xLTEtMS0yMjUyNzE_11894df9-c327-4b75-adb8-0ebc18a6a5da">339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0zLTEtMS0yMjUyNzE_71e0d9ec-058e-4c5f-84b6-4f7b57c80dce">339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS01LTEtMS0yMjUyNzE_1d15f309-58e7-4223-92e2-43f5f6417b10">11,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xMS0xLTEtMjI1Mjcx_65d0869a-a3f3-4091-94f6-e1e4d51c7d3b">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xNS0xLTEtMjI1Mjcx_9361d980-e114-40ba-995c-b49aec8739ec">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtNS0xLTEtMjI1Mjcx_1a52fef4-3e97-46b0-8c33-7b7df0bbc2d1">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtMTEtMS0xLTIyNTI3MQ_78ee0bbf-61f8-43e3-ad81-31af04e9be94">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtMTUtMS0xLTIyNTI3MQ_317a59eb-b71a-4a2b-93b6-17e0101d530d">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MGEyYTE0NTAzYTFiNDA0MmFlYjczZWFhNWVlYjRhOWZfMjI_a90f0852-f29f-4fa8-b181-efa935460f63">0.30</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItNy0xLTEtMjI1Mjcx_bcdddc69-14b9-4819-974f-7a2c94280c0e">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMTEtMS0xLTIyNTI3MQ_66d8ffaa-ab1b-4cfa-a2dc-2491c414f698">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMTUtMS0xLTIyNTI3MQ_b6f73d81-e6cc-41b3-9f1a-06459f63226f">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTMtMTMtMS0xLTIyNTI3MQ_7620919f-c4ab-4daa-a82e-93ed2b9ba989">7,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTMtMTUtMS0xLTIyNTI3MQ_93a445a7-5f50-41c1-a487-d6ecbd1b2870">7,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTctMTctMS0xLTIyNTI3MQ_9da2f92b-e72b-4586-b66f-8b56d4a0bc46">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable noncontrolling interests </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktNS0xLTEtMjI1Mjcx_7e4efe0b-20ff-43db-8fb7-8b2533f56bb1">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTEtMS0xLTIyNTI3MQ_28a9dbfb-14fd-4957-b673-b12a3306fd57">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTUtMS0xLTIyNTI3MQ_8293fab9-1b2b-40da-9781-d2859b020e81">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTctMS0xLTIyNTI3MQ_573cadd4-5a27-4a36-92b5-8073cb01e227">10,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69bc82cfb90b4179b30ea0df867d1278_I20220331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMS0xLTEtMjI1Mjcx_8bfacaf3-a936-474d-ae2b-82044713eb85">539,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69bc82cfb90b4179b30ea0df867d1278_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMy0xLTEtMjI1Mjcx_4f07829b-18e0-48c5-8d23-a4ce87ac5481">539,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804d4f9d03a04437bc94e9a064ca876a_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtNS0xLTEtMjI1Mjcx_93878582-aa0d-4ba9-978a-8a2500257ae1">10,084,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib15aeabd34c04dab92eb0fdb03950e0c_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtNy0xLTEtMjI1Mjcx_65153a47-3f5a-4195-a510-9e7c2b04c664">4,212,941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i980ff73125e2448f9c1841abc88ec5cc_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtOS0xLTEtMjI1Mjcx_7e1551e5-47fe-408e-bc0a-d244575c48b9">3,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fb31decab14836989f7e62f5d94e60_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTEtMS0xLTIyNTI3MQ_bf7105fd-d052-4bea-bfef-002a90429c6b">6,408,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f15128c31ab488daa41c96893b79122_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTMtMS0xLTIyNTI3MQ_7da9779a-4c91-448e-9e15-f4d9c7e3d9f8">539,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTUtMS0xLTIyNTI3MQ_4ea8b540-f581-4459-8636-5bceaeb1bec5">6,947,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTctMS0xLTIyNTI3MQ_022fbf5c-91fb-4dfb-b68c-5e4d96978b5e">97,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMy0xLTEtMS0yMjUyNzE_300b4ba7-429c-4aff-9deb-305373089bf6">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMy0zLTEtMS0yMjUyNzE_e97cae85-a8a2-4e0a-aa0d-329268705196">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNS0xLTEtMS0yMjUyNzE_9b35a9b1-76a0-4126-ada8-5b7cae251ee3">179,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNS0zLTEtMS0yMjUyNzE_168f88e9-b6c4-4f0d-a655-961149fbf7a1">177,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNi0xLTEtMS0yMjUyNzE_d492628f-db33-4ed3-a6e1-5db4617616b2">3,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNi0zLTEtMS0yMjUyNzE_da923451-a07d-428a-bd2d-cec8fdcfc014">4,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNy0xLTEtMS0yMjUyNzE_e8bc0c1f-2f53-49f8-9d07-165b4c3c1115">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNy0zLTEtMS0yMjUyNzE_23c8aed6-0449-4046-8a93-de488c25e6e6">2,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Straight-line rents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:StraightLineRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfOC0xLTEtMS0yMjUyNzE_72a75c26-79d1-4849-ba63-143afc766bbd">747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:StraightLineRent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfOC0zLTEtMS0yMjUyNzE_ccafbee9-c27d-4d37-94be-482b6e498b19">11,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of nonrefundable entrance fees and above (below) market lease intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTAtMS0xLTEtMjI1Mjcx_124c6011-c0b9-4307-a961-fd6aa040fd29">25,690</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTAtMy0xLTEtMjI1Mjcx_57223b0f-b0a5-44b0-ab4f-18153dff2176">24,725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity loss (income) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTEtMS0xLTEtMjI1Mjcx_525f2a06-4a0e-45d8-bf65-03f3a6949840">1,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTEtMy0xLTEtMjI1Mjcx_35958523-2683-4ecb-8c15-cf2fc5a8ed60">2,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions of earnings from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTItMS0xLTEtMjI1Mjcx_bed598da-1087-419e-b284-8a5760f2e3c3">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTItMy0xLTEtMjI1Mjcx_612f4d2f-3be3-4d2e-a923-86d74aa07b13">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on sale of real estate under direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTQtMS0xLTEtMjI1Mjcx_baec4444-394a-49be-861c-7c4bd365c046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTQtMy0xLTEtMjI1Mjcx_94912bd0-5802-41c1-8da2-482ff0f3caee">22,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTUtMS0xLTEtMjI1Mjcx_45bd13fc-1b7f-4284-ae78-f3f2d0a09de6">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTUtMy0xLTEtMjI1Mjcx_56d49c63-5621-4f7f-9861-b7d0930d44bc">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTYtMS0xLTEtMjI1Mjcx_3f5454b0-0078-409c-aafb-27c6ae7144a5">2,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTYtMy0xLTEtMjI1Mjcx_450cfeb3-839e-45a6-9995-43ad1f7b5157">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTgtMS0xLTEtMjI1Mjcx_213937ed-e121-4b43-acc1-4947318d630b">81,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTgtMy0xLTEtMjI1Mjcx_99ffa76a-ee4c-4ec1-9eea-289f3c6f0861">3,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Casualty-related loss (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:InsuredEventGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjAtMS0xLTEtMjI1Mjcx_25539cd6-93b3-425d-bbd8-db27588fe234">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InsuredEventGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjAtMy0xLTEtMjI1Mjcx_9aa0aae6-89b3-435a-ae9a-cf3848112a9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjMtMS0xLTEtMjI1Mjcx_67b3f4f0-3eec-46e9-bc1d-648985239de5">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjMtMy0xLTEtMjI1Mjcx_441e1499-9b94-4dc9-849b-0a2f1d6542ac">1,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease (increase) in accounts receivable and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjUtMS0xLTEtMjI1Mjcx_f80a47f3-e910-46e5-b719-1c52be22abb6">19,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjUtMy0xLTEtMjI1Mjcx_b619629d-e99e-4d83-b861-9e71c320fcbd">4,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjYtMS0xLTEtMjI1Mjcx_24f7e956-d738-41b7-89a8-19ea525311ae">15,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjYtMy0xLTEtMjI1Mjcx_349ff5c6-b395-4eb2-baa5-ac67fbbebead">3,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjctMS0xLTEtMjI1Mjcx_24732ca1-b033-4ea7-88f5-1931f7f0e36b">173,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjctMy0xLTEtMjI1Mjcx_f857f275-973c-444e-8299-c7f5c7b6e951">194,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions of real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjktMS0xLTEtMjI1Mjcx_4c7fa6dc-ee4f-43e3-9bf7-afb3dc555d23">10,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjktMy0xLTEtMjI1Mjcx_37694280-ac20-4d66-a0cd-5472d9bc6bfd">134,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzAtMS0xLTEtMjI1Mjcx_73626908-9f08-44b2-9022-88217db0b2b6">204,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzAtMy0xLTEtMjI1Mjcx_40f5b0d1-533c-4ada-b5ae-9b8214dfcd2a">178,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzEtMS0xLTEtMjI1Mjcx_43cb85db-4b7e-4a51-bc8c-b40eaffd62f3">22,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzEtMy0xLTEtMjI1Mjcx_af5dff8c-9a8e-40ef-b639-881026c8c981">22,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzItMS0xLTEtMjI1Mjcx_0b6ec83f-b2ff-4acf-bfce-2e510e8ee614">141,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzItMy0xLTEtMjI1Mjcx_97d7634e-294b-4b83-9d22-352ea2da93c7">13,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzUtMS0xLTEtMjI1Mjcx_d4fcaa14-b151-42d0-8b65-ad006e15cbd8">9,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzUtMy0xLTEtMjI1Mjcx_eb15de26-5bbf-48ef-83ad-e1b1fe471afd">1,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions in excess of earnings from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzYtMS0xLTEtMjI1Mjcx_26c77025-bb5e-464b-b7b1-df3535eeca08">3,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzYtMy0xLTEtMjI1Mjcx_62f12527-4de0-452d-9965-de7a3086d7b4">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from insurance recovery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzctMS0xLTEtMjI1Mjcx_43197348-d9fc-4e4e-8eb4-fb7110a8e28b">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzctMy0xLTEtMjI1Mjcx_12f58660-14ae-4a70-9584-8c9b60c240a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales/principal repayments on loans receivable, direct financing leases, and marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDItMS0xLTEtMjI1Mjcx_d53ff561-9c2a-4a2d-9d1d-4f4d69419ce6">158,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDItMy0xLTEtMjI1Mjcx_9f44ccd8-a0e6-4e87-8f10-b3be3f913b19">75,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in loans receivable and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:PaymentsToAcquireLoansReceivableAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDMtMS0xLTEtMjI1Mjcx_3c219e9c-ff3c-4263-a43c-6acbb3d0947d">1,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:PaymentsToAcquireLoansReceivableAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDMtMy0xLTEtMjI1Mjcx_a79b0472-1df6-40bc-9c2a-99137a4cba4f">1,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDUtMS0xLTEtMjI1Mjcx_a859dce4-da50-4b4c-9223-a21eb679f927">56,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDUtMy0xLTEtMjI1Mjcx_4c062d30-8152-403b-9809-db626b4b7e57">245,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings under bank line of credit and commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDctMS0xLTEtMjI1Mjcx_ec48bdc6-4231-49e6-80c7-4e53f0e02b05">3,372,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDctMy0xLTEtMjI1Mjcx_da6ced36-942e-4a69-a368-1acc968257fb">3,732,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments under bank line of credit and commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDgtMS0xLTEtMjI1Mjcx_23581428-f15b-419b-ab94-abda714fe887">3,811,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDgtMy0xLTEtMjI1Mjcx_cb2d572e-e87c-4485-b66f-9b5684c450bb">3,567,830</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromBankDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDktMS0xLTEtMjI1Mjcx_b93854d6-dcc3-4375-a615-8f98e43846b5">399,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromBankDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDktMy0xLTEtMjI1Mjcx_2b581874-8079-4b86-82e0-d16192cca8e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfBankDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTAtMS0xLTEtMjI1Mjcx_713b6a5a-fec4-43ba-a476-cc4a83acd7ac">1,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfBankDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTAtMy0xLTEtMjI1Mjcx_38ce7a11-ba8b-4165-a89e-49145ea35f0a">1,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for debt extinguishment and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTItMS0xLTEtMjI1Mjcx_c8926745-a969-4cc8-853e-df596ac26595">4,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTItMy0xLTEtMjI1Mjcx_e6591b13-1675-4b7e-abc1-6d23f590d968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and exercise of options, net of offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTQtMS0xLTEtMjI1Mjcx_7856e035-4edd-46cb-8009-81b00490011b">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTQtMy0xLTEtMjI1Mjcx_d38fce34-76bb-4848-8a63-79f8af6524cb">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTUtMS0xLTEtMjI1Mjcx_e8f7cadf-8d2d-462c-b58a-253cc21490e6">6,467</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTUtMy0xLTEtMjI1Mjcx_8e7221e9-f03b-489e-a5a3-b7725eeb899c">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTYtMS0xLTEtMjI1Mjcx_854d80a0-e3c2-4fc1-9198-954b3b4ad5fe">164,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTYtMy0xLTEtMjI1Mjcx_b85b01f0-3006-405a-9668-22a875b29763">163,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTgtMS0xLTEtMjI1Mjcx_d24b8c82-c644-4c6e-b45a-6ec5ccffd19c">22,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTgtMy0xLTEtMjI1Mjcx_0053e2f6-0a6c-47ec-a189-6cb22efcb383">7,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from and issuance of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTktMS0xLTEtMjI1Mjcx_7f1f5986-fe55-4bd7-866d-8b8634b9943e">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTktMy0xLTEtMjI1Mjcx_390643ad-44ac-4d33-9c38-3a358ce02caa">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjAtMS0xLTEtMjI1Mjcx_c83510f0-bdb6-4a86-be05-eabafd19faf5">239,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjAtMy0xLTEtMjI1Mjcx_f144ab81-ce5d-451e-8879-87be6f317e69">18,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjItMS0xLTEtMjI1Mjcx_94f9b077-fe4a-419e-bba6-234cfd7cecf6">9,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjItMy0xLTEtMjI1Mjcx_2ba9a931-61ab-46c2-ad13-e340389be6a0">70,290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjMtMS0xLTEtMjI1Mjcx_cf28982f-d2aa-4335-9279-6ded1d1d453f">126,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjMtMy0xLTEtMjI1Mjcx_5f6fbadb-273c-4602-a85a-10a079259f07">219,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjQtMS0xLTEtMjI1Mjcx_659adb6e-529b-4cdb-89a3-b1e78dc7d7a7">117,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjQtMy0xLTEtMjI1Mjcx_2e942a02-5948-4b2a-ac5a-574b6e6c1282">149,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_34"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNC9mcmFnOmY4M2RiOTM3Y2RiZTQwZWM5OGNmY2JiNzg4MWE1YzBkL3RleHRyZWdpb246ZjgzZGI5MzdjZGJlNDBlYzk4Y2ZjYmI3ODgxYTVjMGRfODA5_2eee722d-0668-4164-9e5e-2bbcbcb99887" continuedAt="i247159969a5441b697c43c72fc97fa3d" escape="true">Business</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i247159969a5441b697c43c72fc97fa3d"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard&#160;&amp; Poor&#8217;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#8220;REIT&#8221;) that, together with its consolidated entities (collectively, &#8220;Healthpeak&#8221; or the &#8220;Company&#8221;), invests primarily in real estate serving the healthcare industry in the United States (&#8220;U.S.&#8221;). Healthpeak&#174; acquires, develops, owns, leases, and manages healthcare real estate. The Company&#8217;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#8220;CCRC&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters are in Denver, Colorado, and it has additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, Healthpeak Properties, Inc. announced its intent to complete an UPREIT reorganization. As part of the reorganization, the company formerly known as Healthpeak Properties, Inc. (&#8220;Old Healthpeak&#8221;) formed New Healthpeak, Inc. (&#8220;New Healthpeak&#8221;) as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc. (&#8220;Merger Sub&#8221;) as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the &#8220;Merger&#8221;). In connection with the Merger, New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the UPREIT reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (&#8220;Healthpeak OP&#8221;). Following the UPREIT reorganization, New Healthpeak&#8217;s business is conducted through Healthpeak OP and New Healthpeak does not have material assets or liabilities, other than through its investment in Healthpeak OP. This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023, for the quarter ended March 31, 2023. For additional information on the UPREIT reorganization, see the Company&#8217;s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on February 10, 2023.</span></div></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_37"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQwMQ_6add30f1-cfac-407d-9452-cf82f1f31491" continuedAt="ia44b420f60a848228d116301c3a28eb8" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ia44b420f60a848228d116301c3a28eb8" continuedAt="i2c4dec8b21e14d3c88611cd4664d4f9e"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxMg_f1a4b173-2160-4220-b4e7-2f6f34dc92a0" escape="true"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:GovernmentGrantIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQyMA_79ffc74b-6a51-4816-985b-f57d64a35c69" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the coronavirus pandemic. Grant income is recognized to the extent that qualifying expenses and lost revenues exceed grants received and the Company will comply with all conditions attached to the grant. As of March&#160;31, 2023, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i2c4dec8b21e14d3c88611cd4664d4f9e"><div style="margin-top:6pt"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxNA_ff79e854-2ca8-4735-a8cb-27db63b6119e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.147%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic773135133e649b9a40e6c2ae0098c47_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMi0xLTEtMS0yMjUyNzE_e577d6f9-3b00-4fe5-99f4-8b723a9b409a">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3673bf0bac0c46438f86bb54a2b7a090_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMi0zLTEtMS0yMjUyNzE_678bb475-51be-4648-8c13-1a4b01509bbd">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife363d16c20b4fb4829cc5fa5e166ebd_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMy0xLTEtMS0yMjUyNzE_1432a52b-4ae7-427e-b8f4-1222a4ed4509">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04bb152d3876442882602d59cb9257bd_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMy0zLTEtMS0yMjUyNzE_4b453242-b925-48fd-ac11-bf2ee97875c6">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d70f4026c6041ec8a4ea17cbea56b52_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNC0xLTEtMS0yMjUyNzE_8992cd59-54b5-42d8-80be-d062ccac49ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2dda1ede5c4d58a46ce9579d6b92e2_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNC0zLTEtMS0yMjUyNzE_495f6570-65b3-448c-bec7-c0bfcbfd68a7">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNS0xLTEtMS0yMjUyNzE_3236fa4d-9ada-450d-a3cc-e9203860941f">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1bf5123a8b41479133b782e5100a18_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNS0zLTEtMS0yMjUyNzE_ab87b33c-019d-4def-822e-0003a4ef25bb">7,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQwNw_cd64c234-1b60-4cd7-bf69-358dc4991ccb" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company concluded that the dispositions of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 for further information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxNg_2b89a0a2-7538-4e71-9eab-4bf7c55b9628" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. In December 2022, the FASB issued ASU No. 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2022-06&#8221;), which defers the sunset date of the reference rate reform guidance to December 31, 2024. The amendments in ASU 2020-04, ASU 2021-01, and ASU 2022-06 were effective immediately upon issuance. In 2022, the Company elected to apply certain hedge accounting expedients provided by ASU 2020-04 and ASU 2021-01, which preserves the hedging relationship of derivatives. During the first quarter of 2023, the Company amended certain of its variable rate mortgage debt and the related interest rate swap agreements to change the interest rate benchmark from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The Company elected to apply certain practical expedients provided by ASU 2020-04 and ASU 2021-01 related to cash flow hedges, which did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures. The expedients provided by ASU 2020-04, ASU 2021-01, and ASU 2022-06 and the effects of reference rate reform have not had, and are not expected to have, a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:RealEstateDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTgwNA_b0a27306-8a31-4dc6-8151-4cee2f3ec7bf" continuedAt="i7fa3cf17fdb74e8782110777c9259348" escape="true">Real Estate</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i7fa3cf17fdb74e8782110777c9259348" continuedAt="i993e6e0bc2d046a5889bf36315b814ca"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company closed a life science acquisition in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i118359ae91b74e62812988bfeaa797c8_D20230101-20230131" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3NDMxOQ_9dec6e02-247f-4413-b693-dec52a902481">9</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">67 Smith Place</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i9f045cefde3045ae8996ee15bbb51550_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3Mjc4Mw_7739cc51-35fd-46bd-b502-462559b5f093">72</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vista Sorrento Phase II</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in San Diego, California for $<ix:nonFraction unitRef="usd" contextRef="i1ffe53bede314b11a85ecb20ec8a6694_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MjkwNA_585ba115-f7f2-4d7f-ba5a-c21f41549147">24</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i993e6e0bc2d046a5889bf36315b814ca"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Webster MOB Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company acquired a portfolio of <ix:nonFraction unitRef="property" contextRef="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3Mjk4Mg_f19885a0-1e3b-4532-8758-f1cffbbd4e36">two</ix:nonFraction> medical office buildings (&#8220;MOBs&#8221;) in Houston, Texas for $<ix:nonFraction unitRef="usd" contextRef="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzA0Mg_522e3b2c-e7c4-44eb-b63b-22fa1a1a7c8b">43</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Northwest Medical Plaza</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company acquired <ix:nonFraction unitRef="property" contextRef="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzEwNQ_57175f56-2a3c-4e0b-ba95-668e854b65fa">one</ix:nonFraction> MOB in Bentonville, Arkansas for $<ix:nonFraction unitRef="usd" contextRef="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzE0Mg_60b59116-2933-4c54-84bf-27d9a3c65cf4">26</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concord Avenue Land Parcels</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i0492c2ebf6054f6ebe312755f471116e_D20221201-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3NDM0Mw_541c14f3-5bd3-4c79-9ec7-1a043bd37d37">18</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Development Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commitments, which are primarily related to development and redevelopment projects and Company-owned tenant improvements,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" sign="-" name="peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTYxNg_c511d12e-bb18-40ce-83d3-366ecd1f7e82">35</ix:nonFraction> million, to $<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-6" name="peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTYyMw_92bf5456-08dd-4dc8-b924-78049418ed46">217</ix:nonFraction> million at March&#160;31, 2023, when compared to December&#160;31, 2022, primarily as a result of construction spend on existing projects in the first quarter of 2023, thereby decreasing the remaining commitment.</span></div></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMTAxMzI_21d7d2e8-626b-4dd3-ab0d-2c1c88b7a5be" continuedAt="ie50448e6a2fe43e2b7f08e591c3e14c1" escape="true">Dispositions of Real Estate and Discontinued Operations</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ie50448e6a2fe43e2b7f08e591c3e14c1" continuedAt="i065f7a30c6fb40cc92a4b69441ebf408"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company sold <ix:nonFraction unitRef="property" contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQzOQ_c84929dc-e412-40ba-9512-3a6edddb3595">two</ix:nonFraction> life science facilities in Durham, North Carolina, which were classified as held for sale as of December 31, 2022, for $<ix:nonFraction unitRef="usd" contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQyMQ_99256953-9de5-459c-b4b7-663b41ff3e90">113</ix:nonFraction>&#160;million, resulting in total gain on sales of $<ix:nonFraction unitRef="usd" contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQ5MQ_20c115db-d2af-4144-8252-57d5a75f0f98">60</ix:nonFraction>&#160;million. Additionally, in March 2023, the Company sold <ix:nonFraction unitRef="property" contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyNzQ0_ace52b72-d89e-4015-8e95-ef5d83547a99">two</ix:nonFraction> MOBs for $<ix:nonFraction unitRef="usd" contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyNzc1_8e06820f-c96d-4446-9010-eced0ea41998">32</ix:nonFraction>&#160;million, resulting in total gain on sales of $<ix:nonFraction unitRef="usd" contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyODQ1_ec77d8f6-c66a-42be-a824-7793124bd24f">21</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, the Company sold <ix:nonFraction unitRef="property" contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4MzkxMw_f40b4041-8096-4e68-9a2b-550789669f2c">one</ix:nonFraction> life science facility in Salt Lake City, Utah for $<ix:nonFraction unitRef="usd" contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4Mzk2Nw_c09a8004-5d17-4610-b540-0ebef9b3daed">14</ix:nonFraction>&#160;million, resulting in a gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDAwMw_27d2b403-ce94-47ca-8d94-71a66e250406">4</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, the Company sold <ix:nonFraction unitRef="property" contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDA3MA_2dee4c00-7f91-4be4-aec0-563780f3a988">three</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MOBs and <ix:nonFraction unitRef="property" contextRef="i58508407aa974ce7ae2dd7d111863709_D20220401-20220630" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDA4Mw_c6478bfb-fdb6-4915-b113-28933fa807e2">one</ix:nonFraction> MOB land parcel for $<ix:nonFraction unitRef="usd" contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDEwNw_aee72390-d7e0-4d5b-b80d-80465c42a217">27</ix:nonFraction>&#160;million, resulting in total gain on sales of $<ix:nonFraction unitRef="usd" contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE0OA_ff77ed76-e884-490b-b1b9-8c70d7fcbcbd">10</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, the Company sold <ix:nonFraction unitRef="property" contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE4NA_8c79962f-2e76-4c4f-af02-61355da1e01b">two</ix:nonFraction> MOBs for $<ix:nonFraction unitRef="usd" contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE5Nw_7e47854c-31a8-4f03-a320-4778045195c9">9</ix:nonFraction>&#160;million, resulting in total gain on sales of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDIzOA_1c3db944-f67d-49de-ac69-e9ccfcf06080">1</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale and Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company concluded that the dispositions of its senior housing triple-net and SHOP portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each of March&#160;31, 2023 and December&#160;31, 2022, the total assets and total liabilities classified as discontinued operations were <ix:nonFraction unitRef="usd" contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231" decimals="INF" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODM0MDgx_1ca392c3-06e7-4384-8e3a-a06305b30cfa"><ix:nonFraction unitRef="usd" contextRef="ifa2335d07c3144528793163232dd5d77_I20230331" decimals="INF" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODM0MDgx_5efef725-78e1-4f92-ae14-3464c4ce86dc">zero</ix:nonFraction></ix:nonFraction>. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, <ix:nonFraction unitRef="property" contextRef="i04f86893d4664360ad004f5222f209e3_I20230331" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTU5Nw_7069713c-62ee-45bb-ba59-6e5192cae5ce">no</ix:nonFraction> assets were classified as held for sale. As of December&#160;31, 2022, <ix:nonFraction unitRef="property" contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTcwNA_c411ab34-92c1-4741-84f6-36ed50b9ccb1">two</ix:nonFraction> life science assets were classified as held for sale, with an aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231" decimals="-6" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMzOTE1_913718c3-73b2-4c06-995c-b993488aafa4">50</ix:nonFraction> million, primarily comprised of net real estate assets of $<ix:nonFraction unitRef="usd" contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231" decimals="-6" name="peak:NetRealEstateAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTc3OA_53722484-3cb7-4c72-99f5-67c537a5db1e">44</ix:nonFraction>&#160;million. As of December&#160;31, 2022, liabilities related to these assets held for sale were $<ix:nonFraction unitRef="usd" contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231" decimals="-6" name="us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMzOTc1_b3412b9f-4082-424a-9030-bd37a1031d69">4</ix:nonFraction> million. These <ix:nonFraction unitRef="property" contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODQ2MTI0_c411ab34-92c1-4741-84f6-36ed50b9ccb1">two</ix:nonFraction> life science assets were sold in January 2023, as discussed above.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i065f7a30c6fb40cc92a4b69441ebf408" continuedAt="ia4aabac2c7a14f66bb63da18d72f6495"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMTAxMzQ_0bebb11a-821a-4d18-a764-8e1e7a15b1e5" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2023 and 2022 are presented below (in thousands) and are included in the consolidated results of operations for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNC0xLTEtMS0yMjUyNzE_e340e699-66a3-4a3b-9bc8-df9fec981330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNC0zLTEtMS0yMjUyNzE_877a8f00-ae5f-46bd-9c5e-50e40207706c">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNi0xLTEtMS0yMjUyNzE_124849d6-001a-4f88-b7b7-0c7631d26e52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNi0zLTEtMS0yMjUyNzE_828f8f57-80aa-4443-921c-98d0bc1aa0a6">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTAtMS0xLTEtMjI1Mjcx_09e039f8-1b82-4480-bd08-cd83ed912ec9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTAtMy0xLTEtMjI1Mjcx_0e1d784b-8f2d-4f54-b014-08197053258e">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTMtMS0xLTEtMjI1Mjcx_410ae0ac-2e87-4d9d-b5b3-22ddce7436cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTMtMy0xLTEtMjI1Mjcx_38101a48-ae3d-4ded-831d-fb998c900eec">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTUtMS0xLTEtMjI1Mjcx_7f836615-e8ca-4716-9c07-fa1c4857cfef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTUtMy0xLTEtMjI1Mjcx_a50eb84f-ee13-4f47-8624-70c02b78d572">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTYtMS0xLTEtMjI1Mjcx_388d618e-ca48-4252-b8c8-21eb9207f2bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTYtMy0xLTEtMjI1Mjcx_1a930d15-5010-494c-87b0-894e6856fb2b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTctMS0xLTEtMjI1Mjcx_ef345d78-74f7-40b9-a62f-64e3382b1e74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" sign="-" name="peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTctMy0xLTEtMjI1Mjcx_5a580e7f-6153-4274-9e9d-8990905f690b">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTgtMS0xLTEtMjI1Mjcx_8a966a69-f84e-405e-a063-158c9607f717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTgtMy0xLTEtMjI1Mjcx_baa3c241-c212-48e0-b913-c609d04ac36d">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTktMS0xLTEtMjI1Mjcx_da1f2ace-9dad-4ca5-865b-5f8e3519d4b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTktMy0xLTEtMjI1Mjcx_1b5af142-a511-4675-9791-485605830e45">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjAtMS0xLTEtMjI1Mjcx_b53fc512-b4a8-4738-90c0-e4584744ed39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjAtMy0xLTEtMjI1Mjcx_563dcd9c-00ce-4ef3-8048-d7f8474e98b8">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjItMS0xLTEtMjI1Mjcx_9c0c9e78-bedb-43bf-931d-a8fc964a8676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjItMy0xLTEtMjI1Mjcx_b869c216-8976-4ef5-86ae-828223a37dee">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company did <ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:ImpairmentOfRealEstate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNjIxNQ_9c4fb100-25a6-45d2-9aaa-457ed63384a3"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="INF" name="us-gaap:ImpairmentOfRealEstate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNjIxNQ_efef889b-aa4c-4d32-90ce-3ea7264de75c">no</ix:nonFraction></ix:nonFraction>t recognize any impairment charges.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Losses</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia4aabac2c7a14f66bb63da18d72f6495">During the three months ended March&#160;31, 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i864dd3fa811448b2b9b318a07f46f343_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonrecurringExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfOTkwNw_82638189-578d-47f7-9ec3-9ad01da38748">14</ix:nonFraction>&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with the demolition of an MOB.</ix:continuation></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="id2287c84385e40afa1133fb5d1fa8206_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzIz_ecd5685d-51e3-4ac0-b82f-acbf77a81f56" continuedAt="i4037200ce4bc476c8c149409b975e601" escape="true"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzMz_1dd10f19-6040-4137-9a5d-9e6a87ec1e57" continuedAt="i5753175582dc4ccdaaf9fd9b6b99d591" escape="true"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:LessorDirectFinancingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzMz_9116cae5-6511-4b07-a428-bc47032bb653" continuedAt="i1c3dab4abd8a4c458bc26123acd7a125" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i4037200ce4bc476c8c149409b975e601" continuedAt="i3428a61c2290448b861bf22114544357"><ix:continuation id="i5753175582dc4ccdaaf9fd9b6b99d591" continuedAt="iedc27c3b81984e61a4e0497ca3f2b0a8"><ix:continuation id="i1c3dab4abd8a4c458bc26123acd7a125" continuedAt="ie6e0a0d601424f1f883f3ea3bd2babd2"><div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzE3_7196b91f-7edf-41e5-be37-8fce40c645c5" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.200%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNS0xLTEtMS0yMjUyNzE_c107204a-b4d3-445d-895c-062af9b78008">296,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNS0zLTEtMS0yMjUyNzE_8dcd9a1b-af16-45e9-9180-07cd42990ef9">287,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNi0xLTEtMS0yMjUyNzE_76b3984e-828c-44d6-930a-5a0cc31d00f0">96,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNi0zLTEtMS0yMjUyNzE_0cf4075b-d84a-46d2-b1c8-19dc175c20f2">82,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:DirectFinancingLeaseInterestIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNy0xLTEtMS0yMjUyNzE_c9ac7e82-ce09-408a-9b79-8168e0545677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseInterestIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNy0zLTEtMS0yMjUyNzE_85417c78-cfc5-49d1-bc14-11c96fd84cc1">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#8220;DFL&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfLeaseReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfMzMx_9c723548-a524-4405-9429-145cf119be34">68</ix:nonFraction> million and recognized a gain on sale of $<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfMzY3_dfec7c51-c478-410e-955f-f24db0a66855">23</ix:nonFraction> million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had <ix:nonFraction unitRef="property" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="peak:PropertiesWithDirectFinancingLeasesNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE0OTYy_0ebb2b35-2660-4e20-b331-ff22f00730c0"><ix:nonFraction unitRef="property" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="INF" name="peak:PropertiesWithDirectFinancingLeasesNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE0OTYy_4870fdcc-bcd6-44f1-91de-265ea315b3f3">no</ix:nonFraction></ix:nonFraction> leases classified as a DFL.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i3428a61c2290448b861bf22114544357"><ix:continuation id="iedc27c3b81984e61a4e0497ca3f2b0a8"><ix:continuation id="ie6e0a0d601424f1f883f3ea3bd2babd2"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Straight-Line Rents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company wrote off $<ix:nonFraction unitRef="usd" contextRef="i3a54d5ef01f84069a21614fb6b5703d5_D20230101-20230331" decimals="-6" name="us-gaap:StraightLineRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE3MzQz_d97bef1e-c75d-4635-babc-641c01c06a7a">9</ix:nonFraction>&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.</span></div></ix:continuation></ix:continuation></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODk5NQ_a08f0cce-23e8-4436-b3a4-10a327c79156" continuedAt="i203e3623d2f74206908e92b554333797" escape="true">Loans Receivable</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i203e3623d2f74206908e92b554333797" continuedAt="i39c4112304474a85b970ae4769d83805"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODk5Ng_bb376797-35db-436e-9ab0-9a22c23e5649" continuedAt="i42dadc6aee9b4bfd9837f2ddbdc03818" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc9183f82c46689dc6c8c571bb0698_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMS0xLTEtMS0yMjUyNzE_50edf758-ec2b-4941-bb57-db4aebbbcb88">214,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMS0zLTEtMS0yMjUyNzE_640af170-d2f9-4839-8ef9-db64a21386d1">350,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3251deb01d7f43a6b36fce8fe3b868bb_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMi0xLTEtMS0yMjUyNzE_0ecb0c36-14a8-483d-98ea-98d5293ca684">36,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299419585a7445608813f122905f9277_I20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMi0zLTEtMS0yMjUyNzE_a57f38b1-0d64-452a-ae75-d363c53512b6">33,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" sign="-" name="us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMy0xLTEtMS0yMjUyNzE_a0ef4cef-2181-4b8a-aa72-e10dd45aff60">1,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMy0zLTEtMS0yMjUyNzE_f18a57d4-afa9-48da-bb91-cfd51e0b527f">808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNC0xLTEtMS0yMjUyNzE_9b7891d4-bc30-4809-8f60-72a4af19a302">6,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNC0zLTEtMS0yMjUyNzE_c49410e7-edf2-42f9-9608-88362a176d3c">8,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNS0xLTEtMS0yMjUyNzE_c5ae9056-510e-4680-b701-adc218dfd94f">243,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNS0zLTEtMS0yMjUyNzE_e9d0659f-7062-4efe-a374-e5f5eb45b803">374,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i42dadc6aee9b4bfd9837f2ddbdc03818"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-6" name="peak:LoansAndLeasesReceivableRemainingCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTky_1c39f3ce-5872-42b6-b248-10da1e40091e"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-6" name="peak:LoansAndLeasesReceivableRemainingCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTky_e0298e19-72a5-4a30-8fbd-8fe247a9fd3d">40</ix:nonFraction></ix:nonFraction> million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span></ix:continuation><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sunrise Senior Housing Portfolio Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of <ix:nonFraction unitRef="facility" contextRef="if29b037c8ce04a23a923956f784473ee_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMzgy_16334b02-dc7e-4800-bcc3-8bbd873a7be8">32</ix:nonFraction> SHOP facilities for $<ix:nonFraction unitRef="usd" contextRef="if29b037c8ce04a23a923956f784473ee_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNDQ1_e9833000-75f5-456c-bbb6-b2dddcedc0c5">664</ix:nonFraction>&#160;million in January 2021, the Company provided the buyer with initial financing of $<ix:nonFraction unitRef="usd" contextRef="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTM2_e74590f4-f4d6-4515-aa02-db03e414131c">410</ix:nonFraction>&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $<ix:nonFraction unitRef="usd" contextRef="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNjY1_4af7b793-ce95-437a-ab68-aa16f81a660c">92</ix:nonFraction>&#160;million of additional financing for capital expenditures (up to <ix:nonFraction unitRef="number" contextRef="i4ec94601e6824a438f9ff0bea83f0c4c_I20210131" decimals="INF" name="peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzI0_8fbd9ad3-6f79-4f3b-93f0-6b98e0ba6e0d">65</ix:nonFraction>% of the estimated cost of capital expenditures). As of March&#160;31, 2023, the additional financing was reduced to $<ix:nonFraction unitRef="usd" contextRef="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODI4_d26a6de2-ac33-4bd5-87f8-785ec329a244">40</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331" decimals="-5" name="peak:CapitalExpenditureFundingAmountFunded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTYw_5dc73415-9aab-4d62-b811-a20b6119a0f4">0.4</ix:nonFraction> million had been funded. The initial and additional financing is secured by the buyer&#8217;s equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 2022, and December 2022, the Company received principal repayments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="icf2528dacab94d72ab3e440848edce92_D20210601-20210630" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTE2NQ_040581e6-763d-4922-acfe-e6ab18712afe">246</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ibc764c876dea4bdf9388495cb2847238_D20220201-20220228" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODIzNjI1_8bc043f8-cb28-49c4-aac0-f6e19fc611d3">8</ix:nonFraction>&#160;million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iab5284915b80459fb6366e3a5528172e_D20220701-20220731" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODIzNjMz_a4c4d3db-65ca-4ddb-834b-f68de7db9e8b">27</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i4e598ee158714864ac7ec8e1b7c6c04e_D20221201-20221231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI0MDQ5_2d3d1813-f00d-44b1-83cb-4191bd57b1c7">10</ix:nonFraction>&#160;million, respectively, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conjunction with the disposition of the underlying collateral. At each of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023 and December&#160;31, 2022, this secured loan had an outstanding principal balance of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ifc7401311f5444a7a6418fa19740da6b_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTczOA_f36031ce-52dc-4247-be35-23f3352e89d3"><ix:nonFraction unitRef="usd" contextRef="ic385c6dfa277429bad7b41a2a38a66fe_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTczOA_f4e4329d-3a85-4074-88eb-262e9835c6f3">120</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of <ix:nonFraction unitRef="facility" contextRef="ib206c24e874f495eb33a7ef79724c812_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTc5Ng_e5c0d8f8-7820-4d36-b04a-3a49de63ba2b">16</ix:nonFraction> additional SHOP facilities for $<ix:nonFraction unitRef="usd" contextRef="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTgzMA_4ea907a4-5b63-4adc-a753-1aa0769bb2d4">230</ix:nonFraction>&#160;million in January 2021, the Company provided the buyer with financing of $<ix:nonFraction unitRef="usd" contextRef="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTkxMw_242f479a-d9c3-4083-9c6d-ce9bf00f1ae3">150</ix:nonFraction>&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer&#8217;s equity ownership in each property. Upon maturity in January 2023, the borrower did not make the required principal repayment. In February 2023, the borrower made a partial principal repayment of $<ix:nonFraction unitRef="usd" contextRef="ie95535d107b84adab248bbffe4d73975_D20230201-20230228" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMyMDA1_40ca78ba-9484-45db-8580-9861be5e704a">102</ix:nonFraction>&#160;million and the remaining balance owed was refinanced with the Company. In connection with the refinance, the maturity date of the loan was extended to January 2024 and the interest rate on the loan was increased to a variable rate based on Term SOFR (plus an <ix:nonFraction unitRef="number" contextRef="i1a002d72b97442b5b2b389ad5a9d16ce_I20230228" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5MDI4_e9e76c35-05ad-4d9f-88a0-22060af5b290">11</ix:nonFraction> basis point adjustment related to SOFR transition) plus <ix:nonFraction unitRef="number" contextRef="ibaa149a31fb1486581279cc115c490b8_I20230228" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzE0NjgyNTU5OTUzNQ_0b38a3f3-7180-4fdc-a2ec-d5a5ff3d149b">6.0</ix:nonFraction>% for the first six months of the extended term, increasing to <ix:nonFraction unitRef="number" contextRef="i03330e2036c04219b1af6523e1deca30_I20230228" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMyMzMw_fd43cd6e-45cb-4aa4-b883-1d26051e9169">7.0</ix:nonFraction>% for the last six months of the extended term. The Company also received a $<ix:nonFraction unitRef="usd" contextRef="i9a09c60ade2547478c8bde3119807cfa_D20230201-20230228" decimals="-6" name="peak:LoansReceivableExtensionFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5MTg4_5099698f-4b46-40cf-8b00-79189ac9e987">1</ix:nonFraction>&#160;million extension fee in connection with the refinance, which is recognized in interest income over the remaining term of the loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Other Loans Receivable Transactions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company received full repayment of the outstanding balance of <ix:nonFraction unitRef="loan" contextRef="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228" decimals="INF" name="peak:NumberOfSecuredLoans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMwNjgw_84a540f6-ea5f-4860-aa92-44cac78f4f88">one</ix:nonFraction> $<ix:nonFraction unitRef="usd" contextRef="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzI5_0bdac292-90a5-45fa-b042-7484184c0604">35</ix:nonFraction>&#160;million secured loan. In April 2023, the Company received full repayment of the outstanding balance of <ix:nonFraction unitRef="loan" contextRef="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430" decimals="INF" name="peak:NumberOfSecuredLoans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMwNzEx_caffb69f-93c7-48b6-81c0-21896b9b4a5f">one</ix:nonFraction> $<ix:nonFraction unitRef="usd" contextRef="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzQ2_446d4909-711a-496a-ae4c-8bfdeb693c7d">14</ix:nonFraction>&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Other Loans Receivable Transactions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company received full repayment of the outstanding balance of a $<ix:nonFraction unitRef="usd" contextRef="i292c0d5f96754ad2a296029a917f95b0_D20220501-20220531" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMzI0OQ_7ead0f1a-4924-4c13-8e0e-e6cd6b30968b">2</ix:nonFraction>&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company received full repayment of the outstanding balance of a $<ix:nonFraction unitRef="usd" contextRef="ic0139f5e9be640a2abe77bf91136f1bb_D20221101-20221130" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI0NzY5_3632f662-316e-4970-a252-9948fdf99f7d">1</ix:nonFraction>&#160;million mezzanine loan.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i39c4112304474a85b970ae4769d83805" continuedAt="icde6b3d792f04c2e9a37e13f52e4980b"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company extended the maturity dates of <ix:nonFraction unitRef="loan" contextRef="i63393f69a85548b18409a036fee2f946_D20221201-20221231" decimals="INF" name="peak:NumberOfSecuredLoans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzM2_39ce82d5-e02a-47f0-ad15-3195616b494c">four</ix:nonFraction> secured loans with an aggregate outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="i63393f69a85548b18409a036fee2f946_D20221201-20221231" decimals="-6" name="peak:LoansReceivableOutstandingBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzQw_48919800-3d2a-4eec-af91-d172a7eaf6a4">61</ix:nonFraction>&#160;million, originally scheduled to mature in December 2022, by <ix:nonNumeric contextRef="i17ab4619f5bc4ffb844448dc2ded4d10_I20221231" name="peak:LoansReceivableTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzE0NjgyNTU5NzEwMg_4686a2a9-9b71-418c-8d64-1120b96a9378">one year</ix:nonNumeric> to December 2023. In connection with the extensions, the interest rates on the loans were increased to a variable rate based on Term SOFR (plus an <ix:nonFraction unitRef="number" contextRef="i684b88fb97554f22a37f1cbb5a4be09a_I20221231" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5NDMx_b985ff93-8151-4225-9f1d-a49e95abd2d0">11</ix:nonFraction> basis point adjustment related to SOFR transition) with a floor of <ix:nonFraction unitRef="number" contextRef="i5e0f4ebc4c1547e5913529941dba4cd5_I20221231" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzYx_00f44ed1-5d5e-4555-81bd-b627cb1cd102">8.5</ix:nonFraction>% for the first six months of the extended term, increasing to a floor of <ix:nonFraction unitRef="number" contextRef="if21dc8e101854dcebeae8d48af75b96d_I20221231" decimals="INF" name="us-gaap:LoansReceivableBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3Mzcz_24868995-9006-418e-b4f3-7f0bf21e0019">10.5</ix:nonFraction>% for the last six months of the extended term. <ix:nonFraction unitRef="loan" contextRef="i6d00bf264b354d8e9bd17bbbec9cc3db_D20230101-20230428" decimals="INF" name="peak:NumberOfSecuredLoans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzIz_6dff9378-2bcb-4547-8404-214323ba9698">Two</ix:nonFraction> of these secured loans were repaid during 2023 as discussed above.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CCRC Resident Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2023 and December&#160;31, 2022, the Company held</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i00ecc95ec04841c1b95be484ffd8add8_I20230331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTU3OA_370ff3a4-ea76-4285-9627-63b448ef40d8">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i64c1609203464ecf8a00b2af5447978d_I20221231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTU4NQ_08f967b5-0ca5-4bf3-ac0f-46a4fe3659ed">33</ix:nonFraction>&#160;million, respectively, of such notes receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans Receivable Internal Ratings </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTAwMQ_c86d331e-916a-4d74-aa59-c701f604f825" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.164%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0yLTEtMS0yMjUyNzE_ed222504-6f90-4142-bbed-540a4e9612d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC00LTEtMS0yMjUyNzE_42276387-3bf3-4d3f-82d1-1f9f1a0f47af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC02LTEtMS0yMjUyNzE_c9510035-9b2e-4d76-914e-da22468bf78a">163,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC04LTEtMS0yMjUyNzE_bb36ae4e-4854-4b1a-acc8-287d2bdf9db4">43,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMC0xLTEtMjI1Mjcx_e8b78a88-818f-494f-bbae-d45a1aacc75b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMS0xLTEtMjI1Mjcx_4ed2e4c8-1bf5-43d5-99bc-f9338a477a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMy0xLTEtMjI1Mjcx_4acaa1aa-c6c9-4b31-8cfa-1299c37af1f2">206,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0yLTEtMS0yMjUyNzE_2bbf6d56-76fe-4fe0-97cc-05d2be0b9471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS00LTEtMS0yMjUyNzE_d1dab0cf-be0f-414b-bcc0-0ba65aab8ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS02LTEtMS0yMjUyNzE_948a8f97-38b9-421c-aa4a-31fbbc2a2402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS04LTEtMS0yMjUyNzE_e548961a-5252-41de-8b56-51a165280583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMC0xLTEtMjI1Mjcx_b6c5843e-fb51-4778-ba9e-b8d97abb5819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMS0xLTEtMjI1Mjcx_be11e27d-7cb3-4dc4-bc00-0f9b2f7aa9a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMy0xLTEtMjI1Mjcx_ef158685-47f2-4531-b619-b1cb17abc047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0yLTEtMS0yMjUyNzE_bf89be9e-00a4-49b4-8dc6-528fe9c0ebe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi00LTEtMS0yMjUyNzE_a1f5fdcb-5c8d-4c8d-b5a6-989cb81a1116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi02LTEtMS0yMjUyNzE_d3e4bd0e-48f0-4ce2-b754-879535b87451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi04LTEtMS0yMjUyNzE_d7aee4f6-59a8-47bc-a083-643e99a9e895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMC0xLTEtMjI1Mjcx_58437c4b-2778-4ea0-b0b2-81a4cdfda5d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMS0xLTEtMjI1Mjcx_0955692d-bc9b-4e40-bb78-556e9eb6bfd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMy0xLTEtMjI1Mjcx_6fc8ee2f-6ac7-488b-b57f-bca5b564a0b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0yLTEtMS0yMjUyNzE_ea9e8d73-0781-4f23-99c4-7e126c029eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy00LTEtMS0yMjUyNzE_43a2d159-21f2-4dce-be77-30d24ada5be8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy02LTEtMS0yMjUyNzE_39fbf50e-9969-4291-8b29-83b28e1b401d">163,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy04LTEtMS0yMjUyNzE_77615f1b-95e4-47b9-a470-ce65ec7d8d76">43,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMC0xLTEtMjI1Mjcx_176f059c-ca36-4d8a-85e9-9a7fbbb0f193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMS0xLTEtMjI1Mjcx_dc4671d9-7780-4bb5-aa51-4201f4f7cc16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMy0xLTEtMjI1Mjcx_39238998-f0bd-48b3-aaa5-d37fbfbc1b19">206,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0yLTEtMS0yMjUyNzE_13b4d13e-4fb3-4a61-a314-30501dfc621b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC00LTEtMS0yMjUyNzE_e83295ec-9a03-4f89-a2d6-695d3f1f7b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC02LTEtMS0yMjUyNzE_79a3e8ee-0f46-4c87-b548-6321e7f8694b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC04LTEtMS0yMjUyNzE_f131652e-8965-4812-97cf-c39a96f06699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMC0xLTEtMjI1Mjcx_332e586b-a096-4897-b90b-b63193c8d669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMS0xLTEtMjI1Mjcx_19ee8c5b-9330-4612-8d4c-0e37d1c3beac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMy0xLTEtMjM3MjQx_be83cc2e-525a-4bc8-956d-8e1e1066ef65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0yLTEtMS0yMjUyNzE_7cde5630-696c-4aa0-aa35-e1ec43c05d10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS00LTEtMS0yMjUyNzE_c9238ccd-119b-4238-b59f-e41964e246c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS02LTEtMS0yMjUyNzE_4b8b5f9a-b0eb-47f0-afdb-b5d1c7bd5577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS04LTEtMS0yMjUyNzE_6a6d59c5-1ac2-4d71-9f12-e621bc47f1ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMC0xLTEtMjI1Mjcx_a3e80a50-76a8-4779-b06c-3a94ef3a76de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMS0xLTEtMjI1Mjcx_f8680695-6260-4064-bdfb-969fadf4d2ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778bdabbe2148a785c9999be7828073_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMy0xLTEtMjM3MjQx_4c0ae5dc-e5f0-45f7-b07f-23b34304caf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMi0xLTEtMjM3MjAz_0bbbf100-10bd-4a7a-98f9-3f14fa2930ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtNC0xLTEtMjM3MjM3_08dfbc41-0306-425b-ac84-15230cdb52a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtNi0xLTEtMjM3MjQx_a1a832ff-5742-4d86-96b9-f3921f88cefd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtOC0xLTEtMjM3MjQx_08c6edea-34d7-410b-8e63-82ae15b990cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTAtMS0xLTIzNzI0MQ_53857c8f-c5ba-4524-82ba-d0bc384981ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTEtMS0xLTIzNzI0MQ_e08cd1db-08b6-4a8c-8d1b-dcdf2fc2d89c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTMtMS0xLTIzNzI0MQ_2f1e9206-0600-4550-a446-b41f1a94a0a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMi0xLTEtMjI1Mjcx_91354b40-2202-48a5-83b5-f4f434610807">14,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtNC0xLTEtMjI1Mjcx_7573130a-8db6-4493-965f-dc27368a0f95">21,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtNi0xLTEtMjI1Mjcx_90d06e42-cea8-44cd-aec7-3bc0a681bc41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtOC0xLTEtMjI1Mjcx_957ae3c7-344e-42ad-9bac-8e742de688d3">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTAtMS0xLTIyNTI3MQ_b319590d-d68f-4312-8164-c2ae77ed3bd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTEtMS0xLTIyNTI3MQ_f3a437e7-2a0c-4128-9a9c-3c7608aa3770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTMtMS0xLTIyNTI3MQ_ac4832fe-d323-4721-a1f1-8d33c3bb00c7">36,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMi0xLTEtMjI1Mjcx_16c4e454-21cb-459e-85ec-fb6c02354abe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtNC0xLTEtMjI1Mjcx_d90a6a4e-99a0-42bb-a078-9af2df0a8a8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtNi0xLTEtMjI1Mjcx_e9c8cf56-04d2-434f-9f0c-8a7e25f3972a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtOC0xLTEtMjI1Mjcx_42ce4dfa-be0b-4d55-a8b6-7d66e6dd3e17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTAtMS0xLTIyNTI3MQ_176da613-f2ab-4244-b2e6-374e539bb6a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTEtMS0xLTIyNTI3MQ_a0dba524-d2ad-4728-818f-7704c699f900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93ddbb42639d468984faade1da6bb948_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTMtMS0xLTIyNTI3MQ_9ec4302d-7a2c-42c5-96e2-b78429162da5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMi0xLTEtMjI1Mjcx_4cdb1f91-def6-46ec-8fed-94661868051f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtNC0xLTEtMjI1Mjcx_40fa70b0-17a3-49e7-8de5-813a2e9c078c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtNi0xLTEtMjI1Mjcx_d11d3f42-ff62-4c43-b058-e90e0936d236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtOC0xLTEtMjI1Mjcx_f558045d-29ab-435e-9e46-185aadcf12cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTAtMS0xLTIyNTI3MQ_a9f7523d-601d-4927-8615-eb547f949696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTEtMS0xLTIyNTI3MQ_54617c04-e1c2-4d0b-a5bf-cf7ac8edec13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffec5e441b44bef86395108ef570821_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTMtMS0xLTIyNTI3MQ_c4ae54de-6d9a-43b7-a6a4-b7e6eb196f75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CCRC resident loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMi0xLTEtMjI1Mjcx_916839a0-e3e2-4fbd-ba2c-d40dec51a656">14,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtNC0xLTEtMjI1Mjcx_095e7a03-d5ba-43bb-8e24-d38c549423e7">21,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtNi0xLTEtMjI1Mjcx_8189e89e-efc8-4698-bdd2-41e49886d6ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtOC0xLTEtMjI1Mjcx_7c0152e1-e57e-4e9f-aaff-e65d5c20de9b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTAtMS0xLTIyNTI3MQ_041bdc38-26c1-4000-b2b2-ad354e6338ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTEtMS0xLTIyNTI3MQ_89d6bb90-1e49-4db7-be5d-b953ef868a6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTMtMS0xLTIyNTI3MQ_95850cb3-7aa4-4c1a-8b7e-5d314c9bb42b">36,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMi0xLTEtMjI1Mjcx_e2dd3c0b-d8a8-46ef-8b29-a6d761a6d1c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctNC0xLTEtMjI1Mjcx_ff50972c-2f5c-4c2e-984c-f47e07c86b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctNi0xLTEtMjI1Mjcx_6c56bba6-1312-43a9-a561-58c5b454cfee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctOC0xLTEtMjI1Mjcx_585e1a21-f493-457b-85a4-00a82359b2a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTAtMS0xLTIzNzI0NA_03acf667-999b-467d-8d0f-d466232c55a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTEtMS0xLTIyNTI3MQ_2d6bc0da-5b69-49cb-b197-d0e65a9afe9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05931c32871345c2953b6bc7e9725803_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTMtMS0xLTIzNzI0NA_5c64de0f-1d87-44b8-9b76-97589bea85ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMi0xLTEtMjI1Mjcx_5f497260-2478-460c-860e-8b65c0d06db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtNC0xLTEtMjI1Mjcx_e45d5728-eb96-40ba-9306-2a9bf4855a62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtNi0xLTEtMjI1Mjcx_5b9df11e-e09f-4081-8114-99528cf7e471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtOC0xLTEtMjI1Mjcx_a0dfdf8b-a905-4da2-8487-c74e7c882807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTAtMS0xLTIzNzI0NA_c71c54ea-b50e-4721-8de3-d4646929f2e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTEtMS0xLTIyNTI3MQ_cb3ee4b9-da11-4a63-9769-84c3ec824c63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83876e1875415480e127f2f8ee5341_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTMtMS0xLTIzNzI0NA_382ed6f1-1e18-48ac-aff4-e51dcd29dc51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMi0xLTEtMjM3MjQ0_a8037672-6d40-44f0-afec-7b2680c66619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktNC0xLTEtMjM3MjQ0_374f90e9-22e6-4f0b-b5f3-c2f589d5dcbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktNi0xLTEtMjM3MjQ0_71895b82-4379-439c-a196-380f88297ed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktOC0xLTEtMjM3MjQ0_d8ac75ba-860f-4c40-a189-b012b3748384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTAtMS0xLTIzNzI0NA_16c79276-45f6-4107-8bd7-b5898c0de2c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTEtMS0xLTIzNzI0NA_739cc5ad-ffff-4c63-bc63-de26c3390a08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTMtMS0xLTIzNzI0NA_43fa5ace-f474-4b25-8e26-2c13bc2239d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="icde6b3d792f04c2e9a37e13f52e4980b"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Loan Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#8217;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. </span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTAxMQ_34696fc0-a1cb-4b81-9fb3-f661a372b2fe" continuedAt="i744b9da9f32a44998647c6d7c4d43bc3" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0xLTEtMS0yMjUyNzE_ebe4ba47-8df1-4829-ac40-922f9c019069">8,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie53bcb07504e4ad99f3ade31d660d86a_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0zLTEtMS0yMjUyNzE_4ca3c38b-867f-47b7-9f66-023c9b35d692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi01LTEtMS0yMjUyNzE_a07cc5d2-b253-4828-a425-baa72f11d0ef">8,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a30f0743e84f25b4365b13befe7543_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi03LTEtMS0yMjUyNzE_3c6aa900-a840-4fc5-8a65-df90830341bc">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3eb325105c4a489d9e072e95831f43_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi05LTEtMS0yMjUyNzE_898b2d59-e202-42ae-a218-8229ab69efbd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0xMS0xLTEtMjI1Mjcx_0a1d0a95-4cfc-4ddb-bc10-3c14e0753cd1">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0xLTEtMS0yMjUyNzE_e030d79b-fbba-45d9-9bfc-640cc99d17af">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0zLTEtMS0yMjUyNzE_0c948222-af74-4173-a3ea-bc955ceb8571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC01LTEtMS0yMjUyNzE_2b7835dc-6b10-4fc6-b05a-8e4269cbbc84">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC03LTEtMS0yMjUyNzE_b269d4b2-e489-460b-9b03-87ff46016461">6,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC05LTEtMS0yMjUyNzE_8d7660c2-f47d-4ffe-b014-8ae4f7c624ee">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0xMS0xLTEtMjI1Mjcx_d741d3c5-d103-49df-87fa-50ca397a39aa">6,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses (recoveries) related to loans sold or repaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0xLTEtMS0yMjUyNzE_4e64c0c1-e690-4744-9b8c-e0ae569547a2">1,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0zLTEtMS0yMjUyNzE_18df68d4-f08f-462f-94f4-28a2747d9b88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS01LTEtMS0yMjUyNzE_a3ceb3d7-39f5-420e-925c-080670da33f8">1,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS03LTEtMS0yMjUyNzE_71b52946-a943-4a02-96fb-d000a8b43410">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS05LTEtMS0yMjUyNzE_d1b1e307-130c-4cd9-95c6-0e6998599d06">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0xMS0xLTEtMjI1Mjcx_02779021-5e89-4a87-8873-72c91896ad60">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc9183f82c46689dc6c8c571bb0698_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0xLTEtMS0yMjUyNzE_eb53fc6d-0dc2-4e55-b3db-f5a8e8874cf4">6,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966c32afeb843069c788fcb7d555ba1_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0zLTEtMS0yMjUyNzE_d55e5072-64b5-4343-a960-1c035f37bc28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS01LTEtMS0yMjUyNzE_79af2367-1e71-4850-a9ca-f51a651b51ed">6,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS03LTEtMS0yMjUyNzE_9b7b79db-355c-4fc1-ab50-167b10933de6">8,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie53bcb07504e4ad99f3ade31d660d86a_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS05LTEtMS0yMjUyNzE_d60eb2ad-157a-476f-aa87-9cadf1501181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0xMS0xLTEtMjI1Mjcx_8d49535a-108d-400c-9590-640c3e81e6ba">8,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i744b9da9f32a44998647c6d7c4d43bc3" continuedAt="ic699ecd3c84544c68dd10298321731d3">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ic699ecd3c84544c68dd10298321731d3">Includes CCRC resident loans and other loan activity.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at March&#160;31, 2023 and December&#160;31, 2022, a liability of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-5" name="peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODgyNw_f73662ba-4253-4024-a080-5d9443412a5a">0.7</ix:nonFraction> million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-5" name="peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODgzNA_570fd1e6-778c-4ad3-93d8-66666c883e1f">0.8</ix:nonFraction> million, respectively, related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the reserve for expected loan losses during the three months ended March&#160;31, 2023 is primarily due to principal repayments on seller financing, partially offset by increased interest rates on variable rate loans.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMzQxMQ_694a4890-2f47-4f5d-85a5-d0c4d635947d" continuedAt="i237dd083fd0f419ba7bd0462e8282eab" escape="true">Investments in and Advances to Unconsolidated Joint Ventures</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i237dd083fd0f419ba7bd0462e8282eab"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMzQwMQ_3ce1012c-1fd6-4bf6-96ab-9190d776d5d7" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy00LTEtMS0yMjUyNzE_9309d83f-712c-4ae6-84d2-dda4dc3efe1d">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy02LTEtMS0yMjUyNzE_5174d752-2f5c-436d-88e3-ed1ea85a9c77">54</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy04LTEtMS0yMjUyNzE_b33ab554-3632-4140-94d7-a5d88574e3a1">343,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49856b1a6b744d32850fd6e75896a354_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy0xMC0xLTEtMjI1Mjcx_cb1b9f47-b51c-4410-8282-4f8fa7adef76">345,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South San Francisco JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="i563440407d4441eb91bd164b5748f220_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC00LTEtMS0yMjUyNzE_69d1dc08-7cb8-4bd7-a817-2710bcb2cad4">7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i563440407d4441eb91bd164b5748f220_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC02LTEtMS0yMjUyNzE_0699d4c2-de86-4aa6-84d8-c8d42c04fa9d">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563440407d4441eb91bd164b5748f220_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC04LTEtMS0yMjUyNzE_66336dbf-31b5-4739-a969-fb838d7947bf">319,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188028ed6c334da79242d89eee8a840e_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC0xMC0xLTEtMjI1Mjcx_2b26d262-7dee-4737-838e-752336c1ba95">309,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS00LTEtMS0yMjUyNzE_5cfe2eab-1b45-4db1-8ccc-efa7f5945ee0">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS02LTEtMS0yMjUyNzE_2918a23c-0056-49b2-bc7c-30c28c5c2a73">49</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS04LTEtMS0yMjUyNzE_fd871a95-ec65-4cbe-bdbe-c6cb920ff969">26,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd9427916f174bbb8f0807aa0d989019_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS0xMC0xLTEtMjI1Mjcx_460a02a0-f06b-4cc7-83cd-89575216015a">26,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi00LTEtMS0yMjUyNzE_27d97ce2-c114-466f-9e44-5e07b4adbf92">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi02LTEtMS0yMjUyNzE_7898b815-e662-4b10-8417-fd21de971c47">38</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi04LTEtMS0yMjUyNzE_acc9dbe3-228e-4966-9653-45ffba1883df">15,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164fcc3a8c7b43fab61c0b736e5ce0ec_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi0xMC0xLTEtMjI1Mjcx_a21e42bc-549d-43e7-a43a-7b0e0cd4236e">15,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="i8bdefa6de9c94ded98445df17bde5304_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy00LTEtMS0yMjUyNzE_1c6e6668-16d3-48af-a59f-72851cf82330">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife1a0b550fcf40a994feb853ca29945f_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy02LTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjozYjc0ZmVlM2ZkMTU0NTA4YmZmMGUxMTM0MjczMWNkM180_3529b4b2-e38e-4cfb-ad03-be7a4e41c350">20</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="i1ea45485ef014df9bcb3a328007f3a5a_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy02LTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjozYjc0ZmVlM2ZkMTU0NTA4YmZmMGUxMTM0MjczMWNkM185_67dd8656-e39f-4450-99c5-9da845ec6f3a">67</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bdefa6de9c94ded98445df17bde5304_I20230331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy04LTEtMS0yMjUyNzE_a4da06cc-8174-4cae-9616-e63382239840">8,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d045a82e5d472cab0e50a49b069fc3_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy0xMC0xLTEtMjI1Mjcx_d16176df-5259-44f5-b5b7-18d3da430a80">8,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMTItOC0xLTEtMjI1Mjcx_ad9b581f-9aeb-41dc-b55d-794c5db5dafc">714,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMTItMTAtMS0xLTIyNTI3MQ_e663f289-db05-40b1-a805-d94ea7d878e2">706,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2023. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In August 2022, the Company sold a <ix:nonFraction unitRef="number" contextRef="i2addaafadeb048608bb19144472ba521_I20220831" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA3NzUwMg_dd5ae66b-7e88-4ef5-8085-45e2773c7741">30</ix:nonFraction>% interest in <ix:nonFraction unitRef="property" contextRef="ie9cdb1d5067b4c20abc45e5a6b15b490_I20220831" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA3NzUxOA_e2110e93-cd30-4919-b737-7e957f6353af">seven</ix:nonFraction> life science assets in South San Francisco, California to a sovereign wealth fund. This transaction resulted in the recognition of <ix:nonFraction unitRef="joint_venture" contextRef="ibbf0c3be361842da924660620a57f737_I20220831" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTA2_46014c53-3f6f-4a0b-8aca-163d33b2af3e">seven</ix:nonFraction> unconsolidated life science joint ventures in which the Company holds a <ix:nonFraction unitRef="number" contextRef="ibbf0c3be361842da924660620a57f737_I20220831" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNjE2_3e9592ea-c1e9-4825-a7c7-5ea69c95416a">70</ix:nonFraction>% ownership percentage in each joint venture. These joint ventures have been aggregated herein due to similarity of the investments and operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Land held for development is excluded from the property count as of March&#160;31, 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes <ix:nonFraction unitRef="joint_venture" contextRef="idcb7ea32456048788d35e1f70da8c6f5_I20230331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTA0OQ_7aa6a3c8-5eef-4760-9529-99281ee99762">two</ix:nonFraction> unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (<ix:nonFraction unitRef="number" contextRef="i609a39bba39341cca8d2aa1fcce48d99_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTE3Nw_6d20ee96-827b-42ac-bcb8-cb497313441e">20</ix:nonFraction>%) and (ii) Suburban Properties, LLC (<ix:nonFraction unitRef="number" contextRef="i31ebf93813b04ee98f19d52880e6b227_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTIxNg_f7b0f3c0-af31-497a-9167-861bf87de841">67</ix:nonFraction>%). These joint ventures have been aggregated herein due to similarity of the investments and operations. In April 2023, the Company acquired the remaining <ix:nonFraction unitRef="number" contextRef="i21dc87df2f2b491c818391833acfbe83_I20230428" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI0ODYw_261a9f18-dc06-40a3-81f3-b102771a573b">80</ix:nonFraction>% interest in <ix:nonFraction unitRef="property" contextRef="i21dc87df2f2b491c818391833acfbe83_I20230428" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI0ODY1_d98393e2-4717-4dc1-90ce-5a357dd78f64">one</ix:nonFraction> of the <ix:nonFraction unitRef="property" contextRef="idcb7ea32456048788d35e1f70da8c6f5_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA4MDQzMg_7a72303d-751a-4ccd-8ca6-5e8c1eebc84e">two</ix:nonFraction> properties in the Ventures IV unconsolidated joint venture for $<ix:nonFraction unitRef="usd" contextRef="i98f2b1c68dfd4ec0b6cfe198f9aa7452_D20230401-20230428" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI1MDUx_9af1a9e4-f486-4621-b84c-6b24d599092f">4</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3NA_12084de5-6533-43f7-8827-3ad7d4f041dc" continuedAt="i4114c2daee06433d87135c324b3af497" escape="true">Intangibles</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i4114c2daee06433d87135c324b3af497"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3MQ_6b40d6fe-4890-4284-909a-73769fe597dd" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMS0yLTEtMS0yMjUyNzE_b26ed1fe-3f30-4417-be73-2fdb17c78eac">767,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMS00LTEtMS0yMjUyNzE_f0ec6103-0f1f-40b9-b691-ab5cf5263d42">770,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMi0yLTEtMS0yMjUyNzE_ccdc1bd7-56f0-43aa-bfd1-356082bafb96">375,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMi00LTEtMS0yMjUyNzE_874b408d-b145-4d4f-9df3-230204c0fd9a">352,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMy0yLTEtMS0yMjUyNzE_906d0f77-1882-4956-8e22-e8a91a258b88">391,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMy00LTEtMS0yMjUyNzE_0549c7d3-2dc7-4715-9a0a-1b2f266fde79">418,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfNS0yLTEtMS0yMjUyNzE_e5ce96e9-6581-4fd7-8352-fc6b3282cf3a">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfNS00LTEtMS0yMjUyNzE_80653734-3393-491f-b366-27f0ea7cc5a1">5</ix:nonNumeric></span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes intangible assets reported in assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i13ba81585eef4986833dfbc887a0e2d9_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMzcw_b2f379fb-1099-4ed4-aa24-e33e80c06a9a">2</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3NQ_f6d3b7cc-9c74-4b23-bd61-9bc128a6db89" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:72.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMS0yLTEtMS0yMjUyNzE_6d9c509d-70d3-45f2-8762-6b043dd2fff5">236,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMS00LTEtMS0yMjUyNzE_a5d80f2f-6697-4d6b-a441-6be06f3fe352">237,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMi0yLTEtMS0yMjUyNzE_c139346f-3036-4b50-8894-b6f4ed1ba91a">87,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMi00LTEtMS0yMjUyNzE_58f5fcfc-b33b-4eb6-b718-dc247e0934bc">81,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMy0yLTEtMS0yMjUyNzE_d49b2e24-b66e-4c7c-9869-7f3c266d6367">149,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMy00LTEtMS0yMjUyNzE_449db0b9-b0b2-44d3-8cee-dc8ea6970bd1">156,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfNS0yLTEtMS0yMjUyNzE_40035811-e713-4784-a094-74a92eefa10a">7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfNS00LTEtMS0yMjUyNzE_b1b96b20-0a01-44de-a40d-4da045b7f572">7</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, <ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNzE0NjgyNTU4MjIzNQ_3f25a705-d6e6-45ac-a34f-0fe02e08755b"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="peak:FiniteLivedIntangibleLiabilitiesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNzE0NjgyNTU4MjIzNQ_53ff8606-6326-4c29-b978-e03a6d705398">no</ix:nonFraction></ix:nonFraction> intangible assets or liabilities were acquired.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTAwNw_1560bd72-1009-4507-965e-b9ebac8dc32f">7</ix:nonFraction>&#160;million and intangible liabilities of $<ix:nonFraction unitRef="usd" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="-6" name="peak:FiniteLivedIntangibleLiabilitiesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTA0MA_0e9097d7-f0e8-4201-a866-6d9bcaa865f8">6</ix:nonFraction>&#160;million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of <ix:nonNumeric contextRef="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE2OA_5ffabb16-c8bf-4d71-b2e0-9d1c1448887e">7</ix:nonNumeric> years and <ix:nonNumeric contextRef="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNTQ5NzU1ODE1MjE2_37360bc7-5072-4759-b912-6b16265650c3">11</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTY_3b499647-486c-4707-b258-b8773bdfda10" continuedAt="i07c4939008af4c4cb3330bbee1f8cf27" escape="true">Debt</ix:nonNumeric></span></div><div style="margin-bottom:1pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i07c4939008af4c4cb3330bbee1f8cf27" continuedAt="i598ac7351ad84dd4a6cf1589ff02e3f4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#8217;s consolidated operating subsidiary. Healthpeak OP is the borrower under, and the Company is the guarantor of, all of the unsecured debt discussed below, which includes the Revolving Facility, Term Loan Facilities, Commercial Paper Program (each as defined below), and senior unsecured notes. The Company&#8217;s guarantee of the senior unsecured notes is full and unconditional and applicable to existing and future senior unsecured notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank Line of Credit and Term Loans </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2019, the Company executed a $<ix:nonFraction unitRef="usd" contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTc_5c23c350-fcf8-4402-8ad4-8fb2455f1148">2.5</ix:nonFraction> billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and <ix:nonFraction unitRef="renewal_option" contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523" decimals="INF" name="peak:DebtInstrumentNumberofExtensions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTg2_6e7f73ac-3184-436b-9f0f-9340fffeb0d3">two</ix:nonFraction>&#160;<ix:nonNumeric contextRef="ic4babd7df1364a05a31daf2030f872a8_D20190523-20190523" name="peak:DebtInstrumentPeriodOfExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTg5_3946ecbe-283d-40e9-bfeb-a31bd326cfb3">six-month</ix:nonNumeric> extension options, subject to certain customary conditions. In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#8220;Revolving Facility&#8221;) to increase total revolving commitments from $<ix:nonFraction unitRef="usd" contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjE5_492b94cb-804c-4499-9056-00379f85ef42">2.5</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="if1d4050de8b24d7499a2da8155770c96_I20210930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjI1_15275cc3-4447-40ac-937e-b53dd5f09c93">3.0</ix:nonFraction>&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to <ix:nonFraction unitRef="renewal_option" contextRef="if1d4050de8b24d7499a2da8155770c96_I20210930" decimals="INF" name="peak:DebtInstrumentNumberofExtensions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzMz_e5e59ffb-01ab-4f86-bd3f-a395d8fbd6bc">two</ix:nonFraction> <ix:nonNumeric contextRef="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930" name="peak:DebtInstrumentPeriodOfExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzM2_635864fa-cb3c-4127-8d6c-56784bbd0c7f">six-month</ix:nonNumeric> extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at the applicable interest rate benchmark plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. On February 10, 2023, the Company executed an amendment to the Revolving Facility to convert the interest rate benchmark from LIBOR to SOFR. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Additionally, the Revolving Facility includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to <ix:nonFraction unitRef="number" contextRef="ice2627cf08414f8db5d11bcfa2e103c2_D20230101-20230331" decimals="5" name="peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTI0OA_d8792668-1a25-4022-a5db-1b01c13272fb">0.025</ix:nonFraction>% based on the Company&#8217;s achievement of specified sustainability-linked metrics, subject to certain conditions. Based on the Company&#8217;s credit ratings at March&#160;31, 2023, and inclusive of achievement of a sustainability-linked metric during the year ended December 31, 2021, the margin on the Revolving Facility was <ix:nonFraction unitRef="number" contextRef="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTU0NA_e45ed270-aeaa-41c4-8151-5359c0e5b99f">0.85</ix:nonFraction>% and the facility fee was <ix:nonFraction unitRef="number" contextRef="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTU3Mg_6ba20b4a-c339-43ba-8f4c-9dc17eb01a34">0.15</ix:nonFraction>%. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had <ix:nonFraction unitRef="usd" contextRef="i72eb05af2cbe4e208706e4b57decdb88_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTYwNg_541619ae-46da-4459-9117-3372ba583753"><ix:nonFraction unitRef="usd" contextRef="i7305c3d00995417db4dbb2b7d6c583a6_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTYwNg_9dca0a3a-8ce0-4813-9ae4-6f10d71218bd">no</ix:nonFraction></ix:nonFraction> balance outstanding under the Revolving Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930" decimals="INF" name="peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTc5Mg_e303efd6-05ba-4be6-8fa7-7218316ccf5d">750</ix:nonFraction> million, subject to securing additional commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 22, 2022, the Company executed a term loan agreement (the &#8220;Term Loan Agreement&#8221;) that provided for <ix:nonFraction unitRef="loan" contextRef="i0ae753d2f2bb4df0934278cf9eff53e5_D20220822-20220822" decimals="INF" name="peak:NumberOfLoans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMjkzMw_2c305259-55af-4172-98d8-2764b01c94fb">two</ix:nonFraction> senior unsecured delayed draw term loans in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i506c4e4d75c74d20b91a42ee338b3511_I20220822" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzAxOQ_5da82476-e20d-48ac-996b-89dffd070dfb">500</ix:nonFraction>&#160;million (the &#8220;Term Loan Facilities&#8221;). The Term Loan Facilities were available to be drawn from time to time during a <ix:nonNumeric contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822" name="peak:DebtInstrumentDrawTimePeriodAfterClosing" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzE0MQ_ab26caf9-c3f8-43c7-a1cc-1b1344ae9955">180</ix:nonNumeric>-day period after closing, subject to customary borrowing conditions, and the Company drew the entirety of the $<ix:nonFraction unitRef="usd" contextRef="ie44957565290418193123188bc3f9a29_I20221031" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjA0NzMxMzk4MTc4Mw_9208797d-e6ab-4bab-a4b2-035b8ba38cff">500</ix:nonFraction>&#160;million under the Term Loan Facilities in October 2022. $<ix:nonFraction unitRef="usd" contextRef="ic5093505d5344e8bba4c2389265a3a7b_I20220822" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzIxMw_fa57fee6-e01d-4219-9664-9c4a2353d22c">250</ix:nonFraction>&#160;million of the Term Loan Facilities has an initial stated maturity of <ix:nonNumeric contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzI4Mw_dcf091fd-1665-4c90-8597-adfacc60e454">4.5</ix:nonNumeric> years, which may be extended for a <ix:nonNumeric contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822" name="peak:DebtInstrumentPeriodOfExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTA5OTUxMTY3OTI4MQ_0ab075c8-ef90-4f34-8bab-c7d585a9f814">one-year</ix:nonNumeric> period subject to certain customary conditions. The other $<ix:nonFraction unitRef="usd" contextRef="i33fc45189ac34f818a512f00fc01253e_I20220822" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzM4MQ_6a005bd5-e876-4653-99d1-75859e36f955">250</ix:nonFraction>&#160;million of the Term Loan Facilities has a stated maturity of <ix:nonNumeric contextRef="i543d187d7c2f422fb35ffbea57ea780b_D20220822-20220822" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzQ0Mg_176fad52-642a-413d-aa9f-592a5ec5a426">5</ix:nonNumeric> years with no option to extend. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i1b6cf8ab3e074c468afa71e272d04f7e_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5MDYz_56cb66fc-d0fb-4849-988f-839d27b14da9"><ix:nonFraction unitRef="usd" contextRef="i000be30d07554d05a5d03c3a41a8a60e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5MDYz_c29bfaee-d69f-4a54-860d-831317a14f8a">500</ix:nonFraction></ix:nonFraction>&#160;million outstanding under the Term Loan Facilities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans outstanding under the Term Loan Facilities accrue interest at Term SOFR plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. The Term Loan Agreement also includes a sustainability-linked pricing component whereby the applicable margin under the Term Loan Facilities may be reduced by <ix:nonFraction unitRef="number" contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822" decimals="4" name="peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzgyNg_b2f90186-8dd9-460b-a2cd-f5c46a0371df">0.01</ix:nonFraction>% based on the Company&#8217;s achievement of specified sustainability-linked metrics. Based on the Company&#8217;s credit ratings as of March&#160;31, 2023, the margin on the Term Loan Facilities was <ix:nonFraction unitRef="number" contextRef="ib2ebc102c23049bb9221a3b5b00a8855_D20230101-20230331" decimals="4" name="peak:DebtInstrumentMarginRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNDAwNA_c4c979ca-28b6-4bc9-8359-0d56e8658944">0.95</ix:nonFraction>%. The Term Loan Agreement includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to an additional $<ix:nonFraction unitRef="usd" contextRef="i000be30d07554d05a5d03c3a41a8a60e_I20230331" decimals="-6" name="peak:LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNDM2NQ_80b8c53c-912e-451e-acf3-b8903c7a7cd0">500</ix:nonFraction>&#160;million, subject to securing additional commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into <ix:nonFraction unitRef="derivative_held" contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTM3OA_43e6de9d-1ed1-4fd5-8366-8c81fab75f52">two</ix:nonFraction> forward-starting interest rate swap instruments that are designated as cash flow hedges (see Note 17). The Term Loan Facilities associated with these interest rate swap instruments are reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instruments. Based on the Company&#8217;s credit ratings as of March&#160;31, 2023, the Term Loan Facilities had a blended fixed effective interest rate of <ix:nonFraction unitRef="number" contextRef="iddbba9ecd72f4daa98c9e47aeddc18e0_I20230331" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTgwNQ_7a9e19f9-1527-4262-b088-11d246819d83">3.77</ix:nonFraction>%, inclusive of the impact of these interest rate swap instruments and amortization of the related debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility and Term Loan Facilities are subject to certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the applicable agreement: (i) limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to <ix:nonFraction unitRef="number" contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331" decimals="4" name="peak:DebtInstrumentCovenantDebtToAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3NTkw_9389005d-4434-477e-b4ba-56ce21c16dcd">60</ix:nonFraction>%; (ii) limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to <ix:nonFraction unitRef="number" contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331" decimals="4" name="peak:DebtInstrumentCovenantSecuredDebtToAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3Njc4_ed7b9d0a-01da-47ff-842d-1cf5bd14ba33">40</ix:nonFraction>%; (iii) limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to <ix:nonFraction unitRef="number" contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331" decimals="4" name="peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3Nzc2_4f6f98cc-37ba-449b-98f1-06fc88ee849d">60</ix:nonFraction>%; (iv) require a minimum Fixed Charge Coverage ratio of <ix:nonFraction unitRef="number" contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331" decimals="3" name="peak:DebtInstrumentCovenantFixedChargeRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3ODM1_0cdfc0d0-686a-4547-9466-0edeb3b27a49">1.5</ix:nonFraction> times; and (v) require a minimum Consolidated Tangible Net Worth of $<ix:nonFraction unitRef="usd" contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331" decimals="-8" name="peak:DebtInstrumentCovenantNetWorthMinimum" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3OTA3_b4afcc7d-6a14-4857-a969-c9e7dccf1778">7.7</ix:nonFraction>&#160;billion. The Company believes it was in compliance with each of these covenants at March&#160;31, 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i598ac7351ad84dd4a6cf1589ff02e3f4" continuedAt="ia54a0e062d0b4d0ab0b007ff145391f3"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company established an unsecured commercial paper program (the &#8220;Commercial Paper Program&#8221;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. At each of March&#160;31, 2023 and December&#160;31, 2022, the maximum aggregate face or principal amount that can be outstanding at any one time was $<ix:nonFraction unitRef="usd" contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231" decimals="INF" name="peak:DebtInstrumentMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjU2Mg_4c9e679d-cc1c-4a2c-bd27-3d238c7fe4e2"><ix:nonFraction unitRef="usd" contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331" decimals="INF" name="peak:DebtInstrumentMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjU2Mg_bccd0b1e-bc78-4eee-ab3e-f0f7f56e6532">2.0</ix:nonFraction></ix:nonFraction>&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#8217;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzAwNg_2f19f6cd-5cd0-4467-9d76-0c16db7e55cf">556</ix:nonFraction>&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately <ix:nonNumeric contextRef="idef8861b7d7c4e5fbfc001ae1cebeb57_D20230101-20230331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzExMw_6b640569-30a7-41f0-b96f-fbba6dd94c2d">16</ix:nonNumeric> days and a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzE1Ng_cc250f5b-be27-459d-946f-3c9ce21c1d24">5.53</ix:nonFraction>%. At December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzE4Mw_8adfbecf-adaa-429e-8eb8-7e1bf013fed2">996</ix:nonFraction>&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately <ix:nonNumeric contextRef="iac90e17281a0408ebc19a4dd60bf5da8_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTk_0efa0adc-b2f4-4126-91a7-ab9fd94f6151">two months</ix:nonNumeric> and a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzM0MA_ac4dbc59-fdcd-4c07-980f-059a1227e6d0">4.90</ix:nonFraction>%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the Company had senior unsecured notes outstanding with an aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzQ3OQ_bb16076d-d507-474c-a30d-e0a8f1ff1d61">5.1</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i29765404aa624d6d99bc3534f881b7a5_I20221231" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5NjE5_bba6b1cf-45e5-43f4-a3f4-52fa8d0dc192">4.7</ix:nonFraction>&#160;billion, respectively. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions, and other customary terms. The Company believes it was in compliance with these covenants at March&#160;31, 2023.</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTE_2fa44e89-f0a8-4bcb-817b-9394b5ed4cc4" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s senior unsecured notes issuances during the three months ended March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 17, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife87565ec58448679511f93e16e05495_I20230117" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOjNkNzNhNGJiNWFhYjQ1MjFiNmY2MWRlZGJiYTk1MjQ5L3RhYmxlcmFuZ2U6M2Q3M2E0YmI1YWFiNDUyMWI2ZjYxZGVkYmJhOTUyNDlfMS0yLTEtMS0yMjUyNzE_ae77ac65-c5c2-4be1-8022-f1e0c4673547">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife87565ec58448679511f93e16e05495_I20230117" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOjNkNzNhNGJiNWFhYjQ1MjFiNmY2MWRlZGJiYTk1MjQ5L3RhYmxlcmFuZ2U6M2Q3M2E0YmI1YWFiNDUyMWI2ZjYxZGVkYmJhOTUyNDlfMS00LTEtMS0yMjUyNzE_1b1bd8c4-e3a3-4f1f-b879-46e4d8173350">5.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, there were no repurchases or redemptions of senior unsecured notes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, there were no issuances, repurchases, or redemptions of senior unsecured notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Debt</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODYyOQ_4ae841ee-27bb-4b0f-af21-a4184a0bef67">344</ix:nonFraction> million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i827939e6039a4e69bd555a798b90b6f6_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODYzNg_874ba01a-16d1-47f8-be9f-9b364b7607b5">345</ix:nonFraction>&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by <ix:nonFraction unitRef="facility" contextRef="ieb7af8f09e474a1d9f0d3752ba17b366_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDcz_cf3cf78a-04ea-474a-a0e2-b8697375e283"><ix:nonFraction unitRef="facility" contextRef="id56cce58abda458d9545374c913aac55_I20221231" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDcz_da9ea6c0-438c-4049-ab1a-1d1257264a86">15</ix:nonFraction></ix:nonFraction> MOBs and <ix:nonFraction unitRef="facility" contextRef="i195c53570e3d4baa8827ffa006124262_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDc3_441d1ad5-0acf-47a5-a15d-63b1825c13b2"><ix:nonFraction unitRef="facility" contextRef="ibd48946bcbc149b6ba3884e2e5f54793_I20221231" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDc3_61d7afd7-075e-46fb-9c47-c7e4584b4a63">3</ix:nonFraction></ix:nonFraction> CCRCs, with an aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-6" name="peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODc5MA_8e37b768-2f77-4fdd-aa12-69d9af32f9bd">785</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i827939e6039a4e69bd555a798b90b6f6_I20221231" decimals="-6" name="peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODc5Nw_c5f59b17-1d39-4725-96cc-4ad5f8b8da6c">793</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and 2022, the Company made aggregate principal repayments of mortgage debt of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331" decimals="-6" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTU2OQ_9963c4e2-1a79-4358-bb12-8aa748bb2500"><ix:nonFraction unitRef="usd" contextRef="i3cdd8357aeaf42e990fca8f3111eee5f_D20220101-20220331" decimals="-6" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTU2OQ_ac8b18d7-ecae-488b-87d6-162e1ea66959">1</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="i906008fbc48340908eb765f2c3dc8cd1_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTk0Mw_f45a2fc4-0202-49c9-9974-9d7baecd8db3">142</ix:nonFraction>&#160;million of mortgage debt secured by a portfolio of <ix:nonFraction unitRef="facility" contextRef="i906008fbc48340908eb765f2c3dc8cd1_I20230331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NTcz_2bf30492-e31b-46a3-801e-6fab7b82b097">13</ix:nonFraction> MOBs that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap instruments associated with this variable rate mortgage debt and entered into <ix:nonFraction unitRef="derivative_held" contextRef="i08425abe3e614e6d9a9b28ec8e60b022_I20220430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTAxNTg_fdc3361d-4524-46a8-bb8f-285dcb4bcf48">two</ix:nonFraction> interest rate swap instruments that are designated as cash flow hedges</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and mature in May 2026. In February 2023, the agreements associated with this variable rate mortgage debt were amended to change the interest rate benchmarks from LIBOR to SOFR, effective March 2023. Concurrently, the Company modified the related interest rate swap instruments to reflect the change in the interest rate benchmarks from LIBOR to SOFR (see Note 17). The variable rate mortgage debt associated with these interest rate swap instruments is reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instrument.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="ia54a0e062d0b4d0ab0b007ff145391f3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Maturities</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MjQ_1af83066-f5eb-431c-99de-6c21af088d77" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;<br/>of Credit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term&#160;Loans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0yLTEtMS0yMjUyNzE_cfc2cf69-bd93-456a-a934-b62bb365e226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi00LTEtMS0yMjUyNzE_0225fad0-8ddf-47c1-9d0d-de7d2f1bfcf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi02LTEtMS0yMjUyNzE_3b15f34f-9a87-4247-b081-e9d76fbc70f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi04LTEtMS0yMjUyNzE_f5816084-9cf3-4e18-9b9f-238dbaea48de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i469ae1eef4044e5f895df14e6080d08a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xMC0xLTEtMjI1Mjcx_766cc32a-953b-41cf-998c-72538a072d0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xMi0xLTEtMjI1Mjcx_6437486b-92cd-4f6f-8121-8170999e7cb7">88,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1f5e6ae23fa4d63a3b7da9463495857_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xNC0xLTEtMjI1Mjcx_49b72780-93ae-44b9-8388-d2e89f537e78">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xNi0xLTEtMjI1Mjcx_fee89afd-e01d-4aa2-beb7-1d2558fabad9">88,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0yLTEtMS0yMjUyNzE_1a09fcee-e5a1-4b26-8d0e-23672144694c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy00LTEtMS0yMjUyNzE_0853ae6e-1106-4432-9c0c-4ba71a777afd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy02LTEtMS0yMjUyNzE_b3be506f-6e0e-498f-90af-33f593f275bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy04LTEtMS0yMjUyNzE_1070c27d-dc98-47d0-93e0-3c7013dd3b57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ab24ba7b7534ef3b931937c49723e05_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xMC0xLTEtMjI1Mjcx_edaf9f34-c509-4a06-81b8-ada44f5e3b20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xMi0xLTEtMjI1Mjcx_442e961e-d1aa-4455-81cd-b81a12bed00e">7,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9776df6071649b4a36a68b2c62e8753_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xNC0xLTEtMjI1Mjcx_d629387d-82aa-4788-8279-54e9d5ae8fdc">6.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xNi0xLTEtMjI1Mjcx_d5ba84cd-b13f-45d2-a41c-0fa74f8d2ae8">7,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0yLTEtMS0yMjUyNzE_ffd352a7-4fa9-42d2-a23b-6806f6a64dc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC00LTEtMS0yMjUyNzE_23435815-6337-4958-8d88-a5fc08685939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC02LTEtMS0yMjUyNzE_f55836fc-c62f-4e60-a81b-57a10534a0cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC04LTEtMS0yMjUyNzE_f4d1a437-32bd-4d41-a85f-02531d3d2953">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12e46551b1814379a1653a9d1284593d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xMC0xLTEtMjI1Mjcx_a30ddcae-9596-49d0-af3c-768347a7fb23">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xMi0xLTEtMjI1Mjcx_b3142336-be6a-4183-b444-196fe3cf7f80">3,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2038eb8ce7646699de4006ca1c495d3_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xNC0xLTEtMjI1Mjcx_1aebd736-38c2-4841-a848-5945c384d70e">3.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xNi0xLTEtMjI1Mjcx_262ff4e5-e958-4e5a-bba9-f212c78488cc">803,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0yLTEtMS0yMjUyNzE_cb61667b-d287-4c90-a322-0be8edfc3bb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS00LTEtMS0yMjUyNzE_6d4f9ab9-0d6d-4bb0-beeb-1a37aefa5918">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS02LTEtMS0yMjUyNzE_f6a5feeb-c307-4851-9b19-f0cd98c0324f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS04LTEtMS0yMjUyNzE_fabcb912-3a5f-4424-9c76-c1563184968e">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd1122ff910845e8b7d84749fcb941af_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xMC0xLTEtMjI1Mjcx_341cb130-3d66-4780-8b25-1feb754163f8">3.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xMi0xLTEtMjI1Mjcx_4f21bc51-d441-4139-b7be-09d852c6bd0f">244,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic734fa1ccf034c29a212f61c7f547e08_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xNC0xLTEtMjI1Mjcx_6941f2a0-a0c0-4173-9751-89fe76f52e87">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xNi0xLTEtMjI1Mjcx_7da005a1-939e-4d2d-9443-c8fe206a3d16">1,450,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0yLTEtMS0yMjUyNzE_8af56210-88e4-438a-aca7-5a96f73e4b43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi00LTEtMS0yMjUyNzE_c2e742a0-b1fc-4cf2-b3f3-5dcf990cce9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi02LTEtMS0yMjUyNzE_b678c718-05bf-4b61-9ad6-9e8dbf7cb0b8">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi04LTEtMS0yMjUyNzE_6f72f971-3b88-4a75-807e-81963113a461">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46f077c3935347968dfccf4e35e46bc8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xMC0xLTEtMjI1Mjcx_8219a5ec-9ec4-4695-b3f7-499dad487e86">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xMi0xLTEtMjI1Mjcx_79a1591a-21a7-4a2f-b515-003dcd59d062">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2253586656694cfe961e9fd10a8da88a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xNC0xLTEtMjI1Mjcx_21f4f310-879a-4bc8-8045-4a85fc71fd7f">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xNi0xLTEtMjI1Mjcx_1c6c9ab8-1492-49c6-a0bb-bfd2032b5065">950,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0yLTEtMS0yMjUyNzE_7b67b0b9-bc7c-4f63-8ced-ae21b86baf94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy00LTEtMS0yMjUyNzE_75ef0c5d-fff2-439f-bed8-68d85bbb8462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy02LTEtMS0yMjUyNzE_5f69f73e-0d95-4eb7-aa77-1c1b865f21fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy04LTEtMS0yMjUyNzE_28eec776-4553-4394-90b1-a9dfb9831df2">3,200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9765a57b7623473f9f941b33ccfde3f6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xMC0xLTEtMjI1Mjcx_75418b2d-5a64-4f64-89f8-5cb2161200d0">3.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xMi0xLTEtMjI1Mjcx_7f7287ba-480c-4121-ae90-3812abc631ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb996687cada4f59931cae009c110517_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xNC0xLTEtMjI1Mjcx_0ed6c58d-5e9f-4c53-8d21-64b0c4176d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xNi0xLTEtMjI1Mjcx_591eaadb-a186-466c-a8ac-19f0b03ef9f9">3,200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0yLTEtMS0yMjUyNzE_9b0ead6c-f415-4854-a95a-87eb74d02ab9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC00LTEtMS0yMjUyNzE_06f29d95-7ec2-4cf0-a85c-e6b712962fb6">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC02LTEtMS0yMjUyNzE_85d9311a-3745-4400-ac2b-132cd8114293">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC04LTEtMS0yMjUyNzE_01969762-1278-4d0d-aec3-a921d5fc9132">5,100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0xMi0xLTEtMjI1Mjcx_06a1733a-58a6-46f0-a82c-000f9feccbca">343,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0xNi0xLTEtMjI1Mjcx_67c5104b-c4da-46fe-8de4-ac465eb59290">6,499,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums, (discounts), and debt issuance costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0yLTEtMS0yMjUyNzE_c7e5d241-f591-4c65-bd1f-6c839375a354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS00LTEtMS0yMjUyNzE_68f781cc-cc15-4413-ad03-62f5f11da599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS02LTEtMS0yMjUyNzE_9d5826e1-33ec-4f6b-abf9-f9e03c6a10bc">3,832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS04LTEtMS0yMjUyNzE_6deae941-a3b5-4a17-9fa5-7465ca8d0403">43,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0xMi0xLTEtMjI1Mjcx_9d0d16ce-dca0-452c-b533-c0ea5fca3560">1,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0xNi0xLTEtMjI1Mjcx_17898c56-dcdf-4650-a497-355a5ecb0f11">46,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMi0xLTEtMjI1Mjcx_a2c64060-3f31-4175-883c-07d2553b3a37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItNC0xLTEtMjI1Mjcx_30876eb9-8cd8-4b52-a165-0997cbf3d9b6">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItNi0xLTEtMjI1Mjcx_a67092b0-affa-4ba7-b58c-44a125f99638">496,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItOC0xLTEtMjI1Mjcx_2aead66c-ed16-44c4-b709-e64baae6559c">5,056,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMTItMS0xLTIyNTI3MQ_5e140c4b-8587-4328-84f8-1232a81251b9">345,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMTYtMS0xLTIyNTI3MQ_4dee8826-f51e-4d49-92e3-141ce620dbdc">6,453,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from <ix:nonFraction unitRef="number" contextRef="i6ddb72c0e5024725b2aacf24463019d1_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTA5OTQ_737cd129-a618-4f35-9a70-4084bbd69760">1.54</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i56bcb722a57e4a5eb514929d2ed3a154_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwMDA_f846362a-343a-4aac-b074-c1d58e9352cb">6.87</ix:nonFraction>% with a weighted average effective interest rate of <ix:nonFraction unitRef="number" contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwNTQ_8c104199-be4c-4060-96ef-2f962c05223e">3.53</ix:nonFraction>% and a weighted average maturity of <ix:nonNumeric contextRef="i2c875874da304c448ab2b679d2ced02a_D20230101-20230331" name="peak:DebtInstrumentWeightedAverageMaturity" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwOTI_ec56c072-1a51-4b5d-8c4e-66bac425fd0c">6</ix:nonNumeric> years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from <ix:nonFraction unitRef="number" contextRef="ie33b9cb06a4a42afbb61346e750be99c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTExNTQ_3ce66917-f010-46a9-a855-d36dfbd04329">3.44</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i21b4bc2e6a6546b1a01836e0851863d9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTExNjA_42494a5d-2752-43c0-a739-813656c27e37">8.52</ix:nonFraction>% with a weighted average effective interest rate of <ix:nonFraction unitRef="number" contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEyMTQ_9d0b302a-583c-41cd-b994-a6b7b8f26559">4.31</ix:nonFraction>% and a weighted average maturity of <ix:nonNumeric contextRef="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331" name="peak:DebtInstrumentWeightedAverageMaturity" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEyNTI_f2ef5890-a05d-465b-b238-359a959dea94">3</ix:nonNumeric> years. These interest rates include the impact of designated interest rate swap instruments, which effectively fix the interest rate on certain variable rate debt.</span></div></ix:nonNumeric></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMjE2Nw_5598c5a6-fc54-4cd0-866b-b6a873638ae6" continuedAt="ie2fc6da924ba42b78741d6e8723049b2" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ie2fc6da924ba42b78741d6e8723049b2"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#8217;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#8217;s financial condition, results of operations, or cash flows. The Company&#8217;s policy is to expense legal costs as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs and Other Partnerships</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of certain limited liability companies (&#8220;DownREITs&#8221;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#8220;make-whole payments&#8221;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of <ix:nonFraction unitRef="property" contextRef="icd23299bf615464e91aa88b816387e2f_I20230331" decimals="INF" name="peak:ContributionOfPropertyNumberOfProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMTc5Mg_6a521547-e784-43d6-89a5-bf9c7c720a35">29</ix:nonFraction> properties. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company owns a <ix:nonFraction unitRef="number" contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMTg0MQ_2918a23c-0056-49b2-bc7c-30c28c5c2a73">49</ix:nonFraction>% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk2Nw_f017b699-4ff1-48e3-bcc6-19c886f5c8aa" continuedAt="i4234a30c26cb4527bccd264399c8ce99" escape="true">Equity and Redeemable Noncontrolling Interests</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i4234a30c26cb4527bccd264399c8ce99" continuedAt="i6e441d1c37284133913e443d62196d68"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9ae86f1b07b148be8f4de81f938ee842_D20230427-20230427" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTgz_f44713a9-1582-4e44-bcfc-facb6781030d">0.30</ix:nonFraction> per share. The common stock cash dividend will be paid on May 19, 2023 to stockholders of record as of the close of business on May 8, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and 2022, the Company declared and paid common stock cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_3f2c3cc0-8d55-4669-868e-43810b703b4b"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_85f1224b-4ef8-443e-a915-64c0b097d416"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_896527d5-2411-4091-9f4c-4eb33e706837"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_d2ba14cb-a70e-4531-a3bc-e104e28a7af1">0.30</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-The-Market Equity Offering Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, in connection with the UPREIT reorganization, the Company terminated the previous at-the-market equity offering program (as amended from time to time, the &#8220;2020 ATM Program&#8221;) and established a new at-the-market equity offering program (the &#8220;2023 ATM Program&#8221; and, together with the 2020 ATM Program, the &#8220;ATM Programs&#8221;). The ATM Programs allow for the sale of shares of common stock having an aggregate gross sales price of up to $<ix:nonFraction unitRef="usd" contextRef="ie980168387e14a51a49837fe74a3b54e_D20230101-20230331" decimals="-8" name="peak:AtmEquityOfferingProgramAggregateAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfOTM3_71d34c83-8e66-43ef-86dc-489dbd3e0910">1.5</ix:nonFraction> billion (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#8220;ATM forward contract&#8221;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATM forward contracts generally have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTUwMw_5ce2ccbc-5900-4089-b403-cb14df27b311">one</span> to <ix:nonNumeric contextRef="i22723edd392546a88d01e90f6ec4ae55_D20230101-20230331" name="peak:OptionIndexedToIssuersEquityTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk3MQ_60c76e75-32a4-4eda-95d7-553b81af891f">two year</ix:nonNumeric> term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#8217;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#8217; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i7b96d988a94d4b5ca66cf68c72e38da9_D20230101-20230331" decimals="-8" name="peak:ATMEquityOfferingProgramAggregateAmountRemaining" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjA4Ng_660b33a9-d6b7-44b3-9c1b-8edad0c60e81">1.5</ix:nonFraction> billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s common stock remained available for sale under the 2023 ATM Program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company utilized the forward provisions under the 2020 ATM Program to allow for the sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="i8051818203c34f2692f50e33f9538046_D20210101-20211231" decimals="-5" name="us-gaap:ForwardContractIndexedToIssuersEquityShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjMzMQ_00a0426d-d169-4f48-bfd3-62b537c388b4">9.1</ix:nonFraction>&#160;million shares of its common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at an initial weighted average net price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8051818203c34f2692f50e33f9538046_D20210101-20211231" decimals="2" name="us-gaap:ForwardContractIndexedToIssuersEquityForwardRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjQwNQ_0fb610ba-8452-4115-9e8a-2e5937bae523">35.25</ix:nonFraction> per share, after commissions. The Company did not enter into any forward contracts under the 2020 ATM Program during the year ended December 31, 2022. In December 2022, the Company settled all <ix:nonFraction unitRef="shares" contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231" decimals="-5" name="us-gaap:ForwardContractIndexedToIssuersEquityShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ3MA_730deaf1-fc77-4100-828b-3de8a6b825c1">9.1</ix:nonFraction>&#160;million shares previously outstanding under ATM forward contracts at a weighted average net price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231" decimals="2" name="us-gaap:ForwardContractIndexedToIssuersEquityForwardRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ4Mw_b0303a77-75fd-4df7-8dea-bde3d0b85dfd">34.01</ix:nonFraction> per share, after commissions, resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ5MQ_c1a693e5-c6f8-482e-93c8-b4a4f4d4ab3b">308</ix:nonFraction>&#160;million. During the three months ended March&#160;31, 2023, the Company did not utilize the forward provisions under the ATM Programs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Direct Issuances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i37deeeb2d4054785a004587600392cdb_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjg1Mg_6a11821d-2d20-4165-a81e-b692424d077b"><ix:nonFraction unitRef="shares" contextRef="if38c0299b9e346949730c17e3fc40429_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjg1Mg_c6d7e352-8f09-42e7-a285-a76ab8e50ecf">no</ix:nonFraction></ix:nonFraction> direct issuances of shares of common stock under the ATM Programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2022, the Company&#8217;s Board of Directors approved a share repurchase program under which the Company may acquire shares of its common stock in the open market up to an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i89c46ce3b6194ec8a6f4bdaad32eab03_I20220801" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMzE1Mw_0e47f2c3-72d1-49f3-8dab-07d4f655f52f">500</ix:nonFraction>&#160;million (the &#8220;Share Repurchase Program&#8221;). Purchases of common stock under the Share Repurchase Program may be exercised at the Company&#8217;s discretion with the timing and number of shares repurchased depending on a variety of factors, including price, corporate and regulatory requirements, and other corporate liquidity requirements and priorities. The Share Repurchase Program expires in August 2024 and may be suspended or terminated at any time without prior notice. Under Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In August 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM0NTg_4f7c95bb-6641-41fd-83ab-b2992514f85d"><ix:nonFraction unitRef="shares" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM0NTg_ca91e026-e3c7-4854-b7eb-a89af6da4b36">2.1</ix:nonFraction></ix:nonFraction>&#160;million shares of its common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1MjA_19dbf415-c9a6-449f-abc4-8e94e7d2b777"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1MjA_d87e2bb9-10b1-4b07-9876-75434a1c6d86">27.16</ix:nonFraction></ix:nonFraction> per share for a total of $<ix:nonFraction unitRef="usd" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1NDk_116b078c-b5b2-4f63-b021-6391126ae763"><ix:nonFraction unitRef="usd" contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1NDk_25833348-bb30-4554-aa4b-bdb863efe568">56</ix:nonFraction></ix:nonFraction>&#160;million. During the three months ended March&#160;31, 2023, there were <ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NTk4Nw_aa9de332-9037-46e9-b596-80a260cfea5a">no</ix:nonFraction> repurchases under the Share Repurchase Program. Therefore, at March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMzc4Mg_c5a6e377-146e-4768-88cc-ee55c8b2c246">444</ix:nonFraction>&#160;million of the Company&#8217;s common stock remained available for repurchase under the Share Repurchase Program. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i6e441d1c37284133913e443d62196d68"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk2NA_157bdfe9-1fa9-4af9-a504-cbff61c712d2" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on derivatives, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMi0yLTEtMS0yMjUyNzE_b4544588-f363-4dfc-a50f-2c3965f63968">20,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMi00LTEtMS0yMjUyNzE_d3d7260a-2d47-4242-8af9-92f7f8e1c30d">30,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMy0yLTEtMS0yMjUyNzE_22456e82-0fc8-46d5-829c-006954b26cbe">1,947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMy00LTEtMS0yMjUyNzE_b4ce70c9-3906-4675-9510-04733ee7326a">2,011</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfNS0yLTEtMS0yMjUyNzE_25610848-8adf-44ce-aa77-aeff52edd446">18,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfNS00LTEtMS0yMjUyNzE_049887cf-3df7-4598-917a-5b9a703cc7ce">28,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined benefit pension plan, known as the Supplemental Executive Retirement Plan, with <ix:nonFraction unitRef="plan_participant" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="peak:NumberOfPlanParticipants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTA5OTUxMTY0NzE0OA_724ea676-557a-4d7b-8352-6b8a9cb9e749">one</ix:nonFraction> plan participant, a former Chief Executive Officer (&#8220;CEO&#8221;) of the Company who departed in 2003. Changes to the Supplemental Executive Retirement Plan minimum liability are reflected in other comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#8217;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, <ix:nonFraction unitRef="interest" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestRedemptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3Nzg3NQ_a1bff7fe-932e-4d9f-8d7a-7152ede47b3f">one</ix:nonFraction> of the redeemable noncontrolling interests met the conditions for redemption, but was not yet exercised as of March&#160;31, 2023. The <ix:nonFraction unitRef="interest" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3Nzg5NA_00994f8e-0fc1-4ed5-ab87-b9e0a04d88a3">three</ix:nonFraction> remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2023 or December&#160;31, 2022. <ix:nonFraction unitRef="interest" contextRef="i6f249757fb504a429bb6dd03fb8bb2be_D20230101-20241231" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NzkwMA_cf2d0553-8b4d-4727-99a0-fa9c8c9b2836">Two</ix:nonFraction> of the interests will become redeemable following the passage of a predetermined amount of time, which will occur during 2023 and 2024. The third interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2024. The redemption values are subject to change based on the assessment of redemption value at each redemption date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthpeak OP</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the Reorganization, Healthpeak Properties, Inc. was the initial sole member and <ix:nonFraction unitRef="number" contextRef="i6d31221783254ce6bc6a96ffefb649d9_I20230210" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA4OTE4Ng_c4dfdff2-549f-402e-a097-27b8cdfd0e36">100</ix:nonFraction>% owner of Healthpeak OP. Subsequent to the Reorganization, certain employees of the Company (&#8220;OP Unitholders&#8221;) were issued noncontrolling, non-managing member units in Healthpeak OP (&#8220;OP Units&#8221;). As of March&#160;31, 2023, Healthpeak Properties, Inc. owned <ix:nonFraction unitRef="number" contextRef="i8e5a31f73d324958966392fee1b98bb2_I20230331" decimals="4" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA4MDU3Nw_e73bcb2b-70c0-4896-869e-bc93bfa94257">99.6</ix:nonFraction>% of Healthpeak OP, with the OP Unitholders owning the remaining <ix:nonFraction unitRef="number" contextRef="i8e5a31f73d324958966392fee1b98bb2_I20230331" decimals="4" name="peak:RemainingMinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNjA0NzMxMzk2NjYwMQ_39d53831-a5ee-46b4-b52a-377886718a2c">0.4</ix:nonFraction>%. When certain conditions are met, the OP Unitholders have the right to require redemption of part or all of their OP Units for cash or shares of the Company&#8217;s common stock, at the Company&#8217;s option as managing member of Healthpeak OP. The per unit redemption amount is equal to either one share of the Company&#8217;s common stock or cash equal to the fair value of a share of common stock at the time of redemption. The Company classifies the OP Units in permanent equity because it may elect, in its sole discretion, to issue shares of its common stock to OP Unitholders who choose to redeem their OP Units rather than using cash. None of the outstanding OP Units met the criteria for redemption as of March&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-managing member units of the Company&#8217;s DownREITs are exchangeable for an amount of cash approximating the then-current market value of shares of the Company&#8217;s common stock or, at the Company&#8217;s option, shares of the Company&#8217;s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company&#8217;s common stock, the carrying amount of the DownREIT units is reclassified to stockholders&#8217; equity. At March&#160;31, 2023, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-6" name="peak:DownREITUnitsOutstanding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzQwNzg_a6587876-0add-4a69-ab02-fc06ed23bf1b">five million</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT units (<ix:nonFraction unitRef="shares" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-6" name="peak:CommonStockConvertibleSharesIssuable" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MDU1_bab5b2d3-38bc-4e4d-88bd-31a74cf5557e">seven million</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of Healthpeak common stock are issuable upon conversion) outstanding in</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="entity" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="INF" name="peak:NumberOfDownREITLLCs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MDg3_943959d3-2ea6-432d-b84a-ddc0a4a6f868">seven</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT&#160;LLCs, for all of which the Company acts as the managing member. At March&#160;31, 2023, the carrying and market values of the <ix:nonFraction unitRef="shares" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-6" name="peak:DownREITUnitsOutstanding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzQwOTA_a6587876-0add-4a69-ab02-fc06ed23bf1b">five million</ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT units were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-6" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1Mjcz_2a7c8cb1-f0fb-40ec-980a-7a0ec8ac0cf1">200</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331" decimals="-6" name="peak:MinorityInterestInPreferredUnitHoldersFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MzAx_5762e85b-03e9-4e13-aaf0-7f628777d417">160</ix:nonFraction>&#160;million, respectively. At December&#160;31, 2022, the carrying and market values of the <ix:nonFraction unitRef="shares" contextRef="i530e671af080458e9ba7b21a10d74180_I20221231" decimals="-6" name="peak:DownREITUnitsOutstanding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM0ODk1_77714535-b6eb-4f0a-85e8-994d1ca6def7">five million</ix:nonFraction> DownREIT units were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i530e671af080458e9ba7b21a10d74180_I20221231" decimals="-6" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNzE0NjgyNTYwMzgxMQ_08a28506-08d7-4d8f-b1f7-48721b6f40f5">200</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i530e671af080458e9ba7b21a10d74180_I20221231" decimals="-6" name="peak:MinorityInterestInPreferredUnitHoldersFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNzE0NjgyNTYwMzgyNQ_fe039b83-bcfc-45dd-85f7-41cc8427c42e">183</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjU2MA_1b4cc41e-e87a-48da-a529-a436123ff908" continuedAt="id0fa18dfeaeb4603aa2f8eacc80f0024" escape="true">Earnings Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="id0fa18dfeaeb4603aa2f8eacc80f0024"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per common share (&#8220;EPS&#8221;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method, common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#8217;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#8217;s diluted weighted-average common shares for each of the three months ended March&#160;31, 2023 and 2022 was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="INF" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMTY4Ng_3f22b4b1-65a0-4795-9306-41cb270dbd87"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="INF" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMTY4Ng_4e4fdada-0114-4770-b62f-c4ed477cdd28">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted-average incremental shares from forward equity sales agreements.&#160;</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjU2Nw_b823f025-4ecb-4920-b7f9-37750eab264a" continuedAt="i31e03dc990984f10a46a09ee1460aea8" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMy0xLTEtMS0yMjUyNzE_e0ef2b00-8e0b-4508-a859-575085176add">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMy0zLTEtMS0yMjUyNzE_604c1f76-a703-4a56-bdcc-a096f97a9543">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNC0xLTEtMS0yMjUyNzE_e73f7ac9-c9eb-4b26-a2fd-2ebf347858ce">15,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNC0zLTEtMS0yMjUyNzE_aece1cb7-691c-4280-ad90-f2ff17dc3565">3,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNS0xLTEtMS0yMjUyNzE_5c75b285-58a7-4b48-9452-8c520283c8e3">118,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNS0zLTEtMS0yMjUyNzE_d1e0afdb-33a7-4ca2-a75f-f20778664054">71,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNi0xLTEtMS0yMjUyNzE_5e0901ce-3541-4e25-808e-2212d3fff5f6">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNi0zLTEtMS0yMjUyNzE_11fcce6c-ad2f-479c-896b-40ed714b81a5">1,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNy0xLTEtMS0yMjUyNzE_fb7af170-fe79-41c4-b70d-5179d09ae2b2">117,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNy0zLTEtMS0yMjUyNzE_793a9c89-9a31-42e7-92a9-422839ede0dc">69,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfOC0xLTEtMS0yMjUyNzE_3290ffe4-9d92-439c-a3ff-cfa80600f911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfOC0zLTEtMS0yMjUyNzE_3489f416-19b5-42f1-a78c-3d70a81f1bf3">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares - basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMS0xLTEtMjI1Mjcx_0dc2f718-656b-4e9a-9c64-1dabf142141d"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMS0xLTEtMjI1Mjcx_f9bc5d58-cfae-4efd-8d0f-09257932aeb3">117,698</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMy0xLTEtMjI1Mjcx_3af4a83a-3d02-4151-b379-d506d1847661"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMy0xLTEtMjI1Mjcx_f6ad8c11-316e-48f4-86f4-7c9f8de4a32f">69,637</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTYtMS0xLTEtMjI1Mjcx_e4fdd566-304f-4835-8402-cb06357836ac">546,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTYtMy0xLTEtMjI1Mjcx_cc306484-02ae-4ca8-8b04-611a6cb1fa57">539,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTctMS0xLTEtMjI1Mjcx_89d79a12-3ee6-4924-8cf0-beba4b600a11">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTctMy0xLTEtMjI1Mjcx_2db8709a-f5d2-47d2-997c-e62da0e0f811">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjAtMS0xLTEtMjI1Mjcx_794f69c7-8049-4a40-af42-80db62536100">547,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjAtMy0xLTEtMjI1Mjcx_0cc96b71-15c8-4aa3-93aa-02335da177eb">539,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjItMS0xLTEtMjI1Mjcx_3d348ea4-6d07-4f06-a742-4842a484f4d0">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjItMy0xLTEtMjI1Mjcx_eb8969f9-6b33-4ff4-b308-d496ad690f99">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjMtMS0xLTEtMjI1Mjcx_f800c764-1f97-4710-bc47-5f7d751f9e34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjMtMy0xLTEtMjI1Mjcx_32942715-a45d-4d58-a9ae-20ad8093f02b">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjQtMS0xLTEtMjI1Mjcx_084ab728-48b0-4b6a-a4cf-a406f714a3a5">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjQtMy0xLTEtMjI1Mjcx_2b353618-e93b-453e-9af0-95298888dec0">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjYtMS0xLTEtMjI1Mjcx_2c0b182e-d2ff-4342-a563-899a6117dae6">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjYtMy0xLTEtMjI1Mjcx_0c502cfb-6f6e-4c49-994f-324329cf2533">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjctMS0xLTEtMjI1Mjcx_c8541e3c-911f-4761-a7ff-36c057602290">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjctMy0xLTEtMjI1Mjcx_049e8a14-2e68-4c65-af28-a6a4ace20963">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjgtMS0xLTEtMjI1Mjcx_fa00c3a0-5b68-454f-a63c-c1e8a1c17366">0.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjgtMy0xLTEtMjI1Mjcx_5b7c9800-2229-4ba8-aa36-73354afbbfa4">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i31e03dc990984f10a46a09ee1460aea8" continuedAt="i5716312f459d4398a95765c9b28a32be">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i5716312f459d4398a95765c9b28a32be">For all periods presented, represents the dilutive impact of <ix:nonFraction unitRef="shares" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjAwMg_13ee00a3-40d3-4566-bb44-2c8687eced1e"><ix:nonFraction unitRef="shares" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjAwMg_e6e5180a-b98d-4fb0-8aab-b2d0c9f10ef3">1</ix:nonFraction></ix:nonFraction> million outstanding equity awards (restricted stock units and stock options).</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, forward equity sales agreements had <ix:nonFraction unitRef="shares" contextRef="i89007938f53d4ab597b1694f0b7aa3a3_D20230101-20230331" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjc0ODc3OTA3NzQ4MQ_135b69c2-1ffb-496a-a42a-bf8e3ada66ad">no</ix:nonFraction> dilutive impact as no shares were outstanding under ATM forward contracts during the period. For the three months ended March&#160;31, 2022, the <ix:nonFraction unitRef="shares" contextRef="i2b23f95c9490405980d3b3ccc448589e_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjc0ODc3OTA3NzYxMw_f7d6cd43-61fb-49a7-840b-ad3f75099f23">9.1</ix:nonFraction> million shares under forward equity sales agreements that had not been settled during the three months then ended were anti-dilutive.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, all <ix:nonFraction unitRef="shares" contextRef="i4e4a87426c744c7ab4128e461f3c1dce_D20230101-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjQ1Mg_03a49cb1-2c4d-435d-b786-25cfcd7d5db9"><ix:nonFraction unitRef="shares" contextRef="icc3bbec47ce44e14b11efe8fe8b782a7_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjQ1Mg_43bbc2f9-5671-4a64-92f5-4b39499882d3">7</ix:nonFraction></ix:nonFraction> million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfNDE1Mg_65bd1b01-1f0e-4e0e-ac4f-4261c589d777" continuedAt="i882c09a7a541439ca85b3961e043ac8b" escape="true">Segment Disclosures</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i882c09a7a541439ca85b3961e043ac8b" continuedAt="iad7ed9d840b74cd9bb8d6cd06df45e93"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments, based on how its chief operating decision maker (&#8220;CODM&#8221;) evaluates the business and allocates resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#8217;s interests in an unconsolidated JV that owns <ix:nonFraction unitRef="property" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="INF" name="peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfMzc4_2a8d85de-3899-48a0-a51e-7f62358b9cd7">19</ix:nonFraction> senior housing assets (the &#8220;SWF SH JV&#8221;), loans receivable, and marketable debt securities. These non-reportable segments have been presented on an aggregate basis within the Notes to the Consolidated Financial Statements herein. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC, as updated by Note 2 herein. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI are non-GAAP supplemental measures that are calculated as NOI and Adjusted NOI from consolidated properties, plus the Company&#8217;s share of NOI and Adjusted NOI from unconsolidated joint ventures (calculated by applying the Company&#8217;s actual ownership percentage for the period), less noncontrolling interests&#8217; share of NOI and Adjusted NOI from consolidated joint ventures (calculated by applying the Company&#8217;s actual ownership percentage for the period). Management utilizes its share of NOI and Adjusted NOI in assessing its performance as the Company has various joint ventures that contribute to its performance. The Company does not control its unconsolidated joint ventures, and the Company&#8217;s share of amounts from unconsolidated joint ventures do not represent the Company&#8217;s legal claim to such items. The Company&#8217;s share of NOI and Adjusted NOI should not be considered a substitute for, and should only be considered together with and as a supplement to, the Company&#8217;s financial information presented in accordance with GAAP. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-segment assets consist of assets in the Company&#8217;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable debt securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="iad7ed9d840b74cd9bb8d6cd06df45e93" continuedAt="i9929a226d59f4327acf31e9a88e05f3e"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfNDE2NA_d0d0ed00-bf7b-45c7-9c76-04652d9b750d" continuedAt="ia130b180ebee403e975d2633bfe143e9" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0yLTEtMS0yMjUyNzE_5ae3069b-3d9a-41d0-ac05-0bba5e95fbfd">205,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS00LTEtMS0yMjUyNzE_3305024f-947a-490b-9629-42f7bf8ef7d8">186,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS02LTEtMS0yMjUyNzE_463a5e38-dde0-4592-baac-45e6b03e1749">127,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS04LTEtMS0yMjUyNzE_3068b020-6682-4d98-8080-46bf8e9fafc1">6,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0xMC0xLTEtMjI1Mjcx_c72e624e-7ca0-4fbf-b9ba-89a8eb6e6b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0xMi0xLTEtMjI1Mjcx_d0d88d90-2650-4809-acee-fc19b8239df4">525,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0yLTEtMS0yMjUyNzE_994b25d0-b35c-4974-a503-a02c66d7d85c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi00LTEtMS0yMjUyNzE_70e4ea19-cbb9-4372-9974-b8d22554ffe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi02LTEtMS0yMjUyNzE_400d045a-83d0-4481-9b7d-952dda3c3ec9">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi04LTEtMS0yMjUyNzE_98a4c66e-ce6c-4e7e-8929-86f7ce235105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0xMC0xLTEtMjI1Mjcx_7d6f5205-d15b-4a2e-9869-a2b0fd417a0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0xMi0xLTEtMjI1Mjcx_7ba3b872-7afc-474c-9d25-32a1951b31d8">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0yLTEtMS0yMjUyNzE_f2e29670-4c09-44d1-a3c3-74cc92eb3029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy00LTEtMS0yMjUyNzE_149cd1af-6d45-4086-8604-7c82d5622210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy02LTEtMS0yMjUyNzE_ee69aac2-8b8c-4f70-a6dc-3afb1ec09a1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy04LTEtMS0yMjUyNzE_c098ad0e-5f84-48d1-a348-76a88567fb43">6,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0xMC0xLTEtMjI1Mjcx_bec1e6fe-5ee3-49cd-a727-b7e3eb458298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0xMi0xLTEtMjI1Mjcx_12877b42-210a-4a30-a2b8-051c449a164a">6,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0yLTEtMS0yMjUyNzE_5be41e9b-41f9-416d-8cd8-bc592d3c2f53">2,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC00LTEtMS0yMjUyNzE_3a4507b8-e400-4999-b12a-4f02b70f819a">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC02LTEtMS0yMjUyNzE_21884aab-2823-4f02-88df-fda28ffe9225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC04LTEtMS0yMjUyNzE_c012fe67-bd6d-4240-a409-a4f788730462">20,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0xMC0xLTEtMjI1Mjcx_ec54c1e9-4c37-4c9a-bc70-43b7ad92e3b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0xMi0xLTEtMjI1Mjcx_d1f63096-4efa-4d00-bb91-ca395ce96f56">23,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0yLTEtMS0yMjUyNzE_fe351e91-2fc5-420d-b1e1-61f31b38872f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS00LTEtMS0yMjUyNzE_d38367d9-91d8-4252-b2b9-344ca3986b81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS02LTEtMS0yMjUyNzE_58199893-ce48-4170-88c1-d0c2acc0aa9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS04LTEtMS0yMjUyNzE_1b080602-9736-4a69-b9ec-32306f7b3b7d">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0xMC0xLTEtMjI1Mjcx_6e675f99-2018-4151-9012-331eceda8b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0xMi0xLTEtMjI1Mjcx_b77690e1-de0b-441a-9383-97be4ef69b43">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0yLTEtMS0yMjUyNzE_c8af2759-aca4-45c1-b9d6-73096a4e1971">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi00LTEtMS0yMjUyNzE_27fde9c4-bf08-4a30-9e2f-2a465fac999a">8,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi02LTEtMS0yMjUyNzE_2a9cf8bf-c4e8-4316-96da-171a06eb8adb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi04LTEtMS0yMjUyNzE_b18963ed-b170-41c7-b914-7cb79b0c16ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0xMC0xLTEtMjI1Mjcx_e4493c08-bd0a-4ae3-b2be-b1b2a551e97b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0xMi0xLTEtMjI1Mjcx_994ee5b9-91f6-46da-959c-5131b2c4a2b0">9,106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0yLTEtMS0yMjUyNzE_b869a293-d81e-4f6f-8520-5e7f2679f98e">57,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy00LTEtMS0yMjUyNzE_94a54d72-2b2e-4c9f-a220-477fb3bfe8c9">64,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy02LTEtMS0yMjUyNzE_b3d68af4-0326-448a-a806-b181a944ae36">101,124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy04LTEtMS0yMjUyNzE_078d3a7e-0565-4404-a517-0d1fb020aca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0xMC0xLTEtMjI1Mjcx_b24e52fd-42c2-41b1-bca3-bb6907e62ce8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0xMi0xLTEtMjI1Mjcx_06a260c6-3627-4000-9b2e-adad1f131ae1">223,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0yLTEtMS0yMjUyNzE_1394fb76-3015-44aa-969e-b74bd2f45a58">1,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC00LTEtMS0yMjUyNzE_1aae102e-f092-4ff2-a72a-b6cea34d4898">305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC02LTEtMS0yMjUyNzE_dc478de7-d2b5-42bf-a67a-189f22004447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC04LTEtMS0yMjUyNzE_5b476de7-3f42-4499-a19f-1760fb778b5f">15,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0xMC0xLTEtMjI1Mjcx_dd2bcae1-3385-4daf-8a01-1378d6f6d9f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0xMi0xLTEtMjI1Mjcx_0d5b1df7-b8c8-40d3-99c3-01e914b0b82f">16,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0yLTEtMS0yMjUyNzE_7ff1a213-069b-4551-b0c5-0d17e76d089c">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS00LTEtMS0yMjUyNzE_475588f5-7cb8-42f0-932d-770d66acd5a3">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS02LTEtMS0yMjUyNzE_fb620b2a-ebe1-48dd-a8bd-c1d8b1b7ecbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS04LTEtMS0yMjUyNzE_d755b040-767a-4f1f-91a4-1fbe701056da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0xMC0xLTEtMjI1Mjcx_d8aa2568-45eb-4e61-b792-b7a4f006cf37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0xMi0xLTEtMjI1Mjcx_ec144278-6e6b-49b3-b5ea-41e88b58d46c">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMi0xLTEtMjI1Mjcx_54b75f48-6490-4fd1-964c-879082bc7284">832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtNC0xLTEtMjI1Mjcx_16c523a1-905a-4fc2-874c-87b1ef049d19">3,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtNi0xLTEtMjI1Mjcx_410cc081-9ade-40aa-ac92-78aef286feb7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtOC0xLTEtMjI1Mjcx_894d2974-f80c-40eb-9635-a1b8c737fec6">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMTAtMS0xLTIyNTI3MQ_7ec55353-c064-4858-89ce-a09234b3b887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMTItMS0xLTIyNTI3MQ_77daba9a-0f45-416a-bc4d-0779ed73fcce">4,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMi0xLTEtMjI1Mjcx_e62c1c83-5f0f-492f-afda-4fcaeeb72a59">147,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItNC0xLTEtMjI1Mjcx_c1864139-c980-4403-8ae5-44c3de8e920b">112,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItNi0xLTEtMjI1Mjcx_04e295d1-8126-4d47-abf9-00bcde534907">26,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItOC0xLTEtMjI1Mjcx_5d6e43e9-4350-41fc-9829-facb9ca526e4">5,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMTAtMS0xLTIyNTI3MQ_9379448c-d93e-4bb1-a6b9-429c7b3a04d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMTItMS0xLTIyNTI3MQ_1de3cda8-2681-4469-b2c4-ed6e9ee6692d">292,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMi0xLTEtMjI1Mjcx_d4b4c93f-0154-48fd-b4a1-559b43b32eab">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtNC0xLTEtMjI1Mjcx_0115353a-2f2a-4b63-8f39-1fcad98a8292">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtNi0xLTEtMjI1Mjcx_0a735ff9-285e-48cc-9df8-65553012d0b6">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtOC0xLTEtMjI1Mjcx_eeec5636-77d5-452b-829c-823d6a7abd56">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMTAtMS0xLTIyNTI3MQ_e3cb8a35-77b7-4f99-9043-48107300c117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMTItMS0xLTIyNTI3MQ_aa185041-1249-4990-bc36-99ced00579f8">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMi0xLTEtMjI1Mjcx_a23f2bdd-dbd9-49e1-9a6b-47aea98cdb23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtNC0xLTEtMjI1Mjcx_6bab59aa-4928-4b5f-99a2-49db31db166b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtNi0xLTEtMjI1Mjcx_7892985c-9312-407c-8aa9-fad95b916dc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtOC0xLTEtMjI1Mjcx_d6ad97b6-5620-468b-ab7a-5fba5eba1d23">6,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMTAtMS0xLTIyNTI3MQ_8c7bbc13-c1ce-4c6f-b708-31b53459188c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMTItMS0xLTIyNTI3MQ_f6a115d7-24d7-46bd-a5c0-194c7180bccd">6,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMi0xLTEtMjI1Mjcx_862461cf-4753-4267-8b39-b311180005ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtNC0xLTEtMjI1Mjcx_a03ba983-47c9-4231-ba47-9f1d2c334630">1,920</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtNi0xLTEtMjI1Mjcx_9477b8f7-8880-4c07-87a9-e3aad5289d37">1,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtOC0xLTEtMjI1Mjcx_276c32fb-f55d-44bd-897f-9402de56efc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMTAtMS0xLTIyNTI3MQ_6fdfce2e-4a57-4efc-8c64-b9cf1f4bc42b">44,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMTItMS0xLTIyNTI3MQ_19f962dd-73b5-4e44-b7de-1230ead505a4">47,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMi0xLTEtMjI1Mjcx_07f15326-5139-41ee-ad31-620e1fa79280">75,582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtNC0xLTEtMjI1Mjcx_cd98ec55-1584-4415-b3e6-f471162d5d4b">71,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtNi0xLTEtMjI1Mjcx_8ec4152c-1b7f-4b6c-9406-0f7327b9e42a">32,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtOC0xLTEtMjI1Mjcx_414fef7a-d3a7-4bbe-aace-78dddeb507ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMTAtMS0xLTIyNTI3MQ_6caff81e-c96d-4d11-ae4e-c8f1e664f4ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMTItMS0xLTIyNTI3MQ_e8888453-03dd-4b74-9892-101516cf0bc7">179,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMi0xLTEtMjI1Mjcx_a8f9c070-283e-445f-a4aa-74b86c45c89f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctNC0xLTEtMjI1Mjcx_65ea145c-d304-4893-89c4-28a77a190463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctNi0xLTEtMjI1Mjcx_72577db9-95ed-4afc-9f55-085f8572153a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctOC0xLTEtMjI1Mjcx_d9e33fab-7b2a-41b4-948a-e12a7162adbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMTAtMS0xLTIyNTI3MQ_cdae5d6b-b601-4b6a-9050-467fa9a9bbd2">24,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMTItMS0xLTIyNTI3MQ_7558e01b-51ce-4ba1-a74c-59c0b5d3a45c">24,547</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMi0xLTEtMjI1Mjcx_d7eae756-7f18-4f40-809c-cbe1b859f1eb">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtNC0xLTEtMjI1Mjcx_013fe3c8-cd5b-4382-b166-0d56e9eff13c">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtNi0xLTEtMjI1Mjcx_1fdf31da-42f6-4890-8255-c345f857cc2f">219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtOC0xLTEtMjI1Mjcx_a3aafa59-ba9d-4b08-b908-481d13733a75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMTAtMS0xLTIyNTI3MQ_b8689107-c9ce-4582-8aa9-fc0e724a0dd0">1,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMTItMS0xLTIyNTI3MQ_46408839-e629-4bf2-ad7f-4b4eda19b59f">2,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMi0xLTEtMjI1Mjcx_021c0b97-df92-4911-929e-01d3d419065e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktNC0xLTEtMjI1Mjcx_108675ec-de7c-4fc1-be7b-2299f9731d16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktNi0xLTEtMjI1Mjcx_9374d4d7-7127-4ad2-b804-6e9958421668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" sign="-" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktOC0xLTEtMjI1Mjcx_888c0f43-a951-4c35-b9ce-3e5ae3704e2b">2,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMTAtMS0xLTIyNTI3MQ_9510229c-76d8-4896-a330-dbfa1363c488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMTItMS0xLTIyNTI3MQ_7b1403d5-16d9-435a-a2cd-f5a6ca971ff0">2,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMi0xLTEtMjI1Mjcx_d975fac9-c4ce-450e-94c5-7d3dcd87cbc2">60,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtNC0xLTEtMjI1Mjcx_e5f29882-295b-4028-806c-1edbeb6ef88d">21,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtNi0xLTEtMjI1Mjcx_dd179e45-3ac3-4f8d-8769-d0850eb75887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtOC0xLTEtMjI1Mjcx_b60f1a1b-0a2b-412c-a77b-8f26b2c28f36">232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMTAtMS0xLTIyNTI3MQ_8c7fd4c4-9d52-46c9-8b2a-29a7f9779c46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMTItMS0xLTIyNTI3MQ_f6b336e7-5c83-4a4b-98dc-7637feebbf33">81,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMi0xLTEtMjI1Mjcx_748822f8-68c5-4cb6-847a-61384c967ad3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItNC0xLTEtMjI1Mjcx_27c4cc04-8669-4276-b277-b01dc4c66894">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItNi0xLTEtMjI1Mjcx_4f4611d0-80c0-4635-b593-51812c37f49f">667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItOC0xLTEtMjI1Mjcx_a778c551-9747-4159-9fe4-b9bcd5f5e9da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMTAtMS0xLTIyNTI3MQ_088626b4-f252-4adf-b33e-f476a337501c">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMTItMS0xLTIyNTI3MQ_d97899ef-6e91-43ec-b0da-d8a6a0ba1cd7">772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMi0xLTEtMjI1Mjcx_f3e20a0f-306d-4128-bcb4-10d7d0be7001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtNC0xLTEtMjI1Mjcx_6b3cd98c-65cb-44c9-8fcc-a4f48f8b42cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtNi0xLTEtMjI1Mjcx_c2092cf5-4d41-4371-ad31-72fdb806a485">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtOC0xLTEtMjI1Mjcx_eae95730-1f93-45b8-82d1-ad952b18aa0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMTAtMS0xLTIyNTI3MQ_3db59151-6035-4ddc-af2d-b80acb56d05c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMTItMS0xLTIyNTI3MQ_fe697534-cb57-42a9-a917-2c6d070d3ca3">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMi0xLTEtMjI1Mjcx_30ce9536-4bff-4849-b25c-ed861f687fa8">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtNC0xLTEtMjI1Mjcx_49c5ddfa-55f2-4f70-b2d8-a980db0026a9">440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtNi0xLTEtMjI1Mjcx_52d5bfe3-66f5-4fd3-b538-aaed3a641b0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtOC0xLTEtMjI1Mjcx_01b3eeae-a055-440d-9855-3082910cb141">5,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMTAtMS0xLTIyNTI3MQ_07762435-170b-4fff-b167-ad9ac522061a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMTItMS0xLTIyNTI3MQ_aecc70b0-2ea1-4172-9c59-1935143c4192">6,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMi0xLTEtMjI1Mjcx_77208a7e-9820-4214-a78b-a60bbafd2556">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtNC0xLTEtMjI1Mjcx_3fd08ca5-2d3a-4b13-b229-da9385cbfe10">6,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtNi0xLTEtMjI1Mjcx_7f4dc071-810b-4398-b93c-f78bb7d8b799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtOC0xLTEtMjI1Mjcx_4036061e-4f16-4f2f-b7fe-13cf4d269511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMTAtMS0xLTIyNTI3MQ_636e7302-0bd5-4d15-a4a4-1fa716854eeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMTItMS0xLTIyNTI3MQ_34f099e7-98b6-45e4-8c10-6661d5a5acbf">6,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMi0xLTEtMjI1Mjcx_1662259f-a1fd-46fb-9c43-db49230ba8fd">132,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtNC0xLTEtMjI1Mjcx_5ba8f9b0-c470-457a-93b0-5537f8964e75">70,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtNi0xLTEtMjI1Mjcx_fd3b9853-1784-4297-936b-9813619c60d9">9,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtOC0xLTEtMjI1Mjcx_ae3c4a32-ce5a-4a93-adda-f19cad223998">8,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMTAtMS0xLTIyNTI3MQ_b152e59c-e7ea-4d7a-b343-280ea49283f9">69,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMTItMS0xLTIyNTI3MQ_868e6900-b582-4aef-a8d7-7e20836c92db">132,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMi0xLTEtMjI1Mjcx_4b871ca5-1545-4226-9a03-cf035df078a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctNC0xLTEtMjI1Mjcx_fe8e5381-e53d-465e-a5f4-16cc790e43a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctNi0xLTEtMjI1Mjcx_0f15e8e6-c3c6-4e10-9ff6-5d008e5713f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctOC0xLTEtMjI1Mjcx_4ab9c402-4df0-4c58-b178-a023d5dd3d20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMTAtMS0xLTIyNTI3MQ_8e5c7de5-c06b-47f3-bffb-6732815e872b">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMTItMS0xLTIyNTI3MQ_bca0d2e4-902d-46ad-a78f-eaf851d1caff">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMi0xLTEtMjI1Mjcx_14db688a-aa9b-4761-bfa6-d188101f63e6">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtNC0xLTEtMjI1Mjcx_52ece16e-d9d5-4d62-bf9a-a16774a3ed8d">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtNi0xLTEtMjI1Mjcx_48e3844e-9115-4333-8ff2-4a70a6150c9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtOC0xLTEtMjI1Mjcx_e733a0fa-ad31-484e-ae6d-6dd4cb11601c">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMTAtMS0xLTIyNTI3MQ_b685a170-16c7-48f6-bcd1-7af7820731fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMTItMS0xLTIyNTI3MQ_82972a66-fe58-4309-bd27-09b40ab34452">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMi0xLTEtMjI1Mjcx_9ccc2fb1-2340-47c1-ad49-188f35c316a7">133,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtNC0xLTEtMjI1Mjcx_364f473a-5e3d-45ae-b992-53f93b6b4880">71,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtNi0xLTEtMjI1Mjcx_e9f43cce-910e-4b8c-a7eb-bc598673788a">9,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtOC0xLTEtMjI1Mjcx_aa2d166d-5220-49fa-9712-2532d21baea4">9,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMTAtMS0xLTIyNTI3MQ_4bbc2a92-cf39-4d20-8cdb-925de2c364a7">69,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMTItMS0xLTIyNTI3MQ_a34e4ec2-e412-45fc-b376-1a4645f93430">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMi0xLTEtMjI1Mjcx_c7576537-45b2-4ad3-816d-a3cd8455cc56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtNC0xLTEtMjI1Mjcx_e700faa4-0888-4ad7-b8e1-b8226451c776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtNi0xLTEtMjI1Mjcx_475beeb1-0344-41c8-b2b2-f6c17857408d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtOC0xLTEtMjI1Mjcx_52e443d9-f482-4969-a4b4-95d43827e45e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMTAtMS0xLTIyNTI3MQ_f7ea4080-ba2d-4e25-a15b-b3811f0b5eb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMTItMS0xLTIyNTI3MQ_32f641a7-9a31-4ef0-b366-675dd0b3d16f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMi0xLTEtMjI1Mjcx_2595b05b-7520-4bb8-9cd9-ad5e1c8ce9df">133,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItNC0xLTEtMjI1Mjcx_4a46405b-48b5-4300-8d41-100cf5995f20">71,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItNi0xLTEtMjI1Mjcx_f5fe2a7c-f85f-4d88-adba-cf20c1857ab4">9,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItOC0xLTEtMjI1Mjcx_08d05fe7-5928-42d9-bfac-8a48a09c43b6">9,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMTAtMS0xLTIyNTI3MQ_c425ad9c-b9d2-4690-beec-4a960dc0666a">69,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMTItMS0xLTIyNTI3MQ_81fe960a-1b3f-4e6f-966f-b220865b7cee">134,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i9929a226d59f4327acf31e9a88e05f3e"><ix:continuation id="ia130b180ebee403e975d2633bfe143e9" continuedAt="i3d00e5853e9c476aa97f0e571fd37f3a"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0yLTEtMS0yMjUyNzE_15117b3c-0b87-4a08-bb84-e8037d8e4e1f">194,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS00LTEtMS0yMjUyNzE_c75c95c9-c67b-4c5d-ae89-e5e87d263b99">177,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS02LTEtMS0yMjUyNzE_c72f819d-4ed0-462e-a7cc-a10bf0f2e038">121,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS04LTEtMS0yMjUyNzE_4f1bc6c0-92b7-46e4-a560-bf7a9cd5a99a">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0xMC0xLTEtMjI1Mjcx_15551891-6a68-47ee-8890-e78e5999fce2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0xMi0xLTEtMjI1Mjcx_456440bc-c830-42aa-a6fb-31a603ea6b12">498,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0yLTEtMS0yMjUyNzE_e1252da3-6bf8-4447-b244-92e547839f46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi00LTEtMS0yMjUyNzE_529c7d05-1ad5-4e2d-b81a-077fc14ba7bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi02LTEtMS0yMjUyNzE_7c5f6650-627f-4620-8cb4-db31447b645c">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi04LTEtMS0yMjUyNzE_e894757e-c51e-4619-8ea3-847012481a73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0xMC0xLTEtMjI1Mjcx_aa24ae08-1aa9-42d5-b029-0f4cd710728c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0xMi0xLTEtMjI1Mjcx_7bf9376e-9288-484e-ae1d-ca060e6edb75">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0yLTEtMS0yMjUyNzE_dd015608-06b3-4009-8827-ae5804123903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy00LTEtMS0yMjUyNzE_9b6d1401-1ea1-4b34-bcd5-0a90aed25835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy02LTEtMS0yMjUyNzE_d8fa0f4c-6299-4d38-a337-9842f7ce5e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy04LTEtMS0yMjUyNzE_32316572-1202-4d6f-baa9-a266d4bfcac8">5,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0xMC0xLTEtMjI1Mjcx_9a8bd061-a7b5-47c3-b8f9-652799ba709c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0xMi0xLTEtMjI1Mjcx_0096fee5-f564-4471-ab70-d0948f4efb2a">5,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0yLTEtMS0yMjUyNzE_e4e6b5f7-b5f2-4083-abba-7f35c9d58bea">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC00LTEtMS0yMjUyNzE_c5b65171-e250-43be-8592-f65673e49bbd">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC02LTEtMS0yMjUyNzE_6d07bb39-ce63-48e6-b3ff-8140bdd14952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC04LTEtMS0yMjUyNzE_9b7168f5-c956-40ee-b258-ff89e6dfec5c">18,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0xMC0xLTEtMjI1Mjcx_e543b4bd-bcb9-4b75-b610-ebc69db7ed28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0xMi0xLTEtMjI1Mjcx_d2928adf-1b84-4ad0-9aa8-22b9e0478ff2">20,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0yLTEtMS0yMjUyNzE_b26b770c-e90b-4f92-bd8d-f5486a9a1790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS00LTEtMS0yMjUyNzE_ade20677-4d2d-4037-83ca-0058472a57f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS02LTEtMS0yMjUyNzE_2ed37619-6085-4e94-a07e-a6ed940bae77">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS04LTEtMS0yMjUyNzE_0708f846-4050-4821-8f7c-87d30f436722">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0xMC0xLTEtMjI1Mjcx_27e9ddab-2e82-4b8f-86bf-b8099d277eb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0xMi0xLTEtMjI1Mjcx_1a0246ac-f4b9-47b9-94ee-de4c82667274">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0yLTEtMS0yMjUyNzE_12dcc679-5fb9-40ae-b6ec-9332f39f9775">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi00LTEtMS0yMjUyNzE_fcbff360-7237-4ab3-b2a4-2ecd2399eb52">8,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi02LTEtMS0yMjUyNzE_3f9e90a5-f46a-4893-85ca-7169267b08e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi04LTEtMS0yMjUyNzE_7031764d-4169-41f7-9feb-a0f3d6dbcaa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0xMC0xLTEtMjI1Mjcx_a89ca1ac-5e5a-4315-83e5-c4c36d9e8540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0xMi0xLTEtMjI1Mjcx_11be2241-8959-4b2c-8be1-131b703a8fcb">8,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0yLTEtMS0yMjUyNzE_51e09916-4278-4189-b3c3-dfd3b7eed18e">48,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy00LTEtMS0yMjUyNzE_291f6363-5e54-4503-b40a-895bd31e6df0">61,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy02LTEtMS0yMjUyNzE_99cd4035-8e18-40a3-b98f-90f2fa257049">97,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy04LTEtMS0yMjUyNzE_d70e0e3e-128e-4328-9ab3-a3a9c13245ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0xMC0xLTEtMjI1Mjcx_7221e8ba-e3c2-4f75-8d28-617214873af5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0xMi0xLTEtMjI1Mjcx_ade5c4ab-3b04-4c02-9188-287a95bd6442">207,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0yLTEtMS0yMjUyNzE_13244be0-fac8-4df0-931b-5e6c316de054">483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC00LTEtMS0yMjUyNzE_21f89a37-1ba4-47ac-b668-3ac134228ece">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC02LTEtMS0yMjUyNzE_db33f159-b07f-4ba0-a2eb-a1a970a654e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC04LTEtMS0yMjUyNzE_3442b115-7700-4c59-ab5a-9674039477db">14,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0xMC0xLTEtMjI1Mjcx_bf0c9bcf-67ea-4200-8750-fdfa9d848da0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0xMi0xLTEtMjI1Mjcx_d2b905e7-fd63-4cb5-a965-88e916bdb372">14,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0yLTEtMS0yMjUyNzE_d5a6124c-dd1f-44bb-af1a-6aa8af7b74de">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS00LTEtMS0yMjUyNzE_0235ac72-719b-48a0-876c-b922b01b017d">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS02LTEtMS0yMjUyNzE_ccbd3395-4817-4b94-a626-29556949b304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS04LTEtMS0yMjUyNzE_307b1843-7148-482c-951d-bee2b348cc9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0xMC0xLTEtMjI1Mjcx_84c28fbd-a190-4392-acef-156fa054af1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0xMi0xLTEtMjI1Mjcx_aaeda50a-507f-4071-9fa2-c80ecf0f6186">2,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMi0xLTEtMjI1Mjcx_74083c16-6db9-4dfb-981d-c4586b9abc2c">14,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtNC0xLTEtMjI1Mjcx_b3dc45fb-47f7-4c50-b865-a0da41d2a50b">3,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtNi0xLTEtMjI1Mjcx_319c7efd-75f9-4fac-9e5a-5d6f3c4fc57f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtOC0xLTEtMjI1Mjcx_23e014dc-5707-4527-9746-a313ab7374e3">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMTAtMS0xLTIyNTI3MQ_2f0346cf-400a-4fbc-be79-29b581f9d9a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMTItMS0xLTIyNTI3MQ_b2af63b4-a040-414d-b9cb-4eda58f5ed16">17,666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMi0xLTEtMjI1Mjcx_78afe751-7117-49ff-8279-56d38edd9c10">132,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItNC0xLTEtMjI1Mjcx_193124c8-6c92-4f4b-a45a-f2085ff6e3e2">106,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItNi0xLTEtMjI1Mjcx_c5747047-b216-48eb-8eb1-ffe857d43cb8">30,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItOC0xLTEtMjI1Mjcx_31755ba1-80cf-4733-9a6d-840e88794d4b">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMTAtMS0xLTIyNTI3MQ_60be045c-cafb-459f-9ff9-c4af683ec333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMTItMS0xLTIyNTI3MQ_afd17da1-1785-4a69-8990-028e97932819">274,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMi0xLTEtMjI1Mjcx_822d4a4b-ff57-451c-a917-aedab511e90d">14,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtNC0xLTEtMjI1Mjcx_4ef9848a-79bf-49cc-9bce-011fdceb9b89">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtNi0xLTEtMjI1Mjcx_f032039a-2854-493d-bee1-6e1a3ebd1d79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtOC0xLTEtMjI1Mjcx_9fcac993-f0f0-4277-99ed-03221abe95a3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMTAtMS0xLTIyNTI3MQ_9609d3d1-54e0-4890-b2c4-6e4cf9bbdfaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMTItMS0xLTIyNTI3MQ_e428f8fa-c408-417b-8ace-a7663590f975">17,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMi0xLTEtMjI1Mjcx_181a4618-a543-430f-954a-af9fec07fa03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtNC0xLTEtMjI1Mjcx_e15f1378-979f-4eec-9ded-1a1dc4390ae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtNi0xLTEtMjI1Mjcx_3a046079-a853-49c9-9e46-57a2d530fd87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtOC0xLTEtMjI1Mjcx_feb5233a-1321-497d-855e-c346afb63c16">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMTAtMS0xLTIyNTI3MQ_2ea7c8fb-685b-4fd1-b69f-f29a881cbc8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMTItMS0xLTIyNTI3MQ_98d07787-a5eb-4fe3-b143-96e477428762">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMi0xLTEtMjI1Mjcx_27ca3404-7e0d-4411-9a05-110f1e9285ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtNC0xLTEtMjI1Mjcx_230e5264-ce7b-45f4-9083-d972f2fb0147">1,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtNi0xLTEtMjI1Mjcx_6d38bc58-2f84-4186-b8cf-0afdab05fe33">1,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtOC0xLTEtMjI1Mjcx_546ad851-8d11-4b39-a95d-372a89ab410f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMTAtMS0xLTIyNTI3MQ_a210d84a-b777-43f4-941a-e157f3eae472">34,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMTItMS0xLTIyNTI3MQ_41622827-f5c5-4fff-9287-b34a19d2177e">37,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMi0xLTEtMjI1Mjcx_0b800156-9b82-4744-90dd-6f65bd35253b">78,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtNC0xLTEtMjI1Mjcx_cf72ae60-b3b6-400f-97df-a11baaa778cb">67,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtNi0xLTEtMjI1Mjcx_2536e16e-ac4c-404a-babf-1a0704e6ab0c">31,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtOC0xLTEtMjI1Mjcx_c7d6984f-ba9d-4d90-8a3b-c050b096cc8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMTAtMS0xLTIyNTI3MQ_4b579ee4-94cc-4252-9ca3-b78f23bbb094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMTItMS0xLTIyNTI3MQ_aed9e974-c1ac-4030-b6c2-ae480cb8ad3b">177,733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMi0xLTEtMjI1Mjcx_80788a8e-a538-4b7a-aa5e-75efe9268122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctNC0xLTEtMjI1Mjcx_4f9f9814-1e6c-4e04-ba85-ea62270c26bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctNi0xLTEtMjI1Mjcx_a196e122-54a2-4c8d-8c5c-7bf41ad34b2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctOC0xLTEtMjI1Mjcx_3ee1e381-2758-436a-a683-2d4a863f3247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMTAtMS0xLTIyNTI3MQ_d5874838-3c89-46db-9041-f866b36db1b7">23,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMTItMS0xLTIyNTI3MQ_bedd69e0-8a47-486d-8e34-a4b0556b5454">23,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMi0xLTEtMjI1Mjcx_cc723ca8-3a65-4a42-a099-6c72cd895232">292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtNC0xLTEtMjI1Mjcx_2f46d479-a022-4d51-93c0-42236b75dd5b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtNi0xLTEtMjI1Mjcx_8601a87c-db54-402b-aaf9-890881648330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtOC0xLTEtMjI1Mjcx_89da4934-c52b-4e9b-9c6d-100be92e8249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMTAtMS0xLTIyNTI3MQ_6aba4ce3-ee1d-4aae-91e3-fe72f1013be9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMTItMS0xLTIyNTI3MQ_f4200a5c-5dc3-448d-96f9-690e7835547c">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMi0xLTEtMjI1Mjcx_c2cd499f-44f7-46a3-b8c5-4de4d1186ac7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktNC0xLTEtMjI1Mjcx_0cfc57f5-68ac-41fa-9d54-00437e1793c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktNi0xLTEtMjI1Mjcx_d091c64a-b57f-492e-8d1b-9d7d0a32cd46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktOC0xLTEtMjI1Mjcx_61d092a8-2976-4995-854d-0da92a2b2cb7">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMTAtMS0xLTIyNTI3MQ_88613b45-0a2d-4354-81ca-3b638a9f0a1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMTItMS0xLTIyNTI3MQ_212396c7-714c-4ae4-b44f-558f0dfaee01">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMi0xLTEtMjI1Mjcx_5ef84f90-cdad-49ee-85a5-12c25ed1a3f1">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtNC0xLTEtMjI1Mjcx_e4bbc964-bcc0-4712-94e3-c1ee2a97a7c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtNi0xLTEtMjI1Mjcx_bf6e65f3-d3d4-44cc-9902-047dd5501c32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtOC0xLTEtMjI1Mjcx_0da3ab2f-a91f-47c2-af34-60fa15d2a676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMTAtMS0xLTIyNTI3MQ_382f8e5c-c6b1-40db-9a9f-c5d8a638f39c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMTItMS0xLTIyNTI3MQ_679a88aa-df51-4ff0-9479-8ad0d15af28e">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMi0xLTEtMjI1Mjcx_62500976-b426-4ff0-a528-e6453b2109aa">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItNC0xLTEtMjI1Mjcx_e2aba30d-07bb-4e9f-86c9-ef158a6ee3d1">10,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItNi0xLTEtMjI1Mjcx_d394e558-fe53-4faa-bf67-1925dd59ba86">6,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItOC0xLTEtMjI1Mjcx_b7c9a011-cf46-414a-b257-c3bf7fc8eeee">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMTAtMS0xLTIyNTI3MQ_cfd3bbad-cd1d-4530-b54d-c824cb11e1e7">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMTItMS0xLTIyNTI3MQ_fb53e467-749e-4738-932f-cbf1ec2b33be">18,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMi0xLTEtMjI1Mjcx_dd7ccbdc-d9f7-4299-89ee-1fd18028efb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtNC0xLTEtMjI1Mjcx_b6801b2a-06ed-4c77-927c-eaf3868a2170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtNi0xLTEtMjI1Mjcx_3a9abfc2-af29-49ba-a0ec-562799b011e6">6,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtOC0xLTEtMjI1Mjcx_cb6e9b89-5abf-42a7-a8ae-762fa0764043">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMTAtMS0xLTIyNTI3MQ_a71e5680-a087-4b3b-a1b5-f39723fe0fdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMTItMS0xLTIyNTI3MQ_ee19b9aa-30b5-4429-a0db-03e4218f411b">6,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMi0xLTEtMjI1Mjcx_51484bf8-b1de-4fb9-8270-e8788f373fe6">948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtNC0xLTEtMjI1Mjcx_d903cb8d-68a8-474c-9d00-eca136535997">433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtNi0xLTEtMjI1Mjcx_be81fee6-d479-4e33-911d-fa7ff8c15160">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtOC0xLTEtMjI1Mjcx_6c72be6c-6d7f-43a5-9961-78289edee4e4">4,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMTAtMS0xLTIyNTI3MQ_fe2f6161-50c8-47fe-9407-444138ad68d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMTItMS0xLTIyNTI3MQ_4d5ad45f-2217-4a85-b8c4-41b3718e25a2">6,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMi0xLTEtMjI1Mjcx_edae9150-5bae-461c-aaff-f7d4ad4c79a0">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtNC0xLTEtMjI1Mjcx_cecf28e8-4ca7-49f8-abc1-86e6ae27ac77">6,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtNi0xLTEtMjI1Mjcx_5cae890c-81f8-48eb-9c31-acac0f4a30cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtOC0xLTEtMjI1Mjcx_8bd3a58f-5f9d-4415-814e-b779b4dc385c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMTAtMS0xLTIyNTI3MQ_9a0df338-ffff-4608-9bf0-0af2c4901a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMTItMS0xLTIyNTI3MQ_20d7eedd-1c24-464c-b1f0-83939b0631b4">6,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMi0xLTEtMjI1Mjcx_d64b2cb9-d829-4f62-b8da-d7930f90d347">71,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtNC0xLTEtMjI1Mjcx_2fb742ee-f8b4-4eac-be67-50cd2eabf55e">58,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtNi0xLTEtMjI1Mjcx_27e6d51c-0e0c-48bc-a47c-0c39112ab3e1">3,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtOC0xLTEtMjI1Mjcx_f129dfeb-b1fd-4618-b356-a1ac884aa902">5,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMTAtMS0xLTIyNTI3MQ_0ae87836-f6ae-47bc-954c-902fbb3b3fd8">57,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMTItMS0xLTIyNTI3MQ_e4a139d5-67ad-4e0e-b571-e146e65d4aaf">73,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMi0xLTEtMjI1Mjcx_f37c1c1e-fb32-43ea-a7a3-631976fb9795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctNC0xLTEtMjI1Mjcx_4808e1e7-bbe2-4301-a9f1-41fcda3bc7c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctNi0xLTEtMjI1Mjcx_5cd242df-8e06-4adb-ade4-2f0aef0a2e5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctOC0xLTEtMjI1Mjcx_ff3adee0-2769-4b9c-8576-67a5b37f53a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMTAtMS0xLTIyNTI3MQ_2a0b4df4-68d7-4b6d-8e47-e47c65fdb781">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMTItMS0xLTIyNTI3MQ_f995cc56-06e1-4f68-b2c7-413d87d3fcb9">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMi0xLTEtMjI1Mjcx_65d83ef7-23f2-43fe-a52e-9ff151fd332c">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtNC0xLTEtMjI1Mjcx_a5cc6357-4f38-4562-8b9d-6087eb302912">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtNi0xLTEtMjI1Mjcx_27badd95-02bd-4037-be64-95f72bf689ea">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtOC0xLTEtMjI1Mjcx_2d4886f3-7962-42b3-8bb5-4833e645ea31">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMTAtMS0xLTIyNTI3MQ_21d8aac5-90d8-42c6-ba6e-02103f27b6c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMTItMS0xLTIyNTI3MQ_9fb4c17f-1403-45ca-a795-813e067c01b3">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMi0xLTEtMjI1Mjcx_f7da7cd7-7ac1-4396-b8b0-900463a1c3a1">72,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtNC0xLTEtMjI1Mjcx_ccd6d5a8-7b06-44d3-9df0-04e58220fb31">58,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtNi0xLTEtMjI1Mjcx_cbe953a2-da8d-4b9e-8510-cce2c526f7ca">2,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtOC0xLTEtMjI1Mjcx_b4123829-4029-4e38-855e-af2fcb2f5c87">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMTAtMS0xLTIyNTI3MQ_a2cedac7-e588-4b18-a459-b984d35be7df">58,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMTItMS0xLTIyNTI3MQ_46361f34-1e83-4a55-a43a-73aa9a9a112e">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMi0xLTEtMjI1Mjcx_db686df0-81f7-4985-ac2f-e029245d602e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtNC0xLTEtMjI1Mjcx_9eb3d7bf-730e-4549-a1f8-5c0f6e94eb8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtNi0xLTEtMjI1Mjcx_6809d218-dfea-4931-b4d3-18b4a3b7bcdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtOC0xLTEtMjI1Mjcx_4feaced1-0d96-4247-b26f-d41a17d0e161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMTAtMS0xLTIyNTI3MQ_f1303e04-b454-47b0-8236-2c1b3c8313a1">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMTItMS0xLTIyNTI3MQ_7091af12-a0ac-4dc6-a2b9-81eacaa55c4e">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMi0xLTEtMjI1Mjcx_36059c94-33c5-4c43-a1c0-cbc907e88be1">72,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItNC0xLTEtMjI1Mjcx_bfade3e7-936a-4127-a245-0a692c41dbb2">58,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItNi0xLTEtMjI1Mjcx_6d8b7ab4-2315-4682-b20e-86753e5a5596">2,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItOC0xLTEtMjI1Mjcx_a3362889-1846-41c6-8d68-64cb0de654dd">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMTAtMS0xLTIyNTI3MQ_6e2b3d87-9b43-41a4-8915-1a5cf1788d83">58,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMTItMS0xLTIyNTI3MQ_e0b8964f-2af9-479e-b170-0e2bcd19dbf4">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i3d00e5853e9c476aa97f0e571fd37f3a" continuedAt="icc597fdbcba24f84ad4e40b5a51db9ac">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="icc597fdbcba24f84ad4e40b5a51db9ac">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, 5, 6, 7, and 15 for significant transactions impacting the Company&#8217;s segment assets during the periods presented.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzcw_41a2e7ad-e992-4738-abe9-11d7a68c5037" continuedAt="i567383eec87d494ba2b35fac186de1a0" escape="true">Supplemental Cash Flow Information</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i567383eec87d494ba2b35fac186de1a0"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzYz_fc1ab417-3cd1-451b-a662-f56947940316" continuedAt="i0579e98dc076488495f6c3278f9a45c9" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfMy0yLTEtMS0yMjUyNzE_c0c83a3b-8ac4-4ef8-80b2-1057ea6b8472">65,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfMy00LTEtMS0yMjUyNzE_70e17211-bf7b-4fd2-9cf8-de22f194098b">58,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNC0yLTEtMS0yMjUyNzE_20ecfa5b-3f84-44e7-96f6-2ad73027e72c">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNC00LTEtMS0yMjUyNzE_4ff544e6-17a8-4fa5-b985-3302b42ff57b">1,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNS0yLTEtMS0yMjUyNzE_2250aff5-3f39-4231-8c97-7b4445960811">14,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNS00LTEtMS0yMjUyNzE_bf454513-a0ff-4dc1-9374-c3931f12b09d">8,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNy0yLTEtMS0yMzAwMzA_be8c0f30-b8ff-430d-8fab-a0f26b92f8eb">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNy00LTEtMS0yMzAwMzA_e8bfca26-222c-4378-b645-996956411c44">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-3" name="us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfOC0yLTEtMS0yMjUyNzE_cd169975-d2d3-4647-82e8-f034c9af38e5">161,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-3" name="us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfOC00LTEtMS0yMjUyNzE_c39194dd-f4ff-4fc9-a450-6b81f245d2a3">163,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating, investing, and financing cash flows in the Consolidated Statements of Cash Flows are reported inclusive of both cash flows from continuing operations and cash flows from discontinued operations. <ix:continuation id="i0579e98dc076488495f6c3278f9a45c9" continuedAt="i024da8696ce0427abe24c2e81c5c7cd5">The following table summarizes certain cash flow information related to discontinued operations (in thousands):</ix:continuation></span></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><ix:continuation id="i024da8696ce0427abe24c2e81c5c7cd5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfMy0yLTEtMS0yMjUyNzE_0a2da91f-db05-49b0-827a-990df7149017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfMy00LTEtMS0yMjUyNzE_4a0b5c4a-0d75-4b43-9cdc-17f113cd9cde">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNC0yLTEtMS0yMjUyNzE_d0576141-327e-4fad-862c-29f4b013062b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNC00LTEtMS0yMjUyNzE_4647668c-2eca-49a5-a8dd-72cf3abb928b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNS0yLTEtMS0yMjUyNzE_8e7cd88d-63e2-439d-9a8e-364901d88afc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNS00LTEtMS0yMjUyNzE_b484cf3b-99b8-4a9b-94f3-679249f075ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzcy_70eb4a65-e00f-43da-97e6-2951b736cf4f" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents, and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0yLTEtMS0yMjUyNzE_fba17c9c-a425-4ac6-8a08-14b168cc48d0">72,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC00LTEtMS0yMjUyNzE_1fd3ecb5-4f06-4979-83d2-0afd3251cd05">158,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC02LTEtMS0yMjUyNzE_8036c8ae-6e9e-44b9-b4ad-a8da3f3832b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC04LTEtMS0yMjUyNzE_c203063d-5a8e-4f42-8cfb-6feb359cddc2">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0xMC0xLTEtMjI1Mjcx_60b467b7-c7a9-4a14-aa33-58cc0b29a4a4">72,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0xMi0xLTEtMjI1Mjcx_63901272-174b-4acb-9b95-39271f800348">165,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0yLTEtMS0yMjUyNzE_bc35a7b4-72b5-4812-896b-75a5a9c6be78">54,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS00LTEtMS0yMjUyNzE_f542b606-f5ca-49af-a5ce-b4b8e753c1ea">53,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS02LTEtMS0yMjUyNzE_aa054c34-f9e5-462f-b473-d2e429323ac4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS04LTEtMS0yMjUyNzE_7c72f576-b57a-4d37-a4b8-e7ab74fa1ecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0xMC0xLTEtMjI1Mjcx_6640d9e2-2d9e-490c-b5b3-33c7a2bbbabe">54,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0xMi0xLTEtMjI1Mjcx_de871dfc-db46-4c89-8205-b400446fc1df">53,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0yLTEtMS0yMjUyNzE_37b47c1a-5fc0-43fa-bc1d-0f4715f9b1c8">126,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi00LTEtMS0yMjUyNzE_bcddc6de-1df8-481e-88e2-e8230ca62b51">211,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi02LTEtMS0yMjUyNzE_dc31e069-71af-4c2a-845c-bcb13fd56731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi04LTEtMS0yMjUyNzE_c33a7d8b-75d2-4e28-bec3-f2546366f15b">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0xMC0xLTEtMjI1Mjcx_2276526d-9a7d-466e-8a3a-57bd2f09a820">126,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0xMi0xLTEtMjI1Mjcx_5708e06f-a8c5-4b0e-aeeb-7e04418d8f77">219,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0yLTEtMS0yMjUyNzE_4688be91-a461-4d33-9c5b-e68e1448c5b8">59,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC00LTEtMS0yMjUyNzE_b5cbd8f4-9724-4569-a276-44202a3fabdf">89,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC02LTEtMS0yMjUyNzE_ba8a2c6a-a5d0-4492-af65-c1d065ac8930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC04LTEtMS0yMjUyNzE_196747e2-3103-4483-af45-102b94364867">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0xMC0xLTEtMjI1Mjcx_6277d525-473c-4447-8c89-152f3ef77134">59,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0xMi0xLTEtMjI1Mjcx_2530e148-dcab-4917-b680-9f78f5b930e5">97,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0yLTEtMS0yMjUyNzE_323071f5-8f7a-458e-b586-d0bac20071ed">57,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS00LTEtMS0yMjUyNzE_19e7f6e6-3581-4c8c-8dd5-c117e98f54a9">52,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS02LTEtMS0yMjUyNzE_31cb3f9f-a981-480d-9d9e-582086aa4f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS04LTEtMS0yMjUyNzE_d296f255-2f39-45cc-9198-8faf26b7e111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0xMC0xLTEtMjI1Mjcx_b1870465-e46a-4457-ad83-09e134cf5a4b">57,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0xMi0xLTEtMjI1Mjcx_a9b1a567-35e4-4d6a-a135-32c7167e66ee">52,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMi0xLTEtMjI1Mjcx_75061038-6ada-42ec-abc3-6011a2bc5a27">117,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtNC0xLTEtMjI1Mjcx_b70a9816-7b28-4e60-afa2-7a9aa8769231">141,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtNi0xLTEtMjI1Mjcx_6ac655eb-ea32-4b2d-9717-e0c35e179f83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtOC0xLTEtMjI1Mjcx_13c8fdef-f600-45c1-876c-055eeb4dbf9a">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMTAtMS0xLTIyNTI3MQ_f5801056-4d61-4b69-90c9-a49fc2af5ade">117,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMTItMS0xLTIyNTI3MQ_ad3b563a-48c1-4d52-8402-484e10225a41">149,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfNzE0NjgyNTU4MjQ1OQ_5597372d-4832-497e-a25e-487e4e32e5e4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash and cash equivalents at financial institutions insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000 per institution. However, as the account balances at certain institutions exceed the FDIC insurance coverage, there is a concentration of credit risk related to amounts in excess of such coverage.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:VariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg1Mg_1cfb5333-4236-4f9e-8667-5ffa866f7fac" continuedAt="i87826b7e31464e8eaae0bf5cdeb73f9d" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i87826b7e31464e8eaae0bf5cdeb73f9d" continuedAt="ia407b7cf08df4700bd019f7b69ed0f78"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Subsidiary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, in connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#8217;s operating subsidiary and a limited liability company that has governing provisions that are the functional equivalent of a limited partnership. The Company holds a membership interest in Healthpeak OP, acts as the managing member of Healthpeak OP, and exercises full responsibility, discretion, and control over the day-to-day management of Healthpeak OP. Because the noncontrolling interests in Healthpeak OP do not have substantive liquidation rights, substantive kick-out rights without cause, or substantive participating rights, we have determined that Healthpeak OP is a VIE. The Company, as managing member, has the power to direct the core activities of Healthpeak OP that most significantly affect Healthpeak OP&#8217;s performance, and through its interest in Healthpeak OP, has both the right to receive benefits from and the obligation to absorb losses of Healthpeak OP. Accordingly, the Company is the primary beneficiary of Healthpeak OP and consolidates Healthpeak OP. As the Company conducts its business and holds its assets and liabilities through Healthpeak OP, the total consolidated assets and liabilities, income (losses), and cash flows of Healthpeak OP represent substantially all of the total consolidated assets and liabilities, income (losses), and cash flows of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unconsolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had investments in <ix:nonFraction unitRef="joint_venture" contextRef="ic264575fc36449f5a87c5ea91360a740_I20230331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTM2_b3dad3a0-4cfb-422a-bce5-f7808880fbfb"><ix:nonFraction unitRef="joint_venture" contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTM2_c1dadd5a-7c6b-4de7-bf1d-bdb1f2e35c21">two</ix:nonFraction></ix:nonFraction> unconsolidated VIE joint ventures. At December&#160;31, 2022, the Company had investments in: (i) <ix:nonFraction unitRef="joint_venture" contextRef="ic264575fc36449f5a87c5ea91360a740_I20230331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzNzk0_b3dad3a0-4cfb-422a-bce5-f7808880fbfb"><ix:nonFraction unitRef="joint_venture" contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzNzk0_c1dadd5a-7c6b-4de7-bf1d-bdb1f2e35c21">two</ix:nonFraction></ix:nonFraction> unconsolidated VIE joint ventures and (ii) marketable debt securities of <ix:nonFraction unitRef="joint_venture" contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231" decimals="INF" name="peak:NumberOfVieBorrowersWithMarketableDebtSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzOTg1_35061169-9c01-492d-ad63-9eb6d492a7ad">one</ix:nonFraction> VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#8217;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities Investment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December&#160;31, 2022, the Company held $<ix:nonFraction unitRef="usd" contextRef="i79f95a47fff3441784d37b2c5a1ae4f7_I20221231" decimals="-6" name="us-gaap:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODI0MDQy_c5f9c163-8f6b-475f-b492-85e30f29c15d">22</ix:nonFraction>&#160;million of commercial mortgage-backed securities (&#8220;CMBS&#8221;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie Mac) through a special purpose entity that had been identified as a VIE because it was &#8220;thinly capitalized.&#8221; The CMBS issued by the VIE were backed by mortgage debt obligations on real estate assets. These securities were classified as held-to-maturity because the Company had the intent and ability to hold the securities until maturity. These securities matured on December 31, 2022, and the Company received the related proceeds in January 2023.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LLC Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#8217;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of <ix:nonFraction unitRef="hospital" contextRef="i0777696340044807b047c951cc6b7e89_I20230331" decimals="INF" name="peak:NumberOfHospitals" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODI0Mjk3_44a8d7b3-35fe-4132-a852-3f9bd8952b81">three</ix:nonFraction> hospitals as well as senior housing real estate. Any assets generated by the entity may only be used to settle its contractual obligations (primarily capital expenditures and debt service payments).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Needham Land Parcel JV.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In December 2021, the Company acquired a <ix:nonFraction unitRef="number" contextRef="if2e661c65de049509e99f61fdd2bd048_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTgzNQ_964da61d-47ed-4a7c-98cb-adb7dc15d916">38</ix:nonFraction>% interest in a life science development joint venture in Needham, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i64a9401fe4ee4e0b9e32826d28b5b1b0_D20211201-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTkyMQ_26fdae64-f119-4bc5-8378-6c302e35b43a">13</ix:nonFraction>&#160;million. Current equity at risk is not sufficient to finance the joint venture&#8217;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development costs and debt service payments). See Note 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#8217;s unconsolidated VIEs and interests therein.</span></div><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg0OQ_ac302e31-85b7-4345-a96c-eda9c804097e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2023 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure and </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LLC investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjljZGM4OGNmMWZmYTQyMjRiMTlhNjlhYmMxMzU5ZWQ1L3RhYmxlcmFuZ2U6OWNkYzg4Y2YxZmZhNDIyNGIxOWE2OWFiYzEzNTllZDVfNC00LTEtMS0yMjUyNzE_988feeec-81aa-41fd-bb64-ba751686846d">14,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314fcd2c5dec445098b327482f3a7818_I20230331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjljZGM4OGNmMWZmYTQyMjRiMTlhNjlhYmMxMzU5ZWQ1L3RhYmxlcmFuZ2U6OWNkYzg4Y2YxZmZhNDIyNGIxOWE2OWFiYzEzNTllZDVfNi00LTEtMS0yMjUyNzE_d5ab6163-7265-4742-9530-e0d22ccfe0d5">15,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="ia407b7cf08df4700bd019f7b69ed0f78" continuedAt="i1abf6a7848494d72846168aecff5e386"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated total assets and total liabilities at March&#160;31, 2023 and December&#160;31, 2022 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ventures V, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a <ix:nonFraction unitRef="number" contextRef="ieb8e43d445e14ad1b15a9092e886d068_D20230101-20230331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMzM0OA_a4d4e662-57ff-4174-b3dc-def0d57cf44d">51</ix:nonFraction>% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#8220;Ventures V&#8221;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Science JVs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The Company holds a <ix:nonFraction unitRef="number" contextRef="i2003f5627c1f4bf4a0e07c23f54283a8_D20230101-20230331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNDIzNg_c3208c05-fda3-4616-bb7c-663f0299f872">98</ix:nonFraction>% or greater ownership interest in multiple joint venture entities that own and lease life science assets (the &#8220;Life Science JVs&#8221;). The Life Science JVs are VIEs as the members share in certain decisions of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations. Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MSREI MOB JV.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a <ix:nonFraction unitRef="number" contextRef="ic426b90826724d11a95dfb86709ed7fe_D20230101-20230331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTIzMw_43c2df09-2dcd-41c5-b193-48f6a0ba3fd6">51</ix:nonFraction>% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#8220;MSREI JV&#8221;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a controlling ownership interest in and is the managing member of <ix:nonFraction unitRef="joint_venture" contextRef="i83e29cc8fc7747e8908fa487a0e9cd8f_D20230101-20230331" decimals="INF" name="peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNjE3Mw_a10822e9-d119-4166-af92-c73245d4e379">seven</ix:nonFraction> DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Consolidated Real Estate Partnerships.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#8220;Partnerships&#8221;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i1abf6a7848494d72846168aecff5e386"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg1OA_7ea0535c-a330-4af7-ade0-150639946ae0" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMi0xLTEtMS0yMjUyNzE_72e908b6-c320-4367-90d0-5a3d1b5ceb0a">2,348,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMi0zLTEtMS0yMjUyNzE_a5bf28a2-d6f0-452c-a43d-4b767159e0e3">2,356,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMy0xLTEtMS0yMjUyNzE_11944c73-4bcd-4694-9a24-26ca8ef45272">54,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMy0zLTEtMS0yMjUyNzE_7b0a56f0-1448-4dc5-975d-525f156574ee">58,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNC0xLTEtMS0yMjUyNzE_fee6033f-dca8-4169-833a-e4958d432cb5">322,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNC0zLTEtMS0yMjUyNzE_087b2ecc-52aa-4cb6-9322-e12fbe26999a">324,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNS0xLTEtMS0yMjUyNzE_01dc9e82-44f8-4d22-b668-ba8577938bc5">615,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNS0zLTEtMS0yMjUyNzE_db7d97bf-7f39-41cb-85b7-b4c4cc5a4542">623,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNi0xLTEtMS0yMjUyNzE_e03b27b0-dc43-4b2e-87ae-4aed62421f86">2,108,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNi0zLTEtMS0yMjUyNzE_71532dcc-0222-48eb-b7a7-c590a4030636">2,116,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOC0xLTEtMS0yMjUyNzE_2040bdf7-7e8c-4093-93c0-f9d19af69be0">9,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOC0zLTEtMS0yMjUyNzE_7ce0b079-b39f-4cca-973a-3e0e7cc550ae">6,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOS0xLTEtMS0yMjUyNzE_996e8732-00db-4bf0-be8a-16d25c31da9e">21,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOS0zLTEtMS0yMjUyNzE_1d302abd-31d3-4f68-b297-088c29208035">20,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTAtMS0xLTEtMjI1Mjcx_8a677fb4-a5dc-4694-8243-fabada79963f">422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTAtMy0xLTEtMjI1Mjcx_de87cd3d-f889-473e-900f-31f17afd1829">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTEtMS0xLTEtMjI1Mjcx_d0324368-6374-418f-aaf9-d01b60b1975f">69,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTEtMy0xLTEtMjI1Mjcx_3b57f5d3-a268-491d-88e9-e0999ea4445f">73,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTItMS0xLTEtMjI1Mjcx_d4258417-cfbc-406d-a5fa-bc040bceb0cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTItMy0xLTEtMjI1Mjcx_b95e3f86-1a62-41fc-b56d-94d0c0f3c7ab">30,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTMtMS0xLTEtMjI1Mjcx_b1626e12-5b6f-41f5-98d9-3b5b86d87a03">98,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTMtMy0xLTEtMjI1Mjcx_6b7b1e60-ea21-4f60-a091-d6f5aab943ac">99,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTQtMS0xLTEtMjI1Mjcx_3ea43c60-c18e-47bb-ae50-617df6698404">73,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTQtMy0xLTEtMjI1Mjcx_a2b0e98e-ff30-4093-8ff8-a14a154e8a9a">73,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTUtMS0xLTEtMjI1Mjcx_685b235e-b227-4cb5-a0e2-572c303de3af">2,381,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTUtMy0xLTEtMjI1Mjcx_b0f5e76d-deeb-46ab-a1c0-85446bfd336d">2,421,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTctMS0xLTEtMjI1Mjcx_0bc00117-f682-4f35-bdfc-2aa30fbd2bb9">144,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTctMy0xLTEtMjI1Mjcx_a361e881-e178-4074-9936-76cb4cf07a8b">144,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTktMS0xLTEtMjI1Mjcx_ff26727d-ac89-4c67-983e-4881836f5eeb">14,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTktMy0xLTEtMjI1Mjcx_b68e0775-7bff-4e04-bf83-b875611e2dce">15,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjAtMS0xLTEtMjI1Mjcx_015ae19c-831a-4468-9774-72dd8543f2ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjAtMy0xLTEtMjI1Mjcx_0f0ff74f-3ece-4385-8fef-7c1f10227abe">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjEtMS0xLTEtMjI1Mjcx_ced38abf-a160-49b3-a0ee-3db04cdc99b8">99,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjEtMy0xLTEtMjI1Mjcx_59588733-86eb-46f1-ad10-b30a01ca7e26">99,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjItMS0xLTEtMjI1Mjcx_e10d5d36-e6ec-435f-aab8-01fe9a2cf8cf">66,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjItMy0xLTEtMjI1Mjcx_d2d9e8fe-6d66-4835-b806-549726990fc7">68,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjMtMS0xLTEtMjI1Mjcx_6302e8ff-1ebc-4d1e-ac52-7408079d0c5c">47,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjMtMy0xLTEtMjI1Mjcx_106d896c-d3bc-4074-a063-f07ac9712bcd">39,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjQtMS0xLTEtMjI1Mjcx_a8061c57-0d0c-4c13-84d1-520af6bb55ae">371,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjQtMy0xLTEtMjI1Mjcx_a9c3d7de-7967-4808-9046-d02f9c22a54c">367,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities related to assets held for sale include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMi0yLTEtMS0yMjUyNzE_8c30c0ce-b1e1-44f5-a67f-333db628b483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMi00LTEtMS0yMjUyNzE_b40a5b4c-ffdb-40bc-a9e8-da3e5e513739">39,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:Land" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNC0yLTEtMS0yMjUyNzE_38817335-93c2-48f5-91ec-59b0e970583f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNC00LTEtMS0yMjUyNzE_34f525cd-855d-416e-8af2-5a8e7707756d">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNS0yLTEtMS0yMjUyNzE_185cffd3-bbff-4f89-b997-4f6236238431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNS00LTEtMS0yMjUyNzE_e9526b9b-5af0-43cd-8087-6fbb7f1348bc">15,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNi0yLTEtMS0yMjUyNzE_759f0bd1-41bd-4466-9130-a9706eff325e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNi00LTEtMS0yMjUyNzE_7cbdce84-c0a9-4134-9f93-1943f5e25398">26,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTAtMi0xLTEtMjI1Mjcx_e244568e-7844-462a-9dfa-747970a6fa37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTAtNC0xLTEtMjI1Mjcx_1e818c80-c74d-4f9f-8aba-e9b7c8bbee52">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTItMi0xLTEtMjI1Mjcx_ce3d2d74-de82-43e8-8216-06ac1067b334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTItNC0xLTEtMjI1Mjcx_db394602-0a5e-4bd1-9c02-09f2ac762cae">3,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTMtMi0xLTEtMjI1Mjcx_0cf8ddc5-2351-46c7-a8d8-8298c93e8531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTMtNC0xLTEtMjI1Mjcx_25180380-7d9f-49e5-ab83-8c1eaebfc412">30,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTktMi0xLTEtMjI1Mjcx_ca38115a-ea5e-4a35-932e-0afed80514c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTktNC0xLTEtMjI1Mjcx_94922856-609f-4cac-bfc9-bb017a79b8e9">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMjAtMi0xLTEtMjI1Mjcx_e9552281-cedf-41cf-9019-3fcb0c185b14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231" decimals="-3" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMjAtNC0xLTEtMjI1Mjcx_eb0a4a60-9438-4bb7-aeec-65413bc5ae87">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RleHRyZWdpb246OGM0NzNiMjQyOWY5NDkwNGJlODgxZmNlMmJiNDkyMWRfMTE2Ng_891e292c-886c-42ed-81f2-5d5e1167902c" continuedAt="iba245f2f8d4e4c4a9c22e6e2ca6ee65b" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="iba245f2f8d4e4c4a9c22e6e2ca6ee65b"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RleHRyZWdpb246OGM0NzNiMjQyOWY5NDkwNGJlODgxZmNlMmJiNDkyMWRfMTE2Mw_16cf8127-7e81-468d-8996-1437a56c3df3" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments either recorded or disclosed on a recurring basis (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi0xLTEtMS0yMjUyNzE_d3d9b3d8-c542-424b-b15e-b1cfee267412">243,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi0zLTEtMS0yMjUyNzE_8a3848e0-5a73-40a7-8231-1e55998bc4f7">245,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi01LTEtMS0yMjUyNzE_0f787e40-cf72-44f1-89a8-d0eb22ff3697">374,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi03LTEtMS0yMjUyNzE_da0226fd-b865-4cba-ab19-318e799498bd">369,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy0xLTEtMS0yMjUyNzE_ac1e0935-230e-4a1a-a3bc-bd0fea5eed25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy0zLTEtMS0yMjUyNzE_d543a8de-0c7e-4fa9-9b23-7c15742723ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy01LTEtMS0yMjUyNzE_63c3d8dd-d07d-4da6-a108-268aa5c547d0">21,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy03LTEtMS0yMjUyNzE_0478e0ee-786c-4f8f-81ed-4414023e2d12">21,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a162e312664e3e87e4b7cc4e443e3b_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC0xLTEtMS0yMjUyNzE_12ef7acc-4fdb-473e-b173-6309ca1040a2">20,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4741bac17c174ed8a6000db9741edd7e_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC0zLTEtMS0yMjUyNzE_793b4015-d158-4269-aa71-fb9ec2c54fe1">20,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e50d56667947df8e6c0aeaf1a3d0c9_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC01LTEtMS0yMjUyNzE_66c55f35-618e-4886-bb97-47d43924a103">30,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c7e47c923043719f6f4a0f3ca6bd4f_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC03LTEtMS0yMjUyNzE_90be97c1-6559-4925-a581-31e639ecce97">30,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi0xLTEtMS0yMjUyNzE_7e307744-03e2-4373-9dcd-8fc53eb3ad8a">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi0zLTEtMS0yMjUyNzE_0b18231b-87db-41fe-ac0a-92a3154849d2">556,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi01LTEtMS0yMjUyNzE_c6a477dc-c3b0-4c56-9933-5c05c5832b63">995,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi03LTEtMS0yMjUyNzE_57eceb03-c134-4898-b0ed-779e1697909c">995,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:LongTermLoansFromBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy0xLTEtMS0yMjUyNzE_a8b162aa-2fd8-455a-a0ca-c5a90a421239">496,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331" decimals="-3" name="us-gaap:LongTermLoansFromBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy0zLTEtMS0yMjUyNzE_f818b66a-df97-4582-8b48-9edb8fc7d00a">496,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:LongTermLoansFromBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy01LTEtMS0yMjUyNzE_e777de00-aa83-400b-8f4f-9a4d6f389ed9">495,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231" decimals="-3" name="us-gaap:LongTermLoansFromBank" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy03LTEtMS0yMjUyNzE_24fd7a9b-9b79-475d-92b0-987e046f5fd1">495,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC0xLTEtMS0yMjUyNzE_0df5356e-04b6-4e85-ae4a-01c7e4b1972d">5,056,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic507fe90dbae43d6b7714fb76376f6c3_I20230331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC0zLTEtMS0yMjUyNzE_f7d81853-ea76-4e51-be59-45f5e0415c42">4,712,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC01LTEtMS0yMjUyNzE_94f7b047-c638-487c-b6bc-71eb1406349a">4,659,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce9db3b727c4f4e8d642580044e31cd_I20221231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC03LTEtMS0yMjUyNzE_4493e628-e857-4d4a-bc27-f75b9a0a0d1b">4,238,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS0xLTEtMS0yMjUyNzE_3f75a723-19f0-4d0a-9d00-87f39dac18c7">345,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS0zLTEtMS0yMjUyNzE_45eee041-6f1e-4067-9101-bed948746cf9">330,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS01LTEtMS0yMjUyNzE_f605ac03-e26b-4ae7-8b2b-09b6e75763dc">346,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS03LTEtMS0yMjUyNzE_680056d1-ce28-43f3-9a21-39f47f40a10c">330,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value is calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value is based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and interest rate swap instruments, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, commercial paper, and term loans, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and year ended December&#160;31, 2022, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div></ix:nonNumeric></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_82"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17.&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjg4Mw_7d35be93-cf15-42e7-b938-b0e568548ccf" continuedAt="i08a742e568444600894b5fd987801c8b" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i08a742e568444600894b5fd987801c8b" continuedAt="i1601f61028e0440181ecf62d4caf9a52"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates and their related potential impact on future earnings and cash flows. The Company does not use derivative instruments for speculative or trading purposes. At March&#160;31, 2023, a one percentage point increase or decrease in the underlying interest rate curve would result in a corresponding increase or decrease in the fair value of the derivative instruments by approximately $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNjkw_2c16c47c-6aa2-4c61-83cc-2d65d65b9605">22</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company executed <ix:nonFraction unitRef="derivative_held" contextRef="ibff3d7194cc8421785dba30cb9b0f782_I20210430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfOTUw_d8bd1ff0-7394-475b-8983-5647f5c1ac85">two</ix:nonFraction> interest rate cap instruments on $<ix:nonFraction unitRef="usd" contextRef="ibff3d7194cc8421785dba30cb9b0f782_I20210430" decimals="-6" name="peak:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfOTkw_487cc6f8-5c32-4c52-bca4-19d387590723">142</ix:nonFraction>&#160;million of variable rate mortgage debt secured by a portfolio of MOBs (see Note 9). During the three months ended March&#160;31, 2022, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="ie6930d3833b24489bf10582929fa4f52_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NDE1Mw_e81dea72-f2bd-4855-b782-bec4b4347b66">2</ix:nonFraction>&#160;million increase in the fair value of the interest rate cap instruments within other income (expense), net. In April 2022, the Company terminated these interest rate cap instruments and entered into <ix:nonFraction unitRef="derivative_held" contextRef="i08425abe3e614e6d9a9b28ec8e60b022_I20220430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTE5NA_fdc3361d-4524-46a8-bb8f-285dcb4bcf48">two</ix:nonFraction> interest rate swap instruments that are designated as cash flow hedges and mature in May 2026. In February 2023, the Company modified its <ix:nonFraction unitRef="derivative_held" contextRef="icf5ac7cd40be471fb36b2da5759371f7_I20230228" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NTExMg_ffbe3d77-ad72-4c90-a285-9bbfe3144ef5">two</ix:nonFraction> interest rate swap instruments totaling a $<ix:nonFraction unitRef="usd" contextRef="icf5ac7cd40be471fb36b2da5759371f7_I20230228" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NTExNg_fbf87c1d-7063-4cd5-b157-15469601e866">142</ix:nonFraction>&#160;million notional value to reflect the change in the related variable rate mortgage debt&#8217;s interest rate benchmarks from LIBOR to SOFR (see Note 9). The Company applied certain practical expedients provided by ASU 2020-04 and ASU 2021-01 in connection with the modifications to these cash flow hedges (see Note 2).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into <ix:nonFraction unitRef="derivative_held" contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTMzMw_f40ab16b-8f1d-40b8-88c2-0ee9e72c06e5">two</ix:nonFraction> forward-starting interest rate swap instruments on the $<ix:nonFraction unitRef="usd" contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831" decimals="-6" name="peak:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTM5MQ_cb5e36d0-54fe-4a0e-b718-1de4cccc5068">500</ix:nonFraction>&#160;million aggregate principal amount of the Term Loan Facilities (see Note 9). The interest rate swap instruments are designated as cash flow hedges.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><ix:continuation id="i1601f61028e0440181ecf62d4caf9a52" continuedAt="i06b42d266967493fb948926ae6830a77"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjg5Mw_c0c4c747-6ffd-4145-ae1d-6eec1fb2018c" continuedAt="i6dcb141d29a448ff84d8816d67e8cf0c" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate swap instruments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pay Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receive Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi0zLTEtMS0yNTE2NTE_d01ea4b5-6ee8-4045-9de8-c3b9b06a7d0c">51,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi00LTEtMS0yNTE2NTE_9f8853e4-accb-404e-8470-15742d41a976">4.99</ix:nonFraction> %</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  <ix:nonFraction unitRef="number" contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi01LTEtMS0yNTE2NTEvdGV4dHJlZ2lvbjphY2RkYzdiM2IxZGE0ODM2YmJiOGUwNDk5NTMyZjQ2Ml8zNA_0388c7fc-d170-49d4-8282-53a9d6b8aa0b">2.50</ix:nonFraction>% </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi02LTEtMS0yNTE2NTE_394cd519-97bd-4752-8ed0-b0a065f06354">1,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed735a3625541e0b0040bbdb3d6ff39_I20221231" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi04LTEtMS0yNTE2NTE_cf2da70c-a89c-4d68-a1d9-1004d2a8f7a9">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b4be37081f42648c653212038f8710_I20230331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy0zLTEtMS0yNTE2NTE_c9528201-ee1f-4718-bff5-d2eb6d8b7722">91,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12b4be37081f42648c653212038f8710_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy00LTEtMS0yNTE2NTE_8d02efc9-8d70-425d-bf9b-6ee9a484ba3e">4.54</ix:nonFraction> %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  <ix:nonFraction unitRef="number" contextRef="i12b4be37081f42648c653212038f8710_I20230331" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy01LTEtMS0yNTE2NTEvdGV4dHJlZ2lvbjo5ZDY4YWUwMmM1N2M0NGEyYmRlMDMzOWUwMWZjYzllY18zNA_53d11918-505b-416d-b00f-0c2e75870c42">2.05</ix:nonFraction>% </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b4be37081f42648c653212038f8710_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy02LTEtMS0yNTE2NTE_206302a5-7e24-430c-ba24-1517c5891703">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7607072d8464af1a07831fe55ae7d49_I20221231" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy04LTEtMS0yNTE2NTE_d9e2c0dc-d197-45f1-abf0-377b39cff597">4,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS0zLTEtMS0yMjUyNzE_c72b9e04-5c0d-4964-9df3-a00872c70e4c">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS00LTEtMS0yMjUyNzE_20f1e563-c719-466f-99d4-caf070d321e2">2.60</ix:nonFraction> %</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS02LTEtMS0yMjUyNzE_2928a05c-d805-4260-9583-2f8c2d6cef0e">7,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed4d0a4ede45839d5ff5d4cde250f0_I20221231" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS04LTEtMS0yMjUyNzE_1f2be537-0e68-4f2f-a21d-aec2564902c8">11,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i442974227f63407a813cccaa74ab1313_I20230331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi0zLTEtMS0yMjUyNzE_ff546ab2-8516-47a9-9090-0601da5e4c15">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i442974227f63407a813cccaa74ab1313_I20230331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi00LTEtMS0yMjUyNzE_63d29a8a-607d-47a3-86d9-7d40f72e5b26">2.54</ix:nonFraction> %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i442974227f63407a813cccaa74ab1313_I20230331" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi02LTEtMS0yMjUyNzE_5af6db67-cd63-43ed-87ab-a79142ea20bb">8,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef18c30916344f1bc92844528563a35_I20221231" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi04LTEtMS0yMjUyNzE_0f7a8624-008b-4e24-80a3-613518500201">12,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pay rates and receive rates are as of March&#160;31, 2023. As of December&#160;31, 2022, the interest rate swap instrument with a $<ix:nonFraction unitRef="usd" contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIzMTQy_a953268b-6c70-4e98-b1fd-1497c08fd02c">51</ix:nonFraction>&#160;million notional amount had a pay rate of <ix:nonFraction unitRef="number" contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTYx_b847551c-c0d4-4bd9-9df8-dd9457c8364b">5.08</ix:nonFraction>% and a receive rate of 1 mo. USD-LIBOR-BBA + <ix:nonFraction unitRef="number" contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTY4_2e679b42-3201-4d9f-a660-696886345b1f">2.50</ix:nonFraction>%. As of December&#160;31, 2022, the interest rate swap instrument with a $<ix:nonFraction unitRef="usd" contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIzMTY3_8772974c-5ea8-4e8b-a413-6aa94ae940a1">91</ix:nonFraction>&#160;million notional amount had a pay rate of <ix:nonFraction unitRef="number" contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTc1_764ab232-ab4d-4d3b-92b2-ca1f71fed6bf">4.63</ix:nonFraction>% and a receive rate of 1 mo. USD-LIBOR-BBA + <ix:nonFraction unitRef="number" contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTgy_7ef8ad2e-b383-4e86-a842-88ebf5b7634a">2.05</ix:nonFraction>%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the interest rate swap instruments were in an asset position. Derivative assets are recorded at fair value in other assets, net on the Consolidated Balance Sheets.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i06b42d266967493fb948926ae6830a77" continuedAt="ief336360e44d40a081998d5545bbcbd9"><ix:continuation id="i6dcb141d29a448ff84d8816d67e8cf0c" continuedAt="i5d915ed710144fe8b040e5c6485ac875">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ief336360e44d40a081998d5545bbcbd9"><ix:continuation id="i5d915ed710144fe8b040e5c6485ac875">Represents interest rate swap instruments that hedge fluctuations in interest payments on variable rate debt by converting the interest rates to fixed interest rates. The changes in fair value of designated derivatives that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets.</ix:continuation></ix:continuation> </span></div><div id="id2287c84385e40afa1133fb5d1fa8206_85"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfMTYyOQ_62e3352d-c03a-4ec3-a9f3-5fea0455e5b6" continuedAt="i3904d1098c1246cda57f51cd8deeca8e" escape="true">Accounts Payable, Accrued Liabilities, and Other Liabilities</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i3904d1098c1246cda57f51cd8deeca8e"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfMTYzMA_097c0630-f9ba-4cd0-a5c6-22d76fb84f4f" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:RefundableEntranceFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMS0xLTEtMS0yMjUyNzE_390bc05a-fb7f-403b-b7ea-b7d7f1320dbf">264,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:RefundableEntranceFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMS0zLTEtMS0yMjUyNzE_96c42fee-a806-4e36-8b46-c72e0b7e1fb7">268,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:ConstructionPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMi0xLTEtMS0yMjUyNzE_5e1e7c05-de7c-4bc2-9bba-7b011839608f">161,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:ConstructionPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMi0zLTEtMS0yMjUyNzE_677c3095-3343-4cfe-9b12-c1f9a45acd36">178,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMy0xLTEtMS0yMjUyNzE_0d7f78d2-e47b-4433-9d13-dc027ce753a9">39,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMy0zLTEtMS0yMjUyNzE_68165a38-7e48-4104-a014-de20a44458ff">59,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNC0xLTEtMS0yMjUyNzE_a0824199-1d97-4179-b74e-b392bb3addb8">224,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNC0zLTEtMS0yMjUyNzE_37a83347-b257-4045-917a-e281b03e918b">265,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNS0xLTEtMS0yMjUyNzE_1f5f29e1-1441-447d-b892-9f6d7c94b658">688,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNS0zLTEtMS0yMjUyNzE_4c3ac261-bec5-4e3a-8e40-e230a55e3cde">772,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2023 and December&#160;31, 2022, includes $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfNTQ5NzU1ODE5OTI4_9279e9f6-1df8-44e5-80f7-df5fed30a421">12</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfNTQ5NzU1ODE5ODIy_bc8a4dad-8834-4e3d-b06a-fcce36360529">15</ix:nonFraction>&#160;million, respectively,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of severance-related charges associated with the departure of a former CEO in October 2022 that had not yet been paid.</span></div></ix:nonNumeric></ix:continuation><div id="id2287c84385e40afa1133fb5d1fa8206_1349"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV83MTQ2ODI1NTg0MjIw_688a99ca-c9ce-4ff3-a124-019d37a281f9" continuedAt="i76941b72e62949fcbf712c24bf62ea58" escape="true">Deferred Revenue</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i76941b72e62949fcbf712c24bf62ea58"><ix:nonNumeric contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" name="peak:ScheduleOfDeferredRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV83MTQ2ODI1NTg0MjIx_1263470e-6adb-4335-8cb0-b9df2e09ddd6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonrefundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:NonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8yLTEtMS0xLTIyOTc3MA_3be0cadc-c4e1-403f-a09f-b34965133cf1">527,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:NonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8yLTMtMS0xLTIyOTc3MA_42e4b55f-e3c7-4197-8e10-258892050960">518,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="peak:OtherDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl80LTEtMS0xLTIyOTc3MA_0bcdf7aa-8128-4427-a045-2c0863d40ee3">350,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="peak:OtherDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl80LTMtMS0xLTIyOTc3MA_0f8599bf-68b1-4fc7-968d-567f6ec0c1b8">325,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8zLTEtMS0xLTIzMjkyNQ_533b3e60-532f-4cc3-af0a-7760675bbb04">878,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8zLTMtMS0xLTIzMjkyNw_9a9ea5ae-e231-432d-b002-bf1e9c279f06">844,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and 2022, the Company collected nonrefundable entrance fees of $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="peak:ProceedsFromCollectionOfNonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTY0Nzk_1e66ede7-1e54-41d8-8aa3-4c903c328efd">29</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="peak:ProceedsFromCollectionOfNonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcyNzY_4121d703-3bc6-4433-80ac-7a5af4d50cf2">21</ix:nonFraction>&#160;million, respectively. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization of $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="peak:AmortizationOfNonrefundableEntranceFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTY1Mzc_587a89cd-0cb4-4159-826d-321f8a243dbe">20</ix:nonFraction>&#160;million and</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="peak:AmortizationOfNonrefundableEntranceFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTczNTQ_b92e5cbe-6997-456c-965e-16da594a087d">19</ix:nonFraction>&#160;million, respectively, which is included within resident fees and services on the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Other deferred revenue is primarily comprised of prepaid rent, deferred rent, and tenant-funded tenant improvements owned by the Company. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization related to other deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcxMjk_1f9f30ff-758b-4e73-8f60-67f405f3b44d">13</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcxNTQ_75651c0c-f909-4d6c-b2b2-59dbb13d89c5">9</ix:nonFraction>&#160;million,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">respectively, which is included in rental and related revenues on the Consolidated Statements of Operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">On February 7, 2023, we announced our intent to complete an UPREIT reorganization. As part of the reorganization, the company formerly known as Healthpeak Properties, Inc. (&#8220;Old Healthpeak&#8221;) formed New Healthpeak, Inc. (&#8220;New Healthpeak&#8221;) as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc. (&#8220;Merger Sub&#8221;) as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the &#8220;Merger&#8221;). In connection with the Merger, New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the UPREIT reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (&#8220;Healthpeak OP&#8221;). This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, all references in this report to &#8220;Healthpeak,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Old Healthpeak through February 9, 2023 and to New Healthpeak from and including February 10, 2023, in each case together with its consolidated subsidiaries. Unless the context suggests otherwise, references to &#8220;Healthpeak Properties, Inc.&#8221; mean the parent company without its subsidiaries.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_91"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Language Regarding Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).&#160;Forward-looking statements include, among other things, statements regarding our and our officers&#8217; intent, belief or expectation as identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;forecast,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;estimate,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could cause actual results, including our future financial condition and results of operations, to differ materially from those expressed or implied by any forward-looking statements. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions and expected future developments as well as other factors that we believe are appropriate under the circumstances. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Quarterly Report on Form 10-Q. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully set forth under Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 and in Part II, Item 1A. &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">macroeconomic trends, including inflation, interest rates, labor costs, and unemployment;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our existing and future tenants, operators, and borrowers to conduct their respective businesses in a manner that generates sufficient income to make rent and loan payments to us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the financial condition of our tenants, operators, and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our concentration of real estate investments in the healthcare property sector, which makes us more vulnerable to a downturn in a specific sector than if we invested across multiple sectors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the illiquidity of real estate investments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify and secure new or replacement tenants and operators;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our property development, redevelopment, and tenant improvement activity risks, including project abandonments, project delays, and lower profits than expected;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes within the life science industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant regulation, funding requirements, and uncertainty faced by our life science tenants;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the hospitals on whose campuses our medical office buildings (&#8220;MOBs&#8221;) are located and their affiliated healthcare systems to remain competitive or financially viable;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop, maintain, or expand hospital and health system client relationships;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operational risks associated with third party management contracts, including the additional regulation and liabilities of our properties operated through structures permitted by the Housing and Economic Recovery Act of 2008, which includes most of the provisions previously proposed in the REIT Investment Diversification and Empowerment Act of 2007 (commonly referred to as &#8220;RIDEA&#8221;);</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic conditions, natural disasters, weather, and other conditions that negatively affect geographic areas where we have concentrated investments;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uninsured or underinsured losses, which could result in significant losses and/or performance declines by us or our tenants and operators;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners&#8217; financial condition and continued cooperation; </span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our use of fixed rent escalators, contingent rent provisions, and/or rent escalators based on the Consumer Price Index;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition for suitable healthcare properties to grow our investment portfolio;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to foreclose or exercise rights on collateral securing our real estate-related loans;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investment of substantial resources and time in transactions that are not consummated;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully integrate or operate acquisitions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential impact on us and our tenants, operators, and borrowers from litigation matters, including rising liability and insurance costs;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">environmental compliance costs and liabilities associated with our real estate investments;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">epidemics, pandemics, or other infectious diseases, including the coronavirus disease (&#8220;Covid&#8221;), and health and safety measures intended to reduce their spread;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss or limited availability of our key personnel;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on information technology systems and the potential impact of system failures, disruptions, or breaches;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased borrowing costs, including due to rising interest rates; </span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash available for distribution to stockholders and our ability to make dividend distributions at expected levels;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of external capital on acceptable terms or at all, including due to rising interest rates, changes in our credit ratings and the value of our common stock, volatility or uncertainty in the capital markets, and other factors;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage our indebtedness level and covenants in and changes to the terms of such indebtedness;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bank failures or other events affecting financial institutions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of our tenants, operators, and borrowers to comply with federal, state, and local laws and regulations, including resident health and safety requirements, as well as licensure, certification, and inspection requirements;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required regulatory approvals to transfer our senior housing properties;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with the Americans with Disabilities Act and fire, safety, and other regulations;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws or regulations prohibiting eviction of our tenants;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legislation to address federal government operations and administrative decisions affecting the Centers for Medicare and Medicaid Services;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our participation in the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) Provider Relief Fund and other Covid-related stimulus and relief programs;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain our qualification as a real estate investment trust (&#8220;REIT&#8221;);</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to U.S. federal income tax laws, and potential deferred and contingent tax liabilities from corporate acquisitions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">calculating non-REIT tax earnings and profits distributions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ownership limits in our charter that restrict ownership in our stock; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provisions of Maryland law and our charter that could prevent a transaction that may otherwise be in the interest of our stockholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Executive Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market Trends and Uncertainties</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overview of Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP Financial Measures Reconciliations</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Critical Accounting Estimates</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_94"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) 500 company that acquires, develops, owns, leases, and manages healthcare real estate across the United States (&#8220;U.S.&#8221;). Our company was originally founded in 1985. As noted above, we completed an UPREIT reorganization on February 10, 2023, and following that date, we hold substantially all of our assets and conduct our operations through the operating subsidiary, Healthpeak OP, LLC, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. Our corporate headquarters are located in Denver, Colorado, and we have additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy is to invest in a diversified portfolio of high-quality healthcare properties across our three core asset classes of life science, medical office, and continuing care retirement community (&#8220;CCRC&#8221;) real estate. Under the life science and medical office segments, we invest through the acquisition, development, and management of life science facilities, MOBs, and hospitals. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of loans receivable, marketable debt securities, and an interest in an unconsolidated joint venture that owns 19 senior housing assets (our &#8220;SWF SH JV&#8221;). These non-reportable segments have been presented on an aggregate basis herein.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, our portfolio of investments, including properties in our unconsolidated joint ventures, consisted of interests in 476 properties. The following table summarizes information for our reportable and other non-reportable segments, excluding discontinued operations, for the three months ended March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:36.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Portfolio Adjusted NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total Portfolio Adjusted NOI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Properties</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-reportable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total Portfolio metrics include results of operations from disposed properties through the disposition date. See &#8220;Item 2, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures&#8221; for additional information regarding Adjusted NOI and see Note 13 to the Consolidated Financial Statements for a reconciliation of Adjusted NOI by segment to net income (loss).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of our significant activities during 2023, see &#8220;Item 2, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Overview of Transactions&#8221; in this report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we concluded that the dispositions of our senior housing triple-net and senior housing operating property (&#8220;SHOP&#8221;) portfolios represented a strategic shift that had a major effect on our operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 to the Consolidated Financial Statements for further information regarding discontinued operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Strategy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in and manage our real estate portfolio for the long-term to maximize benefit to our stockholders and support the growth of our dividends. Our strategy consists of four core elements:</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">real estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our portfolio is grounded in high-quality properties in desirable locations. We focus on three purposely selected private pay asset classes&#8212;life science, medical office, and continuing care retirement community&#8212;to provide stability through inevitable market cycles.</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We maintain a strong investment-grade balance sheet with ample liquidity as well as long-term fixed-rate debt financing with staggered maturities to reduce our exposure to interest rate volatility and refinancing risk.</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We work with leading pharmaceutical and biotechnology companies, healthcare companies, operators, and service providers and are responsive to their space and capital needs. We provide high-quality property management services to encourage tenants to renew, expand, and relocate into our properties, which drives increased occupancy, rental rates, and property values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have a people-first culture that we believe attracts, develops, and retains top talent. We continually strive to create and maintain an industry-leading platform, with systems and tools that allow us to effectively and efficiently manage our assets and investment activity.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_97"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Trends and Uncertainties</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results have been and will continue to be impacted by global and national economic and market conditions generally and by the local economic conditions where our properties are located.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rising interest rates, high inflation, supply chain disruptions, ongoing geopolitical tensions, and increased volatility in public and private equity and fixed income markets have led to increased costs and limited the availability of capital. In addition, bank failures and other adverse conditions in the financial or credit markets impacting financial institutions, or concerns or rumors about such events, may lead to disruptions in access to bank deposits and the ability of financial institutions to meet their obligations. To the extent our tenants or operators experience increased costs, liquidity constraints, or financing difficulties due to the foregoing macroeconomic and market conditions, they may be unable or unwilling to make payments or perform their obligations when due. In addition, increased interest rates could affect our borrowing costs and the fair value of our fixed rate instruments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also been affected by significant inflation in construction costs over the past couple of years, which, together with rising costs of capital, have negatively affected the expected yields on our development and redevelopment projects. In addition, labor shortages and global supply chain disruptions, including procurement delays and long lead times on certain materials, have adversely impacted and could continue to adversely impact the scheduled completion and/or costs of these projects. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the full, long-term economic impact of the Covid pandemic on the operations of our CCRCs and the senior housing facilities owned by our SWF SH JV remains uncertain. Many factors cannot be predicted and will remain unpredictable, including the impact, duration, and severity of new variants and outbreaks. Due to these uncertainties, at this time, we are not able to estimate the full impact of Covid on our consolidated financial position, results of operations, and cash flows in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously monitor the effects of domestic and global events, including but not limited to inflation, labor shortages, supply chain matters, rising interest rates, and distress in the financial markets on our operations and financial position, as well as on the operations and financial position of our tenants, operators, and borrowers, to ensure that we remain responsive and adaptable to the dynamic changes in our operating environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 for additional discussion of the risks posed by macroeconomic conditions, as well as the uncertainties we and our tenants, operators, and borrowers may face as a result.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we completed our planned UPREIT reorganization. This reorganization provides prospective sellers an alternative for disposing of property that has appreciated in value in a tax-deferred manner to Healthpeak OP and aligns the Company&#8217;s corporate structure with other publicly traded U.S. real estate investment trusts. Following the UPREIT reorganization, Healthpeak OP is the borrower under, and we are the guarantor of, all of the unsecured debt, which includes the Revolving Facility, Term Loan Facilities (each as defined below), commercial paper program, and senior unsecured notes. Our guarantee of the senior unsecured notes is full and unconditional and applicable to existing and future senior unsecured notes. The reorganization did not have a material impact on the Company&#8217;s financial position, consolidated financial statements, outstanding debt securities, material debt facilities, or business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Transactions</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we sold two life science facilities in Durham, North Carolina for $113&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, we closed a life science acquisition in Cambridge, Massachusetts for $9&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In March 2023, we sold two MOBs for $32&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2023, we completed a public offering of $400 million aggregate principal amount of 5.25% senior unsecured notes due in 2032.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2023, we received a partial principal repayment of $102&#160;million on one secured loan with an original maturity of January 2023. The remaining $48 million outstanding was refinanced with us, extending the maturity date to January 2024 and converting the fixed interest rate on the loan to a variable rate based on SOFR (as defined below) plus a margin. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2023, we received full repayment of the outstanding balance of one $35&#160;million secured loan. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In April 2023, we received full repayment of the outstanding balance of one $14&#160;million secured loan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Activities </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2023, the following projects were placed in service:</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) a portion of one life science redevelopment project with total costs of $43 million, (ii) a portion of one life science development project with total costs of $32 million, and (iii) one MOB redevelopment project with total costs of $8 million.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_103"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock cash dividends declared in 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:53.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Declaration&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend<br/>Payment&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="id2287c84385e40afa1133fb5d1fa8206_106"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our business and allocate resources among our reportable business segments: (i) life science, (ii) medical office, and (iii) CCRC.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the life science and medical office segments, we invest through the acquisition, development, and management of life science facilities, MOBs, and hospitals, which generally requires a greater level of property management. Our CCRCs are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in our unconsolidated SWF SH JV, (ii) loans receivable, and (iii) marketable debt securities. These non-reportable segments have been presented on an aggregate basis herein. We evaluate performance based upon property adjusted net operating income (&#8220;Adjusted NOI&#8221; or &#8220;Cash NOI&#8221;) in each segment. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 2 to the Consolidated Financial Statements in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;), as updated by Note 2 to the Consolidated Financial Statements herein.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Operating Income </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI are non-U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 13 to the Consolidated Financial Statements. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. NOI and Adjusted NOI are calculated as NOI and Adjusted NOI from consolidated properties, plus our share of NOI and Adjusted NOI from unconsolidated joint ventures (calculated by applying our actual ownership percentage for the period), less noncontrolling interests&#8217; share of NOI and Adjusted NOI from consolidated joint ventures (calculated by applying our actual ownership percentage for the period). Management utilizes its share of NOI and Adjusted NOI in assessing its performance as we have various joint ventures that contribute to its performance. We do not control our unconsolidated joint ventures, and our share of amounts from unconsolidated joint ventures do not represent our legal claim to such items. Our share of NOI and Adjusted NOI should not be considered a substitute for, and should only be considered together with and as a supplement to, our financial information presented in accordance with GAAP.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted NOI is oftentimes referred to as &#8220;Cash NOI.&#8221; Management believes NOI and Adjusted NOI are important supplemental measures because they provide relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and present them on an unlevered basis. We use NOI and Adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and to evaluate our Same-Store (&#8220;SS&#8221;) performance, as described below. We believe that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. Further, our definitions of NOI and Adjusted NOI may not be comparable to the definitions used by other REITs or real estate companies, as they may use different methodologies for calculating NOI and Adjusted NOI. For a reconciliation of NOI and Adjusted NOI to net income (loss) by segment, refer to Note&#160;13 to the Consolidated Financial Statements. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses generally relate to leased medical office and life science properties, as well as CCRC facilities. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Same-Store</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store NOI and Adjusted (Cash) NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties, excluding properties within the other non-reportable segments. We include properties from our consolidated portfolio, as well as properties owned by our unconsolidated joint ventures in Same-Store NOI and Adjusted NOI (see NOI definition above for further discussion regarding our use of pro-rata share information and its limitations). Same-Store NOI and Adjusted NOI exclude government grant income under the CARES Act. Same-Store Adjusted NOI also excludes amortization of deferred revenue from tenant-funded improvements and certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Properties are included in Same-Store once they are stabilized for the full period in both comparison periods. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) control(s) the physical use of at least 80% of the space and rental payments have commenced) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. Properties that experience a change in reporting structure are considered stabilized after 12 months in operations under a consistent reporting structure. A property is removed from Same-Store when it is classified as held for sale, sold, placed into redevelopment, experiences a casualty event that significantly impacts operations, a change in reporting structure or operator transition has been agreed to, or a significant tenant relocates from a Same-Store property to a non Same-Store property and that change results in a corresponding increase in revenue. We do not report Same-Store metrics for our other non-reportable segments. For a reconciliation of Same-Store to total portfolio Adjusted NOI and other relevant disclosures by segment, refer to our Segment Analysis below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds From Operations (&#8220;FFO&#8221;)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFO encompasses Nareit FFO and FFO as Adjusted, each of which is described in detail below. We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nareit FFO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  FFO, as defined by the National Association of Real Estate Investment Trusts (&#8220;Nareit&#8221;), is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of depreciable property, including any current and deferred taxes directly associated with sales of depreciable property, impairments of, or related to, depreciable real estate, plus real estate and other real estate-related depreciation and amortization, and adjustments to compute our share of Nareit FFO and FFO as Adjusted (see below) from joint ventures. Adjustments for joint ventures are calculated to reflect our pro rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of Nareit FFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. For consolidated joint ventures in which we do not own 100%, we reflect our share of the equity by adjusting our Nareit FFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods. Our pro rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate economic interest in the operating results of properties in our portfolio and is calculated by applying our actual ownership percentage for the period. We do not control the unconsolidated joint ventures, and the pro rata presentations of reconciling items included in Nareit FFO do not represent our legal claim to such items. The joint venture members or partners are entitled to profit or loss allocations and distributions of cash flows according to the joint venture agreements, which provide for such allocations generally according to their invested capital. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presentation of pro rata information has limitations, which include, but are not limited to, the following: (i) the amounts shown on the individual line items were derived by applying our overall economic ownership interest percentage determined when applying the equity method of accounting and do not necessarily represent our legal claim to the assets and liabilities, or the revenues and expenses and (ii) other companies in our industry may calculate their pro rata interest differently, limiting the usefulness as a comparative measure. Because of these limitations, the pro rata financial information should not be considered independently or as a substitute for our financial statements as reported under GAAP. We compensate for these limitations by relying primarily on our GAAP financial statements, using the pro rata financial information as a supplement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nareit FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute Nareit FFO in accordance with the current Nareit definition; however, other REITs may report Nareit FFO differently or have a different interpretation of the current Nareit definition from ours. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">FFO as Adjusted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In addition, we present Nareit FFO on an adjusted basis before the impact of non-comparable items including, but not limited to, transaction-related items, other impairments (recoveries) and other losses (gains), restructuring and severance-related charges, prepayment costs (benefits) associated with early retirement or payment of debt, litigation costs (recoveries), casualty-related charges (recoveries), deferred tax asset valuation allowances, and changes in tax legislation (&#8220;FFO as Adjusted&#8221;). These adjustments are net of tax, when applicable. Transaction-related items include transaction expenses and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Prepayment costs (benefits) associated with early retirement of debt include the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of debt. Other impairments (recoveries) and other losses (gains) include interest income associated with early and partial repayments of loans receivable and other losses or gains associated with non-depreciable assets including goodwill, DFLs, undeveloped land parcels, and loans receivable. Management believes that FFO as Adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. At the same time that Nareit created and defined its FFO measure for the REIT industry, it also recognized that &#8220;management of each of its member companies has the responsibility and authority to publish financial information that it regards as useful to the financial community.&#8221; We believe stockholders, potential investors, and financial analysts who review our operating performance are best served by an FFO run-rate earnings measure that includes certain other adjustments to net income (loss), in addition to adjustments made to arrive at the Nareit defined measure of FFO. FFO as Adjusted is used by management in analyzing our business and the performance of our properties and we believe it is important that stockholders, potential investors, and financial analysts understand this measure used by management. We use FFO as Adjusted to: (i) evaluate our performance in comparison with expected results and results of previous periods, relative to resource allocation decisions, (ii) evaluate the performance of our management, (iii) budget and forecast future results to assist in the allocation of resources, (iv) assess our performance as compared with similar real estate companies and the industry in general, and (v) evaluate how a specific potential investment will impact our future results. Other REITs or real estate companies may use different methodologies for calculating an adjusted FFO measure, and accordingly, our FFO as Adjusted may not be comparable to those reported by other REITs. For a reconciliation of net income (loss) to Nareit FFO and FFO as Adjusted and other relevant disclosure, refer to &#8220;Non-GAAP Financial Measures Reconciliations&#8221; below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted FFO (&#8220;AFFO&#8221;).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AFFO is defined as FFO as Adjusted after excluding the impact of the following: (i) stock-based compensation amortization expense, (ii) amortization of deferred financing costs, net, (iii) straight-line rents, (iv) deferred income taxes, (v) amortization of above (below) market lease intangibles, net and (vi) other AFFO adjustments, which include: (a) non-cash interest related to DFLs and lease incentive amortization (reduction of straight-line rents), (b) actuarial reserves for insurance claims&#160;that have been incurred but not reported, and (c) amortization of deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, AFFO is computed after deducting recurring capital expenditures, including second generation leasing costs and second generation tenant and capital improvements, and includes adjustments to compute our share of AFFO from our unconsolidated joint ventures.</span><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, recurring capital expenditures, including second generation leasing costs and second generation tenant and capital improvements (&#8220;AFFO capital expenditures&#8221;) excludes our share from unconsolidated joint ventures (reported in &#8220;other AFFO adjustments&#8221;). Adjustments for joint ventures are calculated to reflect our pro rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of AFFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. We reflect our share for consolidated joint ventures in which we do not own 100% of the equity by adjusting our AFFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods (reported in &#8220;other AFFO adjustments&#8221;). See FFO for further disclosure regarding our use of pro rata share information and its limitations. We believe AFFO is an alternative run-rate earnings measure that improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods, and (iii) results among REITs more meaningful. AFFO does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs as it excludes the following items which generally flow through our cash flows from operating activities: (i) adjustments for changes in working capital or the actual timing of the payment of income or expense items that are accrued in the period, (ii) transaction-related costs, (iii) litigation settlement expenses, and (iv) restructuring and severance-related charges. Furthermore, AFFO is adjusted for recurring capital expenditures, which are generally not considered when determining cash flows from operations or liquidity. Other REITs or real estate companies may use different methodologies for calculating AFFO, and accordingly, our AFFO may not be comparable to those reported by other REITs. Management believes AFFO provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT, and by presenting AFFO, we are assisting these parties in their evaluation. AFFO is a non-GAAP supplemental financial measure and should not be considered as an alternative to net income (loss) determined in accordance with GAAP and should only be considered together with and as a supplement to the Company&#8217;s financial information prepared in accordance with GAAP. For a reconciliation of net income (loss) to AFFO and other relevant disclosures, refer to &#8220;Non-GAAP Financial Measures Reconciliations&#8221; below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2023 to the Three Months Ended March&#160;31, 2022 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results for the three months ended March&#160;31, 2023 and 2022 (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nareit FFO</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FFO as Adjusted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,277)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFFO</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207,659&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,626&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For the reconciliation of non-GAAP financial measures, see &#8220;Non-GAAP Financial Measure Reconciliations&#8221; below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) applicable to common shares increased primarily as a result of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in gains on sale of depreciable real estate related to higher gains recognized on life science and MOB asset sales during the first quarter of 2023 as compared to 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in NOI generated from our life science and medical office segments related to: (i) development and redevelopment projects placed in service during 2022 and 2023, (ii) new leasing activity during 2022 and 2023 (including the impact to straight-line rents), and (iii) 2022 acquisitions of real estate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in expenses incurred for tenant relocation and other costs associated with the demolition of an MOB; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in loan loss reserves primarily due to principal repayments on seller financing, partially offset by increased interest rates on variable rate loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in net income (loss) applicable to common shares was partially offset by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain on sale associated with the disposition of a hospital under a direct financing lease (&#8220;DFL&#8221;) in 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in interest expense, primarily as a result of: (i) higher interest rates under the commercial paper program, (ii) borrowings under the Term Loan Facilities, which were drawn during the fourth quarter of 2022, and (iii) senior unsecured notes issued during the first quarter of 2023;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in noncontrolling interests&#8217; share in continuing operations as a result of a gain on sale of an MOB in a consolidated partnership that was sold in 2023;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in NOI related to the write-off of the straight-line rent receivable balance that was no longer probable of collection associated with a life science tenant that commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in government grant income received under the CARES Act in 2023;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in transaction costs, primarily as a result of expenses incurred in connection with our reorganization to an UPREIT structure in 2023; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in depreciation, primarily as a result of: (i) development and redevelopment projects placed in service during 2022 and 2023 and (ii) 2022 acquisitions of real estate.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nareit FFO decreased primarily as a result of the aforementioned events impacting net income (loss) applicable to common shares, except for the following, which are excluded from Nareit FFO:</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">gain on sales of depreciable real estate; and</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation and amortization expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFO as Adjusted</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased primarily as a result of the aforementioned events impacting Nareit FFO, except for the following, which are excluded from FFO as Adjusted:</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the gain on sale of a hospital under a DFL;</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expenses for tenant relocation and other costs associated with the demolition of an MOB;</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loan loss reserves; and</span></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">transaction costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AFFO increased primarily as a result of the aforementioned events impacting FFO as Adjusted, except for the impact of straight-line rents, which is excluded from AFFO. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Analysis&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide selected operating information for our Same-Store and total property portfolio for each of our reportable segments. For the three months ended March&#160;31, 2023, our Same-Store consists of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">408 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2022 and that remained in operations under a consistent reporting structure through March&#160;31, 2023. Our total property portfolio consisted of 476 and 483 properties at March&#160;31, 2023 and 2022, respectively. Included in our total property portfolio at each of March&#160;31, 2023 and 2022 are 19 senior housing assets in our SWF SH JV. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life Science</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2023 and 2022 (dollars and square feet in thousands, except per square foot data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,668)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,566)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,531)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,946&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: non-SS Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied square feet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual total revenues per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual base rent per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Total Portfolio includes results of operations from disposed properties through the disposition date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI. See Note 13 to the Consolidated Financial Statements for a reconciliation of Adjusted NOI by segment to net income (loss).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2022 presentation of Same-Store, we added: (i) five stabilized acquisitions, (ii) three stabilized facilities that previously experienced a significant tenant relocation, (iii) two stabilized redevelopments placed in service, and (iv) one stabilized development placed in service, and we removed: (i) nine facilities that were placed into redevelopment, (ii) two facilities that were sold, and (iii) one facility that experienced a significant tenant relocation.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Average annual total revenues does not include non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, and deferred revenues).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, and deferred revenues).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual rent escalations; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new leasing activity; partially offset by</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Portfolio Adjusted NOI increased primarily as a result of the aforementioned impacts to Same-Store and the following Non-Same-Store impacts:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased NOI from developments and redevelopments placed in service in 2022 and 2023; partially offset by</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased NOI from our 2023 dispositions. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Office</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2023 and 2022 (dollars and square feet in thousands, except per square foot data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from direct financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,072)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: non-SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period occupancy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied square feet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual total revenues per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual base rent per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total Portfolio includes results of operations from disposed properties through the disposition date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI. See Note 13 to the Consolidated Financial Statements for a reconciliation of Adjusted NOI by segment to net income (loss).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2022 presentation of Same-Store, we added: (i) 25 stabilized acquisitions and (ii) 2 stabilized redevelopments placed in service, and we removed: (i) 2 MOBs that were sold and (ii) 1 MOB that was placed into redevelopment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Average annual total revenues does not include non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, DFL non-cash interest, and deferred revenues).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, DFL non-cash interest, and deferred revenues).</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mark-to-market lease renewals;</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual rent escalations; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher parking income and percentage-based rents.</span></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Portfolio Adjusted NOI increased primarily as a result of the aforementioned increases to Same-Store and the following Non-Same-Store impacts:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased NOI from our 2022 acquisitions; and</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased occupancy in former redevelopment and development properties that have been placed in service; partially offset by</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased NOI from our 2022 and 2023 dispositions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continuing Care Retirement Community</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2023 and 2022 (dollars in thousands, except per unit data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Resident fees and services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,456&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus (less): non-SS adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,456&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual rent per occupied unit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI. See Note 13 to the Consolidated Financial Statements for a reconciliation of Adjusted NOI by segment to net income (loss).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2022 presentation of Same-Store, no properties were added or removed. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Total Portfolio and Same-Store increase in average occupancy for the period is primarily due to a decrease in available units from decommissioned senior nursing facility beds.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents average occupied units as reported by the operators for the three-month period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased rates for resident fees; partially offset by</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher costs of insurance, utilities, food, and real estate taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Portfolio Adjusted NOI decreased primarily as a result of decreased government grant income received under the CARES Act, partially offset by the aforementioned increases to Same-Store.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income and Expense Items</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the results of our other income and expense items for the three months ended March&#160;31, 2023 and 2022 (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,825)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest income</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income increased for the three months ended March&#160;31, 2023 primarily as a result of higher interest rates, partially offset by principal repayments on loans receivable in 2022 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased for the three months ended March&#160;31, 2023 primarily as a result of: (i) higher interest rates under the commercial paper program, (ii) borrowings under the Term Loan Facilities, which were drawn during the fourth quarter of 2022, and (iii) senior unsecured notes issued during the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization expense</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense increased for the three months ended March&#160;31, 2023 primarily as a result of: (i) development and redevelopment projects placed in service during 2022 and 2023 and (ii) assets acquired during 2022. The increase in depreciation and amortization expense for the three months ended March&#160;31, 2023 was partially offset by: (i) lower depreciation related to the deconsolidation of seven previously consolidated life science assets in South San Francisco, California and (ii) dispositions of real estate in 2022 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction costs</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs increased for the three months ended March&#160;31, 2023 primarily as a result of expenses incurred in connection with our reorganization to an UPREIT structure in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairments and loan loss reserves (recoveries), net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairments and loan loss reserves (recoveries), net decreased for the three months ended March&#160;31, 2023 as a result of a decrease in loan loss reserves under the current expected credit losses model. The decrease in loan loss reserves for the three months ended March&#160;31, 2023 is primarily due to principal repayments on seller financing, partially offset by increased interest rates on variable rate loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain (loss) on sales of real estate, net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) on sales of real estate, net increased during the three months ended March&#160;31, 2023 primarily as a result of: (i) the $60&#160;million gain on sale of two life science facilities in Durham, North Carolina, which were sold in January 2023 and (ii) the $21&#160;million gain on sales of two MOBs, which were sold in March 2023, partially offset by the $4&#160;million gain on sale of one life science facility, which was sold during the three months ended March 31, 2022. Refer to Note 4 to the Consolidated Financial Statements for additional information regarding dispositions of real estate and the associated gain (loss) on sales recognized. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income decreased for the three months ended March&#160;31, 2023 primarily due to: (i) a gain on sale associated with the disposition of a hospital under a DFL in 2022 and (ii) a decrease in government grant income received under the CARES Act in 2023, partially offset by expenses incurred in 2022 for tenant relocation and other costs associated with the demolition of an MOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling interests&#8217; share in continuing operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests&#8217; share in continuing operations increased for the three months ended March&#160;31, 2023 primarily as a result of a gain on sale of an MOB in a consolidated joint venture that was sold in 2023.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_127"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our cash flow from operations, available cash balances, and cash from our various financing activities will be adequate for the next 12 months and for the foreseeable future for purposes of: (i) funding recurring operating expenses; (ii) meeting debt service requirements; and (iii) satisfying funding of distributions to our stockholders and non-controlling interest members. During the three months ended March&#160;31, 2023, distributions to common shareholders and noncontrolling interest holders exceeded cash flows from operations by approximately $14&#160;million. Distributions are made using a combination of cash flows from operations, funds available under our bank line of credit (the &#8220;Revolving Facility&#8221;) and commercial paper program, proceeds from the sale of properties, and other sources of cash available to us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to funding the activities above, our principal liquidity needs for the next 12 months are to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund capital expenditures, including tenant improvements and leasing costs; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund future acquisition, transactional, and development and redevelopment activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our longer term liquidity needs include the items listed above as well as meeting debt service requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate satisfying these future needs using one or more of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash flow from operations;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sale of, or exchange of ownership interests in, properties or other investments;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">borrowings under our Revolving Facility and commercial paper program;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of additional debt, including unsecured notes, term loans, and mortgage debt; and/or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of common or preferred stock or its equivalent, including sales of common stock under the ATM Program (as defined below).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to access the capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. Our two senior unsecured delayed draw term loans with an aggregate principal amount of $500&#160;million (the &#8220;Term Loan Facilities&#8221;) and our Revolving Facility accrue interest at the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus a margin that depends on the credit ratings of our senior unsecured long-term debt. We also pay a facility fee on the entire commitment under our Revolving Facility that depends upon our credit ratings. As of April&#160;26, 2023, we had long-term credit ratings of Baa1 from Moody&#8217;s and BBB+ from S&amp;P Global, and short-term credit ratings of P-2 from Moody&#8217;s and A-2 from S&amp;P Global.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A downgrade in credit ratings by Moody&#8217;s and S&amp;P Global may have a negative impact on the interest rates and facility fees for our Revolving Facility and Term Loan Facilities and may negatively impact the pricing of notes issued under our commercial paper program and senior unsecured notes. While a downgrade in our credit ratings would adversely impact our cost of borrowing, we believe we would continue to have access to the unsecured debt markets, and we could also seek to enter into one or more secured debt financings, issue additional securities, including under our ATM Program, or dispose of certain assets to fund future operating costs, capital expenditures, or acquisitions, although no assurances can be made in this regard. Refer to &#8220;Market Trends and Uncertainties&#8221; above for a more comprehensive discussion of the potential impact of Covid as well as economic and market conditions on our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Material Cash Requirements and Off-Balance Sheet Arrangements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our material cash requirements related to debt decreased by $44 million to $6.5 billion at March&#160;31, 2023, when compared to December&#160;31, 2022, primarily as a result of repayments of notes under our commercial paper program, partially offset by the completion of a public offering in January 2023 of $400 million aggregate principal amount of 5.25% senior unsecured notes due in 2032. As of March&#160;31, 2023, we had $5.1 billion of senior unsecured notes and $556 million outstanding under our commercial paper program. See Note 9 to the Consolidated Financial Statements for additional information about our debt commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development and redevelopment commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Our material cash requirements related to development and redevelopment projects and Company-owned tenant improvements decreased by $35 million, to $217 million at March&#160;31, 2023, when compared to December&#160;31, 2022, primarily as a result of construction spend on existing projects in the first quarter of 2023 thereby decreasing the remaining commitment. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Construction loan commitments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Due to the terms of our SHOP seller financing notes receivable, as of March&#160;31, 2023, we are obligated to provide additional loans up to $40 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to fund senior housing redevelopment capital expenditure projects. There was no change in our material cash requirements to provide this additional funding from December&#160;31, 2022 to March&#160;31, 2023. See Note 6 to the Consolidated Financial Statements for additional information. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable noncontrolling interests.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our material cash requirements related to redeemable noncontrolling interests decreased by $20 million to $86&#160;million at March&#160;31, 2023, when compared to December&#160;31, 2022. Certain of our noncontrolling interest holders have the ability to put their equity interests to us upon specified events or after the passage of a predetermined period of time. Each put option is subject to changes in redemption value in the event that the underlying property generates specified returns for us and meets certain promote thresholds pursuant to the respective agreements. As of March&#160;31, 2023, one of the redeemable noncontrolling interests has met the conditions for redemption, but was not yet exercised. See Note 11 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution and Dividend Requirements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  There have been no changes to our distribution and dividend requirements during the three months ended March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We own interests in certain unconsolidated joint ventures as described in Note 7 to the Consolidated Financial Statements. Two of these joint ventures have mortgage debt of $88 million, of which our share is $40 million. Except in limited circumstances, our risk of loss is limited to our investment in the joint ventures. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other material changes, outside of the ordinary course of business, during the three months ended March&#160;31, 2023 to the material cash requirements or material off-balance sheet arrangements disclosed in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 under &#8220;Material Cash Requirements&#8221; and &#8220;Off-Balance Sheet Arrangements&#8221; in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_133"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary discussion of our cash flows is based on the Consolidated Statements of Cash Flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth changes in cash flows (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,262)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245,962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239,875)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Cash Flows </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from operations are dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants&#8217; performance on their lease obligations, the level of operating expenses, and other factors. Operating cash flows decreased $20 million for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 primarily as a result of: (i) timing of property tax payments, (ii) an increase in interest expense, and (iii) an increase in property operating expenses. The decrease</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in operating cash flows was partially offset by: (i) developments and redevelopments placed in service during 2022 and 2023, (ii) annual rent increases, (iii) higher nonrefundable entrance fee collections, and (iv) new leasing and renewal activity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from investing activities are generally used to fund acquisitions, developments, and redevelopments of real estate assets, net of proceeds received from sales of real estate assets, sales of DFLs, and repayments on loans receivable. Our net cash provided by investing activities increased $302 million for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 primarily as a result of the following: (i) an increase in proceeds from the sales of real estate assets, (ii) a reduction in acquisitions of real estate assets, and (iii) an increase in proceeds from principal repayments on loans receivable and marketable debt securities. The increase in cash provided by investing activities was partially offset by: (i) development and redevelopment of real estate assets and (ii) higher contributions to unconsolidated joint ventures to fund redevelopments of unconsolidated assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from financing activities are generally impacted by issuances of equity, borrowings and repayments under our bank line of credit and commercial paper program, senior unsecured notes, term loans, and mortgage debt, net of dividends paid to common shareholders. Our net cash used in financing activities increased $221 million for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 primarily as a result of the following: (i) lower borrowings and higher repayments under the bank line of credit and commercial paper program and (ii) increased distributions to noncontrolling interests. The increase in net cash used in financing activities was partially offset by proceeds received from the senior unsecured notes issuance in January 2023.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_136"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, we completed a public offering of $400 million aggregate principal amount of 5.25% senior unsecured notes due in 2032.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Revolving Facility was amended to change the interest rate benchmark from LIBOR to SOFR. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in February 2023, the agreements associated with $142&#160;million of variable rate mortgage debt were amended to change the interest rate benchmarks from LIBOR to SOFR, effective March 2023. Concurrently, the Company modified the related interest rate swap instruments to reflect the change in the interest rate benchmarks from LIBOR to SOFR.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 to the Consolidated Financial Statements for additional information about our outstanding debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 91% and 77% of our consolidated debt was fixed rate debt as of March&#160;31, 2023 and 2022, respectively. At March&#160;31, 2023, our fixed rate debt and variable rate debt had weighted average interest rates of 3.59% and 5.55%, respectively. At March&#160;31, 2022, our fixed rate debt and variable rate debt had weighted average interest rates of 3.40% and 1.13%, respectively. As of March&#160;31, 2023, we had</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$142&#160;million of variable rate mortgage debt and the $500 million Term Loan Facilities swapped to fixed through interest rate swap instruments. These interest rate swap instruments are designated as cash flow hedges. For purposes of classification of the amounts above, variable rate debt with a derivative financial instrument designated as a cash flow hedge is reported as fixed rate debt due to us having effectively established a fixed interest rate for the underlying debt instrument. For a more detailed discussion of our interest rate risk, see &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; in Item 3 below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Guarantor Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak OP has issued the senior unsecured notes described in Note 9 to the Consolidated Financial Statements. The obligations of Healthpeak OP to pay principal, premiums, if any, and interest on such senior unsecured notes are guaranteed on a full and unconditional basis by the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsidiary issuers of obligations guaranteed by the parent are not required to provide separate financial statements, provided that the parent guarantee is &#8220;full and unconditional&#8221;, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and consolidated financial statements of the parent company have been filed. Accordingly, separate consolidated financial statements of Healthpeak OP have not been presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Rule 13-01 of Regulation S-X, we have excluded the summarized financial information for the operating subsidiary because the Company and Healthpeak OP have no material assets, liabilities, or operations other than debt financing activities and their investments in non-guarantor subsidiaries, and management believes such summarized financial information would be repetitive and would not provide incremental value to investors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, we had</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">547 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of common stock outstanding, equity totaled $7.1 billion, and our equity securities had a market value of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$12.2 billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-The-Market Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, in connection with the UPREIT reorganization, we terminated our previous at-the-market equity offering program and established a new at-the-market equity offering program (the &#8220;ATM Program&#8221;) that allows for the sale of shares of common stock having an aggregate gross sales price of up to $1.5 billion. In addition to the issuance and sale of shares of our common stock, we may also enter into one or more forward sales agreements (each, an &#8220;ATM forward contract&#8221;) with sales agents for the sale of our shares of common stock under our ATM Program. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we did not</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issue any shares of our common stock under any ATM Program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, $1.5 billion of our common stock remained available for sale under the ATM Program. Actual future sales of our common stock will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock, and our capital needs. We have no obligation to sell any shares under our ATM Program. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the Consolidated Financial Statements for additional information about our ATM Program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthpeak OP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Immediately following the Reorganization, Healthpeak Properties, Inc. was the initial sole member and 100% owner of Healthpeak OP. Subsequent to the Reorganization, certain of our employees (&#8220;OP Unitholders&#8221;) were issued noncontrolling, non-managing member units in Healthpeak OP (&#8220;OP Units&#8221;). As of March&#160;31, 2023, Healthpeak Properties, Inc. owned 99.6% of Healthpeak OP, with the OP Unitholders owning the remaining 0.4%. When certain conditions are met, the OP Unitholders have the right to require redemption of part or all of their OP Units for cash or shares of our common stock, at our option as managing member of Healthpeak OP. The per unit redemption amount is equal to either one share of our common stock or cash equal to the fair value of a share of common stock at the time of redemption. We classify the OP Units in permanent equity because we may elect, in our sole discretion, to issue shares of our common stock to OP Unitholders who choose to redeem their OP Units rather than using cash. None of the outstanding OP Units met the criteria for redemption as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  At March&#160;31, 2023, non-managing members held an aggregate of five million units in seven limited liability companies (&#8220;DownREITs&#8221;) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications). At March&#160;31, 2023, the outstanding DownREIT units were convertible into approximately seven million shares of our common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2022, our Board of Directors approved the Share Repurchase Program under which we may acquire shares of our common stock in the open market up to an aggregate purchase price of $500 million. Purchases of common stock under the Share Repurchase Program may be exercised at our discretion with the timing and number of shares repurchased depending on a variety of factors, including price, corporate and regulatory requirements, and other corporate liquidity requirements and priorities. The Share Repurchase Program expires in August 2024 and may be suspended or terminated at any time without prior notice. During the year ended December 31, 2022, we repurchased 2.1&#160;million shares of our common stock at a weighted average price of $27.16 per share for a total of $56&#160;million. During the three months ended March&#160;31, 2023, there were no repurchases under the Share Repurchase Program. Therefore, at March&#160;31, 2023, $444&#160;million of our common stock remained available for repurchase under the Share Repurchase Program. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company and Healthpeak OP jointly filed a prospectus with the SEC as part of a registration statement on Form&#160;S-3, using an automatic shelf registration process. This shelf registration statement expires on February 13, 2026 and at or prior to such time, we expect to file a new shelf registration statement. Under the &#8220;shelf&#8221; process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include future offerings of the Company&#8217;s common stock, preferred stock, depositary shares, warrants, debt securities, and guarantees of debt securities issued by Healthpeak OP, and Healthpeak OP&#8217;s debt securities and guarantees of debt securities issued by the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures Reconciliations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation from net income (loss) applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to Nareit FFO, FFO as Adjusted, and AFFO (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate related depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of real estate related depreciation and amortization from unconsolidated joint ventures </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of real estate related depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sales of depreciable real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of loss (gain) on sales of depreciable real estate, net, from unconsolidated joint ventures </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of gain (loss) on sales of depreciable real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes associated with real estate dispositions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nareit FFO applicable to common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Nareit FFO applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted Nareit FFO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adjustments to Nareit FFO:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction-related items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other impairments (recoveries) and other losses (gains), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty-related charges (recoveries), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,613)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFO as Adjusted applicable to common shares</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted FFO as Adjusted applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted FFO as Adjusted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFO as Adjusted applicable to common shares</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line rents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AFFO capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of above (below) market lease intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other AFFO adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AFFO applicable to common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted AFFO applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted AFFO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to footnotes on the next page.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The three months ended March 31, 2022 includes the following, which are included in other income (expense), net in the Consolidated Statements of Operations: (i) a $23 million gain on sale of a hospital under a direct financing lease and (ii) $14 million of expenses incurred for tenant relocation and other costs associated with the demolition of an MOB. The three months ended March 31, 2023 and 2022 includes reserves for loan losses recognized in impairments and loan loss reserves (recoveries), net in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Casualty-related charges (recoveries), net are recognized in other income (expense), net and equity income (loss) from unconsolidated joint ventures in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The three months ended March 31, 2023 includes a $9 million write-off of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code. This write-off is reflected as a reduction of rental and related revenues in the Consolidated Statements of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div id="id2287c84385e40afa1133fb5d1fa8206_145"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires our management to use judgment in the application of critical accounting estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A discussion of accounting estimates that we consider critical in that they may require complex judgment in their application or require estimates about matters that are inherently uncertain is included in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 2 to the Consolidated Financial Statements. There have been no significant changes to our critical accounting estimates during the three months ended March&#160;31, 2023.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We use derivative and other financial instruments in the normal course of business to mitigate interest rate risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the Consolidated Balance Sheets at fair value (see Note 17 to the Consolidated Financial Statements).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To illustrate the effect of movements in the interest rate markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves of our derivative portfolio in order to determine the change in fair value. At March&#160;31, 2023, a one percentage point increase or decrease in the underlying interest rate curve would result in a corresponding increase or decrease in the fair value of the derivative instruments by approximately $22&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2023, our exposure to interest rate risk was primarily on our variable rate debt. At March&#160;31, 2023, $142&#160;million of our variable rate mortgage debt and our $500 million Term Loan Facilities were swapped to fixed through interest rate swap instruments. The interest rate swap instruments are designated as cash flow hedges, with the objective of managing the exposure to interest rate risk by converting the interest rates on our variable rate debt to fixed interest rates. At March&#160;31, 2023, both the fair value and carrying value of the interest rate swap instruments were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$21 million.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining variable rate debt at March&#160;31, 2023 was comprised of borrowings under our commercial paper program and certain of our mortgage debt. Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could be adversely affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. Interest rate changes will affect the fair value of our fixed rate instruments. At March&#160;31, 2023, a one percentage point increase in interest rates would decrease the fair value of our fixed rate debt by approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$239 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a one percentage point decrease in interest rates would increase the fair value of our fixed rate debt by approximately $255 million. These changes would not materially impact earnings or cash flows. Conversely, changes in interest rates on variable rate debt would change our future earnings and cash flows, but not materially impact the fair value of those instruments. Assuming a one percentage point increase in the interest rates related to our variable rate debt, and assuming no other changes in the outstanding balance at&#160;March&#160;31, 2023, our annual interest expense would increase by approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million. Lastly, assuming a one percentage point decrease in the interest rates related to our variable rate loans receivable, and assuming no other changes in the outstanding balance at March&#160;31, 2023, our annual interest income would decrease by approximately $2 million. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Controls and Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules&#160;and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rules&#160;13a-15(b)&#160;and 15d-15(b)&#160;of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March&#160;31, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II. OTHER INFORMATION</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_157"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;Risk Factors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described below, there are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank failures or other events affecting financial institutions could have a material adverse effect on our and our tenants&#8217; liquidity, results of operations, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure of a bank, or events involving limited liquidity, defaults, non-performance, or other adverse conditions in the financial or credit markets impacting financial institutions, or concerns or rumors about such events, may adversely impact us, either directly or through an adverse impact on our tenants, operators, and borrowers. A bank failure or other event affecting financial institutions could lead to disruptions in our or our tenants&#8217;, operators&#8217;, and borrowers&#8217; access to bank deposits or borrowing capacity, including access to letters of credit from certain of our tenants relating to lease obligations. In addition, our or our tenants&#8217;, operators&#8217;, and borrowers&#8217; deposits in excess of the Federal Deposit Insurance Corporation (FDIC) limits may not be backstopped by the U.S. government, and banks or financial institutions with which we or our tenants, operators, and borrowers do business may be unable to obtain needed liquidity from other banks, government institutions, or by acquisition in the event of a failure or liquidity crisis. Any adverse effects to our tenants&#8217;, operators&#8217;, or borrowers&#8217; liquidity or financial performance could affect their ability to meet their financial and other contractual obligations to us, which could have a material adverse effect our business, results of operations, and financial condition.</span></div><div id="id2287c84385e40afa1133fb5d1fa8206_160"></div><div style="margin-bottom:6pt;margin-top:12pt"><span id="ifd890f8de7d545e9a4303a4d8ea30c4d_1470"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to purchases of our common stock made by us or on our behalf during the three months ended March&#160;31, 2023.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period&#160;Covered</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of&#160;Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased&#160;as</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Part&#160;of&#160;Publicly</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Announced&#160;Plans&#160;or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Number&#160;(or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate&#160;Dollar&#160;Value)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of&#160;Shares&#160;that May&#160;Yet&#160;be&#160;Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Under&#160;the&#160;Plans&#160;or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,018,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1-28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,018,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,018,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,018,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents shares of our common stock withheld under our equity incentive plans to offset tax withholding obligations that occur upon vesting of restricted stock units. The value of the shares withheld is based on the closing price of our common stock on the last trading day prior to the date the relevant transaction occurred.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">On August 1, 2022, our Board of Directors approved the Share Repurchase Program under which we may acquire shares of our common stock in the open market up to an aggregate purchase price of $500 million. Purchases of common stock under the Share Repurchase Program may be exercised at our discretion with the timing and number of shares repurchased depending on a variety of factors, including price, corporate and regulatory requirements, and other corporate liquidity requirements and priorities. The Share Repurchase Program expires in August 2024 and may be suspended or terminated at any time without prior notice. During the year ended December 31, 2022, we repurchased 2.1&#160;million shares of our common stock at a weighted average price of $27.16 per share. During the first quarter of 2023, there were no repurchases, therefore, at March&#160;31, 2023, $444&#160;million of our common stock remained available for repurchase under the Share Repurchase Program. Amounts do not include the shares of our common stock withheld under our equity incentive plans to offset tax withholding obligations as discussed in footnote 1.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_1389"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;Other Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption of Updates to the Executive Severance Plan and Executive Change in Control Severance Plan</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2023, our Board of Directors amended the Healthpeak Properties, Inc. Executive Severance Plan (the &#8220;Executive Severance Plan&#8221;) and the Healthpeak Properties, Inc. Executive Change in Control Severance Plan (the &#8220;CIC Plan&#8221;). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments to the Executive Severance Plan and CIC Plan included revising the methodology for calculating severance payments under the plans (including any prorated cash bonus payable under the CIC Plan for the year in which a participant&#8217;s termination of employment occurs) in the event of a participant&#8217;s qualifying termination of employment to clarify that the annual cash bonus portion of the cash severance formula will be based on the greater of (1) the participant&#8217;s target level bonus or (2) the average of the participant&#8217;s prior three years&#8217; bonus payments from the Company. In the case of the Executive Severance Plan, a participant&#8217;s prorated cash bonus payment in the year of termination will continue to be based on actual performance for the quantitative portion, while the qualitative portion will be determined in the Compensation and Human Capital Committee&#8217;s discretion. The CIC Plan was also updated to remove the requirement that the Company execute a release of claims in favor of the participant in connection with a qualifying termination of employment, but a participant must still execute a release of claims in favor of the Company as a condition of any severance benefits under the plan. In addition, revisions were made to the &#8220;Good Reason&#8221; definition (as defined in the Executive Severance Plan and CIC Plan) and amendment provision of each plan. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the updates to the Executive Severance Plan and CIC Plan is qualified in its entirety by reference to the Executive Severance Plan and CIC Plan, each as amended and restated April 27, 2023, copies of which are filed as Exhibits 10.15 and 10.16, respectively, to this Quarterly Report on Form 10-Q and incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex2-1.htm">Agreement and Plan of Merger, dated February 7, 2023, by and among Healthpeak Properties, Inc., New Healthpeak, Inc. and Healthpeak Merger Sub, Inc. (incorporated herein by reference to Exhibit 2.1 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex2-1.htm">.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex3-1.htm">Articles of Amendment and Restatement of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.) effective February 10, 2023 (incorporated herein by reference to Exhibit 3.1 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex3-2.htm">Articles of Amendment of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.) effective February 10, 2023 (incorporated herein by reference to Exhibit 3.2 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex3-4.htm">Amended and Restated Bylaws of Healthpeak Properties, Inc. (formerly New Healthpeak, Inc.), dated February 10, 2023 (incorporated herein by reference to Exhibit 3.4 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923004247/tm233500d1_ex4-1.htm">Thirteenth Supplemental Indenture, dated January 17, 2023, between Healthpeak and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.1 to Healthpeak&#8217;s Current Report on Form 8-K filed January 17, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018717/tm235984d25_ex4-6.htm">Amended and Restated Indenture, dated as of February 10, 2023, among Healthpeak OP, LLC, as issuer, Healthpeak Properties, Inc., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.6 to Healthpeak&#8217;s Registration Statement on Form S-3ASR filed February 13, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex4-1.htm">Second Supplemental Indenture, dated as of February 10, 2023, between Healthpeak OP, LLC, as issuer, Healthpeak Properties, Inc., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.1 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex4-2.htm">Fourteenth Supplemental Indenture, dated as of February 10, 2023, between Healthpeak OP, LLC, as issuer, Healthpeak Properties, Inc., as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex10-1.htm">Operating Agreement of Healthpeak OP, LLC, dated as of February 10, 2023 (incorporated herein by reference to Exhibit 10.1 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex10-2.htm">Consent and Amendment No. 1 to Second Amended and Restated Credit Agreement, dated as of February 10, 2023, by and among Healthpeak OP, LLC, Healthpeak Properties, Inc., the lenders listed therein and Bank of America, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.2 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex10-3.htm">Consent and Amendment No. 1 to Term Loan Agreement, dated as of February 10, 2023, by and among Healthpeak OP, LLC, Healthpeak Properties, Inc., the lenders listed therein and Bank of America, N.A., as administrative agent (incorporated herein by reference to Exhibit 10.3 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex10-4.htm">Omnibus Assignment, Assumption and Amendment, dated February 7, 2023 by and between Healthpeak Properties, Inc. and New Healthpeak, Inc. (incorporated herein by reference to Exhibit 10.4 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923018524/tm235984d2_ex10-5.htm">First Amendment to Amended and Restated Healthpeak Properties, Inc. 2014 Performance Incentive Plan (incorporated herein by reference to Exhibit 10.5 to Healthpeak&#8217;s Current Report on Form 8-K12B filed February 10, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000110465923023082/tm235984d32_ex1-1.htm">At-the-Market Equity Offering Sales Agreement, dated February 17, 2023, among Healthpeak Properties, Inc., Healthpeak OP, LLC, and the sales agents, forward sellers and forward purchasers referred to therein (incorporated herein by reference to Exhibit 1.1 to Healthpeak&#8217;s Current Report on Form 8-K filed February 17, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex10703312023.htm">Form of 2014 Performance Incentive Plan NEO Retentive LTIP Unit Agreement (adopted 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex10803312023.htm">Form of 2014 Performance Incentive Plan NEO 3-Year Performance-Based LTIP Unit Agreement (adopted 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex10903312023.htm">Form of 2014 Performance Incentive Plan NEO Retentive LTIP Unit Agreement (adopted 2023, for converted 2021 and 2022 LTIP awards).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101003312023.htm">Form of 2014 Performance Incentive Plan NEO 3-Year Performance-Based LTIP Unit Agreement (adopted 2023, for converted 2021 and 2022 LTIP awards).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101103312023.htm">Form of 2014 Performance Incentive Plan NEO Retentive LTIP Unit Award Agreement (adopted 2023, for converted awards).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101203312023.htm">Form of 2014 Performance Incentive Plan Non-NEO LTIP Unit Award Agreement (adopted 2023, for converted awards).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101303312023.htm">Form of 2023 Performance Incentive Plan Non-NEO Restricted Stock Unit Award Agreement (adopted 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101403312023.htm">Form of 2023 Performance Incentive Plan Non-Employee Director Restricted Stock Unit Award Agreement (adopted 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101503312023.htm">Executive Severance Plan (as amended and restated as of April 27, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101603312023.htm">Executive Change in Control Severance Plan (as amended and restated as of April 27, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex22103312023.htm">List of Issuers of Guaranteed Securities.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31103312023.htm">Certification by Scott M. Brinker, Healthpeak&#8217;s Principal Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31203312023.htm">Certification by Peter A. Scott, Healthpeak&#8217;s Principal Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32103312023.htm">Certification by Scott M. Brinker, Healthpeak&#8217;s Principal Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32203312023.htm">Certification by Peter A. Scott, Healthpeak&#8217;s Principal Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document&#160;- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">+       Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160; &#160;Furnished herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Management Contract or Compensatory Plan or Arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="id2287c84385e40afa1133fb5d1fa8206_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">Table of Content</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id2287c84385e40afa1133fb5d1fa8206_7">s</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-align:center;text-indent:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 28, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak Properties, Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SCOTT M. BRINKER</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott M. Brinker</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PETER A. SCOTT</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SHAWN G. JOHNSTON</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn G. Johnston</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>ex10703312023.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i83ecf16fa5a34761a9455daa4e913022_43"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC. <br>RETENTIVE LTIP UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS RETENTIVE LTIP UNIT AGREEMENT </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is effective as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Compensation and Human Capital Committee of the Board of Directors of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has determined that the Participant is eligible to receive an award of LTIP Units, as described below&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Partnership desires to grant to the Participant, effective as of the date hereof, an award of LTIP Units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) upon the terms and conditions set forth herein, in the Partnership Agreement and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of &#91;&#9679;&#93; LTIP Units.  The Partnership and the Participant acknowledge and agree that the LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The Committee is the Administrator of the Plan for purposes of the LTIP Units.  The LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth in this Agreement, the Plan and the Partnership Agreement, and any rules adopted by the Committee, as such rules are in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to Section 8, the Award shall vest with respect to one-third of the total number of the LTIP Units issued hereby on each of the first, second and third anniversaries of the Award Date.  Notwithstanding the foregoing, no portion of the Award will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">vest (and all outstanding LTIP Units will be forfeited) unless the Corporation&#8217;s Normalized FFO per Share, as defined in the Corporation&#8217;s 202_ Cash Incentive Plan, with respect to the 202_ calendar year equals or exceeds $&#91;&#9679;&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in Section 8, the vesting schedule requires continued employment through each applicable vesting date, as provided in Section 3, as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement.  Employment for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined herein), confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits.  Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">The Award and the LTIP Units are subject to the restrictions on transfer of Membership Units (including, without limitation, LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or LTIP Units shall take such Award or LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested LTIP Units or any portion of the Award attributable to such unvested LTIP Units (or any securities into which such unvested LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, that the Transfer Restrictions shall not apply to any Transfer of unvested LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">As to any vested LTIP Units, the Participant agrees that the Participant will not Transfer such LTIP Units (or any Common Units or shares of Common Stock in respect of which such LTIP Units have been exchanged) prior to the date that is one (1) year after the date such LTIP Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 LTIP Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the LTIP Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Common Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested LTIP Units and the portion of the Award attributable to the unvested LTIP Units, or to effectuate the transfer or surrender of such unvested LTIP Units and portion of the Award to the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is holding the Award and the LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the LTIP Units for investment and not with a view to distribution or resale thereof, except in compliance with applicable laws regulating securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant understands that the LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.02pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code and with respect to the grant of the LTIP Units), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the LTIP Units.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provisions to the contrary in any employment agreement, the Healthpeak Properties, Inc.  Executive Severance Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Healthpeak Properties, Inc.  Change in Control Severance Plan (or successor plan) (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CIC Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or any other severance plan adopted by the Corporation, the provisions set forth in this Section 8 are applicable in the event of a termination of the Participant&#8217;s employment with the Corporation and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Qualifying Termination.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant ceases to be employed by the Corporation or one of its Subsidiaries (the date of such termination of employment is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as a result of (i) the Participant&#8217;s death or Disability, (ii) a termination of employment by the Corporation or one of its Subsidiaries without Cause (as defined herein), or (iii) a termination of employment by the Participant for Good Reason (as defined herein), then, subject to the release requirement set forth in the following paragraph, the Participant&#8217;s LTIP Units, to the extent such units are not then vested and without regard to the last sentence of Section 3, shall become fully vested as of the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any acceleration of vesting pursuant to the preceding paragraph (other than in connection with the Participant&#8217;s death) is subject to the condition  that (x) the Participant has fully executed a valid and effective release (in the form attached to the Severance Plan or, if such release is executed on or after a Change in Control Event, in the form attached to the CIC Severance Plan, or in either case such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to the form attached to the Severance Plan or the CIC Severance Plan, as the case may be, that would otherwise apply in the circumstances but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable and otherwise compliant with applicable laws), (y) such executed release is delivered by the Participant to the Corporation so that it is received by the Corporation in the time period specified below, and (z) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law).  In order to satisfy the requirements of this paragraph, the Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Corporation so that it is received by the Corporation no later than twenty-five (25) calendar days after the Participant&#8217;s Severance Date (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either twenty-one (21) or forty-five (45) days, depending on the circumstances of the termination, to consider the release).  In addition, the Corporation may require that the Participant&#8217;s release be executed no earlier than the Participant&#8217;s Severance Date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Forfeiture of LTIP Units upon Certain Terminations of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Participant ceases to be employed by the Corporation or one of its Subsidiaries as a result of (i) a termination of employment by the Corporation or one of its Subsidiaries for Cause, or (ii) a termination of employment by the Participant, excluding any termination contemplated by Section 8(a) (other than a termination contemplated by Section 8(a) but as to which the Participant did not timely satisfy any applicable release requirement pursuant to Section 8(a)) and subject to the next paragraph, the Participant&#8217;s LTIP Units shall automatically be cancelled and forfeited to the extent such units have not become vested pursuant to Section 3 hereof upon the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, however, the Participant ceases to be employed by the Corporation or one of its Subsidiaries and such termination of employment is a result of a retirement or resignation by the Participant (other than (x) any termination contemplated by Section 8(a) and (y) a termination of employment by the Corporation or one of its Subsidiaries for Cause) and, immediately after such termination of employment, the Participant is a member of the Board or provides consulting services to the Corporation or one of its Subsidiaries under a written consulting agreement entered into by and between the Participant and the Corporation or one of its Subsidiaries, then the termination of employment rules of the preceding paragraph shall not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">apply when the Participant ceases to be employed by the Corporation or one of its Subsidiaries but shall apply if and when, and effective as of the time that, the Participant ceases to be a member of the Board or ceases to provide consulting services to the Corporation or one of its Subsidiaries under such a written consulting agreement.  For clarity, the Participant&#8217;s obligations under a confidentiality, noncompetition, non-solicitation, cooperation or similar clause or agreement shall not constitute &#8220;consulting services&#8221; for purposes of the preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Termination of LTIP Units.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any unvested LTIP Units are terminated pursuant to Section 8(b), such LTIP Units shall automatically terminate and be cancelled and forfeited as of the Severance Date without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Definitions.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Cause&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:56.04pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Good Reason&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time&#59; provided, further, that if &#8220;Good Reason&#8221; is so not defined in the Severance Plan or CIC Severance Plan, as applicable, it shall not constitute a qualifying termination for purposes of Section 8 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt">Adjustments Upon Specified Events&#59; Change in Control Event.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Adjustments.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Change in Control Event.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 or 7.3 of the Plan, any employment agreement, the CIC Severance Plan (or successor plan) or any other severance plan adopted by the Corporation, the Award (to the extent outstanding at the time of such event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the LTIP Units will accelerate in connection with such event and the extent of any such accelerated vesting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Partnership and the Participant intend that (i) the LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and the vesting of the LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the LTIP Units, the Partnership may revalue all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the LTIP Units shall be equal to zero, unless the Participant was a Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant hereby covenants that so long as the Participant holds any LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Certificates evidencing the LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221; </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section 8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement.  Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership).  Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the LTIP Units (including any value received from a disposition thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, any fractional LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of LTIP Units that vest or become entitled to such distributions to exceed the total number of LTIP Units set forth in Section 2(a) of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;The remainder of this page is intentionally left blank.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the date first written above.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">By Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Managing Member</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i83ecf16fa5a34761a9455daa4e913022_46"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;__________&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><div id="i83ecf16fa5a34761a9455daa4e913022_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property described below was transferred the excess (if any) of the fair market value of such property, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXPAYER&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br>TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><div id="i83ecf16fa5a34761a9455daa4e913022_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.238%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RETURN RECEIPT REQUESTED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Internal Revenue Service</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;Address where taxpayer files returns&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;______________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">___________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosures</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>ex10803312023.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6dda12be161b425fa74f3c7b9978144d_42"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.<br>3-YEAR PERFORMANCE-BASED LTIP UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS 3-YEAR PERFORMANCE-BASED LTIP UNIT AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is effective as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Compensation and Human Capital Committee of the Board of Directors of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has determined that the Participant is eligible to receive an award of LTIP Units, as described below&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Partnership hereby desires to grant to the Participant, effective as of the date hereof, an award of LITP Units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) upon the terms and conditions set forth herein, in the Partnership Agreement and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Agreement, the following terms shall have the meanings set forth below.  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Base Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means &#91;&#9679;&#93; Performance LTIP Units subject to the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Distribution Equivalent Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a number of Performance LTIP Units equal to the quotient obtained by dividing (x) the excess of (A) the value of all dividends paid by the Corporation with respect to the Performance Period in respect of that number of shares of Common Stock equal to the aggregate number of Performance LTIP Units that become Vested Base Units as of the applicable vesting date, over (B) the amount of any distributions made by the Partnership to the Participant pursuant to Section 5.1 and Section 16.4(a) of the Partnership Agreement with respect to the Performance Period in respect of the Performance LTIP Units, plus (or minus) the amount of gain (or loss) on such excess dividend amounts had they been reinvested in Common Stock on the date that they were paid (at a price equal to the closing price of the Common Stock on the applicable dividend payment date), by (y) the closing price of a share of Common Stock as of the last trading day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Performance Vesting Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, with respect to a given Peer Group, means the applicable vesting percentage determined as set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto, which is a function of the Corporation&#8217;s Total Stockholder Return performance relative to such Peer Group during the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Vested Base Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, with respect to a given Peer Group, means the product of (x) the total number of Base Units corresponding to such Peer Group, and (y) the Performance Vesting Percentage achieved with respect to such Peer Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Vested Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (x) the Vested Base Units, plus (y) the Distribution Equivalent Units.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Performance LTIP Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to the performance period beginning on January 1, 202_ and ending on December 31, 202_ (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Partnership and the Participant acknowledge and agree that the Performance LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The Committee is the Administrator of the Plan for purposes of the Performance LTIP Units. The Performance LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth in this Agreement, the Plan and the Partnership Agreement, and any rules adopted by the Committee, as such rules are in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to this Section 3 and Section 8, the number of Base Units ultimately earned and vested under the Award shall be determined in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto based on whether the Corporation has attained certain pre-established performance goals with respect to the Performance Period and the number of Distribution Equivalent Units ultimately earned and vested under the Award shall be determined based on the number of Vested Base Units in accordance with the definition of &#8220;Distribution Equivalent Units&#8221; in Section 1. The determination as to whether the Corporation has attained the performance goals set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the Performance Period and the determination of the number of Distribution Equivalent Units shall be made by the Committee (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Committee Determination shall be made no later than March 15 following the end of the Performance Period (or such earlier time as provided in Section 9(b)). Performance LTIP Units that become Vested Units shall vest as of the date of the Committee Determination (or as of the date of the Change in Control Event pursuant to Section 9(b) below, as applicable).  The Performance LTIP Units shall not be deemed vested pursuant to any other provision of this Agreement earlier than the date that the Committee makes such determination.  Any Performance LTIP Units granted hereby which do not satisfy the requirements to become Vested Units as of the date of the Committee Determination (or as of the date of the Change in Control Event pursuant to Section 9(b) below, as applicable) will automatically be cancelled and forfeited without payment of any consideration therefor, and the Participant shall have no further right to or interest in such Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in Section 8 or Section 9(b), the vesting schedule requires continued employment through the date of the Committee Determination (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as provided in Section 3, as a condition to the vesting of the Award and the rights and benefits under this Agreement. Employment for only a portion of the Vesting Period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment as provided in Section 8 below or under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined herein), confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits. Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Performance LTIP Units Subject to the Partnership Agreement&#59; Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Award and the Performance LTIP Units are subject to the restrictions on transfer of Membership Units (including, without limitation, Performance LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or Performance LTIP Units shall take such Award or Performance LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or Performance LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested Performance LTIP Units or any portion of the Award attributable to such unvested Performance LTIP Units (or any securities into which such unvested Performance LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, that the Transfer Restrictions shall not apply to any Transfer of unvested Performance LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;As to any vested Base Units, the Participant agrees that the Participant will not Transfer such Base Units (or any Common Units or shares of Common Stock in respect of which such Base Units have been exchanged) prior to the date that is one (1) year after the date such Base Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 Base Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the Base Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested Performance LTIP Units and the portion of the Award attributable to the unvested Performance LTIP Units, or to effectuate the transfer or surrender of such unvested Performance LTIP Units and portion of the Award to the Partnership.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is holding the Award and the Performance LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the Performance LTIP Units for investment and not with a view to distribution or resale thereof except in compliance with applicable laws regulating securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant understands that the Performance LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the Performance LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the Performance LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.02pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the Performance LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provisions to the contrary in any employment agreement, the Healthpeak Properties, Inc. Executive Severance Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Healthpeak Properties, Inc. Executive Change in Control Severance Plan or successor plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CIC Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or any other severance plan adopted by the Corporation,  the provisions set forth in this Section 8 are applicable in the event of a termination of the Participant&#8217;s employment with the Corporation and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Qualifying Termination. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or its Subsidiaries (the date of such termination of employment is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as a result of (i) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Participant&#8217;s death or Disability or (ii) a termination of employment by the Corporation or one of its Subsidiaries without Cause or by Participant for Good Reason (each as defined herein), then, subject to the following paragraph and the release requirement set forth in the last paragraph of this Section 8(a), (x) the Performance LTIP Units will remain outstanding during the remainder of the Vesting Period and will remain subject to Section 3, and (y) the Participant will vest with respect to the number of Performance LTIP Units that would have vested in accordance with Section 3, if any, had the Participant remained employed until the end of the Vesting Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that the Participant&#8217;s employment terminates in the circumstances described in the preceding paragraph and the Severance Date occurs on or before the last day of the second year of the Performance Period and on or before the Severance Date, or after the Severance Date and before the last day of the second year of the Performance Period, an Interim Date (as defined in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) has been or is established with respect to Peer Group I (as such term is defined in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the Performance Period with respect to Peer Group I will end on such Interim Date (in the event there has been more than one Interim Date on or prior to the Severance Date, the most recent Interim Date on or prior to the Severance Date&#59; and in the event that there has been an Interim Date on or prior to the Severance Date, any new Interim Date after the Severance Date shall be disregarded) and there will be no new or additional measurement period with respect to Peer Group I after such Interim Date as otherwise provided for in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In such circumstances, the determination as to whether the Corporation has attained the performance goals set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to Peer Group I for the Performance Period shall be made by the Committee based solely on performance through such applicable Interim Date, such determination to be made no later than March 15 of the year that follows the later of the Severance Date or the applicable Interim Date as to Peer Group I (such determination to be the Committee Determination as to Peer Group I). In such circumstances, any Performance LTIP Units corresponding to  Peer Group I that are not vested on the date of such Committee Determination (after giving effect to such Committee Determination) shall be cancelled and forfeited. No additional Performance LTIP Units will vest pursuant to Section 8(b) or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to performance after, or a Change in Control Event that occurs after, the applicable Interim Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any benefit to the Participant pursuant to the preceding paragraphs of this Section 8 (other than in connection with the Participant&#8217;s death) is subject to the condition that (i) the Participant has fully executed a valid and effective release (in the form attached to the Severance Plan or, if such release is executed on or after a Change in Control Event, in the form attached to the CIC Severance Plan, or in either case such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to the form attached to the Severance Plan or the CIC Severance Plan, as the case may be, that would otherwise apply in the circumstances but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable and otherwise compliant with applicable laws), (ii) such executed release is delivered by the Participant to the Corporation so that it is received by the Corporation in the time period specified below, and (iii) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law). In order to satisfy the requirements of this paragraph, the Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Corporation so that it is received by the Corporation no later than twenty-five (25) calendar days after the Participant&#8217;s Severance Date (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either twenty-one (21) or forty-five (45) days, depending on the circumstances of the termination, to consider the release). In addition, the Corporation may require that the Participant&#8217;s release be executed no earlier than the Participant&#8217;s Severance Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Forfeiture of Performance LTIP Units upon Certain Terminations of Employment. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or one of its Subsidiaries as a result of (i) a termination of employment by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporation or one of its Subsidiaries for Cause or (ii) a termination of employment by the Participant, excluding any termination contemplated by Section 8(a) (other than a termination contemplated by Section 8(a) but as to which the Participant did not timely satisfy any applicable release requirement pursuant to Section 8(a)) and subject to the next paragraph, all of the Performance LTIP Units shall be automatically cancelled and forfeited in full, effective as of the Severance Date, and this Agreement shall be null and void and of no further force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, however, the Participant ceases to be employed by the Corporation or one of its Subsidiaries and such termination of employment is a result of a retirement or resignation by the Participant (other than (x) any termination contemplated by Section 8(a) and (y) a termination of employment by the Corporation or one of its Subsidiaries for Cause) and, immediately after such termination of employment, the Participant is a member of the Board or provides consulting services to the Corporation or one of its Subsidiaries under a written consulting agreement entered into by and between the Participant and the Corporation or one of its Subsidiaries, then the termination of employment rules of the preceding paragraph shall not apply when the Participant ceases to be employed by the Corporation or one of its Subsidiaries but shall apply if and when, and effective as of the time that, the Participant ceases to be a member of the Board or ceases to provide consulting services to the Corporation or one of its Subsidiaries under such a written consulting agreement. For clarity, the Participant&#8217;s obligations under a confidentiality, noncompetition, non-solicitation, cooperation or similar clause or agreement shall not constitute &#8220;consulting services&#8221; for purposes of the preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Termination of Performance LTIP Units. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any Performance LTIP Units that are not vested on the date of the Committee Determination (after giving effect to such Committee Determination) shall be cancelled and forfeited. If any unvested Performance LTIP Units are cancelled and forfeited pursuant to this Section 8, such Performance LTIP Units shall automatically be cancelled and forfeited as of the Severance Date or as of the date of the Committee Determination, as the case may be, without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Definitions. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Cause&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:56.04pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Good Reason&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time&#59; provided, further, that if &#8220;Good Reason&#8221; is so not defined in the Severance Plan or CIC Severance Plan, as applicable, it shall not constitute a qualifying termination for purposes of Section 8 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Adjustments upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Adjustments. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Change in Control Event. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the occurrence, at any time during the Vesting Period, of a Change in Control Event with respect to the Corporation and notwithstanding any provision of Section 7.2 or 7.3 of the Plan, any employment agreement, the Severance Plan, the CIC Severance Plan (or successor plan) or any other severance plan adopted by the Corporation, the Performance Period for all Performance LTIP Units then outstanding will be shortened, if such Performance Period has not already ended, so that the Performance Period will be deemed to have ended on the day of the Change in Control Event and the Committee Determination pursuant to Section 3 shall be made not later than the date of the Change in Control Event. The Vesting Period will be deemed to end on the date of the Change in Control Event even though the Committee Determination may not occur until after such date, such that a Participant employed by the Corporation or a Subsidiary on the date of the Change in Control Event shall be fully vested in any Performance LTIP Units that vest as a result of the Committee Determination even if the Participant does not remain employed by the Corporation, the Partnership or a Subsidiary through the date of the Committee Determination. The number of Performance LTIP Units, if any, that vest shall be determined in accordance with Section 3 based on such shortened Performance Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Partnership and the Participant intend that (i) the Performance LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and vesting of the Performance LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the Performance LTIP Units, the Partnership may revalue all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the Performance LTIP Units shall be equal to zero, unless the Participant was a  Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the Performance LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the Performance LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant hereby covenants that so long as the Participant holds any Performance LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the Performance LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the Performance LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Certificates evidencing the Performance LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221; </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records. Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government. Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference. The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement. The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement. Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Agreement may be amended pursuant to Section 8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement. Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership). Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award. The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof. The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code. This Agreement shall be construed and interpreted consistent with that intent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Performance LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Performance LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the Performance LTIP Units (including any value received from a disposition thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, any fractional Performance LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of Performance LTIP Units that vest or become entitled to such distributions to exceed the total number of Performance LTIP Units set forth in Section 2(a) of this Agreement. </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the date first written above.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">By Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Managing Member</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Award Subject to Relative TSR Performance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;_______&#93;</font></div><div style="margin-bottom:12pt;padding-left:89.45pt;padding-right:89.45pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i6dda12be161b425fa74f3c7b9978144d_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">_______</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit C</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div><div id="i6dda12be161b425fa74f3c7b9978144d_48"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property was transferred the excess (if any) of the fair market value of the property described below, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXPAYER&#8217;S NAME&#58; ______________________________________________<br><br>TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the  Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the  Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RETURN RECEIPT REQUESTED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Internal Revenue Service</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;Address where taxpayer files returns&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">___________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosures</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>4
<FILENAME>ex10903312023.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib3d56304e2514dea9ea5af96fd3c0168_42"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC. <br>RETENTIVE LTIP UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS RETENTIVE LTIP UNIT AGREEMENT </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is effective as of February 15, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Corporation maintains the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to that certain Retentive &#91;Restricted Stock Unit&#47;LTIP RSU&#93;, dated as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Original Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Old Healthpeak (as defined below) previously granted to the Participant an award of &#91;&#9679;&#93; restricted stock units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Original RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Agreement&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), by and among the entity known as Healthpeak Properties, Inc. prior to the Merger (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Old Healthpeak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), New Healthpeak, Inc. and Healthpeak Merger Sub, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Merger Sub merged with and into Old Healthpeak, with Old Healthpeak being the surviving entity and becoming a subsidiary of New Healthpeak, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, following the Merger, New Healthpeak, Inc. changed its name to &#8220;Healthpeak Properties, Inc.&#8221; and Old Healthpeak converted to a Maryland limited liability company named &#8220;Healthpeak OP, LLC&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, effective as of the effective time of the Merger, the Original RSU Award was automatically converted into a restricted stock unit award with respect to the same number of shares of common stock of the Corporation and subject to the same terms and conditions, including vesting terms, as the Original RSU Award immediately prior to the effective time of the Merger (as so converted, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as of the date hereof, &#91;&#9679;&#93; restricted stock units remained outstanding under the RSU Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in connection with the Merger, the Participant elected to cancel and replace the RSU Award with an award of LTIP Units (as defined in the Plan)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Corporation, the Partnership and the Participant desire to enter into this Agreement to set forth the terms of the award of LTIP Units resulting from the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of &#91;&#9679;&#93; LTIP Units.  The Partnership and the Participant acknowledge and agree that the LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The Committee is the Administrator of the Plan for purposes of the LTIP Units.  The LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth in this Agreement, the Plan and the Partnership Agreement, and any rules adopted by the Committee, as such rules are in effect from time to time.  The parties acknowledge and agree that the LTIP Units are being granted subject to the cancellation of, and as a replacement for, the RSU Award, and the Participant acknowledges, agrees and consents to such cancellation and replacement in accordance with the Merger Agreement and as set forth herein.  The Participant further agrees that, as of the Effective Date, the RSU Award and the restricted stock units subject thereto shall be cancelled and of no further force or effect, and the Participant shall have no further right, title or interest in the RSU Award, such restricted stock units or any shares of stock issuable thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to Section 8, the Award shall vest with respect to &#91;&#9679;&#93; of the total number of the LTIP Units issued hereby on &#91;&#9679;&#93; anniversary&#91;ies&#93; of the Original Award Date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in Section 8, the vesting schedule requires continued employment through each applicable vesting date, as provided in Section 3, as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement.  Employment for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined herein), confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits.  Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">The Award and the LTIP Units are subject to the restrictions on transfer of Membership Units (including, without limitation, LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or LTIP Units shall take such Award or LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested LTIP Units or any portion of the Award attributable to such unvested LTIP Units (or any securities into which such unvested LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, that the Transfer Restrictions shall not apply to any Transfer of unvested LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">As to any vested LTIP Units, the Participant agrees that the Participant will not Transfer such LTIP Units (or any Common Units or shares of Common Stock in respect of which such LTIP Units have been exchanged) prior to the date that is one (1) year after the date such LTIP Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 LTIP Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the LTIP Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Common Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested LTIP Units and the portion of the Award attributable to the unvested LTIP Units, or to effectuate the transfer or surrender of such unvested LTIP Units and portion of the Award to the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is holding the Award and the LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the LTIP Units for investment and not with a view to distribution or resale thereof, except in compliance with applicable laws regulating securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant understands that the LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.02pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code and with respect to the grant of the LTIP Units), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the LTIP Units and with respect to the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provisions to the contrary in any employment agreement, the Healthpeak Properties, Inc.  Executive Severance Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Healthpeak Properties, Inc.  Change in Control Severance Plan (or successor plan) (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CIC Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or any other severance plan adopted by the Corporation, the provisions set forth in this Section 8 are applicable in the event of a termination of the Participant&#8217;s employment with the Corporation and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Qualifying Termination.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant ceases to be employed by the Corporation or one of its Subsidiaries (the date of such termination of employment is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as a result of (i) the Participant&#8217;s death or Disability, (ii) a termination of employment by the Corporation or one of its Subsidiaries without Cause (as defined herein), or (iii) a termination of employment by the Participant for Good Reason (as defined herein) with respect to the Corporation, then, subject to the release requirement set forth in the following paragraph, the Participant&#8217;s LTIP Units, to the extent such units are not then vested and without regard to the last sentence of Section 3, shall become fully vested as of the Severance Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any acceleration of vesting pursuant to the preceding paragraph (other than in connection with the Participant&#8217;s death) is subject to the condition  that (x) the Participant has fully executed a valid and effective release (in the form attached to the Severance Plan or, if such release is executed on or after a Change in Control Event, in the form attached to the CIC Severance Plan, or in either case such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to the form attached to the Severance Plan or the CIC Severance Plan, as the case may be, that would otherwise apply in the circumstances but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable and otherwise compliant with applicable laws), (y) such executed release is delivered by the Participant to the Corporation so that it is received by the Corporation in the time period specified below, and (z) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law).  In order to satisfy the requirements of this paragraph, the Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Corporation so that it is received by the Corporation no later than twenty-five (25) calendar days after the Participant&#8217;s Severance Date (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either twenty-one (21) or forty-five (45) days, depending on the circumstances of the termination, to consider the release).  In addition, the Corporation may require that the Participant&#8217;s release be executed no earlier than the Participant&#8217;s Severance Date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Forfeiture of LTIP Units upon Certain Terminations of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Participant ceases to be employed by the Corporation or one of its Subsidiaries as a result of (i) a termination of employment by the Corporation or one of its Subsidiaries for Cause, or (ii) a termination of employment by the Participant, excluding any termination contemplated by Section 8(a) (other than a termination contemplated by Section 8(a) but as to which the Participant did not timely satisfy any applicable release requirement pursuant to Section 8(a)) and subject to the next paragraph, the Participant&#8217;s LTIP Units shall automatically be cancelled and forfeited to the extent such units have not become vested pursuant to Section 3 hereof upon the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, however, the Participant ceases to be employed by the Corporation or one of its Subsidiaries and such termination of employment is a result of a retirement or resignation by the Participant (other than (x) any termination contemplated by Section 8(a) and (y) a termination of employment by the Corporation or one of its Subsidiaries for Cause) and, immediately after such termination of employment, the Participant is a member of the Board or provides consulting services to the Corporation or one of its Subsidiaries under a written consulting agreement entered into by and between the Participant and the Corporation or one of its Subsidiaries, then the termination of employment rules of the preceding paragraph shall not apply when the Participant ceases to be employed by the Corporation or one of its Subsidiaries but shall apply if and when, and effective as of the time that, the Participant ceases to be a member of the Board or ceases to provide consulting services to the Corporation or one of its Subsidiaries under such a written consulting agreement.  For clarity, the Participant&#8217;s obligations under a confidentiality, noncompetition, non-solicitation, cooperation or similar clause or agreement shall not constitute &#8220;consulting services&#8221; for purposes of the preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Termination of LTIP Units.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any unvested LTIP Units are terminated pursuant to Section 8(b), such LTIP Units shall automatically terminate and be cancelled and forfeited as of the Severance Date without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Definitions.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">after a Change in Control Event, &#8220;Cause&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:56.04pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Good Reason&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time&#59; provided, further, that if &#8220;Good Reason&#8221; is so not defined in the Severance Plan or CIC Severance Plan, as applicable, it shall not constitute a qualifying termination for purposes of Section 8 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt">Adjustments Upon Specified Events&#59; Change in Control Event.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Adjustments.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Change in Control Event.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 or 7.3 of the Plan, any employment agreement, the CIC Severance Plan (or successor plan) or any other severance plan adopted by the Corporation, the Award (to the extent outstanding at the time of such event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the LTIP Units will accelerate in connection with such event and the extent of any such accelerated vesting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Partnership and the Participant intend that (i) the LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and the vesting of the LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the LTIP Units, the Partnership may revalue all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the LTIP Units shall be equal to zero, unless the Participant was a Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such LTIP Units.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant hereby covenants that so long as the Participant holds any LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Certificates evidencing the LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221; </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant is no longer an Eligible Person, shall be deemed to have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section 8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement.  Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership).  Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the LTIP Units (including any value received from a disposition thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, any fractional LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of LTIP Units that vest or become entitled to such distributions to exceed the total number of LTIP Units set forth in Section 2(a) of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;The remainder of this page is intentionally left blank.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the date first written above.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">By Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Managing Member</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ib3d56304e2514dea9ea5af96fd3c0168_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;_________&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><div id="ib3d56304e2514dea9ea5af96fd3c0168_48"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property described below was transferred the excess (if any) of the fair market value of such property, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXPAYER&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.238%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RETURN RECEIPT REQUESTED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Internal Revenue Service</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;Address where taxpayer files returns&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;__________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">___________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosures</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>5
<FILENAME>ex101003312023.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icdb72d46ca274c60b2647245ac984b40_42"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.<br>3-YEAR PERFORMANCE-BASED LTIP UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS 3-YEAR PERFORMANCE-BASED LTIP UNIT AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is effective as of February 15, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Corporation maintains the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to that certain 3-Year &#91;Performance-Based Restricted Stock Unit &#47; LTIP RSU&#93; Agreement, dated as of &#91;&#9679;&#93;, Old Healthpeak (as defined below) previously granted to the Participant an award of &#91;&#9679;&#93; restricted stock units under the Plan  (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Original RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Agreement&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), by and among the entity known as Healthpeak Properties, Inc. prior to the Merger (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Old Healthpeak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), New Healthpeak, Inc. and Healthpeak Merger Sub, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Merger Sub merged with and into Old Healthpeak, with Old Healthpeak being the surviving entity and becoming a subsidiary of New Healthpeak, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, following the Merger, New Healthpeak, Inc. changed its name to &#8220;Healthpeak Properties, Inc.&#8221; and Old Healthpeak converted to a Maryland limited liability company named &#8220;Healthpeak OP, LLC&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, effective as of the effective time of the Merger, the Original RSU Award was automatically converted into a restricted stock unit award with respect to the same number of shares of common stock of the Corporation and subject to the same terms and conditions, including vesting terms, as the Original RSU Award immediately prior to the effective time of the Merger (as so converted, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in connection with the Merger, the Participant elected to cancel and replace the restricted stock units subject to the RSU Award with an award of LTIP Units (as defined in the Plan)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Corporation, the Partnership and the Participant desire to enter into this Agreement to set forth the terms of the award of LTIP Units resulting from the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Agreement, the following terms shall have the meanings set forth below.  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Base Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means &#91;&#9679;&#93; Performance LTIP Units subject to the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Distribution Equivalent Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a number of Performance LTIP Units equal to the quotient obtained by dividing (x) the excess of (A) the value of all dividends paid by the Corporation with respect to the Performance Period in respect of that number of shares of Common Stock equal to the aggregate number of Performance LTIP Units that become Vested </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Base Units as of the applicable vesting date, over (B) the amount of any distributions made by the Partnership to the Participant pursuant to Section 5.1 and Section 16.4(a) of the Partnership Agreement with respect to the Performance Period in respect of the Performance LTIP Units, plus (or minus) the amount of gain (or loss) on such excess dividend amounts had they been reinvested in Common Stock on the date that they were paid (at a price equal to the closing price of the Common Stock on the applicable dividend payment date), by (y) the closing price of a share of Common Stock as of the last trading day of the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Performance Vesting Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, with respect to a given Peer Group, means the applicable vesting percentage determined as set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto, which is a function of the Corporation&#8217;s Total Stockholder Return performance relative to such Peer Group during the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Vested Base Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, with respect to a given Peer Group, means the product of (x) the total number of Base Units corresponding to such Peer Group, and (y) the Performance Vesting Percentage achieved with respect to such Peer Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Vested Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (x) the Vested Base Units, plus (y) the Distribution Equivalent Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Performance LTIP Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to the performance period beginning on January 1, 202_ and ending on December 31, 202_ (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Partnership and the Participant acknowledge and agree that the Performance LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The Committee is the Administrator of the Plan for purposes of the Performance LTIP Units. The Performance LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth in this Agreement, the Plan and the Partnership Agreement, and any rules adopted by the Committee, as such rules are in effect from time to time.  The parties acknowledge and agree that the Performance LTIP Units are being granted subject to the cancellation of, and as a replacement for, the RSU Award, and the Participant acknowledges, agrees and consents to such cancellation and replacement in accordance with the Merger Agreement and as set forth herein.  The Participant further agrees that, as of the Effective Date, the RSU Award and the restricted stock units subject thereto shall be cancelled and of no further force or effect, and the Participant shall have no further right, title or interest in the RSU Award, such restricted stock units or any shares of stock issuable thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the Performance LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to this Section 3 and Section 8, the number of Base Units ultimately earned and vested under the Award shall be determined in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto based on whether the Corporation has attained certain pre-established performance goals with respect to the Performance Period and the number of Distribution Equivalent Units ultimately earned and vested under the Award shall be determined based on the number of Vested Base Units in accordance with the definition of &#8220;Distribution Equivalent Units&#8221; in Section 1. The determination as to whether the Corporation has attained the performance goals set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the Performance Period and the determination of the number of Distribution Equivalent Units shall be made by the Committee (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Committee Determination shall be made no later than March 15 following the end of the Performance Period (or such earlier time as provided in Section 9(b)). Performance LTIP Units that become Vested Units shall vest as of the date of the Committee Determination (or as of the date of the Change in Control Event pursuant to Section 9(b) below, as applicable).  The Performance LTIP Units shall not be deemed vested pursuant to any other provision of this Agreement earlier than the date that the Committee makes such determination.  Any Performance LTIP Units granted hereby which do not satisfy the requirements to become Vested Units as of the date of the Committee Determination (or as of the date of the Change in Control Event pursuant to Section 9(b) below, as applicable) will automatically be cancelled and forfeited without payment of any consideration therefor, and the Participant shall have no further right to or interest in such Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise expressly provided in Section 8 or Section 9(b), the vesting schedule requires continued employment through the date of the Committee Determination (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as provided in Section 3, as a condition to the vesting of the Award and the rights and benefits under this Agreement. Employment for only a portion of the Vesting Period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined herein), confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits. Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Performance LTIP Units Subject to the Partnership Agreement&#59; Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Award and the Performance LTIP Units are subject to the restrictions on transfer of Membership Units (including, without limitation, Performance LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or Performance LTIP Units shall take such Award or Performance LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or Performance LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested Performance LTIP Units or any portion of the Award attributable to such unvested Performance LTIP Units (or any securities into which such unvested Performance LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">however, that the Transfer Restrictions shall not apply to any Transfer of unvested Performance LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;As to any vested Base Units, the Participant agrees that the Participant will not Transfer such Base Units (or any Common Units or shares of Common Stock in respect of which such Base Units have been exchanged) prior to the date that is one (1) year after the date such Base Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 Base Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the Base Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested Performance LTIP Units and the portion of the Award attributable to the unvested Performance LTIP Units, or to effectuate the transfer or surrender of such unvested Performance LTIP Units and portion of the Award to the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is holding the Award and the Performance LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the Performance LTIP Units for investment and not with a view to distribution or resale thereof except in compliance with applicable laws regulating securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant understands that the Performance LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the Performance LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the Performance LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.02pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code and with respect to the grant of the Performance LTIP Units), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the Performance LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the Performance LTIP Units and with respect to the cancellation and replacement of the RSU Award.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any provisions to the contrary in any employment agreement, the Healthpeak Properties, Inc. Executive Severance Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Healthpeak Properties, Inc. Executive Change in Control Severance Plan or successor plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">CIC Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), or any other severance plan adopted by the Corporation, the provisions set forth in this Section 8 are applicable in the event of a termination of the Participant&#8217;s employment with the Corporation and its Subsidiaries.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Qualifying Termination. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or its Subsidiaries (the date of such termination of employment is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as a result of (i) the Participant&#8217;s death or Disability or (ii) a termination of employment by the Corporation or one of its Subsidiaries without Cause or by Participant for Good Reason (each as defined herein), then, subject to the following paragraph and the release requirement set forth in the last paragraph of this Section 8(a), (x) the Performance LTIP Units will remain outstanding during the remainder of the Vesting Period and will remain subject to Section 3, and (y) the Participant will vest with respect to the number of Performance LTIP Units that would have vested in accordance with Section 3, if any, had the Participant remained employed until the end of the Vesting Period (subject to satisfaction of the underlying performance conditions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">For awards granted in 2022</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; In the event that the Participant&#8217;s employment terminates in the circumstances described in the preceding paragraph and the Severance Date occurs on or before the last day of the second year of the Performance Period and on or before the Severance Date, or after the Severance Date and before the last day of the second year of the Performance Period, an Interim Date (as defined in </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) has been or is established with respect to Peer Group I, Peer Group II or Peer Group III (as such term is defined in </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the Performance Period with respect to that Peer Group will end on such Interim Date (in the event there has been more than one Interim Date on or prior to the Severance Date, the most recent Interim Date on or prior to the Severance Date&#59; and in the event that there has been an Interim Date on or prior to the Severance Date, any new Interim Date after the Severance Date with respect to that Peer Group shall be disregarded) and there will be no new or additional measurement period with respect to such Peer Group after such Interim Date as otherwise provided for in </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In such circumstances, the determination as to whether the Corporation has attained the performance goals set forth in </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Peer Group for the Performance Period shall be made by the Committee based solely on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">performance through such applicable Interim Date, such determination to be made no later than March 15 of the year that follows the later of the Severance Date or the applicable Interim Date as to that Peer Group (such determination to be the Committee Determination as to such Peer Group). In such circumstances, any Performance LTIP Units corresponding to  such Peer Group I that are not vested on the date of such Committee Determination (after giving effect to such Committee Determination) shall be cancelled and forfeited. No additional Performance LTIP Units will vest pursuant to Section 8(b) or </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to performance after, or a Change in Control Event that occurs after, the applicable Interim Date.&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any benefit to the Participant pursuant to the preceding paragraphs of this Section 8 (other than in connection with the Participant&#8217;s death) is subject to the condition that (i) the Participant has fully executed a valid and effective release (in the form attached to the Severance Plan or, if such release is executed on or after a Change in Control Event, in the form attached to the CIC Severance Plan, or in either case such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to the form attached to the Severance Plan or the CIC Severance Plan, as the case may be, that would otherwise apply in the circumstances but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable and otherwise compliant with applicable laws), (ii) such executed release is delivered by the Participant to the Corporation so that it is received by the Corporation in the time period specified below, and (iii) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law). In order to satisfy the requirements of this paragraph, the Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Corporation so that it is received by the Corporation no later than twenty-five (25) calendar days after the Participant&#8217;s Severance Date (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either twenty-one (21) or forty-five (45) days, depending on the circumstances of the termination, to consider the release). In addition, the Corporation may require that the Participant&#8217;s release be executed no earlier than the Participant&#8217;s Severance Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Forfeiture of Performance LTIP Units upon Certain Terminations of Employment. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or one of its Subsidiaries as a result of (i) a termination of employment by the Corporation or one of its Subsidiaries for Cause, or (ii) a termination of employment by the Participant, excluding any termination contemplated by Section 8(a) (other than a termination contemplated by Section 8(a) but as to which the Participant did not timely satisfy any applicable release requirement pursuant to Section 8(a)) and subject to the next paragraph, all of the Performance LTIP Units shall be automatically cancelled and forfeited in full, effective as of the Severance Date, and this Agreement shall be null and void and of no further force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, however, the Participant ceases to be employed by the Corporation or one of its Subsidiaries and such termination of employment is a result of a retirement or resignation by the Participant (other than (x) any termination contemplated by Section 8(a) and (y) a termination of employment by the Corporation or one of its Subsidiaries for Cause) and, immediately after such termination of employment, the Participant is a member of the Board or provides consulting services to the Corporation or one of its Subsidiaries under a written consulting agreement entered into by and between the Participant and the Corporation or one of its Subsidiaries, then the termination of employment rules of the preceding paragraph shall not apply when the Participant ceases to be employed by the Corporation or one of its Subsidiaries but shall apply if and when, and effective as of the time that, the Participant ceases to be a member of the Board or ceases to provide consulting services to the Corporation or one of its Subsidiaries under such a written consulting agreement. For clarity, the Participant&#8217;s obligations under a confidentiality, noncompetition, non-solicitation, cooperation or similar clause or agreement shall not constitute &#8220;consulting services&#8221; for purposes of the preceding sentence.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Termination of Performance LTIP Units. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any Performance LTIP Units that are not vested on the date of the Committee Determination (after giving effect to such Committee Determination) shall be cancelled and forfeited. If any unvested Performance LTIP Units are cancelled and forfeited pursuant to this Section 8, such Performance LTIP Units shall automatically be cancelled and forfeited as of the Severance Date or as of the date of the Committee Determination, as the case may be, without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:8pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:21.97pt">Definitions. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:61.36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Cause&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:58.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:56.04pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Severance Plan, as such definition may be amended from time to time&#59; provided, however, that upon and after a Change in Control Event, &#8220;Good Reason&#8221; shall have the meaning set forth in the CIC Severance Plan, as such definition may be amended from time to time&#59; provided, further, that if &#8220;Good Reason&#8221; is so not defined in the Severance Plan or CIC Severance Plan, as applicable, it shall not constitute a qualifying termination for purposes of Section 8 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Adjustments upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">Adjustments. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.97pt">Change in Control Event. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the occurrence, at any time during the Vesting Period, of a Change in Control Event with respect to the Corporation and notwithstanding any provision of Section 7.2 or 7.3 of the Plan, any employment agreement, the Severance Plan, the CIC Severance Plan (or successor plan) or any other severance plan adopted by the Corporation, the Performance Period for all Performance LTIP Units then outstanding will be shortened, if such Performance Period has not already ended, so that the Performance Period will be deemed to have ended on the day of the Change in Control Event and the Committee Determination pursuant to Section 3 shall be made not later than the date of the Change in Control Event. The Vesting Period will be deemed to end on the date of the Change in Control Event even though the Committee Determination may not occur until after such date, such that a Participant employed by the Corporation or a Subsidiary on the date of the Change in Control Event shall be fully vested in any Performance LTIP Units that vest as a result of the Committee Determination even if the Participant does not remain employed by the Corporation, the Partnership or a Subsidiary through the date of the Committee Determination. The number of Performance LTIP Units, if any, that vest shall be determined in accordance with Section 3 based on such shortened Performance Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Partnership and the Participant intend that (i) the Performance LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and vesting of the Performance LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the Performance LTIP Units, the Partnership may revalue </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the Performance LTIP Units shall be equal to zero, unless the Participant was a  Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the Performance LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such Performance LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the Performance LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant hereby covenants that so long as the Participant holds any Performance LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the Performance LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the Performance LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Certificates evidencing the Performance LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221; </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records. Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government. Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference. The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement. The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement. Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Agreement may be amended pursuant to Section 8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement. Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership). Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award. The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof. The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code. This Agreement shall be construed and interpreted consistent with that intent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Performance LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Performance LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the Performance LTIP Units (including any value received from a disposition thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, any fractional Performance LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of Performance LTIP Units that vest or become entitled to such distributions to exceed the total number of Performance LTIP Units set forth in Section 2(a) of this Agreement. </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the date first written above.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">By Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Managing Member</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; __________________________________</font></td></tr></table></div><div style="margin-top:6pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Name&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Title&#58;  </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.442%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Award Subject to Relative TSR Performance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;_________________&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="icdb72d46ca274c60b2647245ac984b40_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">_______</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit C</font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt;text-align:justify"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt;text-align:justify"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.24pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div></div></div><div id="icdb72d46ca274c60b2647245ac984b40_48"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property was transferred the excess (if any) of the fair market value of the property described below, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXPAYER&#8217;S NAME&#58; ______________________________________________<br><br>TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the  Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the  Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RETURN RECEIPT REQUESTED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Internal Revenue Service</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;Address where taxpayer files returns&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">___________________________________</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Enclosures</font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>6
<FILENAME>ex101103312023.htm
<DESCRIPTION>EX-10.11
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i77f02c6bb6c3410691d4683fe4bc566b_84"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2014 PERFORMANCE INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NEO RETENTIVE LTIP UNIT AWARD AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">THIS NEO RETENTIVE LTIP UNIT AWARD AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) is effective as of February 15, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, the Corporation maintains the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, pursuant to that certain Non-Retentive RSU Award Agreement, dated as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Original Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Old Healthpeak (as defined below) previously granted to the Participant an award of &#91;&#9679;&#93; restricted stock units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Original RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Agreement&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), by and among the entity known as Healthpeak Properties, Inc. prior to the Merger (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Old Healthpeak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), New Healthpeak, Inc. and Healthpeak Merger Sub, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Merger Sub merged with and into Old Healthpeak, with Old Healthpeak being the surviving entity and becoming a subsidiary of New Healthpeak, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, following the Merger, New Healthpeak, Inc. changed its name to &#8220;Healthpeak Properties, Inc.&#8221; and Old Healthpeak converted to a Maryland limited liability company named &#8220;Healthpeak OP, LLC&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, effective as of the effective time of the Merger, the Original RSU Award was automatically converted into a restricted stock unit award with respect to the same number of shares of common stock of the Corporation and subject to the same terms and conditions, including vesting terms, as the Original RSU Award immediately prior to the effective time of the Merger (as so converted, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as of the date hereof, &#91;&#9679;&#93; restricted stock units remained outstanding under the RSU Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, in connection with the Merger, the Participant elected to cancel and replace the RSU Award with an award of LTIP Units (as defined in the Plan)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the Corporation, the Partnership and the Participant desire to enter into this Agreement to set forth the terms of the award of LTIP Units resulting from the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) of &#91;&#9679;&#93; LTIP Units.  The Partnership and the Participant acknowledge and agree that the LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth  in this Agreement, the Plan and in the Partnership Agreement, and any rules adopted by the Administrator, as such rules are in effect from time to time.  The parties acknowledge and agree that the LTIP Units are being granted subject to the cancellation of, and as a replacement for, the RSU Award, and the Participant acknowledges, agrees and consents to such cancellation and replacement in accordance with the Merger Agreement and as set forth herein.  The Participant further agrees that, as of the Effective Date, the RSU Award and the restricted stock units subject thereto shall be cancelled and of no further force or effect, and the Participant shall have no further right, title or interest in the RSU Award, such restricted stock units or any shares of stock issuable thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Subject to Section&#160;8 below, the Award shall vest and become nonforfeitable with respect to &#91;&#9679;&#93; of the total number of LTIP Units issued hereby on &#91;&#9679;&#93; anniversary&#91;ies&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">of the Original Award Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Except as otherwise expressly provided in Section 8, the vesting schedule requires continued employment or service through each applicable vesting date, as provided in Section 3, as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement.  Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or service as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined in the Executive Severance Plan, confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits.  Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Restrictions on Transfer.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">The Award and the LTIP Units are subject to  the restrictions on transfer of Membership Units (including, without limitation, LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or LTIP Units shall take such Award or LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested LTIP Units or any portion of the Award attributable to such unvested LTIP Units (or any securities into which such unvested LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, however, that the Transfer Restrictions shall not apply to any Transfer of unvested LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">As to any vested LTIP Units, the Participant agrees that the Participant will not Transfer such LTIP Units (or any Common Units or shares of Common Stock in respect of which such LTIP Units have been exchanged) prior to the date that is one (1) year after the date such LTIP Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 LTIP Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the LTIP Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Total Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Common Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested LTIP Units and the portion of the Award attributable to the unvested LTIP Units, or to effectuate the transfer or surrender of such unvested LTIP Units and portion of the Award to the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant is holding the Award and the LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the LTIP Units for investment and not with a view to distribution or resale thereof except, in compliance with applicable laws regulating securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The Participant understands that the LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:26.01pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code and with respect to the grant of the LTIP Units), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the LTIP Units with respect to the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Effect of Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  If the Participant ceases to be employed by or ceases to provide services to the Corporation or a Subsidiary (the date of such termination of employment or service is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Participant&#8217;s LTIP Units shall be cancelled and forfeited to the extent such units have not become vested pursuant to Section 3 hereof upon the Severance Date regardless of the reason for the termination of the Participant&#8217;s employment or services&#59; provided, however, that if the Participant&#8217;s employment is terminated as a result of the Participant&#8217;s death, Total Disability (as defined below) or Retirement (as defined below), the Participant&#8217;s LTIP Units, to the extent such units are not then vested, shall become fully vested as of the Severance Date.  If any unvested LTIP Units are forfeited hereunder, such LTIP Units shall automatically be cancelled as of the applicable Severance Date without payment of any consideration by the Corporation and without any other action by the Company, the Partnership, the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">For purposes of the Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).  For purposes of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Retirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; means, that, as of the date of termination of the Participant&#8217;s employment or services, the Participant (1) has attained age 65 and completed at least five (5) full years of service as an employee of the Corporation and its Subsidiaries and&#47;or a member of the Board, or (2) has attained age 60 and completed at least fifteen (15) full years of service as an employee of the Corporation and its Subsidiaries and&#47;or a member of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notwithstanding the foregoing, the Participant shall be entitled to any accelerated vesting with respect to the LTIP Units in connection with the Participant&#8217;s severance provided for in the circumstances in, and subject to, the express terms of any written employment agreement entered into between the Participant and Corporation or any of its Subsidiaries and that is in effect on the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Adjustments Upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Adjustments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Change in Control Event.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 and 7.3 of the Plan or any employment agreement to the contrary, the Award (to the extent outstanding at the time of such event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the LTIP Units will accelerate in connection with such event and the extent of any such accelerated vesting.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Partnership and the Participant intend that (i) the LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and vesting of the LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the LTIP Units, the Partnership may revalue all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the LTIP Units shall be equal to zero, unless the Participant was a Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such LTIP Units.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as Exhibit B.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant hereby covenants that so long as the Participant holds any LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  Certificates evidencing the LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five (5) business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">after</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> the date hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section&#160;8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement.  Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership).  Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the LTIP Units (including any value received from a disposition thereof).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  For purposes of this Agreement, any fractional LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of LTIP Units that vest or become entitled to such distributions to exceed the total number of LTIP Units set forth in Section 2 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">THE PARTICIPANT&#8217;S ACCEPTANCE OF THE AWARD THROUGH THE ELECTRONIC STOCK PLAN AWARD RECORDKEEPING SYSTEM MAINTAINED BY THE CORPORATION OR ITS DESIGNEE CONSTITUTES THE PARTICIPANT&#8217;S AGREEMENT TO THE TERMS AND CONDITIONS HEREOF, AND THAT THE AWARD IS GRANTED UNDER AND GOVERNED BY THE TERMS AND CONDITIONS OF THE PLAN AND THIS AGREEMENT.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is intentionally left blank.&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Exhibit A</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;________&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">10</font></div></div></div><div id="i77f02c6bb6c3410691d4683fe4bc566b_87"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property described below was transferred the excess (if any) of the fair market value of such property, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">TAXPAYER&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><br><br>TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">RETURN RECEIPT REQUESTED</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Internal Revenue Service</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">______________________________________</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;Address where taxpayer files returns&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Very truly yours,</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">___________________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Enclosures</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>7
<FILENAME>ex101203312023.htm
<DESCRIPTION>EX-10.12
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6dc5fb75f99b46e99e28e07b42176d99_42"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2014 PERFORMANCE INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NON-NEO LTIP UNIT AWARD AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">THIS NON-NEO LTIP UNIT AWARD AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) is effective as of February 15, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, to the Corporation maintains the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, pursuant to that certain Non-NEO LTIP Unit Award Agreement, dated as of &#91;&#9679;&#93;, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Original Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Old Healthpeak (as defined below) previously granted to the Participant an award of &#91;&#9679;&#93; restricted stock units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Original RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Agreement&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), by and among the entity known as Healthpeak Properties, Inc. prior to the Merger (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Old Healthpeak</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), New Healthpeak, Inc. and Healthpeak Merger Sub, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), Merger Sub merged with and into Old Healthpeak, with Old Healthpeak being the surviving entity and becoming a subsidiary of New Healthpeak, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Merger</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, following the Merger, New Healthpeak, Inc. changed its name to &#8220;Healthpeak Properties, Inc.&#8221; and Old Healthpeak converted to a Maryland limited liability company named &#8220;Healthpeak OP, LLC&#8221;&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, effective as of the effective time of the Merger, the Original RSU Award was automatically converted into a restricted stock unit award with respect to the same number of shares of common stock of the Corporation and subject to the same terms and conditions, including vesting terms, as the Original RSU Award immediately prior to the effective time of the Merger (as so converted, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, as of the date hereof, &#91;&#9679;&#93; restricted stock units remained outstanding under the RSU Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, in connection with the Merger, the Participant elected to cancel and replace the RSU Award with an award of LTIP Units (as defined in the Plan)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, the Corporation, the Partnership and the Participant desire to enter into this Agreement to set forth the terms of the award of LTIP Units resulting from the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, in consideration of services rendered and to be rendered by the Participant to or for the benefit of the Partnership, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan or the Partnership Agreement, as applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Subject to the terms of this Agreement, the Partnership hereby grants to the Participant an award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) of &#91;&#9679;&#93; LTIP Units.  The Partnership and the Participant acknowledge and agree that the LTIP Units are hereby issued to the Participant for the performance of services to or for the benefit of the Partnership in his or her capacity as a Member or in anticipation of the Participant becoming a Member. Upon receipt of the Award, the Participant shall, automatically and without further action on his or her part, be deemed to be a party to, signatory of and bound by the Partnership Agreement. At the request of the Partnership, the Participant shall execute the Partnership Agreement or a joinder or counterpart signature page thereto. The Participant acknowledges that the Partnership may from time to time issue or cancel (or otherwise modify) LTIP Units in accordance with the terms of the Partnership Agreement. The LTIP Units shall have the rights, voting powers, restrictions, limitations as to distributions, qualifications and terms and conditions of redemption and conversion set forth  in this Agreement, the Plan and in the Partnership Agreement, and any rules adopted by the Administrator, as such rules are in effect from time to time.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The parties acknowledge and agree that the LTIP Units are being granted subject to the cancellation of, and as a replacement for, the RSU Award, and the Participant acknowledges, agrees and consents to such cancellation and replacement in accordance with the Merger Agreement and as set forth herein.  The Participant further agrees that, as of the Effective Date, the RSU Award and the restricted stock units subject thereto shall be cancelled and of no further force or effect, and the Participant shall have no further right, title or interest in the RSU Award, such restricted stock units or any shares of stock issuable thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">As a condition to the grant of the Award and the Participant&#8217;s right to receive and retain the LTIP Units, (i) concurrent with or prior to the execution of this Agreement, the Participant shall execute &#160;and deliver to the Company a Non-Referral Source Certification substantially in the form attached hereto as&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;(a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Certification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) and (ii) the Participant&#8217;s representations and warranties set forth therein shall be true and correct in all respects as of the date thereof. &#160;In the event that the Participant has previously delivered a true and correct Certification to the Company, the provisions of this Section 2(b) shall not apply and the Participant shall not be required to execute and deliver an additional Certification in connection with the grant of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Subject to Section&#160;8 below, the Award shall vest and become nonforfeitable with respect to &#91;&#9679;&#93; of the total number of the LTIP Units issued hereby on &#91;&#9679;&#93; anniversary&#91;ies&#93; of the Original Award Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Except as otherwise expressly provided in Section 8, the vesting schedule requires continued employment or service through each applicable vesting date, as provided in Section 3, as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement.  Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or service as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without cause, confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits.  Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Restrictions on Transfer.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">The Award and the LTIP Units are subject to  the restrictions on transfer of Membership Units (including, without limitation, LTIP Units) set forth in Article 11 of the Partnership Agreement.  Any permitted transferee of the Award or LTIP Units shall take such Award or LTIP Units subject to the terms of the Plan, this Agreement, and the Partnership Agreement.  Any such permitted transferee must, upon the request of the Partnership, agree to be bound by the Plan, the Partnership Agreement, and this Agreement, and shall execute the same on request, and must agree to such other waivers, limitations, and restrictions as the Partnership or the Corporation may reasonably require.  Any Transfer of the Award or LTIP Units which is not made in compliance with the Plan, the Partnership Agreement and this Agreement shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Without the consent of the Administrator (which it may give or withhold in its sole discretion), the Participant shall not Transfer any unvested LTIP Units or any portion of the Award attributable to such unvested LTIP Units (or any securities into which such unvested LTIP Units are converted or exchanged), other than by will or pursuant to the laws of descent and distribution (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Transfer Restrictions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, however, that the Transfer Restrictions shall not apply to any Transfer of unvested LTIP Units or of the Award to the Partnership or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">As to any vested LTIP Units, the Participant agrees that the Participant will not Transfer such LTIP Units (or any Common Units or shares of Common Stock in respect of which such LTIP Units have been exchanged) prior to the date that is one (1) year after the date such LTIP Units became vested in accordance with the terms of the Award (for example, if 100 Common Units or shares of Common Stock were acquired in respect of 100 LTIP Units that became vested on a particular date, such one-year period would commence as of such vesting date as to those 100 Common Units or shares)&#59; provided, however, that the restrictions set forth in this Section 5(c) shall (i) not apply to any Units or shares sold by the Participant to satisfy any tax liability arising in connection with the exchange or disposition of the LTIP Units, (ii) not apply to any transfer made without consideration (or for only nominal consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such Units or shares continue in effect after any such transfer, and (iii) lapse upon the Participant&#8217;s death or Total Disability or as otherwise provided by the Corporation. The Corporation may provide for any Units or shares of Common Stock acquired with respect to the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 5(c) (or, as to any such Common Units or shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Execution and Return of Documents and Certificates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  At the Corporation&#8217;s or the Partnership&#8217;s request, the Participant hereby agrees to promptly execute, deliver and return to the Partnership any and all documents or certificates that the Corporation or the Partnership deems necessary or desirable to effectuate the cancellation and forfeiture of the unvested LTIP Units and the portion of the Award attributable to the unvested LTIP Units, or to effectuate the transfer or surrender of such unvested LTIP Units and portion of the Award to the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Covenants, Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The Participant hereby represents, warrants, covenants, acknowledges and agrees on behalf of the Participant and his or her spouse, if applicable, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Investment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant is holding the Award and the LTIP Units for the Participant&#8217;s own account and not for the account of any other Person.  The Participant is holding the Award and the LTIP Units for investment and not with a view to distribution or resale thereof except, in compliance with applicable laws regulating securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Relation to the Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant is presently an employee of, or consultant to, the Partnership, or is otherwise providing services to or for the benefit of the Partnership, and in such capacity has become personally familiar with the business of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Access to Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant has had the opportunity to ask questions of, and to receive answers from, the Partnership with respect to the terms and conditions of the transactions contemplated hereby and with respect to the business, affairs, financial conditions and results of operations of the Partnership.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Registration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The Participant understands that the LTIP Units have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the LTIP Units cannot be transferred by the Participant unless such transfer is registered under the Securities Act or an exemption from such registration is available.  The Partnership has made no agreements, covenants or undertakings whatsoever to register the transfer of the LTIP Units under the Securities Act.  The Partnership has made no representations, warranties or covenants whatsoever as to whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers&#8217; transactions pursuant to Rule 144 of the Securities Act, will be available.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Public Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  None of the Partnership&#8217;s securities are presently publicly traded, and the Partnership has made no representations, covenants or agreements as to whether there will be a public market for any of its securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:26.01pt">Tax Advice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Partnership has made no warranties or representations to the Participant with respect to the income tax consequences of the transactions contemplated by this Agreement (including, without limitation, with respect to the decision of whether to make an election under Section 83(b) of the Code and with respect to the grant of the LTIP Units), and the Participant is in no manner relying on the Partnership or its representatives for an assessment of such tax consequences.  The Participant hereby recognizes that the Internal Revenue Service has proposed regulations under Sections 83 and 704 of the Code that may affect the proper treatment of the LTIP Units for federal income tax purposes.  In the event that those proposed regulations are finalized, the Participant hereby agrees to cooperate with the Partnership in amending this Agreement and the Partnership Agreement, and to take such other action as may be required, to conform to such regulations.  The Participant is advised to consult with his or her own tax advisor with respect to the tax consequences of owning and disposing of the LTIP Units with respect to the cancellation and replacement of the RSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Effect of Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  If the Participant ceases to be employed by or ceases to provide services to the Corporation or a Subsidiary (the date of such termination of employment or service is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Participant&#8217;s LTIP Units shall be cancelled and forfeited to the extent such units have not become vested pursuant to Section 3 hereof upon the Severance Date regardless of the reason for the termination of the Participant&#8217;s employment or services&#59; provided, however, that if the Participant&#8217;s employment is terminated as a result of the Participant&#8217;s death, Total Disability (as defined below) or Retirement (as defined below), the Participant&#8217;s LTIP Units, to the extent such units are not then vested, shall become fully vested as of the Severance Date.  If any unvested LTIP Units are forfeited hereunder, such LTIP Units shall automatically be cancelled as of the applicable Severance Date without payment of any consideration by the Corporation and without any other action by the Company, the Partnership, the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">For purposes of the Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Total Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).  For purposes of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Retirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; means, that, as of the date of termination of the Participant&#8217;s employment or services, the Participant (1) has attained age 65 and completed at least five (5) full years of service as an employee of the Corporation and its Subsidiaries and&#47;or a member of the Board, or (2) has attained age 60 and completed at least fifteen (15) full years of service as an employee of the Corporation and its Subsidiaries and&#47;or a member of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notwithstanding the foregoing, the Participant shall be entitled to any accelerated vesting with respect to the LTIP Units in connection with the Participant&#8217;s severance provided for in the circumstances in, and subject to, the express terms of any written employment agreement entered into between the Participant and Corporation or any of its Subsidiaries and that is in effect on the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Adjustments Upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Adjustments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  To the extent applicable, the Award shall be subject to adjustment by the Administrator in accordance with Section 7.1 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Change in Control Event.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 and 7.3 of the Plan or any employment agreement to the contrary, the Award (to the extent outstanding at the time of such event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the LTIP Units will accelerate in connection with such event and the extent of any such accelerated vesting.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Partnership and the Participant intend that (i) the LTIP Units be treated as a &#8220;profits interest&#8221; as defined in Internal Revenue Service Revenue Procedure 93-27, as clarified by Revenue Procedure 2001-43, (ii) the issuance and vesting of the LTIP Units shall not be taxable events to the Partnership or the Participant as provided in such revenue procedure, and (iii) the Partnership Agreement, the Plan and this Agreement be interpreted consistently with such intent. In furtherance of such intent, effective immediately prior to the issuance of the LTIP Units, the Partnership may revalue all Partnership assets to their respective gross fair market values, and make the resulting adjustments to the &#8220;Capital Accounts&#8221; (as defined in the Partnership Agreement) of the Members, in each case as set forth in the Partnership Agreement. The Corporation, the Partnership or any Subsidiary may withhold from the Participant&#8217;s wages, or require the Participant to pay to such entity, any applicable withholding or employment taxes resulting from the issuance of the Award hereunder, from the vesting or lapse of any restrictions imposed on the Award, or from the ownership or disposition of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Capital Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant shall make no contribution of capital to the Partnership in connection with the Award and, as a result, the Participant&#8217;s Capital Account balance in the Partnership immediately after his or her receipt of the LTIP Units shall be equal to zero, unless the Participant was a Member of the Partnership prior to such issuance, in which case the Participant&#8217;s Capital Account balance shall not be increased as a result of his or her receipt of the LTIP Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Redemption Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  Notwithstanding anything to the contrary in the Partnership Agreement, Membership Units which are acquired upon the conversion of the LTIP Units shall not, without the consent of the Partnership (which may be given or withheld in its sole discretion), be redeemed pursuant to Section 15.1 of the Partnership Agreement within two (2) years following the date of the issuance of such LTIP Units.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant covenants that the Participant shall make a timely election under Section 83(b) of the Code (and any comparable election in the state of the Participant&#8217;s residence) with respect to the LTIP Units covered by the Award, and the Partnership hereby consents to the making of such election(s).  In connection with such election, the Participant and the Participant&#8217;s spouse, if applicable, shall promptly provide a copy of such election to the Partnership.  Instructions for completing an election under Section 83(b) of the Code and a form of election under Section 83(b) of the Code are attached hereto as Exhibit B.  The Participant represents that the Participant has consulted any tax advisor(s) that the Participant deems advisable in connection with the filing of an election under Section 83(b) of the Code and similar state tax provisions. The Participant acknowledges that it is the Participant&#8217;s sole responsibility and not the Corporation&#8217;s to timely file an election under Section 83(b) of the Code (and any comparable state election), even if the Participant requests that the Corporation or any representative of the Corporation make such filing on the Participant&#8217;s behalf. The Participant should consult his or her tax advisor to determine if there is a comparable election to file in the state of his or her residence.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Ownership Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant hereby covenants that so long as the Participant holds any LTIP Units, at the request of the Partnership, the Participant shall disclose to the Partnership in writing such information relating to the Participant&#8217;s ownership of the LTIP Units as the Partnership reasonably believes to be necessary or desirable to ascertain in order to comply with the Code or the requirements of any other appropriate taxing authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Participant shall be liable to the Partnership for all costs and damages, including incidental and consequential damages, resulting from a disposition of the Award or the LTIP Units which is in violation of the provisions of this Agreement. Without limiting the generality of the foregoing, the Participant agrees that the Partnership shall be entitled to obtain specific performance of the obligations of the Participant under this Agreement and immediate injunctive relief in the event any action or proceeding is brought in equity to enforce the same. The Participant will not urge as a defense that there is an adequate remedy at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Restrictive Legends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  Certificates evidencing the LTIP Units, to the extent such certificates are issued, may bear such restrictive legends as the Partnership and&#47;or the Partnership&#8217;s counsel may deem necessary or advisable under applicable law or pursuant to this Agreement, including, without limitation, the following legends or any legends similar thereto&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;). Any transfer of such securities will be invalid unless a Registration Statement under the Securities Act is in effect as to such transfer or in the opinion of counsel for Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Partnership</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) such registration is unnecessary in order for such transfer to comply with the Securities Act.&#8221;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;The securities represented hereby are subject to forfeiture, transferability and other restrictions as set forth in (i) a written agreement with the Partnership, (ii) the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, and (iii) the Operating Agreement of Healthpeak OP, LLC, in each case, as has been and as may in the future be amended (or amended and restated) from time to time, and such securities may not be sold or otherwise transferred except pursuant to the provisions of such documents.&#8221;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five (5) business days after the date mailed in accordance with the foregoing provisions of this Section 17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Plan and Partnership Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan and the Partnership Agreement, each of which is incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan, this Agreement and the Partnership Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, this Agreement and the Partnership Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">after</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> the date hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  This Agreement, the Plan and the Partnership Agreement together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section&#160;8.6 of the Plan and&#47;or the applicable provisions of the Partnership Agreement.  Any such amendment must be in writing and signed by the Corporation (and, if applicable, the Partnership).  Except to the extent provided in the Partnership Agreement, any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation or the Partnership may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan, the Prospectus for the Plan and the Partnership Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The LTIP Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the LTIP Units or any Common Units or shares of Common Stock or other cash or property received with respect to the LTIP Units (including any value received from a disposition thereof).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">. The representations, warranties and covenants contained in Section 7 hereof shall survive the later of the date of execution and delivery of this Agreement or the issuance of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Fractional Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  For purposes of this Agreement, any fractional LTIP Units that vest or become entitled to distributions pursuant to the Partnership Agreement will be rounded as determined by the Corporation or the Partnership&#59; provided, however, that in no event shall such rounding cause the aggregate number of LTIP Units that vest or become entitled to such distributions to exceed the total number of LTIP Units set forth in Section 2 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">THE PARTICIPANT&#8217;S ACCEPTANCE OF THE AWARD THROUGH THE ELECTRONIC STOCK PLAN AWARD RECORDKEEPING SYSTEM MAINTAINED BY THE CORPORATION OR ITS DESIGNEE CONSTITUTES THE PARTICIPANT&#8217;S AGREEMENT TO THE TERMS AND CONDITIONS HEREOF, AND THAT THE AWARD IS GRANTED UNDER AND GOVERNED BY THE TERMS AND CONDITIONS OF THE PLAN AND THIS AGREEMENT.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is intentionally left blank.&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Exhibit A</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NON-REFERRAL SOURCE CERTIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;________&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="padding-left:6.85pt;padding-right:6.85pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">FORM OF SECTION 83(b) ELECTION AND INSTRUCTIONS</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">These instructions are provided to assist you if you choose to make an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the LTIP Units of Healthpeak OP, LLC transferred to you. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Please consult with your personal tax advisor as to whether an election of this nature will be in your best interests in light of your personal tax situation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The executed original of the Section 83(b) election must be filed with the Internal Revenue Service </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">not later than 30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> after the grant date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> PLEASE NOTE&#58; There is no remedy for failure to file on time. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Follow the steps outlined below to ensure that the election is mailed and filed correctly and in a timely manner.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> PLEASE ALSO NOTE&#58; If you make the Section 83(b) election, the election is irrevocable. </font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Complete all of the Section 83(b) election steps below&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Complete the Section 83(b) election form (sample form follows) and make four (4) copies of the signed election form. (Your spouse, if any, should also sign the Section 83(b) election form.) </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Prepare a cover letter to the Internal Revenue Service (sample letter included, following election form). </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Send the cover letter with the originally executed Section 83(b) election form and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">one (1) copy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> via certified mail, return receipt requested to the Internal Revenue Service at the address of the Internal Revenue Service where you file your personal tax returns. </font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:49.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">It is advisable that you have the package date-stamped at the post office. Enclose a self-addressed, stamped envelope so that the Internal Revenue Service may return a date-stamped copy to you. However, your postmarked receipt is your proof of having timely filed the Section 83(b) election if you do not receive confirmation from the Internal Revenue Service. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">One (1) copy </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">must be sent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> to Healthpeak OP, LLC&#8217;s legal department for its records. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt;text-align:justify;text-indent:-14.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:6.07pt">Retain the Internal Revenue Service file stamped copy (when returned) for your records. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Please consult your personal tax advisor for the address of the office of the Internal Revenue Service to which you should mail your election form.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">10</font></div></div></div><div id="i6dc5fb75f99b46e99e28e07b42176d99_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ELECTION PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The undersigned hereby elects pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the undersigned&#8217;s gross income for the taxable year in which the property described below was transferred the excess (if any) of the fair market value of such property, over the amount the undersigned paid for such property, if any, and supplies herewith the following information in accordance with the Treasury regulations promulgated under Section 83(b)&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">TAXPAYER&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><br><br>TAXPAYER&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">TAXABLE YEAR&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The name, address and taxpayer identification (social security) number of the undersigned&#8217;s spouse are (complete if applicable)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">SPOUSE&#8217;S NAME&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"><br><br>SPOUSE&#8217;S SOCIAL SECURITY NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">ADDRESS&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.&#160;&#160;&#160;&#160;The property with respect to which the election is made consists of &#91;&#9679;&#93; LTIP Units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) of Healthpeak OP, LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), representing an interest in the future profits, losses and distributions of the Company.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.&#160;&#160;&#160;&#160;The date on which the above property was transferred to the undersigned was &#91;&#9679;&#93;. </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4.&#160;&#160;&#160;&#160;The above property is subject to the following restrictions&#58; The Units are subject to forfeiture to the extent unvested upon a termination of service with the Company and its affiliates under certain circumstances. These restrictions lapse upon the satisfaction of certain conditions as set forth in an agreement between the taxpayer and the Company.  In addition, the Units are subject to certain transfer restrictions pursuant to such agreement and the Operating Agreement of Healthpeak OP, LLC, as amended (or amended and restated) from time to time, should the taxpayer wish to transfer the Units.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5.&#160;&#160;&#160;&#160;The fair market value of the above property at the time of transfer (determined without regard to any restrictions other than those which by their terms will never lapse) was $0.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">6.&#160;&#160;&#160;&#160;The amount paid for the above property by the undersigned was $0.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">7.&#160;&#160;&#160;&#160;The undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income tax return not later than 30 days after the date of transfer of the property.  A copy of this election will be furnished to the person for whom the services were performed.  The undersigned is the person performing the services in connection with which the property was transferred.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; _________________</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;&#9679;&#93;</font></div></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The undersigned spouse of the taxpayer joins in this election. (Complete if applicable.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Date&#58; _________________ </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">____________________________________ </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Spouse Name&#58;</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">VIA CERTIFIED MAIL</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">RETURN RECEIPT REQUESTED</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Internal Revenue Service</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">______________________________________</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;Address where taxpayer files returns&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Election under Section 83(b) of the Internal Revenue Code of 1986</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Social Security Number&#58; ___________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Spouse&#58; _________________________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Taxpayer&#8217;s Spouse&#8217;s Social Security Number&#58; ____________________</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Enclosed please find an original and one copy of an Election under Section 83(b) of the Internal Revenue Code of 1986, as amended, being made by the taxpayer referenced above. Please acknowledge receipt of the enclosed materials by stamping the enclosed copy of the Election and returning it to me in the self-addressed stamped envelope provided herewith.</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Very truly yours,</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">___________________________________</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;&#9679;&#93;</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Enclosures</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">cc&#58; Healthpeak OP, LLC</font></div><div style="padding-left:216pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>8
<FILENAME>ex101303312023.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46675b3bc5ef42698db286b588bcd9e4_126"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2023 PERFORMANCE INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-EXECUTIVE RESTRICTED STOCK UNIT AWARD AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THIS NON-EXECUTIVE RESTRICTED STOCK UNIT AWARD AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is dated as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to the Healthpeak Properties, Inc. 2023 Performance Incentive Plan, as may amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Corporation hereby grants to the Participant, effective as of the date hereof, an award of restricted stock units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), upon the terms and conditions set forth herein and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Participant, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Subject to the terms of this Agreement, the Corporation hereby grants to the Participant an Award with respect to an aggregate of &#91;&#9679;&#93; stock units (subject to adjustment as provided in Section 7.1 of the Plan) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Stock Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  As used herein, the term &#8220;stock unit&#8221; means a non-voting unit of measurement which is deemed for bookkeeping purposes to be equivalent to one outstanding share of the Corporation&#8217;s Common Stock (subject to adjustment as provided in Section 7.1 of the Plan) solely for purposes of the Plan and this Agreement.  The Stock Units shall be used solely as a device for the determination of the payment to eventually be made to the Participant if such Stock Units vest pursuant to Section 3.  The Stock Units shall not be treated as property or as a trust fund of any kind.  The Award is subject to all of the terms and conditions set forth in this Agreement and is further subject to all of the terms and conditions of the Plan, as it may be amended from time to time, and any rules adopted by the Administrator, as such rules are in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Subject to Section&#160;8 below, the Award shall vest and become nonforfeitable with respect to one third (1&#47;3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) of the total number of the Stock Units (subject to adjustment under Section&#160;7.1 of the Plan) on each of the first, second and third anniversaries of the Award Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The vesting schedule requires continued employment or service through each applicable vesting date as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement.  Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 8 below or under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation, affects the Participant&#8217;s status as an employee at will who is subject to termination without cause, confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits.  Nothing in this paragraph, however, is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:127%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Dividend and Voting Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">&#160;&#160;&#160;&#160;Limitations on Rights Associated with Units.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Participant shall have no rights as a stockholder of the Corporation, no dividend rights (except as expressly provided in Section 5(b) with respect to Dividend Equivalent Rights) and no voting rights, with respect to the Stock Units and any shares of Common Stock underlying or issuable in respect of such Stock Units until such shares of Common Stock are actually issued to and held of record by the Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dividend Equivalent Rights.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As of any date that the Corporation pays an ordinary cash dividend on its Common Stock, the Corporation shall pay the Participant an amount equal to the per share cash dividend paid by the Corporation on its Common Stock on such date multiplied by the number of Stock Units remaining subject to this Award as of the related dividend payment record date.  No such payment shall be made with respect to any Stock Units which, as of such record date, have either been paid pursuant to Section 7 or terminated pursuant to Section 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Neither the Award, nor any interest therein or amount or shares payable in respect thereof may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily.  The transfer restrictions in the preceding sentence shall not apply to (a) transfers to the Corporation, or (b) transfers by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Timing and Manner of Payment of Stock Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  On or as soon as administratively practical following each vesting of the applicable portion of the total Award pursuant to the terms hereof (and in all events within sixty (60) days after such vesting event), the Corporation shall deliver to the Participant a number of shares of Common Stock (either by delivering one or more certificates for such shares or by entering such shares in book entry form, as determined by the Corporation in its discretion) equal to the number of Stock Units subject to this Award that vest on the applicable vesting date&#59; provided, however, that in the event that the vesting and payment of the Stock Units is triggered by the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Treasury Regulation Section 1.409A-1(h)) and the Participant is a &#8220;specified employee&#8221; (within the meaning of Treasury Regulation Section 1.409A-1(i)) on the date of such separation from service, the Participant shall not be entitled to any payment of the Stock Units until the earlier of (i) the date which is six (6) months after the Participant&#8217;s separation from service with the Corporation for any reason other than death, or (ii) the date of the Participant&#8217;s death, if and to the extent such delay in payment is required to comply with Section 409A of the Code.  The Corporation&#8217;s obligation to deliver shares of Common Stock or otherwise make payment with respect to vested Stock Units is subject to the condition precedent that the Participant or other person entitled under the Plan to receive any shares with respect to the vested Stock Units deliver to the Corporation any representations or other documents or assurances that the Administrator may deem necessary or desirable to assure compliance with all applicable legal and accounting requirements.  The Participant shall have no further rights with respect to any Stock Units that are paid or that terminate pursuant to Section 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Effect of Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  If the Participant ceases to be employed by or ceases to provide services to the Corporation or a Subsidiary (the date of such termination of employment or service is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Participant&#8217;s Stock Units shall terminate to the extent such units have not become vested pursuant to Section 3 hereof upon the Severance Date regardless of the reason for the termination of the Participant&#8217;s employment or services&#59; provided, however, that if the Participant&#8217;s employment is terminated as a result of the Participant&#8217;s death, Total Disability (as defined below) or Retirement (as defined below), the Participant&#8217;s Stock Units, to the extent such units are not then vested, shall become fully vested as of the Severance Date and shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:127%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">paid in accordance with Section 7.  If any unvested Stock Units are terminated hereunder, such Stock Units shall automatically terminate and be cancelled as of the applicable Severance Date without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).  For purposes of the Award, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Retirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, that, as of the date of the Participant&#8217;s voluntary retirement from the Corporation&#58; (1) the Participant&#8217;s age plus total &#8220;Years of Service&#8221; (as defined in the Corporation&#8217;s Retirement Policy, as it may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Retirement Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)) equals at least 70&#59; (2) the Participant has attained at least 55 years of age&#59; (3) the Participant has completed at least five (5) &#8220;Years of Service&#8221; (as defined in the Retirement Policy)&#59; and (4) the Participant has satisfied any additional requirements under the Retirement Policy with respect to additional vesting of the Award upon a &#8220;Qualifying Retirement&#8221; (as defined in the Retirement Policy).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, the Participant shall be entitled to any accelerated vesting with respect to the Stock Units in connection with the Participant&#8217;s severance provided for in the circumstances in, and subject to, the express terms of any written employment agreement entered into between the Participant and Corporation or any of its Subsidiaries and that is in effect on the Severance Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Adjustments Upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Adjustments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon the occurrence of certain events relating to the Corporation&#8217;s stock contemplated by Section 7.1 of the Plan (including, without limitation, an extraordinary cash dividend on such stock), the Administrator shall make adjustments in accordance with such section in the number of Stock Units then outstanding and the number and kind of securities that may be issued in respect of the Award.  No such adjustment shall be made with respect to any ordinary cash dividend for which dividend equivalents are paid pursuant to Section 5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change in Control Event.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 and 7.3 of the Plan or any employment agreement to the contrary, the Award (to the extent outstanding at the time of such event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the Stock Units will accelerate in connection with such event and the extent of any such accelerated vesting&#59; provided, further, that any Stock Units that are so accelerated will be paid on or as soon as administratively practical after (and in all events within sixty (60) days after) the first to occur of the original vesting date of such accelerated Stock Units set forth in Section 3 above or the Participant&#8217;s separation from service (and subject to the six-month delayed payment provision of Section 7 in the event payment is triggered by the Participant&#8217;s separation from service).  Notwithstanding the foregoing, the Administrator may provide for payment of the Stock Units in connection with such event, to the extent such payment does not result in noncompliance with Section 409A of the Code, including providing for payment, in accordance with the requirements of Treasury Regulation 1.409A-3(j)(4)(ix)(A), (B) or (C) promulgated under Section 409A of the Code (or any similar successor provision), which regulation generally provides that a deferred compensation arrangement may be terminated in limited circumstances following a dissolution or change in control of the Company, provided that any otherwise outstanding and unvested units shall become vested upon (or, to the extent necessary to effect the acceleration, immediately prior to) such a termination. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon vesting of any Stock Units or any distribution of shares of Common Stock in respect of the Stock Units, the Corporation shall reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of whole shares, valued at their then fair market value to satisfy any withholding obligations of the Corporation or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:127%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">its Subsidiaries with respect to such distribution of shares at the minimum applicable withholding rates&#59; provided, however, that in the event that the Corporation cannot legally satisfy such withholding obligations by such reduction of shares, or in the event of a cash payment or any other withholding event in respect of the Stock Units, the Corporation (or a Subsidiary) shall be entitled to require a cash payment by or on behalf of the Participant and&#47;or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to such distribution or payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five (5) business days after the date mailed in accordance with the foregoing provisions of this    Section 11.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan, incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan and this Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan and this Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">after</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the date hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section&#160;8.6 of the Plan.  Any such amendment must be in writing and signed by the Corporation.  Any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan and the Prospectus for the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Limitation on Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participation in the Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">confers no</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Corporation as to amounts payable and shall not be construed as creating a trust.  Neither the Plan nor any underlying program, in and of itself, has any assets.  The Participant shall have only the rights of a general unsecured creditor of the Corporation with respect to amounts credited and benefits payable, if any, with respect to the Stock Units, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to the Stock Units, as and when payable hereunder.  The Award has been granted to the Participant in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:127%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Stock Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Stock Units or any shares of Common Stock or other cash or property received with respect to the Stock Units (including any value received from a disposition of the shares acquired upon payment of the Stock Units).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE PARTICIPANT&#8217;S ACCEPTANCE OF THE AWARD THROUGH THE ELECTRONIC STOCK PLAN AWARD RECORDKEEPING SYSTEM MAINTAINED BY THE CORPORATION OR ITS DESIGNEE CONSTITUTES THE PARTICIPANT&#8217;S AGREEMENT TO THE TERMS AND CONDITIONS HEREOF, AND THAT THE AWARD IS GRANTED UNDER AND GOVERNED BY THE TERMS AND CONDITIONS OF THE PLAN AND THIS AGREEMENT.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:127%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>9
<FILENAME>ex101403312023.htm
<DESCRIPTION>EX-10.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i08abf0b099fa44a8b11f7a3f5f7ec070_42"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2023 PERFORMANCE INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AWARD AGREEMENT </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AWARD AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is effective as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, pursuant to the Healthpeak Properties, Inc. 2023 Performance Incentive Plan, as may amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Company hereby grants to the Director, effective as of the date hereof, an award of restricted stock units under the Plan (the &#8220;Award&#8221;), upon the terms and conditions set forth herein and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in consideration of services rendered and to be rendered by the Director, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Subject to the terms of this Agreement, the Company hereby grants to the Director an Award of &#91;&#9679;&#93; stock units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  As used herein, the term &#8220;stock unit&#8221; means a non-voting unit of measurement which is deemed for bookkeeping purposes to be equivalent to one outstanding share of the Company&#8217;s Common Stock solely for purposes of the Plan and this Agreement.  The Stock Units shall be used solely as a device for the determination of the payment to eventually be made to the Director if such Stock Units vest pursuant to Section 3.  The Stock Units shall not be treated as property or as a trust fund of any kind.  The Award is subject to all of the terms and conditions set forth in this Agreement and is further subject to all of the terms and conditions of the Plan, as it may be amended from time to time, and any rules adopted by the Administrator, as such rules are in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Subject to Section 8, the Award shall vest and become nonforfeitable with respect to 100% of the total number of the Stock Units on the earlier to occur of (i) the first anniversary of the Award Date or (ii) the date of the Company&#8217;s next annual meeting of stockholders following the Award Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Continuance of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The vesting schedule requires continued service through the vesting date as a condition to the vesting of the Award and the rights and benefits under this Agreement.  Service for only a portion of the vesting period, even if a substantial portion, will not entitle the Director to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of services as provided in Section 8 or under the Plan. Nothing contained in this Agreement or the Plan constitutes a continued service commitment by the Company or interferes with the right of the Company to increase or decrease the compensation of the Director from the rate in existence at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Dividend and Voting Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.57pt">&#160;&#160;&#160;&#160;Limitations on Rights Associated with Units.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Director shall have no rights as a stockholder of the Company, no dividend rights (except as expressly provided in Section 5(b) with respect to Dividend Equivalent Rights) and no voting rights, with respect to the Stock Units and any shares of Common Stock underlying or issuable in respect of such Stock Units until such shares of Common Stock are actually issued to and held of record by the Director.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:174%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dividend Equivalent Rights.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As of any date that the Company pays an ordinary cash dividend on its Common Stock, the Company shall pay the Director an amount equal to the per share cash dividend paid by the Company on its Common Stock on such date multiplied by the number of Stock Units remaining subject to this Award as of the related dividend payment record date.  No such payment shall be made with respect to any Stock Units which, as of such record date, have either been paid pursuant to Section 7 or terminated pursuant to Section 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Neither the Award, nor any interest therein or amount or shares payable in respect thereof may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily.  The transfer restrictions in the preceding sentence shall not apply to (a) transfers to the Company, or (b) transfers by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Timing and Manner of Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  As soon as administratively practical following the vesting of the Award pursuant to the terms hereof (and in all events within sixty (60) days after such vesting event), the Company shall deliver to the Director a number of shares of Common Stock (either by delivering one or more certificates for such shares or by entering such shares in book entry form, as determined by the Company in its discretion) equal to the number of Stock Units subject to this Award that vest on the vesting date.  The Company&#8217;s obligation to deliver shares of Common Stock or otherwise make payment with respect to vested Stock Units is subject to the condition precedent that the Director or other person entitled under the Plan to receive any shares with respect to the vested Stock Units deliver to the Company any representations or other documents or assurances that the Administrator may deem necessary or desirable to assure compliance with all applicable legal and accounting requirements.  The Director shall have no further rights with respect to any Stock Units that are paid or that terminate pursuant to Section 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:26.84pt;text-decoration:underline">Effect of Termination of Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Director&#8217;s Stock Units shall terminate to the extent such units have not become vested pursuant to Section 3 prior to the first date that the Director is no longer a member of the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), regardless of the reason for the termination of the Director&#8217;s services&#59; provided, however, that if the Director&#8217;s services are terminated as a result of the Director&#8217;s death or Total Disability (as defined below), the Director&#8217;s Stock Units, to the extent such units are not then vested, shall become fully vested as of the Severance Date and shall be paid in accordance with Section 7.  If any unvested Stock Units are terminated hereunder, such Stock Units shall automatically terminate and be cancelled as of the applicable Severance Date without payment of any consideration by the Company and without any other action by the Director, or the Director&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the Award, &#8220;Total Disability&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).  </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Adjustments Upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(a)&#160;&#160;&#160;&#160;Adjustments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon the occurrence of certain events relating to the Company&#8217;s stock contemplated by Section 7.1 of the Plan (including, without limitation, an extraordinary cash dividend on such stock), the Administrator shall make adjustments in accordance with such section in the number of Stock Units then outstanding and the number and kind of securities that may be issued in respect of the Award.  No such adjustment shall be made with respect to any ordinary cash dividend for which dividend equivalents are paid pursuant to Section 5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(b)&#160;&#160;&#160;&#160;Change in Control Event.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon the occurrence of an event contemplated by Section 7.2 or 7.3 of the Plan and notwithstanding any provision of Section 7.2 and 7.3 of the Plan to the contrary, the Award (to the extent outstanding at the time of such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:174%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">event) shall continue in effect in accordance with its terms following such event (subject to adjustment in connection with such event pursuant to Section 7.1 of the Plan)&#59; provided, however, that the Administrator shall determine, in its sole discretion, whether the vesting of the Stock Units will accelerate in connection with such event and the extent of any such accelerated vesting&#59; provided, further, that any Stock Units that are so accelerated will be paid on or as soon as administratively practical after (and in all events within sixty (60) days after) the first to occur of the original vesting date of such accelerated Stock Units set forth in Section 3 or the Participant&#8217;s separation from service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Upon vesting of any Stock Units or any distribution of shares of Common Stock in respect of the Stock Units, the Director or other person entitled to receive such distribution may irrevocably elect, in such manner and at such time or times prior to any applicable tax date as may be permitted or required under Section 8.5 of the Plan and rules established by the Administrator, to have the Company reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of whole shares, valued at their then fair market value to satisfy any withholding obligations of the Company or its Subsidiaries with respect to such distribution of shares at the minimum applicable withholding rates&#59; provided, however, that in the event that the Company cannot legally satisfy such withholding obligations by such reduction of shares, or in the event of a cash payment or any other withholding event in respect of the Stock Units, the Company (or a Subsidiary) shall be entitled to require a cash payment by or on behalf of the Director and&#47;or to deduct from other compensation payable to the Director any sums required by federal, state or local tax law to be withheld with respect to such distribution or payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Company at its principal office to the attention of the Secretary, and to the Director at the Director&#8217;s last address reflected on the Company&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Director is no longer an Eligible Person, shall be deemed to have been duly given five (5) business days after the date mailed in accordance with the foregoing provisions of this Section 11.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Award and all rights of the Director under this Agreement are subject to the terms and conditions of the provisions of the Plan, incorporated herein by reference.  The Director agrees to be bound by the terms of the Plan and this Agreement.  The Director acknowledges having read and understanding the Plan, the Prospectus for the Plan and this Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Director unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">after</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the date hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section&#160;8.6 of the Plan.  Any such amendment must be in writing and signed by the Company.  Any such amendment that materially and adversely affects the Director&#8217;s rights under this Agreement requires the consent of the Director in order to be effective with respect to the Award.  The Company may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Director hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Director acknowledges receipt of a copy of this Agreement, the Plan and the Prospectus for the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:174%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Limitation on Director&#8217;s Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participation in the Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">confers no</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust.  Neither the Plan nor any underlying program, in and of itself, has any assets.  The Director shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Stock Units, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to the Stock Units, as and when payable hereunder.  The Award has been granted to the Director in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to<br>the Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE DIRECTOR&#8217;S ACCEPTANCE OF THE AWARD THROUGH THE ELECTRONIC STOCK PLAN AWARD RECORDKEEPING SYSTEM MAINTAINED BY THE COMPANY OR ITS DESIGNEE CONSTITUTES THE DIRECTOR&#8217;S AGREEMENT TO THE TERMS AND CONDITIONS HEREOF, AND THAT THE AWARD IS GRANTED UNDER AND GOVERNED BY THE TERMS AND CONDITIONS OF THE PLAN AND THIS AGREEMENT.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:174%">4</font></div><div><font><br></font></div></div></div><div id="i08abf0b099fa44a8b11f7a3f5f7ec070_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have executed this Agreement effective on the day and year first above written.</font></div><div><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jeffrey H. Miller</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Counsel</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DIRECTOR&#58;</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></div><div style="padding-left:252pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">&#91;Signature Page to Non-Employee Director Restricted Stock Unit Award Agreement&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>10
<FILENAME>ex101503312023.htm
<DESCRIPTION>EX-10.15
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5bf916dbc52747a6b62a27754d1b1f1b_42"></div><div style="min-height:95.04pt;width:100%"><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:214px"></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">EXECUTIVE SEVERANCE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(As Amended and Restated April 27, 2023)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Establishment and Purpose</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">Healthpeak Properties, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) hereby adopts this further amended and restated Healthpeak Properties, Inc. Executive Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), originally effective as of May 6, 2016, as amended and restated by this amendment and restatement effective as of April 27, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  The Company hereby agrees that on and after the Effective Date, subject to the terms and conditions of the Plan, Participants (as defined in Section 3) shall be eligible to receive the severance benefits set forth in Section 5 of the Plan in the event that the Participants&#8217; employment with the Company is terminated under the circumstances described in Section 4 of the Plan.  This amendment and restatement of the Plan does not apply as to any Participant whose employment with the Company terminated prior to the date of this amendment and restatement of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">Notwithstanding anything in the Plan to the contrary, no Participant shall be eligible to receive any benefits under the Plan upon a termination of employment if the Participant would also be eligible to receive benefits under the terms and conditions of the Healthpeak Properties, Inc. Change in Control Severance Plan as a result of such termination.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Term of Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Plan shall become effective on the Effective Date and shall continue in effect until such time as it is terminated by the Company (the period during which the Plan is in effect, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, however, that any such termination of the Term will not become effective with respect to a Participant until the 30</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> day following the date on which notice thereof is given to the Participant.  For purposes of clarity, the Company may give notice of termination of the Term to all or only certain Participants. If such notice is given to only certain Participants, the Term shall continue as set forth above as to all other Participants (subject to the Company&#8217;s rights to similarly terminate the Term in accordance with the foregoing on some future date(s) as to any such Participants).  A Participant shall cease to be eligible for benefits under the Plan (and shall cease to be a Participant) at midnight Mountain Time on the last day of the Term applicable to that Participant.  The termination or expiration of the Term as to a Participant shall not affect the Participant&#8217;s right to benefits (if any) pursuant to Section 5 as to any termination of employment that occurred during such Term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.73pt">Participation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Chief Executive Officer of the Company and each employee of the Company with the title of Executive Vice President and higher, in each case, who is designated from time to time by the Compensation and Human Capital Committee of the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) shall participate in the Plan and are collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Participants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;&#59; provided, that any individual who would otherwise qualify as a Participant but who is then subject to the terms of an individual employment agreement or similar arrangement shall first participate in the Plan as of the date of expiration of such agreement or arrangement unless the Company and the Participant otherwise specifically agree to the contrary.  Notwithstanding anything else contained herein to the contrary, the Committee shall limit the class of persons selected to participate in the Plan to a select </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">group of management or highly compensated employees, as set forth in Sections 201, 301 and 401 of the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  Unless otherwise determined by the Committee, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Severance Multiplier</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; for each Participant shall be as set forth in the following table based on the Participant&#8217;s title with the Company&#58;</font></div><div style="padding-left:62.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.044%"><tr><td style="width:1.0%"></td><td style="width:55.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance Multiplier</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:69.25pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">3.0x</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Chief Investment Officer, Chief Operating Officer and Chief Development Officer</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:69.25pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">2.0x</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice Presidents in the following positions&#58; General Counsel, Chief Accounting Officer, Chief Human Resources Officer, Treasurer &#8211; Corporate Finance</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:69.25pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.5x</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice Presidents not otherwise identified above</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:69.25pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">1.5x</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Termination of Employment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Notwithstanding anything else contained in the Plan to the contrary, a Participant shall not be deemed to have terminated employment with the Company if his or her employment by the Company terminates but he or she otherwise continues, immediately after such termination of employment, as an employee of a subsidiary of the Company (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) or is offered comparable employment by any successor corporation or acquirer of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:24.56pt">Benefit Offset.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Notwithstanding the foregoing provisions, any severance benefits otherwise payable under the Plan to a Participant shall be offset or reduced by the amount of any other severance pay, termination indemnity, notice pay, or similar payment that the Company or any of its Subsidiaries is required by law to make to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Qualifying Termination of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.73pt">General.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  If a Participant&#8217;s employment if terminated due to a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Severance-Eligible Termination,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; which is defined as a termination of Participant&#8217;s employment with the Company during the Term (i) by the Company without Cause (as defined in Section 4(c)), or (ii) by the Participant for Good Reason, and in either case of (i) or (ii), such termination of the Participant&#8217;s employment is not (x) because of the Participant&#8217;s death or Disability (as defined in Section 4(b)), (y) by the Company for Cause or (z) voluntarily by the Participant, then the Participant shall be entitled to the benefits provided in Section 5(b).  In the event that the Participant is entitled to such benefits, such benefits shall be paid notwithstanding the subsequent expiration of the Term.  For the avoidance of doubt, a termination of employment by a Participant for Good Reason shall not be deemed a voluntary termination of employment by the Participant for purposes of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Disability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  As to any particular Participant, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; means the Participant&#8217;s inability, because of physical or mental illness or injury, to perform the essential functions of his or her </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">customary duties to the Company, even with a reasonable accommodation, and the continuation of such disabled condition for a period of 180 continuous days, or for not less than 210 days during any continuous 24-month period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:24.56pt">Cause.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Termination by the Company of a Participant&#8217;s employment for &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean termination (i) upon the Participant&#8217;s willful and continued failure to perform his or her duties with the Company (other than any such failure resulting from his or her incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not performed his or her duties, (ii) upon the Participant&#8217;s willful and continued failure to follow and comply with the specific and lawful directives of the Committee, as reasonably determined by the Committee (other than any such failure resulting from the Participant&#8217;s incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not performed his or her duties, (iii) upon the Participant&#8217;s willful and continued failure to follow and comply with the policies of the Company as in effect from time to time (other than any such failure resulting from the Participant&#8217;s incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not followed or complied with such Company policies&#59; (iv) upon the Participant&#8217;s willful commission of an act of material fraud or dishonesty&#59; (v) upon the Participant&#8217;s willful engagement in illegal conduct or gross misconduct&#59; or (vi) upon the Participant&#8217;s indictment for, conviction of, or a plea of guilty or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">nolo contendere</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> to any felony.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Good Reason.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  A Participant shall be entitled to terminate his or her employment for Good Reason for purposes of the Plan. For purposes of the Plan, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean, without the Participant&#8217;s consent, the occurrence during the Term of any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">(x) the assignment to the Participant of any material duties that are significantly and adversely inconsistent with, or (y) a significant adverse alteration in the nature or status of, in each case of (x) or (y), the Participant&#8217;s primary duties or responsibilities, reporting line, or the conditions of the Participant&#8217;s employment from those in effect immediately prior to such change&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the reduction of the Participant&#8217;s annual base salary as in effect on the Effective Date or as such base salary may be subsequently increased from time to time, excluding, however, a reduction in a Participant&#8217;s annual base salary imposed in connection with, or following, an across-the-board reduction of base salaries of all executive officers of the Company&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.47pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the relocation of offices at which the Participant is principally employed to a location more than 30 miles from such location&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.54pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the Company&#8217;s failure to pay to the Participant any portion of his or her current compensation or to pay to the Participant any portion of an installment of deferred compensation under any deferred compensation program of the Company reasonably promptly after the date such compensation is due&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.83pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the Company&#8217;s failure to obtain a satisfactory agreement from any successor to assume and agree to perform the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notwithstanding the foregoing, no such condition shall constitute &#8220;Good Reason&#8221; unless the Participant provides written notice to the Company that the event giving rise to such claim of Good Reason has occurred within sixty (60) calendar days after the occurrence of such event, and such Good Reason remains uncured thirty (30) calendar days after the Participant has provided such written notice&#59; provided further that any resignation of the Participant&#8217;s employment for Good Reason occurs no later than sixty (60) days following the expiration of such cure period A Participant&#8217;s right to terminate his or her employment pursuant to this Section 4(d) shall not be affected by his or her incapacity due to physical or mental illness. A Participant&#8217;s continued employment through the sixty (60) day period following the expiration of such cure period shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason hereunder, but upon the expiration of such sixty (60) day period, Participant shall have waived his or her rights with respect to any circumstance constituting Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.63pt">Termination Generally.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  For purposes of clarity, a Participant or the Company shall be entitled to terminate the Participant&#8217;s employment for any reason or no reason at any time effective as of the applicable date set forth in Section 4(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:25.68pt">Notice of Termination. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Any purported termination of a Participant&#8217;s employment by the Company or by the Participant (other than termination due to death which shall terminate the Participant&#8217;s employment automatically) shall be communicated by written Notice of Termination to the Participant or the Company, respectively, other party hereto in accordance with Section 12. &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Notice of Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean a notice that shall indicate the specific termination provision in the Plan relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant&#8217;s employment under the provision so indicated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.95pt">Date of Termination, Etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Date of Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean (i) if a Participant&#8217;s employment is terminated due to the Participant&#8217;s death, the date of the Participant&#8217;s death&#59; (ii) if a Participant&#8217;s employment is terminated for Disability, 30 days after Notice of Termination is given (provided that the Participant shall not have returned to the full-time performance of his or her duties during such 30-day period)&#59; and (iii) if a Participant&#8217;s employment is terminated for any other reason, the date specified in the Notice of Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Compensation Upon Qualifying Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  If a Participant&#8217;s employment is terminated during the Term, the Participant shall be entitled to the benefits described below, subject to the other terms and conditions of the Plan&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">If the Participant&#8217;s employment is terminated in such circumstances as do not constitute a Severance-Eligible Termination, the Company shall pay the Participant (i) the Participant&#8217;s accrued and unpaid base salary and vacation (if any) through the Date of Termination, and (ii) all other amounts to which the Participant is entitled under any compensation plan of the Company at the time such payments are due, and the Company shall have no further obligations to the Participant under this Plan.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">If the Participant&#8217;s employment by the Company is terminated in circumstances that constitute a Severance-Eligible Termination, then, subject to the provisions of Section 6, the Participant shall be entitled to the benefits provided below.  For purposes of this Section 5(b), a Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Annual Bonus Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean the greater of (1) the target annual bonus amount in effect for such Participant as of the Participant&#8217;s Date of Termination and (2) the average of the last three annual bonuses actually paid to the Participant for the last three full fiscal years of employment with the Company prior to the Date of Termination (or the average of such lower number of bonuses that were actually paid for full fiscal years of employment with the Company prior to the Date of Termination), which shall, in each case, be determined without regard to the payment of any special bonuses (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, transaction bonuses)&#59; provided, if the Participant, on the Date of Termination, has never been paid an annual bonus with respect to one full fiscal year, then the Participant&#8217;s Annual Bonus Amount shall equal (x) the amount of the Participant&#8217;s guaranteed bonus in respect of the year of termination, if applicable, or if none, the Participant&#8217;s target annual bonus, or (y) if the Participant is not eligible to receive a guaranteed or target bonus in respect of the year of termination, the amount of the Participant&#8217;s Annual Base Salary.  For purposes of this Section 5(b), a Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Annual Base Salary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221; shall mean the Participant&#8217;s annual base salary as in effect as of the Date of Termination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">The Company shall pay to the Participant (A) the Participant&#8217;s accrued and unpaid base salary and vacation (if any) through the Date of Termination, (B) the unpaid portion, if any, of any annual bonus, plus an amount equal to the Participant&#8217;s actual annual bonus for the full year in which the Date of Termination occurs, based on actual results for the entire year of termination, multiplied by a fraction (not greater than one), the numerator of which is the number of calendar days that the Participant was employed by the Company during the year of termination and the denominator of which is 365 with the individual (qualitative) portion of such Participant&#8217;s bonus to be determined at the Committee&#8217;s discretion, and (C) all other amounts to which the Participant is entitled under any compensation plan of the Company at the time such payments are due&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">An amount equal to the sum of&#58; (A) the Participant&#8217;s Severance Multiplier times the Participant&#8217;s Annual Base Salary&#59; plus (B) the Participant&#8217;s Severance Multiplier times the Participant&#8217;s Annual Bonus Amount&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.47pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">An amount equal to the expected monthly cost of the premiums that would be charged to the Participant to continue medical coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">COBRA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), at the same or reasonably equivalent medical coverage for the Participant (and, if applicable, the Participant&#8217;s eligible dependents) as in effect immediately prior to the Participant&#8217;s Date of Termination, for a period of months after the Participant&#8217;s Date of Termination equal to 12 multiplied by the Participant&#8217;s Severance Multiplier&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.54pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">(A) Any stock options or equity or equity-related compensation or grants that vest based on the passage of time and continued performance of services (to the extent outstanding and not otherwise vested as of the Date of Termination, and exclusive of any grants that include performance-based vesting criteria) shall become fully vested immediately prior to such termination&#59; provided, that restricted stock unit awards granted on or after the Effective Date shall continue to vest and be settled in accordance with the schedule set forth in the applicable award agreement without regard to any continued performance of services requirements, and to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">extent not vested in accordance with such schedule as of the second anniversary of the Date of Termination, shall vest and be settled on such second anniversary&#59; (B) any stock options or equity or equity-related compensation or grants that vest based on the satisfaction of performance-based criteria (to the extent outstanding and not otherwise vested as of the Date of Termination) shall continue to be governed by the provisions of the applicable award agreement in the circumstances&#59; provided, however, that to the extent that any such then-outstanding equity-based awards are subject to forfeiture and&#47;or vesting requirements based on the passage of time, such awards shall be fully accelerated with respect to such time-based forfeiture and&#47;or vesting provisions&#59; and (C) the Participant shall have until the date that is 24 months after his or her Date of Termination to exercise any stock option to the extent that it has become vested on the Date of Termination, subject to earlier termination of the stock option upon the stock option&#8217;s original expiration date or the occurrence of a change in control event or certain similar reorganization event under the terms of the applicable award agreement.  Except as provided in this Section 5(b)(iv), the effect of a termination of employment on a Participant&#8217;s equity-based awards shall be determined under the terms of the applicable award agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:24.56pt">The payments described in Sections 5(a)(i) and 5(b)(i)(A) shall be paid to the Participant in cash as soon as practicable following the Date of Termination.  The payments described in Section 5(b)(i)(B) shall be paid to the Participant in cash on the date such payments would have been made had the Participant continued in employment.  The payments described in Sections 5(b)(ii) and 5(b)(iii) shall be paid to the Participant in cash in substantially equal installments ending on the date that is a number of months after the Date of Termination equal to 12 multiplied by the Participant&#8217;s Severance Multiplier, in accordance with the Company&#8217;s normal payroll schedule&#59; provided that the first such payment shall be made on the first regularly scheduled payroll date that occurs after the Participant&#8217;s release contemplated by Section 6(a) becomes irrevocable by the Participant in accordance with applicable law (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">First Payment Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) and shall include all such payments that would have been made to the Participant between the Date of Termination and such payroll date&#59; and provided further, that if the period during which the Participant is permitted to consider the release in accordance with Section 6(a) begins in one calendar year and ends in a second calendar year, the first such payment shall in all events be made in the second calendar year.  Except as otherwise set forth in Section 5(b)(iv), the applicable payments described in Section 5(b)(iv) shall be paid to the Participant in shares on the First Payment Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">The foregoing provisions of this Section 5 shall not affect&#58; (i) a Participant&#8217;s receipt of benefits otherwise due terminated employees under group insurance coverage consistent with the terms of the applicable Company welfare benefit plan&#59; (ii) a Participant&#8217;s rights under COBRA to continue participation in medical, dental, hospitalization and life insurance coverage&#59; or (iii) a Participant&#8217;s receipt of benefits otherwise due in accordance with the terms of the Company&#8217;s 401(k) plan (if any).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Release&#59; Exclusive Remedy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">This Section 6 shall apply notwithstanding anything else contained in the Plan or any other stock option, restricted stock or other equity-based award agreement to the contrary.  The Company&#8217;s obligation to make any payment of benefits with respect to a Participant pursuant to Section 5(b) of the Plan (if the Participant is otherwise entitled to such benefits), other than those set forth in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Section 5(b)(i)(A), is subject to the condition precedent that (i) the Participant has fully executed a valid and effective release (in the form attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> or such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable or otherwise compliant with applicable laws), (ii) such executed release is delivered by the Participant to the Company so that it is received by the Company in the time period specified below, and (iii) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law).  In order to satisfy the requirements of this Section 6(a), a Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Company so that it is received by the Company no later than 25 calendar days after the Participant&#8217;s Date of Termination (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either 5, 21 or 45 days, depending on the circumstances of the termination, to consider the release).  In addition, the Company may require that the Participant&#8217;s release be executed no earlier than the date that the Participant&#8217;s employment with the Company terminates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">Each Participant agrees that the general release agreement described in Section 6(a) will require that the Participant acknowledge, as a condition to the payment of any benefits under Section 5(b) (other than those set forth in Section 5(b)(i)(A)), that the payments contemplated by Section 5(b) shall constitute the exclusive and sole remedy for any termination of the Participant&#8217;s employment, and each Participant will be required to covenant, as a condition to receiving any such payment, not to assert or pursue any other remedies, at law or in equity, with respect to any termination of employment.  No Participant shall be required to mitigate the amount of any payment provided for in Section 5 by seeking other employment or otherwise nor shall the amount of any payment or benefit provided for in Section 5 be reduced by any compensation earned by the Participant as the result of employment by another employer or self-employment, by retirement benefits, by offset against any amount claimed to be owed by the Participant to the Company, or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Section 280G</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Each Participant shall be covered by the provisions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> hereto, incorporated herein by this reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Successors&#59; Assigns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to expressly assume and agree to perform the obligations under the Plan in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  Failure of the Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be deemed a material breach of the Plan by the Company and shall entitle each Participant to terminate his or her employment and receive compensation from the Company in the same amount and on the same terms to which the Participant would be entitled hereunder if the Company had terminated the Participant&#8217;s employment other than for Cause, except that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the Date of Termination.  Unless expressly provided otherwise, &#8220;Company&#8221; as used herein shall mean the Company as defined in the Plan and any successor to its business and&#47;or assets as aforesaid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">None of the benefits, payments, proceeds or claims of any Participant shall be subject to any claim of any creditor and, in particular, the same shall not be subject to attachment or garnishment or other legal process by any creditor, nor shall any such Participant have any right to alienate, anticipate, commute, pledge, encumber or assign any of the benefits or payments or proceeds which he or she may expect to receive, contingently or otherwise, under the Plan.  Notwithstanding the foregoing, benefits which are in pay status may be subject to a court-ordered garnishment or wage assignment, or similar order, or a tax levy.  The Plan shall inure to the benefit of and be enforceable by each Participant&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees.  If a Participant dies while any amount would still be payable to him or her hereunder had he or she continued to live, all such amounts, unless otherwise provided herein, shall be paid to the Participant&#8217;s estate in accordance with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Claims Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.73pt">Presentation of Claim. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Any Participant (such Participant being referred to below as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Claimant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) may deliver to the Committee a written claim for a determination with respect to the benefits payable to such Claimant pursuant to the Plan.  If such a claim relates to the contents of a notice received by the Claimant, the claim must be made within 60 days after such notice was received by the Claimant.  All other claims must be made within 180 days of the date on which the event that caused the claim to arise occurred.  The claim must state with particularity the determination desired by the Claimant. For purposes of this Section 9, references to the &#8220;Committee&#8221; shall include references to any designee of the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Notification of Decision.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Committee shall consider a Claimant&#8217;s claim within a reasonable time, but no later than 90 days after receiving the claim.  If the Committee determines that special circumstances require an extension of time for processing the claim, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 90-day period.  In no event shall such extension exceed a period of 90 days from the end of the initial 90-day period.  The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Committee expects to render the benefit determination.  The Committee shall notify the Claimant in writing&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">that the Claimant&#8217;s requested determination has been made, and that the claim has been allowed in full&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">that the Committee has reached a conclusion contrary, in whole or in part, to the Claimant&#8217;s requested determination, and such notice must set forth in a manner calculated to be understood by the Claimant&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">the specific reason(s) for the denial of the claim, or any part of it&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">specific reference(s) to pertinent provisions of the Plan upon which such denial was based&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">a description of any additional material or information necessary for the Claimant to perfect the claim, and an explanation of why such material or information is necessary&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">an explanation of the claim review procedure and the time limits applicable to such procedures set forth in Section 9(c)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">a statement of the Claimant&#8217;s right to bring a civil action under ERISA Section 502(a) following an adverse determination on review.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:24.56pt">Review of a Denied Claim.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  On or before 60 days after receiving a notice from the Committee that a claim has been denied, in whole or in part, a Claimant (or the Claimant&#8217;s duly authorized representative) may file with the Committee a written request for a review of the denial of the claim.  The Claimant (or the Claimant&#8217;s duly authorized representative)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may, upon request and free of charge, have reasonable access to, and copies of, all documents, records and other information relevant to the claim for benefits&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may submit written comments or other documents&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.47pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may request a hearing, which the Committee, in its sole discretion, may grant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Decision on Review.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Committee shall render its decision on review promptly, and no later than 60 days after the Committee receives the Claimant&#8217;s written request for a review of the denial of the claim.  If the Committee determines that special circumstances require an extension of time for processing the claim, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 60-day period.  In no event shall such extension exceed a period of 60 days from the end of the initial 60-day period.  The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Committee expects to render the benefit determination.  In rendering its decision, the Committee shall take into account all comments, documents, records and other information submitted by the Claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination.  The decision must be written in a manner calculated to be understood by the Claimant, and it must contain&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">specific reasons for the decision&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">specific reference(s) to the pertinent Plan provisions upon which the decision was based&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.47pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to and copies of, all documents, records and other information relevant (as defined in applicable ERISA regulations) to the Claimant&#8217;s claim for benefits&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.54pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">a description of the Claimant's right to bring a civil action under Section 502(a) of ERISA following an adverse benefit determination on review.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Arbitration&#59; Dispute Resolution, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">Notwithstanding anything to the contrary contained in the Plan, the Participant, in his or her sole discretion, may elect to have any claim or controversy arising out of or in connection with the Plan submitted to binding arbitration and adjudicated in accordance with this Section 10 without first having to exhaust the claims procedures set forth in Section 9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">The Company and, by accepting participation in the Plan, each Participant hereby consent to the resolution by mandatory and binding arbitration of all claims or controversies arising out of or in connection with the Plan that the Company may have against the Participant, or that the Participant may have against the Company or against any of its officers, directors, employees or agents acting in their capacity as such, and which are not resolved under the terms of Section 9 (or which are not required to be resolved under the terms of Section 9, as the case may be).  Each party&#8217;s promise to resolve all such claims or controversies by arbitration in accordance with the Plan rather than through the courts is consideration for the other party&#8217;s like promise.  It is further agreed that the decision of an arbitrator on any issue, dispute, claim or controversy submitted for arbitration, shall be final and binding upon the Company and the Participant and that judgment may be entered on the award of the arbitrator in any court having proper jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:24.56pt">Except as otherwise provided in this procedure or by mutual agreement of the parties, any arbitration shall be before a sole arbitrator (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Arbitrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) selected from Judicial Arbitration &#38; Mediation Services, Inc., Denver, Colorado, or its successor (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">JAMS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), or if JAMS is no longer able to supply the Arbitrator, such Arbitrator shall be selected from the American Arbitration Association, and shall be conducted in accordance with the provisions of applicable law as the exclusive remedy of such dispute.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">The Arbitrator shall interpret the Plan, any applicable Company policy or rules and regulations, any applicable substantive law (and the law of remedies, if applicable) of the state in which the claim arose, or applicable federal law.  In reaching his or her decision, the Arbitrator shall have no authority to change or modify any lawful Company policy, rule or regulation, or the Plan.  Except as provided in Section 10(e), the Arbitrator, and not any federal, state or local court or agency, shall have exclusive and broad authority to resolve any dispute relating to the interpretation, applicability, enforceability or formation of the Plan, including but not limited to, any claim that all or any part of the Plan is voidable.  The Arbitrator shall have the authority to decide dispositive motions.  Following completion of the arbitration, the arbitrator shall issue a written decision disclosing the essential findings and conclusions upon which the award is based.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.63pt">Notwithstanding the foregoing, provisional injunctive relief may, but need not, be sought by the Participant or the Company in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally resolved by the Arbitrator in accordance with the foregoing.  Final resolution of any dispute through arbitration may include any remedy or relief which would otherwise be available at law and which the Arbitrator deems just and equitable.  The Arbitrator shall have the authority to award full damages as provided by law.  Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:25.68pt">The Company shall pay the reasonable fees and expenses of the Arbitrator and of a stenographic reporter, if employed.  Each party shall pay its own legal fees and other expenses and costs incurred with respect to the arbitration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Administration of the Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.73pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Company shall be the plan administrator (within the meaning of Section 3(16)(A) of ERISA).  The Company delegates its duties under the Plan to the Committee.  The Committee delegates the day-to-day ministerial duties with respect to the Plan to the Company&#8217;s management.  The Committee and its delegates shall be named fiduciaries of the Plan to the extent required by ERISA. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Powers and Duties of the Committee. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Committee shall enforce the Plan in accordance with its terms, shall be charged with the general administration of the Plan, and shall have all powers necessary to accomplish its purposes, including, but not by way of limitation, the power and authority to do the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:42.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To determine eligibility for and participation in the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.76pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To construe and interpret the terms and provisions of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.47pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To compute and certify to the amount and kind of benefits payable to Participants and their beneficiaries, and to determine the amount of withholding taxes to be deducted pursuant to Section 14&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.54pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To maintain all records that may be necessary for the administration of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.83pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To provide for the disclosure of all information and the filing or provision of all reports and statements to Participants, beneficiaries or governmental agencies as shall be required by law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.54pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To make and publish such rules for the regulation of the Plan and procedures for the administration of the Plan as are not inconsistent with the terms hereof&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:35.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To appoint a plan manager or any other agent, and to delegate to them such powers and duties in connection with the administration of the Plan as the Committee may from time to time prescribe.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:24.56pt">Committee Action. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Subject to Section 9, the Committee shall act with respect to the Plan at meetings by affirmative vote of a majority of the members of the Committee.  Any action permitted to be taken at a meeting with respect to the Plan may be taken without a meeting if, prior to such action, a written consent to the action is signed by all members of the Committee and such written consent is filed with the minutes of the proceedings of the Committee.  A member of the Committee shall not vote or act upon any matter which relates solely to himself or herself as a Participant.  The Chair or any other member or members of the Committee designated by the Chair may execute any certificate or other written direction on behalf of the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.26pt">Construction and Interpretation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Committee shall have full discretion to construe and interpret the terms and provisions of the Plan, which interpretation or construction shall be final and binding on all parties, including but not limited to the Company and any Participant, beneficiary or other person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  All notices under or with respect to the Plan shall be in writing and shall be either personally delivered or mailed postage prepaid, by certified mail, return receipt requested&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.73pt">if to the Company&#58;</font></div><div style="padding-left:108pt;padding-right:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Healthpeak Properties, Inc.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Attention&#58; Compensation and Human Capital Committee</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4600 South Syracuse Street, Suite 500</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Denver, CO 80237</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Email&#58; lalonso&#64;healthpeak.com</font></div><div style="padding-left:108pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">with a copy to&#58;</font></div><div style="padding-left:108pt;padding-right:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Healthpeak Properties, Inc.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Attention&#58; General Counsel</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4600 South Syracuse Street, Suite 500</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Denver, CO 80237</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Email&#58; jhmiller&#64;healthpeak.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.26pt">if to a Participant, to the Participant&#8217;s address most recently on file in the payroll records of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notice shall be effective when personally delivered, or five business days after being so mailed.  Any party may change its address for purposes of giving future notices pursuant to the Plan by notifying the other party in writing of such change in address, such notice to be delivered or mailed in accordance with the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Plan will be governed by and construed in accordance with ERISA and, to the extent not preempted thereby, the laws of the State of Colorado, without giving effect to any choice of law or conflicting provision or rule (whether of the State of Colorado or any other jurisdiction) that would cause the laws of any jurisdiction other than United States federal law and the law of the State of Colorado to be applied.  In furtherance of the foregoing, applicable federal law and, to the extent not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">preempted by applicable federal law, the internal law of the State of Colorado will control the interpretation and construction of the Plan, even if under such jurisdiction&#8217;s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply.  Any statutory reference in the Plan shall also be deemed to refer to all applicable final rules and final regulations promulgated under or with respect to the referenced statutory provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Committee may from time to time amend the Plan in any way it deems to be advisable&#59; provided that no such amendment shall materially and adversely affect the rights of any Participant (or former Participant) under the Plan without the Company providing thirty (30) days&#8217; notice prior to the effective date of such amendment to the affected Participant (or former Participant, as the case may be).  Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under the Plan shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence.  No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.  No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by the Company which are not expressly set forth in the Plan. All references to sections of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), shall be deemed also to refer to any successor provisions to such sections.  The Company may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due or payable under or pursuant to the Plan such federal, state and local income, employment, or other taxes as may be required to be withheld pursuant to any applicable law or regulation.  Any obligations of the Company under Section 5 shall survive the expiration of the Term. The section headings contained in the Plan are for convenience only, and shall not affect the interpretation of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Unsecured General Creditor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Participants and their heirs, successors, and assigns shall have no legal or equitable rights, claims, or interest in any specific property or assets of the Company or any Subsidiary.  No assets of the Company shall be held under any trust, or held in any way as collateral security, for the fulfilling of the obligations of the Company under the Plan.  Any and all of the Company&#8217;s assets shall be, and remain, the general unpledged, unrestricted assets of the Company (unless pledged or restricted with respect to the Company&#8217;s obligations other than the Plan).  The Company&#8217;s obligation under the Plan shall be merely that of an unfunded and unsecured promise of the Company to pay money and benefits in the future, and the rights of the Participants and their heirs or successors as to benefits under the Plan shall be no greater than those of unsecured general creditors of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Other Benefit Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  All payments, benefits and amounts provided under the Plan shall be in addition to and not in substitution for any pension rights under any tax-qualified pension or retirement plan in which the Participant participates, and any disability, workers&#8217; compensation or other Company benefit plan distribution that a Participant is entitled to (other than severance benefits), under the terms of any such plan, at the time the Participant ceases to be employed by the Company.  Notwithstanding the foregoing, the Plan shall not create an inference that any duplicate payments shall be required.  Payments received by a person under the Plan shall not be deemed a part of the person&#8217;s compensation for purposes of the determination of benefits under any other employee pension, welfare or other benefit plans or arrangements, if any, provided by the Company, except where explicitly provided under the terms of such plans or arrangements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> In the event any provision of the Plan shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of the Plan or affecting the validity or enforceability of such provision in any other jurisdiction.  Furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of the Plan, as applicable, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of the Plan or affecting the validity or enforceability of such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Employment Status</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Except as may be expressly provided under any other written agreement between a Participant and the Company (other than the Plan) signed by a duly authorized officer thereof, the employment of each Participant by the Company is &#8220;at will,&#8221; and may be terminated by either the Participant or the Company at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Payments on Behalf of Persons Under Incapacity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  In the event that any amount becomes payable under the Plan to a person who, in the sole judgment of the Committee, is considered by reason of physical or mental condition to be unable to give a valid receipt therefor the Committee may direct that such payment be made to any person found by the Committee, in its sole judgment, to have assumed the care of such person.  Any payment made pursuant to such determination shall constitute a full release and discharge of the Committee and the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The intent of the parties is that payments and benefits under the Plan comply with Section 409A of the Code, to the extent subject thereto, and accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith or exempt therefrom.  Notwithstanding anything contained herein to the contrary, a Participant shall not be considered to have terminated employment with the Company for purposes of any payments under the Plan which are subject to Section 409A of the Code until the Participant has incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A of the Code.  Each amount to be paid or benefit to be provided under the Plan shall be construed as a separate identified payment for purposes of Section 409A of the Code.  Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six-month period immediately following a Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death).  To the extent required to avoid an accelerated or additional tax under Section 409A of the Code, (a) amounts reimbursable to a Participant shall be paid on or before the last day of the year following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in kind benefits provided to a Participant) during one year may not affect amounts reimbursable or provided in any subsequent year, and (b) if applicable, any tax gross-up payments (and related reimbursements) payable to a Participant under the Plan shall be paid no later than the end of the calendar year following the year in which the tax resulting in the gross-up is paid.  The Company makes no representation that any or all of the payments described in the Plan will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, the Company has caused its duly authorized officer to execute the Plan on the date first set forth above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">a Maryland corporation</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Jeffrey H. Miller</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Its&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">General Counsel</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">For Colorado Employees Only</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice of Restrictive Covenant</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This notice is to advise you that Healthpeak Properties, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is, contemporaneously with this notice, providing you with a Release Agreement containing a covenant that could restrict your options for subsequent employment following separation from Company, in that you will be prohibited, for one year after the Release Agreement&#8217;s Effective Date (defined as 14 days after the Release Agreement is fully executed), from using, disclosing, misappropriating, or otherwise leveraging the Company&#8217;s trade secrets to solicit the Company&#8217;s customers, potential customers, suppliers, or vendors.  This covenant is contained in Sections 6(a) and 6(c) of the Release Agreement.  </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged&#58;  &#160;&#160;&#160;&#160;______________________________</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;______________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">FORM OF RELEASE AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">This Release Agreement (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Release Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) is entered into this ___ day of _________ 20__, by and between _____________________, an individual (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), and Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;). This Release Agreement will become effective 14 calendar days after the date on which this Release Agreement is fully executed (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, Executive has been employed by the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, Executive&#8217;s employment by the Company is terminating and, in connection with the Company&#8217;s Executive Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Company and Executive desire to enter into this Release Agreement upon the terms set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, in consideration of the covenants undertaken and the releases contained in this Release Agreement, and in consideration of the obligations of the Company (or one of its subsidiaries) to pay severance benefits (conditioned upon this Release Agreement) under and pursuant to the Plan, Executive and the Company agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive, on behalf of himself or herself, his or her descendants, dependents, heirs, executors, administrators, assigns, and successors, and each of them, hereby acknowledges full and complete satisfaction of and covenants not to sue and fully releases and discharges the Company, its successors and assigns, and each of its and their past, present and future parents, owners, subsidiaries, affiliates, divisions, trustees, directors, officers, members, principals, managers, partners, agents, attorneys, insurers, reinsurers, sureties, subrogees, employees, stockholders, representatives, creditors, liquidators, lienholders, associates, administrators, beneficiaries, heirs, and any other related persons or entities, hereinafter together and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Releasees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">,&#8221; with respect to and from any and all claims, wages, demands, rights, liens, agreements or contracts (written or oral), covenants, actions, suits, causes of action, obligations, debts, costs, expenses, attorneys&#8217; fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden (each, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Claim</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), which he or she now owns or holds or he or she has at any time heretofore owned or held or may in the future hold as against any of said Releasees (including, without limitation, any Claim arising out of or in any way connected with Executive&#8217;s service as an officer, director, employee, member or manager of any Releasee, Executive&#8217;s separation from his or her position as an officer, director, employee, manager and&#47;or member, as applicable, of any Releasee, or any other transactions, occurrences, acts or omissions or any loss, damage or injury whatever), whether known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part of said Releasees, or any of them, committed or omitted prior to the date Executive signs this Release Agreement including, without limiting the generality of the foregoing, any Claim under Title VII of the Civil Rights Act of 1964&#59; the Civil Rights Act of 1991&#59; the Rehabilitation Act of 1973&#59; the Age Discrimination in Employment Act of 1967&#59; the Americans with Disabilities Act of 1990&#59; the Equal Pay Act&#59; the Fair Labor Standards Act&#59; the Fair Credit Reporting Act&#59; the Employee Retirement Income Security Act of 1974&#59; the Family and Medical Leave Act of 1993&#59; the </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  The Company reserves the right to modify this form as to any Participant employed outside of Colorado, as well as to make updates as may be necessary or advisable to comply with applicable Federal, state and local laws, regulations and guidelines, as determined by the Company in its sole discretion.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Worker Adjustment and Retraining Notification Act&#59; Section 806 of the Sarbanes-Oxley Act&#59; the Dodd-Frank Act&#59; the Colorado Anti-Discrimination Act&#59; the California Fair Employment and Housing Act&#59; the California Family Rights Act&#59; the California Labor Code (including but not limited to sections 4558 and 6310)&#59; the Tennessee Human Rights Act&#59; the Tennessee Disability Act&#59; and the Tennessee Public Protection Act&#59; or any other federal, state or local law, regulation, or ordinance, or any Claim for severance pay, bonus, sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any other fringe benefit, workers&#8217; compensation or disability, including any claim under California Labor Code 2802&#59; provided however, that the foregoing release shall not apply to any obligation of the Company to Executive pursuant to any of the forgoing&#58;  (a) any obligation created by or arising out of the Plan for which receipt or satisfaction has not been acknowledged, (b) any equity-based awards previously granted by the Company to Executive, to the extent that such awards continue after the termination of Executive&#8217;s employment with the Company in accordance with the applicable terms of such awards&#59; (c) any right to indemnification that Executive may have pursuant to the Amended and Restated Bylaws of the Company, its corporate charter or under any written indemnification agreement with the Company, as each may be amended from time to time (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys&#8217; fees to the extent otherwise provided) that Executive may in the future incur with respect to his service as an employee, officer or director of the Company or any of its subsidiaries or affiliates&#59; (d) with respect to any rights that Executive may have to insurance coverage for such losses, damages or expenses under any Company (or subsidiary or affiliate) directors and officers liability insurance policy&#59; (e) any rights to continued medical, dental or vision coverage that Executive may have under COBRA&#59; (f) any rights to payment of benefits that Executive may have under a retirement plan sponsored or maintained by the Company that is intended to qualify under Section 401(a) of the Internal Revenue Code of 1986, as amended, or (g) any deferred compensation or supplemental retirement benefits that Executive may be entitled to under a nonqualified deferred compensation or supplemental retirement plan of the Company.  In addition, this release does not cover any Claim that cannot be so released as a matter of applicable law.  Executive acknowledges and agrees that he or she has received any and all leave and other benefits to which he or she has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.  Executive warrants that Executive is not a Medicare beneficiary as of the date of Executive&#8217;s execution of this Release Agreement and therefore no conditional payments have been made by Medicare. Executive will indemnify, defend and hold the Releasees harmless from any and all claims, liens, Medicare conditional payments and rights to payment, known or unknown. This settlement is based upon a good faith determination of the parties to resolve a disputed claim. The parties have not shifted responsibility of medical treatment to Medicare in contravention of 42 U.S.C. Sec. 1395y(b). The parties resolved this matter in compliance with both state and federal law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">To extent permitted by law, Executive, represents and agrees that he, she or it has not and will not file or initiate any legal proceedings, complaints or charges of any kind to the extent released herein with any court or governmental or administrative agency against any one or more of the Releasees, relating to Executive&#8217;s employment or positions with the Company, and that Executive  will not participate in nor accept any monies from any such action in his or her individual capacity or as part of a representative or class action.  The Company and the other Releasees shall be entitled to plead this Release Agreement as a complete defense to any claim or entitlement relating to Executive&#8217;s employment or positions with the Company which hereafter may be asserted by Executive or other parties acting on his behalf in any suit or claim against the Company or any other Releasee.  Executive understands that nothing in this Release Agreement precludes him from filing a charge with or participating in an investigation by the Equal Employment Opportunity Commission or any Federal, state, or administrative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">agency&#59; provided, however, that Executive hereby waives any right to receive any monetary award resulting from such a charge or investigation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Acknowledgment of Payment of Wages</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Except for accrued vacation (which the parties agree totals approximately &#91;&#9679;&#93; days of pay) and salary for the current pay period, Executive acknowledges that he&#47;she has received all amounts owed for his or her regular and usual salary (including, but not limited to, any bonus, severance, or other wages), and usual benefits through the date Executive signs this Release Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Waiver of Unknown and Unsuspected Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  It is the intention of Executive in executing this Release Agreement that the same shall be effective as a bar to each and every Claim hereinabove specified.  &#91;In furtherance of this intention, Executive hereby expressly waives any and all rights and benefits conferred upon him or her by the provisions of Section 1542 of the California Civil Code (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Section 1542</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), as well as any other similar statute or common law doctrine that may apply, and expressly consents that this Release Agreement shall be given full force and effect according to each and all of its express terms and provisions, including those related to unknown and unsuspected Claims, if any, as well as those relating to any other Claims hereinabove specified. Section 1542 provides&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive acknowledges that he may hereafter discover Claims or facts in addition to or different from those which Executive now knows or believes to exist with respect to the subject matter of this Release Agreement and which, if known or suspected at the time of executing this Release Agreement, may have materially affected this settlement.  Nevertheless, Executive hereby waives any right, Claim or cause of action that might arise as a result of such different or additional Claims or facts.  Executive acknowledges that he or she understands the significance and consequences of such release and such specific waiver of Section 1542 and any similar applicable statute or doctrine of law.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;4. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">ADEA Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive expressly acknowledges and agrees that by entering into this Release Agreement and in exchange for the benefits and payments provided to Executive under the Plan and in accordance with the Older Workers Benefit Protection Plan, Executive is knowingly waiving any and all rights or Claims that he or she may have arising under the Age Discrimination in Employment Act of 1967, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), which have arisen on or before the date Executive signs this Release Agreement.  Executive further expressly acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">In return for this Release Agreement, the Executive will receive consideration beyond that which the Executive was already entitled to receive before entering into this Release Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Executive is hereby advised in writing by this Release Agreement to consult with an attorney before signing this Release Agreement&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Executive has voluntarily chosen to enter into this Release Agreement and has not been forced or pressured in any way to sign it&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Executive was given a copy of this Release Agreement on &#91;date&#93; and informed that he or she had &#91;5 &#47;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21 &#47; 45</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> days within which to consider this Release Agreement and that if he or she wished to execute this Release Agreement prior to expiration of such </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5-day &#47;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21-day &#47; 45-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> period, he or she should execute the Endorsement attached hereto&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Executive was informed that he or she has seven (7) days following the date Executive signs this Release Agreement in which to revoke this Release Agreement, and this Release Agreement will become null and void if Executive elects revocation during that time.  Any revocation must be in writing and must be received by the Company during the seven-day (7) revocation period.  In the event that Executive exercises his or her right of revocation, neither the Company nor Executive will have any obligations under this Release Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">Nothing in this Release Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">No Transferred Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive warrants and represents that the Executive has not heretofore assigned or transferred to any person not a party to this Release Agreement any released matter or any part or portion thereof and he or she shall defend, indemnify and hold the Company and each of its affiliates harmless from and against any claim (including the payment of attorneys&#8217; fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed. Each of the Releasees agrees that it has not assigned or transferred any claims released hereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive by executing this Release Agreement expressly agrees to each of the provisions of this Section 6 and acknowledges that the provisions of Section 6 do not impose an economic hardship on Executive and have been supported by adequate consideration from the Company&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Confidentiality. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive shall not at any time directly or indirectly, disclose or make available to any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Information (as defined below)&#59; provided, however, that this Section 6(a) shall not apply when (i) disclosure is required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with apparent jurisdiction to order the Executive to disclose or make available such information (provided, however, that the Executive shall promptly notify the Company in writing upon receiving a request for such information), or (ii) with respect to any other litigation, arbitration or mediation involving this Release Agreement, including but not limited to enforcement of this Release Agreement.  As of the Effective Date of this Release Agreement, all Confidential Information in the Executive&#8217;s possession that is in written, digital or other tangible form (together with all copies or duplicates thereof, including computer files) has been returned to the Company and has not been retained by the Executive or furnished to any third party, in any form except as provided herein&#59; provided, however, that the Executive shall not be obligated to treat as confidential, or return to the Company copies of any Confidential Information that (x) was publicly known at the time it was disclosed to the Executive, (y) becomes publicly known or available thereafter other than by any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">means in violation of the Plan or any other duty owed to the Company by any person or entity, or (z) is lawfully disclosed to the Executive by a third party.  As used in this Release Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Confidential Information&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> means&#58; information disclosed to the Executive or known by the Executive as a consequence of or through the Executive&#8217;s relationship with the Company, about the suppliers, customers, employees, business methods, public relations methods, organization, procedures or finances, including, without limitation, information of or relating to supplier lists or customer lists, of the Company and its affiliates (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Company Group</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  Notwithstanding anything set forth in this Release Agreement to the contrary, Executive shall not be prohibited from reporting possible violations of federal or state law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation, nor is Executive required to notify the Company regarding any such reporting, disclosure or cooperation with the government.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Noncompetition.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Executive acknowledges that the nature of the Company Group&#8217;s business and the Executive&#8217;s position with the Company is such that if the Executive were to become employed by, or substantially involved in, the business of a competitor of the Company Group during the 12 months following the termination of the Executive&#8217;s employment with the Company, it would not be possible, or would be very difficult, for the Executive not to rely on or use the Company Group&#8217;s trade secrets and Confidential Information.  Thus, to avoid the inevitable disclosure of the Company Group&#8217;s trade secrets and Confidential Information, and to protect such trade secrets and Confidential Information and to protect the Company Group&#8217;s legitimate business interests, including the Company Group&#8217;s relationships and goodwill with customers, for a period of 12 months after the Effective Date of this Release Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Restricted Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Executive will not directly or indirectly engage in (whether as an employee, consultant, agent, proprietor, principal, partner, stockholder, corporate officer, director or otherwise), nor have any ownership interest in, or participate in the financing, operation, management or control of, any person, firm, corporation or business anywhere in the United States and Mexico (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Restricted Area</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) that competes with any member of the Company Group in the healthcare real estate acquisition, development, management, investment or financing industry (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Competing Business</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, that the Executive may purchase and hold only for investment purposes less than two percent of the shares of any corporation in competition with the Company Group whose shares are regularly traded on a national securities exchange.  Notwithstanding the preceding sentence, in the event Executive accepts employment with or provides services to a business (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Service Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) that is affiliated with another business that engages in a Competing Business or which derives a de minimis portion of its gross revenues from Competing Businesses, the Executive&#8217;s employment by or service to the Service Recipient shall not constitute a breach by Executive of his or her obligations pursuant to this Section 6(b) so long as each of the following conditions is satisfied at all times during the Restricted Period and while the Executive is employed by or providing service to the Service Recipient&#58; (i) no more than 10% of the gross revenues of the Service Recipient are derived from Competing Businesses&#59; (ii) no more than 10% of the gross revenues of the Service Recipient and those entities that (directly or through one or more intermediaries) are controlled by, control, or are under common control with such Service Recipient, together on a consolidated basis, are derived from Competing Businesses&#59; and (iii) in the course of the Executive&#8217;s services for the Service Recipient, a material portion (no more than 10%) of the Executive&#8217;s services are not directly involved in or responsible for any Competing Business.  The foregoing covenants in this Section 6(b) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.  The foregoing provision shall not apply to any Executive who was employed by the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">in California (or, if applicable, another jurisdiction which specifically and explicitly prohibits the legal enforcement of the foregoing provision) on the termination date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Non-Solicitation of Employees. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> During the Restricted Period, Executive shall not directly or indirectly solicit, induce, attempt to hire, recruit, encourage, take away, or hire any employee or independent contractor of the Company Group whose annual rate of compensation is then $50,000 or more or cause any such Company Group employee or contractor to leave his or her employment or engagement with the Company Group either for employment with the Executive or for any other entity or person.  The foregoing covenants in this Section 6(c) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Non-Solicitation of Customers. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> During the Restricted Period, Executive shall not directly or indirectly influence or attempt to influence customers, vendors, suppliers, licensors, lessors, joint venturers, associates, consultants, agents, or partners of the Company Group to divert their business away from the Company Group to any Competing Business, and each Executive agrees not to otherwise interfere with, disrupt or attempt to disrupt the business relationships, contractual or otherwise, between any member of the Company Group and any of its customers, suppliers, vendors, lessors, licensors, joint venturers, associates, officers, employees, consultants, managers, partners, members or investors.  The foregoing covenants in this Section 6(d) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Non-Disparagement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive and the Company shall use reasonable efforts to refrain from making any false, negative, critical or disparaging statements, implied or expressed, concerning the other, including, but not limited to, management style, methods of doing business, the quality of products and services, role in the community, or treatment of employees, and each party agrees not to encourage others to make any such statements. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:26.01pt">Understanding of Covenants. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive, by accepting participation in the Plan represents as follows&#58; the Executive (i) is familiar with the foregoing covenants set forth in this Section 6, (ii) is fully aware of the Executive&#8217;s obligations hereunder, (iii) agrees to the reasonableness of the length of time, scope and, if applicable, geographic coverage of the foregoing covenants set forth in this Section 6, (iv) agrees that the Company Group currently conducts business throughout the Restricted Area and (v) agrees that such covenants are necessary to protect the Company Group&#8217;s confidential and proprietary information, goodwill, stable workforce, and customer relations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Right to Injunctive and Equitable Relief.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Executive&#8217;s obligations not to disclose or use Confidential Information and to refrain from the solicitations described in this Section 6 are of a special and unique character, which gives them a peculiar value.  The Company cannot be reasonably or adequately compensated in damages in an action at law in the event the Executive breaches such obligations, and the breach of such obligations would cause irreparable harm to the Company.  Therefore, the Company shall be entitled to injunctive and other equitable relief without bond or other security in the event of such breach in addition to any other rights or remedies which the Company may possess.  Furthermore, the Executive&#8217;s obligations and the rights and remedies of the Company under this Section 6 are cumulative and in addition to, and not in lieu of, any obligations, rights, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">or remedies created by applicable law relating to misappropriation or theft of trade secrets or confidential information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Cooperation. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive shall respond to all reasonable inquiries of the Company about any matters concerning the Company or its affairs that occurred or arose during the Executive&#8217;s employment by the Company, and the Executive shall reasonably cooperate with the Company in investigating, prosecuting and defending any charges, claims, demands, liabilities, causes of action, lawsuits or other proceedings by, against or involving the Company relating to the period during which the Executive was employed by the Company or relating to matters of which the Executive had or should have had knowledge or information.  Further, except as required by law, the Executive will at no time voluntarily serve as a witness or offer written or oral testimony against the Company in conjunction with any complaints, charges or lawsuits brought against the Company by or on behalf of any current or former employees, or any governmental or administrative agencies related to the Executive&#8217;s period of employment and will provide the Company with notice of any subpoena or other request for such information or testimony.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> It is the desire and intent of the parties hereto that the provisions of this Release Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  Accordingly, if any particular provision of this Release Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction&#59; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of this Release Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">This Release Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  THIS RELEASE AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH UNITED STATES FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY UNITED STATES FEDERAL LAW, THE LAWS OF THE STATE OF COLORADO, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF COLORADO OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN UNITED STATES FEDERAL LAW AND THE LAW OF THE STATE OF COLORADO TO BE APPLIED.  IN FURTHERANCE OF THE FOREGOING, APPLICABLE FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY APPLICABLE FEDERAL LAW, THE INTERNAL LAW OF THE STATE OF COLORADO, WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS RELEASE AGREEMENT, EVEN IF UNDER SUCH JURISDICTION&#8217;S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Amendment and Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The provisions of this Release Agreement may be amended and waived only with the prior written consent of the Company and Executive, and no course of conduct or failure or delay in enforcing the provisions of this Release Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect or enforceability of this Release Agreement or any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Descriptive Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The descriptive headings of this Release Agreement are inserted for convenience only and do not constitute a part of this Release Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Where specific language is used to clarify by example a general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.  The language used in this Release Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party.  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Any claim or controversy arising out of or relating to this Release Agreement shall be submitted to arbitration in accordance with the arbitration provision set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Nouns and Pronouns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Whenever the context may require, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural and vice-versa.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Legal Counsel</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Each party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal counsel of their choice.  Executive acknowledges and agrees that he has read and understands this Release Agreement completely, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering into this Release Agreement and he has had ample opportunity to do so.  Each party shall bear its own costs and attorneys' fees incurred in negotiating and preparing this Release Agreement. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The undersigned have read and understand the consequences of this Release Agreement and voluntarily sign it.  The undersigned declare under penalty of perjury under the laws of the State of Colorado that the foregoing is true and correct.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">EXECUTED this ________ day of ________ 20__, at ___________, ___________.  </font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Executive</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Print Name&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.,<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">a Maryland corporation<br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">By&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:24pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:95.04pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ENDORSEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">I, _______________________, hereby acknowledge that I was given </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5 &#47; 21 &#47; 45</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> days to consider the foregoing Release Agreement and voluntarily chose to sign the Release Agreement prior to the expiration of the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5-day &#47; 21-day &#47; 45-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">I declare under penalty of perjury under the laws of the United States and the State of _____________  that the foregoing is true and correct.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">EXECUTED this ________ day of ________ 20__, at ___________, ___________.  </font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:22.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.389%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Print Name&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5bf916dbc52747a6b62a27754d1b1f1b_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">SECTION 280G PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">The provisions of this Exhibit B shall apply to each Participant in the Healthpeak Properties, Inc. Executive Severance Plan (the &#8220;Plan&#8221;).  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">In the event that any of the payments and other benefits provided under the Plan or otherwise payable to Participant (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Exhibit B, would be subject to the excise tax imposed by Section 4999 of the Code (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Excise Tax</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), then Participant&#8217;s payments and benefits under the Plan or otherwise shall be payable either&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(A) &#160;&#160;&#160;&#160;in full (with the Participant paying any excise taxes due), or </font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;(B) &#160;&#160;&#160;&#160;in such lesser amount which would result in no portion of such payments or benefits being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Participant, on an after-tax basis, of the greatest amount of payments and benefits under the Plan or otherwise, notwithstanding that all or some portion of such payments or benefits may be taxable under Section 4999 of the Code.  Subject to Section 409A of the Code, any reduction in the payments and benefits required by this Exhibit B will be made in the following order&#58; (i) reduction of cash payments&#59; (ii) reduction of accelerated vesting of equity awards that are not covered by Treas. Reg. Section 1.280G-1 Q&#47;A-24(b)&#59; (iii) reduction of accelerated vesting of equity awards that are not covered by Treas. Reg. Section 1.280G-1 Q&#47;A-24(b)&#59; and (iv) reduction of other benefits paid or provided to Participant.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>11
<FILENAME>ex101603312023.htm
<DESCRIPTION>EX-10.16
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2697dbcc55054f48bbed5cbc3e7c8b8a_103"></div><div style="min-height:81.36pt;width:100%"><div><img alt="image_0.jpg" src="image_0.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:214px"></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">EXECUTIVE CHANGE IN CONTROL SEVERANCE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(As Amended and Restated April 27, 2023)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Establishment and Purpose</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Healthpeak Properties, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) considers it essential to the best interests of its shareholders to foster the continuous employment of key management personnel.  In connection with this, the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) recognizes that, as is the case with many publicly held corporations, the possibility of a change in control of the Company may exist and that the uncertainty and questions that it may raise among management could result in the departure or distraction of management personnel to the detriment of the Company and its shareholders.  The Board has decided to reinforce and encourage the continued attention and dedication of selected members of the Company&#8217;s management to their assigned duties without the distraction arising from the possibility of a change in control of the Company.  In order to induce such members of management to remain in its employ, the Company hereby agrees that on and after the Effective Date (as defined in Section 2), subject to the terms and conditions of the Plan (as defined in Section 2), Participants (as defined in Section 3) shall be eligible to receive the severance benefits set forth in Section 6 of the Plan in the event that the Participants&#8217; employment with the Company is terminated under the circumstances described in Section 5 in connection with or subsequent to a Change in Control (as defined in Section 4).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Term of Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Executive Change in Control Severance Plan was originally established effective July 26, 2007, as amended effective March 13, 2014, as amended and restated as of May 6, 2016, and now further amended and restated effective as of April 27, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) (as so amended and restated, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  The Plan shall continue in effect until such time as it is terminated by the Company (the period during which the Plan is in effect, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, however, that any such termination of the Term will not become effective with respect to a Participant until the 30</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> day following the date on which notice thereof is given to the Participant&#59; provided, further, that if a Change in Control occurs during the Term, the Term shall continue in effect as to each Participant in the Plan at the time of the Change in Control for a period of not less than 24 months beyond the month in which such Change in Control occurred (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Change in Control Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  For purposes of clarity, the Company may give notice of termination of the Term to all or only certain Participants. If such notice is given to only certain Participants, the Term shall continue as set forth above as to all other Participants (subject to the Company&#8217;s rights to similarly terminate the Term in accordance with the foregoing on some future date(s) as to any such Participants).  A Participant shall cease to be eligible for benefits under the Plan (and shall cease to be a Participant) at midnight Mountain Time on the last day of the Term applicable to that Participant.  The termination or expiration of the Term as to a Participant shall not affect the Participant&#8217;s right to benefits (if any) pursuant to Section 6 as to any termination of employment that occurred during such Term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Participation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Chief Executive Officer, Chief Financial Officer, Chief Investment Officer, Chief Operating Officer, Chief Development Officer, General Counsel and each Executive Vice President and Senior Vice President of the Company who holds such position as of April 27, 2023 and each person who is hired or promoted to such a position, in each case, unless otherwise determined by the Compensation and Human Capital Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), shall automatically participate in the Plan (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Automatic Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), provided, that any individual who </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">would otherwise qualify as a Participant but who is then subject to the terms of an individual employment agreement or similar arrangement that provides payments or benefits in connection with a change in control, shall first participate in the Plan as of the date of expiration of such agreement or arrangement unless the Company and the Participant otherwise specifically agree to the contrary.  The Committee may from time to time designate in writing other employees of the Company who may participate in the Plan (together with Automatic Participants, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Participants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  Notwithstanding anything else contained herein to the contrary, the Committee shall limit the class of persons selected to participate in the Plan to a select group of management or highly compensated employees, as set forth in Sections 201, 301 and 401 of the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;).  Unless otherwise determined by the Committee, the Severance Multiplier shall be (i) 3.0 for the Chief Executive Officer of the Company, (ii) 2.5 for each of the Chief Financial Officer, Chief Investment Officer, Chief Operating Officer and Chief Development Officer of the Company, (iii) 2.0 for the General Counsel of the Company and any other Executive Vice President of the Company and (iv) 1.5 for a Senior Vice President of the Company. The Severance Multiplier for all other Participants shall be determined by the Committee at the time they are selected to participate in the Plan, and the Committee may update the Severance Multiplier for any Participant under the Plan from time to time prior to the Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Termination of Employment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Notwithstanding anything else contained in the Plan to the contrary, a Participant shall not be deemed to have terminated employment with the Company if his or her employment by the Company terminates but he or she otherwise continues, immediately after such termination of employment, as an employee of a subsidiary of the Company (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) or is offered employment (which, in either case, would not result in Participant being able to terminate employment for Good Reason if Participant&#8217;s terms of employment were similarly changed by the Company) by any successor corporation or acquirer of the Company&#59; provided that whether the Participant has Good Reason to terminate employment shall be determined by comparing the Participant&#8217;s authority, duties, responsibilities and other terms of employment after giving effect to such change to the Participant&#8217;s authority, duties, responsibilities and other terms of employment before giving effect to such change (in each case relative to the Company and its Subsidiaries on a consolidated basis, not simply with reference to the Participant&#8217;s employer).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Benefit Offset.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Any severance benefits otherwise payable under the Plan to a Participant shall be offset or reduced by (i) any severance benefits payable or deliverable to the Participant under any other plan, program, or agreement of or with the Company or any of its Subsidiaries and (ii) any other severance pay, termination indemnity, notice pay, or similar payment that the Company or any of its Subsidiaries is required by law to make to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  No benefits shall be payable under Section 6 unless there has been a Change in Control.  For purposes of the Plan, a &#8220;Change in Control&#8221; shall be deemed to occur if any of the following take place on or after the Effective Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of either (i) the then-outstanding shares of common stock of the Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Outstanding Company Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Outstanding Company Voting Securities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, however, that, for purposes of this clause (a), the following acquisitions shall not constitute a Change in Control&#58; (A) any acquisition directly from the Company, (B) any acquisition by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate of the Company or a successor, (D) any acquisition by any entity pursuant to a transaction that complies with clauses (c)(i), (ii) and (iii) below, and (E) any acquisition by a Person who owned at least 35% of either the Outstanding Company Common Stock or the Outstanding Company Voting Securities as of the Effective Date or an affiliate of any such Person&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">A change in the Board or its members such that individuals who, as of the later of the Effective Date or the date that is two years prior to such change (the later of such two dates is referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Measurement Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), constitute the Board (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Incumbent Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) cease for any reason to constitute at least a majority of the Board&#59; provided, however, that any individual becoming a director subsequent to the Measurement Date whose election, or nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board (including for these purposes, the new members whose election or nomination was so approved, without counting the member and his predecessor twice) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Company or any of its Subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its Subsidiaries (each, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Business Combination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), in each case unless, following such Business Combination, (i) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 66-2&#47;3% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets directly or through one or more subsidiaries (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (ii) no Person (excluding any entity resulting from such Business Combination or a Parent or any employee benefit plan (or related trust) of the Company or such entity resulting from such Business Combination or Parent) beneficially owns, directly or indirectly, more than 35% of, respectively, the then-outstanding shares of common stock of the entity resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such entity, except to the extent that the ownership in excess of 35% existed prior to the Business Combination, and (iii) at least a majority of the members of the board of directors or trustees of the entity resulting from such Business Combination or a Parent were members of the Incumbent Board (determined pursuant to clause (b) above using the date that is the later of the Effective Date or the date that is two years prior to the Business Combination as the Measurement Date) at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company other than in the context of a transaction that does not constitute a Change in Control under clause (c) above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notwithstanding the foregoing, to the extent required to avoid the imposition of additional taxes under Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), if a Change in Control does not constitute a &#8220;change in control event,&#8221; as defined in Treasury Regulation 1.409A-3(i)(5) (or to the extent otherwise required by Section 409A of the Code), with respect to a Participant's compensation which constitutes deferral of compensation subject to Section 409A of the Code under an arrangement that must be aggregated with the Plan for purposes of Treasury Regulations 1.409A-1(c)(2) (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">409A Arrangement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#34;), payments pursuant to the Plan that are not in excess of the amount that would be payable to such Participant under such 409A Arrangement shall be made at the time and in the manner provided by such 409A Arrangement and the remaining amount, if any, shall be paid in accordance with the Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Termination Following Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">General.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  During the Term, if any of the events described in Section 4 constituting a Change in Control shall have occurred, each Participant shall be entitled to the benefits provided in Section 6(b) upon the subsequent termination of his or her employment, provided that such termination occurs during the Term and within the two year period commencing upon the date of such Change in Control, unless such termination is (i) because of the Participant&#8217;s death or Disability (as defined in Section 5(b)), (ii) by the Company for Cause (as defined in Section 5(c)), or (iii) by the Participant other than for Good Reason (including a voluntary retirement when the Participant otherwise does not have Good Reason to terminate employment).  In the event that the Participant is entitled to such benefits, such benefits shall be paid notwithstanding the subsequent expiration of the Term.  For purposes of clarity, no Participant shall be entitled to any benefits under the Plan if his or her employment with the Company terminates for any reason before a Change in Control occurs or more than two years after a Change in Control occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Disability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  As to any particular Participant, &#8220;Disability&#8221; means the Participant&#8217;s inability, because of physical or mental illness or injury, to perform the essential functions of his or her customary duties to the Company, even with a reasonable accommodation, and the continuation of such disabled condition for a period of 180 continuous days, or for not less than 210 days during any continuous 24 month period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Cause.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Termination by the Company of a Participant&#8217;s employment for &#8220;Cause&#8221; shall mean termination (i) upon the Participant&#8217;s willful and continued failure to perform his or her duties with the Company (other than any such failure resulting from his or her incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not performed his or her duties, (ii) upon the Participant&#8217;s willful and continued failure to follow and comply with the specific and lawful directives of the Committee, as reasonably determined by the Committee (other than any such failure resulting from the Participant&#8217;s incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not performed his or her duties, (iii) upon the Participant&#8217;s willful and continued failure to follow and comply with the policies of the Company as in effect from time to time (other than any such failure resulting from the Participant&#8217;s incapacity due to physical or mental illness), after a written demand for performance is delivered to the Participant by the Committee, which demand specifically identifies the manner in which the Committee believes that the Participant has not followed or complied with such Company policies&#59; (iv) upon the Participant&#8217;s willful commission of an act of material fraud or dishonesty&#59; (v) upon the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Participant&#8217;s willful engagement in illegal conduct or gross misconduct&#59; or (vi) upon the Participant&#8217;s indictment for, conviction of, or a plea of guilty or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">nolo contendere</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> to any felony.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Good Reason.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  A Participant shall be entitled to terminate his or her employment for Good Reason. For purposes of the Plan, &#8220;Good Reason&#8221; shall mean, without the Participant&#8217;s consent, the occurrence after a Change in Control and during the Term of any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">(x) the assignment to the Participant of any material duties that are significantly and adversely inconsistent with, or  (y) a significant adverse alteration in the nature or status of, in each case of (x) or (y), the Participant&#8217;s primary duties or responsibilities, reporting line, or the conditions of the Participant&#8217;s employment from those in effect immediately prior to such Change in Control, or (z) any other action by the Company or its successor or acquirer, that results in a material diminution in the Participant&#8217;s position, authority, duties or responsibilities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.6pt">A material reduction in the aggregate amount of Participant&#8217;s annual base salary, annual target cash bonus opportunity and the grant date target value of annual equity awards as in effect on the Effective Date or as such annual base salary, annual target cash bonus opportunity and grant date target value of annual equity awards may be subsequently increased from time to time&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the relocation of offices at which the Participant is principally employed immediately prior to the date of the Change in Control to a location more than 30 miles from such location&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the Company&#8217;s failure to pay to the Participant any portion of his or her current compensation or to pay to the Participant any portion of an installment of deferred compensation under any deferred compensation program of the Company reasonably promptly after the date such compensation is due&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:38.74pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">the Company&#8217;s failure to obtain a satisfactory agreement from any successor to assume and agree to perform the Plan.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:line-through"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notwithstanding the foregoing, no such condition shall constitute &#8220;Good Reason&#8221; unless the Participant provides written notice to the Company that the event giving rise to such claim of Good Reason has occurred within sixty (60) calendar days after the occurrence of such event, and such Good Reason remains uncured thirty (30) calendar days after the Participant has provided such written notice&#59; provided further that any resignation of the Participant&#8217;s employment for Good Reason occurs no later than sixty (60) days following the expiration of such cure period .A Participant&#8217;s right to terminate his or her employment pursuant to this Section 5(d) shall not be affected by his or her incapacity due to physical or mental illness.  A Participant&#8217;s continued employment through the sixty (60) day period following the expiration of such cure period shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason hereunder, but upon the expiration of such sixty (60) day period, Participant shall have waived his or her rights with respect to any circumstance constituting Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Termination Generally.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  For purposes of clarity, a Participant or the Company shall be entitled to terminate the Participant&#8217;s employment for any reason or no reason at any time, including in connection with or after a Change in Control effective as of the applicable date set forth in Section 5(a).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:26.01pt">Notice of Termination. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Any purported termination of a Participant&#8217;s employment by the Company or by the Participant (other than termination due to death which shall terminate the Participant&#8217;s employment automatically) shall be communicated by written Notice of Termination to the Participant or the Company, respectively, other party hereto in accordance with Section 13. &#8220;Notice of Termination&#8221; shall mean a notice that shall indicate the specific termination provision in the Plan relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant&#8217;s employment under the provision so indicated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Date of Termination, etc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  &#8220;Date of Termination&#8221; shall mean (i) if a Participant&#8217;s employment is terminated due to the Participant&#8217;s death, the date of the Participant&#8217;s death, (ii) if a Participant&#8217;s employment is terminated for Disability, 30 days after Notice of Termination is given (provided that the Participant shall not have returned to the full-time performance of his or her duties during such 30-day period), and (iii) if a Participant&#8217;s employment is terminated for any other reason, the date specified in the Notice of Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Compensation Upon Termination Following a Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  If a Participant&#8217;s employment is terminated following a Change in Control during the Term and during the two year period immediately following the date of the Change in Control, the Participant shall be entitled to the benefits described below, subject to the other terms and conditions of the Plan&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">If the Participant&#8217;s employment is terminated in such circumstances by the Company for Cause or Disability or by the Participant other than for Good Reason or due to the Participant&#8217;s death, the Company shall pay the Participant (i) the Participant&#8217;s accrued and unpaid base salary and vacation (if any) through the Date of Termination, and (ii) all other amounts to which the Participant is entitled under any compensation plan of the Company at the time such payments are due, and the Company shall have no further obligations to the Participant under the Plan&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">If the Participant&#8217;s employment by the Company shall be terminated by the Participant for Good Reason or by the Company other than for Cause or Disability and in all cases other than due to the Participant&#8217;s death, then, subject to the provisions of Section 7, the Participant shall be entitled to the benefits provided below.   For purposes of this Section 6(b), &#8220;Annual Bonus Amount&#8221; shall mean the greater of the (1) target annual bonus amount in effect for such Participant as of the Participant&#8217;s Date of Termination (or, if greater, as of the date of the Change in Control), and (2) the average of the last three annual bonuses actually paid to the Participant for the last three full fiscal years of employment with the Company prior to the Date of Termination (or if greater, prior to the Change in Control) (or the average of such lower number of bonuses that were actually paid for full fiscal years of employment with the Company prior to the Date of Termination or the Change in Control, whichever is greater), which shall, in each case, be determined without regard to the payment of any special bonuses (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, transaction bonuses)&#59; provided, if the Participant, on the Date of Termination, has never been paid an annual bonus with respect to one full fiscal year, then the Participant&#8217;s Annual Bonus Amount shall equal (x) the amount of the Participant&#8217;s guaranteed bonus in respect of the year of termination, if applicable, or if none, the Participant&#8217;s target annual bonus, or (y) if the Participant is not eligible to receive a guaranteed or target bonus in respect of the year of termination, then the amount of the Participant&#8217;s Annual Base Salary.  For purposes of this Section 6(b), a Participant&#8217;s &#8220;Annual Base Salary&#8221; shall mean the greater of (x) the Participant&#8217;s annual base salary as in effect as of the Date of Termination and (y) the Participant&#8217;s annual base salary as in effect immediately prior to the Change in Control&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">The Company shall pay to the Participant (A) the Participant&#8217;s accrued and unpaid base salary and vacation (if any) through the Date of Termination, (B) the unpaid portion, if any, of any annual bonus, plus an amount equal to the Annual Bonus Amount, multiplied by a fraction (not greater than one), the numerator of which is the number of calendar days that the Participant was employed by the Company during the year of termination and the denominator of which is 365, and (C) all other amounts to which the Participant is entitled under any compensation plan of the Company at the time such payments are due&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">A lump sum severance payment equal to the sum of&#58; (A) the Participant&#8217;s Severance Multiplier times the Participant&#8217;s Annual Base Salary&#59; plus (B) the Participant&#8217;s Severance Multiplier times the Participant&#8217;s Annual Bonus Amount&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">A cash payment equal to the expected aggregate cost of the premiums that would be charged to the Participant to continue medical coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), at the same or reasonably equivalent medical coverage for the Participant (and, if applicable, the Participant&#8217;s eligible dependents) as in effect immediately prior to the Participant&#8217;s Date of Termination, for a period of months after the Participant&#8217;s Date of Termination equal to 12 multiplied by the Participant&#8217;s Severance Multiplier&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">(A) Any stock options or equity or equity-related compensation or grants that vest based on the passage of time and continued performance of services (to the extent outstanding and not otherwise vested as of the Date of Termination, and exclusive of any grants that include performance-based vesting criteria) shall become fully vested immediately prior to such termination&#59; (B) any stock options or equity or equity-related compensation or grants that vest based on the satisfaction of performance-based criteria (to the extent outstanding and not otherwise vested as of the Date of Termination) shall continue to be governed by the provisions of the applicable award agreement in the circumstances&#59; provided, however, that to the extent that any such then-outstanding equity-based awards are subject to forfeiture and&#47;or vesting requirements based on the passage of time, such awards shall be fully accelerated with respect to such time-based forfeiture and&#47;or vesting provisions&#59; and (C) the Participant shall have until the date that is 24 months after his or her Date of Termination to exercise any stock option to the extent that it has become vested as of the Date of Termination, subject to earlier termination of the stock option upon the stock option&#8217;s original expiration date or the occurrence of a change in control event or certain similar reorganization event under the terms of the applicable award agreement.  Except as provided in this Section 6(b)(iv), the effect of a termination of employment on a Participant&#8217;s equity-based awards shall be determined under the terms of the applicable award agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:38.74pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">The Participant shall be fully vested in his or her accrued benefits under any nonqualified pension, profit sharing, deferred compensation or supplemental plans maintained by the Company and the Company shall pay the Participant a cash lump sum amount equal to the portion of the Participant&#8217;s account under the Company&#8217;s 401(k) plan (including, without limitation, any 401(k) matching contributions), if any, that has not become vested under the terms of such plan as of the Date of Termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">The Company shall furnish the Participant for six years following the Date of Termination (without reference to whether the Term continues in effect) with directors&#8217; and officers&#8217; liability insurance insuring the Participant against insurable events which occur or have occurred </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">while the Participant was a director or officer of the Company, such insurance to have policy limits aggregating not less than the amount in effect immediately prior to the Change in Control, and otherwise to be in substantially the same form and to contain substantially the same terms, conditions and exceptions as the liability issuance policies provided for officers and directors of the Company in force from time to time, provided, however, that such terms, conditions and exceptions shall not be, in the aggregate, materially less favorable to the Participant than those in effect on the Effective Date&#59; provided, further, that if the aggregate annual premiums for such insurance at any time during such period exceed 150% of the per annum rate of premium currently paid by the Company for such insurance, then the Company shall provide the maximum coverage that will then be available at an annual premium equal to 150% of such rate&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:34.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">In any situation where under applicable law the Company has the power to indemnify (or advance expenses to) the Participant in respect of any judgments, fines, settlements, loss, cost or expense (including attorneys&#8217; fees) of any nature related to or arising out of the Participant&#8217;s activities as an agent, employee, officer or director of the Company or in any other capacity on behalf of or at the request of the Company, the Company shall promptly on written request, indemnify (and advance expenses to) the Participant to the fullest extent permitted by applicable law, including but not limited to making such findings and determinations and taking any and all such actions as the Company may, under applicable law, be permitted to have the discretion to take so as to effectuate such indemnification or advancement.  Such agreement by the Company shall not be deemed to impair any other obligation of the Company respecting the Participant&#8217;s indemnification otherwise arising out of this or any other agreement or promise of the Company or under any statute.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">The payments described in Sections 6(a)(i) and 6(b)(i)(A), as applicable, shall be paid in cash to the Participant as soon as practicable following the Date of Termination.  Subject to Sections 4, 7 and 21, the payments described in Sections 6(b)(i)(B), 6(b)(ii), 6(b)(iii), 6(b)(iv) and 6(b)(v), as applicable, shall be paid in cash (or if so provided in an award agreement relating to the grant of restricted stock units or other equity-based awards other than stock options, in shares) to the Participant in a single lump sum on (or with respect to payment in shares, as soon as practicable after) the first regularly scheduled payroll date that occurs after the Participant&#8217;s release contemplated by Section 7(a) becomes irrevocable by the Participant in accordance with applicable law&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, that if the period during which the Participant is permitted to consider the release in accordance with Section 7(a) begins in one calendar year and ends in a second calendar year, such payment shall in all events be made in the second calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">The foregoing provisions of this Section 6 shall not affect&#58; (i) a Participant&#8217;s receipt of benefits otherwise due terminated employees under group insurance coverage consistent with the terms of the applicable Company welfare benefit plan&#59; (ii) a Participant&#8217;s rights under COBRA to continue participation in medical, dental, hospitalization and life insurance coverage&#59; or (iii) a Participant&#8217;s receipt of benefits otherwise due in accordance with the terms of the Company&#8217;s 401(k) plan (if any).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Release&#59; Exclusive Remedy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">This Section 7 shall apply notwithstanding anything else contained in the Plan or any other stock option, restricted stock or other equity-based award agreement to the contrary.  The Company&#8217;s obligation to make any payment of benefits with respect to a Participant pursuant to Section 6(b) (if the Participant is otherwise entitled to such benefits), other than those set forth in Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">6(b)(i)(A), is subject to the condition precedent that (i) the Participant has fully executed a valid and effective release (in the form attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> or such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable or otherwise compliant with applicable laws), (ii) such executed release is delivered by the Participant to the Company so that it is received by the Company in the time period specified below, and (iii) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law).  In order to satisfy the requirements of this Section 7(a), a Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Company so that it is received by the Company no later than 25 calendar days after the Participant&#8217;s Date of Termination (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either 5, 21 or 45 days, depending on the circumstances of the termination, to consider the release).  In addition, the Company may require that the Participant&#8217;s release be executed no earlier than the date that the Participant&#8217;s employment with the Company terminates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Each Participant agrees that the general release agreement described in Section 7(a) will require that the Participant acknowledge, as a condition to the payment of any benefits under Section 6(b) (other than those set forth in Section 6(b)(i)(A)), that the payments contemplated by Section 6(b) shall constitute the exclusive and sole remedy for any termination of the Participant&#8217;s employment, and each Participant will be required to covenant, as a condition to receiving any such payment, not to assert or pursue any other remedies, at law or in equity, with respect to any termination of employment.  No Participant shall be required to mitigate the amount of any payment provided for in Section 6 by seeking other employment or otherwise nor shall the amount of any payment or benefit provided for in Section 6 be reduced by any compensation earned by the Participant as the result of employment by another employer or self-employment, by retirement benefits, by offset against any amount claimed to be owed by the Participant to the Company, or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Section 280G</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Each Participant shall be covered by the provisions set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> hereto, incorporated herein by this reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Successors&#59; Assigns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to expressly assume and agree to perform the obligations under the Plan in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  Failure of the Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be deemed a material breach of the Plan by the Company and shall entitle each Participant to terminate his or her employment and receive compensation from the Company in the same amount and on the same terms to which the Participant would be entitled hereunder if the Participant terminates his or her employment for Good Reason following a Change in Control, except that for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the Date of Termination.  Unless expressly provided otherwise, &#8220;Company&#8221; as used herein shall mean the Company as defined in the Plan and any successor to its business and&#47;or assets as aforesaid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">None of the benefits, payments, proceeds or claims of any Participant shall be subject to any claim of any creditor and, in particular, the same shall not be subject to attachment or garnishment or other legal process by any creditor, nor shall any such Participant have any right to alienate, anticipate, commute, pledge, encumber or assign any of the benefits or payments or proceeds which he or she may expect to receive, contingently or otherwise, under the Plan.  Notwithstanding the foregoing, benefits which are in pay status may be subject to a court-ordered garnishment or wage assignment, or similar order, or a tax levy.  The Plan shall inure to the benefit of and be enforceable by each Participant&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees.  If a Participant dies while any amount would still be payable to him or her hereunder had he or she continued to live, all such amounts, unless otherwise provided herein, shall be paid to the Participant&#8217;s estate in accordance with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Claims Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Presentation of Claim. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Any Participant (such Participant being referred to below as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Claimant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) may deliver to the Committee a written claim for a determination with respect to the benefits payable to such Claimant pursuant to the Plan.  If such a claim relates to the contents of a notice received by the Claimant, the claim must be made within 60 days after such notice was received by the Claimant.  All other claims must be made within 180 days of the date on which the event that caused the claim to arise occurred.  The claim must state with particularity the determination desired by the Claimant. For purposes of this Section 10, references to the &#8220;Committee&#8221; shall include references to any designee of the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Notification of Decision.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Committee shall consider a Claimant&#8217;s claim within a reasonable time, but no later than 90 days after receiving the claim.  If the Committee determines that special circumstances require an extension of time for processing the claim, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 90 day period.  In no event shall such extension exceed a period of 90 days from the end of the initial 90 day period.  The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Committee expects to render the benefit determination.  The Committee shall notify the Claimant in writing&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">that the Claimant&#8217;s requested determination has been made, and that the claim has been allowed in full&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">that the Committee has reached a conclusion contrary, in whole or in part, to the Claimant&#8217;s requested determination, and such notice must set forth in a manner calculated to be understood by the Claimant&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">the specific reason(s) for the denial of the claim, or any part of it&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">specific reference(s) to pertinent provisions of the Plan upon which such denial was based&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">a description of any additional material or information necessary for the Claimant to perfect the claim, and an explanation of why such material or information is necessary&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">an explanation of the claim review procedure and the time limits applicable to such procedures set forth in Section 10(c)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">a statement of the Claimant&#8217;s right to bring a civil action under ERISA Section 502(a) following an adverse determination on review.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Review of a Denied Claim.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  On or before 60 days after receiving a notice from the Committee that a claim has been denied, in whole or in part, a Claimant (or the Claimant&#8217;s duly authorized representative) may file with the Committee a written request for a review of the denial of the claim.  The Claimant (or the Claimant&#8217;s duly authorized representative)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may, upon request and free of charge, have reasonable access to, and copies of, all documents, records and other information relevant to the claim for benefits&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may submit written comments or other documents&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">may request a hearing, which the Committee, in its sole discretion, may grant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Decision on Review.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Committee shall render its decision on review promptly, and no later than 60 days after the Committee receives the Claimant&#8217;s written request for a review of the denial of the claim.  If the Committee determines that special circumstances require an extension of time for processing the claim, written notice of the extension shall be furnished to the Claimant prior to the termination of the initial 60 day period.  In no event shall such extension exceed a period of 60 days from the end of the initial 60 day period.  The extension notice shall indicate the special circumstances requiring an extension of time and the date by which the Committee expects to render the benefit determination.  In rendering its decision, the Committee shall take into account all comments, documents, records and other information submitted by the Claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination.  The decision must be written in a manner calculated to be understood by the Claimant, and it must contain&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">specific reasons for the decision&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">specific reference(s) to the pertinent Plan provisions upon which the decision was based&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to and copies of, all documents, records and other information relevant (as defined in applicable ERISA regulations) to the Claimant&#8217;s claim for benefits&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">a description of the Claimant's right to bring a civil action under Section 502(a) of ERISA following an adverse benefit determination on review.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Arbitration&#59; Dispute Resolution, Etc</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Notwithstanding anything to the contrary contained in the Plan, the Participant, in his or her sole discretion, may elect to have any claim or controversy arising out of or in connection with the Plan submitted to binding arbitration and adjudicated in accordance with this Section 11 without first having to exhaust the claims procedures set forth in Section 10.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">The Company and, by accepting participation in the Plan, each Participant hereby consent to the resolution by mandatory and binding arbitration of all claims or controversies arising out of or in connection with the Plan that the Company may have against the Participant, or that the Participant may have against the Company or against any of its officers, directors, employees or agents acting in their capacity as such, and which are not resolved under the terms of Section 10 (or which are not required to be resolved under the terms of Section 10, as the case may be).  Each party&#8217;s promise to resolve all such claims or controversies by arbitration in accordance with the Plan rather than through the courts is consideration for the other party&#8217;s like promise.  It is further agreed that the decision of an arbitrator on any issue, dispute, claim or controversy submitted for arbitration, shall be final and binding upon the Company and the Participant and that judgment may be entered on the award of the arbitrator in any court having proper jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Except as otherwise provided in this procedure or by mutual agreement of the parties, any arbitration shall be before a sole arbitrator (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Arbitrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) selected from Judicial Arbitration &#38; Mediation Services, Inc., Denver, Colorado, or its successor (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">JAMS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), or if JAMS is no longer able to supply the Arbitrator, such Arbitrator shall be selected from the American Arbitration Association, and shall be conducted in accordance with the provisions of applicable law as the exclusive remedy of such dispute.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">The Arbitrator shall interpret the Plan, any applicable Company policy or rules and regulations, any applicable substantive law (and the law of remedies, if applicable) of the state in which the claim arose, or applicable federal law.  If arbitration is brought after the claim or controversy has been submitted for review by the Committee in accordance with Section 10, the Arbitrator shall limit his or her review to whether or not the Committee has abused its discretion in its interpretation of the Plan and such policies, rules, and regulations&#59; provided, however, that the Arbitrator shall apply a de novo standard of review with respect to any claim for benefits hereunder in connection with a Change in Control.  In reaching his or her decision, the Arbitrator shall have no authority to change or modify any lawful Company policy, rule or regulation, or the Plan.  Except as provided in Section 11(e), the Arbitrator, and not any federal, state or local court or agency, shall have exclusive and broad authority to resolve any dispute relating to the interpretation, applicability, enforceability or formation of the Plan, including but not limited to, any claim that all or any part of the Plan is voidable.  The Arbitrator shall have the authority to decide dispositive motions.  Following completion of the arbitration, the arbitrator shall issue a written decision disclosing the essential findings and conclusions upon which the award is based.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Notwithstanding the foregoing, provisional injunctive relief may, but need not, be sought by the Participant or the Company in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally resolved by the Arbitrator in accordance with the foregoing.  Final resolution of any dispute through arbitration may include any remedy or relief which would otherwise be available at law and which the Arbitrator deems just and equitable.  The Arbitrator shall have the authority to award full damages as provided by law.  Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">The Company shall pay the reasonable fees and expenses of the Arbitrator and of a stenographic reporter, if employed.  Each party shall pay its own legal fees and other expenses and costs incurred with respect to the arbitration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Administration of the Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">General. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Company shall be the plan administrator (within the meaning of Section 3(16)(A) of ERISA).  The Company delegates its duties under the Plan to the Committee.  The Committee delegates the day-to-day ministerial duties with respect to the Plan to the Company&#8217;s management.  The Committee and its delegates shall be named fiduciaries of the Plan to the extent required by ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Powers and Duties of the Committee. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Committee shall enforce the Plan in accordance with its terms, shall be charged with the general administration of the Plan, and shall have all powers necessary to accomplish its purposes, including, but not by way of limitation, the power and authority to do the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:41.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To determine eligibility for and participation in the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:39.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To construe and interpret the terms and provisions of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:37.08pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To compute and certify to the amount and kind of benefits payable to Participants and their beneficiaries, and to determine the amount of withholding taxes to be deducted pursuant to Section 15&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To maintain all records that may be necessary for the administration of the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:38.74pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To provide for the disclosure of all information and the filing or provision of all reports and statements to Participants, beneficiaries or governmental agencies as shall be required by law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36.52pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To make and publish such rules for the regulation of the Plan and procedures for the administration of the Plan as are not inconsistent with the terms hereof&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:34.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.6pt">To appoint a plan manager or any other agent, and to delegate to them such powers and duties in connection with the administration of the Plan as the Committee may from time to time prescribe.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Committee Action. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Subject to Section 10, the Committee shall act with respect to the Plan at meetings by affirmative vote of a majority of the members of the Committee.  Any action permitted to be taken at a meeting with respect to the Plan may be taken without a meeting if, prior to such action, a written consent to the action is signed by all members of the Committee and such written consent is filed with the minutes of the proceedings of the Committee.  A member of the Committee shall not vote or act upon any matter which relates solely to himself or herself as a Participant.  The Chair or any other member or members of the Committee designated by the Chair may execute any certificate or other written direction on behalf of the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Construction and Interpretation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  As to any event prior to a Change in Control, the Committee shall have full discretion to construe and interpret the terms and provisions of the Plan, which interpretation or construction shall be final and binding on all parties, including but not limited to the Company and any Participant, beneficiary or other person.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  All notices under or with respect to the Plan shall be in writing and shall be either personally delivered or mailed postage prepaid, by certified mail, return receipt requested&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">if to the Company&#58;</font></div><div style="padding-left:108pt;padding-right:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Healthpeak Properties, Inc.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Attention&#58; Compensation and Human Capital Committee</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4600 South Syracuse Street, Suite 500</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Denver, CO 80237</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Email&#58; lalonso&#64;healthpeak.com </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">with a copy to&#58;</font></div><div style="padding-left:108pt;padding-right:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Healthpeak Properties, Inc.</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Attention&#58;  General Counsel</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">4600 South Syracuse Street, Suite 500</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Denver, CO 80237 </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Email&#58; jhmiller&#64;healthpeak.com</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">if to a Participant, to the Participant&#8217;s address most recently on file in the payroll records of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notice shall be effective when personally delivered, or five business days after being so mailed.  Any party may change its address for purposes of giving future notices pursuant to the Plan by notifying the other party in writing of such change in address, such notice to be delivered or mailed in accordance with the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Plan will be governed by and construed in accordance with ERISA and, to the extent not preempted thereby, the laws of the State of Colorado, without giving effect to any choice of law or conflicting provision or rule (whether of the State of Colorado or any other jurisdiction) that would cause the laws of any jurisdiction other than United States federal law and the law of the State of Colorado to be applied.  In furtherance of the foregoing, applicable federal law and, to the extent not preempted by applicable federal law, the internal law of the State of Colorado will control the interpretation and construction of the Plan, even if under such jurisdiction&#8217;s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply.  Any statutory reference in the Plan shall also be deemed to refer to all applicable final rules and final regulations promulgated under or with respect to the referenced statutory provision. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The Committee may from time to time amend the Plan in any way it deems to be advisable&#59; provided that (i) no such amendment shall materially and adversely affect the rights of any Participant (or former Participant) under the Plan without the Company providing thirty (30) days&#8217; notice prior to the effective date of such amendment to the affected Participants (or former Participants, as the case may be), and (ii) no amendment may be made to the Plan in any respect during the Change in Control Term.  Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under the Plan shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence.  No waiver shall be effective unless it is in writing and is signed by the party </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">asserted to have granted such waiver.  No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by the Company which are not expressly set forth in the Plan. All references to sections of the Exchange Act or the Code shall be deemed also to refer to any successor provisions to such sections.  The Company may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due or payable under or pursuant to the Plan such federal, state and local income, employment, or other taxes as may be required to be withheld pursuant to any applicable law or regulation.  Any obligations of the Company under Sections 4 and 6 shall survive the expiration of the Term. The section headings contained in the Plan are for convenience only, and shall not affect the interpretation of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Unsecured General Creditor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Participants and their heirs, successors, and assigns shall have no legal or equitable rights, claims, or interest in any specific property or assets of the Company or any Subsidiary.  No assets of the Company shall be held under any trust, or held in any way as collateral security, for the fulfilling of the obligations of the Company under the Plan.  Any and all of the Company&#8217;s assets shall be, and remain, the general unpledged, unrestricted assets of the Company (unless pledged or restricted with respect to the Company&#8217;s obligations other than the Plan).  The Company&#8217;s obligation under the Plan shall be merely that of an unfunded and unsecured promise of the Company to pay money and benefits in the future, and the rights of the Participants and their heirs or successors as to benefits under the Plan shall be no greater than those of unsecured general creditors of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Other Benefit Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  All payments, benefits and amounts provided under the Plan shall be in addition to and not in substitution for any pension rights under any tax-qualified pension or retirement plan in which the Participant participates, and any disability, workers&#8217; compensation or other Company benefit plan distribution that a Participant is entitled to (other than severance benefits), under the terms of any such plan, at the time the Participant ceases to be employed by the Company.  Notwithstanding the foregoing, the Plan shall not create an inference that any duplicate payments shall be required.  Payments received by a person under the Plan shall not be deemed a part of the person&#8217;s compensation for purposes of the determination of benefits under any other employee pension, welfare or other benefit plans or arrangements, if any, provided by the Company, except where explicitly provided under the terms of such plans or arrangements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> In the event any provision of the Plan shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of the Plan or affecting the validity or enforceability of such provision in any other jurisdiction.  Furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of the Plan, as applicable, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of the Plan or affecting the validity or enforceability of such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Employment Status</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Except as may be expressly provided under any other written agreement between a Participant and the Company (other than the Plan) signed by a duly authorized officer thereof, the employment of each Participant by the Company is &#8220;at will,&#8221; and may be terminated by either the Participant or the Company at any time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Payments on Behalf of Persons Under Incapacity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  In the event that any amount becomes payable under the Plan to a person who, in the sole judgment of the Committee, is considered by reason of physical or mental condition to be unable to give a valid receipt therefor the Committee may direct that such payment be made to any person found by the Committee, in its sole judgment, to have assumed the care of such person.  Any payment made pursuant to such determination shall constitute a full release and discharge of the Committee and the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The intent of the parties is that payments and benefits under the Plan comply with Section 409A of the Code, to the extent subject thereto, and accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith or exempt therefrom.  Notwithstanding anything contained herein to the contrary, a Participant shall not be considered to have terminated employment with the Company for purposes of any payments under the Plan which are subject to Section 409A of the Code until the Participant has incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A of the Code.  Each amount to be paid or benefit to be provided under the Plan shall be construed as a separate identified payment for purposes of Section 409A of the Code.  Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid an accelerated or additional tax under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six-month period immediately following a Participant&#8217;s separation from service shall instead be paid on the first business day after the date that is six months following the Participant&#8217;s separation from service (or, if earlier, the Participant&#8217;s date of death). To the extent any Plan benefits are subject to  such six-month delay, the Company (or the survivor in a Change in Control) shall enter into, establish and fund a rabbi trust to assist the Company in funding such Plan obligations that are subject to such six-month delay&#59; provided that such a trust may be established and funded without resulting in any tax, penalty or interest under Section 409A of the Code.  To the extent required to avoid an accelerated or additional tax under Section 409A of the Code, (a) amounts reimbursable to a Participant shall be paid on or before the last day of the year following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in-kind benefits provided to a Participant) during one year may not affect amounts reimbursable or provided in any subsequent year, and (b) if applicable, any tax gross-up payments (and related reimbursements) payable to a Participant under the Plan shall be paid no later than the end of the calendar year following the year in which the tax resulting in the gross-up is paid.  The Company makes no representation that any or all of the payments described in the Plan will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, the Company has caused its duly authorized officer to execute the Plan on the date first set forth above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">a Maryland corporation</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#47;s&#47; Jeffrey H. Miller</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Its&#58;    </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">General Counsel</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="i2697dbcc55054f48bbed5cbc3e7c8b8a_106"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">For Colorado Employees Only</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice of Restrictive Covenant</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This notice is to advise you that Healthpeak Properties, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) is, contemporaneously with this notice, providing you with a Release Agreement containing a covenant that could restrict your options for subsequent employment following separation from Company, in that you will be prohibited, for one year after the Release Agreement&#8217;s Effective Date (defined as 14 days after the Release Agreement is fully executed), from using, disclosing, misappropriating, or otherwise leveraging the Company&#8217;s trade secrets to solicit the Company&#8217;s customers, potential customers, suppliers, or vendors.  This covenant is contained in Sections 6(a) and 6(c) of the Release Agreement.  </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acknowledged&#58;  &#160;&#160;&#160;&#160;______________________________</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;______________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="i2697dbcc55054f48bbed5cbc3e7c8b8a_109"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">FORM OF RELEASE AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">This Release Agreement (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Release Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) is entered into this ___ day of _________ 20__, by and between _____________________, an individual (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), and Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;). This Release Agreement will become effective </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> calendar days after the date on which this Release Agreement is fully executed (the &#8220;Effective Date&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, Executive has been employed by the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, Executive&#8217;s employment by the Company has terminated and, in connection with the Company&#8217;s Executive Change in Control Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Company and Executive desire to enter into this Release Agreement upon the terms set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">, in consideration of the covenants undertaken and the releases contained in this Release Agreement, and in consideration of the obligations of the Company (or one of its subsidiaries) to pay severance benefits (conditioned upon this Release Agreement) under and pursuant to the Plan, Executive and the Company agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive, on behalf of himself or herself, his or her descendants, dependents, heirs, executors, administrators, assigns, and successors, and each of them, hereby acknowledges full and complete satisfaction of and covenants not to sue and fully releases and discharges the Company, its successors and assigns, and each of its and their past, present, and future parents, owners, subsidiaries, affiliates, divisions, trustees, directors, officers, members, principals, managers, partners, agents, attorneys, insurers, reinsurers, sureties, subrogees, employees, stockholders, representatives, creditors, liquidators, lienholders, associates, administrators, beneficiaries, heirs, and any other related persons or entities, hereinafter together and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Releasees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">,&#8221; with respect to and from any and all claims, wages, demands, rights, liens, agreements or contracts (written or oral), covenants, actions, suits, causes of action, obligations, debts, costs, expenses, attorneys&#8217; fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden (each, a &#8220;Claim&#8221;), which he or she now owns or holds or he or she has at any time heretofore owned or held or may in the future hold as against any of said Releasees (including, without limitation, any Claim arising out of or in any way connected with Executive&#8217;s service as an officer, director, employee, member or manager of any Releasee, Executive&#8217;s separation from his or her position as an officer, director, employee, manager and&#47;or member, as applicable, of any Releasee, or any other transactions, occurrences, acts or omissions or any loss, damage or injury whatever), whether known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part of said Releasees, or any of them, committed or omitted prior to the date Executive signs this Release Agreement including, without limiting the generality of the foregoing, any Claim under Title VII of the Civil Rights Act of 1964, the Rehabilitation Act of 1973, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, the Equal Pay Act, the Fair Labor Standards Act, the Fair Credit Reporting Act, the Employee Retirement Income Security Act of 1974, the Family and Medical Leave Act of 1993, the Worker Adjustment and Retraining </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="padding-left:9pt;padding-right:14.4pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  The Company reserves the right to modify this form as to any Participant employed outside of Colorado, as well as to make updates as may be necessary or advisable to comply with applicable Federal, state and local laws, regulations and guidelines, as determined by the Company in its sole discretion.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Notification Act, Section 806 of the Sarbanes-Oxley Act, the Dodd-Frank Act, the Colorado Anti-Discrimination Act, the California Fair Employment and Housing Act, the California Family Rights Act, the California Labor Code (including but not limited to Sections 4558 and 6310), the Tennessee Human Rights Act, the Tennessee Disability Act, and the Tennessee Public Protection Act, or any other federal, state or local law, regulation, or ordinance, or any Claim for severance pay, bonus, sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any other fringe benefit, workers&#8217; compensation or disability, including any claim under California Labor Code Section 2803&#59; provided however, that the foregoing release shall not apply to any obligation of the Company to Executive pursuant to any of the forgoing&#58;  (a) any obligation created by or arising out of the Plan for which receipt or satisfaction has not been acknowledged, (b) any equity-based awards previously granted by the Company to Executive, to the extent that such awards continue after the termination of Executive&#8217;s employment with the Company in accordance with the applicable terms of such awards&#59; (c) any right to indemnification that Executive may have pursuant to the Amended and Restated Bylaws of the Company, its corporate charter or under any written indemnification agreement with the Company, as each may be amended from time to time (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys&#8217; fees to the extent otherwise provided) that Executive may in the future incur with respect to his service as an employee, officer or director of the Company or any of its subsidiaries or affiliates&#59; (d) with respect to any rights that Executive may have to insurance coverage for such losses, damages or expenses under any Company (or subsidiary or affiliate) directors and officers liability insurance policy&#59; (e) any rights to continued medical, dental or vision coverage that Executive may have under COBRA&#59; (f) any rights to payment of benefits that Executive may have under a retirement plan sponsored or maintained by the Company that is intended to qualify under Section 401(a) of the Internal Revenue Code of 1986, as amended, or (g) any deferred compensation or supplemental retirement benefits that Executive may be entitled to under a nonqualified deferred compensation or supplemental retirement plan of the Company.  In addition, this release does not cover any Claim that cannot be so released as a matter of applicable law.  Executive acknowledges and agrees that he or she has received any and all leave and other benefits to which he or she has been and is entitled to pursuant to the Family and Medical Leave Act of 1993. Executive warrants that Executive is not a Medicare beneficiary as of the date of Executive&#8217;s execution of this Release Agreement and therefore no conditional payments have been made by Medicare. Executive will indemnify, defend and hold the Releasees harmless from any and all claims, liens, Medicare conditional payments and rights to payment, known or unknown. This settlement is based upon a good faith determination of the parties to resolve a disputed claim. The parties have not shifted responsibility of medical treatment to Medicare in contravention of 42 U.S.C. Sec. 1395y(b). The parties resolved this matter in compliance with both state and federal law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;To extent permitted by law, Executive, represents and agrees that he, she or it has not and will not file or initiate any legal proceedings, complaints or charges of any kind to the extent released herein with any court or governmental or administrative agency against any one or more of the Releasees, relating to Executive&#8217;s employment or positions with the Company, and that Executive  will not participate in nor accept any monies from any such action in his or her individual capacity or as part of a representative or class action.  The Company and the other Releasees shall be entitled to plead this Release Agreement as a complete defense to any claim or entitlement relating to Executive&#8217;s employment or positions with the Company which hereafter may be asserted by Executive or other parties acting on his behalf in any suit or claim against the Company or any other Releasee.  Executive understands that nothing in this Release Agreement precludes him from filing a charge with or participating in an investigation by the Equal Employment Opportunity Commission or any Federal, state, or administrative agency&#59; provided, however, that Executive hereby waives any right to receive any monetary award resulting from such a charge or investigation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Acknowledgment of Payment of Wages</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Except for accrued vacation (which the parties agree totals approximately &#91;&#9679;&#93; days of pay) and salary for the current pay period, Executive acknowledges that he&#47;she has received all amounts owed for his or her regular and usual salary (including, but not limited to, any bonus, severance, or other wages), and usual benefits through the date Executive signs this Release Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Waiver of Unknown and Unsuspected Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  It is the intention of Executive in executing this Release Agreement that the same shall be effective as a bar to each and every Claim hereinabove specified.  &#91;In furtherance of this intention, Executive hereby expressly waives any and all rights and benefits conferred upon him or her by the provisions of Section 1542 of the California Civil Code (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Section 1542</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#34;), as well as any other similar statute or common law doctrine that may apply, and expressly consents that this Release Agreement shall be given full force and effect according to each and all of its express terms and provisions, including those related to unknown and unsuspected Claims, if any, as well as those relating to any other Claims hereinabove specified. Section 1542 provides&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive acknowledges that he, she or it may hereafter discover Claims or facts in addition to or different from those which Executive now know or believe to exist with respect to the subject matter of this Release Agreement and which, if known or suspected at the time of executing this Release Agreement, may have materially affected this settlement.  Nevertheless, Executive hereby waives any right, Claim or cause of action that might arise as a result of such different or additional Claims or facts.  Executive acknowledges that he or she understands the significance and consequences of such release and such specific waiver of Section 1542 and any similar applicable statute or doctrine of law.&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:133%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">ADEA Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive expressly acknowledges and agrees that by entering into this Release Agreement and in exchange for the benefits and payments provided to Executive under the Plan and in accordance with the Older Workers Benefit Protection Plan, Executive is knowingly waiving any and all rights or Claims that he or she may have arising under the Age Discrimination in Employment Act of 1967, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), which have arisen on or before the date Executive signs this Release Agreement.  Executive further expressly acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">In return for this Release Agreement, the Executive will receive consideration beyond that which the Executive was already entitled to receive before entering into this Release Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Executive is hereby advised in writing by this Release Agreement to consult with an attorney before signing this Release Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Executive has voluntarily chosen to enter into this Release Agreement and has not been forced or pressured in any way to sign it&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.24pt">Executive was given a copy of this Release Agreement on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> and informed that he or she had </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5 &#47; 21 &#47; 45</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> days within which to consider this Release Agreement and that if he or she </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">wished to execute this Release Agreement prior to expiration of such </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> &#47; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21-day &#47; 45-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> period, he or she should execute the Endorsement attached hereto&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.78pt">Executive was informed that he or she had seven days following the date Executive signs this Release Agreement in which to revoke this Release Agreement, and this Release Agreement will become null and void if Executive elects revocation during that time.  Any revocation must be in writing and must be received by the Company during the seven-day revocation period.  In the event that Executive exercises his or her right of revocation, neither the Company nor Executive will have any obligations under this Release Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.01pt">Nothing in this Release Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">No Transferred Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive warrants and represents that the Executive has not heretofore assigned or transferred to any person not a party to this Release Agreement any released matter or any part or portion thereof and he or she shall defend, indemnify and hold the Company and each of its affiliates harmless from and against any claim (including the payment of attorneys&#8217; fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive by executing this Release Agreement expressly agrees to each of the provisions of this Section 6 and acknowledges that the provisions of Section 6 do not impose an economic hardship on Executive and have been supported by adequate consideration from the Company&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Confidentiality. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive shall not at any time directly or indirectly, disclose or make available to any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Information (as defined below)&#59; provided, however, that this Section 6(a) shall not apply when (i) disclosure is required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with apparent jurisdiction to order the Executive to disclose or make available such information (provided, however, that the Executive shall promptly notify the Company in writing upon receiving a request for such information), or (ii) with respect to any other litigation, arbitration or mediation involving this Release Agreement, including but not limited to enforcement of this Release Agreement.  As of the Effective Date of this Release Agreement, all Confidential Information in the Executive&#8217;s possession that is in written, digital or other tangible form (together with all copies or duplicates thereof, including computer files) has been returned to the Company and has not been retained by the Executive or furnished to any third party, in any form except as provided herein&#59; provided, however, that the Executive shall not be obligated to treat as confidential, or return to the Company copies of any Confidential Information that (x) was publicly known at the time it was disclosed to the Executive, (y) becomes publicly known or available thereafter other than by any means in violation of the Plan or any other duty owed to the Company by any person or entity, or (z) is lawfully disclosed to the Executive by a third party.  As used in this Release Agreement, the term &#8220;Confidential Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> means&#58; information disclosed to the Executive or known by the Executive as a consequence of or through the Executive&#8217;s relationship with the Company, about the suppliers, customers, employees, business methods, public relations methods, organization, procedures or finances, including, without limitation, information of or relating to supplier lists or customer lists, of the Company and its affiliates (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;). Notwithstanding anything set forth in this Release Agreement to the contrary, Executive shall not be prohibited from reporting possible violations of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">federal or state law or regulation to any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation, nor is Executive required to notify the Company regarding any such reporting, disclosure or cooperation with the government.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Noncompetition.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Executive acknowledges that the nature of the Company Group&#8217;s business and the Executive&#8217;s position with the Company is such that if the Executive were to become employed by, or substantially involved in, the business of a competitor of the Company Group during the 12 months following the termination of the Executive&#8217;s employment with the Company, it would not be possible, or would be very difficult, for the Executive not to rely on or use the Company Group&#8217;s trade secrets and Confidential Information.  Thus, to avoid the inevitable disclosure of the Company Group&#8217;s trade secrets and Confidential Information, and to protect such trade secrets and Confidential Information and to protect the Company Group&#8217;s legitimate business interests, including the Company Group&#8217;s relationships and goodwill with customers, for a period of 12 months after the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), the Executive will not directly or indirectly engage in (whether as an employee, consultant, agent, proprietor, principal, partner, stockholder, corporate officer, director or otherwise), nor have any ownership interest in, or participate in the financing, operation, management or control of, any person, firm, corporation or business anywhere in the United States and Mexico (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Restricted Area</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) that competes with any member of the Company Group in the healthcare real estate acquisition, development, management, investment or financing industry (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Competing Business</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;)&#59; provided, that the Executive may purchase and hold only for investment purposes less than two percent of the shares of any corporation in competition with the Company Group whose shares are regularly traded on a national securities exchange.  Notwithstanding the preceding sentence, in the event Executive accepts employment with or provides services to a business (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Service Recipient</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;) that is affiliated with another business that engages in a Competing Business or which derives a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">de minimis</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> portion of its gross revenues from Competing Businesses, the Executive&#8217;s employment by or service to the Service Recipient shall not constitute a breach by Executive of his or her obligations pursuant to this Section 6(b) so long as each of the following conditions is satisfied at all times during the Restricted Period and while the Executive is employed by or providing service to the Service Recipient&#58; (i) no more than 10% of the gross revenues of the Service Recipient are derived from Competing Businesses&#59; (ii) no more than 10% of the gross revenues of the Service Recipient and those entities that (directly or through one or more intermediaries) are controlled by, control, or are under common control with such Service Recipient, together on a consolidated basis, are derived from Competing Businesses&#59; and (iii) in the course of the Executive&#8217;s services for the Service Recipient, a material portion (no more than 10%) of the Executive&#8217;s services are not directly involved in or responsible for any Competing Business.  The foregoing covenants in this Section 6(b) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.  The foregoing provision shall not apply to any Executive who was employed by the Company in California (or, if applicable, another jurisdiction which specifically and explicitly prohibits the legal enforcement of the foregoing provision) on the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Non-Solicitation of Employees. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> During the Restricted Period, Executive shall not directly or indirectly solicit, induce, attempt to hire, recruit, encourage, take away, or hire any employee or independent contractor of the Company Group whose annual rate of compensation is then $50,000 or more or cause any such Company Group employee or contractor to leave his or her employment or engagement with the Company Group either for employment with the Executive or for any other entity or person.  The foregoing covenants in this Section 6(c) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Non-Solicitation of Customers. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> During the Restricted Period, Executive shall not directly or indirectly influence or attempt to influence customers, vendors, suppliers, licensors, lessors, joint venturers, associates, consultants, agents, or partners of the Company Group to divert their business away from the Company Group to any Competing Business, and each Executive agrees not to otherwise interfere with, disrupt or attempt to disrupt the business relationships, contractual or otherwise, between any member of the Company Group and any of its customers, suppliers, vendors, lessors, licensors, joint venturers, associates, officers, employees, consultants, managers, partners, members or investors.  The foregoing covenants in this Section 6(d) shall continue in effect through the entire Restricted Period regardless of whether the Executive is then entitled to receive any severance payments from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.78pt">Non-Disparagement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> The Company and Executive shall use reasonable efforts to refrain from making any false, negative, critical or disparaging statements, implied or expressed, concerning the other, including, but not limited to, management style, methods of doing business, the quality of products and services, role in the community, or treatment of employees, and each party agrees not to encourage others to make any such statements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.54pt">Understanding of Covenants. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive, by accepting participation in the Plan represents as follows&#58; the Executive (i) is familiar with the foregoing covenants set forth in this Section 6&#59; (ii) is fully aware of the Executive&#8217;s obligations hereunder&#59; (iii) agrees to the reasonableness of the length of time,  scope and, if applicable, geographic coverage of the foregoing covenants set forth in this Section 6&#59; (iv) agrees that the Company Group currently conducts business throughout the Restricted Area&#59; and (v) agrees that such covenants are necessary to protect the Company Group&#8217;s confidential and proprietary information, goodwill, stable workforce, and customer relations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:26.01pt">Right to Injunctive and Equitable Relief.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Executive&#8217;s obligations not to disclose or use Confidential Information and to refrain from the solicitations described in this Section 6 are of a special and unique character, which gives them a peculiar value.  The Company cannot be reasonably or adequately compensated in damages in an action at law in the event the Executive breaches such obligations, and the breach of such obligations would cause irreparable harm to the Company.  Therefore, the Company shall be entitled to injunctive and other equitable relief without bond or other security in the event of such breach in addition to any other rights or remedies which the Company may possess.  Furthermore, the Executive&#8217;s obligations and the rights and remedies of the Company under this Section 6 are cumulative and in addition to, and not in lieu of, any obligations, rights, or remedies created by applicable law relating to misappropriation or theft of trade secrets or confidential information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:23.24pt">Cooperation. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Executive shall respond to all reasonable inquiries of the Company about any matters concerning the Company or its affairs that occurred or arose during the Executive&#8217;s employment by the Company, and the Executive shall reasonably cooperate with the Company in investigating, prosecuting and defending any charges, claims, demands, liabilities, causes of action, lawsuits or other proceedings by, against or involving the Company relating to the period during which the Executive was employed by the Company or relating to matters of which the Executive had or should have had knowledge or information.  Further, except as required by law, the Executive will at no time voluntarily serve as a witness or offer written or oral testimony against the Company in conjunction with any complaints, charges or lawsuits brought against the Company by or on behalf of any current or former employees, or any governmental or administrative agencies related to the Executive&#8217;s period of employment and will provide the Company with notice of any subpoena or other request for such information or testimony.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> It is the desire and intent of the parties hereto that the provisions of this Release Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  Accordingly, if any particular provision of this Release Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction&#59; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of this Release Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">This Release Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:27.67pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  THIS RELEASE AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH UNITED STATES FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY UNITED STATES FEDERAL LAW, THE LAWS OF THE STATE OF COLORADO, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF COLORADO OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN UNITED STATES FEDERAL LAW AND THE LAW OF THE STATE OF COLORADO TO BE APPLIED.  IN FURTHERANCE OF THE FOREGOING, APPLICABLE FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY APPLICABLE FEDERAL LAW, THE INTERNAL LAW OF THE STATE OF COLORADO, WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS RELEASE AGREEMENT, EVEN IF UNDER SUCH JURISDICTION&#8217;S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Amendment and Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  The provisions of this Release Agreement may be amended and waived only with the prior written consent of the Company and Executive, and no course of conduct or failure or delay in enforcing the provisions of this Release Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect or enforceability of this Release Agreement or any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Descriptive Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The descriptive headings of this Release Agreement are inserted for convenience only and do not constitute a part of this Release Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Where specific language is used to clarify by example a general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.  The language used in this Release Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">  Any claim or controversy arising out of or relating to this Release Agreement shall be submitted to arbitration in accordance with the arbitration provision set forth in the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Nouns and Pronouns</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Whenever the context may require, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural and vice-versa.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;padding-left:22.11pt;text-decoration:underline">Legal Counsel</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> Each party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal counsel of their choice.  Executive acknowledges and agrees that he has read and understands this Release Agreement completely, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering into this Release Agreement and he has had ample opportunity to do so.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The undersigned have read and understand the consequences of this Release Agreement and voluntarily sign it.  The undersigned declare under penalty of perjury under the laws of the State of Colorado that the foregoing is true and correct.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">EXECUTED this ________ day of ________ 20__, at ___________, ___________.  </font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Executive</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Print Name&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">HEALTHPEAK PROPERTIES, INC.,<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">a Maryland corporation<br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">By&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Name&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Title&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:24pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">ENDORSEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">I, _______________________, hereby acknowledge that I was given </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5&#47; 21 &#47; 45</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> days to consider the foregoing Release Agreement and voluntarily chose to sign the Release Agreement prior to the expiration of the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">5-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">21-day &#47; 45-day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">I declare under penalty of perjury under the laws of the United States and the State of ____________________ that the foregoing is true and correct.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">EXECUTED this ________ day of ________ 20__, at ___________, ___________.  </font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.846%"><tr><td style="width:1.0%"></td><td style="width:22.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.389%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Print Name&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="i2697dbcc55054f48bbed5cbc3e7c8b8a_112"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">SECTION 280G PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">The provisions of this Exhibit B shall apply to each Participant in the Healthpeak Properties, Inc. Executive Change in Control Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">&#8221;).  Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">In the event that any of the payments and other benefits provided under the Plan or otherwise payable to Participant (i) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code and (ii) but for this Exhibit B, would be subject to the excise tax imposed by Section 4999 of the Code (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">Excise Tax</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8221;), then Participant&#8217;s payments and benefits under the Plan or otherwise shall be payable either&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(A) &#160;&#160;&#160;&#160;in full (with the Participant paying any excise taxes due), or </font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;(B) &#160;&#160;&#160;&#160;in such lesser amount which would result in no portion of such payments or benefits being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Participant, on an after-tax basis, of the greatest amount of payments and benefits under the Plan or otherwise, notwithstanding that all or some portion of such payments or benefits may be taxable under Section 4999 of the Code.  Subject to Section 409A of the Code, any reduction in the payments and benefits required by this Exhibit B will be made in the following order&#58; (i) reduction of cash payments&#59; (ii) reduction of accelerated vesting of equity awards that are not covered by Treas. Reg. Section 1.280G-1 Q&#47;A-24(b)&#59; (iii) reduction of accelerated vesting of equity awards that are covered by Treas. Reg. Section 1.280G-1 Q&#47;A-24(c)&#59; and (iv) reduction of other benefits paid or provided to Participant, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the applicable change in ownership or control.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">&#91;The remainder of this page is left blank intentionally.&#93;</font></div><div style="padding-left:297pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22.1
<SEQUENCE>12
<FILENAME>ex22103312023.htm
<DESCRIPTION>EX-22.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i92551f0f5a1d4a52b3c20f5975607649_52"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 22.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">List of Issuers of Guaranteed Securities</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of March 31, 2023, the following subsidiary was the issuer of the 3.400% Senior Notes due 2025, 4.000% Senior Notes due 2025, 3.250% Senior Notes due 2026, 1.350% Senior Notes due 2027, 2.125% Senior Notes due 2028, 3.500% Senior Notes due 2029, 3.000% Senior Notes due 2030, 2.875% Senior Notes due 2031, 5.250% Senior Notes due 2032 and 6.750% Senior Notes due 2041, each of which was guaranteed by Healthpeak Properties, Inc.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Healthpeak OP, LLC</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Maryland</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>13
<FILENAME>ex31103312023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id7f92eee6d214cabb3e6591c70d7cb15_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.1</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott M. Brinker, certify that&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form&#160;10-Q of Healthpeak Properties,&#160;Inc.&#160;for the period ended&#160;March&#160;31, 2023&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SCOTT M. BRINKER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott M. Brinker</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>14
<FILENAME>ex31203312023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i051f4831e3474ea1a98e23003a41cf2f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.2</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter A. Scott, certify that&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form&#160;10-Q of Healthpeak Properties,&#160;Inc.&#160;for the period ended March&#160;31, 2023&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PETER A. SCOTT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>15
<FILENAME>ex32103312023.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2d20baede0714a34b9ddfd366a094961_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32.1</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167;&#160;1350, as created by Section&#160;906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthpeak Properties,&#160;Inc., a Maryland corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="text-indent:96.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;the accompanying quarterly report on Form&#160;10-Q of the Company for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SCOTT M. BRINKER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott M. Brinker</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>16
<FILENAME>ex32203312023.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib2d5ce8dbc934c739f65c0716c263392_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32.2</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167;&#160;1350, as created by Section&#160;906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthpeak Properties,&#160;Inc., a Maryland corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="text-indent:96.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;the accompanying quarterly report on Form&#160;10-Q of the Company for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PETER A. SCOTT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>peak-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:peak="http://www.healthpeak.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.healthpeak.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.healthpeak.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Business" roleURI="http://www.healthpeak.com/role/Business">
        <link:definition>0000009 - Disclosure - Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstate" roleURI="http://www.healthpeak.com/role/RealEstate">
        <link:definition>0000011 - Disclosure - Real Estate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperations" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations">
        <link:definition>0000012 - Disclosure - Dispositions of Real Estate and Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.healthpeak.com/role/Leases">
        <link:definition>0000013 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivable" roleURI="http://www.healthpeak.com/role/LoansReceivable">
        <link:definition>0000014 - Disclosure - Loans Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVentures" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures">
        <link:definition>0000015 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibles" roleURI="http://www.healthpeak.com/role/Intangibles">
        <link:definition>0000016 - Disclosure - Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.healthpeak.com/role/Debt">
        <link:definition>0000017 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.healthpeak.com/role/CommitmentsandContingencies">
        <link:definition>0000018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterests" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests">
        <link:definition>0000019 - Disclosure - Equity and Redeemable Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShare" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShare">
        <link:definition>0000020 - Disclosure - Earnings Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosures" roleURI="http://www.healthpeak.com/role/SegmentDisclosures">
        <link:definition>0000021 - Disclosure - Segment Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformation">
        <link:definition>0000022 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.healthpeak.com/role/VariableInterestEntities">
        <link:definition>0000023 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.healthpeak.com/role/FairValueMeasurements">
        <link:definition>0000024 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstruments">
        <link:definition>0000025 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilities" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities">
        <link:definition>0000026 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenue" roleURI="http://www.healthpeak.com/role/DeferredRevenue">
        <link:definition>0000027 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000029 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsTables" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables">
        <link:definition>0000030 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.healthpeak.com/role/LeasesTables">
        <link:definition>0000031 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableTables" roleURI="http://www.healthpeak.com/role/LoansReceivableTables">
        <link:definition>0000032 - Disclosure - Loans Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables">
        <link:definition>0000033 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesTables" roleURI="http://www.healthpeak.com/role/IntangiblesTables">
        <link:definition>0000034 - Disclosure - Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.healthpeak.com/role/DebtTables">
        <link:definition>0000035 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsTables" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables">
        <link:definition>0000036 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareTables" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareTables">
        <link:definition>0000037 - Disclosure - Earnings Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresTables" roleURI="http://www.healthpeak.com/role/SegmentDisclosuresTables">
        <link:definition>0000038 - Disclosure - Segment Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables">
        <link:definition>0000039 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesTables" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesTables">
        <link:definition>0000040 - Disclosure - Variable Interest Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.healthpeak.com/role/FairValueMeasurementsTables">
        <link:definition>0000041 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>0000042 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables">
        <link:definition>0000043 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueTables" roleURI="http://www.healthpeak.com/role/DeferredRevenueTables">
        <link:definition>0000044 - Disclosure - Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails">
        <link:definition>0000045 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateRealEstateInvestmentsDetails" roleURI="http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails">
        <link:definition>0000046 - Disclosure - Real Estate - Real Estate Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateDevelopmentActivitiesDetails" roleURI="http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails">
        <link:definition>0000047 - Disclosure - Real Estate - Development Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails">
        <link:definition>0000048 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails">
        <link:definition>0000049 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseIncomeDetails" roleURI="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails">
        <link:definition>0000050 - Disclosure - Leases - Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.healthpeak.com/role/LeasesNarrativeDetails">
        <link:definition>0000051 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofLoansReceivableDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails">
        <link:definition>0000052 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableNarrativeDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails">
        <link:definition>0000053 - Disclosure - Loans Receivable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails">
        <link:definition>0000054 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofReserveforLoanLossesDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails">
        <link:definition>0000055 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails">
        <link:definition>0000056 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesIntangiblesLeaseAssetsDetails" roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails">
        <link:definition>0000057 - Disclosure - Intangibles - Intangibles Lease Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesIntangiblesLeaseLiabilitiesDetails" roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails">
        <link:definition>0000058 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesNarrativeDetails" roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails">
        <link:definition>0000059 - Disclosure - Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtBankLineofCreditandTermLoanDetails" roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails">
        <link:definition>0000060 - Disclosure - Debt - Bank Line of Credit and Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtCommercialPaperProgramDetails" roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails">
        <link:definition>0000061 - Disclosure - Debt - Commercial Paper Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorUnsecuredNotesDetails" roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails">
        <link:definition>0000062 - Disclosure - Debt - Senior Unsecured Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMortgageDebtDetails" roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails">
        <link:definition>0000063 - Disclosure - Debt - Mortgage Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtMaturitiesDetails" roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails">
        <link:definition>0000064 - Disclosure - Debt - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000065 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsDividendsDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails">
        <link:definition>0000066 - Disclosure - Equity and Redeemable Noncontrolling Interests - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsATMProgramDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails">
        <link:definition>0000067 - Disclosure - Equity and Redeemable Noncontrolling Interests - ATM Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails">
        <link:definition>0000068 - Disclosure - Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsAOCIDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails">
        <link:definition>0000069 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails">
        <link:definition>0000070 - Disclosure - Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsDownREITsDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails">
        <link:definition>0000071 - Disclosure - Equity and Redeemable Noncontrolling Interests - DownREITs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareNarrativeDetails" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails">
        <link:definition>0000072 - Disclosure - Earnings Per Common Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareComputationofEPSDetails" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails">
        <link:definition>0000073 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresNarrativeDetails" roleURI="http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails">
        <link:definition>0000074 - Disclosure - Segment Disclosures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails">
        <link:definition>0000075 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails">
        <link:definition>0000076 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails">
        <link:definition>0000077 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>0000078 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1">
        <link:definition>0000078 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesNarrativeDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails">
        <link:definition>0000079 - Disclosure - Variable Interest Entities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails">
        <link:definition>0000080 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails">
        <link:definition>0000081 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails">
        <link:definition>0000082 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNarrativeDetails" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails">
        <link:definition>0000083 - Disclosure - Derivative Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails">
        <link:definition>0000084 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails">
        <link:definition>0000085 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueScheduleofDeferredRevenueDetails" roleURI="http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails">
        <link:definition>0000086 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="peak_InterestRateSwap463PayRateMember" abstract="true" name="InterestRateSwap463PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CurrentPeriodGrossWriteOffsMember" abstract="true" name="CurrentPeriodGrossWriteOffsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" abstract="false" name="DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" abstract="false" name="DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CCRCResidentLoansMember" abstract="true" name="CCRCResidentLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfRedeemableNoncontrollingInterestRedemptions" abstract="false" name="NumberOfRedeemableNoncontrollingInterestRedemptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" abstract="false" name="RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PropertiesWithDirectFinancingLeasesNumber" abstract="false" name="PropertiesWithDirectFinancingLeasesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_UnsecuredNote525PercentMember" abstract="true" name="UnsecuredNote525PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MezzanineMember" abstract="true" name="MezzanineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LoansReceivableExtensionFee" abstract="false" name="LoansReceivableExtensionFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SecuredMortgageLoansMember" abstract="true" name="SecuredMortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" abstract="false" name="NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" abstract="false" name="ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RefundableEntranceFeesCurrentAndNoncurrent" abstract="false" name="RefundableEntranceFeesCurrentAndNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PropertiesHeldForSaleNumber" abstract="false" name="PropertiesHeldForSaleNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" abstract="true" name="SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_InterestRateSwap499PayRateMember" abstract="true" name="InterestRateSwap499PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SunriseSeniorHousingPortfolioMember" abstract="true" name="SunriseSeniorHousingPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantDebtToAssets" abstract="false" name="DebtInstrumentCovenantDebtToAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_NumberOfPlanParticipants" abstract="false" name="NumberOfPlanParticipants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" abstract="false" name="TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfLoans" abstract="false" name="NumberOfLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" abstract="false" name="DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" abstract="false" name="FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AdjustmentsOfPermanentEquityToTemporaryEquity" abstract="false" name="AdjustmentsOfPermanentEquityToTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" abstract="false" name="NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" abstract="false" name="GainLossOnSaleOfRealEstateUnderDirectFinancingLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SouthSanFranciscoJVsMember" abstract="true" name="SouthSanFranciscoJVsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DownREITUnitsOutstanding" abstract="false" name="DownREITUnitsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" abstract="false" name="DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CCRVJVInvestmentMember" abstract="true" name="CCRVJVInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfVieBorrowersWithMarketableDebtSecurities" abstract="false" name="NumberOfVieBorrowersWithMarketableDebtSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" abstract="false" name="ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_TermLoanFacilitiesMember" abstract="true" name="TermLoanFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" abstract="true" name="DebtInstrumentRedemptionRemainderOfFiscalYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" abstract="false" name="ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" abstract="false" name="InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LiabilitiesRelatedToAssetsHeldForSaleNet" abstract="false" name="LiabilitiesRelatedToAssetsHeldForSaleNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfUnconsolidatedJointVenture" abstract="false" name="NumberOfUnconsolidatedJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" abstract="false" name="NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" abstract="true" name="VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LessorAssetUnderOperatingLeaseMember" abstract="true" name="LessorAssetUnderOperatingLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MinorityInterestInPreferredUnitHoldersFairValue" abstract="false" name="MinorityInterestInPreferredUnitHoldersFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingAmountCommitted" abstract="false" name="CapitalExpenditureFundingAmountCommitted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" abstract="false" name="ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_InterestRateSwap254PayRateMember" abstract="true" name="InterestRateSwap254PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LifeScienceJVsMember" abstract="true" name="LifeScienceJVsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MedicalOfficeMember" abstract="true" name="MedicalOfficeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfHospitals" abstract="false" name="NumberOfHospitals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentWeightedAverageMaturity" abstract="false" name="DebtInstrumentWeightedAverageMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" abstract="true" name="CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_GovernmentGrantIncomeFromCARESAct" abstract="false" name="GovernmentGrantIncomeFromCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" abstract="false" name="LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SHOPJVMember" abstract="true" name="SHOPJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_OtherDeferredRevenue" abstract="false" name="OtherDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CCRCSegmentMember" abstract="true" name="CCRCSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfPropertiesToBeSold" abstract="false" name="NumberOfPropertiesToBeSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_LifeScienceMember" abstract="true" name="LifeScienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" abstract="false" name="NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestRateSwap508PayRateMember" abstract="true" name="InterestRateSwap508PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_OtherNonReportingSegmentMember" abstract="true" name="OtherNonReportingSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantSecuredDebtToAssets" abstract="false" name="DebtInstrumentCovenantSecuredDebtToAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_DerivativeNotionalAmountTerminated" abstract="false" name="DerivativeNotionalAmountTerminated" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OperatingExpensesFromJointVentureAttributableToParentNet" abstract="false" name="OperatingExpensesFromJointVentureAttributableToParentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_IncomeLossFromDiscontinuedOperationsMember" abstract="true" name="IncomeLossFromDiscontinuedOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_A2023AtTheMarketProgramMember" abstract="true" name="A2023AtTheMarketProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ImpairmentsAndAllowanceForCreditLossReserves" abstract="false" name="ImpairmentsAndAllowanceForCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" abstract="false" name="FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesAcquired" abstract="false" name="FiniteLivedIntangibleLiabilitiesAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LoansAndLeasesReceivableRemainingCommitments" abstract="false" name="LoansAndLeasesReceivableRemainingCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AtTheMarketProgramMember" abstract="true" name="AtTheMarketProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantNetWorthMinimum" abstract="false" name="DebtInstrumentCovenantNetWorthMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestRateSwap454PayRateMember" abstract="true" name="InterestRateSwap454PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantFixedChargeRatioMinimum" abstract="false" name="DebtInstrumentCovenantFixedChargeRatioMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="peak_DownREITMember" abstract="true" name="DownREITMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CommonStockConvertibleSharesIssuable" abstract="false" name="CommonStockConvertibleSharesIssuable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_AmortizationOfNonrefundableEntranceFee" abstract="false" name="AmortizationOfNonrefundableEntranceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_GovernmentAssistanceCARESActMember" abstract="true" name="GovernmentAssistanceCARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_GovernmentGrantIncomePolicyPolicyTextBlock" abstract="false" name="GovernmentGrantIncomePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesNet" abstract="false" name="FiniteLivedIntangibleLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" abstract="false" name="RealEstateRevenuesFromJointVentureGovernmentGrantIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OptionIndexedToIssuersEquityTerm" abstract="false" name="OptionIndexedToIssuersEquityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_NeedhamLandParcelJVMember" abstract="true" name="NeedhamLandParcelJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ScheduleOfDeferredRevenueTableTextBlock" abstract="false" name="ScheduleOfDeferredRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_MedicalOfficeJVsMember" abstract="true" name="MedicalOfficeJVsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AtmEquityOfferingProgramAggregateAmountAuthorized" abstract="false" name="AtmEquityOfferingProgramAggregateAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" abstract="true" name="PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IntangiblesAbstract" abstract="true" name="IntangiblesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" abstract="false" name="AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" abstract="false" name="ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SeniorHousingOperatingPortfolioMember" abstract="true" name="SeniorHousingOperatingPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesGross" abstract="false" name="FiniteLivedIntangibleLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AdjustedNetOperatingIncomeFromContinuingOperations" abstract="false" name="AdjustedNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DownreitPartnershipsMember" abstract="true" name="DownreitPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SorrentoTherapeuticsIncMember" abstract="true" name="SorrentoTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" abstract="false" name="TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" abstract="true" name="LifeScienceJointVentureInSanFranciscoCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" abstract="true" name="SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_GovernmentAssistanceDomain" abstract="true" name="GovernmentAssistanceDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentNumberofExtensions" abstract="false" name="DebtInstrumentNumberofExtensions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentMaximumBorrowingCapacity" abstract="false" name="DebtInstrumentMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_MOBLandParcelsMember" abstract="true" name="MOBLandParcelsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" abstract="false" name="RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" abstract="false" name="CapitalExpenditureFundingCostOfCapitalPercentCommitted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_DebtInstrumentRedemptionPeriodThereafterMember" abstract="true" name="DebtInstrumentRedemptionPeriodThereafterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureAttributableToParent" abstract="false" name="RealEstateRevenuesFromJointVentureAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" abstract="true" name="VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" abstract="false" name="AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" abstract="false" name="LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestRateSwap260PayRateMember" abstract="true" name="InterestRateSwap260PayRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" abstract="false" name="VariableInterestEntityControllingOwnershipInterestThroughPartnership" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_GovernmentGrantIncome" abstract="false" name="GovernmentGrantIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_TermLoanFacilitiesTwoMember" abstract="true" name="TermLoanFacilitiesTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_GovernmentAssistanceAxis" abstract="true" name="GovernmentAssistanceAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="peak_ContributionOfPropertyNumberOfProperties" abstract="false" name="ContributionOfPropertyNumberOfProperties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_VariableInterestEntitiesAbstract" abstract="true" name="VariableInterestEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_HCPVenturesIVLLCMember" abstract="true" name="HCPVenturesIVLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" abstract="false" name="IntangibleAssetsAndLiabilitiesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_NetIncomeLossJointVenturePartnersAttributableToParent" abstract="false" name="NetIncomeLossJointVenturePartnersAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_TermLoanAgreementMember" abstract="true" name="TermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_BrookdaleMTCAMember" abstract="true" name="BrookdaleMTCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MorganStanleyRealEstateInvestmentJVMember" abstract="true" name="MorganStanleyRealEstateInvestmentJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_TermLoanFacilitiesOneMember" abstract="true" name="TermLoanFacilitiesOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_VariableInterestEntitiesTextBlock" abstract="false" name="VariableInterestEntitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" abstract="true" name="EquityIncomeLossFromUnconsolidatedJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingAmountFunded" abstract="false" name="CapitalExpenditureFundingAmountFunded" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" abstract="false" name="InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_HealthpeakOPMember" abstract="true" name="HealthpeakOPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ATMEquityOfferingProgramAggregateAmountRemaining" abstract="false" name="ATMEquityOfferingProgramAggregateAmountRemaining" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfPropertiesSold" abstract="false" name="NumberOfPropertiesSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentPeriodOfExtension" abstract="false" name="DebtInstrumentPeriodOfExtension" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ATMDirectIssuancesMember" abstract="true" name="ATMDirectIssuancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" abstract="false" name="ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_DebtInstrumentMarginRate" abstract="false" name="DebtInstrumentMarginRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_NetRealEstateAssets" abstract="false" name="NetRealEstateAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfDownREITLLCs" abstract="false" name="NumberOfDownREITLLCs" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" abstract="false" name="CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ForwardEquitySalesAgreementsMember" abstract="true" name="ForwardEquitySalesAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_A2020ATMProgramMember" abstract="true" name="A2020ATMProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NonrefundableEntranceFees" abstract="false" name="NonrefundableEntranceFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PaymentsToAcquireLoansReceivableAndOther" abstract="false" name="PaymentsToAcquireLoansReceivableAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_VenturesVLLCMember" abstract="true" name="VenturesVLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" abstract="false" name="OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfPropertiesAcquired" abstract="false" name="NumberOfPropertiesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_SuburbanPropertiesLLCMember" abstract="true" name="SuburbanPropertiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CurrentPeriodNetWriteOffsMember" abstract="true" name="CurrentPeriodNetWriteOffsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_WorkoutFinancingReceivableMember" abstract="true" name="WorkoutFinancingReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LoansReceivableTerm" abstract="false" name="LoansReceivableTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_RemainingMinorityInterestOwnershipPercentageByParent" abstract="false" name="RemainingMinorityInterestOwnershipPercentageByParent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_CurrentPeriodRecoveriesMember" abstract="true" name="CurrentPeriodRecoveriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ProceedsFromCollectionOfNonrefundableEntranceFees" abstract="false" name="ProceedsFromCollectionOfNonrefundableEntranceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" abstract="false" name="CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CommercialPaperProgramMember" abstract="true" name="CommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfSecuredLoans" abstract="false" name="NumberOfSecuredLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_WatchListFinancingReceivableMember" abstract="true" name="WatchListFinancingReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentDrawTimePeriodAfterClosing" abstract="false" name="DebtInstrumentDrawTimePeriodAfterClosing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_LoansReceivableOutstandingBalance" abstract="false" name="LoansReceivableOutstandingBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" abstract="false" name="CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" abstract="false" name="IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>18
<FILENAME>peak-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a27eb77-384d-480a-947d-64db2849bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f5e22566-8270-4582-8388-243d8596dfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a27eb77-384d-480a-947d-64db2849bbc9" xlink:to="loc_us-gaap_StockholdersEquity_f5e22566-8270-4582-8388-243d8596dfba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a56bdd2f-ff19-47ef-a862-d1453aa7570c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3a27eb77-384d-480a-947d-64db2849bbc9" xlink:to="loc_us-gaap_MinorityInterest_a56bdd2f-ff19-47ef-a862-d1453aa7570c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_de17abfd-4738-408a-964b-93452e7a5e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_22bf2746-ae08-460b-9e43-d28b2faef564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_de17abfd-4738-408a-964b-93452e7a5e3a" xlink:to="loc_us-gaap_Liabilities_22bf2746-ae08-460b-9e43-d28b2faef564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4371253-bc5a-4998-b1f3-4aba416b722b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_de17abfd-4738-408a-964b-93452e7a5e3a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4371253-bc5a-4998-b1f3-4aba416b722b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7ef7d443-e52c-4391-a9ac-a6c518ff3af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_de17abfd-4738-408a-964b-93452e7a5e3a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7ef7d443-e52c-4391-a9ac-a6c518ff3af5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_1c17ecd4-95da-4b1b-bf55-6cdf29b5ee86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_de17abfd-4738-408a-964b-93452e7a5e3a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_1c17ecd4-95da-4b1b-bf55-6cdf29b5ee86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6ad305f9-9bea-4019-95d6-700a76a6111f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_LineOfCredit_6ad305f9-9bea-4019-95d6-700a76a6111f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_092dde52-bfeb-48e3-a121-3abde232081a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_UnsecuredDebt_092dde52-bfeb-48e3-a121-3abde232081a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_1a40a2ef-f10f-408c-a295-95077e9f65c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_SecuredDebt_1a40a2ef-f10f-408c-a295-95077e9f65c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_e1032260-4c38-4c3f-ad5d-b055ceeae4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_e1032260-4c38-4c3f-ad5d-b055ceeae4c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_f88cbc4f-cea8-4536-829d-866f9a94cfb2" xlink:href="peak-20230331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_f88cbc4f-cea8-4536-829d-866f9a94cfb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_54b0c0b2-d952-4974-a345-51f32966a99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_OperatingLeaseLiability_54b0c0b2-d952-4974-a345-51f32966a99e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2a791c92-6ad2-4e99-9d8f-01d74e2f008f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2a791c92-6ad2-4e99-9d8f-01d74e2f008f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_09bbe253-c526-4e1f-a795-836f2ec50be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_09bbe253-c526-4e1f-a795-836f2ec50be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableToBank_7b788a4a-86b5-4e0c-b1c0-14b6b7ae7988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBank"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_31c6ec99-2da8-4626-8373-68889027544c" xlink:to="loc_us-gaap_LoansPayableToBank_7b788a4a-86b5-4e0c-b1c0-14b6b7ae7988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_df75901b-964e-4f83-82a2-674b24c59696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures_8824a61c-41d3-4195-a208-ce3efb4c87ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MinorityInterest_df75901b-964e-4f83-82a2-674b24c59696" xlink:to="loc_us-gaap_MinorityInterestInJointVentures_8824a61c-41d3-4195-a208-ce3efb4c87ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_4dade21d-1ba9-4dd5-b1b8-443cece8f2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MinorityInterest_df75901b-964e-4f83-82a2-674b24c59696" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_4dade21d-1ba9-4dd5-b1b8-443cece8f2e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f0c52e9-30ca-4390-8531-cf816358665e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_81ec1bbc-dd20-492c-8435-063c19f57741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9f0c52e9-30ca-4390-8531-cf816358665e" xlink:to="loc_us-gaap_CommonStockValue_81ec1bbc-dd20-492c-8435-063c19f57741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_235a422e-3ec7-4ffe-9e9b-71b1bfc94f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9f0c52e9-30ca-4390-8531-cf816358665e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_235a422e-3ec7-4ffe-9e9b-71b1bfc94f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_0fd28ac6-e33a-4318-b1e7-d23b9131c404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9f0c52e9-30ca-4390-8531-cf816358665e" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_0fd28ac6-e33a-4318-b1e7-d23b9131c404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c90f2ed3-ee65-48b0-8061-32032a26f9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9f0c52e9-30ca-4390-8531-cf816358665e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c90f2ed3-ee65-48b0-8061-32032a26f9bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_a247a39a-437f-4a7c-98d7-4b336899fa16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_b05f897f-ca86-4a43-b684-38dd69fb0f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_a247a39a-437f-4a7c-98d7-4b336899fa16" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_b05f897f-ca86-4a43-b684-38dd69fb0f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_2391d22c-5f0f-4775-8ad1-b8b272566d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_a247a39a-437f-4a7c-98d7-4b336899fa16" xlink:to="loc_us-gaap_DevelopmentInProcess_2391d22c-5f0f-4775-8ad1-b8b272566d0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e3f0eaca-1fd8-465c-acf1-2bbb1c4c0997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_a247a39a-437f-4a7c-98d7-4b336899fa16" xlink:to="loc_us-gaap_Land_e3f0eaca-1fd8-465c-acf1-2bbb1c4c0997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_0ac50a5f-5672-4cfc-9b43-71378dafb479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_a247a39a-437f-4a7c-98d7-4b336899fa16" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_0ac50a5f-5672-4cfc-9b43-71378dafb479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_2bfff231-9a67-4517-8504-c5f0a15027a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_2bfff231-9a67-4517-8504-c5f0a15027a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_abb55b60-5f25-45ff-bca3-7d98e3b14d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_abb55b60-5f25-45ff-bca3-7d98e3b14d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_143e58ee-5bc9-48b7-b5a3-ab84bec8eec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_143e58ee-5bc9-48b7-b5a3-ab84bec8eec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_a58d13bb-b760-4702-afba-cbfddb4250ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_AccountsReceivableNet_a58d13bb-b760-4702-afba-cbfddb4250ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efd7fc3c-667e-4c2f-9d07-05565a7d5aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efd7fc3c-667e-4c2f-9d07-05565a7d5aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_012de8a5-dc2e-4195-ae95-7a1c779018f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_012de8a5-dc2e-4195-ae95-7a1c779018f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7474bc25-4697-4f26-812c-fb55600aa040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7474bc25-4697-4f26-812c-fb55600aa040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2dfc4a6f-8b66-41cf-bea1-3e666cf3d4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2dfc4a6f-8b66-41cf-bea1-3e666cf3d4c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_d5b55c23-25fd-4af6-a958-84d4863aad88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_OtherAssets_d5b55c23-25fd-4af6-a958-84d4863aad88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_61494110-eaa8-4add-ac64-dc59546ca1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_29e16471-c038-43db-96c7-2aa87a989f10" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_61494110-eaa8-4add-ac64-dc59546ca1fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_26a94966-0b7c-40c8-bdf1-8c5864faa772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0206abfc-8ff3-4a74-b835-406559d199e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_26a94966-0b7c-40c8-bdf1-8c5864faa772" xlink:to="loc_us-gaap_Revenues_0206abfc-8ff3-4a74-b835-406559d199e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_db02f3f5-6c9b-4163-90ce-563487fd0ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_26a94966-0b7c-40c8-bdf1-8c5864faa772" xlink:to="loc_us-gaap_CostsAndExpenses_db02f3f5-6c9b-4163-90ce-563487fd0ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e70436c6-2f09-4744-aceb-7780048abf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_26a94966-0b7c-40c8-bdf1-8c5864faa772" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e70436c6-2f09-4744-aceb-7780048abf18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_95100867-8264-45da-ac22-c6929e34ab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_us-gaap_InterestExpense_95100867-8264-45da-ac22-c6929e34ab9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_0a2c4ad2-bae6-4f1f-9253-053a4e9c134a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_us-gaap_DepreciationAndAmortization_0a2c4ad2-bae6-4f1f-9253-053a4e9c134a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b82929c5-679a-4946-bf59-71fcc62b2fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b82929c5-679a-4946-bf59-71fcc62b2fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ed3de974-b8ab-421a-a4bb-bc3b0caea8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ed3de974-b8ab-421a-a4bb-bc3b0caea8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_eb9120dd-0402-4812-83df-c676cad342ec" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_eb9120dd-0402-4812-83df-c676cad342ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0274ba40-b5f8-4826-9afb-764a6450d106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_75b308ac-e094-464c-8f50-eef92d768e32" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0274ba40-b5f8-4826-9afb-764a6450d106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b6854450-a344-4159-9eff-bf3706174a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3bb2b6cc-0d67-4655-a5f0-e9bb6957803f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b6854450-a344-4159-9eff-bf3706174a43" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3bb2b6cc-0d67-4655-a5f0-e9bb6957803f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8f2f2831-d334-415b-a325-741f25f054e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b6854450-a344-4159-9eff-bf3706174a43" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8f2f2831-d334-415b-a325-741f25f054e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4944a248-a90d-4858-bc95-629e1c0b8c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b6854450-a344-4159-9eff-bf3706174a43" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4944a248-a90d-4858-bc95-629e1c0b8c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5dc3286b-a2ca-4247-bee8-26dd140e9393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_755cb7fe-af00-4825-bb79-52aea48f204d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5dc3286b-a2ca-4247-bee8-26dd140e9393" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_755cb7fe-af00-4825-bb79-52aea48f204d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f2b9e1b9-c70d-418e-9e3a-a7df4ebc76bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5dc3286b-a2ca-4247-bee8-26dd140e9393" xlink:to="loc_us-gaap_ProfitLoss_f2b9e1b9-c70d-418e-9e3a-a7df4ebc76bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_638982f2-23dc-49ec-aa06-6914e667b361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_7c9b6d0d-23a9-4198-894a-6d6115499ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_638982f2-23dc-49ec-aa06-6914e667b361" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_7c9b6d0d-23a9-4198-894a-6d6115499ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_798d9b38-68e4-450c-8c97-1a59ba6a7ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_638982f2-23dc-49ec-aa06-6914e667b361" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_798d9b38-68e4-450c-8c97-1a59ba6a7ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_84a63756-b541-4a82-bd14-0f835a6a29c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84d79f46-868e-4f90-b1f2-e944b4766553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_84a63756-b541-4a82-bd14-0f835a6a29c2" xlink:to="loc_us-gaap_NetIncomeLoss_84d79f46-868e-4f90-b1f2-e944b4766553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_9f5a8e65-49be-4933-8a5b-5bc1dccc7a7e" xlink:href="peak-20230331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_84a63756-b541-4a82-bd14-0f835a6a29c2" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_9f5a8e65-49be-4933-8a5b-5bc1dccc7a7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_22b1746c-9e55-401a-867f-cd8360893339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_51178b2b-f9c5-4786-ba36-5b697908ed5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_22b1746c-9e55-401a-867f-cd8360893339" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_51178b2b-f9c5-4786-ba36-5b697908ed5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5999c25-4d9a-46a2-ab12-7c2f47e2df6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_22b1746c-9e55-401a-867f-cd8360893339" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5999c25-4d9a-46a2-ab12-7c2f47e2df6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue_25785c28-b851-40bd-b447-ae46f47b6213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_22b1746c-9e55-401a-867f-cd8360893339" xlink:to="loc_us-gaap_DirectFinancingLeaseRevenue_25785c28-b851-40bd-b447-ae46f47b6213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_081d1285-ae40-4351-b86f-8e3a5ff28e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_22b1746c-9e55-401a-867f-cd8360893339" xlink:to="loc_us-gaap_InterestIncomeOperating_081d1285-ae40-4351-b86f-8e3a5ff28e4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1df3e603-2bba-4eda-bf39-d903fa1fc83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b213386f-e95d-4f92-a68a-3b3d421c55e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1df3e603-2bba-4eda-bf39-d903fa1fc83d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b213386f-e95d-4f92-a68a-3b3d421c55e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46a7070f-e5b5-4be2-8524-76e51204f674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1df3e603-2bba-4eda-bf39-d903fa1fc83d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_46a7070f-e5b5-4be2-8524-76e51204f674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ce0cc58f-a306-4a1d-acb4-8febea9ae9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_2eb2ec56-b082-4625-ae91-e3b686f9dbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ce0cc58f-a306-4a1d-acb4-8febea9ae9fe" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_2eb2ec56-b082-4625-ae91-e3b686f9dbea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4dbffdbb-82d9-47d0-8262-708def595407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ce0cc58f-a306-4a1d-acb4-8febea9ae9fe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4dbffdbb-82d9-47d0-8262-708def595407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5c69ee43-2f5a-4d17-a9e1-3124c2327735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_42dd73ab-a19d-4885-93fe-da25f1248213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5c69ee43-2f5a-4d17-a9e1-3124c2327735" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_42dd73ab-a19d-4885-93fe-da25f1248213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3cc2b01e-98ba-461f-bd90-78b5bf50884c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5c69ee43-2f5a-4d17-a9e1-3124c2327735" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3cc2b01e-98ba-461f-bd90-78b5bf50884c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e4f06809-6f8f-41ab-9350-a025ea3cd884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2f487c31-1025-4354-bb0b-e69c5a634c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e4f06809-6f8f-41ab-9350-a025ea3cd884" xlink:to="loc_us-gaap_ProfitLoss_2f487c31-1025-4354-bb0b-e69c5a634c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bb0062e-2b60-44c9-bb2a-41a11ff17524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e4f06809-6f8f-41ab-9350-a025ea3cd884" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bb0062e-2b60-44c9-bb2a-41a11ff17524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c2b9be31-31de-4785-875b-4e4c92d79733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_73b3d043-8fc1-4591-a453-7ea9f56a1144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c2b9be31-31de-4785-875b-4e4c92d79733" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_73b3d043-8fc1-4591-a453-7ea9f56a1144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_30972097-b145-419d-8133-652d6cdca657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c2b9be31-31de-4785-875b-4e4c92d79733" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_30972097-b145-419d-8133-652d6cdca657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd646bf8-736e-4d83-939d-2bef79cbb6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f48376ed-c331-4fc9-86de-709292b2a8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd646bf8-736e-4d83-939d-2bef79cbb6d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f48376ed-c331-4fc9-86de-709292b2a8d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7358dc1-c248-48e1-9fec-0108da564bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cd646bf8-736e-4d83-939d-2bef79cbb6d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c7358dc1-c248-48e1-9fec-0108da564bf0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9b04da5-53c7-4b1e-9c47-f6078024239c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8452c598-209d-4fdc-be8a-3a1b9829e316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9b04da5-53c7-4b1e-9c47-f6078024239c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8452c598-209d-4fdc-be8a-3a1b9829e316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58518fb5-97aa-438a-b6b9-cafcf28299cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9b04da5-53c7-4b1e-9c47-f6078024239c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58518fb5-97aa-438a-b6b9-cafcf28299cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_03b6318b-ad2a-4811-9280-462a2c35fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9b04da5-53c7-4b1e-9c47-f6078024239c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_03b6318b-ad2a-4811-9280-462a2c35fe06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_db6446b8-00b3-4cb4-9439-3b2273dfef2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_ProfitLoss_db6446b8-00b3-4cb4-9439-3b2273dfef2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_5e862e51-1f66-4838-999e-3ef4795f3c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_5e862e51-1f66-4838-999e-3ef4795f3c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_03bc0692-fb0e-41e3-b16c-c8570267b20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_ShareBasedCompensation_03bc0692-fb0e-41e3-b16c-c8570267b20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fdff7918-4175-4ea1-a1f0-bdf5abf436a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fdff7918-4175-4ea1-a1f0-bdf5abf436a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_4e40821a-68b1-40ca-8c29-7f7d824005bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_StraightLineRent_4e40821a-68b1-40ca-8c29-7f7d824005bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_c7915894-660b-412a-88ad-2818cf203f1d" xlink:href="peak-20230331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_c7915894-660b-412a-88ad-2818cf203f1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_9cf16fa3-b0d0-43ca-a6f5-4262908aa0a0" xlink:href="peak-20230331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_9cf16fa3-b0d0-43ca-a6f5-4262908aa0a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_f300763e-d8ec-4f02-863d-0f9bbc09c506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_f300763e-d8ec-4f02-863d-0f9bbc09c506" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c1d6c73f-6f4e-4c8b-b92f-d0c20e2dc6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_c1d6c73f-6f4e-4c8b-b92f-d0c20e2dc6e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1ef8a8c3-0bb5-4474-aa10-7d632a62944c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_AssetImpairmentCharges_1ef8a8c3-0bb5-4474-aa10-7d632a62944c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_489fd34a-47e6-45b2-bfed-557dccb71599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_489fd34a-47e6-45b2-bfed-557dccb71599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss_b546ddab-ae2a-4f13-9534-e822efdc1e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_InsuredEventGainLoss_b546ddab-ae2a-4f13-9534-e822efdc1e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_2d2a6bf8-2cf4-4904-9d2b-e76a2cf3470f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_2d2a6bf8-2cf4-4904-9d2b-e76a2cf3470f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_9c6f567a-3b9d-4e3d-8ab7-509a19c1325b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_9c6f567a-3b9d-4e3d-8ab7-509a19c1325b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0c0bc693-e057-4c7e-b247-5baa0d100dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0c0bc693-e057-4c7e-b247-5baa0d100dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_30bc7329-6c19-490e-bfaf-feb94e2cd645" xlink:href="peak-20230331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05e06d57-52c9-4c1d-8ce0-368f2f3c231a" xlink:to="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_30bc7329-6c19-490e-bfaf-feb94e2cd645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_0f0d3f7f-89aa-4b73-8495-8b28eaafece7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_0f0d3f7f-89aa-4b73-8495-8b28eaafece7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate_8b3010dd-648a-40d3-8f60-401bb3f04b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_PaymentsToAcquireOtherRealEstate_8b3010dd-648a-40d3-8f60-401bb3f04b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_3ba985e9-63ed-45fe-b37a-b08003ac8bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_3ba985e9-63ed-45fe-b37a-b08003ac8bc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_b32d3c8b-e858-4bc2-ad76-28b19eeb227a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_b32d3c8b-e858-4bc2-ad76-28b19eeb227a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_b1dcbae7-0522-451a-9868-263158d69660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_b1dcbae7-0522-451a-9868-263158d69660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther_74ad6f1f-a749-49fe-a422-ac55666c6df8" xlink:href="peak-20230331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_peak_PaymentsToAcquireLoansReceivableAndOther_74ad6f1f-a749-49fe-a422-ac55666c6df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_5432e261-059f-49b9-8c82-b29311b7afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_5432e261-059f-49b9-8c82-b29311b7afbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_d7495413-edec-47a6-9cf0-5293c1e8d78f" xlink:href="peak-20230331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_d7495413-edec-47a6-9cf0-5293c1e8d78f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_3d2fde4c-7716-40b3-a87c-88e5f7362ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_366cc641-d84b-4dee-8311-fb290331b455" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_3d2fde4c-7716-40b3-a87c-88e5f7362ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_e3ac70c2-f81a-4210-83b2-232e2a1e04e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_e3ac70c2-f81a-4210-83b2-232e2a1e04e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_00cc9af5-a456-4dae-b8d1-025757273f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_00cc9af5-a456-4dae-b8d1-025757273f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt_c053aeb4-de9d-4d81-8570-37e155a4942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_RepaymentsOfBankDebt_c053aeb4-de9d-4d81-8570-37e155a4942d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6c5ab260-cced-4fa5-a0e2-dabb16de402a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6c5ab260-cced-4fa5-a0e2-dabb16de402a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_582b763c-81e1-493e-8327-7faeb66ac392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_582b763c-81e1-493e-8327-7faeb66ac392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1ad15ede-cc4f-4b85-905b-13d1c912ba40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1ad15ede-cc4f-4b85-905b-13d1c912ba40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d44f075a-7b68-4d94-9ecd-bb7038b1c4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_PaymentsOfDividends_d44f075a-7b68-4d94-9ecd-bb7038b1c4d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_778bffae-8707-4be6-a11f-695948506d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_778bffae-8707-4be6-a11f-695948506d59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_68abe81c-24b0-49bb-80a0-f2f84a2b9618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_68abe81c-24b0-49bb-80a0-f2f84a2b9618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromBankDebt_8058f217-83a3-403c-9ad7-0149d290b8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d1098ca-b007-41d4-990a-889b8da1ba34" xlink:to="loc_us-gaap_ProceedsFromBankDebt_8058f217-83a3-403c-9ad7-0149d290b8b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_58597320-55f5-48f2-8039-688de33a225b" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_a214f83c-a44c-48f7-b560-beb493457970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_58597320-55f5-48f2-8039-688de33a225b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_a214f83c-a44c-48f7-b560-beb493457970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_4e9baf9b-2ea4-47d2-b62d-1e0622744b05" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_7ef3f40b-0648-4cbc-a21a-5f8e9b24c9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_4e9baf9b-2ea4-47d2-b62d-1e0622744b05" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_7ef3f40b-0648-4cbc-a21a-5f8e9b24c9e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_3fcd2369-e8af-4984-a651-1e7f0ddb8571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_4e9baf9b-2ea4-47d2-b62d-1e0622744b05" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_3fcd2369-e8af-4984-a651-1e7f0ddb8571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_52a83135-7c23-40ef-8938-466d4decb63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_f50e1a88-155b-49af-93fd-573b683a76a0" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_52a83135-7c23-40ef-8938-466d4decb63d" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_f50e1a88-155b-49af-93fd-573b683a76a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_41824de9-e5ab-4ce3-8fef-320af5432b7c" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_52a83135-7c23-40ef-8938-466d4decb63d" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_41824de9-e5ab-4ce3-8fef-320af5432b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_763ff5dc-c94a-4ea5-992d-8486f022427a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_52a83135-7c23-40ef-8938-466d4decb63d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_763ff5dc-c94a-4ea5-992d-8486f022427a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_fcc3ae99-d7e8-4de9-a747-ee07896a41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_67a0b8e6-3bfe-435c-a942-cc18f3bea8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_fcc3ae99-d7e8-4de9-a747-ee07896a41b7" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_67a0b8e6-3bfe-435c-a942-cc18f3bea8b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6f3e8eac-19ac-4f4f-bd26-8d37b2ac0d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_fcc3ae99-d7e8-4de9-a747-ee07896a41b7" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6f3e8eac-19ac-4f4f-bd26-8d37b2ac0d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04ea52de-1c00-42f0-a2e0-94010b0f4a44" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_fcc3ae99-d7e8-4de9-a747-ee07896a41b7" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_04ea52de-1c00-42f0-a2e0-94010b0f4a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_83d3e1d5-7956-48ea-b928-8dd89ff1a5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_8b371e79-eb2b-4408-b33a-d409fd34d133" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_83d3e1d5-7956-48ea-b928-8dd89ff1a5f9" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_8b371e79-eb2b-4408-b33a-d409fd34d133" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d85f2e53-bde4-40ab-b276-5f66a7440056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_8ade7c98-028c-48f6-be72-ba1d10c15b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d85f2e53-bde4-40ab-b276-5f66a7440056" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_8ade7c98-028c-48f6-be72-ba1d10c15b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_ff67736d-47b9-4fb8-a2fe-58672ae8d20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d85f2e53-bde4-40ab-b276-5f66a7440056" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_ff67736d-47b9-4fb8-a2fe-58672ae8d20b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_5d6649ad-74c0-4997-9dd3-b0ad01b26b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d85f2e53-bde4-40ab-b276-5f66a7440056" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_5d6649ad-74c0-4997-9dd3-b0ad01b26b0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_93313564-de71-48d5-859f-346821f7dc06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_93313564-de71-48d5-859f-346821f7dc06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_1075ad77-9a97-493f-8295-47ce5dfb13b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_1075ad77-9a97-493f-8295-47ce5dfb13b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_842aff24-6bcb-4d25-abe8-9c01c6aec447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_842aff24-6bcb-4d25-abe8-9c01c6aec447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_cdcd15e2-b46c-4901-bf3d-2a603b5965ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_cdcd15e2-b46c-4901-bf3d-2a603b5965ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_d06d2f8d-a99e-427e-ae27-8f0ebacc9f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_d06d2f8d-a99e-427e-ae27-8f0ebacc9f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_824ba5bc-3c75-47ae-ba3d-ad02030eccfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbebf4fa-eb34-43cf-88b5-7d5a76359278" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_824ba5bc-3c75-47ae-ba3d-ad02030eccfd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d149c80f-acab-4acc-835c-6252683957ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_81ef7aa4-6073-4a2b-9066-87845b68fa98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d149c80f-acab-4acc-835c-6252683957ca" xlink:to="loc_us-gaap_EquityMethodInvestments_81ef7aa4-6073-4a2b-9066-87845b68fa98" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesIntangiblesLeaseAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df686bb9-3ac9-4189-bcf2-4b74f485bf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b36014c8-5ae6-4b4e-8d9c-9790eca9f3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df686bb9-3ac9-4189-bcf2-4b74f485bf5d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b36014c8-5ae6-4b4e-8d9c-9790eca9f3bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fe850a7a-8e94-4420-b06e-d484f6db4ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df686bb9-3ac9-4189-bcf2-4b74f485bf5d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fe850a7a-8e94-4420-b06e-d484f6db4ea9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesIntangiblesLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet_4baf65ae-a48d-4e25-b923-8b26700fa830" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_d3fe331d-28e1-4658-a063-16ed33563c64" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet_4baf65ae-a48d-4e25-b923-8b26700fa830" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_d3fe331d-28e1-4658-a063-16ed33563c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross_bea95c9c-c7a6-469e-a943-6c834f301c21" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet_4baf65ae-a48d-4e25-b923-8b26700fa830" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesGross_bea95c9c-c7a6-469e-a943-6c834f301c21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a51bf33e-e90e-4bf6-af37-359623becdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a51bf33e-e90e-4bf6-af37-359623becdf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_174f81bf-20f8-476f-8eed-e51e81289172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_174f81bf-20f8-476f-8eed-e51e81289172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5cea9e8-89c6-4288-ba11-d098523bdf76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5cea9e8-89c6-4288-ba11-d098523bdf76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7be1b2fc-f82f-414d-a6d3-a31c10d5a024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7be1b2fc-f82f-414d-a6d3-a31c10d5a024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ad85611a-ac69-4f30-aa0d-c74fa9582917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ad85611a-ac69-4f30-aa0d-c74fa9582917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_7a6f79fe-abba-453f-9ac4-240a243ac334" xlink:href="peak-20230331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_60fc169f-eb2c-4dc3-bf05-74944e3c3b42" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_7a6f79fe-abba-453f-9ac4-240a243ac334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5b811aec-f096-4c7b-8b61-37d60e8264a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f00491be-ec15-4785-814b-7c38f624c636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_5b811aec-f096-4c7b-8b61-37d60e8264a4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f00491be-ec15-4785-814b-7c38f624c636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_dbdfb1e6-2d61-4495-96a1-0a01146e5dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_5b811aec-f096-4c7b-8b61-37d60e8264a4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_dbdfb1e6-2d61-4495-96a1-0a01146e5dcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33ffcf9d-9d58-466c-b104-dd27221cdbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_6b184831-d688-46f8-8c42-69948ab003ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33ffcf9d-9d58-466c-b104-dd27221cdbfe" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_6b184831-d688-46f8-8c42-69948ab003ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_e6693d97-a5f1-41a4-b292-6b4f5863caab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33ffcf9d-9d58-466c-b104-dd27221cdbfe" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_e6693d97-a5f1-41a4-b292-6b4f5863caab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShareComputationofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_67be8cf2-e514-4129-aeb8-fb239d6bd594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_72238811-0a63-4bfd-8155-c41459b39b75" xlink:href="peak-20230331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_67be8cf2-e514-4129-aeb8-fb239d6bd594" xlink:to="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_72238811-0a63-4bfd-8155-c41459b39b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fbb17727-546b-4bad-a942-3aeaf6248839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_67be8cf2-e514-4129-aeb8-fb239d6bd594" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fbb17727-546b-4bad-a942-3aeaf6248839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_3ca83bf9-f58c-48e5-b7b2-f520a3477dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_4bdbb936-17c4-48a6-a03f-7509b36bcd79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_3ca83bf9-f58c-48e5-b7b2-f520a3477dc2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_4bdbb936-17c4-48a6-a03f-7509b36bcd79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4803573c-072b-4d10-a4bf-25f3ac645096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_3ca83bf9-f58c-48e5-b7b2-f520a3477dc2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4803573c-072b-4d10-a4bf-25f3ac645096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33fc91b5-d859-4cf1-a8e4-e7eb9ce94115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_cbaba671-1217-4c46-a68f-bae5ed4d7805" xlink:href="peak-20230331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33fc91b5-d859-4cf1-a8e4-e7eb9ce94115" xlink:to="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_cbaba671-1217-4c46-a68f-bae5ed4d7805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd516df1-c00b-4e6e-9b98-343315dc13cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_33fc91b5-d859-4cf1-a8e4-e7eb9ce94115" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_bd516df1-c00b-4e6e-9b98-343315dc13cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86f730ef-0ec4-4cfa-b20c-8b05c11ad532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_741eee44-77f8-4431-a960-398c36738151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86f730ef-0ec4-4cfa-b20c-8b05c11ad532" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_741eee44-77f8-4431-a960-398c36738151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_502d11dc-2684-43b1-800c-c6822c4e2acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86f730ef-0ec4-4cfa-b20c-8b05c11ad532" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_502d11dc-2684-43b1-800c-c6822c4e2acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_3e9e9d2a-dbc3-4218-bb14-1e03d0bf0130" xlink:href="peak-20230331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_1771ec73-b550-450e-ab0b-e0b8f1d4fb7c" xlink:href="peak-20230331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_3e9e9d2a-dbc3-4218-bb14-1e03d0bf0130" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_1771ec73-b550-450e-ab0b-e0b8f1d4fb7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_37b2c4b8-5181-465c-9363-33d307f0b047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_3e9e9d2a-dbc3-4218-bb14-1e03d0bf0130" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_37b2c4b8-5181-465c-9363-33d307f0b047" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_568cd6fd-6280-47f1-a8c1-6651efa39f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_DepreciationAndAmortization_568cd6fd-6280-47f1-a8c1-6651efa39f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_644cdb24-1784-4e96-b069-dd60dad06a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_644cdb24-1784-4e96-b069-dd60dad06a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_5b32f78b-290f-4d2c-88e6-3287218a10d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_5b32f78b-290f-4d2c-88e6-3287218a10d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_49943ff9-f3d8-4afd-82e9-982969c1430a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_InterestIncomeOperating_49943ff9-f3d8-4afd-82e9-982969c1430a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_74e6d957-8a8f-46a6-b615-9d56464968a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_74e6d957-8a8f-46a6-b615-9d56464968a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_fe7bef04-bb69-431c-9b91-3c1e32a1943b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_InterestExpense_fe7bef04-bb69-431c-9b91-3c1e32a1943b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f5cc220c-2de3-48d1-a5cc-78ff96426917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f5cc220c-2de3-48d1-a5cc-78ff96426917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_357b410b-c7b7-444c-b147-1421d202aacd" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_357b410b-c7b7-444c-b147-1421d202aacd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_1d51b0ba-b4f3-4f9f-a820-636e4cecd209" xlink:href="peak-20230331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_1d51b0ba-b4f3-4f9f-a820-636e4cecd209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_b25361ca-c7b4-4c1f-b589-3ee74d18ef34" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_b25361ca-c7b4-4c1f-b589-3ee74d18ef34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_50822c73-b08f-4825-bf46-b4a51fe16717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_50822c73-b08f-4825-bf46-b4a51fe16717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_5e4cd9b9-175f-451e-a1b4-2dc2c0a72922" xlink:href="peak-20230331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_5e4cd9b9-175f-451e-a1b4-2dc2c0a72922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_b98653c2-1cc8-4bac-aa49-9c02d09f81ab" xlink:href="peak-20230331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_53aeee90-e6e7-4521-9b95-8a539f6132db" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_b98653c2-1cc8-4bac-aa49-9c02d09f81ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:href="peak-20230331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_434ea262-4d13-441d-a74b-b1e3edaf9070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_us-gaap_Revenues_434ea262-4d13-441d-a74b-b1e3edaf9070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_e32f87d5-51fd-4b81-8a72-c90d9a72973b" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_e32f87d5-51fd-4b81-8a72-c90d9a72973b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_233bc5b9-8b6f-4120-aea8-f2d408c30b97" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_233bc5b9-8b6f-4120-aea8-f2d408c30b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cd22075a-4484-428f-bac1-0f017115db65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_us-gaap_OperatingExpenses_cd22075a-4484-428f-bac1-0f017115db65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_095d2caf-5fc4-40af-9713-f6ade07f74eb" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_095d2caf-5fc4-40af-9713-f6ade07f74eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_ad13e56b-6b86-4411-a068-fc2281199b1e" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_ad13e56b-6b86-4411-a068-fc2281199b1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_18904758-a093-454e-bba4-a4e44d99a3ee" xlink:href="peak-20230331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_18904758-a093-454e-bba4-a4e44d99a3ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_a9498420-cd26-4433-b27c-5c16ca2843a5" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_a9498420-cd26-4433-b27c-5c16ca2843a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_73b2afd0-40a4-4d63-b5c8-babded4188d9" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_73b2afd0-40a4-4d63-b5c8-babded4188d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_135dc6e6-de9c-4ee8-bac2-63896fa27d3c" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_f765c56d-c323-4b19-a170-47fee7e00d11" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_135dc6e6-de9c-4ee8-bac2-63896fa27d3c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05c3288-7162-4c78-a163-1665a728a2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae195735-a37f-4bb9-8296-0bbd327f7e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05c3288-7162-4c78-a163-1665a728a2a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ae195735-a37f-4bb9-8296-0bbd327f7e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_c403c361-35cf-4f3f-b570-19d216c56564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f05c3288-7162-4c78-a163-1665a728a2a6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_c403c361-35cf-4f3f-b570-19d216c56564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e18f5311-cf4d-4d23-bcb3-5a09ad0da09b" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_24063e0d-dd57-449d-b7d0-d3de792eb85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e18f5311-cf4d-4d23-bcb3-5a09ad0da09b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_24063e0d-dd57-449d-b7d0-d3de792eb85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_ef7e34aa-66d7-4fe5-be2d-fe7dee904195" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e18f5311-cf4d-4d23-bcb3-5a09ad0da09b" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_ef7e34aa-66d7-4fe5-be2d-fe7dee904195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_d235ab43-9c72-4b4f-8ca3-03eb77d51ca8" xlink:href="peak-20230331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_b39ef6a6-bdd3-4f21-b9be-bb774f29f49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_d235ab43-9c72-4b4f-8ca3-03eb77d51ca8" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_b39ef6a6-bdd3-4f21-b9be-bb774f29f49e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99232b15-9862-4387-a68a-77d32fa4bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_d235ab43-9c72-4b4f-8ca3-03eb77d51ca8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99232b15-9862-4387-a68a-77d32fa4bf0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_b2c16d45-041e-46c6-b375-8448483c9da0" xlink:href="peak-20230331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_a8b1c09a-313c-4725-b607-2441b180dabe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_b2c16d45-041e-46c6-b375-8448483c9da0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_a8b1c09a-313c-4725-b607-2441b180dabe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_203beb1a-b182-4929-a84e-bc6585a9ce82" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_b2c16d45-041e-46c6-b375-8448483c9da0" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_203beb1a-b182-4929-a84e-bc6585a9ce82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9bd6b49c-b85f-4586-b11a-7a224af187b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83041006-386b-40d8-931b-5bda8de96a3c" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9bd6b49c-b85f-4586-b11a-7a224af187b7" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83041006-386b-40d8-931b-5bda8de96a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94eb6338-9074-4b8d-a625-db883479a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9bd6b49c-b85f-4586-b11a-7a224af187b7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94eb6338-9074-4b8d-a625-db883479a5bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_469f3ea5-c934-4372-b1a3-94e4c84514de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_b7da4a25-b63a-448f-ac45-56b7e6a509a0" xlink:href="peak-20230331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_469f3ea5-c934-4372-b1a3-94e4c84514de" xlink:to="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_b7da4a25-b63a-448f-ac45-56b7e6a509a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_d52c2b2b-fff6-42a7-a41a-95ba2b0e10a0" xlink:href="peak-20230331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_469f3ea5-c934-4372-b1a3-94e4c84514de" xlink:to="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_d52c2b2b-fff6-42a7-a41a-95ba2b0e10a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6cb089e5-012c-4113-b4f2-3ad430830331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_9089bfe8-f1c9-43b9-9ce1-9b6567b863e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6cb089e5-012c-4113-b4f2-3ad430830331" xlink:to="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_9089bfe8-f1c9-43b9-9ce1-9b6567b863e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_d3746676-98ea-48b1-98a6-341ca8ecb09c" xlink:href="peak-20230331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6cb089e5-012c-4113-b4f2-3ad430830331" xlink:to="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_d3746676-98ea-48b1-98a6-341ca8ecb09c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_3e1232e4-ab51-4304-bf36-5014ce1a0fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6cb089e5-012c-4113-b4f2-3ad430830331" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_3e1232e4-ab51-4304-bf36-5014ce1a0fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_9ff16190-7fc5-4135-b96f-0c555f619dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6cb089e5-012c-4113-b4f2-3ad430830331" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_9ff16190-7fc5-4135-b96f-0c555f619dfc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>peak-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="extended" id="id21ba644e86a44b79c959447ec038396_CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8454da4e-8614-403c-90a7-b3e81718aa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_SharesIssued_8454da4e-8614-403c-90a7-b3e81718aa3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f9cce6c-2d6a-4e1b-be25-48b799a7f093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f9cce6c-2d6a-4e1b-be25-48b799a7f093" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_8bb9a0a7-3177-40c5-8d87-15db47ccbc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_8bb9a0a7-3177-40c5-8d87-15db47ccbc98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b60ec8a1-9068-4c34-a22f-e7b4094dbdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b60ec8a1-9068-4c34-a22f-e7b4094dbdc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_37c92a09-d52e-49e4-be09-573d94bdfeec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_37c92a09-d52e-49e4-be09-573d94bdfeec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e690dfa9-17b3-4ae4-84e7-e0ecfde24ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e690dfa9-17b3-4ae4-84e7-e0ecfde24ce8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d6b667c7-8162-46ce-be4a-32f727509720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d6b667c7-8162-46ce-be4a-32f727509720" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ee56de10-c548-4d66-a2c3-7002ba37c8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ee56de10-c548-4d66-a2c3-7002ba37c8df" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b850866d-87a9-4a89-a13e-41262d88a460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b850866d-87a9-4a89-a13e-41262d88a460" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1a971f84-9193-4405-ba99-7bbba12a8f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_DividendsCommonStock_1a971f84-9193-4405-ba99-7bbba12a8f88" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3cc2adb8-59a3-44d1-91b1-eca98e193c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3cc2adb8-59a3-44d1-91b1-eca98e193c1f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_de275e56-ab69-4772-a109-78f8bca7836a" xlink:href="peak-20230331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_de275e56-ab69-4772-a109-78f8bca7836a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e339a29d-7534-45a3-a3ac-25e28e7eaeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a548dbc-5e22-459e-b04c-3dd4b4125024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_da606217-3d26-4ca8-bf25-1fb7e5aafb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_da606217-3d26-4ca8-bf25-1fb7e5aafb0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5111f4e7-c009-4aa5-ae9a-2aa29a9d5898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5111f4e7-c009-4aa5-ae9a-2aa29a9d5898" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b9fb65c9-04bb-4d49-b664-51a11c212684" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b9fb65c9-04bb-4d49-b664-51a11c212684" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_fa47e224-f53f-417d-950e-b38bb2e77eb6" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_fa47e224-f53f-417d-950e-b38bb2e77eb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fe4b92eb-0d75-4edf-805f-2915b5d3c518" xlink:href="peak-20230331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fe4b92eb-0d75-4edf-805f-2915b5d3c518" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_87205c1c-27be-4049-b658-3447d9e6d131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:to="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_746898f4-cc28-491b-a39e-d9ca8ff4f802_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:to="loc_us-gaap_EquityComponentDomain_746898f4-cc28-491b-a39e-d9ca8ff4f802_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:to="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:to="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9862eae9-74e8-40a2-92f6-15b3cc57439c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_CommonStockMember_9862eae9-74e8-40a2-92f6-15b3cc57439c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_db9650ad-8b4c-4612-a431-5389ffa26788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_db9650ad-8b4c-4612-a431-5389ffa26788" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_8435cded-cbcf-4fd5-be1e-fc1240a48ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_8435cded-cbcf-4fd5-be1e-fc1240a48ab7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a1db6d56-0c44-434b-a913-07f9a2004f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a1db6d56-0c44-434b-a913-07f9a2004f5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b0d69ce3-8d93-44b5-b2dc-ee8aaa0a2e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b0d69ce3-8d93-44b5-b2dc-ee8aaa0a2e98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="extended" id="if510230788e9411fa3fd8bb77c6d8b3c_SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome_d6085ca1-4738-4089-b627-da376f4ca25b" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:to="loc_peak_GovernmentGrantIncome_d6085ca1-4738-4089-b627-da376f4ca25b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:to="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_fc1d9632-c9fb-4074-bbb1-4644d6c10e21_default" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:to="loc_peak_GovernmentAssistanceDomain_fc1d9632-c9fb-4074-bbb1-4644d6c10e21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:to="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember_6abd7b94-fe77-4106-9a49-b2449e9b63ce" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:to="loc_peak_GovernmentAssistanceCARESActMember_6abd7b94-fe77-4106-9a49-b2449e9b63ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_677a9193-3f2c-434e-b076-32b4b4e7fa7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_677a9193-3f2c-434e-b076-32b4b4e7fa7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_35a07b17-ffbf-41e2-86c9-170eeb9b62e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_35a07b17-ffbf-41e2-86c9-170eeb9b62e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_dc2fe07f-91c6-475d-8fa9-ededac85301b" xlink:href="peak-20230331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_dc2fe07f-91c6-475d-8fa9-ededac85301b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember_a88bd6d4-3ec9-4391-84a1-a9cccef66919" xlink:href="peak-20230331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_peak_IncomeLossFromDiscontinuedOperationsMember_a88bd6d4-3ec9-4391-84a1-a9cccef66919" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#RealEstateRealEstateInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails" xlink:type="extended" id="if8467aebcf3d4b0583a3531503b5f074_RealEstateRealEstateInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_b314debd-b374-4c86-b121-ec1f403eab22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_b314debd-b374-4c86-b121-ec1f403eab22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_b8de48bd-e1b2-4dba-aa26-9c05f0a5770c" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:to="loc_peak_NumberOfPropertiesAcquired_b8de48bd-e1b2-4dba-aa26-9c05f0a5770c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:to="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f0278f80-6998-4f61-83a3-aa6710a14bab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:to="loc_us-gaap_SegmentDomain_f0278f80-6998-4f61-83a3-aa6710a14bab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:to="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_ec736159-366d-4fbc-a485-93546015e0c3" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:to="loc_peak_LifeScienceMember_ec736159-366d-4fbc-a485-93546015e0c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_59737f81-3cf4-43f5-8b10-e8560777514c" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:to="loc_peak_MedicalOfficeMember_59737f81-3cf4-43f5-8b10-e8560777514c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:to="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:to="loc_srt_SegmentGeographicalDomain_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:to="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_bb209297-781e-442d-951d-dba28b5da4bb" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_MA_bb209297-781e-442d-951d-dba28b5da4bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_2123925d-bc7a-4c86-9c10-57d68900f75b" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_CA_2123925d-bc7a-4c86-9c10-57d68900f75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_db3081be-5e5c-4012-8a33-0bb6985c4fca" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_TX_db3081be-5e5c-4012-8a33-0bb6985c4fca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_ae9a3c5a-f9aa-497b-b969-ac7d7ae50953" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_AR_ae9a3c5a-f9aa-497b-b969-ac7d7ae50953" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="i017fdf75883242abaa014915f084712a_DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold_db9aa510-92da-4206-add8-4f86079597bb" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_NumberOfPropertiesSold_db9aa510-92da-4206-add8-4f86079597bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_742fd16c-1a3f-4e0a-82f4-cc8729fc5a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_742fd16c-1a3f-4e0a-82f4-cc8729fc5a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_c313acf5-0a7c-4302-b94b-2d0443e5fab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_c313acf5-0a7c-4302-b94b-2d0443e5fab7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_59736b9c-fc30-4a0c-9506-8aa96615c934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_59736b9c-fc30-4a0c-9506-8aa96615c934" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_835dc368-45f6-4356-b5fe-12e2b86f61a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_835dc368-45f6-4356-b5fe-12e2b86f61a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber_467d33c4-b297-4aeb-8b36-5c34b9c11842" xlink:href="peak-20230331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_PropertiesHeldForSaleNumber_467d33c4-b297-4aeb-8b36-5c34b9c11842" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c61a215a-5d1a-4601-948c-27dfb4991c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c61a215a-5d1a-4601-948c-27dfb4991c0a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets_a4465cb8-18b6-4922-a36d-e7e8e2858dd0" xlink:href="peak-20230331.xsd#peak_NetRealEstateAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_NetRealEstateAssets_a4465cb8-18b6-4922-a36d-e7e8e2858dd0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_0a7b4b63-c48d-48c6-ac85-4dddf3d81f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_0a7b4b63-c48d-48c6-ac85-4dddf3d81f3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_09809ed5-e9a4-4724-8c6d-b648add84f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_09809ed5-e9a4-4724-8c6d-b648add84f8c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_4d3f46e1-48a5-4c80-8b77-492bb395f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_OtherNonrecurringExpense_4d3f46e1-48a5-4c80-8b77-492bb395f6b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e24bf09c-09b4-4a09-85a2-5097cf28e94a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:to="loc_us-gaap_SegmentDomain_e24bf09c-09b4-4a09-85a2-5097cf28e94a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:to="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_d1bcf95e-495f-42dd-a48e-bc7da350365b" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_LifeScienceMember_d1bcf95e-495f-42dd-a48e-bc7da350365b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_a1b9486c-a32b-4330-994b-9a0937854ab6" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_MedicalOfficeMember_a1b9486c-a32b-4330-994b-9a0937854ab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MOBLandParcelsMember_dccf3a82-c44a-4479-8d79-5c36d5b8d9a1" xlink:href="peak-20230331.xsd#peak_MOBLandParcelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_MOBLandParcelsMember_dccf3a82-c44a-4479-8d79-5c36d5b8d9a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9f218b5b-21ae-40c0-8c81-eea421f18afd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9f218b5b-21ae-40c0-8c81-eea421f18afd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ffcd7d93-cd0a-4412-8de5-b8d73458217b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ffcd7d93-cd0a-4412-8de5-b8d73458217b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_0215be66-228e-4f30-a8b6-13f64a65ddfb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_0215be66-228e-4f30-a8b6-13f64a65ddfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_5c1ff83a-ebd4-4e74-8bea-b2418c1b9fe4" xlink:href="peak-20230331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:to="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_5c1ff83a-ebd4-4e74-8bea-b2418c1b9fe4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended" id="ia0c6f831affe4f8f8023e63e0654dfa4_DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_22cc5007-dd20-4f6b-bc65-41b1ad44f572" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_22cc5007-dd20-4f6b-bc65-41b1ad44f572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f5ea1376-5a78-4c7e-bde8-e0e79018064f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f5ea1376-5a78-4c7e-bde8-e0e79018064f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_5ce1d6df-e6b5-4426-9765-ca9dc7f03c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_5ce1d6df-e6b5-4426-9765-ca9dc7f03c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_12683727-1d14-4dd7-a9c1-bc5a9d280815" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_12683727-1d14-4dd7-a9c1-bc5a9d280815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_18605fb3-fb0e-459d-a412-e4a0f9ad94de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_18605fb3-fb0e-459d-a412-e4a0f9ad94de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_0b279d89-4a16-48dc-a5ae-260597afee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_0b279d89-4a16-48dc-a5ae-260597afee85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_950d77c9-7e5d-409d-bab2-d9d6fb4e8e9c" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_950d77c9-7e5d-409d-bab2-d9d6fb4e8e9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1589b7e6-f3fe-43c8-8dd4-60ea5e2abb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1589b7e6-f3fe-43c8-8dd4-60ea5e2abb35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_93bc31ee-a622-450c-9d58-4e53d01fa521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_93bc31ee-a622-450c-9d58-4e53d01fa521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82e8a514-cde2-4e1a-aa8f-7457abe4bd8e" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82e8a514-cde2-4e1a-aa8f-7457abe4bd8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9493ebcc-dc6f-4db5-ae3e-0acf7b3a24eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9493ebcc-dc6f-4db5-ae3e-0acf7b3a24eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7850a4e5-c523-4e0a-b16c-4d8d987fa533_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7850a4e5-c523-4e0a-b16c-4d8d987fa533_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_b6c5976e-fb72-409d-a4ff-88bdd6e017bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_b6c5976e-fb72-409d-a4ff-88bdd6e017bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i1d05acbc5dfe48a08b68676d43aa81dc_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_1e8e0551-2581-4127-b925-76acb0c15f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLeaseReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_1e8e0551-2581-4127-b925-76acb0c15f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable_55eeee0e-67f9-450a-bcea-8ed225c63628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_GainLossOnSaleOfNotesReceivable_55eeee0e-67f9-450a-bcea-8ed225c63628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesWithDirectFinancingLeasesNumber_38f93dbf-7c38-4d63-8215-9c019e961bbe" xlink:href="peak-20230331.xsd#peak_PropertiesWithDirectFinancingLeasesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_peak_PropertiesWithDirectFinancingLeasesNumber_38f93dbf-7c38-4d63-8215-9c019e961bbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_9073dd51-ce77-4af7-936c-4770bb7925f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_StraightLineRent_9073dd51-ce77-4af7-936c-4770bb7925f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8d19a356-11ea-4770-aa0d-e36722d4f67c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:to="loc_us-gaap_SegmentDomain_8d19a356-11ea-4770-aa0d-e36722d4f67c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:to="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_0ccca533-9c98-443c-a99a-c136aeb5432d" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:to="loc_peak_LifeScienceMember_0ccca533-9c98-443c-a99a-c136aeb5432d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_047b5cf9-7fdd-462d-95e9-6110a28a2d98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:to="loc_us-gaap_RelatedPartyDomain_047b5cf9-7fdd-462d-95e9-6110a28a2d98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:to="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SorrentoTherapeuticsIncMember_dd6c15b6-ca44-49a3-ae43-8f09d7d55209" xlink:href="peak-20230331.xsd#peak_SorrentoTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:to="loc_peak_SorrentoTherapeuticsIncMember_dd6c15b6-ca44-49a3-ae43-8f09d7d55209" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended" id="if2f5b8708d5a4a33a380aa3c7c163e36_LoansReceivableScheduleofLoansReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_838d5005-abd2-429a-839a-bdad19267888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_838d5005-abd2-429a-839a-bdad19267888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_c5c621be-71f9-4d4b-a1dd-8195d8e61410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_c5c621be-71f9-4d4b-a1dd-8195d8e61410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3532c0df-eab0-4f7c-960b-e05341c7579f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3532c0df-eab0-4f7c-960b-e05341c7579f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2c7fbadf-69a6-4df4-8dbe-cbff3867b1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2c7fbadf-69a6-4df4-8dbe-cbff3867b1c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansAndLeasesReceivableRemainingCommitments_4ae08fae-ae40-4a50-a7d8-d4085bc48e22" xlink:href="peak-20230331.xsd#peak_LoansAndLeasesReceivableRemainingCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_peak_LoansAndLeasesReceivableRemainingCommitments_4ae08fae-ae40-4a50-a7d8-d4085bc48e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_94d11dbf-38af-47db-92d3-b5d47f566cf4" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:to="loc_peak_SecuredMortgageLoansMember_94d11dbf-38af-47db-92d3-b5d47f566cf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCResidentLoansMember_88fe3b8b-5308-457e-8e7d-ea81cfaf98c6" xlink:href="peak-20230331.xsd#peak_CCRCResidentLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:to="loc_peak_CCRCResidentLoansMember_88fe3b8b-5308-457e-8e7d-ea81cfaf98c6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="extended" id="i3ba1fe510e174ecabbb89e621707d707_LoansReceivableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_bbdb3110-aec3-4fe6-b5ba-0c68568f808d" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_NumberOfPropertiesToBeSold_bbdb3110-aec3-4fe6-b5ba-0c68568f808d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_b935605c-1396-4f6c-8025-9cc7bc0f01b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_b935605c-1396-4f6c-8025-9cc7bc0f01b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a273387d-b5ac-4d12-a2f2-22477d798868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a273387d-b5ac-4d12-a2f2-22477d798868" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_20f4be26-9d7e-4589-9c80-6c1f2670a63e" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_20f4be26-9d7e-4589-9c80-6c1f2670a63e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_c99b71b0-d86b-49c7-89f1-e761e0dc0a30" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_c99b71b0-d86b-49c7-89f1-e761e0dc0a30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_3d04ca05-65d6-40cc-aa38-8d7096465e77" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_3d04ca05-65d6-40cc-aa38-8d7096465e77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_6f70df88-8a80-4555-ad34-5b980cd210d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_6f70df88-8a80-4555-ad34-5b980cd210d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_f0cd6c18-2eec-46fa-a505-3c699a14d63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_f0cd6c18-2eec-46fa-a505-3c699a14d63e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_e635fb92-9908-4006-b39c-7b1c80a10e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_e635fb92-9908-4006-b39c-7b1c80a10e90" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableExtensionFee_a106f375-5a34-431f-96c6-96d610cf5e4a" xlink:href="peak-20230331.xsd#peak_LoansReceivableExtensionFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableExtensionFee_a106f375-5a34-431f-96c6-96d610cf5e4a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfSecuredLoans_29b1043b-5b3a-4522-ac0b-369a86fb813f" xlink:href="peak-20230331.xsd#peak_NumberOfSecuredLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_NumberOfSecuredLoans_29b1043b-5b3a-4522-ac0b-369a86fb813f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_da7dd1d2-9365-4788-9d73-1ffcab1dcc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_da7dd1d2-9365-4788-9d73-1ffcab1dcc4f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableOutstandingBalance_e12befb7-0477-4030-9f7c-2f682712ad7e" xlink:href="peak-20230331.xsd#peak_LoansReceivableOutstandingBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableOutstandingBalance_e12befb7-0477-4030-9f7c-2f682712ad7e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableTerm_430ada0b-015f-4c9b-b9a4-6a9b319b2671" xlink:href="peak-20230331.xsd#peak_LoansReceivableTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableTerm_430ada0b-015f-4c9b-b9a4-6a9b319b2671" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_d27ad491-ad3b-41b7-b1f6-d9db37155027" xlink:href="peak-20230331.xsd#peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_d27ad491-ad3b-41b7-b1f6-d9db37155027" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_719889c4-f75d-4307-9fcb-4ac04936e30b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_719889c4-f75d-4307-9fcb-4ac04936e30b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_18a08a85-911a-426c-a22e-b9ff742c62b5" xlink:href="peak-20230331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_18a08a85-911a-426c-a22e-b9ff742c62b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5728e2d-585c-411a-ab32-48e4151aef4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:to="loc_us-gaap_SegmentDomain_d5728e2d-585c-411a-ab32-48e4151aef4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:to="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_a3840e6e-375c-4741-8b7d-48b251fedc63" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_a3840e6e-375c-4741-8b7d-48b251fedc63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_cfd0467f-7fa2-4f15-93f6-5f3737080163" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_SecuredMortgageLoansMember_cfd0467f-7fa2-4f15-93f6-5f3737080163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_cf5a4c47-db45-4811-bfef-9bb46f1847e9" xlink:href="peak-20230331.xsd#peak_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_MezzanineMember_cf5a4c47-db45-4811-bfef-9bb46f1847e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_60c563ac-48d7-48d5-94da-d0c018c3804b" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_OtherNonReportingSegmentMember_60c563ac-48d7-48d5-94da-d0c018c3804b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bf1dccef-4c24-4824-a059-e9c37dc07cfe_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:to="loc_srt_SegmentGeographicalDomain_bf1dccef-4c24-4824-a059-e9c37dc07cfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:to="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_2ac08499-51af-4097-b9a0-f677c40ce866" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_2ac08499-51af-4097-b9a0-f677c40ce866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_beac4001-0727-444a-8e1c-c87bb2b9b0ff" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_beac4001-0727-444a-8e1c-c87bb2b9b0ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_d56095dd-299c-4e4a-9ea8-104331c8d72f" xlink:href="peak-20230331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:to="loc_peak_CCRVJVInvestmentMember_d56095dd-299c-4e4a-9ea8-104331c8d72f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ead27933-6bd6-4292-a5be-e2c66f324252_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:to="loc_us-gaap_VariableRateDomain_ead27933-6bd6-4292-a5be-e2c66f324252_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:to="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_b3b6ce03-0c5d-4f67-8482-4efcad014537" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_b3b6ce03-0c5d-4f67-8482-4efcad014537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_c19f1451-9e91-4fbb-afae-7bf3a210fad2" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_c19f1451-9e91-4fbb-afae-7bf3a210fad2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_5bdaa87a-3ff6-41ef-a37f-06fbeededb01" xlink:href="peak-20230331.xsd#peak_BrookdaleMTCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:to="loc_peak_BrookdaleMTCAMember_5bdaa87a-3ff6-41ef-a37f-06fbeededb01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b4580d5e-5488-4186-bbc7-540dda69aee4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_b4580d5e-5488-4186-bbc7-540dda69aee4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember_916ae038-b04a-4037-8971-6fc5b5152ec5" xlink:href="peak-20230331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:to="loc_peak_LessorAssetUnderOperatingLeaseMember_916ae038-b04a-4037-8971-6fc5b5152ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_02a9431d-a929-46f4-bfeb-0b2159d86fbf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:to="loc_srt_ScenarioUnspecifiedDomain_02a9431d-a929-46f4-bfeb-0b2159d86fbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_57994de4-058c-4148-92f8-45411a396ecf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:to="loc_srt_ScenarioForecastMember_57994de4-058c-4148-92f8-45411a396ecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_521eeb2d-c44e-4a45-99c3-be7c466421f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:to="loc_us-gaap_ReceivableTypeDomain_521eeb2d-c44e-4a45-99c3-be7c466421f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:to="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherMember_eb52e310-bd02-4c4d-ad7b-1e2b94655e15" xlink:href="peak-20230331.xsd#peak_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:to="loc_peak_OtherMember_eb52e310-bd02-4c4d-ad7b-1e2b94655e15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7c30d50b-c68d-4802-bfe7-0156f87421e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7c30d50b-c68d-4802-bfe7-0156f87421e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eeaa9161-7839-421a-91c9-7605d2dbe1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:to="loc_us-gaap_SubsequentEventMember_eeaa9161-7839-421a-91c9-7605d2dbe1e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended" id="i0e2ea1d0bb884e4295c2f29024a73ce4_LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_870b3e26-b2bb-45f5-a10b-bf66ecd5cab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_870b3e26-b2bb-45f5-a10b-bf66ecd5cab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_dabce162-bf46-4054-a291-bb4210c29c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_dabce162-bf46-4054-a291-bb4210c29c60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_ec1f375d-f672-4b44-8f16-992be2c303e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_ec1f375d-f672-4b44-8f16-992be2c303e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_e9576749-f48b-4723-a9b5-686c5e74db6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_e9576749-f48b-4723-a9b5-686c5e74db6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_72bad2c1-998c-4af7-a412-b16e3ab141e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_72bad2c1-998c-4af7-a412-b16e3ab141e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_7f1ab9a8-7866-4e90-a54c-10bcffd4ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_7f1ab9a8-7866-4e90-a54c-10bcffd4ac09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_d0f15f6a-c05c-4f3e-bdb4-5d7734ac4375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_d0f15f6a-c05c-4f3e-bdb4-5d7734ac4375" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_c78b2c7c-7774-479b-bea2-22aedf6064dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_c78b2c7c-7774-479b-bea2-22aedf6064dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember_cb2de2ce-2ea1-4822-90dd-3c761f6e8401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_us-gaap_PerformingFinancingReceivableMember_cb2de2ce-2ea1-4822-90dd-3c761f6e8401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember_fd34d3d3-710d-4292-b47a-98ed4e101455" xlink:href="peak-20230331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_WatchListFinancingReceivableMember_fd34d3d3-710d-4292-b47a-98ed4e101455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember_f8870a47-82f6-424c-a34d-cacb1d7d8a83" xlink:href="peak-20230331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_WorkoutFinancingReceivableMember_f8870a47-82f6-424c-a34d-cacb1d7d8a83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodGrossWriteOffsMember_75d14106-0571-4afd-b8ae-e114840266e8" xlink:href="peak-20230331.xsd#peak_CurrentPeriodGrossWriteOffsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodGrossWriteOffsMember_75d14106-0571-4afd-b8ae-e114840266e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodRecoveriesMember_8d8a85c6-9735-4095-9b51-24fc27c664b2" xlink:href="peak-20230331.xsd#peak_CurrentPeriodRecoveriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodRecoveriesMember_8d8a85c6-9735-4095-9b51-24fc27c664b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodNetWriteOffsMember_5a1deeac-5184-45ba-b11e-f580583d9fb9" xlink:href="peak-20230331.xsd#peak_CurrentPeriodNetWriteOffsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodNetWriteOffsMember_5a1deeac-5184-45ba-b11e-f580583d9fb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_93a197b3-0cd8-4542-a6ca-6fc24a21b09c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:to="loc_us-gaap_ReceivableTypeDomain_93a197b3-0cd8-4542-a6ca-6fc24a21b09c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:to="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember_4d3c3243-ca90-4a94-a3dc-aa6dc6a674a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:to="loc_us-gaap_MortgageReceivablesMember_4d3c3243-ca90-4a94-a3dc-aa6dc6a674a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCResidentLoansMember_7f5f2d9d-83a5-45ed-a91e-b233345d1726" xlink:href="peak-20230331.xsd#peak_CCRCResidentLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:to="loc_peak_CCRCResidentLoansMember_7f5f2d9d-83a5-45ed-a91e-b233345d1726" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofReserveforLoanLossesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="extended" id="icfb7e27800934b92b2231582ec445e2a_LoansReceivableScheduleofReserveforLoanLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_266cdacb-26d5-4606-99c6-f9d5445af4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_266cdacb-26d5-4606-99c6-f9d5445af4b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_a8f84792-b272-49d1-8c7a-86576996a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_a8f84792-b272-49d1-8c7a-86576996a4be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_fedfee2f-8f02-4f06-8b62-179cc285470b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_fedfee2f-8f02-4f06-8b62-179cc285470b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3f5d1ded-59ec-43e0-bee1-78209eec0cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8312798e-17da-437b-b51b-b0da828e8fc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_8312798e-17da-437b-b51b-b0da828e8fc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_de9d41f6-f831-4453-abf7-ac2cd368c4cd" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:to="loc_peak_SecuredMortgageLoansMember_de9d41f6-f831-4453-abf7-ac2cd368c4cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherMember_f1d27263-9a2a-4f91-be18-7b0f044f22e3" xlink:href="peak-20230331.xsd#peak_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:to="loc_peak_OtherMember_f1d27263-9a2a-4f91-be18-7b0f044f22e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended" id="i6ad6c44a386345a1b034a76897d4dc9b_InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fff2f6da-10ce-430d-81ee-955e9e12a82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fff2f6da-10ce-430d-81ee-955e9e12a82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3296906b-faf7-4b43-9057-098d8c5461a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3296906b-faf7-4b43-9057-098d8c5461a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_26d8c9a2-1c62-44d2-8461-27b9275b0c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_EquityMethodInvestments_26d8c9a2-1c62-44d2-8461-27b9275b0c32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70e6e35d-c274-4e83-adab-f614ad67fb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70e6e35d-c274-4e83-adab-f614ad67fb0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_71859a54-adbc-49d8-a74e-33da047cad2b" xlink:href="peak-20230331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_71859a54-adbc-49d8-a74e-33da047cad2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_580b08c9-d329-47d7-955f-ec458687dc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_580b08c9-d329-47d7-955f-ec458687dc98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d4aa92d-f2be-467a-a424-7c9fb0d22948_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:to="loc_us-gaap_SegmentDomain_6d4aa92d-f2be-467a-a424-7c9fb0d22948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:to="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_0e9c898d-f698-44e3-b7f6-1ea760327019" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_OtherNonReportingSegmentMember_0e9c898d-f698-44e3-b7f6-1ea760327019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_3526410e-bc49-4350-bd46-3eacb9208ac2" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_LifeScienceMember_3526410e-bc49-4350-bd46-3eacb9208ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_c721ee8f-e084-4f14-a4bb-0a0c17dfd311" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_MedicalOfficeMember_c721ee8f-e084-4f14-a4bb-0a0c17dfd311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f9ac3a37-cd81-461c-875c-84b6bea800ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f9ac3a37-cd81-461c-875c-84b6bea800ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_3c1c2eba-561b-42c9-b12e-22ea5f33b329" xlink:href="peak-20230331.xsd#peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:to="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_3c1c2eba-561b-42c9-b12e-22ea5f33b329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_dc07c570-f99e-4e86-bf59-9ec98a14e80f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_dc07c570-f99e-4e86-bf59-9ec98a14e80f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember_3a87198a-b3df-460e-89ea-615c53a89dcc" xlink:href="peak-20230331.xsd#peak_SHOPJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_SHOPJVMember_3a87198a-b3df-460e-89ea-615c53a89dcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SouthSanFranciscoJVsMember_8d0366fd-030c-4715-906d-5726494b62ee" xlink:href="peak-20230331.xsd#peak_SouthSanFranciscoJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_SouthSanFranciscoJVsMember_8d0366fd-030c-4715-906d-5726494b62ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_40a11985-1919-470a-a12f-368ddc9a97d6" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_LifeScienceJVsMember_40a11985-1919-470a-a12f-368ddc9a97d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_d0a39473-c46b-402b-9520-8ea629746dba" xlink:href="peak-20230331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_NeedhamLandParcelJVMember_d0a39473-c46b-402b-9520-8ea629746dba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:href="peak-20230331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember_2bca58a4-0cf1-4543-8dc7-9a7708391452" xlink:href="peak-20230331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:to="loc_peak_HCPVenturesIVLLCMember_2bca58a4-0cf1-4543-8dc7-9a7708391452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember_225d6ffe-c2a4-49b5-9794-57727f31c842" xlink:href="peak-20230331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:to="loc_peak_SuburbanPropertiesLLCMember_225d6ffe-c2a4-49b5-9794-57727f31c842" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_81d497db-21e5-45be-b6fd-203a88fbb44e" xlink:href="peak-20230331.xsd#peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_81d497db-21e5-45be-b6fd-203a88fbb44e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4551d153-27ca-47c9-bddc-c13b2a74e553_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:to="loc_srt_RangeMember_4551d153-27ca-47c9-bddc-c13b2a74e553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:to="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3746d19b-0b34-4929-acb7-07fa5cddab02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:to="loc_srt_MinimumMember_3746d19b-0b34-4929-acb7-07fa5cddab02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e949b54a-d1c8-46ee-ae5a-cacfdfe552c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:to="loc_srt_MaximumMember_e949b54a-d1c8-46ee-ae5a-cacfdfe552c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1ca9a2a6-4975-4f4f-a949-3d498cd2406d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:to="loc_us-gaap_SubsequentEventMember_1ca9a2a6-4975-4f4f-a949-3d498cd2406d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesIntangiblesLeaseAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="extended" id="ic51aa656871e4233bda2b46d868bfd0b_IntangiblesIntangiblesLeaseAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea842557-4c64-4d42-9555-f23604728136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea842557-4c64-4d42-9555-f23604728136" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5ab957ee-0bf9-49ca-901a-85caa32ed422_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5ab957ee-0bf9-49ca-901a-85caa32ed422_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_70440ded-fd8c-4a66-a650-240fbc59adcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_70440ded-fd8c-4a66-a650-240fbc59adcb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="extended" id="ic556f80d16e1476fa06e9882c20aa028_IntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_25974413-8d2d-4228-a17c-f1d89fc3581f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_25974413-8d2d-4228-a17c-f1d89fc3581f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired_a0e0329b-2175-41df-bd10-5e0383720d1c" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired_a0e0329b-2175-41df-bd10-5e0383720d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44d426e2-f780-40d6-b936-f28ec7a050ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44d426e2-f780-40d6-b936-f28ec7a050ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7f7dc854-db20-4c0b-9138-b632bfd087f0" xlink:href="peak-20230331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7f7dc854-db20-4c0b-9138-b632bfd087f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_4623629d-f8f6-4804-b591-d61f4620f7a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:to="loc_srt_OtherPropertyMember_4623629d-f8f6-4804-b591-d61f4620f7a9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtBankLineofCreditandTermLoanDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails" xlink:type="extended" id="i4766badbbe064ce589ecbdd3726b12bd_DebtBankLineofCreditandTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_121d49aa-5541-45cc-9293-6d17ba0eb912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_121d49aa-5541-45cc-9293-6d17ba0eb912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions_3444d6bf-3cbc-43df-aefd-7e6794708eb8" xlink:href="peak-20230331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentNumberofExtensions_3444d6bf-3cbc-43df-aefd-7e6794708eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension_20791290-2837-42af-a218-74de37322ec8" xlink:href="peak-20230331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentPeriodOfExtension_20791290-2837-42af-a218-74de37322ec8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_ff2b011c-0a52-4e5a-8571-e715b7743094" xlink:href="peak-20230331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_ff2b011c-0a52-4e5a-8571-e715b7743094" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75429289-b4f9-4d4f-9507-1bc1de5aa29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75429289-b4f9-4d4f-9507-1bc1de5aa29f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5dff2a48-3a39-4b41-8934-64bc4e69f26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5dff2a48-3a39-4b41-8934-64bc4e69f26d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_8ea927d9-dd75-4254-801f-b8c7af8dc5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCredit_8ea927d9-dd75-4254-801f-b8c7af8dc5e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a34df5bf-e678-4d22-9e2b-ac07f91baeb0" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a34df5bf-e678-4d22-9e2b-ac07f91baeb0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfLoans_516e5855-6c46-4099-b844-9273c912996e" xlink:href="peak-20230331.xsd#peak_NumberOfLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_NumberOfLoans_516e5855-6c46-4099-b844-9273c912996e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c760ce9f-5c32-4e68-b235-512ade1cfa19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c760ce9f-5c32-4e68-b235-512ade1cfa19" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing_6f5155c5-4bd2-42b2-9030-72b0d460ed8a" xlink:href="peak-20230331.xsd#peak_DebtInstrumentDrawTimePeriodAfterClosing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing_6f5155c5-4bd2-42b2-9030-72b0d460ed8a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9b7fa1ca-8c0e-451f-a5d2-27c2b8732f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentTerm_9b7fa1ca-8c0e-451f-a5d2-27c2b8732f4c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f32e34da-fdd9-43bc-b09c-16c6794b42cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LongTermDebt_f32e34da-fdd9-43bc-b09c-16c6794b42cf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMarginRate_ccb9f590-da2f-498f-ac8b-8581f39ec415" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMarginRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentMarginRate_ccb9f590-da2f-498f-ac8b-8581f39ec415" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_ec4861c7-4e88-48bd-a6ca-f690763f2652" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_ec4861c7-4e88-48bd-a6ca-f690763f2652" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_0a9d100c-ffb3-405e-8ede-af3b440d4e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_0a9d100c-ffb3-405e-8ede-af3b440d4e9c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_b5fbc260-a8c5-4c9d-a5a3-eaf7c849993f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_b5fbc260-a8c5-4c9d-a5a3-eaf7c849993f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets_b2104522-7509-499c-b62b-5a945d309c69" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantDebtToAssets_b2104522-7509-499c-b62b-5a945d309c69" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_51d7cde5-27fb-4b2d-b7d7-013a33e32e4b" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_51d7cde5-27fb-4b2d-b7d7-013a33e32e4b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_e788e080-c2b6-40f2-9038-4b569abdf5bf" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_e788e080-c2b6-40f2-9038-4b569abdf5bf" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_a7273d83-5e9e-4faa-a343-3958f9b9c31e" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_a7273d83-5e9e-4faa-a343-3958f9b9c31e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorthMinimum_a6fff821-bdb2-4c2b-b598-fad9e513b938" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantNetWorthMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantNetWorthMinimum_a6fff821-bdb2-4c2b-b598-fad9e513b938" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f21dba73-8d0a-4a86-a00e-ebc0641c384f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:to="loc_us-gaap_CreditFacilityDomain_f21dba73-8d0a-4a86-a00e-ebc0641c384f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:to="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fc87d215-444b-46b5-906b-975f7d5b24e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fc87d215-444b-46b5-906b-975f7d5b24e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesMember_3f31b45b-d4f5-43a0-a56f-2b929531d4c9" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesMember_3f31b45b-d4f5-43a0-a56f-2b929531d4c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesOneMember_adfa9a0c-f152-4475-b002-52605419f29a" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesOneMember_adfa9a0c-f152-4475-b002-52605419f29a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesTwoMember_8c014e4b-4566-4411-9d0b-d73632e78d8e" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesTwoMember_8c014e4b-4566-4411-9d0b-d73632e78d8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c460f9ef-6e0f-4f72-ac72-ed7605be684b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c460f9ef-6e0f-4f72-ac72-ed7605be684b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e435564c-2d17-4ee5-9f7e-ece3f4a3bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:to="loc_us-gaap_LineOfCreditMember_e435564c-2d17-4ee5-9f7e-ece3f4a3bae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_97694d40-77a8-482b-aa50-bfef37a70555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:to="loc_us-gaap_VariableRateDomain_97694d40-77a8-482b-aa50-bfef37a70555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:to="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFRMember_65fae9e6-980c-49cd-96f3-69fa01658e09" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFRMember_65fae9e6-980c-49cd-96f3-69fa01658e09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanAgreementMember_c9081e9a-6e4a-4297-ae2c-c6b074c74629" xlink:href="peak-20230331.xsd#peak_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:to="loc_peak_TermLoanAgreementMember_c9081e9a-6e4a-4297-ae2c-c6b074c74629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65726a86-570e-4f90-896b-8271f7d5265e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65726a86-570e-4f90-896b-8271f7d5265e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2a959aa8-e8b1-4be9-bc31-a7525ad21e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:to="loc_us-gaap_InterestRateSwapMember_2a959aa8-e8b1-4be9-bc31-a7525ad21e7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cde82559-44db-4a9f-89a3-cd32f46231e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:to="loc_us-gaap_HedgingDesignationDomain_cde82559-44db-4a9f-89a3-cd32f46231e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:to="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2da8fd81-2378-4104-9d73-026f0f4a7b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2da8fd81-2378-4104-9d73-026f0f4a7b61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtCommercialPaperProgramDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="extended" id="i0efa6578acb9460397a4c96812973f29_DebtCommercialPaperProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity_6eb7193d-0391-41ad-bb55-76f051676b1b" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_peak_DebtInstrumentMaximumBorrowingCapacity_6eb7193d-0391-41ad-bb55-76f051676b1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_27c594f9-47be-46b7-ab53-49a9511eb73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_ShortTermBorrowings_27c594f9-47be-46b7-ab53-49a9511eb73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_5b315e6f-419c-4817-803a-4f493be523e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_DebtInstrumentTerm_5b315e6f-419c-4817-803a-4f493be523e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_8567a979-1243-4649-906e-84e8b1df8a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_8567a979-1243-4649-906e-84e8b1df8a06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e2a97fbd-4b10-43df-bb2d-dbf2ee369044_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e2a97fbd-4b10-43df-bb2d-dbf2ee369044_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember_2e2153e9-17e8-4e6c-8c4d-15c72e668c3e" xlink:href="peak-20230331.xsd#peak_CommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:to="loc_peak_CommercialPaperProgramMember_2e2153e9-17e8-4e6c-8c4d-15c72e668c3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtSeniorUnsecuredNotesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="extended" id="i3a6efd2e86f048d4bf64ea4023c35bf8_DebtSeniorUnsecuredNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1b64f763-3429-4e94-8a79-4058e877c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1b64f763-3429-4e94-8a79-4058e877c9fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_105d15cd-2705-422f-b575-7962ed7471b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_105d15cd-2705-422f-b575-7962ed7471b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04bbee85-1d7e-42fb-8951-706eb9052d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04bbee85-1d7e-42fb-8951-706eb9052d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_424fa159-72c5-4618-8c92-eec3100ec383_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_424fa159-72c5-4618-8c92-eec3100ec383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_f957ca89-8ef0-49af-b589-643a6b5dd120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:to="loc_us-gaap_UnsecuredDebtMember_f957ca89-8ef0-49af-b589-643a6b5dd120" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c8715b0-3088-48ac-964a-e927b8b9e4e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c8715b0-3088-48ac-964a-e927b8b9e4e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote525PercentMember_437b79dc-ff41-4b89-ae39-42b612162962" xlink:href="peak-20230331.xsd#peak_UnsecuredNote525PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:to="loc_peak_UnsecuredNote525PercentMember_437b79dc-ff41-4b89-ae39-42b612162962" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtMortgageDebtDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="extended" id="i8433721ce272432198f14e8b1401b133_DebtMortgageDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_75bb3a31-9e47-450e-972c-0a9b20307ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_75bb3a31-9e47-450e-972c-0a9b20307ba8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_dd0964aa-dee4-4a64-b4da-b4069d0a03c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_dd0964aa-dee4-4a64-b4da-b4069d0a03c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_fd2e260a-58e8-4f80-9efe-3dd90a7197ba" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_fd2e260a-58e8-4f80-9efe-3dd90a7197ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3e48e2cd-ee38-491f-8d6a-06ec9f6c8718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3e48e2cd-ee38-491f-8d6a-06ec9f6c8718" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_af094bb7-bb3e-4e32-bc1f-804e69208608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_af094bb7-bb3e-4e32-bc1f-804e69208608" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_bf8b16fd-041c-4cb5-93e8-8efacb4a0d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_bf8b16fd-041c-4cb5-93e8-8efacb4a0d71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8fd4c397-8829-4c3c-b7cd-548cfbb48275_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8fd4c397-8829-4c3c-b7cd-548cfbb48275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d90bcc22-7845-47c3-b98a-5a90d7f60abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:to="loc_us-gaap_SecuredDebtMember_d90bcc22-7845-47c3-b98a-5a90d7f60abb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ee795fb-38d7-4e94-a2fb-7505f20d9957_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:to="loc_us-gaap_SegmentDomain_7ee795fb-38d7-4e94-a2fb-7505f20d9957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:to="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_b21336b1-2ceb-4fc8-93d6-b0f24155f8e4" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:to="loc_peak_MedicalOfficeMember_b21336b1-2ceb-4fc8-93d6-b0f24155f8e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_9d7ae6f8-b551-4f6d-bd48-6faade30112b" xlink:href="peak-20230331.xsd#peak_CCRCSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:to="loc_peak_CCRCSegmentMember_9d7ae6f8-b551-4f6d-bd48-6faade30112b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_63bfefb2-73d7-4bab-9854-4c2f2e939e3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_63bfefb2-73d7-4bab-9854-4c2f2e939e3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5e3b9f49-bbb3-4979-931e-eb355d63daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:to="loc_us-gaap_SecuredDebtMember_5e3b9f49-bbb3-4979-931e-eb355d63daac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_02602636-4d66-450f-937a-da23880e4f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:to="loc_us-gaap_InterestRateSwapMember_02602636-4d66-450f-937a-da23880e4f27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3d46f9a9-34e5-4067-8266-ed4931c7d9a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3d46f9a9-34e5-4067-8266-ed4931c7d9a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4389a98b-05d0-4953-bc1c-850cad66bebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:to="loc_us-gaap_CashFlowHedgingMember_4389a98b-05d0-4953-bc1c-850cad66bebd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_81d2e616-4afa-45b4-a7fc-6d0d8356c23e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:to="loc_us-gaap_HedgingDesignationDomain_81d2e616-4afa-45b4-a7fc-6d0d8356c23e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:to="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0021c717-56d5-48d9-b442-fe22d264bead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0021c717-56d5-48d9-b442-fe22d264bead" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtDebtMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended" id="i5c15da4490a248e3adf187089ec633e1_DebtDebtMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_7c2e328a-80bd-4558-b090-b818bedc0808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_7c2e328a-80bd-4558-b090-b818bedc0808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0e5a1f59-3db1-406c-a711-b74eb73bd821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0e5a1f59-3db1-406c-a711-b74eb73bd821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d68d2e13-20a0-4c9c-bc66-3aadd4306e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d68d2e13-20a0-4c9c-bc66-3aadd4306e05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ca0b9d35-11f4-41b5-961e-d0b32a07d8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ca0b9d35-11f4-41b5-961e-d0b32a07d8c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_031f32c3-94ce-4c1a-917d-e6b852fd6256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_031f32c3-94ce-4c1a-917d-e6b852fd6256" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_411e3f59-c65a-4680-96e2-8623e8283126" xlink:href="peak-20230331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_411e3f59-c65a-4680-96e2-8623e8283126" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_915f4b48-d512-47e8-ba0e-b77f072af1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_915f4b48-d512-47e8-ba0e-b77f072af1be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1417a1df-deac-452b-8c1f-4ab37320e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1417a1df-deac-452b-8c1f-4ab37320e9a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_72624128-8636-4b90-8033-f0fa9f5293c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebt_72624128-8636-4b90-8033-f0fa9f5293c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d406da22-f554-4536-9ccd-06b8fa3558e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d406da22-f554-4536-9ccd-06b8fa3558e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_d3051cbf-78c3-4b4d-9f3a-6d6ec973cc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_d3051cbf-78c3-4b4d-9f3a-6d6ec973cc94" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity_3e96de4d-74e6-464e-80f6-c455f73c2494" xlink:href="peak-20230331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_peak_DebtInstrumentWeightedAverageMaturity_3e96de4d-74e6-464e-80f6-c455f73c2494" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1a3d2eeb-1343-48e4-a072-6637cb1d552b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1a3d2eeb-1343-48e4-a072-6637cb1d552b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3cbd976d-6259-49c4-8478-9ed20a40509a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_LineOfCreditMember_3cbd976d-6259-49c4-8478-9ed20a40509a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_fd960261-3fea-486f-9650-7a23ebefb6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_CommercialPaperMember_fd960261-3fea-486f-9650-7a23ebefb6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_ce3f57fa-b2d3-4e1e-8d68-34eec53af8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_LoansPayableMember_ce3f57fa-b2d3-4e1e-8d68-34eec53af8f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_275b1b51-b1a5-4f52-a2fa-21f9b5fa558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_UnsecuredDebtMember_275b1b51-b1a5-4f52-a2fa-21f9b5fa558f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_42d8e318-e07c-4983-8031-f90f9d91ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_SecuredDebtMember_42d8e318-e07c-4983-8031-f90f9d91ffa5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_169f3096-4af5-43f8-b88f-f64b63dbf956_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:to="loc_srt_RangeMember_169f3096-4af5-43f8-b88f-f64b63dbf956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:to="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8c092333-1c1c-461f-bd53-52b536a5ce9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:to="loc_srt_MinimumMember_8c092333-1c1c-461f-bd53-52b536a5ce9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9cdf05b7-129e-4e45-a12b-7eecdf9b3b52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:to="loc_srt_MaximumMember_9cdf05b7-129e-4e45-a12b-7eecdf9b3b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_b097fcae-43a9-4e86-8dfa-77e1a588a599_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_b097fcae-43a9-4e86-8dfa-77e1a588a599_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_7fc16246-0f48-4061-b7f6-149373518324" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_7fc16246-0f48-4061-b7f6-149373518324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1b68c569-2a7e-4445-b565-ca703df8ae76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1b68c569-2a7e-4445-b565-ca703df8ae76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a88065-f716-44fc-8e1d-9aa4bfa706df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a88065-f716-44fc-8e1d-9aa4bfa706df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_e89dc5d3-faec-403c-a2e6-b3791320351a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_e89dc5d3-faec-403c-a2e6-b3791320351a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_f5a91983-f319-4b2a-9e36-b0fc0762d421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_f5a91983-f319-4b2a-9e36-b0fc0762d421" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_94388551-0f57-435b-92ba-542ec2985b9d" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_94388551-0f57-435b-92ba-542ec2985b9d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i7b24e7563cb94397bd73ccfb4eeede7a_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties_daeea140-b91a-4b68-bf1a-15cc7e4d2345" xlink:href="peak-20230331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:to="loc_peak_ContributionOfPropertyNumberOfProperties_daeea140-b91a-4b68-bf1a-15cc7e4d2345" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_788d1783-3e67-4c96-ac40-16cb9208132a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_788d1783-3e67-4c96-ac40-16cb9208132a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:to="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_68e2a990-d949-431f-a909-7bed28789d3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_68e2a990-d949-431f-a909-7bed28789d3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_f2ccbf0a-2a50-467c-9b73-e644fc4483fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_f2ccbf0a-2a50-467c-9b73-e644fc4483fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0bd5a32b-6694-429c-82f5-cb24d6f2362e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0bd5a32b-6694-429c-82f5-cb24d6f2362e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_ffee450a-6d3d-4188-8c4e-173ee2c33f1a" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:to="loc_peak_LifeScienceJVsMember_ffee450a-6d3d-4188-8c4e-173ee2c33f1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f850c296-3a98-462b-97bf-7cefd4890631_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:to="loc_us-gaap_SegmentDomain_f850c296-3a98-462b-97bf-7cefd4890631_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:to="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_b9e0e032-92ae-446f-b0e2-01d78c087134" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:to="loc_peak_LifeScienceMember_b9e0e032-92ae-446f-b0e2-01d78c087134" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails" xlink:type="extended" id="i246a163c7ecc4c9cb838ea2f72377f9d_EquityandRedeemableNoncontrollingInterestsDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a4c0ac44-d5e8-4949-bb74-d7e810fd7929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a4c0ac44-d5e8-4949-bb74-d7e810fd7929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_06519351-5eb4-4e38-8982-965e0883fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_06519351-5eb4-4e38-8982-965e0883fd1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:to="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8d6780cc-7987-4319-95e7-90bb049088b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8d6780cc-7987-4319-95e7-90bb049088b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_28555318-ad21-43dc-9a84-6508747a59ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:to="loc_us-gaap_SubsequentEventMember_28555318-ad21-43dc-9a84-6508747a59ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsATMProgramDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails" xlink:type="extended" id="ic168ea9dfd334bc292d506e548c527e6_EquityandRedeemableNoncontrollingInterestsATMProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_1636352b-f0ee-4c7c-bb2f-76bade2c882b" xlink:href="peak-20230331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_1636352b-f0ee-4c7c-bb2f-76bade2c882b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm_1206b2d1-acc7-4fa9-b892-241f46862464" xlink:href="peak-20230331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_OptionIndexedToIssuersEquityTerm_1206b2d1-acc7-4fa9-b892-241f46862464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_b94cac9f-aa71-4733-97b4-4e85089929dd" xlink:href="peak-20230331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_b94cac9f-aa71-4733-97b4-4e85089929dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_8827ca12-31b0-44e6-967e-038cde05ebd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_8827ca12-31b0-44e6-967e-038cde05ebd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_b4b99c0e-dc13-42f1-b048-71fadf16820c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_b4b99c0e-dc13-42f1-b048-71fadf16820c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c50addc2-6e6a-4fc6-988f-8e8169d90e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c50addc2-6e6a-4fc6-988f-8e8169d90e96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e5ef4092-d00c-4d7d-b61b-cc4300919d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e5ef4092-d00c-4d7d-b61b-cc4300919d7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_058a6440-f5fe-48e9-915e-4dec8c4cc23f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_058a6440-f5fe-48e9-915e-4dec8c4cc23f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember_88ec08d0-c910-41c2-8ecb-db6bc4098fd1" xlink:href="peak-20230331.xsd#peak_AtTheMarketProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_AtTheMarketProgramMember_88ec08d0-c910-41c2-8ecb-db6bc4098fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2023AtTheMarketProgramMember_e51a79a8-db37-4a5b-9ef4-5b14a3442663" xlink:href="peak-20230331.xsd#peak_A2023AtTheMarketProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_A2023AtTheMarketProgramMember_e51a79a8-db37-4a5b-9ef4-5b14a3442663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember_fd3f3ee7-6909-4427-b047-715bf4022122" xlink:href="peak-20230331.xsd#peak_A2020ATMProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_A2020ATMProgramMember_fd3f3ee7-6909-4427-b047-715bf4022122" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember_ff030edd-184e-486c-a8bd-0e23ed28043c" xlink:href="peak-20230331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_ATMDirectIssuancesMember_ff030edd-184e-486c-a8bd-0e23ed28043c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_969ced65-665f-4ccf-97d9-f1537d2890a5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:to="loc_srt_RangeMember_969ced65-665f-4ccf-97d9-f1537d2890a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:to="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bbbe7962-963f-4a16-9eb3-ce0f02ac5c25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:to="loc_srt_MinimumMember_bbbe7962-963f-4a16-9eb3-ce0f02ac5c25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38352c77-c3aa-45e2-b084-488d23d995b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:to="loc_srt_MaximumMember_38352c77-c3aa-45e2-b084-488d23d995b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a81f502d-a488-4760-bb26-8f03af310596_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:to="loc_us-gaap_ClassOfStockDomain_a81f502d-a488-4760-bb26-8f03af310596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:to="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5f526e4f-9187-475f-ba6d-2af57091a4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:to="loc_us-gaap_CommonStockMember_5f526e4f-9187-475f-ba6d-2af57091a4fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails" xlink:type="extended" id="i7cd52da78f3d46958baa47c164c723d7_EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_491166f8-948b-4215-a949-a2fe51e335c2" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_491166f8-948b-4215-a949-a2fe51e335c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_63f1f435-e218-4f67-888b-d9eedda038c6" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_63f1f435-e218-4f67-888b-d9eedda038c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a6826a5b-2880-4bc9-9e7f-90e8376ad265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a6826a5b-2880-4bc9-9e7f-90e8376ad265" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent_cb0b8eb6-83bd-4601-9897-184ba1af6ead" xlink:href="peak-20230331.xsd#peak_RemainingMinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent_cb0b8eb6-83bd-4601-9897-184ba1af6ead" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:to="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_69ba6bf3-a8c8-4a33-8067-029d8fd91c72_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:to="loc_srt_ScenarioUnspecifiedDomain_69ba6bf3-a8c8-4a33-8067-029d8fd91c72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d8a4ab2e-b58a-4c48-9d07-f3c50da437f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:to="loc_srt_ScenarioForecastMember_d8a4ab2e-b58a-4c48-9d07-f3c50da437f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:to="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7a7f5b66-085e-45df-9067-9f5ffce50fcd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:to="loc_srt_OwnershipDomain_7a7f5b66-085e-45df-9067-9f5ffce50fcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:to="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HealthpeakOPMember_2e793cff-8ac4-4988-9448-c8af0b4e59c6" xlink:href="peak-20230331.xsd#peak_HealthpeakOPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:to="loc_peak_HealthpeakOPMember_2e793cff-8ac4-4988-9448-c8af0b4e59c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsDownREITsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails" xlink:type="extended" id="i2deb3b29957b4c56a5e8d65c6c30effe_EquityandRedeemableNoncontrollingInterestsDownREITsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITUnitsOutstanding_2eae7b05-27c2-46e3-9c8d-da326a38a662" xlink:href="peak-20230331.xsd#peak_DownREITUnitsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_DownREITUnitsOutstanding_2eae7b05-27c2-46e3-9c8d-da326a38a662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommonStockConvertibleSharesIssuable_b52c1800-f5e9-412e-b2f8-091bb0f70618" xlink:href="peak-20230331.xsd#peak_CommonStockConvertibleSharesIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_CommonStockConvertibleSharesIssuable_b52c1800-f5e9-412e-b2f8-091bb0f70618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfDownREITLLCs_decc5fae-4789-4c6e-842b-f155fcc19981" xlink:href="peak-20230331.xsd#peak_NumberOfDownREITLLCs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_NumberOfDownREITLLCs_decc5fae-4789-4c6e-842b-f155fcc19981" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4db0448-07c7-425e-8012-dd04def7c12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4db0448-07c7-425e-8012-dd04def7c12c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue_1045b127-3b4b-490c-a916-c8f118506b03" xlink:href="peak-20230331.xsd#peak_MinorityInterestInPreferredUnitHoldersFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue_1045b127-3b4b-490c-a916-c8f118506b03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7722c84e-26bd-4acc-8323-6ec2042596c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:to="loc_us-gaap_EquityComponentDomain_7722c84e-26bd-4acc-8323-6ec2042596c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:to="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9453d971-c593-4610-a331-f20617acee06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9453d971-c593-4610-a331-f20617acee06" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="extended" id="i06aec323889047a88f1d61d3cd772da1_EarningsPerCommonShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_e8ec2d04-f2f6-4a7e-a268-206fc1bf68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_e8ec2d04-f2f6-4a7e-a268-206fc1bf68cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca9d9fdc-b0df-481b-b7c3-49b35f510d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca9d9fdc-b0df-481b-b7c3-49b35f510d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_62da908b-e513-4000-85c2-b521b64b43a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_62da908b-e513-4000-85c2-b521b64b43a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardEquitySalesAgreementsMember_1559bb02-9bd9-49c0-9d68-62b9475bcd9c" xlink:href="peak-20230331.xsd#peak_ForwardEquitySalesAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:to="loc_peak_ForwardEquitySalesAgreementsMember_1559bb02-9bd9-49c0-9d68-62b9475bcd9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember_fa6a8f4b-494d-4235-90f4-2d9bc61bf691" xlink:href="peak-20230331.xsd#peak_DownREITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:to="loc_peak_DownREITMember_fa6a8f4b-494d-4235-90f4-2d9bc61bf691" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended" id="i9e9db43032f7487a844f297850d9e39e_SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4e36282e-6a38-4f5f-ba4a-573f9bb2cc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_Revenues_4e36282e-6a38-4f5f-ba4a-573f9bb2cc6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_761cf15b-9216-479c-a20a-372643871dad" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_761cf15b-9216-479c-a20a-372643871dad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_7e3707b5-3944-40ae-b988-9c3dc8fea775" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_7e3707b5-3944-40ae-b988-9c3dc8fea775" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_bea2aeb8-6e3b-44c5-96d1-0dc06958f3d9" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_bea2aeb8-6e3b-44c5-96d1-0dc06958f3d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_98e201b6-2528-4766-8093-b4ce8d770d48" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_98e201b6-2528-4766-8093-b4ce8d770d48" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_86b94449-7455-41e0-b424-26338d8a5794" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_86b94449-7455-41e0-b424-26338d8a5794" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_66ea4ad9-5151-4ed0-bdd6-1f5d9c941d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_OperatingExpenses_66ea4ad9-5151-4ed0-bdd6-1f5d9c941d08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_7ac65b2c-9a45-4ce2-b6ab-f078ebb0a622" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_7ac65b2c-9a45-4ce2-b6ab-f078ebb0a622" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_dc1235d8-787e-4320-ae8f-54dde249aad2" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_dc1235d8-787e-4320-ae8f-54dde249aad2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_99feae4e-d49d-406e-848d-670614a0c470" xlink:href="peak-20230331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_99feae4e-d49d-406e-848d-670614a0c470" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_875a7c74-6f8e-47f7-b67d-457976f0585f" xlink:href="peak-20230331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_875a7c74-6f8e-47f7-b67d-457976f0585f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_68167b6e-af70-434f-a7ff-2472718df277" xlink:href="peak-20230331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_68167b6e-af70-434f-a7ff-2472718df277" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_76f56682-5cfa-432c-80f6-4774effefffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_InterestIncomeOperating_76f56682-5cfa-432c-80f6-4774effefffe" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dbd5a8df-1baf-4fc3-94bc-a885e0d2a0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_InterestExpense_dbd5a8df-1baf-4fc3-94bc-a885e0d2a0c7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8041cf05-231d-40e0-9851-61618392c57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_DepreciationAndAmortization_8041cf05-231d-40e0-9851-61618392c57e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b185a8b0-f011-4659-a8ce-d542e211534e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b185a8b0-f011-4659-a8ce-d542e211534e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bba32cf4-c267-46ad-95f1-c7d6d55c3759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bba32cf4-c267-46ad-95f1-c7d6d55c3759" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_060304c6-9853-4fca-a8cd-01480f9b137b" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_060304c6-9853-4fca-a8cd-01480f9b137b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_731eacb9-a1cb-4fe0-aa19-25a7ade8e123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_731eacb9-a1cb-4fe0-aa19-25a7ade8e123" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9e84c9fe-905e-495a-b93d-da4f34e32b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9e84c9fe-905e-495a-b93d-da4f34e32b62" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_0c94742e-0d8f-44cf-b687-373193972aca" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_0c94742e-0d8f-44cf-b687-373193972aca" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_7bc821e6-a5cc-4454-905b-dcfe624705a4" xlink:href="peak-20230331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_7bc821e6-a5cc-4454-905b-dcfe624705a4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_8a4ff48c-9537-4415-ac87-34f10f552457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_8a4ff48c-9537-4415-ac87-34f10f552457" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32dbcb07-4879-45f4-990c-8ddcaf63ae16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32dbcb07-4879-45f4-990c-8ddcaf63ae16" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a2d4cd3-da6c-4ca1-b6ca-ab8a45a4a468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a2d4cd3-da6c-4ca1-b6ca-ab8a45a4a468" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5002fec5-07f2-4986-b820-d8912c817d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5002fec5-07f2-4986-b820-d8912c817d4d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1d83ce5a-5fb0-43fc-8bd4-ec903b056422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1d83ce5a-5fb0-43fc-8bd4-ec903b056422" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1656f8d4-1ff8-419a-a41d-aaa51b63ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1656f8d4-1ff8-419a-a41d-aaa51b63ede3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_794311ec-e377-4887-b5e1-7339c0497bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_ProfitLoss_794311ec-e377-4887-b5e1-7339c0497bb0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3f1a4999-0563-4339-aa9d-02caf9475ed6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:to="loc_us-gaap_SegmentDomain_3f1a4999-0563-4339-aa9d-02caf9475ed6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:to="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_fec23688-8174-44af-a6f2-a03644100ac3" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_LifeScienceMember_fec23688-8174-44af-a6f2-a03644100ac3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_636295f9-ad13-404e-80fa-49187f1cbe7b" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_MedicalOfficeMember_636295f9-ad13-404e-80fa-49187f1cbe7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_e74b0fc1-9e13-4e49-b5db-c53c206533f6" xlink:href="peak-20230331.xsd#peak_CCRCSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_CCRCSegmentMember_e74b0fc1-9e13-4e49-b5db-c53c206533f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_90170eb1-c06f-4da9-8a21-44a0ffb166d0" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_OtherNonReportingSegmentMember_90170eb1-c06f-4da9-8a21-44a0ffb166d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:to="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1542b1df-52cf-4c8b-b16a-46595c69b041_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:to="loc_srt_ConsolidationItemsDomain_1542b1df-52cf-4c8b-b16a-46595c69b041_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:to="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a139371-ffd7-430f-a6f4-21a16d34c559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a139371-ffd7-430f-a6f4-21a16d34c559" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a19214dc-d8d0-4c45-8963-419e6c21d450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a19214dc-d8d0-4c45-8963-419e6c21d450" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="extended" id="if0e60efecb9b4a39a1d20b6d359d24fb_SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c8bfc544-c6a2-43a0-bbc3-bbfc687b712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c8bfc544-c6a2-43a0-bbc3-bbfc687b712e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7a540366-ad97-49e1-9383-548c84f0972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7a540366-ad97-49e1-9383-548c84f0972f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a2acfa6b-6c1d-47d7-82af-6dc931b5f95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_DepreciationAndAmortization_a2acfa6b-6c1d-47d7-82af-6dc931b5f95e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_1a9b8d19-5471-4153-b1e7-a36d196f09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_1a9b8d19-5471-4153-b1e7-a36d196f09b7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended" id="i39dd552d44fa412b86e31a375bdbf76e_VariableInterestEntitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_15bb69c1-6075-46ac-80b0-f3a23c1c7165" xlink:href="peak-20230331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_15bb69c1-6075-46ac-80b0-f3a23c1c7165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_e4c8cdd6-3573-4832-9adf-37db6b1ff448" xlink:href="peak-20230331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_e4c8cdd6-3573-4832-9adf-37db6b1ff448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_af411d0b-1349-4700-ba2b-b3028f6a3bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_DebtSecurities_af411d0b-1349-4700-ba2b-b3028f6a3bae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfHospitals_d9691573-e287-4265-a29c-741ff9adc068" xlink:href="peak-20230331.xsd#peak_NumberOfHospitals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfHospitals_d9691573-e287-4265-a29c-741ff9adc068" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cddd8e65-fd80-4e57-baad-11f943fc4c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cddd8e65-fd80-4e57-baad-11f943fc4c3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_3e13c093-fead-4390-9fe2-10bf97904f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_3e13c093-fead-4390-9fe2-10bf97904f71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_9d5bd5e7-4903-4a16-99e8-df2cbfa4453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_9d5bd5e7-4903-4a16-99e8-df2cbfa4453e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_e3b51937-caea-4ce5-9908-93b7972a14bc" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_e3b51937-caea-4ce5-9908-93b7972a14bc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:to="loc_srt_ConsolidatedEntitiesDomain_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_6c3a8d98-2d7f-4989-bb9e-0d9a4010644d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_6c3a8d98-2d7f-4989-bb9e-0d9a4010644d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember_a1021a0f-bd62-4ea2-ba7d-6c4611e18cad" xlink:href="peak-20230331.xsd#peak_VenturesVLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_VenturesVLLCMember_a1021a0f-bd62-4ea2-ba7d-6c4611e18cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_7f11b325-3e1d-4353-b156-889779c87993" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_LifeScienceJVsMember_7f11b325-3e1d-4353-b156-889779c87993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember_4187f455-ef99-4405-8928-bf6c2951398a" xlink:href="peak-20230331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_MorganStanleyRealEstateInvestmentJVMember_4187f455-ef99-4405-8928-bf6c2951398a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember_3f048391-67ba-4bf2-bc1d-d45f40ecda37" xlink:href="peak-20230331.xsd#peak_DownreitPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_DownreitPartnershipsMember_3f048391-67ba-4bf2-bc1d-d45f40ecda37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa704daf-a11e-4908-bd1e-9a8bdb21dca7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:to="loc_us-gaap_SegmentDomain_fa704daf-a11e-4908-bd1e-9a8bdb21dca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:to="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_1dcab29d-6a34-4da4-b159-0a76a7c2ae30" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:to="loc_peak_LifeScienceMember_1dcab29d-6a34-4da4-b159-0a76a7c2ae30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3360208f-40da-4296-b87a-41444b6110ab_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3360208f-40da-4296-b87a-41444b6110ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_395712cf-7d11-4a3b-8491-7184fef066ad" xlink:href="peak-20230331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:to="loc_peak_NeedhamLandParcelJVMember_395712cf-7d11-4a3b-8491-7184fef066ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3df2ac8e-8cd7-479a-8328-47e4abb03111_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3df2ac8e-8cd7-479a-8328-47e4abb03111_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6d54dcc0-fbf5-4389-a6d4-8393ed2c258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6d54dcc0-fbf5-4389-a6d4-8393ed2c258e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="extended" id="i8b472c609b784606af9f57d35b23efdf_VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bc25cfa2-86ed-4eea-8a6c-1430a2e53765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bc25cfa2-86ed-4eea-8a6c-1430a2e53765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b552c58b-afd8-4c85-847f-2b4ce86c89fa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b552c58b-afd8-4c85-847f-2b4ce86c89fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_28cb3cc7-fc87-4a9b-b982-d0f13d5e04cb" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_28cb3cc7-fc87-4a9b-b982-d0f13d5e04cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_79b118b3-84da-413c-8466-30191c5ea84d" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_79b118b3-84da-413c-8466-30191c5ea84d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="extended" id="ib450f541e4124c2da61d3d5df683e4ae_VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:to="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_775853f5-8e48-4054-80c1-f90e0e41cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_775853f5-8e48-4054-80c1-f90e0e41cc12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_2e96f041-5efc-429a-bedc-f5e53ce0d016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_DevelopmentInProcess_2e96f041-5efc-429a-bedc-f5e53ce0d016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d1195f0c-d959-4e8c-9cdc-3826dc08fbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_Land_d1195f0c-d959-4e8c-9cdc-3826dc08fbb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_dc2c82d7-8a84-46e8-84ac-4d738d86a4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_dc2c82d7-8a84-46e8-84ac-4d738d86a4a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_091c4f69-a5e3-4bb8-800b-b73d7ba82974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_091c4f69-a5e3-4bb8-800b-b73d7ba82974" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_6d6d7936-40c3-45b0-b10f-24395aa86556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_AccountsReceivableNet_6d6d7936-40c3-45b0-b10f-24395aa86556" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514fbcc4-aa3a-4568-a98e-12aed9ecd2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514fbcc4-aa3a-4568-a98e-12aed9ecd2cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c69a5820-3cb6-47e2-aa79-a7df20df10de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c69a5820-3cb6-47e2-aa79-a7df20df10de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa8574b-6f5b-46e8-a273-c01f263469b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa8574b-6f5b-46e8-a273-c01f263469b0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1dfaa69a-7088-469a-8a42-c1a92dcc7361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1dfaa69a-7088-469a-8a42-c1a92dcc7361" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_aafd1f72-8135-40bf-9047-4c8e1b5de9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_aafd1f72-8135-40bf-9047-4c8e1b5de9fb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_21a74da4-1d1c-4bac-9e18-cd62afc10a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_OtherAssets_21a74da4-1d1c-4bac-9e18-cd62afc10a35" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1b189ca2-3fb3-492f-a25b-2f9068201a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_Assets_1b189ca2-3fb3-492f-a25b-2f9068201a42" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_759737e8-1d7b-4721-805f-5aac7d5331cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_SecuredDebt_759737e8-1d7b-4721-805f-5aac7d5331cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_29cf0167-75fa-4800-a5aa-1bbf1bdb05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_29cf0167-75fa-4800-a5aa-1bbf1bdb05f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1593e78e-4718-405f-9896-01f3aa5f5c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1593e78e-4718-405f-9896-01f3aa5f5c89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_10886ed1-f931-4f4a-89c9-6b503569c7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_OperatingLeaseLiability_10886ed1-f931-4f4a-89c9-6b503569c7ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c06175e5-8336-48a4-b68f-3662fae94725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c06175e5-8336-48a4-b68f-3662fae94725" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d6c58345-8541-487d-b391-6cf26708a011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d6c58345-8541-487d-b391-6cf26708a011" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_549b4cf9-9043-474b-8a3e-22a4a37a5396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_Liabilities_549b4cf9-9043-474b-8a3e-22a4a37a5396" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_883ec886-7f94-4934-aa79-667acd6300cb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_883ec886-7f94-4934-aa79-667acd6300cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99af4271-555a-40b0-ad48-e05e5a0bc9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99af4271-555a-40b0-ad48-e05e5a0bc9bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_39535739-2b07-4870-9368-0754b341903f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_39535739-2b07-4870-9368-0754b341903f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_7c93aa89-6e08-4664-9fc2-509d7c54383d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_7c93aa89-6e08-4664-9fc2-509d7c54383d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="iee0c38292b8642a7ab54957feeffca34_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure_77a463e4-05eb-4efc-8cdf-d48ffb274555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LoansReceivableFairValueDisclosure_77a463e4-05eb-4efc-8cdf-d48ffb274555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_27970cb1-09c2-4aad-aa2c-118e0b6c11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_27970cb1-09c2-4aad-aa2c-118e0b6c11ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e570be32-0cab-4c92-9ec6-7ead65ac06d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_DerivativeAssets_e570be32-0cab-4c92-9ec6-7ead65ac06d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_4043cb43-22b9-49e9-a149-589ba2b4e711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LineOfCredit_4043cb43-22b9-49e9-a149-589ba2b4e711" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank_c3c5fb6e-f5b8-4854-adb9-5403446a6a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LongTermLoansFromBank_c3c5fb6e-f5b8-4854-adb9-5403446a6a15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_a5e6f41f-0004-4de2-b55c-1e8fe3ea59f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_UnsecuredDebt_a5e6f41f-0004-4de2-b55c-1e8fe3ea59f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_04bdaf9c-b6db-454e-b6de-0843aab0c484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_SecuredDebt_04bdaf9c-b6db-454e-b6de-0843aab0c484" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d1cada19-fcc1-45bc-923e-851a334c14eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d1cada19-fcc1-45bc-923e-851a334c14eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1697d81c-d8a6-4319-a11d-b1075cbe9786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1697d81c-d8a6-4319-a11d-b1075cbe9786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_51a63ca7-f7ca-4044-9dfa-215e8e50ac8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_51a63ca7-f7ca-4044-9dfa-215e8e50ac8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_18c386dd-a542-4fac-a7c9-a3478893f282_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_18c386dd-a542-4fac-a7c9-a3478893f282_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_03539645-a0e7-45fc-9efc-a1ff051d1889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_03539645-a0e7-45fc-9efc-a1ff051d1889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ef2bd4d7-fd58-4658-b983-af9d2d081d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ef2bd4d7-fd58-4658-b983-af9d2d081d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17668246-e26d-4d85-902a-adbb72f7ed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:to="loc_us-gaap_InterestRateSwapMember_17668246-e26d-4d85-902a-adbb72f7ed2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i3848ed75923b45388ec203f2c091c58e_DerivativeFinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_82992ee7-209d-4bc0-8a4c-2e7c75378736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_82992ee7-209d-4bc0-8a4c-2e7c75378736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_7eb8b63b-722f-4811-8751-59612522d172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_7eb8b63b-722f-4811-8751-59612522d172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated_512bd1b7-8f24-4585-82a1-24c143e1bf53" xlink:href="peak-20230331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_peak_DerivativeNotionalAmountTerminated_512bd1b7-8f24-4585-82a1-24c143e1bf53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_ccfedffd-36c4-4ec0-8d30-40406f69880f" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_peak_NumberOfPropertiesAcquired_ccfedffd-36c4-4ec0-8d30-40406f69880f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6e2b2c0e-e9a8-4b8f-aa87-fe0822584c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6e2b2c0e-e9a8-4b8f-aa87-fe0822584c25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_fcda6d2f-82e4-429a-8c9a-2470582152e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_fcda6d2f-82e4-429a-8c9a-2470582152e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_32229425-818a-4385-8800-dca4b084b4ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_32229425-818a-4385-8800-dca4b084b4ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c4f1cbb4-a9cd-4804-bacb-49e4e1cda498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:to="loc_us-gaap_InterestRateCapMember_c4f1cbb4-a9cd-4804-bacb-49e4e1cda498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_14afe9e1-4616-414c-9550-e91f68a44c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:to="loc_us-gaap_InterestRateSwapMember_14afe9e1-4616-414c-9550-e91f68a44c81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cc5b893a-34bc-4761-b2d2-61191584dd04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:to="loc_us-gaap_HedgingDesignationDomain_cc5b893a-34bc-4761-b2d2-61191584dd04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:to="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_06c473cc-4f29-4dbe-a798-2b2ea69508cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:to="loc_us-gaap_NondesignatedMember_06c473cc-4f29-4dbe-a798-2b2ea69508cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_21141439-8f36-4342-b4dc-0ca4bd05bac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_21141439-8f36-4342-b4dc-0ca4bd05bac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aae317df-b3a0-448e-9ebc-273ee8438ca9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aae317df-b3a0-448e-9ebc-273ee8438ca9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9b2dfd43-0706-496e-abb2-fc0e14db999b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:to="loc_us-gaap_CashFlowHedgingMember_9b2dfd43-0706-496e-abb2-fc0e14db999b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7f237bff-fda3-42d2-9f1b-56e05602bebc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7f237bff-fda3-42d2-9f1b-56e05602bebc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_7d80a51f-5043-40ff-ab6f-de8e6c9c795b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:to="loc_us-gaap_SecuredDebtMember_7d80a51f-5043-40ff-ab6f-de8e6c9c795b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_56437b27-c328-434c-ae4b-afc4d50c5f4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:to="loc_us-gaap_SegmentDomain_56437b27-c328-434c-ae4b-afc4d50c5f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:to="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_ebb21f50-ad69-4c61-9196-529df2d600b8" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:to="loc_peak_MedicalOfficeMember_ebb21f50-ad69-4c61-9196-529df2d600b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFRMember_2ea1acf6-c653-42a6-8300-4187496d0b4d" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFRMember_2ea1acf6-c653-42a6-8300-4187496d0b4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="i5d745baff3974509859e504996c473ae_DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_a8681d37-0e79-48b8-8cd7-689f4913bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_a8681d37-0e79-48b8-8cd7-689f4913bb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_aa2ecfb0-8213-4320-bd78-9a8048d6f6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_aa2ecfb0-8213-4320-bd78-9a8048d6f6ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_ddf910f2-9460-46e7-b441-39b2fac1c24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_ddf910f2-9460-46e7-b441-39b2fac1c24f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_c60deaad-a539-47e3-9457-b353d21c1993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_c60deaad-a539-47e3-9457-b353d21c1993" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_16b97f8a-500b-4819-ba22-e9f0c7430ee8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_16b97f8a-500b-4819-ba22-e9f0c7430ee8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:to="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap499PayRateMember_ae792b2d-3b52-4193-9b35-0106882f8740" xlink:href="peak-20230331.xsd#peak_InterestRateSwap499PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap499PayRateMember_ae792b2d-3b52-4193-9b35-0106882f8740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap454PayRateMember_c18b8921-90bd-4ef3-b572-5948fa369faf" xlink:href="peak-20230331.xsd#peak_InterestRateSwap454PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap454PayRateMember_c18b8921-90bd-4ef3-b572-5948fa369faf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap260PayRateMember_efc6e7d3-83ca-46a9-bc74-e4da5b54302d" xlink:href="peak-20230331.xsd#peak_InterestRateSwap260PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap260PayRateMember_efc6e7d3-83ca-46a9-bc74-e4da5b54302d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap254PayRateMember_81dc40ab-d5c1-455f-bc13-e6205464ee71" xlink:href="peak-20230331.xsd#peak_InterestRateSwap254PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap254PayRateMember_81dc40ab-d5c1-455f-bc13-e6205464ee71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap508PayRateMember_d232834e-360c-443f-8ab4-0fe656b431c3" xlink:href="peak-20230331.xsd#peak_InterestRateSwap508PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap508PayRateMember_d232834e-360c-443f-8ab4-0fe656b431c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap463PayRateMember_b94e3faa-42a3-47c9-a653-1386c411eaf4" xlink:href="peak-20230331.xsd#peak_InterestRateSwap463PayRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap463PayRateMember_b94e3faa-42a3-47c9-a653-1386c411eaf4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdd4fcc9-bb75-4430-a0d4-9a9f67949dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdd4fcc9-bb75-4430-a0d4-9a9f67949dc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d4b0550c-39ee-466e-9f08-aada32b70d58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d4b0550c-39ee-466e-9f08-aada32b70d58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_406a9f6a-6a39-4064-9157-a7945dda5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:to="loc_us-gaap_CashFlowHedgingMember_406a9f6a-6a39-4064-9157-a7945dda5bae" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>peak-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_65d9d8ca-b49c-4b86-ab9e-ebb3b95d320d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental and related revenues</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_b886d3b1-f9aa-4084-844d-4b3506421553_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4eecc62c-3564-40c6-8ab4-c0fc588fe5cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_fdb3aef1-7d6e-408e-a327-9e64a8f8f03c_terseLabel_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM aggregate amount authorized</link:label>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_label_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Authorized</link:label>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_documentation_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:href="peak-20230331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:to="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_414ba97f-fbe6-4c76-907e-b9a99b7bf6af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_15c88a41-622f-40d4-b602-3cb4f5199cb5_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_562cde61-0d02-45c3-b9e7-05d0ed41b993_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_79af6df2-52b7-4155-b4d6-b4f82c1925b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Lessees VIE</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_e62cb50b-72ca-4345-bb5a-032f47d2042c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal balance on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_3520e02c-e21b-4d60-a30d-8f82f3796eed_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt before discount, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_b624604a-f874-405e-838b-aea43adc610d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales/principal repayments on loans receivable, direct financing leases, and marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Principal Repayments on Loans and Leases Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:to="lab_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3c97ba3e-52dc-4710-98b0-961578fdfa7d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_1c74377c-c18f-4e2e-81d7-7834299eecc7_terseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture Government Grant Income</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture Government Grant Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_f674b037-d116-48c4-9f31-ccea6a3f9283_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_4053e064-cf99-43ef-892e-d0de8ef6def9_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_c5634b6b-cdb0-45d3-98d9-03678997ecdb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_1f2bc894-d9fe-4eb1-9e82-a2ac71ee9059_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables_fded1ea7-1f4c-47d3-8143-cdeae62baa1f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of lease receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Lease Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLeaseReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffMarketLeaseUnfavorable_80c0b154-64f7-4d6d-8b5f-dd5137418d72_terseLabel_en-US" xlink:label="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities, net</link:label>
    <link:label id="lab_us-gaap_OffMarketLeaseUnfavorable_label_en-US" xlink:label="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off-Market Lease, Unfavorable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffMarketLeaseUnfavorable" xlink:to="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8e6b18cc-730d-4451-b216-863b8df57d84_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f6fe13de-c558-4356-b83b-4f604f3ea9eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_71bfe30c-40d0-48dd-be64-0e7ed1e69fff_terseLabel_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Government grant income</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:to="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_f50ae220-e12f-43e4-8140-22f3752db7cd_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Assets and Liabilities of Variable Interest Entities</link:label>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Variable Interest Entities Included In The Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:href="peak-20230331.xsd#peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:to="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9beff96e-f53a-4f1d-8f9a-0de5a4a4614c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_8f92a1d1-e52c-4c1e-a467-d6cd849a2425_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateDisclosureTextBlock_2c29a55f-cbbb-4ad1-9b3e-be15dd94e21a_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate</link:label>
    <link:label id="lab_us-gaap_RealEstateDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateDisclosureTextBlock" xlink:to="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_8c9843ef-b44a-4315-8325-811692955248_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f7d7878f-df23-45a0-9e46-46ab6e772ba8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_d4a00c90-4a28-471a-a445-4889a567241a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock and exercise of options, net of offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_4870bb23-f6ba-4974-9e6f-b4652dfab6bc_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_1b6e8f35-8595-4437-9a64-3ddfdfdf7ced_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b4abd151-2fbf-4a26-9dcb-4b54e4fc4fde_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_cc05f818-9bcd-467f-928d-ae8ba3ecc39f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of real estate, in-place lease, and other intangibles</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cd9e9981-6547-4080-aae3-5566a61538f5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_cca8f8da-6087-4dac-923b-a806f39b5111_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_f60de12f-4e1f-489f-859d-f4d6fca6e65c_terseLabel_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from nonrefundable entrance fees</link:label>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_label_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collection Of Nonrefundable Entrance Fees</link:label>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_documentation_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collection Of Nonrefundable Entrance Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:href="peak-20230331.xsd#peak_ProceedsFromCollectionOfNonrefundableEntranceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:to="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_A2020ATMProgramMember_14f5157f-a0b0-46bd-b112-9a949e9d9493_terseLabel_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program</link:label>
    <link:label id="lab_peak_A2020ATMProgramMember_label_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program [Member]</link:label>
    <link:label id="lab_peak_A2020ATMProgramMember_documentation_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember" xlink:href="peak-20230331.xsd#peak_A2020ATMProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_A2020ATMProgramMember" xlink:to="lab_peak_A2020ATMProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_e0af6978-187c-4d15-9d7b-935475b0f56c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_daea06cc-6621-43f9-9260-85a770568880_terseLabel_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour" xlink:href="peak-20230331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LongTermDebtMaturityAfterYearFour" xlink:to="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_3d9eb918-2b5b-42f1-8027-09c229469e35_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_65055d35-fadb-42b4-a210-43ab3ac7e859_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8464aa80-16c3-475f-a2ed-1a3463e20d3b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_3109c842-5525-4cd6-8b91-9a45a4fc807b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DownREITMember_53feef82-255a-4243-97aa-ef7cc23fe8a6_terseLabel_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down REIT</link:label>
    <link:label id="lab_peak_DownREITMember_label_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down R E I T [Member]</link:label>
    <link:label id="lab_peak_DownREITMember_documentation_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental common shares attributable to the conversion of DownREIT units that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember" xlink:href="peak-20230331.xsd#peak_DownREITMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DownREITMember" xlink:to="lab_peak_DownREITMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_e1d1a913-6b7f-4d28-b1ff-ad870d12b07c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ac23e00d-e8be-4e49-9047-c18cd9d7b4e0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, total value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IntangiblesAbstract_705b37ea-96fa-48d4-afa8-546404f403ae_terseLabel_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:label id="lab_peak_IntangiblesAbstract_label_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:label id="lab_peak_IntangiblesAbstract_documentation_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IntangiblesAbstract" xlink:to="lab_peak_IntangiblesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8c358a59-4e05-420a-ae71-6cd6fd70e02f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_17a3f407-2065-42da-9caf-ae21ad03336c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_53e9f47e-7119-4018-a068-f98cbdb08335_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40103a49-c09a-45ee-8240-a6a2611a85bd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_007e3a6d-9478-4e43-8415-9e631e1f4e30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt Maturities and Schedule Principal Repayments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_44eae80a-974a-4f67-b542-9d92ba830892_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_59fb8b45-9b36-4ab3-8daa-e95207ba7a58_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_09766dbd-9e6e-47f6-b96c-e662f5cf1948_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_80430f2c-c831-44c7-90aa-44da2525e541_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in accounts receivable and other assets, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_43cb09d6-1263-4df5-835a-774efaf1a3c8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_ee7193d8-9816-426f-b220-ab3c776c0c72_terseLabel_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: Adjustments to NOI</link:label>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_label_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments</link:label>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_documentation_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:href="peak-20230331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:to="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_068caf3b-388c-4900-b5d8-13f10cfffe5b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_fbd514c6-72a8-42cb-9f45-28745df8097b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_6103933c-d3e2-4d77-87bc-92d25ef5233c_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_HealthpeakOPMember_89813f0f-3b05-4ae5-9777-a30f0ea991fd_terseLabel_en-US" xlink:label="lab_peak_HealthpeakOPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak OP</link:label>
    <link:label id="lab_peak_HealthpeakOPMember_label_en-US" xlink:label="lab_peak_HealthpeakOPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak OP [Member]</link:label>
    <link:label id="lab_peak_HealthpeakOPMember_documentation_en-US" xlink:label="lab_peak_HealthpeakOPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak OP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HealthpeakOPMember" xlink:href="peak-20230331.xsd#peak_HealthpeakOPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_HealthpeakOPMember" xlink:to="lab_peak_HealthpeakOPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OtherPropertyMember_fe0ffd37-8a21-4325-9787-9066502a52b1_terseLabel_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Property</link:label>
    <link:label id="lab_srt_OtherPropertyMember_label_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OtherPropertyMember" xlink:to="lab_srt_OtherPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_efc97bc0-6193-4637-be4e-9005396bd4f0_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_635e55e3-9a86-4702-b27b-6fbfbef8c58e_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_0b194e67-f189-4e79-97f0-6f9b2c4139e4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_fb81b69a-ea0a-4cf0-bb36-6fb3900c58d8_totalLabel_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted NOI</link:label>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Net Operating Income from Continuing Operations</link:label>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20230331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_25e8f715-f6de-4d99-9d77-5e84fb210e21_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest-rate contracts held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_47ed3bad-4b33-4c3f-8e5e-11b1626ff1f0_terseLabel_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of redeemable noncontrolling interest redemptions</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_label_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interest Redemptions</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_documentation_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interest Redemptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:to="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AtTheMarketProgramMember_7772b2d4-7d30-4ed5-ab6c-21b539d82822_terseLabel_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program</link:label>
    <link:label id="lab_peak_AtTheMarketProgramMember_label_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program [Member]</link:label>
    <link:label id="lab_peak_AtTheMarketProgramMember_documentation_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember" xlink:href="peak-20230331.xsd#peak_AtTheMarketProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AtTheMarketProgramMember" xlink:to="lab_peak_AtTheMarketProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_630e8234-bd5d-4089-99af-e2e3ab2d365c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_cd31747b-3d8e-483b-904a-95e629b4de0c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset at fair value, changes in fair value resulting from changes in assumptions</link:label>
    <link:label id="lab_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_label_en-US" xlink:label="lab_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" xlink:to="lab_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecurities_d12346ab-403c-46ca-a60b-bfa43f0d41dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecurities_label_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecurities" xlink:to="lab_us-gaap_DebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bf6b93c3-f424-4bb7-b3b8-366ffd87a3dc_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Executive Retirement Plan minimum liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_2ae2e78d-dd42-4632-9312-509cb85369b1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_819978f9-eb0a-4d84-80c7-69c7fb483221_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_3d8dbe86-3b49-47f3-b484-6b37e82ba651_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Originated, More than Five Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommercialPaperProgramMember_b214b25a-dd1d-42c6-84f1-3282374af60e_terseLabel_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program</link:label>
    <link:label id="lab_peak_CommercialPaperProgramMember_label_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:label id="lab_peak_CommercialPaperProgramMember_documentation_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember" xlink:href="peak-20230331.xsd#peak_CommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommercialPaperProgramMember" xlink:to="lab_peak_CommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLineItems_cf670ca5-31f6-4ae8-bd0c-04d2663b4d8d_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstateLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLineItems" xlink:to="lab_us-gaap_RealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_8b2b734a-9b83-4618-8aaf-aebf921d8652_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_5f86c2d9-3fbf-40b5-bbc3-f35ec59e2fe9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_e7713f54-516b-4031-9dca-caeb3f0afc24_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_567ad2fd-4217-423d-aa05-b6170c6b242d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_861e44d1-6302-4fc2-a0e2-be728a6dccb0_terseLabel_en-US" xlink:label="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science JV in San Francisco, California</link:label>
    <link:label id="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_label_en-US" xlink:label="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science Joint Venture In San Francisco, California [Member]</link:label>
    <link:label id="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_documentation_en-US" xlink:label="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science Joint Venture In San Francisco, California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:href="peak-20230331.xsd#peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:to="lab_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e29e5981-ca3f-4b4e-a8ae-dbdbe5b4ce6a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_36dfacd3-af34-4776-95e8-665b17d2e902_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_12f8ac50-7c19-43ef-9234-8992924d6239_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7d174e64-98dd-4675-8b27-76fc6e7b1b02_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_90a8c2b6-9ba4-44b0-847b-03c84e8d5b4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfDeferredRevenueTableTextBlock_e6a88230-3d6b-4f4e-af1d-423237074c5f_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Revenue</link:label>
    <link:label id="lab_peak_ScheduleOfDeferredRevenueTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Revenue [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfDeferredRevenueTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:href="peak-20230331.xsd#peak_ScheduleOfDeferredRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:to="lab_peak_ScheduleOfDeferredRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_c8d25666-b896-456d-8051-d239b8b0a44a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Three, Originated, Two Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0832ccb5-411a-40b7-a96d-a8afa489080a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_960f0b34-e76d-4c66-a80b-01df5180f837_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_7165813a-3303-4c8f-a508-98e629672f0e_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:to="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_0d937492-3d44-47a1-8d72-cc9c58c75f83_terseLabel_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_label_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:to="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_219e620d-f6d2-4409-9389-04ddb4b48cab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_cb60feb7-9c87-4474-88db-aef64b6375d7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_b8791ed8-14d1-4c4d-914f-b399dd5681f5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable:</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_131567c2-a8e9-40d0-812e-f50de9e7fd45_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_f08431c2-38d1-4d2f-8449-57e0c666ab5c_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, amount funded</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Funded</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Funded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingAmountFunded" xlink:to="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b618b65a-f742-4534-a062-29a984fa4983_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f6a43a18-f3ae-4d77-a725-9224dbe58a59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_50264ed2-81d6-44b4-8dc4-dbf875ce41f3_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_a5eb3acf-14f8-4c92-8701-0cd10fc53423_terseLabel_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interests redeemable over time</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_label_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interests, Redeemable Over Time</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_documentation_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Redeemable Noncontrolling Interests, Redeemable Over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:to="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_0ccdcaac-692f-490f-9c2f-bae2dfa8c1cf_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative dividends in excess of earnings</link:label>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_label_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Distributions in Excess of Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:to="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableOutstandingBalance_9b6da278-8228-4b78-a593-6e3ae649ab91_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, outstanding balance</link:label>
    <link:label id="lab_peak_LoansReceivableOutstandingBalance_label_en-US" xlink:label="lab_peak_LoansReceivableOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Outstanding Balance</link:label>
    <link:label id="lab_peak_LoansReceivableOutstandingBalance_documentation_en-US" xlink:label="lab_peak_LoansReceivableOutstandingBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Outstanding Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableOutstandingBalance" xlink:href="peak-20230331.xsd#peak_LoansReceivableOutstandingBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableOutstandingBalance" xlink:to="lab_peak_LoansReceivableOutstandingBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9bfe4cea-28ca-4901-8ae7-7c381bcb5282_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_edeb7aac-1404-491e-a85e-0f442dbbd1be_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_7b8be3ed-0cdc-404b-ad67-9dbcaf57f337_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for loans receivable</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_4ccaf624-a8b1-47eb-a443-53c02d6e95fc_negatedLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_8d402c95-d9bf-4e34-aa8f-21cc2c18b2af_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses, beginning of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_8805473c-cbfe-43d2-8f20-a1be29115d07_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses, end of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MedicalOfficeMember_d05ed207-8c5a-4515-ab23-8d345b14f958_terseLabel_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Buildings</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_64d28afa-0b33-43a0-83b2-74e272d73746_verboseLabel_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_label_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office [Member]</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_documentation_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties that are part of continuing operations, and which are classified as medical office.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MedicalOfficeMember" xlink:to="lab_peak_MedicalOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VenturesVLLCMember_ad5f9838-5a65-48d0-9776-860adc649fee_terseLabel_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventures V</link:label>
    <link:label id="lab_peak_VenturesVLLCMember_label_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventures V, LLC [Member]</link:label>
    <link:label id="lab_peak_VenturesVLLCMember_documentation_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Ventures V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember" xlink:href="peak-20230331.xsd#peak_VenturesVLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VenturesVLLCMember" xlink:to="lab_peak_VenturesVLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_c259cd88-297f-4740-8a36-3ddbb2cf6782_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Four, Originated, Three Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_a3cd78d2-fb6b-47bf-9dda-f1d749a98ae2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconsolidated Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_9b19e79b-866f-44a9-87eb-e6bb78ca0718_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_4127a082-cbcb-440a-a4e7-7a36d1174e79_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_3fab305c-7d29-4ea3-b491-c23ebb5ccc2f_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Nonoperating Income Expense</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Nonoperating Income Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_372b156b-7e2b-49cd-a418-7a1ff1f30c73_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6927f1e1-92c8-4dcf-802b-47c4148f9fa1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_047bbf7f-2e9c-4215-955c-ce2d0fc0e1d0_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of extensions</link:label>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_label_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_documentation_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions" xlink:href="peak-20230331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentNumberofExtensions" xlink:to="lab_peak_DebtInstrumentNumberofExtensions" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_e2e78e01-2eda-4113-848f-091b5906adda_negatedLabel_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss (income) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Equity Method Investments, Including Discontinued Operations</link:label>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_documentation_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Equity Method Investments, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:href="peak-20230331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:to="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_996f1a7b-d82e-41dd-88f7-dcb8f1176589_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LifeScienceMember_2669d8f2-4ca3-4999-b111-f5908eccc772_terseLabel_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science</link:label>
    <link:label id="lab_peak_LifeScienceMember_9fcd34ec-8dd7-46b4-a461-4de1ed95c851_verboseLabel_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science</link:label>
    <link:label id="lab_peak_LifeScienceMember_label_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science [Member]</link:label>
    <link:label id="lab_peak_LifeScienceMember_documentation_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties that are part of continuing operations, and which are classified as life science.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LifeScienceMember" xlink:to="lab_peak_LifeScienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e84f4183-4d71-4ed8-b04a-7e7f17bb9cc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6d7f5170-1b1c-452c-afe0-f2195b6ab66a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_366bfdd0-df72-4d4b-87a6-919b66ea2691_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateTable_43021127-9064-4862-9328-85a09a859a2a_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:label id="lab_us-gaap_RealEstateTable_label_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateTable" xlink:to="lab_us-gaap_RealEstateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_2a42c747-4759-405f-8748-8126f4533bbf_terseLabel_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCP Ventures IV, LLC</link:label>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_label_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H C P Ventures IV, LLC [Member]</link:label>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_documentation_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Ventures IV, LLC, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember" xlink:href="peak-20230331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_HCPVenturesIVLLCMember" xlink:to="lab_peak_HCPVenturesIVLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_048a717c-b081-41ff-af62-ca337dfddbf2_terseLabel_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative amount terminated</link:label>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_label_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_documentation_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated" xlink:href="peak-20230331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DerivativeNotionalAmountTerminated" xlink:to="lab_peak_DerivativeNotionalAmountTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_b5db049a-1581-471d-a39c-3d56e25b53a8_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_9b4d2178-17d1-4106-a0d2-a1699a7e5d54_terseLabel_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP</link:label>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_label_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Housing Operating Portfolio [Member]</link:label>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_documentation_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represent senior housing operating portfolio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SeniorHousingOperatingPortfolioMember" xlink:to="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_3586c4de-107f-458e-b8c5-d72402caeb7d_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Loss Exposure and Carrying Amount</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_a65e2793-0b66-4fc9-b7fe-584be5331b1e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_af9c05d4-5293-401c-b8f2-0f8e10296238_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_56d13721-b7d7-426b-890a-96cb5d0579a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3da46c32-6f8c-4a2e-b4cf-b58d909fe73d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DownreitPartnershipsMember_a40fda20-fc3f-4c28-977a-70070827dc91_terseLabel_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DownREIT Partnerships</link:label>
    <link:label id="lab_peak_DownreitPartnershipsMember_label_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Downreit Partnerships [Member]</link:label>
    <link:label id="lab_peak_DownreitPartnershipsMember_documentation_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a joint venture, DownREIT Partnerships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember" xlink:href="peak-20230331.xsd#peak_DownreitPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DownreitPartnershipsMember" xlink:to="lab_peak_DownreitPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_03dc0d0f-f5c9-451d-a969-c376468c4bcb_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_5604f8a4-b893-4583-9d65-29f2f97f7146_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_896c23f8-b7cf-4bcb-8548-0dd31ebbd32a_terseLabel_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_label_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months [Member]</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_documentation_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:to="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfSecuredLoans_e485701b-b28e-4d90-a664-8c93a63be61b_terseLabel_en-US" xlink:label="lab_peak_NumberOfSecuredLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of secured loans</link:label>
    <link:label id="lab_peak_NumberOfSecuredLoans_label_en-US" xlink:label="lab_peak_NumberOfSecuredLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Secured Loans</link:label>
    <link:label id="lab_peak_NumberOfSecuredLoans_documentation_en-US" xlink:label="lab_peak_NumberOfSecuredLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Secured Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfSecuredLoans" xlink:href="peak-20230331.xsd#peak_NumberOfSecuredLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfSecuredLoans" xlink:to="lab_peak_NumberOfSecuredLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LifeScienceJVsMember_528aca28-4266-4f51-bb2c-50810af6f265_terseLabel_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science JV</link:label>
    <link:label id="lab_peak_LifeScienceJVsMember_label_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science JVs [Member]</link:label>
    <link:label id="lab_peak_LifeScienceJVsMember_documentation_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Life Science, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LifeScienceJVsMember" xlink:to="lab_peak_LifeScienceJVsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_1a4837e5-4753-4fcc-bef2-f88dbff1be2f_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5d254134-bcc6-4b7f-a5f7-fab42d651065_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_37e5320f-b63b-49ea-a1c9-1fdebd3dbe08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_b074a587-dd5b-4adb-96c0-c396bb7764fb_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net real estate</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MezzanineMember_6e4b5190-7446-4098-ba76-af17b969bfa8_terseLabel_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine</link:label>
    <link:label id="lab_peak_MezzanineMember_label_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:label id="lab_peak_MezzanineMember_documentation_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember" xlink:href="peak-20230331.xsd#peak_MezzanineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MezzanineMember" xlink:to="lab_peak_MezzanineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_9c2d92fa-ab7b-48cb-81e6-bdeab929e3d5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of buildings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_3a218a6f-a911-4393-a0c2-107efcab801c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfBuildings" xlink:to="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_02f5420f-b4c0-4dc7-916a-4b58139fc9f9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap254PayRateMember_06f90556-efd8-4608-9450-87730045bbfe_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap254PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.54% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap254PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap254PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.54% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap254PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap254PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.54% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap254PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap254PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap254PayRateMember" xlink:to="lab_peak_InterestRateSwap254PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_993940fc-7b18-4067-a455-652714baef56_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Total Costs And Expenses</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Total Costs And Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_40c96ad4-5507-4ac4-97f7-5ffd49ced7cc_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2882b2f7-bfdc-431b-be28-fba89438a82d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_fea0a813-3be2-4829-a92a-dc0498f1511b_terseLabel_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]</link:label>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_label_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]</link:label>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_documentation_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:href="peak-20230331.xsd#peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:to="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_3723770e-731c-42ce-b293-fd6d4bab035b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_7c35c4ca-e334-4649-81b9-5a21f7a64b5f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceAxis_d58a7328-9411-41b2-bce9-010a1692a8f0_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Axis]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceAxis_label_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Axis]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceAxis_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceAxis" xlink:to="lab_peak_GovernmentAssistanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4680007a-8bc0-4f3b-b453-c53b8ad2831a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_2e935faa-7c9c-4db1-9fe2-24317284446b_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_be1d7be7-633e-4b05-8a2e-1411b4c978cf_terseLabel_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_label_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV [Member]</link:label>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_documentation_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember" xlink:href="peak-20230331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NeedhamLandParcelJVMember" xlink:to="lab_peak_NeedhamLandParcelJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_7a4aa846-6de8-4204-8f21-8c5b8cfb39cb_terseLabel_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities owned by unconsolidated joint venture</link:label>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_label_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities Owned by Unconsolidated Joint Venture</link:label>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_documentation_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities Owned by Unconsolidated Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:href="peak-20230331.xsd#peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:to="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_ded2ce2f-a025-4ff5-8113-235411f0cf88_negatedTerseLabel_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale of real estate under direct financing leases</link:label>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_label_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</link:label>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_documentation_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:href="peak-20230331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:to="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_e1110241-f0f5-463c-a232-742b8621a960_terseLabel_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of VIE borrowers with marketable debt securities (in joint ventures)</link:label>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_label_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of VIE Borrowers With Marketable Debt Securities</link:label>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_documentation_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of VIE borrowers in which the entity has invested in marketable debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:href="peak-20230331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:to="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_be3759dc-b763-428e-b47b-ae1b51721c4c_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_label_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income From CARES Act</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income From CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncomeFromCARESAct" xlink:to="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_4c202334-21d3-4b2f-93ea-f74300d3b073_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable" xlink:to="lab_us-gaap_LessorLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_d8fb6b33-9f74-4491-bbc3-dc8354fb048f_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8c9a9088-9c18-4a69-a3d4-79c44d0fe3a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6d9f361b-d093-4b9e-a565-68ede9081ae2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3b63f847-0bb7-435b-a05b-41c7746b9494_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_a7f49034-6a89-4aa3-9cda-79930aa33e80_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_38aee27a-7972-4de6-86fb-ba0d4f5cc0dc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d6fb51c3-d001-434e-9c9a-e179ec658d0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent_93a19fef-01a0-4699-9a09-cee8fe4c0ba2_terseLabel_en-US" xlink:label="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining minority interest ownership percentage by parent</link:label>
    <link:label id="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Minority Interest Ownership Percentage By Parent</link:label>
    <link:label id="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent_documentation_en-US" xlink:label="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Minority Interest Ownership Percentage By Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:href="peak-20230331.xsd#peak_RemainingMinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:to="lab_peak_RemainingMinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c0934e88-3751-4960-8f78-841d460d5b8d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_4f5d79c4-2fbe-4756-94ed-1243f6f5ef20_terseLabel_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties classified as DFL</link:label>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_label_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties with Direct Financing Leases, Number</link:label>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_documentation_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties with direct financing leases at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:href="peak-20230331.xsd#peak_PropertiesWithDirectFinancingLeasesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:to="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CCRCSegmentMember_79ce8756-7098-4702-bbcf-72d8dd76bf08_terseLabel_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC</link:label>
    <link:label id="lab_peak_CCRCSegmentMember_label_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Segment [Member]</link:label>
    <link:label id="lab_peak_CCRCSegmentMember_documentation_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember" xlink:href="peak-20230331.xsd#peak_CCRCSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CCRCSegmentMember" xlink:to="lab_peak_CCRCSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_989ad246-95a8-4362-896b-7def08a85603_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap instruments</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_3c808206-fe52-4957-a7a9-3fc65492bfa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_76a5c8f1-6076-4b41-b4a2-3a70cfb6657e_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_bab11a2d-dec8-4053-8b86-ca79df40b8af_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_e16d3d33-a170-47f6-8ffc-17addff67ef3_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesSold_5f4d245a-9503-48de-8635-3b3d3f65512c_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesSold_label_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesSold_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesSold" xlink:to="lab_peak_NumberOfPropertiesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_52b68665-f612-4ca7-88f9-5964920af61f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_07f3f8a3-9805-44be-b847-790a663b485b_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_a79a1da1-a27e-48bb-bbd9-29d406a7ff5e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a2d2b584-701f-44e2-9e24-57293cd4cac8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_17a7e479-c79a-40b5-ae1f-25bd872d9954_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_1b19400f-23e3-472a-8819-93b5a0dfc0db_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_label_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Thereafter [Member]</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_documentation_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the period after the last period separately disclosed of debt redemption features under terms of the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:to="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0f72af56-462d-41b9-b986-fb21488eff90_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent_18dba44e-f54d-4e35-8630-32a44c4b687b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued construction costs</link:label>
    <link:label id="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_dc943292-bc97-42dc-ba03-27c94e77df76_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_25f1e81f-1124-4759-8390-2c20c515c3d4_terseLabel_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable entrance fees</link:label>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Entrance Fees, Current and Noncurrent</link:label>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_documentation_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Entrance Fees, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:href="peak-20230331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:to="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c2bfea60-4bdd-407b-a32d-e9b578a0196c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Line&#160; of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_ad2cef51-a1f6-4304-a5ef-025245a623c6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_37dee162-f09d-484b-9bc3-7306ac9c2b5c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_13ee8f3d-bbe5-4a7f-81fa-5c860ddb568c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_26465e93-4225-48aa-ad64-e834a28fa869_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_abef61ff-5676-4602-bc6d-b3f26746df0a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_fa4be739-64b2-4c0c-a958-a49ffb4da0f0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NonrefundableEntranceFees_afe521e5-7632-46a9-93e0-7187a96d933f_terseLabel_en-US" xlink:label="lab_peak_NonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrefundable entrance fees</link:label>
    <link:label id="lab_peak_NonrefundableEntranceFees_label_en-US" xlink:label="lab_peak_NonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrefundable Entrance Fees</link:label>
    <link:label id="lab_peak_NonrefundableEntranceFees_documentation_en-US" xlink:label="lab_peak_NonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrefundable Entrance Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonrefundableEntranceFees" xlink:href="peak-20230331.xsd#peak_NonrefundableEntranceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NonrefundableEntranceFees" xlink:to="lab_peak_NonrefundableEntranceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_ed815f80-f75a-4ff1-854c-5754ac236ead_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap instruments</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AR_c6062436-9874-454b-86ef-6cb0bdd835e6_terseLabel_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:label id="lab_stpr_AR_label_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AR" xlink:to="lab_stpr_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_bc44d05c-076e-412e-bbb0-6300eaf47f27_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, cost of capital, percent committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Cost of Capital, Percent Committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Cost of Capital, Percent Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:to="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a3554df2-f392-412c-8512-29d5a2656887_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_31ffa8d3-cbf1-47c9-b59f-3e8e1c79d76d_terseLabel_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_documentation_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:href="peak-20230331.xsd#peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:to="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ec46e37e-2682-45ee-a9b8-42aa9c09570d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_25c73de5-abf5-4708-bf30-7b054df057a6_terseLabel_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_label_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months [Member]</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_documentation_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:to="lab_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_87252c03-85df-4b95-acaa-c66a661069f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Lease Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_0ef33edf-1787-4b6f-a00e-4b0b58395d1c_terseLabel_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Reporting Segment</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_b734edf3-2326-46cb-96ea-fc0d82f9ba73_netLabel_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-reportable</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_label_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Reporting Segment [Member]</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_documentation_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to other non-reporting segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OtherNonReportingSegmentMember" xlink:to="lab_peak_OtherNonReportingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_7be5501d-b3ef-4888-b473-7ec611dd1f4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Carry Amounts and Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_140ee0a5-cf23-4c4e-b4fd-d0f181f683ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfBankDebt_a57c6c4e-3acb-4b0e-9744-bd6703770c46_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfBankDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfBankDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfBankDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Bank Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfBankDebt" xlink:to="lab_us-gaap_RepaymentsOfBankDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_08ebf0df-38bd-4b05-9e61-c8ebd8677d28_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bb3c5091-1361-460d-9595-34d5b7ded910_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_e4ac856e-068f-434e-9e3c-3ee679c7be54_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act</link:label>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_label_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act [Member]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceCARESActMember" xlink:to="lab_peak_GovernmentAssistanceCARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_ee8f60e7-e6ff-42df-bcbe-dc89cc2ad744_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act</link:label>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:href="peak-20230331.xsd#peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:to="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_cb3a1514-fbcb-4712-b6a0-e815e9a00099_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_af300de9-14ac-420b-81f5-6849d0e61c29_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on derivatives, net</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_444d217c-89ba-4919-b9d6-078a8d71f6b3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Real Estate Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_f6e00522-05e2-466e-bb25-c2b2d034390d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net of reserves of $6,152 and $8,280</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_ac77a19e-0cf9-4e6d-a74b-e9889001f92a_totalLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_30224711-220b-4ade-902d-01cc80ec1c1a_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, after allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2b5ef473-1904-496d-9632-5eeb81b6e39d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_05ea0df0-50e6-4600-b6e0-5ff313774745_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OtherDeferredRevenue_78220a82-9688-4951-b33d-6d4b7aaa4bd1_terseLabel_en-US" xlink:label="lab_peak_OtherDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:label id="lab_peak_OtherDeferredRevenue_label_en-US" xlink:label="lab_peak_OtherDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deferred Revenue</link:label>
    <link:label id="lab_peak_OtherDeferredRevenue_documentation_en-US" xlink:label="lab_peak_OtherDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherDeferredRevenue" xlink:href="peak-20230331.xsd#peak_OtherDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OtherDeferredRevenue" xlink:to="lab_peak_OtherDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_26109872-20ab-41ca-a150-714fa1084cbe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ForwardEquitySalesAgreementsMember_369aca67-e6d0-483a-a65b-0206dbe26988_terseLabel_en-US" xlink:label="lab_peak_ForwardEquitySalesAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Equity Sales Agreements</link:label>
    <link:label id="lab_peak_ForwardEquitySalesAgreementsMember_label_en-US" xlink:label="lab_peak_ForwardEquitySalesAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Equity Sales Agreements [Member]</link:label>
    <link:label id="lab_peak_ForwardEquitySalesAgreementsMember_documentation_en-US" xlink:label="lab_peak_ForwardEquitySalesAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Equity Sales Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardEquitySalesAgreementsMember" xlink:href="peak-20230331.xsd#peak_ForwardEquitySalesAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ForwardEquitySalesAgreementsMember" xlink:to="lab_peak_ForwardEquitySalesAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_4e117238-b3c5-4659-8f82-87797859e255_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ad9e17a8-35fc-4068-9b1d-a74e51993f7c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a3cdd3f-1f34-4097-aad4-a82130fd6e6a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b080a0ed-9ec9-4df5-bed7-9464d0659259_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6c6c7c52-8751-45e3-acf4-6220d513222a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4b7ec65b-1218-49be-a6b6-1a904fe686a2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_447bf60e-8b79-423f-b4ba-51c94f1e9c0e_totalLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_631d8a7d-65d1-41ff-844d-fa3d871409c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7e8e1ae4-0373-48aa-a32e-cafa8f160676_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_13d2a239-7743-484d-a44f-2c9121860102_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e0d6878e-2389-4602-bc3d-c050c756b06a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6b1c29c7-0aac-4922-967d-7c4cb05bd343_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d7c11f0c-ec77-45c5-904a-9fcd888db188_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1b41aab7-9ee7-472e-a8c3-6cba72d0addc_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_25fb607b-0fa3-4032-9944-09b5a77cf7e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_35aa6c7b-a638-4fa2-a742-1277e87ee745_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of other deferred charges</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentMarginRate_5f2f6b05-700c-42f5-a7e5-4a2421ea878d_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentMarginRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, margin rate</link:label>
    <link:label id="lab_peak_DebtInstrumentMarginRate_label_en-US" xlink:label="lab_peak_DebtInstrumentMarginRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Margin Rate</link:label>
    <link:label id="lab_peak_DebtInstrumentMarginRate_documentation_en-US" xlink:label="lab_peak_DebtInstrumentMarginRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Margin Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMarginRate" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMarginRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentMarginRate" xlink:to="lab_peak_DebtInstrumentMarginRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_eb0c9138-021c-4907-8a51-e415d97c069f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_27ecfd41-9961-41bf-872d-74a09e501a57_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_9c90d16a-dbe9-4109-a713-8d5748a36f5e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average cost per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_629aa2fc-f478-4b7b-a08e-df5cd355534c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected loan losses (recoveries) related to loans sold or repaid</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Sale and Reclassification to Held-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_669ea9f0-0ce9-4c9c-b125-6fcc7d48188c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discounts, fees, and costs</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Unamortized Loan Cost (Fee) and Purchase Premium (Discount)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:to="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_5154cb8a-9502-45d5-bdf3-76c065bfdbb0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_538a6df5-a440-4a1c-b0ae-2e667acbb50e_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, collateral, healthcare facilities carrying value</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_label_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Collateral Healthcare Facilities, Carrying Value</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of healthcare facilities which are secured by mortgage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:to="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_43006f78-7b13-4540-8555-044d2e91732d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends In&#160;Excess Of&#160;Earnings</link:label>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Distributions in Excess of Net Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:to="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_0bfa5418-f3c7-4361-a8fb-59c316cfcb98_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant debt to assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Debt to Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantDebtToAssets" xlink:to="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4659a92b-e2c1-4d0c-98b0-7f745385dc8a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_22c64e93-0879-40d8-84a2-23f8fb763a99_terseLabel_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding equity awards (in shares)</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_label_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_documentation_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:href="peak-20230331.xsd#peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:to="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bd639e5a-0c0f-4019-81a5-a7183c15a782_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_e2fa7935-2982-4290-8fb1-2a1c6de889a3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TermLoanFacilitiesMember_88c3f04c-1819-4205-a560-6f70048842a4_terseLabel_en-US" xlink:label="lab_peak_TermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesMember_label_en-US" xlink:label="lab_peak_TermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities [Member]</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesMember_documentation_en-US" xlink:label="lab_peak_TermLoanFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesMember" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TermLoanFacilitiesMember" xlink:to="lab_peak_TermLoanFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_2b4cd8d2-4df9-41bb-aeed-3af23f47f6d3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_9c148039-9e97-480a-a9f5-89083c092076_negatedTerseLabel_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to redemption value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_label_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_documentation_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:href="peak-20230331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:to="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_0bb92b49-4553-458a-97fe-4c87e4a3df42_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_b202cacd-d04e-4dc2-962a-0599abfc9ab4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_265ae27b-b17b-4ad4-bc01-e3f99fb79c92_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, gross</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_43ce63f6-b7cf-4ef2-88b2-af3740c4ef94_totalLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1d78bdf3-605a-4a3e-80ff-0cda0c3b6e7a_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_1accef2f-8769-4ef3-bd9a-82b5cf2118dd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_f46fdcfe-1e5e-48f1-ad5e-1d6b0795d378_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for expected loan losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a3d005b1-33dd-4686-96e5-43f7796ece2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_ab919587-8aa7-49e3-80da-05d1b5ac3e95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_9100a752-3f6c-4284-81a9-47d2c689a74c_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income, Policy [Policy Text Block]</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:to="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_58184aa3-2f16-43b1-b5d0-4c11995973c3_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_45d15e5d-9e46-4d52-989d-9aed09a0468a_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_bbc8b949-6716-4b35-b326-37a11d5e6acb_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Lease Liabilities</link:label>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite Lived Intangible Liabilities by Major Class [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:href="peak-20230331.xsd#peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:to="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SecuredMortgageLoansMember_06f5408f-5dd5-4b18-bfcb-41eaeb8b20ab_terseLabel_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured mortgage loans</link:label>
    <link:label id="lab_peak_SecuredMortgageLoansMember_fabf22b7-4e92-4e86-b110-46d482b489f4_verboseLabel_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Loans</link:label>
    <link:label id="lab_peak_SecuredMortgageLoansMember_label_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans [Member]</link:label>
    <link:label id="lab_peak_SecuredMortgageLoansMember_documentation_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SecuredMortgageLoansMember" xlink:to="lab_peak_SecuredMortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a2efeb6e-67dd-4396-9d13-a7c6652e6b0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_2b44331e-5910-43ab-b45a-181cd9592b63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_2da33675-37da-4258-ac72-a7b7fc38c0c3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_4fdfbbae-a2b9-4256-9341-b7b87b36f362_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishment and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_ecb26ad6-c538-42de-a958-02a82090f8a8_terseLabel_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to NOI</link:label>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Adjustments To Net Operating Income From Continuing Operations</link:label>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20230331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_870af57a-b640-4038-b307-a74cf4ca660c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_15df4dcd-229f-4945-a8e7-cea459dc0e31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0e2d9f77-07cd-4131-91e8-09096abfdaad_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cb2c02e3-f857-4b79-a651-e0bd83437cf4_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_41f8fb5b-6ebd-49fd-a35c-5a068a342219_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate:</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1637ca1f-8e6a-4173-9701-9eefbbdf0f13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1511d2a1-5d84-427b-bafa-d919e8de399c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities of discontinued operation</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_45345d74-de89-4a6b-82ab-59a42e21227e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_4a22cedd-c5ef-41ad-aea7-f054afb84f17_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Non-segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_58dd936f-b96e-4322-af03-1ef34d40c1bd_terseLabel_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in income (loss) from discontinued operations</link:label>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_label_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Discontinued Operations [Member]</link:label>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_documentation_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:href="peak-20230331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:to="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_ffc833c9-5c35-43e7-8d8a-c601f1b36b2e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to and purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_bf2a689d-4ff7-4de6-89ac-78aad9aa8d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_5c25b449-1bf0-41ae-b2d5-91405757e1a3_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_49c91192-09d1-4e38-bff1-a96279dcd0f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f9260876-1ae3-4069-bc34-41da9d14c3c3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_459b18bc-f086-4f31-8292-83552c339a1f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_efc6b15c-e610-44d3-8704-ab2fad4536da_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_148a9355-d647-4de5-aea6-df406ea57a43_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b7d8a74a-5002-40dc-bc5d-519100d1a8c7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_bbfbeb87-2fb2-4943-b948-aaee96a1827d_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_7ed6c60f-1d70-40e9-a777-8507cf32c165_terseLabel_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development commitments</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_label_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_documentation_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:href="peak-20230331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:to="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_7bce5d5d-2437-40de-862b-7a93bcd65e18_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_0cb9972a-30a9-41d4-9a63-72cf0bb20dae_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward equity sales agreement, initial net price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_label_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Forward Rate Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TermLoanFacilitiesOneMember_e1a5a69c-6759-47b1-aefe-3d32a21bf1b1_terseLabel_en-US" xlink:label="lab_peak_TermLoanFacilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities One</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesOneMember_label_en-US" xlink:label="lab_peak_TermLoanFacilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities One [Member]</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesOneMember_documentation_en-US" xlink:label="lab_peak_TermLoanFacilitiesOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesOneMember" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TermLoanFacilitiesOneMember" xlink:to="lab_peak_TermLoanFacilitiesOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansAndLeasesReceivableRemainingCommitments_f22ef580-5de3-4be4-a915-f29a41fc115d_terseLabel_en-US" xlink:label="lab_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Remaining Commitments</link:label>
    <link:label id="lab_peak_LoansAndLeasesReceivableRemainingCommitments_label_en-US" xlink:label="lab_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Remaining Commitments</link:label>
    <link:label id="lab_peak_LoansAndLeasesReceivableRemainingCommitments_documentation_en-US" xlink:label="lab_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Remaining Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:href="peak-20230331.xsd#peak_LoansAndLeasesReceivableRemainingCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:to="lab_peak_LoansAndLeasesReceivableRemainingCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_6e38824e-c03f-4ccc-9b97-5ab6b32be9de_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss reserve on unfunded loan commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_label_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Unfunded Loan Commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_documentation_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Unfunded Loan Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:href="peak-20230331.xsd#peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:to="lab_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6efe3fae-37cd-43cf-b4ec-5b7eaba0cc7d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_3064a85b-44d5-4fd5-afbf-b274b9d5cbc2_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_1a2c18da-1a2d-4032-9a16-7c80b0c360ab_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_84631abb-d976-49a8-a88e-8d56ed6ede30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a61bc314-92b5-4cc4-a617-a4a6583c6934_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5fa475e2-712b-4961-a6a0-2a7294e1c476_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_ab1fdbcf-5eb9-4a04-a3ee-b41dcb1e3429_terseLabel_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale, net</link:label>
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_label_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related To Assets Held For Sale, Net</link:label>
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_documentation_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related To Assets Held For Sale, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:href="peak-20230331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:to="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleNet" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_32b9bea4-613e-4a46-b43a-5e814b744f33_terseLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross intangible lease liabilities</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Liabilities, Gross</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_81b186e9-2c11-45e9-8d9f-f8f7dc98bcf3_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_4c70d407-26cd-4561-83be-2e9a93096e7e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_73013950-b953-437f-99e6-7488729f242c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_fbb7fa52-7ecc-499d-b058-777698cc915b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8fdcee07-42e7-487b-8e8b-deb840fa763a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_10dc1a55-ced8-4940-8f46-8e2d5e5ad48b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_5d5979e2-a240-4da9-b9a5-dc7436aa108f_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_b6da113f-1b9c-4efa-a6a9-041c4a11ff59_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_46c5a2eb-9f01-47f4-aa53-f317d4be5eaf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_0dc3d350-97e9-433f-9e52-a71bb95532e9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_8c1e296e-cac7-4130-a969-56fd398db4dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_b446b0ee-06c1-494c-a57d-4adaf913331c_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_1d9ad740-dd76-4bd2-a11e-90f759e457f4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceDomain_3f158477-ff71-431b-b3d1-1a73513eb674_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Domain]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceDomain_label_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Domain]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceDomain_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceDomain" xlink:to="lab_peak_GovernmentAssistanceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_f2dfabec-1996-4560-abb8-412ae5601adf_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares - forward equity agreements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_98207200-e156-4b84-b4f8-e1fdcd7a8da8_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageReceivablesMember_96786f7e-b0c7-472e-8439-031d395e0868_verboseLabel_en-US" xlink:label="lab_us-gaap_MortgageReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans</link:label>
    <link:label id="lab_us-gaap_MortgageReceivablesMember_label_en-US" xlink:label="lab_us-gaap_MortgageReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageReceivablesMember" xlink:to="lab_us-gaap_MortgageReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cdf5fe25-eebe-4a55-b00f-d631465c4ce5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_f3073c7e-22cf-4655-afc3-7b2e7cf8f9d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense on other</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringExpense" xlink:to="lab_us-gaap_OtherNonrecurringExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TermLoanAgreementMember_353df67d-611c-4844-b13c-710b742bd920_terseLabel_en-US" xlink:label="lab_peak_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement</link:label>
    <link:label id="lab_peak_TermLoanAgreementMember_label_en-US" xlink:label="lab_peak_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:label id="lab_peak_TermLoanAgreementMember_documentation_en-US" xlink:label="lab_peak_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanAgreementMember" xlink:href="peak-20230331.xsd#peak_TermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TermLoanAgreementMember" xlink:to="lab_peak_TermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_553afebc-4bae-42f9-89df-3996ec7dbac7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a8c6489e-a371-4629-bf00-dc1ec68a1940_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_4e6d4132-2b01-46bf-b6fb-ce858541847b_terseLabel_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period in years</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_aeff51df-bc48-4250-a18a-e736f5623781_verboseLabel_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period, liabilities</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_label_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_documentation_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:href="peak-20230331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:to="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0b0e0ee2-61c6-4e64-a161-a40153364a84_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_edbcc862-d696-4df4-9771-d813f2bec29f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from and issuance of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_cf0c03a2-188d-4606-979b-d04df5443d9c_terseLabel_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation and Other Costs</link:label>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_label_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation And Other Costs [Member]</link:label>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_documentation_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation And Other Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:href="peak-20230331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:to="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_af99bcad-d37c-4f46-84f6-581653fd2dff_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue_e61d0fc4-976d-42b3-bd75-a9456ac62431_terseLabel_en-US" xlink:label="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority interest in preferred unit holders, fair value</link:label>
    <link:label id="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue_label_en-US" xlink:label="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority Interest in Preferred Unit Holders, Fair Value</link:label>
    <link:label id="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue_documentation_en-US" xlink:label="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:href="peak-20230331.xsd#peak_MinorityInterestInPreferredUnitHoldersFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:to="lab_peak_MinorityInterestInPreferredUnitHoldersFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40b5f059-5c24-4594-a1c8-d2a6b4892f1d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5f95f9b0-d032-4792-aea7-cdc80e29bf38_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_0be165ba-ef35-45a4-a27d-eab73eaa9388_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_label_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Remainder of Fiscal Year [Member]</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_documentation_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:to="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetRealEstateAssets_c68e9afb-7a65-4e11-af73-d00aa7e3c4e8_terseLabel_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net real estate assets</link:label>
    <link:label id="lab_peak_NetRealEstateAssets_label_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Real Estate Assets</link:label>
    <link:label id="lab_peak_NetRealEstateAssets_documentation_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets" xlink:href="peak-20230331.xsd#peak_NetRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetRealEstateAssets" xlink:to="lab_peak_NetRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_1f283480-1591-435e-93cd-6f7a689be6a2_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_label_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Not Primary Beneficiary Investment In Joint Venture [Member]</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to investments in an unconsolidated joint venture, which is a Variable Interest Entity (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:to="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfDownREITLLCs_aa96edd6-dafc-40eb-b660-d7cf539dee77_terseLabel_en-US" xlink:label="lab_peak_NumberOfDownREITLLCs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of DownREIT LLCs</link:label>
    <link:label id="lab_peak_NumberOfDownREITLLCs_label_en-US" xlink:label="lab_peak_NumberOfDownREITLLCs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Down REIT LLCs</link:label>
    <link:label id="lab_peak_NumberOfDownREITLLCs_documentation_en-US" xlink:label="lab_peak_NumberOfDownREITLLCs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the number of DownREIT LLCs for which the entity is the managing member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfDownREITLLCs" xlink:href="peak-20230331.xsd#peak_NumberOfDownREITLLCs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfDownREITLLCs" xlink:to="lab_peak_NumberOfDownREITLLCs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7f88c79a-73c7-428b-b4a5-2113a911de46_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_39cb9dfa-4999-48a6-bf3d-46219a7c4160_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f63e972f-2627-42c6-8d88-96665885958d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_c3a17b2e-3ffa-4dd8-87ac-23cca83f14c6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_label_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Building and Building Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:to="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_94d38628-7334-4242-96ab-b22255d9d80d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4f73fcbc-a167-4b81-8395-00f144a1649c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross intangible lease assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_246e8f90-0270-4c14-b393-09471a97071b_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0dca4dc6-2e99-4c05-892c-e2b5636bb0a1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ced3d3a2-9e4d-4b4c-86cf-a9c7dfbed5f7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b381e69e-2f67-441d-90e3-5d7a9553d9e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_9a53a2a3-4cac-47f5-be8b-a4e9e4762af6_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_30e6fc3c-6f29-4c06-8e4c-a6026ab9b7f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_36fce505-30bf-4e60-800f-a0a1645851c6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_55382383-2059-434a-a36b-35303252f956_verboseLabel_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout loans</link:label>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_label_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout Financing Receivable [Member]</link:label>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_documentation_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout Financing Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember" xlink:href="peak-20230331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_WorkoutFinancingReceivableMember" xlink:to="lab_peak_WorkoutFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_77043757-b8c0-4bb4-ad5b-4accd55710ee_terseLabel_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of nonrefundable entrance fees and above (below) market lease intangibles</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_label_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_documentation_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:href="peak-20230331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:to="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_57ab08f0-46d4-4da5-9911-b55b42d0e034_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0f87a3d4-0e8a-465f-a20b-42e83625171b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_48a19e5f-3668-4190-8563-df0dfed7381c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Two, Originated, Fiscal Year before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncomeAbstract_5efe85bf-681f-4c78-b871-c4b66daeafb3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract" xlink:to="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2172454e-3037-4adb-8c79-e3da307be85f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_593dc2b0-3171-46b6-b294-7d1e6622a6b9_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_891064f5-18b5-4b5f-91ca-efea892297be_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c61d8d1-a0f4-4231-87e6-5c3dd12dc380_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_36cd1ade-d18e-48cd-a994-2c4574a3f41c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums, (discounts), and debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_4ab68931-0e30-4d2b-ab63-8df65a187d94_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:to="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_588dc259-8c42-4f9b-94ca-9ffcda1629d9_terseLabel_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suburban Properties, LLC</link:label>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_label_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suburban Properties L L C [Member]</link:label>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_documentation_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to Suburban Properties, LLC, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember" xlink:href="peak-20230331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SuburbanPropertiesLLCMember" xlink:to="lab_peak_SuburbanPropertiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a9788654-671b-4569-b958-4334b10bf57a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a2270af6-a073-4dcd-8811-7a7d2ead332c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap454PayRateMember_5e181d27-9c08-4f51-8c19-39670c2ab876_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap454PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.54% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap454PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap454PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.54% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap454PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap454PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.54% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap454PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap454PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap454PayRateMember" xlink:to="lab_peak_InterestRateSwap454PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_80b4e312-2473-4413-adf5-3c2f13758a77_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c5a67a04-e288-4529-a240-ac4284e49157_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_86361fcb-9c8e-4d6a-b81c-180b434a99fb_terseLabel_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties may be contributed in the agreement</link:label>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_label_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Of Property, Number Of Properties</link:label>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_documentation_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Of Property, Number Of Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties" xlink:href="peak-20230331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ContributionOfPropertyNumberOfProperties" xlink:to="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_ed848599-4a94-48f3-bb0c-df60df7dc3f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_9a7c7152-70f5-46c2-b79b-568d3945650f_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties acquired</link:label>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_label_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Acquired</link:label>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesAcquired" xlink:to="lab_peak_NumberOfPropertiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CurrentPeriodGrossWriteOffsMember_b3f15608-1374-436e-ae31-55e889693665_terseLabel_en-US" xlink:label="lab_peak_CurrentPeriodGrossWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period gross write-offs</link:label>
    <link:label id="lab_peak_CurrentPeriodGrossWriteOffsMember_label_en-US" xlink:label="lab_peak_CurrentPeriodGrossWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Gross Write-Offs [Member]</link:label>
    <link:label id="lab_peak_CurrentPeriodGrossWriteOffsMember_documentation_en-US" xlink:label="lab_peak_CurrentPeriodGrossWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Gross Write-Offs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodGrossWriteOffsMember" xlink:href="peak-20230331.xsd#peak_CurrentPeriodGrossWriteOffsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CurrentPeriodGrossWriteOffsMember" xlink:to="lab_peak_CurrentPeriodGrossWriteOffsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_9de887b0-fd7c-4ff6-80e8-c2ae015f4bcf_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_d55fdc33-15aa-43ca-bd0c-7b9c85a192fe_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_c9900fbe-210d-4559-a40a-c03a4592af5e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income, Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8397000a-4dca-4da7-a0cf-4d206833b51e_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_af1df290-112e-464c-a2f2-a73f8de69f1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7a50c583-8fd8-4eed-9bc8-56d0acf2c452_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4006da3c-2361-4509-b061-c21a09ed601b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_95868264-87dc-4e1e-a289-95bed8b719d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52408f9e-709e-4b2d-b271-e530971dc793_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_52adba89-afec-4b1c-91e3-571f109fb84d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_f10ef474-1606-4546-8c96-ef769acdaba7_terseLabel_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to redemption value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_label_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_documentation_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:href="peak-20230331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:to="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6bb954fd-af40-435d-97a8-e06d2232a5e9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_32d2c7d6-3e01-429d-9af2-4f93c0e9a9a3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2ff5960a-b05e-4188-a07e-fd9a517d6240_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_6415e835-8054-4810-be4b-0278933bb3ea_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebfdc171-0173-4e33-8dff-2fa474366f70_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019122d6-600b-42d9-af61-33b176a2fe2e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_0500965a-3b98-41d1-9c8d-83f2b046812a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_a6a4ff0f-7dbd-47f1-9475-170dcf200360_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_6b999b4b-3c33-47c5-9e37-63657ae724a5_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average maturity (in years)</link:label>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_label_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Weighted Average Maturity</link:label>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_documentation_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents weighted average maturity of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity" xlink:href="peak-20230331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentWeightedAverageMaturity" xlink:to="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_a87546db-bfc4-404e-aa08-80394b68c059_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncome_d2f53342-cff3-4fb1-be9a-8f44844cf8cc_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income received</link:label>
    <link:label id="lab_peak_GovernmentGrantIncome_label_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncome_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncome" xlink:to="lab_peak_GovernmentGrantIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_02ea354d-ea8b-4e32-9e7d-619a5a3acb7c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1.00 par value: 750,000,000 shares authorized; 546,994,803 and 546,641,973 shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_92702cfb-2908-4e38-9060-806dbbac2534_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a6077e5e-b4bb-4f97-8ee7-885e83c3905b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1c07e7f3-a84e-4eb3-a525-5de03829e431_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e0665799-51e7-437c-bd1d-5e7ec85c3356_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_7af77f61-2f33-4598-82f5-579e4ef9d197_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DownREITUnitsOutstanding_992c3325-2e27-47cb-8bd8-1083f210f132_terseLabel_en-US" xlink:label="lab_peak_DownREITUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DownREIT units outstanding (in shares)</link:label>
    <link:label id="lab_peak_DownREITUnitsOutstanding_label_en-US" xlink:label="lab_peak_DownREITUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down REIT Units Outstanding</link:label>
    <link:label id="lab_peak_DownREITUnitsOutstanding_documentation_en-US" xlink:label="lab_peak_DownREITUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of DownREIT units outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITUnitsOutstanding" xlink:href="peak-20230331.xsd#peak_DownREITUnitsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DownREITUnitsOutstanding" xlink:to="lab_peak_DownREITUnitsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dda9db3d-8d1c-4106-83cc-96a7a8b8c666_negatedTerseLabel_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote525PercentMember_cbf2f289-05bb-445a-8096-89fdd694fe3d_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote525PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 5.25 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote525PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote525PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 5.25 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote525PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote525PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 5.25 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote525PercentMember" xlink:href="peak-20230331.xsd#peak_UnsecuredNote525PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote525PercentMember" xlink:to="lab_peak_UnsecuredNote525PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_1e9b8801-48ab-4541-b593-2f44a1f68288_negatedLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Liabilities Accumulated Amortization</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_8efe88a6-745d-48b3-83f4-fb7814db0590_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segment</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_9467e8a6-30f4-45b4-8d68-df1512635ba0_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:to="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_a4ec12f7-138e-4260-b790-0cb391fcebf9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0bb8e72-c6a3-4087-ad45-0db81f91298d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_e2a04e42-a7a6-4718-829e-24aaddd40084_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length of debt instrument extension period (in months)</link:label>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_label_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Period Of Extension</link:label>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_documentation_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the length of the debt instrument extension period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension" xlink:href="peak-20230331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentPeriodOfExtension" xlink:to="lab_peak_DebtInstrumentPeriodOfExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_80b75b19-8b6e-4691-b0e5-6f29e7328416_terseLabel_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves (recoveries), net</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_label_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_documentation_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:to="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_17ed83d0-a2ab-4c4e-9341-af2c3363e5de_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term&#160;Loans</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cd7cf1cb-465f-4720-81da-945dc8875fc4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e5cc87ac-ecdc-4b70-9de1-9dda973b9f1d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_6a862007-4454-4711-b97e-10feaa02f553_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_49aa3138-0f99-49d7-9e8f-44582c15b67a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_1c7ae6ef-94d2-46ea-9b5f-f1d738445da2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SHOPJVMember_ae31bc8b-32d5-4b1f-9e80-0b2828ca4b23_verboseLabel_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWF SH JV</link:label>
    <link:label id="lab_peak_SHOPJVMember_label_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP JV [Member]</link:label>
    <link:label id="lab_peak_SHOPJVMember_documentation_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember" xlink:href="peak-20230331.xsd#peak_SHOPJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SHOPJVMember" xlink:to="lab_peak_SHOPJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromBankDebt_9dabc8c5-6e23-46a5-b283-3871b07cb2f5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromBankDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromBankDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromBankDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Bank Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromBankDebt" xlink:to="lab_us-gaap_ProceedsFromBankDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_42fcea94-7dd3-4a8d-9a01-9fa0838a8786_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfNotesReceivable_04aaaf20-3c07-4b0a-8094-88af6b5a356a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of direct financing lease</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Financing Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:to="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0920bf6c-c7c4-4f9d-ac4c-f47f35ad0715_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0c684fdb-38fc-4a86-8498-a8d29787d019_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9186df5f-b830-4194-ac2e-0f368333dcc1_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_4948b877-371f-4a9e-afb2-5de65c4c3e4f_terseLabel_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM aggregate amount remaining</link:label>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_label_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Remaining</link:label>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_documentation_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:href="peak-20230331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:to="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_65e7cf0f-6274-41d4-a236-bdd6790e2843_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c5224d08-4a00-4b8a-acf4-64237fc07e10_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_14433171-e76c-4093-991b-025b912bc736_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_1391370f-cb78-491c-a723-4f5677559f4f_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LLC investment</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_label_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Not Primary Beneficiary Debt Investment [Member]</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a debt investment with a party that has been identified as a Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:to="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7ac6ae5-18ee-4ca4-8306-c26580334863_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_2f25f964-4f2c-4d29-b6e7-28d92286ed57_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_2e46be0b-b31f-4ee1-9b32-cf7be2bc0945_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_20369231-a1a4-48aa-b9c3-7d6e01fde645_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9ea68c8c-7512-4f3a-9c25-15caf401471d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2fb67993-3cb7-46de-81a6-b5e4bee47b4a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_80e89686-43ce-44c1-916b-4a03c9dada91_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_b0e22d38-d555-4515-8b48-c78a323a7782_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the collection of loans receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_09797226-ac76-4add-b85c-7c20719ba57b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a83d61b7-e8a9-44db-ab89-bafab4a90188_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_1936f410-bf0f-43cd-be12-187b235883a2_terseLabel_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</link:label>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_label_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Joint Venture Partners, Attributable To Parent</link:label>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_documentation_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Joint Venture Partners, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:href="peak-20230331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:to="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ATMDirectIssuancesMember_bf151eb3-51ad-4797-baa1-6fe28e5bc7f0_terseLabel_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances</link:label>
    <link:label id="lab_peak_ATMDirectIssuancesMember_label_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances [Member]</link:label>
    <link:label id="lab_peak_ATMDirectIssuancesMember_documentation_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember" xlink:href="peak-20230331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ATMDirectIssuancesMember" xlink:to="lab_peak_ATMDirectIssuancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_fb13ceac-1a55-4f23-8635-8b9f91324c59_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Five, Originated, Four Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_0275c9e6-8683-47a2-a887-b94f3fbcb539_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfRealEstate" xlink:to="lab_us-gaap_ImpairmentOfRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_ad67bec1-3352-4a67-961a-2c6039779080_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued construction costs</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing_76d5bd52-f027-4691-87aa-586997d20dfd_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, period after closing</link:label>
    <link:label id="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing_label_en-US" xlink:label="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Draw Time Period After Closing</link:label>
    <link:label id="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing_documentation_en-US" xlink:label="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Draw Time Period After Closing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:href="peak-20230331.xsd#peak_DebtInstrumentDrawTimePeriodAfterClosing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:to="lab_peak_DebtInstrumentDrawTimePeriodAfterClosing" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommonStockConvertibleSharesIssuable_5d290b06-ab2b-4383-b7dd-e5609289a71d_terseLabel_en-US" xlink:label="lab_peak_CommonStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuable (in shares)</link:label>
    <link:label id="lab_peak_CommonStockConvertibleSharesIssuable_label_en-US" xlink:label="lab_peak_CommonStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Convertible, Shares Issuable</link:label>
    <link:label id="lab_peak_CommonStockConvertibleSharesIssuable_documentation_en-US" xlink:label="lab_peak_CommonStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Convertible, Shares Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommonStockConvertibleSharesIssuable" xlink:href="peak-20230331.xsd#peak_CommonStockConvertibleSharesIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommonStockConvertibleSharesIssuable" xlink:to="lab_peak_CommonStockConvertibleSharesIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_c2b4d035-8de1-4a41-bf48-68e3ca758622_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_95fdf4b3-f310-41ee-82d8-9cf7c1bdb9ff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5544d0ea-997e-4128-98c7-de79c4f9328d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1e0a6a77-92b8-4288-8d62-d197e036545f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ec1644a5-57fd-4304-bc50-817aac6a58a3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_50d40626-06df-4a4a-bf93-cff7b7775a82_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, redevelopment, and other major improvements of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_a206c807-50fd-4eee-b60a-9c23466eef34_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, redevelopment, and other major improvements of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:to="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap463PayRateMember_def3c1ff-440a-4e2d-9ae6-31b6b8901f73_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap463PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.63% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap463PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap463PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.63% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap463PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap463PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.63% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap463PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap463PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap463PayRateMember" xlink:to="lab_peak_InterestRateSwap463PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_ef8b11e9-e041-40fe-a151-01377c9a09e1_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's Lease Income</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_624ba4cb-9a05-45d3-abcf-01a3bc89ee9d_totalLabel_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, total</link:label>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_label_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_documentation_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:href="peak-20230331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:to="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_c733079d-fb28-4e33-9e36-63213ae00c71_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets to be sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_label_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties To Be Sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties To Be Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesToBeSold" xlink:to="lab_peak_NumberOfPropertiesToBeSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d2d51ed3-1d45-4c84-a10a-0c847b6506da_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Supplemental Executive Retirement Plan obligation and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_1868234b-c76b-49f2-bc07-faa75c7800c7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_e6c2e630-070d-4ecb-abcb-c43158d66fcb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_e4cbe75a-50c2-499d-9480-1727ff5dbaef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_8811622a-3eaf-44ce-ba06-1bee80036b80_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a0563b4f-c455-46c7-9f62-0a86afb46329_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9821f7a8-e785-4f6c-af0f-77074f106cc9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7790af84-6cf9-4c7c-994b-897517599e5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dbb21e62-09be-4bf6-99a9-872f2bd5f3a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_b876f597-5fce-40e1-bb73-73a4ba1900e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_388f5fb7-70db-4c5e-8ab5-3b014d7bbb1b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CurrentPeriodNetWriteOffsMember_21f2d9c8-b535-404e-867d-95c29d0c75ce_terseLabel_en-US" xlink:label="lab_peak_CurrentPeriodNetWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period net write-offs</link:label>
    <link:label id="lab_peak_CurrentPeriodNetWriteOffsMember_label_en-US" xlink:label="lab_peak_CurrentPeriodNetWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Net Write-Offs [Member]</link:label>
    <link:label id="lab_peak_CurrentPeriodNetWriteOffsMember_documentation_en-US" xlink:label="lab_peak_CurrentPeriodNetWriteOffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Net Write-Offs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodNetWriteOffsMember" xlink:href="peak-20230331.xsd#peak_CurrentPeriodNetWriteOffsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CurrentPeriodNetWriteOffsMember" xlink:to="lab_peak_CurrentPeriodNetWriteOffsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9ee4bccb-7a57-49fb-a2f8-9f23b6db6833_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f0bc95f-20ab-44aa-be60-642b1933738b_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfLoans_c92b7b05-6b42-47e6-94b5-3a89101b7ff1_terseLabel_en-US" xlink:label="lab_peak_NumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loans</link:label>
    <link:label id="lab_peak_NumberOfLoans_label_en-US" xlink:label="lab_peak_NumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Loans</link:label>
    <link:label id="lab_peak_NumberOfLoans_documentation_en-US" xlink:label="lab_peak_NumberOfLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfLoans" xlink:href="peak-20230331.xsd#peak_NumberOfLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfLoans" xlink:to="lab_peak_NumberOfLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_d747b2ec-68d2-46c5-af57-343e1f037883_terseLabel_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties classified as held for sale</link:label>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_label_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties Held for Sale, Number</link:label>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_documentation_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of properties held for sale at the reporting date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber" xlink:href="peak-20230331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PropertiesHeldForSaleNumber" xlink:to="lab_peak_PropertiesHeldForSaleNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap260PayRateMember_49e829dd-8c15-4a42-9ce5-efa9cc1f8c01_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap260PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.60% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap260PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap260PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.60% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap260PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap260PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 2.60% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap260PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap260PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap260PayRateMember" xlink:to="lab_peak_InterestRateSwap260PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7fad1f27-662d-4a82-a8c8-8224d1e8247f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformingFinancingReceivableMember_b6b688af-e286-4cf9-95a3-11e4627807ef_terseLabel_en-US" xlink:label="lab_us-gaap_PerformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performing loans</link:label>
    <link:label id="lab_us-gaap_PerformingFinancingReceivableMember_label_en-US" xlink:label="lab_us-gaap_PerformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performing Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformingFinancingReceivableMember" xlink:to="lab_us-gaap_PerformingFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_6e307d9a-d3ee-4ee4-9761-3265157feb82_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_label_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_documentation_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntitiesAbstract" xlink:to="lab_peak_VariableInterestEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_091d73b5-664e-4662-b856-2c424e2af9f8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3e77037a-655a-4601-8c43-6a1eb2f0cc62_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_5a0000fc-22a8-4aa4-9c9e-cf5e19b49c0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid (refunded)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ff76aa35-50a5-48d8-80aa-64a18075d466_terseLabel_en-US" xlink:label="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Including Discontinued Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashIncludingDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:to="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2902a93c-8648-4bb9-bc4e-103b4025d810_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_56ea6319-8531-4499-b7c0-3ce1b6d40964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_cf6a01f6-7a7b-4913-8795-67802f1eb3f5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable income from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Variable Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_8fe3ec40-ef1f-4cdd-ae40-6511d75bed9e_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant secured debt to assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Secured Debt to Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:to="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b25ad04f-e794-4773-9e75-12bcb2be7553_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_f7d9a77c-5ebc-42c8-baeb-f0cfc54384a1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends, per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_61cd28b2-5d9e-4595-94d1-c6b5b5de0a16_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_6df90829-3450-430e-b0fe-b420b97e19e9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b9d3e1da-c6cf-4f4c-8803-496605710db8_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_dbadb579-2659-4acb-9dd1-127cdf9ad74f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_61dea425-c7c1-4804-930c-e82bfb6bd36d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c3e62726-2c12-4894-ad35-a4f74d8b8210_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_35808360-fcb4-41c4-b8e9-acd4a3f05eec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap508PayRateMember_ec480d28-d06f-413f-9724-f455cd4f660c_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap508PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 5.08% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap508PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap508PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 5.08% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap508PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap508PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 5.08% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap508PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap508PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap508PayRateMember" xlink:to="lab_peak_InterestRateSwap508PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_5059d682-20a3-424f-9e1b-5f68ea701afc_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_23f36440-f6dd-47ee-b59b-c6fac7bd4d46_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_e79fccca-4a03-41f2-9b16-a85ac63031f2_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant minimum fixed charge coverage ratio</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Fixed Charge Ratio, Minimum</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The required minimum Fixed Charge Coverage ratio contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:to="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_dcd6a44c-52ae-4b18-98dd-a6962e105758_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_77096eca-e0c8-418b-86b8-d77f0b35bff9_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_5f76b50d-7c3b-4b38-b8a9-abcc13fac3c2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansFromBank_be6d4116-8f5c-403a-9b46-55c9c09d8c45_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansFromBank" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_LongTermLoansFromBank_label_en-US" xlink:label="lab_us-gaap_LongTermLoansFromBank" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable to Bank, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansFromBank" xlink:to="lab_us-gaap_LongTermLoansFromBank" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_551dec32-1ae7-47b6-8cff-48fdb3a1c24c_negatedTerseLabel_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_label_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Parent Net</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_documentation_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Parent Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:to="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_f35f29ab-00fe-4b6a-8bda-831a01a39261_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_bede2695-8cc2-4197-bb55-76a824444de5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property count</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_c8a248f6-7e89-4a2d-a978-d12681ca2e4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d558fa29-246b-46b7-88e4-9cc7c2d66ca0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OtherMember_b82f9204-2aee-48ef-ad4d-8ab7826700eb_terseLabel_en-US" xlink:label="lab_peak_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_peak_OtherMember_label_en-US" xlink:label="lab_peak_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_peak_OtherMember_documentation_en-US" xlink:label="lab_peak_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherMember" xlink:href="peak-20230331.xsd#peak_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OtherMember" xlink:to="lab_peak_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_8e76ba71-702f-4ffb-887a-49d700557d3e_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_ff83d6e0-add9-41d5-95e7-c87230e0d3a3_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_ff7781ae-7d7b-4f30-85a8-d2f38bb79731_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions of earnings from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_1c054f72-bcd7-4cd4-a024-3f02b4bd5b26_terseLabel_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and redevelopment projects, amount decrease</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_label_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements, Amount Increase (Decrease)</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_documentation_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:href="peak-20230331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:to="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_64aab75f-eead-4f8f-a33b-d146e5e530dc_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_43ce2de2-0dd7-4944-b749-8eb3540920e5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_36fe7eb4-3f49-4f35-8e0b-e9c020ce687e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_acc6d5fe-ce90-48e4-8eba-39681f22f3b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_4269a7ef-e812-4ff6-b2f9-efdaa000db88_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_bb9c1bac-05a4-480e-a89f-1ac269c4199d_terseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3743355a-7ab7-427a-bf84-4d2eb5266af8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_5b299f01-7827-4632-8789-edc8d844b889_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f4632fae-81a8-4818-8cb7-a14aff52844d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Disclosures</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_fcd4d75c-ff71-481c-95f5-ef661311fad9_negatedTerseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableExtensionFee_748aa570-849c-4778-bba5-59ed50bdf4bf_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableExtensionFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, extension fee</link:label>
    <link:label id="lab_peak_LoansReceivableExtensionFee_label_en-US" xlink:label="lab_peak_LoansReceivableExtensionFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Extension Fee</link:label>
    <link:label id="lab_peak_LoansReceivableExtensionFee_documentation_en-US" xlink:label="lab_peak_LoansReceivableExtensionFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Extension Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableExtensionFee" xlink:href="peak-20230331.xsd#peak_LoansReceivableExtensionFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableExtensionFee" xlink:to="lab_peak_LoansReceivableExtensionFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_910b3eb9-73f9-41b1-8ba2-88a0c74cfb67_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_52b818fb-c903-4f3d-acf6-d38dba3ab05f_terseLabel_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option indexed to issuers equity, term (in years)</link:label>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_label_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed To Issuers Equity, Term</link:label>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_documentation_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed To Issuers Equity, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm" xlink:href="peak-20230331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OptionIndexedToIssuersEquityTerm" xlink:to="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_e1207317-8a80-4991-9dae-14187705c2dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_e752c377-7f8c-434a-8c16-ce9b809e687e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the fair value of the interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_794e8b88-a427-4311-a8ef-64efded40955_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_679965fc-e7b8-4eb3-8dbe-1ee8b2733c75_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_7eb3690e-1645-4512-8f91-02a0d997e314_terseLabel_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSREI JV</link:label>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_label_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Morgan Stanley Real Estate Investment JV [Member]</link:label>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_documentation_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Morgan Stanley Real Estate Investment JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:href="peak-20230331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:to="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_8dc61e82-837e-442e-bf49-ffb95bf0a1b4_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:to="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2069a79-da12-401b-94fd-6a5a56be9194_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_227d7ad0-e63c-4942-a122-470ad4e6c25e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_5851f83c-30d8-48bd-9df6-5f3f56c7c91e_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TermLoanFacilitiesTwoMember_9f19a1e2-f2e7-4341-a600-671380a32e83_terseLabel_en-US" xlink:label="lab_peak_TermLoanFacilitiesTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities Two</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesTwoMember_label_en-US" xlink:label="lab_peak_TermLoanFacilitiesTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities Two [Member]</link:label>
    <link:label id="lab_peak_TermLoanFacilitiesTwoMember_documentation_en-US" xlink:label="lab_peak_TermLoanFacilitiesTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facilities Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesTwoMember" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TermLoanFacilitiesTwoMember" xlink:to="lab_peak_TermLoanFacilitiesTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SouthSanFranciscoJVsMember_f9fce73f-ec24-43ec-addf-ac574b053bb6_terseLabel_en-US" xlink:label="lab_peak_SouthSanFranciscoJVsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South San Francisco JVs</link:label>
    <link:label id="lab_peak_SouthSanFranciscoJVsMember_label_en-US" xlink:label="lab_peak_SouthSanFranciscoJVsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South San Francisco JVs [Member]</link:label>
    <link:label id="lab_peak_SouthSanFranciscoJVsMember_documentation_en-US" xlink:label="lab_peak_SouthSanFranciscoJVsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South San Francisco JVs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SouthSanFranciscoJVsMember" xlink:href="peak-20230331.xsd#peak_SouthSanFranciscoJVsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SouthSanFranciscoJVsMember" xlink:to="lab_peak_SouthSanFranciscoJVsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_37af0db3-85ed-471c-906a-609b5aafd594_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_d89cca28-41b2-403c-a336-934ca31a9625_negatedLabel_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in loans receivable and other</link:label>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_label_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable and Other</link:label>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_documentation_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:href="peak-20230331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:to="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_c521454c-0370-4b6e-964e-e82882b6d742_terseLabel_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility additional aggregate amount, maximum</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_label_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Additional Available Borrowing Capacity Maximum</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_documentation_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:to="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableFairValueDisclosure_8c169126-986e-4d1f-b47e-80d5ef57dd78_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_LoansReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableFairValueDisclosure" xlink:to="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4aef3ed6-18c7-412d-b2c2-1d5eeb2fd40d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_671a57c9-4bf9-4148-a731-5e94d43bc1cd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_f10e0cd6-e051-45c0-80bb-d283f1b839c2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_d40963b2-d8e2-40a2-9f31-9f26ee92d48e_terseLabel_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of nonrefundable entrance fee</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_label_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fee</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_documentation_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFee" xlink:href="peak-20230331.xsd#peak_AmortizationOfNonrefundableEntranceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AmortizationOfNonrefundableEntranceFee" xlink:to="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_c3a8c5e7-0f9a-4671-b750-fc8c12fb8976_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_0b7db43a-7dc7-474b-b423-d1cff80e1d1f_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resident fees and services</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Resident Fees And Services</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Resident Fees And Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_19efdc77-2703-4750-be67-421fe60c1064_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8409de8a-5a64-44ec-b10b-50bfa66455e4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_85c44bd1-107d-44ba-91a0-828870c2fc25_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3659ce47-c74d-411c-b1bb-4a8b6ed2a029_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5781768c-8fe5-470c-aa85-d8d222e20cbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8611d1a4-b119-4a73-9134-817e22567e94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFRMember_47207d0b-9de8-4d63-b36b-8657142ce0f1_terseLabel_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_peak_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_peak_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFRMember" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_peak_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_2af125dc-01b6-4fc6-88e4-f8d108dec1e4_verboseLabel_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watch list loans</link:label>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_label_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watch List Financing Receivable [Member]</link:label>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_documentation_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a financing receivable that is being monitored closely in order to spot irregularities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember" xlink:href="peak-20230331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_WatchListFinancingReceivableMember" xlink:to="lab_peak_WatchListFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_b98f643d-b9f3-4af5-8450-78d8c753d597_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f12699a6-ad23-41f7-b109-72e7605ffa25_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_66bf90b3-a98b-4238-ac4b-6688d821400b_terseLabel_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_label_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Income (Loss) From Unconsolidated Joint Ventures [Member]</link:label>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_documentation_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Income (Loss) From Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:href="peak-20230331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:to="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_eba2e241-bb1a-454e-a2ff-6a2b3c502121_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares_6ea0b116-e616-4d1d-b203-8b348db14932_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares issuable under forward equity sales agreement (in shares)</link:label>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares_label_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_bb745b61-88e8-4de2-81ee-31945bb6f825_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_93a060c5-7097-445c-81bb-a3a5db08269e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period in years</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_ca6a6350-7169-4f5b-8144-863efd3c64d3_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_label_en-US" xlink:label="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Liabilities Associated with Assets Held for Development and Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:to="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_372f216f-f3bd-4ad4-a858-bf9b22e45677_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $2,413 and $2,399</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_b275278d-225b-477b-a6e0-8f6090424145_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c23423d0-9bba-460b-bb34-8cec6150d6a2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_d272f0aa-e1bf-480f-a846-a8f8334aaa42_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_d90043b6-a6bd-4d3a-ae00-5f607b04d264_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_44cfc63e-4362-44f3-b02c-05fa646d42c7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resident fees and services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e7ef3ece-3cef-4a82-93a0-83bfa8ec1b67_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_38563259-f155-4cb5-ab0a-06e33517a314_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_90ca0d0a-f1af-4500-a75e-6eae61f75818_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_c26a6e2e-c48e-4d94-be12-ec0f2edb8101_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year One, Originated, Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_da507863-275c-4794-a1c0-b9ac3c76264e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_90b52b1f-19fd-4c4c-b4cb-f01db06d5136_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_5b6b47d3-007c-4fb6-af9e-a9e876bf8bce_negatedLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_daa224dd-6d82-4e69-8f62-5c2cb30b37bb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of real estate, in-place lease, and other intangibles</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_c9bb5dcb-3786-481b-994f-31061af2259b_negatedLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_83759f15-e6a2-4dcd-8097-39af2fa7ec60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_eba6b313-f74c-41f9-bb82-81b50654f549_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f855feb8-a9b4-4646-ac86-37e4986c1f81_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_1f2e7024-8e6f-4432-a2fa-43b9d40a3c10_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_3ffe8a92-eec0-4643-918d-3906ae33a4e0_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired_647893ce-7394-4fef-b8ea-f453189aa034_terseLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities acquired</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Liabilities Acquired</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Liabilities Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_602ee943-f787-4a55-8122-0b275a731cd1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c21a701f-3e36-4f1f-999c-ca1861076baa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CCRCResidentLoansMember_4cd5e64e-9793-4055-b91c-d7b7c4cf90a4_terseLabel_en-US" xlink:label="lab_peak_CCRCResidentLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC resident loans</link:label>
    <link:label id="lab_peak_CCRCResidentLoansMember_label_en-US" xlink:label="lab_peak_CCRCResidentLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Resident Loans [Member]</link:label>
    <link:label id="lab_peak_CCRCResidentLoansMember_documentation_en-US" xlink:label="lab_peak_CCRCResidentLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Resident Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCResidentLoansMember" xlink:href="peak-20230331.xsd#peak_CCRCResidentLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CCRCResidentLoansMember" xlink:to="lab_peak_CCRCResidentLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9a5b5823-9da0-4d91-b308-46a14357c654_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_f59ba583-f01c-4b6d-8205-4bcf9fefb27d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_b6bc0358-356e-4ea9-98c2-f9660dd66ec4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPlanParticipants_464e961b-e818-415b-a413-3047d3275feb_terseLabel_en-US" xlink:label="lab_peak_NumberOfPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of participants</link:label>
    <link:label id="lab_peak_NumberOfPlanParticipants_label_en-US" xlink:label="lab_peak_NumberOfPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Participants</link:label>
    <link:label id="lab_peak_NumberOfPlanParticipants_documentation_en-US" xlink:label="lab_peak_NumberOfPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPlanParticipants" xlink:href="peak-20230331.xsd#peak_NumberOfPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPlanParticipants" xlink:to="lab_peak_NumberOfPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_7d7862a4-823a-4ea3-8a17-7a60238169dc_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_2f28e87a-4d06-4da7-99f2-02b887c17ab7_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum outstanding amount capacity</link:label>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_label_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:to="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfHospitals_ea89caa3-e5ec-4a2a-be32-0c39113b73a8_terseLabel_en-US" xlink:label="lab_peak_NumberOfHospitals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of hospitals</link:label>
    <link:label id="lab_peak_NumberOfHospitals_label_en-US" xlink:label="lab_peak_NumberOfHospitals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hospitals</link:label>
    <link:label id="lab_peak_NumberOfHospitals_documentation_en-US" xlink:label="lab_peak_NumberOfHospitals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hospitals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfHospitals" xlink:href="peak-20230331.xsd#peak_NumberOfHospitals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfHospitals" xlink:to="lab_peak_NumberOfHospitals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ad4724e5-d4e1-46d1-9b62-ed249adc0d4e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_cc230716-b8e3-40ca-aff3-77fc4b51d622_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term (in months)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_69aae763-c476-43bd-96c8-01ab3c609329_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CurrentPeriodRecoveriesMember_e41e04b4-d240-40eb-8d83-913f5c4af11b_terseLabel_en-US" xlink:label="lab_peak_CurrentPeriodRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period recoveries</link:label>
    <link:label id="lab_peak_CurrentPeriodRecoveriesMember_label_en-US" xlink:label="lab_peak_CurrentPeriodRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Recoveries [Member]</link:label>
    <link:label id="lab_peak_CurrentPeriodRecoveriesMember_documentation_en-US" xlink:label="lab_peak_CurrentPeriodRecoveriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Period Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodRecoveriesMember" xlink:href="peak-20230331.xsd#peak_CurrentPeriodRecoveriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CurrentPeriodRecoveriesMember" xlink:to="lab_peak_CurrentPeriodRecoveriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b0869ce2-d2fc-431c-8afe-366c53136685_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c2891aad-8c02-4d05-9ee3-669b491e1eb0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_55f6c53c-2488-408a-93be-1e526cd3567a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_3f058326-849e-4690-909e-d949d15eff7d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing costs, tenant improvements, and recurring capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_eeb09344-5370-4b48-8093-19b61848bd97_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing costs, tenant improvements, and recurring capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Leasing Costs, Commissions, and Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:to="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuredEventGainLoss_5fd82d16-8260-40dd-813a-a051344153b2_negatedLabel_en-US" xlink:label="lab_us-gaap_InsuredEventGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty-related loss (recoveries), net</link:label>
    <link:label id="lab_us-gaap_InsuredEventGainLoss_label_en-US" xlink:label="lab_us-gaap_InsuredEventGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insured Event, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuredEventGainLoss" xlink:to="lab_us-gaap_InsuredEventGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_97ba0f95-5e66-48d3-a34a-340804dd0540_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares - equity awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_e030fa6e-e6fd-49e7-ab07-31f22e36c8f8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_3e7405b8-fc20-433f-94a6-b277676b1206_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89974b63-32c6-4281-a222-86c103b7a7af_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f50f61ef-8e49-4d4e-952c-a35c4edfc024_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_1c9c1571-f551-453e-bcc7-0fb21d53cd2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_00ba679a-55ad-43cb-b012-b828786872c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestInPreferredUnitHolders_48f6ca86-f834-464d-b0d2-b7885c4c94c7_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-managing member unitholders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestInPreferredUnitHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Preferred Unit Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:to="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_128cf390-bca5-4fe0-8f96-78085e322110_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_463b5c9d-bebe-482e-9a87-910193c2b3c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_5d33574f-1dcf-4ec8-a4e7-b92c35461e1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseRevenue_6060f46b-6ed9-412c-ade6-04a6f168b179_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from direct financing leases</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseRevenue" xlink:to="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a36c9e42-656d-4510-b768-42766c61407d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_bd1e26c4-3d76-4bfb-a049-5296d080d16c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_64ed1fb4-d8da-4d33-8703-09faf7e30ec7_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total asset of discontinued operation</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0851d359-a2be-47db-95c9-62c181ccd6bd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_10c6eeb1-1163-404e-a9be-29301f9e364f_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_40e11465-a121-498a-830b-207fcaefdf3f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fd1c40a6-cdfb-4a21-95a1-f0f722c55d4e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_7d0d2c27-1503-4f18-a171-db1b214d4e24_terseLabel_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures (in joint ventures)</link:label>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_label_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Venture</link:label>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_documentation_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture" xlink:href="peak-20230331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfUnconsolidatedJointVenture" xlink:to="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseInterestIncome_8e68f619-007c-48b5-8f58-5bc667d9a64e_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income from direct financing leases</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseInterestIncome_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseInterestIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseInterestIncome" xlink:to="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopmentInProcess_9fbf8e7b-410c-4e69-870d-97bc18a80d33_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development costs and construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_f9f61783-9c94-4d6a-8b83-18f694ddc1a3_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development costs and construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopmentInProcess" xlink:to="lab_us-gaap_DevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_ea2234f9-9e56-4fb0-9c20-995c8a3fac9f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_da27c62e-f59b-4d91-9a4a-0c600e1e059a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_b56f896f-5fa4-4056-a568-e5bf7e8fef51_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_ebf57427-dd19-44c6-9204-666b2ce66813_negatedLabel_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest income</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_00c99abe-88e9-46c2-8091-a5e457117055_terseLabel_en-US" xlink:label="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, loan feature, higher borrowing capacity option</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_label_en-US" xlink:label="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Loan Feature, Higher Borrowing Capacity Option</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_documentation_en-US" xlink:label="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Loan Feature, Higher Borrowing Capacity Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:to="lab_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SorrentoTherapeuticsIncMember_9a665b50-7e39-4c94-9af5-d4dbaf6f21d1_terseLabel_en-US" xlink:label="lab_peak_SorrentoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sorrento Therapeutics, Inc.</link:label>
    <link:label id="lab_peak_SorrentoTherapeuticsIncMember_label_en-US" xlink:label="lab_peak_SorrentoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sorrento Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_peak_SorrentoTherapeuticsIncMember_documentation_en-US" xlink:label="lab_peak_SorrentoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sorrento Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SorrentoTherapeuticsIncMember" xlink:href="peak-20230331.xsd#peak_SorrentoTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SorrentoTherapeuticsIncMember" xlink:to="lab_peak_SorrentoTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_8122e894-5479-427e-9af8-e8d2c9601263_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from insurance recovery</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Insurance Settlement, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_402ff9f4-aec2-4bdc-9585-33e46476164c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f47232ab-f91e-412d-bfb7-8ed9d124b5fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loans Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_0f14cd81-c793-42b6-92aa-7042ad6afab4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_3ba787bd-dcc1-460c-8da4-ca0f469416c0_totalLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities, net</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Liabilities, Net</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_58dd3e06-10c5-4dac-8035-3d1e0a242708_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions of Real Estate and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_4d8402a5-a8df-4c47-859a-4af3b3e38361_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of controlling ownership interest entities as a managing member</link:label>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_label_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Controlling Ownership Interest Through Partnership</link:label>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:to="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableToBank_f7a6b7e9-c6c0-4c6a-9768-5ce1fab40c36_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableToBank" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_LoansPayableToBank_label_en-US" xlink:label="lab_us-gaap_LoansPayableToBank" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable to Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableToBank" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBank"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableToBank" xlink:to="lab_us-gaap_LoansPayableToBank" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2fe308b7-637e-46e8-ac04-4ef55a7bca62_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, facility fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_6b43a59b-d493-41ee-aef0-7363ec3643f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_30319268-2c67-44ce-8876-6fd309d78d36_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_652a5f57-3485-4f00-b3af-557d682950d3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_48c15bf0-099a-494f-a359-5676da64d2dd_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorthMinimum_bdfb09ec-d58c-4462-8f77-51676b229abc_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant net worth, minimum</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorthMinimum_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Net Worth, Minimum</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorthMinimum_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantNetWorthMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:to="lab_peak_DebtInstrumentCovenantNetWorthMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_99c38fdf-e367-44a2-b3c0-684bb0cee1ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e4ddd94f-53f6-4edb-a1b8-6c3dc6b6e197_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b2eb794d-1201-4494-95d9-d01cfbed33b4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_0a8a09d4-b586-48dd-9229-d4a85ed6c869_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, interest rate, reduction available for sustainability metrics</link:label>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_label_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</link:label>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_documentation_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:href="peak-20230331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:to="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_4fbbf849-b6ef-4ff8-85e8-d71183611619_terseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Parent</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_162cb810-73cc-4351-a4cc-910b6c5187df_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Unsecured Debt to Unencumbered Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:to="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MOBLandParcelsMember_e8aab416-ba6b-47e1-9782-b60ce99318de_terseLabel_en-US" xlink:label="lab_peak_MOBLandParcelsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MOB Land Parcels</link:label>
    <link:label id="lab_peak_MOBLandParcelsMember_label_en-US" xlink:label="lab_peak_MOBLandParcelsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MOB Land Parcels [Member]</link:label>
    <link:label id="lab_peak_MOBLandParcelsMember_documentation_en-US" xlink:label="lab_peak_MOBLandParcelsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MOB Land Parcels</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MOBLandParcelsMember" xlink:href="peak-20230331.xsd#peak_MOBLandParcelsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MOBLandParcelsMember" xlink:to="lab_peak_MOBLandParcelsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_1d8b0e73-6a3a-400b-a7bf-afd770f5db8e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestInJointVentures_4ceece47-c6f4-4bfb-a156-d9dac074bcbc_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestInJointVentures_label_en-US" xlink:label="lab_us-gaap_MinorityInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestInJointVentures" xlink:to="lab_us-gaap_MinorityInterestInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_31a9a6a1-f074-45b8-87ce-414d650f80b2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_32d3eeab-49e9-4ad6-bf87-029934a82517_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8057e532-f2a9-4394-a2e7-0c004c2f138e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CCRVJVInvestmentMember_258ea6a7-6a36-46f3-8a37-f3cead1cf85f_terseLabel_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC JV</link:label>
    <link:label id="lab_peak_CCRVJVInvestmentMember_label_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRV JV Investment [Member]</link:label>
    <link:label id="lab_peak_CCRVJVInvestmentMember_documentation_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the unconsolidated joint venture formed by the Company and Brookdale, under a RIDEA structure, to own and operate CCRC campuses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember" xlink:href="peak-20230331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CCRVJVInvestmentMember" xlink:to="lab_peak_CCRVJVInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_a3b7e241-ab08-4b13-9ee6-e3ea248ae1c5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_21336124-8c4d-41c2-8173-8d0edecc279e_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Text Block]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_documentation_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesTextBlock" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntitiesTextBlock" xlink:to="lab_peak_VariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3549c95d-6d24-475c-aedc-57b1edc24ad3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate_3213d2e3-f97e-4558-8de0-b3a2dc3d5691_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_LoansReceivableBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_63fb71bb-373a-49d5-8002-996085fd751e_terseLabel_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions in excess of earnings from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_label_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions in Excess of Earnings from Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:href="peak-20230331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:to="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0bc120b4-319a-45f8-aaea-fb5e8344e6a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Senior Notes Issuances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_ae12618d-23d0-47a3-9c28-c53bec6651fe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_afe90bd6-7347-42eb-a5d5-79c977a6b764_negatedLabel_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves, net</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_label_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_documentation_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:to="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_40cc353a-023b-4136-9226-12edd15bc20a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_06b7fcbc-2d15-4b8b-8052-ee2f2e12f528_totalLabel_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, total</link:label>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_label_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_documentation_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:href="peak-20230331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:to="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ece081cc-fe97-4a7b-aea1-008b51d30a57_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_29c1fb6f-f82c-4068-a703-975feb2d7c05_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherRealEstate_1b542d43-8052-42cb-a951-a61e3abd8b43_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_412984f5-9568-49f7-8bfe-95aa2541787f_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_932a53a7-81d0-4126-9674-74a7ff0c6259_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_19857b00-f323-45a8-8ff5-f6694b8ec57a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_53e68d13-1d1d-4ad9-a12b-aa828aac8821_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StraightLineRent_fd2b2598-c236-4f9e-9d88-1b7b09ec7392_negatedLabel_en-US" xlink:label="lab_us-gaap_StraightLineRent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rents</link:label>
    <link:label id="lab_us-gaap_StraightLineRent_16d2be48-952e-4bb7-a91a-4522b42d3e85_terseLabel_en-US" xlink:label="lab_us-gaap_StraightLineRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent receivable</link:label>
    <link:label id="lab_us-gaap_StraightLineRent_label_en-US" xlink:label="lab_us-gaap_StraightLineRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight Line Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StraightLineRent" xlink:to="lab_us-gaap_StraightLineRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_05b2f761-4c90-40cf-8b0d-5dee36db6b1c_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_ff61dc2c-44b8-48f6-afad-9914cd826099_terseLabel_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:to="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableTerm_f4ae9324-985e-44d7-8d3f-33c4f4474d12_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, term</link:label>
    <link:label id="lab_peak_LoansReceivableTerm_label_en-US" xlink:label="lab_peak_LoansReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Term</link:label>
    <link:label id="lab_peak_LoansReceivableTerm_documentation_en-US" xlink:label="lab_peak_LoansReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableTerm" xlink:href="peak-20230331.xsd#peak_LoansReceivableTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableTerm" xlink:to="lab_peak_LoansReceivableTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2e4f62ad-f68b-41dd-bdab-ca058ed34745_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3b13e43f-75dd-42e7-8574-1ec8faedb08e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateAbstract_9135094b-e20e-45a8-a292-da83a80ba507_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:label id="lab_us-gaap_RealEstateAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateAbstract" xlink:to="lab_us-gaap_RealEstateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_A2023AtTheMarketProgramMember_466205ef-6cd6-407f-8126-578cad106bc9_terseLabel_en-US" xlink:label="lab_peak_A2023AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 At-The-Market Program</link:label>
    <link:label id="lab_peak_A2023AtTheMarketProgramMember_label_en-US" xlink:label="lab_peak_A2023AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 At-The-Market Program [Member]</link:label>
    <link:label id="lab_peak_A2023AtTheMarketProgramMember_documentation_en-US" xlink:label="lab_peak_A2023AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 At-The-Market Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2023AtTheMarketProgramMember" xlink:href="peak-20230331.xsd#peak_A2023AtTheMarketProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_A2023AtTheMarketProgramMember" xlink:to="lab_peak_A2023AtTheMarketProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_1680a88b-8b44-4f5e-a115-81241d20fa15_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_7b91c696-672c-40ab-881e-662d986a57ef_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, amount committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingAmountCommitted" xlink:to="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_134f7894-735e-4d85-9145-ae331c9a30e2_terseLabel_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease</link:label>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_label_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease [Member]</link:label>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_documentation_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember" xlink:href="peak-20230331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LessorAssetUnderOperatingLeaseMember" xlink:to="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_61a95d03-e660-42ab-b9cd-7fc05ea2f88a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4a54d24b-565e-4aee-a23c-5a6137ed26ca_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_b1a4ff8c-fea3-4f2e-9a66-17fcaf1ae224_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_b9ccc7e0-0b4f-459b-9411-4b825b84184d_negatedLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2ee14033-8442-4c67-b6d9-2f1f4f859678_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MedicalOfficeJVsMember_ec0beaa9-5100-4f45-9ca0-7784567d0ffb_terseLabel_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs</link:label>
    <link:label id="lab_peak_MedicalOfficeJVsMember_label_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs [Member]</link:label>
    <link:label id="lab_peak_MedicalOfficeJVsMember_documentation_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember" xlink:href="peak-20230331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MedicalOfficeJVsMember" xlink:to="lab_peak_MedicalOfficeJVsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_fe6c70c4-13fe-4743-847d-f3a39db86498_terseLabel_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio</link:label>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_label_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio [Member]</link:label>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_documentation_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember" xlink:href="peak-20230331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SunriseSeniorHousingPortfolioMember" xlink:to="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_37a4233b-3a1b-426d-9346-5a0d1dd2e93b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_48b53ebc-4e93-40b1-abaa-eb16474d9c59_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestRateSwap499PayRateMember_83d54591-62ed-4cbb-b56b-1dcf661b944d_terseLabel_en-US" xlink:label="lab_peak_InterestRateSwap499PayRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.99% Pay Rate</link:label>
    <link:label id="lab_peak_InterestRateSwap499PayRateMember_label_en-US" xlink:label="lab_peak_InterestRateSwap499PayRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.99% Pay Rate [Member]</link:label>
    <link:label id="lab_peak_InterestRateSwap499PayRateMember_documentation_en-US" xlink:label="lab_peak_InterestRateSwap499PayRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, 4.99% Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap499PayRateMember" xlink:href="peak-20230331.xsd#peak_InterestRateSwap499PayRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestRateSwap499PayRateMember" xlink:to="lab_peak_InterestRateSwap499PayRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_78b532bc-277c-4f81-a113-a2226eecb275_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_0588784f-6f90-4927-a7c4-a53c7505681c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6aa59e81-abbb-487f-9533-40eaba8da68c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99ae11ee-1e5b-4f03-b468-ef6ab5a066fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_92330812-1ba8-436c-861f-61b8958d1160_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation amortization expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_e9cb0fa6-6a20-4aea-8492-2c0687b1c027_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_f29cccfa-6312-406e-8939-109c3b79cba2_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c082dabb-7c59-414b-b399-f26970cf25ab_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_64e404f3-72bd-4bf6-9a31-0ec71a793864_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_83bceeb5-fb12-42aa-b677-912e2e98a851_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_50cdbd22-e73e-4c6d-90dc-7bdf327718a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_aa7f3a67-29f0-41c0-9248-dd4b9a10a0c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_9b880ce4-fafd-4dce-b590-3ecc5279463b_negatedLabel_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating securities&#8217; share in earnings</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_7940514c-0100-4397-ab82-fe39a1d1b28b_negatedTerseLabel_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Participating securities' share in continuing operations</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_label_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities Distributed And Undistributed Earnings Loss Basic and Diluted</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_documentation_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:href="peak-20230331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:to="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_68810dd2-b56f-448a-aff6-2e09022e7c87_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_c080e9f9-e485-4b1f-8ec2-c66ce4e00c17_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves (recoveries), net</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_16b26d50-71eb-46fd-9303-c0df4eb92eb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_b54f7e47-36ab-4904-a011-5c4dc673153d_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6371ae00-f92f-43e6-9cd9-483e4d83b1af_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in ROU asset in exchange for new lease liability related to operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_BrookdaleMTCAMember_f713a0ff-ddb7-4f3c-9ad3-33c9d2b9a54a_terseLabel_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookedale MTCA</link:label>
    <link:label id="lab_peak_BrookdaleMTCAMember_label_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale MTCA [Member]</link:label>
    <link:label id="lab_peak_BrookdaleMTCAMember_documentation_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale MTCA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember" xlink:href="peak-20230331.xsd#peak_BrookdaleMTCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_BrookdaleMTCAMember" xlink:to="lab_peak_BrookdaleMTCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a6bb0afe-e355-486a-bb9e-09679375e772_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_b6d55d50-af1c-4f46-b40d-55cfacb99db7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_65c03b5a-3f1f-4667-8b80-5486ca6edaa5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share in continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_17f8afac-6c13-4428-b9e9-45e54e5e540c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests' share in continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_38060cb3-5c44-4d84-b2da-509b0b2abd68_terseLabel_en-US" xlink:label="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Parenthetical Disclosures</link:label>
    <link:label id="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Transactions, Parenthetical Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:to="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_376ec7d6-1ab6-44c2-ac89-cb6bf2a2f62d_totalLabel_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations applicable to common shares</link:label>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Loss Continuing Operations Available To Common Stockholders Basic</link:label>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_documentation_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Loss Continuing Operations Available To Common Stockholders Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:href="peak-20230331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:to="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>peak-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bbc927e2-721c-4158-8ea3-5d6e6fcf2879,g:618a7c64-2a1b-4c53-a8b6-ffa71292d3dc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.healthpeak.com/role/CoverPage" xlink:type="simple" xlink:href="peak-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_221a3623-4042-420f-bb66-939f2d26af58" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentType_221a3623-4042-420f-bb66-939f2d26af58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4be70e22-ae95-40f5-9464-f7ec071f3ebf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentQuarterlyReport_4be70e22-ae95-40f5-9464-f7ec071f3ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7efc154c-96dc-4ff7-940c-fafe32e0693d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentPeriodEndDate_7efc154c-96dc-4ff7-940c-fafe32e0693d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_edbc2f42-0b93-4070-b839-0f4f57815ce9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentTransitionReport_edbc2f42-0b93-4070-b839-0f4f57815ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_10fea7c4-bd02-4ebb-bca3-0d0e2d848948" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityFileNumber_10fea7c4-bd02-4ebb-bca3-0d0e2d848948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_26760ae5-5642-4d8d-a2b1-04d97f1c51bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityRegistrantName_26760ae5-5642-4d8d-a2b1-04d97f1c51bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ff9aa3c4-fba7-42c8-8da7-8c92a48fd3d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ff9aa3c4-fba7-42c8-8da7-8c92a48fd3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_01b2e961-f421-440c-a078-86a3c6666ba5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityTaxIdentificationNumber_01b2e961-f421-440c-a078-86a3c6666ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f7f93c15-6673-4570-aed5-1be149fd59bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityAddressAddressLine1_f7f93c15-6673-4570-aed5-1be149fd59bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_26300d4f-2218-4330-87f8-3c718385a03d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityAddressAddressLine2_26300d4f-2218-4330-87f8-3c718385a03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1c7694f7-97ed-4332-afdb-27066729f99b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityAddressCityOrTown_1c7694f7-97ed-4332-afdb-27066729f99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ee4f4875-67f6-454b-8dc7-a2ce45d0f92e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityAddressStateOrProvince_ee4f4875-67f6-454b-8dc7-a2ce45d0f92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bb1b092a-9238-4877-95d7-b65421a3fe77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityAddressPostalZipCode_bb1b092a-9238-4877-95d7-b65421a3fe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea62c814-b037-4a5a-b8cf-c9d9a17f4fb3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_CityAreaCode_ea62c814-b037-4a5a-b8cf-c9d9a17f4fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5a027c58-d34b-495a-9100-41e2569e23f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_LocalPhoneNumber_5a027c58-d34b-495a-9100-41e2569e23f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5119db69-6a82-4098-8d3a-1e8b53c5c447" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_Security12bTitle_5119db69-6a82-4098-8d3a-1e8b53c5c447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3fce16be-34ca-4d82-9552-489ee631837c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_TradingSymbol_3fce16be-34ca-4d82-9552-489ee631837c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6ab65bbe-d347-4982-90b6-e4df773ce07a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_SecurityExchangeName_6ab65bbe-d347-4982-90b6-e4df773ce07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_23a7e516-bf28-440b-b26c-575f0769e111" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityCurrentReportingStatus_23a7e516-bf28-440b-b26c-575f0769e111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1a4ee0e8-fd16-45f7-836a-77fc30f49424" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityInteractiveDataCurrent_1a4ee0e8-fd16-45f7-836a-77fc30f49424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e96f350c-81e8-4d2c-bf18-0e807a953b46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityFilerCategory_e96f350c-81e8-4d2c-bf18-0e807a953b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e6986795-5e2d-466f-9e4f-eb040d94815c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntitySmallBusiness_e6986795-5e2d-466f-9e4f-eb040d94815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68304e09-3799-48c0-94f2-98615cb769c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityEmergingGrowthCompany_68304e09-3799-48c0-94f2-98615cb769c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f08b9c80-ed81-4246-9342-a8ff8dce46cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityShellCompany_f08b9c80-ed81-4246-9342-a8ff8dce46cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ccb4961f-7ccb-4f74-ae4d-ee3b176001e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ccb4961f-7ccb-4f74-ae4d-ee3b176001e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_57b86a67-dd5c-4ab4-992a-cec63cf5c82a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_EntityCentralIndexKey_57b86a67-dd5c-4ab4-992a-cec63cf5c82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_44f7aa60-5966-420c-bb16-c78808b00eeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_AmendmentFlag_44f7aa60-5966-420c-bb16-c78808b00eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dbec5b36-e8af-4526-a6fb-e9b60bffc015" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_CurrentFiscalYearEndDate_dbec5b36-e8af-4526-a6fb-e9b60bffc015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e63264a2-712f-473d-8191-4081d08be96c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentFiscalYearFocus_e63264a2-712f-473d-8191-4081d08be96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b14d33cf-c9c5-4fcf-b35e-f9b837e0676f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e162e2a4-f3cf-4909-99e0-9beff0c9e996" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b14d33cf-c9c5-4fcf-b35e-f9b837e0676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_83ebd5ec-3ca6-4ba1-9927-5bbd0adf97c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_83ebd5ec-3ca6-4ba1-9927-5bbd0adf97c9" xlink:to="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_8236c79f-26ea-4935-878c-aa57cd5f2fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_8236c79f-26ea-4935-878c-aa57cd5f2fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_6a7b4e69-f567-47c6-8d8f-542e17837677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:to="loc_us-gaap_DevelopmentInProcess_6a7b4e69-f567-47c6-8d8f-542e17837677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e00e75c5-c509-4784-acc9-3bef91954e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:to="loc_us-gaap_Land_e00e75c5-c509-4784-acc9-3bef91954e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7b108a5f-724e-4746-87a8-5ebe7e49e553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7b108a5f-724e-4746-87a8-5ebe7e49e553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_1e223010-6d95-474b-9113-fc47fe2e4963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_2801c7f4-9804-4a03-8add-8dce2265dd47" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_1e223010-6d95-474b-9113-fc47fe2e4963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_416211e2-9138-43d9-9927-073383903345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_416211e2-9138-43d9-9927-073383903345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f975146d-82cb-4e16-9306-576e0ee6ec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_f975146d-82cb-4e16-9306-576e0ee6ec7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_041902e5-5ca9-427c-9654-2a0f970059ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_AccountsReceivableNet_041902e5-5ca9-427c-9654-2a0f970059ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_401d4ebd-590f-4a5e-ac45-948c3660d067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_401d4ebd-590f-4a5e-ac45-948c3660d067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_da3ee48e-bac2-483c-8442-d9711376123e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_da3ee48e-bac2-483c-8442-d9711376123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4367167a-5edf-4275-bbc0-a656de472d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4367167a-5edf-4275-bbc0-a656de472d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c801ab4a-bec7-4bae-8e5f-28d9a6b96075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c801ab4a-bec7-4bae-8e5f-28d9a6b96075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b28b2265-fe39-4ad2-8b66-ff8bff00baa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b28b2265-fe39-4ad2-8b66-ff8bff00baa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_40aa2eac-5766-4126-9e59-fb716ab2e53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_OtherAssets_40aa2eac-5766-4126-9e59-fb716ab2e53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1766bc34-d73d-4921-9368-c8f11c22df9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_cb7758e8-9523-427e-ae5e-98cde43bd0dc" xlink:to="loc_us-gaap_Assets_1766bc34-d73d-4921-9368-c8f11c22df9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_83ebd5ec-3ca6-4ba1-9927-5bbd0adf97c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_96332407-9dc6-4721-89da-2f640c4611b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_LineOfCredit_96332407-9dc6-4721-89da-2f640c4611b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableToBank_2e5ff01f-5039-43ad-87f7-939084bd28f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableToBank"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_LoansPayableToBank_2e5ff01f-5039-43ad-87f7-939084bd28f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_25050577-01d7-4ce4-9f45-73140e95bc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_UnsecuredDebt_25050577-01d7-4ce4-9f45-73140e95bc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_9ce4ac0e-be61-4abc-a6cd-883c61affc44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_SecuredDebt_9ce4ac0e-be61-4abc-a6cd-883c61affc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_a2e30246-8d26-47c0-89e5-227e08a8ada2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_a2e30246-8d26-47c0-89e5-227e08a8ada2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_34849b49-b1d6-49a6-bba6-b9007cfe4d6b" xlink:href="peak-20230331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleNet_34849b49-b1d6-49a6-bba6-b9007cfe4d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e2d1c46d-a9fb-4350-8b17-f56666cf9ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_OperatingLeaseLiability_e2d1c46d-a9fb-4350-8b17-f56666cf9ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_bcae0cb9-f6a2-4eb4-a0b7-689976a06d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_bcae0cb9-f6a2-4eb4-a0b7-689976a06d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_40ec2a54-37ef-4c94-901b-3cf27dac43ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_40ec2a54-37ef-4c94-901b-3cf27dac43ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_575b3d7b-af18-4ef2-8083-6b3f966d40af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_Liabilities_575b3d7b-af18-4ef2-8083-6b3f966d40af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_db68664c-9ecc-48e7-a328-29e3c00686e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_db68664c-9ecc-48e7-a328-29e3c00686e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_be44fb6a-5100-4b65-b1e2-d1d9f4bbf0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_be44fb6a-5100-4b65-b1e2-d1d9f4bbf0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cb8213a4-2fd6-4c22-be45-48bbdd7d792f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_CommonStockValue_cb8213a4-2fd6-4c22-be45-48bbdd7d792f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6bd5249c-6a4f-406b-a340-8a2fe3786ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6bd5249c-6a4f-406b-a340-8a2fe3786ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_545e1de7-e3d7-4061-8dba-261fc6372deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_545e1de7-e3d7-4061-8dba-261fc6372deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5338506-502d-4326-b3fb-6b6051d491d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5338506-502d-4326-b3fb-6b6051d491d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d557b0d8-b811-44ab-8203-7660f7edc43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_StockholdersEquity_d557b0d8-b811-44ab-8203-7660f7edc43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures_8c4c3d86-a7b2-4260-9cc0-15924f823934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_MinorityInterestInJointVentures_8c4c3d86-a7b2-4260-9cc0-15924f823934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_bf1bbbb5-75f4-437c-973f-c267b2dbac06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_bf1bbbb5-75f4-437c-973f-c267b2dbac06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_13a1d9ac-b0ce-4075-9236-00f05b8659a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_MinorityInterest_13a1d9ac-b0ce-4075-9236-00f05b8659a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c84c637-0bef-45fd-a795-1db583c7d868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c84c637-0bef-45fd-a795-1db583c7d868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf571e5-0d26-434d-b0e9-044276061402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c615500-e515-44c6-99c8-9982664b4b4f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7cf571e5-0d26-434d-b0e9-044276061402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3b582c64-288e-4438-b5f5-fef6cb4f2286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3b582c64-288e-4438-b5f5-fef6cb4f2286" xlink:to="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f9b6ea46-3682-4747-932d-ef6480d10611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f9b6ea46-3682-4747-932d-ef6480d10611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0ba44e06-fe74-4bc0-a18c-cb5f271df565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0ba44e06-fe74-4bc0-a18c-cb5f271df565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a1e2853f-ff1c-4b21-b49c-faa7720f0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a1e2853f-ff1c-4b21-b49c-faa7720f0c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_95132450-a081-4e42-8952-94ae546e1b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_95132450-a081-4e42-8952-94ae546e1b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e0a5f52a-1af2-4549-a96a-c2eb8f0dfeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_CommonStockSharesIssued_e0a5f52a-1af2-4549-a96a-c2eb8f0dfeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_82158497-120e-4260-9dc7-2d89e18dba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_3b33051d-4df5-460c-96fb-f93e072ff720" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_82158497-120e-4260-9dc7-2d89e18dba4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_30888f5a-124d-4a6b-9684-e7c95db36335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_30888f5a-124d-4a6b-9684-e7c95db36335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c60255d-5bb1-4cf5-8701-c628066980cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c60255d-5bb1-4cf5-8701-c628066980cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_3775316d-52fa-40a7-a428-75829b141c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:to="loc_us-gaap_InterestIncomeOperating_3775316d-52fa-40a7-a428-75829b141c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue_09fd6083-3a42-4772-9dec-ee97e2d119c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:to="loc_us-gaap_DirectFinancingLeaseRevenue_09fd6083-3a42-4772-9dec-ee97e2d119c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5bebd813-9c45-4732-8ec1-23e61fee8596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3950d57a-44bb-48e0-824b-6e94616ec603" xlink:to="loc_us-gaap_Revenues_5bebd813-9c45-4732-8ec1-23e61fee8596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e72d6618-d778-4d27-b264-5685057546cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_InterestExpense_e72d6618-d778-4d27-b264-5685057546cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_22d06b08-8597-46ca-b3de-b6f7efc2f467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_DepreciationAndAmortization_22d06b08-8597-46ca-b3de-b6f7efc2f467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3ec9050a-7817-451d-856e-71ef6260f64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3ec9050a-7817-451d-856e-71ef6260f64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5e0f37e9-2ac2-4c10-8a98-c9c553b113ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5e0f37e9-2ac2-4c10-8a98-c9c553b113ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_aaeaa0bf-2c03-41e3-a57a-ac99d9d522c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_aaeaa0bf-2c03-41e3-a57a-ac99d9d522c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_bac2fafc-bed1-407b-a40c-a115a1819403" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_bac2fafc-bed1-407b-a40c-a115a1819403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_4af36f8d-6e7c-4812-a327-f3d383f64bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fb4f99e2-bce8-45c5-a808-0d37d5b01cd2" xlink:to="loc_us-gaap_CostsAndExpenses_4af36f8d-6e7c-4812-a327-f3d383f64bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3702f96e-12df-40e8-8bfe-2fe1661a5b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3702f96e-12df-40e8-8bfe-2fe1661a5b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_6f75136c-b118-45c7-b846-42c235329d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3702f96e-12df-40e8-8bfe-2fe1661a5b51" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_6f75136c-b118-45c7-b846-42c235329d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b6e3bb14-2f20-4aa5-8ea2-2ef9836af34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3702f96e-12df-40e8-8bfe-2fe1661a5b51" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b6e3bb14-2f20-4aa5-8ea2-2ef9836af34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1b28c212-3601-4187-8ee0-cbc1d1be81cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3702f96e-12df-40e8-8bfe-2fe1661a5b51" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1b28c212-3601-4187-8ee0-cbc1d1be81cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13510459-0ac4-42ae-89b6-79ba92fe0215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13510459-0ac4-42ae-89b6-79ba92fe0215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2e88a66e-4860-40c5-be64-214178463dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2e88a66e-4860-40c5-be64-214178463dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_098012da-ecf7-460d-b3b1-20ef9c45487f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_098012da-ecf7-460d-b3b1-20ef9c45487f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f3bf0098-1b52-4ac3-b34c-fd9c8cb987b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f3bf0098-1b52-4ac3-b34c-fd9c8cb987b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7a10c2d0-6bd8-4720-965d-60d129a96d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7a10c2d0-6bd8-4720-965d-60d129a96d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d0951d97-2e97-4a52-a1df-d38cfcb0c16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_ProfitLoss_d0951d97-2e97-4a52-a1df-d38cfcb0c16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_7afa2b3a-4dbc-44d6-a26d-d37ac4a074dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_7afa2b3a-4dbc-44d6-a26d-d37ac4a074dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ced9610f-29ce-410f-9238-f0e9f59e44b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_NetIncomeLoss_ced9610f-29ce-410f-9238-f0e9f59e44b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_2123d3c7-bdaf-483e-9a78-2a89550b67ce" xlink:href="peak-20230331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_2123d3c7-bdaf-483e-9a78-2a89550b67ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_43b2e2a0-27b6-4733-8aa0-a04bf2cf5bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_43b2e2a0-27b6-4733-8aa0-a04bf2cf5bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_766f267a-2c6b-4f75-9103-19f0925a5be4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_766f267a-2c6b-4f75-9103-19f0925a5be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b978ffb5-e8fe-49aa-acf3-287ee110c0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_766f267a-2c6b-4f75-9103-19f0925a5be4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b978ffb5-e8fe-49aa-acf3-287ee110c0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9b9139db-735d-4c91-ac97-9493e8cab426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_766f267a-2c6b-4f75-9103-19f0925a5be4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9b9139db-735d-4c91-ac97-9493e8cab426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7a19ac14-c302-4396-ab38-548546a7a4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_766f267a-2c6b-4f75-9103-19f0925a5be4" xlink:to="loc_us-gaap_EarningsPerShareBasic_7a19ac14-c302-4396-ab38-548546a7a4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_94135c0f-2261-44b7-9818-53c2d21e21ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_94135c0f-2261-44b7-9818-53c2d21e21ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_88eb49f9-1dec-4e3a-9321-bd107b1b5b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_94135c0f-2261-44b7-9818-53c2d21e21ba" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_88eb49f9-1dec-4e3a-9321-bd107b1b5b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3333473c-9830-447e-a0df-ce3300e70847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_94135c0f-2261-44b7-9818-53c2d21e21ba" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_3333473c-9830-447e-a0df-ce3300e70847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_64720d9c-2436-4b57-85ed-21a6f1a484e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_94135c0f-2261-44b7-9818-53c2d21e21ba" xlink:to="loc_us-gaap_EarningsPerShareDiluted_64720d9c-2436-4b57-85ed-21a6f1a484e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_9dc67b4e-847e-4471-9ad8-72eadb99c25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ed56f70-574f-416d-9571-550fece6384d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_9dc67b4e-847e-4471-9ad8-72eadb99c25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_24e0dc5e-fd39-4217-bb14-cadfdac07acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_9dc67b4e-847e-4471-9ad8-72eadb99c25d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_24e0dc5e-fd39-4217-bb14-cadfdac07acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_523da9e3-3724-42e9-8bf2-39c85c303646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_9dc67b4e-847e-4471-9ad8-72eadb99c25d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_523da9e3-3724-42e9-8bf2-39c85c303646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_18198029-9e53-490b-b195-a1d18a8b791c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:to="loc_us-gaap_ProfitLoss_18198029-9e53-490b-b195-a1d18a8b791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b6489ea1-030e-49a3-9512-5fa3cc1c3059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b6489ea1-030e-49a3-9512-5fa3cc1c3059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a91ea38a-04fc-49da-a2ff-f8607010b953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b6489ea1-030e-49a3-9512-5fa3cc1c3059" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a91ea38a-04fc-49da-a2ff-f8607010b953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a711886a-5add-4971-8261-c6710fbaceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b6489ea1-030e-49a3-9512-5fa3cc1c3059" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a711886a-5add-4971-8261-c6710fbaceb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e8810cb-4a44-40a2-9477-532652513e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b6489ea1-030e-49a3-9512-5fa3cc1c3059" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e8810cb-4a44-40a2-9477-532652513e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bd1d6fbd-e4f7-4a61-8df0-224ddf257cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bd1d6fbd-e4f7-4a61-8df0-224ddf257cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_587dc61f-f311-4655-8cff-c439ca98323d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_587dc61f-f311-4655-8cff-c439ca98323d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_380e6adf-5521-445d-8c5e-f337f4e6ee59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b5c015e-1387-4e4b-9e34-9fa57bb2e050" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_380e6adf-5521-445d-8c5e-f337f4e6ee59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_baebb29d-03f6-4241-9c47-b2e533f39594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_baebb29d-03f6-4241-9c47-b2e533f39594" xlink:to="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_746898f4-cc28-491b-a39e-d9ca8ff4f802" xlink:to="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:to="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9862eae9-74e8-40a2-92f6-15b3cc57439c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_CommonStockMember_9862eae9-74e8-40a2-92f6-15b3cc57439c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_db9650ad-8b4c-4612-a431-5389ffa26788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_db9650ad-8b4c-4612-a431-5389ffa26788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_8435cded-cbcf-4fd5-be1e-fc1240a48ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_8435cded-cbcf-4fd5-be1e-fc1240a48ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a1db6d56-0c44-434b-a913-07f9a2004f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_43e3027b-11e7-48ba-8387-44b66bb67771" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a1db6d56-0c44-434b-a913-07f9a2004f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b0d69ce3-8d93-44b5-b2dc-ee8aaa0a2e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8b29cc1c-ee6e-4dea-b377-0f657afa1717" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b0d69ce3-8d93-44b5-b2dc-ee8aaa0a2e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd3ed126-157c-4ad9-bdfc-8f2bf20e31a3" xlink:to="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8454da4e-8614-403c-90a7-b3e81718aa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_SharesIssued_8454da4e-8614-403c-90a7-b3e81718aa3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f9cce6c-2d6a-4e1b-be25-48b799a7f093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f9cce6c-2d6a-4e1b-be25-48b799a7f093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_8bb9a0a7-3177-40c5-8d87-15db47ccbc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_8bb9a0a7-3177-40c5-8d87-15db47ccbc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b60ec8a1-9068-4c34-a22f-e7b4094dbdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b60ec8a1-9068-4c34-a22f-e7b4094dbdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_37c92a09-d52e-49e4-be09-573d94bdfeec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_37c92a09-d52e-49e4-be09-573d94bdfeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e690dfa9-17b3-4ae4-84e7-e0ecfde24ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e690dfa9-17b3-4ae4-84e7-e0ecfde24ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d6b667c7-8162-46ce-be4a-32f727509720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d6b667c7-8162-46ce-be4a-32f727509720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ee56de10-c548-4d66-a2c3-7002ba37c8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ee56de10-c548-4d66-a2c3-7002ba37c8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b850866d-87a9-4a89-a13e-41262d88a460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b850866d-87a9-4a89-a13e-41262d88a460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1a971f84-9193-4405-ba99-7bbba12a8f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_DividendsCommonStock_1a971f84-9193-4405-ba99-7bbba12a8f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3cc2adb8-59a3-44d1-91b1-eca98e193c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3cc2adb8-59a3-44d1-91b1-eca98e193c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_de275e56-ab69-4772-a109-78f8bca7836a" xlink:href="peak-20230331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_de275e56-ab69-4772-a109-78f8bca7836a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e339a29d-7534-45a3-a3ac-25e28e7eaeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_SharesIssued_e339a29d-7534-45a3-a3ac-25e28e7eaeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a548dbc-5e22-459e-b04c-3dd4b4125024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7ae8ff50-c667-47e9-a133-960eafce0979" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a548dbc-5e22-459e-b04c-3dd4b4125024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fb3a0b1-1415-40ee-aad6-c747527316de" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_da606217-3d26-4ca8-bf25-1fb7e5aafb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_da606217-3d26-4ca8-bf25-1fb7e5aafb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5111f4e7-c009-4aa5-ae9a-2aa29a9d5898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5111f4e7-c009-4aa5-ae9a-2aa29a9d5898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b9fb65c9-04bb-4d49-b664-51a11c212684" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b9fb65c9-04bb-4d49-b664-51a11c212684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_fa47e224-f53f-417d-950e-b38bb2e77eb6" xlink:href="peak-20230331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_fa47e224-f53f-417d-950e-b38bb2e77eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fe4b92eb-0d75-4edf-805f-2915b5d3c518" xlink:href="peak-20230331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fe4b92eb-0d75-4edf-805f-2915b5d3c518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_87205c1c-27be-4049-b658-3447d9e6d131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_7b5c1b01-7d08-4d7e-b4dd-2f378bcec3d9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_87205c1c-27be-4049-b658-3447d9e6d131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ece9d4fd-57d2-4934-9600-c0e2f76db8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_dfe510eb-034e-4c52-8527-bc6b784626b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ece9d4fd-57d2-4934-9600-c0e2f76db8f6" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_dfe510eb-034e-4c52-8527-bc6b784626b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="peak-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1c6d431d-cc56-407b-bdaf-46120d790c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1c6d431d-cc56-407b-bdaf-46120d790c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_52257d16-bbc1-4817-87bd-96b1563a09f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1c6d431d-cc56-407b-bdaf-46120d790c5c" xlink:to="loc_us-gaap_ProfitLoss_52257d16-bbc1-4817-87bd-96b1563a09f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1c6d431d-cc56-407b-bdaf-46120d790c5c" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_8de645ed-261a-4937-b06b-300e937a26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_8de645ed-261a-4937-b06b-300e937a26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b5158ad3-99d7-4c7d-9244-38f24cf08b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_ShareBasedCompensation_b5158ad3-99d7-4c7d-9244-38f24cf08b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a1f7abb8-0d60-4b3f-8be1-c619c83026e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a1f7abb8-0d60-4b3f-8be1-c619c83026e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_3986e6d3-b33a-45bd-b675-dd5a5b7d70a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_StraightLineRent_3986e6d3-b33a-45bd-b675-dd5a5b7d70a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_99e11862-6be6-4b9d-8898-85fc4e0ef97f" xlink:href="peak-20230331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_99e11862-6be6-4b9d-8898-85fc4e0ef97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_786d6bde-f9cd-4c1a-81fe-a9dcbaf35b6d" xlink:href="peak-20230331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_786d6bde-f9cd-4c1a-81fe-a9dcbaf35b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_373a0320-5f0c-421e-860d-c99c4b15d21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_373a0320-5f0c-421e-860d-c99c4b15d21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_ba2fa250-cb7e-492e-a9f1-19173328d52c" xlink:href="peak-20230331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_ba2fa250-cb7e-492e-a9f1-19173328d52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7213ca8a-f205-4db8-9438-719a3165a4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7213ca8a-f205-4db8-9438-719a3165a4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_91c1e112-8201-4b7b-890a-470f60fca059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_AssetImpairmentCharges_91c1e112-8201-4b7b-890a-470f60fca059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_90d55b9d-ae23-44aa-807f-b96dbf604162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_90d55b9d-ae23-44aa-807f-b96dbf604162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss_38ff4a0e-b6a5-4c2b-972a-c697e8199bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_InsuredEventGainLoss_38ff4a0e-b6a5-4c2b-972a-c697e8199bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b904ef72-cea7-42c4-813f-7d1dcf412208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b904ef72-cea7-42c4-813f-7d1dcf412208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18b3a1b5-eba7-492a-b0a4-59d900942baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_994fd400-47c0-4286-b08c-cc8565479e35" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18b3a1b5-eba7-492a-b0a4-59d900942baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_5bbd430f-9944-4ee3-a6a2-1a83ea0e8b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18b3a1b5-eba7-492a-b0a4-59d900942baa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_5bbd430f-9944-4ee3-a6a2-1a83ea0e8b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_40a55626-21ba-47bb-bc29-ea1dbea04ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18b3a1b5-eba7-492a-b0a4-59d900942baa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_40a55626-21ba-47bb-bc29-ea1dbea04ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0983fba2-e0aa-4b54-930d-88240ea52797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1c6d431d-cc56-407b-bdaf-46120d790c5c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0983fba2-e0aa-4b54-930d-88240ea52797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate_9d9c506a-b6a8-4af5-864a-dd0ad37ca959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_PaymentsToAcquireOtherRealEstate_9d9c506a-b6a8-4af5-864a-dd0ad37ca959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7639a186-02e9-412b-b43d-c35fe6730713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7639a186-02e9-412b-b43d-c35fe6730713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_89371a43-6371-463c-b78b-308d10ff9719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_89371a43-6371-463c-b78b-308d10ff9719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_5826d6db-8bb0-43ea-bfa9-d207f70e751d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_5826d6db-8bb0-43ea-bfa9-d207f70e751d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_777eeb19-5775-4e6f-ba90-e0462741fdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_777eeb19-5775-4e6f-ba90-e0462741fdcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_7b11a4ca-c2a3-41d1-895c-cbf04df64ffb" xlink:href="peak-20230331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_7b11a4ca-c2a3-41d1-895c-cbf04df64ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_165050bd-907c-479a-a9cf-ba56ac17eae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_165050bd-907c-479a-a9cf-ba56ac17eae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_b06e41be-9c7a-4972-89a8-23b00c6e7c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment_b06e41be-9c7a-4972-89a8-23b00c6e7c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther_66686815-1a69-4ea6-b4a5-fb92a8c45752" xlink:href="peak-20230331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_peak_PaymentsToAcquireLoansReceivableAndOther_66686815-1a69-4ea6-b4a5-fb92a8c45752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f89a807-0943-4b84-943e-ffaa4b92c4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e9b873d8-098a-4af3-ad42-9ec1ff0c4027" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f89a807-0943-4b84-943e-ffaa4b92c4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f4e2f6c2-0190-4d07-8d10-2f76f4642980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f4e2f6c2-0190-4d07-8d10-2f76f4642980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_6e228bb5-01b7-4eee-97c1-4895f401ffb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_6e228bb5-01b7-4eee-97c1-4895f401ffb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromBankDebt_3102585a-3d08-486f-b4cf-12c1455c14a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_ProceedsFromBankDebt_3102585a-3d08-486f-b4cf-12c1455c14a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt_be27702e-7998-45aa-b471-a84ff8dbd44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_RepaymentsOfBankDebt_be27702e-7998-45aa-b471-a84ff8dbd44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_697833e4-6009-40ca-8544-73550d796bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_697833e4-6009-40ca-8544-73550d796bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_6b7717d2-095e-464c-bd02-540f03b59844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_6b7717d2-095e-464c-bd02-540f03b59844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ed6044e5-fc09-40ae-b562-73eaaecf30de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ed6044e5-fc09-40ae-b562-73eaaecf30de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_3ea4ed0e-8475-42c5-9314-c69f63f294fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_PaymentsOfDividends_3ea4ed0e-8475-42c5-9314-c69f63f294fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_39a78b7a-d33c-430d-9fed-0d889ed5ba96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_39a78b7a-d33c-430d-9fed-0d889ed5ba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_5b42137f-26d0-4af8-82aa-f0389d7c07eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_5b42137f-26d0-4af8-82aa-f0389d7c07eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15278be6-9426-4b86-addf-65d354c6fc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6e7c06d0-8bfb-47d2-93ff-ddb73841c7bf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15278be6-9426-4b86-addf-65d354c6fc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1a62db-4d0d-471c-a184-5c56dd01c650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5b1a62db-4d0d-471c-a184-5c56dd01c650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7594190a-cf6d-4f45-9050-6cbb63753c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7594190a-cf6d-4f45-9050-6cbb63753c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d12f16f7-3c18-4e8b-892d-5fdcdcade4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bc88f847-1ec6-41cc-8b99-87eec5590cfb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d12f16f7-3c18-4e8b-892d-5fdcdcade4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Business" xlink:type="simple" xlink:href="peak-20230331.xsd#Business"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Business" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1914888b-d03b-44cc-aa03-f685aa045400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_75d02a41-4628-4553-8f84-3d819faf3743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1914888b-d03b-44cc-aa03-f685aa045400" xlink:to="loc_us-gaap_NatureOfOperations_75d02a41-4628-4553-8f84-3d819faf3743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="peak-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_79677755-2db6-4314-a3c2-cc91cc85d2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d70379ca-f3d4-4eb0-8001-cc8d381e509b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79677755-2db6-4314-a3c2-cc91cc85d2cb" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d70379ca-f3d4-4eb0-8001-cc8d381e509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstate" xlink:type="simple" xlink:href="peak-20230331.xsd#RealEstate"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstate" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_a16062f6-6454-4b6c-8dc0-e217aef7bd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateDisclosureTextBlock_57d1ea42-8eae-43b3-870e-588fbed97503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_a16062f6-6454-4b6c-8dc0-e217aef7bd20" xlink:to="loc_us-gaap_RealEstateDisclosureTextBlock_57d1ea42-8eae-43b3-870e-588fbed97503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_da0d2626-f7be-4468-88ec-fc955d0d6843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_733c6c24-36bb-4e59-9979-e1a6d2a0222d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_da0d2626-f7be-4468-88ec-fc955d0d6843" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_733c6c24-36bb-4e59-9979-e1a6d2a0222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Leases" xlink:type="simple" xlink:href="peak-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_97309546-ebe6-4e9f-a267-65b26f9f3919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_64e13a48-c7f8-4007-acf1-fda8e4edfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97309546-ebe6-4e9f-a267-65b26f9f3919" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_64e13a48-c7f8-4007-acf1-fda8e4edfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_bb1650ba-7cce-41d7-98f6-073fa7cb578b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97309546-ebe6-4e9f-a267-65b26f9f3919" xlink:to="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_bb1650ba-7cce-41d7-98f6-073fa7cb578b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2a87aca9-ce07-4c59-b38c-e67a891c0c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97309546-ebe6-4e9f-a267-65b26f9f3919" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2a87aca9-ce07-4c59-b38c-e67a891c0c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivable" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivable"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_25a10786-71a7-4893-8cf1-d90b39d36481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_f92ea982-efb2-4620-a45c-a3f393c87fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_25a10786-71a7-4893-8cf1-d90b39d36481" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_f92ea982-efb2-4620-a45c-a3f393c87fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures" xlink:type="simple" xlink:href="peak-20230331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVentures"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2862cf53-8e93-4bf7-af80-a785ea355801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_30f6ab63-3bd3-47e5-9cba-33e97ccb7265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2862cf53-8e93-4bf7-af80-a785ea355801" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_30f6ab63-3bd3-47e5-9cba-33e97ccb7265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Intangibles" xlink:type="simple" xlink:href="peak-20230331.xsd#Intangibles"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Intangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_f94da6ff-e7c9-44d0-b1e3-92f3b09c4f02" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_6225f863-5533-427b-aafe-320aefd81503" xlink:href="peak-20230331.xsd#peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_f94da6ff-e7c9-44d0-b1e3-92f3b09c4f02" xlink:to="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_6225f863-5533-427b-aafe-320aefd81503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Debt" xlink:type="simple" xlink:href="peak-20230331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_da3569e5-aed5-4201-87e1-ecaf6ed14f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_a2fe8a7d-db5f-4301-9d4e-4aa9c277ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_da3569e5-aed5-4201-87e1-ecaf6ed14f2a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_a2fe8a7d-db5f-4301-9d4e-4aa9c277ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="peak-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2754db1a-a2fb-4d7e-a755-22f76f4ab8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b44318b6-68d8-4ea0-ab90-934b5ce61a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2754db1a-a2fb-4d7e-a755-22f76f4ab8a9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b44318b6-68d8-4ea0-ab90-934b5ce61a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c36002b2-b6ff-4421-975b-3f03aa494333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_371c4662-ee75-4aa6-baad-26fa5142c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c36002b2-b6ff-4421-975b-3f03aa494333" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_371c4662-ee75-4aa6-baad-26fa5142c55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShare" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c7a8bc6a-07d0-41d9-b7b3-964f85175df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_942ffd37-32ec-4f50-b97f-8717e4ee7b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c7a8bc6a-07d0-41d9-b7b3-964f85175df1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_942ffd37-32ec-4f50-b97f-8717e4ee7b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosures" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosures"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8c69bfa7-49f8-4dbe-9a98-c1e414634c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_56ef28b7-8de4-4ae0-89cb-9546eb724c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8c69bfa7-49f8-4dbe-9a98-c1e414634c5c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_56ef28b7-8de4-4ae0-89cb-9546eb724c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_287294a5-e3ae-4ab2-86c8-dc8bc47cb4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8e99e385-0b08-4d0d-8b79-f66568a59029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_287294a5-e3ae-4ab2-86c8-dc8bc47cb4e5" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8e99e385-0b08-4d0d-8b79-f66568a59029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_41703ece-9bb3-4524-98bd-f68eccd62287" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesTextBlock_96a23861-c56b-49b9-a83b-80ae3dc26a9c" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_41703ece-9bb3-4524-98bd-f68eccd62287" xlink:to="loc_peak_VariableInterestEntitiesTextBlock_96a23861-c56b-49b9-a83b-80ae3dc26a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="peak-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2889e502-b766-47ed-88bf-f8e93c8c6284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1c73d261-2e08-42e2-85dc-5efa338226c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2889e502-b766-47ed-88bf-f8e93c8c6284" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1c73d261-2e08-42e2-85dc-5efa338226c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88152a7c-ba3c-465d-80ab-4ecef5e95c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7b4ae1ea-f812-4878-bd5c-cbe2c5077501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_88152a7c-ba3c-465d-80ab-4ecef5e95c71" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7b4ae1ea-f812-4878-bd5c-cbe2c5077501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities" xlink:type="simple" xlink:href="peak-20230331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_41796412-911f-44d3-8bd8-6c86fd74d696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_345dc5ee-0b67-46d8-be73-faf7c2ebeae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_41796412-911f-44d3-8bd8-6c86fd74d696" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_345dc5ee-0b67-46d8-be73-faf7c2ebeae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DeferredRevenue" xlink:type="simple" xlink:href="peak-20230331.xsd#DeferredRevenue"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DeferredRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_56085cea-6a22-42d3-a327-4624154d0f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_50958b40-16f8-4d18-857b-0a13b15c012d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_56085cea-6a22-42d3-a327-4624154d0f30" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_50958b40-16f8-4d18-857b-0a13b15c012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="peak-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7441dfc9-ba41-42e0-9978-c0d5b8e5523d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7441dfc9-ba41-42e0-9978-c0d5b8e5523d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock_6c58f098-945e-422a-bc7c-e781b960e279" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:to="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock_6c58f098-945e-422a-bc7c-e781b960e279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_5c7e8660-39d2-4a48-89a4-f71b8ee14687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_5c7e8660-39d2-4a48-89a4-f71b8ee14687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc370c0b-d2fe-46ec-baea-39fcfe995c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc370c0b-d2fe-46ec-baea-39fcfe995c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_43a7ad1f-a99b-402d-855d-32e18737d412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d4570c9-b6bc-4af5-a0a8-05753b9ca38b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_43a7ad1f-a99b-402d-855d-32e18737d412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d44bc410-a9a8-475a-ba3c-35d302e4a177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_9b8b0da5-6191-4ff9-9853-46588f143cce" xlink:href="peak-20230331.xsd#peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d44bc410-a9a8-475a-ba3c-35d302e4a177" xlink:to="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_9b8b0da5-6191-4ff9-9853-46588f143cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_72097173-e6b8-4b91-b40f-9858dcf28214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c7de1198-612e-444d-8e8d-c225ddd12247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_72097173-e6b8-4b91-b40f-9858dcf28214" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c7de1198-612e-444d-8e8d-c225ddd12247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7b438766-86e2-4295-a27c-1a7df513ccbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_fdab616c-7ec9-417b-987d-b5fba1dda0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b438766-86e2-4295-a27c-1a7df513ccbf" xlink:to="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_fdab616c-7ec9-417b-987d-b5fba1dda0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableTables" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_5948fabe-44fe-4eba-80b3-7020cc73a12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4b2b17ed-7ad6-4121-b296-bb5af57262e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_5948fabe-44fe-4eba-80b3-7020cc73a12d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4b2b17ed-7ad6-4121-b296-bb5af57262e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_33815e95-cfa3-4046-9654-a9ecdcd97cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_5948fabe-44fe-4eba-80b3-7020cc73a12d" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_33815e95-cfa3-4046-9654-a9ecdcd97cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_9dd24aa3-b489-4fb2-8753-9904cfbaef10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_5948fabe-44fe-4eba-80b3-7020cc73a12d" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_9dd24aa3-b489-4fb2-8753-9904cfbaef10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_389dc5bf-b3ba-4b20-90df-fd4c1a20981b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_5df6cc03-cd51-4cf1-9192-a44cf40080b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_389dc5bf-b3ba-4b20-90df-fd4c1a20981b" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_5df6cc03-cd51-4cf1-9192-a44cf40080b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_4df63bea-4dc1-4a06-aa94-104206fe9f5f" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c1e21149-fb37-40d7-94b3-4c3f0c5ae3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_4df63bea-4dc1-4a06-aa94-104206fe9f5f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c1e21149-fb37-40d7-94b3-4c3f0c5ae3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_7fe96109-4425-42a3-a362-c594eeef22f2" xlink:href="peak-20230331.xsd#peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_4df63bea-4dc1-4a06-aa94-104206fe9f5f" xlink:to="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_7fe96109-4425-42a3-a362-c594eeef22f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtTables" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8588eb2c-fd36-44fb-bfcd-d1f4e3e1028b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2efa5e98-63a3-49f9-b029-831157be686e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8588eb2c-fd36-44fb-bfcd-d1f4e3e1028b" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2efa5e98-63a3-49f9-b029-831157be686e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_df0592a1-bd4e-49ef-8cdb-3f49cd413d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8588eb2c-fd36-44fb-bfcd-d1f4e3e1028b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_df0592a1-bd4e-49ef-8cdb-3f49cd413d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_175b39a8-2e42-41b7-84bf-d38b862ebea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5bc07d14-e583-44c5-8f18-12617247bc00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_175b39a8-2e42-41b7-84bf-d38b862ebea4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5bc07d14-e583-44c5-8f18-12617247bc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareTables" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9e11fa63-cc2b-40c1-b70b-04afbab5e75a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e6728b4b-bd2c-42a4-8999-04bf4b86311e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9e11fa63-cc2b-40c1-b70b-04afbab5e75a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e6728b4b-bd2c-42a4-8999-04bf4b86311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresTables" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_12b2dfe0-2340-4321-ab44-99d563ba8b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_456fe716-538c-4911-81d0-0fd34dc57e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_12b2dfe0-2340-4321-ab44-99d563ba8b80" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_456fe716-538c-4911-81d0-0fd34dc57e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_34e6aef4-0206-4fb0-b1b1-70f4a6205a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8873b1c3-8add-4d25-94ba-d5dc2aafcd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_34e6aef4-0206-4fb0-b1b1-70f4a6205a68" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8873b1c3-8add-4d25-94ba-d5dc2aafcd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6c6ff3b1-6d03-4225-af29-69ff25953c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_34e6aef4-0206-4fb0-b1b1-70f4a6205a68" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6c6ff3b1-6d03-4225-af29-69ff25953c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_f98b362a-684f-453c-bb3a-46ab9e9bdbcd" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_77db2604-25c4-479a-bdcf-053cd7604b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_f98b362a-684f-453c-bb3a-46ab9e9bdbcd" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_77db2604-25c4-479a-bdcf-053cd7604b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_6ec5c313-fbf4-40fc-9142-1fe73905c4ac" xlink:href="peak-20230331.xsd#peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_f98b362a-684f-453c-bb3a-46ab9e9bdbcd" xlink:to="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_6ec5c313-fbf4-40fc-9142-1fe73905c4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="peak-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_df996fed-4e1d-4030-9698-00649948895a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_99f8d348-f15b-4e66-9e6d-ac7ead9aee96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_df996fed-4e1d-4030-9698-00649948895a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_99f8d348-f15b-4e66-9e6d-ac7ead9aee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b914e8f2-5bdc-455e-a4e1-b890d485b896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4af2469a-6eaf-48cf-bda6-96a89057e270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b914e8f2-5bdc-455e-a4e1-b890d485b896" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4af2469a-6eaf-48cf-bda6-96a89057e270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" xlink:type="simple" xlink:href="peak-20230331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_669e64d3-e1db-46ef-84b3-c94ebc5841bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da727fd3-cb91-497d-8fcb-28c875399335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_669e64d3-e1db-46ef-84b3-c94ebc5841bd" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_da727fd3-cb91-497d-8fcb-28c875399335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DeferredRevenueTables" xlink:type="simple" xlink:href="peak-20230331.xsd#DeferredRevenueTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DeferredRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5de4899a-92dc-4c1d-8c77-69da3f35ad5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfDeferredRevenueTableTextBlock_0b333603-1dc3-49ec-a0ba-d43712b6103c" xlink:href="peak-20230331.xsd#peak_ScheduleOfDeferredRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_5de4899a-92dc-4c1d-8c77-69da3f35ad5e" xlink:to="loc_peak_ScheduleOfDeferredRevenueTableTextBlock_0b333603-1dc3-49ec-a0ba-d43712b6103c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8d235b51-a70b-494c-bbba-02db7b07d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d235b51-a70b-494c-bbba-02db7b07d34f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:to="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_GovernmentAssistanceAxis_fc1d9632-c9fb-4074-bbb1-4644d6c10e21" xlink:to="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember_6abd7b94-fe77-4106-9a49-b2449e9b63ce" xlink:href="peak-20230331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_GovernmentAssistanceDomain_12fc00d2-c14b-4d7f-82fa-c2a6cd8c3e1a" xlink:to="loc_peak_GovernmentAssistanceCARESActMember_6abd7b94-fe77-4106-9a49-b2449e9b63ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_677a9193-3f2c-434e-b076-32b4b4e7fa7f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_35a07b17-ffbf-41e2-86c9-170eeb9b62e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_35a07b17-ffbf-41e2-86c9-170eeb9b62e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_dc2fe07f-91c6-475d-8fa9-ededac85301b" xlink:href="peak-20230331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_dc2fe07f-91c6-475d-8fa9-ededac85301b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember_a88bd6d4-3ec9-4391-84a1-a9cccef66919" xlink:href="peak-20230331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6dcb271c-f9d4-473e-8b01-dcb83eff7637" xlink:to="loc_peak_IncomeLossFromDiscontinuedOperationsMember_a88bd6d4-3ec9-4391-84a1-a9cccef66919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_d99bb1c2-ae7a-4514-a3c0-23a7ea5a6e2b" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome_d6085ca1-4738-4089-b627-da376f4ca25b" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_003dad7c-e2ed-43f2-af51-fce777cb732d" xlink:to="loc_peak_GovernmentGrantIncome_d6085ca1-4738-4089-b627-da376f4ca25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#RealEstateRealEstateInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_824acbd2-e0db-40b6-8acc-51a742608462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_824acbd2-e0db-40b6-8acc-51a742608462" xlink:to="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f0278f80-6998-4f61-83a3-aa6710a14bab" xlink:to="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_ec736159-366d-4fbc-a485-93546015e0c3" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:to="loc_peak_LifeScienceMember_ec736159-366d-4fbc-a485-93546015e0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_59737f81-3cf4-43f5-8b10-e8560777514c" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6000544e-93d7-4834-bd4a-7c8bcb907bfe" xlink:to="loc_peak_MedicalOfficeMember_59737f81-3cf4-43f5-8b10-e8560777514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:to="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d5c65f13-4e45-4e7f-be03-41ffbe7ba76f" xlink:to="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_bb209297-781e-442d-951d-dba28b5da4bb" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_MA_bb209297-781e-442d-951d-dba28b5da4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_2123925d-bc7a-4c86-9c10-57d68900f75b" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_CA_2123925d-bc7a-4c86-9c10-57d68900f75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_db3081be-5e5c-4012-8a33-0bb6985c4fca" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_TX_db3081be-5e5c-4012-8a33-0bb6985c4fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_ae9a3c5a-f9aa-497b-b969-ac7d7ae50953" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9c41cfb1-61a4-44cb-a348-fce4a2004abe" xlink:to="loc_stpr_AR_ae9a3c5a-f9aa-497b-b969-ac7d7ae50953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_1ca94a3e-4658-4ec6-a952-4c11bd1a1640" xlink:to="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_b314debd-b374-4c86-b121-ec1f403eab22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_b314debd-b374-4c86-b121-ec1f403eab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_b8de48bd-e1b2-4dba-aa26-9c05f0a5770c" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_380843d8-4d1e-4980-ae58-530693fdd038" xlink:to="loc_peak_NumberOfPropertiesAcquired_b8de48bd-e1b2-4dba-aa26-9c05f0a5770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#RealEstateDevelopmentActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_7747b945-3917-4c61-b73e-e0db101918fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_76e28963-200d-41f9-8532-31c9f98f2ce0" xlink:href="peak-20230331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_7747b945-3917-4c61-b73e-e0db101918fa" xlink:to="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_76e28963-200d-41f9-8532-31c9f98f2ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_549e6d02-84db-402c-9e87-1dd65a93dbcd" xlink:href="peak-20230331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_7747b945-3917-4c61-b73e-e0db101918fa" xlink:to="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_549e6d02-84db-402c-9e87-1dd65a93dbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7111d3a4-da32-4383-833f-f895a7620b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_7111d3a4-da32-4383-833f-f895a7620b72" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e24bf09c-09b4-4a09-85a2-5097cf28e94a" xlink:to="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_d1bcf95e-495f-42dd-a48e-bc7da350365b" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_LifeScienceMember_d1bcf95e-495f-42dd-a48e-bc7da350365b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_a1b9486c-a32b-4330-994b-9a0937854ab6" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_MedicalOfficeMember_a1b9486c-a32b-4330-994b-9a0937854ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MOBLandParcelsMember_dccf3a82-c44a-4479-8d79-5c36d5b8d9a1" xlink:href="peak-20230331.xsd#peak_MOBLandParcelsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_34a7119f-616f-4641-bc65-5cd863edb01b" xlink:to="loc_peak_MOBLandParcelsMember_dccf3a82-c44a-4479-8d79-5c36d5b8d9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9f218b5b-21ae-40c0-8c81-eea421f18afd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ffcd7d93-cd0a-4412-8de5-b8d73458217b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_33ee8062-4672-4726-be13-7cdf8247393e" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_ffcd7d93-cd0a-4412-8de5-b8d73458217b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_0215be66-228e-4f30-a8b6-13f64a65ddfb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_5c1ff83a-ebd4-4e74-8bea-b2418c1b9fe4" xlink:href="peak-20230331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_b31438be-f228-4bef-b5cd-98b34bbc4fd3" xlink:to="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_5c1ff83a-ebd4-4e74-8bea-b2418c1b9fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_7b48a857-e558-40d4-a6fa-0ef5720f831c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold_db9aa510-92da-4206-add8-4f86079597bb" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_NumberOfPropertiesSold_db9aa510-92da-4206-add8-4f86079597bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_742fd16c-1a3f-4e0a-82f4-cc8729fc5a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_742fd16c-1a3f-4e0a-82f4-cc8729fc5a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_c313acf5-0a7c-4302-b94b-2d0443e5fab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_c313acf5-0a7c-4302-b94b-2d0443e5fab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_59736b9c-fc30-4a0c-9506-8aa96615c934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_59736b9c-fc30-4a0c-9506-8aa96615c934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_835dc368-45f6-4356-b5fe-12e2b86f61a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_835dc368-45f6-4356-b5fe-12e2b86f61a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber_467d33c4-b297-4aeb-8b36-5c34b9c11842" xlink:href="peak-20230331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_PropertiesHeldForSaleNumber_467d33c4-b297-4aeb-8b36-5c34b9c11842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c61a215a-5d1a-4601-948c-27dfb4991c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_c61a215a-5d1a-4601-948c-27dfb4991c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets_a4465cb8-18b6-4922-a36d-e7e8e2858dd0" xlink:href="peak-20230331.xsd#peak_NetRealEstateAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_peak_NetRealEstateAssets_a4465cb8-18b6-4922-a36d-e7e8e2858dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_0a7b4b63-c48d-48c6-ac85-4dddf3d81f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_0a7b4b63-c48d-48c6-ac85-4dddf3d81f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_09809ed5-e9a4-4724-8c6d-b648add84f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_09809ed5-e9a4-4724-8c6d-b648add84f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_4d3f46e1-48a5-4c80-8b77-492bb395f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a87d0d48-0f85-43e4-91da-7ecfae5bcf0a" xlink:to="loc_us-gaap_OtherNonrecurringExpense_4d3f46e1-48a5-4c80-8b77-492bb395f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_16976aab-e2e0-403b-bc4e-efc126ea1a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_16976aab-e2e0-403b-bc4e-efc126ea1a61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7850a4e5-c523-4e0a-b16c-4d8d987fa533" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_b6c5976e-fb72-409d-a4ff-88bdd6e017bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_066f954f-08c4-4636-ab6b-32db6e852471" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_b6c5976e-fb72-409d-a4ff-88bdd6e017bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d27305dc-6a85-4b69-a9b2-8dfd2debaacc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_22cc5007-dd20-4f6b-bc65-41b1ad44f572" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_22cc5007-dd20-4f6b-bc65-41b1ad44f572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f5ea1376-5a78-4c7e-bde8-e0e79018064f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2f486441-a14a-4efe-97e2-a3f29b2911b6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f5ea1376-5a78-4c7e-bde8-e0e79018064f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_5ce1d6df-e6b5-4426-9765-ca9dc7f03c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_5ce1d6df-e6b5-4426-9765-ca9dc7f03c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_12683727-1d14-4dd7-a9c1-bc5a9d280815" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_5e8a1970-62f4-4f3f-abb8-4c1576da5c9b" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_12683727-1d14-4dd7-a9c1-bc5a9d280815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_18605fb3-fb0e-459d-a412-e4a0f9ad94de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_18605fb3-fb0e-459d-a412-e4a0f9ad94de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_0b279d89-4a16-48dc-a5ae-260597afee85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome_0b279d89-4a16-48dc-a5ae-260597afee85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_950d77c9-7e5d-409d-bab2-d9d6fb4e8e9c" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_8b46c925-61ee-4936-a295-cfccde475e60" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_950d77c9-7e5d-409d-bab2-d9d6fb4e8e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1589b7e6-f3fe-43c8-8dd4-60ea5e2abb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1589b7e6-f3fe-43c8-8dd4-60ea5e2abb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_93bc31ee-a622-450c-9d58-4e53d01fa521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_93bc31ee-a622-450c-9d58-4e53d01fa521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82e8a514-cde2-4e1a-aa8f-7457abe4bd8e" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82e8a514-cde2-4e1a-aa8f-7457abe4bd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9493ebcc-dc6f-4db5-ae3e-0acf7b3a24eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_281f9bf6-52ef-4c1b-984b-e01125d81be1" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_9493ebcc-dc6f-4db5-ae3e-0acf7b3a24eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LeasesLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f78cdfa5-c4a2-4d25-b0c2-51719d81dd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncomeAbstract_d8f45ece-5dcf-474c-864a-e1066c96acdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f78cdfa5-c4a2-4d25-b0c2-51719d81dd44" xlink:to="loc_us-gaap_InterestAndOtherIncomeAbstract_d8f45ece-5dcf-474c-864a-e1066c96acdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_34ec075f-2c84-4098-ae3e-dca91f0a57f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_d8f45ece-5dcf-474c-864a-e1066c96acdd" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_34ec075f-2c84-4098-ae3e-dca91f0a57f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome_8ad83424-b6d8-4f89-bc3e-7cf3618b4633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_d8f45ece-5dcf-474c-864a-e1066c96acdd" xlink:to="loc_us-gaap_OperatingLeaseVariableLeaseIncome_8ad83424-b6d8-4f89-bc3e-7cf3618b4633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseInterestIncome_d82b97c9-f728-4259-abbc-4cb5970790f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseInterestIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_d8f45ece-5dcf-474c-864a-e1066c96acdd" xlink:to="loc_us-gaap_DirectFinancingLeaseInterestIncome_d82b97c9-f728-4259-abbc-4cb5970790f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c751add1-bf4b-40f5-9875-45a7ac40e5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c751add1-bf4b-40f5-9875-45a7ac40e5e2" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8d19a356-11ea-4770-aa0d-e36722d4f67c" xlink:to="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_0ccca533-9c98-443c-a99a-c136aeb5432d" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3a8e9714-ea86-479d-b019-08f4606ca1c5" xlink:to="loc_peak_LifeScienceMember_0ccca533-9c98-443c-a99a-c136aeb5432d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_047b5cf9-7fdd-462d-95e9-6110a28a2d98" xlink:to="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SorrentoTherapeuticsIncMember_dd6c15b6-ca44-49a3-ae43-8f09d7d55209" xlink:href="peak-20230331.xsd#peak_SorrentoTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_bc370923-fd3f-4a49-b03d-d7e9015a4278" xlink:to="loc_peak_SorrentoTherapeuticsIncMember_dd6c15b6-ca44-49a3-ae43-8f09d7d55209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_0ee7545e-9c79-4309-a495-cce87be64423" xlink:to="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_1e8e0551-2581-4127-b925-76acb0c15f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLeaseReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_1e8e0551-2581-4127-b925-76acb0c15f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable_55eeee0e-67f9-450a-bcea-8ed225c63628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_GainLossOnSaleOfNotesReceivable_55eeee0e-67f9-450a-bcea-8ed225c63628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesWithDirectFinancingLeasesNumber_38f93dbf-7c38-4d63-8215-9c019e961bbe" xlink:href="peak-20230331.xsd#peak_PropertiesWithDirectFinancingLeasesNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_peak_PropertiesWithDirectFinancingLeasesNumber_38f93dbf-7c38-4d63-8215-9c019e961bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_9073dd51-ce77-4af7-936c-4770bb7925f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StraightLineRent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_76a8cda9-a070-4e25-b2c4-86a38effe796" xlink:to="loc_us-gaap_StraightLineRent_9073dd51-ce77-4af7-936c-4770bb7925f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_77d72779-71f2-4987-8561-f59178a3b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_77d72779-71f2-4987-8561-f59178a3b941" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_ac844f7b-1b9e-45bc-86d0-f58ca9619e1f" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_94d11dbf-38af-47db-92d3-b5d47f566cf4" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:to="loc_peak_SecuredMortgageLoansMember_94d11dbf-38af-47db-92d3-b5d47f566cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCResidentLoansMember_88fe3b8b-5308-457e-8e7d-ea81cfaf98c6" xlink:href="peak-20230331.xsd#peak_CCRCResidentLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_3b94f641-7344-48c1-8372-e35792203222" xlink:to="loc_peak_CCRCResidentLoansMember_88fe3b8b-5308-457e-8e7d-ea81cfaf98c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_49eb1d01-ae3f-46fc-a25f-1802aaea1515" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_838d5005-abd2-429a-839a-bdad19267888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_838d5005-abd2-429a-839a-bdad19267888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_c5c621be-71f9-4d4b-a1dd-8195d8e61410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_c5c621be-71f9-4d4b-a1dd-8195d8e61410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3532c0df-eab0-4f7c-960b-e05341c7579f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3532c0df-eab0-4f7c-960b-e05341c7579f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2c7fbadf-69a6-4df4-8dbe-cbff3867b1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2c7fbadf-69a6-4df4-8dbe-cbff3867b1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansAndLeasesReceivableRemainingCommitments_4ae08fae-ae40-4a50-a7d8-d4085bc48e22" xlink:href="peak-20230331.xsd#peak_LoansAndLeasesReceivableRemainingCommitments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_838c05e9-d688-4e9c-acab-84683d2558e6" xlink:to="loc_peak_LoansAndLeasesReceivableRemainingCommitments_4ae08fae-ae40-4a50-a7d8-d4085bc48e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_a75c4188-a5c5-471b-a280-a39463fa9935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_a75c4188-a5c5-471b-a280-a39463fa9935" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_719889c4-f75d-4307-9fcb-4ac04936e30b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_18a08a85-911a-426c-a22e-b9ff742c62b5" xlink:href="peak-20230331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_142c8061-f971-41f4-9c9b-dda1987012e9" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_18a08a85-911a-426c-a22e-b9ff742c62b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5728e2d-585c-411a-ab32-48e4151aef4a" xlink:to="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_a3840e6e-375c-4741-8b7d-48b251fedc63" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_a3840e6e-375c-4741-8b7d-48b251fedc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_cfd0467f-7fa2-4f15-93f6-5f3737080163" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_SecuredMortgageLoansMember_cfd0467f-7fa2-4f15-93f6-5f3737080163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_cf5a4c47-db45-4811-bfef-9bb46f1847e9" xlink:href="peak-20230331.xsd#peak_MezzanineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_MezzanineMember_cf5a4c47-db45-4811-bfef-9bb46f1847e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_60c563ac-48d7-48d5-94da-d0c018c3804b" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8d60a4-1123-4d78-81a2-a8e3dc2164b0" xlink:to="loc_peak_OtherNonReportingSegmentMember_60c563ac-48d7-48d5-94da-d0c018c3804b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_bf1dccef-4c24-4824-a059-e9c37dc07cfe" xlink:to="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_2ac08499-51af-4097-b9a0-f677c40ce866" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53132e7f-5d07-49d1-abb8-41ee427ecfab" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_2ac08499-51af-4097-b9a0-f677c40ce866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c5c8e721-e32f-4ac7-b903-e9f81f06b6c3" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_beac4001-0727-444a-8e1c-c87bb2b9b0ff" xlink:href="peak-20230331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_beac4001-0727-444a-8e1c-c87bb2b9b0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_d56095dd-299c-4e4a-9ea8-104331c8d72f" xlink:href="peak-20230331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_25cae6af-fc6b-4868-99b2-714448e5a781" xlink:to="loc_peak_CCRVJVInvestmentMember_d56095dd-299c-4e4a-9ea8-104331c8d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ead27933-6bd6-4292-a5be-e2c66f324252" xlink:to="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3ceac411-576b-46e2-915a-4055e6c58c22" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_b3b6ce03-0c5d-4f67-8482-4efcad014537" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember_b3b6ce03-0c5d-4f67-8482-4efcad014537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_c19f1451-9e91-4fbb-afae-7bf3a210fad2" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1e64940c-88e2-43b2-8079-975b51ba61be" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember_c19f1451-9e91-4fbb-afae-7bf3a210fad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_30fd0fa5-a6c0-4c23-a6ff-16ff5e525f60" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_5bdaa87a-3ff6-41ef-a37f-06fbeededb01" xlink:href="peak-20230331.xsd#peak_BrookdaleMTCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1e0c2e48-0edf-42e5-be7b-60c49e2cac9d" xlink:to="loc_peak_BrookdaleMTCAMember_5bdaa87a-3ff6-41ef-a37f-06fbeededb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_b4580d5e-5488-4186-bbc7-540dda69aee4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember_916ae038-b04a-4037-8971-6fc5b5152ec5" xlink:href="peak-20230331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_dee00b2f-a70e-4197-9904-2ae84682d87a" xlink:to="loc_peak_LessorAssetUnderOperatingLeaseMember_916ae038-b04a-4037-8971-6fc5b5152ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_02a9431d-a929-46f4-bfeb-0b2159d86fbf" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_57994de4-058c-4148-92f8-45411a396ecf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_d72cf17d-3fbb-4953-8c1d-4e03ac4ae9ad" xlink:to="loc_srt_ScenarioForecastMember_57994de4-058c-4148-92f8-45411a396ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_521eeb2d-c44e-4a45-99c3-be7c466421f9" xlink:to="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherMember_eb52e310-bd02-4c4d-ad7b-1e2b94655e15" xlink:href="peak-20230331.xsd#peak_OtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_094233d1-3ad1-4aa2-bf5c-0fc1ba4d974e" xlink:to="loc_peak_OtherMember_eb52e310-bd02-4c4d-ad7b-1e2b94655e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7c30d50b-c68d-4802-bfe7-0156f87421e5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eeaa9161-7839-421a-91c9-7605d2dbe1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_13bd73da-801d-4cc0-b89b-e3e757f3c51b" xlink:to="loc_us-gaap_SubsequentEventMember_eeaa9161-7839-421a-91c9-7605d2dbe1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d74e9137-4ca4-40b7-ba5c-07d783050df7" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_bbdb3110-aec3-4fe6-b5ba-0c68568f808d" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_NumberOfPropertiesToBeSold_bbdb3110-aec3-4fe6-b5ba-0c68568f808d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_b935605c-1396-4f6c-8025-9cc7bc0f01b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_b935605c-1396-4f6c-8025-9cc7bc0f01b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a273387d-b5ac-4d12-a2f2-22477d798868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a273387d-b5ac-4d12-a2f2-22477d798868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_20f4be26-9d7e-4589-9c80-6c1f2670a63e" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_20f4be26-9d7e-4589-9c80-6c1f2670a63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_c99b71b0-d86b-49c7-89f1-e761e0dc0a30" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_c99b71b0-d86b-49c7-89f1-e761e0dc0a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_3d04ca05-65d6-40cc-aa38-8d7096465e77" xlink:href="peak-20230331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_3d04ca05-65d6-40cc-aa38-8d7096465e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_6f70df88-8a80-4555-ad34-5b980cd210d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_6f70df88-8a80-4555-ad34-5b980cd210d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_f0cd6c18-2eec-46fa-a505-3c699a14d63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_f0cd6c18-2eec-46fa-a505-3c699a14d63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_e635fb92-9908-4006-b39c-7b1c80a10e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_LoansReceivableBasisSpreadOnVariableRate_e635fb92-9908-4006-b39c-7b1c80a10e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableExtensionFee_a106f375-5a34-431f-96c6-96d610cf5e4a" xlink:href="peak-20230331.xsd#peak_LoansReceivableExtensionFee"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableExtensionFee_a106f375-5a34-431f-96c6-96d610cf5e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfSecuredLoans_29b1043b-5b3a-4522-ac0b-369a86fb813f" xlink:href="peak-20230331.xsd#peak_NumberOfSecuredLoans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_NumberOfSecuredLoans_29b1043b-5b3a-4522-ac0b-369a86fb813f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_da7dd1d2-9365-4788-9d73-1ffcab1dcc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_da7dd1d2-9365-4788-9d73-1ffcab1dcc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableOutstandingBalance_e12befb7-0477-4030-9f7c-2f682712ad7e" xlink:href="peak-20230331.xsd#peak_LoansReceivableOutstandingBalance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableOutstandingBalance_e12befb7-0477-4030-9f7c-2f682712ad7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableTerm_430ada0b-015f-4c9b-b9a4-6a9b319b2671" xlink:href="peak-20230331.xsd#peak_LoansReceivableTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_LoansReceivableTerm_430ada0b-015f-4c9b-b9a4-6a9b319b2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_d27ad491-ad3b-41b7-b1f6-d9db37155027" xlink:href="peak-20230331.xsd#peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_850facea-927a-4342-9db7-563d57a4007b" xlink:to="loc_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments_d27ad491-ad3b-41b7-b1f6-d9db37155027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e9a5c1fa-6e38-4bfe-b1b0-6043f2731d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e9a5c1fa-6e38-4bfe-b1b0-6043f2731d09" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_c78b2c7c-7774-479b-bea2-22aedf6064dd" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember_cb2de2ce-2ea1-4822-90dd-3c761f6e8401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_us-gaap_PerformingFinancingReceivableMember_cb2de2ce-2ea1-4822-90dd-3c761f6e8401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember_fd34d3d3-710d-4292-b47a-98ed4e101455" xlink:href="peak-20230331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_WatchListFinancingReceivableMember_fd34d3d3-710d-4292-b47a-98ed4e101455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember_f8870a47-82f6-424c-a34d-cacb1d7d8a83" xlink:href="peak-20230331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_WorkoutFinancingReceivableMember_f8870a47-82f6-424c-a34d-cacb1d7d8a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodGrossWriteOffsMember_75d14106-0571-4afd-b8ae-e114840266e8" xlink:href="peak-20230331.xsd#peak_CurrentPeriodGrossWriteOffsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodGrossWriteOffsMember_75d14106-0571-4afd-b8ae-e114840266e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodRecoveriesMember_8d8a85c6-9735-4095-9b51-24fc27c664b2" xlink:href="peak-20230331.xsd#peak_CurrentPeriodRecoveriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodRecoveriesMember_8d8a85c6-9735-4095-9b51-24fc27c664b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CurrentPeriodNetWriteOffsMember_5a1deeac-5184-45ba-b11e-f580583d9fb9" xlink:href="peak-20230331.xsd#peak_CurrentPeriodNetWriteOffsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_d93cd10f-8d56-4f6f-8629-5cd138cbf9d2" xlink:to="loc_peak_CurrentPeriodNetWriteOffsMember_5a1deeac-5184-45ba-b11e-f580583d9fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_93a197b3-0cd8-4542-a6ca-6fc24a21b09c" xlink:to="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember_4d3c3243-ca90-4a94-a3dc-aa6dc6a674a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:to="loc_us-gaap_MortgageReceivablesMember_4d3c3243-ca90-4a94-a3dc-aa6dc6a674a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCResidentLoansMember_7f5f2d9d-83a5-45ed-a91e-b233345d1726" xlink:href="peak-20230331.xsd#peak_CCRCResidentLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0a7d497e-782a-4ca7-86e8-883b9e86fd00" xlink:to="loc_peak_CCRCResidentLoansMember_7f5f2d9d-83a5-45ed-a91e-b233345d1726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_20159750-5155-40f2-b9e3-ca1395fdbf93" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_870b3e26-b2bb-45f5-a10b-bf66ecd5cab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_870b3e26-b2bb-45f5-a10b-bf66ecd5cab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_dabce162-bf46-4054-a291-bb4210c29c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_dabce162-bf46-4054-a291-bb4210c29c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_ec1f375d-f672-4b44-8f16-992be2c303e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_ec1f375d-f672-4b44-8f16-992be2c303e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_e9576749-f48b-4723-a9b5-686c5e74db6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_e9576749-f48b-4723-a9b5-686c5e74db6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_72bad2c1-998c-4af7-a412-b16e3ab141e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_72bad2c1-998c-4af7-a412-b16e3ab141e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_7f1ab9a8-7866-4e90-a54c-10bcffd4ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_7f1ab9a8-7866-4e90-a54c-10bcffd4ac09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_d0f15f6a-c05c-4f3e-bdb4-5d7734ac4375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_97a640c3-a42a-494e-9084-a056c5731fda" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_d0f15f6a-c05c-4f3e-bdb4-5d7734ac4375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#LoansReceivableScheduleofReserveforLoanLossesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ddf12110-b397-4e13-aaf3-9c7ed2cd2aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ddf12110-b397-4e13-aaf3-9c7ed2cd2aa7" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_8312798e-17da-437b-b51b-b0da828e8fc2" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_de9d41f6-f831-4453-abf7-ac2cd368c4cd" xlink:href="peak-20230331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:to="loc_peak_SecuredMortgageLoansMember_de9d41f6-f831-4453-abf7-ac2cd368c4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherMember_f1d27263-9a2a-4f91-be18-7b0f044f22e3" xlink:href="peak-20230331.xsd#peak_OtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_40c09ae4-9b90-4af0-87b3-623c95a85d48" xlink:to="loc_peak_OtherMember_f1d27263-9a2a-4f91-be18-7b0f044f22e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_7f2753ec-b4e8-47d5-a4d1-50f48491ec68" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_35e16059-a9f0-4540-a2eb-22518a4adae4" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_266cdacb-26d5-4606-99c6-f9d5445af4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_266cdacb-26d5-4606-99c6-f9d5445af4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_a8f84792-b272-49d1-8c7a-86576996a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal_a8f84792-b272-49d1-8c7a-86576996a4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_fedfee2f-8f02-4f06-8b62-179cc285470b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale_fedfee2f-8f02-4f06-8b62-179cc285470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3f5d1ded-59ec-43e0-bee1-78209eec0cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_4e142377-2d8f-41eb-9b5a-545f47d75732" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_3f5d1ded-59ec-43e0-bee1-78209eec0cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f31078bf-cda2-496c-8de9-7ced6f65099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f31078bf-cda2-496c-8de9-7ced6f65099e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d4aa92d-f2be-467a-a424-7c9fb0d22948" xlink:to="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_0e9c898d-f698-44e3-b7f6-1ea760327019" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_OtherNonReportingSegmentMember_0e9c898d-f698-44e3-b7f6-1ea760327019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_3526410e-bc49-4350-bd46-3eacb9208ac2" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_LifeScienceMember_3526410e-bc49-4350-bd46-3eacb9208ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_c721ee8f-e084-4f14-a4bb-0a0c17dfd311" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8e30d9ff-40b4-4997-968a-646495a696f8" xlink:to="loc_peak_MedicalOfficeMember_c721ee8f-e084-4f14-a4bb-0a0c17dfd311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f9ac3a37-cd81-461c-875c-84b6bea800ba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_3c1c2eba-561b-42c9-b12e-22ea5f33b329" xlink:href="peak-20230331.xsd#peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76c974e8-3dfb-4b5a-b1bd-a79c987ae097" xlink:to="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_3c1c2eba-561b-42c9-b12e-22ea5f33b329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dc07c570-f99e-4e86-bf59-9ec98a14e80f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember_3a87198a-b3df-460e-89ea-615c53a89dcc" xlink:href="peak-20230331.xsd#peak_SHOPJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_SHOPJVMember_3a87198a-b3df-460e-89ea-615c53a89dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SouthSanFranciscoJVsMember_8d0366fd-030c-4715-906d-5726494b62ee" xlink:href="peak-20230331.xsd#peak_SouthSanFranciscoJVsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_SouthSanFranciscoJVsMember_8d0366fd-030c-4715-906d-5726494b62ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_40a11985-1919-470a-a12f-368ddc9a97d6" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_LifeScienceJVsMember_40a11985-1919-470a-a12f-368ddc9a97d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_d0a39473-c46b-402b-9520-8ea629746dba" xlink:href="peak-20230331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_NeedhamLandParcelJVMember_d0a39473-c46b-402b-9520-8ea629746dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:href="peak-20230331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember_2bca58a4-0cf1-4543-8dc7-9a7708391452" xlink:href="peak-20230331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:to="loc_peak_HCPVenturesIVLLCMember_2bca58a4-0cf1-4543-8dc7-9a7708391452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember_225d6ffe-c2a4-49b5-9794-57727f31c842" xlink:href="peak-20230331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_MedicalOfficeJVsMember_80f73b85-847f-4d2d-a02d-3c578a44be32" xlink:to="loc_peak_SuburbanPropertiesLLCMember_225d6ffe-c2a4-49b5-9794-57727f31c842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_81d497db-21e5-45be-b6fd-203a88fbb44e" xlink:href="peak-20230331.xsd#peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8119bcf8-b8ca-46cc-94cc-a01adc1bb1d2" xlink:to="loc_peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember_81d497db-21e5-45be-b6fd-203a88fbb44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4551d153-27ca-47c9-bddc-c13b2a74e553" xlink:to="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3746d19b-0b34-4929-acb7-07fa5cddab02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:to="loc_srt_MinimumMember_3746d19b-0b34-4929-acb7-07fa5cddab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e949b54a-d1c8-46ee-ae5a-cacfdfe552c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a68aff59-73ee-49f2-8ef3-11223ba07eb8" xlink:to="loc_srt_MaximumMember_e949b54a-d1c8-46ee-ae5a-cacfdfe552c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5cdaf3dd-5db2-4de4-b6fd-77831f28f2f9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1ca9a2a6-4975-4f4f-a949-3d498cd2406d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9288139c-52ee-4529-9189-3f9da4b6d6d7" xlink:to="loc_us-gaap_SubsequentEventMember_1ca9a2a6-4975-4f4f-a949-3d498cd2406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8081685e-c0e1-46f9-a6b4-a944e37d48d7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fff2f6da-10ce-430d-81ee-955e9e12a82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fff2f6da-10ce-430d-81ee-955e9e12a82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3296906b-faf7-4b43-9057-098d8c5461a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3296906b-faf7-4b43-9057-098d8c5461a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_26d8c9a2-1c62-44d2-8461-27b9275b0c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_EquityMethodInvestments_26d8c9a2-1c62-44d2-8461-27b9275b0c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70e6e35d-c274-4e83-adab-f614ad67fb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70e6e35d-c274-4e83-adab-f614ad67fb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_71859a54-adbc-49d8-a74e-33da047cad2b" xlink:href="peak-20230331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_71859a54-adbc-49d8-a74e-33da047cad2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_580b08c9-d329-47d7-955f-ec458687dc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4025585-7dff-4e32-96d8-310281076e47" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_580b08c9-d329-47d7-955f-ec458687dc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesIntangiblesLeaseAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e41e087-1e99-4e04-aabd-23540575326d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9e41e087-1e99-4e04-aabd-23540575326d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c70daa14-3826-4c04-a76a-b8c266d513c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c70daa14-3826-4c04-a76a-b8c266d513c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ff72cefe-f5f1-48c8-8f63-4d259b4dd03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ff72cefe-f5f1-48c8-8f63-4d259b4dd03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30fa987a-4643-4365-b6d8-1c259aecf7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30fa987a-4643-4365-b6d8-1c259aecf7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_68a5363d-d391-44f0-b32d-e9bae3d42679" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ab957ee-0bf9-49ca-901a-85caa32ed422" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_70440ded-fd8c-4a66-a650-240fbc59adcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c654e408-e22e-4975-814c-185b5e207f01" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_70440ded-fd8c-4a66-a650-240fbc59adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b8931a1f-8462-4e5f-bbec-8ff3333fe5c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea842557-4c64-4d42-9555-f23604728136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3273ed71-3bdd-475e-81e5-41136ba5d028" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea842557-4c64-4d42-9555-f23604728136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesIntangiblesLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_e5a19871-5485-4169-a4de-20b8762a9648" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross_b3b4f08b-179e-4fd4-9c2f-edaae9c30b9e" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_e5a19871-5485-4169-a4de-20b8762a9648" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesGross_b3b4f08b-179e-4fd4-9c2f-edaae9c30b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_ded074ae-5d18-4537-bafe-3fc7482e13b0" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_e5a19871-5485-4169-a4de-20b8762a9648" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_ded074ae-5d18-4537-bafe-3fc7482e13b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet_d9599be7-cdcf-44b1-bbd1-b539d6cd0d60" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_e5a19871-5485-4169-a4de-20b8762a9648" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesNet_d9599be7-cdcf-44b1-bbd1-b539d6cd0d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_a7f5fae6-c0bc-454f-ae9b-b3d4db13a946" xlink:href="peak-20230331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_e5a19871-5485-4169-a4de-20b8762a9648" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_a7f5fae6-c0bc-454f-ae9b-b3d4db13a946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#IntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_26112c00-8cae-45bb-93b9-6cf51234e02c" xlink:href="peak-20230331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_26112c00-8cae-45bb-93b9-6cf51234e02c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e747d9cb-2d32-4b6d-a401-5b6083b2d4f4" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_4623629d-f8f6-4804-b591-d61f4620f7a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9b7dae68-c7a7-4b2a-966a-0be8bc8ffe07" xlink:to="loc_srt_OtherPropertyMember_4623629d-f8f6-4804-b591-d61f4620f7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c2d7c93-42be-4cd2-af23-ed712b403982" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_25974413-8d2d-4228-a17c-f1d89fc3581f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_25974413-8d2d-4228-a17c-f1d89fc3581f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired_a0e0329b-2175-41df-bd10-5e0383720d1c" xlink:href="peak-20230331.xsd#peak_FiniteLivedIntangibleLiabilitiesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAcquired_a0e0329b-2175-41df-bd10-5e0383720d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44d426e2-f780-40d6-b936-f28ec7a050ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_44d426e2-f780-40d6-b936-f28ec7a050ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7f7dc854-db20-4c0b-9138-b632bfd087f0" xlink:href="peak-20230331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_613ca198-7963-44b3-aa83-07a59b5c81fa" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7f7dc854-db20-4c0b-9138-b632bfd087f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtBankLineofCreditandTermLoanDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_793d9cd9-bfa7-4eff-a870-cf3be3ce1053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_793d9cd9-bfa7-4eff-a870-cf3be3ce1053" xlink:to="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f21dba73-8d0a-4a86-a00e-ebc0641c384f" xlink:to="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fc87d215-444b-46b5-906b-975f7d5b24e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fc87d215-444b-46b5-906b-975f7d5b24e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesMember_3f31b45b-d4f5-43a0-a56f-2b929531d4c9" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesMember_3f31b45b-d4f5-43a0-a56f-2b929531d4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesOneMember_adfa9a0c-f152-4475-b002-52605419f29a" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesOneMember_adfa9a0c-f152-4475-b002-52605419f29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanFacilitiesTwoMember_8c014e4b-4566-4411-9d0b-d73632e78d8e" xlink:href="peak-20230331.xsd#peak_TermLoanFacilitiesTwoMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b6bb51c1-0837-41a6-8050-90acb6abdd49" xlink:to="loc_peak_TermLoanFacilitiesTwoMember_8c014e4b-4566-4411-9d0b-d73632e78d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c460f9ef-6e0f-4f72-ac72-ed7605be684b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e435564c-2d17-4ee5-9f7e-ece3f4a3bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b0914528-b0a5-471b-b449-729f6ca982a0" xlink:to="loc_us-gaap_LineOfCreditMember_e435564c-2d17-4ee5-9f7e-ece3f4a3bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_97694d40-77a8-482b-aa50-bfef37a70555" xlink:to="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFRMember_65fae9e6-980c-49cd-96f3-69fa01658e09" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2ba0c552-ce6b-4392-a129-051f67d124a9" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFRMember_65fae9e6-980c-49cd-96f3-69fa01658e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8330b52-7bcf-44d5-a9ff-1dedfb0e27b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TermLoanAgreementMember_c9081e9a-6e4a-4297-ae2c-c6b074c74629" xlink:href="peak-20230331.xsd#peak_TermLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_087eb304-7228-4afa-878f-c340d7adf197" xlink:to="loc_peak_TermLoanAgreementMember_c9081e9a-6e4a-4297-ae2c-c6b074c74629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65726a86-570e-4f90-896b-8271f7d5265e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2a959aa8-e8b1-4be9-bc31-a7525ad21e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_aefe7766-ffeb-407b-8982-fcf3248655a7" xlink:to="loc_us-gaap_InterestRateSwapMember_2a959aa8-e8b1-4be9-bc31-a7525ad21e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_cde82559-44db-4a9f-89a3-cd32f46231e3" xlink:to="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2da8fd81-2378-4104-9d73-026f0f4a7b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a61d0b4d-3352-4c1a-9bf7-24ba034792a1" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2da8fd81-2378-4104-9d73-026f0f4a7b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f2cffb46-7d6b-48e4-a35a-cb71b69bd8cd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_121d49aa-5541-45cc-9293-6d17ba0eb912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_121d49aa-5541-45cc-9293-6d17ba0eb912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions_3444d6bf-3cbc-43df-aefd-7e6794708eb8" xlink:href="peak-20230331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentNumberofExtensions_3444d6bf-3cbc-43df-aefd-7e6794708eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension_20791290-2837-42af-a218-74de37322ec8" xlink:href="peak-20230331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentPeriodOfExtension_20791290-2837-42af-a218-74de37322ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_ff2b011c-0a52-4e5a-8571-e715b7743094" xlink:href="peak-20230331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_ff2b011c-0a52-4e5a-8571-e715b7743094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75429289-b4f9-4d4f-9507-1bc1de5aa29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_75429289-b4f9-4d4f-9507-1bc1de5aa29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5dff2a48-3a39-4b41-8934-64bc4e69f26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5dff2a48-3a39-4b41-8934-64bc4e69f26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_8ea927d9-dd75-4254-801f-b8c7af8dc5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LineOfCredit_8ea927d9-dd75-4254-801f-b8c7af8dc5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a34df5bf-e678-4d22-9e2b-ac07f91baeb0" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a34df5bf-e678-4d22-9e2b-ac07f91baeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfLoans_516e5855-6c46-4099-b844-9273c912996e" xlink:href="peak-20230331.xsd#peak_NumberOfLoans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_NumberOfLoans_516e5855-6c46-4099-b844-9273c912996e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c760ce9f-5c32-4e68-b235-512ade1cfa19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c760ce9f-5c32-4e68-b235-512ade1cfa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing_6f5155c5-4bd2-42b2-9030-72b0d460ed8a" xlink:href="peak-20230331.xsd#peak_DebtInstrumentDrawTimePeriodAfterClosing"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentDrawTimePeriodAfterClosing_6f5155c5-4bd2-42b2-9030-72b0d460ed8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9b7fa1ca-8c0e-451f-a5d2-27c2b8732f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DebtInstrumentTerm_9b7fa1ca-8c0e-451f-a5d2-27c2b8732f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f32e34da-fdd9-43bc-b09c-16c6794b42cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_LongTermDebt_f32e34da-fdd9-43bc-b09c-16c6794b42cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMarginRate_ccb9f590-da2f-498f-ac8b-8581f39ec415" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMarginRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentMarginRate_ccb9f590-da2f-498f-ac8b-8581f39ec415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_ec4861c7-4e88-48bd-a6ca-f690763f2652" xlink:href="peak-20230331.xsd#peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption_ec4861c7-4e88-48bd-a6ca-f690763f2652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_0a9d100c-ffb3-405e-8ede-af3b440d4e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_0a9d100c-ffb3-405e-8ede-af3b440d4e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_b5fbc260-a8c5-4c9d-a5a3-eaf7c849993f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_b5fbc260-a8c5-4c9d-a5a3-eaf7c849993f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets_b2104522-7509-499c-b62b-5a945d309c69" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantDebtToAssets_b2104522-7509-499c-b62b-5a945d309c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_51d7cde5-27fb-4b2d-b7d7-013a33e32e4b" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_51d7cde5-27fb-4b2d-b7d7-013a33e32e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_e788e080-c2b6-40f2-9038-4b569abdf5bf" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_e788e080-c2b6-40f2-9038-4b569abdf5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_a7273d83-5e9e-4faa-a343-3958f9b9c31e" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_a7273d83-5e9e-4faa-a343-3958f9b9c31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorthMinimum_a6fff821-bdb2-4c2b-b598-fad9e513b938" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCovenantNetWorthMinimum"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebb1e54d-19c2-464f-a5a3-6ae70feb815c" xlink:to="loc_peak_DebtInstrumentCovenantNetWorthMinimum_a6fff821-bdb2-4c2b-b598-fad9e513b938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtCommercialPaperProgramDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f7f49a15-011c-43e9-979b-9111acb27ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f7f49a15-011c-43e9-979b-9111acb27ab9" xlink:to="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_e2a97fbd-4b10-43df-bb2d-dbf2ee369044" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember_2e2153e9-17e8-4e6c-8c4d-15c72e668c3e" xlink:href="peak-20230331.xsd#peak_CommercialPaperProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_454de242-5754-4d28-8d19-bc122f4d76c0" xlink:to="loc_peak_CommercialPaperProgramMember_2e2153e9-17e8-4e6c-8c4d-15c72e668c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_da233f17-c374-429d-96a3-6235400a5947" xlink:to="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity_6eb7193d-0391-41ad-bb55-76f051676b1b" xlink:href="peak-20230331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_peak_DebtInstrumentMaximumBorrowingCapacity_6eb7193d-0391-41ad-bb55-76f051676b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_27c594f9-47be-46b7-ab53-49a9511eb73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_ShortTermBorrowings_27c594f9-47be-46b7-ab53-49a9511eb73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_5b315e6f-419c-4817-803a-4f493be523e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_DebtInstrumentTerm_5b315e6f-419c-4817-803a-4f493be523e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_8567a979-1243-4649-906e-84e8b1df8a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70ab07d1-defd-4691-9181-edf5876892dd" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_8567a979-1243-4649-906e-84e8b1df8a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtSeniorUnsecuredNotesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c85a2445-1070-426f-9ecb-d7ea0f2da1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c85a2445-1070-426f-9ecb-d7ea0f2da1a9" xlink:to="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_424fa159-72c5-4618-8c92-eec3100ec383" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_f957ca89-8ef0-49af-b589-643a6b5dd120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c01d76a-568c-40f3-bfcf-97d52a820093" xlink:to="loc_us-gaap_UnsecuredDebtMember_f957ca89-8ef0-49af-b589-643a6b5dd120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c8715b0-3088-48ac-964a-e927b8b9e4e2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote525PercentMember_437b79dc-ff41-4b89-ae39-42b612162962" xlink:href="peak-20230331.xsd#peak_UnsecuredNote525PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55713103-02f8-43e0-ad04-0084c337fcb4" xlink:to="loc_peak_UnsecuredNote525PercentMember_437b79dc-ff41-4b89-ae39-42b612162962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_66d4b7df-0ba1-4845-aa22-dc1efc08faa1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1b64f763-3429-4e94-8a79-4058e877c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1b64f763-3429-4e94-8a79-4058e877c9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_105d15cd-2705-422f-b575-7962ed7471b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_105d15cd-2705-422f-b575-7962ed7471b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04bbee85-1d7e-42fb-8951-706eb9052d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_748193f1-e7e1-4bdc-9eba-e82b01e4a64e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04bbee85-1d7e-42fb-8951-706eb9052d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtMortgageDebtDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_39476a62-90de-4d08-96ab-7c5800d514a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_39476a62-90de-4d08-96ab-7c5800d514a8" xlink:to="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd4c397-8829-4c3c-b7cd-548cfbb48275" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d90bcc22-7845-47c3-b98a-5a90d7f60abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3126949d-f44c-4d05-8ea7-11d78fae23b1" xlink:to="loc_us-gaap_SecuredDebtMember_d90bcc22-7845-47c3-b98a-5a90d7f60abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ee795fb-38d7-4e94-a2fb-7505f20d9957" xlink:to="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_b21336b1-2ceb-4fc8-93d6-b0f24155f8e4" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:to="loc_peak_MedicalOfficeMember_b21336b1-2ceb-4fc8-93d6-b0f24155f8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_9d7ae6f8-b551-4f6d-bd48-6faade30112b" xlink:href="peak-20230331.xsd#peak_CCRCSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_80e84e11-904a-4031-b1c9-d728bdbdbd73" xlink:to="loc_peak_CCRCSegmentMember_9d7ae6f8-b551-4f6d-bd48-6faade30112b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_63bfefb2-73d7-4bab-9854-4c2f2e939e3c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5e3b9f49-bbb3-4979-931e-eb355d63daac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e278206-3959-437d-86c7-61ba356e06a4" xlink:to="loc_us-gaap_SecuredDebtMember_5e3b9f49-bbb3-4979-931e-eb355d63daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_649fd78d-bf8d-4dac-a98c-66d4cb7ce7d6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_02602636-4d66-450f-937a-da23880e4f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d9d3d90f-7d73-4a20-81f5-c3638628234d" xlink:to="loc_us-gaap_InterestRateSwapMember_02602636-4d66-450f-937a-da23880e4f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3d46f9a9-34e5-4067-8266-ed4931c7d9a9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_4389a98b-05d0-4953-bc1c-850cad66bebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9bd13c07-b108-428c-8429-63e263b9f472" xlink:to="loc_us-gaap_CashFlowHedgingMember_4389a98b-05d0-4953-bc1c-850cad66bebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_81d2e616-4afa-45b4-a7fc-6d0d8356c23e" xlink:to="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0021c717-56d5-48d9-b442-fe22d264bead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_97ee79c5-c826-4826-ab1d-d4c53577d40b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0021c717-56d5-48d9-b442-fe22d264bead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb053886-b2d8-4f45-956c-ea0b8a791578" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_75bb3a31-9e47-450e-972c-0a9b20307ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_75bb3a31-9e47-450e-972c-0a9b20307ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_dd0964aa-dee4-4a64-b4da-b4069d0a03c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_dd0964aa-dee4-4a64-b4da-b4069d0a03c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_fd2e260a-58e8-4f80-9efe-3dd90a7197ba" xlink:href="peak-20230331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_fd2e260a-58e8-4f80-9efe-3dd90a7197ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3e48e2cd-ee38-491f-8d6a-06ec9f6c8718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3e48e2cd-ee38-491f-8d6a-06ec9f6c8718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_af094bb7-bb3e-4e32-bc1f-804e69208608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_af094bb7-bb3e-4e32-bc1f-804e69208608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_bf8b16fd-041c-4cb5-93e8-8efacb4a0d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a43b496c-a9b9-45ec-a905-e4856b089c9c" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_bf8b16fd-041c-4cb5-93e8-8efacb4a0d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DebtDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4563ff7-edc0-4d10-bf0b-1c0651961cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4563ff7-edc0-4d10-bf0b-1c0651961cac" xlink:to="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1a3d2eeb-1343-48e4-a072-6637cb1d552b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3cbd976d-6259-49c4-8478-9ed20a40509a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_LineOfCreditMember_3cbd976d-6259-49c4-8478-9ed20a40509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_fd960261-3fea-486f-9650-7a23ebefb6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_CommercialPaperMember_fd960261-3fea-486f-9650-7a23ebefb6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_ce3f57fa-b2d3-4e1e-8d68-34eec53af8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_LoansPayableMember_ce3f57fa-b2d3-4e1e-8d68-34eec53af8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_275b1b51-b1a5-4f52-a2fa-21f9b5fa558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_UnsecuredDebtMember_275b1b51-b1a5-4f52-a2fa-21f9b5fa558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_42d8e318-e07c-4983-8031-f90f9d91ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7e8545a4-58b1-456a-9b45-b1b617d9370f" xlink:to="loc_us-gaap_SecuredDebtMember_42d8e318-e07c-4983-8031-f90f9d91ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_169f3096-4af5-43f8-b88f-f64b63dbf956" xlink:to="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8c092333-1c1c-461f-bd53-52b536a5ce9f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:to="loc_srt_MinimumMember_8c092333-1c1c-461f-bd53-52b536a5ce9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9cdf05b7-129e-4e45-a12b-7eecdf9b3b52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_480ffa91-ac2a-483a-a00c-69213910a710" xlink:to="loc_srt_MaximumMember_9cdf05b7-129e-4e45-a12b-7eecdf9b3b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b097fcae-43a9-4e86-8dfa-77e1a588a599" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_7fc16246-0f48-4061-b7f6-149373518324" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_7fc16246-0f48-4061-b7f6-149373518324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1b68c569-2a7e-4445-b565-ca703df8ae76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1b68c569-2a7e-4445-b565-ca703df8ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a88065-f716-44fc-8e1d-9aa4bfa706df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_a6a88065-f716-44fc-8e1d-9aa4bfa706df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_e89dc5d3-faec-403c-a2e6-b3791320351a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_e89dc5d3-faec-403c-a2e6-b3791320351a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_f5a91983-f319-4b2a-9e36-b0fc0762d421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_f5a91983-f319-4b2a-9e36-b0fc0762d421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_94388551-0f57-435b-92ba-542ec2985b9d" xlink:href="peak-20230331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_295d183c-58ca-45a6-aed0-ed751dbcd0eb" xlink:to="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_94388551-0f57-435b-92ba-542ec2985b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e175d0fd-7b61-4675-8dc3-057039fc67f4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_7c2e328a-80bd-4558-b090-b818bedc0808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_7c2e328a-80bd-4558-b090-b818bedc0808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0e5a1f59-3db1-406c-a711-b74eb73bd821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0e5a1f59-3db1-406c-a711-b74eb73bd821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d68d2e13-20a0-4c9c-bc66-3aadd4306e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d68d2e13-20a0-4c9c-bc66-3aadd4306e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ca0b9d35-11f4-41b5-961e-d0b32a07d8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ca0b9d35-11f4-41b5-961e-d0b32a07d8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_031f32c3-94ce-4c1a-917d-e6b852fd6256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_031f32c3-94ce-4c1a-917d-e6b852fd6256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_411e3f59-c65a-4680-96e2-8623e8283126" xlink:href="peak-20230331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_411e3f59-c65a-4680-96e2-8623e8283126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_915f4b48-d512-47e8-ba0e-b77f072af1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_915f4b48-d512-47e8-ba0e-b77f072af1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1417a1df-deac-452b-8c1f-4ab37320e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1417a1df-deac-452b-8c1f-4ab37320e9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_72624128-8636-4b90-8033-f0fa9f5293c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_LongTermDebt_72624128-8636-4b90-8033-f0fa9f5293c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d406da22-f554-4536-9ccd-06b8fa3558e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d406da22-f554-4536-9ccd-06b8fa3558e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_d3051cbf-78c3-4b4d-9f3a-6d6ec973cc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_d3051cbf-78c3-4b4d-9f3a-6d6ec973cc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity_3e96de4d-74e6-464e-80f6-c455f73c2494" xlink:href="peak-20230331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_89de7025-5b97-41c9-8ad9-49d61771c428" xlink:to="loc_peak_DebtInstrumentWeightedAverageMaturity_3e96de4d-74e6-464e-80f6-c455f73c2494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f27b0926-6bfc-46e1-ba64-38f83a195270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f27b0926-6bfc-46e1-ba64-38f83a195270" xlink:to="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_68e2a990-d949-431f-a909-7bed28789d3d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_f2ccbf0a-2a50-467c-9b73-e644fc4483fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ce426012-e7f1-47fc-b824-45f16fcbb00d" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_f2ccbf0a-2a50-467c-9b73-e644fc4483fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0bd5a32b-6694-429c-82f5-cb24d6f2362e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_ffee450a-6d3d-4188-8c4e-173ee2c33f1a" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8047640e-779f-423e-a847-3d361242cfa8" xlink:to="loc_peak_LifeScienceJVsMember_ffee450a-6d3d-4188-8c4e-173ee2c33f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f850c296-3a98-462b-97bf-7cefd4890631" xlink:to="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_b9e0e032-92ae-446f-b0e2-01d78c087134" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4052588e-94ee-433b-920a-a80be7c56aef" xlink:to="loc_peak_LifeScienceMember_b9e0e032-92ae-446f-b0e2-01d78c087134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41ff7352-f472-41a9-acb5-2995de39fde2" xlink:to="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties_daeea140-b91a-4b68-bf1a-15cc7e4d2345" xlink:href="peak-20230331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:to="loc_peak_ContributionOfPropertyNumberOfProperties_daeea140-b91a-4b68-bf1a-15cc7e4d2345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_788d1783-3e67-4c96-ac40-16cb9208132a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_15375a0c-c534-42fc-9aba-27aa0706d119" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_788d1783-3e67-4c96-ac40-16cb9208132a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_60be0c58-aecb-4e0a-b551-3202ee158c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_60be0c58-aecb-4e0a-b551-3202ee158c30" xlink:to="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8d6780cc-7987-4319-95e7-90bb049088b6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_28555318-ad21-43dc-9a84-6508747a59ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4b46d82-87e4-49ed-ae72-604de8041dd4" xlink:to="loc_us-gaap_SubsequentEventMember_28555318-ad21-43dc-9a84-6508747a59ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9c54fa24-e484-4aa0-bda2-3560f7ad08ac" xlink:to="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a4c0ac44-d5e8-4949-bb74-d7e810fd7929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a4c0ac44-d5e8-4949-bb74-d7e810fd7929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_06519351-5eb4-4e38-8982-965e0883fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_cda3aa81-7e60-4ba3-b1bc-7d51ecd72cf5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_06519351-5eb4-4e38-8982-965e0883fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsATMProgramDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c4ad1c31-a769-42c0-bf3b-83fda4134619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c4ad1c31-a769-42c0-bf3b-83fda4134619" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_058a6440-f5fe-48e9-915e-4dec8c4cc23f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember_88ec08d0-c910-41c2-8ecb-db6bc4098fd1" xlink:href="peak-20230331.xsd#peak_AtTheMarketProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_AtTheMarketProgramMember_88ec08d0-c910-41c2-8ecb-db6bc4098fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2023AtTheMarketProgramMember_e51a79a8-db37-4a5b-9ef4-5b14a3442663" xlink:href="peak-20230331.xsd#peak_A2023AtTheMarketProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_A2023AtTheMarketProgramMember_e51a79a8-db37-4a5b-9ef4-5b14a3442663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember_fd3f3ee7-6909-4427-b047-715bf4022122" xlink:href="peak-20230331.xsd#peak_A2020ATMProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_A2020ATMProgramMember_fd3f3ee7-6909-4427-b047-715bf4022122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember_ff030edd-184e-486c-a8bd-0e23ed28043c" xlink:href="peak-20230331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243417ec-b218-4a4d-b868-51f40a3cdac7" xlink:to="loc_peak_ATMDirectIssuancesMember_ff030edd-184e-486c-a8bd-0e23ed28043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_969ced65-665f-4ccf-97d9-f1537d2890a5" xlink:to="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bbbe7962-963f-4a16-9eb3-ce0f02ac5c25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:to="loc_srt_MinimumMember_bbbe7962-963f-4a16-9eb3-ce0f02ac5c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38352c77-c3aa-45e2-b084-488d23d995b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1abaecf-06a9-41ef-8511-b79f321752fc" xlink:to="loc_srt_MaximumMember_38352c77-c3aa-45e2-b084-488d23d995b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a81f502d-a488-4760-bb26-8f03af310596" xlink:to="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5f526e4f-9187-475f-ba6d-2af57091a4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c0c792cf-2b3d-445e-b5c2-7ebb5dd58492" xlink:to="loc_us-gaap_CommonStockMember_5f526e4f-9187-475f-ba6d-2af57091a4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_ef52615f-bf9b-49d2-8f07-b1eac45d1e70" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_1636352b-f0ee-4c7c-bb2f-76bade2c882b" xlink:href="peak-20230331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_1636352b-f0ee-4c7c-bb2f-76bade2c882b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm_1206b2d1-acc7-4fa9-b892-241f46862464" xlink:href="peak-20230331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_OptionIndexedToIssuersEquityTerm_1206b2d1-acc7-4fa9-b892-241f46862464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_b94cac9f-aa71-4733-97b4-4e85089929dd" xlink:href="peak-20230331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_b94cac9f-aa71-4733-97b4-4e85089929dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_8827ca12-31b0-44e6-967e-038cde05ebd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_8827ca12-31b0-44e6-967e-038cde05ebd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_b4b99c0e-dc13-42f1-b048-71fadf16820c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_b4b99c0e-dc13-42f1-b048-71fadf16820c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c50addc2-6e6a-4fc6-988f-8e8169d90e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c50addc2-6e6a-4fc6-988f-8e8169d90e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e5ef4092-d00c-4d7d-b61b-cc4300919d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_33a602ae-f4b0-4342-9f6f-5bac655e0413" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e5ef4092-d00c-4d7d-b61b-cc4300919d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_304d0b94-7ac8-43a2-80c9-73f726ec5ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_304d0b94-7ac8-43a2-80c9-73f726ec5ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_11c01eac-da84-4914-8174-e9c41401e52d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_11c01eac-da84-4914-8174-e9c41401e52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d6650094-d4fc-49bb-8815-0a210d67a207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_d6650094-d4fc-49bb-8815-0a210d67a207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b9dc3c68-c43a-4846-974b-51973201a24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b9dc3c68-c43a-4846-974b-51973201a24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f404191f-7357-4e7e-a771-fb7aa6083752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0af47b94-5994-470b-984f-76b8872bf6db" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f404191f-7357-4e7e-a771-fb7aa6083752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c95850f7-d819-4e0a-8979-9cd5917fb34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c244e00c-e5ab-47fa-b1f1-8a414469544d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c95850f7-d819-4e0a-8979-9cd5917fb34e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c244e00c-e5ab-47fa-b1f1-8a414469544d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_10de8c59-d12a-4411-88e7-20ee30725720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c244e00c-e5ab-47fa-b1f1-8a414469544d" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_10de8c59-d12a-4411-88e7-20ee30725720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_115c62b1-a4c0-4b5f-87f5-5287d828b80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c244e00c-e5ab-47fa-b1f1-8a414469544d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_115c62b1-a4c0-4b5f-87f5-5287d828b80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e977fc9-a162-4d08-9f1f-6529ae86eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_c244e00c-e5ab-47fa-b1f1-8a414469544d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e977fc9-a162-4d08-9f1f-6529ae86eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPlanParticipants_e80b6ab5-555c-48a1-ab69-2709da72bd22" xlink:href="peak-20230331.xsd#peak_NumberOfPlanParticipants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c95850f7-d819-4e0a-8979-9cd5917fb34e" xlink:to="loc_peak_NumberOfPlanParticipants_e80b6ab5-555c-48a1-ab69-2709da72bd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e343a6fd-84fc-499f-894d-14ff174b6ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e343a6fd-84fc-499f-894d-14ff174b6ac7" xlink:to="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:to="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_69ba6bf3-a8c8-4a33-8067-029d8fd91c72" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_d8a4ab2e-b58a-4c48-9d07-f3c50da437f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b2c21830-84be-46d5-bdfd-c23c172c5c8f" xlink:to="loc_srt_ScenarioForecastMember_d8a4ab2e-b58a-4c48-9d07-f3c50da437f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:to="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_7a7f5b66-085e-45df-9067-9f5ffce50fcd" xlink:to="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HealthpeakOPMember_2e793cff-8ac4-4988-9448-c8af0b4e59c6" xlink:href="peak-20230331.xsd#peak_HealthpeakOPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_9d6585ef-b4cb-4a8a-917b-b9f47f85c899" xlink:to="loc_peak_HealthpeakOPMember_2e793cff-8ac4-4988-9448-c8af0b4e59c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_a3206530-d929-4223-9e07-427719f192f6" xlink:to="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_491166f8-948b-4215-a949-a2fe51e335c2" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_491166f8-948b-4215-a949-a2fe51e335c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_63f1f435-e218-4f67-888b-d9eedda038c6" xlink:href="peak-20230331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_63f1f435-e218-4f67-888b-d9eedda038c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a6826a5b-2880-4bc9-9e7f-90e8376ad265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_a6826a5b-2880-4bc9-9e7f-90e8376ad265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent_cb0b8eb6-83bd-4601-9897-184ba1af6ead" xlink:href="peak-20230331.xsd#peak_RemainingMinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_9ba5982f-0834-4671-ad70-80081447ec12" xlink:to="loc_peak_RemainingMinorityInterestOwnershipPercentageByParent_cb0b8eb6-83bd-4601-9897-184ba1af6ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EquityandRedeemableNoncontrollingInterestsDownREITsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4a44bd3e-22fc-47c8-8cea-b015dc39db61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4a44bd3e-22fc-47c8-8cea-b015dc39db61" xlink:to="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7722c84e-26bd-4acc-8323-6ec2042596c7" xlink:to="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9453d971-c593-4610-a331-f20617acee06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_096d8d5a-0573-4cc4-80c6-ef0954c94902" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9453d971-c593-4610-a331-f20617acee06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_b641d147-3cda-4ec9-8b32-191c1af25cf8" xlink:to="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITUnitsOutstanding_2eae7b05-27c2-46e3-9c8d-da326a38a662" xlink:href="peak-20230331.xsd#peak_DownREITUnitsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_DownREITUnitsOutstanding_2eae7b05-27c2-46e3-9c8d-da326a38a662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommonStockConvertibleSharesIssuable_b52c1800-f5e9-412e-b2f8-091bb0f70618" xlink:href="peak-20230331.xsd#peak_CommonStockConvertibleSharesIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_CommonStockConvertibleSharesIssuable_b52c1800-f5e9-412e-b2f8-091bb0f70618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfDownREITLLCs_decc5fae-4789-4c6e-842b-f155fcc19981" xlink:href="peak-20230331.xsd#peak_NumberOfDownREITLLCs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_NumberOfDownREITLLCs_decc5fae-4789-4c6e-842b-f155fcc19981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4db0448-07c7-425e-8012-dd04def7c12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4db0448-07c7-425e-8012-dd04def7c12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue_1045b127-3b4b-490c-a916-c8f118506b03" xlink:href="peak-20230331.xsd#peak_MinorityInterestInPreferredUnitHoldersFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_17d068ea-2aed-46b2-8c1f-c04441677bf0" xlink:to="loc_peak_MinorityInterestInPreferredUnitHoldersFairValue_1045b127-3b4b-490c-a916-c8f118506b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d652055e-a4b4-45ed-986d-413fbe0ba449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d652055e-a4b4-45ed-986d-413fbe0ba449" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_62da908b-e513-4000-85c2-b521b64b43a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardEquitySalesAgreementsMember_1559bb02-9bd9-49c0-9d68-62b9475bcd9c" xlink:href="peak-20230331.xsd#peak_ForwardEquitySalesAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:to="loc_peak_ForwardEquitySalesAgreementsMember_1559bb02-9bd9-49c0-9d68-62b9475bcd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember_fa6a8f4b-494d-4235-90f4-2d9bc61bf691" xlink:href="peak-20230331.xsd#peak_DownREITMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5721a5cc-50c9-4311-87b5-852635c93bc8" xlink:to="loc_peak_DownREITMember_fa6a8f4b-494d-4235-90f4-2d9bc61bf691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_684af0ef-4550-4e88-aa2d-083cd54f38b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_e8ec2d04-f2f6-4a7e-a268-206fc1bf68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_e8ec2d04-f2f6-4a7e-a268-206fc1bf68cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca9d9fdc-b0df-481b-b7c3-49b35f510d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_23e8ec2a-77b4-4d71-9621-991811ac35d7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca9d9fdc-b0df-481b-b7c3-49b35f510d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#EarningsPerCommonShareComputationofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7fc4191e-d83f-4c89-935f-8b038ba821f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7fc4191e-d83f-4c89-935f-8b038ba821f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_a1f735bd-998c-45db-95cd-de652834da0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_a1f735bd-998c-45db-95cd-de652834da0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_15f5269b-16d0-4a17-a0ff-6e9b7b37512d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_15f5269b-16d0-4a17-a0ff-6e9b7b37512d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_685d1611-9308-4a54-9b0d-e94b6ab3fa12" xlink:href="peak-20230331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_685d1611-9308-4a54-9b0d-e94b6ab3fa12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_c8490d32-f35b-4292-980d-c9f1cb84811b" xlink:href="peak-20230331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_c8490d32-f35b-4292-980d-c9f1cb84811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f3eb09cd-c1e2-484d-b1b6-cbcc8a2ab17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f3eb09cd-c1e2-484d-b1b6-cbcc8a2ab17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1a07e9ec-ea50-4c51-9487-b145016c875c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1a07e9ec-ea50-4c51-9487-b145016c875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_09c17742-b2e2-43cf-80ba-ac57b158bb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_91b9f5b1-09f2-491a-a5bf-abd7db1b1fca" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_09c17742-b2e2-43cf-80ba-ac57b158bb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d14826d4-f461-4ad7-b1d6-d8839a535a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d14826d4-f461-4ad7-b1d6-d8839a535a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18160e83-0906-4a4f-b1b4-1a7e788a8a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d14826d4-f461-4ad7-b1d6-d8839a535a8a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18160e83-0906-4a4f-b1b4-1a7e788a8a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_319d6877-3b0c-49db-803d-21b868edf933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d14826d4-f461-4ad7-b1d6-d8839a535a8a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_319d6877-3b0c-49db-803d-21b868edf933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cd66f19f-7621-438a-8dd3-176395b2424f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_d14826d4-f461-4ad7-b1d6-d8839a535a8a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cd66f19f-7621-438a-8dd3-176395b2424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_7eff470a-5f19-4d1e-8d3c-9c5eba854dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_7eff470a-5f19-4d1e-8d3c-9c5eba854dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5a2752ae-f193-458f-b746-d329f1152462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7eff470a-5f19-4d1e-8d3c-9c5eba854dc2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5a2752ae-f193-458f-b746-d329f1152462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a6a902a3-8991-4436-ba5d-94c9dc884864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7eff470a-5f19-4d1e-8d3c-9c5eba854dc2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a6a902a3-8991-4436-ba5d-94c9dc884864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8f3782d0-b851-451e-a05e-6256ab165590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_7eff470a-5f19-4d1e-8d3c-9c5eba854dc2" xlink:to="loc_us-gaap_EarningsPerShareBasic_8f3782d0-b851-451e-a05e-6256ab165590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_9403cfd2-3214-4100-96c9-42f525994837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_9403cfd2-3214-4100-96c9-42f525994837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_5ae9d785-78b0-4cd4-a395-adee672d346b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9403cfd2-3214-4100-96c9-42f525994837" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_5ae9d785-78b0-4cd4-a395-adee672d346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_920b283a-3d5a-4527-ba54-e7aaf625893f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9403cfd2-3214-4100-96c9-42f525994837" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_920b283a-3d5a-4527-ba54-e7aaf625893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_93f1729a-24f5-4bff-8849-07c7998b239b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9403cfd2-3214-4100-96c9-42f525994837" xlink:to="loc_us-gaap_EarningsPerShareDiluted_93f1729a-24f5-4bff-8849-07c7998b239b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_d9283fa0-1515-4cd3-b327-94e7e0d8d7b9" xlink:href="peak-20230331.xsd#peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b3a0f28-e473-4477-9011-02861f541f19" xlink:to="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_d9283fa0-1515-4cd3-b327-94e7e0d8d7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosuresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5dd90457-ebd3-47aa-b809-9b4e374ed9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_c1a515be-5e59-4e3d-a227-9bdfe9671fe3" xlink:href="peak-20230331.xsd#peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5dd90457-ebd3-47aa-b809-9b4e374ed9a0" xlink:to="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_c1a515be-5e59-4e3d-a227-9bdfe9671fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_30d7ad9f-e972-4112-877e-f2ad008dacd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_30d7ad9f-e972-4112-877e-f2ad008dacd7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3f1a4999-0563-4339-aa9d-02caf9475ed6" xlink:to="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_fec23688-8174-44af-a6f2-a03644100ac3" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_LifeScienceMember_fec23688-8174-44af-a6f2-a03644100ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_636295f9-ad13-404e-80fa-49187f1cbe7b" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_MedicalOfficeMember_636295f9-ad13-404e-80fa-49187f1cbe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_e74b0fc1-9e13-4e49-b5db-c53c206533f6" xlink:href="peak-20230331.xsd#peak_CCRCSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_CCRCSegmentMember_e74b0fc1-9e13-4e49-b5db-c53c206533f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_90170eb1-c06f-4da9-8a21-44a0ffb166d0" xlink:href="peak-20230331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6e685677-a123-4f0a-b5be-6e0525f4fd95" xlink:to="loc_peak_OtherNonReportingSegmentMember_90170eb1-c06f-4da9-8a21-44a0ffb166d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:to="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_1542b1df-52cf-4c8b-b16a-46595c69b041" xlink:to="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a139371-ffd7-430f-a6f4-21a16d34c559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a139371-ffd7-430f-a6f4-21a16d34c559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a19214dc-d8d0-4c45-8963-419e6c21d450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3121a11b-855f-40b0-90b9-e5bdd047a505" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a19214dc-d8d0-4c45-8963-419e6c21d450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_523c92fc-807d-416a-8ce9-acf85a3d094a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3b30c81c-0b3f-4f60-8e3d-790157871141" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4e36282e-6a38-4f5f-ba4a-573f9bb2cc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_Revenues_4e36282e-6a38-4f5f-ba4a-573f9bb2cc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_761cf15b-9216-479c-a20a-372643871dad" xlink:href="peak-20230331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_761cf15b-9216-479c-a20a-372643871dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_7e3707b5-3944-40ae-b988-9c3dc8fea775" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_7e3707b5-3944-40ae-b988-9c3dc8fea775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_bea2aeb8-6e3b-44c5-96d1-0dc06958f3d9" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_bea2aeb8-6e3b-44c5-96d1-0dc06958f3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_98e201b6-2528-4766-8093-b4ce8d770d48" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_98e201b6-2528-4766-8093-b4ce8d770d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_86b94449-7455-41e0-b424-26338d8a5794" xlink:href="peak-20230331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_86b94449-7455-41e0-b424-26338d8a5794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_66ea4ad9-5151-4ed0-bdd6-1f5d9c941d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_OperatingExpenses_66ea4ad9-5151-4ed0-bdd6-1f5d9c941d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_7ac65b2c-9a45-4ce2-b6ab-f078ebb0a622" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_7ac65b2c-9a45-4ce2-b6ab-f078ebb0a622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_dc1235d8-787e-4320-ae8f-54dde249aad2" xlink:href="peak-20230331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_dc1235d8-787e-4320-ae8f-54dde249aad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_99feae4e-d49d-406e-848d-670614a0c470" xlink:href="peak-20230331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_99feae4e-d49d-406e-848d-670614a0c470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_875a7c74-6f8e-47f7-b67d-457976f0585f" xlink:href="peak-20230331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_875a7c74-6f8e-47f7-b67d-457976f0585f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_68167b6e-af70-434f-a7ff-2472718df277" xlink:href="peak-20230331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_68167b6e-af70-434f-a7ff-2472718df277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_76f56682-5cfa-432c-80f6-4774effefffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_InterestIncomeOperating_76f56682-5cfa-432c-80f6-4774effefffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dbd5a8df-1baf-4fc3-94bc-a885e0d2a0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_InterestExpense_dbd5a8df-1baf-4fc3-94bc-a885e0d2a0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8041cf05-231d-40e0-9851-61618392c57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_DepreciationAndAmortization_8041cf05-231d-40e0-9851-61618392c57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b185a8b0-f011-4659-a8ce-d542e211534e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b185a8b0-f011-4659-a8ce-d542e211534e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bba32cf4-c267-46ad-95f1-c7d6d55c3759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bba32cf4-c267-46ad-95f1-c7d6d55c3759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_060304c6-9853-4fca-a8cd-01480f9b137b" xlink:href="peak-20230331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_060304c6-9853-4fca-a8cd-01480f9b137b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_731eacb9-a1cb-4fe0-aa19-25a7ade8e123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_731eacb9-a1cb-4fe0-aa19-25a7ade8e123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9e84c9fe-905e-495a-b93d-da4f34e32b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9e84c9fe-905e-495a-b93d-da4f34e32b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_0c94742e-0d8f-44cf-b687-373193972aca" xlink:href="peak-20230331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_0c94742e-0d8f-44cf-b687-373193972aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_7bc821e6-a5cc-4454-905b-dcfe624705a4" xlink:href="peak-20230331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_7bc821e6-a5cc-4454-905b-dcfe624705a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_8a4ff48c-9537-4415-ac87-34f10f552457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_8a4ff48c-9537-4415-ac87-34f10f552457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32dbcb07-4879-45f4-990c-8ddcaf63ae16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32dbcb07-4879-45f4-990c-8ddcaf63ae16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a2d4cd3-da6c-4ca1-b6ca-ab8a45a4a468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a2d4cd3-da6c-4ca1-b6ca-ab8a45a4a468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5002fec5-07f2-4986-b820-d8912c817d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5002fec5-07f2-4986-b820-d8912c817d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1d83ce5a-5fb0-43fc-8bd4-ec903b056422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1d83ce5a-5fb0-43fc-8bd4-ec903b056422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1656f8d4-1ff8-419a-a41d-aaa51b63ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1656f8d4-1ff8-419a-a41d-aaa51b63ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_794311ec-e377-4887-b5e1-7339c0497bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e5f5c0eb-5fa2-4c8b-81c1-7f55c9c6172c" xlink:to="loc_us-gaap_ProfitLoss_794311ec-e377-4887-b5e1-7339c0497bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_d6e6f3b0-2e6c-478e-b942-d38e059c756e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7c14d44f-306c-4458-9fd5-80739057c684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_d6e6f3b0-2e6c-478e-b942-d38e059c756e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7c14d44f-306c-4458-9fd5-80739057c684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_dc87c32c-4222-4928-985e-26d8be988729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7c14d44f-306c-4458-9fd5-80739057c684" xlink:to="loc_us-gaap_InterestPaidNet_dc87c32c-4222-4928-985e-26d8be988729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_658b4468-54df-42a8-92af-1ef2222885c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7c14d44f-306c-4458-9fd5-80739057c684" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_658b4468-54df-42a8-92af-1ef2222885c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_ec56b8f4-d0b9-4b6c-8227-cd5a5d436519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7c14d44f-306c-4458-9fd5-80739057c684" xlink:to="loc_us-gaap_InterestCostsCapitalized_ec56b8f4-d0b9-4b6c-8227-cd5a5d436519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_511458db-a141-49cd-bfaf-a68f2cc19385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_d6e6f3b0-2e6c-478e-b942-d38e059c756e" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_511458db-a141-49cd-bfaf-a68f2cc19385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_040954e1-e108-4cca-9b07-998ae6c880fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_511458db-a141-49cd-bfaf-a68f2cc19385" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_040954e1-e108-4cca-9b07-998ae6c880fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_0adb316c-969d-4173-b8f1-cf6f1e913246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_511458db-a141-49cd-bfaf-a68f2cc19385" xlink:to="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_0adb316c-969d-4173-b8f1-cf6f1e913246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2f65f2e6-e0e8-41c7-98c8-ec01376bd010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2f65f2e6-e0e8-41c7-98c8-ec01376bd010" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_27fcdd43-f69b-4d1f-bee6-8b02abbb37fc" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_1a9b8d19-5471-4153-b1e7-a36d196f09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_3b7ad394-f02c-4ac8-aa17-c8a180708329" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_1a9b8d19-5471-4153-b1e7-a36d196f09b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d5677f93-d3c7-4aaa-b873-994afbbadbbd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c8bfc544-c6a2-43a0-bbc3-bbfc687b712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c8bfc544-c6a2-43a0-bbc3-bbfc687b712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7a540366-ad97-49e1-9383-548c84f0972f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_7a540366-ad97-49e1-9383-548c84f0972f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a2acfa6b-6c1d-47d7-82af-6dc931b5f95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ddd327f9-fb27-405b-84fb-a3050a2c41b4" xlink:to="loc_us-gaap_DepreciationAndAmortization_a2acfa6b-6c1d-47d7-82af-6dc931b5f95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_5fe83cc0-691a-47a7-aeff-319cee2e2451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_ffab75af-30be-4c4a-87cc-35f7f912e856" xlink:href="peak-20230331.xsd#peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_5fe83cc0-691a-47a7-aeff-319cee2e2451" xlink:to="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_ffab75af-30be-4c4a-87cc-35f7f912e856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cc62485e-03d5-4c49-b0bc-9d12006e064f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_ffab75af-30be-4c4a-87cc-35f7f912e856" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cc62485e-03d5-4c49-b0bc-9d12006e064f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91d921d9-8247-4866-9458-eeb2d40d81a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cc62485e-03d5-4c49-b0bc-9d12006e064f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91d921d9-8247-4866-9458-eeb2d40d81a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_b49079dd-afa7-4261-9844-6dbd27555f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cc62485e-03d5-4c49-b0bc-9d12006e064f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_b49079dd-afa7-4261-9844-6dbd27555f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe01fe4-e80d-455e-b501-34bd1795b2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cc62485e-03d5-4c49-b0bc-9d12006e064f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbe01fe4-e80d-455e-b501-34bd1795b2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_2630f8b9-6611-4797-9629-092bc1d354e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashIncludingDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_ffab75af-30be-4c4a-87cc-35f7f912e856" xlink:to="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_2630f8b9-6611-4797-9629-092bc1d354e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_a2752b2f-8b95-4c10-83e6-e892f566863e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_2630f8b9-6611-4797-9629-092bc1d354e3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_a2752b2f-8b95-4c10-83e6-e892f566863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_7d9125be-6410-419a-be5f-b79e6750c838" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_2630f8b9-6611-4797-9629-092bc1d354e3" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_7d9125be-6410-419a-be5f-b79e6750c838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90f988a6-73f3-48af-9711-d2e6f47ee53f" xlink:href="peak-20230331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_2630f8b9-6611-4797-9629-092bc1d354e3" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_90f988a6-73f3-48af-9711-d2e6f47ee53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_bbd7a107-2b32-4a1d-a7cc-e5bf845f7e6d" xlink:href="peak-20230331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_5fe83cc0-691a-47a7-aeff-319cee2e2451" xlink:to="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_bbd7a107-2b32-4a1d-a7cc-e5bf845f7e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_629d3367-cca0-4b25-b042-2e6eca415317" xlink:href="peak-20230331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_5fe83cc0-691a-47a7-aeff-319cee2e2451" xlink:to="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_629d3367-cca0-4b25-b042-2e6eca415317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c3bfb322-5b14-4798-9e33-0a4d2f47c90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_5fe83cc0-691a-47a7-aeff-319cee2e2451" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c3bfb322-5b14-4798-9e33-0a4d2f47c90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="peak-20230331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_a54a161d-493a-48b6-ad77-c312d9fe073a" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_a54a161d-493a-48b6-ad77-c312d9fe073a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_43b818b7-ecb2-47e4-aeb2-c3a2ad4c4522" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_6c3a8d98-2d7f-4989-bb9e-0d9a4010644d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_6c3a8d98-2d7f-4989-bb9e-0d9a4010644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember_a1021a0f-bd62-4ea2-ba7d-6c4611e18cad" xlink:href="peak-20230331.xsd#peak_VenturesVLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_VenturesVLLCMember_a1021a0f-bd62-4ea2-ba7d-6c4611e18cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_7f11b325-3e1d-4353-b156-889779c87993" xlink:href="peak-20230331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_LifeScienceJVsMember_7f11b325-3e1d-4353-b156-889779c87993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember_4187f455-ef99-4405-8928-bf6c2951398a" xlink:href="peak-20230331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_MorganStanleyRealEstateInvestmentJVMember_4187f455-ef99-4405-8928-bf6c2951398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember_3f048391-67ba-4bf2-bc1d-d45f40ecda37" xlink:href="peak-20230331.xsd#peak_DownreitPartnershipsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e79bb972-fe2a-45b8-be27-78d45fd756c6" xlink:to="loc_peak_DownreitPartnershipsMember_3f048391-67ba-4bf2-bc1d-d45f40ecda37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa704daf-a11e-4908-bd1e-9a8bdb21dca7" xlink:to="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_1dcab29d-6a34-4da4-b159-0a76a7c2ae30" xlink:href="peak-20230331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cab8b9c7-4b3a-4fdf-a035-d997c00b2578" xlink:to="loc_peak_LifeScienceMember_1dcab29d-6a34-4da4-b159-0a76a7c2ae30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3360208f-40da-4296-b87a-41444b6110ab" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_395712cf-7d11-4a3b-8491-7184fef066ad" xlink:href="peak-20230331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d1d0fabc-2c58-4514-97ed-65ebc863a9cf" xlink:to="loc_peak_NeedhamLandParcelJVMember_395712cf-7d11-4a3b-8491-7184fef066ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3df2ac8e-8cd7-479a-8328-47e4abb03111" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6d54dcc0-fbf5-4389-a6d4-8393ed2c258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_72e51d8b-dae9-4663-979b-c53349ef5e64" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6d54dcc0-fbf5-4389-a6d4-8393ed2c258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4d77f317-2c95-426b-bece-235354dd4f55" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_15bb69c1-6075-46ac-80b0-f3a23c1c7165" xlink:href="peak-20230331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_15bb69c1-6075-46ac-80b0-f3a23c1c7165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_e4c8cdd6-3573-4832-9adf-37db6b1ff448" xlink:href="peak-20230331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_e4c8cdd6-3573-4832-9adf-37db6b1ff448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_af411d0b-1349-4700-ba2b-b3028f6a3bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_DebtSecurities_af411d0b-1349-4700-ba2b-b3028f6a3bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfHospitals_d9691573-e287-4265-a29c-741ff9adc068" xlink:href="peak-20230331.xsd#peak_NumberOfHospitals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_NumberOfHospitals_d9691573-e287-4265-a29c-741ff9adc068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cddd8e65-fd80-4e57-baad-11f943fc4c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cddd8e65-fd80-4e57-baad-11f943fc4c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_3e13c093-fead-4390-9fe2-10bf97904f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_3e13c093-fead-4390-9fe2-10bf97904f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_9d5bd5e7-4903-4a16-99e8-df2cbfa4453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_9d5bd5e7-4903-4a16-99e8-df2cbfa4453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_e3b51937-caea-4ce5-9908-93b7972a14bc" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_5d49ac90-d507-4722-9fd1-76aeea57fab4" xlink:to="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_e3b51937-caea-4ce5-9908-93b7972a14bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_83e8a770-0a22-4f00-8614-5a01e4e3cb52" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_83e8a770-0a22-4f00-8614-5a01e4e3cb52" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:to="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_b552c58b-afd8-4c85-847f-2b4ce86c89fa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_28cb3cc7-fc87-4a9b-b982-d0f13d5e04cb" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_28cb3cc7-fc87-4a9b-b982-d0f13d5e04cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_79b118b3-84da-413c-8466-30191c5ea84d" xlink:href="peak-20230331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a7a6c816-168f-439b-a66b-b7b195e2e3f4" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_79b118b3-84da-413c-8466-30191c5ea84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_74f3e352-342a-4b15-829f-fdfe92ecd7f9" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bc25cfa2-86ed-4eea-8a6c-1430a2e53765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_54cdfb9d-8873-48fb-bd73-cd1c9c82e1cc" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bc25cfa2-86ed-4eea-8a6c-1430a2e53765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_d6a3efc5-6c33-4357-8e32-216d78bbb9cb" xlink:href="peak-20230331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_d6a3efc5-6c33-4357-8e32-216d78bbb9cb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_883ec886-7f94-4934-aa79-667acd6300cb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99af4271-555a-40b0-ad48-e05e5a0bc9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8b7b596d-32b4-4d68-9a41-e7f53e424305" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_99af4271-555a-40b0-ad48-e05e5a0bc9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_39535739-2b07-4870-9368-0754b341903f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_7c93aa89-6e08-4664-9fc2-509d7c54383d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e2969125-4b57-4b6a-a9bb-2febc4e9b4a6" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_7c93aa89-6e08-4664-9fc2-509d7c54383d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_feb3edf7-c0df-4ea7-822e-cd9932648ce3" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:to="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_775853f5-8e48-4054-80c1-f90e0e41cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_775853f5-8e48-4054-80c1-f90e0e41cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_2e96f041-5efc-429a-bedc-f5e53ce0d016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_DevelopmentInProcess_2e96f041-5efc-429a-bedc-f5e53ce0d016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d1195f0c-d959-4e8c-9cdc-3826dc08fbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_Land_d1195f0c-d959-4e8c-9cdc-3826dc08fbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_dc2c82d7-8a84-46e8-84ac-4d738d86a4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_dc2c82d7-8a84-46e8-84ac-4d738d86a4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_091c4f69-a5e3-4bb8-800b-b73d7ba82974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_091c4f69-a5e3-4bb8-800b-b73d7ba82974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_6d6d7936-40c3-45b0-b10f-24395aa86556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_AccountsReceivableNet_6d6d7936-40c3-45b0-b10f-24395aa86556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514fbcc4-aa3a-4568-a98e-12aed9ecd2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514fbcc4-aa3a-4568-a98e-12aed9ecd2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c69a5820-3cb6-47e2-aa79-a7df20df10de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c69a5820-3cb6-47e2-aa79-a7df20df10de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa8574b-6f5b-46e8-a273-c01f263469b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa8574b-6f5b-46e8-a273-c01f263469b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1dfaa69a-7088-469a-8a42-c1a92dcc7361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_1dfaa69a-7088-469a-8a42-c1a92dcc7361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_aafd1f72-8135-40bf-9047-4c8e1b5de9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_aafd1f72-8135-40bf-9047-4c8e1b5de9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_21a74da4-1d1c-4bac-9e18-cd62afc10a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_OtherAssets_21a74da4-1d1c-4bac-9e18-cd62afc10a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1b189ca2-3fb3-492f-a25b-2f9068201a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b83b311e-897f-46e7-b2c4-6f665c79fdda" xlink:to="loc_us-gaap_Assets_1b189ca2-3fb3-492f-a25b-2f9068201a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_1f6497b4-9c4b-4f72-a5fe-2f3c54b29155" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_759737e8-1d7b-4721-805f-5aac7d5331cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_SecuredDebt_759737e8-1d7b-4721-805f-5aac7d5331cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_29cf0167-75fa-4800-a5aa-1bbf1bdb05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_29cf0167-75fa-4800-a5aa-1bbf1bdb05f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1593e78e-4718-405f-9896-01f3aa5f5c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1593e78e-4718-405f-9896-01f3aa5f5c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_10886ed1-f931-4f4a-89c9-6b503569c7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_OperatingLeaseLiability_10886ed1-f931-4f4a-89c9-6b503569c7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c06175e5-8336-48a4-b68f-3662fae94725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c06175e5-8336-48a4-b68f-3662fae94725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d6c58345-8541-487d-b391-6cf26708a011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d6c58345-8541-487d-b391-6cf26708a011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_549b4cf9-9043-474b-8a3e-22a4a37a5396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a413b00f-51c3-4a0c-b46b-ead191959113" xlink:to="loc_us-gaap_Liabilities_549b4cf9-9043-474b-8a3e-22a4a37a5396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ceccf283-9e31-4e76-b993-210643fcdc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ceccf283-9e31-4e76-b993-210643fcdc48" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d1cada19-fcc1-45bc-923e-851a334c14eb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5ceaba36-d666-48ab-842a-6faf5a00d06e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1697d81c-d8a6-4319-a11d-b1075cbe9786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1697d81c-d8a6-4319-a11d-b1075cbe9786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_51a63ca7-f7ca-4044-9dfa-215e8e50ac8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_004f1cd1-942b-4104-b0f1-d25f617f27dd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_51a63ca7-f7ca-4044-9dfa-215e8e50ac8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_18c386dd-a542-4fac-a7c9-a3478893f282" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_03539645-a0e7-45fc-9efc-a1ff051d1889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_03539645-a0e7-45fc-9efc-a1ff051d1889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ef2bd4d7-fd58-4658-b983-af9d2d081d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2500879f-9505-4009-8e55-bb35d04d45c5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ef2bd4d7-fd58-4658-b983-af9d2d081d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2cbcacf6-8e13-4f0e-9f66-c112950a0b6c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17668246-e26d-4d85-902a-adbb72f7ed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9c023df7-de35-418d-b5ba-f754886da897" xlink:to="loc_us-gaap_InterestRateSwapMember_17668246-e26d-4d85-902a-adbb72f7ed2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_965c9b51-ec8e-4633-b356-0a83edfee0be" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure_77a463e4-05eb-4efc-8cdf-d48ffb274555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LoansReceivableFairValueDisclosure_77a463e4-05eb-4efc-8cdf-d48ffb274555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_27970cb1-09c2-4aad-aa2c-118e0b6c11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_27970cb1-09c2-4aad-aa2c-118e0b6c11ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_e570be32-0cab-4c92-9ec6-7ead65ac06d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_DerivativeAssets_e570be32-0cab-4c92-9ec6-7ead65ac06d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_4043cb43-22b9-49e9-a149-589ba2b4e711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LineOfCredit_4043cb43-22b9-49e9-a149-589ba2b4e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank_c3c5fb6e-f5b8-4854-adb9-5403446a6a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_LongTermLoansFromBank_c3c5fb6e-f5b8-4854-adb9-5403446a6a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_a5e6f41f-0004-4de2-b55c-1e8fe3ea59f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_UnsecuredDebt_a5e6f41f-0004-4de2-b55c-1e8fe3ea59f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_04bdaf9c-b6db-454e-b6de-0843aab0c484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_84c69f0b-3280-4b76-8964-725ef0e71973" xlink:to="loc_us-gaap_SecuredDebt_04bdaf9c-b6db-454e-b6de-0843aab0c484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c3692b9-00e8-4b84-8c3a-94d3b0f2c5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c3692b9-00e8-4b84-8c3a-94d3b0f2c5ca" xlink:to="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_32229425-818a-4385-8800-dca4b084b4ab" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c4f1cbb4-a9cd-4804-bacb-49e4e1cda498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:to="loc_us-gaap_InterestRateCapMember_c4f1cbb4-a9cd-4804-bacb-49e4e1cda498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_14afe9e1-4616-414c-9550-e91f68a44c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a89d3005-11e4-49b1-a1ad-949de272f9bc" xlink:to="loc_us-gaap_InterestRateSwapMember_14afe9e1-4616-414c-9550-e91f68a44c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_cc5b893a-34bc-4761-b2d2-61191584dd04" xlink:to="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_06c473cc-4f29-4dbe-a798-2b2ea69508cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:to="loc_us-gaap_NondesignatedMember_06c473cc-4f29-4dbe-a798-2b2ea69508cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_21141439-8f36-4342-b4dc-0ca4bd05bac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_08062e07-7db7-45a7-bea2-44e601f798a6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_21141439-8f36-4342-b4dc-0ca4bd05bac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aae317df-b3a0-448e-9ebc-273ee8438ca9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9b2dfd43-0706-496e-abb2-fc0e14db999b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ed9164a1-73a5-4735-84be-0f83864f1807" xlink:to="loc_us-gaap_CashFlowHedgingMember_9b2dfd43-0706-496e-abb2-fc0e14db999b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f237bff-fda3-42d2-9f1b-56e05602bebc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_7d80a51f-5043-40ff-ab6f-de8e6c9c795b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3400ee2-2d11-42ec-b9b1-104691021493" xlink:to="loc_us-gaap_SecuredDebtMember_7d80a51f-5043-40ff-ab6f-de8e6c9c795b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_56437b27-c328-434c-ae4b-afc4d50c5f4e" xlink:to="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_ebb21f50-ad69-4c61-9196-529df2d600b8" xlink:href="peak-20230331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6cb7cc2b-7c7e-49bd-a61b-5eb61a6bdd16" xlink:to="loc_peak_MedicalOfficeMember_ebb21f50-ad69-4c61-9196-529df2d600b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b4e4911-e3e8-42e0-a316-b46ffa3c6ad8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredOvernightFinancingRateSOFRMember_2ea1acf6-c653-42a6-8300-4187496d0b4d" xlink:href="peak-20230331.xsd#peak_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_37c06c40-80f2-41bf-80be-a9f065165087" xlink:to="loc_peak_SecuredOvernightFinancingRateSOFRMember_2ea1acf6-c653-42a6-8300-4187496d0b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_06ee9880-5f0b-4469-8003-a507f81544d4" xlink:to="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_82992ee7-209d-4bc0-8a4c-2e7c75378736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions_82992ee7-209d-4bc0-8a4c-2e7c75378736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_7eb8b63b-722f-4811-8751-59612522d172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_7eb8b63b-722f-4811-8751-59612522d172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated_512bd1b7-8f24-4585-82a1-24c143e1bf53" xlink:href="peak-20230331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_peak_DerivativeNotionalAmountTerminated_512bd1b7-8f24-4585-82a1-24c143e1bf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_ccfedffd-36c4-4ec0-8d30-40406f69880f" xlink:href="peak-20230331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_peak_NumberOfPropertiesAcquired_ccfedffd-36c4-4ec0-8d30-40406f69880f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6e2b2c0e-e9a8-4b8f-aa87-fe0822584c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6e2b2c0e-e9a8-4b8f-aa87-fe0822584c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_fcda6d2f-82e4-429a-8c9a-2470582152e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_be2d4d2b-55fc-4896-900e-e2e53057fe39" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_fcda6d2f-82e4-429a-8c9a-2470582152e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_334186f5-b571-4cf6-bd96-7e36c996f982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_334186f5-b571-4cf6-bd96-7e36c996f982" xlink:to="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16b97f8a-500b-4819-ba22-e9f0c7430ee8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0a477d73-b56a-47f5-9a53-b0adf71ff9e3" xlink:to="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap499PayRateMember_ae792b2d-3b52-4193-9b35-0106882f8740" xlink:href="peak-20230331.xsd#peak_InterestRateSwap499PayRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap499PayRateMember_ae792b2d-3b52-4193-9b35-0106882f8740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap454PayRateMember_c18b8921-90bd-4ef3-b572-5948fa369faf" xlink:href="peak-20230331.xsd#peak_InterestRateSwap454PayRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap454PayRateMember_c18b8921-90bd-4ef3-b572-5948fa369faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap260PayRateMember_efc6e7d3-83ca-46a9-bc74-e4da5b54302d" xlink:href="peak-20230331.xsd#peak_InterestRateSwap260PayRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap260PayRateMember_efc6e7d3-83ca-46a9-bc74-e4da5b54302d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap254PayRateMember_81dc40ab-d5c1-455f-bc13-e6205464ee71" xlink:href="peak-20230331.xsd#peak_InterestRateSwap254PayRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap254PayRateMember_81dc40ab-d5c1-455f-bc13-e6205464ee71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap508PayRateMember_d232834e-360c-443f-8ab4-0fe656b431c3" xlink:href="peak-20230331.xsd#peak_InterestRateSwap508PayRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap508PayRateMember_d232834e-360c-443f-8ab4-0fe656b431c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestRateSwap463PayRateMember_b94e3faa-42a3-47c9-a653-1386c411eaf4" xlink:href="peak-20230331.xsd#peak_InterestRateSwap463PayRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_4e5d77a0-63f5-48c4-a8e4-64935867e334" xlink:to="loc_peak_InterestRateSwap463PayRateMember_b94e3faa-42a3-47c9-a653-1386c411eaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_10cd9cc5-cbf8-4bde-a244-6c7c3efd9f9b" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdd4fcc9-bb75-4430-a0d4-9a9f67949dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0e55b081-2351-4eba-8773-d3f27c7ccba9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fdd4fcc9-bb75-4430-a0d4-9a9f67949dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d4b0550c-39ee-466e-9f08-aada32b70d58" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_406a9f6a-6a39-4064-9157-a7945dda5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f8758d7a-0b08-433d-bf3a-2aa223bd0a75" xlink:to="loc_us-gaap_CashFlowHedgingMember_406a9f6a-6a39-4064-9157-a7945dda5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_45b6e40c-704a-46b9-af46-248ec7644007" xlink:to="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_a8681d37-0e79-48b8-8cd7-689f4913bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_a8681d37-0e79-48b8-8cd7-689f4913bb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_aa2ecfb0-8213-4320-bd78-9a8048d6f6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_aa2ecfb0-8213-4320-bd78-9a8048d6f6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_ddf910f2-9460-46e7-b441-39b2fac1c24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_ddf910f2-9460-46e7-b441-39b2fac1c24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_c60deaad-a539-47e3-9457-b353d21c1993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_de842626-0333-4bed-9c23-45f0ed9f3022" xlink:to="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_c60deaad-a539-47e3-9457-b353d21c1993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_4ddb4b43-d1ca-4ec2-bfac-149c1d01fd7b" xlink:href="peak-20230331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_4ddb4b43-d1ca-4ec2-bfac-149c1d01fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_5862b5c2-9ccd-4221-ae44-74851ab0646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_5862b5c2-9ccd-4221-ae44-74851ab0646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_4f865a81-739b-4fec-b455-9c2dc0f7fc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_4f865a81-739b-4fec-b455-9c2dc0f7fc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_876d3100-a0e0-4b2c-a7a3-579326ee6514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_876d3100-a0e0-4b2c-a7a3-579326ee6514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1dfebeb9-7810-498d-b698-c6c0559e9a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1dfebeb9-7810-498d-b698-c6c0559e9a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_27cfdafa-1f30-47fb-87c4-bbeef382c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_9c39bca5-dc60-4069-83a8-79621b8d4a89" xlink:to="loc_us-gaap_SeveranceCosts1_27cfdafa-1f30-47fb-87c4-bbeef382c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails" xlink:type="simple" xlink:href="peak-20230331.xsd#DeferredRevenueScheduleofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonrefundableEntranceFees_7f154741-276f-46e2-99df-015d40908f31" xlink:href="peak-20230331.xsd#peak_NonrefundableEntranceFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_peak_NonrefundableEntranceFees_7f154741-276f-46e2-99df-015d40908f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherDeferredRevenue_5e41a8ba-ac1b-4f40-b89c-1a66984bdd82" xlink:href="peak-20230331.xsd#peak_OtherDeferredRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_peak_OtherDeferredRevenue_5e41a8ba-ac1b-4f40-b89c-1a66984bdd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_baf563d7-cbf7-401f-a4d7-efbbbf31b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_us-gaap_ContractWithCustomerLiability_baf563d7-cbf7-401f-a4d7-efbbbf31b82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_9a31a751-efb9-4733-9973-6e5ea5a180b4" xlink:href="peak-20230331.xsd#peak_ProceedsFromCollectionOfNonrefundableEntranceFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_9a31a751-efb9-4733-9973-6e5ea5a180b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFee_8ad731e0-b875-46a3-80d0-b8f239d48afa" xlink:href="peak-20230331.xsd#peak_AmortizationOfNonrefundableEntranceFee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFee_8ad731e0-b875-46a3-80d0-b8f239d48afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_86f0ee90-3ae3-42d2-bb85-eb1d38bd00b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ecdabf52-d40a-4485-b445-509d5a4488bb" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_86f0ee90-3ae3-42d2-bb85-eb1d38bd00b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" /C#@8# 2(  A$! Q$!_\0
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MV13PKXFU"91_PEMI$H_=.QY-]&@);.3,JE^6#T ?L911G/2B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$XCAM+:)"\DKL> JJ"2:_DR_X. /^"Y_CC_@JE\97^&/PHU*^TGX(>$=0?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4[R^S^>.I+JZNKZZDO;VYDFFFD9YII7+,[$Y+$GDDGDD]:CH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM)?M$>,IM;\4>(KKS;J=V;RK>,<1V\"$GRH8UPJ1@X4#N<D]7_P4*_X*!?M
M_P#!2C]I36/VD_V@_$+SWEXWDZ+HL,C?8]$L5)\JTMT/"HN<DXR[EG;)8UX=
M0 4444 %%%% !1110 445W7[-_[-'QV_:Z^,&D? ;]G'X::EXK\5:Y<+%8Z7
MIL6< D RRNQ"0Q+G+RR,J(.68#F@#B;.SO-1O(M/T^TDGN)Y%C@@AC+/(['
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M\$IOBL/!/QX\,_VAX<U"1CX8\>Z/ [:9JT8/W0Y'[F8#EH7(<9R-RD,?EF@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445R7QU^.GPH_9I^$>O_'3XX^-['PYX5\,Z>][K&KZC,$CAC7H!W=V
M;"HBY9W954%B 0#GOVQ/VO?@7^PM^SWX@_:7_:)\81Z/X;\/VN^1OO37DYXB
MM8(^LDTC?*JCZDA0Q'\>?_!67_@JA\<_^"KG[3-W\:?B?<-I_A[33):>!O",
M,I-OHUAO)48R0\[C:99?XF  PJJH[[_@M_\ \%G/BK_P5K_:%?4;8WNA?"SP
MO<S0> _"+738,><&_NE'RM<R@ ]"(E(C4G#._P /T %%%% !1110 4444 %%
M !)P!7ZW?\$0O^#87XN_MSG1_P!I7]M.RU7P/\(9T6ZTO2=K6^L>)X\Y0QJR
MYMK5QSYQ&YU(\L882  ^0_\ @E=_P1Q_:W_X*O\ Q/\ ^$;^#'AUM'\'Z;.@
M\4?$+6+9UTW34)&40X_TBX(Y6!#N[L47+#^K+_@F=_P2A_9*_P""5_PC/PW_
M &=_"/G:M?K&WB;QIJT:R:GK,JCK)(!\D8).V%,(N3P22Q]L^"?P,^$7[.'P
MRTGX-_ KX>:3X6\+Z':K;Z9H^CV:PPQ(!C)"CYG;JSMEG8EF)))KK* # /44
M444 %%%% !1110 4444 <7^T!^SU\%?VI?A/K'P/_:"^&NE>*_"NN6K0ZAI&
MKVBRQMQPZ9YCE4X9)$(=& 92" :_F3_X+=_\&RWQH_8"FU;]H[]DFWU/QU\'
M8V\^^M=AFU;PPA/(G5!F>V7M.HRHQY@&"[?U05'<VL-W#);74221R(4DCD4,
MK*1@@@]010!_ /17]('_  7 _P"#5'PA\;_[8_:F_P"":6AV?A_QG-,]WKWP
MQ5U@TW6&.6>2Q9B$M)R>?)XA<L<&(CYOYU/''@;QG\,_%VH^ /B'X5U#0]<T
MB[>UU32=5M'@N+69#AHY(W 96!'0B@#*HHHH **** "BBB@#JO@?\;OBI^S?
M\6=!^./P2\;7WAWQ1X9U&.]T?5M.G,<D,BGH<?>1AE70Y5T9E8%20?Z[/^"'
M?_!:'X6?\%:OV?5N=0EL=#^+'A>UBB\>>$8[@#<WW1?VJL=S6TA&>YB8^6Q/
MRL_\=->F?L@_M=?'7]AK]H'P_P#M*_L[>,IM&\2>'KL21LI)AO(2?WMK<1])
M8)%RK(>QR"&"L #^[#/O17RO_P $E/\ @JI\"_\ @J_^S/:_&7X97"Z=XDTM
M8;7QUX/GF4W&C7Y3)P 26MY"',4O&]000K*RK]44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVH/AO:Z]HMY&QL[G:$O-,N",+<VLV-T,J]B.#C#!E)4_RS_\%F_^#?3]IO\
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M003Z50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FFM(B#+.
M!]30 ZBH_M5L/^7B/_OH4Y9$895P?H: '449'K10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!)% !FO
MYTO^#FW_ (.#6^*=]K?_  3B_8C\:$>&;29K3XF>.-)O/^0O*C$/I=LZ?\NZ
M,,2R!OWIS&/D#&3U_P#X.<O^#@I_A%:ZW_P3@_8G\9/'XKN(FL_BAXTT]QG1
MXR2LFE6S]KEAQ-(!^Z5MBGS"QC_G1)+'<QH **** "BBB@ HHJQI6E:IKNJ6
M^B:'IMQ>7EY.L-I9VL+22SR,=JHBJ"68D@  $DGB@"O7Z+?\$8/^#=[]I3_@
MJ-K-E\6/B!'?> ?@Q'*6N/%]U:D7.M!6VM#IL;C$ASE3.W[I"&^^PV5]M?\
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M^$O[6'[%O[8G_!-[XU0_#_\ :,^&NN>!_$EE/]IT75(Y"(;KRW^6YL[N([9
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M)Q7\ =?3W_!%C_E+'^S[_P!E2TO_ -'"@#^UZB@<#%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 $XHKE?CL ?@CXRS_T*NH?^
MDTE?P6T ?W^45_ '10!_?Y17\ =% ']_E (/2OX"=._Y"$'_ %V7^=?WI_!\
M?\6F\+G_ *EVQ_\ 1"4 ='1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 &><45_*O_P 'B0Q_
MP5[C'_5*M%_]&WE?E70!_?Y17\ =% ']_E%?P!U['_P3O_Y/Z^"?_95_#_\
MZ<8* /[F00>E% &.:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** #.* <C-?'?_!P%_RAH_:#
M_P"Q#?\ ]*(:_C'H _O\HK^ .B@#^_RBOX Z* /[_ 0>AHK\<_\ @RG_ .4;
MWQ&_[+1=?^FK3:_8R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH * V3BBOSW_X.DAC_ ((B_%[_ *^-"_\ 3S9T ?H117\
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M#^U7_P G0_$C_L?M8_\ 2V:N1L_"7BO4;9;W3_#&H3PR<QS0V4C*W.."!@T
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M9)%#8&Y0IP,XHH _BA_:0_Y.(\>_]CIJG_I7+7%UVG[2'_)Q'CW_ +'35/\
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M91AE60Y5E)5@02*_=[_@E-_P>&:?>1Z7\%O^"I.@_9IO,6WA^+/AS3R8BI(
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M_P"2(^,O^Q5U#_TFDK^"VO[TOCK_ ,D1\9?]BKJ'_I-)7\%M !1110 4444
M3:=_R$(/^NR_SK^]3X/_ /))?"__ &+MC_Z(2OX*]._Y"$'_ %V7^=?WJ?!_
M_DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&_\ Z40U_&/0 4444 %%%% '].'_  93?\HWOB-_V6BZ_P#35IU?L97XY_\
M!E-_RC>^(W_9:+K_ --6G5^QE !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX+3?$Z"ZN_,AT&QT?2;--V1%''I\+%1R<?O))&/NQXK]E?\ @SK^$^F>!/\
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M_P!*Y:XNNT_:0_Y.(\>_]CIJG_I7+7%T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5]$?\$X_^"8'[6'_  5!^,T?PD_9
MK\$M):VQ63Q%XKU%6CTS1(,_ZR>7'+'^&)<R.>@P&(^J/^")_P#P;A?M!_\
M!3+4-,^.?QK^W> ?@JMT&?6Y;<+J'B)5(+16$;]$;[INF!C7G8)&4J/ZAOV5
M_P!DW]G_ /8K^#&E? +]FKX;6'A?PSI,>(;.S0EYY#]Z::1LO-*QY9W)8_0
M  ^?O^"3'_!$_P#9,_X).?#Q(/AKHZ^(OB#J5A'%XJ^(VK6J_;+QL9>*W7G[
M);%N1$A)("[VD*AJ^QZ.G044 %%%% !1110 45#?ZA8:58RZGJE]#;6T$9DG
MN+B0)'&H&2S,>  .YK\BO^"K7_!V9^RY^RBNL?!S]AZULOBQ\0+=FMI->68_
M\([I4P.&8S)S?LO]V$B,G_EKP5(!^H/[1/[3?P"_9+^&&H?&7]H_XL:+X/\
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M0!_)%_P6H_X-U?VCO^"7VJWWQD^&27GCWX+37S?9?$UK;[KS058DI#J,2?=
M'RBY4>4Q W>6SJA_."O[\M;T72?$>E7&@:_I-M?6-Y"T-Y9WD"RPSQL,,CHP
M*LI'!!!!%?@/_P %P?\ @U%:%=6_:G_X);>%V956:\\1?!^#+-W=GTGN>_\
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M2TO_ -'"@#^UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Y7XZ_\D1\9?\ 8JZA_P"DTE?P6U_>E\=?^2(^,O\ L5=0_P#2
M:2OX+: "BBB@ HHHH FT[_D(0?\ 79?YU_>I\'_^22^%_P#L7;'_ -$)7\%>
MG?\ (0@_Z[+_ #K^]3X/_P#))?"__8NV/_HA* .BHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB-_V6BZ_]-6G5^QE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGPK_ .%U9_\ Q5?UI44 ?R6_\0F7_!9__HC/A7_PNK/_ .*H_P"(3+_@L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_*O_ ,'B?_*7M/\
MLE6B_P#HV\K\JZ_53_@\3_Y2]I_V2K1?_1MY7Y5T %%%% !7L?\ P3O_ .3^
MO@G_ -E7\/\ _IQ@KQRO8_\ @G?_ ,G]?!/_ +*OX?\ _3C!0!_<S1110 44
M44 %%%% !1110 4444 ?SP_\'Q?_ "53]G;_ +%_Q)_Z/T^OPAK]WO\ @^+_
M .2J?L[?]B_XD_\ 1^GU^$- !1110 4444 ?W??LI_\ )KOPV_[$'1__ $BA
MKOJX']E/_DUWX;?]B#H__I%#7?4 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'QW_P ' 7_*&C]H/_L0W_\ 2B&OXQZ_LX_X. O^4-'[0?\ V(;_ /I1
M#7\8] !1110 4444 ?TX?\&4W_*-[XC?]EHNO_35IU?L97XY_P#!E-_RC>^(
MW_9:+K_TU:=7[&4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/!WQG^&FO_"/XAZ/'J&@^)M'N-,UBQD'$UM/&T<B_P#?+'GL>:_BN_X*G_\
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M1?\ !(K_ ()P_$#_ (*@?MK^&?V=?#-C<1^'X[A=0\>:Y$I":7H\;KYS[O\
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MO]ZXDM6?R%_VI JYXSGBODDY'!%?W\RP1SQM%-&KJZX967(([@^M?#7[?/\
MP;L?\$Q?V^K>YUSQ)\%H? OBZ8LR^,OAZJ:?<NYR<SPA3;W )/)>,OV#K0!_
M'717ZT?M[_\ !H=^W]^S?<W7BS]E/5].^,WA9%+I;:>!8ZY !DD/:2-Y<PZ
M&*5F8Y_=KQG\L?B)\-OB'\(?&>H?#GXK>!=8\->(-*G,.IZ)KVFRVEW:R#JL
MD4JJR'V(% &+1110 4444 %%%% !1110 4444 :7A'QAXL\ >);/QEX%\3:A
MHVKZ=.)M/U32[Q[>XMI!T=)$(93[@BOVH_X)2?\ !WW\6_A-)I'P6_X*7:/=
M>-/#,:+:P_$C1;5/[9LE VHUU"-J7BCC=(NV;&6/G/PWXBT4 ?W=?LS?M5?L
M\?MC?"FR^-?[,WQ;T?QAX;OOE74-'N@_DR  M#,G#PRKD;HW"L,\BO0LU_"[
M^Q]^W/\ M6?L%_$^W^+?[*GQFU;PGJD<J-=0VLN^SU!5/^JN;9\Q7"=1AU.,
MG&#S7]#G_!*O_@[=_9D_:<6U^$_[>]EI_P )_&C%([?Q,LS?\([J3' RTCDM
M8OGG$I,>.?-'W: /V&HJOIFJZ=K6G6^KZ-?PW=G=0K-:W5M,)(YHV&5=67(9
M2"""#@BK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7R%_P7R_Y0W_M"_\ 9/;C_P!&QU]>U\A?\%\O^4-_
M[0O_ &3VX_\ 1L= '\8%%%% !1110 5]/?\ !%C_ )2Q_L^_]E2TO_T<*^8:
M^GO^"+'_ "EC_9]_[*EI?_HX4 ?VO4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% '*_'7_DB/C+_L5=0_])I*_@MK^]+XZ_\
M)$?&7_8JZA_Z325_!;0 4444 %%%% $VG?\ (0@_Z[+_ #K^]3X/_P#))?"_
M_8NV/_HA*_@KT[_D(0?]=E_G7]ZGP?\ ^22^%_\ L7;'_P!$)0!T5%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_V6BZ_]-6G5^QE?CG_P93?\HWOB-_V6BZ_]-6G5^QE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%W_1ZLW_ (;3Q)_\KJ /T%HK\^O^(I?_ ((7?]'JS?\ AM/$G_RNH_XBE_\
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M .5U 'Z"T5^?7_$4O_P0N_Z/5F_\-IXD_P#E=1_Q%+_\$+O^CU9O_#:>)/\
MY74 ?H+17Y]?\12__!"[_H]6;_PVGB3_ .5U'_$4O_P0N_Z/5F_\-IXD_P#E
M=0!^@M%?GU_Q%+_\$+O^CU9O_#:>)/\ Y74?\12__!"[_H]6;_PVGB3_ .5U
M 'Z"T5^?7_$4O_P0N_Z/5F_\-IXD_P#E=1_Q%+_\$+O^CU9O_#:>)/\ Y74
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Y5
M_P#@\3_Y2]I_V2K1?_1MY7Y5U^JG_!XG_P I>T_[)5HO_HV\K\JZ "BBB@ K
MV/\ X)W_ /)_7P3_ .RK^'__ $XP5XY7L?\ P3O_ .3^O@G_ -E7\/\ _IQ@
MH _N9HHHH **** "BBB@ HHHH **** /YX?^#XO_ )*I^SM_V+_B3_T?I]?A
M#7[O?\'Q?_)5/V=O^Q?\2?\ H_3Z_"&@ HHHH **** /[OOV4_\ DUWX;?\
M8@Z/_P"D4-=]7 _LI_\ )KOPV_[$'1__ $BAKOJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#X[_P"#@+_E#1^T'_V(;_\ I1#7\8]?V<?\' 7_ "AH
M_:#_ .Q#?_THAK^,>@ HHHH **** /Z</^#*;_E&]\1O^RT77_IJTZOV,K\<
M_P#@RF_Y1O?$;_LM%U_Z:M.K]C* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBB@#^%']MC_D\SXN?]E.U_\ ].,]>8UZ=^VQ_P GF?%S_LIVO_\ IQGKS&@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _LA_X-R_\ E"[\"?\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E7_X/$_\ E+VG_9*M%_\
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M/8P2LDBM_LE0?:O>HY8YHUEBD5E9<JRG(8>HH =1110 4444 %%%% !1110
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MT)?QPEOJN1Z&OJWPOXL\,>-M'A\1^#?$NGZOIUPN;>_TN\2XAD'JKQDJ?P-
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MP7KEQX8\8>'K[2M2LY-EUI^I6KP30M_=9' 93[$5_?;M%> ?MI_\$N?V$/\
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M 4444 %%%% !1110 4444 %%%% '*_'7_DB/C+_L5=0_])I*_@MK^]+XZ_\
M)$?&7_8JZA_Z325_!;0 4444 %%%% $VG?\ (0@_Z[+_ #K^]3X/_P#))?"_
M_8NV/_HA*_@KT[_D(0?]=E_G7]ZGP?\ ^22^%_\ L7;'_P!$)0!T5%%% !11
M10 4444 %%%% !1110 4444 %%%>,_ML?\% /V3O^">GPHN/C!^U9\7=.\-Z
M>D9_L_3VD$FH:I)G AM+9?WD[Y(SM&%&68JH+  ]F)YQ7SW^VW_P50_8,_X)
MY^'9M8_:G_:(T70[Y8]UKX:M9#>:M=D]!'9P[I>?[[!4&<LRCFOP+_X*<?\
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ME>Q_\$[_ /D_KX)_]E7\/_\ IQ@H _N9HHHH **** "OR'_X+\_\'#/[3_\
MP24_:R\,_ #X*?!;P'XDTS6_ <&NW%YXICO6GCF>[NH"B^1<1KLVP*>03DGG
MI7Z\5_,3_P 'J/\ RDJ\ ?\ 9&;/_P!.>HT :W_$;-_P4 _Z-4^#O_?C5?\
MY-H_XC9O^"@'_1JGP=_[\:K_ /)M?C'10!^SG_$;-_P4 _Z-4^#O_?C5?_DV
MC_B-F_X* ?\ 1JGP=_[\:K_\FU^,=% 'V!_P5N_X++_'C_@L%XB\$>)/CE\,
M/"/AF7P+97UMIL?A-+I5G6Z>%G,GVB:3D&!<;<=3G/&/C^BB@ HHHH ****
M/V"^'/\ P>8?MX?#7X?Z#\.])_9?^$<]KH&BVNFVTUQ#JGF21P1+$K-B\ W$
M*"< #-;7_$;-_P % /\ HU3X._\ ?C5?_DVOQCHH _9S_B-F_P""@'_1JGP=
M_P"_&J__ ";1_P 1LW_!0#_HU3X._P#?C5?_ )-K\8Z* /V<_P"(V;_@H!_T
M:I\'?^_&J_\ R;1_Q&S?\% /^C5/@[_WXU7_ .3:_&.B@#]G/^(V;_@H!_T:
MI\'?^_&J_P#R;1_Q&S?\% /^C5/@[_WXU7_Y-K\8Z* /V<_XC9O^"@'_ $:I
M\'?^_&J__)M'_$;-_P % /\ HU3X._\ ?C5?_DVOQCHH _MR_P""3O[8?CO]
MO[_@GO\ #?\ :^^)7AC2='USQI87D]_INAK*+6!H=0N;91'YKN^"L*DY8\D]
ML"OHJOAG_@VL_P"4(?P%_P"P-JO_ *>K^ON:@ HHHH **** /CO_ (. O^4-
M'[0?_8AO_P"E$-?QCU_9Q_P<!?\ *&C]H/\ [$-__2B&OXQZ "BBB@ HHHH
M_IP_X,IO^4;WQ&_[+1=?^FK3J_8ROQS_ .#*;_E&]\1O^RT77_IJTZOV,H *
MCN[RTL+62^OKF.&&&,O--,X544#)8D\  =S7A7_!0+_@I'^RE_P31^"\_P :
M/VH/B%#IT;;H]$\/VA$NI:U<=H;6 '<Y_O.<(@Y=E%?S"?\ !6G_ (.*OVSO
M^"F6JZM\.O#NN77PZ^$<UP5L_ ^AWK+-J$ ^Z=1N$P;DG[QB&(@<?*Q4,0#]
MN/\ @I%_P=1?\$_?V(=4OOAK\')YOC+XXL]R7&G^%;Q8]*LI?[DVH%61CZK
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MOI7_ *37E 'P)_Q&S?\ !0#_ *-4^#O_ 'XU7_Y-H_XC9O\ @H!_T:I\'?\
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M)N/[%LWC;@QNMKL>5,<;9'<'OFOC^>>>YE:>YF:21FRSR,22?4FFT4 %%%%
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M (@C/V//^CT/B5_X*M/_ /B* /YMZ*_I(_X@C/V//^CT/B5_X*M/_P#B*/\
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M>([?QO\ $K1-;^+^K6=QYUFOCR=#I\1'3-E J13C_9F\Q3_=Z8 /YM/V,?\
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ME<_\3?A3\,?C1X0NOA]\7_ASH?BK0;^,QWVC>(M)AO;6=3U#Q3*RM^(KH**
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M<7"M,\NYQ& H.7(X'05Z]0 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_\ 8NV/_HA*_@KT[_D(0?\ 79?YU_>I\'_^22^%_P#L7;'_ -$)0!T5%%%
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M HHHH **** "BBB@#^5?_@\3_P"4O:?]DJT7_P!&WE?E77ZJ?\'B?_*7M/\
MLE6B_P#HV\K\JZ "BBB@ KV/_@G?_P G]?!/_LJ_A_\ ].,%>.5['_P3O_Y/
MZ^"?_95_#_\ Z<8* /[F:*** "BBB@ K^8G_ (/4?^4E7@#_ +(S9_\ ISU&
MOZ=J_F)_X/4?^4E7@#_LC-G_ .G/4: /QYHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _L6_X-K/^4(?P%_[ VJ_^GJ_K[FKX9_X-
MK/\ E"'\!?\ L#:K_P"GJ_K[FH **** "BBB@#X[_P"#@+_E#1^T'_V(;_\
MI1#7\8]?V<?\' 7_ "AH_:#_ .Q#?_THAK^,>@ HHHH **** /Z</^#*;_E&
M]\1O^RT77_IJTZOK;_@L]_P6G^!'_!([X,+J&MK#XB^)7B*UE'@CP/#-AIF
MQ]KNB#F*U1L9/#2$;4YW,OY(_P#!#+_@K+\'_P#@DS_P0^^*'Q6\626NJ>--
M:^,U_:?#WP<TQ#ZK?#2-..^0+\R6T60TDG'54!W.M?D-^U#^T]\:OVQOCGX@
M_:*_:"\:W.O>*/$EZUQ?7EPQVQKT2&)>D<4:X1$'"J * -?]LK]M7]H[]OCX
MYZI^T)^TY\1+K7]?U)ML2LQ6UT^W'W+:VASM@A7LJ]22QRS,Q\IHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_33_ ((1?\'#GQ;_ ."9?BO3_@-\?-2U
M+Q5\"[Z[(N--_P!=>>&'<\W-EDY,6[YI+?.TC<R .3O_ #+HH _O:^$OQ8^'
M/QU^&FA_&'X1^+[+7O#7B33(=0T75]/F$D5S;R*&5@1WP>0<$'((!!%=%7\H
MO_!N7_P76U__ ()O?%ZW_9P_:%\3W%Q\$/%VI 733;I3X6OI/E%[".H@8X\Z
M,=OWBC<&#_U9:7JNFZYIEOK.C7\-U9WD"S6MU;R!XYHV 975AD,I!!!'!!H
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MD;;.Y;D>6S>7(P^1@SK$/U[K^ 6*66"59H9&1T8,K*V"I'0@^M?O-_P;R?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXSD=ZZG(]: "BC-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?(7_!?+_E#?^T+_ -D]N/\
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M_&* /T"HK\_?^(H/_@BI_P!':-_X2>I?_&*/^(H/_@BI_P!':-_X2>I?_&*
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M2OX*]._Y"$'_ %V7^=?WJ?!__DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%%
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M_?S3%%><^/?^#2+_ (+(^#+=KG2/AQX+\2*O\.A^-8-S<9X%P(C[?6OZR**
M/XB/VD/^"3W_  4D_9(MYM2_: _8N\?Z%IMOS-K<>@R7FGI];NV\R ?0N#7S
MY)')$[12QLK*<,K#!!K^_B2-)$:-T5E8896'45\J_MG_ /!$W_@FA^WAI-Q%
M\<_V7- AUJ8,8O%WA> :5JL,AS\_GV^WSL9SLF$B$\E2: /XKZ*_9O\ X*6?
M\&?'[3'P$MKGXF?L!>-)/BMX=C626Y\):E$EKKUFHY BP?*OAC^[Y<F< 1OR
M1^.?BGPKXG\#^)+[P=XU\.7VCZOI=U):ZEI>J6CV]Q:3HQ5XI(W 9'5@058
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M;C_Y,H _"6BOW:_X@=OB[_TD-\-_^&]N/_DRC_B!V^+O_20WPW_X;VX_^3*
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M?:* /Y7_ !/_ ,&<7_!6W0K<S:1K7PHUI@N?*T_QA/&Q/I^_M(QG\<<UX/\
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M#\!_&UYX?\5>%]2CO=+U*SDQAD8$QR+]V6)QE7C8%'1F5@02*_L0_P""-?\
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M%%% 'T?_ ,$?O^4I?[/_ /V5?1?_ $J2O[;:_B2_X(_?\I2_V?\ _LJ^B_\
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M($7:L<:* %4 =!6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ'P(^-.EK:ZI;QR7'@WQ=:Q*;S0+_ VS1DCYHV*JLL1XD3(^5@KK_'3^V?\
ML=_&_P#8-_:.\2?LP_M!>&6TWQ!X=O"GF+DP7]L23#=P-_'#*F&5NO." P8
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M:HHH **** "BBB@ HHHH *CNK.UOK:2SO;=)H9D*30R(&5U(P5(/4$=JDHH
M_ 3_ (.*?^#:72+72=;_ &\?^"=/@,6[VZR7WQ ^&.DP*L7E!2TNH:?&,;2,
M%I+=1SRR $%3_/\ 5_?VR*ZE77<",$'O7\O'_!U#_P $;-._8H^.D/[:G[._
MA"*Q^&/Q(U)TUK2[!-L/A_7"-[JJ_P $%S\\B ?*KK*@"KY:D _(NBBB@ HH
MHH  2#D&O[*_^" G[=2?M^_\$P_A_P#%#6O$/]H>*O#=L?"WC9I)-TJZC9*B
MAY#W:6W:WGSW\[GG-?QJ5^W7_!E5^UK%X-_:8^)?[&?B'61#:^-O#<?B#P_;
MRR8674+%PDT:#N[6\QDX_AM6ST% '](5%%% !1110 4444 %%%% '\J__!XG
M_P I>T_[)5HO_HV\K\JZ_53_ (/$_P#E+VG_ &2K1?\ T;>5^5= !1110 5[
M'_P3O_Y/Z^"?_95_#_\ Z<8*\<KV/_@G?_R?U\$_^RK^'_\ TXP4 ?W,T444
M %%%% !1110 4444 %%%% '\\/\ P?%_\E4_9V_[%_Q)_P"C]/K\(:_=[_@^
M+_Y*I^SM_P!B_P")/_1^GU^$- !1110 4444 ?W??LI_\FN_#;_L0='_ /2*
M&N^K@?V4_P#DUWX;?]B#H_\ Z10UWU !1110 4444 %%%% !1110 4444 %%
M%% !1110!\=_\' 7_*&C]H/_ +$-_P#THAK^,>O[./\ @X"_Y0T?M!_]B&__
M *40U_&/0 4444 %%%% !116Q\/O 'C3XK>.=(^&?PY\-W6L:]KVHPV&CZ78
MQ[YKJXE<)'&H[DL0* .R_9(_9(^/7[</QYT3]G#]F_P-<:]XFUR;$4,:D0VD
M(QYES<2 $0P1@Y:0\#@#)(!_K*_X(Y_\$)OV8/\ @D_X BUFQLK7QA\6-0MP
M/$7Q$OK7]Y'E<-;6*,3]FMQ\W(_>2;CO8@*J2?\ !"W_ ((Y_#K_ ()/?LR6
M^G:MI]GJ'Q8\66L5S\1/$L;>9MDV@KI]NW:WA.1Q_K'W.205"_<@ '04  &!
M@4444 %%%% !1110 4444 (RDG(K\F/^"\O_  ;9_"W]N[0=8_:@_8\T#3_"
MGQFM;>2ZO]+MHA#8^,6')249"P79&=LX&'.%DZB1/UHHP,<"@#^!7QGX-\6?
M#KQ=JG@'QYX;O='UO1;^:QU?2=2MVAN+.YB<I)#(C ,CJP*E2,@BLVOZ._\
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ME7TK_P!)KROUEK\FO^#R;_E%%I/_ &5?2O\ TFO* /Y:**** "BBB@ HHHH
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M]ISX+:TM]X=\8:/'?63<>9 QXEMY!_#+%('C=>S(17HU?SI?\&;_ /P4NO\
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M^%E% '[I_P#$<)\<?^D?WA3_ ,+JY_\ D:C_ (CA/CC_ -(_O"G_ (75S_\
M(U?A910!^Z?_ !'"?''_ *1_>%/_  NKG_Y&H_XCA/CC_P!(_O"G_A=7/_R-
M7X644 ?NG_Q'"?''_I']X4_\+JY_^1J/^(X3XX_](_O"G_A=7/\ \C5^%E%
M'[I_\1PGQQ_Z1_>%/_"ZN?\ Y&H_XCA/CC_TC^\*?^%U<_\ R-7X644 ?NG_
M ,1PGQQ_Z1_>%/\ PNKG_P"1J\D_:=_X/*/^"CGQ;T&3PW^S]\-? _PJ6:/#
MZO:6KZQJ*'OY;W?^CJ/K Q'8BOR'HH ]@_:2_P""@'[;'[8$SO\ M,?M0^-/
M&4,C[SI^KZY*UF&!R"+92(5(/3"#%>/T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#R-1_Q'"?''_I']X4_\+JY_P#D:OPLHH _=/\ XCA/CC_TC^\*?^%U<_\
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M2OX*]._Y"$'_ %V7^=?WJ?!__DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%%
M!7Y\_P#!RC_P48U#_@GW_P $W]<3X?ZXEGX[^)LDGA?PG(LF);6.6,_;+R,=
M=T4!8*P^Y)+$?0']!J_DQ_X.J_VYT_:Y_P""G^L?"[PIXD-]X4^#=J?#&FK'
M(3#_ &D"'U)U']X3@0,V.?L@Z@ T ?FB6+'<QR3U-%%% !1110 5-86%]JM]
M#I>F6<MQ<W,RQ6]O!&6>61CA551R220 !R34-?LY_P &DO\ P20L?VD?C9<_
M\%#OCMX8FF\'_#C4A!X#L[F,"'5=> !-P01^\CM58, , S/&<GRG4@'Z/_\
M!MW_ ,$/](_X)O\ P.A_:/\ CQX>63XU>.M+1KZ*[B7=X7T]P&73X^I$S<-.
MV>2%0 !"7_4&@'(HH **** "BBB@ HHHH **** "BBB@ HHHH *_,O\ X.8/
M^"05A_P40_9(N/CC\(O",,WQ>^&%C-?:+);KB?6M+4%[G33_ ,]&P#+"#DB1
M2BD>:V?TTI' 92&% '\ TD<D,C12QLK*V&5A@@^E-K]%?^#FO_@G%IG[ /\
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M)-<VD4LB?\!=F7J>E>D4 %%%% !1110 4444 ?RK_P#!XG_RE[3_ +)5HO\
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M=_\ !P%_RAH_:#_[$-__ $HAK^,>O[./^#@+_E#1^T'_ -B&_P#Z40U_&/0
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MK'!&"2>2269F)9F8EF9BQ)))KK* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /X-_VD/^3B/'O_8Z:I_Z5RUQ==M^
MTM#-;_M'?$"WN(FCDC\;:JKHRX*L+R7((]:XF@ HHHH **** "BBB@ HHHH
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M235/!=['&/?>8]I'N#BO(98I;>5H)XF1U;#(RX(/H10 VBBB@ HHHH ****
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MH_XA$_\ @C3_ -"#X\_\+R?_ .)H _D_HK^L#_B$3_X(T_\ 0@^//_"\G_\
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MB@ HHHH ,#&,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XP?\
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M#H__ *10UWU<#^RG_P FN_#;_L0='_\ 2*&N^H **** "BBB@ HHHH ****
M"BBB@ HHHH **** /CO_ (. O^4-'[0?_8AO_P"E$-?QCU_9Q_P<!?\ *&C]
MH/\ [$-__2B&OXQZ "BBB@ HHHH _2K_ (-0OV7W_:(_X*[^&O&.H6'G:3\+
M_#]_XJOV=/E\Y56TM5STW>?=1R =2(FQT)']:2GC@5^!'_!CY\,8%TWX_?&>
M2U4RR3Z)HL,Q'*J!<SNH^I9"?]T>E?OO0 4444 %%%% !1110 4444 %%%%
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M<9Z\QH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6F/->_LZ?MU^']8C.3#I_C+PC-I[H,?=,]O-.'/OY:#GIWH _"6BOTM^+_\
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M)R?]&_?%S_P7Z?\ _)= '[%45^.O_$:A_P $Y/\ HW[XN?\ @OT__P"2Z/\
MB-0_X)R?]&_?%S_P7Z?_ /)= '[%45^.O_$:A_P3D_Z-^^+G_@OT_P#^2Z/^
M(U#_ ()R?]&_?%S_ ,%^G_\ R70!^Q5%?CK_ ,1J'_!.3_HW[XN?^"_3_P#Y
M+H_XC4/^"<G_ $;]\7/_  7Z?_\ )= '[%45^.O_ !&H?\$Y/^C?OBY_X+]/
M_P#DNC_B-0_X)R?]&_?%S_P7Z?\ _)= '[%$9K^0/_@YZ^!EI\#?^"T/Q632
M;+R-/\7?V;XFLUQ]YKNRB-RW09S=I<G\<<D$U^N7_$:A_P $Y/\ HW[XN?\
M@OT__P"2Z_'7_@O]_P %+_@#_P %4_VOM"_:-^ 7@OQ)HEI9>";?1=1M_$UO
M!',\L5Q/(K+Y,D@*[9L<D'.>* /A>BBB@ HHHH ]L_X)M>,G^'O_  4'^"/C
M.-V5M/\ BIH,FY3@C_3X1Z'UK^Y"OX,?@!J4^C_'CP3J]LJM):^+M-FC5LX+
M+=1D9QVXK^\R(YB4_P"R* '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\'_\ !S/;07'_  0^^.CSQ*QAT_1GC+?P
MM_;FGC/Y$_G7\>=?V(?\',/_ "@\^/'_ &#-&_\ 3[IU?QWT %%%% !1110!
M_4Y_P9LW5S<?\$DM4BGG=U@^,.LQPJS9$:_8]/;:/0;F8_4FOU@K\F_^#-/_
M )1*ZU_V676/_2'3:_62@ HHHH **** "BBB@#^5?_@\3_Y2]I_V2K1?_1MY
M7Y5U^JG_  >)_P#*7M/^R5:+_P"C;RORKH **** "O8_^"=__)_7P3_[*OX?
M_P#3C!7CE>Q_\$[_ /D_KX)_]E7\/_\ IQ@H _N9HHHH **** "BBB@ HHHH
M **** /YX?\ @^+_ .2J?L[?]B_XD_\ 1^GU^$-?N]_P?%_\E4_9V_[%_P 2
M?^C]/K\(: "BBB@ HHHH _N^_93_ .37?AM_V(.C_P#I%#7?5P/[*?\ R:[\
M-O\ L0='_P#2*&N^H **** "BBB@ HHHH **** "BBB@ HHHH **** /CO\
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M444 %%%% !7Y-?\ !Y-_RBBTG_LJ^E?^DUY7ZRU^37_!Y-_RBBTG_LJ^E?\
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M **** "BBB@#^IS_ (,X?B1=^,_^"2M_X2O;AF'A#XL:QIMM&S9V0RV]E>C
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M:VMO&/,GD/,EQ,^,RS2-EGD;EF/T%>B4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\I>)_P#@AM_P
M20\9^)=0\8^*OV"? -]JFK7TU[J5]<:>YDN+B5R\DC'?U9F)/N:H_P##A'_@
MCC_TCT^'?_@M?_XNOKNB@#Y$_P"'"/\ P1Q_Z1Z?#O\ \%K_ /Q='_#A'_@C
MC_TCT^'?_@M?_P"+KZ[HH ^1/^'"/_!''_I'I\.__!:__P 71_PX1_X(X_\
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M:5IVDVBV.DZ?!:PK]V&WA"(/H ,58HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *:\:RHT<BAE8896'!%.HH \U^+/[&O[)'QYL7TWXW?LO_#WQ=#(
MK*R^)/!ME>D9ZD&6)BI]P01VKP^3_@@K_P $<Y)&D?\ X)Y_#G+-D[=+=1^
M#X'T%?75% 'R)_PX1_X(X_\ 2/3X=_\ @M?_ .+H_P"'"/\ P1Q_Z1Z?#O\
M\%K_ /Q=?7=% 'R)_P .$?\ @CC_ -(]/AW_ ."U_P#XNC_APC_P1Q_Z1Z?#
MO_P6O_\ %U]=T4 ?(G_#A'_@CC_TCT^'?_@M?_XNC_APC_P1Q_Z1Z?#O_P %
MK_\ Q=?7=% 'R)_PX1_X(X_](]/AW_X+7_\ BZ/^'"/_  1Q_P"D>GP[_P#!
M:_\ \77UW10!\B?\.$?^"./_ $CT^'?_ (+7_P#BZ/\ APC_ ,$<?^D>GP[_
M /!:_P#\77UW10!\B?\ #A'_ ((X_P#2/3X=_P#@M?\ ^+H_X<(_\$<?^D>G
MP[_\%K__ !=?7=% 'R)_PX1_X(X_](]/AW_X+7_^+H_X<(_\$<?^D>GP[_\
M!:__ ,77UW10!\B?\.$?^"./_2/3X=_^"U__ (NC_APC_P $<?\ I'I\._\
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MS3_Y1*ZU_P!EEUC_ -(=-K]9* "BBB@ HHHH **** /Y5_\ @\3_ .4O:?\
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MHH **** "BBB@ K\FO\ @\F_Y11:3_V5?2O_ $FO*_66OR:_X/)O^446D_\
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MY$&>-S-.BL<<<*H]J /Z:PP-*#FOY-/%/_!VW_P6A\0%CI/Q:\&Z'N^Z-+\
M63[>>WVE9?USU^E<E>?\'2G_  72N;EIX/VV([=6Z0P_#/PT57Z;].8_F30!
M_7Q17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_\QGX8_\
ME90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_\QGX
M8_\ E90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_
M\QGX8_\ E90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3:_62@ HHHH **** "BBB@#^5?\ X/$_^4O:?]DJT7_T;>5^5=?JI_P>)_\
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MR+J^\*64,A0?+Y2:L[@'KSYJ9'3A?P_?*@ HHHH *_F9_P"#V/\ Y2(?"_\
M[(O!_P"G?4:_IFK^:+_@]HTNXB_;Y^$^M,Z>5<?"!8$4$[@T>JWK$GCIB1<<
M]CT[@'XP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!_5;_ ,&?7PGNOA[_ ,$@+?QG=02*OCOX
MF:UK5N\B8WQQ"WTWY3W4/82?\"W5^I]?*'_!#/X/O\"_^"1WP#^'DUL895\
M6^I7$9[2WSR7TGYO<L?QKZOH **** "BBB@ H)QUH/TKYU_X*4_\%/?V7/\
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MFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\ 6_\ \:H
M_LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[_6__ ,:H
M _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O];__ !J@
M#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\ O];_ /QJ
M@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\ 6_\
M\:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[_6__
M ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O];__
M !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\ O];_
M /QJ@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\
M6_\ \:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[
M_6__ ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O
M];__ !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\
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MQ$ ?\%EO^D@_CS_O];__ !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\
M$0!_P66_Z2#^//\ O];_ /QJ@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\
M1 '_  66_P"D@_CS_O\ 6_\ \:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\
M^-4?\1 '_!9;_I(/X\_[_6__ ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\
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M'"@#^UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH Y7XZ_\ )$?&7_8JZA_Z325_!;7]Z7QU_P"2(^,O^Q5U#_TFDK^"V@ H
MHHH **** )M._P"0A!_UV7^=?WJ?!_\ Y)+X7_[%VQ_]$)7\%>G?\A"#_KLO
M\Z_O4^#_ /R27PO_ -B[8_\ HA* .BHHHH **** "J?B+28M?T&^T*X/[N]L
MY().O1U*GICL?6KE(V.AH _@=^(NBW?AOX@Z[X=OH#%/8:S=6TT;=49)64C\
M"*QJ^BO^"NOPG?X(?\%0_C]\-?):.&S^+&MSV*,N"+6XNY+F#IC_ )8S1]
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M"/\ Q \^%_\ I(+J'_A!)_\ )5'_ ! \^%_^D@NH?^$$G_R57[W44 ?@C_Q
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MH **** /YX?^#XO_ )*I^SM_V+_B3_T?I]?A#7[O?\'Q?_)5/V=O^Q?\2?\
MH_3Z_"&@ HHHH **** /[OOV4_\ DUWX;?\ 8@Z/_P"D4-=]7 _LI_\ )KOP
MV_[$'1__ $BAKOJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X[_P"#
M@+_E#1^T'_V(;_\ I1#7\8]?V<?\' 7_ "AH_:#_ .Q#?_THAK^,>@ HHHH
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M&[L))E7_ ,DG_*@#^;NBBB@ HHHH N>'].AUC7['2+FY\F.ZO(X9)@N?+5G
M+8R,XSGK7[]:7_P9$^#M6TVWU6T_X*#Z@T-U"LL1_P"$"CY5@"/^7OT-?S]Q
M2R02K/"^UD8,K#L1WK^Z;]AGXH6?QK_8L^$?Q=L;A9(_$WPUT/4@T;;AF:PA
M<CZ@L01U!!!H _&7_B!Y\+_])!=0_P#""3_Y*H_X@>?"_P#TD%U#_P ()/\
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MC_B!Y\+_ /2074/_  @D_P#DJOWNHH _!'_B!Y\+_P#2074/_""3_P"2J/\
MB!Y\+_\ 2074/_""3_Y*K][J* /P1_X@>?"__2074/\ P@D_^2J/^('GPO\
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M_P#A5O@.XGTCX?:>TA$5RBOMFU(ITWW#*&!/S"(1*<$$5\'T %%%% !1110
M4444 %%265E>:C=QZ?I]I)<7$T@2&&&,L\C$X"@#DDGL*]E\!?\ !.'_ (*!
M_%"VCOO '[$WQ4U2WF7,-U;> [_R7&,Y$AB"G@=C_,4 >+45]5:9_P $/?\
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MS_!?XJ_L[_$[5O@Q\;O NH>&?%6@S+#K&AZI%LN+21HUD577)P2CJWT85R]
M!1110 5]H?\ !N__ ,II?V?_ /L;IO\ T@N:^+Z^T/\ @W?_ .4TO[/_ /V-
MTW_I!<T ?V64444 %%%% !1110 5^?'_  =)_P#*$7XN_P#7QH7_ *>;.OT'
MK\^/^#I/_E"+\7?^OC0O_3S9T ?R%4444 %%%% 'T?\ \$?O^4I?[/\ _P!E
M7T7_ -*DK^VVOXDO^"/W_*4O]G__ +*OHO\ Z5)7]MM !7RO_P %=?\ @EK\
M'O\ @JY^RKJ'P,\>I%IWB33]]]X#\6+'F71M1V\$XY:"0#RY8^05.1AT1E^J
M*.>U '\'W[2_[-GQD_9#^./B+]G;X^^#;C0O%7AF^:UU*QN!P>ZRQL.)(G4A
MT<9#*P(KA*_K._X.*?\ @A[H?_!3CX&/\:_@AH-C:?&WP3I[OH]R(PC>)+%
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M%S_LIVO_ /IQGKS&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML=>)=36/1?BQH(NM)CED^YK&GAY$"@_\]+:2Y#8Y)BC]* /Z;J*** "BBB@
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MR3_P3'_X(,_M[?\ !4'4+;Q#\,O R^%?A^S'[5\1O%R/!IY4'!6V4 R7CY!
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M_P!/-G0!_(51110 4444 ?1__!'[_E*7^S__ -E7T7_TJ2O[;:_B2_X(_?\
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M+G_93M?_ /3C/7F- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!_9#_P;E_\H7?@3_V+=Q_Z6W%?;=?$G_!N7_RA=^!/_8MW'_I;<5]M
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5\A?\%\O^4-_P"T+_V3VX_]&QU]>U\A?\%\O^4-_P"T+_V3VX_]&QT ?Q@4
M444 %%%% !7T]_P18_Y2Q_L^_P#94M+_ /1PKYAKZ>_X(L?\I8_V??\ LJ6E
M_P#HX4 ?VO4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% '*_'7_DB/C+_ +%74/\ TFDK^"VO[TOCK_R1'QE_V*NH?^DTE?P6
MT %%%% !1110!-IW_(0@_P"NR_SK^]3X/_\ ))?"_P#V+MC_ .B$K^"O3O\
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M%%% !1110 4444 %%%% 'QW_ ,' 7_*&C]H/_L0W_P#2B&OXQZ_LX_X. O\
ME#1^T'_V(;_^E$-?QCT %%%% !1110!_3A_P93?\HWOB-_V6BZ_]-6G5^QE?
MCG_P93?\HWOB-_V6BZ_]-6G5^QE !1110 4444 %%%% !1110 4444 %%%%
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M5_36#D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444F[G&*
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M.X806EPG':5L]J_I?!R,T %%%% !1110 4444 %%%% !1110 4444 %>%_\
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M*_NFHH _A9_X8/\ VXO^C,_BM_X;O4__ (Q1_P ,'_MQ?]&9_%;_ ,-WJ?\
M\8K^Z:B@#^%G_A@_]N+_ *,S^*W_ (;O4_\ XQ1_PP?^W%_T9G\5O_#=ZG_\
M8K^Z:B@#^%G_ (8/_;B_Z,S^*W_AN]3_ /C%'_#!_P"W%_T9G\5O_#=ZG_\
M&*_NFHH _A9_X8/_ &XO^C,_BM_X;O4__C%'_#!_[<7_ $9G\5O_  W>I_\
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MWJ?_ ,8K^Z:B@#^%G_A@_P#;B_Z,S^*W_AN]3_\ C%'_  P?^W%_T9G\5O\
MPW>I_P#QBO[IJ* /X6?^&#_VXO\ HS/XK?\ AN]3_P#C%'_#!_[<7_1F?Q6_
M\-WJ?_QBO[IJ* /X6?\ A@_]N+_HS/XK?^&[U/\ ^,4?\,'_ +<7_1F?Q6_\
M-WJ?_P 8K^Z:B@#^%G_A@_\ ;B_Z,S^*W_AN]3_^,4?\,'_MQ?\ 1F?Q6_\
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MPW_X)W?L?^"_V4/AF/.M_#>FC^U-3>,+)J>H2?/=7;^[REB!SM7:HX45[=0
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M-+^S_P#]C=-_Z07-?%]?:'_!N_\ \II?V?\ _L;IO_2"YH _LLHHHH ****
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MB5UK_LLNL?\ I#IM?K)0 4444 %%%% !1110!_*O_P 'B?\ RE[3_LE6B_\
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M_9]^%J_\%(_V@/#S0^,?'.F>5\/=+O+?:VE:)( 3>G=R);H?=Z8A"G)\X@?
M'_!M9_P0XU/_ (*&?&:#]JG]HGPO<Q?!?P1J:O'#/'M3Q5JD3*PLESR;=.&F
M8#!XC!RS%/ZIK6UMK*VCL[.WCBAA0)#%&@544# 4 = !0!)1110 4444 %%%
M% !1110 5F^,O"'AGX@>$M4\">--%M]2T?6=/FL=4T^Z3='<V\J%)(V'=65B
M#]:TJ* /XT/^"X__  2G\7?\$I_VR]2^'%AIVH7'PY\3-)J?PVUZZ0LL]D6^
M:T>0#:9[=B$<=2ICD( D%?&5?VT?\%5_^":?PA_X*F_LF:Q^SG\2PMCJ<>;[
MP;XECC!FT;4T4^7*/[T;?<D3^)&.,,%8?QM_M7?LK_&S]BOX^>(OV;?VA/!\
MVB^*/#=X8;RWDYCGC/,=Q"_22&1"'1QP0>Q!  /.Z*** "BBB@!T,TUO,MQ;
MRM')&P:.1&PRL.A![&OUZ_X)"?\ !UU^T'^R!:Z/\!/VX['4/B=\.;.-;6Q\
M1),IU_0X1]WYW_Y"$:]-DK+(JGY9"$6,_D'10!_<W^QU^WQ^R1^WS\.(_BA^
MRC\;=%\66&T"]M+2Z"WVG/\ \\[JV;$MN_H'49'*D@@GV&OX*?A)\:?B]\ _
M&=M\1?@C\3M>\):]9L&M]6\.ZI+:7"8.<;XV!(SV/!K]8/V+O^#R+]NKX*6N
MG^%?VM?ACH'Q=TJW58IM6CD&CZPT8 &YI(8V@E<#GF%2W=LDM0!_3M17YN_L
MW?\ !U?_ ,$??C_!;V_B7XP:Y\-M1FVK)8?$#P^\"QN>WVBV:>';G^(N..2%
MK[H^#'[4/[-G[1FA+XG^ /[0'@OQMI[*&^U>%?$UK?HF>S&&1MI[$'!!X(S0
M!W5%(&!&0:6@ HHS0651N8X'K0 45YW\<OVN_P!E;]F71?\ A(?VB/VCO _@
MFSVYCE\4>*+6R\WV197#2-Z*H)/85\'_ +2?_!V;_P $B_@1:W4/@/Q[XF^)
MVJ1*RV]GX)\/L(9''3=<7C0QA,]67><<A6H _30D@9%>8_M2?MF_LN?L5?#J
MX^*?[4?QP\/^"](A4^4VL:@JS7;?\\[> 9EN)#_<C5FP"<8!(_G+_;%_X/&_
M^"@/QNLKWPQ^R]\._#?P@TVY5HX]1A8:QJR(>XFGC6%&QW$&1V((S7Y7?%[X
MX?&7]H#QA/\ $'XY_%7Q%XPURY8F;5O$NL37MPWMOE9CCVZ4 ?MM_P %._\
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M\?H_X;S_ &&_^CSOA/\ ^'$TS_X_0!ZQ17D__#>?[#?_ $>=\)__  XFF?\
MQ^C_ (;S_8;_ .CSOA/_ .'$TS_X_0!ZQ17D_P#PWG^PW_T>=\)__#B:9_\
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MO/\ 8;_Z/.^$_P#X<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\
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M/.^$_P#X<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\ AO/]AO\
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M<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\ AO/]AO\ Z/.^$_\
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M^#VD7$=UX;T>[C$;>,KA'R!M89^PJ5^=\#S3\B'&]E /F.__ ."07CKX6_\
M!&K5/^"I'QQBN=+F\2>*M'TWX9Z"ZLCS:=.SM+J<H/5)0JK"O=0TG1HS7Q'7
M]6'_  =UV%EI/_!&6ZTK3+.*WMK7X@Z!%;V\$85(HU,H5%4<     < "OY3Z
M "BBB@ K[0_X-W_^4TO[/_\ V-TW_I!<U\7U]H?\&[__ "FE_9__ .QNF_\
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M 4444 %%%% !1110 4444 ?V0_\ !N7_ ,H7?@3_ -BW<?\ I;<5]MU\2?\
M!N7_ ,H7?@3_ -BW<?\ I;<5]MT %%%% !1110 4444 %%%% !1110 4444
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MU\$_^RK^'_\ TXP5XY7L?_!._P#Y/Z^"?_95_#__ *<8* /[F:*** "BBB@
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M'_ +(LK>)/&EBZ7EXA_AM+'B60XYWR>5'CHS$;: /SR\&>"_%_Q&\5Z?X$\
M>%]0UK6M6NDMM+TG2K-[BYNYF.%CCC0%G8GH ":_>/\ X(M_\&E=[<W&A_M-
M_P#!4JQ6*%6%WI/P;AFRTO\ <.K2+]T?Q_9HF)(VB1Q\\5?J9_P31_X(E?L)
M?\$NO#MO-\#_ (=+J_C1K4QZI\1O$JI<:K=%OO"-L;+6,]/+A500!N+G+'ZZ
M QTH S_"WA?PYX(\.6/@_P 'Z!9Z5I.FVJ6VG:;IUJL,%K"@PL<:( J* ,
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M10 5)9VEWJ%W%86%K)///(L<,,,99Y')P%4#DDG@ <DU]3?\$]/^",?[?O\
MP4M\16,7[/\ \&;JU\+7%QY=]\0/$BM9Z+9H#\S^<REIR.FR!9'SV !(_HZ_
MX)*_\&W/[&?_  31^P_%'QA;Q_$[XKPLLR>,->LE%MI,@'33[4Y6$@\^:Y>7
M/1E&% !^=/\ P0N_X-6O%?Q&O]'_ &L_^"FWA6YT7P[;W"W7A_X2WBF.\U7
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M_@W+_P"4+OP)_P"Q;N/_ $MN*^VZ^)/^#<O_ )0N_ G_ +%NX_\ 2VXK[;H
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M 4444 <U\9;"^U;X0^*M+TRTDN+BY\-WT5O!$NYI)&MW"J!W)) K^+;_ (=
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M9-%DNK''T6&55'7L*\\UC_@U5_X(H:S-YS_LS:K;?,QVV?CK5(UY[8$_0=J
M/Y%Z*_K&N?\ @T>_X(R7%R\T7PN\;6ZLV5AB\?795/8;B3CZDFMS2?\ @U,_
MX(H:3+YP_9MUJZ;:!B\\>ZHX/OCSP,\?K0!_([3HXY)I%BBC9F9L*JC))]!7
M]DG@O_@W6_X(Q^")5GL?V$O"U](GW6UJYN[T?BLTS*?Q%?0GP0_8B_8Y_9GD
M^T?L\?LJ_#OP1/\ Q77A;P;96,S].6EAB5V. .22>!Z4 ?QD_ __ ()C_P#!
M0S]I&>"+X)_L9?$77H[A@(;N'PO<16YSW\Z55C"_[18 >M??7[+O_!G)_P %
M*_B];VNM_M">+_!7PIL9L&6POM2_M74T7K_JK/= ./6?(/4"OZC0,=J6@#\I
M?V,_^#0W_@FC^SS#;Z]^T#=>(OC'X@CVM(?$%Q]ATI&'_/.SMB&(]1-+*#C@
M"OTR^$'P2^#O[/O@>U^&?P+^%OA_P?X>L_\ CVT7PWI,-G;(QZMLB506/=CE
MF/))-=110 8&,8HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,>U%% 'Q
M=^WI_P $!_\ @F;_ ,%"KC4O%/Q7^!4/A[QAJ;-)-XY\#R+INI-.?^6TNU3#
M<N>YFC<GZX(_'_\ :T_X,M/VMO 0OM>_8\_:%\+_ ! LH0SVNA^)HVT?4I5S
MQ&K_ +RW=_=WB4X)XX%?THT4 ?Q'?'W_ ()&_P#!3+]F&ZN+?XU_L2?$#2X[
M7/G7UIH;ZA:8'5A<6GFPLH_O!R/>OGBYMKFSN'M+RWDBEC8K)'(I5E8=00>A
MK^_@C(Q7F_QM_8Z_9-_:5Y_:(_9D^'_CIA&$27Q;X/LM0D11TVO/$S+C)Q@C
M':@#^$NBO[*_&O\ P;Q_\$9_'3R2ZC^P7X1LGD^\^BR7-CCKT6"55'7L*\ZU
MG_@U6_X(HZU/Y[?LRZK:_,S;;/QUJD:\GI@3]!V]* /Y&:*_K&G_ .#1S_@C
M)-<//'\,/&T*LY988_'UWM09^Z-V3@=.23[UO:/_ ,&J'_!%#1IQ./V:]8NB
M,?+>>/-4D4X]O/Q0!_(W5K1M$UKQ'J<.B^'M(NK^\N&VV]I9V[2RR-Z*J@DG
MZ"O[(O O_!O1_P $:?A_(D^E_L%>#[Z2/[KZ\;C4 ?JMQ*ZG\17TQ\&/V9?V
M=/V<-+;1/V>_@)X+\"V<B[9;;PCX7M--20<?>%O&F[H.N>E '\=W[-7_  0P
M_P""KW[5U];0_"S]BOQ=;V5PRAM9\4VJZ-9Q*?XS)>M'N '.$#,1T4G K]/?
MV/?^#)[Q#/>V7B+]NW]JRUM[565[SPQ\-+5I)9.YC^W7:!4]R(&[X(X-?T&4
M4 ?/?[$O_!+']@W_ ()Y:=Y/[*7[.VB^']1DM?(NO$DT;7>JW4?=9+N8M+M)
M&2H8+GMP*^A*** "BBB@ .>U?RV_\'&7_!.#]OGX]_\ !97XQ?%GX*_L>_$3
MQ5X9U;_A'O[-U[0O"MS<VMUY7AW3(9-DB*5;;+&Z'!X9&'45_4E10!_$C_PZ
M _X*E_\ 2/WXM?\ A$7G_P 11_PZ _X*E_\ 2/WXM?\ A$7G_P 17]MU% '\
M2/\ PZ _X*E_](_?BU_X1%Y_\11_PZ _X*E_](_?BU_X1%Y_\17]MU% 'YF_
M\&HG[//QT_9F_P""9&K?#S]H3X2^(/!FO2_%?5;V/2/$FF26EPUN]G8*DH20
M ["R. >A*GTK],J** "BBB@ HHHH **** /YM?\ @ZC_ & /VW?VE/\ @J,G
MQ'^ '[*?CSQEH/\ PK;2+7^V/#OANXN[?STENB\>^-2-P#+D=1D5^;?_  Z
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MB>&?A'ILS RZ2LRZSJR)ZF.W?[.I(Z#SR1W /%?T>?LL? '0_P!E;]G#P/\
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M/154<D^PK^QSP/\ \&Z'_!&+P'*LUA^PKX9U!UQM;7+R[OA^*S3,I_$5]*_
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MA;Q]X1TO7-,N.+C3M8T^.Y@DXQ\T<@*GKW%?.'Q!_P"")G_!)+XGS27'BO\
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MLC\4:A"U_JHXP2+NY+R)GOL*@^F*^E/PHHH   .E%%% !1110 4444 %%%%
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M^D?OQ:_\(B\_^(H_X= ?\%2_^D?OQ:_\(B\_^(K^VZB@#^)'_AT!_P %2_\
MI'[\6O\ PB+S_P"(KZS_ ."%G_!,[_@H1\&?^"M7P1^)_P 6/V,OB1X=\.Z/
MXHEFU36]8\)W,%M:1FRN%#22,@51N8#)/4BOZNZ*  &BBB@ HHHH **** "O
MAO\ X.-O@[\5_CY_P2#^*'PL^"OP\U?Q5XDU*?1CI^AZ%8O<W5QY>K6DC[(T
M!9MJ*S' X )K[DHH _B1_P"'0'_!4O\ Z1^_%K_PB+S_ .(H_P"'0'_!4O\
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MDW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U
M'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<_P"AJ^%?_A4W'_R-
M0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %7/\ H:OA7_X5-Q_\
MC4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?
M_(U 'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<_P"AJ^%?_A4W
M'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %7/\ H:OA7_X5
M-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^
M%3<?_(U 'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<_P"AJ^%?
M_A4W'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %7/\ H:OA
M7_X5-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&K
MX5_^%3<?_(U 'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<_P"A
MJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %7/\
MH:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_
M *&KX5_^%3<?_(U 'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<
M_P"AJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %
M7/\ H:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\
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MJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U 'Y-T5^LG_$&W_P %7/\
MH:OA7_X5-Q_\C4?\0;?_  5<_P"AJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_
M *&KX5_^%3<?_(U'_$&W_P %7/\ H:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<
M_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U '[>_\&Y?_*%WX$_]
MBW<?^EMQ7VW7S?\ \$D/V4_B9^Q#_P $\?AG^RU\8+G39O$?A'1Y;;5)-'N&
MFMF=KF60;'95)&UQV'-?2% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?DU_P>3?\HHM)_P"RKZ5_
MZ37E?K+7Y-?\'DW_ "BBTG_LJ^E?^DUY0!_+11110 4444 %?V(?\&U'_*%3
MX)_]@O4/_3E=5_'?7]B'_!M1_P H5/@G_P!@O4/_ $Y75 'W91110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?DU_P>3?\HHM)_[*OI7_ *37E?K+7Y-?
M\'DW_**+2?\ LJ^E?^DUY0!_+11110 4444 %?V(?\&U'_*%3X)_]@O4/_3E
M=5_'?7]B'_!M1_RA4^"?_8+U#_TY75 'W91110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?DU_P 'DW_**+2?^RKZ5_Z37E?K+7Y-?\'DW_**+2?^RKZ5
M_P"DUY0!_+11110 4444 %?V(?\ !M1_RA4^"?\ V"]0_P#3E=5_'?7]B'_!
MM1_RA4^"?_8+U#_TY75 'W91110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_C]'_$8-_P1[_Z"'Q-_\(<?_'Z_E/HH _JP_P"(P;_@CW_T$/B;_P"$./\
MX_1_Q&#?\$>_^@A\3?\ PAQ_\?K^4^B@#^K#_B,&_P""/?\ T$/B;_X0X_\
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M_P#A#C_X_1_Q&#?\$>_^@A\3?_"''_Q^OY3Z* /ZL/\ B,&_X(]_]!#XF_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /[(?^#<O_E"[\"?^Q;N/_2VXK[;KXD_X-R_^4+OP)_[%
MNX_]+;BOMN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'&"QR/J:^0=6U?5M?U.XUO7=3N+V\NIFENKR[F:26:1CDNS,268GJ2<FJ]%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% ']D/_!N7_P H7?@3_P!BW<?^
MEMQ7VW7Q)_P;E_\ *%WX$_\ 8MW'_I;<5]MT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^37_!Y-
M_P HHM)_[*OI7_I->5^LM?DU_P 'DW_**+2?^RKZ5_Z37E '\M%%%% !1110
M 5_8A_P;4?\ *%3X)_\ 8+U#_P!.5U7\=]?V(?\ !M1_RA4^"?\ V"]0_P#3
ME=4 ?=E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?D[XT_X,[/^"8?COQEJWC?6/BC\8DN
M]9U.XOKI;?Q+IXC6261I&"@V!(7+'&2>.]9O_$&#_P $L/\ HJWQH_\ "FT[
M_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\ HJWQH_\
M"FT[_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\ HJWQ
MH_\ "FT[_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\
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M?#;X)_&7XRZI'H?P@^$OB;Q5>22;([3PWH-Q?2,WH%A1B37V[^S=_P &P/\
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M?]%6^-'_ (4VG?\ ROK]=** /R+_ .(,'_@EA_T5;XT?^%-IW_ROH_X@P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ5;V=M&,1V]K"L<:_15  JUM%%% !1110 4444 %%%% !1110 4444 %%%%
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M.FZY"N9/"VEW7]HZJN1D;[6V#R1 CH9 H/8FOSD_:4_X/8/V4?!SR:9^RO\
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M^(FS_@B?_P!'G6O_ (2VJ?\ R-0!]ZT5\%?\1-G_  1/_P"CSK7_ ,);5/\
MY&H_XB;/^")__1YUK_X2VJ?_ "-0!]ZT5\'VG_!S%_P1-O+A;9OVU["'=_RT
MF\+ZJ%'UQ:FO2/AG_P %O_\ @D;\6[B.S\(?\%#/A?'-,P6*+7/$D>E,Y(X
M%[Y1)/IUSQUXH ^J**SO#/C#PGXTTN'7/!WBC3M6LKB,/!>:9?1W$4BG^)70
MD$>X-:.1B@ HHHH **** "BBB@ HHKB?VC/VB/A!^RC\&=<^/_QZ\7+H/A+P
M[ DVL:LUK),+=&D6,'9$K.?F=1P#UH [:BO@D?\ !S7_ ,$3P.?VSK7_ ,);
M5/\ Y&I?^(FS_@B?_P!'G6O_ (2VJ?\ R-0!]ZT5\%?\1-G_  1/_P"CSK7_
M ,);5/\ Y&H_XB;/^")__1YUK_X2VJ?_ "-0!]ZT5\%?\1-G_!$__H\ZU_\
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M .CSK7_PEM4_^1J /O6BO@EO^#FO_@B>1C_ALZU_\);5/_D:M[PG_P '%O\
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M/^")_P#T>=:_^$MJG_R-0!]ZT5\%?\1-G_!$_P#Z/.M?_"6U3_Y&H_XB;/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/^(UO_@H%_T;/\)_^_.H?_)- '],U%?S,_\ $:W_ ,% O^C9_A/_ -^=0_\
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MU:?_ !Z@#XVHK[)_XA\/^"SO_2/SQM_WU:?_ !ZC_B'P_P""SO\ TC\\;?\
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M)=&OBI((SAFMY0K/%(1\P#+]Y&  /JZBBB@ HHHH *^'_P#@Y _Y0L_'/_L
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M_P '6W[)/[:5_IWP>_:TTZV^$/Q#O+A+:RN+J\WZ!JLCG:@CNG(:VD+<>7,
MO*[9&)P/UC5U<;D;(/((K^ 0$CD5^Y7_  ;3_P#!P[XK^'OC30O^">_[<WC^
M34/"NK3+9?#SQQKEZ6FT:Y;"Q:?<2N?FMG/RQNQS$Q"D["-@!_1E10,]S10
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M1_Q#X?\ !9W_ *1^>-O^^K3_ ./4 ?&U%?9/_$/A_P %G?\ I'YXV_[ZM/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!_!O\ M(?\G$>/?^QTU3_T
MKEKBZ[3]I#_DXCQ[_P!CIJG_ *5RUQ= !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?=G_!*'_@X!_;6_X);:O;>$M&UQO'
M7PQ8[;SX>>)+QVAMESDR6,W+6DG7@!HVR=R$[67^F?\ X)H_\%B/V*/^"I7@
MB/5_V??B"MIXHM[(3Z[\/]<9(=6TSH')C!(FB#' FB+*<C.TG:/XK*W/AM\3
M?B)\'/'&F_$SX4>-]4\.>(='N!/I>M:+?/;W-M(/XDD0@CC@\X()!R#0!_?
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MR2R,<L[,>68DDDGDFH:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/8?%+QIILBAM6F *RZ5;2 DK;H?EFD7:TCHT8/EAO-_"NAF9CN8Y)Y)/>B@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?MERA^1"N1Y$)"D,P=I>,?E_110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?V0_P#!N7_RA=^!/_8MW'_I
M;<5]MU\2?\&Y?_*%WX$_]BW<?^EMQ7VW0 4444 %%%% !1110 4444 %%%%
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M+?\ [)GKG\[>OZL*_E/_ .#/G_E,);_]DSUS^=O7]6% !1110 4444 %%%%
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M,2^#?_AL-)_^1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_D>C_AW1_P $^?\
MHQ+X-_\ AL-)_P#D>@#^&>BO[F/^'='_  3Y_P"C$O@W_P"&PTG_ .1Z/^'=
M'_!/G_HQ+X-_^&PTG_Y'H _AGHK^YC_AW1_P3Y_Z,2^#?_AL-)_^1Z/^'='_
M  3Y_P"C$O@W_P"&PTG_ .1Z /X9Z*_N8_X=T?\ !/G_ *,2^#?_ (;#2?\
MY'H_X=T?\$^?^C$O@W_X;#2?_D>@#P?_ (-RS_QI=^!7_8MW'_I;<5]N5D^!
M_ ?@?X9>%K/P-\-O!FD^']$T^,I8:/H>G16EK;*225CBB5409). !R36M0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R
M%_P7R_Y0W_M"_P#9/;C_ -&QU]>U\A?\%\O^4-_[0O\ V3VX_P#1L= '\8%%
M%% ']MG_  1U_P"43_[-W_9$?#/_ *;(*^D*^;_^".O_ "B?_9N_[(CX9_\
M39!7TA0 4444 %%&:;++'#&TTTBJJKEF8X 'J: '$XYK^2?_ (.IOVQM#_:P
M_P""K>O>'/!>N)?:'\*]%@\(6\UO)NB:\AEEFO2O;*W$SQ$]S!Z 5^L/_!>W
M_@Y/^#W['O@+7OV6?V)_'6G^*_C!J5JUG?:]I4XGL/"*."KR&5#MEO N0D2L
M1$Q#R?=$;_R_7EY=ZC>2ZA?W,DT\\C2332L6:1R<EB3U)/.: (Z_43_@T4^
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M?L^_]DKTG_T0M?35 !1110 4444 %%%% !1110 4444 ?RR_\'E'_*6W2?\
MLCNC?^EFHU^3M?K%_P 'E'_*6W2?^R.Z-_Z6:C7Y.T ?J9_P9\_\IA+?_LF>
MN?SMZ_JPK^4__@SY_P"4PEO_ -DSUS^=O7]6% !1110 4444 %%%% !7\S/_
M  >Q_P#*1#X7_P#9%X/_ $[ZC7],U?S,_P#!['_RD0^%_P#V1>#_ -.^HT ?
MC37Z,?\ !J7_ ,IO?A=_V!_$?_IEO*_.>NP^!'[0'QJ_9@^)MC\9OV?/B7JW
MA'Q5IL<T>GZ]HER8;B!98FBD"L.@:-V4^S&@#^\RBOXL_P#A^K_P6"_Z2(_$
M[_PH&_PH_P"'ZO\ P6"_Z2(_$[_PH&_PH _M,HK^+/\ X?J_\%@O^DB/Q._\
M*!O\*/\ A^K_ ,%@O^DB/Q._\*!O\* /[3**_BS_ .'ZO_!8+_I(C\3O_"@;
M_"C_ (?J_P#!8+_I(C\3O_"@;_"@#^TRBOXL_P#A^K_P6"_Z2(_$[_PH&_PK
M^MK_ ()E_$#QK\5O^">OP7^)7Q'\2W6LZ]KOPWTF]UC5KZ3?-=W$ELC/*[=V
M9B230![E1110 4444 %%%% !01FBB@#\%O\ @[[_ ."2&O>,(K?_ (*D? CP
MJMS-IFGPZ=\6K.RA_?-;Q@1VNJ$#[XC3;!(>JH(3]U&*_P ]E?WYZQH^D^(=
M*NM"U[2[>^L;VW>"\L[R!9(IXF&UD=&!#*02"I!!!P:_FP_X+O\ _!KSX^_9
MRU+6OVM/^"=GA*^\1?#ME:\\1?#^TS-J'APEB7DM4'S7-H.#L&Z6(9)W("R@
M'XMU]^?\$G_^#A_]MC_@E]+IOPWBU-?B!\*;>X/G^ ?$5T^;*)B2_P#9]QRU
MHVXEMF'B)+$QY8L/@6:&:WF:WN(FCDC8K)&ZX96'4$=C3: /[%_^"?'_  <-
M_P#!-3_@H3:6^A>%?C#!X'\:2*OG>"?'TJ6%TS'M;S,?(NN0>(W+@<LBY&?N
M1'5T#JP(89!'>OX!59D8.C$,#D$=J^T_V"_^#@#_ (*;_P#!/BSLO"?PN^.D
MOB7PC8[5A\%>/%?4M/BC'_+.$LXFMD_V8I$4>E ']E%%?D5^PA_P>!_L%_M"
MOIO@W]K;PQJ7P9\176R"74;EGU+0WF.!N^T11B2W1F[RQA(P?FDP"]?JS\.O
MB?\ #?XO>%;;QS\*?'^B^)M%O%#6NK:#JD5Y;3*1D%9(F93QZ&@#<HHR/6B@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** .=^*WPC^%_P =/ 6I?"WXR?#[1_%'AW5[=H-2T77-/2YMKB,]
MF1P1[@]0<$$$ U^$G_!5K_@SR7%Y\9/^"66O8^5Y;SX4^)=0ZGK_ *!>RM^
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M+_V4OA!I^@6\@!U35W7SM2U23_GI<W+YDE/HN0BYPJJ.*]OVC& *6@ HHHH
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M^'?PZ\ _";P/I?PU^%_@W3?#_A_1;-+32=%T>S2WMK2%!A8XXT 55 [ 5M4
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MR"&:(A]T*C))&">.]?<7_$:)_P %/?\ HC?P=_\ !#J'_P G5^0=% 'Z^?\
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M+' 4 DD $U_7]_P0R_X)'>#_ /@DS^R=#X%U(:?J7Q*\5-'J'Q&\1V:EEEN
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M'S2,"4K]X-#T'1/#&CVOAWPWI%MI^GV-NEO8V-E L4-O$@VK&B* JJ   H
M XH MJH4844444 %%%% !1110 4444 %%%% !7QS_P ' _\ RAF_:"_[$8_^
ME,%?8U?'/_!P/_RAF_:"_P"Q&/\ Z4P4 ?QDT444 ?VQ?\$8_P#E%%^S[_V2
MO2?_ $0M?35?,O\ P1C_ .447[/O_9*])_\ 1"U]-4 %%%% !1110 4444 %
M%%% !1110!_++_P>4?\ *6W2?^R.Z-_Z6:C7Y.U^L7_!Y1_REMTG_LCNC?\
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M\+>);%;BQNX6&^)NCP2KG,<T; H\;<JRD&O0: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH#=L44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !103CM0#GI0 4444 %-
M=$EC:*1 RLN&5AP13J* /S&_X*M?\&O_ .QA_P % )-3^+7P1AMOA'\3[B%I
M&U30]/7^R=6GP2#>6:;0'8_>GBVN<EF$I %?S??M^_\ !+[]L_\ X)H_$!/
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M&>WA/PS;Z;\:/^"HFNQZUJ0E6>W^%?AV^86<*C! OKN,AIF)X,,.U!CF1PQ
M_6G]A'_@FQ^QY_P3A^&,/PR_97^$5CHZ^2JZIX@N%$^J:M)WDNKIAOD)/.T8
M1>B*H  ]W P: ,;P%\/O WPL\)6/@+X:>#M+\/Z'IL*PZ?I&C6,=M;6T8'"I
M'& JCZ"MFBB@ HHHH **"<4 YZ4 %%%% !1110 4444 %%%% !1110 4444
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M/_@7\3_$'P:^*GARXT?Q)X8U:?3=:TVZ7#V]Q$Y1U/KR.#T(P1P:YVOZ//\
M@[7_ .".2_%[X?3?\%.OV??#J_\ "3>$M/6+XH:79VOS:EI,:G;J?RC+2VP
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M6?[L95?88%?4=M!#:PK;6\*QQQJ%CCC4!5 [ #H*DHH **** "BBB@ HHHH
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M,,QW)#>3>HA^80W*HSKD85UE0%O+R?MF@ HHHH **** "BBB@ HHHH ****
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MO^#KO]F?]D-+[X-?L/?V7\6/B%&SP76MPW6_P_H[CC)FC/\ IL@/\$1"<<R
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M /@J#_TD ^+G_A>7O_QRC_A[?_P5!_Z2 ?%S_P +R]_^.5\[T4 ?1'_#V_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ1@9SB@#^!_XD_#+XB?!SQQJ/PT^+'@?5?#?B#2+@P:GHNM6+VUS;2#^%XW
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M;I)I#P .RHJA45!A45550  *Y.@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#^R'_ (-R_P#E"[\"?^Q;N/\ TMN*
M^VZ^)/\ @W+_ .4+OP)_[%NX_P#2VXK[;H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KY"_X+Y?\ *&_]H7_LGMQ_Z-CK
MZ]KY"_X+Y?\ *&_]H7_LGMQ_Z-CH _C HHHH _ML_P"".O\ RB?_ &;O^R(^
M&?\ TV05](5\W_\ !'7_ )1/_LW?]D1\,_\ IL@KZ0H **** "BBB@ HHHH
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MQ1^T5^P'\>=6_9U_:9\!S:+KVES-Y,RY>UU*WW$)=VLN )H7 RK8!'1@K!E
M!O\ _!.__@HI^TA_P3-_:'T_]H7]G/Q-Y,\;+#KV@W;%K'7;+=E[6Y0=5/\
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M& _\NGQ8^+/Q*^.OQ'UCXN_&'QKJ'B+Q-X@OGN]8UK5+@R3W4S'EF8_D ,
M    "N=9F=BS')/))[T4 %?I!_P;J?\ !%S7O^"F_P"TI;_%7XO>'KV#X+^
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M  K^&'[<?@G6O$7B#4(K'1=)LKN4S7=Q(VU(D!C'S$G YH ^HZ*** "BBB@
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M !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\ I&[\;?\
MPVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P5A_Z1N_&W_PV
MNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\ I&[\
M;?\ PVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P5A_Z1N_&
MW_PVNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\
MI&[\;?\ PVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P5A_Z
M1N_&W_PVNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %
M8?\ I&[\;?\ PVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P
M5A_Z1N_&W_PVNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE
M_P %8?\ I&]\;?\ PVNI?_&:\6^,?P/^,O[/'CJX^&/QY^%?B#P;XBM8TDN-
M#\3:3-8W4:.,JQBE56 (Z'&#0!RU%%% #[>YN+.XCN[2=XI8G#QR1L59&!R"
M".A![U_21_P;;?\ !Q0G[2%EI?[!?[=OCE%^(-O&MOX#\;ZI,J+XDB'"V5PY
MQ_IJC 1C_KU&"?,'[S^;2I+.\N]/NXK^PN9(9X)%DAFA<JT;@Y# CD$'D$=*
M /[^ <T5^-__  ;@_P#!Q#:?MD:7I/[#'[9_B-8?BO86GD^$_%=UA8_%=O&H
M AE;/%\J_A,%)^_D-^R )(R: "BBB@ HHHH **** "FR1I*I210RD8*L.#3J
M* /RM_X*N_\ !K#^Q]^W!!J/Q7_9;@L?A#\3)Y'N)9--L\:'J\C9+"XM4 \E
MV;GSH<<EBR2$@C^<G]NG_@F_^V+_ ,$Y/B7+\-/VK/@]?:$S3LFEZY#_ *1I
MFJH.1);72920%?FV$B1>CHK @?W$5Q_QW_9_^"G[3GPPU+X,_M!?#'1_%WA?
M5HPE_HNN6:S0R8.5<9Y1U/*NI#*0""",T ?P9T5^[?\ P5C_ .#/[Q=X0;5/
MC?\ \$O-8FUS2UC:YN?A3KUZOVZ#&2RV%TY59UQ]V&4B3L'D)"U^'?CSP!XY
M^%OBZ^\ ?$KP=J>@:YI<YAU+1]8L7MKFVD'\+QR ,I^HH R**** "BBB@ HI
M45Y&"(I9F.%51UK]-?\ @E/_ ,&P'[:?_!0!-/\ BM\;8;CX1_#&:1'75M<L
M2=5U6'JWV.S8JRJ1P)IMJ?,"HEP10!^=WPB^#?Q7^/OC[3_A9\%/AWK'BKQ%
MJDPCL-&T.P>XN)FSV5 2 .['  Y)%?O'_P $H_\ @SUL].ETOXU_\%2/$$=U
M)Y*7%O\ ";P[?'RXW(!"ZA>1GYBO1H8#M)_Y:LH*M^MW[ /_  2W_8I_X)I>
M!7\'?LJ?""UTN\O(4CUKQ3?A;C5]6V]/M%T0&9<Y(C7;&I)*H,FOH;'.<4 <
M[\*?A-\,O@9\/],^%/P<\ Z3X7\-Z-;^1I>AZ'8I;6MM'UPD:  9)))ZDDDY
M))KHJ** "BBB@ HHHH **** "@D#K02>U?'_ /P6*_X*_? W_@DK^SS)X^\7
M-:Z[XZUJ-X/ W@6.\5)]0GP?W\O5H[6,X+R8YX5<LPH Q_\ @M+_ ,%H/@A_
MP23^!<FIWUQ9Z_\ $_Q!:R)X'\#K<?O)9,$?;+D#F.UC;&YN"Y^1><E?Y%/V
MD?VDOC5^UQ\:-<_:"_:$\>WWB3Q7XBNO.U'4KZ0L< 82)%Z1Q(H")&N%55
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MC0)XM4T'7M/DM;NT<WD[!9(I &0E2#@CH17UY0 4444 %%%% !1110 4444
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M7&G>.?!WPZ?QQX_L8U9?'GCB.*ZN;>?'S26D.T169SG:R*9 IP9&R2?ND#%
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M^']_!;6=NEPI>661X@J(HY+$@ 4 ?UU4444 %%%% !1110!^:W_!V9_RA?\
M&G_8U:%_Z6+7\EE?U_?\',WP,^,_[1?_  2;\6?"[X!_"KQ!XS\277B31Y;;
M0?#.DRWMW+''=*SLL42LQ"KR3C@5_,G_ ,.<O^"L)Z?\$WOC;_X;74O_ (S0
M!\VCK7]X7[+O_)LWPZ_[$72/_2**OXSQ_P $<O\ @K#G_E&]\;?_  VNI?\
MQFO[-_V<])U70/V?? N@ZYITUG>V/@W2[>\M+B,I)#*EI&KHRGE6!!!!Y!%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !^%%%% !1110 4444
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M]I7]H[QC)J_B'6IOE096WT^W!/E6EO'G$4,8.%4<GEF+,S,=#]N_]N_]H?\
MX*+?M$:M^TE^TCXJ^WZQJ'[JQL+?*V>DV:D^7:6T9)\N)<GN2S%F8EF)/C=
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M'P]\%Z3H.FVL?EVNGZ-IL5K!"F<[5CC5549[ 8K6HHH **** "BBB@ HHHH
M**** "BBB@ HHHH ,>U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4?A110 4444 %%%% !1110 4444
M %'OBBB@ HHHH **** "BBB@ HP/2BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,>U%%% ![XHHHH ***
M* "BBB@ HHHH *.G0444 %%%% !1110 4444 %%%% !1110 4?A110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *^/?^"Q7_  1W^ G_  5L^ ;>#?&<<.A^/-!AFE\"^.;>V4SV%P5_
MU$W&9;61@N^//'WE(8 U]A44 ?PG_M>?LA_'K]AGX^:Y^S=^TAX(FT/Q-H4^
MV2-OFANX3S'<P2#Y989%^97'N#A@RCS.O[0/^"O/_!'C]G7_ (*U_!#_ (0S
MXC6RZ'XVT2&63P3X\LK93<Z;.5.(I>,S6KMC?"2.FY2K &OY%/VS_P!B_P#:
M"_8&^/\ K/[-W[2G@F71?$6CR;D8'?;W]NW^KNK>0<2PN.0PY!RK!65E !Y5
M1110!K>!/'GC;X7^,M+^(GPX\6:AH.O:+>QWFDZQI-X]O<V=PC;DECD0AD8$
M9!!K^K/_ (-_?^"^_@/_ (*=_#VW^ WQVU.ST3XY^'M-SJ%FTB10^*;>,#-]
M:+@ 2 8,MNN2N"Z_(2$_DVKH?A1\6/B3\"_B1HOQ?^$'C2_\.^)O#VH1WNBZ
MUIDQCFM9T.593W'8J058$@@@D$ _O;!R,T5^=7_!!'_@NO\ #W_@JS\)5^''
MQ0O+#0OC=X9L=WB708V6.+6;=2%_M&S7/*'*B2,<Q.>Z,I/Z*YH **** "BB
MB@ HHHH **** "C%%% !CG-%%% !1110 4444 %%%% !1110 445XA_P4"_X
M*!_LY?\ !-G]G?4OVBOVC_%B6=C;_N='T>"13>ZW>E24M+6,GYW;!)/W44,S
M$*": ,S_ (*5?\%(?V>_^"7_ .S9J'[0WQ[U8N=QM?#7ARTD'VS7+\J2EM".
MPXR\A&V-1D\X!_CZ_P""B/\ P4*_:!_X*7_M*:K^TG^T#K"FZNL0:+H=G(_V
M+1;%2?+M;=&)VJ,DLW5W+,W)K3_X*8?\%+_VB/\ @J-^T?J'Q^^.VL206JEH
M/"WA.UNF>QT"QW$K;P@@ MW>7:&D;YCC@#YWH **** "K&E:5JFNZG;Z+HFG
M3WEY>3+#:VEK"9))I&.%154$LQ)   R33]!T+6_%&MV?AKPUI%SJ&H:A=1V]
MC8V<+237$SL%2-$4$LS,0  ,DFOZ:?\ @W:_X-RM._8GM=-_;0_;;\,6]Y\7
M)XS)X7\,3,LUOX3A8<2N,;7OB,\\B$'"_.25 (_^#=/_ (-T-)_8RTO2_P!M
M?]MGPK;WOQ9O(?.\+>%[H"2'PE"Z#$DBD8:^()SU$(.!\^2/V,QDYH%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?)?_!7+_@D1^S[_ ,%:/@#)\.?B1!%HOC#2$DF\$^.[
M6S5[K2K@@_NWZ&6V<X\R$D X# AE5A]:44 ?PL?MG?L7_M!_L#?'[6/V;_VE
M?!$VB^(=)?=&WWK?4+9B?+NK:3&)87 R&'0@JP5E91Y57]JG_!5__@DU^SI_
MP5>_9_G^%?Q7T^'2?$^GJTO@WQU:6:O>Z-<XZ9X,ENYXDA) 8<C#*K#^0O\
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M:,#THH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM@?'K]A;X^:'^T=^SGXXNM#\1:+<*VZ&0^3?6^X&2UN$Z2PR ;61@1W&" 0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN++X,Z3>C^V-:C\R&?QA=1N<,P."MDC!6CC90791(W1%7I?^#C__ (.(+_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"'7P>_X),?!]=<UU+'Q)\8/$=E'_ ,)AXP$)*VBD!CI]ENY2W1LY?"O,P#.
M B)][!1UQ2CBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#7X[_#K3_$VBCPY=7T5GJ"']Q=00N\,\3J0\4B,.'1E8 D9P2"44 ?G_ /\
M!G]^SI\$O!W_  3^OOVB/#GPZL;?QMXF\37VG:YXD^=[FXM+>0>5 "[$1Q@\
M[4"AFP6R0#7ZY444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" /C#@8# 2(  A$! Q$!_\0
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MV13PKXFU"91_PEMI$H_=.QY-]&@);.3,JE^6#T ?L911G/2B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$XCAM+:)"\DKL> JJ"2:_DR_X. /^"Y_CC_@JE\97^&/PHU*^TGX(>$=0?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4[R^S^>.I+JZNKZZDO;VYDFFFD9YII7+,[$Y+$GDDGDD]:CH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM)?M$>,IM;\4>(KKS;J=V;RK>,<1V\"$GRH8UPJ1@X4#N<D]7_P4*_X*!?M
M_P#!2C]I36/VD_V@_$+SWEXWDZ+HL,C?8]$L5)\JTMT/"HN<DXR[EG;)8UX=
M0 4444 %%%% !1110 445W7[-_[-'QV_:Z^,&D? ;]G'X::EXK\5:Y<+%8Z7
MIL6< D RRNQ"0Q+G+RR,J(.68#F@#B;.SO-1O(M/T^TDGN)Y%C@@AC+/(['
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M\$IOBL/!/QX\,_VAX<U"1CX8\>Z/ [:9JT8/W0Y'[F8#EH7(<9R-RD,?EF@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVH/AO:Z]HMY&QL[G:$O-,N",+<VLV-T,J]B.#C#!E)4_RS_\%F_^#?3]IO\
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M003Z50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FFM(B#+.
M!]30 ZBH_M5L/^7B/_OH4Y9$895P?H: '449'K10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!)% !FO
MYTO^#FW_ (.#6^*=]K?_  3B_8C\:$>&;29K3XF>.-)O/^0O*C$/I=LZ?\NZ
M,,2R!OWIS&/D#&3U_P#X.<O^#@I_A%:ZW_P3@_8G\9/'XKN(FL_BAXTT]QG1
MXR2LFE6S]KEAQ-(!^Z5MBGS"QC_G1)+'<QH **** "BBB@ HHJQI6E:IKNJ6
M^B:'IMQ>7EY.L-I9VL+22SR,=JHBJ"68D@  $DGB@"O7Z+?\$8/^#=[]I3_@
MJ-K-E\6/B!'?> ?@Q'*6N/%]U:D7.M!6VM#IL;C$ASE3.W[I"&^^PV5]M?\
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M^$O[6'[%O[8G_!-[XU0_#_\ :,^&NN>!_$EE/]IT75(Y"(;KRW^6YL[N([9
M&P=R-E3C.T\4 ?W*ALFEK\!/^" /_!T)J^L:SH?[%/\ P4L\9I*UQMLO!OQ:
MU!\,TA/[NTU1R<'/W$NL#G:)<Y,H_?I22.: %HHHH  <T5_!O^TA_P G$>/?
M^QTU3_TKEKBZ /[_ "BOX Z* /[_ "BOX Z* /[_ "BOX Z* /[_ "BOX Z*
M /[_ "BOX Z* /[_ "BOX Z* /[_ "BOX Z* /[_ "BOX Z* /[_ "BOX Z*
M /[_ "BOX Z* /[_  \C%?D3_P '(W_!?[3OV%?!=]^QC^R3XKM[CXQZ]8F/
M7M:M)"W_  AEI(%(?.-IO)4)\M<YB!\QADH&_EYHH EOKZ]U.]FU+4KN6XN+
MB5I;BXFD+/(['+,S'DDDDDGDFHJ** "BBB@ HHK[(_X)*_\ !%#]J_\ X*R?
M$9;;X=:2_AOX>Z?<[/$WQ(U6U)L[/&"88%R#=7!!XC0X7J[(.2 ?/?[+/[)W
M[0G[:GQCT[X"?LR_#'4/%7BC4OFCL;%0%@B# -/-(Q"00J67=(Y51D#.2 ?Z
MBO\ @BI_P;B_L]_\$RM/L_C/\97T_P"(/QFDC63^WIK7=8>'3MYBT]'&=_)S
M<. [<!1&,AOJC_@G-_P3$_90_P""8'P9C^$G[-/@E;>XNHX3XE\47V)-2UVX
M0'][<2^F68K&N$3<0JC)S]#8YS0 4444 %%%% !1110 445RGQF^.7P?_9U^
M'E]\6/CO\2M%\)>&]-7=>ZUKVH);V\>>@W.1ECV49)[ T =7FOG+_@H-_P %
M6?V)O^"9G@.7Q;^U!\6;>TU22S:?1_!NE[;C6-6QP%@M]PP"W'F2%(P<Y<8-
M?CY_P5:_X/"M4UI-7^"?_!+SPW+I\'F-;3?%CQ%9CSI%!P7L+-P0@;^&6<;@
M/^62L05_#/XI_%CXF_''Q]J7Q4^,7CW5O$_B36+CSM4US7+Y[FYN7QC+.Y).
M   .@  &  * /T2_X*J_\'/?[;'_  4 >\^&7P5O+GX1?#.19(9-&\/Z@W]I
MZM&W'^F7BX;;CCRHMB<D,9."/S-HHH *^I_^";__  6-_;F_X)?^+[?4/V>O
MBE/<>%FO/.UCX>Z\S7&CZB#]_,1.8)#Q^]A*/D#)894_+%% ']=7_!*O_@Y(
M_8<_X*16MG\/O%>MQ?"WXG22)"?!OBB_00:E(0,&PNSM2<%OE$;;)<\!&&&/
MZ) BOX!4D>)UEB=E96RK*<$'UK]3/^"5?_!T]^V5^P_)8_"W]IZ:^^,'PWA2
M.&*'5;S_ (G>DQKQFWNWR9E"\>5.6'RKM>/G(!_5<#GI17@?[!O_  4S_8S_
M ."D7PXA^(/[*GQ@LM8D6U275O#=T?L^K:0YQF.YMF.Y2K?+O7=&QY1V!!/O
M@SWH **** "BBB@ H.>U%% 'S;_P4I_X)6?LF_\ !4GX.R?#+]HOP8O]J6=O
M(/"_C+3U":GH4S?QPR?Q)D#="^8W'49PP_E0_P""KG_!&7]K+_@D_P#$^31?
MBOH3ZYX&O[K9X5^(VE6S?8-14@D12=3;W  .Z%SV)4NN&/\ :#7+_&?X*?"?
M]HGX9:M\&_CAX TOQ1X7UVU-OJNBZQ:K-!.G49!Z," RL,,K $$$ T ?P5T5
M^O7_  6__P"#7SXK?L5R:O\ M,?L-66J>-_A7YTEQJ7AI4:XU?PM$?F).T9N
MK5>0) #(B@>8&PTA_(6@ HHHH **** /V!_X-LO^#@.^_8I\5V'[$7[8'B^>
M?X2:Y?+'X9\1:A=%AX.NG/W6+=+&1L;E'$3$N."]?TZV%Y::A917^GW<=Q;S
MQK)#/#(&21&&0RD<$$'((X(K^ FB@#^_RBOX Z* /[_**_@#HH _O\HK^ .B
M@#^_RBOX Z* /[_**_@#HH _O\HK^ .B@#^_RBOX Z* /[_**_@#HH _O\HK
M^ .B@#^_RBOX Z* /[_**_@#HH _O\HKXC_X-RQ_QI>^!)_ZENX_]+;BOMR@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBOD+_@OF,_\$;_VA?\ LGL__HV.@#Z]!STHK^ .B@#^_P HK^ .B@#^_P H
M)Q7\ =?3W_!%C_E+'^S[_P!E2TO_ -'"@#^UZB@<#%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 $XHKE?CL ?@CXRS_T*NH?^
MDTE?P6T ?W^45_ '10!_?Y17\ =% ']_E (/2OX"=._Y"$'_ %V7^=?WI_!\
M?\6F\+G_ *EVQ_\ 1"4 ='1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 &><45_*O_P 'B0Q_
MP5[C'_5*M%_]&WE?E70!_?Y17\ =% ']_E%?P!U['_P3O_Y/Z^"?_95_#_\
MZ<8* /[F00>E% &.:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** #.* <C-?'?_!P%_RAH_:#
M_P"Q#?\ ]*(:_C'H _O\HK^ .B@#^_RBOX Z* /[_ 0>AHK\<_\ @RG_ .4;
MWQ&_[+1=?^FK3:_8R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH * V3BBOSW_X.DAC_ ((B_%[_ *^-"_\ 3S9T ?H117\
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M#^U7_P G0_$C_L?M8_\ 2V:N1L_"7BO4;9;W3_#&H3PR<QS0V4C*W.."!@T
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M9)%#8&Y0IP,XHH _BA_:0_Y.(\>_]CIJG_I7+7%UVG[2'_)Q'CW_ +'35/\
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M91AE60Y5E)5@02*_=[_@E-_P>&:?>1Z7\%O^"I.@_9IO,6WA^+/AS3R8BI(
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M_P"2(^,O^Q5U#_TFDK^"VO[TOCK_ ,D1\9?]BKJ'_I-)7\%M !1110 4444
M3:=_R$(/^NR_SK^]3X/_ /))?"__ &+MC_Z(2OX*]._Y"$'_ %V7^=?WJ?!_
M_DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&_\ Z40U_&/0 4444 %%%% '].'_  93?\HWOB-_V6BZ_P#35IU?L97XY_\
M!E-_RC>^(W_9:+K_ --6G5^QE !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX+3?$Z"ZN_,AT&QT?2;--V1%''I\+%1R<?O))&/NQXK]E?\ @SK^$^F>!/\
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M_P!*Y:XNNT_:0_Y.(\>_]CIJG_I7+7%T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5]$?\$X_^"8'[6'_  5!^,T?PD_9
MK\$M):VQ63Q%XKU%6CTS1(,_ZR>7'+'^&)<R.>@P&(^J/^")_P#P;A?M!_\
M!3+4-,^.?QK^W> ?@JMT&?6Y;<+J'B)5(+16$;]$;[INF!C7G8)&4J/ZAOV5
M_P!DW]G_ /8K^#&E? +]FKX;6'A?PSI,>(;.S0EYY#]Z::1LO-*QY9W)8_0
M  ^?O^"3'_!$_P#9,_X).?#Q(/AKHZ^(OB#J5A'%XJ^(VK6J_;+QL9>*W7G[
M);%N1$A)("[VD*AJ^QZ.G044 %%%% !1110 45#?ZA8:58RZGJE]#;6T$9DG
MN+B0)'&H&2S,>  .YK\BO^"K7_!V9^RY^RBNL?!S]AZULOBQ\0+=FMI->68_
M\([I4P.&8S)S?LO]V$B,G_EKP5(!^H/[1/[3?P"_9+^&&H?&7]H_XL:+X/\
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M0!_)%_P6H_X-U?VCO^"7VJWWQD^&27GCWX+37S?9?$UK;[KS058DI#J,2?=
M'RBY4>4Q W>6SJA_."O[\M;T72?$>E7&@:_I-M?6-Y"T-Y9WD"RPSQL,,CHP
M*LI'!!!!%?@/_P %P?\ @U%:%=6_:G_X);>%V956:\\1?!^#+-W=GTGN>_\
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M2TO_ -'"@#^UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Y7XZ_\D1\9?\ 8JZA_P"DTE?P6U_>E\=?^2(^,O\ L5=0_P#2
M:2OX+: "BBB@ HHHH FT[_D(0?\ 79?YU_>I\'_^22^%_P#L7;'_ -$)7\%>
MG?\ (0@_Z[+_ #K^]3X/_P#))?"__8NV/_HA* .BHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB-_V6BZ_]-6G5^QE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGPK_ .%U9_\ Q5?UI44 ?R6_\0F7_!9__HC/A7_PNK/_ .*H_P"(3+_@L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_*O_ ,'B?_*7M/\
MLE6B_P#HV\K\JZ_53_@\3_Y2]I_V2K1?_1MY7Y5T %%%% !7L?\ P3O_ .3^
MO@G_ -E7\/\ _IQ@KQRO8_\ @G?_ ,G]?!/_ +*OX?\ _3C!0!_<S1110 44
M44 %%%% !1110 4444 ?SP_\'Q?_ "53]G;_ +%_Q)_Z/T^OPAK]WO\ @^+_
M .2J?L[?]B_XD_\ 1^GU^$- !1110 4444 ?W??LI_\ )KOPV_[$'1__ $BA
MKOJX']E/_DUWX;?]B#H__I%#7?4 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'QW_P ' 7_*&C]H/_L0W_\ 2B&OXQZ_LX_X. O^4-'[0?\ V(;_ /I1
M#7\8] !1110 4444 ?TX?\&4W_*-[XC?]EHNO_35IU?L97XY_P#!E-_RC>^(
MW_9:+K_TU:=7[&4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/!WQG^&FO_"/XAZ/'J&@^)M'N-,UBQD'$UM/&T<B_P#?+'GL>:_BN_X*G_\
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M1?\ !(K_ ()P_$#_ (*@?MK^&?V=?#-C<1^'X[A=0\>:Y$I":7H\;KYS[O\
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MO]ZXDM6?R%_VI JYXSGBODDY'!%?W\RP1SQM%-&KJZX967(([@^M?#7[?/\
MP;L?\$Q?V^K>YUSQ)\%H? OBZ8LR^,OAZJ:?<NYR<SPA3;W )/)>,OV#K0!_
M'717ZT?M[_\ !H=^W]^S?<W7BS]E/5].^,WA9%+I;:>!8ZY !DD/:2-Y<PZ
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M 4444 %%%% !1110 4444 %%%% '*_'7_DB/C+_L5=0_])I*_@MK^]+XZ_\
M)$?&7_8JZA_Z325_!;0 4444 %%%% $VG?\ (0@_Z[+_ #K^]3X/_P#))?"_
M_8NV/_HA*_@KT[_D(0?]=E_G7]ZGP?\ ^22^%_\ L7;'_P!$)0!T5%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_V6BZ_]-6G5^QE?CG_P93?\HWOB-_V6BZ_]-6G5^QE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%W_1ZLW_ (;3Q)_\KJ /T%HK\^O^(I?_ ((7?]'JS?\ AM/$G_RNH_XBE_\
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M .5U 'Z"T5^?7_$4O_P0N_Z/5F_\-IXD_P#E=1_Q%+_\$+O^CU9O_#:>)/\
MY74 ?H+17Y]?\12__!"[_H]6;_PVGB3_ .5U'_$4O_P0N_Z/5F_\-IXD_P#E
M=0!^@M%?GU_Q%+_\$+O^CU9O_#:>)/\ Y74?\12__!"[_H]6;_PVGB3_ .5U
M 'Z"T5^?7_$4O_P0N_Z/5F_\-IXD_P#E=1_Q%+_\$+O^CU9O_#:>)/\ Y74
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#7[O?\'Q?_)5/V=O^Q?\2?\ H_3Z_"&@ HHHH **** /[OOV4_\ DUWX;?\
M8@Z/_P"D4-=]7 _LI_\ )KOPV_[$'1__ $BAKOJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#X[_P"#@+_E#1^T'_V(;_\ I1#7\8]?V<?\' 7_ "AH
M_:#_ .Q#?_THAK^,>@ HHHH **** /Z</^#*;_E&]\1O^RT77_IJTZOV,K\<
M_P#@RF_Y1O?$;_LM%U_Z:M.K]C* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBB@#^%']MC_D\SXN?]E.U_\ ].,]>8UZ=^VQ_P GF?%S_LIVO_\ IQGKS&@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _LA_X-R_\ E"[\"?\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E7_X/$_\ E+VG_9*M%_\
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M/8P2LDBM_LE0?:O>HY8YHUEBD5E9<JRG(8>HH =1110 4444 %%%% !1110
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MT)?QPEOJN1Z&OJWPOXL\,>-M'A\1^#?$NGZOIUPN;>_TN\2XAD'JKQDJ?P-
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MP7KEQX8\8>'K[2M2LY-EUI^I6KP30M_=9' 93[$5_?;M%> ?MI_\$N?V$/\
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M 4444 %%%% !1110 4444 %%%% '*_'7_DB/C+_L5=0_])I*_@MK^]+XZ_\
M)$?&7_8JZA_Z325_!;0 4444 %%%% $VG?\ (0@_Z[+_ #K^]3X/_P#))?"_
M_8NV/_HA*_@KT[_D(0?]=E_G7]ZGP?\ ^22^%_\ L7;'_P!$)0!T5%%% !11
M10 4444 %%%% !1110 4444 %%%>,_ML?\% /V3O^">GPHN/C!^U9\7=.\-Z
M>D9_L_3VD$FH:I)G AM+9?WD[Y(SM&%&68JH+  ]F)YQ7SW^VW_P50_8,_X)
MY^'9M8_:G_:(T70[Y8]UKX:M9#>:M=D]!'9P[I>?[[!4&<LRCFOP+_X*<?\
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ME>Q_\$[_ /D_KX)_]E7\/_\ IQ@H _N9HHHH **** "OR'_X+\_\'#/[3_\
MP24_:R\,_ #X*?!;P'XDTS6_ <&NW%YXICO6GCF>[NH"B^1<1KLVP*>03DGG
MI7Z\5_,3_P 'J/\ RDJ\ ?\ 9&;/_P!.>HT :W_$;-_P4 _Z-4^#O_?C5?\
MY-H_XC9O^"@'_1JGP=_[\:K_ /)M?C'10!^SG_$;-_P4 _Z-4^#O_?C5?_DV
MC_B-F_X* ?\ 1JGP=_[\:K_\FU^,=% 'V!_P5N_X++_'C_@L%XB\$>)/CE\,
M/"/AF7P+97UMIL?A-+I5G6Z>%G,GVB:3D&!<;<=3G/&/C^BB@ HHHH ****
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M'[0?_8AO_P"E$-?QCU_9Q_P<!?\ *&C]H/\ [$-__2B&OXQZ "BBB@ HHHH
M_IP_X,IO^4;WQ&_[+1=?^FK3J_8ROQS_ .#*;_E&]\1O^RT77_IJTZOV,H *
MCN[RTL+62^OKF.&&&,O--,X544#)8D\  =S7A7_!0+_@I'^RE_P31^"\_P :
M/VH/B%#IT;;H]$\/VA$NI:U<=H;6 '<Y_O.<(@Y=E%?S"?\ !6G_ (.*OVSO
M^"F6JZM\.O#NN77PZ^$<UP5L_ ^AWK+-J$ ^Z=1N$P;DG[QB&(@<?*Q4,0#]
MN/\ @I%_P=1?\$_?V(=4OOAK\')YOC+XXL]R7&G^%;Q8]*LI?[DVH%61CZK
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MOI7_ *37E 'P)_Q&S?\ !0#_ *-4^#O_ 'XU7_Y-H_XC9O\ @H!_T:I\'?\
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M)N/[%LWC;@QNMKL>5,<;9'<'OFOC^>>>YE:>YF:21FRSR,22?4FFT4 %%%%
M!1110 4444 %>E_LW_ME_M8?L?\ B5O%O[+W[1/C#P)>RE?M7_"-Z]-;178'
M19X5;RYUS@[9%9<@'' KS2B@#]E/V%_^#R3]LGX07UOX6_;;^&6C_%/P_@(V
MM:2BZ5K4'^T2H-O<#_8,<;'.?,[5^W/_  3U_P""U/\ P3X_X*6:5#;_ +/G
MQHM[7Q1L'VSP'XF46.KP-C)"PN=MPH_OP-(H[D'('\656M%UO6O#>KVVO^'=
M7NM/O[.99K.^LKAHIH)%.5='4AE8'D$$$4 ?WY @]**_FI_X)&_\';WQN^!%
M]8?!7_@I*]]\0/!NR.WL_'UK%YFNZ7@@;[GG_3X]O4\3Y!):4G;7]%7P2^.?
MPA_:0^&.D_&;X$?$/2O%7A?7+5;C3-9T>[6:&52.F1RKKT9& 96!5@""* .L
MHHHH **** "BBB@ HHHH **** "OSX_X.D_^4(OQ=_Z^-"_]/-G7Z#U^?'_!
MTG_RA%^+O_7QH7_IYLZ /Y"J*** "BBB@#Z/_P""/W_*4O\ 9_\ ^RKZ+_Z5
M)7]MM?Q)?\$?O^4I?[/_ /V5?1?_ $J2O[;: "BBB@ HHHH **** "BBB@ H
MHHH *Y/XW?&WX5?LY?"K7/C?\;/&]CX=\+^'+![S6-8U"7;'!$OZLQ.%50"S
M,0H!) JQ\7OB[\-?@)\,=<^,OQB\8V7A_P ,>&]/DO=:UC4)-D-K @Y8GJ3T
M 4 LS$* 20*_DS_X+T_\%TOB%_P5>^+G_"!_#>6_T'X*^%[S=X8\/S9CFU:X
M4%?[2O%!P9"&81Q](D..69F(!]>?'3_@]B_:0C^+>N0_LW?LK>!&\#Q7S)X=
MF\8_;GU*>W7@2S_9[E(T9OO;%!V@@;F(R>3_ .(V;_@H!_T:I\'?^_&J_P#R
M;7XQT4 ?LY_Q&S?\% /^C5/@[_WXU7_Y-H_XC9O^"@'_ $:I\'?^_&J__)M?
MC'10!^SG_$;-_P % /\ HU3X._\ ?C5?_DVC_B-F_P""@'_1JOP=_P"_.J__
M ";7XQU^OW_!NQ_P;K:Q^W!K.F_ME_MH>%[BQ^#]C<^9X?\ #-W')#/XQF0C
M#=BMBK?><<RD%%XW, #]A/\ @B#^W=_P4V_X*,_#NX_:3_:T_9^\ _#OX<WU
MNR>#X])T_4$U379,C_2D^T7+K': ;@&*$R-]W"@L?OJJNBZ)I'AO2;70/#^E
MV]C86-LEO96-I"L<5O"BA4C15 "JJ@ *!@ 8%6J "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH _A1_;8_Y/,^+G_93M?_\ 3C/7F-?TU?%S_@S/
M_9,^+WQ7\3_%C5?VP/B):77BCQ#>ZM<VMOI=@8X9+F=YF124SM!<@9YP*YW_
M (@C/V//^CT/B5_X*M/_ /B* /YMZ*_I(_X@C/V//^CT/B5_X*M/_P#B*/\
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M>([?QO\ $K1-;^+^K6=QYUFOCR=#I\1'3-E J13C_9F\Q3_=Z8 /YM/V,?\
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ME<_\3?A3\,?C1X0NOA]\7_ASH?BK0;^,QWVC>(M)AO;6=3U#Q3*RM^(KH**
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M<7"M,\NYQ& H.7(X'05Z]0 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_\ 8NV/_HA*_@KT[_D(0?\ 79?YU_>I\'_^22^%_P#L7;'_ -$)0!T5%%%
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M HHHH **** "BBB@#^5?_@\3_P"4O:?]DJT7_P!&WE?E77ZJ?\'B?_*7M/\
MLE6B_P#HV\K\JZ "BBB@ KV/_@G?_P G]?!/_LJ_A_\ ].,%>.5['_P3O_Y/
MZ^"?_95_#_\ Z<8* /[F:*** "BBB@ K^8G_ (/4?^4E7@#_ +(S9_\ ISU&
MOZ=J_F)_X/4?^4E7@#_LC-G_ .G/4: /QYHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _L6_X-K/^4(?P%_[ VJ_^GJ_K[FKX9_X-
MK/\ E"'\!?\ L#:K_P"GJ_K[FH **** "BBB@#X[_P"#@+_E#1^T'_V(;_\
MI1#7\8]?V<?\' 7_ "AH_:#_ .Q#?_THAK^,>@ HHHH **** /Z</^#*;_E&
M]\1O^RT77_IJTZOK;_@L]_P6G^!'_!([X,+J&MK#XB^)7B*UE'@CP/#-AIF
MQ]KNB#F*U1L9/#2$;4YW,OY(_P#!#+_@K+\'_P#@DS_P0^^*'Q6\626NJ>--
M:^,U_:?#WP<TQ#ZK?#2-..^0+\R6T60TDG'54!W.M?D-^U#^T]\:OVQOCGX@
M_:*_:"\:W.O>*/$EZUQ?7EPQVQKT2&)>D<4:X1$'"J * -?]LK]M7]H[]OCX
MYZI^T)^TY\1+K7]?U)ML2LQ6UT^W'W+:VASM@A7LJ]22QRS,Q\IHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_33_ ((1?\'#GQ;_ ."9?BO3_@-\?-2U
M+Q5\"[Z[(N--_P!=>>&'<\W-EDY,6[YI+?.TC<R .3O_ #+HH _O:^$OQ8^'
M/QU^&FA_&'X1^+[+7O#7B33(=0T75]/F$D5S;R*&5@1WP>0<$'((!!%=%7\H
MO_!N7_P76U__ ()O?%ZW_9P_:%\3W%Q\$/%VI 733;I3X6OI/E%[".H@8X\Z
M,=OWBC<&#_U9:7JNFZYIEOK.C7\-U9WD"S6MU;R!XYHV 975AD,I!!!'!!H
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MD;;.Y;D>6S>7(P^1@SK$/U[K^ 6*66"59H9&1T8,K*V"I'0@^M?O-_P;R?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXSD=ZZG(]: "BC-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?(7_!?+_E#?^T+_ -D]N/\
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M_&* /T"HK\_?^(H/_@BI_P!':-_X2>I?_&*/^(H/_@BI_P!':-_X2>I?_&*
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M2OX*]._Y"$'_ %V7^=?WJ?!__DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%%
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M_?S3%%><^/?^#2+_ (+(^#+=KG2/AQX+\2*O\.A^-8-S<9X%P(C[?6OZR**
M/XB/VD/^"3W_  4D_9(MYM2_: _8N\?Z%IMOS-K<>@R7FGI];NV\R ?0N#7S
MY)')$[12QLK*<,K#!!K^_B2-)$:-T5E8896'45\J_MG_ /!$W_@FA^WAI-Q%
M\<_V7- AUJ8,8O%WA> :5JL,AS\_GV^WSL9SLF$B$\E2: /XKZ*_9O\ X*6?
M\&?'[3'P$MKGXF?L!>-)/BMX=C626Y\):E$EKKUFHY BP?*OAC^[Y<F< 1OR
M1^.?BGPKXG\#^)+[P=XU\.7VCZOI=U):ZEI>J6CV]Q:3HQ5XI(W 9'5@058
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M;C_Y,H _"6BOW:_X@=OB[_TD-\-_^&]N/_DRC_B!V^+O_20WPW_X;VX_^3*
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M?:* /Y7_ !/_ ,&<7_!6W0K<S:1K7PHUI@N?*T_QA/&Q/I^_M(QG\<<UX/\
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M#\!_&UYX?\5>%]2CO=+U*SDQAD8$QR+]V6)QE7C8%'1F5@02*_L0_P""-?\
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M%%% 'T?_ ,$?O^4I?[/_ /V5?1?_ $J2O[;:_B2_X(_?\I2_V?\ _LJ^B_\
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M($7:L<:* %4 =!6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ'P(^-.EK:ZI;QR7'@WQ=:Q*;S0+_ VS1DCYHV*JLL1XD3(^5@KK_'3^V?\
ML=_&_P#8-_:.\2?LP_M!>&6TWQ!X=O"GF+DP7]L23#=P-_'#*F&5NO." P8
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M:HHH **** "BBB@ HHHH *CNK.UOK:2SO;=)H9D*30R(&5U(P5(/4$=JDHH
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M#KQ=JG@'QYX;O='UO1;^:QU?2=2MVAN+.YB<I)#(C ,CJP*E2,@BLVOZ._\
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ME7TK_P!)KROUEK\FO^#R;_E%%I/_ &5?2O\ TFO* /Y:**** "BBB@ HHHH
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M]ISX+:TM]X=\8:/'?63<>9 QXEMY!_#+%('C=>S(17HU?SI?\&;_ /P4NO\
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M^%E% '[I_P#$<)\<?^D?WA3_ ,+JY_\ D:C_ (CA/CC_ -(_O"G_ (75S_\
M(U?A910!^Z?_ !'"?''_ *1_>%/_  NKG_Y&H_XCA/CC_P!(_O"G_A=7/_R-
M7X644 ?NG_Q'"?''_I']X4_\+JY_^1J/^(X3XX_](_O"G_A=7/\ \C5^%E%
M'[I_\1PGQQ_Z1_>%/_"ZN?\ Y&H_XCA/CC_TC^\*?^%U<_\ R-7X644 ?NG_
M ,1PGQQ_Z1_>%/\ PNKG_P"1J\D_:=_X/*/^"CGQ;T&3PW^S]\-? _PJ6:/#
MZO:6KZQJ*'OY;W?^CJ/K Q'8BOR'HH ]@_:2_P""@'[;'[8$SO\ M,?M0^-/
M&4,C[SI^KZY*UF&!R"+92(5(/3"#%>/T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#R-1_Q'"?''_I']X4_\+JY_P#D:OPLHH _=/\ XCA/CC_TC^\*?^%U<_\
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M2OX*]._Y"$'_ %V7^=?WJ?!__DDOA?\ [%VQ_P#1"4 =%1110 4444 %%%%
M!7Y\_P#!RC_P48U#_@GW_P $W]<3X?ZXEGX[^)LDGA?PG(LF);6.6,_;+R,=
M=T4!8*P^Y)+$?0']!J_DQ_X.J_VYT_:Y_P""G^L?"[PIXD-]X4^#=J?#&FK'
M(3#_ &D"'U)U']X3@0,V.?L@Z@ T ?FB6+'<QR3U-%%% !1110 5-86%]JM]
M#I>F6<MQ<W,RQ6]O!&6>61CA551R220 !R34-?LY_P &DO\ P20L?VD?C9<_
M\%#OCMX8FF\'_#C4A!X#L[F,"'5=> !-P01^\CM58, , S/&<GRG4@'Z/_\
M!MW_ ,$/](_X)O\ P.A_:/\ CQX>63XU>.M+1KZ*[B7=X7T]P&73X^I$S<-.
MV>2%0 !"7_4&@'(HH **** "BBB@ HHHH **** "BBB@ HHHH *_,O\ X.8/
M^"05A_P40_9(N/CC\(O",,WQ>^&%C-?:+);KB?6M+4%[G33_ ,]&P#+"#DB1
M2BD>:V?TTI' 92&% '\ TD<D,C12QLK*V&5A@@^E-K]%?^#FO_@G%IG[ /\
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M)-<VD4LB?\!=F7J>E>D4 %%%% !1110 4444 ?RK_P#!XG_RE[3_ +)5HO\
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M=_\ !P%_RAH_:#_[$-__ $HAK^,>O[./^#@+_E#1^T'_ -B&_P#Z40U_&/0
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MK'!&"2>2269F)9F8EF9BQ)))KK* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /X-_VD/^3B/'O_8Z:I_Z5RUQ==M^
MTM#-;_M'?$"WN(FCDC\;:JKHRX*L+R7((]:XF@ HHHH **** "BBB@ HHHH
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M235/!=['&/?>8]I'N#BO(98I;>5H)XF1U;#(RX(/H10 VBBB@ HHHH ****
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MH_XA$_\ @C3_ -"#X\_\+R?_ .)H _D_HK^L#_B$3_X(T_\ 0@^//_"\G_\
MB:/^(1/_ ((T_P#0@^//_"\G_P#B: /Y/Z*_K _XA$_^"-/_ $(/CS_PO)__
M (FC_B$3_P""-/\ T(/CS_PO)_\ XF@#^3^BOZP/^(1/_@C3_P!"#X\_\+R?
M_P")H_XA$_\ @C3_ -"#X\_\+R?_ .)H _D_HK^L#_B$3_X(T_\ 0@^//_"\
MG_\ B:/^(1/_ ((T_P#0@^//_"\G_P#B: /Y/Z*_K _XA$_^"-/_ $(/CS_P
MO)__ (FC_B$3_P""-/\ T(/CS_PO)_\ XF@#^3^BOZP/^(1/_@C3_P!"#X\_
M\+R?_P")H_XA$_\ @C3_ -"#X\_\+R?_ .)H _D_HK^J/XH_\&F7_!'OPI\-
M/$7BC1_ ?CI;K3="O+JU:3QU.RB2.%W4D;>1D#BOY7* "BBB@ HHHH FT[_D
M(0?]=E_G7]ZGP?\ ^22^%_\ L7;'_P!$)7\%>G?\A"#_ *[+_.O[U/@__P D
ME\+_ /8NV/\ Z(2@#HJ*** "BBB@ HHHH \C_;V_:<T']C/]C+XF?M0^([Z.
M"'P7X.O;^T\S_EO>",I:P#MNEN&AB7/&Z09K^&WQ/XCUGQCXEU#Q=XBO6N=0
MU6^FO+ZXD8EI9I7+NY)[EF)_&OZ9_P#@\Y_:._X5M_P3V\'_ +/%EJ'EW7Q,
M\=+)<6X;F:QTU!/)]5$\EH?J5K^8J@ HHHH **** .T_9S^ _C[]J'X\>$?V
M=_A=8BX\0>,_$%KI.EHV=JR32!/,?'(1 2['LJDU_;S^Q?\ LJ?#S]B+]EKP
M3^RK\+8V_L;P7H<5C%<2(%>[FY:>Y<#C?+*TDC>[FOY]_P#@S*_8<TGXL?M6
M^-/VW?&NCBXL_AAI2Z9X6\Q?E75[Y6#S#U:.U$J@=C<ANH!K^E>@ Z=!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ?FC_P=8?L8V7[47_!*SQ!\
M3=(\/)=>)/A!>IXHTVXCC!FCL1B/4$!ZB/R&\YQT/V93R5%?R8U_?)\0?!6@
M?$GP'K7PZ\5V$=UI>OZ1<Z;J5K,NY)K>>)HI$8=P58@CT-?PF_M$?"75/@'\
M?/&WP.UI66[\'^+-0T:XW]=UM<O"<_\ ?% '&T444 %%%% '[9?\&3GQR?PW
M^US\6OV>+B\"Q>*O MOK-O"3]^:PNA&<>IV7K>^,^]?TE5_';_P;6?&2X^"_
M_!:3X*ZC]L,5IXAU2]\/7T><"9;ZQG@B4_2X:!OJ@K^Q*@ HHHH **** "BB
MB@ HHHH ,#&,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XP?\
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M#H__ *10UWU<#^RG_P FN_#;_L0='_\ 2*&N^H **** "BBB@ HHHH ****
M"BBB@ HHHH **** /CO_ (. O^4-'[0?_8AO_P"E$-?QCU_9Q_P<!?\ *&C]
MH/\ [$-__2B&OXQZ "BBB@ HHHH _2K_ (-0OV7W_:(_X*[^&O&.H6'G:3\+
M_#]_XJOV=/E\Y56TM5STW>?=1R =2(FQT)']:2GC@5^!'_!CY\,8%TWX_?&>
M2U4RR3Z)HL,Q'*J!<SNH^I9"?]T>E?OO0 4444 %%%% !1110 4444 %%%%
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M<9Z\QH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6F/->_LZ?MU^']8C.3#I_C+PC-I[H,?=,]O-.'/OY:#GIWH _"6BOTM^+_\
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M)R?]&_?%S_P7Z?\ _)= '[%45^.O_$:A_P $Y/\ HW[XN?\ @OT__P"2Z/\
MB-0_X)R?]&_?%S_P7Z?_ /)= '[%45^.O_$:A_P3D_Z-^^+G_@OT_P#^2Z/^
M(U#_ ()R?]&_?%S_ ,%^G_\ R70!^Q5%?CK_ ,1J'_!.3_HW[XN?^"_3_P#Y
M+H_XC4/^"<G_ $;]\7/_  7Z?_\ )= '[%45^.O_ !&H?\$Y/^C?OBY_X+]/
M_P#DNC_B-0_X)R?]&_?%S_P7Z?\ _)= '[%$9K^0/_@YZ^!EI\#?^"T/Q632
M;+R-/\7?V;XFLUQ]YKNRB-RW09S=I<G\<<D$U^N7_$:A_P $Y/\ HW[XN?\
M@OT__P"2Z_'7_@O]_P %+_@#_P %4_VOM"_:-^ 7@OQ)HEI9>";?1=1M_$UO
M!',\L5Q/(K+Y,D@*[9L<D'.>* /A>BBB@ HHHH ]L_X)M>,G^'O_  4'^"/C
M.-V5M/\ BIH,FY3@C_3X1Z'UK^Y"OX,?@!J4^C_'CP3J]LJM):^+M-FC5LX+
M+=1D9QVXK^\R(YB4_P"R* '4444 %%%% !1110 4444 %%%% !1110 4444
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M-O\ L0='_P#2*&N^H **** "BBB@ HHHH **** "BBB@ HHHH **** /CO\
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M444 %%%% !7Y-?\ !Y-_RBBTG_LJ^E?^DUY7ZRU^37_!Y-_RBBTG_LJ^E?\
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M **** "BBB@#^IS_ (,X?B1=^,_^"2M_X2O;AF'A#XL:QIMM&S9V0RV]E>C
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M:VMO&/,GD/,EQ,^,RS2-EGD;EF/T%>B4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\I>)_P#@AM_P
M20\9^)=0\8^*OV"? -]JFK7TU[J5]<:>YDN+B5R\DC'?U9F)/N:H_P##A'_@
MCC_TCT^'?_@M?_XNOKNB@#Y$_P"'"/\ P1Q_Z1Z?#O\ \%K_ /Q='_#A'_@C
MC_TCT^'?_@M?_P"+KZ[HH ^1/^'"/_!''_I'I\.__!:__P 71_PX1_X(X_\
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M:5IVDVBV.DZ?!:PK]V&WA"(/H ,58HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *:\:RHT<BAE8896'!%.HH \U^+/[&O[)'QYL7TWXW?LO_#WQ=#(
MK*R^)/!ME>D9ZD&6)BI]P01VKP^3_@@K_P $<Y)&D?\ X)Y_#G+-D[=+=1^
M#X'T%?75% 'R)_PX1_X(X_\ 2/3X=_\ @M?_ .+H_P"'"/\ P1Q_Z1Z?#O\
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MP[_\%K__ !=?7=% 'R)_PX1_X(X_](]/AW_X+7_^+H_X<(_\$<?^D>GP[_\
M!:__ ,77UW10!\B?\.$?^"./_2/3X=_^"U__ (NC_APC_P $<?\ I'I\._\
MP6O_ /%U]=T4 ?(G_#A'_@CC_P!(]/AW_P""U_\ XNC_ (<(_P#!''_I'I\.
M_P#P6O\ _%U]=T4 ?(G_  X1_P""./\ TCT^'?\ X+7_ /BZ/^'"/_!''_I'
MI\.__!:__P 77UW10!\B?\.$?^"./_2/3X=_^"U__BZ/^'"/_!''_I'I\.__
M  6O_P#%U]=T4 <M\%_@G\*OV=OAGI/P;^"/@:Q\-^%M"A:'2-#TV,K!:QEB
MY502<#<Q/XUU-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %?(7_  7R_P"4-_[0O_9/;C_T;'7U[7R%_P %\O\ E#?^
MT+_V3VX_]&QT ?Q@4444 %%%% !7T]_P18_Y2Q_L^_\ 94M+_P#1PKYAKZ>_
MX(L?\I8_V??^RI:7_P"CA0!_:]1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 <K\=?^2(^,O^Q5U#_P!)I*_@MK^]+XZ_\D1\
M9?\ 8JZA_P"DTE?P6T %%%% !1110!-IW_(0@_Z[+_.O[U/@_P#\DE\+_P#8
MNV/_ *(2OX*]._Y"$'_79?YU_>I\'_\ DDOA?_L7;'_T0E '14444 %%%% !
M45Y<P6=M)=W3[8X8V>1L=% R3^52URWQPU,Z)\%_%VMK(J&S\+ZA/N<X V6T
MC9/H.* /X7/VA_'5]\4/C_XY^)FILS7/B+QAJ>IW#,<DO<7<DK9]\N:X^I]3
MN#=ZE<71;/F3N^1WRQ-04 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!TWP6_Y+'X3_ .QFL/\ TH2O
M[U(?]4O^Z*_@W_9ST>7Q%^T)X#\/P;_,OO&6EVZ>7'N;+W<2C [GGIWK^\B,
M%8U4]EH =1110 4444 %%%% !1110 445PWQU_::_9W_ &8?"<OCK]HGXX>%
M?!.DPKEK[Q/KL%DCG^ZGFL"['LJ@L3P 30!W-%?F%\?O^#N'_@D/\&Y+BQ\$
M>+O&7Q&NH<A%\'>%V6%V]I;Y[=<>XSQTS7Q%\:/^#W_XCWEW-:?L\?L':+I]
MNK8M[_QEXPEO'D']YH+:&$(?;S7^IH _H:W<XQ2!L]17\L7CC_@\9_X*P^(Y
M6/A/1?ACX=C9B0MKX5EN&7G@ S3L/S%>;:[_ ,'6'_!;W5]_]G_M3:1I>Y0%
M^P_#G1&V<]1YUI)UZ<YH _KG!SR**_D"_P"(HW_@NO\ ]'R_^8R\,?\ RLH_
MXBC?^"Z__1\O_F,_#'_RLH _K]HK^0+_ (BC?^"Z_P#T?+_YC/PQ_P#*RC_B
M*-_X+K_]'R_^8S\,?_*R@#^OVBOY O\ B*-_X+K_ /1\O_F,_#'_ ,K*/^(H
MW_@NO_T?+_YC/PQ_\K* /Z_:*_D"_P"(HW_@NO\ ]'R_^8S\,?\ RLH_XBC?
M^"Z__1\O_F,_#'_RLH _K]HK^0+_ (BC?^"Z_P#T?+_YC/PQ_P#*RC_B*-_X
M+K_]'R_^8S\,?_*R@#^A'_@YA_Y0>_'C_L&:-_Z?=.K^.^OL3]IC_@OM_P %
M:OVP_@=KW[-_[1O[6'_"1>"_$T<,>N:+_P ()H-G]I6*>.XC'G6MC'*F)8HV
M^1USMP<@D'X[H **** "BBB@#^IC_@S3_P"42NM?]EEUC_TATVOUDK\F_P#@
MS3_Y1*ZU_P!EEUC_ -(=-K]9* "BBB@ HHHH **** /Y5_\ @\3_ .4O:?\
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MHH **** "BBB@ K\FO\ @\F_Y11:3_V5?2O_ $FO*_66OR:_X/)O^446D_\
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MY$&>-S-.BL<<<*H]J /Z:PP-*#FOY-/%/_!VW_P6A\0%CI/Q:\&Z'N^Z-+\
M63[>>WVE9?USU^E<E>?\'2G_  72N;EIX/VV([=6Z0P_#/PT57Z;].8_F30!
M_7Q17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_\QGX8_\
ME90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_\QGX
M8_\ E90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\ Z/E_
M\QGX8_\ E90!_7[17\@7_$4;_P %U_\ H^7_ ,QGX8_^5E'_ !%&_P#!=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KY"_X+Y?\H;_ -H7_LGMQ_Z-CKZ]KY"_X+Y?\H;_ -H7_LGMQ_Z-CH _
MC HHHH **** "OI[_@BQ_P I8_V??^RI:7_Z.%?,-?3W_!%C_E+'^S[_ -E2
MTO\ ]'"@#^UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Y7XZ_\D1\9?]BKJ'_I-)7\%M?WI?'7_DB/C+_L5=0_])I*_@MH
M **** "BBB@";3O^0A!_UV7^=?WJ?!__ ))+X7_[%VQ_]$)7\%>G?\A"#_KL
MO\Z_O4^#_P#R27PO_P!B[8_^B$H Z*BBB@ HHHH *X7]J,_\8S?$7_L1=7_]
M(I:[JN-_:)T\ZM^S_P".M*&[_2O!VIQ?NURWS6D@X]^: /X-:*DNH?L]S);\
M_NY"O/L:CH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#W;_@E]X&E^)7_!1SX%^!H(!(VH?%;0H]C=
M#B^B;^E?W#5_(G_P:S_ >X^-_P#P6=^&^I261FT_P+I^J>)]2^4_(L-H\$#>
MV+JYMOY5_790 4444 %%%% !1103@=* "OFO_@H3_P %9?V'O^"8_A6'7?VI
M_BW'9ZI?6[3:/X/T>,76L:DHR-T5N&&$R"OF2,D>[@N#7YT?\%U/^#I7PW^S
M-J.K_LF_\$Z-7T_7_'UOYUGXD^(A1+BP\.S#*M#:JP*7=TISEFS%&1C$C;@G
M\YWQ1^*OQ*^-OCS4OBC\7_'>J^)?$6L7!GU/6M:OGN+FYD/=G<DGT Z <# H
M _53]O[_ (.^_P!NO]HK^U/ _P"R%X?LO@YX7N'DBAU2W*WVO36YR 3<.OEV
MSL.?W*;T.-LAQN/Y6_$SXN_%;XT^)IO&GQ@^)6O>*M8N&+3:IXBU>:\N').2
M3)*S-R?>N=HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /ZF/\ @S3_ .42NM?]EEUC_P!(=-K]9*_)O_@S3_Y1*ZU_V676/_2'
M3:_62@ HHHH **** "BBB@#^5?\ X/$_^4O:?]DJT7_T;>5^5=?JI_P>)_\
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MR+J^\*64,A0?+Y2:L[@'KSYJ9'3A?P_?*@ HHHH *_F9_P"#V/\ Y2(?"_\
M[(O!_P"G?4:_IFK^:+_@]HTNXB_;Y^$^M,Z>5<?"!8$4$[@T>JWK$GCIB1<<
M]CT[@'XP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!_5;_ ,&?7PGNOA[_ ,$@+?QG=02*OCOX
MF:UK5N\B8WQQ"WTWY3W4/82?\"W5^I]?*'_!#/X/O\"_^"1WP#^'DUL895\
M6^I7$9[2WSR7TGYO<L?QKZOH **** "BBB@ H)QUH/TKYU_X*4_\%/?V7/\
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MFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\ 6_\ \:H
M_LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[_6__ ,:H
M _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O];__ !J@
M#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\ O];_ /QJ
M@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\ 6_\
M\:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[_6__
M ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O];__
M !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\ O];_
M /QJ@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\1 '_  66_P"D@_CS_O\
M6_\ \:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\ ^-4?\1 '_!9;_I(/X\_[
M_6__ ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\ XU1_Q$ ?\%EO^D@_CS_O
M];__ !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\ $0!_P66_Z2#^//\
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MQ$ ?\%EO^D@_CS_O];__ !J@#^SFBOXQO^(@#_@LM_TD'\>?]_K?_P"-4?\
M$0!_P66_Z2#^//\ O];_ /QJ@#^SFBOXQO\ B( _X++?])!_'G_?ZW_^-4?\
M1 '_  66_P"D@_CS_O\ 6_\ \:H _LYHK^,;_B( _P""RW_20?QY_P!_K?\
M^-4?\1 '_!9;_I(/X\_[_6__ ,:H _LYHK^,;_B( _X++?\ 20?QY_W^M_\
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M'"@#^UZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH Y7XZ_\ )$?&7_8JZA_Z325_!;7]Z7QU_P"2(^,O^Q5U#_TFDK^"V@ H
MHHH **** )M._P"0A!_UV7^=?WJ?!_\ Y)+X7_[%VQ_]$)7\%>G?\A"#_KLO
M\Z_O4^#_ /R27PO_ -B[8_\ HA* .BHHHH **** "J?B+28M?T&^T*X/[N]L
MY().O1U*GICL?6KE(V.AH _@=^(NBW?AOX@Z[X=OH#%/8:S=6TT;=49)64C\
M"*QJ^BO^"NOPG?X(?\%0_C]\-?):.&S^+&MSV*,N"+6XNY+F#IC_ )8S1]
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M"/\ Q \^%_\ I(+J'_A!)_\ )5'_ ! \^%_^D@NH?^$$G_R57[W44 ?@C_Q
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MH **** /YX?^#XO_ )*I^SM_V+_B3_T?I]?A#7[O?\'Q?_)5/V=O^Q?\2?\
MH_3Z_"&@ HHHH **** /[OOV4_\ DUWX;?\ 8@Z/_P"D4-=]7 _LI_\ )KOP
MV_[$'1__ $BAKOJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X[_P"#
M@+_E#1^T'_V(;_\ I1#7\8]?V<?\' 7_ "AH_:#_ .Q#?_THAK^,>@ HHHH
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M&[L))E7_ ,DG_*@#^;NBBB@ HHHH N>'].AUC7['2+FY\F.ZO(X9)@N?+5G
M+8R,XSGK7[]:7_P9$^#M6TVWU6T_X*#Z@T-U"LL1_P"$"CY5@"/^7OT-?S]Q
M2R02K/"^UD8,K#L1WK^Z;]AGXH6?QK_8L^$?Q=L;A9(_$WPUT/4@T;;AF:PA
M<CZ@L01U!!!H _&7_B!Y\+_])!=0_P#""3_Y*H_X@>?"_P#TD%U#_P ()/\
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MC_B!Y\+_ /2074/_  @D_P#DJOWNHH _!'_B!Y\+_P#2074/_""3_P"2J/\
MB!Y\+_\ 2074/_""3_Y*K][J* /P1_X@>?"__2074/\ P@D_^2J/^('GPO\
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M_P#A5O@.XGTCX?:>TA$5RBOMFU(ITWW#*&!/S"(1*<$$5\'T %%%% !1110
M4444 %%265E>:C=QZ?I]I)<7$T@2&&&,L\C$X"@#DDGL*]E\!?\ !.'_ (*!
M_%"VCOO '[$WQ4U2WF7,-U;> [_R7&,Y$AB"G@=C_,4 >+45]5:9_P $/?\
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MS_!?XJ_L[_$[5O@Q\;O NH>&?%6@S+#K&AZI%LN+21HUD577)P2CJWT85R]
M!1110 5]H?\ !N__ ,II?V?_ /L;IO\ T@N:^+Z^T/\ @W?_ .4TO[/_ /V-
MTW_I!<T ?V64444 %%%% !1110 5^?'_  =)_P#*$7XN_P#7QH7_ *>;.OT'
MK\^/^#I/_E"+\7?^OC0O_3S9T ?R%4444 %%%% 'T?\ \$?O^4I?[/\ _P!E
M7T7_ -*DK^VVOXDO^"/W_*4O]G__ +*OHO\ Z5)7]MM !7RO_P %=?\ @EK\
M'O\ @JY^RKJ'P,\>I%IWB33]]]X#\6+'F71M1V\$XY:"0#RY8^05.1AT1E^J
M*.>U '\'W[2_[-GQD_9#^./B+]G;X^^#;C0O%7AF^:UU*QN!P>ZRQL.)(G4A
MT<9#*P(KA*_K._X.*?\ @A[H?_!3CX&/\:_@AH-C:?&WP3I[OH]R(PC>)+%
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M%S_LIVO_ /IQGKS&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML=>)=36/1?BQH(NM)CED^YK&GAY$"@_\]+:2Y#8Y)BC]* /Z;J*** "BBB@
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MR3_P3'_X(,_M[?\ !4'4+;Q#\,O R^%?A^S'[5\1O%R/!IY4'!6V4 R7CY!
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M_P!/-G0!_(51110 4444 ?1__!'[_E*7^S__ -E7T7_TJ2O[;:_B2_X(_?\
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M+G_93M?_ /3C/7F- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!_9#_P;E_\H7?@3_V+=Q_Z6W%?;=?$G_!N7_RA=^!/_8MW'_I;<5]M
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5\A?\%\O^4-_P"T+_V3VX_]&QU]>U\A?\%\O^4-_P"T+_V3VX_]&QT ?Q@4
M444 %%%% !7T]_P18_Y2Q_L^_P#94M+_ /1PKYAKZ>_X(L?\I8_V??\ LJ6E
M_P#HX4 ?VO4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% '*_'7_DB/C+_ +%74/\ TFDK^"VO[TOCK_R1'QE_V*NH?^DTE?P6
MT %%%% !1110!-IW_(0@_P"NR_SK^]3X/_\ ))?"_P#V+MC_ .B$K^"O3O\
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M%%% !1110 4444 %%%% 'QW_ ,' 7_*&C]H/_L0W_P#2B&OXQZ_LX_X. O\
ME#1^T'_V(;_^E$-?QCT %%%% !1110!_3A_P93?\HWOB-_V6BZ_]-6G5^QE?
MCG_P93?\HWOB-_V6BZ_]-6G5^QE !1110 4444 %%%% !1110 4444 %%%%
M!1110!_#/_P45_Y2"_';_LLGB?\ ].US7C=>R?\ !17_ )2"_';_ ++)XG_]
M.US7C= !1110 5^F?_!I!_RF?\*_]B7K_P#Z1FOS,K],_P#@T@_Y3/\ A7_L
M2]?_ /2,T ?UDT444 %%%% !1110 5^37_!Y-_RBBTG_ +*OI7_I->5^LM?D
MU_P>3?\ **+2?^RKZ5_Z37E '\M%%%% !1110 4444 ?OY_P9G_\%)2G_"4?
M\$ROB;XAB"EIO$OPS6XDPY;&=0LDR?F& MPJ#D?Z0W(/R_T 5_!E\ ?CE\1_
MV9_C5X7^/_PAUU]-\2^$=:@U/1[Q"?EFB8-M8 C<C#*LN<,K,#P:_M/_ ."9
M_P#P4"^%7_!3#]D'PS^U+\+"MLVI0_9O$6AM,))=&U2-1]HM'(QG:Q#*Q WQ
MNC8&[% 'OU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_.-_P '
MB_\ P4UT[XH?%3P__P $V_A+XJ^TZ3X(N$UKXBM:M^[?6&C86UFS#[Q@AD:1
MEZ!YU!^:,A?U[_X+5?\ !4[P-_P2H_8TUCXNSZA8W'CS7(Y-,^&OA^Z^<WNI
MLAQ,\8()MX!^\D.0#A4W!I$S_&U\1/B#XS^+'CS6?B?\1?$-QJVO>(-3FU#6
M-3NWW275S,Y>21CZEB3Z#MQ0!C4444 %%%% !7]$W_!E9^Q1'X;^%?Q*_;W\
M4:?_ *9XEOH_"GA-WCQY=E;D37L@/<23&!/;[*W7=Q_/G\./ 'BGXK_$+0OA
M?X'TN2^UKQ)K%MIFDV<*%FGN9Y5BB0 9))=@./6O[@/V ?V2?!W["O[&_P /
M?V4?!,$8M_!WAN"UO+B-<?;+YAYEW<GD\RW#RR=<#?@< 4 >Q#..:*** "BB
MB@ I""32T4 ?R#_\'.G[)]]^RS_P5V^(%Y!H[6^C?$A8?&.BS*F$F^U[A<D>
MXNXKC(Z\@]Q7Y]U_3E_P>._L0:A\<?V(?#?[8'@W1OM.J?"'6637##'F3^QK
M]HXI'XY(CN%MF/\ =5Y&X )K^8V@ HHHH *Z[X!_&WX@_LV_&OPK\?OA3K<F
MG>(_!^O6VK:/>1_P30R!P".C*<;64Y#*2"""17(T4 ?W4?L3?M9?#?\ ;C_9
M:\$_M4?"C489](\8:)'=^3')N-G<CY+BU?T>*99(V'JGI@UZI7\RG_!IC_P5
MWM/V7?CE/_P3[^.6NQV_@?XE:HLW@_4KRXV)I&OL @A.?E$=TH5,GI+''C[[
M5_36#D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444F[G&*
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M.X806EPG':5L]J_I?!R,T %%%% !1110 4444 %%%% !1110 4444 %>%_\
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M*_NFHH _A9_X8/\ VXO^C,_BM_X;O4__ (Q1_P ,'_MQ?]&9_%;_ ,-WJ?\
M\8K^Z:B@#^%G_A@_]N+_ *,S^*W_ (;O4_\ XQ1_PP?^W%_T9G\5O_#=ZG_\
M8K^Z:B@#^%G_ (8/_;B_Z,S^*W_AN]3_ /C%'_#!_P"W%_T9G\5O_#=ZG_\
M&*_NFHH _A9_X8/_ &XO^C,_BM_X;O4__C%'_#!_[<7_ $9G\5O_  W>I_\
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MWJ?_ ,8K^Z:B@#^%G_A@_P#;B_Z,S^*W_AN]3_\ C%'_  P?^W%_T9G\5O\
MPW>I_P#QBO[IJ* /X6?^&#_VXO\ HS/XK?\ AN]3_P#C%'_#!_[<7_1F?Q6_
M\-WJ?_QBO[IJ* /X6?\ A@_]N+_HS/XK?^&[U/\ ^,4?\,'_ +<7_1F?Q6_\
M-WJ?_P 8K^Z:B@#^%G_A@_\ ;B_Z,S^*W_AN]3_^,4?\,'_MQ?\ 1F?Q6_\
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MPW_X)W?L?^"_V4/AF/.M_#>FC^U-3>,+)J>H2?/=7;^[REB!SM7:HX45[=0
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M-+^S_P#]C=-_Z07-?%]?:'_!N_\ \II?V?\ _L;IO_2"YH _LLHHHH ****
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MB5UK_LLNL?\ I#IM?K)0 4444 %%%% !1110!_*O_P 'B?\ RE[3_LE6B_\
MHV\K\JZ_53_@\3_Y2]I_V2K1?_1MY7Y5T %%%% !7L?_  3O_P"3^O@G_P!E
M7\/_ /IQ@KQRO8_^"=__ "?U\$_^RK^'_P#TXP4 ?W,T444 %%%% !1110 4
M444 %%%% '%_M'_!_2?V@_V??''P(UY$:S\9>$M0T6Y\S[NRYMGA)/\ WW7\
M*7Q+\ >)?A/\1_$'PM\9Z;+9ZQX:UJZTK5;.9=KP7-O,T4J,.Q#H0?I7]\/-
M?RG_ /!VK^POJ'[,'_!2B?\ :$T#P\+?PI\:K ZS:W4$86+^UX D6H1<='):
M&=O[QNLY)S@ _+.BBB@ HHHH T/"OBKQ+X&\3:?XT\&:_>:5J^DWD=WI>IZ?
M<-#/:7$;!XY8W4AD=6 (8$$$5_63_P $$O\ @O;\+?\ @I]\*['X/_&+7[#0
MOCIH-AMUS1II$AC\11Q\?VA9#@,2,-+"HS&VX@;,-7\DU:/A+Q?XK\ >)K'Q
MIX%\3:AHVL:9<+<:;JNEWCV]Q:RJ<K)'(A#(P[$$&@#^^L'/-%?S<?\ !-?_
M (/&OC=\(;+2/A3_ ,%$?AM-\0M$MT6W;X@>'7C@UR&)5PKSV[;8;YN "P>%
MR,L3(V0W['?LJ_\ !=?_ ()3?M@FUT[X5?MD>%+'6+S:(/#OC"\&C7SN?^6:
M1W>P3/\ [,1<]^E 'US14-I?V-_$)[&\AFC895X9 P(^HJ8'/2@ HHHH **,
MCUJ*XO;.S3S+N[CB7^])(%_G0!+17SO^T%_P5J_X)H_LMM<6GQP_;=^'.DW]
MKD7&BP^)8;S4$([&TMC),/Q2O8O@U\7/ ?Q]^%7A_P"-GPMUDZCX;\5:3#J6
MAWS0O'Y]M*H>-]K@,N5(." : .FHHHH **** /CO_@X"_P"4-'[0?_8AO_Z4
M0U_&/7]G'_!P%_RAH_:#_P"Q#?\ ]*(:_C'H **** "BBB@#^G#_ (,IO^4;
MWQ&_[+1=?^FK3J_8ROQS_P"#*;_E&]\1O^RT77_IJTZOV,H **** "BBB@ H
MHHH **** "BBB@ HHHH **** /X9_P#@HK_RD%^.W_99/$__ *=KFO&Z]D_X
M**_\I!?CM_V63Q/_ .G:YKQN@ HHHH *_3/_ (-(/^4S_A7_ +$O7_\ TC-?
MF97Z9_\ !I!_RF?\*_\ 8EZ__P"D9H _K)HHHH **** "BBB@ K\FO\ @\F_
MY11:3_V5?2O_ $FO*_66OR:_X/)O^446D_\ 95]*_P#2:\H _EHHHHH ****
M "BBB@ HHHH *^CO^"<?_!5+]L'_ ()=_%3_ (6-^S1X_>.PO,)X@\'ZJSS:
M3J\>>DT&X 2#^&9-LB9(#89E/SC10!_7A_P2Q_X.0?V%?^"D-KI7P\U[Q##\
M,_BE=QK'-X)\37JK#>W'0K879VI<YZK&0DO.-AP37Z%(X9<A@<]"#UK^ >.6
M2&19H9&5E;*LIP0?45]]_P#!/O\ X.2_^"FO[ UI;>#+;XH+\2/!=NP$?A7X
MA-)>_9U&/EM[O<+B!<# 0.T8R2$R<T ?U_T5^17['/\ P>*?\$\/C7HMGIG[
M4OA#Q-\(_$C-LNVDMCJ^D?[Z7,"B8 ]P\"[>@9NM?HW^SI^WK^Q7^UQIZZA^
MS3^U-X%\:?N]\EGH?B2WENX%_P"FMON$T1]G130!ZU12*Z,NY6!!Z$&EH **
M,\XILDT4*>9+*JJ/XF; H =17A'[2_\ P4Z_X)]?L?)(G[1W[8'@/PS>0J6.
MBW'B"&;46 _NV<)>=OJ$QS7YN?MH?\'FG[&'PMTV;0OV+_@]XC^)VO;BJ:IK
MB_V/H\0_O@MON)B/[GE1@]I* /V6N;F"T@>YNIDCCC4M))(P554=22>@K\M?
M^"K?_!TW^QO^P_9:M\*OV7;[3_B]\3[<M;^3I-Z&T/29^A-S=QY$S(>L,))+
M JSQD$C\'_\ @H5_P7N_X*1?\%'1+X:^+'QED\.^#69O+\#>"5;3]/=3VG*L
M9;OC'$SNH/*JN3GXQH ]@_;9_;N_:A_X*$_&J\^/'[4_Q.N_$&L7'R6-K_J[
M+2[?C;;VMNOR01@ 9"C+'+.6=F8^/T44 %%%% !1110 5_2C_P &F/\ P1TG
M_9]^%J_\%(_V@/#S0^,?'.F>5\/=+O+?:VE:)( 3>G=R);H?=Z8A"G)\X@?
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MX?&7]H#QA/\ $'XY_%7Q%XPURY8F;5O$NL37MPWMOE9CCVZ4 ?MM_P %._\
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M\?H_X;S_ &&_^CSOA/\ ^'$TS_X_0!ZQ17D__#>?[#?_ $>=\)__  XFF?\
MQ^C_ (;S_8;_ .CSOA/_ .'$TS_X_0!ZQ17D_P#PWG^PW_T>=\)__#B:9_\
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MO/\ 8;_Z/.^$_P#X<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\
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M/.^$_P#X<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\ AO/]AO\
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M<33/_C] 'K%%>3_\-Y_L-_\ 1YWPG_\ #B:9_P#'Z/\ AO/]AO\ Z/.^$_\
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M^#VD7$=UX;T>[C$;>,KA'R!M89^PJ5^=\#S3\B'&]E /F.__ ."07CKX6_\
M!&K5/^"I'QQBN=+F\2>*M'TWX9Z"ZLCS:=.SM+J<H/5)0JK"O=0TG1HS7Q'7
M]6'_  =UV%EI/_!&6ZTK3+.*WMK7X@Z!%;V\$85(HU,H5%4<     < "OY3Z
M "BBB@ K[0_X-W_^4TO[/_\ V-TW_I!<U\7U]H?\&[__ "FE_9__ .QNF_\
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M 4444 %%%% !1110 4444 ?V0_\ !N7_ ,H7?@3_ -BW<?\ I;<5]MU\2?\
M!N7_ ,H7?@3_ -BW<?\ I;<5]MT %%%% !1110 4444 %%%% !1110 4444
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MU\$_^RK^'_\ TXP5XY7L?_!._P#Y/Z^"?_95_#__ *<8* /[F:*** "BBB@
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M'_ +(LK>)/&EBZ7EXA_AM+'B60XYWR>5'CHS$;: /SR\&>"_%_Q&\5Z?X$\
M>%]0UK6M6NDMM+TG2K-[BYNYF.%CCC0%G8GH ":_>/\ X(M_\&E=[<W&A_M-
M_P#!4JQ6*%6%WI/P;AFRTO\ <.K2+]T?Q_9HF)(VB1Q\\5?J9_P31_X(E?L)
M?\$NO#MO-\#_ (=+J_C1K4QZI\1O$JI<:K=%OO"-L;+6,]/+A500!N+G+'ZZ
M QTH S_"WA?PYX(\.6/@_P 'Z!9Z5I.FVJ6VG:;IUJL,%K"@PL<:( J* ,
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M10 5)9VEWJ%W%86%K)///(L<,,,99Y')P%4#DDG@ <DU]3?\$]/^",?[?O\
MP4M\16,7[/\ \&;JU\+7%QY=]\0/$BM9Z+9H#\S^<REIR.FR!9'SV !(_HZ_
MX)*_\&W/[&?_  31^P_%'QA;Q_$[XKPLLR>,->LE%MI,@'33[4Y6$@\^:Y>7
M/1E&% !^=/\ P0N_X-6O%?Q&O]'_ &L_^"FWA6YT7P[;W"W7A_X2WBF.\U7
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M_@W+_P"4+OP)_P"Q;N/_ $MN*^VZ^)/^#<O_ )0N_ G_ +%NX_\ 2VXK[;H
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M 4444 <U\9;"^U;X0^*M+TRTDN+BY\-WT5O!$NYI)&MW"J!W)) K^+;_ (=
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M9-%DNK''T6&55'7L*\\UC_@U5_X(H:S-YS_LS:K;?,QVV?CK5(UY[8$_0=J
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MQ'^ '[*?CSQEH/\ PK;2+7^V/#OANXN[?STENB\>^-2-P#+D=1D5^;?_  Z
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MB>&?A'ILS RZ2LRZSJR)ZF.W?[.I(Z#SR1W /%?T>?LL? '0_P!E;]G#P/\
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M/154<D^PK^QSP/\ \&Z'_!&+P'*LUA^PKX9U!UQM;7+R[OA^*S3,I_$5]*_
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MA;Q]X1TO7-,N.+C3M8T^.Y@DXQ\T<@*GKW%?.'Q!_P"")G_!)+XGS27'BO\
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MLC\4:A"U_JHXP2+NY+R)GOL*@^F*^E/PHHH   .E%%% !1110 4444 %%%%
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M^D?OQ:_\(B\_^(H_X= ?\%2_^D?OQ:_\(B\_^(K^VZB@#^)'_AT!_P %2_\
MI'[\6O\ PB+S_P"(KZS_ ."%G_!,[_@H1\&?^"M7P1^)_P 6/V,OB1X=\.Z/
MXHEFU36]8\)W,%M:1FRN%#22,@51N8#)/4BOZNZ*  &BBB@ HHHH **** "O
MAO\ X.-O@[\5_CY_P2#^*'PL^"OP\U?Q5XDU*?1CI^AZ%8O<W5QY>K6DC[(T
M!9MJ*S' X )K[DHH _B1_P"'0'_!4O\ Z1^_%K_PB+S_ .(H_P"'0'_!4O\
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MDW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U
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MJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %7/\
MH:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_
M *&KX5_^%3<?_(U 'Y-T5^LG_$&W_P %7/\ H:OA7_X5-Q_\C4?\0;?_  5<
M_P"AJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_ *&KX5_^%3<?_(U'_$&W_P %
M7/\ H:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<_P"AJ^%?_A4W'_R-1_Q!M_\
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MJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U 'Y-T5^LG_$&W_P %7/\
MH:OA7_X5-Q_\C4?\0;?_  5<_P"AJ^%?_A4W'_R-0!^3=%?K)_Q!M_\ !5S_
M *&KX5_^%3<?_(U'_$&W_P %7/\ H:OA7_X5-Q_\C4 ?DW17ZR?\0;?_  5<
M_P"AJ^%?_A4W'_R-1_Q!M_\ !5S_ *&KX5_^%3<?_(U '[>_\&Y?_*%WX$_]
MBW<?^EMQ7VW7S?\ \$D/V4_B9^Q#_P $\?AG^RU\8+G39O$?A'1Y;;5)-'N&
MFMF=KF60;'95)&UQV'-?2% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?DU_P>3?\HHM)_P"RKZ5_
MZ37E?K+7Y-?\'DW_ "BBTG_LJ^E?^DUY0!_+11110 4444 %?V(?\&U'_*%3
MX)_]@O4/_3E=5_'?7]B'_!M1_P H5/@G_P!@O4/_ $Y75 'W91110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?DU_P>3?\HHM)_[*OI7_ *37E?K+7Y-?
M\'DW_**+2?\ LJ^E?^DUY0!_+11110 4444 %?V(?\&U'_*%3X)_]@O4/_3E
M=5_'?7]B'_!M1_RA4^"?_8+U#_TY75 'W91110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?DU_P 'DW_**+2?^RKZ5_Z37E?K+7Y-?\'DW_**+2?^RKZ5
M_P"DUY0!_+11110 4444 %?V(?\ !M1_RA4^"?\ V"]0_P#3E=5_'?7]B'_!
MM1_RA4^"?_8+U#_TY75 'W91110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_C]'_$8-_P1[_Z"'Q-_\(<?_'Z_E/HH _JP_P"(P;_@CW_T$/B;_P"$./\
MX_1_Q&#?\$>_^@A\3?\ PAQ_\?K^4^B@#^K#_B,&_P""/?\ T$/B;_X0X_\
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M_P#A#C_X_1_Q&#?\$>_^@A\3?_"''_Q^OY3Z* /ZL/\ B,&_X(]_]!#XF_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /[(?^#<O_E"[\"?^Q;N/_2VXK[;KXD_X-R_^4+OP)_[%
MNX_]+;BOMN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'&"QR/J:^0=6U?5M?U.XUO7=3N+V\NIFENKR[F:26:1CDNS,268GJ2<FJ]%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% ']D/_!N7_P H7?@3_P!BW<?^
MEMQ7VW7Q)_P;E_\ *%WX$_\ 8MW'_I;<5]MT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^37_!Y-
M_P HHM)_[*OI7_I->5^LM?DU_P 'DW_**+2?^RKZ5_Z37E '\M%%%% !1110
M 5_8A_P;4?\ *%3X)_\ 8+U#_P!.5U7\=]?V(?\ !M1_RA4^"?\ V"]0_P#3
ME=4 ?=E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?D[XT_X,[/^"8?COQEJWC?6/BC\8DN
M]9U.XOKI;?Q+IXC6261I&"@V!(7+'&2>.]9O_$&#_P $L/\ HJWQH_\ "FT[
M_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\ HJWQH_\
M"FT[_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\ HJWQ
MH_\ "FT[_P"5]?KI10!^1?\ Q!@_\$L/^BK?&C_PIM._^5]'_$&#_P $L/\
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M?#;X)_&7XRZI'H?P@^$OB;Q5>22;([3PWH-Q?2,WH%A1B37V[^S=_P &P/\
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M?]%6^-'_ (4VG?\ ROK]=** /R+_ .(,'_@EA_T5;XT?^%-IW_ROH_X@P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ5;V=M&,1V]K"L<:_15  JUM%%% !1110 4444 %%%% !1110 4444 %%%%
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M.FZY"N9/"VEW7]HZJN1D;[6V#R1 CH9 H/8FOSD_:4_X/8/V4?!SR:9^RO\
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M^(FS_@B?_P!'G6O_ (2VJ?\ R-0!]ZT5\%?\1-G_  1/_P"CSK7_ ,);5/\
MY&H_XB;/^")__1YUK_X2VJ?_ "-0!]ZT5\'VG_!S%_P1-O+A;9OVU["'=_RT
MF\+ZJ%'UQ:FO2/AG_P %O_\ @D;\6[B.S\(?\%#/A?'-,P6*+7/$D>E,Y(X
M%[Y1)/IUSQUXH ^J**SO#/C#PGXTTN'7/!WBC3M6LKB,/!>:9?1W$4BG^)70
MD$>X-:.1B@ HHHH **** "BBB@ HHKB?VC/VB/A!^RC\&=<^/_QZ\7+H/A+P
M[ DVL:LUK),+=&D6,'9$K.?F=1P#UH [:BO@D?\ !S7_ ,$3P.?VSK7_ ,);
M5/\ Y&I?^(FS_@B?_P!'G6O_ (2VJ?\ R-0!]ZT5\%?\1-G_  1/_P"CSK7_
M ,);5/\ Y&H_XB;/^")__1YUK_X2VJ?_ "-0!]ZT5\%?\1-G_!$__H\ZU_\
M"6U3_P"1J/\ B)L_X(G_ /1YUK_X2VJ?_(U 'WK17P5_Q$V?\$3_ /H\ZU_\
M);5/_D:C_B)L_P"")_\ T>=:_P#A+:I_\C4 ?>M%?!7_ !$V?\$3_P#H\ZU_
M\);5/_D:C_B)L_X(G_\ 1YUK_P"$MJG_ ,C4 ?>M%?!7_$39_P $3_\ H\ZU
M_P#"6U3_ .1J^E?V,?V\OV5_^"@OP[U'XK_LD_%"/Q9H&DZRVE:A?1Z?<6PB
MNUBCE,>V>-&/R2QG(&/FZY!H ]@HHHH **** "BBB@ HKS?]JW]K7X!?L2_!
MN\^/W[2_CQ/#?A/3[J"VN]5DLYIQ'),^R-=D*.YRQQP..]?*(_X.;/\ @BAC
MG]LZU_\ "6U3_P"1J /O:BO@K_B)L_X(G_\ 1YUK_P"$MJG_ ,C4?\1-G_!$
M_P#Z/.M?_"6U3_Y&H ^]:*^"O^(FS_@B?_T>=:_^$MJG_P C4?\ $39_P1/_
M .CSK7_PEM4_^1J /O6BO@EO^#FO_@B>1C_ALZU_\);5/_D:M[PG_P '%O\
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M/^")_P#T>=:_^$MJG_R-0!]ZT5\%?\1-G_!$_P#Z/.M?_"6U3_Y&H_XB;/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/^(UO_@H%_T;/\)_^_.H?_)- '],U%?S,_\ $:W_ ,% O^C9_A/_ -^=0_\
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MU:?_ !Z@#XVHK[)_XA\/^"SO_2/SQM_WU:?_ !ZC_B'P_P""SO\ TC\\;?\
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M)=&OBI((SAFMY0K/%(1\P#+]Y&  /JZBBB@ HHHH *^'_P#@Y _Y0L_'/_L
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M_P '6W[)/[:5_IWP>_:TTZV^$/Q#O+A+:RN+J\WZ!JLCG:@CNG(:VD+<>7,
MO*[9&)P/UC5U<;D;(/((K^ 0$CD5^Y7_  ;3_P#!P[XK^'OC30O^">_[<WC^
M34/"NK3+9?#SQQKEZ6FT:Y;"Q:?<2N?FMG/RQNQS$Q"D["-@!_1E10,]S10
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M1_Q#X?\ !9W_ *1^>-O^^K3_ ./4 ?&U%?9/_$/A_P %G?\ I'YXV_[ZM/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!_!O\ M(?\G$>/?^QTU3_T
MKEKBZ[3]I#_DXCQ[_P!CIJG_ *5RUQ= !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?=G_!*'_@X!_;6_X);:O;>$M&UQO'
M7PQ8[;SX>>)+QVAMESDR6,W+6DG7@!HVR=R$[67^F?\ X)H_\%B/V*/^"I7@
MB/5_V??B"MIXHM[(3Z[\/]<9(=6TSH')C!(FB#' FB+*<C.TG:/XK*W/AM\3
M?B)\'/'&F_$SX4>-]4\.>(='N!/I>M:+?/;W-M(/XDD0@CC@\X()!R#0!_?
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MR2R,<L[,>68DDDGDFH:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/8?%+QIILBAM6F *RZ5;2 DK;H?EFD7:TCHT8/EAO-_"NAF9CN8Y)Y)/>B@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?MERA^1"N1Y$)"D,P=I>,?E_110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?V0_P#!N7_RA=^!/_8MW'_I
M;<5]MU\2?\&Y?_*%WX$_]BW<?^EMQ7VW0 4444 %%%% !1110 4444 %%%%
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M+?\ [)GKG\[>OZL*_E/_ .#/G_E,);_]DSUS^=O7]6% !1110 4444 %%%%
M!7\S/_!['_RD0^%__9%X/_3OJ-?TS5_,S_P>Q_\ *1#X7_\ 9%X/_3OJ- 'X
MTU^C'_!J7_RF]^%W_8'\1_\ IEO*_.>OT8_X-2_^4WOPN_[ _B/_ -,MY0!_
M7)1110 4444 %%%% !1110 4444 %%%% !1110 5\\_\%;O!>H_$/_@EU^T-
MX0TBQ^U7EW\&?$AL[;;DRS)IT\B*/]HLH ]\5]#54UW1M-\1:/>>']9LX[BS
MOK62WNH)5W++&ZE60CN""0?K0!_ =17IO[9W[.VO?LD_M8_$3]FKQ):R177@
MOQ=>Z6OG*0TD,<I\F3GJ'B*.#T(8$<&O,J /[8O^",WQOT/]H7_@EC\"?B3H
M-[',A^'.G:9=;)-Q2YL8A93(W^T)(&!]Z^FJ_EK_ .#9'_@N3X=_X)Z>/KS]
MD3]I_6IH/A3XXUE+G3=<DES'X7U5PL;32 ]+65502$?<9 ^""YK^HG0M=T7Q
M-HUKXB\-ZM;:AI]];I/8WUG.LL-Q$PRLB.I(92"""#@B@"W1110 4444 %&/
M:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /X-_VD/\ DXCQ[_V.FJ?^E<M<77]SE]_P3V_8&U2]FU+4OV'O
M@_<7%Q*TMQ<3_#32G>5V.69F-ODDDDDGDFH_^'='_!/G_HQ+X-_^&PTG_P"1
MZ /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_ )'H_P"'='_!/G_HQ+X-_P#AL-)_
M^1Z /X9Z*_N8_P"'='_!/G_HQ+X-_P#AL-)_^1Z/^'='_!/G_HQ+X-_^&PTG
M_P"1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_ )'H_P"'='_!/G_HQ+X-_P#A
ML-)_^1Z /X9Z*_N8_P"'='_!/G_HQ+X-_P#AL-)_^1Z/^'='_!/G_HQ+X-_^
M&PTG_P"1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_ )'H_P"'='_!/G_HQ+X-
M_P#AL-)_^1Z /X9Z*_N8_P"'='_!/G_HQ+X-_P#AL-)_^1Z/^'='_!/G_HQ+
MX-_^&PTG_P"1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_ )'H_P"'='_!/G_H
MQ+X-_P#AL-)_^1Z /X9Z*_N8_P"'='_!/G_HQ+X-_P#AL-)_^1Z/^'='_!/G
M_HQ+X-_^&PTG_P"1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_ )'H_P"'='_!
M/G_HQ+X-_P#AL-)_^1Z /X9Z*_N8_P"'='_!/G_HQ+X-_P#AL-)_^1Z/^'='
M_!/G_HQ+X-_^&PTG_P"1Z /X9Z*_N7/_  3H_P""?./^3$O@W_X;#2?_ )'K
MXL_X*A_\&NO["?[<NA7OC3]GWPSIOP9^(RV_^@ZCX5TN.'1[UU'"7=C$%0 C
MCS(=C@X8^9@J0#^3NBOHK_@H/_P2N_;4_P""9?Q#;P1^U#\)KJSL)Y,:-XNT
MU6N-'U5<\&&Z4;=^.3$^V1<C<H!!/SK0 4444 %%%% 'NW[!W_!27]L/_@FW
M\3#\3?V4?BU>:(UTT?\ ;6@W#--I>L(A.U+JU)"RXRP#\.@9MK+DY_I6_P""
M2/\ P<S_ +'W_!1-=/\ A)\8KBS^%?Q6EA1?[#UB]QIFLS8 8V-T^!N+'BWE
M(EP?E\S:S#^3.E1WC<21L593E64\@T ?W]@Y&:*_EC_X)%_\'4'[4?[$;:7\
M%/VO!J'Q6^%]M"MI:W%Q=#^W="C!&TPSO_Q]Q*N1Y,QSC:%D0*%/]'_[&O[=
M/[+7[?GPEL_C1^RO\7--\3:3<1K]JMX9@E[ILIZP75N3YEO(/[K@9&"I92&(
M!Z[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111F@ H)P
M,UD^.O'G@KX8^$[[Q[\1O%VFZ#H>EVYGU+6-8OH[:UM8AU>220A47W)%?A)_
MP5R_X.^M.TU-0^!G_!+"U6ZNEFDM]0^+&N:>3"BC*G^SK:0#>V>D\R[<#Y8V
MR' !^J'_  4E_P""O?[%?_!+GP"WB3]HGXBQS>(+J+.A>!=$9;C5]3;L5B!Q
M%'ZS2E$&, EB%/\ ,U_P5C_X.$?VU/\ @J)J6H^!+C69/ /PIEN,V?P\T"\;
M;<QJ<H;^X 5KQ\X;:0L0(4A 1N/Q1\4/BI\2OC9X]U/XI?%_QYJWB;Q)K-TU
MQJNN:Y?/<W5U(3RSR.23[=@.!@"L"@ HHHH **** "BBNS^ G[/'QQ_:C^)N
MF_!O]GGX6ZSXO\3:M,L5EI.BV9ED.3C>Y^[%&,Y:1RJ*,EF !- '&45_15_P
M2G_X,^? G@'['\8O^"H&N6_B;5QLEL_ACX?O3_9UJ>I%]<IAKEL\>7$5C&.7
MD!P/UJM?^"<'_!/*SM8[.V_8.^#*1Q1JD:#X8:3\J@8 _P"/?TH _AKHK^YC
M_AW1_P $^?\ HQ+X-_\ AL-)_P#D>C_AW1_P3Y_Z,2^#?_AL-)_^1Z /X9Z*
M_N8_X=T?\$^?^C$O@W_X;#2?_D>C_AW1_P $^?\ HQ+X-_\ AL-)_P#D>@#^
M&>BO[F/^'='_  3Y_P"C$O@W_P"&PTG_ .1Z/^'='_!/G_HQ+X-_^&PTG_Y'
MH _AGHK^YC_AW1_P3Y_Z,2^#?_AL-)_^1Z/^'='_  3Y_P"C$O@W_P"&PTG_
M .1Z /X9Z*_N8_X=T?\ !/G_ *,2^#?_ (;#2?\ Y'H_X=T?\$^?^C$O@W_X
M;#2?_D>@#^&>BO[F/^'='_!/G_HQ+X-_^&PTG_Y'H_X=T?\ !/G_ *,2^#?_
M (;#2?\ Y'H _AGHK^YC_AW1_P $^?\ HQ+X-_\ AL-)_P#D>C_AW1_P3Y_Z
M,2^#?_AL-)_^1Z /X9Z*_N8_X=T?\$^?^C$O@W_X;#2?_D>C_AW1_P $^?\
MHQ+X-_\ AL-)_P#D>@#^&>BO[F/^'='_  3Y_P"C$O@W_P"&PTG_ .1Z/^'=
M'_!/G_HQ+X-_^&PTG_Y'H _AGHK^YC_AW1_P3Y_Z,2^#?_AL-)_^1Z/^'='_
M  3Y_P"C$O@W_P"&PTG_ .1Z /X9Z*_N8_X=T?\ !/G_ *,2^#?_ (;#2?\
MY'H_X=T?\$^?^C$O@W_X;#2?_D>@#P?_ (-RS_QI=^!7_8MW'_I;<5]N5D^!
M_ ?@?X9>%K/P-\-O!FD^']$T^,I8:/H>G16EK;*225CBB5409). !R36M0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R
M%_P7R_Y0W_M"_P#9/;C_ -&QU]>U\A?\%\O^4-_[0O\ V3VX_P#1L= '\8%%
M%% ']MG_  1U_P"43_[-W_9$?#/_ *;(*^D*^;_^".O_ "B?_9N_[(CX9_\
M39!7TA0 4444 %%&:;++'#&TTTBJJKEF8X 'J: '$XYK^2?_ (.IOVQM#_:P
M_P""K>O>'/!>N)?:'\*]%@\(6\UO)NB:\AEEFO2O;*W$SQ$]S!Z 5^L/_!>W
M_@Y/^#W['O@+7OV6?V)_'6G^*_C!J5JUG?:]I4XGL/"*."KR&5#MEO N0D2L
M1$Q#R?=$;_R_7EY=ZC>2ZA?W,DT\\C2332L6:1R<EB3U)/.: (Z_43_@T4^
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M?L^_]DKTG_T0M?35 !1110 4444 %%%% !1110 4444 ?RR_\'E'_*6W2?\
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MF1P1[@]0<$$$ U^$G_!5K_@SR7%Y\9/^"66O8^5Y;SX4^)=0ZGK_ *!>RM^
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M+_V4OA!I^@6\@!U35W7SM2U23_GI<W+YDE/HN0BYPJJ.*]OVC& *6@ HHHH
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M^'?PZ\ _";P/I?PU^%_@W3?#_A_1;-+32=%T>S2WMK2%!A8XXT 55 [ 5M4
M%%%% !1110 4$9&,T4,<#I0!_$Q_P62GU"Y_X*M?M#3ZI%LN&^+FN>8I7;@_
M:Y.U?-5?7G_!?'P==>!?^"Q_[0FB7<;*T_Q"GU$!C_#=Q1W:G\5F!_QZU\AT
M ?T _P#!CS%8?9_V@YC,?M6_0%\OMY>+SG\Z_?NOYV_^#('QK#!\8OCU\.Y)
M )+KPSH^HQ)QEEBN)XG/X&9/SK^B2@ HHHH **** "BBB@ HHHH **** "BB
MB@ K^2/_ (.O+6TMO^"TGCYK5 &F\/:&\V&SE_L,8S[< 5_6VQ(YK^/;_@YE
M\<67CC_@M;\:)-/G62+2[W3=-WK_ 'X=,M5D'U#[E^JT ?!M?KO_ ,&7MS<P
M_P#!4CQA#!(RK-\%=2695_B7^TM,.#^(!_"OR(K]IO\ @R5\"WNH?MR?%WXF
M)%(;?1_A2FF2L%^0/=ZG;2J#QU(LGQR. W![ ']*U% .>U% !1110 4444 ?
MQ_\ _!SO_P IJ_B__P!=-+_]-MM7P'7WY_P<[_\ *:OXO_\ 732__3;;5\!T
M ?37_!+O_@JG^T#_ ,$FOB[X@^,_[/'A;POJVJ>)/#9T6^A\56<\T*6YN(I]
MR"&:(A]T*C))&">.]?<7_$:)_P %/?\ HC?P=_\ !#J'_P G5^0=% 'Z^?\
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M+' 4 DD $U_7]_P0R_X)'>#_ /@DS^R=#X%U(:?J7Q*\5-'J'Q&\1V:EEEN
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M'S2,"4K]X-#T'1/#&CVOAWPWI%MI^GV-NEO8V-E L4-O$@VK&B* JJ   H
M XH MJH4844444 %%%% !1110 4444 %%%% !7QS_P ' _\ RAF_:"_[$8_^
ME,%?8U?'/_!P/_RAF_:"_P"Q&/\ Z4P4 ?QDT444 ?VQ?\$8_P#E%%^S[_V2
MO2?_ $0M?35?,O\ P1C_ .447[/O_9*])_\ 1"U]-4 %%%% !1110 4444 %
M%%% !1110!_++_P>4?\ *6W2?^R.Z-_Z6:C7Y.U^L7_!Y1_REMTG_LCNC?\
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M\+>);%;BQNX6&^)NCP2KG,<T; H\;<JRD&O0: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH#=L44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !103CM0#GI0 4444 %-
M=$EC:*1 RLN&5AP13J* /S&_X*M?\&O_ .QA_P % )-3^+7P1AMOA'\3[B%I
M&U30]/7^R=6GP2#>6:;0'8_>GBVN<EF$I %?S??M^_\ !+[]L_\ X)H_$!/
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M&>WA/PS;Z;\:/^"HFNQZUJ0E6>W^%?AV^86<*C! OKN,AIF)X,,.U!CF1PQ
M_6G]A'_@FQ^QY_P3A^&,/PR_97^$5CHZ^2JZIX@N%$^J:M)WDNKIAOD)/.T8
M1>B*H  ]W P: ,;P%\/O WPL\)6/@+X:>#M+\/Z'IL*PZ?I&C6,=M;6T8'"I
M'& JCZ"MFBB@ HHHH **"<4 YZ4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 44 Y.** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *^0O\ @OE_RAO_ &A?^R>W'_HV
M.OKVOD+_ (+Y?\H;_P!H7_LGMQ_Z-CH _C HHHH _>W]B'_@T%_9O_:L_8Y^
M%O[3/B']K_QQI-]X_P# .D^(+S3+/0[-X;62[M(YVB1F.YE4N0"><"O4?^((
M;]E?_H]_X@?^$_8_XU^EW_!'7_E$_P#LW?\ 9$?#/_IL@KZ0H _$'_B"&_97
M_P"CW_B!_P"$_8_XT'_@R'_97'_-[_Q _P#"?L?\:_;ZB@#\7?#G_!DY^PKI
M[QR>)?VJ_BEJ6 /-2&/3[=6.>W[AB./<U[E\%_\ @TQ_X(W_  IO8=3\5?"?
MQ5X\N()%=5\6>,KE8=PZ9BLS KKG^%]RGH01Q7Z844 <+\$?V9/V<_V:]"7P
MU^SW\!_"/@BP6,)]E\*^';:Q5E'][R47<>^3DD\GFNZHHH **** "BBB@ HH
MHH *^0O^"^7_ "AO_:%_[)[<?^C8Z^O:^0O^"^7_ "AO_:%_[)[<?^C8Z /X
MP**** /WH_86_P"#0S]G#]K3]C3X7_M.^(OVOO&^DW_C[P+INO7FEV6AV;PV
MLES;I*T:,QW%5+8!/->K?\00W[*__1[_ ,0/_"?L?\:_27_@C#_RB6_9P_[(
MSX?_ /2&*OIF@#\0?^((;]E?_H]_X@?^$_8_XUC_ !"_X,C/@G#X$UJ;X7?M
MK>+)O$D>ESMH$.N:#:K9RW@C)A2=H_G6(OM#,H+ $D D8/[K44 ?P2_%OX4^
M/_@7\3_$'P:^*GARXT?Q)X8U:?3=:TVZ7#V]Q$Y1U/KR.#T(P1P:YVOZ//\
M@[7_ .".2_%[X?3?\%.OV??#J_\ "3>$M/6+XH:79VOS:EI,:G;J?RC+2VP
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M6?[L95?88%?4=M!#:PK;6\*QQQJ%CCC4!5 [ #H*DHH **** "BBB@ HHHH
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M,,QW)#>3>HA^80W*HSKD85UE0%O+R?MF@ HHHH **** "BBB@ HHHH ****
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MO^#KO]F?]D-+[X-?L/?V7\6/B%&SP76MPW6_P_H[CC)FC/\ IL@/\$1"<<R
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M /@J#_TD ^+G_A>7O_QRC_A[?_P5!_Z2 ?%S_P +R]_^.5\[T4 ?1'_#V_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ1@9SB@#^!_XD_#+XB?!SQQJ/PT^+'@?5?#?B#2+@P:GHNM6+VUS;2#^%XW
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M;I)I#P .RHJA45!A45550  *Y.@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#^R'_ (-R_P#E"[\"?^Q;N/\ TMN*
M^VZ^)/\ @W+_ .4+OP)_[%NX_P#2VXK[;H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KY"_X+Y?\ *&_]H7_LGMQ_Z-CK
MZ]KY"_X+Y?\ *&_]H7_LGMQ_Z-CH _C HHHH _ML_P"".O\ RB?_ &;O^R(^
M&?\ TV05](5\W_\ !'7_ )1/_LW?]D1\,_\ IL@KZ0H **** "BBB@ HHHH
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MQ1^T5^P'\>=6_9U_:9\!S:+KVES-Y,RY>UU*WW$)=VLN )H7 RK8!'1@K!E
M!O\ _!.__@HI^TA_P3-_:'T_]H7]G/Q-Y,\;+#KV@W;%K'7;+=E[6Y0=5/\
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M& _\NGQ8^+/Q*^.OQ'UCXN_&'QKJ'B+Q-X@OGN]8UK5+@R3W4S'EF8_D ,
M    "N=9F=BS')/))[T4 %?I!_P;J?\ !%S7O^"F_P"TI;_%7XO>'KV#X+^
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M  K^&'[<?@G6O$7B#4(K'1=)LKN4S7=Q(VU(D!C'S$G YH ^HZ*** "BBB@
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M !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\ I&[\;?\
MPVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P5A_Z1N_&W_PV
MNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\ I&[\
M;?\ PVNI?_&:/^'.7_!6'_I&[\;?_#:ZE_\ &: /FVBOI+_ASE_P5A_Z1N_&
MW_PVNI?_ !FC_ASE_P %8?\ I&[\;?\ PVNI?_&: /FVBOI+_ASE_P %8?\
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MD?VDOC5^UQ\:-<_:"_:$\>WWB3Q7XBNO.U'4KZ0L< 82)%Z1Q(H")&N%55
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MC0)XM4T'7M/DM;NT<WD[!9(I &0E2#@CH17UY0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7R%_P7R_Y0W_M"_P#9/;C_
M -&QU]>U\N_\%K/AM\0?C#_P2H^.7PQ^%/@G5/$GB+6O \UMI&AZ+8O<W=Y,
M9(R(XHHP6=L \ $\4 ?Q2T5])?\ #G+_ (*PGI_P3>^-O_AM=2_^,T?\.<O^
M"L/_ $C=^-O_ (;74O\ XS0!_6U_P1U_Y1/_ +-W_9$?#/\ Z;(*^D*\#_X)
M6^!_&7PR_P"":7P#^'7Q$\+:AH>O:'\(?#UCK.C:K:O!=6-U%I\*20RQN R.
MK J5(!!!!KWR@ HHHH **** "BBB@ HHHH **** "BBB@ KY"_X+Y?\ *&_]
MH7_LGMQ_Z-CKZ]KY=_X+5_#;XA?&'_@E5\<OAA\*?!.J>)/$6M>!IK?1]#T6
MQ>YN[V8R1D1Q11@L[8!X )XH _BEHKZ2_P"'.7_!6'_I&[\;?_#:ZE_\9H_X
M<Y?\%8?^D;WQM_\ #:ZE_P#&: /ZT?\ @C#_ ,HEOV</^R,^'_\ TABKZ9KY
M\_X).>!/&OPO_P""97P%^'/Q'\*:AH.OZ'\)]#LM8T75K-[>ZLKF.SC62&6-
MP&1U8$%2 017T'0 4444 %%%% !7G/[7'[+OPH_;3_9Q\6_LO_&[1_MGAKQA
MI36=\J@>9 P8/%<1D@@2Q2JDJ'!PZ*:]&H(S0!_#C_P4/_85^+7_  3C_:R\
M4?LJ?%^%I+O0[K?I.L+;F.'6-/<DV][$"3\KJ.1D[75T))4UXC7]='_!QA_P
M1[M?^"GW[)K>,/A;I"_\+<^&]O-?>#9(XQOU>W(W3Z6QZ_O,!HSVE11T=J_F
MI_X<Y?\ !6'_ *1N_&W_ ,-KJ7_QF@#U#_@@I_P5HU__ ()3?MBV_BCQ%)<7
M7PT\;-!I?Q&TN*0C; &;R;]!T,MLTCM@CYHWE08+AA_85X3\5^'/'7AC3O&G
M@[6[74])U>QAO=+U*RF$D-U;RH'CE1APRLK!@1P0:_BE_P"'.7_!6'_I&[\;
M?_#:ZE_\9K]YO^#6SXL?\%&/A!\.[S_@G_\ MS?L>?%3PQX?T&WDOOAOXT\5
M>#;^UM;:#=F;2I99HPB ,?,AR1]Z1.R"@#]A**** "BBB@ HHHH *^>O^"C/
M_!,;]E'_ (*@?!A_A#^TSX(6XFM4E?PWXHL,1ZEH5PX ,MO+@\$JNZ-LHX4!
ME. 1]"T4 ?QS_P#!5K_@@7^VO_P2U\0W/B'Q#X<E\<?#-G)T[XD>';-FMT7.
M E[""SV4G3[^8VW?)(Q#!?ANO[]-3TK3-:TZXT?6-.@N[.ZA:*ZM;J$21S1L
M,,C*V0RD$@@C!%?E7_P46_X-*OV"?VKTU#QW^RW.WP3\93R&58M#L5FT"X;G
M*-8 I]G!/1H'15Z^6W2@#^5^BOO_ /;2_P"#9_\ X*P?L;O<:U'\"6^)'AJ$
M_+XA^&TIU$JOK): "ZCP.2WE%!_?KX2\6>#?%_@/6I/#GCGPKJ6C:A#_ *ZQ
MU:QDMYD^J2 ,/RH ]&^"?[>/[;/[-MBFD_ ']K?XD>#K&,@KIOAWQG>VMJ<>
ML"2",_BIKVC2_P#@OU_P62T>U%G9_P#!07QXR#G_ $BX@F;_ +ZDB8_K7Q_1
M0!];>)O^"\'_  6%\6VK6>K_ /!0CXBJC+M)T_5%M&Q_O0(C9]\YKY]^,?[2
M'[0W[1&J+K?Q^^.WC+QQ>1MF*Y\7>)KK47C_ -TW$C[>/3'%<710 45UGPF^
M OQP^/6N+X:^"'P>\3^+]0:0(+/PUH5Q?2;CT!$*-C\:_2C]BO\ X-&/^"EW
M[2"6?B3]H :+\&/#]SM?=XDE6^U4QG^(65N_R'_8FDB8'J!0!^5]M;7-Y<1V
M=G;R332N$BBC4LSL3@  <DD]J_73_@CI_P &K'[0W[8%YI/QW_;GL]3^&GPS
M,RSP>'9HC#KWB"$8.%C8?Z%"W3S)!YA .V/!5Z_9O_@G!_P;R?\ !.;_ ()P
M7&G>.?!WPZ?QQX_L8U9?'GCB.*ZN;>?'S26D.T169SG:R*9 IP9&R2?ND#%
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M^']_!;6=NEPI>661X@J(HY+$@ 4 ?UU4444 %%%% !1110!^:W_!V9_RA?\
M&G_8U:%_Z6+7\EE?U_?\',WP,^,_[1?_  2;\6?"[X!_"KQ!XS\277B31Y;;
M0?#.DRWMW+''=*SLL42LQ"KR3C@5_,G_ ,.<O^"L)Z?\$WOC;_X;74O_ (S0
M!\VCK7]X7[+O_)LWPZ_[$72/_2**OXSQ_P $<O\ @K#G_E&]\;?_  VNI?\
MQFO[-_V<])U70/V?? N@ZYITUG>V/@W2[>\M+B,I)#*EI&KHRGE6!!!!Y!%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !^%%%% !1110 4444
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M]I7]H[QC)J_B'6IOE096WT^W!/E6EO'G$4,8.%4<GEF+,S,=#]N_]N_]H?\
MX*+?M$:M^TE^TCXJ^WZQJ'[JQL+?*V>DV:D^7:6T9)\N)<GN2S%F8EF)/C=
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M'P]\%Z3H.FVL?EVNGZ-IL5K!"F<[5CC5549[ 8K6HHH **** "BBB@ HHHH
M**** "BBB@ HHHH ,>U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4?A110 4444 %%%% !1110 4444
M %'OBBB@ HHHH **** "BBB@ HP/2BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,>U%%% ![XHHHH ***
M* "BBB@ HHHH *.G0444 %%%% !1110 4444 %%%% !1110 4?A110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?)?_!7+_@D1^S[_ ,%:/@#)\.?B1!%HOC#2$DF\$^.[
M6S5[K2K@@_NWZ&6V<X\R$D X# AE5A]:44 ?PL?MG?L7_M!_L#?'[6/V;_VE
M?!$VB^(=)?=&WWK?4+9B?+NK:3&)87 R&'0@JP5E91Y57]JG_!5__@DU^SI_
MP5>_9_G^%?Q7T^'2?$^GJTO@WQU:6:O>Z-<XZ9X,ENYXDA) 8<C#*K#^0O\
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M:,#THH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OEC_@K!_P $G?V>?^"L/[/L
M_P */BQ8Q:7XFTZ-Y?!7CJULU>\T2Z/Y&2!\ 20D@,.1AE5A]3T4 ?PS_MU?
ML'?M(?\ !.SX^ZE^SS^TOX(FTO5;5FDTV_C!:SU>TWE4N[:3&)(FV^S*?E8*
M017C=?VQ?\%3O^"67[.W_!5;]G:Z^#/QFTN.QUJSC>;P;XTM;57O=!O"!\Z$
MXWQ-@"2$D*Z^C!67^0?]OG]@;]HG_@G%^T1JW[.?[1OA.2RU"SD:32=6AC;[
M'K5GN(CO+:0CYXVQT^\C95@&!% 'BM%%% 'H7[*_[4OQN_8P^._A_P#:._9Y
M\:W&@^*/#EV)K.ZA),<R'B2"9.DL,BY5T/!!['!']>'_  1I_P""Q7P3_P""
MMW[/R>,= :ST'XA:#$D7CKP+]JW2V,O07,.?FDM9#RC]5.4;D9/\9M>G_L??
MM@?'K]A;X^:'^T=^SGXXNM#\1:+<*VZ&0^3?6^X&2UN$Z2PR ;61@1W&" 0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN++X,Z3>C^V-:C\R&?QA=1N<,P."MDC!6CC90791(W1%7I?^#C__ (.(+_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"'7P>_X),?!]=<UU+'Q)\8/$=E'_ ,)AXP$)*VBD!CI]ENY2W1LY?"O,P#.
M B)][!1UQ2CBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#7X[_#K3_$VBCPY=7T5GJ"']Q=00N\,\3J0\4B,.'1E8 D9P2"44 ?G_ /\
M!G]^SI\$O!W_  3^OOVB/#GPZL;?QMXF\37VG:YXD^=[FXM+>0>5 "[$1Q@\
M[4"AFP6R0#7ZY444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087998080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Healthpeak Properties, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0091377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4600 South Syracuse Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-5050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PEAK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,995,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000765880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085761568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNetAbstract', window );"><strong>Real estate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">$ 12,889,290<span></span>
</td>
<td class="nump">$ 12,784,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">819,810<span></span>
</td>
<td class="nump">760,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">2,674,942<span></span>
</td>
<td class="nump">2,667,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(3,296,781)<span></span>
</td>
<td class="num">(3,188,138)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">13,087,261<span></span>
</td>
<td class="nump">13,023,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Loans receivable, net of reserves of $6,152 and $8,280</a></td>
<td class="nump">243,149<span></span>
</td>
<td class="nump">374,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to unconsolidated joint ventures</a></td>
<td class="nump">714,679<span></span>
</td>
<td class="nump">706,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net of allowance of $2,413 and $2,399</a></td>
<td class="nump">57,705<span></span>
</td>
<td class="nump">53,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">59,235<span></span>
</td>
<td class="nump">72,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">57,990<span></span>
</td>
<td class="nump">54,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">391,956<span></span>
</td>
<td class="nump">418,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup', window );">Assets held for sale, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">235,591<span></span>
</td>
<td class="nump">237,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">754,723<span></span>
</td>
<td class="nump">780,722<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,602,289<span></span>
</td>
<td class="nump">15,771,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="nump">995,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableToBank', window );">Term loans</a></td>
<td class="nump">496,168<span></span>
</td>
<td class="nump">495,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">5,056,543<span></span>
</td>
<td class="nump">4,659,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">345,167<span></span>
</td>
<td class="nump">346,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">149,604<span></span>
</td>
<td class="nump">156,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LiabilitiesRelatedToAssetsHeldForSaleNet', window );">Liabilities related to assets held for sale, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">207,734<span></span>
</td>
<td class="nump">208,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">688,994<span></span>
</td>
<td class="nump">772,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">878,444<span></span>
</td>
<td class="nump">844,076<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,378,654<span></span>
</td>
<td class="nump">8,482,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">85,902<span></span>
</td>
<td class="nump">105,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1.00 par value: 750,000,000 shares authorized; 546,994,803 and 546,641,973 shares issued and outstanding</a></td>
<td class="nump">546,995<span></span>
</td>
<td class="nump">546,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">10,360,058<span></span>
</td>
<td class="nump">10,349,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDistributionsInExcessOfNetIncome', window );">Cumulative dividends in excess of earnings</a></td>
<td class="num">(4,316,038)<span></span>
</td>
<td class="num">(4,269,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">18,721<span></span>
</td>
<td class="nump">28,134<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">6,609,736<span></span>
</td>
<td class="nump">6,654,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestInJointVentures', window );">Joint venture partners</a></td>
<td class="nump">320,363<span></span>
</td>
<td class="nump">327,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestInPreferredUnitHolders', window );">Non-managing member unitholders</a></td>
<td class="nump">207,634<span></span>
</td>
<td class="nump">200,176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Total noncontrolling interests</a></td>
<td class="nump">527,997<span></span>
</td>
<td class="nump">527,897<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">7,137,733<span></span>
</td>
<td class="nump">7,182,598<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 15,602,289<span></span>
</td>
<td class="nump">$ 15,771,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LiabilitiesRelatedToAssetsHeldForSaleNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities Related To Assets Held For Sale, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LiabilitiesRelatedToAssetsHeldForSaleNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDistributionsInExcessOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=66023616&amp;loc=d3e9120-115832<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDistributionsInExcessOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982154&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableToBank">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableToBank</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInPreferredUnitHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInPreferredUnitHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffMarketLeaseUnfavorable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffMarketLeaseUnfavorable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087763680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract', window );"><strong>Balance Sheet Parenthetical Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserves for loans receivable</a></td>
<td class="nump">$ 6,152<span></span>
</td>
<td class="nump">$ 8,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for accounts receivable</a></td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="nump">$ 2,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">546,994,803<span></span>
</td>
<td class="nump">546,641,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">546,994,803<span></span>
</td>
<td class="nump">546,641,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockTransactionsParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087153664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental and related revenues</a></td>
<td class="nump">$ 392,431<span></span>
</td>
<td class="nump">$ 370,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Resident fees and services</a></td>
<td class="nump">127,084<span></span>
</td>
<td class="nump">121,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">6,163<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseRevenue', window );">Income from direct financing leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">525,678<span></span>
</td>
<td class="nump">498,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">47,963<span></span>
</td>
<td class="nump">37,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">179,225<span></span>
</td>
<td class="nump">177,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Operating</a></td>
<td class="nump">223,088<span></span>
</td>
<td class="nump">207,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">24,547<span></span>
</td>
<td class="nump">23,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet', window );">Impairments and loan loss reserves (recoveries), net</a></td>
<td class="num">(2,213)<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">475,035<span></span>
</td>
<td class="nump">446,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">81,578<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">18,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">82,350<span></span>
</td>
<td class="nump">22,172<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">132,993<span></span>
</td>
<td class="nump">73,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(777)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">1,816<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">134,507<span></span>
</td>
<td class="nump">75,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">134,507<span></span>
</td>
<td class="nump">75,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Noncontrolling interests&#8217; share in continuing operations</a></td>
<td class="num">(15,555)<span></span>
</td>
<td class="num">(3,730)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">118,952<span></span>
</td>
<td class="nump">71,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted', window );">Participating securities&#8217; share in earnings</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,976)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) applicable to common shares</a></td>
<td class="nump">$ 117,698<span></span>
</td>
<td class="nump">$ 69,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">546,842<span></span>
</td>
<td class="nump">539,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">547,110<span></span>
</td>
<td class="nump">539,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct financing lease revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087757312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 134,507<span></span>
</td>
<td class="nump">$ 75,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="num">(9,477)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Change in Supplemental Executive Retirement Plan obligation and other</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(9,413)<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">125,094<span></span>
</td>
<td class="nump">75,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Total comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(15,555)<span></span>
</td>
<td class="num">(3,730)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">$ 109,539<span></span>
</td>
<td class="nump">$ 71,713<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080501952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Cumulative Dividends In&#160;Excess Of&#160;Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Total Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 7,058,760<span></span>
</td>
<td class="nump">$ 6,515,470<span></span>
</td>
<td class="nump">$ 539,097<span></span>
</td>
<td class="nump">$ 10,100,294<span></span>
</td>
<td class="num">$ (4,120,774)<span></span>
</td>
<td class="num">$ (3,147)<span></span>
</td>
<td class="nump">$ 543,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">75,331<span></span>
</td>
<td class="nump">71,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
<td class="num">(437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(11,352)<span></span>
</td>
<td class="num">(11,352)<span></span>
</td>
<td class="num">$ (339)<span></span>
</td>
<td class="num">(11,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,144<span></span>
</td>
<td class="nump">6,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends</a></td>
<td class="num">(163,780)<span></span>
</td>
<td class="num">(163,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(7,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,509)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="num">(10,301)<span></span>
</td>
<td class="num">(10,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">6,947,722<span></span>
</td>
<td class="nump">6,408,223<span></span>
</td>
<td class="nump">$ 539,524<span></span>
</td>
<td class="nump">10,084,687<span></span>
</td>
<td class="num">(4,212,941)<span></span>
</td>
<td class="num">(3,047)<span></span>
</td>
<td class="nump">539,499<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">87,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income (loss)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="nump">10,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">97,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">7,182,598<span></span>
</td>
<td class="nump">6,654,701<span></span>
</td>
<td class="nump">$ 546,642<span></span>
</td>
<td class="nump">10,349,614<span></span>
</td>
<td class="num">(4,269,689)<span></span>
</td>
<td class="nump">28,134<span></span>
</td>
<td class="nump">527,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">134,341<span></span>
</td>
<td class="nump">118,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9,413)<span></span>
</td>
<td class="num">(9,413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
<td class="num">(417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(6,467)<span></span>
</td>
<td class="num">(6,467)<span></span>
</td>
<td class="num">$ (238)<span></span>
</td>
<td class="num">(6,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,565<span></span>
</td>
<td class="num">(2,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends</a></td>
<td class="num">(165,301)<span></span>
</td>
<td class="num">(165,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(22,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,731)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="nump">19,967<span></span>
</td>
<td class="nump">19,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">7,137,733<span></span>
</td>
<td class="nump">$ 6,609,736<span></span>
</td>
<td class="nump">$ 546,995<span></span>
</td>
<td class="nump">$ 10,360,058<span></span>
</td>
<td class="num">$ (4,316,038)<span></span>
</td>
<td class="nump">$ 18,721<span></span>
</td>
<td class="nump">$ 527,997<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">105,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income (loss)</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="num">(19,967)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 85,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments Of Permanent Equity To Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AdjustmentsOfPermanentEquityToTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230091784272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common dividends, per share (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081143040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 134,507<span></span>
</td>
<td class="nump">$ 75,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">179,225<span></span>
</td>
<td class="nump">177,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation amortization expense</a></td>
<td class="nump">3,287<span></span>
</td>
<td class="nump">4,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">2,821<span></span>
</td>
<td class="nump">2,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StraightLineRent', window );">Straight-line rents</a></td>
<td class="num">(747)<span></span>
</td>
<td class="num">(11,158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet', window );">Amortization of nonrefundable entrance fees and above (below) market lease intangibles</a></td>
<td class="num">(25,690)<span></span>
</td>
<td class="num">(24,725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations', window );">Equity loss (income) from unconsolidated joint ventures</a></td>
<td class="num">(1,816)<span></span>
</td>
<td class="num">(2,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions of earnings from unconsolidated joint ventures</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease', window );">Loss (gain) on sale of real estate under direct financing leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(22,693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairments and loan loss reserves (recoveries), net</a></td>
<td class="num">(2,213)<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Loss (gain) on sales of real estate, net</a></td>
<td class="num">(81,578)<span></span>
</td>
<td class="num">(3,785)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuredEventGainLoss', window );">Casualty-related loss (recoveries), net</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="num">(1,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">Decrease (increase) in accounts receivable and other assets, net</a></td>
<td class="num">(19,949)<span></span>
</td>
<td class="num">(4,144)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</a></td>
<td class="num">(15,936)<span></span>
</td>
<td class="nump">3,653<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">173,921<span></span>
</td>
<td class="nump">194,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherRealEstate', window );">Acquisitions of real estate</a></td>
<td class="num">(10,219)<span></span>
</td>
<td class="num">(134,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="num">(204,889)<span></span>
</td>
<td class="num">(178,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="num">(22,789)<span></span>
</td>
<td class="num">(22,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">Proceeds from sales of real estate, net</a></td>
<td class="nump">141,559<span></span>
</td>
<td class="nump">13,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Investments in unconsolidated joint ventures</a></td>
<td class="num">(9,640)<span></span>
</td>
<td class="num">(1,486)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures', window );">Distributions in excess of earnings from unconsolidated joint ventures</a></td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">3,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities', window );">Proceeds from insurance recovery</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment', window );">Proceeds from sales/principal repayments on loans receivable, direct financing leases, and marketable debt securities</a></td>
<td class="nump">158,381<span></span>
</td>
<td class="nump">75,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_PaymentsToAcquireLoansReceivableAndOther', window );">Investments in loans receivable and other</a></td>
<td class="num">(1,918)<span></span>
</td>
<td class="num">(1,860)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">56,345<span></span>
</td>
<td class="num">(245,962)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under bank line of credit and commercial paper</a></td>
<td class="nump">3,372,255<span></span>
</td>
<td class="nump">3,732,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under bank line of credit and commercial paper</a></td>
<td class="num">(3,811,861)<span></span>
</td>
<td class="num">(3,567,830)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromBankDebt', window );">Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt</a></td>
<td class="nump">399,532<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt</a></td>
<td class="num">(1,325)<span></span>
</td>
<td class="num">(1,270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishment and deferred financing costs</a></td>
<td class="num">(4,175)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance of common stock and exercise of options, net of offering costs</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(6,467)<span></span>
</td>
<td class="num">(11,352)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid on common stock</a></td>
<td class="num">(164,976)<span></span>
</td>
<td class="num">(163,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to and purchase of noncontrolling interests</a></td>
<td class="num">(22,803)<span></span>
</td>
<td class="num">(7,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Contributions from and issuance of noncontrolling interests</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(239,875)<span></span>
</td>
<td class="num">(18,511)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(9,609)<span></span>
</td>
<td class="num">(70,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">126,834<span></span>
</td>
<td class="nump">219,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">$ 117,225<span></span>
</td>
<td class="nump">$ 149,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Loss From Equity Method Investments, Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PaymentsToAcquireLoansReceivableAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Loans Receivable and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PaymentsToAcquireLoansReceivableAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuredEventGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess (deficiency) of insurance recovery over the loss incurred from an insured event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuredEventGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of other real estate investments held by the entity for investment purposes not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21B<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080549-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInsuranceSettlementInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from repayments of the balance excluding interest (principal) on loans receivable and leases held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StraightLineRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between actual rental income due and rental income recognized on a straight-line basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StraightLineRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086149616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Business</a></td>
<td class="text">Business<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard&#160;&amp; Poor&#8217;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#8220;REIT&#8221;) that, together with its consolidated entities (collectively, &#8220;Healthpeak&#8221; or the &#8220;Company&#8221;), invests primarily in real estate serving the healthcare industry in the United States (&#8220;U.S.&#8221;). Healthpeak&#174; acquires, develops, owns, leases, and manages healthcare real estate. The Company&#8217;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#8220;CCRC&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters are in Denver, Colorado, and it has additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, Healthpeak Properties, Inc. announced its intent to complete an UPREIT reorganization. As part of the reorganization, the company formerly known as Healthpeak Properties, Inc. (&#8220;Old Healthpeak&#8221;) formed New Healthpeak, Inc. (&#8220;New Healthpeak&#8221;) as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc. (&#8220;Merger Sub&#8221;) as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the &#8220;Merger&#8221;). In connection with the Merger, New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the UPREIT reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (&#8220;Healthpeak OP&#8221;). Following the UPREIT reorganization, New Healthpeak&#8217;s business is conducted through Healthpeak OP and New Healthpeak does not have material assets or liabilities, other than through its investment in Healthpeak OP. This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023, for the quarter ended March 31, 2023. For additional information on the UPREIT reorganization, see the Company&#8217;s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on February 10, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230189479264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the coronavirus pandemic. Grant income is recognized to the extent that qualifying expenses and lost revenues exceed grants received and the Company will comply with all conditions attached to the grant. As of March&#160;31, 2023, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.147%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company concluded that the dispositions of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 for further information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. In December 2022, the FASB issued ASU No. 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2022-06&#8221;), which defers the sunset date of the reference rate reform guidance to December 31, 2024. The amendments in ASU 2020-04, ASU 2021-01, and ASU 2022-06 were effective immediately upon issuance. In 2022, the Company elected to apply certain hedge accounting expedients provided by ASU 2020-04 and ASU 2021-01, which preserves the hedging relationship of derivatives. During the first quarter of 2023, the Company amended certain of its variable rate mortgage debt and the related interest rate swap agreements to change the interest rate benchmark from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The Company elected to apply certain practical expedients provided by ASU 2020-04 and ASU 2021-01 related to cash flow hedges, which did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures. The expedients provided by ASU 2020-04, ASU 2021-01, and ASU 2022-06 and the effects of reference rate reform have not had, and are not expected to have, a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230169495536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateDisclosureTextBlock', window );">Real Estate</a></td>
<td class="text">Real Estate<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company closed a life science acquisition in Cambridge, Massachusetts for $9&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">67 Smith Place</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $72&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vista Sorrento Phase II</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in San Diego, California for $24&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Webster MOB Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company acquired a portfolio of two medical office buildings (&#8220;MOBs&#8221;) in Houston, Texas for $43&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Northwest Medical Plaza</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company acquired one MOB in Bentonville, Arkansas for $26&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concord Avenue Land Parcels</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $18&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Development Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commitments, which are primarily related to development and redevelopment projects and Company-owned tenant improvements,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $35 million, to $217 million at March&#160;31, 2023, when compared to December&#160;31, 2022, primarily as a result of construction spend on existing projects in the first quarter of 2023, thereby decreasing the remaining commitment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 970<br> -URI https://asc.fasb.org/topic&amp;trid=2156125<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 978<br> -URI https://asc.fasb.org/topic&amp;trid=2134977<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 976<br> -URI https://asc.fasb.org/topic&amp;trid=2134846<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 974<br> -URI https://asc.fasb.org/topic&amp;trid=2156429<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 972<br> -URI https://asc.fasb.org/topic&amp;trid=2134617<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230169531344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Dispositions of Real Estate and Discontinued Operations</a></td>
<td class="text">Dispositions of Real Estate and Discontinued Operations<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company sold two life science facilities in Durham, North Carolina, which were classified as held for sale as of December 31, 2022, for $113&#160;million, resulting in total gain on sales of $60&#160;million. Additionally, in March 2023, the Company sold two MOBs for $32&#160;million, resulting in total gain on sales of $21&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, the Company sold one life science facility in Salt Lake City, Utah for $14&#160;million, resulting in a gain on sale of $4&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, the Company sold three</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MOBs and one MOB land parcel for $27&#160;million, resulting in total gain on sales of $10&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, the Company sold two MOBs for $9&#160;million, resulting in total gain on sales of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale and Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company concluded that the dispositions of its senior housing triple-net and SHOP portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each of March&#160;31, 2023 and December&#160;31, 2022, the total assets and total liabilities classified as discontinued operations were zero. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, no assets were classified as held for sale. As of December&#160;31, 2022, two life science assets were classified as held for sale, with an aggregate carrying value of $50 million, primarily comprised of net real estate assets of $44&#160;million. As of December&#160;31, 2022, liabilities related to these assets held for sale were $4 million. These two life science assets were sold in January 2023, as discussed above.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2023 and 2022 are presented below (in thousands) and are included in the consolidated results of operations for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(68)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company did not recognize any impairment charges.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Losses</span></div>During the three months ended March&#160;31, 2022, the Company recognized $14&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with the demolition of an MOB.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087750128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#8220;DFL&#8221;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Straight-Line Rents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#8220;DFL&#8221;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Straight-Line Rents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#8220;DFL&#8221;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Straight-Line Rents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088414480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Loans Receivable</a></td>
<td class="text">Loans Receivable<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$40 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sunrise Senior Housing Portfolio Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of 32 SHOP facilities for $664&#160;million in January 2021, the Company provided the buyer with initial financing of $410&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $92&#160;million of additional financing for capital expenditures (up to 65% of the estimated cost of capital expenditures). As of March&#160;31, 2023, the additional financing was reduced to $40&#160;million, of which $0.4 million had been funded. The initial and additional financing is secured by the buyer&#8217;s equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 2022, and December 2022, the Company received principal repayments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$246&#160;million, $8&#160;million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$27&#160;million, and $10&#160;million, respectively, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conjunction with the disposition of the underlying collateral. At each of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023 and December&#160;31, 2022, this secured loan had an outstanding principal balance of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$120&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of 16 additional SHOP facilities for $230&#160;million in January 2021, the Company provided the buyer with financing of $150&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer&#8217;s equity ownership in each property. Upon maturity in January 2023, the borrower did not make the required principal repayment. In February 2023, the borrower made a partial principal repayment of $102&#160;million and the remaining balance owed was refinanced with the Company. In connection with the refinance, the maturity date of the loan was extended to January 2024 and the interest rate on the loan was increased to a variable rate based on Term SOFR (plus an 11 basis point adjustment related to SOFR transition) plus 6.0% for the first six months of the extended term, increasing to 7.0% for the last six months of the extended term. The Company also received a $1&#160;million extension fee in connection with the refinance, which is recognized in interest income over the remaining term of the loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Other Loans Receivable Transactions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company received full repayment of the outstanding balance of one $35&#160;million secured loan. In April 2023, the Company received full repayment of the outstanding balance of one $14&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Other Loans Receivable Transactions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company received full repayment of the outstanding balance of a $2&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company received full repayment of the outstanding balance of a $1&#160;million mezzanine loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company extended the maturity dates of four secured loans with an aggregate outstanding balance of $61&#160;million, originally scheduled to mature in December 2022, by one year to December 2023. In connection with the extensions, the interest rates on the loans were increased to a variable rate based on Term SOFR (plus an 11 basis point adjustment related to SOFR transition) with a floor of 8.5% for the first six months of the extended term, increasing to a floor of 10.5% for the last six months of the extended term. Two of these secured loans were repaid during 2023 as discussed above.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CCRC Resident Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2023 and December&#160;31, 2022, the Company held</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$36 million and $33&#160;million, respectively, of such notes receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans Receivable Internal Ratings </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.164%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CCRC resident loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Loan Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#8217;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses (recoveries) related to loans sold or repaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes CCRC resident loans and other loan activity. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at March&#160;31, 2023 and December&#160;31, 2022, a liability of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.7 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $0.8 million, respectively, related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the reserve for expected loan losses during the three months ended March&#160;31, 2023 is primarily due to principal repayments on seller financing, partially offset by increased interest rates on variable rate loans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088484576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments in and Advances to Unconsolidated Joint Ventures</a></td>
<td class="text">Investments in and Advances to Unconsolidated Joint Ventures<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South San Francisco JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 67</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2023. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In August 2022, the Company sold a 30% interest in seven life science assets in South San Francisco, California to a sovereign wealth fund. This transaction resulted in the recognition of seven unconsolidated life science joint ventures in which the Company holds a 70% ownership percentage in each joint venture. These joint ventures have been aggregated herein due to similarity of the investments and operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Land held for development is excluded from the property count as of March&#160;31, 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). These joint ventures have been aggregated herein due to similarity of the investments and operations. In April 2023, the Company acquired the remaining 80% interest in one of the two properties in the Ventures IV unconsolidated joint venture for $4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088640192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock', window );">Intangibles</a></td>
<td class="text">Intangibles<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375,268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes intangible assets reported in assets held for sale of $2&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:72.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, no intangible assets or liabilities were acquired.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $7&#160;million and intangible liabilities of $6&#160;million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of 7 years and 11 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088560000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#8217;s consolidated operating subsidiary. Healthpeak OP is the borrower under, and the Company is the guarantor of, all of the unsecured debt discussed below, which includes the Revolving Facility, Term Loan Facilities, Commercial Paper Program (each as defined below), and senior unsecured notes. The Company&#8217;s guarantee of the senior unsecured notes is full and unconditional and applicable to existing and future senior unsecured notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank Line of Credit and Term Loans </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2019, the Company executed a $2.5 billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and two&#160;six-month extension options, subject to certain customary conditions. In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#8220;Revolving Facility&#8221;) to increase total revolving commitments from $2.5&#160;billion to $3.0&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to two six-month extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at the applicable interest rate benchmark plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. On February 10, 2023, the Company executed an amendment to the Revolving Facility to convert the interest rate benchmark from LIBOR to SOFR. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Additionally, the Revolving Facility includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to 0.025% based on the Company&#8217;s achievement of specified sustainability-linked metrics, subject to certain conditions. Based on the Company&#8217;s credit ratings at March&#160;31, 2023, and inclusive of achievement of a sustainability-linked metric during the year ended December 31, 2021, the margin on the Revolving Facility was 0.85% and the facility fee was 0.15%. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had no balance outstanding under the Revolving Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 22, 2022, the Company executed a term loan agreement (the &#8220;Term Loan Agreement&#8221;) that provided for two senior unsecured delayed draw term loans in an aggregate principal amount of up to $500&#160;million (the &#8220;Term Loan Facilities&#8221;). The Term Loan Facilities were available to be drawn from time to time during a 180-day period after closing, subject to customary borrowing conditions, and the Company drew the entirety of the $500&#160;million under the Term Loan Facilities in October 2022. $250&#160;million of the Term Loan Facilities has an initial stated maturity of 4.5 years, which may be extended for a one-year period subject to certain customary conditions. The other $250&#160;million of the Term Loan Facilities has a stated maturity of 5 years with no option to extend. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had $500&#160;million outstanding under the Term Loan Facilities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans outstanding under the Term Loan Facilities accrue interest at Term SOFR plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. The Term Loan Agreement also includes a sustainability-linked pricing component whereby the applicable margin under the Term Loan Facilities may be reduced by 0.01% based on the Company&#8217;s achievement of specified sustainability-linked metrics. Based on the Company&#8217;s credit ratings as of March&#160;31, 2023, the margin on the Term Loan Facilities was 0.95%. The Term Loan Agreement includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to an additional $500&#160;million, subject to securing additional commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into two forward-starting interest rate swap instruments that are designated as cash flow hedges (see Note 17). The Term Loan Facilities associated with these interest rate swap instruments are reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instruments. Based on the Company&#8217;s credit ratings as of March&#160;31, 2023, the Term Loan Facilities had a blended fixed effective interest rate of 3.77%, inclusive of the impact of these interest rate swap instruments and amortization of the related debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility and Term Loan Facilities are subject to certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the applicable agreement: (i) limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to 60%; (ii) limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to 40%; (iii) limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to 60%; (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times; and (v) require a minimum Consolidated Tangible Net Worth of $7.7&#160;billion. The Company believes it was in compliance with each of these covenants at March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company established an unsecured commercial paper program (the &#8220;Commercial Paper Program&#8221;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. At each of March&#160;31, 2023 and December&#160;31, 2022, the maximum aggregate face or principal amount that can be outstanding at any one time was $2.0&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#8217;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2023, the Company had $556&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately 16 days and a weighted average interest rate of 5.53%. At December&#160;31, 2022, the Company had $996&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately two months and a weighted average interest rate of 4.90%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the Company had senior unsecured notes outstanding with an aggregate principal balance of $5.1&#160;billion and $4.7&#160;billion, respectively. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions, and other customary terms. The Company believes it was in compliance with these covenants at March&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s senior unsecured notes issuances during the three months ended March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 17, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, there were no repurchases or redemptions of senior unsecured notes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, there were no issuances, repurchases, or redemptions of senior unsecured notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Debt</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and December&#160;31, 2022, the Company had $344 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $345&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by 15 MOBs and 3 CCRCs, with an aggregate carrying value of $785 million and $793&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and 2022, the Company made aggregate principal repayments of mortgage debt of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $142&#160;million of mortgage debt secured by a portfolio of 13 MOBs that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap instruments associated with this variable rate mortgage debt and entered into two interest rate swap instruments that are designated as cash flow hedges</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and mature in May 2026. In February 2023, the agreements associated with this variable rate mortgage debt were amended to change the interest rate benchmarks from LIBOR to SOFR, effective March 2023. Concurrently, the Company modified the related interest rate swap instruments to reflect the change in the interest rate benchmarks from LIBOR to SOFR (see Note 17). The variable rate mortgage debt associated with these interest rate swap instruments is reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instrument.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Maturities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;<br/>of Credit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term&#160;Loans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,450,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,499,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums, (discounts), and debt issuance costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,457)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,056,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,453,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from 1.54% to 6.87% with a weighted average effective interest rate of 3.53% and a weighted average maturity of 6 years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from 3.44% to 8.52% with a weighted average effective interest rate of 4.31% and a weighted average maturity of 3 years. These interest rates include the impact of designated interest rate swap instruments, which effectively fix the interest rate on certain variable rate debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088379664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#8217;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#8217;s financial condition, results of operations, or cash flows. The Company&#8217;s policy is to expense legal costs as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs and Other Partnerships</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of certain limited liability companies (&#8220;DownREITs&#8221;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#8220;make-whole payments&#8221;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of 29 properties. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company owns a 49% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088390432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity and Redeemable Noncontrolling Interests</a></td>
<td class="text">Equity and Redeemable Noncontrolling Interests<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share. The common stock cash dividend will be paid on May 19, 2023 to stockholders of record as of the close of business on May 8, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and 2022, the Company declared and paid common stock cash dividends of $0.30 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-The-Market Equity Offering Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, in connection with the UPREIT reorganization, the Company terminated the previous at-the-market equity offering program (as amended from time to time, the &#8220;2020 ATM Program&#8221;) and established a new at-the-market equity offering program (the &#8220;2023 ATM Program&#8221; and, together with the 2020 ATM Program, the &#8220;ATM Programs&#8221;). The ATM Programs allow for the sale of shares of common stock having an aggregate gross sales price of up to $1.5 billion (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#8220;ATM forward contract&#8221;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATM forward contracts generally have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTUwMw_5ce2ccbc-5900-4089-b403-cb14df27b311">one</span> to two year term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#8217;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#8217; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.5 billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s common stock remained available for sale under the 2023 ATM Program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company utilized the forward provisions under the 2020 ATM Program to allow for the sale of an aggregate of 9.1&#160;million shares of its common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at an initial weighted average net price of $35.25 per share, after commissions. The Company did not enter into any forward contracts under the 2020 ATM Program during the year ended December 31, 2022. In December 2022, the Company settled all 9.1&#160;million shares previously outstanding under ATM forward contracts at a weighted average net price of $34.01 per share, after commissions, resulting in net proceeds of $308&#160;million. During the three months ended March&#160;31, 2023, the Company did not utilize the forward provisions under the ATM Programs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Direct Issuances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2023 and March&#160;31, 2022, there were no direct issuances of shares of common stock under the ATM Programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2022, the Company&#8217;s Board of Directors approved a share repurchase program under which the Company may acquire shares of its common stock in the open market up to an aggregate purchase price of $500&#160;million (the &#8220;Share Repurchase Program&#8221;). Purchases of common stock under the Share Repurchase Program may be exercised at the Company&#8217;s discretion with the timing and number of shares repurchased depending on a variety of factors, including price, corporate and regulatory requirements, and other corporate liquidity requirements and priorities. The Share Repurchase Program expires in August 2024 and may be suspended or terminated at any time without prior notice. Under Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In August 2022, the Company repurchased 2.1&#160;million shares of its common stock at a weighted average price of $27.16 per share for a total of $56&#160;million. During the three months ended March&#160;31, 2023, there were no repurchases under the Share Repurchase Program. Therefore, at March&#160;31, 2023, $444&#160;million of the Company&#8217;s common stock remained available for repurchase under the Share Repurchase Program. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on derivatives, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined benefit pension plan, known as the Supplemental Executive Retirement Plan, with one plan participant, a former Chief Executive Officer (&#8220;CEO&#8221;) of the Company who departed in 2003. Changes to the Supplemental Executive Retirement Plan minimum liability are reflected in other comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#8217;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, one of the redeemable noncontrolling interests met the conditions for redemption, but was not yet exercised as of March&#160;31, 2023. The three remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2023 or December&#160;31, 2022. Two of the interests will become redeemable following the passage of a predetermined amount of time, which will occur during 2023 and 2024. The third interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2024. The redemption values are subject to change based on the assessment of redemption value at each redemption date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthpeak OP</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the Reorganization, Healthpeak Properties, Inc. was the initial sole member and 100% owner of Healthpeak OP. Subsequent to the Reorganization, certain employees of the Company (&#8220;OP Unitholders&#8221;) were issued noncontrolling, non-managing member units in Healthpeak OP (&#8220;OP Units&#8221;). As of March&#160;31, 2023, Healthpeak Properties, Inc. owned 99.6% of Healthpeak OP, with the OP Unitholders owning the remaining 0.4%. When certain conditions are met, the OP Unitholders have the right to require redemption of part or all of their OP Units for cash or shares of the Company&#8217;s common stock, at the Company&#8217;s option as managing member of Healthpeak OP. The per unit redemption amount is equal to either one share of the Company&#8217;s common stock or cash equal to the fair value of a share of common stock at the time of redemption. The Company classifies the OP Units in permanent equity because it may elect, in its sole discretion, to issue shares of its common stock to OP Unitholders who choose to redeem their OP Units rather than using cash. None of the outstanding OP Units met the criteria for redemption as of March&#160;31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-managing member units of the Company&#8217;s DownREITs are exchangeable for an amount of cash approximating the then-current market value of shares of the Company&#8217;s common stock or, at the Company&#8217;s option, shares of the Company&#8217;s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company&#8217;s common stock, the carrying amount of the DownREIT units is reclassified to stockholders&#8217; equity. At March&#160;31, 2023, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT units (seven million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of Healthpeak common stock are issuable upon conversion) outstanding in</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seven</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT&#160;LLCs, for all of which the Company acts as the managing member. At March&#160;31, 2023, the carrying and market values of the five million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DownREIT units were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$200&#160;million and $160&#160;million, respectively. At December&#160;31, 2022, the carrying and market values of the five million DownREIT units were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$200&#160;million and $183&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088379664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Common Share</a></td>
<td class="text">Earnings Per Common Share<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per common share (&#8220;EPS&#8221;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method, common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#8217;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#8217;s diluted weighted-average common shares for each of the three months ended March&#160;31, 2023 and 2022 was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">zero</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted-average incremental shares from forward equity sales agreements.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,952&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares - basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, forward equity sales agreements had no dilutive impact as no shares were outstanding under ATM forward contracts during the period. For the three months ended March&#160;31, 2022, the 9.1 million shares under forward equity sales agreements that had not been settled during the three months then ended were anti-dilutive.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, all 7 million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088567264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Disclosures</a></td>
<td class="text">Segment Disclosures<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments, based on how its chief operating decision maker (&#8220;CODM&#8221;) evaluates the business and allocates resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#8217;s interests in an unconsolidated JV that owns 19 senior housing assets (the &#8220;SWF SH JV&#8221;), loans receivable, and marketable debt securities. These non-reportable segments have been presented on an aggregate basis within the Notes to the Consolidated Financial Statements herein. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC, as updated by Note 2 herein. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI are non-GAAP supplemental measures that are calculated as NOI and Adjusted NOI from consolidated properties, plus the Company&#8217;s share of NOI and Adjusted NOI from unconsolidated joint ventures (calculated by applying the Company&#8217;s actual ownership percentage for the period), less noncontrolling interests&#8217; share of NOI and Adjusted NOI from consolidated joint ventures (calculated by applying the Company&#8217;s actual ownership percentage for the period). Management utilizes its share of NOI and Adjusted NOI in assessing its performance as the Company has various joint ventures that contribute to its performance. The Company does not control its unconsolidated joint ventures, and the Company&#8217;s share of amounts from unconsolidated joint ventures do not represent the Company&#8217;s legal claim to such items. The Company&#8217;s share of NOI and Adjusted NOI should not be considered a substitute for, and should only be considered together with and as a supplement to, the Company&#8217;s financial information presented in accordance with GAAP. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-segment assets consist of assets in the Company&#8217;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable debt securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(223,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,568)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,459)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,761)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,064&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,761)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,384)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, 5, 6, 7, and 15 for significant transactions impacting the Company&#8217;s segment assets during the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088518400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">Supplemental Cash Flow Information<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating, investing, and financing cash flows in the Consolidated Statements of Cash Flows are reported inclusive of both cash flows from continuing operations and cash flows from discontinued operations. The following table summarizes certain cash flow information related to discontinued operations (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents, and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash and cash equivalents at financial institutions insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000 per institution. However, as the account balances at certain institutions exceed the FDIC insurance coverage, there is a concentration of credit risk related to amounts in excess of such coverage.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088525600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_VariableInterestEntitiesTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Subsidiary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, in connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#8217;s operating subsidiary and a limited liability company that has governing provisions that are the functional equivalent of a limited partnership. The Company holds a membership interest in Healthpeak OP, acts as the managing member of Healthpeak OP, and exercises full responsibility, discretion, and control over the day-to-day management of Healthpeak OP. Because the noncontrolling interests in Healthpeak OP do not have substantive liquidation rights, substantive kick-out rights without cause, or substantive participating rights, we have determined that Healthpeak OP is a VIE. The Company, as managing member, has the power to direct the core activities of Healthpeak OP that most significantly affect Healthpeak OP&#8217;s performance, and through its interest in Healthpeak OP, has both the right to receive benefits from and the obligation to absorb losses of Healthpeak OP. Accordingly, the Company is the primary beneficiary of Healthpeak OP and consolidates Healthpeak OP. As the Company conducts its business and holds its assets and liabilities through Healthpeak OP, the total consolidated assets and liabilities, income (losses), and cash flows of Healthpeak OP represent substantially all of the total consolidated assets and liabilities, income (losses), and cash flows of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unconsolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had investments in two unconsolidated VIE joint ventures. At December&#160;31, 2022, the Company had investments in: (i) two unconsolidated VIE joint ventures and (ii) marketable debt securities of one VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#8217;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities Investment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December&#160;31, 2022, the Company held $22&#160;million of commercial mortgage-backed securities (&#8220;CMBS&#8221;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie Mac) through a special purpose entity that had been identified as a VIE because it was &#8220;thinly capitalized.&#8221; The CMBS issued by the VIE were backed by mortgage debt obligations on real estate assets. These securities were classified as held-to-maturity because the Company had the intent and ability to hold the securities until maturity. These securities matured on December 31, 2022, and the Company received the related proceeds in January 2023.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LLC Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#8217;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of three hospitals as well as senior housing real estate. Any assets generated by the entity may only be used to settle its contractual obligations (primarily capital expenditures and debt service payments).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Needham Land Parcel JV.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Current equity at risk is not sufficient to finance the joint venture&#8217;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development costs and debt service payments). See Note 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#8217;s unconsolidated VIEs and interests therein.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2023 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure and </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LLC investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated total assets and total liabilities at March&#160;31, 2023 and December&#160;31, 2022 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ventures V, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a 51% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#8220;Ventures V&#8221;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Science JVs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The Company holds a 98% or greater ownership interest in multiple joint venture entities that own and lease life science assets (the &#8220;Life Science JVs&#8221;). The Life Science JVs are VIEs as the members share in certain decisions of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations. Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MSREI MOB JV.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a 51% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#8220;MSREI JV&#8221;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a controlling ownership interest in and is the managing member of seven DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Consolidated Real Estate Partnerships.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#8220;Partnerships&#8221;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,612&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities related to assets held for sale include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088478720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments either recorded or disclosed on a recurring basis (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,238,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value is calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value is based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and interest rate swap instruments, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, commercial paper, and term loans, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and year ended December&#160;31, 2022, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087987648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates and their related potential impact on future earnings and cash flows. The Company does not use derivative instruments for speculative or trading purposes. At March&#160;31, 2023, a one percentage point increase or decrease in the underlying interest rate curve would result in a corresponding increase or decrease in the fair value of the derivative instruments by approximately $22&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company executed two interest rate cap instruments on $142&#160;million of variable rate mortgage debt secured by a portfolio of MOBs (see Note 9). During the three months ended March&#160;31, 2022, the Company recognized a $2&#160;million increase in the fair value of the interest rate cap instruments within other income (expense), net. In April 2022, the Company terminated these interest rate cap instruments and entered into two interest rate swap instruments that are designated as cash flow hedges and mature in May 2026. In February 2023, the Company modified its two interest rate swap instruments totaling a $142&#160;million notional value to reflect the change in the related variable rate mortgage debt&#8217;s interest rate benchmarks from LIBOR to SOFR (see Note 9). The Company applied certain practical expedients provided by ASU 2020-04 and ASU 2021-01 in connection with the modifications to these cash flow hedges (see Note 2).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into two forward-starting interest rate swap instruments on the $500&#160;million aggregate principal amount of the Term Loan Facilities (see Note 9). The interest rate swap instruments are designated as cash flow hedges.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate swap instruments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pay Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receive Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.99 %</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  2.50% </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.54 %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  2.05% </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.60 %</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.54 %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pay rates and receive rates are as of March&#160;31, 2023. As of December&#160;31, 2022, the interest rate swap instrument with a $51&#160;million notional amount had a pay rate of 5.08% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.50%. As of December&#160;31, 2022, the interest rate swap instrument with a $91&#160;million notional amount had a pay rate of 4.63% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.05%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the interest rate swap instruments were in an asset position. Derivative assets are recorded at fair value in other assets, net on the Consolidated Balance Sheets.</span></div>(3)Represents interest rate swap instruments that hedge fluctuations in interest payments on variable rate debt by converting the interest rates to fixed interest rates. The changes in fair value of designated derivatives that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088446832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable, Accrued Liabilities, and Other Liabilities</a></td>
<td class="text">Accounts Payable, Accrued Liabilities, and Other Liabilities<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,994&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2023 and December&#160;31, 2022, includes $12&#160;million and $15&#160;million, respectively,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of severance-related charges associated with the departure of a former CEO in October 2022 that had not yet been paid.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230171850144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Deferred Revenue</a></td>
<td class="text">Deferred Revenue<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonrefundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and 2022, the Company collected nonrefundable entrance fees of $29&#160;million and $21&#160;million, respectively. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization of $20&#160;million and</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$19&#160;million, respectively, which is included within resident fees and services on the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Other deferred revenue is primarily comprised of prepaid rent, deferred rent, and tenant-funded tenant improvements owned by the Company. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization related to other deferred revenue of $13&#160;million and $9&#160;million,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">respectively, which is included in rental and related revenues on the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081121104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomePolicyPolicyTextBlock', window );">Government Grant Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the coronavirus pandemic. Grant income is recognized to the extent that qualifying expenses and lost revenues exceed grants received and the Company will comply with all conditions attached to the grant. As of March&#160;31, 2023, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company concluded that the dispositions of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 for further information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. In December 2022, the FASB issued ASU No. 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2022-06&#8221;), which defers the sunset date of the reference rate reform guidance to December 31, 2024. The amendments in ASU 2020-04, ASU 2021-01, and ASU 2022-06 were effective immediately upon issuance. In 2022, the Company elected to apply certain hedge accounting expedients provided by ASU 2020-04 and ASU 2021-01, which preserves the hedging relationship of derivatives. During the first quarter of 2023, the Company amended certain of its variable rate mortgage debt and the related interest rate swap agreements to change the interest rate benchmark from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The Company elected to apply certain practical expedients provided by ASU 2020-04 and ASU 2021-01 related to cash flow hedges, which did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures. The expedients provided by ASU 2020-04, ASU 2021-01, and ASU 2022-06 and the effects of reference rate reform have not had, and are not expected to have, a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash and cash equivalents at financial institutions insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000 per institution. However, as the account balances at certain institutions exceed the FDIC insurance coverage, there is a concentration of credit risk related to amounts in excess of such coverage.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087911648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock', window );">Schedule of Government Grant Receivables, CARES Act</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.147%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Government Grant Receivables, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088476288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2023 and 2022 are presented below (in thousands) and are included in the consolidated results of operations for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(68)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">317&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088525600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock', window );">Schedule of Company's Lease Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of lease income from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087757184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Loans Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$40 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock', window );">Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.164%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,117&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC resident loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CCRC resident loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period gross write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period recoveries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period net write-offs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Financing Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses (recoveries) related to loans sold or repaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div>(1)Includes CCRC resident loans and other loan activity.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953659-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088478720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South San Francisco JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 67</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2023. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In August 2022, the Company sold a 30% interest in seven life science assets in South San Francisco, California to a sovereign wealth fund. This transaction resulted in the recognition of seven unconsolidated life science joint ventures in which the Company holds a 70% ownership percentage in each joint venture. These joint ventures have been aggregated herein due to similarity of the investments and operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Land held for development is excluded from the property count as of March&#160;31, 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). These joint ventures have been aggregated herein due to similarity of the investments and operations. In April 2023, the Company acquired the remaining 80% interest in one of the two properties in the Ventures IV unconsolidated joint venture for $4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088596096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Lease Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375,268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes intangible assets reported in assets held for sale of $2&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock', window );">Schedule of Intangible Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:72.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080027264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Senior Notes Issuances</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s senior unsecured notes issuances during the three months ended March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 17, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Summary of Debt Maturities and Schedule Principal Repayments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2023 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;<br/>of Credit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Term&#160;Loans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,450,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,499,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Premiums, (discounts), and debt issuance costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,457)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,056,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,453,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from 1.54% to 6.87% with a weighted average effective interest rate of 3.53% and a weighted average maturity of 6 years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from 3.44% to 8.52% with a weighted average effective interest rate of 4.31% and a weighted average maturity of 3 years. These interest rates include the impact of designated interest rate swap instruments, which effectively fix the interest rate on certain variable rate debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088445600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other comprehensive Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on derivatives, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087893808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,952&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares - basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div>(1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088567264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Information of Reportable Segments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(223,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,568)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,459)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,761)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,064&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,227)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,761)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,384)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div>(2)Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087770240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The following table summarizes certain cash flow information related to discontinued operations (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents, and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088612176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2023 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure and </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LLC investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock', window );">Consolidated Assets and Liabilities of Variable Interest Entities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108,612&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381,166&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities related to assets held for sale include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088511104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of Carry Amounts and Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments either recorded or disclosed on a recurring basis (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,712,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,238,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value is calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value is based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and interest rate swap instruments, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, commercial paper, and term loans, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and year ended December&#160;31, 2022, there were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088662416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate swap instruments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pay Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Receive Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.99 %</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  2.50% </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.54 %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD-SOFR w/ -5 Day Lookback +  2.05% </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.60 %</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">August 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.54 %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;1 mo. USD-SOFR CME Term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pay rates and receive rates are as of March&#160;31, 2023. As of December&#160;31, 2022, the interest rate swap instrument with a $51&#160;million notional amount had a pay rate of 5.08% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.50%. As of December&#160;31, 2022, the interest rate swap instrument with a $91&#160;million notional amount had a pay rate of 4.63% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.05%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At each of March&#160;31, 2023 and December&#160;31, 2022, the interest rate swap instruments were in an asset position. Derivative assets are recorded at fair value in other assets, net on the Consolidated Balance Sheets.</span></div>(3)Represents interest rate swap instruments that hedge fluctuations in interest payments on variable rate debt by converting the interest rates to fixed interest rates. The changes in fair value of designated derivatives that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088514544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,994&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2023 and December&#160;31, 2022, includes $12&#160;million and $15&#160;million, respectively,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of severance-related charges associated with the departure of a former CEO in October 2022 that had not yet been paid.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087911648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ScheduleOfDeferredRevenueTableTextBlock', window );">Schedule of Deferred Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonrefundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023 and 2022, the Company collected nonrefundable entrance fees of $29&#160;million and $21&#160;million, respectively. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization of $20&#160;million and</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$19&#160;million, respectively, which is included within resident fees and services on the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Other deferred revenue is primarily comprised of prepaid rent, deferred rent, and tenant-funded tenant improvements owned by the Company. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization related to other deferred revenue of $13&#160;million and $9&#160;million,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">respectively, which is included in rental and related revenues on the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfDeferredRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfDeferredRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080475360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Government Grant Income (Details) - Government Assistance, CARES Act - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 7,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=peak_IncomeLossFromDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=peak_IncomeLossFromDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081069840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate - Real Estate Investments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | MASSACHUSETTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | TEXAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | ARKANSAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085472832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate - Development Activities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease', window );">Development and redevelopment projects, amount decrease</a></td>
<td class="num">$ (35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements', window );">Development commitments</a></td>
<td class="nump">$ 217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments, Development and Redevelopment Projects and Tenant Improvements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments, Development and Redevelopment Projects, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081211216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81,578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup', window );">Assets held for sale, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,866,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfRealEstate', window );">Impairment of real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember', window );">Planned MOB Demolition, Tenant Relocation and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringExpense', window );">Expense on other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total asset of discontinued operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities of discontinued operation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup', window );">Assets held for sale, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale', window );">Liabilities related to assets held for sale, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesSold', window );">Number of properties sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_PropertiesHeldForSaleNumber', window );">Number of properties classified as held for sale | property</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetRealEstateAssets', window );">Net real estate assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesSold', window );">Number of properties sold | property</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="nump">$ 32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MOBLandParcelsMember', window );">MOB Land Parcels</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesSold', window );">Number of properties sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Real Estate Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PropertiesHeldForSaleNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of properties held for sale at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PropertiesHeldForSaleNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982154&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period to reduce the carrying amount of real property to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of buildings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MOBLandParcelsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MOBLandParcelsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087858096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details) - Held-for-sale - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices', window );">Resident fees and services</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,655<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Operating</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome', window );">Other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Nonoperating Income Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Resident Fees And Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Total Costs And Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085828336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncomeAbstract', window );"><strong>Interest and Other Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Fixed income from operating leases</a></td>
<td class="nump">$ 296,217<span></span>
</td>
<td class="nump">$ 287,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseVariableLeaseIncome', window );">Variable income from operating leases</a></td>
<td class="nump">96,214<span></span>
</td>
<td class="nump">82,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseInterestIncome', window );">Interest income from direct financing leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from net investment in direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseVariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseVariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230079839728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLeaseReceivables', window );">Proceeds from sale of lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfNotesReceivable', window );">Gain on sale of direct financing lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_PropertiesWithDirectFinancingLeasesNumber', window );">Number of properties classified as DFL | property</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StraightLineRent', window );">Straight-line rent receivable</a></td>
<td class="nump">$ 747<span></span>
</td>
<td class="nump">$ 11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=peak_SorrentoTherapeuticsIncMember', window );">Sorrento Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StraightLineRent', window );">Straight-line rent receivable</a></td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PropertiesWithDirectFinancingLeasesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of properties with direct financing leases at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PropertiesWithDirectFinancingLeasesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107425-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of receivables arising from the lease of real estate, equipment or other fixed assets for a specified time in exchange for payment, usually in the form of rent; excludes proceeds from sales-type lease transactions, which are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StraightLineRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between actual rental income due and rental income recognized on a straight-line basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StraightLineRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=peak_SorrentoTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=peak_SorrentoTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085738832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Loans Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount', window );">Unamortized discounts, fees, and costs</a></td>
<td class="num">$ (1,407)<span></span>
</td>
<td class="num">$ (808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses</a></td>
<td class="num">(6,152)<span></span>
</td>
<td class="num">(8,280)<span></span>
</td>
<td class="num">$ (1,813)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Loans receivable, net</a></td>
<td class="nump">243,149<span></span>
</td>
<td class="nump">374,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LoansAndLeasesReceivableRemainingCommitments', window );">Loans and Leases Receivable, Remaining Commitments</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="nump">214,238<span></span>
</td>
<td class="nump">350,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses</a></td>
<td class="num">(6,152)<span></span>
</td>
<td class="num">(8,280)<span></span>
</td>
<td class="num">$ (1,804)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_CCRCResidentLoansMember', window );">CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="nump">$ 36,470<span></span>
</td>
<td class="nump">$ 33,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansAndLeasesReceivableRemainingCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans and Leases Receivable, Remaining Commitments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansAndLeasesReceivableRemainingCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized loan commitment, origination, and other costs (fees) and purchase premium (discount) on financing receivable recognized as adjustment to yield. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10152-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6378536&amp;loc=d3e10092-111533<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_CCRCResidentLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_CCRCResidentLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230079062240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($) </div>
<div>facility</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 28, 2023 </div>
<div>loan</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (239,875)<span></span>
</td>
<td class="num">$ (18,511)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 374,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LoansReceivableExtensionFee', window );">Loans receivable, extension fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments', window );">Credit loss reserve on unfunded loan commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Proceeds from the collection of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Proceeds from the collection of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfSecuredLoans', window );">Number of secured loans | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Principal repayments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LoansReceivableOutstandingBalance', window );">Loans receivable, outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LoansReceivableTerm', window );">Loans receivable, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Other | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfSecuredLoans', window );">Number of secured loans | loan</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Principal repayments received</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate', window );">Loans receivable, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MezzanineMember', window );">Mezzanine | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Principal repayments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember', window );">Other Non-Reporting Segment | CCRC JV | Brookedale MTCA | Lessor Asset Under Operating Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember', window );">Sunrise Senior Housing Portfolio | SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountCommitted', window );">Capital expenditure funding, amount committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted', window );">Capital expenditure funding, cost of capital, percent committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountFunded', window );">Capital expenditure funding, amount funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember', window );">Sunrise Senior Housing Portfolio | SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Proceeds from the collection of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Committed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountFunded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Funded</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountFunded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Cost of Capital, Percent Committed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Unfunded Loan Commitments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableExtensionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Extension Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableExtensionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableOutstandingBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Outstanding Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableOutstandingBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties To Be Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfSecuredLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Secured Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfSecuredLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage added to reference rate used to compute variable rate on loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of buildings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MezzanineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MezzanineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_CCRVJVInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_CCRVJVInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=peak_LessorAssetUnderOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=peak_LessorAssetUnderOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086842832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember', window );">Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">163,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">43,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">206,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_CCRCResidentLoansMember', window );">CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">14,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">21,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">36,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember', window );">Performing loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">163,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">43,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">206,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember', window );">Performing loans | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">14,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">21,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">36,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember', window );">Watch list loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember', window );">Watch list loans | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember', window );">Workout loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember', window );">Workout loans | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodGrossWriteOffsMember', window );">Current period gross write-offs | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodGrossWriteOffsMember', window );">Current period gross write-offs | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodRecoveriesMember', window );">Current period recoveries | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodRecoveriesMember', window );">Current period recoveries | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodNetWriteOffsMember', window );">Current period net write-offs | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodNetWriteOffsMember', window );">Current period net write-offs | CCRC resident loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable originated more than five years prior to current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable originated four years prior to current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable originated three years prior to current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable originated in current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable originated two years prior to current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI https://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_CCRCResidentLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_CCRCResidentLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodGrossWriteOffsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodGrossWriteOffsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodRecoveriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodRecoveriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodNetWriteOffsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_CurrentPeriodNetWriteOffsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080954784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Reserve for Loan Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">$ 8,280<span></span>
</td>
<td class="nump">$ 1,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal', window );">Provision for expected loan losses</a></td>
<td class="num">(171)<span></span>
</td>
<td class="nump">6,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale', window );">Expected loan losses (recoveries) related to loans sold or repaid</a></td>
<td class="num">(1,957)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">6,152<span></span>
</td>
<td class="nump">8,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember', window );">Secured Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">8,280<span></span>
</td>
<td class="nump">1,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal', window );">Provision for expected loan losses</a></td>
<td class="num">(171)<span></span>
</td>
<td class="nump">6,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale', window );">Expected loan losses (recoveries) related to loans sold or repaid</a></td>
<td class="num">(1,957)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">6,152<span></span>
</td>
<td class="nump">8,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal', window );">Provision for expected loan losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale', window );">Expected loan losses (recoveries) related to loans sold or repaid</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding accrued interest, of credit loss expense (reversal of expense) on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of decrease from sale and reclassification to held-for-sale of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080354544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 28, 2023 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>property </div>
<div>joint_venture</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>property </div>
<div>joint_venture</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to unconsolidated joint ventures | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714,679<span></span>
</td>
<td class="nump">$ 706,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember', window );">Medical Office JVs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures) | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember', window );">HCP Ventures IV, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember', window );">HCP Ventures IV, LLC | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid | $</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember', window );">Suburban Properties, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember', window );">Other Non-Reporting Segment | SWF SH JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,873<span></span>
</td>
<td class="nump">345,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | South San Francisco JVs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,535<span></span>
</td>
<td class="nump">309,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures) | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Life Science JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,817<span></span>
</td>
<td class="nump">26,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,658<span></span>
</td>
<td class="nump">15,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Life Science JV in San Francisco, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Life Science JV in San Francisco, California | Life Science JV in San Francisco, California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,796<span></span>
</td>
<td class="nump">$ 8,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SHOPJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SHOPJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SouthSanFranciscoJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SouthSanFranciscoJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087080240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Intangibles Lease Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross intangible lease assets</a></td>
<td class="nump">$ 767,224<span></span>
</td>
<td class="nump">$ 770,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(375,268)<span></span>
</td>
<td class="num">(352,224)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 391,956<span></span>
</td>
<td class="nump">$ 418,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 391,956<span></span>
</td>
<td class="nump">$ 418,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-sale or Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230079948672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Intangibles Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesGross', window );">Gross intangible lease liabilities</a></td>
<td class="nump">$ 236,831<span></span>
</td>
<td class="nump">$ 237,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(87,227)<span></span>
</td>
<td class="num">(81,271)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesNet', window );">Intangible liabilities, net</a></td>
<td class="nump">$ 149,604<span></span>
</td>
<td class="nump">$ 156,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080467840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesAcquired', window );">Intangible liabilities acquired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period, liabilities</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Other Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Liabilities Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086454160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Bank Line of Credit and Term Loan (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 22, 2022 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>May 23, 2019 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>derivative_held</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 556,000,000<span></span>
</td>
<td class="nump">$ 995,606,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,453,878,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=peak_TermLoanAgreementMember', window );">Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfLoans', window );">Number of loans | loan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCovenantDebtToAssets', window );">Debt instrument, covenant debt to assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCovenantSecuredDebtToAssets', window );">Debt instrument, covenant secured debt to assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets', window );">Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCovenantFixedChargeRatioMinimum', window );">Debt instrument, covenant minimum fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCovenantNetWorthMinimum', window );">Debt instrument, covenant net worth, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=peak_TermLoanAgreementMember', window );">Term Loan Agreement | Interest rate swap instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160; of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Bank Line&#160; of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentNumberofExtensions', window );">Number of extensions | renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentPeriodOfExtension', window );">Length of debt instrument extension period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics', window );">Debt Instrument, interest rate, reduction available for sustainability metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum', window );">Line of credit facility additional aggregate amount, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Bank Line&#160; of Credit | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Debt instrument, facility fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesMember', window );">Term Loan Facilities | Bank Line&#160; of Credit | Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentPeriodOfExtension', window );">Length of debt instrument extension period (in months)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics', window );">Debt Instrument, interest rate, reduction available for sustainability metrics</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentDrawTimePeriodAfterClosing', window );">Debt instrument, period after closing</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in months)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentMarginRate', window );">Debt instrument, margin rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption', window );">Line of credit facility, loan feature, higher borrowing capacity option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesOneMember', window );">Term Loan Facilities One | Bank Line&#160; of Credit | Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesTwoMember', window );">Term Loan Facilities Two | Bank Line&#160; of Credit | Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in months)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantDebtToAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantDebtToAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantFixedChargeRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The required minimum Fixed Charge Coverage ratio contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantFixedChargeRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantNetWorthMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantNetWorthMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantSecuredDebtToAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantSecuredDebtToAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentDrawTimePeriodAfterClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Draw Time Period After Closing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentDrawTimePeriodAfterClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentMarginRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Margin Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentMarginRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentNumberofExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Extensions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentNumberofExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentPeriodOfExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the length of the debt instrument extension period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentPeriodOfExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Loan Feature, Higher Borrowing Capacity Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=peak_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=peak_TermLoanFacilitiesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230079832384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Commercial Paper Program (Details) - Commercial Paper Program - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentMaximumBorrowingCapacity', window );">Maximum outstanding amount capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Borrowings</a></td>
<td class="nump">$ 556,000,000<span></span>
</td>
<td class="nump">$ 996,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in months)</a></td>
<td class="text">16 days<span></span>
</td>
<td class="text">2 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">5.53%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=peak_CommercialPaperProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=peak_CommercialPaperProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085555712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Senior Unsecured Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 17, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 6,499,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 5.25 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote525PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote525PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086797344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Mortgage Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>facility</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>facility</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>derivative_held</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>derivative_held</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 6,499,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | facility</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">343,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue', window );">Debt instrument, collateral, healthcare facilities carrying value</a></td>
<td class="nump">785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 793,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument, periodic payment</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | facility</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | CCRC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | facility</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of healthcare facilities which are secured by mortgage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230079087168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Debt Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 88,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">803,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">1,450,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">950,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">6,499,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="num">(46,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">6,453,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160; of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term&#160;Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="num">(3,832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">496,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="num">(43,457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 5,056,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">3.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentWeightedAverageMaturity', window );">Weighted-average maturity (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.87%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 88,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">244,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">343,887<span></span>
</td>
<td class="nump">$ 345,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Premiums, (discounts), and debt issuance costs, net</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 345,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">4.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DebtInstrumentWeightedAverageMaturity', window );">Weighted-average maturity (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.91%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">8.52%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentWeightedAverageMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents weighted average maturity of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentWeightedAverageMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionPeriodThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionPeriodThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080555280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>property</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember', window );">Life Science JV | Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ContributionOfPropertyNumberOfProperties', window );">Number of properties may be contributed in the agreement</a></td>
<td class="nump">29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ContributionOfPropertyNumberOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution Of Property, Number Of Properties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ContributionOfPropertyNumberOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080012752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081672912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - ATM Program (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember', window );">At-The-Market Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AtmEquityOfferingProgramAggregateAmountAuthorized', window );">ATM aggregate amount authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityShares', window );">Maximum shares issuable under forward equity sales agreement (in shares)</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate', window );">Forward equity sales agreement, initial net price (in dollars per share)</a></td>
<td class="nump">$ 34.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">$ 308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember', window );">At-The-Market Program | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OptionIndexedToIssuersEquityTerm', window );">Option indexed to issuers equity, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember', window );">At-The-Market Program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OptionIndexedToIssuersEquityTerm', window );">Option indexed to issuers equity, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2023AtTheMarketProgramMember', window );">2023 At-The-Market Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ATMEquityOfferingProgramAggregateAmountRemaining', window );">ATM aggregate amount remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember', window );">2020 ATM Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityShares', window );">Maximum shares issuable under forward equity sales agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate', window );">Forward equity sales agreement, initial net price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember', window );">ATM Direct Issuances | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ATMEquityOfferingProgramAggregateAmountRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ATM Equity Offering Program Aggregate Amount Remaining</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ATMEquityOfferingProgramAggregateAmountRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AtmEquityOfferingProgramAggregateAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AtmEquityOfferingProgramAggregateAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OptionIndexedToIssuersEquityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option Indexed To Issuers Equity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OptionIndexedToIssuersEquityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share price of the Company's stock at which the contract holder of the freestanding contract has the right to purchase or sell the Company's stock at a future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityForwardRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2023AtTheMarketProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_A2023AtTheMarketProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230090135296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (in shares)</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average cost per share (in dollars per share)</a></td>
<td class="nump">$ 27.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Stock repurchase program, total value</a></td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 444,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088007360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - AOCI (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>plan_participant</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Unrealized gains (losses) on derivatives, net</a></td>
<td class="nump">$ 20,668<span></span>
</td>
<td class="nump">$ 30,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Supplemental Executive Retirement Plan minimum liability</a></td>
<td class="num">(1,947)<span></span>
</td>
<td class="num">(2,011)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive income (loss)</a></td>
<td class="nump">$ 18,721<span></span>
</td>
<td class="nump">$ 28,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfPlanParticipants', window );">Number of participants | plan_participant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Plan Participants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080960576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details) - interest<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestRedemptions', window );">Number of redeemable noncontrolling interest redemptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime', window );">Number of interests redeemable over time</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=peak_HealthpeakOPMember', window );">Healthpeak OP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="nump">99.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RemainingMinorityInterestOwnershipPercentageByParent', window );">Remaining minority interest ownership percentage by parent</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime', window );">Number of interests redeemable over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfRedeemableNoncontrollingInterestRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Redeemable Noncontrolling Interest Redemptions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfRedeemableNoncontrollingInterestRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Redeemable Noncontrolling Interests, Redeemable Over Time</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RemainingMinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining Minority Interest Ownership Percentage By Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RemainingMinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=peak_HealthpeakOPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=peak_HealthpeakOPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080829616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - DownREITs (Details)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>entity </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestInPreferredUnitHolders', window );">Non-managing member unitholders</a></td>
<td class="nump">$ 207,634<span></span>
</td>
<td class="nump">$ 200,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Total Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DownREITUnitsOutstanding', window );">DownREIT units outstanding (in shares) | shares</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CommonStockConvertibleSharesIssuable', window );">Common stock issuable (in shares) | shares</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfDownREITLLCs', window );">Number of DownREIT LLCs | entity</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestInPreferredUnitHolders', window );">Non-managing member unitholders</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_MinorityInterestInPreferredUnitHoldersFairValue', window );">Minority interest in preferred unit holders, fair value</a></td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">$ 183,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CommonStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Convertible, Shares Issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CommonStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DownREITUnitsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of DownREIT units outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DownREITUnitsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_MinorityInterestInPreferredUnitHoldersFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_MinorityInterestInPreferredUnitHoldersFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfDownREITLLCs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the number of DownREIT LLCs for which the entity is the managing member.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfDownREITLLCs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInPreferredUnitHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInPreferredUnitHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230090124864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements', window );">Dilutive potential common shares - forward equity agreements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_ForwardEquitySalesAgreementsMember', window );">Forward Equity Sales Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember', window );">Down REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 35<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2366-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_ForwardEquitySalesAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_ForwardEquitySalesAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230078889392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share - Computation of EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 134,507<span></span>
</td>
<td class="nump">$ 75,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Noncontrolling interests' share in continuing operations</a></td>
<td class="num">(15,555)<span></span>
</td>
<td class="num">(3,730)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">118,952<span></span>
</td>
<td class="nump">71,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted', window );">Less: Participating securities' share in continuing operations</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,976)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic', window );">Income (loss) from continuing operations applicable to common shares</a></td>
<td class="nump">117,698<span></span>
</td>
<td class="nump">69,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) applicable to common shares</a></td>
<td class="nump">117,698<span></span>
</td>
<td class="nump">69,637<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) applicable to common shares</a></td>
<td class="nump">$ 117,698<span></span>
</td>
<td class="nump">$ 69,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">546,842<span></span>
</td>
<td class="nump">539,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares - equity awards (in shares)</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares (in shares)</a></td>
<td class="nump">547,110<span></span>
</td>
<td class="nump">539,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">0.22<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards', window );">Outstanding equity awards (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of Equity Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income Loss Continuing Operations Available To Common Stockholders Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085477712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Disclosures - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture', window );">Number of facilities owned by unconsolidated joint venture</a></td>
<td class="nump">19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Facilities Owned by Unconsolidated Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230075312208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 525,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(223,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207,247)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,493)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,666)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177,733)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,547)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,552)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,019)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(777)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Non-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,685)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,547)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,831)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(777)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,384)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,067)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,112)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(948)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,820)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(299)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,546)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,920)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,036)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,773)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember', window );">CCRC | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,816)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,865)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(219)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,552)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember', window );">Other Non-reportable | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AdjustedNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncomeFromCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income From CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncomeFromCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ImpairmentsAndAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairments And Allowance For Credit Loss Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ImpairmentsAndAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Joint Venture Partners, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetIncomeLossJointVenturePartnersAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses From Joint Venture, Attributable To Parent Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OperatingExpensesFromJointVentureAttributableToParentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture Government Grant Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080951936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of capitalized interest</a></td>
<td class="nump">$ 65,367<span></span>
</td>
<td class="nump">$ 58,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid (refunded)</a></td>
<td class="nump">160<span></span>
</td>
<td class="num">(1,947)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">14,093<span></span>
</td>
<td class="nump">8,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Increase in ROU asset in exchange for new lease liability related to operating leases</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid', window );">Accrued construction costs</a></td>
<td class="nump">$ 161,774<span></span>
</td>
<td class="nump">$ 163,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for construction in progress expenditures that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230088003248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="nump">$ 22,789<span></span>
</td>
<td class="nump">$ 22,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="nump">204,889<span></span>
</td>
<td class="nump">178,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">179,225<span></span>
</td>
<td class="nump">177,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230081002256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Continuing operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 59,235<span></span>
</td>
<td class="nump">$ 72,032<span></span>
</td>
<td class="nump">$ 89,066<span></span>
</td>
<td class="nump">$ 158,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">57,990<span></span>
</td>
<td class="nump">54,802<span></span>
</td>
<td class="nump">52,103<span></span>
</td>
<td class="nump">53,454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">117,225<span></span>
</td>
<td class="nump">126,834<span></span>
</td>
<td class="nump">141,169<span></span>
</td>
<td class="nump">211,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashIncludingDiscontinuedOperationsAbstract', window );"><strong>Discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal', window );">Cash and cash equivalents, total</a></td>
<td class="nump">59,235<span></span>
</td>
<td class="nump">72,032<span></span>
</td>
<td class="nump">97,055<span></span>
</td>
<td class="nump">165,994<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal', window );">Restricted cash, total</a></td>
<td class="nump">57,990<span></span>
</td>
<td class="nump">54,802<span></span>
</td>
<td class="nump">52,103<span></span>
</td>
<td class="nump">53,454<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, total</a></td>
<td class="nump">$ 117,225<span></span>
</td>
<td class="nump">$ 126,834<span></span>
</td>
<td class="nump">$ 149,158<span></span>
</td>
<td class="nump">$ 219,448<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents, Including Discontinued Operations, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashIncludingDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashIncludingDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086565376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>joint_venture </div>
<div>hospital</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>joint_venture</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investment | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Unconsolidated Variable Interest Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfVieBorrowersWithMarketableDebtSecurities', window );">Number of VIE borrowers with marketable debt securities (in joint ventures)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Unconsolidated Variable Interest Entities | Commercial Mortgage-Backed Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NumberOfHospitals', window );">Number of hospitals | hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember', window );">Ventures V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember', window );">Life Science JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember', window );">MSREI JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember', window );">DownREIT Partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership', window );">Number of controlling ownership interest entities as a managing member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfHospitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Hospitals</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfHospitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfVieBorrowersWithMarketableDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of VIE borrowers in which the entity has invested in marketable debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfVieBorrowersWithMarketableDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230091806320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Schedule of Variable Interest Entities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember', window );">LLC investment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Loss Exposure and Carrying Amount</a></td>
<td class="nump">$ 14,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember', window );">Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Loss Exposure and Carrying Amount</a></td>
<td class="nump">$ 15,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086751936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">$ 12,889,290<span></span>
</td>
<td class="nump">$ 12,784,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">819,810<span></span>
</td>
<td class="nump">760,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">2,674,942<span></span>
</td>
<td class="nump">2,667,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(3,296,781)<span></span>
</td>
<td class="num">(3,188,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">13,087,261<span></span>
</td>
<td class="nump">13,023,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">57,705<span></span>
</td>
<td class="nump">53,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">59,235<span></span>
</td>
<td class="nump">72,032<span></span>
</td>
<td class="nump">$ 89,066<span></span>
</td>
<td class="nump">$ 158,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">391,956<span></span>
</td>
<td class="nump">418,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">235,591<span></span>
</td>
<td class="nump">237,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">754,723<span></span>
</td>
<td class="nump">780,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,602,289<span></span>
</td>
<td class="nump">15,771,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">345,167<span></span>
</td>
<td class="nump">346,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">149,604<span></span>
</td>
<td class="nump">156,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">207,734<span></span>
</td>
<td class="nump">208,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">688,994<span></span>
</td>
<td class="nump">772,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">878,444<span></span>
</td>
<td class="nump">844,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,378,654<span></span>
</td>
<td class="nump">8,482,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Lessees VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">2,348,215<span></span>
</td>
<td class="nump">2,356,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">54,319<span></span>
</td>
<td class="nump">58,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">322,014<span></span>
</td>
<td class="nump">324,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(615,936)<span></span>
</td>
<td class="num">(623,244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">2,108,612<span></span>
</td>
<td class="nump">2,116,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">9,024<span></span>
</td>
<td class="nump">6,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">21,631<span></span>
</td>
<td class="nump">20,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">69,477<span></span>
</td>
<td class="nump">73,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">98,893<span></span>
</td>
<td class="nump">99,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">73,107<span></span>
</td>
<td class="nump">73,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,381,166<span></span>
</td>
<td class="nump">2,421,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">144,668<span></span>
</td>
<td class="nump">144,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">14,255<span></span>
</td>
<td class="nump">15,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">99,185<span></span>
</td>
<td class="nump">99,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">66,477<span></span>
</td>
<td class="nump">68,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">47,410<span></span>
</td>
<td class="nump">39,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">371,995<span></span>
</td>
<td class="nump">367,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Lessees VIE | Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,612)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffMarketLeaseUnfavorable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffMarketLeaseUnfavorable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230080267120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">$ 556,000<span></span>
</td>
<td class="nump">$ 995,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">5,056,543<span></span>
</td>
<td class="nump">4,659,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">345,167<span></span>
</td>
<td class="nump">346,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableFairValueDisclosure', window );">Loans receivable, net</a></td>
<td class="nump">243,149<span></span>
</td>
<td class="nump">374,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="nump">995,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Term loans</a></td>
<td class="nump">496,168<span></span>
</td>
<td class="nump">495,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">5,056,543<span></span>
</td>
<td class="nump">4,659,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">345,167<span></span>
</td>
<td class="nump">346,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value | Interest rate swap instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap instruments</a></td>
<td class="nump">20,782<span></span>
</td>
<td class="nump">30,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair&#160;Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">4,712,340<span></span>
</td>
<td class="nump">4,238,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair&#160;Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableFairValueDisclosure', window );">Loans receivable, net</a></td>
<td class="nump">245,125<span></span>
</td>
<td class="nump">369,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Marketable debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">556,000<span></span>
</td>
<td class="nump">995,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Term loans</a></td>
<td class="nump">496,168<span></span>
</td>
<td class="nump">495,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">330,856<span></span>
</td>
<td class="nump">330,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair&#160;Value | Level 2 | Interest rate swap instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap instruments</a></td>
<td class="nump">$ 20,782<span></span>
</td>
<td class="nump">$ 30,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansFromBank">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansFromBank</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230075305392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($) </div>
<div>derivative_held</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($) </div>
<div>derivative_held</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>derivative_held</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>derivative_held</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions', window );">Asset at fair value, changes in fair value resulting from changes in assumptions</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate cap instruments | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DerivativeNotionalAmountTerminated', window );">Derivative amount terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Increase in the fair value of the interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_DerivativeNotionalAmountTerminated', window );">Derivative amount terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap instruments | Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivative_held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DerivativeNotionalAmountTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DerivativeNotionalAmountTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value from changes in the assumptions or model used to calculate the fair value of a contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=peak_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=peak_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230086814480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Schedule of Derivative Instruments (Details) - Designated as Hedging Instrument - Cash Flow Hedging - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap499PayRateMember', window );">Interest Rate Swap, 4.99% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 51,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Receive Rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 1,675<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap454PayRateMember', window );">Interest Rate Swap, 4.54% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="nump">4.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Receive Rate</a></td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 2,983<span></span>
</td>
<td class="nump">4,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap260PayRateMember', window );">Interest Rate Swap, 2.60% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 7,658<span></span>
</td>
<td class="nump">11,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap254PayRateMember', window );">Interest Rate Swap, 2.54% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="nump">2.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 8,466<span></span>
</td>
<td class="nump">12,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap508PayRateMember', window );">Interest Rate Swap, 5.08% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.08%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Receive Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap463PayRateMember', window );">Interest Rate Swap, 4.63% Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Pay Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.63%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Receive Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative assets not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap499PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap499PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap454PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap454PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap260PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap260PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap254PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap254PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap508PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap508PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap463PayRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=peak_InterestRateSwap463PayRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230085406832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_RefundableEntranceFeesCurrentAndNoncurrent', window );">Refundable entrance fees</a></td>
<td class="nump">$ 264,065<span></span>
</td>
<td class="nump">$ 268,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionPayableCurrentAndNoncurrent', window );">Accrued construction costs</a></td>
<td class="nump">161,774<span></span>
</td>
<td class="nump">178,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="nump">39,065<span></span>
</td>
<td class="nump">59,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other accounts payable and accrued liabilities</a></td>
<td class="nump">224,090<span></span>
</td>
<td class="nump">265,596<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">688,994<span></span>
</td>
<td class="nump">772,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance-related charges</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RefundableEntranceFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refundable Entrance Fees, Current and Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RefundableEntranceFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140230087953984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Schedule of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_NonrefundableEntranceFees', window );">Nonrefundable entrance fees</a></td>
<td class="nump">$ 527,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 518,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_OtherDeferredRevenue', window );">Other deferred revenue</a></td>
<td class="nump">350,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">878,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 844,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_ProceedsFromCollectionOfNonrefundableEntranceFees', window );">Proceeds from nonrefundable entrance fees</a></td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_peak_AmortizationOfNonrefundableEntranceFee', window );">Amortization of nonrefundable entrance fee</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of other deferred charges</a></td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AmortizationOfNonrefundableEntranceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Nonrefundable Entrance Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AmortizationOfNonrefundableEntranceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NonrefundableEntranceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonrefundable Entrance Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NonrefundableEntranceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OtherDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OtherDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ProceedsFromCollectionOfNonrefundableEntranceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Collection Of Nonrefundable Entrance Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ProceedsFromCollectionOfNonrefundableEntranceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>peak-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:peak="http://www.healthpeak.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="peak-20230331.xsd" xlink:type="simple"/>
    <context id="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if7b47f0a1b274852999d6d4b2ead62d8_I20230426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="if4882bfad4354d8ea1cac4348c817159_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaecb36bec2724a3594acf3e81eca36dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iacdd5f56e1a64a2f909772d23fa79232_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3db6d623777a4436baf821bd0afcff29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0f6cf1f29914223a101cf9dfaee1c2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cf4d0c742ae47a892216777fa79e08b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i530e671af080458e9ba7b21a10d74180_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7de8610900b8400ea338f115550cc75e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0563220fc3204262b0a60fd550eae320_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia08b165391414939958c319482d7e2da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie6c895598a3c42b7afdb9ff3193e487c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i807e77a17a3d456481946b1b5c29dc29_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i99f56515023941089672801d0df27438_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i57bcf974abc44e3d904f70df65e9044d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i83ebcfd7fc764a069ccd0143794750e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i252b5f72bd3f474cb0b445240f777230_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i30bf6bfeb0434265ba52f1329cc43b46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5eba404d7984f2bb0b0aebd3dd90f27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2fecc3b0cc14458b9cad2f8b45fe191_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie94947a66a6b4b0db78654d659d35ae7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00fa5f4d9ca644438e3562b42ba2334c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i503ad2df9c9240088b9e5481b385a0f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iabf59758b312417ebb52a26e8b708bf1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69bc82cfb90b4179b30ea0df867d1278_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i804d4f9d03a04437bc94e9a064ca876a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib15aeabd34c04dab92eb0fdb03950e0c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i980ff73125e2448f9c1841abc88ec5cc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia8fb31decab14836989f7e62f5d94e60_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f15128c31ab488daa41c96893b79122_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic773135133e649b9a40e6c2ae0098c47_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3673bf0bac0c46438f86bb54a2b7a090_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife363d16c20b4fb4829cc5fa5e166ebd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04bb152d3876442882602d59cb9257bd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d70f4026c6041ec8a4ea17cbea56b52_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1c2dda1ede5c4d58a46ce9579d6b92e2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibc1bf5123a8b41479133b782e5100a18_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i118359ae91b74e62812988bfeaa797c8_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i9f045cefde3045ae8996ee15bbb51550_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i1ffe53bede314b11a85ecb20ec8a6694_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i0492c2ebf6054f6ebe312755f471116e_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i44e261bd07684db7946bf96652492c6f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i58508407aa974ce7ae2dd7d111863709_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MOBLandParcelsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i20b93e6524fd44e6ac71b8975be978f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa2335d07c3144528793163232dd5d77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i04f86893d4664360ad004f5222f209e3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i868c4fb89cf748b39a591564a160cb85_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i864dd3fa811448b2b9b318a07f46f343_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">peak:PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3a54d5ef01f84069a21614fb6b5703d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">peak:SorrentoTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i35fc9183f82c46689dc6c8c571bb0698_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3251deb01d7f43a6b36fce8fe3b868bb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i299419585a7445608813f122905f9277_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if29b037c8ce04a23a923956f784473ee_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i4ec94601e6824a438f9ff0bea83f0c4c_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icf2528dacab94d72ab3e440848edce92_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibc764c876dea4bdf9388495cb2847238_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="iab5284915b80459fb6366e3a5528172e_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i4e598ee158714864ac7ec8e1b7c6c04e_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifc7401311f5444a7a6418fa19740da6b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic385c6dfa277429bad7b41a2a38a66fe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib206c24e874f495eb33a7ef79724c812_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ie95535d107b84adab248bbffe4d73975_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="i1a002d72b97442b5b2b389ad5a9d16ce_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="ibaa149a31fb1486581279cc115c490b8_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i03330e2036c04219b1af6523e1deca30_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i9a09c60ade2547478c8bde3119807cfa_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i292c0d5f96754ad2a296029a917f95b0_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="ic0139f5e9be640a2abe77bf91136f1bb_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i63393f69a85548b18409a036fee2f946_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i17ab4619f5bc4ffb844448dc2ded4d10_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i684b88fb97554f22a37f1cbb5a4be09a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e0f4ebc4c1547e5913529941dba4cd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if21dc8e101854dcebeae8d48af75b96d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d00bf264b354d8e9bd17bbbec9cc3db_D20230101-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="i00ecc95ec04841c1b95be484ffd8add8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i64c1609203464ecf8a00b2af5447978d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i775c707a41964704bb6f55b0b3e9ab6a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7022374097c345abbd7b9628054b8bb1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie2b8336de4304e599fe3da77c86692a7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f6c558ccada4265a95f7250fb0f8a48_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodGrossWriteOffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia778bdabbe2148a785c9999be7828073_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodNetWriteOffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia427c7d52bef42c28adc94497ec593ae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i93ddbb42639d468984faade1da6bb948_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8ffec5e441b44bef86395108ef570821_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i859ad1c33bde4dffb72acaca2240e037_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i05931c32871345c2953b6bc7e9725803_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodGrossWriteOffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iec83876e1875415480e127f2f8ee5341_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodRecoveriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8b5e7a36d21347b2982d484d7fe52b84_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:CCRCResidentLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:CurrentPeriodNetWriteOffsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie53bcb07504e4ad99f3ade31d660d86a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03a30f0743e84f25b4365b13befe7543_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d3eb325105c4a489d9e072e95831f43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8966c32afeb843069c788fcb7d555ba1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i893e14a7026040f8939a46fc89d040eb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i49856b1a6b744d32850fd6e75896a354_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i563440407d4441eb91bd164b5748f220_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i188028ed6c334da79242d89eee8a840e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd9427916f174bbb8f0807aa0d989019_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fdf3a793faf4597a6b092e7c936f32a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i164fcc3a8c7b43fab61c0b736e5ce0ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8bdefa6de9c94ded98445df17bde5304_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife1a0b550fcf40a994feb853ca29945f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ea45485ef014df9bcb3a328007f3a5a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97d045a82e5d472cab0e50a49b069fc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2addaafadeb048608bb19144472ba521_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="ie9cdb1d5067b4c20abc45e5a6b15b490_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJointVentureInSanFranciscoCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="ibbf0c3be361842da924660620a57f737_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SouthSanFranciscoJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="idcb7ea32456048788d35e1f70da8c6f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i609a39bba39341cca8d2aa1fcce48d99_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i31ebf93813b04ee98f19d52880e6b227_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SuburbanPropertiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i21dc87df2f2b491c818391833acfbe83_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="i98f2b1c68dfd4ec0b6cfe198f9aa7452_D20230401-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="i13ba81585eef4986833dfbc887a0e2d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7242708209774688bf6a0fa92eee7c92_I20190523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-23</instant>
        </period>
    </context>
    <context id="ic4babd7df1364a05a31daf2030f872a8_D20190523-20190523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-23</startDate>
            <endDate>2019-05-23</endDate>
        </period>
    </context>
    <context id="if1d4050de8b24d7499a2da8155770c96_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice2627cf08414f8db5d11bcfa2e103c2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">peak:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i72eb05af2cbe4e208706e4b57decdb88_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7305c3d00995417db4dbb2b7d6c583a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ae753d2f2bb4df0934278cf9eff53e5_D20220822-20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-08-22</endDate>
        </period>
    </context>
    <context id="i506c4e4d75c74d20b91a42ee338b3511_I20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-22</instant>
        </period>
    </context>
    <context id="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-08-22</endDate>
        </period>
    </context>
    <context id="ie44957565290418193123188bc3f9a29_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ic5093505d5344e8bba4c2389265a3a7b_I20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-22</instant>
        </period>
    </context>
    <context id="i33fc45189ac34f818a512f00fc01253e_I20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-22</instant>
        </period>
    </context>
    <context id="i543d187d7c2f422fb35ffbea57ea780b_D20220822-20220822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-22</startDate>
            <endDate>2022-08-22</endDate>
        </period>
    </context>
    <context id="i1b6cf8ab3e074c468afa71e272d04f7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i000be30d07554d05a5d03c3a41a8a60e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2ebc102c23049bb9221a3b5b00a8855_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:TermLoanFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8a237e0795d475c9e344be93e2de478_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="iddbba9ecd72f4daa98c9e47aeddc18e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie2ef959dde734cdeb101f4075ab3a223_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:TermLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i581333276c1c4e509b4209a5ef42ea34_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0a9825d537dc48a1ace8af19b8cf7906_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idef8861b7d7c4e5fbfc001ae1cebeb57_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iac90e17281a0408ebc19a4dd60bf5da8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i376fe1f063af437aa4e2b807a6bbf62c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i29765404aa624d6d99bc3534f881b7a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife87565ec58448679511f93e16e05495_I20230117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote525PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-17</instant>
        </period>
    </context>
    <context id="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i827939e6039a4e69bd555a798b90b6f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb7af8f09e474a1d9f0d3752ba17b366_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id56cce58abda458d9545374c913aac55_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i195c53570e3d4baa8827ffa006124262_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd48946bcbc149b6ba3884e2e5f54793_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3cdd8357aeaf42e990fca8f3111eee5f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i906008fbc48340908eb765f2c3dc8cd1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i08425abe3e614e6d9a9b28ec8e60b022_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iea247eaec89041d2888fa7256233e2b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i469ae1eef4044e5f895df14e6080d08a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1f5e6ae23fa4d63a3b7da9463495857_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ab24ba7b7534ef3b931937c49723e05_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9776df6071649b4a36a68b2c62e8753_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i12e46551b1814379a1653a9d1284593d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2038eb8ce7646699de4006ca1c495d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd1122ff910845e8b7d84749fcb941af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic734fa1ccf034c29a212f61c7f547e08_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i46f077c3935347968dfccf4e35e46bc8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2253586656694cfe961e9fd10a8da88a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9765a57b7623473f9f941b33ccfde3f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb996687cada4f59931cae009c110517_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ddb72c0e5024725b2aacf24463019d1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56bcb722a57e4a5eb514929d2ed3a154_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c875874da304c448ab2b679d2ced02a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie33b9cb06a4a42afbb61346e750be99c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i21b4bc2e6a6546b1a01836e0851863d9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd23299bf615464e91aa88b816387e2f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ae86f1b07b148be8f4de81f938ee842_D20230427-20230427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-27</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="ie980168387e14a51a49837fe74a3b54e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8a25e7b5d67943c7b2f4785d0bbd801e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22723edd392546a88d01e90f6ec4ae55_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7b96d988a94d4b5ca66cf68c72e38da9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2023AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8051818203c34f2692f50e33f9538046_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i37deeeb2d4054785a004587600392cdb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if38c0299b9e346949730c17e3fc40429_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i89c46ce3b6194ec8a6f4bdaad32eab03_I20220801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2022-08-01</instant>
        </period>
    </context>
    <context id="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i6f249757fb504a429bb6dd03fb8bb2be_D20230101-20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="i6d31221783254ce6bc6a96ffefb649d9_I20230210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">peak:HealthpeakOPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-10</instant>
        </period>
    </context>
    <context id="i8e5a31f73d324958966392fee1b98bb2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">peak:HealthpeakOPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i89007938f53d4ab597b1694f0b7aa3a3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:ForwardEquitySalesAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2b23f95c9490405980d3b3ccc448589e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:ForwardEquitySalesAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e4a87426c744c7ab4128e461f3c1dce_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icc3bbec47ce44e14b11efe8fe8b782a7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic264575fc36449f5a87c5ea91360a740_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7fff501744fd4e71876ffa2b83de611a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79f95a47fff3441784d37b2c5a1ae4f7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0777696340044807b047c951cc6b7e89_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if2e661c65de049509e99f61fdd2bd048_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64a9401fe4ee4e0b9e32826d28b5b1b0_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i314fcd2c5dec445098b327482f3a7818_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb8e43d445e14ad1b15a9092e886d068_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VenturesVLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2003f5627c1f4bf4a0e07c23f54283a8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic426b90826724d11a95dfb86709ed7fe_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:MorganStanleyRealEstateInvestmentJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83e29cc8fc7747e8908fa487a0e9cd8f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:DownreitPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia947c487c4384345a0b1601d6fa7c4e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11644f24761048e48bf148bb3be4cf35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c865e06411947d296af7de408e5f4ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30df8d22282b41fd9bf4802f9a1b4777_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1e722ab6f64c43d1b27228769a5d22f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifc7ba3154c774008b8363208076ad8ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i62e1f932c1974d209acc82e118a8b04e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2a162e312664e3e87e4b7cc4e443e3b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4741bac17c174ed8a6000db9741edd7e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if8e50d56667947df8e6c0aeaf1a3d0c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i70c7e47c923043719f6f4a0f3ca6bd4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic507fe90dbae43d6b7714fb76376f6c3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ce9db3b727c4f4e8d642580044e31cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibff3d7194cc8421785dba30cb9b0f782_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="ie6930d3833b24489bf10582929fa4f52_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icf5ac7cd40be471fb36b2da5759371f7_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">peak:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap499PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ed735a3625541e0b0040bbdb3d6ff39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap499PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12b4be37081f42648c653212038f8710_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap454PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia7607072d8464af1a07831fe55ae7d49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap454PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e4af01407e54b35b8771e2572ef8748_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap260PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4ed4d0a4ede45839d5ff5d4cde250f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap260PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i442974227f63407a813cccaa74ab1313_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap254PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6ef18c30916344f1bc92844528563a35_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap254PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap508PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i654b6eb550f645f58b5769d07a3beabd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">peak:InterestRateSwap463PayRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="property">
        <measure>peak:property</measure>
    </unit>
    <unit id="facility">
        <measure>peak:facility</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="loan">
        <measure>peak:loan</measure>
    </unit>
    <unit id="joint_venture">
        <measure>peak:joint_venture</measure>
    </unit>
    <unit id="renewal_option">
        <measure>peak:renewal_option</measure>
    </unit>
    <unit id="derivative_held">
        <measure>peak:derivative_held</measure>
    </unit>
    <unit id="plan_participant">
        <measure>peak:plan_participant</measure>
    </unit>
    <unit id="interest">
        <measure>peak:interest</measure>
    </unit>
    <unit id="entity">
        <measure>peak:entity</measure>
    </unit>
    <unit id="hospital">
        <measure>peak:hospital</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl80LTEtMS0xLTIyNTI3MQ_13e36c76-5f39-4d12-8cf4-c418f682e440">0000765880</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl81LTEtMS0xLTIyNTI3MQ_f9dc247d-1226-4fc2-bd77-a85521be96f4">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl82LTEtMS0xLTIyNTI3MQ_97f375a3-f513-4566-8d0b-45c96733d25e">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl83LTEtMS0xLTIyNTI3MQ_d9de996b-85df-4a1c-b9c4-e6331b33318b">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80L2ZyYWc6MWM2MjJmNTJiYTFjNDhkZThjY2JjMDY1MzYwMDJjODIvdGFibGU6Mzg2ODZmMDUwMzZlNDA4MGJhMDk0YTYyN2ZiNWYxYjIvdGFibGVyYW5nZTozODY4NmYwNTAzNmU0MDgwYmEwOTRhNjI3ZmI1ZjFiMl84LTEtMS0xLTIyNTI3MQ_f29e78ff-d6c1-466d-8ae2-ffd244e4e63b">Q1</dei:DocumentFiscalPeriodFocus>
    <peak:OptionIndexedToIssuersEquityTerm
      contextRef="i8a25e7b5d67943c7b2f4785d0bbd801e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTUwMw_5ce2ccbc-5900-4089-b403-cb14df27b311">P1Y</peak:OptionIndexedToIssuersEquityTerm>
    <dei:DocumentType
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgx_9fddc342-96af-43d8-9c81-340362aeac5b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6OWY1ZDg3MjRmMDY5NDBmYTg3ZjcwYzAxYjE1NDY1ZGYvdGFibGVyYW5nZTo5ZjVkODcyNGYwNjk0MGZhODdmNzBjMDFiMTU0NjVkZl8wLTAtMS0xLTIyNTI3MQ_c4cd12f6-3f4c-45f6-8f2a-2a9ee5c3ba40">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8xMzg_19418ca3-17d6-4349-957e-5c2115295192">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDA2NmRhNTBjMjFkNGNjM2I2Yjc3MmViNDgzMjU4NzEvdGFibGVyYW5nZTpkMDY2ZGE1MGMyMWQ0Y2MzYjZiNzcyZWI0ODMyNTg3MV8wLTAtMS0xLTIyNTI3MQ_b36cc286-eee5-420e-a632-153ffda81adc">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgy_7febe987-6c67-43f6-96b9-ae75cc489c8b">001-08895</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgz_fc14bbda-8409-4ad4-8d6d-846ad00d0086">Healthpeak Properties, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6MDA1NGFiNDU5MGM3NGVjMzg3YThmYTQ5MDY2MGI2MWIvdGFibGVyYW5nZTowMDU0YWI0NTkwYzc0ZWMzODdhOGZhNDkwNjYwYjYxYl8xLTAtMS0xLTIyNTI3MQ_0c610f0c-11c2-45c3-af9f-cfcc00d8ffc8">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6MDA1NGFiNDU5MGM3NGVjMzg3YThmYTQ5MDY2MGI2MWIvdGFibGVyYW5nZTowMDU0YWI0NTkwYzc0ZWMzODdhOGZhNDkwNjYwYjYxYl8xLTItMS0xLTIyNTI3MQ_126c0228-3306-4b80-9733-6a8e2fcee164">33-0091377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDcz_f9d89f35-9af3-4f61-8b8d-773946b966c4">4600 South Syracuse Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc0_13b3838d-ec33-41dc-ac8c-ac244f97be3f">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc1_3806ed21-c484-446e-940c-c8ab9df98f72">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDg0_5daedcda-1ae4-4d10-8e6b-69bd8a3feb52">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc2_c1005ccf-0e8f-491f-938e-6cae376b2832">80237</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc3_7ac0c693-7290-42c3-9c09-74fed1341dbb">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc4_8897674c-ee6c-4532-96f5-bbbf0fcf5282">428-5050</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTAtMS0xLTIyNTI3MQ_6566b5ca-49e7-472a-ba7f-d97b0650281b">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTEtMS0xLTIyNTI3MQ_ac464144-7768-4241-8b74-0e3bb90491a6">PEAK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6NmE4NWEzZjM3YzI3NGVlNDgxYzNiODdiOGQ3OTg1ZGEvdGFibGVyYW5nZTo2YTg1YTNmMzdjMjc0ZWU0ODFjM2I4N2I4ZDc5ODVkYV8xLTItMS0xLTIyNTI3MQ_2a1f646b-83e1-4c91-badb-35e4cc2c1e1b">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDc5_6b636467-3007-4cd0-8a2b-03dfaa1027c6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDcy_362e4224-1623-4725-b302-a8460caa6f9d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8wLTAtMS0xLTIyNTI3MQ_8182ccad-0365-49a8-a0ee-93df3052a36f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8xLTMtMS0xLTIyNTI3MQ_f1fb42ba-891c-4f4f-a8e2-3db406c68cec">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGFibGU6ZDFhZDQxNWYxZTA4NDE4YWIzNWNmMGQwMjlkMzNjMGUvdGFibGVyYW5nZTpkMWFkNDE1ZjFlMDg0MThhYjM1Y2YwZDAyOWQzM2MwZV8yLTMtMS0xLTIyNTI3MQ_9abf3ce6-7413-44f1-98ac-2420f42d0da4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDgw_170eb5ec-5145-4fb7-a91a-25ced6ebd4f0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="if7b47f0a1b274852999d6d4b2ead62d8_I20230426"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xL2ZyYWc6YjRkYmRlZGU4Y2VkNDQzMzlkNWM5NTExNzdhNDk5ZDQvdGV4dHJlZ2lvbjpiNGRiZGVkZThjZWQ0NDMzOWQ1Yzk1MTE3N2E0OTlkNF8yMDAw_1d3e3421-9c13-4ffe-b53b-01b04373569b"
      unitRef="shares">546995686</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMy0xLTEtMS0yMjUyNzE_da7904bd-1da0-4d73-87f7-9b03ccc1e7b2"
      unitRef="usd">12889290000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMy0zLTEtMS0yMjUyNzE_9c936741-f303-46c0-9bb8-a96cec13031c"
      unitRef="usd">12784078000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:DevelopmentInProcess
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNC0xLTEtMS0yMjUyNzE_0699e1ef-ecfd-4f02-9d2c-636d16bb354c"
      unitRef="usd">819810000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNC0zLTEtMS0yMjUyNzE_51e3d574-d1d2-461c-b5bc-dd98a8388486"
      unitRef="usd">760355000</us-gaap:DevelopmentInProcess>
    <us-gaap:Land
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNS0xLTEtMS0yMjUyNzE_93a5df16-1d78-4180-b6e5-32df821d64f7"
      unitRef="usd">2674942000</us-gaap:Land>
    <us-gaap:Land
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNS0zLTEtMS0yMjUyNzE_ddaf6dc7-0bcf-438c-ad4c-8305871b4de4"
      unitRef="usd">2667188000</us-gaap:Land>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNi0xLTEtMS0yMjUyNzE_5313f716-ba0b-48c7-afe2-9d22ce3f29f6"
      unitRef="usd">3296781000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNi0zLTEtMS0yMjUyNzE_fcebd4a4-8c15-482e-8064-65df6a2e683c"
      unitRef="usd">3188138000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNy0xLTEtMS0yMjUyNzE_8a549c83-6a8a-4295-8a2a-0ea720ca0cbe"
      unitRef="usd">13087261000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNy0zLTEtMS0yMjUyNzE_55d6c698-81cc-4b89-adac-42554c0f6695"
      unitRef="usd">13023483000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0wLTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjoxYjRlMjMzYmM3NGI0N2E2ODU1ZTVlN2YwZjg5MjE0Yl80MQ_ab50e8dc-43c7-4afc-b137-6dc93186141a"
      unitRef="usd">6152000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0wLTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjoxYjRlMjMzYmM3NGI0N2E2ODU1ZTVlN2YwZjg5MjE0Yl80OA_a71e1f25-42e2-4a43-ba25-de7b6db36e85"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0xLTEtMS0yMjUyNzE_1dcb6061-2bbe-4615-ac5d-8074516bf6e9"
      unitRef="usd">243149000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfOS0zLTEtMS0yMjUyNzE_501a8f28-9b68-4809-b2a0-9fda64e12119"
      unitRef="usd">374832000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTAtMS0xLTEtMjI1Mjcx_000d12c8-f742-4aff-8019-3f6090b56d44"
      unitRef="usd">714679000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTAtMy0xLTEtMjI1Mjcx_53956029-fac8-4bf7-951e-d626b48068a1"
      unitRef="usd">706677000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMC0xLTEtMjI1MjcxL3RleHRyZWdpb246NGE1MTAwZDVlZDQ5NDFiNGJiMTNjMWJkNmY5YzVkZmFfNDU_8bd1979a-b54d-4468-8e0a-3a6fe4b0eafa"
      unitRef="usd">2413000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMC0xLTEtMjI1MjcxL3RleHRyZWdpb246NGE1MTAwZDVlZDQ5NDFiNGJiMTNjMWJkNmY5YzVkZmFfNTI_defba5be-77dc-45fd-8df8-1e8c5ed05c26"
      unitRef="usd">2399000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMS0xLTEtMjI1Mjcx_4e3ba901-e45d-4c44-9f6e-9c7cd9cf7ce1"
      unitRef="usd">57705000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTEtMy0xLTEtMjI1Mjcx_bd7e9852-05cd-459f-ba3c-941e00c5b7ba"
      unitRef="usd">53436000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTItMS0xLTEtMjI1Mjcx_7e073e28-aead-4ea6-abbe-79aa309d57dd"
      unitRef="usd">59235000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTItMy0xLTEtMjI1Mjcx_35ea21b1-164b-4b8c-938d-9a7b3ca06d78"
      unitRef="usd">72032000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTMtMS0xLTEtMjI1Mjcx_e8c7859d-fac0-44b2-ab7f-53bd674c56f9"
      unitRef="usd">57990000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTMtMy0xLTEtMjI1Mjcx_cb7453d2-c740-4f72-8161-fe7148e9b5d8"
      unitRef="usd">54802000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTQtMS0xLTEtMjI1Mjcx_c0a67723-4b82-4584-b1f1-1804017df48e"
      unitRef="usd">391956000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTQtMy0xLTEtMjI1Mjcx_21d59b29-735d-4a32-8195-db2c2d1b9b10"
      unitRef="usd">418061000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTUtMS0xLTEtMjI1Mjcx_a6c6ed85-55f5-4047-9ce4-795bddd99348"
      unitRef="usd">0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTUtMy0xLTEtMjI1Mjcx_3a48a3ca-2dce-473f-9a7a-26a2639bf00d"
      unitRef="usd">49866000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTYtMS0xLTEtMjI1Mjcx_2d52c3bd-9b83-4cb4-bd0d-c8f53cc005d2"
      unitRef="usd">235591000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTYtMy0xLTEtMjI1Mjcx_b0d79bef-9871-4551-b783-84ddcb0cfd9f"
      unitRef="usd">237318000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTctMS0xLTEtMjI1Mjcx_e1388cc1-22b7-4c27-b6d3-a6c56dd4e66e"
      unitRef="usd">754723000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTctMy0xLTEtMjI1Mjcx_1208d977-8085-4450-ae0c-ea69824de76d"
      unitRef="usd">780722000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTgtMS0xLTEtMjI1Mjcx_193de18b-57c2-4de4-868c-da126e885023"
      unitRef="usd">15602289000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMTgtMy0xLTEtMjI1Mjcx_2d06e327-c7a2-4f55-a1d8-106f4f5fb0a8"
      unitRef="usd">15771229000</us-gaap:Assets>
    <us-gaap:LineOfCredit
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjEtMS0xLTEtMjI1Mjcx_3246bf75-76c8-479a-a28c-66072d69af72"
      unitRef="usd">556000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjEtMy0xLTEtMjI1Mjcx_a2fe2b6c-9490-430c-9853-594364c863f3"
      unitRef="usd">995606000</us-gaap:LineOfCredit>
    <us-gaap:LoansPayableToBank
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjItMS0xLTEtMjI1Mjcx_74b55132-ca73-4515-9f13-d38b93422eb5"
      unitRef="usd">496168000</us-gaap:LoansPayableToBank>
    <us-gaap:LoansPayableToBank
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjItMy0xLTEtMjI1Mjcx_26fbf5ea-713a-46c3-8124-c9e089ed9c30"
      unitRef="usd">495957000</us-gaap:LoansPayableToBank>
    <us-gaap:UnsecuredDebt
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjMtMS0xLTEtMjI1Mjcx_4af2f99f-711f-428a-ac56-976e983b348d"
      unitRef="usd">5056543000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjMtMy0xLTEtMjI1Mjcx_540d96c3-bb2c-4c18-a5b5-ab70365a57bd"
      unitRef="usd">4659451000</us-gaap:UnsecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjQtMS0xLTEtMjI1Mjcx_1ff873d9-957b-4625-862a-d52ab2f4fb9b"
      unitRef="usd">345167000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjQtMy0xLTEtMjI1Mjcx_80a56c0f-8b92-49f0-b83d-dea1d8e1c0ae"
      unitRef="usd">346599000</us-gaap:SecuredDebt>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjUtMS0xLTEtMjI1Mjcx_cb803ce4-4f08-4a83-8076-878d8a6eabe1"
      unitRef="usd">149604000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjUtMy0xLTEtMjI1Mjcx_f8aed826-ea70-4cb3-80d8-7b304f92149d"
      unitRef="usd">156193000</us-gaap:OffMarketLeaseUnfavorable>
    <peak:LiabilitiesRelatedToAssetsHeldForSaleNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjYtMS0xLTEtMjI1Mjcx_88386d4d-4933-43fa-9e6b-13707506fd2a"
      unitRef="usd">0</peak:LiabilitiesRelatedToAssetsHeldForSaleNet>
    <peak:LiabilitiesRelatedToAssetsHeldForSaleNet
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjYtMy0xLTEtMjI1Mjcx_06efa2c6-797a-4970-ac0d-58be538dde5f"
      unitRef="usd">4070000</peak:LiabilitiesRelatedToAssetsHeldForSaleNet>
    <us-gaap:OperatingLeaseLiability
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjctMS0xLTEtMjI1Mjcx_1cfb5197-6fcc-49d4-9fe9-210421e6a068"
      unitRef="usd">207734000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjctMy0xLTEtMjI1Mjcx_b51fe850-7983-462b-9320-f9668bc0e118"
      unitRef="usd">208515000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjgtMS0xLTEtMjI1Mjcx_4733c290-f8e0-4077-b12d-a0b222eba4e6"
      unitRef="usd">688994000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjgtMy0xLTEtMjI1Mjcx_56352194-25d3-4bb0-9848-8f83a9985216"
      unitRef="usd">772485000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjktMS0xLTEtMjI1Mjcx_2cdcf7b6-851b-4306-8b00-5cdae297fbfd"
      unitRef="usd">878444000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMjktMy0xLTEtMjI1Mjcx_0c3e9c04-d034-4ed3-936c-202614e1007b"
      unitRef="usd">844076000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:Liabilities
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzAtMS0xLTEtMjI1Mjcx_207b15b8-88d2-4efa-af71-7baf85c4e91a"
      unitRef="usd">8378654000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzAtMy0xLTEtMjI1Mjcx_58ab84a2-2745-4036-be8a-dcd97bb9f401"
      unitRef="usd">8482952000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzItMS0xLTEtMjI1Mjcx_18493664-5e08-40e4-83a2-701d0658fd7d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzItMy0xLTEtMjI1Mjcx_7e81fed1-6223-4690-9f91-bafe73e11d61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzQtMS0xLTEtMjI1Mjcx_e743f5b1-deef-4047-9c0a-c3dbdbdfe2a3"
      unitRef="usd">85902000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzQtMy0xLTEtMjI1Mjcx_e223ea43-4df6-4ccd-b223-215fa801265d"
      unitRef="usd">105679000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDE2_8508108d-6ca6-4cda-bd5d-011068d2b22a"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDE2_d91f62f9-507a-4cc4-ab7a-ed1c52579d43"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDMy_30d1da3c-0d99-4cbc-812c-72d25825f093"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDMy_a473cd96-0752-40e7-b43d-86e863932fc3"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDQ2_37e9f338-68a6-4c72-8a87-098cd8c12a5a"
      unitRef="shares">546994803</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDQ2_8b7a2ee7-6d87-4425-9020-bdf7069fa88d"
      unitRef="shares">546994803</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDYw_a88f6edf-493d-471d-8360-8056ebaf65d5"
      unitRef="shares">546641973</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MzQyZjJjMzllYTE1NGVlNTllZTk4ZWUzZGRhY2NmNTZfNTQ5NzU1ODE0MDYw_d0a8bc52-928e-49fb-b6c8-fec3b43494ce"
      unitRef="shares">546641973</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMS0xLTEtMjI1Mjcx_2242607f-a8d9-41fa-9982-72f829625ba7"
      unitRef="usd">546995000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzctMy0xLTEtMjI1Mjcx_7b6a9dad-eff4-4e4a-8eb6-8a62299054ed"
      unitRef="usd">546642000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzgtMS0xLTEtMjI1Mjcx_f41cc173-dc82-4721-957e-e0f24d97a5c7"
      unitRef="usd">10360058000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzgtMy0xLTEtMjI1Mjcx_77cfb1de-eeb6-40aa-b7b2-1c8274ad3308"
      unitRef="usd">10349614000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedDistributionsInExcessOfNetIncome
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzktMS0xLTEtMjI1Mjcx_7297920d-626d-499e-a147-f0c8176c0955"
      unitRef="usd">4316038000</us-gaap:AccumulatedDistributionsInExcessOfNetIncome>
    <us-gaap:AccumulatedDistributionsInExcessOfNetIncome
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfMzktMy0xLTEtMjI1Mjcx_f0872735-6d12-4e41-a4ff-65b2a60bf21f"
      unitRef="usd">4269689000</us-gaap:AccumulatedDistributionsInExcessOfNetIncome>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDAtMS0xLTEtMjI1Mjcx_419d7131-7862-49e8-bd72-b284ec2608e9"
      unitRef="usd">18721000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDAtMy0xLTEtMjI1Mjcx_736b1336-0b3a-43f1-a7fe-2282fb5d317b"
      unitRef="usd">28134000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDEtMS0xLTEtMjI1Mjcx_d1ce1f38-fd6c-4430-bb4f-5f44f8b44af1"
      unitRef="usd">6609736000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDEtMy0xLTEtMjI1Mjcx_c830b39d-fcca-418b-9c71-dba5b084c35a"
      unitRef="usd">6654701000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterestInJointVentures
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDItMS0xLTEtMjI1Mjcx_522ad3dc-47fa-4980-b1af-8fd60b2db369"
      unitRef="usd">320363000</us-gaap:MinorityInterestInJointVentures>
    <us-gaap:MinorityInterestInJointVentures
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDItMy0xLTEtMjI1Mjcx_f9980450-28f0-4777-afde-e700244dc61f"
      unitRef="usd">327721000</us-gaap:MinorityInterestInJointVentures>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDMtMS0xLTEtMjI1Mjcx_fa7a376d-330e-4006-aa01-fe1cbbcc83af"
      unitRef="usd">207634000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDMtMy0xLTEtMjI1Mjcx_e20fbaac-bc30-4243-9d8a-284e4390f39a"
      unitRef="usd">200176000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <us-gaap:MinorityInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDQtMS0xLTEtMjI1Mjcx_7d2d9691-54a1-4d26-b47b-38dbbdecafcd"
      unitRef="usd">527997000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDQtMy0xLTEtMjI1Mjcx_fdd4f47b-fc3f-45b2-9e19-f4706d3dc71a"
      unitRef="usd">527897000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDUtMS0xLTEtMjI1Mjcx_83eadce5-e299-4886-8b24-060c438d0fab"
      unitRef="usd">7137733000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDUtMy0xLTEtMjI1Mjcx_a07b99b0-6b8b-4744-9009-99732d99d908"
      unitRef="usd">7182598000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDYtMS0xLTEtMjI1Mjcx_7c348286-67b5-46ce-b285-fef540024b8d"
      unitRef="usd">15602289000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xNi9mcmFnOjY1OTcwNTBiZmU1OTQzYjk4NTgwNThlZDkwMzU1YzUxL3RhYmxlOjYxNmQ4YzIyYTAzMTQwMjM4YWZhM2MxZDA4YTBiNzE5L3RhYmxlcmFuZ2U6NjE2ZDhjMjJhMDMxNDAyMzhhZmEzYzFkMDhhMGI3MTlfNDYtMy0xLTEtMjI1Mjcx_4567c9e4-7113-4e14-a226-8c14df349b04"
      unitRef="usd">15771229000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMy0xLTEtMS0yMjUyNzE_2c8dc726-eaea-4975-81f6-15690c9110b2"
      unitRef="usd">392431000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMy0zLTEtMS0yMjUyNzE_fa66ddea-b30e-4d94-b5ee-ef5cf61de50b"
      unitRef="usd">370150000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNC0xLTEtMS0yMjUyNzE_0b1e13b5-366c-497e-93de-bf2d6a362beb"
      unitRef="usd">127084000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNC0zLTEtMS0yMjUyNzE_18f1200e-ee3e-4941-ae10-2238bee8d450"
      unitRef="usd">121560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InterestIncomeOperating
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0xLTEtMS0yMjcxOTg_c882a88e-f646-4f8f-99ab-40c7ca9700ef"
      unitRef="usd">6163000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0zLTEtMS0yMjcxOTg_18f5d2b8-6770-4768-a358-78f13d0c381f"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:DirectFinancingLeaseRevenue
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0xLTEtMS0yMjUyNzE_66eeafdb-e335-4eb2-aa4a-97dd64f91331"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseRevenue>
    <us-gaap:DirectFinancingLeaseRevenue
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNS0zLTEtMS0yMjUyNzE_d45349c5-429a-49c7-ad8d-df87048bd8fa"
      unitRef="usd">1168000</us-gaap:DirectFinancingLeaseRevenue>
    <us-gaap:Revenues
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNy0xLTEtMS0yMjUyNzE_4afd793d-8ab3-49f3-94da-e93e8c613204"
      unitRef="usd">525678000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNy0zLTEtMS0yMjUyNzE_83fd5374-7d39-4045-9c78-f251789b09f2"
      unitRef="usd">498372000</us-gaap:Revenues>
    <us-gaap:InterestExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfOS0xLTEtMS0yMjUyNzE_c5d5bdb3-a493-47b3-a4a9-aa7bbeaec38b"
      unitRef="usd">47963000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfOS0zLTEtMS0yMjUyNzE_b54a1456-f807-4142-9b5f-8e34877f0087"
      unitRef="usd">37586000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTAtMS0xLTEtMjI1Mjcx_0b2f70b8-2a7a-47ce-b388-7cbdc2d13ef2"
      unitRef="usd">179225000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTAtMy0xLTEtMjI1Mjcx_47403f38-bf5b-49d8-8697-244da2a99ee3"
      unitRef="usd">177733000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTEtMS0xLTEtMjI1Mjcx_e643642e-798a-4d2b-a0b0-74cd1e7d7658"
      unitRef="usd">223088000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTEtMy0xLTEtMjI1Mjcx_70bb28b0-d65f-4ecb-9c37-6571c38aa0ad"
      unitRef="usd">207247000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTItMS0xLTEtMjI1Mjcx_4dfd803c-064e-407c-ab6c-4be3a0a7eb1d"
      unitRef="usd">24547000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTItMy0xLTEtMjI1Mjcx_26942a0a-40bd-4fb5-b09e-3526585963b9"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTMtMS0xLTEtMjI1Mjcx_d07e0b48-67be-4f5f-96ec-0295223c61a3"
      unitRef="usd">2425000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTMtMy0xLTEtMjI1Mjcx_11942c81-3278-4f2e-a49f-710353d2d475"
      unitRef="usd">296000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTUtMS0xLTEtMjI1Mjcx_4bcd6190-4be1-4377-9bc4-8f95e2527fcf"
      unitRef="usd">-2213000</peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet>
    <peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTUtMy0xLTEtMjI1Mjcx_09c690d9-dba3-4cfe-8d71-3eb66dfb1897"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet>
    <us-gaap:CostsAndExpenses
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTYtMS0xLTEtMjI1Mjcx_8e9333d6-3734-4d04-8988-181aca84bcf9"
      unitRef="usd">475035000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTYtMy0xLTEtMjI1Mjcx_424d4268-eb09-47d7-b149-a17e69181fd6"
      unitRef="usd">446825000</us-gaap:CostsAndExpenses>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTgtMS0xLTEtMjI1Mjcx_88aea79a-b9d0-4254-98ea-483ef1accbf4"
      unitRef="usd">81578000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMTgtMy0xLTEtMjI1Mjcx_f16c6cfe-2728-4d2a-a90f-26bfa55d41ca"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjAtMS0xLTEtMjI1Mjcx_efbe22db-72fa-4012-8b5a-0882f90cd8f6"
      unitRef="usd">772000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjAtMy0xLTEtMjI1Mjcx_10d501fb-b1d6-47f6-8183-2ce4290b0a4f"
      unitRef="usd">18316000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjEtMS0xLTEtMjI1Mjcx_2efd5be4-e436-4d54-99d7-fc214e0909a4"
      unitRef="usd">82350000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjEtMy0xLTEtMjI1Mjcx_2824c176-136b-4420-ae6f-e93b56c339ce"
      unitRef="usd">22172000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjItMS0xLTEtMjI1Mjcx_a795054a-bfea-4396-ac34-1b2adf3ececf"
      unitRef="usd">132993000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjItMy0xLTEtMjI1Mjcx_5c5273c3-54ef-4fbf-96fb-77520a2ef6b4"
      unitRef="usd">73719000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjMtMS0xLTEtMjI1Mjcx_4329368d-aec7-4e71-b97c-2f85327f303b"
      unitRef="usd">302000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjMtMy0xLTEtMjI1Mjcx_78f86c02-df40-42f7-be39-15ee11c79726"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjQtMS0xLTEtMjI1Mjcx_87a2484a-3b70-40ad-a3ad-fcf10ce42355"
      unitRef="usd">1816000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjQtMy0xLTEtMjI1Mjcx_078c74f7-2e61-41c2-9e70-18e68a6b8ba3"
      unitRef="usd">2084000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjUtMS0xLTEtMjI1Mjcx_ee771099-fa26-42fe-a376-ffef4c8dca07"
      unitRef="usd">134507000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjUtMy0xLTEtMjI1Mjcx_7f0519da-19ef-40c3-a51a-8205d42057db"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjYtMS0xLTEtMjI1Mjcx_60e9027b-bde0-45c9-9a50-a2402512de17"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjYtMy0xLTEtMjI1Mjcx_28944e3c-6769-4437-81f4-0e86c4751127"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjctMS0xLTEtMjI1Mjcx_42d1569d-4fc2-449d-9624-3768ced25d45"
      unitRef="usd">134507000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjctMy0xLTEtMjI1Mjcx_81861c2f-defd-4391-b9ca-7910d2da5758"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjgtMS0xLTEtMjI1Mjcx_ee2a5210-c58c-4bfe-bca4-310d43537007"
      unitRef="usd">15555000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMjgtMy0xLTEtMjI1Mjcx_2f612666-5aba-4ace-92d9-7b2b263e45be"
      unitRef="usd">3730000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzAtMS0xLTEtMjI1Mjcx_f984ddad-82f2-4110-bec9-fbe6e282e0eb"
      unitRef="usd">118952000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzAtMy0xLTEtMjI1Mjcx_e10408fb-6a07-4aff-b913-f7ead5b7d249"
      unitRef="usd">71613000</us-gaap:NetIncomeLoss>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzItMS0xLTEtMjI1Mjcx_21787eae-3254-45ba-98b5-9883587d9a5b"
      unitRef="usd">1254000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzItMy0xLTEtMjI1Mjcx_d933c25f-5ed5-4d98-bd7e-06666f2ef9a8"
      unitRef="usd">1976000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzMtMS0xLTEtMjI1Mjcx_ed5af48e-d6a2-4ddd-b413-9c45f0f2190d"
      unitRef="usd">117698000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzMtMy0xLTEtMjI1Mjcx_cc2b334f-4c45-4409-83c2-662018fc20be"
      unitRef="usd">69637000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzYtMS0xLTEtMjI1Mjcx_97c738ab-6bfb-43ed-b093-024064fef7d3"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzYtMy0xLTEtMjI1Mjcx_fde2b991-8881-488e-81e5-7170c22d1d25"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzctMS0xLTEtMjI1Mjcx_22a6bfbe-d95d-462b-a947-8001671e1d48"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzctMy0xLTEtMjI1Mjcx_cce1feec-19c4-44be-b88f-c231f225af4c"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzgtMS0xLTEtMjI1Mjcx_94f237b6-4eba-4797-859a-0d03be4a8c1d"
      unitRef="usdPerShare">0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfMzgtMy0xLTEtMjI1Mjcx_3d49dc99-6ae0-4fb3-a872-ab62b6d9e0a3"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDAtMS0xLTEtMjI1Mjcx_84743f27-7f1b-4fdf-a1f9-f03becdf058d"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDAtMy0xLTEtMjI1Mjcx_fe22a28b-c3e1-4636-b2b3-f741995a1d0c"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDEtMS0xLTEtMjI1Mjcx_cfa61f09-ae36-4484-b151-9ed6710d810a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDEtMy0xLTEtMjI1Mjcx_2b679823-df55-48f4-91ed-10c75b51fc08"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDItMS0xLTEtMjI1Mjcx_6df91f04-c181-4e4f-8af3-002793efd865"
      unitRef="usdPerShare">0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDItMy0xLTEtMjI1Mjcx_cbc66233-1e31-4e19-80e5-435d680b0e49"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDctMS0xLTEtMjI1Mjcx_ab52d8b2-5637-4ce8-866c-0fa763d1e689"
      unitRef="shares">546842000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDctMy0xLTEtMjI1Mjcx_218f2ea1-2d06-46c2-8f19-fb44b3a78e97"
      unitRef="shares">539352000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDgtMS0xLTEtMjI1Mjcx_344948b4-b756-4d61-9003-fd64cda126cc"
      unitRef="shares">547110000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xOS9mcmFnOmJkZGFmMGEzZWQ5NzQxOGY4YjVjYjQ3MjdkZjE5MzFiL3RhYmxlOjE5ZjYzYWYxZjE3ZjRmZDM5NDgxMjFjZTdmMWM0ZDI5L3RhYmxlcmFuZ2U6MTlmNjNhZjFmMTdmNGZkMzk0ODEyMWNlN2YxYzRkMjlfNDgtMy0xLTEtMjI1Mjcx_9d7b7199-91ea-492e-b2fe-1c35b44f8c1b"
      unitRef="shares">539586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMi0xLTEtMS0yMjUyNzE_1d8df4f6-4f9b-436e-9ba4-1d936b2e5384"
      unitRef="usd">134507000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMi0zLTEtMS0yMjUyNzE_bd9222b1-7f41-4744-adb2-4b88109e034e"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNC0xLTEtMS0yMjUyNzE_061869bb-4683-4b37-8136-66a542fb4e9e"
      unitRef="usd">-9477000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNC0zLTEtMS0yMjUyNzE_5e3e73bf-2584-42b6-bfc2-596c431acf00"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNS0xLTEtMS0yMjUyNzE_6573b88c-3976-458c-8f76-7e396651924f"
      unitRef="usd">-64000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNS0zLTEtMS0yMjUyNzE_54cab68b-ae79-409c-82d8-8e41a8c292ff"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNy0xLTEtMS0yMjUyNzE_36d497a9-de54-4f8b-a348-587f00aa88bc"
      unitRef="usd">-9413000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfNy0zLTEtMS0yMjUyNzE_8a7f756a-6e29-4cf8-8d97-e81b99923eb1"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOC0xLTEtMS0yMjUyNzE_45d5b1a8-6a13-4baf-b6a3-c4f8bfe4867e"
      unitRef="usd">125094000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOC0zLTEtMS0yMjUyNzE_7d3b3fef-74bd-459c-8cf9-302105f5e193"
      unitRef="usd">75443000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOS0xLTEtMS0yMjUyNzE_ca5a0328-6e58-4384-859f-9edaeaf03ed8"
      unitRef="usd">15555000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfOS0zLTEtMS0yMjUyNzE_58af3077-d9d4-49a1-a9d6-972b6f681399"
      unitRef="usd">3730000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMTEtMS0xLTEtMjI1Mjcx_5779e784-5a70-452d-94a8-4cb98f0fcc43"
      unitRef="usd">109539000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yMi9mcmFnOjI3ZGIwNWIyNDIzNjQ1YmI4N2E4MjFlYTFkNWM3N2RjL3RhYmxlOmQ0NjA5YjJhMDRlNTQ4YTNiZjUzNjUyZTNmNzg5ZTViL3RhYmxlcmFuZ2U6ZDQ2MDliMmEwNGU1NDhhM2JmNTM2NTJlM2Y3ODllNWJfMTEtMy0xLTEtMjI1Mjcx_7b763f84-4d65-45e8-a112-bb13cdc01531"
      unitRef="usd">71713000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xLTEtMS0yMjUyNzE_453ea1e6-438e-4f43-b327-0c051f785508"
      unitRef="shares">546642000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d6b36de6ceb4a49bb4220cb933a6790_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0zLTEtMS0yMjUyNzE_ade23c9b-a4f0-4bb2-a9de-9f7e8949f1c3"
      unitRef="usd">546642000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacdd5f56e1a64a2f909772d23fa79232_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC01LTEtMS0yMjUyNzE_78792364-5a45-4a71-8dfe-a8fe39e97162"
      unitRef="usd">10349614000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3db6d623777a4436baf821bd0afcff29_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC03LTEtMS0yMjUyNzE_640cb6b4-1d35-43b2-a9f2-edcc1fb037aa"
      unitRef="usd">-4269689000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0f6cf1f29914223a101cf9dfaee1c2b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC05LTEtMS0yMjUyNzE_81d98170-39aa-458b-896e-aeaa7b9c43ae"
      unitRef="usd">28134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cf4d0c742ae47a892216777fa79e08b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xMS0xLTEtMjI1Mjcx_7ae2dec0-f9e3-4fa0-a07b-e158bacb89b8"
      unitRef="usd">6654701000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530e671af080458e9ba7b21a10d74180_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xMy0xLTEtMjI1Mjcx_f9252049-9fb5-497f-9dea-ad0e9c35e62b"
      unitRef="usd">527897000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xNS0xLTEtMjI1Mjcx_a8a195b0-b5d4-4654-a5ef-88738f380bee"
      unitRef="usd">7182598000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNC0xNy0xLTEtMjI1Mjcx_b0524dbb-9f9e-4090-8eb8-db47b96cb750"
      unitRef="usd">105679000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7de8610900b8400ea338f115550cc75e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS03LTEtMS0yMjUyNzE_2754fa17-9870-4d9b-9823-20ef17cdb599"
      unitRef="usd">118952000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xMS0xLTEtMjI1Mjcx_0441d21f-f86a-4d2f-914b-07fa3b146a17"
      unitRef="usd">118952000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xMy0xLTEtMjI1Mjcx_040445ff-3719-481c-a24b-d38bd8d8322a"
      unitRef="usd">15389000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xNS0xLTEtMjI1Mjcx_b584b987-3c35-4ffc-901c-42b12a028f17"
      unitRef="usd">134341000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNS0xNy0xLTEtMjI1Mjcx_4f4cf55e-a154-4be6-8783-9ee5bebe9caa"
      unitRef="usd">166000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0563220fc3204262b0a60fd550eae320_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi05LTEtMS0yMjUyNzE_821ea5dd-979a-43a1-a7e2-45828f2714fc"
      unitRef="usd">-9413000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi0xMS0xLTEtMjI1Mjcx_a311b1e1-515f-44b9-a9df-88f52d8ffc1e"
      unitRef="usd">-9413000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNi0xNS0xLTEtMjI1Mjcx_8bd5e480-7b2b-41f4-825f-6eb15a02d3a0"
      unitRef="usd">-9413000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xLTEtMS0yMjUyNzE_e9e451fb-980f-49d6-80b3-caf2ec12ea62"
      unitRef="shares">591000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0zLTEtMS0yMjUyNzE_526058ec-36c4-4a71-863d-72f584b6913b"
      unitRef="usd">591000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy01LTEtMS0yMjUyNzE_2e9b439d-79f3-4ab5-82be-8b3bf86606dc"
      unitRef="usd">-417000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xMS0xLTEtMjI1Mjcx_b8b3e95e-d96d-4fc4-a869-0fe08ea337d5"
      unitRef="usd">174000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfNy0xNS0xLTEtMjI1Mjcx_e039a593-c92f-4e7a-a6a6-03809b75670d"
      unitRef="usd">174000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xLTEtMS0yMjUyNzE_20bf4e72-5f1e-4ad2-836b-2d024ab08243"
      unitRef="shares">238000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia08b165391414939958c319482d7e2da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0zLTEtMS0yMjUyNzE_09cc78e0-b54e-4965-8abd-4451082d2d91"
      unitRef="usd">238000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS01LTEtMS0yMjUyNzE_07ea5e21-be1b-431e-984b-9fc9dfce6571"
      unitRef="usd">6229000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xMS0xLTEtMjI1Mjcx_91d54119-e6b4-4193-8628-c662c7bb2e2d"
      unitRef="usd">6467000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfOS0xNS0xLTEtMjI1Mjcx_d40703c2-7e6e-4256-b8b7-a5b9f644c5d7"
      unitRef="usd">6467000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtNS0xLTEtMjI1Mjcx_5a4f621b-2d99-4cca-a29c-6076cc31c7f3"
      unitRef="usd">-2877000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTEtMS0xLTIyNTI3MQ_ee75a6e4-6076-4aba-b970-2c5393e2f123"
      unitRef="usd">-2877000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTMtMS0xLTIyNTI3MQ_f07e5ede-10fa-4ded-b86d-3adf1ca16899"
      unitRef="usd">7442000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTEtMTUtMS0xLTIyNTI3MQ_6d83bc5f-bdc0-457e-9604-a0564e2e2975"
      unitRef="usd">4565000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMC0xLTEtMjI1MjcxL3RleHRyZWdpb246ZWI5YjMwM2UzNWQ2NDQxMGI2ZTE5Nzc2OWIwYTg4ODBfMjI_ecc511f1-6bf0-41cb-b3e0-b4f815c93ca6"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock
      contextRef="i7de8610900b8400ea338f115550cc75e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItNy0xLTEtMjI1Mjcx_2528ddef-6a5d-4f25-be47-01ccbb33e3a2"
      unitRef="usd">165301000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMTEtMS0xLTIyNTI3MQ_708acdde-a0e2-4553-af73-de0c2e879508"
      unitRef="usd">165301000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTItMTUtMS0xLTIyNTI3MQ_dcfba858-eb7a-422b-85c8-271ef03f398f"
      unitRef="usd">165301000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i536dd7e8b0614cc4887b9f026133067e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTMtMS0xLTIyNTI3MQ_5aa1320f-fbec-4203-bf5d-112c94287c36"
      unitRef="usd">22731000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTUtMS0xLTIyNTI3MQ_0d294520-f66f-441d-8fb8-8e3756dc7deb"
      unitRef="usd">22731000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTMtMTctMS0xLTIyNTI3MQ_dd8d91ba-cb60-4257-93f5-5f09c2bdd0eb"
      unitRef="usd">72000</peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTQtMTctMS0xLTIyNTI3MQ_e6cca0f5-3d19-436b-b52c-db301acbfdfe"
      unitRef="usd">96000</peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="i8184ee033a2f481db877fd5ba8f3ec1c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtNS0xLTEtMjI1Mjcx_e47770f8-7b63-48bd-9453-c0110e6f2533"
      unitRef="usd">-19967000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iee380a52cc734b6db1e0656df95f3cd2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTEtMS0xLTIyNTI3MQ_5261393a-9adc-49cd-9bfa-45293702bd90"
      unitRef="usd">-19967000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTUtMS0xLTIyNTI3MQ_a658b13c-b55e-44aa-86b1-80bd367c88d6"
      unitRef="usd">-19967000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTUtMTctMS0xLTIyNTI3MQ_013f8fd6-975e-4ae5-8a45-caab03060a0f"
      unitRef="usd">-19967000</peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity>
    <us-gaap:SharesIssued
      contextRef="ie6c895598a3c42b7afdb9ff3193e487c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMS0xLTEtMjI1Mjcx_b94ac234-20fb-463d-aace-f07a365fd6bf"
      unitRef="shares">546995000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6c895598a3c42b7afdb9ff3193e487c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMy0xLTEtMjI1Mjcx_02b9d656-8981-4d80-b6b8-331c12ac9a29"
      unitRef="usd">546995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i807e77a17a3d456481946b1b5c29dc29_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktNS0xLTEtMjI1Mjcx_3c23847b-1080-4e91-890f-5b2ea957e231"
      unitRef="usd">10360058000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99f56515023941089672801d0df27438_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktNy0xLTEtMjI1Mjcx_55b582b5-405f-4440-8c1b-b1a775b3ee58"
      unitRef="usd">-4316038000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i57bcf974abc44e3d904f70df65e9044d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktOS0xLTEtMjI1Mjcx_9b1b31ef-4ab0-4527-846b-e576c0d6e18d"
      unitRef="usd">18721000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83ebcfd7fc764a069ccd0143794750e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTEtMS0xLTIyNTI3MQ_f0b43c12-707e-40e5-ac28-18f55c92c127"
      unitRef="usd">6609736000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTMtMS0xLTIyNTI3MQ_aa6a28e6-5f0b-423f-8317-03ab242979ef"
      unitRef="usd">527997000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTUtMS0xLTIyNTI3MQ_d82fd655-b011-479e-ab54-2a998a6b3937"
      unitRef="usd">7137733000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjc5M2ViMTlmNjYzZjQxZjhhYmEzZjdmN2EwMTg3YjQ2L3RhYmxlcmFuZ2U6NzkzZWIxOWY2NjNmNDFmOGFiYTNmN2Y3YTAxODdiNDZfMTktMTctMS0xLTIyNTI3MQ_693b6dfd-8a56-4144-bd49-6807d0612ddf"
      unitRef="usd">85902000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesIssued
      contextRef="i30bf6bfeb0434265ba52f1329cc43b46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xLTEtMS0yMjUyNzE_c2687390-3e40-47f1-8bba-e891688ae1db"
      unitRef="shares">539097000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30bf6bfeb0434265ba52f1329cc43b46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0zLTEtMS0yMjUyNzE_65cdd59d-9633-4feb-9741-44fbe2143a66"
      unitRef="usd">539097000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5eba404d7984f2bb0b0aebd3dd90f27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC01LTEtMS0yMjUyNzE_f2d0d1d3-d21f-48f1-9ced-eb8265498e9e"
      unitRef="usd">10100294000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2fecc3b0cc14458b9cad2f8b45fe191_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC03LTEtMS0yMjUyNzE_c7d253c9-0f09-4a1f-9234-9b5fb6600c9f"
      unitRef="usd">-4120774000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie94947a66a6b4b0db78654d659d35ae7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC05LTEtMS0yMjUyNzE_d5283661-7411-4e32-952e-1eeb698fd9dd"
      unitRef="usd">-3147000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00fa5f4d9ca644438e3562b42ba2334c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xMS0xLTEtMjI1Mjcx_89d1d1eb-c870-4341-a9fe-684bf37fb462"
      unitRef="usd">6515470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i503ad2df9c9240088b9e5481b385a0f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xMy0xLTEtMjI1Mjcx_ae4377a1-0989-46fa-bc30-446dccb25651"
      unitRef="usd">543290000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xNS0xLTEtMjI1Mjcx_1086a19d-e147-472b-bce6-2cd0d40e04e0"
      unitRef="usd">7058760000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNC0xNy0xLTEtMjI1Mjcx_b6994495-26cd-4e3a-a616-c5b5b780c2b3"
      unitRef="usd">87344000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS03LTEtMS0yMjUyNzE_08f0c37f-9749-4986-bf05-d7a407788e76"
      unitRef="usd">71613000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xMS0xLTEtMjI1Mjcx_0661f88c-4f80-4844-92d0-d641896036af"
      unitRef="usd">71613000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xMy0xLTEtMjI1Mjcx_13fed783-e8c0-4d05-9ff9-d9a59e4f84c8"
      unitRef="usd">3718000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xNS0xLTEtMjI1Mjcx_7b9e04f5-22a1-4639-969f-0d08502e0123"
      unitRef="usd">75331000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNS0xNy0xLTEtMjI1Mjcx_d04c012a-187c-4e38-b8d1-4fe558abfe1c"
      unitRef="usd">12000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iabf59758b312417ebb52a26e8b708bf1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi05LTEtMS0yMjUyNzE_e67d6db1-71a2-4f90-a07e-01d026079f3c"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi0xMS0xLTEtMjI1Mjcx_010051cd-4f35-41d8-b576-57c30b406829"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNi0xNS0xLTEtMjI1Mjcx_718c6130-652b-4e48-a852-c19c0b7d5f17"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xLTEtMS0yMjUyNzE_567d5313-ced9-4f5f-84a1-77478dd29eb8"
      unitRef="shares">766000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0zLTEtMS0yMjUyNzE_61028990-bcbe-4399-acca-d4895b282e5a"
      unitRef="usd">766000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy01LTEtMS0yMjUyNzE_8f29310b-01b1-4149-b64d-165db00ab596"
      unitRef="usd">-437000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xMS0xLTEtMjI1Mjcx_68b68819-9b4c-41fd-a446-a6cbbff9657b"
      unitRef="usd">329000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfNy0xNS0xLTEtMjI1Mjcx_c3f7d29e-352c-4ee9-bdc5-69cd8bca403c"
      unitRef="usd">329000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xLTEtMS0yMjUyNzE_11894df9-c327-4b75-adb8-0ebc18a6a5da"
      unitRef="shares">339000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4d179051afdb4e3abc83765bd17fb0c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0zLTEtMS0yMjUyNzE_71e0d9ec-058e-4c5f-84b6-4f7b57c80dce"
      unitRef="usd">339000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS01LTEtMS0yMjUyNzE_1d15f309-58e7-4223-92e2-43f5f6417b10"
      unitRef="usd">11013000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xMS0xLTEtMjI1Mjcx_65d0869a-a3f3-4091-94f6-e1e4d51c7d3b"
      unitRef="usd">11352000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfOS0xNS0xLTEtMjI1Mjcx_9361d980-e114-40ba-995c-b49aec8739ec"
      unitRef="usd">11352000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtNS0xLTEtMjI1Mjcx_1a52fef4-3e97-46b0-8c33-7b7df0bbc2d1"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtMTEtMS0xLTIyNTI3MQ_78ee0bbf-61f8-43e3-ad81-31af04e9be94"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTEtMTUtMS0xLTIyNTI3MQ_317a59eb-b71a-4a2b-93b6-17e0101d530d"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMC0xLTEtMjI1MjcxL3RleHRyZWdpb246MGEyYTE0NTAzYTFiNDA0MmFlYjczZWFhNWVlYjRhOWZfMjI_a90f0852-f29f-4fa8-b181-efa935460f63"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock
      contextRef="icd6f56a43c1d4339ab8c7fb59bf8cb28_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItNy0xLTEtMjI1Mjcx_bcdddc69-14b9-4819-974f-7a2c94280c0e"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMTEtMS0xLTIyNTI3MQ_66d8ffaa-ab1b-4cfa-a2dc-2491c414f698"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTItMTUtMS0xLTIyNTI3MQ_b6f73d81-e6cc-41b3-9f1a-06459f63226f"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2437d13c79474b27be7632b8e6c27e5d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTMtMTMtMS0xLTIyNTI3MQ_7620919f-c4ab-4daa-a82e-93ed2b9ba989"
      unitRef="usd">7509000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTMtMTUtMS0xLTIyNTI3MQ_93a445a7-5f50-41c1-a487-d6ecbd1b2870"
      unitRef="usd">7509000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTctMTctMS0xLTIyNTI3MQ_9da2f92b-e72b-4586-b66f-8b56d4a0bc46"
      unitRef="usd">233000</peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="i516876e0843a4ad18d8a7c3d3f01debd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktNS0xLTEtMjI1Mjcx_7e4efe0b-20ff-43db-8fb7-8b2533f56bb1"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="id228d39333ec4be0ba6b9161584f2295_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTEtMS0xLTIyNTI3MQ_28a9dbfb-14fd-4957-b673-b12a3306fd57"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTUtMS0xLTIyNTI3MQ_8293fab9-1b2b-40da-9781-d2859b020e81"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMTktMTctMS0xLTIyNTI3MQ_573cadd4-5a27-4a36-92b5-8073cb01e227"
      unitRef="usd">10301000</peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity>
    <us-gaap:SharesIssued
      contextRef="i69bc82cfb90b4179b30ea0df867d1278_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMS0xLTEtMjI1Mjcx_8bfacaf3-a936-474d-ae2b-82044713eb85"
      unitRef="shares">539524000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69bc82cfb90b4179b30ea0df867d1278_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMy0xLTEtMjI1Mjcx_4f07829b-18e0-48c5-8d23-a4ce87ac5481"
      unitRef="usd">539524000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i804d4f9d03a04437bc94e9a064ca876a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtNS0xLTEtMjI1Mjcx_93878582-aa0d-4ba9-978a-8a2500257ae1"
      unitRef="usd">10084687000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib15aeabd34c04dab92eb0fdb03950e0c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtNy0xLTEtMjI1Mjcx_65153a47-3f5a-4195-a510-9e7c2b04c664"
      unitRef="usd">-4212941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i980ff73125e2448f9c1841abc88ec5cc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtOS0xLTEtMjI1Mjcx_7e1551e5-47fe-408e-bc0a-d244575c48b9"
      unitRef="usd">-3047000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8fb31decab14836989f7e62f5d94e60_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTEtMS0xLTIyNTI3MQ_bf7105fd-d052-4bea-bfef-002a90429c6b"
      unitRef="usd">6408223000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f15128c31ab488daa41c96893b79122_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTMtMS0xLTIyNTI3MQ_7da9779a-4c91-448e-9e15-f4d9c7e3d9f8"
      unitRef="usd">539499000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTUtMS0xLTIyNTI3MQ_4ea8b540-f581-4459-8636-5bceaeb1bec5"
      unitRef="usd">6947722000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yNS9mcmFnOjc4MDg1MDRlOGY5MjRjN2VhYjhkZjA4NjNhNGZiOGMzL3RhYmxlOjI4OTdjMjFjMmYyODRkNDM4ZjAxMDI2NjY2N2ZlYmZjL3RhYmxlcmFuZ2U6Mjg5N2MyMWMyZjI4NGQ0MzhmMDEwMjY2NjY3ZmViZmNfMjAtMTctMS0xLTIyNTI3MQ_022fbf5c-91fb-4dfb-b68c-5e4d96978b5e"
      unitRef="usd">97890000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ProfitLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMy0xLTEtMS0yMjUyNzE_300b4ba7-429c-4aff-9deb-305373089bf6"
      unitRef="usd">134507000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMy0zLTEtMS0yMjUyNzE_e97cae85-a8a2-4e0a-aa0d-329268705196"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNS0xLTEtMS0yMjUyNzE_9b35a9b1-76a0-4126-ada8-5b7cae251ee3"
      unitRef="usd">179225000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNS0zLTEtMS0yMjUyNzE_168f88e9-b6c4-4f0d-a655-961149fbf7a1"
      unitRef="usd">177733000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNi0xLTEtMS0yMjUyNzE_d492628f-db33-4ed3-a6e1-5db4617616b2"
      unitRef="usd">3287000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNi0zLTEtMS0yMjUyNzE_da923451-a07d-428a-bd2d-cec8fdcfc014"
      unitRef="usd">4721000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNy0xLTEtMS0yMjUyNzE_e8bc0c1f-2f53-49f8-9d07-165b4c3c1115"
      unitRef="usd">2821000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNy0zLTEtMS0yMjUyNzE_23c8aed6-0449-4046-8a93-de488c25e6e6"
      unitRef="usd">2689000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:StraightLineRent
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfOC0xLTEtMS0yMjUyNzE_72a75c26-79d1-4849-ba63-143afc766bbd"
      unitRef="usd">747000</us-gaap:StraightLineRent>
    <us-gaap:StraightLineRent
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfOC0zLTEtMS0yMjUyNzE_ccafbee9-c27d-4d37-94be-482b6e498b19"
      unitRef="usd">11158000</us-gaap:StraightLineRent>
    <peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTAtMS0xLTEtMjI1Mjcx_124c6011-c0b9-4307-a961-fd6aa040fd29"
      unitRef="usd">-25690000</peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet>
    <peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTAtMy0xLTEtMjI1Mjcx_57223b0f-b0a5-44b0-ab4f-18153dff2176"
      unitRef="usd">-24725000</peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet>
    <peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTEtMS0xLTEtMjI1Mjcx_525f2a06-4a0e-45d8-bf65-03f3a6949840"
      unitRef="usd">1816000</peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations>
    <peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTEtMy0xLTEtMjI1Mjcx_35958523-2683-4ecb-8c15-cf2fc5a8ed60"
      unitRef="usd">2148000</peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTItMS0xLTEtMjI1Mjcx_bed598da-1087-419e-b284-8a5760f2e3c3"
      unitRef="usd">185000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTItMy0xLTEtMjI1Mjcx_612f4d2f-3be3-4d2e-a923-86d74aa07b13"
      unitRef="usd">237000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTQtMS0xLTEtMjI1Mjcx_baec4444-394a-49be-861c-7c4bd365c046"
      unitRef="usd">0</peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease>
    <peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTQtMy0xLTEtMjI1Mjcx_94912bd0-5802-41c1-8da2-482ff0f3caee"
      unitRef="usd">22693000</peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTUtMS0xLTEtMjI1Mjcx_45bd13fc-1b7f-4284-ae78-f3f2d0a09de6"
      unitRef="usd">-402000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTUtMy0xLTEtMjI1Mjcx_56d49c63-5621-4f7f-9861-b7d0930d44bc"
      unitRef="usd">-79000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:AssetImpairmentCharges
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTYtMS0xLTEtMjI1Mjcx_3f5454b0-0078-409c-aafb-27c6ae7144a5"
      unitRef="usd">-2213000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTYtMy0xLTEtMjI1Mjcx_450cfeb3-839e-45a6-9995-43ad1f7b5157"
      unitRef="usd">132000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTgtMS0xLTEtMjI1Mjcx_213937ed-e121-4b43-acc1-4947318d630b"
      unitRef="usd">81578000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMTgtMy0xLTEtMjI1Mjcx_99ffa76a-ee4c-4ec1-9eea-289f3c6f0861"
      unitRef="usd">3785000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:InsuredEventGainLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjAtMS0xLTEtMjI1Mjcx_25539cd6-93b3-425d-bbd8-db27588fe234"
      unitRef="usd">-529000</us-gaap:InsuredEventGainLoss>
    <us-gaap:InsuredEventGainLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjAtMy0xLTEtMjI1Mjcx_9aa0aae6-89b3-435a-ae9a-cf3848112a9e"
      unitRef="usd">0</us-gaap:InsuredEventGainLoss>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjMtMS0xLTEtMjI1Mjcx_67b3f4f0-3eec-46e9-bc1d-648985239de5"
      unitRef="usd">-1698000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjMtMy0xLTEtMjI1Mjcx_441e1499-9b94-4dc9-849b-0a2f1d6542ac"
      unitRef="usd">1593000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjUtMS0xLTEtMjI1Mjcx_f80a47f3-e910-46e5-b719-1c52be22abb6"
      unitRef="usd">19949000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjUtMy0xLTEtMjI1Mjcx_b619629d-e99e-4d83-b861-9e71c320fcbd"
      unitRef="usd">4144000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjYtMS0xLTEtMjI1Mjcx_24f7e956-d738-41b7-89a8-19ea525311ae"
      unitRef="usd">-15936000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjYtMy0xLTEtMjI1Mjcx_349ff5c6-b395-4eb2-baa5-ac67fbbebead"
      unitRef="usd">3653000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjctMS0xLTEtMjI1Mjcx_24732ca1-b033-4ea7-88f5-1931f7f0e36b"
      unitRef="usd">173921000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjctMy0xLTEtMjI1Mjcx_f857f275-973c-444e-8299-c7f5c7b6e951"
      unitRef="usd">194183000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOtherRealEstate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjktMS0xLTEtMjI1Mjcx_4c7fa6dc-ee4f-43e3-9bf7-afb3dc555d23"
      unitRef="usd">10219000</us-gaap:PaymentsToAcquireOtherRealEstate>
    <us-gaap:PaymentsToAcquireOtherRealEstate
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMjktMy0xLTEtMjI1Mjcx_37694280-ac20-4d66-a0cd-5472d9bc6bfd"
      unitRef="usd">134067000</us-gaap:PaymentsToAcquireOtherRealEstate>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzAtMS0xLTEtMjI1Mjcx_73626908-9f08-44b2-9022-88217db0b2b6"
      unitRef="usd">204889000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzAtMy0xLTEtMjI1Mjcx_40f5b0d1-533c-4ada-b5ae-9b8214dfcd2a"
      unitRef="usd">178285000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzEtMS0xLTEtMjI1Mjcx_43cb85db-4b7e-4a51-bc8c-b40eaffd62f3"
      unitRef="usd">22789000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzEtMy0xLTEtMjI1Mjcx_af5dff8c-9a8e-40ef-b639-881026c8c981"
      unitRef="usd">22839000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzItMS0xLTEtMjI1Mjcx_0b6ec83f-b2ff-4acf-bfce-2e510e8ee614"
      unitRef="usd">141559000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzItMy0xLTEtMjI1Mjcx_97d7634e-294b-4b83-9d22-352ea2da93c7"
      unitRef="usd">13265000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzUtMS0xLTEtMjI1Mjcx_d4fcaa14-b151-42d0-8b65-ad006e15cbd8"
      unitRef="usd">9640000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzUtMy0xLTEtMjI1Mjcx_eb15de26-5bbf-48ef-83ad-e1b1fe471afd"
      unitRef="usd">1486000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzYtMS0xLTEtMjI1Mjcx_26c77025-bb5e-464b-b7b1-df3535eeca08"
      unitRef="usd">3210000</peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures>
    <peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzYtMy0xLTEtMjI1Mjcx_62f12527-4de0-452d-9965-de7a3086d7b4"
      unitRef="usd">3875000</peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures>
    <us-gaap:ProceedsFromInsuranceSettlementInvestingActivities
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzctMS0xLTEtMjI1Mjcx_43197348-d9fc-4e4e-8eb4-fb7110a8e28b"
      unitRef="usd">2650000</us-gaap:ProceedsFromInsuranceSettlementInvestingActivities>
    <us-gaap:ProceedsFromInsuranceSettlementInvestingActivities
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfMzctMy0xLTEtMjI1Mjcx_12f58660-14ae-4a70-9584-8c9b60c240a3"
      unitRef="usd">0</us-gaap:ProceedsFromInsuranceSettlementInvestingActivities>
    <us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDItMS0xLTEtMjI1Mjcx_d53ff561-9c2a-4a2d-9d1d-4f4d69419ce6"
      unitRef="usd">158381000</us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment>
    <us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDItMy0xLTEtMjI1Mjcx_9f44ccd8-a0e6-4e87-8f10-b3be3f913b19"
      unitRef="usd">75435000</us-gaap:ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment>
    <peak:PaymentsToAcquireLoansReceivableAndOther
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDMtMS0xLTEtMjI1Mjcx_3c219e9c-ff3c-4263-a43c-6acbb3d0947d"
      unitRef="usd">1918000</peak:PaymentsToAcquireLoansReceivableAndOther>
    <peak:PaymentsToAcquireLoansReceivableAndOther
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDMtMy0xLTEtMjI1Mjcx_a79b0472-1df6-40bc-9c2a-99137a4cba4f"
      unitRef="usd">1860000</peak:PaymentsToAcquireLoansReceivableAndOther>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDUtMS0xLTEtMjI1Mjcx_a859dce4-da50-4b4c-9223-a21eb679f927"
      unitRef="usd">56345000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDUtMy0xLTEtMjI1Mjcx_4c062d30-8152-403b-9809-db626b4b7e57"
      unitRef="usd">-245962000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDctMS0xLTEtMjI1Mjcx_ec48bdc6-4231-49e6-80c7-4e53f0e02b05"
      unitRef="usd">3372255000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDctMy0xLTEtMjI1Mjcx_da6ced36-942e-4a69-a368-1acc968257fb"
      unitRef="usd">3732668000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDgtMS0xLTEtMjI1Mjcx_23581428-f15b-419b-ab94-abda714fe887"
      unitRef="usd">3811861000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDgtMy0xLTEtMjI1Mjcx_cb2d572e-e87c-4485-b66f-9b5684c450bb"
      unitRef="usd">3567830000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromBankDebt
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDktMS0xLTEtMjI1Mjcx_b93854d6-dcc3-4375-a615-8f98e43846b5"
      unitRef="usd">399532000</us-gaap:ProceedsFromBankDebt>
    <us-gaap:ProceedsFromBankDebt
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNDktMy0xLTEtMjI1Mjcx_2b581874-8079-4b86-82e0-d16192cca8e3"
      unitRef="usd">0</us-gaap:ProceedsFromBankDebt>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTAtMS0xLTEtMjI1Mjcx_713b6a5a-fec4-43ba-a476-cc4a83acd7ac"
      unitRef="usd">1325000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTAtMy0xLTEtMjI1Mjcx_38ce7a11-ba8b-4165-a89e-49145ea35f0a"
      unitRef="usd">1270000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTItMS0xLTEtMjI1Mjcx_c8926745-a969-4cc8-853e-df596ac26595"
      unitRef="usd">4175000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTItMy0xLTEtMjI1Mjcx_e6591b13-1675-4b7e-abc1-6d23f590d968"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTQtMS0xLTEtMjI1Mjcx_7856e035-4edd-46cb-8009-81b00490011b"
      unitRef="usd">-151000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTQtMy0xLTEtMjI1Mjcx_d38fce34-76bb-4848-8a63-79f8af6524cb"
      unitRef="usd">-4000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTUtMS0xLTEtMjI1Mjcx_e8f7cadf-8d2d-462c-b58a-253cc21490e6"
      unitRef="usd">6467000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTUtMy0xLTEtMjI1Mjcx_8e7221e9-f03b-489e-a5a3-b7725eeb899c"
      unitRef="usd">11352000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTYtMS0xLTEtMjI1Mjcx_854d80a0-e3c2-4fc1-9198-954b3b4ad5fe"
      unitRef="usd">164976000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTYtMy0xLTEtMjI1Mjcx_b85b01f0-3006-405a-9668-22a875b29763"
      unitRef="usd">163447000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTgtMS0xLTEtMjI1Mjcx_d24b8c82-c644-4c6e-b45a-6ec5ccffd19c"
      unitRef="usd">22803000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTgtMy0xLTEtMjI1Mjcx_0053e2f6-0a6c-47ec-a189-6cb22efcb383"
      unitRef="usd">7509000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTktMS0xLTEtMjI1Mjcx_7f1f5986-fe55-4bd7-866d-8b8634b9943e"
      unitRef="usd">96000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNTktMy0xLTEtMjI1Mjcx_390643ad-44ac-4d33-9c38-3a358ce02caa"
      unitRef="usd">233000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjAtMS0xLTEtMjI1Mjcx_c83510f0-bdb6-4a86-be05-eabafd19faf5"
      unitRef="usd">-239875000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjAtMy0xLTEtMjI1Mjcx_f144ab81-ce5d-451e-8879-87be6f317e69"
      unitRef="usd">-18511000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjItMS0xLTEtMjI1Mjcx_94f9b077-fe4a-419e-bba6-234cfd7cecf6"
      unitRef="usd">-9609000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjItMy0xLTEtMjI1Mjcx_2ba9a931-61ab-46c2-ad13-e340389be6a0"
      unitRef="usd">-70290000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjMtMS0xLTEtMjI1Mjcx_cf28982f-d2aa-4335-9279-6ded1d1d453f"
      unitRef="usd">126834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjMtMy0xLTEtMjI1Mjcx_5f6fbadb-273c-4602-a85a-10a079259f07"
      unitRef="usd">219448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjQtMS0xLTEtMjI1Mjcx_659adb6e-529b-4cdb-89a3-b1e78dc7d7a7"
      unitRef="usd">117225000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8yOC9mcmFnOjk2NmY3MTQ0YmNiYjQzYmQ5YTY1MmI5NjdkYzM5NDk1L3RhYmxlOjM0NjRkMDc5MGM2ZDRhMTdhZmUwY2FhMjgxY2NmNmViL3RhYmxlcmFuZ2U6MzQ2NGQwNzkwYzZkNGExN2FmZTBjYWEyODFjY2Y2ZWJfNjQtMy0xLTEtMjI1Mjcx_2e942a02-5948-4b2a-ac5a-574b6e6c1282"
      unitRef="usd">149158000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:NatureOfOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNC9mcmFnOmY4M2RiOTM3Y2RiZTQwZWM5OGNmY2JiNzg4MWE1YzBkL3RleHRyZWdpb246ZjgzZGI5MzdjZGJlNDBlYzk4Y2ZjYmI3ODgxYTVjMGRfODA5_2eee722d-0668-4164-9e5e-2bbcbcb99887">Business&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthpeak Properties, Inc., a Standard&#160;&amp;amp; Poor&#x2019;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#x201c;REIT&#x201d;) that, together with its consolidated entities (collectively, &#x201c;Healthpeak&#x201d; or the &#x201c;Company&#x201d;), invests primarily in real estate serving the healthcare industry in the United States (&#x201c;U.S.&#x201d;). Healthpeak&#xae; acquires, develops, owns, leases, and manages healthcare real estate. The Company&#x2019;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#x201c;CCRC&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters are in Denver, Colorado, and it has additional offices in California, Tennessee, and Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2023, Healthpeak Properties, Inc. announced its intent to complete an UPREIT reorganization. As part of the reorganization, the company formerly known as Healthpeak Properties, Inc. (&#x201c;Old Healthpeak&#x201d;) formed New Healthpeak, Inc. (&#x201c;New Healthpeak&#x201d;) as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc. (&#x201c;Merger Sub&#x201d;) as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the &#x201c;Merger&#x201d;). In connection with the Merger, New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the UPREIT reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (&#x201c;Healthpeak OP&#x201d;). Following the UPREIT reorganization, New Healthpeak&#x2019;s business is conducted through Healthpeak OP and New Healthpeak does not have material assets or liabilities, other than through its investment in Healthpeak OP. This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023, for the quarter ended March 31, 2023. For additional information on the UPREIT reorganization, see the Company&#x2019;s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) on February 10, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQwMQ_6add30f1-cfac-407d-9452-cf82f1f31491">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#x201c;JVs&#x201d;), and variable interest entities (&#x201c;VIEs&#x201d;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Government Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) to provide financial aid to individuals, businesses, and state and local governments.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the coronavirus pandemic. Grant income is recognized to the extent that qualifying expenses and lost revenues exceed grants received and the Company will comply with all conditions attached to the grant. As of March&#160;31, 2023, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information related to government grant income received and recognized by the Company (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total government grants received&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company concluded that the dispositions of its senior housing triple-net and Senior Housing Operating Property (&#x201c;SHOP&#x201d;) portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-10&#x201d;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#x2019;s accounting for assistance, and the effect of the assistance on an entity&#x2019;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Scope &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-01&#x201d;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. In December 2022, the FASB issued ASU No. 2022-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2022-06&#x201d;), which defers the sunset date of the reference rate reform guidance to December 31, 2024. The amendments in ASU 2020-04, ASU 2021-01, and ASU 2022-06 were effective immediately upon issuance. In 2022, the Company elected to apply certain hedge accounting expedients provided by ASU 2020-04 and ASU 2021-01, which preserves the hedging relationship of derivatives. During the first quarter of 2023, the Company amended certain of its variable rate mortgage debt and the related interest rate swap agreements to change the interest rate benchmark from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). The Company elected to apply certain practical expedients provided by ASU 2020-04 and ASU 2021-01 related to cash flow hedges, which did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures. The expedients provided by ASU 2020-04, ASU 2021-01, and ASU 2022-06 and the effects of reference rate reform have not had, and are not expected to have, a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxMg_f1a4b173-2160-4220-b4e7-2f6f34dc92a0">&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#x201c;JVs&#x201d;), and variable interest entities (&#x201c;VIEs&#x201d;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <peak:GovernmentGrantIncomePolicyPolicyTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQyMA_79ffc74b-6a51-4816-985b-f57d64a35c69">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Government Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) to provide financial aid to individuals, businesses, and state and local governments.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the coronavirus pandemic. Grant income is recognized to the extent that qualifying expenses and lost revenues exceed grants received and the Company will comply with all conditions attached to the grant. As of March&#160;31, 2023, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.&lt;/span&gt;&lt;/div&gt;</peak:GovernmentGrantIncomePolicyPolicyTextBlock>
    <peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxNA_ff79e854-2ca8-4735-a8cb-27db63b6119e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information related to government grant income received and recognized by the Company (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.147%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total government grants received&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock>
    <peak:GovernmentGrantIncome
      contextRef="ic773135133e649b9a40e6c2ae0098c47_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMi0xLTEtMS0yMjUyNzE_e577d6f9-3b00-4fe5-99f4-8b723a9b409a"
      unitRef="usd">137000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i3673bf0bac0c46438f86bb54a2b7a090_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMi0zLTEtMS0yMjUyNzE_678bb475-51be-4648-8c13-1a4b01509bbd"
      unitRef="usd">6552000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="ife363d16c20b4fb4829cc5fa5e166ebd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMy0xLTEtMS0yMjUyNzE_1432a52b-4ae7-427e-b8f4-1222a4ed4509"
      unitRef="usd">228000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i04bb152d3876442882602d59cb9257bd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfMy0zLTEtMS0yMjUyNzE_4b453242-b925-48fd-ac11-bf2ee97875c6"
      unitRef="usd">648000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i7d70f4026c6041ec8a4ea17cbea56b52_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNC0xLTEtMS0yMjUyNzE_8992cd59-54b5-42d8-80be-d062ccac49ac"
      unitRef="usd">0</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i1c2dda1ede5c4d58a46ce9579d6b92e2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNC0zLTEtMS0yMjUyNzE_495f6570-65b3-448c-bec7-c0bfcbfd68a7"
      unitRef="usd">206000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNS0xLTEtMS0yMjUyNzE_3236fa4d-9ada-450d-a3cc-e9203860941f"
      unitRef="usd">365000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="ibc1bf5123a8b41479133b782e5100a18_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RhYmxlOjU2NmVmZDVmMDhkYTQzZDI5NGRmNTgxNjljOTcyYmM5L3RhYmxlcmFuZ2U6NTY2ZWZkNWYwOGRhNDNkMjk0ZGY1ODE2OWM5NzJiYzlfNS0zLTEtMS0yMjUyNzE_ab87b33c-019d-4def-822e-0003a4ef25bb"
      unitRef="usd">7406000</peak:GovernmentGrantIncome>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQwNw_cd64c234-1b60-4cd7-bf69-358dc4991ccb">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company concluded that the dispositions of its senior housing triple-net and Senior Housing Operating Property (&#x201c;SHOP&#x201d;) portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein. See Note 4 for further information.&lt;/span&gt;&lt;/div&gt;</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8zNy9mcmFnOmE5NDA1YmMwN2ViZDQ4ZTI5ODFmOGIwNjgwNjRiNjJhL3RleHRyZWdpb246YTk0MDViYzA3ZWJkNDhlMjk4MWY4YjA2ODA2NGI2MmFfNTQxNg_2b89a0a2-7538-4e71-9eab-4bf7c55b9628">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-10&#x201d;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#x2019;s accounting for assistance, and the effect of the assistance on an entity&#x2019;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Scope &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-01&#x201d;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. In December 2022, the FASB issued ASU No. 2022-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2022-06&#x201d;), which defers the sunset date of the reference rate reform guidance to December 31, 2024. The amendments in ASU 2020-04, ASU 2021-01, and ASU 2022-06 were effective immediately upon issuance. In 2022, the Company elected to apply certain hedge accounting expedients provided by ASU 2020-04 and ASU 2021-01, which preserves the hedging relationship of derivatives. During the first quarter of 2023, the Company amended certain of its variable rate mortgage debt and the related interest rate swap agreements to change the interest rate benchmark from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). The Company elected to apply certain practical expedients provided by ASU 2020-04 and ASU 2021-01 related to cash flow hedges, which did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures. The expedients provided by ASU 2020-04, ASU 2021-01, and ASU 2022-06 and the effects of reference rate reform have not had, and are not expected to have, a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RealEstateDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTgwNA_b0a27306-8a31-4dc6-8151-4cee2f3ec7bf">Real Estate&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023 Real Estate Investment Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, the Company closed a life science acquisition in Cambridge, Massachusetts for $9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022 Real Estate Investment Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;67 Smith Place&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $72&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vista Sorrento Phase II&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company closed a life science acquisition in San Diego, California for $24&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Webster MOB Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company acquired a portfolio of two medical office buildings (&#x201c;MOBs&#x201d;) in Houston, Texas for $43&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Northwest Medical Plaza&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company acquired one MOB in Bentonville, Arkansas for $26&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concord Avenue Land Parcels&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $18&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Development Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s commitments, which are primarily related to development and redevelopment projects and Company-owned tenant improvements,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;decreased by $35 million, to $217 million at March&#160;31, 2023, when compared to December&#160;31, 2022, primarily as a result of construction spend on existing projects in the first quarter of 2023, thereby decreasing the remaining commitment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RealEstateDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i118359ae91b74e62812988bfeaa797c8_D20230101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3NDMxOQ_9dec6e02-247f-4413-b693-dec52a902481"
      unitRef="usd">9000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i9f045cefde3045ae8996ee15bbb51550_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3Mjc4Mw_7739cc51-35fd-46bd-b502-462559b5f093"
      unitRef="usd">72000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i1ffe53bede314b11a85ecb20ec8a6694_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MjkwNA_585ba115-f7f2-4d7f-ba5a-c21f41549147"
      unitRef="usd">24000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3Mjk4Mg_f19885a0-1e3b-4532-8758-f1cffbbd4e36"
      unitRef="property">2</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="ifec10acfde894d95b69deee49b783b2b_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzA0Mg_522e3b2c-e7c4-44eb-b63b-22fa1a1a7c8b"
      unitRef="usd">43000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzEwNQ_57175f56-2a3c-4e0b-ba95-668e854b65fa"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i8f96108dfe4b40388aff104c1f088d09_D20220501-20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3MzE0Mg_60b59116-2933-4c54-84bf-27d9a3c65cf4"
      unitRef="usd">26000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i0492c2ebf6054f6ebe312755f471116e_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMjc0ODc3OTA3NDM0Mw_541c14f3-5bd3-4c79-9ec7-1a043bd37d37"
      unitRef="usd">18000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTYxNg_c511d12e-bb18-40ce-83d3-366ecd1f7e82"
      unitRef="usd">-35000000</peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease>
    <peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80MC9mcmFnOjIyYWU4OWY0MDBiYTQwYzViZjQ3MmQxNWMxNGE2ZTVlL3RleHRyZWdpb246MjJhZTg5ZjQwMGJhNDBjNWJmNDcyZDE1YzE0YTZlNWVfMTYyMw_92bf5456-08dd-4dc8-b924-78049418ed46"
      unitRef="usd">217000000</peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMTAxMzI_21d7d2e8-626b-4dd3-ab0d-2c1c88b7a5be">Dispositions of Real Estate and Discontinued Operations&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023 Dispositions of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, the Company sold two life science facilities in Durham, North Carolina, which were classified as held for sale as of December 31, 2022, for $113&#160;million, resulting in total gain on sales of $60&#160;million. Additionally, in March 2023, the Company sold two MOBs for $32&#160;million, resulting in total gain on sales of $21&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022 Dispositions of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2022, the Company sold one life science facility in Salt Lake City, Utah for $14&#160;million, resulting in a gain on sale of $4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2022, the Company sold three&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MOBs and one MOB land parcel for $27&#160;million, resulting in total gain on sales of $10&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September 30, 2022, the Company sold two MOBs for $9&#160;million, resulting in total gain on sales of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale and Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company concluded that the dispositions of its senior housing triple-net and SHOP portfolios represented a strategic shift that had a major effect on its operations and financial results. Therefore, senior housing triple-net and SHOP assets are classified as discontinued operations in all periods presented herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each of March&#160;31, 2023 and December&#160;31, 2022, the total assets and total liabilities classified as discontinued operations were zero. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, no assets were classified as held for sale. As of December&#160;31, 2022, two life science assets were classified as held for sale, with an aggregate carrying value of $50 million, primarily comprised of net real estate assets of $44&#160;million. As of December&#160;31, 2022, liabilities related to these assets held for sale were $4 million. These two life science assets were sold in January 2023, as discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of discontinued operations during the three months ended March&#160;31, 2023 and 2022 are presented below (in thousands) and are included in the consolidated results of operations for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Resident fees and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairments of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company did not recognize any impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Losses&lt;/span&gt;&lt;/div&gt;During the three months ended March&#160;31, 2022, the Company recognized $14&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with the demolition of an MOB.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <peak:NumberOfPropertiesSold
      contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQzOQ_c84929dc-e412-40ba-9512-3a6edddb3595"
      unitRef="property">2</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQyMQ_99256953-9de5-459c-b4b7-663b41ff3e90"
      unitRef="usd">113000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i465f267d1ffc4fee932a9d98034f7846_D20230101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDQ5MQ_20c115db-d2af-4144-8252-57d5a75f0f98"
      unitRef="usd">60000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesSold
      contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyNzQ0_ace52b72-d89e-4015-8e95-ef5d83547a99"
      unitRef="property">2</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyNzc1_8e06820f-c96d-4446-9010-eced0ea41998"
      unitRef="usd">32000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="if62c1de184f94d6a8ac73126b23129dd_D20230301-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMyODQ1_ec77d8f6-c66a-42be-a824-7793124bd24f"
      unitRef="usd">21000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesSold
      contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4MzkxMw_f40b4041-8096-4e68-9a2b-550789669f2c"
      unitRef="property">1</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4Mzk2Nw_c09a8004-5d17-4610-b540-0ebef9b3daed"
      unitRef="usd">14000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i44e261bd07684db7946bf96652492c6f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDAwMw_27d2b403-ce94-47ca-8d94-71a66e250406"
      unitRef="usd">4000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesSold
      contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDA3MA_2dee4c00-7f91-4be4-aec0-563780f3a988"
      unitRef="property">3</peak:NumberOfPropertiesSold>
    <peak:NumberOfPropertiesSold
      contextRef="i58508407aa974ce7ae2dd7d111863709_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDA4Mw_c6478bfb-fdb6-4915-b113-28933fa807e2"
      unitRef="property">1</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDEwNw_aee72390-d7e0-4d5b-b80d-80465c42a217"
      unitRef="usd">27000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ibec574f2ed344cb59a1a8687a147b854_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE0OA_ff77ed76-e884-490b-b1b9-8c70d7fcbcbd"
      unitRef="usd">10000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesSold
      contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE4NA_8c79962f-2e76-4c4f-af02-61355da1e01b"
      unitRef="property">2</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDE5Nw_7e47854c-31a8-4f03-a320-4778045195c9"
      unitRef="usd">9000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i5093d9bbb5b8475cbdf48f844c96b513_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMjc0ODc3OTA4NDIzOA_1c3db944-f67d-49de-ac69-e9ccfcf06080"
      unitRef="usd">1000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODM0MDgx_1ca392c3-06e7-4384-8e3a-a06305b30cfa"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ifa2335d07c3144528793163232dd5d77_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODM0MDgx_5efef725-78e1-4f92-ae14-3464c4ce86dc"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i04f86893d4664360ad004f5222f209e3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTU5Nw_7069713c-62ee-45bb-ba59-6e5192cae5ce"
      unitRef="property">0</peak:PropertiesHeldForSaleNumber>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTcwNA_c411ab34-92c1-4741-84f6-36ed50b9ccb1"
      unitRef="property">2</peak:PropertiesHeldForSaleNumber>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup
      contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMzOTE1_913718c3-73b2-4c06-995c-b993488aafa4"
      unitRef="usd">50000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
    <peak:NetRealEstateAssets
      contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTc3OA_53722484-3cb7-4c72-99f5-67c537a5db1e"
      unitRef="usd">44000000</peak:NetRealEstateAssets>
    <us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale
      contextRef="i20b93e6524fd44e6ac71b8975be978f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODMzOTc1_b3412b9f-4082-424a-9030-bd37a1031d69"
      unitRef="usd">4000000</us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i868c4fb89cf748b39a591564a160cb85_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNTQ5NzU1ODQ2MTI0_c411ab34-92c1-4741-84f6-36ed50b9ccb1"
      unitRef="property">2</peak:PropertiesHeldForSaleNumber>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfMTAxMzQ_0bebb11a-821a-4d18-a764-8e1e7a15b1e5">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of discontinued operations during the three months ended March&#160;31, 2023 and 2022 are presented below (in thousands) and are included in the consolidated results of operations for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Resident fees and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNC0xLTEtMS0yMjUyNzE_e340e699-66a3-4a3b-9bc8-df9fec981330"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices>
    <peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNC0zLTEtMS0yMjUyNzE_877a8f00-ae5f-46bd-9c5e-50e40207706c"
      unitRef="usd">2655000</peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNi0xLTEtMS0yMjUyNzE_124849d6-001a-4f88-b7b7-0c7631d26e52"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfNi0zLTEtMS0yMjUyNzE_828f8f57-80aa-4443-921c-98d0bc1aa0a6"
      unitRef="usd">2655000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTAtMS0xLTEtMjI1Mjcx_09e039f8-1b82-4480-bd08-cd83ed912ec9"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTAtMy0xLTEtMjI1Mjcx_0e1d784b-8f2d-4f54-b014-08197053258e"
      unitRef="usd">2674000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTMtMS0xLTEtMjI1Mjcx_410ae0ac-2e87-4d9d-b5b3-22ddce7436cc"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses>
    <peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTMtMy0xLTEtMjI1Mjcx_38101a48-ae3d-4ded-831d-fb998c900eec"
      unitRef="usd">2674000</peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTUtMS0xLTEtMjI1Mjcx_7f836615-e8ca-4716-9c07-fa1c4857cfef"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTUtMy0xLTEtMjI1Mjcx_a50eb84f-ee13-4f47-8624-70c02b78d572"
      unitRef="usd">-71000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTYtMS0xLTEtMjI1Mjcx_388d618e-ca48-4252-b8c8-21eb9207f2bd"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTYtMy0xLTEtMjI1Mjcx_1a930d15-5010-494c-87b0-894e6856fb2b"
      unitRef="usd">3000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherIncome>
    <peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTctMS0xLTEtMjI1Mjcx_ef345d78-74f7-40b9-a62f-64e3382b1e74"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTctMy0xLTEtMjI1Mjcx_5a580e7f-6153-4274-9e9d-8990905f690b"
      unitRef="usd">-68000</peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTgtMS0xLTEtMjI1Mjcx_8a966a69-f84e-405e-a063-158c9607f717"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTgtMy0xLTEtMjI1Mjcx_baa3c241-c212-48e0-b913-c609d04ac36d"
      unitRef="usd">-87000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTktMS0xLTEtMjI1Mjcx_da1f2ace-9dad-4ca5-865b-5f8e3519d4b2"
      unitRef="usd">0</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMTktMy0xLTEtMjI1Mjcx_1b5af142-a511-4675-9791-485605830e45"
      unitRef="usd">-340000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjAtMS0xLTEtMjI1Mjcx_b53fc512-b4a8-4738-90c0-e4584744ed39"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjAtMy0xLTEtMjI1Mjcx_563dcd9c-00ce-4ef3-8048-d7f8474e98b8"
      unitRef="usd">64000</peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjItMS0xLTEtMjI1Mjcx_9c0c9e78-bedb-43bf-931d-a8fc964a8676"
      unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="i732bf40417604c41a5b9edca391f79e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RhYmxlOjM4YmY5NWNkMzEzNzQ0Yjk5ZDhmZmYyOGFlMWY2YjhjL3RhYmxlcmFuZ2U6MzhiZjk1Y2QzMTM3NDRiOTlkOGZmZjI4YWUxZjZiOGNfMjItMy0xLTEtMjI1Mjcx_b869c216-8976-4ef5-86ae-828223a37dee"
      unitRef="usd">317000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNjIxNQ_9c4fb100-25a6-45d2-9aaa-457ed63384a3"
      unitRef="usd">0</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfNjIxNQ_efef889b-aa4c-4d32-90ce-3ea7264de75c"
      unitRef="usd">0</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:OtherNonrecurringExpense
      contextRef="i864dd3fa811448b2b9b318a07f46f343_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80My9mcmFnOjVkZTQ5OTI5YTg2MDQ2NTNhZGZiMTg1ODJlNGEzZTcxL3RleHRyZWdpb246NWRlNDk5MjlhODYwNDY1M2FkZmIxODU4MmU0YTNlNzFfOTkwNw_82638189-578d-47f7-9ec3-9ad01da38748"
      unitRef="usd">14000000</us-gaap:OtherNonrecurringExpense>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzIz_ecd5685d-51e3-4ac0-b82f-acbf77a81f56">Leases&lt;div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Direct Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Direct Financing Lease Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#x201c;DFL&#x201d;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Straight-Line Rents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzMz_1dd10f19-6040-4137-9a5d-9e6a87ec1e57">Leases&lt;div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Direct Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Direct Financing Lease Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#x201c;DFL&#x201d;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Straight-Line Rents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorDirectFinancingLeasesTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzMz_9116cae5-6511-4b07-a428-bc47032bb653">Leases&lt;div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Direct Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Direct Financing Lease Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company sold its remaining hospital under a direct financing lease (&#x201c;DFL&#x201d;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. Therefore, at March&#160;31, 2023 and December&#160;31, 2022, the Company had no leases classified as a DFL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Straight-Line Rents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight-line basis over the lease term when collectibility of future minimum lease payments is probable. If the Company determines that collectibility of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period and future revenue recognition is limited to amounts contractually owed and paid. The Company does not resume recognition of income on a straight-line basis unless it determines that collectibility of future payments related to these leases is probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company wrote off $9&#160;million of straight-line rent receivable associated with Sorrento Therapeutics, Inc., which commenced voluntary reorganization proceedings under Chapter 11 of the U.S. Bankruptcy Code during the period. This write-off was recognized as a reduction in rental and related revenues on the Consolidated Statements of Operations and future revenue related to this tenant will be recognized on a cash basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorDirectFinancingLeasesTextBlock>
    <us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNzE3_7196b91f-7edf-41e5-be37-8fce40c645c5">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNS0xLTEtMS0yMjUyNzE_c107204a-b4d3-445d-895c-062af9b78008"
      unitRef="usd">296217000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNS0zLTEtMS0yMjUyNzE_8dcd9a1b-af16-45e9-9180-07cd42990ef9"
      unitRef="usd">287292000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseVariableLeaseIncome
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNi0xLTEtMS0yMjUyNzE_76b3984e-828c-44d6-930a-5a0cc31d00f0"
      unitRef="usd">96214000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:OperatingLeaseVariableLeaseIncome
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNi0zLTEtMS0yMjUyNzE_0cf4075b-d84a-46d2-b1c8-19dc175c20f2"
      unitRef="usd">82858000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:DirectFinancingLeaseInterestIncome
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNy0xLTEtMS0yMjUyNzE_c9ac7e82-ce09-408a-9b79-8168e0545677"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseInterestIncome>
    <us-gaap:DirectFinancingLeaseInterestIncome
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RhYmxlOjkwNGQzOGQ4ZmQ3ZjQ4NzJiNmFkMmMzZGUyM2MyNjVjL3RhYmxlcmFuZ2U6OTA0ZDM4ZDhmZDdmNDg3MmI2YWQyYzNkZTIzYzI2NWNfNy0zLTEtMS0yMjUyNzE_85417c78-cfc5-49d1-bc14-11c96fd84cc1"
      unitRef="usd">1168000</us-gaap:DirectFinancingLeaseInterestIncome>
    <us-gaap:ProceedsFromSaleOfLeaseReceivables
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfMzMx_9c723548-a524-4405-9429-145cf119be34"
      unitRef="usd">68000000</us-gaap:ProceedsFromSaleOfLeaseReceivables>
    <us-gaap:GainLossOnSaleOfNotesReceivable
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfMzY3_dfec7c51-c478-410e-955f-f24db0a66855"
      unitRef="usd">23000000</us-gaap:GainLossOnSaleOfNotesReceivable>
    <peak:PropertiesWithDirectFinancingLeasesNumber
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE0OTYy_0ebb2b35-2660-4e20-b331-ff22f00730c0"
      unitRef="property">0</peak:PropertiesWithDirectFinancingLeasesNumber>
    <peak:PropertiesWithDirectFinancingLeasesNumber
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE0OTYy_4870fdcc-bcd6-44f1-91de-265ea315b3f3"
      unitRef="property">0</peak:PropertiesWithDirectFinancingLeasesNumber>
    <us-gaap:StraightLineRent
      contextRef="i3a54d5ef01f84069a21614fb6b5703d5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80Ni9mcmFnOjg0OWJmNWU5ODBiMjRhMDFiZjQ3N2VjMTg0YmQyMzM3L3RleHRyZWdpb246ODQ5YmY1ZTk4MGIyNGEwMWJmNDc3ZWMxODRiZDIzMzdfNTQ5NzU1ODE3MzQz_d97bef1e-c75d-4635-babc-641c01c06a7a"
      unitRef="usd">9000000</us-gaap:StraightLineRent>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODk5NQ_a08f0cce-23e8-4436-b3a4-10a327c79156">Loans Receivable&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s loans receivable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts, fees, and costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$40 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sunrise Senior Housing Portfolio Seller Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the sale of 32 SHOP facilities for $664&#160;million in January 2021, the Company provided the buyer with initial financing of $410&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $92&#160;million of additional financing for capital expenditures (up to 65% of the estimated cost of capital expenditures). As of March&#160;31, 2023, the additional financing was reduced to $40&#160;million, of which $0.4 million had been funded. The initial and additional financing is secured by the buyer&#x2019;s equity ownership in each property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2022, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;July 2022, and December 2022, the Company received principal repayments of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$246&#160;million, $8&#160;million, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$27&#160;million, and $10&#160;million, respectively, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in conjunction with the disposition of the underlying collateral. At each of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2023 and December&#160;31, 2022, this secured loan had an outstanding principal balance of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$120&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Seller Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the sale of 16 additional SHOP facilities for $230&#160;million in January 2021, the Company provided the buyer with financing of $150&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer&#x2019;s equity ownership in each property. Upon maturity in January 2023, the borrower did not make the required principal repayment. In February 2023, the borrower made a partial principal repayment of $102&#160;million and the remaining balance owed was refinanced with the Company. In connection with the refinance, the maturity date of the loan was extended to January 2024 and the interest rate on the loan was increased to a variable rate based on Term SOFR (plus an 11 basis point adjustment related to SOFR transition) plus 6.0% for the first six months of the extended term, increasing to 7.0% for the last six months of the extended term. The Company also received a $1&#160;million extension fee in connection with the refinance, which is recognized in interest income over the remaining term of the loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Other Loans Receivable Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Company received full repayment of the outstanding balance of one $35&#160;million secured loan. In April 2023, the Company received full repayment of the outstanding balance of one $14&#160;million secured loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Other Loans Receivable Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company received full repayment of the outstanding balance of a $2&#160;million secured loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, the Company received full repayment of the outstanding balance of a $1&#160;million mezzanine loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company extended the maturity dates of four secured loans with an aggregate outstanding balance of $61&#160;million, originally scheduled to mature in December 2022, by one year to December 2023. In connection with the extensions, the interest rates on the loans were increased to a variable rate based on Term SOFR (plus an 11 basis point adjustment related to SOFR transition) with a floor of 8.5% for the first six months of the extended term, increasing to a floor of 10.5% for the last six months of the extended term. Two of these secured loans were repaid during 2023 as discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CCRC Resident Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2023 and December&#160;31, 2022, the Company held&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$36 million and $33&#160;million, respectively, of such notes receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loans Receivable Internal Ratings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by year of origination, the Company&#x2019;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period gross write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period net write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period gross write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period net write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserve for Loan Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#x2019;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s reserve for loan losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected loan losses (recoveries) related to loans sold or repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes CCRC resident loans and other loan activity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, at March&#160;31, 2023 and December&#160;31, 2022, a liability of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.7 million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $0.8 million, respectively, related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the reserve for expected loan losses during the three months ended March&#160;31, 2023 is primarily due to principal repayments on seller financing, partially offset by increased interest rates on variable rate loans.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODk5Ng_bb376797-35db-436e-9ab0-9a22c23e5649">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s loans receivable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts, fees, and costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(808)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$40 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.&lt;/span&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i35fc9183f82c46689dc6c8c571bb0698_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMS0xLTEtMS0yMjUyNzE_50edf758-ec2b-4941-bb57-db4aebbbcb88"
      unitRef="usd">214238000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMS0zLTEtMS0yMjUyNzE_640af170-d2f9-4839-8ef9-db64a21386d1"
      unitRef="usd">350837000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i3251deb01d7f43a6b36fce8fe3b868bb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMi0xLTEtMS0yMjUyNzE_0ecb0c36-14a8-483d-98ea-98d5293ca684"
      unitRef="usd">36470000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i299419585a7445608813f122905f9277_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMi0zLTEtMS0yMjUyNzE_a57f38b1-0d64-452a-ae75-d363c53512b6"
      unitRef="usd">33083000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMy0xLTEtMS0yMjUyNzE_a0ef4cef-2181-4b8a-aa72-e10dd45aff60"
      unitRef="usd">-1407000</us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount>
    <us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfMy0zLTEtMS0yMjUyNzE_f18a57d4-afa9-48da-bb91-cfd51e0b527f"
      unitRef="usd">-808000</us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNC0xLTEtMS0yMjUyNzE_9b7891d4-bc30-4809-8f60-72a4af19a302"
      unitRef="usd">6152000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNC0zLTEtMS0yMjUyNzE_c49410e7-edf2-42f9-9608-88362a176d3c"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNS0xLTEtMS0yMjUyNzE_c5ae9056-510e-4680-b701-adc218dfd94f"
      unitRef="usd">243149000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjY3OTQ2YTcxMDIzNDQ1MDI4MDY1NzI1M2ZmNDgxZTUxL3RhYmxlcmFuZ2U6Njc5NDZhNzEwMjM0NDUwMjgwNjU3MjUzZmY0ODFlNTFfNS0zLTEtMS0yMjUyNzE_e9d0659f-7062-4efe-a374-e5f5eb45b803"
      unitRef="usd">374832000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <peak:LoansAndLeasesReceivableRemainingCommitments
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTky_1c39f3ce-5872-42b6-b248-10da1e40091e"
      unitRef="usd">40000000</peak:LoansAndLeasesReceivableRemainingCommitments>
    <peak:LoansAndLeasesReceivableRemainingCommitments
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTky_e0298e19-72a5-4a30-8fbd-8fe247a9fd3d"
      unitRef="usd">40000000</peak:LoansAndLeasesReceivableRemainingCommitments>
    <peak:NumberOfPropertiesToBeSold
      contextRef="if29b037c8ce04a23a923956f784473ee_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMzgy_16334b02-dc7e-4800-bcc3-8bbd873a7be8"
      unitRef="facility">32</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="if29b037c8ce04a23a923956f784473ee_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNDQ1_e9833000-75f5-456c-bbb6-b2dddcedc0c5"
      unitRef="usd">664000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTM2_e74590f4-f4d6-4515-aa02-db03e414131c"
      unitRef="usd">410000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="i66bbac8b2af54853a0c713a21e2b2748_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNjY1_4af7b793-ce95-437a-ab68-aa16f81a660c"
      unitRef="usd">92000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted
      contextRef="i4ec94601e6824a438f9ff0bea83f0c4c_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzI0_8fbd9ad3-6f79-4f3b-93f0-6b98e0ba6e0d"
      unitRef="number">0.65</peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODI4_d26a6de2-ac33-4bd5-87f8-785ec329a244"
      unitRef="usd">40000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountFunded
      contextRef="i060bdbdbb3ff482aab38e55a777bdf6a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTYw_5dc73415-9aab-4d62-b811-a20b6119a0f4"
      unitRef="usd">400000</peak:CapitalExpenditureFundingAmountFunded>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="icf2528dacab94d72ab3e440848edce92_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTE2NQ_040581e6-763d-4922-acfe-e6ab18712afe"
      unitRef="usd">246000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="ibc764c876dea4bdf9388495cb2847238_D20220201-20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODIzNjI1_8bc043f8-cb28-49c4-aac0-f6e19fc611d3"
      unitRef="usd">8000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="iab5284915b80459fb6366e3a5528172e_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODIzNjMz_a4c4d3db-65ca-4ddb-834b-f68de7db9e8b"
      unitRef="usd">27000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i4e598ee158714864ac7ec8e1b7c6c04e_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI0MDQ5_2d3d1813-f00d-44b1-83cb-4191bd57b1c7"
      unitRef="usd">10000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ifc7401311f5444a7a6418fa19740da6b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTczOA_f36031ce-52dc-4247-be35-23f3352e89d3"
      unitRef="usd">120000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ic385c6dfa277429bad7b41a2a38a66fe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTczOA_f4e4329d-3a85-4074-88eb-262e9835c6f3"
      unitRef="usd">120000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <peak:NumberOfPropertiesToBeSold
      contextRef="ib206c24e874f495eb33a7ef79724c812_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTc5Ng_e5c0d8f8-7820-4d36-b04a-3a49de63ba2b"
      unitRef="facility">16</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTgzMA_4ea907a4-5b63-4adc-a753-1aa0769bb2d4"
      unitRef="usd">230000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i13bf5e92c8e14efeac5486ac5ced282e_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMTkxMw_242f479a-d9c3-4083-9c6d-ce9bf00f1ae3"
      unitRef="usd">150000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="ie95535d107b84adab248bbffe4d73975_D20230201-20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMyMDA1_40ca78ba-9484-45db-8580-9861be5e704a"
      unitRef="usd">102000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="i1a002d72b97442b5b2b389ad5a9d16ce_I20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5MDI4_e9e76c35-05ad-4d9f-88a0-22060af5b290"
      unitRef="number">0.0011</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="ibaa149a31fb1486581279cc115c490b8_I20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzE0NjgyNTU5OTUzNQ_0b38a3f3-7180-4fdc-a2ec-d5a5ff3d149b"
      unitRef="number">0.060</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="i03330e2036c04219b1af6523e1deca30_I20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMyMzMw_fd43cd6e-45cb-4aa4-b883-1d26051e9169"
      unitRef="number">0.070</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <peak:LoansReceivableExtensionFee
      contextRef="i9a09c60ade2547478c8bde3119807cfa_D20230201-20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5MTg4_5099698f-4b46-40cf-8b00-79189ac9e987"
      unitRef="usd">1000000</peak:LoansReceivableExtensionFee>
    <peak:NumberOfSecuredLoans
      contextRef="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMwNjgw_84a540f6-ea5f-4860-aa92-44cac78f4f88"
      unitRef="loan">1</peak:NumberOfSecuredLoans>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="id0daf4feaadc4e0a819fd11c78d1396a_D20230201-20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzI5_0bdac292-90a5-45fa-b042-7484184c0604"
      unitRef="usd">35000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <peak:NumberOfSecuredLoans
      contextRef="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODMwNzEx_caffb69f-93c7-48b6-81c0-21896b9b4a5f"
      unitRef="loan">1</peak:NumberOfSecuredLoans>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i64802c224c3740c2b941586bdafec7c6_D20230401-20230430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzQ2_446d4909-711a-496a-ae4c-8bfdeb693c7d"
      unitRef="usd">14000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i292c0d5f96754ad2a296029a917f95b0_D20220501-20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfMzI0OQ_7ead0f1a-4924-4c13-8e0e-e6cd6b30968b"
      unitRef="usd">2000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="ic0139f5e9be640a2abe77bf91136f1bb_D20221101-20221130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI0NzY5_3632f662-316e-4970-a252-9948fdf99f7d"
      unitRef="usd">1000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <peak:NumberOfSecuredLoans
      contextRef="i63393f69a85548b18409a036fee2f946_D20221201-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzM2_39ce82d5-e02a-47f0-ad15-3195616b494c"
      unitRef="loan">4</peak:NumberOfSecuredLoans>
    <peak:LoansReceivableOutstandingBalance
      contextRef="i63393f69a85548b18409a036fee2f946_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzQw_48919800-3d2a-4eec-af91-d172a7eaf6a4"
      unitRef="usd">61000000</peak:LoansReceivableOutstandingBalance>
    <peak:LoansReceivableTerm
      contextRef="i17ab4619f5bc4ffb844448dc2ded4d10_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNzE0NjgyNTU5NzEwMg_4686a2a9-9b71-418c-8d64-1120b96a9378">P1Y</peak:LoansReceivableTerm>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="i684b88fb97554f22a37f1cbb5a4be09a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODM5NDMx_b985ff93-8151-4225-9f1d-a49e95abd2d0"
      unitRef="number">0.0011</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="i5e0f4ebc4c1547e5913529941dba4cd5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3MzYx_00f44ed1-5d5e-4555-81bd-b627cb1cd102"
      unitRef="number">0.085</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRate
      contextRef="if21dc8e101854dcebeae8d48af75b96d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI3Mzcz_24868995-9006-418e-b4f3-7f0bf21e0019"
      unitRef="number">0.105</us-gaap:LoansReceivableBasisSpreadOnVariableRate>
    <peak:NumberOfSecuredLoans
      contextRef="i6d00bf264b354d8e9bd17bbbec9cc3db_D20230101-20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTQ5NzU1ODI5NzIz_6dff9378-2bcb-4547-8404-214323ba9698"
      unitRef="loan">2</peak:NumberOfSecuredLoans>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i00ecc95ec04841c1b95be484ffd8add8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTU3OA_370ff3a4-ea76-4285-9627-63b448ef40d8"
      unitRef="usd">36000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i64c1609203464ecf8a00b2af5447978d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfNTU4NQ_08f967b5-0ca5-4bf3-ac0f-46a4fe3659ed"
      unitRef="usd">33000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTAwMQ_c86d331e-916a-4d74-aa59-c701f604f825">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by year of origination, the Company&#x2019;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period gross write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period net write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CCRC resident loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period gross write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period net write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0yLTEtMS0yMjUyNzE_ed222504-6f90-4142-bbed-540a4e9612d9"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC00LTEtMS0yMjUyNzE_42276387-3bf3-4d3f-82d1-1f9f1a0f47af"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC02LTEtMS0yMjUyNzE_c9510035-9b2e-4d76-914e-da22468bf78a"
      unitRef="usd">163562000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC04LTEtMS0yMjUyNzE_bb36ae4e-4854-4b1a-acc8-287d2bdf9db4"
      unitRef="usd">43117000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMC0xLTEtMjI1Mjcx_e8b78a88-818f-494f-bbae-d45a1aacc75b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMS0xLTEtMjI1Mjcx_4ed2e4c8-1bf5-43d5-99bc-f9338a477a9b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i775c707a41964704bb6f55b0b3e9ab6a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNC0xMy0xLTEtMjI1Mjcx_4acaa1aa-c6c9-4b31-8cfa-1299c37af1f2"
      unitRef="usd">206679000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0yLTEtMS0yMjUyNzE_2bbf6d56-76fe-4fe0-97cc-05d2be0b9471"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS00LTEtMS0yMjUyNzE_d1dab0cf-be0f-414b-bcc0-0ba65aab8ae6"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS02LTEtMS0yMjUyNzE_948a8f97-38b9-421c-aa4a-31fbbc2a2402"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS04LTEtMS0yMjUyNzE_e548961a-5252-41de-8b56-51a165280583"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMC0xLTEtMjI1Mjcx_b6c5843e-fb51-4778-ba9e-b8d97abb5819"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMS0xLTEtMjI1Mjcx_be11e27d-7cb3-4dc4-bc00-0f9b2f7aa9a9"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i7022374097c345abbd7b9628054b8bb1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNS0xMy0xLTEtMjI1Mjcx_ef158685-47f2-4531-b619-b1cb17abc047"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0yLTEtMS0yMjUyNzE_bf89be9e-00a4-49b4-8dc6-528fe9c0ebe2"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi00LTEtMS0yMjUyNzE_a1f5fdcb-5c8d-4c8d-b5a6-989cb81a1116"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi02LTEtMS0yMjUyNzE_d3e4bd0e-48f0-4ce2-b754-879535b87451"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi04LTEtMS0yMjUyNzE_d7aee4f6-59a8-47bc-a083-643e99a9e895"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMC0xLTEtMjI1Mjcx_58437c4b-2778-4ea0-b0b2-81a4cdfda5d3"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMS0xLTEtMjI1Mjcx_0955692d-bc9b-4e40-bb78-556e9eb6bfd7"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ie2b8336de4304e599fe3da77c86692a7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNi0xMy0xLTEtMjI1Mjcx_6fc8ee2f-6ac7-488b-b57f-bca5b564a0b8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0yLTEtMS0yMjUyNzE_ea9e8d73-0781-4f23-99c4-7e126c029eed"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy00LTEtMS0yMjUyNzE_43a2d159-21f2-4dce-be77-30d24ada5be8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy02LTEtMS0yMjUyNzE_39fbf50e-9969-4291-8b29-83b28e1b401d"
      unitRef="usd">163562000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy04LTEtMS0yMjUyNzE_77615f1b-95e4-47b9-a470-ce65ec7d8d76"
      unitRef="usd">43117000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMC0xLTEtMjI1Mjcx_176f059c-ca36-4d8a-85e9-9a7fbbb0f193"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMS0xLTEtMjI1Mjcx_dc4671d9-7780-4bb5-aa51-4201f4f7cc16"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfNy0xMy0xLTEtMjI1Mjcx_39238998-f0bd-48b3-aaa5-d37fbfbc1b19"
      unitRef="usd">206679000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0yLTEtMS0yMjUyNzE_13b4d13e-4fb3-4a61-a314-30501dfc621b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC00LTEtMS0yMjUyNzE_e83295ec-9a03-4f89-a2d6-695d3f1f7b0f"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC02LTEtMS0yMjUyNzE_79a3e8ee-0f46-4c87-b548-6321e7f8694b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC04LTEtMS0yMjUyNzE_f131652e-8965-4812-97cf-c39a96f06699"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMC0xLTEtMjI1Mjcx_332e586b-a096-4897-b90b-b63193c8d669"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMS0xLTEtMjI1Mjcx_19ee8c5b-9330-4612-8d4c-0e37d1c3beac"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i9f6c558ccada4265a95f7250fb0f8a48_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOC0xMy0xLTEtMjM3MjQx_be83cc2e-525a-4bc8-956d-8e1e1066ef65"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0yLTEtMS0yMjUyNzE_7cde5630-696c-4aa0-aa35-e1ec43c05d10"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS00LTEtMS0yMjUyNzE_c9238ccd-119b-4238-b59f-e41964e246c4"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS02LTEtMS0yMjUyNzE_4b8b5f9a-b0eb-47f0-afdb-b5d1c7bd5577"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS04LTEtMS0yMjUyNzE_6a6d59c5-1ac2-4d71-9f12-e621bc47f1ca"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMC0xLTEtMjI1Mjcx_a3e80a50-76a8-4779-b06c-3a94ef3a76de"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMS0xLTEtMjI1Mjcx_f8680695-6260-4064-bdfb-969fadf4d2ca"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ia778bdabbe2148a785c9999be7828073_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfOS0xMy0xLTEtMjM3MjQx_4c0ae5dc-e5f0-45f7-b07f-23b34304caf3"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMi0xLTEtMjM3MjAz_0bbbf100-10bd-4a7a-98f9-3f14fa2930ce"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtNC0xLTEtMjM3MjM3_08dfbc41-0306-425b-ac84-15230cdb52a5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtNi0xLTEtMjM3MjQx_a1a832ff-5742-4d86-96b9-f3921f88cefd"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtOC0xLTEtMjM3MjQx_08c6edea-34d7-410b-8e63-82ae15b990cc"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTAtMS0xLTIzNzI0MQ_53857c8f-c5ba-4524-82ba-d0bc384981ed"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTEtMS0xLTIzNzI0MQ_e08cd1db-08b6-4a8c-8d1b-dcdf2fc2d89c"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i613735bfaf704f0f9a6ba1a6b091f0be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTAtMTMtMS0xLTIzNzI0MQ_2f1e9206-0600-4550-a446-b41f1a94a0a9"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMi0xLTEtMjI1Mjcx_91354b40-2202-48a5-83b5-f4f434610807"
      unitRef="usd">14482000</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtNC0xLTEtMjI1Mjcx_7573130a-8db6-4493-965f-dc27368a0f95"
      unitRef="usd">21910000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtNi0xLTEtMjI1Mjcx_90d06e42-cea8-44cd-aec7-3bc0a681bc41"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtOC0xLTEtMjI1Mjcx_957ae3c7-344e-42ad-9bac-8e742de688d3"
      unitRef="usd">78000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTAtMS0xLTIyNTI3MQ_b319590d-d68f-4312-8164-c2ae77ed3bd5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTEtMS0xLTIyNTI3MQ_f3a437e7-2a0c-4128-9a9c-3c7608aa3770"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ia427c7d52bef42c28adc94497ec593ae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTMtMTMtMS0xLTIyNTI3MQ_ac4832fe-d323-4721-a1f1-8d33c3bb00c7"
      unitRef="usd">36470000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMi0xLTEtMjI1Mjcx_16c4e454-21cb-459e-85ec-fb6c02354abe"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtNC0xLTEtMjI1Mjcx_d90a6a4e-99a0-42bb-a078-9af2df0a8a8b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtNi0xLTEtMjI1Mjcx_e9c8cf56-04d2-434f-9f0c-8a7e25f3972a"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtOC0xLTEtMjI1Mjcx_42ce4dfa-be0b-4d55-a8b6-7d66e6dd3e17"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTAtMS0xLTIyNTI3MQ_176da613-f2ab-4244-b2e6-374e539bb6a2"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTEtMS0xLTIyNTI3MQ_a0dba524-d2ad-4728-818f-7704c699f900"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i93ddbb42639d468984faade1da6bb948_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTQtMTMtMS0xLTIyNTI3MQ_9ec4302d-7a2c-42c5-96e2-b78429162da5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMi0xLTEtMjI1Mjcx_4cdb1f91-def6-46ec-8fed-94661868051f"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtNC0xLTEtMjI1Mjcx_40fa70b0-17a3-49e7-8de5-813a2e9c078c"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtNi0xLTEtMjI1Mjcx_d11d3f42-ff62-4c43-b058-e90e0936d236"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtOC0xLTEtMjI1Mjcx_f558045d-29ab-435e-9e46-185aadcf12cb"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTAtMS0xLTIyNTI3MQ_a9f7523d-601d-4927-8615-eb547f949696"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTEtMS0xLTIyNTI3MQ_54617c04-e1c2-4d0b-a5bf-cf7ac8edec13"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i8ffec5e441b44bef86395108ef570821_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTUtMTMtMS0xLTIyNTI3MQ_c4ae54de-6d9a-43b7-a6a4-b7e6eb196f75"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMi0xLTEtMjI1Mjcx_916839a0-e3e2-4fbd-ba2c-d40dec51a656"
      unitRef="usd">14482000</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtNC0xLTEtMjI1Mjcx_095e7a03-d5ba-43bb-8e24-d38c549423e7"
      unitRef="usd">21910000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtNi0xLTEtMjI1Mjcx_8189e89e-efc8-4698-bdd2-41e49886d6ed"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtOC0xLTEtMjI1Mjcx_7c0152e1-e57e-4e9f-aaff-e65d5c20de9b"
      unitRef="usd">78000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTAtMS0xLTIyNTI3MQ_041bdc38-26c1-4000-b2b2-ad354e6338ed"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTEtMS0xLTIyNTI3MQ_89d6bb90-1e49-4db7-be5d-b953ef868a6a"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i859ad1c33bde4dffb72acaca2240e037_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTYtMTMtMS0xLTIyNTI3MQ_95850cb3-7aa4-4c1a-8b7e-5d314c9bb42b"
      unitRef="usd">36470000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMi0xLTEtMjI1Mjcx_e2dd3c0b-d8a8-46ef-8b29-a6d761a6d1c5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctNC0xLTEtMjI1Mjcx_ff50972c-2f5c-4c2e-984c-f47e07c86b2f"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctNi0xLTEtMjI1Mjcx_6c56bba6-1312-43a9-a561-58c5b454cfee"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctOC0xLTEtMjI1Mjcx_585e1a21-f493-457b-85a4-00a82359b2a7"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTAtMS0xLTIzNzI0NA_03acf667-999b-467d-8d0f-d466232c55a8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTEtMS0xLTIyNTI3MQ_2d6bc0da-5b69-49cb-b197-d0e65a9afe9e"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i05931c32871345c2953b6bc7e9725803_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTctMTMtMS0xLTIzNzI0NA_5c64de0f-1d87-44b8-9b76-97589bea85ca"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMi0xLTEtMjI1Mjcx_5f497260-2478-460c-860e-8b65c0d06db0"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtNC0xLTEtMjI1Mjcx_e45d5728-eb96-40ba-9306-2a9bf4855a62"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtNi0xLTEtMjI1Mjcx_5b9df11e-e09f-4081-8114-99528cf7e471"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtOC0xLTEtMjI1Mjcx_a0dfdf8b-a905-4da2-8487-c74e7c882807"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTAtMS0xLTIzNzI0NA_c71c54ea-b50e-4721-8de3-d4646929f2e8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTEtMS0xLTIyNTI3MQ_cb3ee4b9-da11-4a63-9769-84c3ec824c63"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="iec83876e1875415480e127f2f8ee5341_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTgtMTMtMS0xLTIzNzI0NA_382ed6f1-1e18-48ac-aff4-e51dcd29dc51"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMi0xLTEtMjM3MjQ0_a8037672-6d40-44f0-afec-7b2680c66619"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktNC0xLTEtMjM3MjQ0_374f90e9-22e6-4f0b-b5f3-c2f589d5dcbc"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktNi0xLTEtMjM3MjQ0_71895b82-4379-439c-a196-380f88297ed8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktOC0xLTEtMjM3MjQ0_d8ac75ba-860f-4c40-a189-b012b3748384"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTAtMS0xLTIzNzI0NA_16c79276-45f6-4107-8bd7-b5898c0de2c6"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTEtMS0xLTIzNzI0NA_739cc5ad-ffff-4c63-bc63-de26c3390a08"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i8b5e7a36d21347b2982d484d7fe52b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjZhMTcxYTM1Y2QxMTRiNmNhMzEwZjNhNjQxNGY1MGEyL3RhYmxlcmFuZ2U6NmExNzFhMzVjZDExNGI2Y2EzMTBmM2E2NDE0ZjUwYTJfMTktMTMtMS0xLTIzNzI0NA_43fa5ace-f474-4b25-8e26-2c13bc2239d5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfOTAxMQ_34696fc0-a1cb-4b81-9fb3-f661a372b2fe">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s reserve for loan losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected loan losses (recoveries) related to loans sold or repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;(1)Includes CCRC resident loans and other loan activity.</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0xLTEtMS0yMjUyNzE_ebe4ba47-8df1-4829-ac40-922f9c019069"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ie53bcb07504e4ad99f3ade31d660d86a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0zLTEtMS0yMjUyNzE_4ca3c38b-867f-47b7-9f66-023c9b35d692"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi01LTEtMS0yMjUyNzE_a07cc5d2-b253-4828-a425-baa72f11d0ef"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i03a30f0743e84f25b4365b13befe7543_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi03LTEtMS0yMjUyNzE_3c6aa900-a840-4fc5-8a65-df90830341bc"
      unitRef="usd">1804000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i1d3eb325105c4a489d9e072e95831f43_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi05LTEtMS0yMjUyNzE_898b2d59-e202-42ae-a218-8229ab69efbd"
      unitRef="usd">9000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfMi0xMS0xLTEtMjI1Mjcx_0a1d0a95-4cfc-4ddb-bc10-3c14e0753cd1"
      unitRef="usd">1813000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0xLTEtMS0yMjUyNzE_e030d79b-fbba-45d9-9bfc-640cc99d17af"
      unitRef="usd">-171000</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0zLTEtMS0yMjUyNzE_0c948222-af74-4173-a3ea-bc955ceb8571"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC01LTEtMS0yMjUyNzE_2b7835dc-6b10-4fc6-b05a-8e4269cbbc84"
      unitRef="usd">-171000</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC03LTEtMS0yMjUyNzE_b269d4b2-e489-460b-9b03-87ff46016461"
      unitRef="usd">6527000</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC05LTEtMS0yMjUyNzE_8d7660c2-f47d-4ffe-b014-8ae4f7c624ee"
      unitRef="usd">7000</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNC0xMS0xLTEtMjI1Mjcx_d741d3c5-d103-49df-87fa-50ca397a39aa"
      unitRef="usd">6534000</us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="id10ca599500d4b19b22a84e0d522a4c0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0xLTEtMS0yMjUyNzE_4e64c0c1-e690-4744-9b8c-e0ae569547a2"
      unitRef="usd">1957000</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="i13fcf1b525de4ac5b5654d353e3fa51a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0zLTEtMS0yMjUyNzE_18df68d4-f08f-462f-94f4-28a2747d9b88"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS01LTEtMS0yMjUyNzE_a3ceb3d7-39f5-420e-925c-080670da33f8"
      unitRef="usd">1957000</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="i9d7a71ddd88f49f99751a8b2df6b2ca1_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS03LTEtMS0yMjUyNzE_71b52946-a943-4a02-96fb-d000a8b43410"
      unitRef="usd">51000</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="i8f22797433dd46abaab552b9837d2e47_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS05LTEtMS0yMjUyNzE_d1b1e307-130c-4cd9-95c6-0e6998599d06"
      unitRef="usd">16000</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfNS0xMS0xLTEtMjI1Mjcx_02779021-5e89-4a87-8873-72c91896ad60"
      unitRef="usd">67000</us-gaap:FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i35fc9183f82c46689dc6c8c571bb0698_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0xLTEtMS0yMjUyNzE_eb53fc6d-0dc2-4e55-b3db-f5a8e8874cf4"
      unitRef="usd">6152000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i8966c32afeb843069c788fcb7d555ba1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0zLTEtMS0yMjUyNzE_d55e5072-64b5-4343-a960-1c035f37bc28"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS01LTEtMS0yMjUyNzE_79af2367-1e71-4850-a9ca-f51a651b51ed"
      unitRef="usd">6152000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i5c6a0239574c4b02b1c3a3a79c95712f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS03LTEtMS0yMjUyNzE_9b7b79db-355c-4fc1-ab50-167b10933de6"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ie53bcb07504e4ad99f3ade31d660d86a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS05LTEtMS0yMjUyNzE_d60eb2ad-157a-476f-aa87-9cadf1501181"
      unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RhYmxlOjgxZjQwYWVmNmU1MTQ4Nzg4M2FlMmRlMTIxNWEwMGI1L3RhYmxlcmFuZ2U6ODFmNDBhZWY2ZTUxNDg3ODgzYWUyZGUxMjE1YTAwYjVfOS0xMS0xLTEtMjI1Mjcx_8d49535a-108d-400c-9590-640c3e81e6ba"
      unitRef="usd">8280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODgyNw_f73662ba-4253-4024-a080-5d9443412a5a"
      unitRef="usd">700000</peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments>
    <peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl80OS9mcmFnOjQ1Zjg1ZmFiMWVkNzQ3NGRiNzU3NWZhZWUzYTIyMWE4L3RleHRyZWdpb246NDVmODVmYWIxZWQ3NDc0ZGI3NTc1ZmFlZTNhMjIxYThfODgzNA_570fd1e6-778c-4ad3-93d8-66666c883e1f"
      unitRef="usd">800000</peak:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMzQxMQ_694a4890-2f47-4f5d-85a5-d0c4d635947d">Investments in and Advances to Unconsolidated Joint Ventures&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property Count&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership %&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SWF SH JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South San Francisco JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Science JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Office JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 - 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Property counts and ownership percentages are as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In August 2022, the Company sold a 30% interest in seven life science assets in South San Francisco, California to a sovereign wealth fund. This transaction resulted in the recognition of seven unconsolidated life science joint ventures in which the Company holds a 70% ownership percentage in each joint venture. These joint ventures have been aggregated herein due to similarity of the investments and operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Land held for development is excluded from the property count as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). These joint ventures have been aggregated herein due to similarity of the investments and operations. In April 2023, the Company acquired the remaining 80% interest in one of the two properties in the Ventures IV unconsolidated joint venture for $4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMzQwMQ_3ce1012c-1fd6-4bf6-96ab-9190d776d5d7">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property Count&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership %&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SWF SH JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South San Francisco JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Science JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Office JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 - 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Property counts and ownership percentages are as of March&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In August 2022, the Company sold a 30% interest in seven life science assets in South San Francisco, California to a sovereign wealth fund. This transaction resulted in the recognition of seven unconsolidated life science joint ventures in which the Company holds a 70% ownership percentage in each joint venture. These joint ventures have been aggregated herein due to similarity of the investments and operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Land held for development is excluded from the property count as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). These joint ventures have been aggregated herein due to similarity of the investments and operations. In April 2023, the Company acquired the remaining 80% interest in one of the two properties in the Ventures IV unconsolidated joint venture for $4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy00LTEtMS0yMjUyNzE_9309d83f-712c-4ae6-84d2-dda4dc3efe1d"
      unitRef="property">19</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy02LTEtMS0yMjUyNzE_5174d752-2f5c-436d-88e3-ed1ea85a9c77"
      unitRef="number">0.54</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i893e14a7026040f8939a46fc89d040eb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy04LTEtMS0yMjUyNzE_b33ab554-3632-4140-94d7-a5d88574e3a1"
      unitRef="usd">343873000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i49856b1a6b744d32850fd6e75896a354_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMy0xMC0xLTEtMjI1Mjcx_cb1b9f47-b51c-4410-8282-4f8fa7adef76"
      unitRef="usd">345978000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i563440407d4441eb91bd164b5748f220_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC00LTEtMS0yMjUyNzE_69d1dc08-7cb8-4bd7-a817-2710bcb2cad4"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i563440407d4441eb91bd164b5748f220_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC02LTEtMS0yMjUyNzE_0699d4c2-de86-4aa6-84d8-c8d42c04fa9d"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i563440407d4441eb91bd164b5748f220_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC04LTEtMS0yMjUyNzE_66336dbf-31b5-4739-a969-fb838d7947bf"
      unitRef="usd">319535000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i188028ed6c334da79242d89eee8a840e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNC0xMC0xLTEtMjI1Mjcx_2b26d262-7dee-4737-838e-752336c1ba95"
      unitRef="usd">309969000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS00LTEtMS0yMjUyNzE_5cfe2eab-1b45-4db1-8ccc-efa7f5945ee0"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS02LTEtMS0yMjUyNzE_2918a23c-0056-49b2-bc7c-30c28c5c2a73"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS04LTEtMS0yMjUyNzE_fd871a95-ec65-4cbe-bdbe-c6cb920ff969"
      unitRef="usd">26817000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ibd9427916f174bbb8f0807aa0d989019_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNS0xMC0xLTEtMjI1Mjcx_460a02a0-f06b-4cc7-83cd-89575216015a"
      unitRef="usd">26601000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi00LTEtMS0yMjUyNzE_27d97ce2-c114-466f-9e44-5e07b4adbf92"
      unitRef="property">0</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi02LTEtMS0yMjUyNzE_7898b815-e662-4b10-8417-fd21de971c47"
      unitRef="number">0.38</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i9fdf3a793faf4597a6b092e7c936f32a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi04LTEtMS0yMjUyNzE_acc9dbe3-228e-4966-9653-45ffba1883df"
      unitRef="usd">15658000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i164fcc3a8c7b43fab61c0b736e5ce0ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNi0xMC0xLTEtMjI1Mjcx_a21e42bc-549d-43e7-a43a-7b0e0cd4236e"
      unitRef="usd">15391000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i8bdefa6de9c94ded98445df17bde5304_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy00LTEtMS0yMjUyNzE_1c6e6668-16d3-48af-a59f-72851cf82330"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ife1a0b550fcf40a994feb853ca29945f_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy02LTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjozYjc0ZmVlM2ZkMTU0NTA4YmZmMGUxMTM0MjczMWNkM180_3529b4b2-e38e-4cfb-ad03-be7a4e41c350"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1ea45485ef014df9bcb3a328007f3a5a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy02LTEtMS0yMjUyNzEvdGV4dHJlZ2lvbjozYjc0ZmVlM2ZkMTU0NTA4YmZmMGUxMTM0MjczMWNkM185_67dd8656-e39f-4450-99c5-9da845ec6f3a"
      unitRef="number">0.67</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i8bdefa6de9c94ded98445df17bde5304_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy04LTEtMS0yMjUyNzE_a4da06cc-8174-4cae-9616-e63382239840"
      unitRef="usd">8796000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i97d045a82e5d472cab0e50a49b069fc3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfNy0xMC0xLTEtMjI1Mjcx_d16176df-5259-44f5-b5b7-18d3da430a80"
      unitRef="usd">8738000</us-gaap:EquityMethodInvestments>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMTItOC0xLTEtMjI1Mjcx_ad9b581f-9aeb-41dc-b55d-794c5db5dafc"
      unitRef="usd">714679000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RhYmxlOmE4MTJjYTk0ZTM1MTQzMzRhOTk4ZTE0OWQyNTNiY2FmL3RhYmxlcmFuZ2U6YTgxMmNhOTRlMzUxNDMzNGE5OThlMTQ5ZDI1M2JjYWZfMTItMTAtMS0xLTIyNTI3MQ_e663f289-db05-40b1-a805-d94ea7d878e2"
      unitRef="usd">706677000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i2addaafadeb048608bb19144472ba521_I20220831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA3NzUwMg_dd5ae66b-7e88-4ef5-8085-45e2773c7741"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ie9cdb1d5067b4c20abc45e5a6b15b490_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA3NzUxOA_e2110e93-cd30-4919-b737-7e957f6353af"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="ibbf0c3be361842da924660620a57f737_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTA2_46014c53-3f6f-4a0b-8aca-163d33b2af3e"
      unitRef="joint_venture">7</peak:NumberOfUnconsolidatedJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibbf0c3be361842da924660620a57f737_I20220831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNjE2_3e9592ea-c1e9-4825-a7c7-5ea69c95416a"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="idcb7ea32456048788d35e1f70da8c6f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTA0OQ_7aa6a3c8-5eef-4760-9529-99281ee99762"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i609a39bba39341cca8d2aa1fcce48d99_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTE3Nw_6d20ee96-827b-42ac-bcb8-cb497313441e"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i31ebf93813b04ee98f19d52880e6b227_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMTIxNg_f7b0f3c0-af31-497a-9167-861bf87de841"
      unitRef="number">0.67</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i21dc87df2f2b491c818391833acfbe83_I20230428"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI0ODYw_261a9f18-dc06-40a3-81f3-b102771a573b"
      unitRef="number">0.80</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i21dc87df2f2b491c818391833acfbe83_I20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI0ODY1_d98393e2-4717-4dc1-90ce-5a357dd78f64"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="idcb7ea32456048788d35e1f70da8c6f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfMjc0ODc3OTA4MDQzMg_7a72303d-751a-4ccd-8ca6-5e8c1eebc84e"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i98f2b1c68dfd4ec0b6cfe198f9aa7452_D20230401-20230428"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81Mi9mcmFnOmE4MjdmYjE0YTdiNDRhNzY4MDc1YTc4YzZmYjBlNGNiL3RleHRyZWdpb246YTgyN2ZiMTRhN2I0NGE3NjgwNzVhNzhjNmZiMGU0Y2JfNTQ5NzU1ODI1MDUx_9af1a9e4-f486-4621-b84c-6b24d599092f"
      unitRef="usd">4000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3NA_12084de5-6533-43f7-8827-3ad7d4f041dc">Intangibles&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#x2019;s intangible lease assets (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes intangible assets reported in assets held for sale of $2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#x2019;s intangible lease liabilities (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, no intangible assets or liabilities were acquired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, in conjunction with the Company&#x2019;s acquisitions of real estate, the Company acquired intangible assets of $7&#160;million and intangible liabilities of $6&#160;million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of 7 years and 11 years, respectively.&lt;/span&gt;&lt;/div&gt;</peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3MQ_6b40d6fe-4890-4284-909a-73769fe597dd">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#x2019;s intangible lease assets (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes intangible assets reported in assets held for sale of $2&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMS0yLTEtMS0yMjUyNzE_b26ed1fe-3f30-4417-be73-2fdb17c78eac"
      unitRef="usd">767224000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMS00LTEtMS0yMjUyNzE_f0ec6103-0f1f-40b9-b691-ab5cf5263d42"
      unitRef="usd">770285000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMi0yLTEtMS0yMjUyNzE_ccdc1bd7-56f0-43aa-bfd1-356082bafb96"
      unitRef="usd">375268000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMi00LTEtMS0yMjUyNzE_874b408d-b145-4d4f-9df3-230204c0fd9a"
      unitRef="usd">352224000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMy0yLTEtMS0yMjUyNzE_906d0f77-1882-4956-8e22-e8a91a258b88"
      unitRef="usd">391956000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfMy00LTEtMS0yMjUyNzE_0549c7d3-2dc7-4715-9a0a-1b2f266fde79"
      unitRef="usd">418061000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfNS0yLTEtMS0yMjUyNzE_e5ce96e9-6581-4fd7-8352-fc6b3282cf3a">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmJiODg0MWNkODRiZDRhOTRhODE1MzM3OWQ1YjIyNzQxL3RhYmxlcmFuZ2U6YmI4ODQxY2Q4NGJkNGE5NGE4MTUzMzc5ZDViMjI3NDFfNS00LTEtMS0yMjUyNzE_80653734-3393-491f-b366-27f0ea7cc5a1">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i13ba81585eef4986833dfbc887a0e2d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMzcw_b2f379fb-1099-4ed4-aa24-e33e80c06a9a"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE3NQ_f6d3b7cc-9c74-4b23-bd61-9bc128a6db89">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#x2019;s intangible lease liabilities (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock>
    <peak:FiniteLivedIntangibleLiabilitiesGross
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMS0yLTEtMS0yMjUyNzE_6d9c509d-70d3-45f2-8762-6b043dd2fff5"
      unitRef="usd">236831000</peak:FiniteLivedIntangibleLiabilitiesGross>
    <peak:FiniteLivedIntangibleLiabilitiesGross
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMS00LTEtMS0yMjUyNzE_a5d80f2f-6697-4d6b-a441-6be06f3fe352"
      unitRef="usd">237464000</peak:FiniteLivedIntangibleLiabilitiesGross>
    <peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMi0yLTEtMS0yMjUyNzE_c139346f-3036-4b50-8894-b6f4ed1ba91a"
      unitRef="usd">87227000</peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization>
    <peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMi00LTEtMS0yMjUyNzE_58f5fcfc-b33b-4eb6-b718-dc247e0934bc"
      unitRef="usd">81271000</peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization>
    <peak:FiniteLivedIntangibleLiabilitiesNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMy0yLTEtMS0yMjUyNzE_d49b2e24-b66e-4c7c-9869-7f3c266d6367"
      unitRef="usd">149604000</peak:FiniteLivedIntangibleLiabilitiesNet>
    <peak:FiniteLivedIntangibleLiabilitiesNet
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfMy00LTEtMS0yMjUyNzE_449db0b9-b0b2-44d3-8cee-dc8ea6970bd1"
      unitRef="usd">156193000</peak:FiniteLivedIntangibleLiabilitiesNet>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfNS0yLTEtMS0yMjUyNzE_40035811-e713-4784-a094-74a92eefa10a">P7Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RhYmxlOmU2YWQxNDI5YzMzYTRmYmQ4ZDExNTk0NTZkZmY3OGQ2L3RhYmxlcmFuZ2U6ZTZhZDE0MjljMzNhNGZiZDhkMTE1OTQ1NmRmZjc4ZDZfNS00LTEtMS0yMjUyNzE_b1b96b20-0a01-44de-a40d-4da045b7f572">P7Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNzE0NjgyNTU4MjIzNQ_3f25a705-d6e6-45ac-a34f-0fe02e08755b"
      unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <peak:FiniteLivedIntangibleLiabilitiesAcquired
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNzE0NjgyNTU4MjIzNQ_53ff8606-6326-4c29-b978-e03a6d705398"
      unitRef="usd">0</peak:FiniteLivedIntangibleLiabilitiesAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTAwNw_1560bd72-1009-4507-965e-b9ebac8dc32f"
      unitRef="usd">7000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <peak:FiniteLivedIntangibleLiabilitiesAcquired
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTA0MA_0e9097d7-f0e8-4201-a866-6d9bcaa865f8"
      unitRef="usd">6000000</peak:FiniteLivedIntangibleLiabilitiesAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfMTE2OA_5ffabb16-c8bf-4d71-b2e0-9d1c1448887e">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="i9cd0a50e420c4aa0b25e4bbd1dc84f12_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81NS9mcmFnOjA4NWJlNjQzNmM2ZjQ0NzU5NDM2NzgzNmZhMWFlODQyL3RleHRyZWdpb246MDg1YmU2NDM2YzZmNDQ3NTk0MzY3ODM2ZmExYWU4NDJfNTQ5NzU1ODE1MjE2_37360bc7-5072-4759-b912-6b16265650c3">P11Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTY_3b499647-486c-4707-b258-b8773bdfda10">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#x2019;s consolidated operating subsidiary. Healthpeak OP is the borrower under, and the Company is the guarantor of, all of the unsecured debt discussed below, which includes the Revolving Facility, Term Loan Facilities, Commercial Paper Program (each as defined below), and senior unsecured notes. The Company&#x2019;s guarantee of the senior unsecured notes is full and unconditional and applicable to existing and future senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bank Line of Credit and Term Loans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2019, the Company executed a $2.5 billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and two&#160;six-month extension options, subject to certain customary conditions. In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#x201c;Revolving Facility&#x201d;) to increase total revolving commitments from $2.5&#160;billion to $3.0&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to two six-month extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at the applicable interest rate benchmark plus a margin that depends on the credit ratings of the Company&#x2019;s senior unsecured long-term debt. On February 10, 2023, the Company executed an amendment to the Revolving Facility to convert the interest rate benchmark from LIBOR to SOFR. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Additionally, the Revolving Facility includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to 0.025% based on the Company&#x2019;s achievement of specified sustainability-linked metrics, subject to certain conditions. Based on the Company&#x2019;s credit ratings at March&#160;31, 2023, and inclusive of achievement of a sustainability-linked metric during the year ended December 31, 2021, the margin on the Revolving Facility was 0.85% and the facility fee was 0.15%. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had no balance outstanding under the Revolving Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 22, 2022, the Company executed a term loan agreement (the &#x201c;Term Loan Agreement&#x201d;) that provided for two senior unsecured delayed draw term loans in an aggregate principal amount of up to $500&#160;million (the &#x201c;Term Loan Facilities&#x201d;). The Term Loan Facilities were available to be drawn from time to time during a 180-day period after closing, subject to customary borrowing conditions, and the Company drew the entirety of the $500&#160;million under the Term Loan Facilities in October 2022. $250&#160;million of the Term Loan Facilities has an initial stated maturity of 4.5 years, which may be extended for a one-year period subject to certain customary conditions. The other $250&#160;million of the Term Loan Facilities has a stated maturity of 5 years with no option to extend. At each of March&#160;31, 2023 and December&#160;31, 2022, the Company had $500&#160;million outstanding under the Term Loan Facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loans outstanding under the Term Loan Facilities accrue interest at Term SOFR plus a margin that depends on the credit ratings of the Company&#x2019;s senior unsecured long-term debt. The Term Loan Agreement also includes a sustainability-linked pricing component whereby the applicable margin under the Term Loan Facilities may be reduced by 0.01% based on the Company&#x2019;s achievement of specified sustainability-linked metrics. Based on the Company&#x2019;s credit ratings as of March&#160;31, 2023, the margin on the Term Loan Facilities was 0.95%. The Term Loan Agreement includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to an additional $500&#160;million, subject to securing additional commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company entered into two forward-starting interest rate swap instruments that are designated as cash flow hedges (see Note 17). The Term Loan Facilities associated with these interest rate swap instruments are reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instruments. Based on the Company&#x2019;s credit ratings as of March&#160;31, 2023, the Term Loan Facilities had a blended fixed effective interest rate of 3.77%, inclusive of the impact of these interest rate swap instruments and amortization of the related debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Facility and Term Loan Facilities are subject to certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the applicable agreement: (i) limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to 60%; (ii) limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to 40%; (iii) limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to 60%; (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times; and (v) require a minimum Consolidated Tangible Net Worth of $7.7&#160;billion. The Company believes it was in compliance with each of these covenants at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, the Company established an unsecured commercial paper program (the &#x201c;Commercial Paper Program&#x201d;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. At each of March&#160;31, 2023 and December&#160;31, 2022, the maximum aggregate face or principal amount that can be outstanding at any one time was $2.0&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#x2019;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2023, the Company had $556&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately 16 days and a weighted average interest rate of 5.53%. At December&#160;31, 2022, the Company had $996&#160;million of securities outstanding under the Commercial Paper Program, with original maturities of approximately two months and a weighted average interest rate of 4.90%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and December&#160;31, 2022, the Company had senior unsecured notes outstanding with an aggregate principal balance of $5.1&#160;billion and $4.7&#160;billion, respectively. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions, and other customary terms. The Company believes it was in compliance with these covenants at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s senior unsecured notes issuances during the three months ended March&#160;31, 2023 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 17, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, there were no repurchases or redemptions of senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, there were no issuances, repurchases, or redemptions of senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and December&#160;31, 2022, the Company had $344 million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $345&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by 15 MOBs and 3 CCRCs, with an aggregate carrying value of $785 million and $793&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During each of the three months ended March&#160;31, 2023 and 2022, the Company made aggregate principal repayments of mortgage debt of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $142&#160;million of mortgage debt secured by a portfolio of 13 MOBs that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap instruments associated with this variable rate mortgage debt and entered into two interest rate swap instruments that are designated as cash flow hedges&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and mature in May 2026. In February 2023, the agreements associated with this variable rate mortgage debt were amended to change the interest rate benchmarks from LIBOR to SOFR, effective March 2023. Concurrently, the Company modified the related interest rate swap instruments to reflect the change in the interest rate benchmarks from LIBOR to SOFR (see Note 17). The variable rate mortgage debt associated with these interest rate swap instruments is reported as fixed rate debt due to the Company having effectively established a fixed interest rate for the underlying debt instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stated debt maturities and scheduled principal repayments at March&#160;31, 2023 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Senior Unsecured&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mortgage&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Bank Line&#160;&lt;br/&gt;of Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Term&#160;Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,450,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,499,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Premiums, (discounts), and debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,056,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,453,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the senior unsecured notes range from 1.54% to 6.87% with a weighted average effective interest rate of 3.53% and a weighted average maturity of 6 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the mortgage debt range from 3.44% to 8.52% with a weighted average effective interest rate of 4.31% and a weighted average maturity of 3 years. These interest rates include the impact of designated interest rate swap instruments, which effectively fix the interest rate on certain variable rate debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTc_5c23c350-fcf8-4402-8ad4-8fb2455f1148"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <peak:DebtInstrumentNumberofExtensions
      contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTg2_6e7f73ac-3184-436b-9f0f-9340fffeb0d3"
      unitRef="renewal_option">2</peak:DebtInstrumentNumberofExtensions>
    <peak:DebtInstrumentPeriodOfExtension
      contextRef="ic4babd7df1364a05a31daf2030f872a8_D20190523-20190523"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTg5_3946ecbe-283d-40e9-bfeb-a31bd326cfb3">P6M</peak:DebtInstrumentPeriodOfExtension>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7242708209774688bf6a0fa92eee7c92_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjE5_492b94cb-804c-4499-9056-00379f85ef42"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if1d4050de8b24d7499a2da8155770c96_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjI1_15275cc3-4447-40ac-937e-b53dd5f09c93"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <peak:DebtInstrumentNumberofExtensions
      contextRef="if1d4050de8b24d7499a2da8155770c96_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzMz_e5e59ffb-01ab-4f86-bd3f-a395d8fbd6bc"
      unitRef="renewal_option">2</peak:DebtInstrumentNumberofExtensions>
    <peak:DebtInstrumentPeriodOfExtension
      contextRef="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzM2_635864fa-cb3c-4127-8d6c-56784bbd0c7f">P6M</peak:DebtInstrumentPeriodOfExtension>
    <peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics
      contextRef="ice2627cf08414f8db5d11bcfa2e103c2_D20230101-20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTI0OA_d8792668-1a25-4022-a5db-1b01c13272fb"
      unitRef="number">0.00025</peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTU0NA_e45ed270-aeaa-41c4-8151-5359c0e5b99f"
      unitRef="number">0.0085</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic81a445f8f2947df90563ab47ea94634_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTU3Mg_6ba20b4a-c339-43ba-8f4c-9dc17eb01a34"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCredit
      contextRef="i72eb05af2cbe4e208706e4b57decdb88_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTYwNg_541619ae-46da-4459-9117-3372ba583753"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i7305c3d00995417db4dbb2b7d6c583a6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTYwNg_9dca0a3a-8ce0-4813-9ae4-6f10d71218bd"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum
      contextRef="ia34ba6017a2943bdbdcda39868c9b3b1_D20210901-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTc5Mg_e303efd6-05ba-4be6-8fa7-7218316ccf5d"
      unitRef="usd">750000000</peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum>
    <peak:NumberOfLoans
      contextRef="i0ae753d2f2bb4df0934278cf9eff53e5_D20220822-20220822"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMjkzMw_2c305259-55af-4172-98d8-2764b01c94fb"
      unitRef="loan">2</peak:NumberOfLoans>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i506c4e4d75c74d20b91a42ee338b3511_I20220822"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzAxOQ_5da82476-e20d-48ac-996b-89dffd070dfb"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <peak:DebtInstrumentDrawTimePeriodAfterClosing
      contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzE0MQ_ab26caf9-c3f8-43c7-a1cc-1b1344ae9955">P180D</peak:DebtInstrumentDrawTimePeriodAfterClosing>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie44957565290418193123188bc3f9a29_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjA0NzMxMzk4MTc4Mw_9208797d-e6ab-4bab-a4b2-035b8ba38cff"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic5093505d5344e8bba4c2389265a3a7b_I20220822"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzIxMw_fa57fee6-e01d-4219-9664-9c4a2353d22c"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzI4Mw_dcf091fd-1665-4c90-8597-adfacc60e454">P4Y6M</us-gaap:DebtInstrumentTerm>
    <peak:DebtInstrumentPeriodOfExtension
      contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTA5OTUxMTY3OTI4MQ_0ab075c8-ef90-4f34-8bab-c7d585a9f814">P1Y</peak:DebtInstrumentPeriodOfExtension>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i33fc45189ac34f818a512f00fc01253e_I20220822"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzM4MQ_6a005bd5-e876-4653-99d1-75859e36f955"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i543d187d7c2f422fb35ffbea57ea780b_D20220822-20220822"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzQ0Mg_176fad52-642a-413d-aa9f-592a5ec5a426">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebt
      contextRef="i1b6cf8ab3e074c468afa71e272d04f7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5MDYz_56cb66fc-d0fb-4849-988f-839d27b14da9"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i000be30d07554d05a5d03c3a41a8a60e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5MDYz_c29bfaee-d69f-4a54-860d-831317a14f8a"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics
      contextRef="i218d45a9e0bf410e9c3d3bfd91f30065_D20220822-20220822"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMzgyNg_b2f90186-8dd9-460b-a2cd-f5c46a0371df"
      unitRef="number">0.0001</peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics>
    <peak:DebtInstrumentMarginRate
      contextRef="ib2ebc102c23049bb9221a3b5b00a8855_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNDAwNA_c4c979ca-28b6-4bc9-8359-0d56e8658944"
      unitRef="number">0.0095</peak:DebtInstrumentMarginRate>
    <peak:LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption
      contextRef="i000be30d07554d05a5d03c3a41a8a60e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNDM2NQ_80b8c53c-912e-451e-acf3-b8903c7a7cd0"
      unitRef="usd">500000000</peak:LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTM3OA_43e6de9d-1ed1-4fd5-8366-8c81fab75f52"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="iddbba9ecd72f4daa98c9e47aeddc18e0_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTgwNQ_7a9e19f9-1527-4262-b088-11d246819d83"
      unitRef="number">0.0377</us-gaap:DerivativeFixedInterestRate>
    <peak:DebtInstrumentCovenantDebtToAssets
      contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3NTkw_9389005d-4434-477e-b4ba-56ce21c16dcd"
      unitRef="number">0.60</peak:DebtInstrumentCovenantDebtToAssets>
    <peak:DebtInstrumentCovenantSecuredDebtToAssets
      contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3Njc4_ed7b9d0a-01da-47ff-842d-1cf5bd14ba33"
      unitRef="number">0.40</peak:DebtInstrumentCovenantSecuredDebtToAssets>
    <peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets
      contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3Nzc2_4f6f98cc-37ba-449b-98f1-06fc88ee849d"
      unitRef="number">0.60</peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets>
    <peak:DebtInstrumentCovenantFixedChargeRatioMinimum
      contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3ODM1_0cdfc0d0-686a-4547-9466-0edeb3b27a49"
      unitRef="number">1.5</peak:DebtInstrumentCovenantFixedChargeRatioMinimum>
    <peak:DebtInstrumentCovenantNetWorthMinimum
      contextRef="ie2ef959dde734cdeb101f4075ab3a223_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI3OTA3_b4afcc7d-6a14-4857-a969-c9e7dccf1778"
      unitRef="usd">7700000000</peak:DebtInstrumentCovenantNetWorthMinimum>
    <peak:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjU2Mg_4c9e679d-cc1c-4a2c-bd27-3d238c7fe4e2"
      unitRef="usd">2000000000</peak:DebtInstrumentMaximumBorrowingCapacity>
    <peak:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNjU2Mg_bccd0b1e-bc78-4eee-ab3e-f0f7f56e6532"
      unitRef="usd">2000000000</peak:DebtInstrumentMaximumBorrowingCapacity>
    <us-gaap:ShortTermBorrowings
      contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzAwNg_2f19f6cd-5cd0-4467-9d76-0c16db7e55cf"
      unitRef="usd">556000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="idef8861b7d7c4e5fbfc001ae1cebeb57_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzExMw_6b640569-30a7-41f0-b96f-fbba6dd94c2d">P16D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i0a9825d537dc48a1ace8af19b8cf7906_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzE1Ng_cc250f5b-be27-459d-946f-3c9ce21c1d24"
      unitRef="number">0.0553</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:ShortTermBorrowings
      contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzE4Mw_8adfbecf-adaa-429e-8eb8-7e1bf013fed2"
      unitRef="usd">996000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="iac90e17281a0408ebc19a4dd60bf5da8_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTk_0efa0adc-b2f4-4126-91a7-ab9fd94f6151">P2M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i581333276c1c4e509b4209a5ef42ea34_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzM0MA_ac4dbc59-fdcd-4c07-980f-059a1227e6d0"
      unitRef="number">0.0490</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNzQ3OQ_bb16076d-d507-474c-a30d-e0a8f1ff1d61"
      unitRef="usd">5100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i29765404aa624d6d99bc3534f881b7a5_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODI5NjE5_bba6b1cf-45e5-43f4-a3f4-52fa8d0dc192"
      unitRef="usd">4700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MTE_2fa44e89-f0a8-4bcb-817b-9394b5ed4cc4">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s senior unsecured notes issuances during the three months ended March&#160;31, 2023 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 17, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ife87565ec58448679511f93e16e05495_I20230117"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOjNkNzNhNGJiNWFhYjQ1MjFiNmY2MWRlZGJiYTk1MjQ5L3RhYmxlcmFuZ2U6M2Q3M2E0YmI1YWFiNDUyMWI2ZjYxZGVkYmJhOTUyNDlfMS0yLTEtMS0yMjUyNzE_ae77ac65-c5c2-4be1-8022-f1e0c4673547"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ife87565ec58448679511f93e16e05495_I20230117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOjNkNzNhNGJiNWFhYjQ1MjFiNmY2MWRlZGJiYTk1MjQ5L3RhYmxlcmFuZ2U6M2Q3M2E0YmI1YWFiNDUyMWI2ZjYxZGVkYmJhOTUyNDlfMS00LTEtMS0yMjUyNzE_1b1bd8c4-e3a3-4f1f-b879-46e4d8173350"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODYyOQ_4ae841ee-27bb-4b0f-af21-a4184a0bef67"
      unitRef="usd">344000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i827939e6039a4e69bd555a798b90b6f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODYzNg_874ba01a-16d1-47f8-be9f-9b364b7607b5"
      unitRef="usd">345000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ieb7af8f09e474a1d9f0d3752ba17b366_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDcz_cf3cf78a-04ea-474a-a0e2-b8697375e283"
      unitRef="facility">15</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="id56cce58abda458d9545374c913aac55_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDcz_da9ea6c0-438c-4049-ab1a-1d1257264a86"
      unitRef="facility">15</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i195c53570e3d4baa8827ffa006124262_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDc3_441d1ad5-0acf-47a5-a15d-63b1825c13b2"
      unitRef="facility">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ibd48946bcbc149b6ba3884e2e5f54793_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NDc3_61d7afd7-075e-46fb-9c47-c7e4584b4a63"
      unitRef="facility">3</us-gaap:NumberOfRealEstateProperties>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODc5MA_8e37b768-2f77-4fdd-aa12-69d9af32f9bd"
      unitRef="usd">785000000</peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue
      contextRef="i827939e6039a4e69bd555a798b90b6f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfODc5Nw_c5f59b17-1d39-4725-96cc-4ad5f8b8da6c"
      unitRef="usd">793000000</peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTU2OQ_9963c4e2-1a79-4358-bb12-8aa748bb2500"
      unitRef="usd">1000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i3cdd8357aeaf42e990fca8f3111eee5f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTU2OQ_ac8b18d7-ecae-488b-87d6-162e1ea66959"
      unitRef="usd">1000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i906008fbc48340908eb765f2c3dc8cd1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfOTk0Mw_f45a2fc4-0202-49c9-9974-9d7baecd8db3"
      unitRef="usd">142000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i906008fbc48340908eb765f2c3dc8cd1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfNTQ5NzU1ODY1NTcz_2bf30492-e31b-46a3-801e-6fab7b82b097"
      unitRef="facility">13</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i08425abe3e614e6d9a9b28ec8e60b022_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTAxNTg_fdc3361d-4524-46a8-bb8f-285dcb4bcf48"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTE0MjQ_1af83066-f5eb-431c-99de-6c21af088d77">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stated debt maturities and scheduled principal repayments at March&#160;31, 2023 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Senior Unsecured&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mortgage&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Bank Line&#160;&lt;br/&gt;of Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Term&#160;Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,450,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,499,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Premiums, (discounts), and debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,056,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,453,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the senior unsecured notes range from 1.54% to 6.87% with a weighted average effective interest rate of 3.53% and a weighted average maturity of 6 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the mortgage debt range from 3.44% to 8.52% with a weighted average effective interest rate of 4.31% and a weighted average maturity of 3 years. These interest rates include the impact of designated interest rate swap instruments, which effectively fix the interest rate on certain variable rate debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0yLTEtMS0yMjUyNzE_cfc2cf69-bd93-456a-a934-b62bb365e226"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi00LTEtMS0yMjUyNzE_0225fad0-8ddf-47c1-9d0d-de7d2f1bfcf0"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi02LTEtMS0yMjUyNzE_3b15f34f-9a87-4247-b081-e9d76fbc70f2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi04LTEtMS0yMjUyNzE_f5816084-9cf3-4e18-9b9f-238dbaea48de"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i469ae1eef4044e5f895df14e6080d08a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xMC0xLTEtMjI1Mjcx_766cc32a-953b-41cf-998c-72538a072d0b"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xMi0xLTEtMjI1Mjcx_6437486b-92cd-4f6f-8121-8170999e7cb7"
      unitRef="usd">88765000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1f5e6ae23fa4d63a3b7da9463495857_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xNC0xLTEtMjI1Mjcx_49b72780-93ae-44b9-8388-d2e89f537e78"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMi0xNi0xLTEtMjI1Mjcx_fee89afd-e01d-4aa2-beb7-1d2558fabad9"
      unitRef="usd">88765000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0yLTEtMS0yMjUyNzE_1a09fcee-e5a1-4b26-8d0e-23672144694c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy00LTEtMS0yMjUyNzE_0853ae6e-1106-4432-9c0c-4ba71a777afd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy02LTEtMS0yMjUyNzE_b3be506f-6e0e-498f-90af-33f593f275bd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy04LTEtMS0yMjUyNzE_1070c27d-dc98-47d0-93e0-3c7013dd3b57"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7ab24ba7b7534ef3b931937c49723e05_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xMC0xLTEtMjI1Mjcx_edaf9f34-c509-4a06-81b8-ada44f5e3b20"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xMi0xLTEtMjI1Mjcx_442e961e-d1aa-4455-81cd-b81a12bed00e"
      unitRef="usd">7024000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9776df6071649b4a36a68b2c62e8753_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xNC0xLTEtMjI1Mjcx_d629387d-82aa-4788-8279-54e9d5ae8fdc"
      unitRef="number">0.0648</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMy0xNi0xLTEtMjI1Mjcx_d5ba84cd-b13f-45d2-a41c-0fa74f8d2ae8"
      unitRef="usd">7024000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0yLTEtMS0yMjUyNzE_ffd352a7-4fa9-42d2-a23b-6806f6a64dc1"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC00LTEtMS0yMjUyNzE_23435815-6337-4958-8d88-a5fc08685939"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC02LTEtMS0yMjUyNzE_f55836fc-c62f-4e60-a81b-57a10534a0cd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC04LTEtMS0yMjUyNzE_f4d1a437-32bd-4d41-a85f-02531d3d2953"
      unitRef="usd">800000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i12e46551b1814379a1653a9d1284593d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xMC0xLTEtMjI1Mjcx_a30ddcae-9596-49d0-af3c-768347a7fb23"
      unitRef="number">0.0392</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xMi0xLTEtMjI1Mjcx_b3142336-be6a-4183-b444-196fe3cf7f80"
      unitRef="usd">3209000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib2038eb8ce7646699de4006ca1c495d3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xNC0xLTEtMjI1Mjcx_1aebd736-38c2-4841-a848-5945c384d70e"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNC0xNi0xLTEtMjI1Mjcx_262ff4e5-e958-4e5a-bba9-f212c78488cc"
      unitRef="usd">803209000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0yLTEtMS0yMjUyNzE_cb61667b-d287-4c90-a322-0be8edfc3bb1"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS00LTEtMS0yMjUyNzE_6d4f9ab9-0d6d-4bb0-beeb-1a37aefa5918"
      unitRef="usd">556000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS02LTEtMS0yMjUyNzE_f6a5feeb-c307-4851-9b19-f0cd98c0324f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS04LTEtMS0yMjUyNzE_fabcb912-3a5f-4424-9c76-c1563184968e"
      unitRef="usd">650000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd1122ff910845e8b7d84749fcb941af_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xMC0xLTEtMjI1Mjcx_341cb130-3d66-4780-8b25-1feb754163f8"
      unitRef="number">0.0340</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xMi0xLTEtMjI1Mjcx_4f21bc51-d441-4139-b7be-09d852c6bd0f"
      unitRef="usd">244523000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic734fa1ccf034c29a212f61c7f547e08_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xNC0xLTEtMjI1Mjcx_6941f2a0-a0c0-4173-9751-89fe76f52e87"
      unitRef="number">0.0444</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNS0xNi0xLTEtMjI1Mjcx_7da005a1-939e-4d2d-9443-c8fe206a3d16"
      unitRef="usd">1450523000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0yLTEtMS0yMjUyNzE_8af56210-88e4-438a-aca7-5a96f73e4b43"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi00LTEtMS0yMjUyNzE_c2e742a0-b1fc-4cf2-b3f3-5dcf990cce9a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi02LTEtMS0yMjUyNzE_b678c718-05bf-4b61-9ad6-9e8dbf7cb0b8"
      unitRef="usd">500000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi04LTEtMS0yMjUyNzE_6f72f971-3b88-4a75-807e-81963113a461"
      unitRef="usd">450000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i46f077c3935347968dfccf4e35e46bc8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xMC0xLTEtMjI1Mjcx_8219a5ec-9ec4-4695-b3f7-499dad487e86"
      unitRef="number">0.0154</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xMi0xLTEtMjI1Mjcx_79a1591a-21a7-4a2f-b515-003dcd59d062"
      unitRef="usd">366000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2253586656694cfe961e9fd10a8da88a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xNC0xLTEtMjI1Mjcx_21f4f310-879a-4bc8-8045-4a85fc71fd7f"
      unitRef="number">0.0591</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNi0xNi0xLTEtMjI1Mjcx_1c6c9ab8-1492-49c6-a0bb-bfd2032b5065"
      unitRef="usd">950366000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0yLTEtMS0yMjUyNzE_7b67b0b9-bc7c-4f63-8ced-ae21b86baf94"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy00LTEtMS0yMjUyNzE_75ef0c5d-fff2-439f-bed8-68d85bbb8462"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy02LTEtMS0yMjUyNzE_5f69f73e-0d95-4eb7-aa77-1c1b865f21fb"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy04LTEtMS0yMjUyNzE_28eec776-4553-4394-90b1-a9dfb9831df2"
      unitRef="usd">3200000000</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9765a57b7623473f9f941b33ccfde3f6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xMC0xLTEtMjI1Mjcx_75418b2d-5a64-4f64-89f8-5cb2161200d0"
      unitRef="number">0.0374</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xMi0xLTEtMjI1Mjcx_7f7287ba-480c-4121-ae90-3812abc631ae"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ieb996687cada4f59931cae009c110517_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xNC0xLTEtMjI1Mjcx_0ed6c58d-5e9f-4c53-8d21-64b0c4176d00"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfNy0xNi0xLTEtMjI1Mjcx_591eaadb-a186-466c-a8ac-19f0b03ef9f9"
      unitRef="usd">3200000000</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0yLTEtMS0yMjUyNzE_9b0ead6c-f415-4854-a95a-87eb74d02ab9"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC00LTEtMS0yMjUyNzE_06f29d95-7ec2-4cf0-a85c-e6b712962fb6"
      unitRef="usd">556000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC02LTEtMS0yMjUyNzE_85d9311a-3745-4400-ac2b-132cd8114293"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC04LTEtMS0yMjUyNzE_01969762-1278-4d0d-aec3-a921d5fc9132"
      unitRef="usd">5100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0xMi0xLTEtMjI1Mjcx_06a1733a-58a6-46f0-a82c-000f9feccbca"
      unitRef="usd">343887000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOC0xNi0xLTEtMjI1Mjcx_67c5104b-c4da-46fe-8de4-ac465eb59290"
      unitRef="usd">6499887000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0yLTEtMS0yMjUyNzE_c7e5d241-f591-4c65-bd1f-6c839375a354"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS00LTEtMS0yMjUyNzE_68f781cc-cc15-4413-ad03-62f5f11da599"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS02LTEtMS0yMjUyNzE_9d5826e1-33ec-4f6b-abf9-f9e03c6a10bc"
      unitRef="usd">3832000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS04LTEtMS0yMjUyNzE_6deae941-a3b5-4a17-9fa5-7465ca8d0403"
      unitRef="usd">43457000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0xMi0xLTEtMjI1Mjcx_9d0d16ce-dca0-452c-b533-c0ea5fca3560"
      unitRef="usd">-1280000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfOS0xNi0xLTEtMjI1Mjcx_17898c56-dcdf-4650-a497-355a5ecb0f11"
      unitRef="usd">46009000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebt
      contextRef="i08cad1ea9ea54bcc9bcc51fdc962ce18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMi0xLTEtMjI1Mjcx_a2c64060-3f31-4175-883c-07d2553b3a37"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icc5c2c59eb7c45f4a13c7c00c2706536_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItNC0xLTEtMjI1Mjcx_30876eb9-8cd8-4b52-a165-0997cbf3d9b6"
      unitRef="usd">556000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iea247eaec89041d2888fa7256233e2b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItNi0xLTEtMjI1Mjcx_a67092b0-affa-4ba7-b58c-44a125f99638"
      unitRef="usd">496168000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItOC0xLTEtMjI1Mjcx_2aead66c-ed16-44c4-b709-e64baae6559c"
      unitRef="usd">5056543000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMTItMS0xLTIyNTI3MQ_5e140c4b-8587-4328-84f8-1232a81251b9"
      unitRef="usd">345167000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RhYmxlOmM3YzRhYmRjMWEwNjQ2NjY4MTY5OGZhMjM1NTdiOThiL3RhYmxlcmFuZ2U6YzdjNGFiZGMxYTA2NDY2NjgxNjk4ZmEyMzU1N2I5OGJfMTItMTYtMS0xLTIyNTI3MQ_4dee8826-f51e-4d49-92e3-141ce620dbdc"
      unitRef="usd">6453878000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6ddb72c0e5024725b2aacf24463019d1_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTA5OTQ_737cd129-a618-4f35-9a70-4084bbd69760"
      unitRef="number">0.0154</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i56bcb722a57e4a5eb514929d2ed3a154_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwMDA_f846362a-343a-4aac-b074-c1d58e9352cb"
      unitRef="number">0.0687</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i376fe1f063af437aa4e2b807a6bbf62c_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwNTQ_8c104199-be4c-4060-96ef-2f962c05223e"
      unitRef="number">0.0353</us-gaap:DebtWeightedAverageInterestRate>
    <peak:DebtInstrumentWeightedAverageMaturity
      contextRef="i2c875874da304c448ab2b679d2ced02a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEwOTI_ec56c072-1a51-4b5d-8c4e-66bac425fd0c">P6Y</peak:DebtInstrumentWeightedAverageMaturity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie33b9cb06a4a42afbb61346e750be99c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTExNTQ_3ce66917-f010-46a9-a855-d36dfbd04329"
      unitRef="number">0.0344</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i21b4bc2e6a6546b1a01836e0851863d9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTExNjA_42494a5d-2752-43c0-a739-813656c27e37"
      unitRef="number">0.0852</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i4e6793a63f3b4c6da674c3e1427a0edb_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEyMTQ_9d0b302a-583c-41cd-b994-a6b7b8f26559"
      unitRef="number">0.0431</us-gaap:DebtWeightedAverageInterestRate>
    <peak:DebtInstrumentWeightedAverageMaturity
      contextRef="i56151a9adcc746a491a683137e5b44aa_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl81OC9mcmFnOjZkZTYwOGU4Y2QzNzQxNmE5NGM3YmM3NzQxYjRlYWNiL3RleHRyZWdpb246NmRlNjA4ZThjZDM3NDE2YTk0YzdiYzc3NDFiNGVhY2JfMTEyNTI_f2ef5890-a05d-465b-b238-359a959dea94">P3Y</peak:DebtInstrumentWeightedAverageMaturity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMjE2Nw_5598c5a6-fc54-4cd0-866b-b6a873638ae6">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#x2019;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#x2019;s financial condition, results of operations, or cash flows. The Company&#x2019;s policy is to expense legal costs as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DownREITs and Other Partnerships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of certain limited liability companies (&#x201c;DownREITs&#x201d;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#x201c;make-whole payments&#x201d;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of 29 properties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Company owns a 49% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <peak:ContributionOfPropertyNumberOfProperties
      contextRef="icd23299bf615464e91aa88b816387e2f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMTc5Mg_6a521547-e784-43d6-89a5-bf9c7c720a35"
      unitRef="property">29</peak:ContributionOfPropertyNumberOfProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibc7a7c8342fd4301bda1ac23efa4626c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82MS9mcmFnOjU1MGVmMGFjY2JjMzQxODQ4MzZjMDk3NGQ2NzU1MjEzL3RleHRyZWdpb246NTUwZWYwYWNjYmMzNDE4NDgzNmMwOTc0ZDY3NTUyMTNfMTg0MQ_2918a23c-0056-49b2-bc7c-30c28c5c2a73"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk2Nw_f017b699-4ff1-48e3-bcc6-19c886f5c8aa">Equity and Redeemable Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share. The common stock cash dividend will be paid on May 19, 2023 to stockholders of record as of the close of business on May 8, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During each of the three months ended March&#160;31, 2023 and 2022, the Company declared and paid common stock cash dividends of $0.30 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;At-The-Market Equity Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, in connection with the UPREIT reorganization, the Company terminated the previous at-the-market equity offering program (as amended from time to time, the &#x201c;2020 ATM Program&#x201d;) and established a new at-the-market equity offering program (the &#x201c;2023 ATM Program&#x201d; and, together with the 2020 ATM Program, the &#x201c;ATM Programs&#x201d;). The ATM Programs allow for the sale of shares of common stock having an aggregate gross sales price of up to $1.5 billion (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#x201c;ATM forward contract&#x201d;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ATM forward contracts generally have a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTUwMw_5ce2ccbc-5900-4089-b403-cb14df27b311"&gt;one&lt;/span&gt; to two year term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#x2019;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#x2019; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.5 billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the Company&#x2019;s common stock remained available for sale under the 2023 ATM Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ATM Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company utilized the forward provisions under the 2020 ATM Program to allow for the sale of an aggregate of 9.1&#160;million shares of its common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;at an initial weighted average net price of $35.25 per share, after commissions. The Company did not enter into any forward contracts under the 2020 ATM Program during the year ended December 31, 2022. In December 2022, the Company settled all 9.1&#160;million shares previously outstanding under ATM forward contracts at a weighted average net price of $34.01 per share, after commissions, resulting in net proceeds of $308&#160;million. During the three months ended March&#160;31, 2023, the Company did not utilize the forward provisions under the ATM Programs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ATM Direct Issuances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During each of the three months ended March&#160;31, 2023 and March&#160;31, 2022, there were no direct issuances of shares of common stock under the ATM Programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2022, the Company&#x2019;s Board of Directors approved a share repurchase program under which the Company may acquire shares of its common stock in the open market up to an aggregate purchase price of $500&#160;million (the &#x201c;Share Repurchase Program&#x201d;). Purchases of common stock under the Share Repurchase Program may be exercised at the Company&#x2019;s discretion with the timing and number of shares repurchased depending on a variety of factors, including price, corporate and regulatory requirements, and other corporate liquidity requirements and priorities. The Share Repurchase Program expires in August 2024 and may be suspended or terminated at any time without prior notice. Under Maryland General Corporation Law, outstanding shares of common stock acquired by a corporation become authorized but unissued shares, which may be re-issued. In August 2022, the Company repurchased 2.1&#160;million shares of its common stock at a weighted average price of $27.16 per share for a total of $56&#160;million. During the three months ended March&#160;31, 2023, there were no repurchases under the Share Repurchase Program. Therefore, at March&#160;31, 2023, $444&#160;million of the Company&#x2019;s common stock remained available for repurchase under the Share Repurchase Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accumulated other comprehensive income (loss) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on derivatives, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental Executive Retirement Plan minimum liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a defined benefit pension plan, known as the Supplemental Executive Retirement Plan, with one plan participant, a former Chief Executive Officer (&#x201c;CEO&#x201d;) of the Company who departed in 2003. Changes to the Supplemental Executive Retirement Plan minimum liability are reflected in other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#x2019;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, one of the redeemable noncontrolling interests met the conditions for redemption, but was not yet exercised as of March&#160;31, 2023. The three remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2023 or December&#160;31, 2022. Two of the interests will become redeemable following the passage of a predetermined amount of time, which will occur during 2023 and 2024. The third interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2024. The redemption values are subject to change based on the assessment of redemption value at each redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Healthpeak OP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately following the Reorganization, Healthpeak Properties, Inc. was the initial sole member and 100% owner of Healthpeak OP. Subsequent to the Reorganization, certain employees of the Company (&#x201c;OP Unitholders&#x201d;) were issued noncontrolling, non-managing member units in Healthpeak OP (&#x201c;OP Units&#x201d;). As of March&#160;31, 2023, Healthpeak Properties, Inc. owned 99.6% of Healthpeak OP, with the OP Unitholders owning the remaining 0.4%. When certain conditions are met, the OP Unitholders have the right to require redemption of part or all of their OP Units for cash or shares of the Company&#x2019;s common stock, at the Company&#x2019;s option as managing member of Healthpeak OP. The per unit redemption amount is equal to either one share of the Company&#x2019;s common stock or cash equal to the fair value of a share of common stock at the time of redemption. The Company classifies the OP Units in permanent equity because it may elect, in its sole discretion, to issue shares of its common stock to OP Unitholders who choose to redeem their OP Units rather than using cash. None of the outstanding OP Units met the criteria for redemption as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DownREITs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The non-managing member units of the Company&#x2019;s DownREITs are exchangeable for an amount of cash approximating the then-current market value of shares of the Company&#x2019;s common stock or, at the Company&#x2019;s option, shares of the Company&#x2019;s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company&#x2019;s common stock, the carrying amount of the DownREIT units is reclassified to stockholders&#x2019; equity. At March&#160;31, 2023, there were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;five million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DownREIT units (seven million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares of Healthpeak common stock are issuable upon conversion) outstanding in&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;seven&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DownREIT&#160;LLCs, for all of which the Company acts as the managing member. At March&#160;31, 2023, the carrying and market values of the five million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DownREIT units were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$200&#160;million and $160&#160;million, respectively. At December&#160;31, 2022, the carrying and market values of the five million DownREIT units were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$200&#160;million and $183&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9ae86f1b07b148be8f4de81f938ee842_D20230427-20230427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTgz_f44713a9-1582-4e44-bcfc-facb6781030d"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_3f2c3cc0-8d55-4669-868e-43810b703b4b"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_85f1224b-4ef8-443e-a915-64c0b097d416"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_896527d5-2411-4091-9f4c-4eb33e706837"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNDQ3_d2ba14cb-a70e-4531-a3bc-e104e28a7af1"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <peak:AtmEquityOfferingProgramAggregateAmountAuthorized
      contextRef="ie980168387e14a51a49837fe74a3b54e_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfOTM3_71d34c83-8e66-43ef-86dc-489dbd3e0910"
      unitRef="usd">1500000000</peak:AtmEquityOfferingProgramAggregateAmountAuthorized>
    <peak:OptionIndexedToIssuersEquityTerm
      contextRef="i22723edd392546a88d01e90f6ec4ae55_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk3MQ_60c76e75-32a4-4eda-95d7-553b81af891f">P2Y</peak:OptionIndexedToIssuersEquityTerm>
    <peak:ATMEquityOfferingProgramAggregateAmountRemaining
      contextRef="i7b96d988a94d4b5ca66cf68c72e38da9_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjA4Ng_660b33a9-d6b7-44b3-9c1b-8edad0c60e81"
      unitRef="usd">1500000000</peak:ATMEquityOfferingProgramAggregateAmountRemaining>
    <us-gaap:ForwardContractIndexedToIssuersEquityShares
      contextRef="i8051818203c34f2692f50e33f9538046_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjMzMQ_00a0426d-d169-4f48-bfd3-62b537c388b4"
      unitRef="shares">9100000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
    <us-gaap:ForwardContractIndexedToIssuersEquityForwardRate
      contextRef="i8051818203c34f2692f50e33f9538046_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjQwNQ_0fb610ba-8452-4115-9e8a-2e5937bae523"
      unitRef="usdPerShare">35.25</us-gaap:ForwardContractIndexedToIssuersEquityForwardRate>
    <us-gaap:ForwardContractIndexedToIssuersEquityShares
      contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ3MA_730deaf1-fc77-4100-828b-3de8a6b825c1"
      unitRef="shares">9100000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
    <us-gaap:ForwardContractIndexedToIssuersEquityForwardRate
      contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ4Mw_b0303a77-75fd-4df7-8dea-bde3d0b85dfd"
      unitRef="usdPerShare">34.01</us-gaap:ForwardContractIndexedToIssuersEquityForwardRate>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i778e5b0baba642d79a5395664c15c5d9_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NjQ5MQ_c1a693e5-c6f8-482e-93c8-b4a4f4d4ab3b"
      unitRef="usd">308000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i37deeeb2d4054785a004587600392cdb_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjg1Mg_6a11821d-2d20-4165-a81e-b692424d077b"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if38c0299b9e346949730c17e3fc40429_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjg1Mg_c6d7e352-8f09-42e7-a285-a76ab8e50ecf"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i89c46ce3b6194ec8a6f4bdaad32eab03_I20220801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMzE1Mw_0e47f2c3-72d1-49f3-8dab-07d4f655f52f"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM0NTg_4f7c95bb-6641-41fd-83ab-b2992514f85d"
      unitRef="shares">2100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM0NTg_ca91e026-e3c7-4854-b7eb-a89af6da4b36"
      unitRef="shares">2100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1MjA_19dbf415-c9a6-449f-abc4-8e94e7d2b777"
      unitRef="usdPerShare">27.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1MjA_d87e2bb9-10b1-4b07-9876-75434a1c6d86"
      unitRef="usdPerShare">27.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1NDk_116b078c-b5b2-4f63-b021-6391126ae763"
      unitRef="usd">56000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2d0b64c4e63b4d5d9a9bca810b6dd97c_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzM1NDk_25833348-bb30-4554-aa4b-bdb863efe568"
      unitRef="usd">56000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NTk4Nw_aa9de332-9037-46e9-b596-80a260cfea5a"
      unitRef="usd">0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMzc4Mg_c5a6e377-146e-4768-88cc-ee55c8b2c246"
      unitRef="usd">444000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTk2NA_157bdfe9-1fa9-4af9-a504-cbff61c712d2">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accumulated other comprehensive income (loss) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on derivatives, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental Executive Retirement Plan minimum liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMi0yLTEtMS0yMjUyNzE_b4544588-f363-4dfc-a50f-2c3965f63968"
      unitRef="usd">20668000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMi00LTEtMS0yMjUyNzE_d3d7260a-2d47-4242-8af9-92f7f8e1c30d"
      unitRef="usd">30145000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMy0yLTEtMS0yMjUyNzE_22456e82-0fc8-46d5-829c-006954b26cbe"
      unitRef="usd">1947000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfMy00LTEtMS0yMjUyNzE_b4ce70c9-3906-4675-9510-04733ee7326a"
      unitRef="usd">2011000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfNS0yLTEtMS0yMjUyNzE_25610848-8adf-44ce-aa77-aeff52edd446"
      unitRef="usd">18721000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RhYmxlOmVjYjcwMTVkYmZkYzQ1M2M5OTU2YjdmNzIyNmU4MmJkL3RhYmxlcmFuZ2U6ZWNiNzAxNWRiZmRjNDUzYzk5NTZiN2Y3MjI2ZTgyYmRfNS00LTEtMS0yMjUyNzE_049887cf-3df7-4598-917a-5b9a703cc7ce"
      unitRef="usd">28134000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <peak:NumberOfPlanParticipants
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTA5OTUxMTY0NzE0OA_724ea676-557a-4d7b-8352-6b8a9cb9e749"
      unitRef="plan_participant">1</peak:NumberOfPlanParticipants>
    <peak:NumberOfRedeemableNoncontrollingInterestRedemptions
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3Nzg3NQ_a1bff7fe-932e-4d9f-8d7a-7152ede47b3f"
      unitRef="interest">1</peak:NumberOfRedeemableNoncontrollingInterestRedemptions>
    <peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3Nzg5NA_00994f8e-0fc1-4ed5-ab87-b9e0a04d88a3"
      unitRef="interest">3</peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime>
    <peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime
      contextRef="i6f249757fb504a429bb6dd03fb8bb2be_D20230101-20241231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA3NzkwMA_cf2d0553-8b4d-4727-99a0-fa9c8c9b2836"
      unitRef="interest">2</peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i6d31221783254ce6bc6a96ffefb649d9_I20230210"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA4OTE4Ng_c4dfdff2-549f-402e-a097-27b8cdfd0e36"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i8e5a31f73d324958966392fee1b98bb2_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMjc0ODc3OTA4MDU3Nw_e73bcb2b-70c0-4896-869e-bc93bfa94257"
      unitRef="number">0.996</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <peak:RemainingMinorityInterestOwnershipPercentageByParent
      contextRef="i8e5a31f73d324958966392fee1b98bb2_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNjA0NzMxMzk2NjYwMQ_39d53831-a5ee-46b4-b52a-377886718a2c"
      unitRef="number">0.004</peak:RemainingMinorityInterestOwnershipPercentageByParent>
    <peak:DownREITUnitsOutstanding
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzQwNzg_a6587876-0add-4a69-ab02-fc06ed23bf1b"
      unitRef="shares">5000000</peak:DownREITUnitsOutstanding>
    <peak:CommonStockConvertibleSharesIssuable
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MDU1_bab5b2d3-38bc-4e4d-88bd-31a74cf5557e"
      unitRef="shares">7000000</peak:CommonStockConvertibleSharesIssuable>
    <peak:NumberOfDownREITLLCs
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MDg3_943959d3-2ea6-432d-b84a-ddc0a4a6f868"
      unitRef="entity">7</peak:NumberOfDownREITLLCs>
    <peak:DownREITUnitsOutstanding
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfMTIwOTQ2Mjc5MzQwOTA_a6587876-0add-4a69-ab02-fc06ed23bf1b"
      unitRef="shares">5000000</peak:DownREITUnitsOutstanding>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1Mjcz_2a7c8cb1-f0fb-40ec-980a-7a0ec8ac0cf1"
      unitRef="usd">200000000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <peak:MinorityInterestInPreferredUnitHoldersFairValue
      contextRef="i252b5f72bd3f474cb0b445240f777230_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM1MzAx_5762e85b-03e9-4e13-aaf0-7f628777d417"
      unitRef="usd">160000000</peak:MinorityInterestInPreferredUnitHoldersFairValue>
    <peak:DownREITUnitsOutstanding
      contextRef="i530e671af080458e9ba7b21a10d74180_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNTQ5NzU1ODM0ODk1_77714535-b6eb-4f0a-85e8-994d1ca6def7"
      unitRef="shares">5000000</peak:DownREITUnitsOutstanding>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="i530e671af080458e9ba7b21a10d74180_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNzE0NjgyNTYwMzgxMQ_08a28506-08d7-4d8f-b1f7-48721b6f40f5"
      unitRef="usd">200000000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <peak:MinorityInterestInPreferredUnitHoldersFairValue
      contextRef="i530e671af080458e9ba7b21a10d74180_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82NC9mcmFnOjk1MmY0NGQ3MWU0YjQwNThiZTliZmM4MWM4Y2Q3YjQyL3RleHRyZWdpb246OTUyZjQ0ZDcxZTRiNDA1OGJlOWJmYzgxYzhjZDdiNDJfNzE0NjgyNTYwMzgyNQ_fe039b83-bcfc-45dd-85f7-41cc8427c42e"
      unitRef="usd">183000000</peak:MinorityInterestInPreferredUnitHoldersFairValue>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjU2MA_1b4cc41e-e87a-48da-a529-a436123ff908">Earnings Per Common Share&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income (loss) per common share (&#x201c;EPS&#x201d;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method, common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#x2019;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#x2019;s diluted weighted-average common shares for each of the three months ended March&#160;31, 2023 and 2022 was&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;zero&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;weighted-average incremental shares from forward equity sales agreements.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Participating securities' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares - equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023, forward equity sales agreements had no dilutive impact as no shares were outstanding under ATM forward contracts during the period. For the three months ended March&#160;31, 2022, the 9.1 million shares under forward equity sales agreements that had not been settled during the three months then ended were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022, all 7 million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMTY4Ng_3f22b4b1-65a0-4795-9306-41cb270dbd87"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMTY4Ng_4e4fdada-0114-4770-b62f-c4ed477cdd28"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjU2Nw_b823f025-4ecb-4920-b7f9-37750eab264a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Participating securities' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;546,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares - equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;547,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;(1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options).</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMy0xLTEtMS0yMjUyNzE_e0ef2b00-8e0b-4508-a859-575085176add"
      unitRef="usd">134507000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMy0zLTEtMS0yMjUyNzE_604c1f76-a703-4a56-bdcc-a096f97a9543"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNC0xLTEtMS0yMjUyNzE_e73f7ac9-c9eb-4b26-a2fd-2ebf347858ce"
      unitRef="usd">15555000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNC0zLTEtMS0yMjUyNzE_aece1cb7-691c-4280-ad90-f2ff17dc3565"
      unitRef="usd">3730000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNS0xLTEtMS0yMjUyNzE_5c75b285-58a7-4b48-9452-8c520283c8e3"
      unitRef="usd">118952000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNS0zLTEtMS0yMjUyNzE_d1e0afdb-33a7-4ca2-a75f-f20778664054"
      unitRef="usd">71296000</us-gaap:IncomeLossFromContinuingOperations>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNi0xLTEtMS0yMjUyNzE_5e0901ce-3541-4e25-808e-2212d3fff5f6"
      unitRef="usd">1254000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNi0zLTEtMS0yMjUyNzE_11fcce6c-ad2f-479c-896b-40ed714b81a5"
      unitRef="usd">1976000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNy0xLTEtMS0yMjUyNzE_fb7af170-fe79-41c4-b70d-5179d09ae2b2"
      unitRef="usd">117698000</peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic>
    <peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfNy0zLTEtMS0yMjUyNzE_793a9c89-9a31-42e7-92a9-422839ede0dc"
      unitRef="usd">69320000</peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfOC0xLTEtMS0yMjUyNzE_3290ffe4-9d92-439c-a3ff-cfa80600f911"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfOC0zLTEtMS0yMjUyNzE_3489f416-19b5-42f1-a78c-3d70a81f1bf3"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMS0xLTEtMjI1Mjcx_0dc2f718-656b-4e9a-9c64-1dabf142141d"
      unitRef="usd">117698000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMS0xLTEtMjI1Mjcx_f9bc5d58-cfae-4efd-8d0f-09257932aeb3"
      unitRef="usd">117698000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMy0xLTEtMjI1Mjcx_3af4a83a-3d02-4151-b379-d506d1847661"
      unitRef="usd">69637000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTAtMy0xLTEtMjI1Mjcx_f6ad8c11-316e-48f4-86f4-7c9f8de4a32f"
      unitRef="usd">69637000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTYtMS0xLTEtMjI1Mjcx_e4fdd566-304f-4835-8402-cb06357836ac"
      unitRef="shares">546842000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTYtMy0xLTEtMjI1Mjcx_cc306484-02ae-4ca8-8b04-611a6cb1fa57"
      unitRef="shares">539352000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTctMS0xLTEtMjI1Mjcx_89d79a12-3ee6-4924-8cf0-beba4b600a11"
      unitRef="shares">268000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMTctMy0xLTEtMjI1Mjcx_2db8709a-f5d2-47d2-997c-e62da0e0f811"
      unitRef="shares">234000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjAtMS0xLTEtMjI1Mjcx_794f69c7-8049-4a40-af42-80db62536100"
      unitRef="shares">547110000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjAtMy0xLTEtMjI1Mjcx_0cc96b71-15c8-4aa3-93aa-02335da177eb"
      unitRef="shares">539586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjItMS0xLTEtMjI1Mjcx_3d348ea4-6d07-4f06-a742-4842a484f4d0"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjItMy0xLTEtMjI1Mjcx_eb8969f9-6b33-4ff4-b308-d496ad690f99"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjMtMS0xLTEtMjI1Mjcx_f800c764-1f97-4710-bc47-5f7d751f9e34"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjMtMy0xLTEtMjI1Mjcx_32942715-a45d-4d58-a9ae-20ad8093f02b"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjQtMS0xLTEtMjI1Mjcx_084ab728-48b0-4b6a-a4cf-a406f714a3a5"
      unitRef="usdPerShare">0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjQtMy0xLTEtMjI1Mjcx_2b353618-e93b-453e-9af0-95298888dec0"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjYtMS0xLTEtMjI1Mjcx_2c0b182e-d2ff-4342-a563-899a6117dae6"
      unitRef="usdPerShare">0.22</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjYtMy0xLTEtMjI1Mjcx_0c502cfb-6f6e-4c49-994f-324329cf2533"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjctMS0xLTEtMjI1Mjcx_c8541e3c-911f-4761-a7ff-36c057602290"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjctMy0xLTEtMjI1Mjcx_049e8a14-2e68-4c65-af28-a6a4ace20963"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjgtMS0xLTEtMjI1Mjcx_fa00c3a0-5b68-454f-a63c-c1e8a1c17366"
      unitRef="usdPerShare">0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RhYmxlOmVkYTliNDAxZmUzZDRmZTJhYmIzMTJkNzRlYzdkNTkyL3RhYmxlcmFuZ2U6ZWRhOWI0MDFmZTNkNGZlMmFiYjMxMmQ3NGVjN2Q1OTJfMjgtMy0xLTEtMjI1Mjcx_5b7c9800-2229-4ba8-aa36-73354afbbfa4"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjAwMg_13ee00a3-40d3-4566-bb44-2c8687eced1e"
      unitRef="shares">1000000</peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards>
    <peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjAwMg_e6e5180a-b98d-4fb0-8aab-b2d0c9f10ef3"
      unitRef="shares">1000000</peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i89007938f53d4ab597b1694f0b7aa3a3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjc0ODc3OTA3NzQ4MQ_135b69c2-1ffb-496a-a42a-bf8e3ada66ad"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2b23f95c9490405980d3b3ccc448589e_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjc0ODc3OTA3NzYxMw_f7d6cd43-61fb-49a7-840b-ad3f75099f23"
      unitRef="shares">9100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4e4a87426c744c7ab4128e461f3c1dce_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjQ1Mg_03a49cb1-2c4d-435d-b786-25cfcd7d5db9"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icc3bbec47ce44e14b11efe8fe8b782a7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl82Ny9mcmFnOmQ5YWQxYWE3NGIxOTQ0YzFhNzI0NDIwN2EwZTI2OWFlL3RleHRyZWdpb246ZDlhZDFhYTc0YjE5NDRjMWE3MjQ0MjA3YTBlMjY5YWVfMjQ1Mg_43bbc2f9-5671-4a64-92f5-4b39499882d3"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfNDE1Mg_65bd1b01-1f0e-4e0e-ac4f-4261c589d777">Segment Disclosures&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments, based on how its chief operating decision maker (&#x201c;CODM&#x201d;) evaluates the business and allocates resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#x2019;s interests in an unconsolidated JV that owns 19 senior housing assets (the &#x201c;SWF SH JV&#x201d;), loans receivable, and marketable debt securities. These non-reportable segments have been presented on an aggregate basis within the Notes to the Consolidated Financial Statements herein. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC, as updated by Note 2 herein. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOI and Adjusted NOI are non-GAAP supplemental measures that are calculated as NOI and Adjusted NOI from consolidated properties, plus the Company&#x2019;s share of NOI and Adjusted NOI from unconsolidated joint ventures (calculated by applying the Company&#x2019;s actual ownership percentage for the period), less noncontrolling interests&#x2019; share of NOI and Adjusted NOI from consolidated joint ventures (calculated by applying the Company&#x2019;s actual ownership percentage for the period). Management utilizes its share of NOI and Adjusted NOI in assessing its performance as the Company has various joint ventures that contribute to its performance. The Company does not control its unconsolidated joint ventures, and the Company&#x2019;s share of amounts from unconsolidated joint ventures do not represent the Company&#x2019;s legal claim to such items. The Company&#x2019;s share of NOI and Adjusted NOI should not be considered a substitute for, and should only be considered together with and as a supplement to, the Company&#x2019;s financial information presented in accordance with GAAP. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-segment assets consist of assets in the Company&#x2019;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable debt securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information for the reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;525,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(223,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(207,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(177,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Notes 3, 4, 5, 6, 7, and 15 for significant transactions impacting the Company&#x2019;s segment assets during the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfMzc4_2a8d85de-3899-48a0-a51e-7f62358b9cd7"
      unitRef="property">19</peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RleHRyZWdpb246YWQ4M2FlYmFmMjNlNGI3YjgyOGRkM2QzMTc4NTEzMjdfNDE2NA_d0d0ed00-bf7b-45c7-9c76-04652d9b750d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information for the reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;525,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(223,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(832)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,920)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(179,225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(207,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(177,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;(2)Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0yLTEtMS0yMjUyNzE_5ae3069b-3d9a-41d0-ac05-0bba5e95fbfd"
      unitRef="usd">205464000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS00LTEtMS0yMjUyNzE_3305024f-947a-490b-9629-42f7bf8ef7d8"
      unitRef="usd">186967000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS02LTEtMS0yMjUyNzE_463a5e38-dde0-4592-baac-45e6b03e1749"
      unitRef="usd">127084000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS04LTEtMS0yMjUyNzE_3068b020-6682-4d98-8080-46bf8e9fafc1"
      unitRef="usd">6163000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0xMC0xLTEtMjI1Mjcx_c72e624e-7ca0-4fbf-b9ba-89a8eb6e6b2f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMS0xMi0xLTEtMjI1Mjcx_d0d88d90-2650-4809-acee-fc19b8239df4"
      unitRef="usd">525678000</us-gaap:Revenues>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0yLTEtMS0yMjUyNzE_994b25d0-b35c-4974-a503-a02c66d7d85c"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi00LTEtMS0yMjUyNzE_70e4ea19-cbb9-4372-9974-b8d22554ffe0"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi02LTEtMS0yMjUyNzE_400d045a-83d0-4481-9b7d-952dda3c3ec9"
      unitRef="usd">137000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi04LTEtMS0yMjUyNzE_98a4c66e-ce6c-4e7e-8929-86f7ce235105"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0xMC0xLTEtMjI1Mjcx_7d6f5205-d15b-4a2e-9869-a2b0fd417a0f"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMi0xMi0xLTEtMjI1Mjcx_7ba3b872-7afc-474c-9d25-32a1951b31d8"
      unitRef="usd">137000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0yLTEtMS0yMjUyNzE_f2e29670-4c09-44d1-a3c3-74cc92eb3029"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy00LTEtMS0yMjUyNzE_149cd1af-6d45-4086-8604-7c82d5622210"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy02LTEtMS0yMjUyNzE_ee69aac2-8b8c-4f70-a6dc-3afb1ec09a1b"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy04LTEtMS0yMjUyNzE_c098ad0e-5f84-48d1-a348-76a88567fb43"
      unitRef="usd">6163000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0xMC0xLTEtMjI1Mjcx_bec1e6fe-5ee3-49cd-a727-b7e3eb458298"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMy0xMi0xLTEtMjI1Mjcx_12877b42-210a-4a30-a2b8-051c449a164a"
      unitRef="usd">6163000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0yLTEtMS0yMjUyNzE_5be41e9b-41f9-416d-8cd8-bc592d3c2f53"
      unitRef="usd">2165000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC00LTEtMS0yMjUyNzE_3a4507b8-e400-4999-b12a-4f02b70f819a"
      unitRef="usd">745000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC02LTEtMS0yMjUyNzE_21884aab-2823-4f02-88df-fda28ffe9225"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC04LTEtMS0yMjUyNzE_c012fe67-bd6d-4240-a409-a4f788730462"
      unitRef="usd">20346000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0xMC0xLTEtMjI1Mjcx_ec54c1e9-4c37-4c9a-bc70-43b7ad92e3b9"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNC0xMi0xLTEtMjI1Mjcx_d1f63096-4efa-4d00-bb91-ca395ce96f56"
      unitRef="usd">23256000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0yLTEtMS0yMjUyNzE_fe351e91-2fc5-420d-b1e1-61f31b38872f"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS00LTEtMS0yMjUyNzE_d38367d9-91d8-4252-b2b9-344ca3986b81"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS02LTEtMS0yMjUyNzE_58199893-ce48-4170-88c1-d0c2acc0aa9b"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS04LTEtMS0yMjUyNzE_1b080602-9736-4a69-b9ec-32306f7b3b7d"
      unitRef="usd">228000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0xMC0xLTEtMjI1Mjcx_6e675f99-2018-4151-9012-331eceda8b44"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNS0xMi0xLTEtMjI1Mjcx_b77690e1-de0b-441a-9383-97be4ef69b43"
      unitRef="usd">228000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0yLTEtMS0yMjUyNzE_c8af2759-aca4-45c1-b9d6-73096a4e1971"
      unitRef="usd">143000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi00LTEtMS0yMjUyNzE_27fde9c4-bf08-4a30-9e2f-2a465fac999a"
      unitRef="usd">8963000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi02LTEtMS0yMjUyNzE_2a9cf8bf-c4e8-4316-96da-171a06eb8adb"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi04LTEtMS0yMjUyNzE_b18963ed-b170-41c7-b914-7cb79b0c16ca"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0xMC0xLTEtMjI1Mjcx_e4493c08-bd0a-4ae3-b2be-b1b2a551e97b"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNi0xMi0xLTEtMjI1Mjcx_994ee5b9-91f6-46da-959c-5131b2c4a2b0"
      unitRef="usd">9106000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <us-gaap:OperatingExpenses
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0yLTEtMS0yMjUyNzE_b869a293-d81e-4f6f-8520-5e7f2679f98e"
      unitRef="usd">57566000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy00LTEtMS0yMjUyNzE_94a54d72-2b2e-4c9f-a220-477fb3bfe8c9"
      unitRef="usd">64398000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy02LTEtMS0yMjUyNzE_b3d68af4-0326-448a-a806-b181a944ae36"
      unitRef="usd">101124000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy04LTEtMS0yMjUyNzE_078d3a7e-0565-4404-a517-0d1fb020aca3"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0xMC0xLTEtMjI1Mjcx_b24e52fd-42c2-41b1-bca3-bb6907e62ce8"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfNy0xMi0xLTEtMjI1Mjcx_06a260c6-3627-4000-9b2e-adad1f131ae1"
      unitRef="usd">223088000</us-gaap:OperatingExpenses>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0yLTEtMS0yMjUyNzE_1394fb76-3015-44aa-969e-b74bd2f45a58"
      unitRef="usd">1182000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC00LTEtMS0yMjUyNzE_1aae102e-f092-4ff2-a72a-b6cea34d4898"
      unitRef="usd">305000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC02LTEtMS0yMjUyNzE_dc478de7-d2b5-42bf-a67a-189f22004447"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC04LTEtMS0yMjUyNzE_5b476de7-3f42-4499-a19f-1760fb778b5f"
      unitRef="usd">15006000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0xMC0xLTEtMjI1Mjcx_dd2bcae1-3385-4daf-8a01-1378d6f6d9f9"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOC0xMi0xLTEtMjI1Mjcx_0d5b1df7-b8c8-40d3-99c3-01e914b0b82f"
      unitRef="usd">16493000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0yLTEtMS0yMjUyNzE_7ff1a213-069b-4551-b0c5-0d17e76d089c"
      unitRef="usd">40000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS00LTEtMS0yMjUyNzE_475588f5-7cb8-42f0-932d-770d66acd5a3"
      unitRef="usd">2595000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS02LTEtMS0yMjUyNzE_fb620b2a-ebe1-48dd-a8bd-c1d8b1b7ecbf"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS04LTEtMS0yMjUyNzE_d755b040-767a-4f1f-91a4-1fbe701056da"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0xMC0xLTEtMjI1Mjcx_d8aa2568-45eb-4e61-b792-b7a4f006cf37"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfOS0xMi0xLTEtMjI1Mjcx_ec144278-6e6b-49b3-b5ea-41e88b58d46c"
      unitRef="usd">2635000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMi0xLTEtMjI1Mjcx_54b75f48-6490-4fd1-964c-879082bc7284"
      unitRef="usd">-832000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtNC0xLTEtMjI1Mjcx_16c523a1-905a-4fc2-874c-87b1ef049d19"
      unitRef="usd">-3821000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtNi0xLTEtMjI1Mjcx_410cc081-9ade-40aa-ac92-78aef286feb7"
      unitRef="usd">50000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtOC0xLTEtMjI1Mjcx_894d2974-f80c-40eb-9635-a1b8c737fec6"
      unitRef="usd">-21000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMTAtMS0xLTIyNTI3MQ_7ec55353-c064-4858-89ce-a09234b3b887"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTEtMTItMS0xLTIyNTI3MQ_77daba9a-0f45-416a-bc4d-0779ed73fcce"
      unitRef="usd">-4624000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMi0xLTEtMjI1Mjcx_e62c1c83-5f0f-492f-afda-4fcaeeb72a59"
      unitRef="usd">147946000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItNC0xLTEtMjI1Mjcx_c1864139-c980-4403-8ae5-44c3de8e920b"
      unitRef="usd">112820000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItNi0xLTEtMjI1Mjcx_04e295d1-8126-4d47-abf9-00bcde534907"
      unitRef="usd">26147000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItOC0xLTEtMjI1Mjcx_5d6e43e9-4350-41fc-9829-facb9ca526e4"
      unitRef="usd">5547000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMTAtMS0xLTIyNTI3MQ_9379448c-d93e-4bb1-a6b9-429c7b3a04d8"
      unitRef="usd">0</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTItMTItMS0xLTIyNTI3MQ_1de3cda8-2681-4469-b2c4-ed6e9ee6692d"
      unitRef="usd">292460000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMi0xLTEtMjI1Mjcx_d4b4c93f-0154-48fd-b4a1-559b43b32eab"
      unitRef="usd">832000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtNC0xLTEtMjI1Mjcx_0115353a-2f2a-4b63-8f39-1fcad98a8292"
      unitRef="usd">3821000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtNi0xLTEtMjI1Mjcx_0a735ff9-285e-48cc-9df8-65553012d0b6"
      unitRef="usd">-50000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtOC0xLTEtMjI1Mjcx_eeec5636-77d5-452b-829c-823d6a7abd56"
      unitRef="usd">21000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMTAtMS0xLTIyNTI3MQ_e3cb8a35-77b7-4f99-9043-48107300c117"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTMtMTItMS0xLTIyNTI3MQ_aa185041-1249-4990-bc36-99ced00579f8"
      unitRef="usd">4624000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <us-gaap:InterestIncomeOperating
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMi0xLTEtMjI1Mjcx_a23f2bdd-dbd9-49e1-9a6b-47aea98cdb23"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtNC0xLTEtMjI1Mjcx_6bab59aa-4928-4b5f-99a2-49db31db166b"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtNi0xLTEtMjI1Mjcx_7892985c-9312-407c-8aa9-fad95b916dc0"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtOC0xLTEtMjI1Mjcx_d6ad97b6-5620-468b-ab7a-5fba5eba1d23"
      unitRef="usd">6163000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMTAtMS0xLTIyNTI3MQ_8c7bbc13-c1ce-4c6f-b708-31b53459188c"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTQtMTItMS0xLTIyNTI3MQ_f6a115d7-24d7-46bd-a5c0-194c7180bccd"
      unitRef="usd">6163000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMi0xLTEtMjI1Mjcx_862461cf-4753-4267-8b39-b311180005ec"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtNC0xLTEtMjI1Mjcx_a03ba983-47c9-4231-ba47-9f1d2c334630"
      unitRef="usd">1920000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtNi0xLTEtMjI1Mjcx_9477b8f7-8880-4c07-87a9-e3aad5289d37"
      unitRef="usd">1816000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtOC0xLTEtMjI1Mjcx_276c32fb-f55d-44bd-897f-9402de56efc0"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMTAtMS0xLTIyNTI3MQ_6fdfce2e-4a57-4efc-8c64-b9cf1f4bc42b"
      unitRef="usd">44227000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTUtMTItMS0xLTIyNTI3MQ_19f962dd-73b5-4e44-b7de-1230ead505a4"
      unitRef="usd">47963000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMi0xLTEtMjI1Mjcx_07f15326-5139-41ee-ad31-620e1fa79280"
      unitRef="usd">75582000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtNC0xLTEtMjI1Mjcx_cd98ec55-1584-4415-b3e6-f471162d5d4b"
      unitRef="usd">71158000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtNi0xLTEtMjI1Mjcx_8ec4152c-1b7f-4b6c-9406-0f7327b9e42a"
      unitRef="usd">32485000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtOC0xLTEtMjI1Mjcx_414fef7a-d3a7-4bbe-aace-78dddeb507ee"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMTAtMS0xLTIyNTI3MQ_6caff81e-c96d-4d11-ae4e-c8f1e664f4ee"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTYtMTItMS0xLTIyNTI3MQ_e8888453-03dd-4b74-9892-101516cf0bc7"
      unitRef="usd">179225000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMi0xLTEtMjI1Mjcx_a8f9c070-283e-445f-a4aa-74b86c45c89f"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctNC0xLTEtMjI1Mjcx_65ea145c-d304-4893-89c4-28a77a190463"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctNi0xLTEtMjI1Mjcx_72577db9-95ed-4afc-9f55-085f8572153a"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctOC0xLTEtMjI1Mjcx_d9e33fab-7b2a-41b4-948a-e12a7162adbd"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMTAtMS0xLTIyNTI3MQ_cdae5d6b-b601-4b6a-9050-467fa9a9bbd2"
      unitRef="usd">24547000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTctMTItMS0xLTIyNTI3MQ_7558e01b-51ce-4ba1-a74c-59c0b5d3a45c"
      unitRef="usd">24547000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMi0xLTEtMjI1Mjcx_d7eae756-7f18-4f40-809c-cbe1b859f1eb"
      unitRef="usd">158000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtNC0xLTEtMjI1Mjcx_013fe3c8-cd5b-4382-b166-0d56e9eff13c"
      unitRef="usd">132000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtNi0xLTEtMjI1Mjcx_1fdf31da-42f6-4890-8255-c345f857cc2f"
      unitRef="usd">219000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtOC0xLTEtMjI1Mjcx_a3aafa59-ba9d-4b08-b908-481d13733a75"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMTAtMS0xLTIyNTI3MQ_b8689107-c9ce-4582-8aa9-fc0e724a0dd0"
      unitRef="usd">1916000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTgtMTItMS0xLTIyNTI3MQ_46408839-e629-4bf2-ad7f-4b4eda19b59f"
      unitRef="usd">2425000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMi0xLTEtMjI1Mjcx_021c0b97-df92-4911-929e-01d3d419065e"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktNC0xLTEtMjI1Mjcx_108675ec-de7c-4fc1-be7b-2299f9731d16"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktNi0xLTEtMjI1Mjcx_9374d4d7-7127-4ad2-b804-6e9958421668"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktOC0xLTEtMjI1Mjcx_888c0f43-a951-4c35-b9ce-3e5ae3704e2b"
      unitRef="usd">-2213000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMTAtMS0xLTIyNTI3MQ_9510229c-76d8-4896-a330-dbfa1363c488"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMTktMTItMS0xLTIyNTI3MQ_7b1403d5-16d9-435a-a2cd-f5a6ca971ff0"
      unitRef="usd">-2213000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMi0xLTEtMjI1Mjcx_d975fac9-c4ce-450e-94c5-7d3dcd87cbc2"
      unitRef="usd">60498000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtNC0xLTEtMjI1Mjcx_e5f29882-295b-4028-806c-1edbeb6ef88d"
      unitRef="usd">21312000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtNi0xLTEtMjI1Mjcx_dd179e45-3ac3-4f8d-8769-d0850eb75887"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtOC0xLTEtMjI1Mjcx_b60f1a1b-0a2b-412c-a77b-8f26b2c28f36"
      unitRef="usd">-232000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMTAtMS0xLTIyNTI3MQ_8c7fd4c4-9d52-46c9-8b2a-29a7f9779c46"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjAtMTItMS0xLTIyNTI3MQ_f6b336e7-5c83-4a4b-98dc-7637feebbf33"
      unitRef="usd">81578000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMi0xLTEtMjI1Mjcx_748822f8-68c5-4cb6-847a-61384c967ad3"
      unitRef="usd">4000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItNC0xLTEtMjI1Mjcx_27c4cc04-8669-4276-b277-b01dc4c66894"
      unitRef="usd">204000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItNi0xLTEtMjI1Mjcx_4f4611d0-80c0-4635-b593-51812c37f49f"
      unitRef="usd">-667000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItOC0xLTEtMjI1Mjcx_a778c551-9747-4159-9fe4-b9bcd5f5e9da"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMTAtMS0xLTIyNTI3MQ_088626b4-f252-4adf-b33e-f476a337501c"
      unitRef="usd">1231000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjItMTItMS0xLTIyNTI3MQ_d97899ef-6e91-43ec-b0da-d8a6a0ba1cd7"
      unitRef="usd">772000</us-gaap:OtherNonoperatingIncomeExpense>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMi0xLTEtMjI1Mjcx_f3e20a0f-306d-4128-bcb4-10d7d0be7001"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtNC0xLTEtMjI1Mjcx_6b3cd98c-65cb-44c9-8fcc-a4f48f8b42cd"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtNi0xLTEtMjI1Mjcx_c2092cf5-4d41-4371-ad31-72fdb806a485"
      unitRef="usd">-137000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtOC0xLTEtMjI1Mjcx_eae95730-1f93-45b8-82d1-ad952b18aa0e"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMTAtMS0xLTIyNTI3MQ_3db59151-6035-4ddc-af2d-b80acb56d05c"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjMtMTItMS0xLTIyNTI3MQ_fe697534-cb57-42a9-a917-2c6d070d3ca3"
      unitRef="usd">-137000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMi0xLTEtMjI1Mjcx_30ce9536-4bff-4849-b25c-ed861f687fa8"
      unitRef="usd">-983000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtNC0xLTEtMjI1Mjcx_49c5ddfa-55f2-4f70-b2d8-a980db0026a9"
      unitRef="usd">-440000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtNi0xLTEtMjI1Mjcx_52d5bfe3-66f5-4fd3-b538-aaed3a641b0b"
      unitRef="usd">0</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtOC0xLTEtMjI1Mjcx_01b3eeae-a055-440d-9855-3082910cb141"
      unitRef="usd">-5568000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMTAtMS0xLTIyNTI3MQ_07762435-170b-4fff-b167-ad9ac522061a"
      unitRef="usd">0</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjQtMTItMS0xLTIyNTI3MQ_aecc70b0-2ea1-4172-9c59-1935143c4192"
      unitRef="usd">-6991000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMi0xLTEtMjI1Mjcx_77208a7e-9820-4214-a78b-a60bbafd2556"
      unitRef="usd">-103000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtNC0xLTEtMjI1Mjcx_3fd08ca5-2d3a-4b13-b229-da9385cbfe10"
      unitRef="usd">-6368000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtNi0xLTEtMjI1Mjcx_7f4dc071-810b-4398-b93c-f78bb7d8b799"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtOC0xLTEtMjI1Mjcx_4036061e-4f16-4f2f-b7fe-13cf4d269511"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMTAtMS0xLTIyNTI3MQ_636e7302-0bd5-4d15-a4a4-1fa716854eeb"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjUtMTItMS0xLTIyNTI3MQ_34f099e7-98b6-45e4-8c10-6661d5a5acbf"
      unitRef="usd">-6471000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMi0xLTEtMjI1Mjcx_1662259f-a1fd-46fb-9c43-db49230ba8fd"
      unitRef="usd">132660000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtNC0xLTEtMjI1Mjcx_5ba8f9b0-c470-457a-93b0-5537f8964e75"
      unitRef="usd">70875000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtNi0xLTEtMjI1Mjcx_fd3b9853-1784-4297-936b-9813619c60d9"
      unitRef="usd">-9227000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtOC0xLTEtMjI1Mjcx_ae3c4a32-ce5a-4a93-adda-f19cad223998"
      unitRef="usd">8144000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMTAtMS0xLTIyNTI3MQ_b152e59c-e7ea-4d7a-b343-280ea49283f9"
      unitRef="usd">-69459000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjYtMTItMS0xLTIyNTI3MQ_868e6900-b582-4aef-a8d7-7e20836c92db"
      unitRef="usd">132993000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMi0xLTEtMjI1Mjcx_4b871ca5-1545-4226-9a03-cf035df078a6"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctNC0xLTEtMjI1Mjcx_fe8e5381-e53d-465e-a5f4-16cc790e43a5"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctNi0xLTEtMjI1Mjcx_0f15e8e6-c3c6-4e10-9ff6-5d008e5713f2"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctOC0xLTEtMjI1Mjcx_4ab9c402-4df0-4c58-b178-a023d5dd3d20"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMTAtMS0xLTIyNTI3MQ_8e5c7de5-c06b-47f3-bffb-6732815e872b"
      unitRef="usd">302000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjctMTItMS0xLTIyNTI3MQ_bca0d2e4-902d-46ad-a78f-eaf851d1caff"
      unitRef="usd">302000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMi0xLTEtMjI1Mjcx_14db688a-aa9b-4761-bfa6-d188101f63e6"
      unitRef="usd">598000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtNC0xLTEtMjI1Mjcx_52ece16e-d9d5-4d62-bf9a-a16774a3ed8d"
      unitRef="usd">189000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtNi0xLTEtMjI1Mjcx_48e3844e-9115-4333-8ff2-4a70a6150c9d"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtOC0xLTEtMjI1Mjcx_e733a0fa-ad31-484e-ae6d-6dd4cb11601c"
      unitRef="usd">1029000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMTAtMS0xLTIyNTI3MQ_b685a170-16c7-48f6-bcd1-7af7820731fe"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMjgtMTItMS0xLTIyNTI3MQ_82972a66-fe58-4309-bd27-09b40ab34452"
      unitRef="usd">1816000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMi0xLTEtMjI1Mjcx_9ccc2fb1-2340-47c1-ad49-188f35c316a7"
      unitRef="usd">133258000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtNC0xLTEtMjI1Mjcx_364f473a-5e3d-45ae-b992-53f93b6b4880"
      unitRef="usd">71064000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtNi0xLTEtMjI1Mjcx_e9f43cce-910e-4b8c-a7eb-bc598673788a"
      unitRef="usd">-9227000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtOC0xLTEtMjI1Mjcx_aa2d166d-5220-49fa-9712-2532d21baea4"
      unitRef="usd">9173000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMTAtMS0xLTIyNTI3MQ_4bbc2a92-cf39-4d20-8cdb-925de2c364a7"
      unitRef="usd">-69761000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzAtMTItMS0xLTIyNTI3MQ_a34e4ec2-e412-45fc-b376-1a4645f93430"
      unitRef="usd">134507000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMi0xLTEtMjI1Mjcx_c7576537-45b2-4ad3-816d-a3cd8455cc56"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtNC0xLTEtMjI1Mjcx_e700faa4-0888-4ad7-b8e1-b8226451c776"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtNi0xLTEtMjI1Mjcx_475beeb1-0344-41c8-b2b2-f6c17857408d"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtOC0xLTEtMjI1Mjcx_52e443d9-f482-4969-a4b4-95d43827e45e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMTAtMS0xLTIyNTI3MQ_f7ea4080-ba2d-4e25-a15b-b3811f0b5eb8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzEtMTItMS0xLTIyNTI3MQ_32f641a7-9a31-4ef0-b366-675dd0b3d16f"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i4bba8bb266a84b3193241dd0d0463e53_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMi0xLTEtMjI1Mjcx_2595b05b-7520-4bb8-9cd9-ad5e1c8ce9df"
      unitRef="usd">133258000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i16b7b2448d2349cbbb1f31ae4a06b020_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItNC0xLTEtMjI1Mjcx_4a46405b-48b5-4300-8d41-100cf5995f20"
      unitRef="usd">71064000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9a810840ba2f44f59b3c9e4e494ab149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItNi0xLTEtMjI1Mjcx_f5fe2a7c-f85f-4d88-adba-cf20c1857ab4"
      unitRef="usd">-9227000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i09e973746f194e91bfbe974afc6b4fc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItOC0xLTEtMjI1Mjcx_08d05fe7-5928-42d9-bfac-8a48a09c43b6"
      unitRef="usd">9173000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic540232a8bf1470e9590abe2b8475cd0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMTAtMS0xLTIyNTI3MQ_c425ad9c-b9d2-4690-beec-4a960dc0666a"
      unitRef="usd">-69761000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmI4MGYyNWY1M2E4MzQxYTBiM2VlYTFhM2E1NzEzOGUyL3RhYmxlcmFuZ2U6YjgwZjI1ZjUzYTgzNDFhMGIzZWVhMWEzYTU3MTM4ZTJfMzItMTItMS0xLTIyNTI3MQ_81fe960a-1b3f-4e6f-966f-b220865b7cee"
      unitRef="usd">134507000</us-gaap:ProfitLoss>
    <us-gaap:Revenues
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0yLTEtMS0yMjUyNzE_15117b3c-0b87-4a08-bb84-e8037d8e4e1f"
      unitRef="usd">194055000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS00LTEtMS0yMjUyNzE_c75c95c9-c67b-4c5d-ae89-e5e87d263b99"
      unitRef="usd">177263000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS02LTEtMS0yMjUyNzE_c72f819d-4ed0-462e-a7cc-a10bf0f2e038"
      unitRef="usd">121560000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS04LTEtMS0yMjUyNzE_4f1bc6c0-92b7-46e4-a560-bf7a9cd5a99a"
      unitRef="usd">5494000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0xMC0xLTEtMjI1Mjcx_15551891-6a68-47ee-8890-e78e5999fce2"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMS0xMi0xLTEtMjI1Mjcx_456440bc-c830-42aa-a6fb-31a603ea6b12"
      unitRef="usd">498372000</us-gaap:Revenues>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0yLTEtMS0yMjUyNzE_e1252da3-6bf8-4447-b244-92e547839f46"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi00LTEtMS0yMjUyNzE_529c7d05-1ad5-4e2d-b81a-077fc14ba7bb"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi02LTEtMS0yMjUyNzE_7c5f6650-627f-4620-8cb4-db31447b645c"
      unitRef="usd">6552000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi04LTEtMS0yMjUyNzE_e894757e-c51e-4619-8ea3-847012481a73"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0xMC0xLTEtMjI1Mjcx_aa24ae08-1aa9-42d5-b029-0f4cd710728c"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMi0xMi0xLTEtMjI1Mjcx_7bf9376e-9288-484e-ae1d-ca060e6edb75"
      unitRef="usd">6552000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0yLTEtMS0yMjUyNzE_dd015608-06b3-4009-8827-ae5804123903"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy00LTEtMS0yMjUyNzE_9b6d1401-1ea1-4b34-bcd5-0a90aed25835"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy02LTEtMS0yMjUyNzE_d8fa0f4c-6299-4d38-a337-9842f7ce5e61"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy04LTEtMS0yMjUyNzE_32316572-1202-4d6f-baa9-a266d4bfcac8"
      unitRef="usd">5494000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0xMC0xLTEtMjI1Mjcx_9a8bd061-a7b5-47c3-b8f9-652799ba709c"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMy0xMi0xLTEtMjI1Mjcx_0096fee5-f564-4471-ab70-d0948f4efb2a"
      unitRef="usd">5494000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0yLTEtMS0yMjUyNzE_e4e6b5f7-b5f2-4083-abba-7f35c9d58bea"
      unitRef="usd">1431000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC00LTEtMS0yMjUyNzE_c5b65171-e250-43be-8592-f65673e49bbd"
      unitRef="usd">732000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC02LTEtMS0yMjUyNzE_6d07bb39-ce63-48e6-b3ff-8140bdd14952"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC04LTEtMS0yMjUyNzE_9b7168f5-c956-40ee-b258-ff89e6dfec5c"
      unitRef="usd">18045000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0xMC0xLTEtMjI1Mjcx_e543b4bd-bcb9-4b75-b610-ebc69db7ed28"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNC0xMi0xLTEtMjI1Mjcx_d2928adf-1b84-4ad0-9aa8-22b9e0478ff2"
      unitRef="usd">20208000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0yLTEtMS0yMjUyNzE_b26b770c-e90b-4f92-bd8d-f5486a9a1790"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS00LTEtMS0yMjUyNzE_ade20677-4d2d-4037-83ca-0058472a57f8"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS02LTEtMS0yMjUyNzE_2ed37619-6085-4e94-a07e-a6ed940bae77"
      unitRef="usd">333000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS04LTEtMS0yMjUyNzE_0708f846-4050-4821-8f7c-87d30f436722"
      unitRef="usd">315000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0xMC0xLTEtMjI1Mjcx_27e9ddab-2e82-4b8f-86bf-b8099d277eb1"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNS0xMi0xLTEtMjI1Mjcx_1a0246ac-f4b9-47b9-94ee-de4c82667274"
      unitRef="usd">648000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0yLTEtMS0yMjUyNzE_12dcc679-5fb9-40ae-b6ec-9332f39f9775"
      unitRef="usd">57000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi00LTEtMS0yMjUyNzE_fcbff360-7237-4ab3-b2a4-2ecd2399eb52"
      unitRef="usd">8820000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi02LTEtMS0yMjUyNzE_3f9e90a5-f46a-4893-85ca-7169267b08e9"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi04LTEtMS0yMjUyNzE_7031764d-4169-41f7-9feb-a0f3d6dbcaa2"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0xMC0xLTEtMjI1Mjcx_a89ca1ac-5e5a-4315-83e5-c4c36d9e8540"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNi0xMi0xLTEtMjI1Mjcx_11be2241-8959-4b2c-8be1-131b703a8fcb"
      unitRef="usd">8877000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <us-gaap:OperatingExpenses
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0yLTEtMS0yMjUyNzE_51e09916-4278-4189-b3c3-dfd3b7eed18e"
      unitRef="usd">48189000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy00LTEtMS0yMjUyNzE_291f6363-5e54-4503-b40a-895bd31e6df0"
      unitRef="usd">61170000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy02LTEtMS0yMjUyNzE_99cd4035-8e18-40a3-b98f-90f2fa257049"
      unitRef="usd">97888000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy04LTEtMS0yMjUyNzE_d70e0e3e-128e-4328-9ab3-a3a9c13245ae"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0xMC0xLTEtMjI1Mjcx_7221e8ba-e3c2-4f75-8d28-617214873af5"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfNy0xMi0xLTEtMjI1Mjcx_ade5c4ab-3b04-4c02-9188-287a95bd6442"
      unitRef="usd">207247000</us-gaap:OperatingExpenses>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0yLTEtMS0yMjUyNzE_13244be0-fac8-4df0-931b-5e6c316de054"
      unitRef="usd">483000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC00LTEtMS0yMjUyNzE_21f89a37-1ba4-47ac-b668-3ac134228ece"
      unitRef="usd">299000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC02LTEtMS0yMjUyNzE_db33f159-b07f-4ba0-a2eb-a1a970a654e8"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC04LTEtMS0yMjUyNzE_3442b115-7700-4c59-ab5a-9674039477db"
      unitRef="usd">14055000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0xMC0xLTEtMjI1Mjcx_bf0c9bcf-67ea-4200-8750-fdfa9d848da0"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOC0xMi0xLTEtMjI1Mjcx_d2b905e7-fd63-4cb5-a965-88e916bdb372"
      unitRef="usd">14837000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0yLTEtMS0yMjUyNzE_d5a6124c-dd1f-44bb-af1a-6aa8af7b74de"
      unitRef="usd">19000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS00LTEtMS0yMjUyNzE_0235ac72-719b-48a0-876c-b922b01b017d"
      unitRef="usd">2602000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS02LTEtMS0yMjUyNzE_ccbd3395-4817-4b94-a626-29556949b304"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS04LTEtMS0yMjUyNzE_307b1843-7148-482c-951d-bee2b348cc9a"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0xMC0xLTEtMjI1Mjcx_84c28fbd-a190-4392-acef-156fa054af1a"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfOS0xMi0xLTEtMjI1Mjcx_aaeda50a-507f-4071-9fa2-c80ecf0f6186"
      unitRef="usd">2621000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMi0xLTEtMjI1Mjcx_74083c16-6db9-4dfb-981d-c4586b9abc2c"
      unitRef="usd">-14112000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtNC0xLTEtMjI1Mjcx_b3dc45fb-47f7-4c50-b865-a0da41d2a50b"
      unitRef="usd">-3546000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtNi0xLTEtMjI1Mjcx_319c7efd-75f9-4fac-9e5a-5d6f3c4fc57f"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtOC0xLTEtMjI1Mjcx_23e014dc-5707-4527-9746-a313ab7374e3"
      unitRef="usd">-8000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMTAtMS0xLTIyNTI3MQ_2f0346cf-400a-4fbc-be79-29b581f9d9a9"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTEtMTItMS0xLTIyNTI3MQ_b2af63b4-a040-414d-b9cb-4eda58f5ed16"
      unitRef="usd">-17666000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMi0xLTEtMjI1Mjcx_78afe751-7117-49ff-8279-56d38edd9c10"
      unitRef="usd">132664000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItNC0xLTEtMjI1Mjcx_193124c8-6c92-4f4b-a45a-f2085ff6e3e2"
      unitRef="usd">106762000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItNi0xLTEtMjI1Mjcx_c5747047-b216-48eb-8eb1-ffe857d43cb8"
      unitRef="usd">30557000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItOC0xLTEtMjI1Mjcx_31755ba1-80cf-4733-9a6d-840e88794d4b"
      unitRef="usd">4297000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMTAtMS0xLTIyNTI3MQ_60be045c-cafb-459f-9ff9-c4af683ec333"
      unitRef="usd">0</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTItMTItMS0xLTIyNTI3MQ_afd17da1-1785-4a69-8990-028e97932819"
      unitRef="usd">274280000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMi0xLTEtMjI1Mjcx_822d4a4b-ff57-451c-a917-aedab511e90d"
      unitRef="usd">14112000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtNC0xLTEtMjI1Mjcx_4ef9848a-79bf-49cc-9bce-011fdceb9b89"
      unitRef="usd">3546000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtNi0xLTEtMjI1Mjcx_f032039a-2854-493d-bee1-6e1a3ebd1d79"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtOC0xLTEtMjI1Mjcx_9fcac993-f0f0-4277-99ed-03221abe95a3"
      unitRef="usd">8000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMTAtMS0xLTIyNTI3MQ_9609d3d1-54e0-4890-b2c4-6e4cf9bbdfaa"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTMtMTItMS0xLTIyNTI3MQ_e428f8fa-c408-417b-8ace-a7663590f975"
      unitRef="usd">17666000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <us-gaap:InterestIncomeOperating
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMi0xLTEtMjI1Mjcx_181a4618-a543-430f-954a-af9fec07fa03"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtNC0xLTEtMjI1Mjcx_e15f1378-979f-4eec-9ded-1a1dc4390ae3"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtNi0xLTEtMjI1Mjcx_3a046079-a853-49c9-9e46-57a2d530fd87"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtOC0xLTEtMjI1Mjcx_feb5233a-1321-497d-855e-c346afb63c16"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMTAtMS0xLTIyNTI3MQ_2ea7c8fb-685b-4fd1-b69f-f29a881cbc8e"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTQtMTItMS0xLTIyNTI3MQ_98d07787-a5eb-4fe3-b143-96e477428762"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMi0xLTEtMjI1Mjcx_27ca3404-7e0d-4411-9a05-110f1e9285ca"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtNC0xLTEtMjI1Mjcx_230e5264-ce7b-45f4-9083-d972f2fb0147"
      unitRef="usd">1036000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtNi0xLTEtMjI1Mjcx_6d38bc58-2f84-4186-b8cf-0afdab05fe33"
      unitRef="usd">1865000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtOC0xLTEtMjI1Mjcx_546ad851-8d11-4b39-a95d-372a89ab410f"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMTAtMS0xLTIyNTI3MQ_a210d84a-b777-43f4-941a-e157f3eae472"
      unitRef="usd">34685000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTUtMTItMS0xLTIyNTI3MQ_41622827-f5c5-4fff-9287-b34a19d2177e"
      unitRef="usd">37586000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMi0xLTEtMjI1Mjcx_0b800156-9b82-4744-90dd-6f65bd35253b"
      unitRef="usd">78138000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtNC0xLTEtMjI1Mjcx_cf72ae60-b3b6-400f-97df-a11baaa778cb"
      unitRef="usd">67773000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtNi0xLTEtMjI1Mjcx_2536e16e-ac4c-404a-babf-1a0704e6ab0c"
      unitRef="usd">31822000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtOC0xLTEtMjI1Mjcx_c7d6984f-ba9d-4d90-8a3b-c050b096cc8a"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMTAtMS0xLTIyNTI3MQ_4b579ee4-94cc-4252-9ca3-b78f23bbb094"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTYtMTItMS0xLTIyNTI3MQ_aed9e974-c1ac-4030-b6c2-ae480cb8ad3b"
      unitRef="usd">177733000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMi0xLTEtMjI1Mjcx_80788a8e-a538-4b7a-aa5e-75efe9268122"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctNC0xLTEtMjI1Mjcx_4f9f9814-1e6c-4e04-ba85-ea62270c26bc"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctNi0xLTEtMjI1Mjcx_a196e122-54a2-4c8d-8c5c-7bf41ad34b2b"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctOC0xLTEtMjI1Mjcx_3ee1e381-2758-436a-a683-2d4a863f3247"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMTAtMS0xLTIyNTI3MQ_d5874838-3c89-46db-9041-f866b36db1b7"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTctMTItMS0xLTIyNTI3MQ_bedd69e0-8a47-486d-8e34-a4b0556b5454"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMi0xLTEtMjI1Mjcx_cc723ca8-3a65-4a42-a099-6c72cd895232"
      unitRef="usd">292000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtNC0xLTEtMjI1Mjcx_2f46d479-a022-4d51-93c0-42236b75dd5b"
      unitRef="usd">4000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtNi0xLTEtMjI1Mjcx_8601a87c-db54-402b-aaf9-890881648330"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtOC0xLTEtMjI1Mjcx_89da4934-c52b-4e9b-9c6d-100be92e8249"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMTAtMS0xLTIyNTI3MQ_6aba4ce3-ee1d-4aae-91e3-fe72f1013be9"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTgtMTItMS0xLTIyNTI3MQ_f4200a5c-5dc3-448d-96f9-690e7835547c"
      unitRef="usd">296000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMi0xLTEtMjI1Mjcx_c2cd499f-44f7-46a3-b8c5-4de4d1186ac7"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktNC0xLTEtMjI1Mjcx_0cfc57f5-68ac-41fa-9d54-00437e1793c5"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktNi0xLTEtMjI1Mjcx_d091c64a-b57f-492e-8d1b-9d7d0a32cd46"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktOC0xLTEtMjI1Mjcx_61d092a8-2976-4995-854d-0da92a2b2cb7"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMTAtMS0xLTIyNTI3MQ_88613b45-0a2d-4354-81ca-3b638a9f0a1d"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMTktMTItMS0xLTIyNTI3MQ_212396c7-714c-4ae4-b44f-558f0dfaee01"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMi0xLTEtMjI1Mjcx_5ef84f90-cdad-49ee-85a5-12c25ed1a3f1"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtNC0xLTEtMjI1Mjcx_e4bbc964-bcc0-4712-94e3-c1ee2a97a7c3"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtNi0xLTEtMjI1Mjcx_bf6e65f3-d3d4-44cc-9902-047dd5501c32"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtOC0xLTEtMjI1Mjcx_0da3ab2f-a91f-47c2-af34-60fa15d2a676"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMTAtMS0xLTIyNTI3MQ_382f8e5c-c6b1-40db-9a9f-c5d8a638f39c"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjAtMTItMS0xLTIyNTI3MQ_679a88aa-df51-4ff0-9479-8ad0d15af28e"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMi0xLTEtMjI1Mjcx_62500976-b426-4ff0-a528-e6453b2109aa"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItNC0xLTEtMjI1Mjcx_e2aba30d-07bb-4e9f-86c9-ef158a6ee3d1"
      unitRef="usd">10937000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItNi0xLTEtMjI1Mjcx_d394e558-fe53-4faa-bf67-1925dd59ba86"
      unitRef="usd">6511000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItOC0xLTEtMjI1Mjcx_b7c9a011-cf46-414a-b257-c3bf7fc8eeee"
      unitRef="usd">-32000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMTAtMS0xLTIyNTI3MQ_cfd3bbad-cd1d-4530-b54d-c824cb11e1e7"
      unitRef="usd">909000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjItMTItMS0xLTIyNTI3MQ_fb53e467-749e-4738-932f-cbf1ec2b33be"
      unitRef="usd">18316000</us-gaap:OtherNonoperatingIncomeExpense>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMi0xLTEtMjI1Mjcx_dd7ccbdc-d9f7-4299-89ee-1fd18028efb1"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtNC0xLTEtMjI1Mjcx_b6801b2a-06ed-4c77-927c-eaf3868a2170"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtNi0xLTEtMjI1Mjcx_3a9abfc2-af29-49ba-a0ec-562799b011e6"
      unitRef="usd">-6552000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtOC0xLTEtMjI1Mjcx_cb6e9b89-5abf-42a7-a8ae-762fa0764043"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMTAtMS0xLTIyNTI3MQ_a71e5680-a087-4b3b-a1b5-f39723fe0fdb"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjMtMTItMS0xLTIyNTI3MQ_ee19b9aa-30b5-4429-a0db-03e4218f411b"
      unitRef="usd">-6552000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMi0xLTEtMjI1Mjcx_51484bf8-b1de-4fb9-8270-e8788f373fe6"
      unitRef="usd">-948000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtNC0xLTEtMjI1Mjcx_d903cb8d-68a8-474c-9d00-eca136535997"
      unitRef="usd">-433000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtNi0xLTEtMjI1Mjcx_be81fee6-d479-4e33-911d-fa7ff8c15160"
      unitRef="usd">-333000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtOC0xLTEtMjI1Mjcx_6c72be6c-6d7f-43a5-9961-78289edee4e4"
      unitRef="usd">-4305000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMTAtMS0xLTIyNTI3MQ_fe2f6161-50c8-47fe-9407-444138ad68d1"
      unitRef="usd">0</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjQtMTItMS0xLTIyNTI3MQ_4d5ad45f-2217-4a85-b8c4-41b3718e25a2"
      unitRef="usd">-6019000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMi0xLTEtMjI1Mjcx_edae9150-5bae-461c-aaff-f7d4ad4c79a0"
      unitRef="usd">-38000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtNC0xLTEtMjI1Mjcx_cecf28e8-4ca7-49f8-abc1-86e6ae27ac77"
      unitRef="usd">-6218000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtNi0xLTEtMjI1Mjcx_5cae890c-81f8-48eb-9c31-acac0f4a30cc"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtOC0xLTEtMjI1Mjcx_8bd3a58f-5f9d-4415-814e-b779b4dc385c"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMTAtMS0xLTIyNTI3MQ_9a0df338-ffff-4608-9bf0-0af2c4901a91"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjUtMTItMS0xLTIyNTI3MQ_20d7eedd-1c24-464c-b1f0-83939b0631b4"
      unitRef="usd">-6256000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMi0xLTEtMjI1Mjcx_d64b2cb9-d829-4f62-b8da-d7930f90d347"
      unitRef="usd">71283000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtNC0xLTEtMjI1Mjcx_2fb742ee-f8b4-4eac-be67-50cd2eabf55e"
      unitRef="usd">58217000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtNi0xLTEtMjI1Mjcx_27e6d51c-0e0c-48bc-a47c-0c39112ab3e1"
      unitRef="usd">-3504000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtOC0xLTEtMjI1Mjcx_f129dfeb-b1fd-4618-b356-a1ac884aa902"
      unitRef="usd">5330000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMTAtMS0xLTIyNTI3MQ_0ae87836-f6ae-47bc-954c-902fbb3b3fd8"
      unitRef="usd">-57607000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjYtMTItMS0xLTIyNTI3MQ_e4a139d5-67ad-4e0e-b571-e146e65d4aaf"
      unitRef="usd">73719000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMi0xLTEtMjI1Mjcx_f37c1c1e-fb32-43ea-a7a3-631976fb9795"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctNC0xLTEtMjI1Mjcx_4808e1e7-bbe2-4301-a9f1-41fcda3bc7c3"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctNi0xLTEtMjI1Mjcx_5cd242df-8e06-4adb-ade4-2f0aef0a2e5c"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctOC0xLTEtMjI1Mjcx_ff3adee0-2769-4b9c-8576-67a5b37f53a7"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMTAtMS0xLTIyNTI3MQ_2a0b4df4-68d7-4b6d-8e47-e47c65fdb781"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjctMTItMS0xLTIyNTI3MQ_f995cc56-06e1-4f68-b2c7-413d87d3fcb9"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMi0xLTEtMjI1Mjcx_65d83ef7-23f2-43fe-a52e-9ff151fd332c"
      unitRef="usd">966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtNC0xLTEtMjI1Mjcx_a5cc6357-4f38-4562-8b9d-6087eb302912"
      unitRef="usd">200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtNi0xLTEtMjI1Mjcx_27badd95-02bd-4037-be64-95f72bf689ea"
      unitRef="usd">539000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtOC0xLTEtMjI1Mjcx_2d4886f3-7962-42b3-8bb5-4833e645ea31"
      unitRef="usd">379000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMTAtMS0xLTIyNTI3MQ_21d8aac5-90d8-42c6-ba6e-02103f27b6c5"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMjgtMTItMS0xLTIyNTI3MQ_9fb4c17f-1403-45ca-a795-813e067c01b3"
      unitRef="usd">2084000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMi0xLTEtMjI1Mjcx_f7da7cd7-7ac1-4396-b8b0-900463a1c3a1"
      unitRef="usd">72249000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtNC0xLTEtMjI1Mjcx_ccd6d5a8-7b06-44d3-9df0-04e58220fb31"
      unitRef="usd">58417000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtNi0xLTEtMjI1Mjcx_cbe953a2-da8d-4b9e-8510-cce2c526f7ca"
      unitRef="usd">-2965000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtOC0xLTEtMjI1Mjcx_b4123829-4029-4e38-855e-af2fcb2f5c87"
      unitRef="usd">5709000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMTAtMS0xLTIyNTI3MQ_a2cedac7-e588-4b18-a459-b984d35be7df"
      unitRef="usd">-58384000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzAtMTItMS0xLTIyNTI3MQ_46361f34-1e83-4a55-a43a-73aa9a9a112e"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMi0xLTEtMjI1Mjcx_db686df0-81f7-4985-ac2f-e029245d602e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtNC0xLTEtMjI1Mjcx_9eb3d7bf-730e-4549-a1f8-5c0f6e94eb8d"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtNi0xLTEtMjI1Mjcx_6809d218-dfea-4931-b4d3-18b4a3b7bcdb"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtOC0xLTEtMjI1Mjcx_4feaced1-0d96-4247-b26f-d41a17d0e161"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMTAtMS0xLTIyNTI3MQ_f1303e04-b454-47b0-8236-2c1b3c8313a1"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzEtMTItMS0xLTIyNTI3MQ_7091af12-a0ac-4dc6-a2b9-81eacaa55c4e"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ia1251264844f4f67b15a2946ecb7b726_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMi0xLTEtMjI1Mjcx_36059c94-33c5-4c43-a1c0-cbc907e88be1"
      unitRef="usd">72249000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0a1e7a63a446428b91bbf5079210e385_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItNC0xLTEtMjI1Mjcx_bfade3e7-936a-4127-a245-0a692c41dbb2"
      unitRef="usd">58417000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5efb6381b20e45398f94a5ddf03e566f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItNi0xLTEtMjI1Mjcx_6d8b7ab4-2315-4682-b20e-86753e5a5596"
      unitRef="usd">-2965000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8529eda436e046ad8d3c702f819c3bb1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItOC0xLTEtMjI1Mjcx_a3362889-1846-41c6-8d68-64cb0de654dd"
      unitRef="usd">5709000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia779d72b2de440eea10423e19cf7297d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMTAtMS0xLTIyNTI3MQ_6e2b3d87-9b43-41a4-8915-1a5cf1788d83"
      unitRef="usd">-58067000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83MC9mcmFnOmFkODNhZWJhZjIzZTRiN2I4MjhkZDNkMzE3ODUxMzI3L3RhYmxlOmY0ZWMyOWY4Yzc0MjQzM2U5NWZkNGNjNDI3NzU1NjdhL3RhYmxlcmFuZ2U6ZjRlYzI5ZjhjNzQyNDMzZTk1ZmQ0Y2M0Mjc3NTU2N2FfMzItMTItMS0xLTIyNTI3MQ_e0b8964f-2af9-479e-b170-0e2bcd19dbf4"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzcw_41a2e7ad-e992-4738-abe9-11d7a68c5037">Supplemental Cash Flow Information&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental cash flow information (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (refunded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental schedule of non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in ROU asset in exchange for new lease liability related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating, investing, and financing cash flows in the Consolidated Statements of Cash Flows are reported inclusive of both cash flows from continuing operations and cash flows from discontinued operations. The following table summarizes certain cash flow information related to discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing costs, tenant improvements, and recurring capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development, redevelopment, and other major improvements of real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of real estate, in-place lease, and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes cash, cash equivalents, and restricted cash (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains its cash and cash equivalents at financial institutions insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000 per institution. However, as the account balances at certain institutions exceed the FDIC insurance coverage, there is a concentration of credit risk related to amounts in excess of such coverage.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzYz_fc1ab417-3cd1-451b-a662-f56947940316">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental cash flow information (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (refunded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental schedule of non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in ROU asset in exchange for new lease liability related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes certain cash flow information related to discontinued operations (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing costs, tenant improvements, and recurring capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development, redevelopment, and other major improvements of real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of real estate, in-place lease, and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfMy0yLTEtMS0yMjUyNzE_c0c83a3b-8ac4-4ef8-80b2-1057ea6b8472"
      unitRef="usd">65367000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfMy00LTEtMS0yMjUyNzE_70e17211-bf7b-4fd2-9cf8-de22f194098b"
      unitRef="usd">58487000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNC0yLTEtMS0yMjUyNzE_20ecfa5b-3f84-44e7-96f6-2ad73027e72c"
      unitRef="usd">160000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNC00LTEtMS0yMjUyNzE_4ff544e6-17a8-4fa5-b985-3302b42ff57b"
      unitRef="usd">-1947000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestCostsCapitalized
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNS0yLTEtMS0yMjUyNzE_2250aff5-3f39-4231-8c97-7b4445960811"
      unitRef="usd">14093000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNS00LTEtMS0yMjUyNzE_bf454513-a0ff-4dc1-9374-c3931f12b09d"
      unitRef="usd">8305000</us-gaap:InterestCostsCapitalized>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNy0yLTEtMS0yMzAwMzA_be8c0f30-b8ff-430d-8fab-a0f26b92f8eb"
      unitRef="usd">80000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfNy00LTEtMS0yMzAwMzA_e8bfca26-222c-4378-b645-996956411c44"
      unitRef="usd">179000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfOC0yLTEtMS0yMjUyNzE_cd169975-d2d3-4647-82e8-f034c9af38e5"
      unitRef="usd">161774000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjczODNhYTk2YzgxNjRmMDA4NTAxNTUzOTNiNTdmNjhlL3RhYmxlcmFuZ2U6NzM4M2FhOTZjODE2NGYwMDg1MDE1NTM5M2I1N2Y2OGVfOC00LTEtMS0yMjUyNzE_c39194dd-f4ff-4fc9-a450-6b81f245d2a3"
      unitRef="usd">163277000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfMy0yLTEtMS0yMjUyNzE_0a2da91f-db05-49b0-827a-990df7149017"
      unitRef="usd">0</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfMy00LTEtMS0yMjUyNzE_4a0b5c4a-0d75-4b43-9cdc-17f113cd9cde"
      unitRef="usd">18000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNC0yLTEtMS0yMjUyNzE_d0576141-327e-4fad-862c-29f4b013062b"
      unitRef="usd">0</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNC00LTEtMS0yMjUyNzE_4647668c-2eca-49a5-a8dd-72cf3abb928b"
      unitRef="usd">0</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:DepreciationAndAmortization
      contextRef="i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNS0yLTEtMS0yMjUyNzE_8e7cd88d-63e2-439d-9a8e-364901d88afc"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7a3ee95eb347467fb30657f1fd131a39_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOmViODFlNTIyNjAyYTRkOWVhNzg3ZTFmYjY2OTUxM2VhL3RhYmxlcmFuZ2U6ZWI4MWU1MjI2MDJhNGQ5ZWE3ODdlMWZiNjY5NTEzZWFfNS00LTEtMS0yMjUyNzE_b484cf3b-99b8-4a9b-94f3-679249f075ec"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfMzcy_70eb4a65-e00f-43da-97e6-2951b736cf4f">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes cash, cash equivalents, and restricted cash (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0yLTEtMS0yMjUyNzE_fba17c9c-a425-4ac6-8a08-14b168cc48d0"
      unitRef="usd">72032000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC00LTEtMS0yMjUyNzE_1fd3ecb5-4f06-4979-83d2-0afd3251cd05"
      unitRef="usd">158287000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC02LTEtMS0yMjUyNzE_8036c8ae-6e9e-44b9-b4ad-a8da3f3832b7"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC04LTEtMS0yMjUyNzE_c203063d-5a8e-4f42-8cfb-6feb359cddc2"
      unitRef="usd">7707000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0xMC0xLTEtMjI1Mjcx_60b467b7-c7a9-4a14-aa33-58cc0b29a4a4"
      unitRef="usd">72032000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNC0xMi0xLTEtMjI1Mjcx_63901272-174b-4acb-9b95-39271f800348"
      unitRef="usd">165994000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0yLTEtMS0yMjUyNzE_bc35a7b4-72b5-4812-896b-75a5a9c6be78"
      unitRef="usd">54802000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS00LTEtMS0yMjUyNzE_f542b606-f5ca-49af-a5ce-b4b8e753c1ea"
      unitRef="usd">53454000</us-gaap:RestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS02LTEtMS0yMjUyNzE_aa054c34-f9e5-462f-b473-d2e429323ac4"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS04LTEtMS0yMjUyNzE_7c72f576-b57a-4d37-a4b8-e7ab74fa1ecd"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0xMC0xLTEtMjI1Mjcx_6640d9e2-2d9e-490c-b5b3-33c7a2bbbabe"
      unitRef="usd">54802000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNS0xMi0xLTEtMjI1Mjcx_de871dfc-db46-4c89-8205-b400446fc1df"
      unitRef="usd">53454000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0yLTEtMS0yMjUyNzE_37b47c1a-5fc0-43fa-bc1d-0f4715f9b1c8"
      unitRef="usd">126834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi00LTEtMS0yMjUyNzE_bcddc6de-1df8-481e-88e2-e8230ca62b51"
      unitRef="usd">211741000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi02LTEtMS0yMjUyNzE_dc31e069-71af-4c2a-845c-bcb13fd56731"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi04LTEtMS0yMjUyNzE_c33a7d8b-75d2-4e28-bec3-f2546366f15b"
      unitRef="usd">7707000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0xMC0xLTEtMjI1Mjcx_2276526d-9a7d-466e-8a3a-57bd2f09a820"
      unitRef="usd">126834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iea2ddd1511fc43b0a22d67fb83c4076e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfNi0xMi0xLTEtMjI1Mjcx_5708e06f-a8c5-4b0e-aeeb-7e04418d8f77"
      unitRef="usd">219448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0yLTEtMS0yMjUyNzE_4688be91-a461-4d33-9c5b-e68e1448c5b8"
      unitRef="usd">59235000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC00LTEtMS0yMjUyNzE_b5cbd8f4-9724-4569-a276-44202a3fabdf"
      unitRef="usd">89066000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC02LTEtMS0yMjUyNzE_ba8a2c6a-a5d0-4492-af65-c1d065ac8930"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC04LTEtMS0yMjUyNzE_196747e2-3103-4483-af45-102b94364867"
      unitRef="usd">7989000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0xMC0xLTEtMjI1Mjcx_6277d525-473c-4447-8c89-152f3ef77134"
      unitRef="usd">59235000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOC0xMi0xLTEtMjI1Mjcx_2530e148-dcab-4917-b680-9f78f5b930e5"
      unitRef="usd">97055000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0yLTEtMS0yMjUyNzE_323071f5-8f7a-458e-b586-d0bac20071ed"
      unitRef="usd">57990000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS00LTEtMS0yMjUyNzE_19e7f6e6-3581-4c8c-8dd5-c117e98f54a9"
      unitRef="usd">52103000</us-gaap:RestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS02LTEtMS0yMjUyNzE_31cb3f9f-a981-480d-9d9e-582086aa4f62"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS04LTEtMS0yMjUyNzE_d296f255-2f39-45cc-9198-8faf26b7e111"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0xMC0xLTEtMjI1Mjcx_b1870465-e46a-4457-ad83-09e134cf5a4b"
      unitRef="usd">57990000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfOS0xMi0xLTEtMjI1Mjcx_a9b1a567-35e4-4d6a-a135-32c7167e66ee"
      unitRef="usd">52103000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMi0xLTEtMjI1Mjcx_75061038-6ada-42ec-abc3-6011a2bc5a27"
      unitRef="usd">117225000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtNC0xLTEtMjI1Mjcx_b70a9816-7b28-4e60-afa2-7a9aa8769231"
      unitRef="usd">141169000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtNi0xLTEtMjI1Mjcx_6ac655eb-ea32-4b2d-9717-e0c35e179f83"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtOC0xLTEtMjI1Mjcx_13c8fdef-f600-45c1-876c-055eeb4dbf9a"
      unitRef="usd">7989000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMTAtMS0xLTIyNTI3MQ_f5801056-4d61-4b69-90c9-a49fc2af5ade"
      unitRef="usd">117225000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i0e3e4e9fac0c42b1b12d278fe604def4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RhYmxlOjc1YmY1MjE3Nzc4MTQzNmJhMjg1M2QwMzc2YjQwMWE1L3RhYmxlcmFuZ2U6NzViZjUyMTc3NzgxNDM2YmEyODUzZDAzNzZiNDAxYTVfMTAtMTItMS0xLTIyNTI3MQ_ad3b563a-48c1-4d52-8402-484e10225a41"
      unitRef="usd">149158000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83My9mcmFnOjBlMzk4N2QyNDE4MDQzMDY4MmNmZDFiYmRmYjQxODRiL3RleHRyZWdpb246MGUzOTg3ZDI0MTgwNDMwNjgyY2ZkMWJiZGZiNDE4NGJfNzE0NjgyNTU4MjQ1OQ_5597372d-4832-497e-a25e-487e4e32e5e4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains its cash and cash equivalents at financial institutions insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000 per institution. However, as the account balances at certain institutions exceed the FDIC insurance coverage, there is a concentration of credit risk related to amounts in excess of such coverage.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <peak:VariableInterestEntitiesTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg1Mg_1cfb5333-4236-4f9e-8667-5ffa866f7fac">Variable Interest Entities&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, in connection with the UPREIT reorganization, Old Healthpeak converted to Healthpeak OP, which is the Company&#x2019;s operating subsidiary and a limited liability company that has governing provisions that are the functional equivalent of a limited partnership. The Company holds a membership interest in Healthpeak OP, acts as the managing member of Healthpeak OP, and exercises full responsibility, discretion, and control over the day-to-day management of Healthpeak OP. Because the noncontrolling interests in Healthpeak OP do not have substantive liquidation rights, substantive kick-out rights without cause, or substantive participating rights, we have determined that Healthpeak OP is a VIE. The Company, as managing member, has the power to direct the core activities of Healthpeak OP that most significantly affect Healthpeak OP&#x2019;s performance, and through its interest in Healthpeak OP, has both the right to receive benefits from and the obligation to absorb losses of Healthpeak OP. Accordingly, the Company is the primary beneficiary of Healthpeak OP and consolidates Healthpeak OP. As the Company conducts its business and holds its assets and liabilities through Healthpeak OP, the total consolidated assets and liabilities, income (losses), and cash flows of Healthpeak OP represent substantially all of the total consolidated assets and liabilities, income (losses), and cash flows of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the Company had investments in two unconsolidated VIE joint ventures. At December&#160;31, 2022, the Company had investments in: (i) two unconsolidated VIE joint ventures and (ii) marketable debt securities of one VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#x2019;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities Investment. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At December&#160;31, 2022, the Company held $22&#160;million of commercial mortgage-backed securities (&#x201c;CMBS&#x201d;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie Mac) through a special purpose entity that had been identified as a VIE because it was &#x201c;thinly capitalized.&#x201d; The CMBS issued by the VIE were backed by mortgage debt obligations on real estate assets. These securities were classified as held-to-maturity because the Company had the intent and ability to hold the securities until maturity. These securities matured on December 31, 2022, and the Company received the related proceeds in January 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LLC Investment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#x2019;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of three hospitals as well as senior housing real estate. Any assets generated by the entity may only be used to settle its contractual obligations (primarily capital expenditures and debt service payments).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Needham Land Parcel JV.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Current equity at risk is not sufficient to finance the joint venture&#x2019;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development costs and debt service payments). See Note 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#x2019;s unconsolidated VIEs and interests therein.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#x2019;s involvement with these VIEs at March&#160;31, 2023 was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;VIE Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum&#160;Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exposure and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LLC investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in and advances to unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s maximum loss exposure represents the aggregate carrying amount of such investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated total assets and total liabilities at March&#160;31, 2023 and December&#160;31, 2022 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ventures V, LLC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160; The Company holds a 51% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#x201c;Ventures V&#x201d;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#x2019;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Life Science JVs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;The Company holds a 98% or greater ownership interest in multiple joint venture entities that own and lease life science assets (the &#x201c;Life Science JVs&#x201d;). The Life Science JVs are VIEs as the members share in certain decisions of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations. Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MSREI MOB JV.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds a 51% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#x201c;MSREI JV&#x201d;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#x2019;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DownREITs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160; The Company holds a controlling ownership interest in and is the managing member of seven DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Consolidated Real Estate Partnerships.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#x201c;Partnerships&#x201d;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development costs and construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities related to assets held for sale include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:VariableInterestEntitiesTextBlock>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="ic264575fc36449f5a87c5ea91360a740_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTM2_b3dad3a0-4cfb-422a-bce5-f7808880fbfb"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTM2_c1dadd5a-7c6b-4de7-bf1d-bdb1f2e35c21"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="ic264575fc36449f5a87c5ea91360a740_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzNzk0_b3dad3a0-4cfb-422a-bce5-f7808880fbfb"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzNzk0_c1dadd5a-7c6b-4de7-bf1d-bdb1f2e35c21"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfVieBorrowersWithMarketableDebtSecurities
      contextRef="i7fff501744fd4e71876ffa2b83de611a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODIzOTg1_35061169-9c01-492d-ad63-9eb6d492a7ad"
      unitRef="joint_venture">1</peak:NumberOfVieBorrowersWithMarketableDebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="i79f95a47fff3441784d37b2c5a1ae4f7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODI0MDQy_c5f9c163-8f6b-475f-b492-85e30f29c15d"
      unitRef="usd">22000000</us-gaap:DebtSecurities>
    <peak:NumberOfHospitals
      contextRef="i0777696340044807b047c951cc6b7e89_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTQ5NzU1ODI0Mjk3_44a8d7b3-35fe-4132-a852-3f9bd8952b81"
      unitRef="hospital">3</peak:NumberOfHospitals>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if2e661c65de049509e99f61fdd2bd048_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTgzNQ_964da61d-47ed-4a7c-98cb-adb7dc15d916"
      unitRef="number">0.38</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i64a9401fe4ee4e0b9e32826d28b5b1b0_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMTkyMQ_26fdae64-f119-4bc5-8378-6c302e35b43a"
      unitRef="usd">13000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg0OQ_ac302e31-85b7-4345-a96c-eda9c804097e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#x2019;s involvement with these VIEs at March&#160;31, 2023 was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;VIE Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum&#160;Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exposure and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LLC investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in and advances to unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s maximum loss exposure represents the aggregate carrying amount of such investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjljZGM4OGNmMWZmYTQyMjRiMTlhNjlhYmMxMzU5ZWQ1L3RhYmxlcmFuZ2U6OWNkYzg4Y2YxZmZhNDIyNGIxOWE2OWFiYzEzNTllZDVfNC00LTEtMS0yMjUyNzE_988feeec-81aa-41fd-bb64-ba751686846d"
      unitRef="usd">14985000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i314fcd2c5dec445098b327482f3a7818_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjljZGM4OGNmMWZmYTQyMjRiMTlhNjlhYmMxMzU5ZWQ1L3RhYmxlcmFuZ2U6OWNkYzg4Y2YxZmZhNDIyNGIxOWE2OWFiYzEzNTllZDVfNi00LTEtMS0yMjUyNzE_d5ab6163-7265-4742-9530-e0d22ccfe0d5"
      unitRef="usd">15658000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ieb8e43d445e14ad1b15a9092e886d068_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfMzM0OA_a4d4e662-57ff-4174-b3dc-def0d57cf44d"
      unitRef="number">0.51</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i2003f5627c1f4bf4a0e07c23f54283a8_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNDIzNg_c3208c05-fda3-4616-bb7c-663f0299f872"
      unitRef="number">0.98</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ic426b90826724d11a95dfb86709ed7fe_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNTIzMw_43c2df09-2dcd-41c5-b193-48f6a0ba3fd6"
      unitRef="number">0.51</us-gaap:VariableInterestEntityOwnershipPercentage>
    <peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership
      contextRef="i83e29cc8fc7747e8908fa487a0e9cd8f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfNjE3Mw_a10822e9-d119-4166-af92-c73245d4e379"
      unitRef="joint_venture">7</peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership>
    <peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RleHRyZWdpb246ODYyMzliMDkwZDJiNDAyMThjMWFkZDA4OWNjZjcxNGVfOTg1OA_7ea0535c-a330-4af7-ade0-150639946ae0">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development costs and construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities related to assets held for sale include VIE assets and liabilities, excluding those of Healthpeak OP, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMi0xLTEtMS0yMjUyNzE_72e908b6-c320-4367-90d0-5a3d1b5ceb0a"
      unitRef="usd">2348215000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMi0zLTEtMS0yMjUyNzE_a5bf28a2-d6f0-452c-a43d-4b767159e0e3"
      unitRef="usd">2356905000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:DevelopmentInProcess
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMy0xLTEtMS0yMjUyNzE_11944c73-4bcd-4694-9a24-26ca8ef45272"
      unitRef="usd">54319000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMy0zLTEtMS0yMjUyNzE_7b0a56f0-1448-4dc5-975d-525f156574ee"
      unitRef="usd">58499000</us-gaap:DevelopmentInProcess>
    <us-gaap:Land
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNC0xLTEtMS0yMjUyNzE_fee6033f-dca8-4169-833a-e4958d432cb5"
      unitRef="usd">322014000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNC0zLTEtMS0yMjUyNzE_087b2ecc-52aa-4cb6-9322-e12fbe26999a"
      unitRef="usd">324714000</us-gaap:Land>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNS0xLTEtMS0yMjUyNzE_01dc9e82-44f8-4d22-b668-ba8577938bc5"
      unitRef="usd">615936000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNS0zLTEtMS0yMjUyNzE_db7d97bf-7f39-41cb-85b7-b4c4cc5a4542"
      unitRef="usd">623244000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNi0xLTEtMS0yMjUyNzE_e03b27b0-dc43-4b2e-87ae-4aed62421f86"
      unitRef="usd">2108612000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfNi0zLTEtMS0yMjUyNzE_71532dcc-0222-48eb-b7a7-c590a4030636"
      unitRef="usd">2116874000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:AccountsReceivableNet
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOC0xLTEtMS0yMjUyNzE_2040bdf7-7e8c-4093-93c0-f9d19af69be0"
      unitRef="usd">9024000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOC0zLTEtMS0yMjUyNzE_7ce0b079-b39f-4cca-973a-3e0e7cc550ae"
      unitRef="usd">6893000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOS0xLTEtMS0yMjUyNzE_996e8732-00db-4bf0-be8a-16d25c31da9e"
      unitRef="usd">21631000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfOS0zLTEtMS0yMjUyNzE_1d302abd-31d3-4f68-b297-088c29208035"
      unitRef="usd">20586000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTAtMS0xLTEtMjI1Mjcx_8a677fb4-a5dc-4694-8243-fabada79963f"
      unitRef="usd">422000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTAtMy0xLTEtMjI1Mjcx_de87cd3d-f889-473e-900f-31f17afd1829"
      unitRef="usd">354000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTEtMS0xLTEtMjI1Mjcx_d0324368-6374-418f-aaf9-d01b60b1975f"
      unitRef="usd">69477000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTEtMy0xLTEtMjI1Mjcx_3b57f5d3-a268-491d-88e9-e0999ea4445f"
      unitRef="usd">73860000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTItMS0xLTEtMjI1Mjcx_d4258417-cfbc-406d-a5fa-bc040bceb0cd"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTItMy0xLTEtMjI1Mjcx_b95e3f86-1a62-41fc-b56d-94d0c0f3c7ab"
      unitRef="usd">30355000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTMtMS0xLTEtMjI1Mjcx_b1626e12-5b6f-41f5-98d9-3b5b86d87a03"
      unitRef="usd">98893000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTMtMy0xLTEtMjI1Mjcx_6b7b1e60-ea21-4f60-a091-d6f5aab943ac"
      unitRef="usd">99376000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTQtMS0xLTEtMjI1Mjcx_3ea43c60-c18e-47bb-ae50-617df6698404"
      unitRef="usd">73107000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTQtMy0xLTEtMjI1Mjcx_a2b0e98e-ff30-4093-8ff8-a14a154e8a9a"
      unitRef="usd">73690000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTUtMS0xLTEtMjI1Mjcx_685b235e-b227-4cb5-a0e2-572c303de3af"
      unitRef="usd">2381166000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTUtMy0xLTEtMjI1Mjcx_b0f5e76d-deeb-46ab-a1c0-85446bfd336d"
      unitRef="usd">2421988000</us-gaap:Assets>
    <us-gaap:SecuredDebt
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTctMS0xLTEtMjI1Mjcx_0bc00117-f682-4f35-bdfc-2aa30fbd2bb9"
      unitRef="usd">144668000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTctMy0xLTEtMjI1Mjcx_a361e881-e178-4074-9936-76cb4cf07a8b"
      unitRef="usd">144604000</us-gaap:SecuredDebt>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTktMS0xLTEtMjI1Mjcx_ff26727d-ac89-4c67-983e-4881836f5eeb"
      unitRef="usd">14255000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMTktMy0xLTEtMjI1Mjcx_b68e0775-7bff-4e04-bf83-b875611e2dce"
      unitRef="usd">15066000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjAtMS0xLTEtMjI1Mjcx_015ae19c-831a-4468-9774-72dd8543f2ba"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjAtMy0xLTEtMjI1Mjcx_0f0ff74f-3ece-4385-8fef-7c1f10227abe"
      unitRef="usd">401000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjEtMS0xLTEtMjI1Mjcx_ced38abf-a160-49b3-a0ee-3db04cdc99b8"
      unitRef="usd">99185000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjEtMy0xLTEtMjI1Mjcx_59588733-86eb-46f1-ad10-b30a01ca7e26"
      unitRef="usd">99039000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjItMS0xLTEtMjI1Mjcx_e10d5d36-e6ec-435f-aab8-01fe9a2cf8cf"
      unitRef="usd">66477000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjItMy0xLTEtMjI1Mjcx_d2d9e8fe-6d66-4835-b806-549726990fc7"
      unitRef="usd">68979000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjMtMS0xLTEtMjI1Mjcx_6302e8ff-1ebc-4d1e-ac52-7408079d0c5c"
      unitRef="usd">47410000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjMtMy0xLTEtMjI1Mjcx_106d896c-d3bc-4074-a063-f07ac9712bcd"
      unitRef="usd">39661000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:Liabilities
      contextRef="ia947c487c4384345a0b1601d6fa7c4e6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjQtMS0xLTEtMjI1Mjcx_a8061c57-0d0c-4c13-84d1-520af6bb55ae"
      unitRef="usd">371995000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i11644f24761048e48bf148bb3be4cf35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjNjYjNkZTc1MTg3MTRmMTU5NzY4OTBjOTk3YjEzOGI5L3RhYmxlcmFuZ2U6M2NiM2RlNzUxODcxNGYxNTk3Njg5MGM5OTdiMTM4YjlfMjQtMy0xLTEtMjI1Mjcx_a9c3d7de-7967-4808-9046-d02f9c22a54c"
      unitRef="usd">367750000</us-gaap:Liabilities>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMi0yLTEtMS0yMjUyNzE_8c30c0ce-b1e1-44f5-a67f-333db628b483"
      unitRef="usd">0</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMi00LTEtMS0yMjUyNzE_b40a5b4c-ffdb-40bc-a9e8-da3e5e513739"
      unitRef="usd">39934000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:Land
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNC0yLTEtMS0yMjUyNzE_38817335-93c2-48f5-91ec-59b0e970583f"
      unitRef="usd">0</us-gaap:Land>
    <us-gaap:Land
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNC00LTEtMS0yMjUyNzE_34f525cd-855d-416e-8af2-5a8e7707756d"
      unitRef="usd">1926000</us-gaap:Land>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNS0yLTEtMS0yMjUyNzE_185cffd3-bbff-4f89-b997-4f6236238431"
      unitRef="usd">0</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNS00LTEtMS0yMjUyNzE_e9526b9b-5af0-43cd-8087-6fbb7f1348bc"
      unitRef="usd">15612000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNi0yLTEtMS0yMjUyNzE_759f0bd1-41bd-4466-9130-a9706eff325e"
      unitRef="usd">0</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfNi00LTEtMS0yMjUyNzE_7cbdce84-c0a9-4134-9f93-1943f5e25398"
      unitRef="usd">26248000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTAtMi0xLTEtMjI1Mjcx_e244568e-7844-462a-9dfa-747970a6fa37"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTAtNC0xLTEtMjI1Mjcx_1e818c80-c74d-4f9f-8aba-e9b7c8bbee52"
      unitRef="usd">215000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTItMi0xLTEtMjI1Mjcx_ce3d2d74-de82-43e8-8216-06ac1067b334"
      unitRef="usd">0</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTItNC0xLTEtMjI1Mjcx_db394602-0a5e-4bd1-9c02-09f2ac762cae"
      unitRef="usd">3892000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTMtMi0xLTEtMjI1Mjcx_0cf8ddc5-2351-46c7-a8d8-8298c93e8531"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTMtNC0xLTEtMjI1Mjcx_25180380-7d9f-49e5-ab83-8c1eaebfc412"
      unitRef="usd">30355000</us-gaap:Assets>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTktMi0xLTEtMjI1Mjcx_ca38115a-ea5e-4a35-932e-0afed80514c4"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMTktNC0xLTEtMjI1Mjcx_94922856-609f-4cac-bfc9-bb017a79b8e9"
      unitRef="usd">401000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:Liabilities
      contextRef="i9c865e06411947d296af7de408e5f4ff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMjAtMi0xLTEtMjI1Mjcx_e9552281-cedf-41cf-9019-3fcb0c185b14"
      unitRef="usd">0</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i872860f23f9b4b9b9f0b8e10daaf29ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83Ni9mcmFnOjg2MjM5YjA5MGQyYjQwMjE4YzFhZGQwODljY2Y3MTRlL3RhYmxlOjExMGIwNDRlN2YzOTQxN2ViY2M0YzBjOTYzMGZiNjZlL3RhYmxlcmFuZ2U6MTEwYjA0NGU3ZjM5NDE3ZWJjYzRjMGM5NjMwZmI2NmVfMjAtNC0xLTEtMjI1Mjcx_eb0a4a60-9438-4bb7-aeec-65413bc5ae87"
      unitRef="usd">401000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RleHRyZWdpb246OGM0NzNiMjQyOWY5NDkwNGJlODgxZmNlMmJiNDkyMWRfMTE2Ng_891e292c-886c-42ed-81f2-5d5e1167902c">Fair Value Measurements&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the carrying amounts and fair values of the Company&#x2019;s financial instruments either recorded or disclosed on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank line of credit and commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,712,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,659,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,238,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;1: Fair value is calculated based on quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;2: Fair value is based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and interest rate swap instruments, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, commercial paper, and term loans, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#x2019;s credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023 and year ended December&#160;31, 2022, there were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;no material transfers of financial assets or liabilities within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RleHRyZWdpb246OGM0NzNiMjQyOWY5NDkwNGJlODgxZmNlMmJiNDkyMWRfMTE2Mw_16cf8127-7e81-468d-8996-1437a56c3df3">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the carrying amounts and fair values of the Company&#x2019;s financial instruments either recorded or disclosed on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank line of credit and commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,056,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,712,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,659,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,238,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;1: Fair value is calculated based on quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;2: Fair value is based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and interest rate swap instruments, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, commercial paper, and term loans, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#x2019;s credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023 and year ended December&#160;31, 2022, there were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;no material transfers of financial assets or liabilities within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi0xLTEtMS0yMjUyNzE_d3d9b3d8-c542-424b-b15e-b1cfee267412"
      unitRef="usd">243149000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi0zLTEtMS0yMjUyNzE_8a3848e0-5a73-40a7-8231-1e55998bc4f7"
      unitRef="usd">245125000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi01LTEtMS0yMjUyNzE_0f787e40-cf72-44f1-89a8-d0eb22ff3697"
      unitRef="usd">374832000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMi03LTEtMS0yMjUyNzE_da0226fd-b865-4cba-ab19-318e799498bd"
      unitRef="usd">369425000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy0xLTEtMS0yMjUyNzE_ac1e0935-230e-4a1a-a3bc-bd0fea5eed25"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy0zLTEtMS0yMjUyNzE_d543a8de-0c7e-4fa9-9b23-7c15742723ee"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy01LTEtMS0yMjUyNzE_63c3d8dd-d07d-4da6-a108-268aa5c547d0"
      unitRef="usd">21702000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfMy03LTEtMS0yMjUyNzE_0478e0ee-786c-4f8f-81ed-4414023e2d12"
      unitRef="usd">21702000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:DerivativeAssets
      contextRef="ia2a162e312664e3e87e4b7cc4e443e3b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC0xLTEtMS0yMjUyNzE_12ef7acc-4fdb-473e-b173-6309ca1040a2"
      unitRef="usd">20782000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4741bac17c174ed8a6000db9741edd7e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC0zLTEtMS0yMjUyNzE_793b4015-d158-4269-aa71-fb9ec2c54fe1"
      unitRef="usd">20782000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if8e50d56667947df8e6c0aeaf1a3d0c9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC01LTEtMS0yMjUyNzE_66c55f35-618e-4886-bb97-47d43924a103"
      unitRef="usd">30259000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i70c7e47c923043719f6f4a0f3ca6bd4f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNC03LTEtMS0yMjUyNzE_90be97c1-6559-4925-a581-31e639ecce97"
      unitRef="usd">30259000</us-gaap:DerivativeAssets>
    <us-gaap:LineOfCredit
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi0xLTEtMS0yMjUyNzE_7e307744-03e2-4373-9dcd-8fc53eb3ad8a"
      unitRef="usd">556000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi0zLTEtMS0yMjUyNzE_0b18231b-87db-41fe-ac0a-92a3154849d2"
      unitRef="usd">556000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi01LTEtMS0yMjUyNzE_c6a477dc-c3b0-4c56-9933-5c05c5832b63"
      unitRef="usd">995606000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNi03LTEtMS0yMjUyNzE_57eceb03-c134-4898-b0ed-779e1697909c"
      unitRef="usd">995606000</us-gaap:LineOfCredit>
    <us-gaap:LongTermLoansFromBank
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy0xLTEtMS0yMjUyNzE_a8b162aa-2fd8-455a-a0ca-c5a90a421239"
      unitRef="usd">496168000</us-gaap:LongTermLoansFromBank>
    <us-gaap:LongTermLoansFromBank
      contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy0zLTEtMS0yMjUyNzE_f818b66a-df97-4582-8b48-9edb8fc7d00a"
      unitRef="usd">496168000</us-gaap:LongTermLoansFromBank>
    <us-gaap:LongTermLoansFromBank
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy01LTEtMS0yMjUyNzE_e777de00-aa83-400b-8f4f-9a4d6f389ed9"
      unitRef="usd">495957000</us-gaap:LongTermLoansFromBank>
    <us-gaap:LongTermLoansFromBank
      contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfNy03LTEtMS0yMjUyNzE_24fd7a9b-9b79-475d-92b0-987e046f5fd1"
      unitRef="usd">495957000</us-gaap:LongTermLoansFromBank>
    <us-gaap:UnsecuredDebt
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC0xLTEtMS0yMjUyNzE_0df5356e-04b6-4e85-ae4a-01c7e4b1972d"
      unitRef="usd">5056543000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ic507fe90dbae43d6b7714fb76376f6c3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC0zLTEtMS0yMjUyNzE_f7d81853-ea76-4e51-be59-45f5e0415c42"
      unitRef="usd">4712340000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC01LTEtMS0yMjUyNzE_94f7b047-c638-487c-b6bc-71eb1406349a"
      unitRef="usd">4659451000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i9ce9db3b727c4f4e8d642580044e31cd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOC03LTEtMS0yMjUyNzE_4493e628-e857-4d4a-bc27-f75b9a0a0d1b"
      unitRef="usd">4238124000</us-gaap:UnsecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i30df8d22282b41fd9bf4802f9a1b4777_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS0xLTEtMS0yMjUyNzE_3f75a723-19f0-4d0a-9d00-87f39dac18c7"
      unitRef="usd">345167000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i1e722ab6f64c43d1b27228769a5d22f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS0zLTEtMS0yMjUyNzE_45eee041-6f1e-4067-9101-bed948746cf9"
      unitRef="usd">330856000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="ifc7ba3154c774008b8363208076ad8ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS01LTEtMS0yMjUyNzE_f605ac03-e26b-4ae7-8b2b-09b6e75763dc"
      unitRef="usd">346599000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i62e1f932c1974d209acc82e118a8b04e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl83OS9mcmFnOjhjNDczYjI0MjlmOTQ5MDRiZTg4MWZjZTJiYjQ5MjFkL3RhYmxlOjZlZWZiZDJjNmQxNjRkZTI4N2RmN2Q4OThjNDU2NjcwL3RhYmxlcmFuZ2U6NmVlZmJkMmM2ZDE2NGRlMjg3ZGY3ZDg5OGM0NTY2NzBfOS03LTEtMS0yMjUyNzE_680056d1-ce28-43f3-9a21-39f47f40a10c"
      unitRef="usd">330867000</us-gaap:SecuredDebt>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjg4Mw_7d35be93-cf15-42e7-b938-b0e568548ccf">Derivative Financial Instruments&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates and their related potential impact on future earnings and cash flows. The Company does not use derivative instruments for speculative or trading purposes. At March&#160;31, 2023, a one percentage point increase or decrease in the underlying interest rate curve would result in a corresponding increase or decrease in the fair value of the derivative instruments by approximately $22&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company executed two interest rate cap instruments on $142&#160;million of variable rate mortgage debt secured by a portfolio of MOBs (see Note 9). During the three months ended March&#160;31, 2022, the Company recognized a $2&#160;million increase in the fair value of the interest rate cap instruments within other income (expense), net. In April 2022, the Company terminated these interest rate cap instruments and entered into two interest rate swap instruments that are designated as cash flow hedges and mature in May 2026. In February 2023, the Company modified its two interest rate swap instruments totaling a $142&#160;million notional value to reflect the change in the related variable rate mortgage debt&#x2019;s interest rate benchmarks from LIBOR to SOFR (see Note 9). The Company applied certain practical expedients provided by ASU 2020-04 and ASU 2021-01 in connection with the modifications to these cash flow hedges (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company entered into two forward-starting interest rate swap instruments on the $500&#160;million aggregate principal amount of the Term Loan Facilities (see Note 9). The interest rate swap instruments are designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate swap instruments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date&#160;Entered&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pay Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Receive Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.99 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;USD-SOFR w/ -5 Day Lookback +  2.50% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.54 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;USD-SOFR w/ -5 Day Lookback +  2.05% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;February 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.60 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;1 mo. USD-SOFR CME Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.54 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;1 mo. USD-SOFR CME Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pay rates and receive rates are as of March&#160;31, 2023. As of December&#160;31, 2022, the interest rate swap instrument with a $51&#160;million notional amount had a pay rate of 5.08% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.50%. As of December&#160;31, 2022, the interest rate swap instrument with a $91&#160;million notional amount had a pay rate of 4.63% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.05%.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At each of March&#160;31, 2023 and December&#160;31, 2022, the interest rate swap instruments were in an asset position. Derivative assets are recorded at fair value in other assets, net on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;(3)Represents interest rate swap instruments that hedge fluctuations in interest payments on variable rate debt by converting the interest rates to fixed interest rates. The changes in fair value of designated derivatives that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNjkw_2c16c47c-6aa2-4c61-83cc-2d65d65b9605"
      unitRef="usd">22000000</us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ibff3d7194cc8421785dba30cb9b0f782_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfOTUw_d8bd1ff0-7394-475b-8983-5647f5c1ac85"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <peak:DerivativeNotionalAmountTerminated
      contextRef="ibff3d7194cc8421785dba30cb9b0f782_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfOTkw_487cc6f8-5c32-4c52-bca4-19d387590723"
      unitRef="usd">142000000</peak:DerivativeNotionalAmountTerminated>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie6930d3833b24489bf10582929fa4f52_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NDE1Mw_e81dea72-f2bd-4855-b782-bec4b4347b66"
      unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i08425abe3e614e6d9a9b28ec8e60b022_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTE5NA_fdc3361d-4524-46a8-bb8f-285dcb4bcf48"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="icf5ac7cd40be471fb36b2da5759371f7_I20230228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NTExMg_ffbe3d77-ad72-4c90-a285-9bbfe3144ef5"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="icf5ac7cd40be471fb36b2da5759371f7_I20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjc0ODc3OTA3NTExNg_fbf87c1d-7063-4cd5-b157-15469601e866"
      unitRef="usd">142000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTMzMw_f40ab16b-8f1d-40b8-88c2-0ee9e72c06e5"
      unitRef="derivative_held">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <peak:DerivativeNotionalAmountTerminated
      contextRef="ib8a237e0795d475c9e344be93e2de478_I20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMTM5MQ_cb5e36d0-54fe-4a0e-b718-1de4cccc5068"
      unitRef="usd">500000000</peak:DerivativeNotionalAmountTerminated>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfMjg5Mw_c0c4c747-6ffd-4145-ae1d-6eec1fb2018c">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate swap instruments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date&#160;Entered&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pay Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Receive Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.99 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;USD-SOFR w/ -5 Day Lookback +  2.50% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.54 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;USD-SOFR w/ -5 Day Lookback +  2.05% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;February 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.60 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;1 mo. USD-SOFR CME Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;August 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.54 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;1 mo. USD-SOFR CME Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pay rates and receive rates are as of March&#160;31, 2023. As of December&#160;31, 2022, the interest rate swap instrument with a $51&#160;million notional amount had a pay rate of 5.08% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.50%. As of December&#160;31, 2022, the interest rate swap instrument with a $91&#160;million notional amount had a pay rate of 4.63% and a receive rate of 1 mo. USD-LIBOR-BBA + 2.05%.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At each of March&#160;31, 2023 and December&#160;31, 2022, the interest rate swap instruments were in an asset position. Derivative assets are recorded at fair value in other assets, net on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;(3)Represents interest rate swap instruments that hedge fluctuations in interest payments on variable rate debt by converting the interest rates to fixed interest rates. The changes in fair value of designated derivatives that qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) on the Consolidated Balance Sheets.</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi0zLTEtMS0yNTE2NTE_d01ea4b5-6ee8-4045-9de8-c3b9b06a7d0c"
      unitRef="usd">51100000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi00LTEtMS0yNTE2NTE_9f8853e4-accb-404e-8470-15742d41a976"
      unitRef="number">0.0499</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi01LTEtMS0yNTE2NTEvdGV4dHJlZ2lvbjphY2RkYzdiM2IxZGE0ODM2YmJiOGUwNDk5NTMyZjQ2Ml8zNA_0388c7fc-d170-49d4-8282-53a9d6b8aa0b"
      unitRef="number">0.0250</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i3ef70f9721254f3b8cc366b0a5efd98a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi02LTEtMS0yNTE2NTE_394cd519-97bd-4752-8ed0-b0a065f06354"
      unitRef="usd">1675000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i7ed735a3625541e0b0040bbdb3d6ff39_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMi04LTEtMS0yNTE2NTE_cf2da70c-a89c-4d68-a1d9-1004d2a8f7a9"
      unitRef="usd">2300000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i12b4be37081f42648c653212038f8710_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy0zLTEtMS0yNTE2NTE_c9528201-ee1f-4718-bff5-d2eb6d8b7722"
      unitRef="usd">91000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i12b4be37081f42648c653212038f8710_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy00LTEtMS0yNTE2NTE_8d02efc9-8d70-425d-bf9b-6ee9a484ba3e"
      unitRef="number">0.0454</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i12b4be37081f42648c653212038f8710_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy01LTEtMS0yNTE2NTEvdGV4dHJlZ2lvbjo5ZDY4YWUwMmM1N2M0NGEyYmRlMDMzOWUwMWZjYzllY18zNA_53d11918-505b-416d-b00f-0c2e75870c42"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i12b4be37081f42648c653212038f8710_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy02LTEtMS0yNTE2NTE_206302a5-7e24-430c-ba24-1517c5891703"
      unitRef="usd">2983000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ia7607072d8464af1a07831fe55ae7d49_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfMy04LTEtMS0yNTE2NTE_d9e2c0dc-d197-45f1-abf0-377b39cff597"
      unitRef="usd">4096000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS0zLTEtMS0yMjUyNzE_c72b9e04-5c0d-4964-9df3-a00872c70e4c"
      unitRef="usd">250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS00LTEtMS0yMjUyNzE_20f1e563-c719-466f-99d4-caf070d321e2"
      unitRef="number">0.0260</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i7e4af01407e54b35b8771e2572ef8748_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS02LTEtMS0yMjUyNzE_2928a05c-d805-4260-9583-2f8c2d6cef0e"
      unitRef="usd">7658000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ib4ed4d0a4ede45839d5ff5d4cde250f0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNS04LTEtMS0yMjUyNzE_1f2be537-0e68-4f2f-a21d-aec2564902c8"
      unitRef="usd">11299000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i442974227f63407a813cccaa74ab1313_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi0zLTEtMS0yMjUyNzE_ff546ab2-8516-47a9-9090-0601da5e4c15"
      unitRef="usd">250000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i442974227f63407a813cccaa74ab1313_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi00LTEtMS0yMjUyNzE_63d29a8a-607d-47a3-86d9-7d40f72e5b26"
      unitRef="number">0.0254</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i442974227f63407a813cccaa74ab1313_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi02LTEtMS0yMjUyNzE_5af6db67-cd63-43ed-87ab-a79142ea20bb"
      unitRef="usd">8466000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i6ef18c30916344f1bc92844528563a35_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RhYmxlOjVjYTkzMzkyNTdiZjRmMjI4MDI0ZjJiOTUwMjcwYjI0L3RhYmxlcmFuZ2U6NWNhOTMzOTI1N2JmNGYyMjgwMjRmMmI5NTAyNzBiMjRfNi04LTEtMS0yMjUyNzE_0f7a8624-008b-4e24-80a3-613518500201"
      unitRef="usd">12564000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIzMTQy_a953268b-6c70-4e98-b1fd-1497c08fd02c"
      unitRef="usd">51000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTYx_b847551c-c0d4-4bd9-9df8-dd9457c8364b"
      unitRef="number">0.0508</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i81e298ecd7a74fd3b9a6d9f589c2fc91_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTY4_2e679b42-3201-4d9f-a660-696886345b1f"
      unitRef="number">0.0250</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIzMTY3_8772974c-5ea8-4e8b-a413-6aa94ae940a1"
      unitRef="usd">91000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTc1_764ab232-ab4d-4d3b-92b2-ca1f71fed6bf"
      unitRef="number">0.0463</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i654b6eb550f645f58b5769d07a3beabd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84Mi9mcmFnOjMyMmU3YWJiMDYyNzRiN2Y5ZTgwYTlmZTFhMmE0NDc0L3RleHRyZWdpb246MzIyZTdhYmIwNjI3NGI3ZjllODBhOWZlMWEyYTQ0NzRfNTQ5NzU1ODIwMTgy_7ef8ad2e-b383-4e86-a842-88ebf5b7634a"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfMTYyOQ_62e3352d-c03a-4ec3-a9f3-5fea0455e5b6">Accounts Payable, Accrued Liabilities, and Other Liabilities&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accounts payable, accrued liabilities, and other liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refundable entrance fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accounts payable and accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, includes $12&#160;million and $15&#160;million, respectively,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of severance-related charges associated with the departure of a former CEO in October 2022 that had not yet been paid.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfMTYzMA_097c0630-f9ba-4cd0-a5c6-22d76fb84f4f">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accounts payable, accrued liabilities, and other liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refundable entrance fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accounts payable and accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, includes $12&#160;million and $15&#160;million, respectively,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of severance-related charges associated with the departure of a former CEO in October 2022 that had not yet been paid.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <peak:RefundableEntranceFeesCurrentAndNoncurrent
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMS0xLTEtMS0yMjUyNzE_390bc05a-fb7f-403b-b7ea-b7d7f1320dbf"
      unitRef="usd">264065000</peak:RefundableEntranceFeesCurrentAndNoncurrent>
    <peak:RefundableEntranceFeesCurrentAndNoncurrent
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMS0zLTEtMS0yMjUyNzE_96c42fee-a806-4e36-8b46-c72e0b7e1fb7"
      unitRef="usd">268972000</peak:RefundableEntranceFeesCurrentAndNoncurrent>
    <us-gaap:ConstructionPayableCurrentAndNoncurrent
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMi0xLTEtMS0yMjUyNzE_5e1e7c05-de7c-4bc2-9bba-7b011839608f"
      unitRef="usd">161774000</us-gaap:ConstructionPayableCurrentAndNoncurrent>
    <us-gaap:ConstructionPayableCurrentAndNoncurrent
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMi0zLTEtMS0yMjUyNzE_677c3095-3343-4cfe-9b12-c1f9a45acd36"
      unitRef="usd">178626000</us-gaap:ConstructionPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMy0xLTEtMS0yMjUyNzE_0d7f78d2-e47b-4433-9d13-dc027ce753a9"
      unitRef="usd">39065000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfMy0zLTEtMS0yMjUyNzE_68165a38-7e48-4104-a014-de20a44458ff"
      unitRef="usd">59291000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNC0xLTEtMS0yMjUyNzE_a0824199-1d97-4179-b74e-b392bb3addb8"
      unitRef="usd">224090000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNC0zLTEtMS0yMjUyNzE_37a83347-b257-4045-917a-e281b03e918b"
      unitRef="usd">265596000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNS0xLTEtMS0yMjUyNzE_1f5f29e1-1441-447d-b892-9f6d7c94b658"
      unitRef="usd">688994000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RhYmxlOjMxZWM3Mjc4YThkMzQyMDZiNGQ1ZDQ3NTMwZWQwYTcxL3RhYmxlcmFuZ2U6MzFlYzcyNzhhOGQzNDIwNmI0ZDVkNDc1MzBlZDBhNzFfNS0zLTEtMS0yMjUyNzE_4c3ac261-bec5-4e3a-8e40-e230a55e3cde"
      unitRef="usd">772485000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:SeveranceCosts1
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfNTQ5NzU1ODE5OTI4_9279e9f6-1df8-44e5-80f7-df5fed30a421"
      unitRef="usd">12000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl84NS9mcmFnOjJkYWM1OGNjZWYyMDQ3OTliODBlMWQ2MzQxMjRhZDc3L3RleHRyZWdpb246MmRhYzU4Y2NlZjIwNDc5OWI4MGUxZDYzNDEyNGFkNzdfNTQ5NzU1ODE5ODIy_bc8a4dad-8834-4e3d-b06a-fcce36360529"
      unitRef="usd">15000000</us-gaap:SeveranceCosts1>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV83MTQ2ODI1NTg0MjIw_688a99ca-c9ce-4ff3-a124-019d37a281f9">Deferred Revenue&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonrefundable entrance fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company collected nonrefundable entrance fees of $29&#160;million and $21&#160;million, respectively. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization of $20&#160;million and&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$19&#160;million, respectively, which is included within resident fees and services on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Other deferred revenue is primarily comprised of prepaid rent, deferred rent, and tenant-funded tenant improvements owned by the Company. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization related to other deferred revenue of $13&#160;million and $9&#160;million,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;respectively, which is included in rental and related revenues on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <peak:ScheduleOfDeferredRevenueTableTextBlock
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV83MTQ2ODI1NTg0MjIx_1263470e-6adb-4335-8cb0-b9df2e09ddd6">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s deferred revenue, excluding deferred revenue related to assets classified as held for sale (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonrefundable entrance fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company collected nonrefundable entrance fees of $29&#160;million and $21&#160;million, respectively. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization of $20&#160;million and&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$19&#160;million, respectively, which is included within resident fees and services on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Other deferred revenue is primarily comprised of prepaid rent, deferred rent, and tenant-funded tenant improvements owned by the Company. During the three months ended March&#160;31, 2023 and 2022, the Company recognized amortization related to other deferred revenue of $13&#160;million and $9&#160;million,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;respectively, which is included in rental and related revenues on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</peak:ScheduleOfDeferredRevenueTableTextBlock>
    <peak:NonrefundableEntranceFees
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8yLTEtMS0xLTIyOTc3MA_3be0cadc-c4e1-403f-a09f-b34965133cf1"
      unitRef="usd">527476000</peak:NonrefundableEntranceFees>
    <peak:NonrefundableEntranceFees
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8yLTMtMS0xLTIyOTc3MA_42e4b55f-e3c7-4197-8e10-258892050960"
      unitRef="usd">518573000</peak:NonrefundableEntranceFees>
    <peak:OtherDeferredRevenue
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl80LTEtMS0xLTIyOTc3MA_0bcdf7aa-8128-4427-a045-2c0863d40ee3"
      unitRef="usd">350968000</peak:OtherDeferredRevenue>
    <peak:OtherDeferredRevenue
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl80LTMtMS0xLTIyOTc3MA_0f8599bf-68b1-4fc7-968d-567f6ec0c1b8"
      unitRef="usd">325503000</peak:OtherDeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if4882bfad4354d8ea1cac4348c817159_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8zLTEtMS0xLTIzMjkyNQ_533b3e60-532f-4cc3-af0a-7760675bbb04"
      unitRef="usd">878444000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iaecb36bec2724a3594acf3e81eca36dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGFibGU6NmE4MzM2NzVmMDNiNDc3M2E1NzNmMDgwNTAwYzIwN2IvdGFibGVyYW5nZTo2YTgzMzY3NWYwM2I0NzczYTU3M2YwODA1MDBjMjA3Yl8zLTMtMS0xLTIzMjkyNw_9a9ea5ae-e231-432d-b002-bf1e9c279f06"
      unitRef="usd">844076000</us-gaap:ContractWithCustomerLiability>
    <peak:ProceedsFromCollectionOfNonrefundableEntranceFees
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTY0Nzk_1e66ede7-1e54-41d8-8aa3-4c903c328efd"
      unitRef="usd">29000000</peak:ProceedsFromCollectionOfNonrefundableEntranceFees>
    <peak:ProceedsFromCollectionOfNonrefundableEntranceFees
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcyNzY_4121d703-3bc6-4433-80ac-7a5af4d50cf2"
      unitRef="usd">21000000</peak:ProceedsFromCollectionOfNonrefundableEntranceFees>
    <peak:AmortizationOfNonrefundableEntranceFee
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTY1Mzc_587a89cd-0cb4-4159-826d-321f8a243dbe"
      unitRef="usd">20000000</peak:AmortizationOfNonrefundableEntranceFee>
    <peak:AmortizationOfNonrefundableEntranceFee
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTczNTQ_b92e5cbe-6997-456c-965e-16da594a087d"
      unitRef="usd">19000000</peak:AmortizationOfNonrefundableEntranceFee>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="iab8ac01ab7f94115954b27f33879edba_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcxMjk_1f9f30ff-758b-4e73-8f60-67f405f3b44d"
      unitRef="usd">13000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQyMjg3Yzg0Mzg1ZTQwYWZhMTEzM2ZiNWQxZmE4MjA2L3NlYzpkMjI4N2M4NDM4NWU0MGFmYTExMzNmYjVkMWZhODIwNl8xMzQ5L2ZyYWc6ZmNhNTViNGNlZjIzNGFjY2EzZGUwNTk1ZTNlNzAxZmUvdGV4dHJlZ2lvbjpmY2E1NWI0Y2VmMjM0YWNjYTNkZTA1OTVlM2U3MDFmZV81NDk3NTU4MTcxNTQ_75651c0c-f909-4d6c-b2b2-59dbb13d89c5"
      unitRef="usd">9000000</us-gaap:OtherAmortizationOfDeferredCharges>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M0ROW0QNYGWG,HHA<Y1G<SLSM%M>I76; X]KR5::'-C(]US&72]TQ/X "?&W
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M7'9O(2-O><_KMXCB.2(!H9[F5]/-KT6V:TX.FR_ WYW39.<T:?NC(_U]$KQ
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M?+N,O6I=L#E#ZIJ$*8O'%FC//CP-OW8#<*R>CQN]'=1QE1[0 7S38;KVVB5
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MM>FJT!&$KWCA,N?JPT=4<>VTP6:N8T*PE60.@J,#50]W](;]_-:4Y:E5_9Q
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M_/R ?@"C909:4 M*"T%I$2B-0='Z,NO<7WKL2Q]^Z/,#5%%<*TUGH)6UH+0
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M__+RQ9@7A8?&$YKUM*[/+F,X#>%HR9R\;)= U$ =SUE%DE?=)GBMWHY'H94
M9%@"G!<@-+78B[,# O)B]U ZGA'<RS"?'66S.*#!2$O_9)C^+R$Q*KFQ_#\&
M;\O#R[90K/.?$I:W:QNCO-$*SP#G4P0SEJ8]=!Y#G*0DQ*VDU07D"5T 16._
M/APCPT% FB,<#4JHCENEG&6^$<;"LKJM%$'93#QJ@)"DC\UKE]* ;B.M;"##
MLN&;D@7GY2[;7J1X2%\18(:CJ.>[QXZ2.#0KK7H@P^KARI6&)HR@GK]XR4(\
M>B&+65?G^\Q@ 18'W&]E!1E>VA^OP(3=-"FX?HVU&.FO]"G!/5P>JS0)S IM
M%00=5A#' 25JO6V6_SLA^N#=X>TS/\1'UV&/54"!TE8;T&%MX G_Z08RN! ;
M2 #%01OLZE3MEC2'"F@<6E VQ:#9V'!2J>0+@[0M#D'BI7U9@*.4IEWB]=@E
M$:.A:6OU QW6#YUDZF)MB[C7^;X: (6'NP+=:Y;&H4D\.%@8W@!X0OOX)(07
M17]!'\64=3<Q/&83PJ(L#BP_:<OZE+U(^[1Q]=0)R:":>/$1R2OU=CP*K92@
MPU+BO530QI6_9MMFD=>_D-O_A-(( A[HU(5C(==KK@H!B;K)-X'([&L"2A-"
MHMZL>@P38*DXL--&6_% A\7#][:(O (>W^Y!BB&+>H7"9QG%24I#^=9J!CJL
M&:ZTWMJ:WNST+-KY CR&JW53/<90\6H!>F];N]('V5A+LZ^.4IF;_*:IC5ZD
MGH."+(MH=SO+8Q<"V"H+.JPL#J:LD76;K2I6MK2_+D2?LJ"]@QRO&4E"*%L!
M0H<%R+='C$M X"B*W]LR"2N/E7UPO/1]QBD)]9PP,)ST\/3- EA8JSK8L.IX
M#$F74I!'=O?.GE0Y#/S>II5V#^7&Z2TG:MWU$O -HF*^[8NHFVX^J\#.!6O5
M"1M6)]_W@=?%Y774LP,1L[AW<NS;J, T"M 7:R4$>^I(P9)O7=H=%5%:Q?2D
MQSY!$+,LZ6Z:^ TI8X&%*VNU QO6#L<JW$@7,(>C7DLKOXV2567#!+0W!]8+
MA(KW2""==7>O?79)- LLYMC!]P7#VP87UM$]&*<A+!QQD!PO@M/?+LAZ,].W
M(:$S9M9J #:L 9Y0=#YAY 7@VSJ@6=HK23Y#G$8X<.3,6O)GP^2_^^3#M_]H
M\8T;E/SW%F1V=;B18*.RL,L]:^#%YN'W+)YU%]\^LV1&LE#%;44 >_*\X;GN
MC]&"WXC:+FEM"(*T$;+T8O+L%) XI:P+JF]'<,9"IZ*L)7XV3/PO L7MDF@0
M3O.RHV]Y<-+_4L-GQ[+^R?STX&,V4(HW[AL_C=PV=O-9V/[N_CO"<_?U7.?^
M>_SNHOD:L.VF^3CQ<ZY@IC0L9)?0Y>QM F.LFN_]F@LC-^Z3N84T1J[=SQ7/
M0=9: WB^E"" =A?V!?NO+N?_ U!+ P04    "  +@IQ6AX];M\T%  !J#@
M&    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;(U7;6_;-A#^*P<7*%+ ]5O2
MIHN3 (F7H,&:Q8V;[<.P#[1TMHA0I$M2<;U?OSM2DB77,?K%IDC>W7-O#\GS
MM;'/+D/T\"-7VEUT,N]79_V^2S+,A>N9%6I:61B;"T^?=MEW*XLB#4*YZH\&
M@X_]7$C=N3P/<U-[>6X*KZ3&J057Y+FPFVM49GW1&7:JB4>YS#Q/]"_/5V*)
M,_1/JZFEKWZM)94Y:B>-!HN+B\[5\.SZA/>'#7])7+O&&-B3N3'/_'&77G0&
M# @5)IXU"/I[P0DJQ8H(QO=29Z<VR8+-<:7]-OA.OLR%PXE1?\O49Q>=3QU(
M<2$*Y1_-^C.6_GQ@?8E1+OS"NMP[Z$!2.&_R4I@0Y%+'?_&CC,.O"(Q*@5'
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M000AEW:UF/>TK8_.!=U,,*39J,/24Z1CFE1D[35%TS5E9L&!'%O+EJ4H,-N
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M@B0BPPOP/;?(GO:!-^C.U1;_ 5!+ P04    "  +@IQ6"2N#H9L-   =*@
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M*ZL+F0J'*;S34CGX3-*U07LV<.0!XPR2UMIE8RU\Q%H$[[5RN877*L7T6']
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MX;8"='H+G;#]:<^Q ;@7WASY\>,; +]HN?+^(-;/[7VX;SCRKFMV(.4!7NN
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M948-NU+B=Y[:[*PS[9"4S6DI[)U:?6*5/R.TERAAW'^R\K*#L$.2TEB55\J
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M:0 F+:>BXH[KV 8Z(YIKV%_OV]H1G,(G"15)*:BM?-D6A N+U&'N4 3^,+6
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M*G?+C%%(& K \[F"8EE=X ;-=[#S?P!02P,$%     @ "X*<5M$J]K5T#0
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M6ZTRM@9X7D)$+C5]=MU6]28Y=KI1(FV<1)%"5G"IG:%=+8@^Q-E/=",__Z>
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M0)<,Q;,7\KX/(+9+EQ::\I^V<?(6U:;I'MLVFEVYXGK6C.QI 77WL*\])E7
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M%RVK162#COXCYRPD_E;=D/(4E*OAZ>Y>HN K+K%XO'05Z(_.%:QNY+J0*YF
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M-F!TA0Z0$'W^F0U:GY5:3/LVL@$R?Z,%M3MHH'5W:I\@.<PJM.7D@IXHK.=
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MZW3>, -!KHKZ*6X;/ZPQ' 1;&**&(?*X:T4>Y9EPXN3(Z"49IH8T?O&F>FZ
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MIQ5]L:!V!VA_K93M!7?!_AMH\0]02P,$%     @ "X*<5N'B@P ?"P  FA\
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M0JLM:(<F-C?PH7IK$L>E.Y0[JVF7DYU=O>:F4H:[#!E0.=PB$W!E++,(3&9
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MY:@L :W/I#3K@=V@_4=B_"]02P,$%     @ "X*<5FW[U"(4!0  K L  !D
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M7RL@:\FQR)G8$&.9U%<Z^XY(!K=O9=U0\?SVS32.\G=ZH-\#]OY=EHA#E15
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MJH;C')FDNI;=38QL7)M<28--UPTK?.6 L@*XOY;2[";6P/[=M/@'4$L#!!0
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M1(&;> ]EX(5/]C_W/:&Y8_;';I@, A"B9S62+BH#=^%#(W!\;V$X&"'Q6A$
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M*'#.:N'N].H+KO,9>+Y<"]O\PJKU'0P#R&OKM%R#28'DJOVRE_4]O .,X@\
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MEC34T7@'.I]K[3:&#]#]361_ 5!+ P04    "  +@IQ6C\@&,LX#  #)"0
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MO%.NNO;\3;Q[Y% GVW!RJ\0UJ?KC2>* [!X.W42+QC;KE=#4^NVPH+<62B-
M^VM!R=A/C('A];;X#U!+ P04    "  +@IQ6Y+BV<\((  !('0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S."YX;6SE66MOVS@6_2N$QQC8 ">F2$F4TB1
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MM 'OIR4$;2?$8/WQ].QO4$L#!!0    (  N"G%;A]!V2B 0  *0+   9
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MT@C _4H(O=\8 \/#?/$O4$L#!!0    (  N"G%;L+[(4904  *$-   9
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M;W)K<VAE971S+W-H965T-#$N>&ULC599;^,V$/XKA+=8)( 0Z_21. 9R-&B
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MO6468>K:!OR>?(E(Y$AT/.2^U(Y8O>OTR*>+.)B%$;,.I;BIL"T$[E1$M:Y
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M2R'M%5+/NS/D67YBEBWG6NU .VE"<POOJM<F<ERZI#Q:3;><].QR512JE=;
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M!*$-\/F"<[6[T2^HA]?I?U!+ P04    "  +@IQ60:\5>[ "   G!P  &0
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M4GJG(ZRDK-MR/=%B:3O;7&CLDW98X$L&T@3@?BZ$WDY,@O9M3'X#4$L#!!0
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M52A6AY@H$DT%WX$PLS7--*R8UEJ'3YG9]V<E]%>J[53TB%HT":_A/1&"F#V
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M%\Z'6V Q2&. ]]="Z(<3LR&NOIC,?P%02P,$%     @ "X*<5HKP-@:1$
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M1Y-ZJ&:VVO8^H.<$KH5V:K?:]OO2.-GKU$$[=7LZ/=WKT^O;M-%^"M5'MRU
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M'$#"*!+&D# .@FFI^_O4?1.]J<,)*QW.1N]PMN<<N7_L<'Z05TWG@+%&VW,
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M_\6/^@^Q%>!.#@2X=8"[$^"-#P1X=8"W&W HP[ .&.X6R3T0,*H#1J<&C.N
M\:D!DSI@LGL-@P,!5W7 5?7I;CZ.ZK/T12'N;K+TF63EV8I6OJ@$446KCS!*
M2NU^*S)U-%)QQ9TO'POREMR+Y#OYJ(Z1=$8>,CF-"B*2*?E59C'YF(J$O/%E
M(:)E_LM-OU!YR^A^6.?P-SG< SD<\BE-BD5.:#*5TY9X:H_W+/%]=;W-1;NO
M%WWO6H'OU_-+XKH7Q!VX+OGMFT_>_/T7LE27V5*X!SOKDW@AKE>BG.L&E<E$
M/HOE'^FJ_(*V_<7LT&]R=4F\055 YW0J/5;43%&=BNJ]4ELP@1WCR[#!N!8,
MLV,^A\5)&'["9]E@IC*+GD19'?ZQD$N;5KSF"^)5?,_V!?F0Y$6V5E5VT5+
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MFF![YLXZA/H/4!JM:2=58E + DKC*)HI16U!#'_"@OBLY FQ(>S).ZL1:D-
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MKEXNI)C*K#Q!'9^E:?'ZIDS0//;^[K]02P,$%     @ "X*<5F+QL%O8 @
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M0UG<J@LA<-U!/5\SM9'5%7V#:*Z8X3]02P,$%     @ "X*<5BQHC<>^!0
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MWJ7E.R\@;SWJTT 1SPV^_%8L#LLI$DYP>"J#K5Z /94?\JHN-TVBUZHG:"?
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MH*0<(L/"^%435S:-'%B!:&%!23E$I@4I<A>D0  5B)85E)A#9%B0(G?!"01
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M+DI\ "4^P-^W?VT\[.0^%FFNO%2%*YQ\*<9%B0^@Q ?AY"M/EDIYY]<%& 0
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M:\H[/^"23Q?%G$,QYW@QEWRN=SW6/[VS+/=^BK2LU/9PV7"W5$4O^$I3P\
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M]TU=/&\_I.2^J.MBO?WR2:1+4;8/:'[_4!3U_IMV@\,'W5S]#U!+ P04
M"  +@IQ6S(<"+GD"  #(!@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6RUE6UKVS 0Q[_*X<'88,2.G8>M<PQMREA'-TK+NA=C+Q3['(M:DB<I<0/[
M\#O)B<E*DL%8W]AZN/OK=R?IE+9*/Y@*T<*CJ*69!96US5D8FKQ"P<Q -2AI
MIE1:,$M=O0Q-HY$5WDG481Q%DU P+H,L]6,W.DO5RM9<XHT&LQ*"Z<T%UJJ=
M!<-@-W#+EY5U V&6-FR)=VB_-C>:>F&O4G"!TG E06,Y"\Z'9Q=39^\-[CFV
M9J\-+I*%4@^N<U7,@L@!88VY=0J,?FN<8UT[(<+XN=4,^B6=XWY[I_[!QTZQ
M+)C!N:J_\<)6L^!M  66;%7;6]5^Q&T\8Z>7J]KX+[2=[7@:0+XR5HFM,Q$(
M+KL_>]SF8<\A3HXXQ%N'V'-W"WG*2V99EFK5@G;6I.8:/E3O37!<NDVYLYIF
M.?G9;*Z$X):R; TP6<!<2<OE$F7.T<"K2[2,U^9U&EI:S+F$^5;XHA..CPA_
M9GH R? -Q%&<0*/I&&F[^5,G)-B>..Z)8R\\.B)\S4N$.\*3.<*G>_@%^R.'
M0$_JN5-_9AJ6XRR@8VU0KS'(7KX83J+W)VB3GC;QZLDQ6F7,DZ1^OR8;N+(H
MS(]#N,DSX(YZW-')Y%[)-1I_'$"U$K6I> .T<SF-T!T]A-L)#B.OZ&K .HL&
MHW=IN#[ ,>XYQG_A*%!(7O*<^<M[OM2(#NL0P4FI?TS8I >=_._]G3P#[K3'
MG9[,ZY>56* &5>YNI ,6; ,+A)RBT'RQLE@ EV K!'8J[=U*X[U]CY_N>KA7
MF%R-IZ*PY-) C24Y18,I>>NN;G8=JQI?JQ;*4N7SS8J>&M3.@.9+I>RNX\I?
M_WAEOP%02P,$%     @ "X*<5@G*L=SD @  @@L  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C8N>&ULM59=;YLP%/TK%INF5MH"(9_J$J0V=%JE=:I:;7N8
M]N# 3; *-K5-TO[[71M"DRIAB<1>P#;W'-]S,)<[60OYJ!( 39ZSE*NIDVB=
M7[BNBA+(J.J('#@^60B948U3N715+H'&%I2EKN]Y0S>CC#O!Q*[=R6 B"ITR
M#G>2J"++J'RY@E2LIT[7V2S<LV6BS8(;3'*ZA ?0/_([B3.W9HE9!EPQP8F$
MQ=2Y[%Z$8Q-O WXR6*NM,3%*YD(\FLE-/'4\DQ"D$&G#0/&V@AFDJ2'"-)XJ
M3J?>T@"WQQOV+U8[:IE3!3.1_F*Q3J;.V"$Q+&B1ZGNQ_@J5GH'ABT2J[)6L
MJUC/(5&AM,@J,&:0,5[>Z7/EPQ:@VS\ \"N _Q8P. #H58#>L3OT*T#?.E-*
ML3Z$5--@(L6:2!.-;&9@S;1HE,^X>>T/6N)3AC@=7#\53+\0RF-R#S'@F9JG
M0+X+'@FNI4@Q?DENN 8)2BORB81LQ6+@L2)G(6C*4G6.J^^)2U1",6CB:DS+
MD+M1E<*L3,$_D$*/W.)>B2+7/(9X%^^BG%J3O]%TY3<27N:R0_S11^)[?F]?
M/LWP6XKP7O<@/#P>[C>HZ=5OJ&?Y>@?X'HJY@J<"N";7*W/]_0TCR(V&3/W9
MD]Y52=??3V?*R(7*:013!^N$ KD")_CPKCOT/N^SJDVRL"6R'1O[M8W])O;@
M]=S&$*5X4F-RQCB)\8A3J4@.LCS Y_LL;:0^U=*2;&3)3%5>!5X'S]EJVZGF
MF!T#!K4!@R,-R"D[17PC[:GB!T>(;X[9$3^LQ0\;Q;_]B/;I;&0X56>;9&%+
M9#O.C6KG1NV6GU&;-K9)%K9$MF/CN+9Q_/_*S_C?'\VL<?M3G6J)K'3*W>I.
M,I!+V^4I$HF"Z_*G7J_6C>2E[9_>K,^PP2S[P5>:LCO%?^Z2<4526""EUQEA
M"9%EQU=.M,AM#S07&CLJ.TRP209I O#Y0@B]F9@-ZK8[^ M02P,$%     @
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MK4?M#&A_J93=35R [M]#]@M02P,$%     @ "X*<5@1(O1F\ P  J!0  !D
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M3,[D*%AS+-84!*WJ<Y\5%8*6]64&. 6F*LCG:TK%H: :Z XGPS]02P,$%
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M$K)2(;W;4$'BY?EC>2-97ASAO3 I65I<;@B."=<&ZOV**6%5W>@/U*? L_\
M4$L#!!0    (  N"G%91ARX^&0(  #L$   9    >&PO=V]R:W-H965T<R]S
M:&5E=#<T+GAM;(5446_3,!#^*U:0$$@PMPD=K"21UE4('IBJ5L #XL%-+HV9
M8P?[TJS_GK.35D7JQDOL.]_WW7?G<]+>V =7 R![;)1V650CMG/.75%#(]R5
M:4'3265L(Y!,N^.NM2#* &H4CR>3:]X(J:,\#;Z5S5/3H9(:5I:YKFF$/2Q
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M][6!81)P2-JF+Q,,YQQ\[KU<VS,_,OY5[ B1X'M95&)A[:2L'VU;9#M28O'
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M)1+30GQ0$E_6*7C_[@-X!V@%?M^QO5 ,,;>E\J!G8F?=?#^V\T47YOL;Y@_
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MB&]PO[6[WT'2N).NNZNB;D(G3>BDQ/-/X,VKS$5LB99I08LDI9F*4$B^+>?
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M.8VSPQW!:Y+*!N+^AE+^="(W&8M-Y=G_4$L#!!0    (  N"G%979=O*. ,
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M /1NU)K,J\C4C;D)7,MW?&^B;W;M&<QYJCT].<V1Z]MMSCWA;BO<'13^5:3
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M$D7V/;CW/@HW[ZEP^W_(\1]02P,$%     @ "X*<5I>*NQS     $P(   L
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M'=4ZW+13HY@7!L1BF(@'!UFP[G] W?_KNI:'6@Q5./:AMH]ZA2IEM\"P[G]
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MV^6ORZ^=DWO\BG.XKQB>_P)02P,$%     @ "X*<5H/1K $N @  1#$  !,
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  +@IQ6)5K[CN\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  +@IQ6
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    (  N"G%8A)IX [04  +P?   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  +@IQ6
M@2^)$A<(  "5'P  &               @($Q#@  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ "X*<5G04JT'[ @  Q0@  !@
M     ("!?A8  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M  N"G%:#.&7X<@<  * A   8              " @:\9  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    "  +@IQ6KV%&-[,#  !T"P  &
M            @(%7(0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ "X*<5@NS8G[""@  .&0  !@              ("!0"4  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  N"G%9D-5:_G@(  /T%
M   8              " @3@P  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    "  +@IQ6,'+R):,)  "!*0  &               @($,,P
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ "X*<5H>/6[?-
M!0  :@X  !@              ("!Y3P  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    (  N"G%88E!LORPH  / =   9              "
M@>A"  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ "X*<
M5A;7\3SK P  8PD  !D              ("!ZDT  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    "  +@IQ696KT):(%  !"$   &0
M        @($,4@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   (  N"G%83&PDS3@4  &,;   9              " @>57  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ "X*<5@DK@Z&;#0  '2H
M !D              ("!:ET  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    "  +@IQ6WBO\@0(%  #W"P  &0              @($\:P
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  N"G%9-2,'Q
M]0,  % *   9              " @75P  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ "X*<5N3$N'$X#P   C(  !D
M ("!H70  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  +
M@IQ6-:G\"W<%  !)#0  &0              @($0A   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  N"G%96W?/3RPP  #DF   9
M          " @;Z)  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#
M%     @ "X*<5AN/PYZ@!@  $Q,  !D              ("!P)8  'AL+W=O
M<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  +@IQ6T2KVM70-  #G
M+0  &0              @(&7G0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM
M;%!+ 0(4 Q0    (  N"G%;G<SCL904  * -   9              " @4*K
M  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ "X*<5D;]
M>V7##0  PS$  !D              ("!WK   'AL+W=O<FMS:&5E=',O<VAE
M970R,RYX;6Q02P$"% ,4    "  +@IQ6(UP'ZK@$  #>"@  &0
M    @('8O@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M  N"G%99+IMTHP8  "D1   9              " @<?#  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ "X*<5FA"V'%- P  QP<  !D
M             ("!H<H  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    "  +@IQ6")A92IH#   /"0  &0              @($ES@  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (  N"G%;AXH, 'PL
M )H?   9              " @?;1  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ "X*<5M'@< T  P  Q08  !D              ("!
M3-T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  +@IQ6
MD^Q&^VP#  !B"   &0              @(&#X   >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    (  N"G%8V"N9UI0(  -L%   9
M      " @2;D  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ "X*<5@ ZJ>D8!0  G1   !D              ("! N<  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  +@IQ6;?O4(A0%  "L"P
M&0              @(%1[   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    (  N"G%8VCF.-BP,  $,)   9              " @9SQ  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ "X*<5B?#U?HQ
M!0  ^ P  !D              ("!7O4  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    "  +@IQ6+?.6]NH"   R!@  &0
M@('&^@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  N"
MG%:/R 8RS@,  ,D)   9              " @>?]  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ "X*<5N2XMG/""   2!T  !D
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M=#0R+GAM;%!+ 0(4 Q0    (  N"G%8&LR$J8P,  (L'   9
M  " @9\> 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M"X*<5D8-%'ZN P  $PD  !D              ("!.2(! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    "  +@IQ6=^" UID#  #+#@  &0
M            @($>)@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    (  N"G%9YX%V44@0  -(>   9              " @>XI 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ "X*<5L'^?W!4 @
M3P4  !D              ("!=RX! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    "  +@IQ64+)???4'   H4   &0              @($"
M,0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  N"G%8_
MZ!N*] ,  ,@.   9              " @2XY 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ "X*<5D&O%7NP @  )P<  !D
M     ("!63T! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  N"G%;=G(?_  0  #X2   9              "
M@2MA 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ "X*<
M5K=1C/6<"0  YFH  !D              ("!8F4! 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    "  +@IQ6L$DETK,#  "B#@  &0
M        @($U;P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   (  N"G%8B].>A[P(  $ (   9              " @1]S 0!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ "X*<5M>LGS45 P  70P
M !D              ("!178! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    "  +@IQ6TGLV!",+   "?P  &0              @(&1>0$
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (  N"G%9B\;!;
MV (  "4(   9              " @>N$ 0!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ "X*<5I9 %<L. P  ;@X  !D
M ("!^H<! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    "  +
M@IQ6+&B-Q[X%   A+P  &0              @($_BP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (  N"G%;HJ_O7' L  /1F   9
M          " @321 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#
M%     @ "X*<5LR' BYY @  R 8  !D              ("!AYP! 'AL+W=O
M<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    "  +@IQ6"<JQW.0"  ""
M"P  &0              @($WGP$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM
M;%!+ 0(4 Q0    (  N"G%81Q4.IT@4  'HK   9              " @5*B
M 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ "X*<5JH:
M>,9. P  N L  !D              ("!6Z@! 'AL+W=O<FMS:&5E=',O<VAE
M970V."YX;6Q02P$"% ,4    "  +@IQ6NV%W#"L#  !)"   &0
M    @('@JP$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M  N"G%8$2+T9O ,  *@4   9              " @4*O 0!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ "X*<5D;-&\)+ P  1PL  !D
M             ("!-;,! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"
M% ,4    "  +@IQ6FI  ^C0#   H#   &0              @(&WM@$ >&PO
M=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    (  N"G%:T)BKM! 4
M !$6   9              " @2*Z 0!X;"]W;W)K<VAE971S+W-H965T-S,N
M>&UL4$L! A0#%     @ "X*<5E&'+CX9 @  .P0  !D              ("!
M7;\! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    "  +@IQ6
M &PWY T=  !4@ $ &0              @(&MP0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;%!+ 0(4 Q0    (  N"G%;&8$R76 ,  .L)   9
M      " @?'> 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%
M  @ "X*<5FS3]]^G P  "0T  !D              ("!@.(! 'AL+W=O<FMS
M:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    "  +@IQ6L\5EVK@#  !>$
M&0              @(%>Y@$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+
M 0(4 Q0    (  N"G%8&P'<P404  * B   9              " @4WJ 0!X
M;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ "X*<5FS/RSUT
M @  \P8  !D              ("!U>\! 'AL+W=O<FMS:&5E=',O<VAE970X
M,"YX;6Q02P$"% ,4    "  +@IQ6>)FOCID)  #^2@  &0
M@(& \@$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    (  N"
MG%;;*8?1R 0  ,89   9              " @5#\ 0!X;"]W;W)K<VAE971S
M+W-H965T.#(N>&UL4$L! A0#%     @ "X*<5I[.9,5?!0  <RT  !D
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M<R\N<F5L<U!+ 0(4 Q0    (  N"G%8:V54'6@8  )0X   /
M  "  2T7 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  +@IQ64C7&HXH"
M  "Y,@  &@              @ &T'0( >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    "  +@IQ6@]&L 2X"  !$,0  $P
M@ %V( ( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     7@!> ,D9  #5(@(
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>277</ContextCount>
  <ElementCount>404</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>118</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Business</Role>
      <ShortName>Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Real Estate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstate</Role>
      <ShortName>Real Estate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Dispositions of Real Estate and Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Loans Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivable</Role>
      <ShortName>Loans Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Intangibles</Role>
      <ShortName>Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Equity and Redeemable Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShare</Role>
      <ShortName>Earnings Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Segment Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosures</Role>
      <ShortName>Segment Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Loans Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableTables</Role>
      <ShortName>Loans Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/LoansReceivable</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesTables</Role>
      <ShortName>Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Intangibles</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Debt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Earnings Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareTables</Role>
      <ShortName>Earnings Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EarningsPerCommonShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Segment Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosuresTables</Role>
      <ShortName>Segment Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SegmentDisclosures</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Variable Interest Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesTables</Role>
      <ShortName>Variable Interest Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/VariableInterestEntities</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/FairValueMeasurements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DeferredRevenue</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Government Grant Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Real Estate - Real Estate Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails</Role>
      <ShortName>Real Estate - Real Estate Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Real Estate - Development Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails</Role>
      <ShortName>Real Estate - Development Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Leases - Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesLeaseIncomeDetails</Role>
      <ShortName>Leases - Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails</Role>
      <ShortName>Loans Receivable - Schedule of Loans Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Loans Receivable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableNarrativeDetails</Role>
      <ShortName>Loans Receivable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails</Role>
      <ShortName>Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails</Role>
      <ShortName>Loans Receivable - Schedule of Reserve for Loan Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Intangibles - Intangibles Lease Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails</Role>
      <ShortName>Intangibles - Intangibles Lease Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails</Role>
      <ShortName>Intangibles - Intangibles Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesNarrativeDetails</Role>
      <ShortName>Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Debt - Bank Line of Credit and Term Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails</Role>
      <ShortName>Debt - Bank Line of Credit and Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Debt - Commercial Paper Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails</Role>
      <ShortName>Debt - Commercial Paper Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Debt - Senior Unsecured Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails</Role>
      <ShortName>Debt - Senior Unsecured Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Debt - Mortgage Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtMortgageDebtDetails</Role>
      <ShortName>Debt - Mortgage Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Debt - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtDebtMaturitiesDetails</Role>
      <ShortName>Debt - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/CommitmentsandContingencies</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Equity and Redeemable Noncontrolling Interests - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Equity and Redeemable Noncontrolling Interests - ATM Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - ATM Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Equity and Redeemable Noncontrolling Interests - DownREITs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - DownREITs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Earnings Per Common Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails</Role>
      <ShortName>Earnings Per Common Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails</Role>
      <ShortName>Earnings Per Common Share - Computation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Segment Disclosures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails</Role>
      <ShortName>Segment Disclosures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails</Role>
      <ShortName>Segment Disclosures - Summary Information for the Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Variable Interest Entities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails</Role>
      <ShortName>Variable Interest Entities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities - Schedule of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails</Role>
      <ShortName>Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Derivative Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="peak-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails</Role>
      <ShortName>Deferred Revenue - Schedule of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: peak:OptionIndexedToIssuersEquityTerm -  peak-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="peak-20230331.htm">peak-20230331.htm</File>
    <File>ex101003312023.htm</File>
    <File>ex101103312023.htm</File>
    <File>ex101203312023.htm</File>
    <File>ex101303312023.htm</File>
    <File>ex101403312023.htm</File>
    <File>ex101503312023.htm</File>
    <File>ex101603312023.htm</File>
    <File>ex10703312023.htm</File>
    <File>ex10803312023.htm</File>
    <File>ex10903312023.htm</File>
    <File>ex22103312023.htm</File>
    <File>ex31103312023.htm</File>
    <File>ex31203312023.htm</File>
    <File>ex32103312023.htm</File>
    <File>ex32203312023.htm</File>
    <File>peak-20230331.xsd</File>
    <File>peak-20230331_cal.xml</File>
    <File>peak-20230331_def.xml</File>
    <File>peak-20230331_lab.xml</File>
    <File>peak-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1148">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "peak-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 39,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1148,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 277,
   "dts": {
    "calculationLink": {
     "local": [
      "peak-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "peak-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "peak-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "peak-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "peak-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "peak-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 685,
   "entityCount": 1,
   "hidden": {
    "http://www.healthpeak.com/20230331": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 6
   },
   "keyCustom": 105,
   "keyStandard": 299,
   "memberCustom": 61,
   "memberStandard": 47,
   "nsprefix": "peak",
   "nsuri": "http://www.healthpeak.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.healthpeak.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealEstateDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Real Estate",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.healthpeak.com/role/RealEstate",
     "shortName": "Real Estate",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealEstateDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Dispositions of Real Estate and Discontinued Operations",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations",
     "shortName": "Dispositions of Real Estate and Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.healthpeak.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Loans Receivable",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.healthpeak.com/role/LoansReceivable",
     "shortName": "Loans Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Intangibles",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.healthpeak.com/role/Intangibles",
     "shortName": "Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.healthpeak.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.healthpeak.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Equity and Redeemable Noncontrolling Interests",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests",
     "shortName": "Equity and Redeemable Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LoansPayableToBank",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings Per Common Share",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShare",
     "shortName": "Earnings Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Segment Disclosures",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.healthpeak.com/role/SegmentDisclosures",
     "shortName": "Segment Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Supplemental Cash Flow Information",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:VariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Variable Interest Entities",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.healthpeak.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:VariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.healthpeak.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Derivative Financial Instruments",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Deferred Revenue",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.healthpeak.com/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables",
     "shortName": "Dispositions of Real Estate and Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.healthpeak.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Loans Receivable (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.healthpeak.com/role/LoansReceivableTables",
     "shortName": "Loans Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Intangibles (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.healthpeak.com/role/IntangiblesTables",
     "shortName": "Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.healthpeak.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables",
     "shortName": "Equity and Redeemable Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Earnings Per Common Share (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareTables",
     "shortName": "Earnings Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Segment Disclosures (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.healthpeak.com/role/SegmentDisclosuresTables",
     "shortName": "Segment Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Variable Interest Entities (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesTables",
     "shortName": "Variable Interest Entities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.healthpeak.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Derivative Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfDeferredRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Deferred Revenue (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.healthpeak.com/role/DeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfDeferredRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:GovernmentGrantIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Government Grant Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i8a0702a7ac7545d2a11faac0f40d4410_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:GovernmentGrantIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i118359ae91b74e62812988bfeaa797c8_D20230101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Real Estate - Real Estate Investments (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails",
     "shortName": "Real Estate - Real Estate Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i118359ae91b74e62812988bfeaa797c8_D20230101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Real Estate - Development Activities (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails",
     "shortName": "Real Estate - Development Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnSalesOfInvestmentRealEstate",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
     "shortName": "Dispositions of Real Estate and Discontinued Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
     "shortName": "Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i219177f6054b460eb51c30bbf64d60c4_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Leases - Lease Income (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails",
     "shortName": "Leases - Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfLeaseReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.healthpeak.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iaf21f110458c4c2bba4b3d1dba41c307_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfLeaseReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
     "shortName": "Loans Receivable - Schedule of Loans Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInFinancingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Loans Receivable - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
     "shortName": "Loans Receivable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i9a09c60ade2547478c8bde3119807cfa_D20230201-20230228",
      "decimals": "-6",
      "lang": "en-US",
      "name": "peak:LoansReceivableExtensionFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails",
     "shortName": "Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ia71f0b0ceb8b4ce1b2e36e4277c209ad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iaecb36bec2724a3594acf3e81eca36dc_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails",
     "shortName": "Loans Receivable - Schedule of Reserve for Loan Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "idcb7ea32456048788d35e1f70da8c6f5_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Intangibles - Intangibles Lease Assets (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
     "shortName": "Intangibles - Intangibles Lease Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:FiniteLivedIntangibleLiabilitiesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails",
     "shortName": "Intangibles - Intangibles Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:FiniteLivedIntangibleLiabilitiesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Intangibles - Narrative (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
     "shortName": "Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i30bf6bfeb0434265ba52f1329cc43b46_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i30bf6bfeb0434265ba52f1329cc43b46_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Debt - Bank Line of Credit and Term Loan (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
     "shortName": "Debt - Bank Line of Credit and Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i0ae753d2f2bb4df0934278cf9eff53e5_D20220822-20220822",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:NumberOfLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "loan",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "peak:DebtInstrumentMaximumBorrowingCapacity",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i0a9825d537dc48a1ace8af19b8cf7906_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:DebtInstrumentMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Debt - Commercial Paper Program (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
     "shortName": "Debt - Commercial Paper Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "peak:DebtInstrumentMaximumBorrowingCapacity",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i0a9825d537dc48a1ace8af19b8cf7906_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:DebtInstrumentMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Debt - Senior Unsecured Notes (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
     "shortName": "Debt - Senior Unsecured Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ife87565ec58448679511f93e16e05495_I20230117",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Debt - Mortgage Debt (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
     "shortName": "Debt - Mortgage Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i906008fbc48340908eb765f2c3dc8cd1_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Debt - Debt Maturities (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
     "shortName": "Debt - Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ibc7a7c8342fd4301bda1ac23efa4626c_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "icd23299bf615464e91aa88b816387e2f_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:ContributionOfPropertyNumberOfProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Equity and Redeemable Noncontrolling Interests - Dividends (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Equity and Redeemable Noncontrolling Interests - ATM Program (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - ATM Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ie980168387e14a51a49837fe74a3b54e_D20230101-20230331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "peak:AtmEquityOfferingProgramAggregateAmountAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - Share Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberOfRedeemableNoncontrollingInterestRedemptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "interest",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - Healthpeak OP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ifadba107786f4ec5bb57d8a584bfca64_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberOfRedeemableNoncontrollingInterestRedemptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "interest",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestInPreferredUnitHolders",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Equity and Redeemable Noncontrolling Interests - DownREITs (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - DownREITs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i252b5f72bd3f474cb0b445240f777230_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "peak:DownREITUnitsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Earnings Per Common Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails",
     "shortName": "Earnings Per Common Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
     "shortName": "Earnings Per Common Share - Computation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Segment Disclosures - Narrative (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails",
     "shortName": "Segment Disclosures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
     "shortName": "Segment Disclosures - Summary Information for the Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "peak:GovernmentGrantIncomeFromCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
     "shortName": "Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i49bd62aeb5e74858940c029687c58ff5_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i0e3e4e9fac0c42b1b12d278fe604def4_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if2e661c65de049509e99f61fdd2bd048_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Variable Interest Entities - Narrative (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
     "shortName": "Variable Interest Entities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ic264575fc36449f5a87c5ea91360a740_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:NumberOfUnconsolidatedJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "joint_venture",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ib9a26b40f92a44a6b6ce8ccab69a4e01_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
     "shortName": "Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "ia947c487c4384345a0b1601d6fa7c4e6_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.healthpeak.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i30df8d22282b41fd9bf4802f9a1b4777_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LoansReceivableFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Derivative Financial Instruments - Narrative (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
     "shortName": "Derivative Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i3ef70f9721254f3b8cc366b0a5efd98a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails",
     "shortName": "Derivative Financial Instruments - Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "i3ef70f9721254f3b8cc366b0a5efd98a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:RefundableEntranceFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:RefundableEntranceFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfDeferredRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:NonrefundableEntranceFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Deferred Revenue - Schedule of Deferred Revenue (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails",
     "shortName": "Deferred Revenue - Schedule of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfDeferredRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "if4882bfad4354d8ea1cac4348c817159_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:NonrefundableEntranceFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Business",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.healthpeak.com/role/Business",
     "shortName": "Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20230331.htm",
      "contextRef": "iab8ac01ab7f94115954b27f33879edba_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 118,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "peak_A2020ATMProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 ATM Program [Member]",
        "label": "2020 ATM Program [Member]",
        "terseLabel": "2020 ATM Program"
       }
      }
     },
     "localname": "A2020ATMProgramMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_A2023AtTheMarketProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 At-The-Market Program",
        "label": "2023 At-The-Market Program [Member]",
        "terseLabel": "2023 At-The-Market Program"
       }
      }
     },
     "localname": "A2023AtTheMarketProgramMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ATMDirectIssuancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM Direct Issuances [Member]",
        "label": "ATM Direct Issuances [Member]",
        "terseLabel": "ATM Direct Issuances"
       }
      }
     },
     "localname": "ATMDirectIssuancesMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ATMEquityOfferingProgramAggregateAmountRemaining": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM Equity Offering Program Aggregate Amount Remaining",
        "label": "ATM Equity Offering Program Aggregate Amount Remaining",
        "terseLabel": "ATM aggregate amount remaining"
       }
      }
     },
     "localname": "ATMEquityOfferingProgramAggregateAmountRemaining",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life",
        "label": "Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life",
        "terseLabel": "Weighted average remaining amortization period in years",
        "verboseLabel": "Weighted average remaining amortization period, liabilities"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_AdjustedNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.",
        "label": "Adjusted Net Operating Income from Continuing Operations",
        "totalLabel": "Adjusted NOI"
       }
      }
     },
     "localname": "AdjustedNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AdjustmentsOfPermanentEquityToTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments Of Permanent Equity To Temporary Equity",
        "label": "Adjustments Of Permanent Equity To Temporary Equity",
        "negatedTerseLabel": "Adjustments to redemption value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "AdjustmentsOfPermanentEquityToTemporaryEquity",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AmortizationOfNonrefundableEntranceFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Nonrefundable Entrance Fee",
        "label": "Amortization Of Nonrefundable Entrance Fee",
        "terseLabel": "Amortization of nonrefundable entrance fee"
       }
      }
     },
     "localname": "AmortizationOfNonrefundableEntranceFee",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net",
        "label": "Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net",
        "terseLabel": "Amortization of nonrefundable entrance fees and above (below) market lease intangibles"
       }
      }
     },
     "localname": "AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AtTheMarketProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Program [Member]",
        "label": "At-The-Market Program [Member]",
        "terseLabel": "At-The-Market Program"
       }
      }
     },
     "localname": "AtTheMarketProgramMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_AtmEquityOfferingProgramAggregateAmountAuthorized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.",
        "label": "ATM Equity Offering Program Aggregate Amount Authorized",
        "terseLabel": "ATM aggregate amount authorized"
       }
      }
     },
     "localname": "AtmEquityOfferingProgramAggregateAmountAuthorized",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_BrookdaleMTCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brookdale MTCA [Member]",
        "label": "Brookdale MTCA [Member]",
        "terseLabel": "Brookedale MTCA"
       }
      }
     },
     "localname": "BrookdaleMTCAMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CCRCResidentLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CCRC Resident Loans",
        "label": "CCRC Resident Loans [Member]",
        "terseLabel": "CCRC resident loans"
       }
      }
     },
     "localname": "CCRCResidentLoansMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CCRCSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CCRC Segment [Member]",
        "label": "CCRC Segment [Member]",
        "terseLabel": "CCRC"
       }
      }
     },
     "localname": "CCRCSegmentMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CCRVJVInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the unconsolidated joint venture formed by the Company and Brookdale, under a RIDEA structure, to own and operate CCRC campuses.",
        "label": "CCRV JV Investment [Member]",
        "terseLabel": "CCRC JV"
       }
      }
     },
     "localname": "CCRVJVInvestmentMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CapitalExpenditureFundingAmountCommitted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Amount Committed",
        "label": "Capital Expenditure Funding, Amount Committed",
        "terseLabel": "Capital expenditure funding, amount committed"
       }
      }
     },
     "localname": "CapitalExpenditureFundingAmountCommitted",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CapitalExpenditureFundingAmountFunded": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Amount Funded",
        "label": "Capital Expenditure Funding, Amount Funded",
        "terseLabel": "Capital expenditure funding, amount funded"
       }
      }
     },
     "localname": "CapitalExpenditureFundingAmountFunded",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Cost of Capital, Percent Committed",
        "label": "Capital Expenditure Funding, Cost of Capital, Percent Committed",
        "terseLabel": "Capital expenditure funding, cost of capital, percent committed"
       }
      }
     },
     "localname": "CapitalExpenditureFundingCostOfCapitalPercentCommitted",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "label": "Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "totalLabel": "Cash and cash equivalents, total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations",
        "label": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]",
        "terseLabel": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]"
       }
      }
     },
     "localname": "CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "peak_CommercialPaperProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper Program [Member]",
        "label": "Commercial Paper Program [Member]",
        "terseLabel": "Commercial Paper Program"
       }
      }
     },
     "localname": "CommercialPaperProgramMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments, Development and Redevelopment Projects and Tenant Improvements",
        "label": "Commitments, Development and Redevelopment Projects and Tenant Improvements",
        "terseLabel": "Development commitments"
       }
      }
     },
     "localname": "CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments, Development and Redevelopment Projects, Increase (Decrease)",
        "label": "Commitments, Development and Redevelopment Projects and Tenant Improvements, Amount Increase (Decrease)",
        "terseLabel": "Development and redevelopment projects, amount decrease"
       }
      }
     },
     "localname": "CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CommonStockConvertibleSharesIssuable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Convertible, Shares Issuable",
        "label": "Common Stock, Convertible, Shares Issuable",
        "terseLabel": "Common stock issuable (in shares)"
       }
      }
     },
     "localname": "CommonStockConvertibleSharesIssuable",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_ContributionOfPropertyNumberOfProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Of Property, Number Of Properties",
        "label": "Contribution Of Property, Number Of Properties",
        "terseLabel": "Number of properties may be contributed in the agreement"
       }
      }
     },
     "localname": "ContributionOfPropertyNumberOfProperties",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_CurrentPeriodGrossWriteOffsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Period Gross Write-Offs",
        "label": "Current Period Gross Write-Offs [Member]",
        "terseLabel": "Current period gross write-offs"
       }
      }
     },
     "localname": "CurrentPeriodGrossWriteOffsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CurrentPeriodNetWriteOffsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Period Net Write-Offs",
        "label": "Current Period Net Write-Offs [Member]",
        "terseLabel": "Current period net write-offs"
       }
      }
     },
     "localname": "CurrentPeriodNetWriteOffsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CurrentPeriodRecoveriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Period Recoveries",
        "label": "Current Period Recoveries [Member]",
        "terseLabel": "Current period recoveries"
       }
      }
     },
     "localname": "CurrentPeriodRecoveriesMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of healthcare facilities which are secured by mortgage debt.",
        "label": "Debt Instrument, Collateral Healthcare Facilities, Carrying Value",
        "terseLabel": "Debt instrument, collateral, healthcare facilities carrying value"
       }
      }
     },
     "localname": "DebtInstrumentCollateralHealthcareFacilitiesCarryingValue",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentCovenantDebtToAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Debt to Assets",
        "terseLabel": "Debt instrument, covenant debt to assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToAssets",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentCovenantFixedChargeRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The required minimum Fixed Charge Coverage ratio contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Fixed Charge Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant minimum fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFixedChargeRatioMinimum",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "peak_DebtInstrumentCovenantNetWorthMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Net Worth, Minimum",
        "terseLabel": "Debt instrument, covenant net worth, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantNetWorthMinimum",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentCovenantSecuredDebtToAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Secured Debt to Assets",
        "terseLabel": "Debt instrument, covenant secured debt to assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredDebtToAssets",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Unsecured Debt to Unencumbered Assets",
        "terseLabel": "Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentDrawTimePeriodAfterClosing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Draw Time Period After Closing",
        "label": "Debt Instrument, Draw Time Period After Closing",
        "terseLabel": "Debt instrument, period after closing"
       }
      }
     },
     "localname": "DebtInstrumentDrawTimePeriodAfterClosing",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics",
        "label": "Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics",
        "terseLabel": "Debt Instrument, interest rate, reduction available for sustainability metrics"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "peak_DebtInstrumentMarginRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Margin Rate",
        "label": "Debt Instrument, Margin Rate",
        "terseLabel": "Debt instrument, margin rate"
       }
      }
     },
     "localname": "DebtInstrumentMarginRate",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Borrowing Capacity",
        "label": "Debt Instrument, Maximum Borrowing Capacity",
        "terseLabel": "Maximum outstanding amount capacity"
       }
      }
     },
     "localname": "DebtInstrumentMaximumBorrowingCapacity",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentNumberofExtensions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Extensions",
        "label": "Debt Instrument, Number of Extensions",
        "terseLabel": "Number of extensions"
       }
      }
     },
     "localname": "DebtInstrumentNumberofExtensions",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_DebtInstrumentPeriodOfExtension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the length of the debt instrument extension period.",
        "label": "Debt Instrument, Period Of Extension",
        "terseLabel": "Length of debt instrument extension period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentPeriodOfExtension",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_DebtInstrumentRedemptionPeriodThereafterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the period after the last period separately disclosed of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Thereafter [Member]",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThereafterMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Remainder of Fiscal Year",
        "label": "Debt Instrument, Redemption, Remainder of Fiscal Year [Member]",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionRemainderOfFiscalYearMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DebtInstrumentWeightedAverageMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents weighted average maturity of debt.",
        "label": "Debt Instrument, Weighted Average Maturity",
        "terseLabel": "Weighted-average maturity (in years)"
       }
      }
     },
     "localname": "DebtInstrumentWeightedAverageMaturity",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_DerivativeNotionalAmountTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Terminated",
        "label": "Derivative, Notional Amount, Terminated",
        "terseLabel": "Derivative amount terminated"
       }
      }
     },
     "localname": "DerivativeNotionalAmountTerminated",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Nonoperating Income Expense",
        "label": "Disposal Group Including Discontinued Operation Nonoperating Income Expense",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Resident Fees And Services",
        "label": "Disposal Group Including Discontinued Operation Resident Fees And Services",
        "terseLabel": "Resident fees and services"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents",
        "label": "Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Total Costs And Expenses",
        "label": "Disposal Group Including Discontinued Operation Total Costs And Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "label": "Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "terseLabel": "Equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "label": "Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.",
        "label": "Distributions in Excess of Earnings from Unconsolidated Joint Ventures",
        "terseLabel": "Distributions in excess of earnings from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DownREITMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to the conversion of DownREIT units that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Down R E I T [Member]",
        "terseLabel": "Down REIT"
       }
      }
     },
     "localname": "DownREITMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DownREITUnitsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of DownREIT units outstanding.",
        "label": "Down REIT Units Outstanding",
        "terseLabel": "DownREIT units outstanding (in shares)"
       }
      }
     },
     "localname": "DownREITUnitsOutstanding",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_DownreitPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a joint venture, DownREIT Partnerships.",
        "label": "Downreit Partnerships [Member]",
        "terseLabel": "DownREIT Partnerships"
       }
      }
     },
     "localname": "DownreitPartnershipsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Income (Loss) From Unconsolidated Joint Ventures",
        "label": "Equity Income (Loss) From Unconsolidated Joint Ventures [Member]",
        "terseLabel": "Government grant income recorded in equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "EquityIncomeLossFromUnconsolidatedJointVenturesMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Unfunded Loan Commitments",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest, Unfunded Loan Commitments",
        "terseLabel": "Credit loss reserve on unfunded loan commitments"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "peak_FiniteLivedIntangibleLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Liabilities Accumulated Amortization",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesAccumulatedAmortization",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Liabilities Acquired",
        "label": "Finite-Lived Intangible Liabilities Acquired",
        "terseLabel": "Intangible liabilities acquired"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesAcquired",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "peak_FiniteLivedIntangibleLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Liabilities, Gross",
        "terseLabel": "Gross intangible lease liabilities"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesGross",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.",
        "label": "Finite-Lived Intangible Liabilities, Net",
        "totalLabel": "Intangible liabilities, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesNet",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ForwardEquitySalesAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Equity Sales Agreements",
        "label": "Forward Equity Sales Agreements [Member]",
        "terseLabel": "Forward Equity Sales Agreements"
       }
      }
     },
     "localname": "ForwardEquitySalesAgreementsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease",
        "label": "Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease",
        "negatedTerseLabel": "Loss (gain) on sale of real estate under direct financing leases"
       }
      }
     },
     "localname": "GainLossOnSaleOfRealEstateUnderDirectFinancingLease",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentAssistanceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Assistance [Axis]",
        "terseLabel": "Government Assistance [Axis]"
       }
      }
     },
     "localname": "GovernmentAssistanceAxis",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "peak_GovernmentAssistanceCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance, CARES Act",
        "label": "Government Assistance, CARES Act [Member]",
        "terseLabel": "Government Assistance, CARES Act"
       }
      }
     },
     "localname": "GovernmentAssistanceCARESActMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_GovernmentAssistanceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Assistance [Domain]",
        "terseLabel": "Government Assistance [Domain]"
       }
      }
     },
     "localname": "GovernmentAssistanceDomain",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_GovernmentGrantIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income",
        "label": "Government Grant Income",
        "terseLabel": "Government grant income received"
       }
      }
     },
     "localname": "GovernmentGrantIncome",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentGrantIncomeFromCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 9.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income From CARES Act",
        "label": "Government Grant Income From CARES Act",
        "terseLabel": "Government grant income"
       }
      }
     },
     "localname": "GovernmentGrantIncomeFromCARESAct",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentGrantIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income, Policy [Policy Text Block]",
        "label": "Government Grant Income, Policy [Policy Text Block]",
        "terseLabel": "Government Grant Income"
       }
      }
     },
     "localname": "GovernmentGrantIncomePolicyPolicyTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_HCPVenturesIVLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Ventures IV, LLC, an unconsolidated joint venture of the entity.",
        "label": "H C P Ventures IV, LLC [Member]",
        "terseLabel": "HCP Ventures IV, LLC"
       }
      }
     },
     "localname": "HCPVenturesIVLLCMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_HealthpeakOPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthpeak OP",
        "label": "Healthpeak OP [Member]",
        "terseLabel": "Healthpeak OP"
       }
      }
     },
     "localname": "HealthpeakOPMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ImpairmentsAndAllowanceForCreditLossReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairments And Allowance For Credit Loss Reserves",
        "label": "Impairments And Allowance For Credit Loss Reserves",
        "negatedLabel": "Impairments and loan loss reserves, net"
       }
      }
     },
     "localname": "ImpairmentsAndAllowanceForCreditLossReserves",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairments And Allowance For Credit Loss Reserves (Recoveries), Net",
        "label": "Impairments And Allowance For Credit Loss Reserves (Recoveries), Net",
        "terseLabel": "Impairments and loan loss reserves (recoveries), net"
       }
      }
     },
     "localname": "ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_IncomeLossFromDiscontinuedOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Discontinued Operations",
        "label": "Income Loss From Discontinued Operations [Member]",
        "terseLabel": "Government grant income recorded in income (loss) from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Equity Method Investments, Including Discontinued Operations",
        "label": "Income Loss From Equity Method Investments, Including Discontinued Operations",
        "negatedLabel": "Equity loss (income) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Equity Awards",
        "label": "Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards",
        "terseLabel": "Outstanding equity awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.",
        "label": "Intangible Assets and Liabilities Disclosure [Text Block]",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/Intangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_IntangiblesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangibles [Abstract]",
        "label": "Intangibles [Abstract]",
        "terseLabel": "Intangibles [Abstract]"
       }
      }
     },
     "localname": "IntangiblesAbstract",
     "nsuri": "http://www.healthpeak.com/20230331",
     "xbrltype": "stringItemType"
    },
    "peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations",
        "label": "Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations",
        "terseLabel": "Less: Government grant income"
       }
      }
     },
     "localname": "InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 8.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations",
        "label": "Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations",
        "negatedLabel": "Less: Interest income"
       }
      }
     },
     "localname": "InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_InterestRateSwap254PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2.54% Pay Rate",
        "label": "Interest Rate Swap, 2.54% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 2.54% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap254PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_InterestRateSwap260PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 2.60% Pay Rate",
        "label": "Interest Rate Swap, 2.60% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 2.60% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap260PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_InterestRateSwap454PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.54% Pay Rate",
        "label": "Interest Rate Swap, 4.54% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.54% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap454PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_InterestRateSwap463PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.63% Pay Rate",
        "label": "Interest Rate Swap, 4.63% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.63% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap463PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_InterestRateSwap499PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 4.99% Pay Rate",
        "label": "Interest Rate Swap, 4.99% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 4.99% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap499PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_InterestRateSwap508PayRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap, 5.08% Pay Rate",
        "label": "Interest Rate Swap, 5.08% Pay Rate [Member]",
        "terseLabel": "Interest Rate Swap, 5.08% Pay Rate"
       }
      }
     },
     "localname": "InterestRateSwap508PayRateMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LessorAssetUnderOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor Asset Under Operating Lease",
        "label": "Lessor Asset Under Operating Lease [Member]",
        "terseLabel": "Lessor Asset Under Operating Lease"
       }
      }
     },
     "localname": "LessorAssetUnderOperatingLeaseMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LiabilitiesRelatedToAssetsHeldForSaleNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities Related To Assets Held For Sale, Net",
        "label": "Liabilities Related To Assets Held For Sale, Net",
        "terseLabel": "Liabilities related to assets held for sale, net"
       }
      }
     },
     "localname": "LiabilitiesRelatedToAssetsHeldForSaleNet",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LifeScienceJVsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Life Science, an unconsolidated joint venture of the entity.",
        "label": "Life Science JVs [Member]",
        "terseLabel": "Life Science JV"
       }
      }
     },
     "localname": "LifeScienceJVsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Science Joint Venture In San Francisco, California",
        "label": "Life Science Joint Venture In San Francisco, California [Member]",
        "terseLabel": "Life Science JV in San Francisco, California"
       }
      }
     },
     "localname": "LifeScienceJointVentureInSanFranciscoCaliforniaMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LifeScienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Properties that are part of continuing operations, and which are classified as life science.",
        "label": "Life Science [Member]",
        "terseLabel": "Life Science",
        "verboseLabel": "Life Science"
       }
      }
     },
     "localname": "LifeScienceMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LeasesNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.",
        "label": "Line of Credit Facility, Additional Available Borrowing Capacity Maximum",
        "terseLabel": "Line of credit facility additional aggregate amount, maximum"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Loan Feature, Higher Borrowing Capacity Option",
        "label": "Line of Credit Facility, Loan Feature, Higher Borrowing Capacity Option",
        "terseLabel": "Line of credit facility, loan feature, higher borrowing capacity option"
       }
      }
     },
     "localname": "LineOfCreditFacilityLoanFeatureHigherBorrowingCapacityOption",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LoansAndLeasesReceivableRemainingCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans and Leases Receivable, Remaining Commitments",
        "label": "Loans and Leases Receivable, Remaining Commitments",
        "terseLabel": "Loans and Leases Receivable, Remaining Commitments"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableRemainingCommitments",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LoansReceivableExtensionFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Extension Fee",
        "label": "Loans Receivable, Extension Fee",
        "terseLabel": "Loans receivable, extension fee"
       }
      }
     },
     "localname": "LoansReceivableExtensionFee",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LoansReceivableOutstandingBalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Outstanding Balance",
        "label": "Loans Receivable, Outstanding Balance",
        "terseLabel": "Loans receivable, outstanding balance"
       }
      }
     },
     "localname": "LoansReceivableOutstandingBalance",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LoansReceivableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Term",
        "label": "Loans Receivable, Term",
        "terseLabel": "Loans receivable, term"
       }
      }
     },
     "localname": "LoansReceivableTerm",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_MOBLandParcelsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MOB Land Parcels",
        "label": "MOB Land Parcels [Member]",
        "terseLabel": "MOB Land Parcels"
       }
      }
     },
     "localname": "MOBLandParcelsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MedicalOfficeJVsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Office JVs [Member]",
        "label": "Medical Office JVs [Member]",
        "terseLabel": "Medical Office JVs"
       }
      }
     },
     "localname": "MedicalOfficeJVsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MedicalOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Properties that are part of continuing operations, and which are classified as medical office.",
        "label": "Medical Office [Member]",
        "terseLabel": "Medical Office Buildings",
        "verboseLabel": "Medical Office"
       }
      }
     },
     "localname": "MedicalOfficeMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MezzanineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mezzanine [Member]",
        "label": "Mezzanine [Member]",
        "terseLabel": "Mezzanine"
       }
      }
     },
     "localname": "MezzanineMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MinorityInterestInPreferredUnitHoldersFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.",
        "label": "Minority Interest in Preferred Unit Holders, Fair Value",
        "terseLabel": "Minority interest in preferred unit holders, fair value"
       }
      }
     },
     "localname": "MinorityInterestInPreferredUnitHoldersFairValue",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_MorganStanleyRealEstateInvestmentJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Morgan Stanley Real Estate Investment JV [Member]",
        "label": "Morgan Stanley Real Estate Investment JV [Member]",
        "terseLabel": "MSREI JV"
       }
      }
     },
     "localname": "MorganStanleyRealEstateInvestmentJVMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_NeedhamLandParcelJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Needham Land Parcel JV",
        "label": "Needham Land Parcel JV [Member]",
        "terseLabel": "Needham Land Parcel JV"
       }
      }
     },
     "localname": "NeedhamLandParcelJVMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income Loss Continuing Operations Available To Common Stockholders Basic",
        "label": "Net Income Loss Continuing Operations Available To Common Stockholders Basic",
        "totalLabel": "Income (loss) from continuing operations applicable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NetIncomeLossJointVenturePartnersAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss) Joint Venture Partners, Attributable To Parent",
        "label": "Net Income (Loss) Joint Venture Partners, Attributable To Parent",
        "terseLabel": "Less: Healthpeak\u2019s share of unconsolidated joint venture NOI"
       }
      }
     },
     "localname": "NetIncomeLossJointVenturePartnersAttributableToParent",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NetRealEstateAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Real Estate Assets",
        "label": "Net Real Estate Assets",
        "terseLabel": "Net real estate assets"
       }
      }
     },
     "localname": "NetRealEstateAssets",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 7.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.",
        "label": "Non Cash Adjustments To Net Operating Income From Continuing Operations",
        "terseLabel": "Adjustments to NOI"
       }
      }
     },
     "localname": "NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NonrefundableEntranceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrefundable Entrance Fees",
        "label": "Nonrefundable Entrance Fees",
        "terseLabel": "Nonrefundable entrance fees"
       }
      }
     },
     "localname": "NonrefundableEntranceFees",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NumberOfDownREITLLCs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the number of DownREIT LLCs for which the entity is the managing member.",
        "label": "Number of Down REIT LLCs",
        "terseLabel": "Number of DownREIT LLCs"
       }
      }
     },
     "localname": "NumberOfDownREITLLCs",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfHospitals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Hospitals",
        "label": "Number Of Hospitals",
        "terseLabel": "Number of hospitals"
       }
      }
     },
     "localname": "NumberOfHospitals",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Loans",
        "label": "Number Of Loans",
        "terseLabel": "Number of loans"
       }
      }
     },
     "localname": "NumberOfLoans",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Plan Participants",
        "label": "Number Of Plan Participants",
        "terseLabel": "Number of participants"
       }
      }
     },
     "localname": "NumberOfPlanParticipants",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties Acquired",
        "label": "Number Of Properties Acquired",
        "terseLabel": "Number of properties acquired"
       }
      }
     },
     "localname": "NumberOfPropertiesAcquired",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties Sold",
        "label": "Number Of Properties Sold",
        "terseLabel": "Number of properties sold"
       }
      }
     },
     "localname": "NumberOfPropertiesSold",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesToBeSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties To Be Sold",
        "label": "Number Of Properties To Be Sold",
        "terseLabel": "Number of assets to be sold"
       }
      }
     },
     "localname": "NumberOfPropertiesToBeSold",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfRedeemableNoncontrollingInterestRedemptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Redeemable Noncontrolling Interest Redemptions",
        "label": "Number Of Redeemable Noncontrolling Interest Redemptions",
        "terseLabel": "Number of redeemable noncontrolling interest redemptions"
       }
      }
     },
     "localname": "NumberOfRedeemableNoncontrollingInterestRedemptions",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Redeemable Noncontrolling Interests, Redeemable Over Time",
        "label": "Number Of Redeemable Noncontrolling Interests, Redeemable Over Time",
        "terseLabel": "Number of interests redeemable over time"
       }
      }
     },
     "localname": "NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfSecuredLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Secured Loans",
        "label": "Number of Secured Loans",
        "terseLabel": "Number of secured loans"
       }
      }
     },
     "localname": "NumberOfSecuredLoans",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfUnconsolidatedJointVenture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of unconsolidated joint ventures between entity and an institutional capital partner.",
        "label": "Number of Unconsolidated Joint Venture",
        "terseLabel": "Number of unconsolidated joint ventures (in joint ventures)"
       }
      }
     },
     "localname": "NumberOfUnconsolidatedJointVenture",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfVieBorrowersWithMarketableDebtSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of VIE borrowers in which the entity has invested in marketable debt securities.",
        "label": "Number Of VIE Borrowers With Marketable Debt Securities",
        "terseLabel": "Number of VIE borrowers with marketable debt securities (in joint ventures)"
       }
      }
     },
     "localname": "NumberOfVieBorrowersWithMarketableDebtSecurities",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Facilities Owned by Unconsolidated Joint Venture",
        "label": "Number of Facilities Owned by Unconsolidated Joint Venture",
        "terseLabel": "Number of facilities owned by unconsolidated joint venture"
       }
      }
     },
     "localname": "NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 6.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest",
        "label": "Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests\u2019 share of consolidated joint venture operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_OperatingExpensesFromJointVentureAttributableToParentNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 5.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses From Joint Venture, Attributable To Parent Net",
        "label": "Operating Expenses From Joint Venture, Attributable To Parent Net",
        "negatedTerseLabel": "Healthpeak\u2019s share of unconsolidated joint venture operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesFromJointVentureAttributableToParentNet",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_OptionIndexedToIssuersEquityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Indexed To Issuers Equity, Term",
        "label": "Option Indexed To Issuers Equity, Term",
        "terseLabel": "Option indexed to issuers equity, term (in years)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTerm",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_OtherDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Deferred Revenue",
        "label": "Other Deferred Revenue",
        "terseLabel": "Other deferred revenue"
       }
      }
     },
     "localname": "OtherDeferredRevenue",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mezzanine And Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_OtherNonReportingSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to other non-reporting segment",
        "label": "Other Non-Reporting Segment [Member]",
        "netLabel": "Other Non-reportable",
        "terseLabel": "Other Non-Reporting Segment"
       }
      }
     },
     "localname": "OtherNonReportingSegmentMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities Distributed And Undistributed Earnings Loss Basic and Diluted",
        "negatedLabel": "Participating securities\u2019 share in earnings",
        "negatedTerseLabel": "Less: Participating securities' share in continuing operations"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PaymentsToAcquireLoansReceivableAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Loans Receivable and Other",
        "label": "Payments to Acquire Loans Receivable and Other",
        "negatedLabel": "Investments in loans receivable and other"
       }
      }
     },
     "localname": "PaymentsToAcquireLoansReceivableAndOther",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned MOB Demolition, Tenant Relocation And Other Costs",
        "label": "Planned MOB Demolition, Tenant Relocation And Other Costs [Member]",
        "terseLabel": "Planned MOB Demolition, Tenant Relocation and Other Costs"
       }
      }
     },
     "localname": "PlannedMOBDemolitionTenantRelocationAndOtherCostsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ProceedsFromCollectionOfNonrefundableEntranceFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Collection Of Nonrefundable Entrance Fees",
        "label": "Proceeds From Collection Of Nonrefundable Entrance Fees",
        "terseLabel": "Proceeds from nonrefundable entrance fees"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNonrefundableEntranceFees",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PropertiesHeldForSaleNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of properties held for sale at the reporting date.",
        "label": "Properties Held for Sale, Number",
        "terseLabel": "Number of properties classified as held for sale"
       }
      }
     },
     "localname": "PropertiesHeldForSaleNumber",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_PropertiesWithDirectFinancingLeasesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of properties with direct financing leases at the balance sheet date.",
        "label": "Properties with Direct Financing Leases, Number",
        "terseLabel": "Number of properties classified as DFL"
       }
      }
     },
     "localname": "PropertiesWithDirectFinancingLeasesNumber",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest",
        "label": "Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest",
        "negatedTerseLabel": "Noncontrolling interests\u2019 share of consolidated joint venture total revenues"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture, Attributable To Parent",
        "label": "Real Estate Revenues From Joint Venture, Attributable To Parent",
        "terseLabel": "Healthpeak\u2019s share of unconsolidated joint venture total revenues"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureAttributableToParent",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 10.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture Government Grant Income",
        "label": "Real Estate Revenues From Joint Venture Government Grant Income",
        "terseLabel": "Healthpeak\u2019s share of unconsolidated joint venture government grant income"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureGovernmentGrantIncome",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.",
        "label": "Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments",
        "terseLabel": "Plus: Adjustments to NOI"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RefundableEntranceFeesCurrentAndNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refundable Entrance Fees, Current and Noncurrent",
        "label": "Refundable Entrance Fees, Current and Noncurrent",
        "terseLabel": "Refundable entrance fees"
       }
      }
     },
     "localname": "RefundableEntranceFeesCurrentAndNoncurrent",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RemainingMinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Minority Interest Ownership Percentage By Parent",
        "label": "Remaining Minority Interest Ownership Percentage By Parent",
        "terseLabel": "Remaining minority interest ownership percentage by parent"
       }
      }
     },
     "localname": "RemainingMinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "label": "Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "totalLabel": "Restricted cash, total"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_SHOPJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SHOP JV [Member]",
        "label": "SHOP JV [Member]",
        "verboseLabel": "SWF SH JV"
       }
      }
     },
     "localname": "SHOPJVMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ScheduleOfDeferredRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Deferred Revenue",
        "label": "Schedule of Deferred Revenue [Table Text Block]",
        "terseLabel": "Schedule of Deferred Revenue"
       }
      }
     },
     "localname": "ScheduleOfDeferredRevenueTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite Lived Intangible Liabilities by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Intangible Lease Liabilities"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Government Grant Receivables, CARES Act",
        "label": "Schedule of Government Grant Receivables, CARES Act [Table Text Block]",
        "terseLabel": "Schedule of Government Grant Receivables, CARES Act"
       }
      }
     },
     "localname": "ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.",
        "label": "Schedule Of Variable Interest Entities Included In The Balance Sheet [Table Text Block]",
        "terseLabel": "Consolidated Assets and Liabilities of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_SecuredMortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Mortgage Loans [Member]",
        "label": "Secured Mortgage Loans [Member]",
        "terseLabel": "Secured mortgage loans",
        "verboseLabel": "Secured Loans"
       }
      }
     },
     "localname": "SecuredMortgageLoansMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, First Six Months"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFROvernightIndexSwapRateFirstSixMonthsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate, Last Six Months"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFROvernightIndexSwapRateLastSixMonthsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SeniorHousingOperatingPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent senior housing operating portfolio.",
        "label": "Senior Housing Operating Portfolio [Member]",
        "terseLabel": "SHOP"
       }
      }
     },
     "localname": "SeniorHousingOperatingPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SorrentoTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sorrento Therapeutics, Inc.",
        "label": "Sorrento Therapeutics, Inc. [Member]",
        "terseLabel": "Sorrento Therapeutics, Inc."
       }
      }
     },
     "localname": "SorrentoTherapeuticsIncMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SouthSanFranciscoJVsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "South San Francisco JVs",
        "label": "South San Francisco JVs [Member]",
        "terseLabel": "South San Francisco JVs"
       }
      }
     },
     "localname": "SouthSanFranciscoJVsMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SuburbanPropertiesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Suburban Properties, LLC, an unconsolidated joint venture of the entity.",
        "label": "Suburban Properties L L C [Member]",
        "terseLabel": "Suburban Properties, LLC"
       }
      }
     },
     "localname": "SuburbanPropertiesLLCMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SunriseSeniorHousingPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sunrise Senior Housing Portfolio",
        "label": "Sunrise Senior Housing Portfolio [Member]",
        "terseLabel": "Sunrise Senior Housing Portfolio"
       }
      }
     },
     "localname": "SunriseSeniorHousingPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity",
        "label": "Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity",
        "terseLabel": "Adjustments to redemption value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest",
        "label": "Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_TermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement",
        "label": "Term Loan Agreement [Member]",
        "terseLabel": "Term Loan Agreement"
       }
      }
     },
     "localname": "TermLoanAgreementMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_TermLoanFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facilities",
        "label": "Term Loan Facilities [Member]",
        "terseLabel": "Term Loan Facilities"
       }
      }
     },
     "localname": "TermLoanFacilitiesMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_TermLoanFacilitiesOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facilities One",
        "label": "Term Loan Facilities One [Member]",
        "terseLabel": "Term Loan Facilities One"
       }
      }
     },
     "localname": "TermLoanFacilitiesOneMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_TermLoanFacilitiesTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facilities Two",
        "label": "Term Loan Facilities Two [Member]",
        "terseLabel": "Term Loan Facilities Two"
       }
      }
     },
     "localname": "TermLoanFacilitiesTwoMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote525PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 5.25 Percent",
        "label": "Unsecured Note 5.25 Percent [Member]",
        "terseLabel": "Unsecured Note 5.25 Percent"
       }
      }
     },
     "localname": "UnsecuredNote525PercentMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VariableInterestEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities [Abstract]",
        "label": "Variable Interest Entities [Abstract]",
        "terseLabel": "Variable Interest Entities [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntitiesAbstract",
     "nsuri": "http://www.healthpeak.com/20230331",
     "xbrltype": "stringItemType"
    },
    "peak_VariableInterestEntitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.",
        "label": "Variable Interest Entities [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntitiesTextBlock",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.",
        "label": "Variable Interest Entity Controlling Ownership Interest Through Partnership",
        "terseLabel": "Number of controlling ownership interest entities as a managing member"
       }
      }
     },
     "localname": "VariableInterestEntityControllingOwnershipInterestThroughPartnership",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a debt investment with a party that has been identified as a Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.",
        "label": "Variable Interest Entity Not Primary Beneficiary Debt Investment [Member]",
        "terseLabel": "LLC investment"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to investments in an unconsolidated joint venture, which is a Variable Interest Entity (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.",
        "label": "Variable Interest Entity Not Primary Beneficiary Investment In Joint Venture [Member]",
        "terseLabel": "Needham Land Parcel JV"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VenturesVLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Ventures V.",
        "label": "Ventures V, LLC [Member]",
        "terseLabel": "Ventures V"
       }
      }
     },
     "localname": "VenturesVLLCMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_WatchListFinancingReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a financing receivable that is being monitored closely in order to spot irregularities.",
        "label": "Watch List Financing Receivable [Member]",
        "verboseLabel": "Watch list loans"
       }
      }
     },
     "localname": "WatchListFinancingReceivableMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_WorkoutFinancingReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workout Financing Receivable [Member]",
        "label": "Workout Financing Receivable [Member]",
        "verboseLabel": "Workout loans"
       }
      }
     },
     "localname": "WorkoutFinancingReceivableMember",
     "nsuri": "http://www.healthpeak.com/20230331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r304",
      "r530",
      "r531",
      "r534",
      "r535",
      "r573",
      "r678",
      "r765",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r304",
      "r530",
      "r531",
      "r534",
      "r535",
      "r573",
      "r678",
      "r765",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r304",
      "r351",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r373",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r440",
      "r441",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r304",
      "r351",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r373",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r440",
      "r441",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r302",
      "r303",
      "r446",
      "r474",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r512",
      "r609",
      "r643",
      "r680",
      "r681",
      "r706",
      "r711",
      "r718",
      "r770",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r512",
      "r609",
      "r643",
      "r680",
      "r681",
      "r706",
      "r711",
      "r718",
      "r770",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r665",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OtherPropertyMember": {
     "auth_ref": [
      "r798",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Property [Member]",
        "terseLabel": "Other Property"
       }
      }
     },
     "localname": "OtherPropertyMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r504",
      "r512",
      "r516",
      "r517",
      "r518",
      "r581",
      "r609",
      "r643",
      "r680",
      "r681",
      "r706",
      "r711",
      "r718",
      "r760",
      "r770",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r504",
      "r512",
      "r516",
      "r517",
      "r518",
      "r581",
      "r609",
      "r643",
      "r680",
      "r681",
      "r706",
      "r711",
      "r718",
      "r760",
      "r770",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r679",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r679",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r302",
      "r303",
      "r446",
      "r474",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r513",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r318",
      "r513",
      "r727",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r376",
      "r377",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r707",
      "r717",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r376",
      "r377",
      "r665",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r707",
      "r717",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r318",
      "r513",
      "r727",
      "r728",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_AR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "ARKANSAS"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "CALIFORNIA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "MASSACHUSETTS"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "TEXAS"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Loans Receivable:",
        "verboseLabel": "Loans receivable"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r221",
      "r247"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities, and other liabilities",
        "totalLabel": "Accounts payable, accrued liabilities, and other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails",
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable, Accrued Liabilities, and Other Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r632",
      "r666"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net of allowance of $2,413 and $2,399"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDistributionsInExcessOfNetIncome": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).",
        "label": "Accumulated Distributions in Excess of Net Income",
        "negatedLabel": "Cumulative dividends in excess of earnings"
       }
      }
     },
     "localname": "AccumulatedDistributionsInExcessOfNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative distributions to shareholders (or partners) in excess of retained earnings (or accumulated earnings).",
        "label": "Accumulated Distributions in Excess of Net Income [Member]",
        "terseLabel": "Cumulative Dividends In\u00a0Excess Of\u00a0Earnings"
       }
      }
     },
     "localname": "AccumulatedDistributionsInExcessOfNetIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r52",
      "r56",
      "r774"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Supplemental Executive Retirement Plan minimum liability"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r54",
      "r55",
      "r56",
      "r271",
      "r633",
      "r647",
      "r648"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "totalLabel": "Total accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r53",
      "r56",
      "r169",
      "r570",
      "r644",
      "r645",
      "r732",
      "r733",
      "r734",
      "r744",
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average remaining amortization period in years"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r35",
      "r716"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r744",
      "r745",
      "r746",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r158",
      "r159",
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r109",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r272",
      "r382",
      "r391",
      "r394",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r465",
      "r556",
      "r704",
      "r705",
      "r739"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r276"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Unrealized gains (losses) on derivatives, net"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value from changes in the assumptions or model used to calculate the fair value of a contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.",
        "label": "Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions",
        "terseLabel": "Asset at fair value, changes in fair value resulting from changes in assumptions"
       }
      }
     },
     "localname": "AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r91",
      "r129"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Impairments and loan loss reserves (recoveries), net"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r216",
      "r235",
      "r267",
      "r300",
      "r359",
      "r365",
      "r371",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r530",
      "r534",
      "r546",
      "r716",
      "r766",
      "r767",
      "r785"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group",
        "terseLabel": "Assets held for sale, net"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroup",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r21",
      "r131",
      "r262",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale, net",
        "verboseLabel": "Total asset of discontinued operation"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Transaction costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r93",
      "r264",
      "r687"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r88",
      "r93",
      "r99"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Continuing operations"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r88",
      "r93",
      "r99"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash, total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r207"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashIncludingDiscontinuedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Including Discontinued Operations [Abstract]",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "CashIncludingDiscontinuedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r300",
      "r322",
      "r326",
      "r333",
      "r335",
      "r343",
      "r344",
      "r388",
      "r430",
      "r433",
      "r434",
      "r435",
      "r441",
      "r442",
      "r472",
      "r473",
      "r476",
      "r480",
      "r487",
      "r546",
      "r682",
      "r725",
      "r740",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r115",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial Mortgage-Backed Securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r223",
      "r242"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r423",
      "r424",
      "r668",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in dollars per share)",
        "verboseLabel": "Common dividends, per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r744",
      "r745",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r34",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r34",
      "r716"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $1.00 par value: 750,000,000 shares authorized; 546,994,803 and 546,641,973 shares issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r57",
      "r279",
      "r281",
      "r290",
      "r629",
      "r637"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss) attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r165",
      "r166",
      "r180",
      "r279",
      "r281",
      "r289",
      "r628",
      "r636"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Total comprehensive (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r164",
      "r180",
      "r279",
      "r281",
      "r288",
      "r627",
      "r635"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r205",
      "r206",
      "r379",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r205",
      "r206",
      "r379",
      "r649",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r96",
      "r97",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for construction in progress expenditures that have occurred.",
        "label": "Construction in Progress Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued construction costs"
       }
      }
     },
     "localname": "ConstructionInProgressExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r222",
      "r246"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables.",
        "label": "Construction Payable",
        "terseLabel": "Accrued construction costs"
       }
      }
     },
     "localname": "ConstructionPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r489",
      "r490",
      "r501"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r108",
      "r364",
      "r365",
      "r366",
      "r367",
      "r373",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Non-segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r67",
      "r610"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r143",
      "r298",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r459",
      "r466",
      "r467",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r217",
      "r218",
      "r233",
      "r304",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r557",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r32",
      "r218",
      "r233",
      "r470"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total debt before discount, net",
        "verboseLabel": "Principal balance on debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r210",
      "r213",
      "r443",
      "r557",
      "r702",
      "r703"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r44",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Coupon Rate",
        "verboseLabel": "Interest Rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r304",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r557",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt instrument, periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r151",
      "r152",
      "r153",
      "r154",
      "r209",
      "r210",
      "r213",
      "r231",
      "r304",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r468",
      "r557",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term (in months)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r771"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Premiums, (discounts), and debt issuance costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted-average interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r91",
      "r130"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "negatedLabel": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization of real estate, in-place lease, and other intangibles",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r775",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional Amount",
        "verboseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r273",
      "r274",
      "r545",
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap instruments"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Receive Rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Pay Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r778"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Increase in the fair value of the interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r189",
      "r190",
      "r193",
      "r194",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r200",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r187",
      "r189",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r187",
      "r188",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopmentInProcess": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current amount of expenditures for a real estate project that has not yet been completed.",
        "label": "Development in Process",
        "terseLabel": "Development costs and construction in progress",
        "verboseLabel": "Development costs and construction in progress"
       }
      }
     },
     "localname": "DevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseInterestIncome": {
     "auth_ref": [
      "r341",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income from net investment in direct financing lease.",
        "label": "Direct Financing Lease, Interest Income",
        "terseLabel": "Interest income from direct financing leases"
       }
      }
     },
     "localname": "DirectFinancingLeaseInterestIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r341",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of lease income from direct financing lease.",
        "label": "Direct Financing Lease, Lease Income [Table Text Block]",
        "terseLabel": "Schedule of Company's Lease Income"
       }
      }
     },
     "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DirectFinancingLeaseRevenue": {
     "auth_ref": [
      "r341",
      "r564"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct financing lease revenue.",
        "label": "Direct Financing Lease, Revenue",
        "terseLabel": "Income from direct financing leases"
       }
      }
     },
     "localname": "DirectFinancingLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r8",
      "r10",
      "r12"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "totalLabel": "Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r8",
      "r10",
      "r12",
      "r23"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "totalLabel": "Income (loss) from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r12",
      "r19",
      "r23",
      "r522",
      "r525",
      "r527"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": {
     "auth_ref": [
      "r3",
      "r4",
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale or disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale or Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r3",
      "r7",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r21",
      "r131"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "auth_ref": [
      "r20",
      "r263"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "terseLabel": "Gain (loss) on sales of real estate, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Other Income",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r20",
      "r263"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r28",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Dispositions of Real Estate and Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r155",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Common dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r291",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r319",
      "r322",
      "r333",
      "r334",
      "r335",
      "r339",
      "r540",
      "r541",
      "r630",
      "r638",
      "r692"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income (loss) applicable to common shares (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic earnings (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r291",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r322",
      "r333",
      "r334",
      "r335",
      "r339",
      "r540",
      "r541",
      "r630",
      "r638",
      "r692"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income (loss) applicable to common shares (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings (loss) per common share:",
        "verboseLabel": "Diluted earnings (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r150",
      "r259",
      "r282",
      "r283",
      "r284",
      "r305",
      "r306",
      "r307",
      "r309",
      "r315",
      "r317",
      "r342",
      "r390",
      "r488",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r539",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r553",
      "r570",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r60",
      "r87",
      "r91",
      "r248"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distributions of earnings from unconsolidated joint ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Investment ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r117",
      "r360",
      "r729"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments in and Advances to Unconsolidated Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r457",
      "r545",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair\u00a0Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Summary of financial instruments"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r201",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r201",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Summary of Carry Amounts and Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r457",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r542",
      "r578",
      "r579",
      "r580",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r201",
      "r202",
      "r457",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r457",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r457",
      "r505",
      "r510",
      "r542",
      "r578",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r457",
      "r505",
      "r510",
      "r542",
      "r579",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r457",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r578",
      "r579",
      "r580",
      "r702",
      "r703",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r384",
      "r386",
      "r393",
      "r397",
      "r398",
      "r399",
      "r402",
      "r404",
      "r405",
      "r406",
      "r468",
      "r485",
      "r537",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r699",
      "r752",
      "r753",
      "r754",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentPerformanceStatusAxis": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of performance or non-performance status of financial instruments.",
        "label": "Financial Instrument Performance Status [Axis]",
        "terseLabel": "Financial Instrument Performance Status [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentPerformanceStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentPerformanceStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of performance or non-performance status of financial instruments, including but not limited to, financing receivables, loans, debt, and investments.",
        "label": "Financial Instrument Performance Status [Domain]",
        "terseLabel": "Financial Instrument Performance Status [Domain]"
       }
      }
     },
     "localname": "FinancialInstrumentPerformanceStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "auth_ref": [
      "r756"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "negatedLabel": "Reserve for loan losses",
        "periodEndLabel": "Reserve for loan losses, end of period",
        "periodStartLabel": "Reserve for loan losses, beginning of period",
        "terseLabel": "Reserves for loans receivable"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "auth_ref": [
      "r110",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "terseLabel": "Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r756"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Loans receivable, net of reserves of $6,152 and $8,280",
        "totalLabel": "Loans receivable, net",
        "verboseLabel": "Financing receivable, after allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r400",
      "r401",
      "r756"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "totalLabel": "Total",
        "verboseLabel": "Financing receivable, gross"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding accrued interest, of credit loss expense (reversal of expense) on financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for expected loan losses"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated more than five years prior to current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Originated, More than Five Years before Current Fiscal Year",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of decrease from sale and reclassification to held-for-sale of financing receivable. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Sale and Reclassification to Held-for-Sale",
        "negatedTerseLabel": "Expected loan losses (recoveries) related to loans sold or repaid"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated four years prior to current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Five, Originated, Four Years before Current Fiscal Year",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated three years prior to current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Four, Originated, Three Years before Current Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated in current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year One, Originated, Current Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated two years prior to current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Three, Originated, Two Years before Current Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r400",
      "r403",
      "r697"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year. Excludes net investment in lease.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Two, Originated, Fiscal Year before Current Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "auth_ref": [
      "r111",
      "r112",
      "r381",
      "r398",
      "r399",
      "r402",
      "r683",
      "r684",
      "r685",
      "r686",
      "r695",
      "r696",
      "r697",
      "r698",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Axis]",
        "terseLabel": "Class of Financing Receivable [Axis]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "auth_ref": [
      "r683",
      "r684",
      "r685",
      "r686",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Domain]",
        "terseLabel": "Class of Financing Receivable [Domain]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount": {
     "auth_ref": [
      "r382",
      "r383",
      "r726"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized loan commitment, origination, and other costs (fees) and purchase premium (discount) on financing receivable recognized as adjustment to yield. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Unamortized Loan Cost (Fee) and Purchase Premium (Discount)",
        "terseLabel": "Unamortized discounts, fees, and costs"
       }
      }
     },
     "localname": "FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r265",
      "r417"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r127",
      "r612"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross intangible lease assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r127",
      "r611"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityForwardRate": {
     "auth_ref": [
      "r144",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share price of the Company's stock at which the contract holder of the freestanding contract has the right to purchase or sell the Company's stock at a future date.",
        "label": "Forward Contract Indexed to Issuer's Equity, Forward Rate Per Share",
        "terseLabel": "Forward equity sales agreement, initial net price (in dollars per share)"
       }
      }
     },
     "localname": "ForwardContractIndexedToIssuersEquityForwardRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityShares": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.",
        "label": "Forward Contract Indexed to Issuer's Equity, Shares",
        "terseLabel": "Maximum shares issuable under forward equity sales agreement (in shares)"
       }
      }
     },
     "localname": "ForwardContractIndexedToIssuersEquityShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "negatedLabel": "Loss (gain) on sales of real estate, net"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfNotesReceivable": {
     "auth_ref": [
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale of financing receivable.",
        "label": "Gain (Loss) on Sale of Financing Receivable",
        "terseLabel": "Gain on sale of direct financing lease"
       }
      }
     },
     "localname": "GainLossOnSaleOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": {
     "auth_ref": [
      "r640",
      "r641",
      "r642",
      "r735",
      "r736",
      "r739",
      "r793",
      "r796"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.",
        "label": "Gains (Losses) on Sales of Investment Real Estate",
        "terseLabel": "Gain (loss) on sales of real estate, net"
       }
      }
     },
     "localname": "GainsLossesOnSalesOfInvestmentRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General and administrative",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r187",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r116",
      "r385",
      "r625"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfRealEstate": {
     "auth_ref": [
      "r739",
      "r759"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.",
        "label": "Impairment of Real Estate",
        "terseLabel": "Impairment of real estate"
       }
      }
     },
     "localname": "ImpairmentOfRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r65",
      "r92",
      "r163",
      "r310",
      "r311",
      "r312",
      "r313",
      "r331",
      "r335"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "auth_ref": [
      "r161",
      "r164"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Noncontrolling interests' share in continuing operations",
        "negatedTerseLabel": "Noncontrolling interests\u2019 share in continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r359",
      "r364",
      "r370",
      "r373",
      "r694"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r164",
      "r300",
      "r308",
      "r359",
      "r364",
      "r370",
      "r373",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r541",
      "r546",
      "r694",
      "r766"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r59",
      "r224",
      "r226",
      "r249",
      "r291",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r322",
      "r333",
      "r334",
      "r541",
      "r630"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r59",
      "r249",
      "r252",
      "r291",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r322",
      "r333",
      "r334",
      "r335",
      "r541",
      "r630",
      "r638"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r23",
      "r250",
      "r263",
      "r528"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r61",
      "r250",
      "r252",
      "r291",
      "r326",
      "r333",
      "r334",
      "r794",
      "r795"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r181",
      "r326",
      "r333",
      "r334"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r60",
      "r91",
      "r117",
      "r225",
      "r248",
      "r356"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r22",
      "r24",
      "r25",
      "r26",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r301",
      "r316",
      "r317",
      "r357",
      "r522",
      "r525",
      "r526",
      "r639"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "negatedTerseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid (refunded)"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets": {
     "auth_ref": [
      "r738"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables, and operating assets classified as other.",
        "label": "Increase (Decrease) in Accounts Receivable and Other Operating Assets",
        "negatedLabel": "Decrease (increase) in accounts receivable and other assets, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements": {
     "auth_ref": [
      "r335",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements",
        "terseLabel": "Dilutive potential common shares - forward equity agreements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToEquityForwardAgreements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r335",
      "r515"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares - equity awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r136",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnification Agreement"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuredEventGainLoss": {
     "auth_ref": [
      "r763"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess (deficiency) of insurance recovery over the loss incurred from an insured event.",
        "label": "Insured Event, Gain (Loss)",
        "negatedLabel": "Casualty-related loss (recoveries), net"
       }
      }
     },
     "localname": "InsuredEventGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r122",
      "r125"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest and Other Income [Abstract]",
        "terseLabel": "Interest and Other Income [Abstract]"
       }
      }
     },
     "localname": "InterestAndOtherIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r211",
      "r228",
      "r285",
      "r353",
      "r555"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r292",
      "r295",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of capitalized interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r222",
      "r246"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap instruments"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative assets not designated as hedging instruments.",
        "label": "Interest Rate Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap instruments"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentBuildingAndBuildingImprovements": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.",
        "label": "Investment Building and Building Improvements",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "InvestmentBuildingAndBuildingImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investment [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r731"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in and advances to unconsolidated joint ventures",
        "totalLabel": "Investments in and advances to unconsolidated joint ventures"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r730"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorDirectFinancingLeasesTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's direct financing leases.",
        "label": "Lessor, Direct Financing Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessor, Lease, Description [Line Items]",
        "terseLabel": "Lessor, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LessorLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorLeaseDescriptionTable": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessor's leases.",
        "label": "Lessor, Lease, Description [Table]",
        "terseLabel": "Lessor, Lease, Description [Table]"
       }
      }
     },
     "localname": "LessorLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r300",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r531",
      "r534",
      "r535",
      "r546",
      "r693",
      "r766",
      "r785",
      "r786"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r38",
      "r220",
      "r241",
      "r716",
      "r742",
      "r755",
      "r781"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r21",
      "r131",
      "r262",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities related to assets held for sale, net",
        "verboseLabel": "Total liabilities of discontinued operation"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r32",
      "r218",
      "r233"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Bank line of credit and commercial paper",
        "verboseLabel": "Bank line of credit and commercial paper"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Debt instrument, facility fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Bank Line\u00a0 of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Loans Receivable"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term\u00a0Loans"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableToBank": {
     "auth_ref": [
      "r32",
      "r218",
      "r232"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the normal operating cycle if longer.",
        "label": "Loans Payable to Bank",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "LoansPayableToBank",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansReceivableBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage added to reference rate used to compute variable rate on loan receivable.",
        "label": "Loans Receivable, Basis Spread on Variable Rate",
        "terseLabel": "Loans receivable, basis spread on variable rate"
       }
      }
     },
     "localname": "LoansReceivableBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LoansReceivableFairValueDisclosure": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.",
        "label": "Loans Receivable, Fair Value Disclosure",
        "terseLabel": "Loans receivable, net"
       }
      }
     },
     "localname": "LoansReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r218",
      "r238",
      "r456",
      "r471",
      "r702",
      "r703"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term Debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r141",
      "r304",
      "r461"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r141",
      "r304",
      "r461"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r141",
      "r304",
      "r461"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r141",
      "r304",
      "r461"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansFromBank": {
     "auth_ref": [
      "r32",
      "r218",
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.",
        "label": "Loans Payable to Bank, Noncurrent",
        "terseLabel": "Term loans"
       }
      }
     },
     "localname": "LongTermLoansFromBank",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r425",
      "r426",
      "r427",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r137",
      "r138",
      "r425",
      "r426",
      "r427",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r425",
      "r426",
      "r427",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r219",
      "r240",
      "r300",
      "r388",
      "r430",
      "r433",
      "r434",
      "r435",
      "r441",
      "r442",
      "r546"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "totalLabel": "Total noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestInJointVentures": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_MinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.",
        "label": "Noncontrolling Interest in Joint Ventures",
        "terseLabel": "Joint venture partners"
       }
      }
     },
     "localname": "MinorityInterestInJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestInPreferredUnitHolders": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_MinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.",
        "label": "Noncontrolling Interest in Preferred Unit Holders",
        "terseLabel": "Non-managing member unitholders"
       }
      }
     },
     "localname": "MinorityInterestInPreferredUnitHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling interest, ownership percentage by parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r51",
      "r66",
      "r162",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsHealthpeakOPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MortgageReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due the Company for loans secured by the collateral of specified real estate property and which loan the borrower (debtor) is obligated to repay in accordance with a predetermined set of payments.",
        "label": "Mortgage Receivable [Member]",
        "verboseLabel": "Secured Mortgage Loans"
       }
      }
     },
     "localname": "MortgageReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/Business"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "terseLabel": "Net cash provided by financing activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r89",
      "r92"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r62",
      "r92",
      "r227",
      "r251",
      "r263",
      "r277",
      "r280",
      "r284",
      "r300",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r316",
      "r317",
      "r331",
      "r359",
      "r364",
      "r370",
      "r373",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r541",
      "r546",
      "r694",
      "r766"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r332",
      "r335",
      "r359",
      "r364",
      "r370",
      "r373",
      "r694"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) applicable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r321",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r335"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income (loss) applicable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r147",
      "r167",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.",
        "label": "Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable",
        "negatedTerseLabel": "Plus: Noncontrolling interests\u2019 share of consolidated joint venture NOI"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r161",
      "r488",
      "r744",
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Total Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r183",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest-rate contracts held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of real estate properties owned as of the balance sheet date.",
        "label": "Number of Real Estate Properties",
        "terseLabel": "Property count"
       }
      }
     },
     "localname": "NumberOfRealEstateProperties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffMarketLeaseUnfavorable": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.",
        "label": "Off-Market Lease, Unfavorable",
        "terseLabel": "Intangible liabilities, net"
       }
      }
     },
     "localname": "OffMarketLeaseUnfavorable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTerseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r341",
      "r562",
      "r568"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Rental and related revenues"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": {
     "auth_ref": [
      "r341",
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income, Lease Payments",
        "terseLabel": "Fixed income from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r559"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use asset",
        "verboseLabel": "Right-of-use asset, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseVariableLeaseIncome": {
     "auth_ref": [
      "r341",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.",
        "label": "Operating Lease, Variable Lease Income",
        "terseLabel": "Variable income from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseVariableLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "verboseLabel": "Operating Segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Other accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r68",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization of other deferred charges"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenueScheduleofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r215",
      "r234",
      "r266"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r58",
      "r150",
      "r278",
      "r281",
      "r287",
      "r547",
      "r552",
      "r553",
      "r626",
      "r634",
      "r732",
      "r733"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r52",
      "r54"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Change in Supplemental Executive Retirement Plan obligation and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r68",
      "r91",
      "r130"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization of real estate, in-place lease, and other intangibles"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Government grant income recorded in other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonrecurringExpense": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring Expense",
        "terseLabel": "Expense on other"
       }
      }
     },
     "localname": "OtherNonrecurringExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.",
        "label": "Payments for Leasing Costs, Commissions, and Tenant Improvements",
        "negatedLabel": "Leasing costs, tenant improvements, and recurring capital expenditures",
        "terseLabel": "Leasing costs, tenant improvements, and recurring capital expenditures"
       }
      }
     },
     "localname": "PaymentsForLeasingCostsCommissionsAndTenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedLabel": "Payments for debt extinguishment and deferred financing costs"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Cash paid",
        "verboseLabel": "Payments to acquire equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Investments in unconsolidated joint ventures"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherRealEstate": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of other real estate investments held by the entity for investment purposes not otherwise defined in the taxonomy.",
        "label": "Payments to Acquire Other Real Estate",
        "negatedLabel": "Acquisitions of real estate"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireRealEstate": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.",
        "label": "Payments to Acquire Real Estate",
        "terseLabel": "Payments to acquire real estate"
       }
      }
     },
     "localname": "PaymentsToAcquireRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopRealEstateAssets": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.",
        "label": "Payments to Develop Real Estate Assets",
        "negatedLabel": "Development, redevelopment, and other major improvements of real estate",
        "terseLabel": "Development, redevelopment, and other major improvements of real estate"
       }
      }
     },
     "localname": "PaymentsToDevelopRealEstateAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions to and purchase of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformingFinancingReceivableMember": {
     "auth_ref": [
      "r110",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category status of financial instruments in which payments are received or paid on a timely basis in accordance with the terms of the contract. Financial instruments include, but are not limited to, financing receivables, loans, debt instruments, and investments.",
        "label": "Performing Financial Instruments [Member]",
        "terseLabel": "Performing loans"
       }
      }
     },
     "localname": "PerformingFinancingReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromBankDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from bank borrowing during the year.",
        "label": "Proceeds from Bank Debt",
        "terseLabel": "Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt"
       }
      }
     },
     "localname": "ProceedsFromBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfFinanceReceivables": {
     "auth_ref": [
      "r737"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection of receivables arising from the financing of goods and services.",
        "label": "Proceeds from Collection of Finance Receivables",
        "terseLabel": "Principal repayments received"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLoansReceivable": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.",
        "label": "Proceeds from Collection of Loans Receivable",
        "terseLabel": "Proceeds from the collection of loans receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": {
     "auth_ref": [
      "r76",
      "r86"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.",
        "label": "Proceeds from Insurance Settlement, Investing Activities",
        "terseLabel": "Proceeds from insurance recovery"
       }
      }
     },
     "localname": "ProceedsFromInsuranceSettlementInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Issuance of common stock and exercise of options, net of offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r80",
      "r741"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under bank line of credit and commercial paper"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Contributions from and issuance of noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from repayments of the balance excluding interest (principal) on loans receivable and leases held for investment purposes.",
        "label": "Proceeds from Principal Repayments on Loans and Leases Held-for-investment",
        "verboseLabel": "Proceeds from sales/principal repayments on loans receivable, direct financing leases, and marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfBuildings": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sale of buildings.",
        "label": "Proceeds from Sale of Buildings",
        "terseLabel": "Proceeds from sale of property",
        "verboseLabel": "Proceeds from sale of buildings"
       }
      }
     },
     "localname": "ProceedsFromSaleOfBuildings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLeaseReceivables": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of receivables arising from the lease of real estate, equipment or other fixed assets for a specified time in exchange for payment, usually in the form of rent; excludes proceeds from sales-type lease transactions, which are classified as operating activities.",
        "label": "Proceeds from Sale of Lease Receivables",
        "terseLabel": "Proceeds from sale of lease receivable"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLeaseReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.",
        "label": "Proceeds from Sale of Real Estate Held-for-investment",
        "terseLabel": "Proceeds from sales of real estate, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r263",
      "r277",
      "r280",
      "r293",
      "r300",
      "r308",
      "r316",
      "r317",
      "r359",
      "r364",
      "r370",
      "r373",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r529",
      "r532",
      "r533",
      "r541",
      "r546",
      "r631",
      "r694",
      "r712",
      "r713",
      "r734",
      "r766"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Abstract]",
        "terseLabel": "Real Estate [Abstract]"
       }
      }
     },
     "localname": "RealEstateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.",
        "label": "Real Estate Disclosure [Text Block]",
        "terseLabel": "Real Estate"
       }
      }
     },
     "localname": "RealEstateDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.",
        "label": "Real Estate Investment Property, Accumulated Depreciation",
        "negatedLabel": "Accumulated depreciation and amortization",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNet": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.",
        "label": "Real Estate Investment Property, Net",
        "totalLabel": "Net real estate"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate Investment Property, Net [Abstract]",
        "terseLabel": "Real estate:"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale.",
        "label": "Real Estate Liabilities Associated with Assets Held for Development and Sale",
        "terseLabel": "Liabilities related to assets held for sale, net"
       }
      }
     },
     "localname": "RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Real Estate [Line Items]",
        "terseLabel": "Real Estate [Line Items]"
       }
      }
     },
     "localname": "RealEstateLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateTable": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions.",
        "label": "Real Estate [Table]",
        "terseLabel": "Real Estate [Table]"
       }
      }
     },
     "localname": "RealEstateTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r511",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r511",
      "r571",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfBankDebt": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to settle a bank borrowing during the year.",
        "label": "Repayments of Bank Debt",
        "negatedLabel": "Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt"
       }
      }
     },
     "localname": "RepaymentsOfBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r83",
      "r741"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments under bank line of credit and commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r93",
      "r99",
      "r214",
      "r239",
      "r264"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r93",
      "r99",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r350",
      "r351",
      "r363",
      "r368",
      "r369",
      "r375",
      "r376",
      "r379",
      "r499",
      "r500",
      "r610"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Resident fees and services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r286",
      "r300",
      "r350",
      "r351",
      "r363",
      "r368",
      "r369",
      "r375",
      "r376",
      "r379",
      "r388",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r437",
      "r439",
      "r441",
      "r442",
      "r546",
      "r631",
      "r766"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r560",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Increase in ROU asset in exchange for new lease liability related to operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Loans Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r56",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r45",
      "r151",
      "r152",
      "r153",
      "r154",
      "r209",
      "r210",
      "r213",
      "r231",
      "r702",
      "r704",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Senior Notes Issuances"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r187",
      "r188",
      "r192",
      "r193",
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r22",
      "r24",
      "r25",
      "r26",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r119",
      "r263",
      "r300",
      "r388",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": {
     "auth_ref": [
      "r686",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r123",
      "r126",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r123",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Lease Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Summary of Debt Maturities and Schedule Principal Repayments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Information of Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r171",
      "r173",
      "r175",
      "r177",
      "r178",
      "r530",
      "r531",
      "r534",
      "r535",
      "r590",
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r171",
      "r173",
      "r175",
      "r177",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r32",
      "r218",
      "r238"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Mortgage debt",
        "verboseLabel": "Mortgage debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Mortgage Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r2",
      "r5",
      "r6",
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r347",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r379",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r421",
      "r422",
      "r700",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LeasesNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r359",
      "r362",
      "r367",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Disclosures"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance-related charges"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation amortization expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r29",
      "r217",
      "r236",
      "r716"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r101",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r261",
      "r347",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r379",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r419",
      "r421",
      "r422",
      "r700",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LeasesNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r300",
      "r322",
      "r326",
      "r333",
      "r335",
      "r343",
      "r344",
      "r388",
      "r430",
      "r433",
      "r434",
      "r435",
      "r441",
      "r442",
      "r472",
      "r473",
      "r476",
      "r480",
      "r487",
      "r546",
      "r682",
      "r725",
      "r740",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r49",
      "r150",
      "r259",
      "r282",
      "r283",
      "r284",
      "r305",
      "r306",
      "r307",
      "r309",
      "r315",
      "r317",
      "r342",
      "r390",
      "r488",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r539",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r553",
      "r570",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDownREITsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "verboseLabel": "Quarterly Financial Data"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r342",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r33",
      "r34",
      "r150",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r33",
      "r34",
      "r150",
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r33",
      "r34",
      "r150",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r33",
      "r34",
      "r150",
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockTransactionsParentheticalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Transactions, Parenthetical Disclosure [Abstract]",
        "terseLabel": "Balance Sheet Parenthetical Disclosures"
       }
      }
     },
     "localname": "StockTransactionsParentheticalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r34",
      "r36",
      "r37",
      "r113",
      "r716",
      "r742",
      "r755",
      "r781"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r161",
      "r162",
      "r179",
      "r259",
      "r260",
      "r283",
      "r305",
      "r306",
      "r307",
      "r309",
      "r315",
      "r390",
      "r488",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r539",
      "r547",
      "r548",
      "r553",
      "r570",
      "r645",
      "r646",
      "r742",
      "r755",
      "r781"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r299",
      "r473",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r488",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StraightLineRent": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis.",
        "label": "Straight Line Rent",
        "negatedLabel": "Straight-line rents",
        "terseLabel": "Straight-line rent receivable"
       }
      }
     },
     "localname": "StraightLineRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r554",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r554",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r554",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r554",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsDividendsDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsATMProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r48",
      "r300",
      "r388",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r384",
      "r386",
      "r468",
      "r485",
      "r537",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r752",
      "r753",
      "r754",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average cost per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r34",
      "r150",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Common stock repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r150",
      "r155",
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Stock repurchase program, total value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsShareRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r32",
      "r218",
      "r238"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Senior unsecured notes"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Senior Unsecured Note"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual or Infrequent Item, or Both [Line Items]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemTable": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Table]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Table]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r172",
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "verboseLabel": "Maximum Loss Exposure and Carrying Amount"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Unconsolidated Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "VIE ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r171",
      "r530",
      "r531",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Consolidated Lessees VIE"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoanDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r321",
      "r335"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r319",
      "r335"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 14
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126982154&loc=d3e400-110220",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e13051-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.10)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "970",
   "URI": "https://asc.fasb.org/topic&trid=2156125",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "972",
   "URI": "https://asc.fasb.org/topic&trid=2134617",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "974",
   "URI": "https://asc.fasb.org/topic&trid=2156429",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "976",
   "URI": "https://asc.fasb.org/topic&trid=2134846",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "978",
   "URI": "https://asc.fasb.org/topic&trid=2134977",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=6378536&loc=d3e10092-111533",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL120267963-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919232-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888252",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1404",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2366-109256",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10152-111534",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(14)(d))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080549-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0001628280-23-014190-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-014190-xbrl.zip
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M$PB#8\[ :["[D<@DP30KT:9FA@BQ<M42*$',I1SJ#'1P>+Z-D]4P0L.!ZT'
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M..OT<C@^VO'A]KYUAO0"S%?+7AC*\]#<>" #X1?F%-B.D.!(A%1:8%"6J@B
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MY_0-NQX!IPHDR@2@<?!E.,;R[307EM\W ?E G+AO2T4X+'()\MK@E-[I L:
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MBU6S0?!M1>6LU102;^(# 4$R)6^IW@(.B 5G ^C @G8-9NF831YNR:)M?Q=
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M-UB^_13WRA:0/7S*:M3/JBL>) -CDU>,R%N:3=90<IF& QOIS"3O6-TN%ZB
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M*L%$WZK>A7D+-C #HG&55Y0I4-6)WZ8$6F579<9Q5=E:2A>\1??;9"&YOP'
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M Y*J_;"L).0T7ZGT[J)T<VJ0&G;BZ*8$*C?.XYO4#F(O"MUFJQ0;4)/U+N-
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M*Y?HX;>E\[%_;NW-*4LITXG)?T);M2E',,'KE,+H[1_$OAYRPT]4WVV=_;N
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ME5%U#!NT- NW=/Q:YNHX(E@D:!.Z9(R5BLH*^^P&[6<>I9<)T(FE3YVB7XD
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MU#"U[_M\:L^&:3B'?ZZ*2?SF?P!02P,$%     @ "X*<5D[1+J0#'   J9\
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MNL<Z3T'N$BN?I"J2Z"XYS9/YR=;!]FN\_08=6X&,#)^,9*:8$C;AB6@[290
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MXC=@IL>Y3&%+V"WC?6'"M/:)+KV4SMJD$0$,"A1'W=&,1U=V&1Q&Q^H"V1&
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M1%&%.SPDN<0H-KO#L\-PIM4JXAI#'Q]F[Z7L*P*7,O"OKU03)\T&&>=7!=K
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MSR:TY'>2W<,Z+FBJ_]54VM_\PW/W]1Q]GZ]G9Y2$"_AKFL^B=_\/4$L#!!0
M   (  N"G%:9.WE+DQ@  *B-   2    97@Q,#$T,#,S,3(P,C,N:'1M[5WI
M4QM)EO^^?T4.CNV!#0'B,I?;$6JH-MHV@I#D=O2GCE15"N50JM+4@:SYZ_<=
MF5594@ELSQB)9GMB,*@JKY?O^+TC4^_^=GEST?_CUA.C;!R*VT^_?&Q?B(WM
MW=W/!Q>[NY?]2W'5O_XH#G>:>Z*?R"C5F8XC&>[N>IT-L3'*LLG9[NYT.MV9
M'NS$R=UNO[N+71WNAG&<JIT@"S;>O\-/X*>2P?O_>O>W[6UQ&?OY6$69\!,E
M,Q6(/-71G?@<J/1>;&^;MR[BR2S1=Z-,[#?W#\3G.+G7#Y*?9SH+U7O;S[M=
M_OO=+@WR;A 'L_?O OT@=/#SAFZ>R,&P.6B>G@[EX:$\&>SM#8_EP?!H>*S\
MYG'SS\-]F.4NO,^-TFP6JI\WQCK:'BF<P-GQ_B0[G^H@&YWM-9O_O4'OO7\W
MC*,,1DN@,?]:]+'TV<(HF?J2;<M0WT5G/BQ%)1O<UC[WXS!.SMXTZ;]S?+(]
ME&,=SL[^WDJT#/_>2&%?ME.5Z"$_3O6_U-G>'LR8_IR:)4#K4$?*+HG7<>6U
M/O:O;KW6;^*V>W/K=?MMK]<0[<[%SL*:UF/&Q LPT5]ONM>MSH6'<_4Z_?;O
MGKC]V.HLG?58)G>PH8,XR^+QV1YNZ&H7TKGI;'O7MQ]O_O \<=GN>A?]FZ[H
M>KU^MWW1]RY%KW]S\9OXU&GW1>MSJWLI6A^ZGG<-BQ7?N<I_Y&FFAS/^2$<!
M+/KLX.TD^T'K/JQ==W^D4SO_YZ.V^#?(_2-G6T\CL9D!E<1/;T[V]YOGSST^
M\T>@_#B1J._/<F"5!-_:>-^Z2Y1BG?O<1"%J[)UO":",&@Z5G^D')60JXB%0
MZG3O''Z\/3[%?P[.D8)J+0DXE4D@+L'LK9""@YF042 &*ILJ%8DK)<-L-%'R
M7MPF\40EF58I6('(WVD(*:YE,@OQ?5C/Q"QI;>E[$8\G,IJMCK@-(NW+8<A+
MG8 HQ<GJ*+8COM>@K<!L?Q9MT1<=X8D>_,^#WZ]>AC5>LIPKK^NU>L^_^0TQ
MR9,TES!>%@N4C4>T$'L MRH9QLE81K["3X%>: !N034UT R,)6@U,$T!.!0@
M@C^].3P^CQ.1J#0C)V.8Q&.1Z;&B ?'?=15)7-(J%1B2Q>A1,5*) G-Q!]Y?
MEMJMLCJCL6"(\6D Y*9V\1"5H9!D\N A;D6B?=R,-(O]>Y%'&CJEE5-+7'AE
M5\A:EA/+)V!Y\#%(_3@5;).B@+S25*0J$\ @V8@&UQ$]UU'1\W*7Y@4(:N?F
ML^BCL(+CXZU"7(&00.M4PUXQ H -A<X>M*]2V%G<0Q8\9)*!*C\"[JGR#+T#
MGXSS+)>AF(!<ZE2A  ?*W3KGG8&*U% S T+?T#&P'+V1*)1KYMF)))TA)()4
M9,AA'(;Q-/WIS=')^4O>_+V=Y_:8SB<R"'1TMQVJ87:V_W;GY-#290F,@/V)
M8$OZ*)G/[]_]4 (M<=+$A9SH#-CD7\B*I)'R%'YU6#B*,Q$CETZ!PX%MF4;F
MA70DPU",)"A/8G4E(Z XL&^: N<I$J0T]T>F[[^*)MM??V;^@-;NE3!Q+Q_\
M Q2S->W,:V3)P<\NW/UO  5H\EO6Y"_Z0:[E7U< UJ,Y?L(YKM0M:E4T2J/8
M($NSDI:F$2D1T""@>*+MASC#L#H^QJV 1VF>T&Z*Z4B#7H$-#G![ X1-8A#'
M]_=*3; -8/-)C#:9[:WZ9ZX?9*@8K,>1$G&> :R.4*I0CR7*@C_#(CB?O>/S
M%/\> UA@BJ9QJ,(9C5:,8-H1]&.K[_(=$*$/3YT-,6H39D6D,5U*7'2@$(U0
M]X1#%=)*1P5<88PP&YMUJ ?X!= %-(?>"'W,L[(>L@9VQW\ %%MQ7GJ(@&&$
M@Z6313, 0V0FW0&3G;"',Q,H+SCW+ '=+(; A#A3%+)[4-"F1Q8GH$M:"BOV
M:];T!!HFP^$2E8$QP*,\0=OT+;TZNT5.%[ 6^EVP..MZ+;A9#/AP14D>(CH+
MXDE6XL)6 %NDP3&0# Y3IKAY%Q@+IL]>QF+7+]H.'JR_'?P=6!W>?WV6T(KT
M">M<EC^691)_CI[Z,; B:%H0LZ$")#@(E9AJD#AP=">F)^R\D*@8T**(\O$
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M4@"<L5<2K>@83BUB"0CL$N)Y<DLQ7IB9E"]^SCHA3BSV 1&:!TT95\_8T#K
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M8"!H6$]G>73K/Z .4DTOP3$<;U(V:T LC-D<)6)LG(H=A67D960O*T.J<F=
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MQTZH:Z![/4RC01>JI$F?)LT:6/(5V3!23HU@NX7M?LAX_;J5B5U&D@D\'FR
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M=7NNJ%<LN#Y*#C2B"L!;98O>)1\;NUR6_&H-!^?X)T+CH,#,\8A<D^2J<!P
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MYC8'I"AOZCJ:X#+6E76IN3'HKBV2=[9?:1MB\=X7=':4VL&)]!1EYLBL;OJ
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M8U(P1JYW@K+#15&^W.> YE8Z,VE<BEOGLI5+3Y((Q M6CO8-H!-*8Q554XI
M=Q_]USOQK6C;G#I0WVP$9Z55LRZ&Y6PD73YJ?EI1I0KL:!P9^+ %++:Q9?21
M%_>2/BO!C<=51->Q&,"F'0O#>*><A:2GRX;G%L,',2"Q12,V"<B-Y6QK LPS
MF1@JET[R4N>FZ&0VZ=''L:Y1B2@G, 4<AL76UFC;[V 8ZN!@<%7D9;E3SRV7
MWN*,B)1.T%M4N>W"*?O'T<?@Z'0P<<4-UV/+(].;&#1S^ M6O-(1X9P+5=:I
MTTG;+@);Z<(+6VE\GQ3U(_4S1*UI@G1J4T;,3L0"X^AGG6F?J$ACNEF4A':[
MCB&6O<R&MJR*/DD'0Y-MW/LT9Q-BY8@\8H.;/.7'4%9_*,LQ.\;4*OM>ZZ'^
MSU__LG>T^ZK]W_XOOM"F^C:+HW%>(KY,,EXI-_?%WJM+XY:.=24CW4^L,2X#
M-'V"$5RH3Z+A)UQ+/8!GG_:#=#P2\@,PJ4_/@E]/+\^&%Q?!KV^'Y\/W/]Z_
M[6AP24D$H)U R=O2,ZC/G9L;5$D;.,FL&L:*FDWHCT;Y=8>3]1]_X]1,0WVH
M%^]0XN.\5"_U/UYA:\4T6KQ,,IH_/?3*/]]#6.PU K^ F)0CIJ/EKRT9#7:9
ME"J@GRK6;Y:O!_35DRIN?W?P?/!BM__KW<%>[W=?:=@G-&6>-NQ,">?U]Q^>
M_M  5WFY&^P1%>OQEOQT?_XYV/.O!7*;YC[R%OHWU7?,#)X=MD" ^,-[O4YO
MA\?O+M]^&![_3_#A_/V'X?GEZ? B#$[/3@8NO[B_NQ4%/X,EF'+5+5BD;&3<
M)K"J?,ZHYVO>Y.XUO68DNSYQ?.\0+DN\@7_]RP%89_3?X+_59%*H1?!V$/Q,
M^#D/^Q1.JY+A@.[=V[@47V,9BI5E8D^(@7MRH$>HW_+=H[*SRN[<ET;?S91_
MS N+3S"4I,<R>)^EB\V;,>V\P!F!(GXNI0D8ZSH!#28#"_Z+"'1]*!.THCYF
M?8F&AM1*)Y1@0X7@*ECD-5O]2Y#UUE=,26L2C?5>V9]L)M=3!HAO@=Y>-4/)
M3M@#VK%1V8W5^;GHBL!M%:3%<PD@'IL4#'$HL\MT+-3&I\#I5KI0!H<!.W'.
M-3 3*@TQSBPGZ&!=1$T'I\D03L2YPQ,33Y3)TN)R(^-ILZ[6UN2-)W1H"IK?
MH!VP%:L)^<C!K-@[<"&^.H<A^/X:D^;$NHBW0YXQNGRO0MWXB/X]2\IHCH5:
M<*05?>*6,(/=C+FD5]I#UJP'J@J,_I8*$<TYM2RG].C.'X_ASN8SA25G\YQL
M<(R-VP_+FL!\"JXJ@Y.+\X)K9"G<+D>9-.HS+W09\Q%Y<T%)/-H:;VM/5FMS
M!D&[%N=+!>=]WI?C\:<LO^%Z+]%9^OC1;TO_;ZVKZ)OR7?^[L<>$]W6I9M_W
MWZ]\G(^:WI=K>NOP>"Y7_MZ?_QR\_S$X'[X;'E\,@^.?SH?#GX=GEU]1;!\-
M#E=*)6E1"UIX.T\''9ZC$3!>MFCV'D;&3K>12.*G+62W2#M9&PI&:T+K@\20
MPCG%87D*<\,GP)MT1-0PJV!_][??0@V9J+-E._E:R 5L0"I)7(.>L+6VG1Z2
M$@6DOD[0$0+>[[<B,+^FRTFV=JB6^[<NO(T;!#VW5]1T3 YUX(- N3;QX8:6
MS<D)-C;<.6I+\5[S_OMVQ!J/X6'P_^Y-I)C2\<4Z8DJ&]5!$B:"@>BJ%OZA#
MZ.-.MW?:6*N."Z!=2F&2FSF_+>SK[MDT@>V!7IB*<@K[K9=/X!36*=V\>A*0
M8':;L",?HU^1AN'H%VWN2UT$;1FVC9MR:N&=>RAOVO4X>_]K&%SB'0&#8+B.
M6\)43LFZ'J*5=LZ4)LM(V0;:DN3?@M7J.L-0^N!UOV8).,^6N-C@8ZILT(!"
MH"%M:TB9-HA#L&5*,S!KENFG:U[;IOBK.Z'39=7-<B\J#T/7'7L2RR_K!K9!
M=+BW[@J&9X.C9\LK&.0 OY,*J+5U+/D:/5GTO0G]=JGM5J]A@%>3_Z9D2=33
M"<(C5G-%TX=_"[X9*^ ,;V8[;//?#'46ZO:W'@X:E5$R;YF% >/Q!Y'UO;*"
M+PC@H"&H"J%8JZ2<1 8*G+_4'%$JN$OI\<GV@>&)7N53Z?*-4!B9A:NR,&W^
M7!,/Z6H>(1B:AA[@5Q+VP#PJ>(ORFTS\[99)AM07.4T8=P>M[I)130E<3?&'
M6'M&.R4)3/ O::5+O8HS3,Y-\4/NFHZ?1D7%+Z.FZ?B_0(I%IA;4;K2$>>&7
M*)[UO_%_V;"%^17Y%;U;P[S@IU4^_H00F?*DS;&]QJ\-!%<8I,F_:RQ:ES]4
M9IZ";<S'LM8F>=@VIC0)H2>-1,2ENSI?>2Z5EU337B65/('+$<L1YD]/,$VD
M*9MCJ8"OZVQV/OAU^Y+4-RWV[M$I=)5,&_TW=O!,!65/@P[> #71O0=*BY$*
M<$0Y9*(U%ZB72TG&*.UUQ38J"T64;H?VGH;2/IOH+B&$0TS@X[(B 4EP] ]\
M^8A^E9<5\1M.TG<(7"-43?CV1#.>M*ZWI"@7DB-#JR:,AI#P&V^F0%^(<4P)
M_3!=L#7P#B.T!D*($![CP@O583M@IC7@50$RK(SQ(>B?N"K:6XT:8?YDVC8=
M0 K&D,I!38I2_O$TB8&Y!EO(;T);]K0&=Q(>_SKM%';^3*D4HIPJVFG87)9*
MP%Q$/.FOT6AWRN,#KNVCHA'DP;&!K,RY ,,#.*0!J4[K*L)"'F8_$Y V21R8
M&QMLF:;-%JZ#"K$BZ18/3]&^!<#02JKYJ*FLA( [#5*F&*\:/;)M#NMJ'IQ0
MI@6 %0J618=NHW46!+HT3\^ZR]QN!M<=6:]C#BN]6]X(-$T9:Z;;>PLJIC4G
MK\<-<(RL-!S! I SGZ"I(7JE )_PDVE>FHO.V_M[72S,7=ZV-_0NM].6GUAV
M.*[<":!_@LP?4[+:IA.[/*W;C*6\.I:AZ)\>U#^Y/*U=PP"Q?9[/'BK4B0."
MD"EP+PUD'$NC;&5=(@9?\,OIJ;'R$",^."<N'QQSAY2]%T<'[/7J_\6+/?N+
M<U MB<4RD9G?/'MJ?W,,!_<&^[,GIG0=[HB#B6+?_<QY:@9\98Q8;W1WWFBP
M0N3E=BJ[]H$A8B0BQAY^;3_^,0+U[5TT@A.XP$+)"!O<M7_!.,:PGGE>T/YZ
M/]&Y8?"]@5P\)<1NS)0@_%MG[0?NV+-$>E#\K&)",'BGL!;7+L'9J5Z30[+/
MM<DQKR@E),;:B_&GCFQS)T^4V+&$= ]W.?VZ.;QG"+Z8^ZVR=UY\+>/E</"\
M&0[MBO?WAT/W5HN'?H6IOE@I+\$O44.5N;@6>X.4)[SSLSP&<Y!O.';I$+2H
M9LL1XX&&2XX^&K\O&3QSH]!"HF>Q^BRHYS&U^++@.B!JP*B)"JZ%TUU3\ &W
MKLW!A/^Q#XP>&XV%7K<A_.X*]'[::M+U#1A%RVON 6&@&8:F!R%</*9./*#V
M7[\2)&QP'./+9]KL!0982"8@YJ).$.Y/.#_S,5WY^'SWR/0"BXI1!&2S\_YS
MJAKL^4T>QSL_%EA"YGUNTG*/P03<:8@/_Y>(C O&01(Q)W<$"\5W<\K/6_(,
M<6@KY#I_Q0*$*CBM;AB,:FYK1T*9K4[3_^/@\/ Y)\X]W=O=MH->J@P+Q$&6
M<,OWKA?;WQBQYVR;=H7:7WVHP88:8_RZDMTW/_;TKT;W"?C.W'?WNG.V(C4Z
MR\96AV-E@G(ZC<]W'BW N,^S&BV\9/PI2%&ZA:AF)YBG0-]?1T(D]!?LJ6(O
M!8_.?8(9V(<EI/FR,7LLKC9NYELQBUUX8WMDU,C1T8JZSWC_^>Y^H]W4-+]1
MUUQH+P#$%HQ!(^XX[2JPPM?TV['X[FU8=JL*-KMW6)6.WB+YB9R/Z0W*V,2Q
M:*P-B\34P.'!L:FE(9'P)%TOVU2@$2DDZKCG0%_&ZG-\*YO(.RATP8RZ(65J
M7JCKA!.,=9>?AD!PE]G$GK"H2S(<>A82[)1CTP0:N,5+PXHM.).>SK:.'/0!
MAGD:?/J8\VHZ.>'$42>:99;MT>SM$:(D)JB59CCC6)K\, NEZQ<'KQ=N.U+/
M0ZFS311V]"TJ-OPL5)YVN32G$SFI&/XVD,@FWZ9H"[KM4+LSVY;<.I@#NHYR
M!A?QL%\U2@&WEQ!<2G9T-I:SW=F!RC7JV-&GX1B6<]=.-U"#H&R:M;Z[VUW'
MY+L%""FB-574V7P3W=K$NMR4. V;S#U].#JB9]Z.:5J+N_=*\.#[*(V(4O-+
M=+P5:"ASYCV<-NZTZMEK2T]NP*_G7+>MJYJH6'NKC9-MX<QCC@GKDCZQI;:]
M=>3FAL>:XZ/?CS#=,$-=H[C*2OK6+>S[_>OS8WG/I/D>C;KC0ITO'RYJ8>HC
M_9>Y[96M@ZU-#B?8+E0&+^ @C-G?[*-TL+N'+/RN[<%("F]=\1)C[>9NRCQ*
M]E<"D.<L9=GR$0;# >C7&Y'EF6TZ<.<7TMXUVW4@J*#&D@G9(M*2,\Y5*3[2
M:^6J&UQC$F6":E7F^A%!6Y+F;OFDT>P* 9YL\-@--9';&_FD[(;O6330_*Z'
MG)0:IOK* ;\G(FMZ+TU.D73'<_>V*156\0YX"[DAT/OV.7)%#Z8KTC"%<@(N
MA/*L6P (@^Z0H/R)5E$ZW5&B>!:,T)/E%H(QLMTR.AKLZ4D-W)4D!*7$XFL1
M$H5E+!_)1>N4F2@<LYA1;Y[>X(4$*<SZ.Z=&J#A-]A"V'(>2WUBJJDI-"B*K
M/)3-$ 57>1YC]\RJB<G80+BC!G9@DA(>)2(%4/HBS9F[I.D?2F\HA$1*)@S:
M0YPGL6C.6CNN4-O334'->CF[ VRS:X;AP"<.]H./@XO!R0"9SR#8>_KB< &*
MG/]FF5_,AR[7R0>P(ZD$ENG4<10X3: ?2!YB3QYZW@+]0Y(EB\C164U$M(M_
MA'3QT3==&1V:PC^)6 ,@0L5W#23).[B0-F"@HXR5H@YY(>\YRA@.L4GX6O0M
M"EHU<=N$%0K,&SMX2'4CX/T""!78:38STM6)RQ)CO%+9>.$'0S*:*H&G^^5>
MBGQ"J>"5Y\O5\-Q&&,HN932+FSS,;I?3K@8ID;K3CAE).J,>5DBWAA.PTC[6
M?F4GQ.$DNFOT7FZ:YO2V]4/=M.UI!(PFTB#\KH=/6]XL!2Q[LCU376:?(DI<
M'RLMJ9!2<AV(^94&9Y;M4QW^%A;T=7;>B"M@(F1>:6M ]VL%VK='8KJ]:&81
M,?1\SMLL>24&M2RI9/\P+B8DU:4/>[OGR3=2/@C/4"X7D,/4@(1U[J2&W"HQ
MN86I C56KE1EZ%N-O6GI2H:D8HAK,,>T)2U:'8<2'$?2^SF&!>H,*8@0=$O=
M@PD7Y/M1PXY[]NCX?$".3V:*OOLG;/A_G!QRSF:BEL:E[RP075)S+561,H;N
MA6;\D7F8IE>2% Y9/A !VP/-O/EYC;8*6)N+'ZSE^"N:S=\)5+/T:YBPP"5(
M6^.[W;+XC48:4 YNE8-N05D 1?XYF3'$*H''P7^.GKUX16!P7/F#2.[1@@O*
MRRC%^Z AV3D7@,"@!;,U[+/@1.UB")V6W89A,MVI^08=7)1L8Y0"=G-S[EA=
M(I^7B;@Y'VW7$\?3M:=;^[^='LV4/24U93RN8W07>7TUO6OX_T%?^Z>;?^U_
MY8;W0),?V>ZCL_MHTT38!?&]-&LYK1B07:.U-YWMJ#")EX#23SJU,1,<*:.9
M<O1B4S)'BN\H8I@^0N#&G%LX!^WPD41/!.73/8^I>2)QE-,LF'!3+ X/B:O"
M3#AL"V;;<L81T=I[(,X #WL:S&AQ=I&Q/V55G-P^K!WZS9FT7V_O$,QM[?&R
M025.H>' X=I2_-PYKK7>UJ8Q6$- =PQ#Y;GFJ"1F4>64E!G$^;@J8$BF++16
M*+0FN=KF;+&R11G'6 ]Q&G+$!B$9YYQ3SRP>3$":=7L CT(%6ACI0UXJ42.J
M73$$X48:N:.Q3FHFSZKE,G6+R]B>F6ZRAQW#@0N6;JST6-]]\<A2M-B[%\EX
M+/69^TEA[99-<^G(-3L.?AJ>#<^/WQF$AS?OAQ?!V?O+8/C/R^'9F^#R?7#R
M[OCTYXO@\NWQ)1:!!2?GPS>GE^_/ _C__-CIV4_!A^/SRW_9Q__G[/VO^(.+
MCQ<?AB>7.,[PGZ<7E\'I6?#V] *_>CL\#WX\_@7^)0-?GOX\1+2)X3^')Q\O
M<5#\U&!/X&Q@#F%P^B,-?Q:\_A>,];.,%0:_OO_X[DWP]OB78?#S\>7P_/3X
MW;M_!<<__@@3&+YQ7WLQO+Q\1T 6".#ZEM[S9OC:6Q0\06L:R-W\8YK&>DI;
M.G5"#N@8[P9F'U% 02X+]HRD3--&;V8*XDVHKV^E6TO@S6.=U[Y2)X&7C%2?
M)NJ:O;SJ,QC[G3WB=5\,&ZA8XEVG]Q$G,#YIRR?<OL>$8+]<%H<VN(5*.>X\
MQAJ(RVEWKW5Q8Q\2%,/P!G2T=PC2IH4;BL!&?HU)_3:G7W@UF<&8C2!2GVU>
M$V>W&^ZW&&@<57\@IQ&]\7U'K%I39#P3!D\R I'(QLI&^]UF2?2!\- QK[=H
MB7A=LZ+%EA-V<B28$5OP.+K(/4#LKW!9OBFPS-<L?;MWPX/TQ(-!+_#3O9LE
MRQP/;X;' 9LAWXV'05]EJ[LMC<ZB!H\Q<O;8]I>I2X6S^CR>8E=PXU8P:CTI
M:CH0Z/;P:'B?;<*4#-F5//0>2]X"SI L@]?2+\C)OVN6+\.<<9'4=8HXB\Y%
M:U@BN1%5#>YF>+E.[[*3O4M^O9M2L&9X!"3^#2@[TGNJLG8#FKLX:UPQ)3;J
MBC3^M4O7OV&U<?=);D7;]X[T[#M[G@Z>/<=%GV:8A%(7F=S_;KV(0CQ^)H)V
MU?L("2.UR'6@TKH_W70,.,P4E,UXX87^]&A"2JLPL*^-HW'_1#!:/Q'L'^"B
M/:ZKB\T).YCX.>9.4GKAHM>)19DMI*Q*1-TD'NHC)>6R5_5>?IB/,;^'0,[C
M]9,S\S0?KNH:CCRK0&"ATPMMU&PU&!]*K'+SN\GQ%7/[,9!1=6'[CV'I*I8R
MP&$$R9^ ,\7K/\HF9T+)P5Y(3 .9+Y;X!4 .D4T3$P@NAM)8,<5B,A6W<QAC
M_OEA0/&Q^]?KUF!6[._Q8H.#P_M?[]<V[5<UI2B@*EU/13G)C?ZR/(43<Y4G
M#M'<)/#?V.^<U)-L(Y7,H-DF%D:*'"=KV?F]->S\X0Y6-GU/M\LN&&X8_O']
MW#*=BF O2SFEC@=NC[$A@>K+#:NJ:#R5G,PJ?_C24ZU?>C85(>[MVB< 2\K/
MR(*M9]O,)/U^I'<#8+"LM5#7^:<^SJ@S6F^%Q<TTT!7UVDW<^+I"'*.2WB,Y
M-Z:A,;K^DQGF2AY3H;GYQ:PN*^DXKNT:ZD\J'YNLF$:YBMLI&?>*+CCNES,T
M4SY7;5#.\;4)\+M>/%6,DY*R+VV*#7G^02[8T<(@4PEC@#C3P,S>AB'._ABO
MOM$V'?]S&LZ3=5^PH\$N]>4[6R79]EHC0-G$6\?QA:&S,8;954;M3:A86'WB
M=%R_5 +>XI112.;$-1Q,;/!,8 X2A7&\G6^&QR%1#M4,)7!)9]A/7?+>I>J#
M9J=BNIESE45I)55WA"S%\XRI=K?,0QB=BDMTZ(<#9;:S)%R>KG*'-0F_AQB4
M.=S\;+"S/+A$>"+)_5E;ZM=ZHS*FP(P;B)NB%Y/7Y7LCT)O@X&\QD")[%2IG
M,R5OA8']I%(-DT@7P3*'Q<+6M^C@.>?;<_4&ECD4$FZ&*0A$I*NG85R%Z\I"
M6VKFEYBYE1T>\J,ISFW5GL5>N0Q7.VRY:3_*+3SMKECF<#1RHFA<U<1O3*_Z
M!F@<0AY)=0(U:9K-,( =;TM!&L<L.H"RVT@ MEB&CDD7B^B#HG*]$&L4<5_Y
M$&EUF$XTM B>3MV+&ZAS:Y]ZR,#L5^E7+M$MO'NVZ[J8V='F,S/=$/ [86"6
M*8T6M^>H.E$YH=_<1:AMY'?2(#H#Y(CO?RL+I3\M] C4#+H41DL)X,2R?):,
MD;/$Y329XR7VD:YM#2T66.>Z,@LNZ+]K H7PPE22L.2V+7@,*/ZQ*Z9MSI,\
MFR0Q=]4#M73-TMG!EW$ ,!F7(5VP(-!_F8:$7,Z)D&'1=92D&A/,"N006Z(3
M=J'I<&/!?*7,C5-.*<;))1LLGJ.2OR:A0?ER457F7"?%N!)V^\".1(M=JDD(
M0(S[+XX46.?;R^NM_%N(  I-K!T0FS!LLJV73:@>*&C^72>%*>JE /_"ULC"
M-(M1PC#%(9581P3DT:K@0ZPD=964'*4+1GGL5HS(@(S]J+1"LFT0UP@D.O@=
MK.XR3L8VZU ;-?:(X>,EYT;B.W'WL7_#5(MPX+>S.1(*=O^<M##;M .!TM[9
M<\!V&^ZA*BL+*N+,8)N!*9*D&[R$Z<;J,':_A;!XR]D>O,[3ZV7YC$NA851&
M$2VM=_5F:1P;,(1&/]#>AT)*T.DE90&2:=?DS@EZI30)D52HH*%[\'I>)5*5
M+>BH$=C,>,H$$[AE4*Z9B!#K()^+%1O7E'18,=@@TIJ[.UA77*.^C'7GY;:%
MI.#<"&7*R%WMUPL.P@\]F!.O)'@"8YB  8.?)$7,"GVH8XBT!L7U9)&3<.5T
M#5ERV=NT*_@?XA62)2 2 HX^=LZ&Z%&20!K+U/LW6<Z;: Y;G[?)S3@G:#6X
M,Y*[[^3@@L:+O]#7U>RJ QNPM=@6QU]K)&0QEA_;E&6AA6F4:4;UF$CP@(J'
M9PHA:^$27"=YZF&"4$ZA5P(?U^CHNFG?1SEXL9<U$,""6>U_J#4@R#)N>M!/
M?C2,>SF9^]7E\EXQ&G!MG0WNNF]FHUCA'E4P.E4&X'.E[Y*]SS4>=8N#"O2#
MR447V'"W2+0M2_A6PT-H+G3 :8S0QN=R ]/NV6D"[71Z&"$<)KHS9B!=<L3Y
M9\9D7V&_R8NK*$O^(Y*;H$IBT*LX.9_1(=V2IVZL='?#>*EN/9.>+SQ2"NR)
M3)L_"9N@:I3\X'MHMMP>$$S ZV[.&/P$ISE?9XM&A&?%XZ"*"%%1V;UO6WCU
M._J%GAE2J%B$??+8-F1G*[0P^-FH_9 V8Q@A25[M2,\+ 1,2I=RBCVJMPH.N
M$: :PPI%-R;O%O-2H_6+28Z@2'-.R,923A,_N($%5ZD:@<V!P":>T7[[Y#CR
MD+@Q#V-A5'F78@W/1H6Q$:3F1#8I=(T5"DY@ ]+([W9G]Z'?1;9Q!ORW309=
MR8#GE*NS/"/,NBKQD#3N478L+5_" Y8N) T^1PS$\'_#M34$4:>YD73V241R
M);K3B3^-)&;%K0!UWU;;"C,,! X26$B5B)?ZFM'"DHP9K9D8H2GIK6YC8=)R
MW+CSWCYBH@!_:H3G.]#4[H3W&I)>3BD:FD<))Z+E\#?P*96<8PU:,JY34'MT
MP8A;["<H+NA:87RX4BTY(^"4,<;3$>^<#ZI/D2%8*0220%9'B0!<=J^N06J.
M!#5=LX5E9+'Z*R5!(=<\42ABY>>;C_?/"=TD%>& 6.)(J)$UB7,_4M(]A*OM
M"/9\GL>4'T#'[6@VY(N27 4J<C%D9>&#5S7TUUP0@[C 14+BZ@.M9]W-0QNI
M&7@?NGV-()2O$*LU(9@8Z<W5P,N5C/J(_"E7')@O\GF1*'*]F4YGIKV9UY3,
M>B=5NU6-<:$@ZN\VBVB;1T)]V5!MUD1(O,N# U,&#9B46I+,1A+K]C<Z7D8Z
M48YP .%R)RKY&BW?7MR@D:_?]#$CI>FBXB8.A #Z.1GGFT.#QV#(KX\"65BQ
M/%&E13;4;9"ZI(ML+0/*$RHF+"$-E*!6CD%/*P5\-E9@*^1S72>MSS<4X"U]
MUH8>D-B!Z2!,T#I;=;%XA>F\%KI:WP$U77@=GCNL69S7Q7BJ"ZPI[)YG*8<0
MG*V6^ $*C[)DYU=UD^/5&AM_+ED>A?7?N3=-\$I%RVMK0$P?-U33+Z,P>1 6
M%"+UHR"D:'H4L/*!P%#<V@=]AKJNM,.NXM@?9ANQ<858-(@,E;AI<ZX.B#[1
MM@J3%P:F0V..<Z,8RT/6RQHN! C]7 '/3&#>ZV8.B>,$B#6'$(!FO67T0Y9.
M#/H0M.\0J864Y0F"AC$.X%\!AG]F26FR3"0SY*H =3(H&*Y;DD+:8Z)?Y%;5
ME?LU:(!Y,;E;V^P8W"A#@<0Q[1C(HJ"@M0_8.7'S,-T42A]ZV@NFC;815CO-
MT40MO4BXU<Q-8EU)U@1UC4@8DP(GA_[PTM7N6[J,AK=(58-))*5K<MAKP)=I
M^=:P1PZ#?EG.B+7$.O9V_[=>0>.T=$.:UAXC-^#3C_N/5'#FDZ_Q/C+CD!TI
M:7$J80=7P=(N01>2EY08"IIQ%V[!ND:-)!6C3?YD'-)"E[4+II+67NBZD W0
MFEQH&ZSFF?@JJ9T+92%$98+]GU;?+UPJ[!ELFG!$#+R6JM^X,]Q/FV0=,XP,
MIHFYGUO-,]E>X151H7R]UC%PV?,C,-P<EC/-$ORE"DRP;0AC&Q5K%YM_W:8<
MSI-&)XA;P.!3KA,8":/HNDGL44K%Z-;Z=NM651@0[ZI*)C^4V\&',1&:622M
M1=D.(#U];AQ[89I3;,R]V:X\?@QI]8:TUAR_ EITT.NVT#1+)EZ+3RUCO6P&
MEI]^ C4#M,%S"5XL[2EF<!X&/V_%[#O);5LWX71=0\B-[I0RZ+9$W,B<IV];
M<'R'G*>S/-NYR.G<;,LE'4!:2P;4FR6*17=HHL=/4?*R*!VX1B4=\XIG<VGV
M4Q#0_[BH\1>@Q(.<@NL/XI"2<&XB=HCB[XC=:=^&O$/-%9&.:8W=YP1E,R3*
M,@2)%8^&WUA%<^___W WA VU>/P::LN$$OR1W1DYLX#%<0<31S?T >-90^[N
MGR5#<_4.RL NYZN?(.)%N6W ACTE=Q*6XX<B+!]TNN6W+9"_6[2FQ7I.M+/W
M8;.>))ND$N\O7+9C/W>\VG AL*(T=,/YL"L*6U'A/X&<Z1^_PP6J\-<802I*
MF[:I2M?C6HK+M31^3_2)=G,G2D!$:#C\+G$]F @+T:1[^U"W9AS:R@K'!<)I
MUQ)?L?W:R+9!3$#B*Q0<+6KN4^ALF/[4BSYY$8/0,+_:R:_#5X3!2%4WW)UI
MN2]1P_R)U>^<C7,DYIC,@3B'M/1L=/<T+S7#.S#IN5X:?WBI>\"7MD% 7MS-
M]H@?/#O=.-[Y;<NC[ZBVO4E*H!81Y>L(=OME#.ZU8KJK"<X8T\8IS@FD!]:[
M],F:8&-A)@5)[:!$TBC%>YNIJXAS*L?HDAWSQ8YEO>0L0B__C+E<@KVKN !)
MJCW010U$#W<NT_R<N(*7OM0%^^\$?V@+0YT>A1> 2TA'AMGAL-0UCRM8P80!
M-5,BJ]KG #HF-L8VSI#9C/K*A%PMI7M[(<"KY0R&B7+5G,] C:;**[(MPHV6
M:+=F<"=LSXVWF;YMZ?0*ET^73G\TX+.4DH2]VX4+K[=D)*0D4 HYD$UM.R#9
MS'5*3'4;G.F4#,EX]+D[>ENQE3W.-HD*:P)T2:!VJIF112$[4G$HRF/%OCA+
MG(*N+]O4#(;B6+1U7/BPY2\Z,84]#MF5U)DG,VS9-L[GQ*5:#HXKE5\5T7R:
MC&T7TI9W8N4U7F][99)M34,:GS"(/;,+)WQ!,EDG=S:BL^Q:;;R +KR='3DX
M0?B6)?8X62F!P\VFU_CV%*?'$1(WI41G95#G*^3GV)*;7#K,LDPJIU'/'K:=
M=+5N=J/M)&H:CZ=YFOU>9V,C<(?8GIM.XAS!R2?KS7?KO+PBM-PB)U0*;LL[
M\M0#"@8[9B+6DB'^[<C);'=*-IFO1.R>%)H&F?OOFKMK@YV K(1=F%<4 (07
MS"BM:%P3D[N.P$9K- .T36D-P^$6=U*D21=:G#H\+]V#F3O/"58Z7%G,,DU\
MD!4OC9\"?4J2^)R]#(V2);% #<7E[C<GO+';* %.@_H2$@B6M3?J#GB!W-XU
M[%#>&@T.$Y_VQ-MC*+ @"C0IX2-$4C6U3A):7_CKUO.7Y31 ^JU+R8(E8[OA
M&*-G%IY5SYFR#[@$"Q;V(T/RSLS2EE.IWEBG08QY5<->=,!I?)H;U[-:R@4U
ME+1=#9\=%09GV+RV-OE$W@'S^\/'@,E#J@%RZ7*,&KU4;WL-JKTJB%E24O\T
M$+,F=0QH;,)A$2])DUV[EE<Z OEA"]?II@C7$YN%OQ'UWAR#YFI+^M.8STF&
MI0<=/(GK@9@+(G)*V;1]G9:L4DP3)85HD/E8D$@H?P!EM)/8<5M"BY>)W4I6
M-RLR E.7/*B.M'6O.RO:YW.<C8 [X-@,[F+JK[E?<FAZ@L=JAMU T"L741_M
MA+Y%45C:;B4AWD9L7ELZ_6YM5V9*J="(+^QX,V7*;I6'O<R4$,;N,MFX/NSP
MOO!XHT9*GR%YW-HC(>0K8=Z0I*?$5_S(E!KPK-WD<Q&&H5.@VZB3[TP IGZ\
M7/OJPA"C8T/*VN ,=495CMU==+4S?8"5-14>YRS/%IT-@AG&AK6*W&MGK?MB
MA[8K=F'/;4164M4Y)N<4$9@[=2O6V8/2;I+#53,3$2-WB\2O5FF>S2W438^O
M[BMBT].=RV(ZA$O:GS=K6CI6$W%]('MR1O,<K#I+I<OJ\DF"Z,U^T)TDGVT^
MW,X%>;2)Q:P!&G4M0LIVBP33BR/BL?1A-#@ZTB:6 <*"'J"<GE(,LC4$HUSN
M%?J)D-SA'"AG&+-!I,;0EO<A3V"G!5>USLE,5"5K7VR'D7'AI:\8G$\W(P43
M'8FO8-VT[@J(!:;<J$^<:=1,UJ9&]:_(V%!1_'L=$WH#JX6,1&*2 *HNJ!""
M^"1PQ-"MN43C.9,Y1W8C:';LSF/ !BHP([9.?,),E]K!4!5N8T=".UTX>UT_
M8PM\93(BHLCI-@/>Z^7M+#M>Y*8\JCQO@1^+P"PHT8YT?]8:8Z*=A\09AQ/7
MUK/FE>:1]*KVUMGAJRG'(/5Q869X5 .#C"J=VU0*@MU2U!#.<@IY;>S#[WP?
M(M9*-S$TAZFOI#Z4%:8+CZ.MZU2Z]62I&^\ED7!C3\>Z,(XR3;*H*$!]6 1Q
M$=UDF!\<&=?-JK289%UTE<A-6$)Z(_3N-*:P\:3WH&7L\\V7L2?8TEL5>.G6
M@FJW!B%[V4W <MD%@)PD6DEN/0*&L[L4FEQ^EFT)NDG5C 7JB*#H\B(!TA27
MJ/2X%1,C^D2M1201W*D\P&QT;=A1E^?H3]&P_,7F7X&?R!Y!MO4NNOE.NI)?
M8F=;TR;WI_.A[FS[[EWP>AC\]/Z7X?G9\ VVR\4FNB?OSRXNSS_"!Z=GP?')
MR?OS-\=G)T/NA/OQ[!1[Y5Y<'E\.+X(?AV^H._"[XU_QT1#;^&*O7&H.?$F-
M?C_@ZSY<\O"]3X?T&/SC AO\XK_I-_C'R?MW[\^/W[P/:0+O/UX&/YW^@LU_
MA]2X%U]Y?/:OX.3M^],3>@ G\_X<E_'CN],3ZA/\X?S]+Z<7I^_/J'WOQW?#
M8.O7M\-+;/7;]SK\)8[[GG[UWQ_/3R_>X&COS[:YU3%W$SXY_@B;ZDX>'W)_
M+B/ ,V?+=T^/TC\E6"J<U_&'#^].AV\05?XL^/'C.0Y/!R3/_?C^?/C3>UAV
MR#\].7X-"[[K474_RN=T>G8)%".#+3LO(# XALOS]^_L<_ 6^"ENC$-LLE,_
M]M!J& Q_&9YA8^>/9V^P/_/'D[?>)HN;X**?#/1'QS#O?UV<7O!*+CZ^AHF?
M79[^8K;^XCUVF6Z=NIPW7(;3L^/STW>\0__JY]>/484'(+'V=M<MLO8'>WO+
M1=8QMAHU[JZUM;I=B^1:U=4A^ISNRDI^P8@JZZA4VOC%N?F2]J@2@IAUMKCP
M6$[V#P<9G9([R3'A]MI)*L!#,5QM<K^R_6/+FE>8OG$4D(Y8U+@$\@6;_MF^
M"55:"\PSO\#N2]A6E8343G-LB5%'3@]MIS$JYH/62/?V-O]^OZ&\BSGYP]^J
MB"(FWXUUIB3MA)<_E>4OH=*("GCA?827QI'<:Y4E7!:02=&< (9[Q=[+?4T/
MF\SW-Y_,3YBUD:/G.W'P_TI.4%W1&:11=E43QH\@B&*SP30J$.Z.0/>CV3Q%
M2KU2&6'HF9QCJC5@-&$&_Q4G='MH#UG0NBIF>0QO"3DK6XJR*0U2.^-F49:)
M^W_L')2IR6_-" 85ET@EP3M=1F'FLAPEU0H]SZ-2N2-(=U8)[>I@"/=.+#BY
M$^MK9C55J7#HQ CLHDY)7,M"O6790(*$--Q^)!KH]22:([HT]2]BCW)=FA,P
MN4>V]D:#L<L/^!T42\;9(_XI\;9(I]EISRV/[602/VQ>]'3S>=&Q!5#_3C3I
M8]-GQ\!O@699+IH-;AII$[==W;(>$5X_9]8XL/1X02C>1T5*1O]V?^)@(?CI
MWW^&2W"P^9?@+*\E2_-#D6?XQ_<CEC/,-M#2#O>(+$A)X FU'42;XC%])GPN
M=U+R?"')97AE9L#<:WQE&$P49KHP[$RFN)= 7LR<C&.\=Q3Z)J!_N'R9.1'S
M\O8+YV!P2K0!:Z%V\!I'#_NR' Z"O_YE[VCW5?N_]WZ+EER8=P2X@4&T4J7?
MR5T9VHJY C;E*H.'31E.0DA6$J,'RTL['W3I<+O3$[=^\TIY%C;=CBH*J5<3
ME?/I9MQU*B@)C'@RY@,0U134/] 2X2(,>E&"FR^=<N.] HQ-J6/0A6>]36PI
M>TY5A(V.:%L8(&1(0TSB!^D%/Q33TTGK"TU7$.H($L4@[T3O4^J368CM".X-
MNZ3]N*P ]XQMAL:N@?E;YK@A]O2TR(XX6Q5A]:5['NZ.[K#W7]Q;SS32 Y:7
MJ:N\2B*3,#JG^H?^'C-+RB,=QC.FM=YK2OG_Z>,Q_5]\(5?]-HNC<5Z213)>
M8;G4V?W2Y';$NDH?X?C$"$5-(1B!KO5);"?";$P7@^7-4A\C&QLE5/M=:\S8
MN(\D,=D.EF=,?FFEL=3WYK,WZOL-W$3L?O=M($!3BYO'W8.YG%L5O]?%HIEM
MJ$'^*H'R.<&]B6(GX]&6C6+.9%$K:0!:(#9(6_WI/<N-:(K9TX+QG\.3CQA^
MI>W_3?X/^Z_CEIB_]W=_^PU1E\PGO^'?SA^.*W>5-?MVP]Y]:W]&:/?.N7>"
MRX_WWM;5V1Y\B1[9)VXV[;_N[M[?+?A0(.;+63137@_.QX/K-XY6N.4KW9@O
M?&S-#.3M\/C=Y=L/P^/_P3R?#\/SR]/A11B<GIT,PO60<!3\'!6+5 241MC^
MLCW<D*WO7NCKQ>,=_=([NN:C>V2P=SB\>W2X;"J]7")FP2/!/"""N8./XBYJ
M 19X?^% CXZ#.VSE/5E?9V_>GU]0DNW#""%TWX)3SP#^S;.,,71#"%ZVFIN\
M"J=4/XY@-=DW]:QW;SRYY^Z?71P&?_W+P;-7P?Z>_./@<"UK?[H.5AG#Y=9!
MA43[GZQCZ7:'%^6CD/\>/5\,)]9\QGCS"9/G\SS1G:S8Q?7]4-H..JXTM3E_
M'- WWP_5,7+! XG0]K#7+W7HMENT>6Y>CU,'7^SL_9X=NE_3<<"@8T;M*N!$
M=[ O=#0OU4O]CU<(&)M&BY=)1BNFAU[Y6W\(VX/XUUCJ+71,!\%?B_YT^'3P
M_. (5:@*)EK%^L6B70U(NWI2Q>WO]O<'!WM[O5_O#OJ_6S;LL\/!T^<O5AKV
M"4VY:"BV>X>\C4BJ:3F/LK__\/2'QHZ_W T([=2\8]6?RBMO>V9__CG8\UD(
MGG'S./@D[O4V]#AVE^R#D* V  :PO819& <XQU?R-4+KMK[KW\(G1+!W#!5M
MAN6"0R?QWW](#D>3%WM'\6A\N/_LX%ET-#K:C_:?/3L\B/=&>Y.]T6\'AS_\
M<7.'5ONM@J3KL'7^^?;T]>EE\'JCPOK+&P8.N?AP__FN4\5Z\<=TB7M=04\)
MU_ S85X$KR4QQ33!HGK[#QIC.:MT2NA;ZD@Z!^+%=,6Y*AB)[#0;#YR\GPN#
MBT^(S&ZW1_Q -S_<S.3N-4,NGOKPJ5&EFS=P[KVT&; PI2.5P9[ 1[J!J:,#
MTNZ[72-P -(N8%_<TT4H;*=*1\X*D1C&4_Q OU=.CO+ 9#-ESW&&&C24KHFI
MYHN5;IRW3;#TW O/);[0]C(OZ]'O5$ZG#;<QSKJ*/B,0?EXRSI!^S\&+%R^\
M]VRMK:7HD"=Z&7U><ZOKS#U7"]OFTHVAF&6$8G++-<5PVR1?9UCYZBP7ZYMF
M9VT=;_=FPB)P<PT[LV62Z=U[!)NE,1PMZ5(_4>SF#1N\FB5P>+!,8GQ9.LWZ
M.%K?5FZ]7KK-Q+>Q/PO"@,T0#49*G9A9%(HR4C$U,G<[VW*)KJ;WW&&0(T7-
M-7P.8R^NX&:K:]M(QQK /(&2.JB9U% LK:@%Y-J!Q)VH&*NTPD"Z=<.52_,Q
M54:-\YDF"8LH:B? :S)RBEK-S F,U"&RD'J9PO]'Y7$'6:-T,C6-6Q&G%XNH
M>-/0.W#7ZX^=YYNH6](@%Q$:<14K;;D4A,,D'4RW/O8-ZL"%/1SSJ]T7Q^ZO
MN"R@4'%M .]:DM&\W\4";2@\&A1MAI#$,HCM$DPVC6W*:U^'A>=1.74DHNFD
MZ_T(.U6D! <;!X3\RB*20,6Y140L>="Z<2MU:."I7B*L[" X5U<#LP][ Q2K
M.WO!_R7_W?'._L'6:-N\?JWO9_E^W9A"4S^)&/S-Z"F^#K*20O9 \Y7_;"G(
M#\=6?S+*XP7\S[2:I?_X?U!+ P04    "  +@IQ6*%&J$E][  !Z\ ( $@
M &5X,3 Q-C S,S$R,#(S+FAT;>Q]^7/;5I;N[^^OP$N_Z1%?P8I6+TE/5\DR
MG6B>([DD.9G^J0L$+D7$(,#&(IG]U[^SW0T+)3FV2,6:FDK+$@G<Y=QSS_*=
M[_SM?[\Y.[[\Q_MQ,*OG6?#^P^MW)\?!=\^^__ZW_>/OOW]S^2;X^?*7=\'!
M]LYN<%E&>976:9%'V???CT^_"[Z;U?7BA^^_O[FYV;[9WR[*J^\OS[_'1QU\
MGQ5%I;:3.OGN[W_#W\!_593\_7_][7\_>Q:\*>)FKO(ZB$L5U2H)FBK-KX+?
M$E5]#)X]DT\=%XMEF5[-ZF!O9V\_^*TH/Z;7$?^]3NM,_5T_YV_?\[__]CV]
MY&^3(EG^_6])>AVDR7]]E^X]?_4BF<3QX>'.X<'TX.5DHI+#>!+OJQ?QR\G+
MZ)^[._LPS._A"_RMJEYFZK^^FZ?YLYG"$?SP<G=[__FB_O$F3>K9#[L[.__Q
M'7WT[W]+YU=!E-7PFGETI?ZYL_W[XNJ[H"KC]F_XF?*\PU>+3S_.H_(*7C$I
MZKJ8_W (C[]699W&4?8LRM*K_(=:?:KES_+FO=V#Q2<S5C/BO_]M6N0U3+R$
M7_*/W=EX;]O=@]?1\_E5,2RC*K_C!^FOQ$56E#_\98?^[T?\R[-I-$^SY0__
M>52F4?:?804R\:Q293KE/U?IOQ4L#SR;_GG#LWT!W\[27.G5W-W?A_4;_\_X
M^,/ER:_CX/CGH].?QL'):7!\=GIY?O8NN!C_.CX_.CT>!^_?'9T^GCEM'57!
M$8AD D(=Y4EPKJJ:)/QH4:99L/<B)&$>?>:,?F^J.ITN^5<IO"6O?T"Y?- Y
M[F[KT3_4.W]<1$D"&N)9IJ;U#WLOMI^_T.N2J+@H(]1*/S2P'B5^%40+5GV2
MI=6,M QNQ/NF7(!&>NB1?_?WK[I8![VO#(*?%:BDV4)%'X/W9;% K:*J,#C)
MX^U@JYZIX*]_>;FWM_/C0X]MU9X=%_-%E"\??KEH+79_' 5Q 1<<C*<*TCI0
M506R P\/ZB+ )9O 40Y2U"CP0Q444_A4%52SJ%2S(J.OP2>G106?H"_ X^HT
M;XJF"M1\D15+$D;XWD>U#.91#I<#_0:VIRKR7&7; >P0?BU7,:Y.<)/6,WA4
M"EN'#Y05PO'NOOBQ"EX749G@ ]^D)7RC@!%LZN;24->XM; ^Q54.WX1-FD5U
M&$2PR15O4U0I7FG8DV6P:$!QQ-DRF*DL@<T M<'3D4T +5*EDS1+ZR4N?13$
MLRB_4B 9M.%ED>&OG>V"QRX#]2FM6!'AZ^G/31[#N8Q HI;TAW\U(%?X'OX(
MB"!^L8Q2&%XT+\ ^<F0F+AH8'4ABDZ%0T@,3M8C*NBE54)1! N\K(Q8C&$^?
MN&G!3E1=IEHVW8'CJ-HR#C)Z"1]AT9O!*L)^IWC;P<-*E>;3HHP5?5/E,,@2
MWNH>!KP6ZQH/%HP+/P5?!8-'#[-2&0@R?&BNYA,\4?Z(C.0[T^%)I"7L: 57
M)'PW:5#;T986#:^UNQI1F9*U.2V+^>?M*)_3HDSPH!?PN:2!.5=-/'/'[8^Q
M5'/8:GPFKBCK ^]4@[R5:@*+?E4JD=) UBB::I4RGDY1-5RKX U8%<$6K?\T
MQ5G#DR]$;>R-0AC-Y'?XI]YC>,"\HH?!E)*4Y4QF]3Z+\E6/>A^A49K"(&'D
M Y_;'Z&49!EHR4"!J9).,L73CA4.%]]3*3!O(Y!Z^% .CT#)4C5HS!+.GO.L
MY][ 1+CAN[B0^O"X8Q*I<)6L*$Z[N'C680G2G-V-/-$Z.BW!A0!K 8:%$ZOB
M,IWX4SL40?"4,IPP6.%*P:'E_8V"8R,UQR(U VMU,-I^S.;?WN:;?Y>PU2A$
M*$#?B,6'2GG\2<4-:8>N+%Z8PT>GZ@9$LP#G&@Y$!G>=TO8R2*HR.N:_&_C3
MWG-T679>T)49B6MC/_-+5(+:V]W'#^T>>!]";5-J_R<B=?,+W&CTO%WX+_X]
M+VZ":0,* ,YC[_?LF_@)OA^UL?:.KZC7:/B@#JJ*WK7EZV<#%^]K']O52R86
M#AT3OM.T[8+GB>41;I :Q)"N_!IL)S(GZ]8M Y>Y>P61J(+QE19HHI1H@MS,
MTGCF7'65?</&;@[JUO5MSE__<OCJQV!1%M=H=(;!K+A!Q1:R98#+S'LBNR!F
M)2XEW0DW*6QG7M1@@<0%;)O5+G2KP\E8B-$4N2:&;#<^9G_G"T[^^?;A778#
M#%2RV'XH51;A:'^LB\4/S_:W>T*&$_!F>*/JV1KNH004_+3(LN(&Y9M,;S14
MT6PB68>U3V,R!TN%'G057,%\<FVF.FO>WFFY)62GTVFOQ57$<0/6MQPOO>VA
M%8#! QV1]ZXB&*.[\6)]TO$4TY/.NW8(.B, :Q9&)L<</H7"EJF*#'HPIP\"
M\.3J604"N"S(&U3\&WP&+Q$)\,#42E KFWKE=8>\7E4!>OPM;,:" W]D/,09
M.']UR^]"+QN%4,LF;NV ^D"] .(#3RUR,(W$?_><D>W@9,I;*(]S17SP6\,2
M&KE.4C0IV!#2 R&[R??/6HY?VW.FA H]H$IAR:,21F3N+#L*&%\4PRXG9#(:
M=PJ&H:X*/%NP,A5JT&E#$0<\Y5O52(]-ZV%W:+@A1][ADJDJ#,# MUS7$8^1
M\1*MNR:N*AR<[G<]C3W"TSI/DYSR1[\4H,!QS2_I[/*9SJ*J)GWE[G"T6&2@
M3<5[)57C/%5, T\\RD!]6J1E5UAD*7IFC#HA8K7347KN-O'$9!&V4.7ERQ$*
M=-5$['5:E]DN?$MX':^88PI:CXB2I'W" 3]JIW1_\YU2L\WXAS5XI4'P!3?X
MQ=X#;_!6-%KS#N]OOWB)D_;V<6V^_O$L55/'XS^;3N&V ?.(__ 6-$ >8_:B
M]8>3_!K</U('K;^<@=$"<P*5T/K#&["PLV+A?^<GT$LE//X85"M8G!SQ1>O)
M#NE7O/[>@TV=)CH+=Z'R%#1FZR^ML//-K @PVERQ;M+6;W\ P+R7P]KT9;AR
M9RFJ.+S^RV)>U!R?IL=%YH$AF7_X74P!A'#-D*%&E^H-1MT3Q;K4]^547D4F
M?/US,X<;Z3A:I#4MQGR>UK4R]B&'R3?68M/#79^1%LJ5&#6@>2)R9, @69@C
MICP+? MW"P-'F[B:1WH*[H6^SI6UOI-QCD%[I_"[!F05#\K@A2!/1"W?XWVV
M03#Z6W)_[-BO1).JR)JZ^Y4[KPA:;%5PJFZ"<UC=?&AM]FY;&WIS:\+N?V>E
M'LPBNE+/)J6*/CZCQ,L/4783+:OO[@\-XG=U,#F?=_U^I=NV7XAN*+UH->&_
M0&)@#!3=]0S:25-KE0L?SOO33IA4RUW9<VQ22G=Q\K'4+DD0E27ZDM9H%5&N
M0#/0US!X;4WCGOQ,3Q)/JYII6H+A/Z1B(I,6X\#%M&7>\QWB#MH=K%PA[21J
MR\IW%A;C3>E4U!X]5B\=C3HJE^)SV*L%_57.7:(S@Y_&_X7% 6&1V=R ETM.
M&OF'O-I*M;.IM''XM$%U6Q=7BAY!:]JKX,!UW4!=[ YPK1&(TZ+&M<,$(YJ2
MJ(3K&?Z@LHKW."+[ N-A:=[>>Q.HD*UG <[@E+#G&(,/2[O*QD]E\^?PH*%=
M):>4/QA<E46S:"6K0:1G,!F,5&AK!_,P6HA"/R1A\YH5IG7"8']GEV3^ /Y7
MY&TLWPW.50UV&;WE)*< +'RWP9!,<!23';C[ZH6?1-K:0.D:GY]<'*U5K#[<
MR51EJ6$ALOF_7YJL3A=9"L?:I.RWTE&PO[U#89=ZV+MH*9 0O@=?W-L^I"^2
M*6T"HU_*"R%A&G1$^D9$0[)S:7LJ/2 7_%_6E8/>2\^WMM+K4; KDX_NY-ML
MDR[OW0MZ2'],SVS3BEWVHM/P PRQ5'?1!Z&YH?PKIEDD.B(X/%Y8"3]-X@7J
MNK<4^&Y%:4*3[8#QEXQ /7R 8K+^ ,7> 4[ZT@\ CHVQM99@Q5UOP-85Y5^#
M0U%4.A-PH9" SZ)KY>9?5^*!IG#)D15I+23Z9"MI:QY7D:D[(VQ=A?]C5*\.
MU</-F,YA*"E\&HTY FWU92/MV_BFR\WERO S!!:E\)ARV=8Z6]$F&EL79KQK
MQ#G MN!^3J>J]+=^B[)J'.M)2;=RM(=='!0BBZ+T/!M%TJHS 29%XCP:5>!/
M18$H_PAC3R!4?;%\XP2Y JE0.YL,##LK;<C "/\MN908[GMXG8-')=\C_E<#
M%E7[&O1SI^Q"W<S8E&_[(HCA="<Q--F!2PAMQ,AD6_NF'S7UK."T&R,S0\JS
M(]::0)>(U<0KB"^^OL7BHW0%WB.J#4F<2#A/W+R^_/$7>_]$8=YK]0"VW%AB
MH$,EK2R<0=2:(X,OQU B8<^++$T8.1)5B/E&X00968" "#P!I1OOX173%5U2
M?E&0X</?IO'Z;U,.][_F* ,:G.#UK.4*/4(5T 7/VBMH$2U)4;7LKX'TXP3O
M&9P,:A#0EDW,1QF=@*C_5?H%""Q768I_-RE2U6,"6H-Z028FJ**K,IJ'I+-L
M\&2*_^[<S6)82H&%=U38[)9Q\@OL:&&0H7?7HO#.<SKYDHRGCSB!)@DG65SQ
M'<8 UTRI2.W2JF71#:[#//K8MQZ/.JEZL/E)U8X/\8W ?4\=9( YU;X:L-@
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MK5($]*:ZJ:K6<4W2ZL'6<H15'?:+^BM!E-6JU,QA-!00=FFG344H%5T-7KD
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M4-?U:_M5$CP!_'706%M^L5);3UDWB%P)4$5-F5M8V[3)LF?<J-,!P/DQ3,G
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MFY(3,#ZQ^YA;+HMF7=U!PE,-ZP*LC@J?<$M?1)=-UZ?.-6@*!/7/HSQ7I:X
M,+]V2V'=(1CF#]?LTZ]-:Z;@DYYAO*0I-> CN*8B[B%074'P5MI"=F<H72(9
MRHES7)BDN?5:O!H($UZG5=0\DZTA."6BA*UTFGUC'@2#PI;KNZ\ 4,@-.1_5
MM>WOT,P.GZ+Y SU#4_JA=^*%M!-B^5%5A_-KSN4/TD"9?3()--/MK8_IT'KD
M V-OL_BNY((/I<B"Q6?:HBE,YU)YV=-<TL06"AUEZ=M+C1RS>97V[@Y#$S]P
M!TI[CHQ[8$ZMX>5U\J'(B@A6?U/9&[E%DFAD!0/(TTX.E^2WW=L4/>$5QQ\]
M0ER<*DI7M(QYRF-N7![S*2[%<:E3A 7J:\YXN#I60^5;6)E$"D?"WZ*^>]T)
M)T5+SKKN]4K_@+LHK2E@DU"0EG%9B&@-K=;T4/;NXRB]IR,'5Q%5SWJ1AR!3
M5U2.5.#Q-?$">6OH!"6,QO(SQ-=L:)C6IR P*J<R,S0*"$"F0N[SA3\L)*P&
MIKXP$I): "'C$(^_J!0 TB$P!NCSPK(2G5&"K)IQ%HZIOAPVVU#0;%=<]^5:
M,&'+=J! T,K^P!82POJ;4[%8+$\5 29;XJX^O+\IZV>4A0*]V5K_&X3[\=PY
M=$)%S)R?I:](;]0Z^@2[=*W1+*1V-:A46E [:\:"(W>D3=3 QK;O=A/@ SL'
M4Y1DSK$XE JO$<3YH;*M0HF:@], VYJ XDFKFG@FJ]!J?O@9C@[^3X)_QBI\
MI2@9 -XQ_40(0:K^4]B4MMVJ)<"P7L!UJDYPB.]\4$ :\;[4M8HS/"=\IULS
M (TR*QB6_P@^GY%0V(H:)IT,=?MF&XHSER??B6V\_0J>+X72<#>DHM?A^S%Z
MN[L[ZW9W][9W=V]IF,3J]STJC@1.RY.CNU&.[CV:_+XW&HFC^+2S:^O&Z2$5
M.M?B1#%)E<4)$!J"<R$;F+>FM82!KR]W+3@:@DHX@7X!V42FK).-(R9.](HG
M.XD?SXYP+@W:+#WA#F.G& ,G4H@=R0NY:M;T[Z%LG,!'3 O0#EQ#WL%V&C]'
M@T*H^@-'#!?%<Z_-(+U6GHCD#$-/Q:;NACY9C,R^I^^^E,=[#4URQ[]FCBSR
M:>.(/$$[7K1B2BJ)%,81,4*<V?"%1ZMO;5,LZZ6W>5N4J"HM^Z:RDO)_=R>T
MX6&S!=:791GQ.?XUP:#_/>*O5FAP*3=$PP]XW&KZZ_I&]VA>BFTA;2'N-'BC
M8LJ-."#\A],NEYX6L6ER0IE$1@!]K)(^.9';;I=Y.;BTVT5?O?(.K\ULFR/$
MRL179P8O*% &W3S&1\G8."Z'+2N=IT^9WT0[;=[K0J,I<].?TT""_(BAD"E9
MFF.K%-TP9 ]* .Q_C/?*Y 7ZQT =1-5<V[(W 2/J=PMCA\MYJQ?0! L5,2FM
M?,^E-R&9Z%#SY8%U9?A!S\H:!GM\"K:D-HK2;B"[FA7[FL:1U!Z8I_1L#8(G
MA3CHJ:\&"8(%FP<CNW=3QJ?F$O>A_;#A_[8"$-8(U6)F$,Y,.%5XM>K&?_(0
M5AKF$Q%&D#E*BMAY7?KVU&/@Z^^F.6,S,IP8V4[@(X)"%;FI#!*\8\$0:PFK
MA6U%>)M8L""X%AM;1"X((-*IJ#C*T#2J#<R%[.^JQNQ#RR#Z8\?_Q7IC!?WB
M<O3@$(Z6L#S?/GS!TF)Z6<=RP6]5(\,7#ZN#-X9<0'*E"EX.980R/7^04W4C
M-^CUIFR0LSEBNV\Q?P1<_W W&K"=1V5-05$B'9:V?G@F92_1BZ)RP3_AKAVO
M?]=V=G'.D2!N%]I.I "NH+9A$TQ6FM0M<:/3)W.%)BQV8](GT)A#DH$G=]Z>
M14XXH@4&6VZLTIN9)">&WH/U)OI53XW2-CKON/FG[LW&G+K.0; &::FN4Q"=
MA8Y\&\>&O!S-UVG+0G1HS'RAZ@>J[^YLQ:,_3DZXD1L[7O_&\B48<5A-UQCT
M&Z4ZY3IA9Q;<W.LT$YXXR6^.ST\NCLS6'>[L806$ W+!RIIKL$+;D3JLL2/Y
M>=Q1L:_+<W:/Y,4Y'T8*%[\!LP2< ,Y?K /8?,;=RA5FMUO19Z<T0[LT+HI+
MW"LN'6X[O@G-:\"SLL$VTT>Z(]!)@_B_IIX5)<PG:66A.44PQ>2P6WG5R1!H
MVDC.$91FX0>L>QV?^:.C>PK9?%4GGVDN%X7=7[S.IB4'\KE?6\AP%"=J&Q$T
M(4#P.3=#6J248& 00%+$C2!V2DR+)94EF?:,1RPONW:21#8)I1-,3VTDO_;N
M([ &SKI-!,+1U[ @WC&SG<8X$=SA4^_%K[LSYD0&,R4-2GJ"YG0QH,U)I8B6
M@C8DO4X,E(_;V/BZG'?W2,'IE!M:<6QX;$SR3;(E*=&CVE%:7X5XG$/IA.8F
MVGP[Q;_\)4=>]5_<GV\8_&D3=\^_0.+N^1T2=^WW/++$W4DNG\)WNC(;MAXK
M9;O(Y)+F"#201D><;YZ+D7%G>X.ONKJ+E.@0]VK1,>ULKI 0S>EE(QS>]MD8
M#;7/1X"RY,,ML%_OWJI\ICF]&G.BI?<S4QY\Y.%E]#SABWNRJ;_JW=U*@U1.
M$H0W]\FJ?:CU]S,=5%1LLAV4VW!2'DZ:P]VL+Y7G>#)Z;]TX-SK7P1)@JL&E
M=S3%"+=ZKWV.ZY?Q6[?\ZBTGZLL!0N9(YZ9Y@TGP :_WZ[>H^::;1G<2:^[>
M_.?=HL"M^"\\A+>]-Q#<>^M_G8#PPU<L[&Y^Q<)1.4GKTNE=_2:M%DCJ<ZXH
MH4CFY[B.GWB4[^N@;TS-?KO4S) EM_B+^WF3PW;Q4=AJ+]L;8(&K@''QIF1/
MZ@Q+::J,IW_9;IC#(7SX0"XJQ(3>N0S-.!*H@%*9C15@SM8GOS?LVR7]=5$N
MUGO7^#+<O0-&*PNC/LTB] V,VU/=(57Y5%Z\L6G^C5,/&U->?.E3-! ]!QJ$
M"VXUWV[,8/5"A[T!RQ<GI$8JAQZ]-!<)/AE$+L%23J:#Z#O$F+7$0(94,KL*
M@SK"W4ME=*@W4#FQ3A)>L(YV(Z^TAZ>O]YM.TRZ7:(Q@>Y5IS1G:OIRATYN#
MOD19A8@[CO'RIDZS.@J?Q#..5]A:8":SA76][F\I;542]S=J?=&2CDS4'9\3
M:KHV(NSDZF-DRR3:*A022WBO^YJ1-T+/MD6P0[N*,N?(P$!!*VTI?,1A."R+
MYFHFUUA3PE*FE8DQ"2^(A!G88?&'FJ4?E1XO1N#(G9).HDR4XB"O;0AY2A:L
MC!<S0EQ.CHU:%=4C+ZCZO/?*LY<818;MI)VR7W"=HLP[(.3-U?Y)[4BHP8GK
MUHZZ2AQ)@HD@6IJS4A\#W>#%3D/Z)=)"ZJL0%@>[G/[>P+&#:Y5B<H_:+-N8
M9G1C9G>)>BO!21.DCLU!& I07TV-'5R=/H+2K K%@(O>_9-D9$H &!';:\ZN
M;SGU;9M4)7IDAKC&.M&*#%D\K)AW^&^T+#%6[7A-L'3[+W\,?J'.TOCO"U5>
MIT1R?)+'VR$"<*BE\C&..$H*NF$H,VG9LC9P^?_[Z)>+=9)+<W-!' 6SMP=9
MD5^A5C;H0>H$@\)K)46:H=E?.+0GWD[2U^8PQA@TN;N;1[ A<>K66U@:QCQI
MXD&W0K5PXJU^OG)[6II<8<?5/9CETGCL3N]&=6+KB$&*]^ "_%3'BB6%V6UR
M)HWFL:5"DZE*:,=,W++S/4-,=\W[O:4O:.(,GCH\PJDK&R.MP V1APVUL_D0
ME042R!1>P]VI2HB)&AXNS":N\03F%)E%M9.^[K5%#)C.-THD66WIVR3ON**1
M(1J(==^2$_+7#1?(PYVD(?R!>)@[-571A.K#*15J>P@+KL/LI<\HK5G"&%R,
MFTB+3IL8MG>QW4-^5MRH:]-#OG<^W'\*PZ0PZ.LBH*B*F%,RM3Y.Z&XTVZ62
MZSHP/7QP.D,,!C<:9LZ2^GGBSI#):0$%*FC"F@@"N<,(/F%>)%@;BJ,$<9HV
M6>L,\.)Q<Q&]<N(E&0(#:\NX%HP-LVRI47MP&G7!#I,(="CG *F!BAA3\F2+
MBJ.$8W&FY%..@\A'B3]'XWU@(;Z$-=LI;5^,0G/(THSXO0VI$?T;!V+S'8[(
MK6[('3HBP&!6)K-TJ[R,\,*V7A=I@L=<DM_]&TJVNSM;E(*$(G$<+8+/S L2
M<V2*-+%W:NNBW EX/DC+)1"]61$INLFZ&T\(CV56&&@)6#.*N#G]MN.V(K*3
M3F17))54XN/V+-3Z[[[^@"\NM,,M9NR4"&_$WYO<=-5*U90[O),,*VI;45-G
M]XKODQZ:],+ HS3I9J1/[90N/V'8<BXHX55C^2@Q^4SCU-56RUM&2. ]1JMP
M3('>IA%?<^0]M9R6#<@C4]S#J<7+$!U\=*^IR95$/B9M.W+(Q#.KB$>*G'0G
MNB5E:%K3Z-B$.W/TQS59"#<98B.PU'/CD\$<9-8MA V(KJ,TXV0M]R&P :'6
MT)&\LPKP2'#_!.Q4<']MP@<32\J#))I'THS*:/?)4FP/9">2>$+9LT&ML=D[
M;T6L0Z(4XM*:7F'P"1/.(*7L]!L0<2,^6*+<_?/$*Z;KUBJZ^LN-$_/N(1TA
M1W@-DF"JQ%9&Z%M>V>X[CA!$C-Q#6(/*"Q"6Q8Q0*8NBK-'X2G4G".+_L0%&
MYZT47+W)A3_0O%0:1NA7\]U3D;'(?$*]M$W. 7U*X#S6!,[#)_?W'D%RWY)G
MM@S6)U["34KFWZ.T[R?N0;46)L+N#3!ARX':G7M,K<&6T%J1Y:6BG"YVFU#:
MW]I]CMVG##IHY'=/1G(^HFZMV/UOR!1H,?"WB?LZY$?V(8S47CZKBV<($>>1
M<NF^/+OO9FB]Q6OK#*H7U**T=?)?R]CBRGF]6:T\0F+U:9HT<1J5J?(I)?R&
M>B9/!V8.K='C/D(;PQGWOKA1)5L';WCO.^1\:SQ='L9?+%TG.M#U2U#2*&'K
M)! 9XYE8QT6WKHL&;P0WVLUI;K2U>*DL;894&V!GV(I?K8D4G1!(:&(@6!<1
M49";HB%.C(&>S Z?%\0HQ,^2<,43)O^KPCTO"Z>;,#AO5ZD$NJ9BIP_"/Y[
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M#PAENZCLQIC?[D><\GP?PWS;(7C*[#]E]AU]<[#Y^N:T: 3,^;XL<OS'MV,
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MYCNZ5MY8ER3*2B]5S#BB QT3( 1. 2B*I8'2863NXSER<N,LD)FH*7P!U_=
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MXGH(T82WH+I/V*G!#<JFY"UU_5.E1Y'C@* )WR,N&UFV?$KC#CP4[Y)@F<_
MH&"]QSG$\+UBUGSCIKT8T:&MW":"T1Y$>$O!N=*7DS0AR-E"V0[P^P[P!(RE
MD]!TZI":OG99P>LGC&PK*B!]R+DE0+*.<7@V2(/$^/J6U;T*FQVJ6YL2J$I"
MB=,?;B71NB:</PPR&+1FOU;W&NRT5@T5RZ=>EK#/?-LU*IM-80<3VQB+F4[Q
MPYF[F$D>V67'1<I(NLJ/\UD1<PIYN?*P'RE0!EU,6,FI]#F"-YMYUJ:.BAI@
M1SI1\>G9Y51UGZZATR\- ."L#RV6^T[]U5[[ 0V;_866"Q;^T^^QZDKF^W?M
M?*QDI*S,R=K0W+P>@?8$JDAHAX:=[DW7FH_?1U8]P6K<%RE4AT@;M^PR&F)N
MRRYE*5F\-)\>O6X?/SF;/O/I?#XM\U)6QZQ(UGD)UXA@Z"(Q&?[4PRTTTS3X
MC:BZ*/+7?&%E<.SO;\GMK0.WLJ2*46CBQ,:V<S"DE\-66YX?7K5W#Y^>(9XY
M8CY'6/E.S_?7\O>7M7TKNL6J"U(MYM6"HL&<F6(>4DIN@BH:;"W5I6&R-OY5
MU.!W$*H5.66EVN[(JKNAS$2NM7W>D+" WVPZ68_J%K!:0MP/SCGYC)1^8])D
MB*ISIJ4&FM]LTW5M4K2M0UB)Z=IUHG@N@)W;=;;G]+X19MY>[<&'>JX9^KA=
M=K'!#G7/.0D/XP5I8M15D-5G'<]-^WU"^N048TS-NM,-SGR1P^/V/MXOQ^T#
MFT0T4EUSF9E]8?C':-U3=5:_TKQE3'^E\$:A_+N!<[MYKLH!HOM<US/0?FEH
M>P^HN8?1".2?H*3*'/-RK&#+S\:>Q&7K2SX_;X61%P#S=V4$K\G8(:V&OC0M
M&T&BVF"TVF_8I''+>Q:D0ZCZ& 8ESG4Y1JA?M]$:Q][NJE6.W?;QP3T%M>+;
M3U,PVQU68:(]" [4+E*E_ZL:&Z?%",,:<&BD]!YD*?64I8:=0+E:M7?;9S=B
M,.C?K[*T+T-,;CLYV-GGG%:*:W(.]<SSX/[N[M[.X8&J[\'9(BP\R22]O&;.
M+0V%'J$!4 H4L:D#_U'IZ.,D1+AM<55>-T]RK"=I-WJHCGGJW@;FUJG +O0D
M[^T81),,.<R4%XRC4TH8.CRX>,\3;7_I;M;6QRTK!FYGLC@]:,PF>GJ(5)?
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M,P,3YJB!Y:H#\SM]JJQ:_$;^2*F&$-@DR2/=O%9U^ZF$)LQW5 (!MD")XN5
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M!.F6 C!'24LM)N"D26#>?]3?>:PKOO,J'NQFY[4&_ZOH&AIH_A[-@_S>"!.
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M$%@F8T'>*:VR5X<9A&5&QL43MS\@MS?N[HUA\&F6AB7?O%K1*HCD*MW%TDB
MNW!D],TA336HC5TW^J*:+P,#X(M(HI.F/N/:H$]$>J]$NA8F@J:U!N-H)4^1
MT%P[IYTPFE3PK#5A[J]_S<[3FZ:<IOA:R^1&YI[^EJ+:W>HK8IBG<5DTO[(@
MV8__O<[TR%/@KIUA)L77'3&&&_JUB&_%+'^VD@3#M7"/[JV_>_3/[(%S.!:Y
M1=?[7/U"!4S07W_IO=Q]T_SWTO4^L1.SQ0?K"0M2+##WF<<FU/<4S?-'\[QY
MD);38UWWS>]U6.%&^OPGMMH_9?_)4 *;HN\>[:[_$DDILEG0ZV#B^C])'Y.L
MKL&G;^5(DEJWKS_?A,-@6V6%^6W!H"8D=/#1D0NCKTEZ&\L055OT,U&,L<K0
M\7L T6^C1$Z4YR6'7>I#ZYBI??AV(';9R"JZME#\P8/PSF DIF(4%3.*V 0?
MF3+@,XH>\<MM\]2>$?DLD:CT][K!9PSB4[+1U+R;1%&G\6T*/8&M4,+% J\8
MP6^<"8P4GY:PX#+#L!7L*4_ F38&<3L<Y 49KB//@OX^"]#&Q@"6*-)LQKY0
M8)&T3$*?^]-<!-W@F,\ID_\N02GUQJ6]ZPCD-SDJ"SG'$0H3%\&_THBR0>"7
M$7H@98835G,MR9EX)3E@7:05R7G(*W?SOO3[)F+F20<BJJ*7(MG$Y""M8H*3
M-(1+?-NF2#S]$;!D2&1&,JAV@;9NX4#Y-SGI+V(+\S@$0D$U'D_$#(!AQ'$C
M/-K&)FH[6N),;B"3JG; CKA)V5V5WL)$.Y0QE45$3_!;',$D!;O&!3&0XR[O
M!.C'C<9 FNJ9)/0GI\"T,QG*R=3D0,*'-_!&_+7RB%'TU*-XX#;8PL073D59
MDLR"K(PQ<R%,IX6TXAMJMRGL2H:S>@X("E[*B4M-LMAHFWIKV*KU':,D,\>C
M92DG=MDRR2?!C<^-Z[Z<U,D0?L;8%'W'#DEL1=OXOE&992;D@60--U:F7\\"
MPDA2O_[IERF\*GQ_*.,(@SUJ3$R]1:H0P5F:[%S(L<PR=!2F90;<<8(YAIIZ
M,1";%RC12<ZJ12 GU;V30$/\PG72!+3W]H]5* "X&5MB'14DYXA7J*22PR^*
MMMNY24Y!]J+/KQ*EP(+(DIB*5<G(PDE,@2N]R$JI1&J&^>)T-<%'2B7.Z\F8
M!6=C=A77G#*ARQMD3&^F-&93P^1NHK3,XYEF,8QF--_MLI3+A1WM2KV)<GTK
M$)_K<.D>B"RU+LS)P:C*S*M$5L\,616),M9PM$"P10'>'6&HJF)K$^3$O42]
MW]SB34FX(3>!WWNQO_Y^'>7X_CD2WARGBT7_^T[RP!'SBS?"4,:@G@ S W](
MD24JN51%YJMT:K[$C:2P I$>]76=Q/8:Q2*#H<!\010/UY+,K7K&#,I'_!)M
M[ CD"VI (#!WL/I@&$<Y#F8;I5>IB/-E\SZT_*OH8*ZW_Z^3AEFO^]9FXDV+
M"40)E)%6Y)1.,'?..N@! YK,&;9E]+14[129($L=0]T/P%ON6!I/],[T?D<Z
M=(]$W9'+$J>A-SO1JK*%U]7-5LWPK;WZ5?O:6J95V^4D#6*0!\@PH I]%!E8
MO[T7=D8UJG])V)[M1-X0SA(3L",X%!K)I!:FF(@5VJS["K0XF.#RN7PV::"<
MJBNL5DJ8;[4XN99OP(*O)&>J)466QD&?M%Q?ZA[.FG/&:ZG9L)3%;A6EBBI7
MFQ*V]FO0""5_4J7_-LW<:GOQI!K9=-8.3,17J1P9#C_"7(_A32US);5676S
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M@G$L-=U8M%3U</+#8]1UNSSE38N4]YYR[KW! ;6!%'Q0JCM*QF@<X?,*N]U
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MU>#,LL=F?C6S0SR':V!>J10"E"M6%W5C<BM'%*B2E/[($2V)NMD5)F-0#,'
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M6@^>[O5[NP>L%+\U6O^3L%T_8;M8R'KE["8OV0C:.UP?3\ZW[W*^.4MXE'#
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MEX^)-%(0)".9"#/LNHJ(S0RPREU%&%#H%L-]=I22(D78;C#88I^8F?-81%E
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M>6%^L&4N<_M8MLWCSY[&61X/CS3R8Y6YPX62-2>9*HZ<CU]WWX>YUC1PL0(
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MAVNU1PT/R]FQ'+:,5GR\<^#L&[T P].J?H-B.X12#T<O16$7N55<A4,94O:
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M*]#QVS4P))]J4L(@LZ1L5%2:?/DF8# 6,YU]A#-WH7(\LLL.-I3A:Y7!Y=-
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M.]&X.46JLB=!7\3$'A[I4,\?M.!QJ,QE[$,F,L:O1+\5+N7?,DO;&M^Q5I=
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M3-A/3WV'@R[,*D+[]Y)8IFTS%"46 7>3,4<7?S@!8F&Z(01BW0J^BHQ-24-
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M'<7]]3M25I+"5E^ %</J#S+IAW=\[O3<^6:O+FX6J[]N+U%I*H%N__Q]>;5
MGH_Q7;+ ^&)U@=ZMWB_1. @CM%*DUMQP61.!\>6UA[S2F";#N&W;H$T"J39X
M]0%;5V,LI-0LH(9Z\YG]!9Z,T/DOLU>^CRYDL:U8;5"A&#&,HJWF]0;=4:;O
MD>_O3RUDLU-\4QH4AW&"[J2ZYP^DPPTW@LU[/S/<[6?873++)=W-9Y0_($[/
M/3Z-TS1:A^N41'1,TCA/BAAVTTEZ$DY.QM._TQA88CC?&6FS$^S<JWCME\P2
MR"9Q8\Y:3DV916'XVG/GYK.UK W<IL"X6W8^#CP9]FA\(OBFSEQ 7F?:PX44
M4F6_ANYS9A%_32HN=MF;%:^81M>L11]D1>HW(PTOP==,\75W4/-/+(LL/;=M
M]WS!C^ UZ_EWI"\?2YYS2&<<1)\S/LZU@-0R]1^177)MD%RC*ZVW3&F[?+LE
MH$'#0# ?6;%5($:F#P(9?"U/V(\+97PTE-\<^_=$%25*HI&3\PB9DJ&U%$*V
M5OMZFVM..5$[U!+M0.XBMZ9VEP3@_#4$7G.IT+4TP(]NF766CFR%?@%-@C@=
M0$]&* J2(70"9(,H3H^CI]9S.G3OU*)#K)+0>CZ='/=LDY0.<DYB1&J*3H+)
MP($QF#,"R8;4M26'A4WIYED]^0Z]8T28LF'D'MTJV3!EM31"5W41?*>B#,D%
MZR652T69\D%9@C2:9?WBC'+="+++>.WTX8S.*J(VT&1R:8RLLA3$]&")%$3L
M*] 58P<_MQ^75*A* W0,[6_>PX&#L*&'V/@TF(;#<!A$@]B_Y!8[RAUMR(QN
M2'WN)5YOT!!*H1:RN'E$40-]"KZ38#*!O+SH2H*M#_,DFQ_>IH[7]C6IF-79
MQZ?Z?9+(/AL_2:!_0+_5E!=V + !WZ@-J?DG8O>?A?R5E[RO$ @$I &21UH*
M3E$?P/\Q-2]ZR<WM""V7BV_0P$^8!_B'VPEHS8=RP*[??6-+[6F_G+T:V8V>
MF6(")/? #J:QY[RZ9AH^FY <4KLUAR9?&>#VSVZ8=&/M_!]02P,$%     @
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MF;,$W[3@DD4\P$^:J4189I6OMU8AA0",X7I*51)^#PX <YL&OX7H#'8IG3S
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MW:&C@^30G@=2H,J8S#GRJ.(_C5>2&?;"^";.2+Z@U2$(>\V6F[:T=B#K>@-
M0C\M0D2A]X-YCS%OFWHL1_8L79B(<2YA)NBPO'2^)6!*F*%C(:DR-*B;8<(Y
MX#2$0#C*J0*=KUST2EE.\M@\1X6)3?N, XW4BCL6F>!EUU3WN.Q]=R^P)9$+
M3 >U*/J.F=H<A6IT+B2&^@9BY:10M%_]&21,%9QL^BRW*]I)@U+77&@MED;=
MX-I$[9CP<F?LEKCA,N/L];SN4=,DG1HS39U4"Y?YJ&?S45\GNV.MGA>&O0>'
M R]\<.P?U7:]=O?AJ=MJ?0O9P<:-44B0E[5FK9I0D"3!@-F/BAL(BS*K=/O
M:;J[-Z+XSQGR&$&"+Q"DM/K[,NCYN^K1PVQ-.\609A,=."DDXQ!UW:OSWWFO
M#%C/QLK]O59GH.P5+D?GLQF\\^ 55A6_;E40WY-;GWP$RWALHC4:!$IPED"%
M[QOR\&6,+P'K5<GR*RK_WUY]7HZS&OM,XU+Q$ZR<8M[$3))CDZA1QFB*63-F
MT)I=4SAWY>$/_WZS_CV8XA&-68'Y\HY;#W?]ZMM4\)'RXOFFP\^DGW,"57M%
M,DRI<>]M'<*P\L7"5-,< 6$J8#O-90G\Y8Y.AJ7JG*)\(<4U,X6W%G>*<W-H
MUPRKI;FII\KZ"C7=ETE7,F<JNU6P522;\<^%,DY:,J5,585%-\.""J&F*:P*
M?&*P4J4]N%S%6=73B5UY9U'D0ALD"47;[%)S4P-6S2('3=*42IK'9@0E;(N!
M<=.;L(VI^^AN*_?F=N5>![$C^EBU7P=Z$]-"5WN 9#$>,.VG.QMFRDUKF&E:
M;,%7N!]W+-BM)Q]LO&^1]%[OOA#NXT5?4D[,\=SIYM^F#[8R"VZGD#GF$"O]
M\)2'NLP/?AHHK^Y#A?UD<OPW4$L#!!0    (  N"G%8ZF&))BP4  'L9   1
M    97@S,C(P,S,Q,C R,RYH=&WM66U/&SD0_GZ_8AIT%*1DWQ((>2D2#4&-
MU$(.4O7NT\GQ>ED+9[VU'4+NU]_8WBTO*0+I*I7VF@_1[GH\?L;S['AF=OCJ
M^&PT^VLZAMPL!$P_OGT_&4&C%8:?VJ,P/)X=P[O9A_?0":(89HH4FALN"R+"
M<'S:@$9N3-D/P]5J%:S:@527X>P\M*HZH9!2LR U:>-P:)_@/R/IX6_#5ZT6
M'$NZ7+#" %6,&);"4O/B$CZE3%]!JU5)C62Y5OPR-Y!$21L^277%KXD?-]P(
M=ECK&8;^?ABZ189SF:X/ARF_!IZ^:?!YDNY1=I#.::_=H=UV+]O?HU$WWJ?)
M?KO=2_Z.$62(XGZ.-FO!WC06O&CES*[?[R1!=Z\T@Q5/3=Z/H^CWAA,]'&:R
M,+B>POG^TJO94&;8C6D1P2^+OC-IX![P(D7T_6Y2FH;75<M3*:3J;T7N-[ C
MK8PLN%CW7\_X@FDX92LXEPM2O&YJ]$M+,\4S+ZCY/PQ!(EYWN_(V=%&/X 6K
M;8H3:\7XSW>3MY/9]E:\'PW:29#<M^-%6=#YJ@4>^G-@4T3*U'?:Z-'X?#8Y
MF8R.9I.S4S@[@>GYY'0TF1Z]AY/)Z1%>XM79"4J,SY]OS(_DA IE?/#=4$Z7
M2B\)KFLDQ ?P,;@(1@%8[-V!MR!N[T5-(/I+8)JOX8)1&_2\0"_:!YF!R1E<
M$#4G!=.MLQO!UG!$C1U)HBAINO$EVJLT^@K5R"SCE"DK\(X18?*2D2N8*EDR
M93C33:]]4M  EX</1*T%*5*@4I52$;L^[%BEVUL'21(-1G)1DF+M[N+!;A-R
MIAABI59=9A5:&W.NX:J0*\'22V9!$;.]M7?P/#_U]EW,>_F$2KK?#>4.W_5
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M;X@'1>]@#:KBH'=3ROGX!,25:GSMA;BG!Z*R^( O_P 7S]XNJO=7F[*1RP5
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M]8W=162)$+CW$(0.( 10X2F%!";E58B&.;UDB?L'PFP8P7N7[4"EG!$^%\A
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MW>BX?Y)Y_AU9)Y-=:<?9]C<2T0V%T?$.:AS;\R]QKCF$K01!T.1VA! %$5*
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MT$ '@8 P.DAFJ5=(1WZJDZ@V."LKN+$HI:TSZI^WO%9&_7Q0/Q'ID-I(JC'
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MXZ  @^F(K+4TE0C5P#MD&69"19:)8N#5E Y)$[^HG>I>[7NR]>O:G9.PG^9
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M;2X=#-JLK8LZ(J(NR,S;1CG[90D)8W[9+YDP7IPPQC62AL(H92#@1AI !:5
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M*K(5$$3@86D+NZ<^Q>4Z7]]YW??%'XM4+7MW;[2K=O+/M\-X7>/M]N7AY]2
M\L/Y[ML#&J\_/CC^0!K'[MOA\39K7+YI_=Q5VV:'QP>7!Y\/SN-KY/#XX\GA
M5H,UM[Z>-X[?'!_NNY/&YP8\W-J9V%5K[+=/FL?-H\/C^)WQNN;;PV^-RV]P
M=VO[HO&YV6[B@_.#RX_Q6=KA>D=M#\:Q^'31O-S^@JUT5F .O/:I0(I@0*+
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MTC4$8!0B( BO'3/"8:K6U@6J\RE]O!<']PNGP*IWPXMRY6I%;]_K="NMTZ)
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M,1%":$H)-SI(C(R#.M@0L+J;'.]H39!9LG(L228:<-'H%W!# 7(DLB0IY&/
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MM?=$0LUPY&5"#7<&><@9=T&Q0*S#F:J7AZHGM[0AI<AA%$"07$>NQ@$H1 V
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M2D7B4@)^8-C)$"SR&=Z+!N\LL1;!2H\AX1("CYF$*T+"$[L+TCCFJ81 &&P
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MJX7#C%@%8( *4!VI4J62Y<JP8#B'T*J02H<A#.M"3)+D4TN'97ZL%$]D?GP
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MQV0-$USB)-G&)G[*YBOW-DYCKU&=!9M$^RL=*('TDNY0I%2D5*3TL*1TDW1
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MTOJM7D$@;WC=MV+'QS_@Y=9OC9,8,G#F1A<M>+&^+C\'O MO#T&EZH!1/\H
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M>A-%G2-(W''!**<HRP1QG0*RGA#D$HW1**V$ET"0;E\Z_LX5]0$PH ?J4EQ
M?<)4:=FI;.J'TA-H^5BJ@L*)8RJ]Q)Q$KV$7M41Y%ZV03M"ED)YI2S2UOL6
MOL=>MV#L#3!V[]D\&=+&4 _['A+< <;2 $8H!G,T8$E]KL!OK,_%\#0E](\5
M:M'QR+OW+%^)B:<A6!)#%)X' 3HL?31"F2!A^XVT$*)?KJSSA,B()(7"2 K'
M$.?:(Q>]0AZ[Y%T*4N>&"!3+E5?4!T"(UM E=-@=7#SA,),0_@A;^RP](/$
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M'*SK?CU;Q\/9&M1SV;ER+NL:.Y.BW0=_36J^3@J09^M]6#0F'ZZ"B<DUKX\
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MCDP0$[A;7.ZW$E*VLGK^P(SK>H4OBCV?8D_MC#IA$^$464$(XE()9)2!W[0
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MXY>C90O + )@SE[_V/<V)2?!?S;,*P 8)Y$F'N?*%$8ZXP!_T@( YH[S?7.
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M ^KA*FB.79FV- YZ&0;_IQ4HU<IKSK2(N:*Y!:1CR8E DM44RWVU\7ROHF(
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MJ8"'0()UN=HXZ'S*85P..>\QPLY*87.FGR@+#!08N#<8N$.$0(&!V\+ 5'"
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M&X:,% D%3Q63VN)DQ,9S2C8-P07:"K05:"L1W:N':E.$#0<L(Z?(QYSRA?N
M;/0*,>>QE3JG?R*K>'B\P%J!M16$M;E#KPM^S85?NY.LS AE(\N Q7E$G-J
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M'%)(VB%KL$ \6(HTUPIYQ:/R6E.-%Q=W4("@ $'93E\%')BQG>X5\8)'BYS
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MDBH@-?XX=ZBZ(D0'# DTMN5CH\HQ!B:WWSCNP["U.M5XV#ST_=RJ2K8S:>A
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MH6[Z/ Q5RF!*D(@YXL!JA;16#"GJ#=%&VB#!A,L5X>CEJ,L3O[((P!._L@C
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MUTV-E]F$=P;_^LVN;5_Z5>-GJ,*5*GSO"CM[":2YN_>ZH;9JV!VN-EU:X%A
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M:EE?Y96/#29>1NC7:[K'4DX]8J2*\B<D_/?NM?92<[9H8OL:S]A=WYML]LZ
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MV7&&JW8MG,<,8+TF,"[;A:7,*)2EJWGC81GP5GBXS2-Z_78$7S6>6A1P.HY
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M?B(='FU@G_UQ#.>MN)=^!Y.K'_]J?H]A6K?W\WN\946N?SR4CN,@4T1<&XR
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M<%O-<2O5K/?=\R*H(F9ZE.,@\I5C[IKKC[H9<UQL^^-<R+IVUCKO%?9:]E#
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MS4('@QAC%QD.L*4)'K"P(F#FF>7$:@L49D[WDFHM'[^6GAJ7;"ZW+P$+N!5
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M1#E7K -2 [B6\S\=TD0Y9)CA3L3 O0>B& $2SF Z8=;B D?-*T4%LA"G3DY
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M=ECATMA(8!XXYCR*I(T(*:?S8HT#UO;>:>6+=%BY Q#6N_/*\R'"C_H[_*-
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M ((\J=K'E&ZH\%>#A945''\7A]_^)$<O#PA8J^2#L[FN?V"(:><1CSP@K5U
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MDG$UNU/[N7BP6B%O1RD34Z],;V6NG5M#/=5FE0WK^>XX5&5HPMH]KJX/EP4
MJAH&PTE5A?@(RQE,2H:LWH*R.$ #N:;$H!Q+K$L,E1S/8?2P%M6AETFV,TP9
MKLV5)NQ%M5OY$?EX,)!$BIU171JDU5DZP&@+28=^K ZT9]IHUWF759I[?G[M
MI!Q]Z:.2!5E3=.M+2:@OH,O/JK8\WSS9SC@1<=.=?'R;]2Z[ 7+*YV$N,4)(
M%8LN>>3CX02D>7DR0YA)LJT:G)=Z*7$TJJHUS;*1)?YQ)8W/9\1?$D>YNI\U
M\WP:L,)FOU#6N%LV9<I=)N^=>6.=K0\2W9<N,M5<5FQ:=G #-&.=^%N8U<S
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MAC=MT$)K>--]\Z9%&RPZ;:1)!DG'&/"FQ)%C6*/ C;1!&IR,R;R)L*WG34]
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M.GSY*@M(*5P@#E:.)!P1C_##>IX0*+O$B]RF5:G%> )(38_!P+&"$\Z,MUJ
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M= I4FX=WV"^H[-<T/D/!KSL]V_,=@-<?8+9/ AA \YU>A2SK?;;:\X3/X2Y
MYG "ENF8,JC*!T"6&=&CT_XP3VSH!QT'+X%1Y!&TZ,V'4 ]\$8_[/>#SW5:E
M%^5YO^X/SEH$H_^7O0KEEM3)U-VZB'90N]=>PN)GD,S[O.'"['W,JU3N^^/5
MBW8>_/B\&I:[F QZLAR/SN4XRQDOF3/PHN*! 0Y[R?<G/*JU'_*8X</#HS>[
M^4<+2"G$! \/>7G N.R"OI1W"G[_'$&& @:*JV"8@QE &X,2 RYT7LSZ&*97
MYAR&82=;AJT48QU1C(//G2(0ZO,N:= _:X4.8 :NJH@#J*\;8:S#"CXG?=![
M>D5).QG8WO2D3/XN?IT9RH1_UQ=D/&:1-)UM%\;5G1%S\>MY[,%K?BTSCY5G
M:UA<L'T@DL%D/#"]X8186[;XM8:7_A(@WM[B\9W=N97-BPI4ZL?5\L"ZY@^+
MS=Z*W0Y8Z-5X,F'&$BHOJ!N.!C;O+\I[7=89%N3EZW\7;N'M\'0ZX78>%:B&
MWRJM".ZM6$ZUC/DRVSOI &>!!\ =U0OAPKPK<*\?C4$NPBPSCQE\CL,"KTX/
ME.%"-[YK.V?#"E"U9W_"EF#6X\$@ V@\*FZDBHOE_)6\/7E&E_DJ0%BQ7)R/
M,V6!>9%',+^=94<>(?K*CL(,YO;=#BK6_MO^_MO6<'Q^WJU3)D#-L<74F-%3
ME@ED\7$%*G,J24W:G;R-YP"$E6RT. 7S^J]_Z(*F\S'K#ZW/E0(!@)\9&S#*
M?#3M8D*OBR\KQ-3-.E(<#$\[YYD!90=<[C(]8=I5V'("3UB@$MP$Q3 _=*J$
MU8^\R? ?8/"[K0/;@\\+3QB/0!O[EAVOH^N6.VN6H$H,BU*1+Y]ET'9N XM^
M^QF0"2K(XJP*V91ER]DVY8S@PL/F5>70C\."SWJIR]57[OHE@-?2TX05WH"$
M0G_"'2H]9N6#NZ#0="MNDR<T''M@<<!VAW-SN2%=#T%SZTX"D(5"0!)EYF/A
MP0Y8Q2BO&ZQ6-='Z\GX/S(/YZT?]DUBD05$>BGTS+ ^9P!FN:*^<SZ7XZ/2J
M,$BG/ZO)95H A6L0RN:7QV=.,4=:#@1$_#S9\46I GP.V&M6&^'250QFZLWO
MC#*S^-P)Q2H#29COR).!+]-X?H0 DT%,79!#I?9<7I(9'KTD/ZL]NN1D4YE@
MJVU>D+_Y&?4:5!BH-=IQ+W]?9$G6:+,(#<7W#_+XH@T2;<V:+ G?O##YO6=]
M4 4JS0)FD.U .RCJ=6''DP4"0EM%/[LWH:K/G?BEXM>V"URK5X(:E[R]/VM3
MS^(<WKD\:GNI><$&5"*C4Z[.@9@I@,J^3-E"K;2$"4X>G]P$\5B;%A,;JV!O
M6#2&^I,U]D&EI*VSG?+> ;C.L^.Z$L/S[]F%YZW_=CJ*.:_!Y?.JJ]JU&I@W
MN&ADY:7YEYP9 4IXI;3-9-CE+]L3.VO>5 226&5!KK<>V_4*3,8RJZW7LSB-
M0*U9=.44C3*ZL+I@3\4%NQWK:L?"5)L'8EWUL"8.>+LX(%L?!VQ">DU([Q'.
M96U(;Z67_EJO^X*7WAAJ+*4R"),XH\KZQ$@T5NN(16*7Z>]W%I7SIS&,N_$H
M+<;GWESJ2O^XJ+]\QI$Z>KC_(>" 8\ 8N:1RD7ROD/%*(LREH+#92N"P%(<A
M+%=&Q=%%H#$6C1*!2L9<BH3#GXN1NAM'9;9*P<F62Q7T*%9GQC^8+N.SK%1\
MBW-Z]\3$7*7-_%1T(%#Y0$P/?_[E^T*26[4PMTN1_,X9BW4S?C1Q629V%:<W
MBLO>[CO!;A;MO<U@]:XTHAEK,]9FK'<P5H79;?(SUB5CW*('QG=<NJ+V365X
MW4^IEVN/;1<N_.^<>/!'E7AP@_873W49#NIDBZ.2;/&,%R+GECSCZ1\5-]+A
MG"/M&2_'I5]PQCOYC-?CN#^RW;GY;ZBP>:ENI"H/UA;72BOSGV8UW$7[J>ON
M>ZX](F\]_4=;8&[Q4)]S5CM'I;2:.T8,HYR$[&7ADD5QW1EQQ!:]6>]JZKW9
M@2SV.+U8=9TY^/ZW]Q>'?[TG!Q3&\.WWK^^/_]$YH/_IOC]^?0J?D<-OK[X=
M_?;G4IVY]Q]/OL![R-\?__SV_OCDV^%+N/XW>.]?_SD]^.L5?/8G.S@^X'_G
M.G-_X(M28P[^/?CXYP4\\X.PD6%I'&+!6 0[AI'U6" ,VRFB$<FEL+-'L6AS
MR3=4%GIK^N V/*[A<;?A<40ZY2CG.E"6C\,Z1Q(C-G*+I<,4-SQN&W@<7N1Q
MC&&!*4_(< 4\SF"'C,Q%-6E2N0Y&4D'O[!$MVT8NGUUM>%S#XYX1CS-6$YQC
MGI8FSI,PCGD3>>2&6T>X:7C<-O XNLCC0,D&?8UI%$+$B M#D;/6PV\11!.+
M1'$#/(ZJ-FQNP^,:'O><>1PVT2BFN$S$\&B(2PX^X#9YZ7CRM.%QV\#C^)(>
MAZ7.:C:24E/$@]%(8PW<3F8MSB38/[*S)]M$_G!-](;#-1SN,7,X+S@P+FJU
M2X0K'(TPV+I(G>9*^+ I2W5%S<6&N=V(N7T]>+'8>E'1*"F/2'F+<P75A)QQ
M%FG0R*.3H,;1M.G6BPU_:_C;]LS[%OSM1TN#-QK<_3"YS@*3"SAH'0Q&5 I@
M<AH;9(&&$6ANQFG*3$A\9T]0T99*/Q8FMZ'6CS=F2>NZ+\@2EWX8[/ZV^LC[
MG30]$+M:W&!0*T[M9!I ;)>L2('-I0:JDQJE>\/<&8$-MG.;/N.J#L,KZ./Q
M=QB^JWAQ*3-S27Z_9>JKV@R7BI_[[U[]L>^OKQ7>L/0;L/3.<@#9&)"\(F#D
MF/"(&\61%9@ABZF7,JB@A=^8VGI%S]P':L_8X'G3L=$&S_>)YZ5@J<*11TL,
M@BTTB#-%D<F@=K"Q5 B>4L0-GI\^GC<6![PIGAO<W@:WRP% G%4G89%F((R!
M#Q-DG K("!J"99Y%GP. [(<3'!K,;BUF-Q;7:F3P?6)Y*=!EM.6@/$?DHP2=
M.JJ(M*$&:9F4CY0)@D4C@Y\^GC<6Q6GP?)]X7H[MJ""3H%B@0(1#W-*(C)8&
M6>IP"IPHBS<7VVD O;6 WEC8HE&J[P:XB_$*Y2QS&FQ@!4H4XHI[9 (5")@R
M,8(X1DKJ\%9IU<_KJ-N_XW#X2^O-?"'=NSCQ=B,FMF(IGQP3VZSG?K)S%?>:
M;=8U*6-X&$='DZ*$,SRNJLP#GQU-2\(U"LPF^.#%LI,_T4B-5!AQCPWB/!"4
M70H(^*$W-#J&J=ET;LH6I9\TT+\3)W\#_>V#_E(\@, ^!V(3DH$+Q+&62$O,
MD?*:!B$II61S\8 &^EL+_<W& QKH;Q_TET(*,4ICK:=(.PW&3P+Y;V7PB-GD
M2,P=K(AKH/](H?_3@\45[@[[3;KF#S& I3@$0%S;@",227,$6E]6^[E&"BP_
M+:1*CK-U!VY^;I"_I<A_L !$(_2W#_/+L0H7/8DR >AC9"AK_\@JJI!3D47'
MA:9&-U+_D6+_-E)_L\&*1NIO+0=8#'H0JI5RG"(P[2WBEN$<J-0("^(Y!ZU?
M<KM58G]#!S >2<3CG]%V1Z<95,N-I:[J:=4:_7A5P";0^Q QDG>PXZ]*EYS)
M,;7,&6=[YNZ/JKYJN0[J<?^MS;T7&RZY*2YY^&)%X3P7.8G&(4Z2@1\R(.V#
M1LX+0P/S- FPC2@P2;%%L>$&Y]L<$/E>G#=0O@V4E^O#62ZP @4G CV Q6,,
M<H2"YI,P=0HG30SH.XHW0'ZZ0-YL>&,3 KOQ:7POP)<"&91HS:UUB&K*"JR1
MUB&A%"S5*45#:9-/_0Q OMDX1J.5/SC25T0L"$U1*N0"*.2<<HPLST4F>%):
M*P;F%\WEK-N,RP;H3Q;HFXU;--+\(3&^'*&(L+T>;&_$/5/PPUBPNG-R(G/*
M!D,C<YO+1FQ0OK4HWVR HA'G6P#UI7I1)$F&C40\)C#(2[]69PCREAGAHY%)
MR-RJNDW%-LGSYW4$X[L#$B=7%XUJPKI/(#*Q\I!:HQMM@F&N:.>3(A.@&<'>
M)2_ _L$!.1()DMDM[1B80)LO(MHD;VP?RN\[+M&@_ Y1OA2P"$PSJ8)!A@0-
M*!<4.>H,8IQGQ4A+ITF#\J>/\OL.6C0HOT.4+T4MA";&:,.0CQQ03A1&6GN"
M O;4>H^M-<WQBV> \ON.6JQ!>8/FVZ!Y*3)!'-988HI@+R7B5AKD3/2(P8[)
MI!QS*C?:I)NJ>MT@>?N0?-]AB49>WR'"E^,2,DHEDC&P>20+;$&0P80BV,;H
M8X!MY[P1V$\?YO<=EV@$]D;@O!A[<$I)@R,HW!$[Q#FQR(#A#0+<@8V5I"FG
M'[=+8C^ODQ"'_1Q=& WZ7?CNI-6ICQ@-ZS#$912B.12Q%2?*'O94Q#RU3,ZC
M-7SR-GQR10,(KVVB2N1&/I8C+CP!PR9(I'+<UO)(C"([>X3_R%FQ)@EC>T']
ML$<@UH&ZR<K8&.*7P@^@RX9H/$<N85V=#S61)D0MER)9;TP^+Z';YH?.AS:8
MWUH#YV$/2]P$\HU;XWO1OGQXPAJ?M$O(\PAH9T0B(X-%1!'@\!%LW;"Y,$0#
M^JT%_<,>GFA ?Y>@7XI6.*)!>L></903JXE7H-237/71*>.P)]+;!O1/'_0/
M>Y"B ?U=@G[%P0K.#?.@T[M0"K]$EO.*(C !1ZW(B86J$?6/%?4/5_JIL>FW
M$/N+T0X#2ET4+N<4)HEXUO"!V7LD" /T>YY;U>SLF3;!RP<M'L2H?UYG+*:5
MT5KQZWGL#;\S5/&L0[@/$JH8#]&)M>>_3#?P5;U_#3_;&#];T;'":6DL-0P%
M32+B22:D!<5(1)6H5"89'7?VA&H+^2/\K,G"V%X(;RPPT4#X/B"\%&8PW H>
M%$74T9B/>2=D*4"8*Y4<<RGJW-%6\C8SRRD8#82? H0W%FAH('P?$%Z*'3@6
MI+:)(\RHS$VI+;(:2^2()M;P[&&0.WNP?6U">8/A1X/AAP@;W!#"C3_P>]&[
M% 3 2@=F54182 'HQ1Q9013"@:2L0%EO69//_/0AO+$@0 /A.X;PBFX.E$=!
M4ZZ%YBGBQ!'D +;(.6FPBI+ZV'1S>*P8?A"7?J-*WP^2%QWT6%HJL9>(2:H0
M$ 1&)AO&-EB0QR1[-D@^CL#:6&^)/?R\3B-\=QFD_F9\^TUT\T&.(2SQP9N4
MC3N,33QS8^SR:$5[!L(,3TX!M\0DVR[6(B--1$YQ%VCBP@K0>TB;:+H=X<P&
MY=OJ_O]!E#= O@V0E_M/6]!K,.@Y"1LP8%*BN1V=14[Z:!D/7.=V= PO-V=H
M8+RM,'ZPHP:;D=6-?^)[T;T4( B>*QVB0H&Z7*_0)62ELHAHDRC%F'.NFHS#
M1PKSAVLQW>CD6P#VI7B"<%S)#':6.(AR;@RRQ"1$E,2@JROM1 *=7+3QMN08
M-C#?TDA"(\VW .#+T88 8MR#OHX8TR#.@TU(6]A,PD#*RR2#24UGAL>*\X<[
M0-"(\ZU ^U)$(@A'0E+(::\1QX$A8SQ#.%<@YPX[G8N-$]GF9DL* 3RO,P.;
M*(^TH=C$LP[3/I;01%,@Z<?YY(J>#"HE8BD!OBASNV@A"'+8BYQ&I2(81%@;
MO[/'<9-]\61A_:"QB.8XY9UC?BEJ >:LT#J)7# A=VA(& $K#T@I'("W^R!L
MZ0X/BG$#^R<+^P<-7C3%$^X2\4N1C.0DQ8Y:%%TD"#A]0*#) ;F3H!UQ*GK7
M=%YZ!IA_T$!&@_F[Q/Q20". E'>88Z1RS)(GDI AEB,">ZY@BX4,FZN2U&!^
M:S'_H&&-!O-WB?D5,0YM+142M'H1P9R/$LQY92C\L#QA+'UBFTM9:$"_M:!_
MT!!'8]/? _(7XQW1$\ZITDA&"<@':PXY$4'PDZBU$SIPZ;-1+]DV&?77Q#Q"
M9WC>M1=YL/%J5M%<^=2OW-!YG1O'Q$+G\^39]2-0OOX764)K#R,!]L/'\7"4
MF^D,6Z-^Z_#HS02T&QV,V-7B!N/Y];P_[&0&\LL@=D$^?(Z_COKGOR"V2_+M
MBPMKAS$_86?O)WH97X55;M(<MO8DT1#F"[_-*0,@W5_8X>D,*8+$CZ.ICE!U
M>,H:P@L83:<WAL_J+_N]82/H;R'H#[* 7Q3TH,DID3@(>FXPV/6!(".Y1Z#9
M84V=5U3SG3W-FJ-#3Q/6&PC7W06L&^5^<Y@_7#3KB?2",IM;-HKLR_,4X%XP
M[TA,F)M S,X>:X-9WZ#^T:#^P8)UC0B_7S@OBG!.L/=8 YQMB(AC:Y'UAB*E
M;4Q4RQ2=VMD3/YQTTP!Z>\7X!D)QC7;^X- ^6I34VO! 81]1TM@#M*,#[9P)
M9(G3'O8[12]W]AHQ_8A0_6"QMDVJY$V0[?LM\./]'%@'G+^Y.#Q^PPY^_Z"B
M%X()ACR6''$M--+&1V2Q :/,,:=U<S+XL>+]GH\2-<;XML/_S1+\5;#.&HMP
MX@)Q(BURG@>$5=YUQ9+W<6>/M^4/U0W>TJ-%Q&SWP:(*-#',1D<>*L? ]0<A
M#E".BN3E*^>86I,5>'R<\<'."DWVM.&!#\$#WRP'(7)M5N(U0R+AA+BA"=D4
MBFO2QN@4M<+DONJJ;?ARN83ORS>X,9@>41+2\V40FSUUU#"(AV402Q$+3[3D
MA!GDC<:Y/#M#VL9<[-"S$'4T%#M@$(2V-=W4X<*&03PE!K'9D$?#(!Z802S5
M9^"1&A$(TB1W7PE<(>N201@['T!!Y :KG3TJVZ!$-/RAX0]W?):IX0\/RQ^6
M BDBR,A9-(@SD9N\)X^,I@:HSCOCK:#P]<Z>:(N&/33LX<Y#,3_*'IKPR_?[
M'I;#+X8I Y:C1\&PB#B8CLA*!ZR"&J\<LYB'C?>->5;<X6FSALT>CFHTAX?F
M#TOQ&1(B\\%J1*4FB'-I4.X2CR+H%"9&*0T-8%L8VN;RSIT/V]2LYE$??GG;
M'0]_:35'8)YY>/[!@E#O(CS<=[J=PL6/TI3;OQWT4V?T[_ZPG(O](Y[4$?L7
M,Y4+ER/Z#:._%:,_6 Y"!>ZX-RPA3$3.PDD!.6X)$L(XSARCT;K5)V&:#)RG
M O'-AI$V#O%&T=L<_I=B3!AT=R:81311"V:@9$@G9A!)W@:CK08-;]VIF(8#
M;#4'N$T.W@8"1:MR\!IQ_\!P7XH86<5$2@91+2*(>^^1"4DC*82 [:4!.[GR
MU$R36K^M,'^P<$\#[H<%]U*X)\;HA602*14$XH(Z!.+;PP\6I%76!;'ZW$PC
MR)\*PC<;L;E35;X)YWR_%;\<SHG,.VV9 .P[A7@R!AG,&8AX@A7#V!/2G*9Y
M!@Q@LW&9QI;?:BZP%+2QEFB!.4&$<H.X,1@Y#PJ!,3X&C(4R2:\[5/-P/.!Y
M->V9U')L=4J \Z&/USQI;KBQX,5XB$ZL/?]ELGE5<'K*#AO-9B,\[??E^(2E
M+%$7 @HN9(X6<\&/7)Q3V6B-]L%1UA3C??I(WEB,HD'R_2!Y*=(@G77"6)M/
MNFG$G4B@EE@*?P;@S,$1*5V#Y*>/Y(V=26F0?$](7I3)2AMJM/#(, +XQ<HC
M;6U.*P]&.$-D\+A!\M-'\L;"";="<N,V^#$X+X4-@@3<*B>1D!0C+K5#UBF+
M1')61&=)R"JV;!.YW.2W ?-3 ?/&(@>-6+XG4WDY"*"]<LX3ACSQ$7$O$W(*
M:\2($XP+0[3VC6!^^EC>6!"@$<SW"N@E?WZ2%K8O*$0Y_.#2!62%QPCT+:^(
MQL[[L'VB>4,'+1Z;/S]6C9V^RZ'?A#<?V*%?=^5JM).-,+,_EQWY6E(NB4\(
MU$F&.)4*:<<,@DTDP,DP%G%SNDF3H+"]J<9WYLE?">%&*?DQ'"^Y\2UFSAH-
M$%8^GQ9G!#G+%3*)!.H9 SZ,=_9(VZPH2=4D$3\% -^9 [\!\%T >%$0&ZZ4
MTPG$K\Y5Y3R&WY0U*#)K@Z#:A-S>EK0U62XZV0!X6P&\#6[[1H?>+'27//54
M2<]H<B@)$1#G+B!M5$*&8QJBD#%M,/#6('A[1?"=.>L;$7P7MO"RIUZFD'RD
M$7$K%.( 7*2]Y,@9GTCBSG/J=O8X;U.Z7)JMD<)/ <-WYJ1O,'PG&%ZND&22
MD30$I)@3@&$.\%4A(@*;%4&5QL)RP+!JFQ7>^4??PF+['?,OX_D J+T<76G9
M7FC9LSX,[EOYH$F[W_*VV?.\;78O]WMA?V8G&SZW.3[W?MEOCU4B@E&)1*Y$
MSTF,R 9&D*0XDF25H1IL#B7:0O](M^PFFV![T;QQCWV#YGM"\W)+B6!T[KN'
MB- <<4X$<BQ*E+@B!)09$3C8'8JTX?L&S4\2S1MWWS=HOB\T+\74HP<$4X\(
M&)&Y>)?/KD")<%*,*@>[2NW.'J-MKD6#YD>#YH?TY=\8S(U?_[MQO.37YX2G
MF)1%@5F5:[&#CFU]1$J'$*(36,78Y.T^?31OW*W?H/D>+.85WGUO4](D(F]D
M0#P0@L!:@C]U(E%*GGB#YT>+YP?U\3>Z]KVA>LG?'S7\QP5#F 5 M5,<&6TH
M@MT31/J$G<^),\JT*=T2=?MY9>+_%GMQ8+N5KS^<=7J=X6A0&@HT.?F/*2>_
MWL?,W^9VL<DOVB2/\RN*[>AD/%8849U[0G&1D.76(L6=EIX+KTUJ\HN>/J(W
M[O!O$'T_B%XNNB.B)0!<%!C.[3T,0]IX#@"W2EEB,HMN$/WT$;UQIW^#Z'M"
M]%+Q'2J4"LX@(V!-LZ<7F20$PEHD+10E@MD&T4\?T1OW_#>(OA]$+]??,9&Q
M9!T"G<LB3AQ'AFN+(J%6$4EM<*%!]"-%](-F]=\*THW'\ >MZ>4X@ \VBB =
M<A+VC#MID<&Y$[M4R1IKG MT9X_RE0W8FRS_IX#IC4< &DS?*Z:7H@!*"!TQ
M<4B4&EO.$F05]T@8CYT(S(*UO5V8?EY9_\<#N+?&I>\/1\,FT_]19?K_8SR$
M 0V'+_IGKM.K IW^?\>=JD7TN]PA.H87>6,;;G8K;G:RHOFOBC8J(9%*1".>
M.$8:&X^\B\1I81*);F>O205^JN#=N)^_ >^=@7=%YUZ6(O,:^2 <XDQ3E&OH
M(QR$C :(ES!01,B*SMT->)\">#?NTF_ >W?@792\) 7@M,$B3I/,<3F0O%0(
MY!DO;GSO:<JM.DT#WD<#WH=TWM\&NXT??R.87O+C6V9MLL(@9TW.#\0:.0,_
MN":!,,685:+)^GVDX'Y0/_[WHKMQ__V@P;SLTG=::D.P0MYD]Y\ K;OJ?>-Q
M5!0,IQ"J\I<_5#VO0??VHGOC'OT&W0^%[B7G/I<<:\T,BI(:$.&)(AO*T5H>
M@R7&B9P 2]N\2?!_D%+[9^>V,RBMI$N2?[</0^CVA\/6(,(3/\=AN]6+HR;;
M_S%D^Y<&XS,[FB.:W6[_B^WY^+H_>#&(H>HP_J[>V\9RV0CC^[2BQ@\E'CNC
M4$@F-^0D!!EJ(L(DL,")P5)L[KQBDZVPM=C>6#R@P?9#87LI3$"PEDI$#VJB
M\H@G3Y"+RB%*C4E&,1*(;+#]]+&]L7!!@^T'P_92*7^F>,B=P12A"G$;*'(:
M<R2C,4)S2J34#;:?/K8W$$X8PG3AMPV!O'%-_!C2EV(+6FN/$V?(&D$0]TSD
M4N$1@<5E(U.8QUPOG+8I^>%&@ W.MQ;G&PLL-#+\P6SOY9 "(!J#-NZ1DB%'
M"XU$EC&,@DN6,,D\UXT4?P;HWD!@H9'BVX7UY=,#8&IA%@0B,AC$F;#(4A]0
M$E9Z:Q1)"6^?'']>)PA^LYU>ZZ<<5OBY!8@= LT/6_W4&D3;;<7AR([B]X<9
MGG68]4&+"L&N#C.OB\.CWA]Y3X_2FQ[PO%%FC>]@;U^5K6U8X,98X,?]%4<.
MC!+)>H,\+_D3."+#O4 JL."#5MYYNK,G<9N;Y5,'38[44X'WYBL,-?!^ '@O
M11NB2-1H31$U^5 "IAII+#TBH,!&)V/2.N2\YC8CR^<2&G@_%7AOOMS0=\&[
M\5-\/[*7!'<@8(9R@9CU#/&D ])*&A2P!B'NE-!:-=G-CQ3:M\E_W'RPX?8@
M;\!\*S OA1.<Q(E8XA"V%,0TH1Y9I1S2B4I'/=6)21#3S=G!1X3A!RTTU(CG
M>[:KE\,(VJL4N.?(!$$1EV!CZUQ0C!JKDE'*>+ZY1)\&W%L+[LU7'&I,ZP=!
M^%+P($G'F(P*":]!!;?<(:-#CALRE6)T#C9Y9T^3ME#;Y#N[)GH0.L/SKKW(
M@XU7\X3FRJ=^Y?,ZSG(T.HV#5J?G^V>Q]5.L"KC]W!QA>72QI;*1A_U>_SSF
M8GR]DS=E3Z<E^1K1=PO1]V8Y:*2XUI0FC:3V G'O_G_VWKVYJ2-;'_XJ*O_.
M6S53I<7T_4*F7,4 R6%J;'(ADTK^2:V^@8AM<229!#[]NUHR8+P-V'C+VI)[
MS@E@:TM[J[N?IU>O9UT,T$D%P7#I5/3&8J*-3PU(,6^0';A>U"#;*V0[0I"P
M4<7(%#AC/"AA#= IQ$)@/-$KQCBO]O8%:Z#=,M#><HFJ3[B*&WS[A>_%'5<5
M93A/M1YDK/6J:[RY]A(T=UQ$.FZJF@AOS$!*W#;D#BZAY'IX;6[A7G#<K4EE
M+9G,F@/-G@7%M0=?LH+@0TRZZ.Q3ZQ9S!P#=N^)S'4 W5_ -S\-=L8<Y9P1Q
M,111Q1Y,!8*4&8JR!J6TFO%:_'4L)&^HWEE4]R[U-+.Z9^!V-)SDK?,^EYJC
MS4')'.E(G!"20X-T4.(QV;U]:V\<'=G2/[X2?__)\_G]T7=3>J23*G".GL^0
M_ERYZ5O.QS;XY5=Y;_3)LSQ?O*.P>'2:<OIV-CU^D%Z>SA<Y?9CC[^H4KRZL
M%SRDIYJ<G-) /UT1X?2D9<#V0XH'7>]^D5DP9 4D,ZD&HSD(D4P;SI)-+&3+
M&&^!*[L/_YZK3S7X#Q+^W1;50<;D702C8P"E:MQ:B1%0%>6*"TK$_MI?-OC?
M);5@/430 '\]P%_<[Z-@7L2B0255CT"6 R;)P8J2@F,&E=.U<<U-M(6&\\%N
M\[UI"VV;'S#J.TI$QNRUE0QX\1*4#@Z<2!7Z7HO '2+KK\9L@_]@X=]S#:L&
M_T'"_Q+)0J:@/=<<#)-U[T]DXA>1:L5*C$&;Q&KCW$8 6TD M]Q H]GY0X1\
M-V$E&V^U5$#XMJ $>D#/+8A(:+<LR8AR0);^W<H^6.D<_YOQ:/&B FC)O/:;
M^6C^ F>Y%KPZ)8"<S*='DU0[T(Q>3B<GB]%K@L\IO7[X]$E+4AAX9^W+:/(P
MGQ%?S>C[=YW2_ZYF]'N<+4[R;/Y@L9A-PND"PU%^-J7?TLN-#*]%AC]T10[)
M(IFZTM2F0@644QZ"T!%R<H87XVQ!M[?O7;?L7PNHW 4T]R!N-#1O"LT=S8)F
M4*=4$+0N E2QC-"<'%DWCJ7 F##H]_:58@W-6X/FC?72^$H,-T]%/]B^N%-K
MD70H68(Q5:,H24+0DK"-.4DTB@<66LCTEH)\LX6N^H)["ZB^&>8[X@3C0>:,
M&9!IPKQB";RC?TGFA.<L$JGSO7T]UJ9;6*/MZ$,%^\94B;:C;_3L?4FZA+5&
M**F!6Q9H3Z<C>.#&5O$1HQ:"&=[2H+85Y@/0'MJ>/@#4=^0'S#$2WAF(C!P4
MMP+HW.Z!>ZFYDE%Q7VO-C[WO)DEM9%>_6XD6WQ^=SN^/#J=595C,ID=TQ?/1
MY$S%FY_)$1_4B#5H$7=:LMVH%/$NX>SCV?\@X7Z14.F-LYQR/JZ,VLCR6F3Y
M\R45EJQ@#FVF8X]@H 17@-8%0,-H[DL26IN]?<YNW)6H!68,%N7]2Q1]H[S9
M2_U10$?3D"4Q%U&#2!)!!2XA".$AH9=.QU R9]5:DI?X0!H)[ H)]-ZY8QW8
M;\Z1KX=]9^<O*D5F.="\!U#2.PA>1BBT_0>;7+#>M[#,W0=^[R6?&O '!?R.
MYJ&8-,SP#*IP0W^( L&6#%Q&H@1AO.8M[?H. +_WTE -^(,"_B5RB*E=!"03
MP$*JJ1A< RI4P M:;IQ6.?<7XM"@/UCH]Z^&M!/_D(F@HY!(59CWV8)W@6P
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M!CURZUD+WMA]E-^V+M%0OD:4=P0+3%DP8RVH)!(H)BTX&1$8TTY9@=J6_@Y
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M6.DBH=G8L;6RH7DGT=R[^[ZA^;;0W-'4M329FPQ()TA"<_4G8"C D5FFLL'
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MI@>-Z5M.)&D&]FT N*,0!1L],LXA%D4&-J]984);H&DKMD27Z7][^T.)5&W
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M1@*[2P*]%W=:!_:;;^3K8=\)0(B8G6<1'"?$*Y<#^"@Y8,3(BD+)8JM!?@>
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M)MI])*])?VI(7A>2.S*1<LS5[I,00JY(IIE"7S@H7F)"&:*-K53['4!R[TE
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M>E!"<G#16[!!*:6]88YS8C8U9O[&^7G#\P$U.*_=:=+@O$8X=PR54)16FDM
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M'A1R!8A2@G8QLB \*E3-C=4H:_-?[1:MK4990Z*LR47*DIYQVHR 6Q6JYSV
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M[(1D$8T(FN_MTR2/K>*-#QL?WF4^O&TU<-XC<3;IX&LYLZ,5IBAY9L:#Y5A
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M\SV^L_O'T<[N-[9W]/9\Y]U[,5NOH4&;K0;]V&Z>?_ZQLYVMU[T?3;B_>70
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M%,&G<QSULPY$J["?KVDS5QTX[FEIG@WRKZQ>U;(.')7Z>3O\/UH4G6V$  %
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M\4E!3=?S><L7)K2;1]].]ZDGTG/ED;26(NXE09IYCVB0 O[GC,1B8XLNZ[(
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M7MPY.=(M4>%&'H5;44GE45@5A8C&AWWO1&0R8)1;T2)N<01CC6@$)ASW\)_
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MK]M[?.\+O.^X <]KX.:[MV=[QQ_;C6UX1_[\R]>CO?-V>X\4_GC! B$&))O
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M6W "M5!274D;6_?,_9\\2(5A.^ZDZ^# ;K[R@B'@O/%Z'V>OOF08)>,  GS
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MN.[EQVXV@ZVCBM4Q_C7U [8& TMT^AA%L"X'E3W!ONE8E&-2E@"X.D:O@).
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M8;PD,N?OL%^00]0B=OL /.AVC@+=UI'X7_;!)B\9LX!UM)1M;*T=3.B_DU(
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M[F6S&EA"49C[MM0'I[;2G5YHWZVIZA75$I0,KU0YJ0GX6 L14RJ]FOK'9VS
M;GZ+4F98/3DZYZU:(%!\[R'O_<8_A94C2C4Q+KOT]O%")O/CBT.6RB:I5SA5
M\?7I%6-\H%U[+'%C?ZYVSD]@;=3%%]L3NJG_Q)NY>GPJ.J_82(Z!-:L:BTB4
MD<V?N%^LLW%8W@ETNOH8XH%W13$FIW^/5R)5R#G)P5>N3 +6,0_8-2(L)Y#2
MU:)^4C",HD+MX1^?BV+6O#J'3C<O3W)D49[O&LG4GZ1\:5,'+\V</^!+C!J^
M8R%3I8R3#]F06"!X&A7BQ PH$H=OK-T)KB^O%L6R,*S5XR6 3K*JR(;JO((
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M:%=<]*IRIG1L1)^ZXKXG.E6_XE*O:%+VXTHI#HGA;;Z]*#:21QVH)Z3\CER
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MJ&=1M&3%'B]A%-9>Y&Y-=$?QM<JQ!#YG=#'O*.^)#(58.& E1U;=5'R+ZD?
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MSI.W'5Q_.^K<=IO-@A?CO"HB6NRW?A(<W[C8BKUR,F9IJ%S]&*SCU8X4)J,
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M>1ZZF<RQJB^_Q-@/)EW )K,P/<G*R]Z/5%Z>;%FZ?:-'QFD('0Q"#=YQUO)
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MI 9ZSU+ (;MKVX; SAQ>#\Z,73^D4<Q,XYD!SGK,>V-<^:\->P!;<<8 W/\
M.!WWS\Q/!"HA#EWY>(]Z2\P\]L2":,XQ9!XX+OP64!YV]N2[\ %\[AD]?#-
M4/D9X]/G7Y!9.2E<BQFVG?6*+UAX65QUE)<"/I6^=R:XU&\;+JW/LO$B^".,
M4BFC:(R:ZR13>4N)"5[Y'=8QN;Z4I+&#G[[&99#/-P'\F('0\_^3(R>H%=^
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MC(+1K9M@; <8&4X 0IYFB'8?>0EOA=,ILBI>R?]&*>+>'2E#RPAV'49X2XB
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M]F\B<_'*B[\<@ (#Z@"N3MBCPECLSFKKD!F:$<P3($\L4R52BQ"]H"B_Y"J
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MW>]GVY-TJ6?+B[Z X(DW ^XCEF)  "RW:O L@\%:"U\=!2QM).)[TNAY'+-
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M]/:"N] G-X+OS3UTX12H _HK$ZDE01BT9'@KFC=FSK<LKEH1*3M4*EA=F!;
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MOGKS=+X*9"?U%\MQGL\DQOP>#6HY_O_%I+^M/'OUT?G$SQ0P]AM[$+_]DTO
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M^C4P41AB+.]H$219>QJEN\MES.<+/Q0M;LD:CU]5U#&L>@\HS#XPD.:_]I5
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M+%\=TX?(KH?[ 73OL:YVS'T??05XE_J;ZHL1Q0)K(U$@5OD1=L/EIZ=4K)!
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MZM^!G4%PX@V86L7<##F5- J\>-:HZ<@,)T,-]'EAU=YJ#+B6]O+][4CP&PL
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M$__2*_G-'?N*_*2X%GQ8U9?]V^[Q+Q]R^+B.1)?(O#^>[@G)*K920 M^KSI
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M^8P4X="\P>&2.&DZE:R'-3D-^V#^_ ?_7X]AZ )["?;HIY_^'U!+ P04
M"  +@IQ6C,_W9TLT  #<%P( %0   '!E86LM,C R,S S,S%?8V%L+GAM;.U]
M67-;1Y+N>_\*7=_7F^W:EX[IGJ DVM:$;"HDN7ON$Z*6+ EC$.  ("7=7W^S
M .XKECK H<81MDB"(,Y7E5]E95;E\F___O5X].(,I[/A9/SW'_A?V0\O<)PF
M>3C^]/<??O_X$[@?_OT??_G+O_TO@/]\^?[MB]>3='J,X_F+5U,,<\POO@SG
MGU_\*^/LCQ=E.CE^\:_)](_A60#XQ^*/7DU.ODV'GS[/7P@FY.W?3O\68_+"
MH@ K> +%M0.'08+.!DU)13CK_\^GOQGN@DU&@0@\@DI:0G#10"G!<N%%ECDM
M/G0T'/_QM_I/##-\08,;SQ8__OV'S_/YR=]^_/'+ER]__1JGH[].II]^%(S)
M'R_>_</YV[_>>?\7N7@W]][_N/CMY5MGP_O>2!_+?_S/7]]^2)_Q.,!P/)N'
M<:H/F W_-EN\^':2PGPQYT_B>O'@.^I/</$VJ"\!%R#Y7[_.\@__^,N+%\OI
MF$Y&^![+B_KU]_=O;CSR,X;1_/,)AC_^FB;'/]:W_/CJZ+</1V_?O#[X>/CZ
MY<';@]]>'7[XY?#PXP<:P.(#Y]].\.\_S(;')R.\>.WS%,O??Z@?!%723"YA
M_.^'/^S'*X0IC-+I:#$A;^GG\X^L8%J!Q:]S'&=<3LO%8T>3=.--HRJ4R?3B
M+T<AXFCQZN!T!I]".!E\F$_2'Y\GHTPKYO"_3X?S;V_&:71:E\N[R;3B/YC/
MI\-X.@]QA!\GOTUH,8WGA)0^\=.;\1RG.)L/9"#.1VM!.I5!.1; *YO!J!R%
M4[ZNBIL36V=A1M.P($ )L[A@P3DL8H,0/^)H/KMXI<I +.:_+?*ET%K.WZ!H
M%$(; TY8!DH[ 4XZ!T+)[+0WN<30^5S<'-<U.AY,TXO)E-Y(RO&'%U^PJK)S
M/;F$%*;I#D]OKM+S=_PX.ST^7GPF#.=X?/'W56GNG6/S25,Q+=E X]Z6+K\.
MQY/I8@+.!Q6TB3F+0HJ?>U 6"^T#1D#F2LL0K+8L-2;+;0RK4$7\SZ'*5B)J
M1I2WPQ"'H^%\B+.#<;Z'OAFY#;'0Z*QTH)BC(1H5P4NE!=J@4;;6,D]A:CCF
M@1"Q"*L,!&0T/,-H9*@D9.&B* &+-JJ[X?5)>S9EPFVR;SKES7C>:,$33C*;
MR8B.20=0WCN(O$A0(0;%3;0TN&=@?^Q7^7;*M#T(NAE)7TV.CX?SZB76B7E%
ML @2>95UU=!V8+.B98):D+\G/8?@0X)@DN:N%!F*;LR\1^"L0B?Y/="IE4B:
M<>0]9B0WF+A[/W.78WX5IM-O].K!\>1T/!_PQ"VFK,#K3&R./$(L6H-)N0@?
M-:(SC<FS"<Y56*6^!U9U+L0N[,.!Y,E@\AY$#G7C%N332"O!..<\$U8KU=J'
M>-!6VF0D8SPJKZ:8A_.!"5DR73SXB#27C QNFE4#EK%@33"<\])\*%?/[ZG=
MMY:$[YIX&\YO,Z[^/IYA.B4 KS'.!\R+G$DSTR+!2+X92@A<<) A9A12,,=;
M.RXW /34XMI*QIO/<#M#_AH 'A0+@OSDPEFI*ICV7N$U48U9B[X8G7AK:WP]
M >_!!MI*P)O.;C/Q'I7R:YC^@?.W&&;X^[B$L\FT;I0#Y$P*81BH5/?;) N$
MK#-$IG5"#*B:'_T^"*:GALI6HF\S\UL3H5Y27!_3>QS5Z[*/DX/9#.>S7W"4
M?YI,/P0RG7 ^*,ZEF%2!A'7 6M9C5I_!&5-\\"J5*)ZZ:%GKB:M(7C\3R7<W
MU>W4P0E.0W6Y%J2\P/IMH%5DB44!V=/^H[Q5$,CN!DT^NO#&!.^QM3*X'\HJ
MA##/A! M9[T9!0Y2JN[/[%WX5K41.6/TRO04\[71OCJ=3LE%I]]5?VKYPT $
MZWGR L@8);1(<^&S*\!XM@I%8<RUMO$WQ;H*B>PS(]%.Y-;PZ(V<\)#F_QK.
M/[\ZG<TGQSB](C[S,6(]#4R:ID AIQW0DBGDI"D"DV816QN:CP):A2_NF?&E
MG03:'7Y,POB"OQ\G+\/XCX&-UKF@ FU[41,.EB#RQ("K:*(-:+USK0\.[J!8
M1?S^F8E_R[GN[N8\%ZL]X[&>[B&HXB39/8&TDU51J*2]\:W/3A^_.=]^3&_&
M_S$9CN?_)&U+WMYLX)Q0P2S"R+*D?VA=!?+>R=*36*)*SI;6.^43D/IT0+85
M(YZZ]=]&%)UQ_LWX'4D9:3O.OX^'\U^6Y]X#E4-&P3/P&#RHG#6MQT@+7<F$
M"1TI8M$Y3>Y#UJ>CMH[9LK5@.KQ1'_C":'M&#Y*E4"_$&#@M.:3BN)&:/$7=
MVBMK'QU2;_PFX\7G_C.,3G'@."8>8X*<!2.O1R1P2FI@1B;NB[96M3?^;F+H
MDSK<4N[W7;!N/-WMG,R<AW7L8?0N#/.;\:MP,IR'T4!('900"!*3I<5;$#SZ
M");3 BO)J\);,_H!*'W2<8TIT&+R6QXWG!Z?+@["7@]GRT@1PC9[,S[\FG V
M.RJ_(>GA1.[)@)4L7$@&4,HZ:%Z#1-!"%C)Z3M:P8JV#Q]: M^;]!#PKRG0D
MI2YH=#3_C%-2<R=3_(SCV? ,E\#>3F8S0GE4/H:O@^09[=)D\B$:\G5<I,E@
MAH,43)*U8(J/'1Q6K0.Q3W<>W;&IN; :!OZ$T>%L3B#?C,_(%JPQ2>^FDQ.<
MSK_5\_D@E W2U['; BK8!-YETIM12N.\+X&WC_%Y%-*V([[ZT)>GPU&-X#L8
MYXMOWY"()F>XB,P:1*:+\S3L%)RAL2L)T3@%TN5L?(FLF-8FVLK@^F2[M>30
M[474C;2:+9_7>(:CR4E%4+VH2=TER,+P/ NR,'6I5]S6:G A<X@N"EN3-C)K
M;=[=AZ-/MEV7%-E:!NU.=L,X#U 6AH%V"UYR/:[4"4(J'$2,D:R"Q+RWK<]R
MZ;E]BAOI4MIKS_%.MLKKEB/2+I^&BWD:L) T"[J -E: 2H5&&DDS62ZMRZ%$
M95N'EVP <TTCK%N;ODOR="W"=H;^(E9B(#QRHRS9FZS&R,A<S_O(:Q4A.!N\
M\X6SUO;[XLE=FY4BEE($&=(^&!*=YI;L:J8@D;H.7#-A0VLEN999N5^#:@/I
MK\/T=070C-4_#<=AG,AP>X\)AV?U4HX<ZV4:S?DU_L69]$&AKP>CT>1+3=7_
M:3)=A@!7AVD08M0Z&D9[NR!'29<",05:D=D[E)&KK%H?D+1!WB>+K '']B#.
M9E2\6A6S-^.#4H8C4O<X^W :9\,\#-.:H#&;3=+B57(Y;MZG<251.T30,?GJ
MJEN(FB"'Z%3$1+])K=.FM@+<)^.P ?%V)[SF\6972V5ARVB7N8P1HJV!L)8)
M((,B0(HEYZ@$&1[-+P+N ]*G4[@&_-A^LMM%@(79YYKB1U_JD>)9&"V2_N87
M65C+VRDLV98D$QACD6Q,4<!G9H%I;72P60=LG56R$K ^Q24WX$5[831T+NM]
M0R+GXWZ0 \9%1A<TY"3P/(0#Z1\;>++6,^Z*;&XQ/XZI3T'*34SFAB)H:*C,
MP_C3L,:Z+H9(FNS2R/IY,LE?AJ/1P"JK8JK6D_'U3K.&R'&1H)!E91@+@:G6
M?N(JN/H4@-S$[&@LBHX2&M[7Z3PJO\^6. <BEZ2"*>"B,<3;1 8V!@X2C3&I
MR*R:6ZN/ NI3G'$#6K2;_'9\J/>-YT/+FIB7A 2A:UIY* :"KW7]R*]R1H:0
MF\<67WM\GX**6\AZPXEM?#!X/8EJ,G\7IL2XU\/9R6061C]/)Z<G \.55YPS
MP%"#ID/.$&K!QIRTU\JDP$ONY.3P26@K';2QYT.)+B1RBR[_]N/MN7I+/[>I
M*/GA(_W[Z^%O'S\<_73T[O#]P<<W]-N;0-8O+?G I[:O,;D*_$;%)J]"-GXB
M'BV+MIR2VC_7_Y/Q["66R?0\M.-C^(JSVY&V9%3>_)1EF,FO./\\R==.-0;"
M!*\\;1@LV@2*)0<Q%PXN:6=4"<':UD'1.QS>]L[2&8Y/D2QRP4R()4&MBU/O
M@A1$)\GV8D9KG[GWS3.H+I[=I_N"OC+SKH>U@=P:)N/-%N66#K^>X'A&*')D
MHLA2:]WX2*:9D>!90M!&*F=+9B&V+WYU$\.:-P+=WKP^%QIM)<AF=/IM,IY<
M6/[+,9_C&:!E2IID0!162VXJ13L]1K#6,:8<$9^WMK@?!-.GD__GPJ\VDNU.
M;UD=)7,A 3*O0!E5]:@FPQ*+%]D:A[*U<?"XWMKH5&M9DNQ\8KWFC#ECP0DR
MB54M11:2$)",)]M<JA!]ZPJ8MR#T:3_?2N+WG%IM/-4-XR2O(FIJSOYQ+9KY
M_RX";$12-2D_!C2@"B_@:TXVTS(H](D3IN;AD@_"Z=,=?5,>M!)!,T[\C&-2
MLJ.*)1\/QS7A@M"<72K;Z 0Q,M&N;FNTEU>F5B;T8'E)R8A:U;=U[-P3D/JT
MF3;E1DM1-./'R]/9<(RSV:O)<1R.E_.<:+N?+=*ZSLL*+:9A@%EF] LO(I !
M*#CI-%5O>I.,+ 4,+K=6(:NCZ]/E>E/6="2@-L6^WAR?A.'THL3N_:%'[W&&
MT[-:HBI-SK"&C=0X 8R>"Y8S,,4$*,=K:X5<:(.T)H4LE<!;!4D?J/ZU,80^
M7;LW8<P.)=+4[#XJ]5YO4:J78 T3SCY,1GG A%4Q* 91%T=XA $?"KD!1@6C
M-,N<M4Z*>AA-GV[AFZJ71@)H>!/_E/NZ44WX:)Q6A+D6/5.UY98'CS4&LDC+
M#+<UDVGG1[W[:$:TFF,O8Q31I 0LU\!EHS4$78A1/D;C-3GBLG5*ZP9GVGT_
M#^Z<J7>]T-;";;RN/X:OYUKK)1G#93@?N"**<))#EG(QW$@#%QJLXD40*DV>
M42=,NP/EF9T2[XE<VTEPA]M$NU-.\L14$,I!\*QVBM*.+&I/;EJ]T$XLNM2\
MC=+>K@G[?G:]9Y7:'Z*UNV&Y*+:Q2!/1.4GA#"UA44LQ"&4A(CH0)F>N&'KI
M6]M)-P!TKQ<>8\PAO7W^C>QIG:(M"*$P5@U?#3%:#UJ0#ZU(WS'5.JRG!>XU
MC:-N-[#-:;7^"FPLTF9+Z]UT4L[3KXJ(M(:CAV3KTN:NUD.2 8+-16%,UC2O
M$7/U]#Z=MK?CQ8:SVTRZAV$Z)H+-WN'TP^<PQ9=A-DP#(YUW9!"!J-V9E<<$
M(3 #QG.%QM@HFY<SN1=(6T7Z>CA+RX6'^6K=7135H0<OGKEX^L F'TTF.0A9
M*QIR[\!Y%<!DP[E6WH?<.NMX8[!]\B>WY]/CFK,K&>[0IK\%TKOLHW1@'-8[
M5I; )6^!!^UC,,%B\[9Z:T+LD^+MFEYMY=6->7MP%H:CI95PK7;E>3&RY80X
M%8RTVD#4BH,*3D"DK0A8<5(32.%3Z["/-2&V-?B=RM879<"15$ 5SVJS3 %(
MODA4UABM=VCP[U<#=\F5.^%/&TNAS<U=#9X?IN')(OYJT3IJ40?^LB(C9G);
M?Q_GJY\O%$@%O!@_O>'U<%1_-?!%![<HJ.<CX?=2@@LZUN1OGE-*EA;W2K=Y
M36'UZD1O%^3:LV0;YNF>AS +$;E5)I$YKVO@,J\-!6KUN>RD88[0R/:5G>X+
M/=\V6W#QSWE14\VY=5%$*#780UE',@[2T)0:;SUSF'7KXX4'P?1)_6XD]2?Z
M'VTX[:V9?&$@W6Z2<E7)939#^B_7$J59>^\7R:VYQ@'14H<0N0";1%$612ZF
M=:_6#6#VR;9MPIRN1=4NS',XQ32_K NT3(A=@A\(;9U.PD%TFG8-%C-$I2P$
M5(8012-X:W/N$3A]NEMHPI%64]^R<,%Y=XFJXRZ5WX YGKEPM7:"8J"DKD4Y
M:WXTRJ!+$>2!M:YY\P"4/@7F->% BRGOXHB9YR+1,%GK<Y(NPASJ!9>'[)DL
M@9?D9&NSXJ$CYFZ/&P>15I*L4XM>Y^HMD=8U+H",,BO!D];-$Q+7P=<GFVI#
M?FQSDKB6>/H>-T9;NF66T5AT[6,648#30H$UJ+E@JAC;N@KB+N+&]FNN=4+*
MO8A\!WF."5E*VA4(DM6*Z[Q6-(@*7,&(P0?TI?5.OF*>XP;)*&$X7IPRX.QH
M7*LXS([*50#$5375@<!8.T.2A\:<J-T(%T6@.*",AC2+S[%YJ;95L?5)N[=A
MS9T\E2ZDU+;JSL,#5SF6DF,$)W)-'LVLIN"11\9<QE*+@+#6MX^/(^J3XNV&
M+PTETMGE_,5QID[&(RK:;XJF_29S\L\\<I!<J"2DL%:VOC-\ ,J.+^C/G[J\
MB5,B9RM#A,!]#30CI\7+@I"#T(5FPK4_)=@";I\T;@M>;7E-O[$D=WM1?P.F
M3$E$QA&\JV:>X04BF7A@7=2Q:.:<:GVDN3;(/BGJ[FG66FI[*J;UZNC7=^\/
M?SG\[<.;?QZ^^8U^/'Q[]*%I9:V''M%MF:V5!M:HYM8]/=,N],U&'A2JPHQC
M'DPABT)Q4D]>UO!K)C0&F3(1I_%J;SR$AL=RHBAGD^3 6;TGD%I!C"P"&I]T
M,%*USQY8+_)S=_4V]L>R1V)'UY%/6R?FJ5:%DG P(Q!$[=N@5/*$3(0Z5,Y+
MX5:+ULNH53/)W=7NZ ^GFLNT89+U@[,TH!W>1Y35A,A8;\4U.*LC*"1L(EMO
M96M7X!$X'8YT(S[8>F;-R-YR)7%0VG,(2DNPY!,7;4AFS9O@=+J3]78'6(N'
M]_0AWYO4=[%(5P(MF;>"_H?(E:XAVQD<EQ*,%MFDG(+1K0^^MH3<J_"\/7"S
MN5AW:YZD;)2)Q8&5AF8E.TE[)<$3$8OU*4:36]?G6-\\:3OVVJOBI]'DRR^8
M/V$])E]$3"[R/]]C&H79;%B&:<GAVHNK3A.9E](:S)#(T015:,=WAFADF1=>
MT-[O<NN \L9#Z-,6TIR9ZUAQ78M_)^OW77UA49QN\:YWD]E\BO/A=-'@^3RG
M_]THC&<'^;].EU<^5Q-KI7:9]L14LY250PZ^8 +&F<M!&Q5+ZPXH'0VE5WO/
M7DF]*S[LZX#PX,,O/[T]^E?;(\'+#^WX$/!^\*V._4B=W>J^=*<[T\T7KKWS
M'4Z'M7I!FM88R->X_'II;A]^39_#^!.^#W,\+,2)^2#YR!2Q K1,M9%P/5=.
MRD(QS#HFE)"^]1W ;D?8(#&K0G@WG9P-2;HOO_T^J[T]+Z--#])\>+;(Y1@X
MI472WM&0Z[5/R0DBUA"KP*-WM<(L;VU[K8ZN3_9"CSE^3T98%^)OF4EY'[[+
M -AK^+33W)6HP=M06X@3M&AJ>GXHJ0@"2/O5;NAY#[I>G5\^>WIN*_ZNZ;D,
M7+J)C\EH)'<10JY'KXZ3V2(<JQ%,022I"S:O++DZNC[E3#Q_>FXK_GUH3Z8)
M0-862,E[4(EG< D92%-+K<DD)&]]8[BI]MSJ9C1'H\BE<<!8E#3.J, KZ4%&
M(:S,!8MHO4OT\V:T(VX\<NFYSM2W/95XK$"^1F<$:@Z\U"Z.3CKPWB-(+,IZ
M3<.3G5QX/I-&!3NB25,Q-2//1<V26NO\N :6+K&0+D_,> $ELMHM&"5$;A(D
MIRT3QD;!6M?5NA])G[;M'1&E@4C:=>R\1M"C<NDS793*7@15UF;U@Y)+L9X[
M F8UJ-HD-O#":M\B'6)1TH36]]VK8NM3IN2.*-2)V-KIG/DTU+E^.QSC>S)I
M!PH5<[6M@G&QIOBF0$,5'FRQV0G%F&Y>Q>\VAC6[%G1>TV0GBF8;.;0IEW.3
MJ+]-QB3=TW&N5[>'M59 ;;& N&BY$"=G^!)'DR^_AND?.#\O07'1U'S1:B$1
ME;7S"HQAM94>N2'.A0S"<4<>,I.%WTK5?:!<3E-8?>IQT#&S]BS31LU75BDJ
M?.EOWY]7,/"I<%,"[=$LUZQU6DK!%%*QP@C/7 @LL)6HV +-*@RTWXERVX\(
MVR58W8OU];#.U3C/CJ:7]:86&(MDS!J)D!TF4(4)<$9F8,5',A=]TLV/W-9#
MN KUW/>A_'8@PH8M#0M.IYBOE5<G?4Q?E]V,9@,:L4E6%C!%D;>17(3H18',
MDF H<C+8.J'O*4RK4,E_7U1J*J9V3N%LAO.KAEBOR%_]1 /E6%QP20*+-<%?
M604A< 8V&RD"Z4S5/!GM?B0KG4&R[XLI#632KC?F>0C7,LO]>I+[;*"<+UFJ
M ,K69ITZ"H@%,VAM<TK1<NV;]\5\&,Y*3-EE;?]=4*65>!KFO<Y.29\=GA&$
M"W"#J)7)N6;@8KU-*ER"UU(!.B&PY,11MT]MO8MC)8;LLMCI+ABRM4":5Z5(
M-.J;Y0]$)OU5X_9$*@J49PI\%A'0FD O266;GU _"&8EDLCOC"1M1-,R>?[6
MA?A!6AYROL>$P[-Z_' 1C'DU%777K)X>^77&UE):->X'R?IV(=*L,!]X;2 M
M=/L&[AO#78EMZCMCVZ[$NP,^O@O?SM'2*]-3S&^'(0Y'YW.46$S&2T!&$Z62
M18BU?8N.(=3.H"PWKY._&=*56+BK/K][)V$SF;8YPKQMXET5E_I]G&LUBKOE
M5@>20%HI/)C$?=7:A+*$ @6C5RAJG/PMC_^!$\L-'KX2F<QWHM)V(J%]Q/])
M8U(RBD-V*H+*B. DYU"B\)4B4>G69T:;QO]M$& 5OBU<I(^3UWB&H\G)E<3.
MMQE66);%%G"^AF=&*\$IK\%%X3"$0OM4ZTS1)T'UK7==%U2Z$X_55%+M2@I?
MPCI(_WU*ZWMAJUPK^^>B9+PVBC?*$2J""*[4:@:,QR@+4]&TKDCY%*9>I7/M
MG#X-Y-2R('5"S(O[K'?3X;@V(AF]QY-SL$>TF=1<LG%>;!6S7W"4?YI,KXYV
M!C(&[S32YB&1C&!=:/.09!-'YD@8(3DR4=I'A6Z%^1G$?C4GWR[%W)UJNZKE
M_N$TSH9Y&*;#Y8U_*605TRJ:#:(46=8+"ZP->55, D*V!H2+W"/6B-GF!9PV
MP+EF]-CWJ0);R[,3M7C;D*Z+HTQH$5TNCLASB@$M,"T$+0X>P#M3VZ)*KETV
MWIC6>=9K 5PS".V[H%IG FS5S^W64E@HX+MG3@.K0C:%%PA65>>L]D16!#(D
MK0U-D,G%K>0^K_K$-</*GK5BZDX4S?= VH[KWGP1;5O;T UGM1+ XN8>R:&O
MU[0T3[B\<=-*"A2&$Z5]J=W@/+A4F]()3[,2;2CM.UAO!O4Y1)%UM1-V*=4V
MBNI&4-&;\>'7A+/94;FH>%OUZ^^U$M)L,AIF4J[Y/R;#\?R?A/:4=O9!IJ6B
M%9> N48AV6# I\) $^#$T67KRDKJ:SL<SR!<K*E.VZ'4.K&Y%C?%-:+W \[G
MHP7Y[YV?+$I&E<!:;FH/+PG!V03.H2Y6&M&^=_GZ*)]!?%F7UE<'HNSZ$/J^
M&@XR<^9=JAXOLZ!X5N ]JT'C/KH<> S-DQTW+>&QW=)[.QS7#B++2, !DF]O
M&?E<Q9%1K 1GQ()8^X_3/A0X,M6\=]>#8)Y!#O"VS'EL(6TNF(;M42]/C,I-
M.(REY$/1M?(F+=\<$&AP9*<(;;455A;>.M3A03#/X72Y-5':2*83HKP,XS]>
M8YP/$M,R8%20L<9+9,>AYIB"M,BU#LHKT;KCX7TXUCS^_>[HL9$\FONS1Z5B
M./Q:S8#3X>SS(KJX^D #DW2(PC!(J1XUET#492@@AQBY(1N!B:X.<!\$]1Q.
M:YOO/4TEU8V;,)N=5M/R:+H\XUNFR RT$]$:2<8C1TY>LJRFJ[!@"]'=F)"D
M;QWL]#2J9W (VZ7UTD!479RID6(\G:;/84:0ZNG+9/QA/DE_#'C(7)/W2]16
M!52LC9J8CL!I/I+G(@;5_$C_253/X6BV*RW42%9=[&,7&7B#K%1A5@>PT;C:
M8Y[&B2E#C)9)%WE2N;6/> ^,YW">VN%>M9$T.KBR_G4XGDQ)Q2W*KGR>C&C>
M9P-K72RDVL#9.L:(!FHC$3!>>^5TC?EKG:;T.*(U#T:_*[(TD%$G5LV]J(RC
M/W(\@5"1U9/_"(X%!D44IX*(WG#7H4VS*7?V?+#9I46SM9@Z(<^E=^>8=D5P
M2_94D* 8V5@^9 N,*Y^%9]'%+H,2UO&V]YTTVR5+-I)'Q\777P]G)Y/9<'$Y
M-+D6&!'.2SC=J5GQ(7W&?#K"^N;9*7%@4NY_XVN<A^%H=G,<JQ5O[QY4F^+O
M.YZ\+8O'7]P&$N0P^GDZ.3UYO#S)Q\D\C"[J>9TGWBTJ!'LK!0.M:Z$2XC%I
M->G!.)=1RB#N)+(]?(N[%9*MZU.L_OS+M(R+],,@N"J.EFU0*M5)L!"U81 Q
MDM^JM/6VM4+= FX?+DMV3[X[A2YV).]FL1:KHGVD?SOZ&(J/(#"HVK]=0#0B
M T=FA+"*[)+5\JU:H-GE>JTQ6LN'#RP6612+P$QM=)(B";'6G]/%T>P(E3RV
M/@#<#.ES7*5MJ+?-2MU0TNVJ'*V.E=XRFUVKY"Q+RD(:#^A"#>!R"H*IM7G1
M%I9S=-JVOD_?'&T?JBD_.W9N(_&6#+T'V7EN:'5++@9T=+\MNNR2=ED>:J!%
M<))+#3:)ZKQ@S7&3M.",R2ICBD:VOKIM/(1=;<SWVS!%,^3!.>"Z-J+TQ 0O
M2P9M933D$%JS8MG&M@;TGA,W]\G2V^&2NY-OGVQ%[@1-#.DF'0AVPIIR2+-&
MUG8H-=8XVK0G6W&_M?N?(S/;B'D?1M)[/$-Z86"-+$7G!,G74F$8-'A/.[13
MSA3:'U3[U+WU4?8I>[0/--V1O'=C&AV-GYBQRUZ:)249T'O(%NOM(JVN8)4%
M1&:=-T'QV#KTO WROIF6Q@86'1J0L2 HJ<F#\TI 2MP5&3&XV(%'U)UIN=^X
MY#VP^QY%L#>"=*LE",VR]=D#R >F2'08$G ?:LUE52!F8<!E::,(B>7FE6HV
M MJK".F^4K:IM'=N],]N+2.<'7Z=3P,)=S@.TV]O2"2S6F61_I"D-5K8C,MD
M_ &K.['("#PQ!DH4!D$@ Z\89Y$5%91J[15L#O?9V&/=4KFG_-BG.^%DEL@S
M6;.^9C[04JU%S!VMS^Q\*3SHTCK8:EMWHCM]\!YG-2YN?MXBY0-.SX:I]B:.
MTG*TY!M&0;ZA8@ZBE &R8HN2S9E+V7JQ/X"E9W94EW3;=-6VD&+'P26WJB=<
M13_<^L46H2+K/J)-X,=6 ]LRC.."EI>12E>/._QZ3ICS"J$7:OJ@T->#T6CR
M9=$9:3)=YH,M^XDZ701J2?8**O+S0X0HK %=C*&=IG;D:EVTJPWR;7>1-5 L
M]\<')M"%C#9Y!TRX16R @8A60 P\<Y:XCJIUNF,CZ'U2LGM@\VW+?Q^$:&83
MW0/^]W%8MDG#7-72HJ#(HL;1T73XB=Y>I4*;!^T=[Z9X/#P]?GW>LW%0BK%6
MF@S*1D_>3'1DU9'#K9VQ(J#+@NV TAOC[]/M03]YO1MJ=$GN^^?IH:D=Z&R,
M\B&#5:G&8GL+/N?:=RUDQJ,PD;5N];$UZ%XE)_>3QQVRH">F<?QV;4G^7PS3
M'=C*#SYSM\;S:D/?O37]Z.:?(\:B2B#O2ZK:T;& <Y$<P:R#-5)[85OGYG1B
M#78Z@Q=RQ?PKP?GX.8Q_&IYA%?'Y4=2KT^FTNK:TZX11?7W@9;V,-+5 @>5D
M5)%O[6K=,ZF,$[S8G)IWH>QT0,_4]F[&_2V,[X[9TZ75\M"0*LB/7R97([O"
M_M"0>,UGS99VL$#;F/*2)EMX37990IU+Y#*V3C#N=$#/U&COPX+HF#W[6A _
M34ZG5V/Z2"1^?)$[)4(I0H&)J5:I$QIJ B;XQ'@R 9-2K<,PNAU1GZZSGN&2
MZ)(_>]LDZBBN#>K+Y-$AI9QJ/0P!49E4V_EPB$5F$,$P&;4W&G?@]K8;T)JU
ME_Y<$3MCS[X6Q-'XVH#N#B$SDT5Q&8+W"$I8K+U%+;C",(:4?#&M(\J:#J!/
ME:*>(>$;LF-O5A#Y-M<L.]K3'M_$A(I!QP0RV6K.U1*/@=9LR$PPR3"ETCH[
MI],!K5GGZL\%L#/V='Q >JUE>!UR/LAG=29G\\DCU<JW.!S=ZGEM#D;;#;G1
MH>@U0&_&5WUX;C3HF<TF:?'JP?AVY7BN?'*L0$@UU83T*;@:L6N$%L9)KVUJ
MG<*Q%>!M%?NRC.&O./\\R=<;WCN.Q89 ?@6S$FKE'_#,&'#6*1V-*\&W/A)^
M $J?#AUWQZW;*K2%G#I7?O,P_C0DY3Z[]NVB(=NRO^16BF[%SVZEU#892KM;
M'6+A6]H$\]7#EX_]#>>#7(PS,7J0H;;6Y<Y#3$74=IVJ**=CT1T82X\@:F!;
M/O3I9!R<'E<98CY8WOTO(]>C-(RKY$ '-#1RA>"R3^"MI_T^^")C![$>:Z+L
M5:IR0U+=8]UU*;^6/LQ#.!<U#P8%G6;!!G#HR<15@D%D!B$KIXK)A#*TCK=^
M"E//+ACV0*'U1;._;>Y:<_MN]KI['M#YAO?4H%H4>+M7_M<>7/E%3EXQI"\@
M*)=!H= U/%W6YM3&,E:"DZN5H%CA85LE-3SU^0\IQ2P+$M ,PM52XD8[",Q(
MX :SE-K(9%9+6]H00"_VJT[H<"-;81?B:9,M]Q32I6J,I/ITHLTSU39GRGBL
MZ:423')2%<EX$KP);7JS(>V?(^O/?-<543'.Z_^_!G(UM]V 'OZP1A5(5P/;
MR)VJ3WHSGLVGIXO&'V$Z_5:/'8\7D<&&E<2-+S7O*('*24(L3(-57BF424;5
MO-#>(WBV-7'?3L:?/N+T^.;L7F^><ZUY^G$8TO1.C\JUL]2@>2Q2(B 9XF2Z
M%0.A2 M2>R-DQ)1+ZP"=;3'WZ7RH&==N&\@[%6PSCVL-U&_&O]%Z__@%1V?X
MZV0\_SP;</(;'*$FRA0'RII"UC]F0,W1<>$\MZW7YE: ^[ U]HF(6XIT/RP\
M#TL;9)UH=T<'SB?:VX5S-16*0V;>:5HPN=C6H;N;X.Q3M%4_.+>) /=(M1K<
M,K 1>10E07&B@.(J0S!90I \<99U8&*/N^XUI'T*9>H1W=86XOX(5V_3!R$[
M;3@/$)*I^7"200@LDQ^C"KDT3I >WC??*M ^!1+UAVYKB[#-:<0].+\MLN8N
M,9$77*POY 7'&$!I6<"'I$ H%H22(<G;+:8?.(EX\E%]"K!I3HP.9KL3?3/0
MT1$#D30>\[3%)AO!1<-!VFP8.F%4Z'+;VKHBSV."*XPISR/Y2XG7H"*GP7$5
MP2;IBA$J&=G:_EO]8&"_3N[&'+A3M:R5 -H5:;J!Z%K"^44J^7EF^>*^*]:4
M$S0@,HU7*:_!F\"!!<:Y,JAS:GT'O0:\7E7(ZX@Q[>33\>GL,G@GC/-[S(C'
M-?[Q_M)DLX.C5V^V.+G=[$%M3G4;#++1B>^U&YQ%JXU7D^.3*7[&\6QX=EXP
MKH:T7I:KD[*45'P&G_6B5G""R)F"G(45@J<<"S9>R6M"W%:OK?BXUUB&8\PO
M<4S?S-_57Y/"&"__YMV$UAW.A[3":.V]&X7QU0R:R)URDKQKX^H,%G*[DQ)@
MO%<N1-(9S5-V.AY2+RY#=T'HVRJV3U1IMJ\?3-*PHJ[-$W\:3;[\@OD3OEJ.
MDX9U4>%R86!7D&B,E]E;"+K0WL&#@B@\@8RJ:&=D"J'UWKXFQ#X=-N^4GAU*
MLFLK($S'M W.WBUFJ';_KHU7ZV2=SA<?/RF'[SYLL_NO]8!&N_[F@VJTVQ.M
MKCAV<$;/J:;'Q\FU#NOGS6U?AMDP#8R-Z&I@&FJNB!'"0\#HH$0A?38Q:]_:
M:UT3XE;'-#>>]6I9@),$=%4W=X4IHE4H'5GI9"L;62\+,_E>6D-27&D?I8]V
MM19\#<#TR?/MDFHW3G]V+<1F&^T5ZO-"^?<4;KXJ$QTCMU98T,I$0ACRLC"^
M#!BJB^^<;!UONPZ^/FVQNV!>YS+LB&7WK8\!;>Q.QN*!=OE:SQ(U1!L%_2A8
MD,K:G%H'#SR-JOMQ'\SGTV&DK7?!CIO^]R&]??YMH&*.T4L#W":BA@L& I,%
MK&:D%4Q,V7:[ZC;#W2N'K#$!'U^!.Y#S#E?F97WP=_7HCL3WR$@N:R JQZ2V
M,@&SM3QXY@R"JF$DNLB0C*(AM3Z-[V8D?=I3]D[BSJG0C-:K;[^OAZ-3\H.K
MCYL\CQJRTQY4(N<S.%2 %J-/Z!7GK3OIK UR[WY&BB$&8SEPP2U-DB(595R!
M&%!C5MFZ%5M]_X_U,S:A6W-/8QTQ[L?3('N7FTR3DA@CI8$&P4?O0"JBD<Z)
MR^9W==^_I[$-]SJ78C.>_6LQZ9@/S@C/)_SM]#C6T.KSP2].NV9'I_/9/(SK
M5C9PIEA9&T\RK&97*@&B8 E<9#IQ'K*6K1V/-2%V-"-WGG-^#*$X(BH%UM:0
M7R6)'=XPD-XE::QT7+<N9K46P#[I_2ZY=GOE=2?%EBI^>8-4&U9?GBW?\GT6
MKQ%(S.^6 7,'TVD8?\)E>0S-1.8\)Q#&U:I%D8-C-$/)."&20A%2ZV()VZ/N
MTW:P2TKN6-YMPB);&% 2/?HL N28)"C!'<3(%7!D,K-8&%\QM;FY';SF9+P+
MY,C54-7:P_L#IHOTON%L*4+BT3C_3DRY_/GB_J@"7CR?WG!A6'!K.28K(6K-
M@#R[&NM(.S^RZ K/JJS:W;TIK%X<1.V%>C<<A_V)>J?'R#:2VH@.-'>+I.\$
M7AH)4F;);&&1-2_/O.XQ\AYSL/=%P(X$V/']_P?\5#>IZN2,)K-:$>Q#G>3I
MMS?C,IDN9YN^F7^F3SVAKXL^(\N_V2:;N\5CV\0*-)^ 9A4#GZ+1G5ZSOP['
MDQJ2?]D^:)QO?LI#]=JT#&1(>P;DO5I2=()7'U:#"UK6RJU2Y&Y/(CH=WO;Q
MUR=3K-7SEL%D-^IO:.-2-B6#$8ZV"+LX9D@<C-$<2Z#9$ZTK$CX"IQ=60-\)
M?#=\NXUXFUD +T]GPS'6O>LXGO=L.D@T\-FP?OL>%S%MKR8S&K=1*N4H:&.R
MU;- ;VH%*@\Y&Y9#9B;HUF%#JZ/K5;3_<V%C1\)O1LX:R[@PELG#'G\((_I2
MKL;^GC;80W*[YSC048IB703A6:D](,C==FA "F?)G@J<Y=9&ZJK8^I2?_EQX
MV8G<&SI-RZE8SL/YW(T_#93W2I9Z52RS Q5JN)E #]X);WSB2K+VA9/OA=*G
M)/7GPKD64FUWVW[OS7\M)W+-W;Q>6KF>18S)HZ0_G%XF'PVL0I.]MC0!CI:'
M":2T#=<UZMPHH[QQH7702!OD:Z:]_[F;[XDTS77JX=<3',]P4-!&+$Q!C#6Y
M7_)4YX&#3!RE")S69'LG\0:$-1/L_Z3@MF)L9S4BD3J,JGN5CX?C>ORZR(RY
M!*53$O5&1F24M:LD^5GT$EA':MXH8=K7_G@"TBI<LW]RK3LQM[D(NVE"+/N[
M8*[C/\C_=3HC7^KGR1E.QW7L/T_#^/R-#Y_<:AL59Q&2C30[Y(%!Y,H"5X)G
MXEBX<W7[P.U/8V"KT-7]:5[V@QAMJ'V!LT8B79C&3X#D6?/(8H"H"JV_X@L$
M)Q@8:5 E3 34K\3>]9^]"D']GP3=F7@;J=?CDS"<+D9:E?Z]3;K>XPRG-"&#
M*+0T/(6Z1&H4!B\0M?,@$:W*W&%9L1+3.D]=Z4B<_;F1[T*HS<S)14(WN4B3
MFPOCPLS0K,;5U'M[5MTE5RML%T4^DPJ:%^3&-K<F'T>T$@EWURZJWQSL0,AM
ME-U[)%\^+;IKT2P=E4NU_&XZ*<ME4>?BXG*X1A=<=9JC@=3J $NM?CXYI)0S
M30=PJVD$FB,$3HM(Y"02"U9X(5;2AXV!K<36_N0#]4!C[I,9'00,WG<@=3/>
MD5ZE7P^B=T;+)("GY&J>;8(0E*]]OD5FOCA^NR+)*B&"JSY^)9[^>8^S4RGO
MS;4IUNBD388D12TLP#TM&;NXLR=+!!G+?+6&(]NZ-NM;,^_Q#,>G9$LIJ3 (
M(VH"(8U!\0S!JDB.)$K,H7AF66.[Y>+9?4@XV(7H;QL9&\U]*W/BXL[T D0=
MX?55>>]J1"F*LUD#63F91NLXK7LK('F6?=T:[.UC^ >MADV>WYLPSQT195>B
MV@^G'DAG%E+&I,G^<-'4JN&"0<#@H(BLF$N216\[X=CF^>ER)\'M?29= UFV
M<] O)N?<6YL-4A:"61U(M=9@);'(Q$T<6&'<<JYS-*U3S^^ 6#,&X_GSJ(TX
MVJBF.QA64:&U9"[S.HL4"NA2D[<8?><M[='%A(S,%JMPM0UO4P2]B'S8N?K9
MB;SV0JT'%&4@PP^UB6"B,]4"Y+65(BG*)(3CW'LR!;O@V>9[7M?-!/K.N0:"
M;'1Z<N<(A\"M<6_C/%-VT;K3TWQIA1!C4! 4*I6]#Q)78]YV.-8,>?@^*+=#
MT>TJHF$-^,$K[VK?:K('ZE*1$J*P"73B)@7AE RKU;IIB6K-6(;O9+_=FUS;
MT/+A:(F#]X<?#M)\0,ZN""6S:A*079!-S:M-M0%:I($J[EQ>+?C@R4?U(=9@
MY_QI*X!='4?<BWK I<[)H(&,/H%"K""3 ".=-R4(F^5J.?8; E@W:.#[8- N
MI-5U-O/IR<GHHEK'>3'V:WF\'])GS*<CG)3ZR_I_O6(Y"Z.Z[R^:A-2Z *EF
M6-'OMDEO[@)'HWSGSJ>H40+T/<^_^?"#VVBNO7-0F";^.P>6UT/]9,E$XZ3Q
MN#$Z6.&":)YGL17@;4_<SC__UJ<>7#:P^F<8G>(@(/?:2@U!VD*ZH1X+"F^
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M:LB3+?F26WBSAZ(W<>9@@??@$M_ ]'RQCW4"-;B1P=F(#6L!M=RI-V6@;N'
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MS!8/FDW*I7$.X[S^:OPU3.MWGP_)W#Q\T":7T(WG?N-^F@M7,BV2WBNI)40
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M*WOV&:?CX?L/\\O5C2"^G93IU]_\/,[XY]L_X%/]S2HB#ZT.FB?F/>'6BC9
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M7\F%"<YP9H0QY.$6VC,"*I9 J&!*CB6TMAX>2XOH0UAW#'6M.Y X18OHB\G
MZ.?QC,:KC_P5I_0J?:QO48V//E_V)4O.1YE<8LXY369ZB"PB2"8E8"Z66YU[
M\M;NQ/;0HCEVXLGZ%;&MOOH['=N*<U5AN@/2GL(]NJ,\3?Q'/]K>@U('J.JT
MY,I!I2QX83X;6\MIT7=6!F;H4^43O6HWZU ]>%+=$4-RWSBUBX9ZX-(%+%JF
MUZS7JRI846:4"5F]*:^]9"09$SDSE9P5Q:+7-TN$'$RB#K".;_/WI=5)ORII
M7;?QGS!/'UX-9_/-\$I6.JNLF!,\+RNB1NV !8]9HZAE_+I%*-\]UJ.C01\R
M;AV-_L_)]%^3\VW@O'<<M&->UJ(X4B<&!)=LO!1%=MF#[];V]*Z1'JGZ6\JW
MX=78LE[]\OR+)CV<Y+]/)[/9/Z?#.;D!954VT9DLM."6<>-J%'_)+'I AD)H
M6IFDI06JD_;O'.IQJK^MA!O>&MU&1\R<?*;O<(7,5^Z99%EPJGIWP; 0C6!2
MER1=LE;';I5/MP[S#>C](,DVO$>YC>PUSF_RT8#(B)#(I_=D+)L(+ J!K!C/
MC5<YE-BM1_(= WT#>C]0NCW<+QR4A1<4B.!B+>B<%[G@LM96A%KS16J0(O*0
M^@Q+?>29U8<<IAU-KST$YZS-'NR"Z7MF=3.M=LF9W4<E1\NL!I=U<,B<KY<D
M"<B<)KN)>:_H'?*V9-XZC/9Q9%8W9\DNFNB!':LJ:9?85CLO>=A)25W7T\#)
MS@Z:_*Q,SA;8G"Q81]-M3)&-8.Y+BO8NNIKT(>C6!UK/GKUY]@9GPTPVV.)5
M6#E9Q1290V9> >VM!FM))#*[HE1*:?+ G.S63WK#  ]8H<WDMO%M/E;V'$T
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M Y7-1Y+WT1+BL*CUC74*Y56ZI*9'WL)B :OI-QR2_.[VR6T2W0>LXEY2FUO
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M <(=<\#H3Y?+Z0R7VTEU&S9'8S79MW0L*>EK]B0Q0!T9E*2SX<D4W9KY\E%
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MBB1"\ZO7]JMX^<9W8LV.2J.SR9*1IVE1\\0<UT"O3@P,BK9,:H_)6:UY\QK
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MHUVV1 +G/" >' #G\F]_^_XX!U]%665%_N]_\7_R_@)$S@J>Y??__I??[SY
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MB_&^+%=:D)*=&(KVB9]9H2RFIP7<&15M85JJNR@L/Y4&:"7&7T!1<E$JJ_B
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MH3*CY"$'8&#V78.KP-_"7?UK-W87?*E5 (.4P.Z+GZN0/MONQXWVZPG.BT#
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MQ[?M5TMX)%,<8AB1.(((<P^F21)#''N$LQBE4AB=>QYI?VIKRDI"\(?%;#\
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MF"1^PB#UL ^1+R74U6\@(V&8<+6WH]+\*O5T?U-CUHW$@-2B@L5:5BLWZI-
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M['!C^;YVO)W,0)JML*\[- .OO/L1-!?[F\?MQ;C5$6PKJ3T@K*.=K%?DX<;
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MW7?T-&YD_6F57X3/&[S2CSI^SY?5DLRORZM<EHT/OX[9:3R>L:0Q#4.8*K*
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M2H!L53BQ6*D!GM9ZZ%W!4ZV)A=->KZ'JIJ11!F!@HMI@OY(?K(M6KC4 &Q7
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MXZ .MNW]KIG@RN))S59/XD;O:!"V^JX::O,0AB@0(B )9#**(6)(*"J3'/)
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MN%CP2E'IO_Y+F ;_V>@ ;F7[*RD7:N0L%TOL!\G,*A\4^H$GK!W9P9[PRJ0
M+>J*)W4^GS8KC+]Z!A?CY\F0M^]_5)/>&9Z7QKU[0Q[,_">Q((N5_O;[\KJJ
MQ*J:!522!(4YE#'+((K3$))<4IA@%H<IDXQB\R*YY_N;&N$=,=P;H6L+0^\H
MD5IN\(94@.@ "R;ZUA6=QL#!+K\,V?$-\!;4=RVHC<A^4;S H+X,S9$LY^_W
M LR+AZ*VF5?J%[TVL-2_W"C^6,X+7D\@35+^CPO]_ J^T'.' OS();6B[4E
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MHM:1P6 K+%#26OAU?; :N-:>P!J8F4[AY))]H0\P"P?7$W C.:[6#YJ=%VH
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M 2&9B!D2YM/#D0ZF1O_:"2N5C$#40@)22VE!2<= -"#\"Z$9P375XH%&OO:
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MN0ZDT0]!:WQJZ8 1K[YPZ\](G%?>DTTXT<&D)N"\@L]G?,^3PX_G+E3YV<4
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M(#^7QCLUI7 73 H9I5FB'7\>011F&#*6)!"GE$1(_Y^03D&!OL[F9A!;R7X
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MQDZ?9X5L+%^ZMF#-NWQ%5UQO+O=>T^UR6?RI?RC?%65S.?Q#455MK8>%#*,
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MY\R9VC!/[#2N=K;D:K1&MA]#@7(V&KU >#(4I_N8U#CTJOG<(/0_/,P(.+A
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M#):=+1II"$:V3:W48"LV:.4V!R*-Y/^W HWL-VTV@C^+-0 R3Q;,I>=)+=H
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MK!]D:<X5VI1B1R^K;UQLHXA>T![9B^E*>0/TOY9RAWE7Y-HM>2H+L>&]'_F
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M#?+B'WI;1G[QD<N+CWJ^^.WRLHY7I7S^G_G\\691S8LG6;;Y?:\3%DJ69%A
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M1+-8!!&4A 00A]H-9QD7,%$\B"4-59HZ%=.PG_KB*-LTB=F0$31R.^T[]#"
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M=5"K5^]E+!5\,TLZ)"2_F45'REY>-B(KU(I.6U=STY#&:+M_3Z>ULZ/_=EZ
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MXQ?]I__XI_8W^C^F?\9__-/_!U!+ P04    "  +@IQ6!#J\2WG7  "A@0D
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M-,JI@1 &@*7K+)4K/X#X=96<M\'$JP8)]+-WLVFZZM 84T"6HH=BPFJ,H8+
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M ?)9&^#.4B7]1PYV(G9*1HRU2%YV+I!02L;0,J=:ER4>0>ZP#+CN0-J=# <
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M(HRG(T<;JEXI &+M )BQSJ.R%E@QNO;8X):WSD'>2LA ,'.\H.\G?1[-]0%
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MMGEBPN;[^\5-IX*^K[<.Y?K!B/FZRFZCO3%?-CK:[O/FH,P?5\A00)- 9!-
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MJO]?/9YOY/NL"O1KMF$B'5M_<#;-=[^Q\<GWJTFT#PNGK]KROOZ=C-OI9_Q
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MHA@P=%R!BH8L]YP8H. V8+$QB_:YPO>I.#Z_\/J)U>R?S&HK\ENH:ILY!B7
M84#:#9'.5<L0-/DL$;.WFK6V=YXDJ%^U<20&'F84MF+]<+7$VK<<KZRTV49[
MD_"HIWZ ,MG_)8UTSI&K:Z2:MK]J[<C?.O:W1UP.+(O:H97@2<A2QH%SF* D
MK\F.SL8U=V+V)/'H^55WGOK,6,1MF\]*F4P2Y$"82.X):@_>6P_(@\DBT/)$
MZS9)Q]+<KVKL$H,/QEF=4KK#5:WK*OM#].75;S92@MOH:*39UH^^'11@)?-:
M&<#5:%[T!8(P%HR.PA1?I&_>:N\N!4?/2+EN4+Q^['EYBXO%;+X-HT8AET$Y
M2+8X4(Q9"*EP*#DX5)@+BM8M_'>GKE]=<P0J'HP\Z48@ \BKN5[(PYF4&YYH
MC+7'3 Q@4\+:",F"=V3,,BM+L"EJZUI?#^Q"5[^%CPWAU5P( P$6XKV-<[L:
M$9P-*7A(2#M$)3I;HW0)T-C@/$\LN=;&Y=,4]5OQV!A,C1@_8*/F;G^7@ZR;
M>X]H9>8\15FS2Z;KQ]]"1NC F74&+*\C/)R7X.JYDSV+TF=IE..--]06,H[6
M&I5[[V9+0NP\Y)N^/1MOVG;F%B\P>"< 2Q0UML,@*)T@2-HI,CE;8NNBL(,(
M[?M:ZCC4/% TG<MJN/IG8P!H/:_S6?Y6Z^ 6R]E3C3</T%*'O:B1+FNPRD8:
M;UU8^ LNO]2$R!NJ"'-WWGV+:V=$*C6\B[YV52IDA1='4+-.8Y!:.]9:&^Y)
MXK&:\I'7;=MRDA43HI$@8R9F6-3@$QF24J(G8S):85K/R]J=NGYU8I>XNJ\O
M.Y+8D)7D,DP_C^M)<)CJN_WU9@KM$8J.5%.K)H0;#[_!2_$J!U,*H$T>E,H,
M(D<)7A09F4^JL-UZ/FYY^%%=*V^?MQ[$4=MQWDYGVWJQ(80NCC"IM21,"ALA
MA((@!0M8LN,/8GS/+F7'5_>C(IK(]$Z7RFYY/EP]L.H!<TB\[J9W3(,0W ,:
M6D75Z,&WHML(7$AM/.GM@+G6#S->,W4Y8 K%8.:JB-;5!MLI.3I&=N>IM] ,
MHJ +-D..NM2:50X^*P05@D_"VH2LM5'Q""D]1[2.E_^#P%4#E@]7&ZQ&ZZQ-
M'W(I7JY"<9]Q>FC*XE./:Z0[=J:XD4K9>-_9O?=M09JP6N7( Q \:N&71;)&
M:V+:NJEBB"ZTCG;M1>#1]2V[O&SCFEPIR5TT8%RNY0>!C//H&7BIHDYH>%#-
M*R7WHK!?==4=MAX4G70GM^$JM[6/%VHY34:\J+=@[V;UKF1)/Z8G?KX>BG.0
MKMOCZ8U4WZ'K:7KM<P/') UC(@J(U?Q62M !:'4$69@,07DE9>N@T5T*CD['
MKGV*KCHPK)]<[T^WW@!8GI0Q A!K_YE0&]6'D$&8$C2O_6ATZ\RBG8D;PI7-
M09AXD(C=B3@&K)VN!A^]Q_E5WZS:$>0@3;3]2:VTS@YTMM(PMZ]:O>065S:X
MF$P 9FM_%)X]1!O)RS>J.,VMSJ7Y#?(CM!Q]57SON;>P]DJ4DJ4%*3"!*II!
M]+:0J\(M*L)Z5,UOAA\CIF>MT@('#VY\FS!^N/KD(WZN]MVMPCRLZ.SA4UH5
MF#U#7R,=<O6:#_AU-E]-][C&CDO&QU(#J[[F@N4ZTBAX!XFCXLI(E73K,96/
MT7*TY7+ON5M+$0P6X6+MZ8^*#DEDX'R*4#-9,%JA4O.!"SN0U:]>:8*-!W9+
M8V$,6,-<?OVZGGP7)M<]$=Y,RVQ^L7KX0>KFF4<V*V[=@_)6BFC+.U]/[I54
M"V>%KS.O4-:"H4"FLS/)04YTSBF;HL+69_XN=+5H@U*?N_FN#<5_NS$<>H_2
M:6"Q-O:OC9)HFW@HQFCC@O9,-+\OVY&VGE55:_1L:T/27$3#U5U_#?-QO3"Y
MOB)Y/5VN6P >H+0>?58C;;4;K2VBY(^]Z09ABELF,=%Q&,G,5EHH\"[FVO(!
M4\I&$ 1WBC,_]Z:CXN>//7S#Q#=!2&<X)&TBG?+10W R@F,!94["!)^.6L<0
MXN--I7DG6-Z6P</5$C^%\?RO87*)OV"H:G"E;@]1$=L?U$@_[$!E(QOFYDT;
M)\/&Z>,\:B;(!3>FYD71P>!B@5+3L1*9U*+YZ-^GZ#G69MGV[%M\\V1E%H1O
M@?44%$A'K<X)-)8@I1/"I%,L=B#623-<W+=*V@EAN$KF%<['W^@YW_"FV=*;
M*?'N\F!M\\P3FV7M[$YWLWR>ZU=NO.ELFO^"^?.=CL5;PJ7.<2V"31!#[>-N
M=*Z'42T=3E@T>IULZSOC(\@]/C-H[U=OU%9'%9!CH"W*!2AG'<2L$Z2((FEF
MK6Z>H'T,O7WG&)T&DP\3D4XDX>%JSJL&38OWX?MJD'A*\TO<3-L,5V4O&]\Z
M1)\>])Y&6O;X-3;2O5<$5(BMB B3.XZ$-XJ0Y#FO<=XL@?P(!R8Y4[)5V70Q
MP.0Q<H[5G?=9?O4&?"XA6"HR/C0BL&@L[69B0$0KH81BD\"( 5N7^Q](:K\:
MLQ62[FO$4\AMN,KPU14U'_ ;3B\/2ARX_XAFAN(3E#6KNET]^Q9(VC"G$YUP
M)@@ZX00!*4A1Q2L4URJS(MLW=KM+P_%MW5;/JU-B:H9>?>3?QLLO+R\7R]D%
MSC?"2<QK%Q4#;E;A*N[(#[(16. R<IT8;][I:%?:^JZJ/0(5#UN]=2".X>J3
MW1K =M_0MI_&MKTUN,U*6Y8\1!-3G?RD(;#@@&FK9?0IR.;=7+IK</LB+,:+
M\W+O!=_7?VXX(TKQ7.J:5]V?!;+:RLM!8EE'AUH+V5I][4;9<!O<[H&2^VJL
M Z'TV-%F%8[X>?8-Y]/J /\\I]W\9DJ;';<ORR3M"O,.O*K3;X4($!,YX&@=
MC]XP%-8_I[?V?&>_G9 :HZA+?@^@,=+V_H/W%Z6316<, ^DS61&UH9CS04&Q
MG+8&<F7N1T$[:KYY"-(Z:Y/4D;YJ+Y(!X.P=_K;!KOEL2E^F=>!N^S[*21(#
M680L2IW:C?7.D.Q8Z4LJZ+U.JG7)ZKXT]CLEKB/T=2JH 0#Q:L#0_>%V]Q:E
M9+ A\P+!^PB*B4P>C<XU09H[*XG!O/7-UDZ$]3M7K2/(M1?)']W)_!0.;5.R
MU_-/ZF!N6U/W[F56*B;%&:&&T*BL#NO0D]19,H$J<-O:<FGO7JYLT(_I"^;+
M"9Z7>];H1HNSEV<?7G\\2\L5KS=RDZ*++ <-AGMR;4KQX)V6-?[F7.%*IO0L
ML(ZD8;">Y3X N>,3G$@>PU5E>\\1.%RK'?JJOB8F=*CK]NU9;P7SEEL):"+A
M.Q+@HF*E L[E5(03O'7>UHGG)MQNQ+UZ[*^=^)LI;R_"I'83_/@%<5D#:3FO
MY/U(3GBR&3DG+]]P42<!*#)&T&5(0NB<,Q="M3Y6>ECF'VLZPSY(?U##-' ,
M#?<4N.KH?+!JO_/[38<[=*B$[S7(ME%)5W,]G<$:9//D_ B;@ >;B^9TG,?2
M6!NT'?&PK=G[VZOQ[@3P>^9+R2$:;A)8K"WGN(VTQVR&J$L,/.? 8NN:I;T(
M'-2@AWVP\? FL"NQ#%B?W.U8?H1BV?J@;OJJ=ZAJMO7)UEZY$E8CB.J5&\8
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MWYO=$Z.RJ;B&>PX_.NWCX /XF2=V/#>GJVR=9^>M%.^B-"* <:J (O%#C#*
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M6>+%:JN-LO<Q\B0@H WD(W$%0:::GA4L!AT,BM8UAT_1,]A.X/L@XK[%U$P
M?8>C;K?HV6(Q7BSK->'9[^/%J)#J]T8*,B!+S4*VJG*'##RC5#:),Q1\IW/P
ML3?TBXMV MP^-^H(;@X1$J]F%V$\'7%1$F.9EL$5+2-;<C)$"9!$,"F[))&'
M@T&Q?D>/\>PVTGL.#P>P<HB(N!YU\ M>1)R/3(C91J^@(%F+BC,#/B@/42A5
MPZM&[CARXOEW#0PAA\CS.8P<P=P!I/S=ZY+^MOY"E4[=2L;:X+F7($LM-)$*
M@8Y: U)$%17:$FQK,^P)<OI-YFM^!K46P'"Q=+7I3$Y16)Z@^%P3?R2"BXP#
M?=M)+,4:V;HM\),$]6O3-!/[;G Z0 8# -0J!/!N-IVMASK40I.ZNM>_?\7I
M J\4KM2!V<@ME!(+*5P4X$SRP"U#C*1P!;:N&=B%KD'"ZQ 8S#J62=\&T[HJ
M_;92O(Y4?Z+QY]4*<Q(%&1D.GB=31U/5F_3@ 3/FD)R6['[3S4=LJ(->W^]9
MV!Y<)Q)$WU"[N[;M8VNNEA6<B]D0 ^5J8(3T')P*'()/*6$QA@Z(G?"U^SO[
M;>7<$:@Z8OD #L='+-*WXRG6OQ<C>F<.N8ZW%C4IC8P)"$5S*(D\$YNBE<TG
M43Q'4[\0Z\R&;RJ*OI74UD# *!OF=*+=0'O/@6*N3I,5%G*0UA25@M"[G7=;
M'S_(^\4#Q??L;/J]>#G<L-KMJ,7;KS;:/Q\1.MOQR8W"8X>LHUG@_OJ%MX$.
MH4**60"RFAK"H@$74@+-@U6"@*-,Z^'6#ZDX]FBZ?>):M_(4O H25T-402$9
M:L%K44/6/&8>N%&MTROOD=!WY/XH.=\_;HYA[P ,E]N1C)<+4K&+Q57'B,7Z
M_IX)ZXIC8+RGQ11#5EAMC1F"L9P%KF)H'1%]DJ"A(.< 4=_/'&O&]R& Z*HE
MSY5[P!C32B%XF2TH)U5M91G )A=3],S&TKR/U28!/;<_:"?8^Y YF,M]6[%O
MQP4_IC%.T_6=%"8K#=<>I#&Y5MHG",II6HQ6AG&-+,F=+-@'CQY$KY]#9#1K
MQK"^Q?T+UM%AD_-2QC?T:V^E+8Z#3+6$4Q8-+G(&Z+1A9+>3B[=;=N"6A_?<
M6:*-R(]E6H]"7\R7MVKO9YQ]GH>O7^IB5BHOZV1TX9(.2*6A1DP@8NUYP4N)
M:&,@-VN7XX#>LG$4T+]NCX$G">A[;-_Q-D,[_O8-DO56V5S"U;;Q2?%4:CL4
M'E1M 1LAK HK$ZI 9"AZ4 N0/$9 /Z=&0\'.6G.Y3Z@LO\Y'OYR-8A3,"V_!
M.EXG"(H,7O,,.0;AHLY!Q:>\CP6F/W^>??NQ/FX-BOK5!B#6K^E1]&T$-3N<
M:WT+^>792' AO= 98JI7O<D9\(G..&VS<9ZQ8N_?9>XOY)>[";GY(="1D/?D
M6M]"_O0?HQPE<SPB:-0)%.,"7) 26(S&.YU424_U;MA)R)_^HY^ 1D="WI-K
M?0OY[,,HH \RZ0#%AU#KV2)$;WSMAI!M0,V\EL<*^>S#3D)6?Q A[\FU 5SU
MW-JSMQ$9Z9A3,I,YF^N)XQT#(MR!ELQX67)FLG72SQ8R^AY^W.YN\%@>#P F
M[\/W=6^ V5GZS\OQ?".<,XJ2JXR1SBYIU?KLBG6^/29>%),8HF@=57F"G*%<
M*1\HZEDW?._["NG=9;T .2_OYS6U;=6/;+V>/(JN5EK2,I!'VD]DUD((HMH_
M3!<6M+5LMYNDQ]\QE"N#XS#1DI%_A,CW*_R&D]G754' ;2N4%I'O)Y_<//*]
M^SJZBWQ;JVK=A ;IN25=8>HH#3K-:H"4,^ZY*ZV;K;6+?*^ 7^?9C*^S!FX9
MNA[:=?-OVA;_!].JB\XGG-:LD(NO\]FWJ[[ %[4"\LTTS3$L2"SKOT?6H'#>
M2%H"R_4VQH/34H#DR1?OBDC(=E) G9$XE#/M(#C=45_#D&+?IV$#+HRTJJWI
M&+F0:I7C(!)X=!9XSD8'+W?N,-R F*&<KX/ YUZ2&>XY_&J\^#I;C%<YO+-R
MR^-0)R=M2_1]%^;S52NQ(X[HXU_:JK],V]6W:DZX]=6K65:5W#!9M;2\+>RW
MG/,L@ZK)CV012B?!25F@U&Z9U@@6;6O/;$\2&U?%;;;WK"V;<EZ)\,X4B1??
M[Y*R;EH\GG[>3OK:_;=1N>"T!=35_6=903 E ,.BK6#%T3'3F),G6EK/+1 [
M1/0SU7N#P,H KG:>3G!"H6)A/@'S48$*K)I508!FWJ8B''K5VG$8<,;@("&T
M5R;B/O(< CCO).-(%4@!^ *&FU*;3I!9EXP&G;(S$G-\4!?XSY.)N)=@G\Q$
MW(?+?7M2#Q/K,H^I>%TOU311+W*NB758 ZMT9F@FS8ZU-(/.1-Q+1D]G(N[#
ML+[%O2VI+G#R])Q)0!8!N5NR=H;W*H*G+2"MTRI$LY/ !YZ)>+#(CV5:[T(_
M?_&6_*[W1 %.;BN34Y'!"4A*!5#*DKK+](=.TF0=7?9AMZY<VY[>;^BQE=B/
M9=L CO\[IM/+25@L5BT6;YIY^"*XBSJ"X 'KA&@&+CD.B$$)7K@+I745[C,D
M#:IYP"#MTY8R'39$KW>P1'3,D+MJ+/UAA8&(7()-N3BAK/2R=?W,LT3U[O6W
M@\#N\#I 'L, V)9]^!><Y#*;TT*OC_124K;92TB95=5>L\LR:B"E;J723G#;
MVCG:D;3!@NT00#R$6W/I# !TCU3MKW8G$US'.AM)D%<)JI#M&%PTP&4Q*AB=
M<SE16]V=#]Q3-589Y(';2I;#A>75/JX)4=)%A$*K 16Q0"0S&>K 0Q5C4B4_
ME;#:$)A#.&2;B7TW.!T@@[X=R_>T6:>8R5%ZA1>SR6JKKN.Y'W!RW3/P:E;.
MR]EB>>U$Z<0+[;@ &&N_)+0*:,6A=B'E+I%G75#=Q=DCON>!! P25X?(?W9B
M80Q @W5_8+R]23(,SN8Z# SH?-"@)"KP/ >PF$I '5-AK6,W)UQ>/X4#?Z2#
M?ZA8ZUOO/\RA_3B;Y%&./@3-69WX0B:Z8 9"KBFZQ1EFO?;V?GGBSHG(]?G_
MZ)'+ ['P='+SWH(9@(HGZA-B7O5$_!CJ(* 7ER0;8MQB9)4HF9L$/,A"IQ7Y
M@DX4!2DY*WQ).K#6)NH3Y/RC7U8>!\G6\CP8FM]P'F>-P/DS&6F+VK$3%^?3
MNIK%>;EMR+9175+GLX=4-+!@:Y]L)B#6")'(3!'_= FQ=4?Q76G[1W?YV\"V
M$TD/0+V>T8J6M)8[+'V:HZO&*R;Z!"61JZL"2^ UJUWA@C>&Z^2E:@SF \C\
M1[=HV^"Z:_D/0DUO3!G=;Z5.ZIRD(>-(%T.<U8;\[X+ !8KH3#$\^,9(/Y36
MG>"N_]GA?A(D](KY]?7/C<E?8R<_S>;UQ%K[ R-E;)8R*8BU#8H*&,%%:6K2
M@J)-S;E38B?'[(F7[ 1&\\\*QJ8B&HP-L;F,V?)]F"_O[;!1HDTBN Z@,R?/
MTS .7KD$PN82E?<\-;]!VY&TG?!J_UGQVJ6<>[^]P@WC?;W 45#*Z!0=\!K%
M45X("-)D0(L.A=,NY]U*6+<\?">DN7]6I#41R0 TXF:3@AN#@Y8R2^,Z'.9O
MX^67.YOI;G5DW5HC<A^CBD9"4BX#;1\#=48,J)QSD=GQ(EOG!1Q/]4[H]O^L
MZ.X)'0/8#V\NOH;QO"[@?*/\<\2\8QZS!O2U,Y05"F@E&:)1KMY)J^*:UP%N
MI62W: +[9P=N S$. (S78^'FF"[G<V+9U4"XD<JR*(.<]E/0M040([.[3D;U
M(D;IR?&+K6<_/$;+;H#\IXUO-17E/U#7@(_I"^;+"=8/+RX)>;.R_8.G["JP
M-U%]=1TXCGL]=27@QEL30JP#GQ@H)B/$I!"P)"X,!AX,;ZRT_D&[$F1A)=,Y
M@0E5$<7:9M+'FEE<LL@80TC_?U>"$W0EV ?1?74EV <K S!YGBL1L4ZSH%!#
MTD*N ^^QQN%5=MD[6X*6K1,I6E1^_8'MGP-@M&?EUSXR'39$KY)AF3'%:U6
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M@"-+ C2WW!/>R)QNW4CN/@6GI_>N=?JVE?;&Q=_N+[NB-"8$G1.AV:H$SJ@
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M- C25MY8Q<%%2T: BT+S@CD9V>TNZ[+<F)J2'"3+>:^,'1XJ>_/ 4LE,&5O
MEMJ7M]3B*5F[@A=II66.\<[X."D%K[][J!4HFK!P:"3\CO_Y3YB1"KVA70>5
ME(4<E2;L\MHS#@OX&)4IW"G[T'_:(_X''SSL4U\CF9_"K*$%O>HJ^J[.C_]6
M7]1G%QN>;+9B6-)&AE1'T]GZA3"K<H#,$N,N2<=4["3WI]<9]CVL$0P:LG)
M5"P75[=FU+]P?K$(W[Y,4[A<F5"Q\)S2:A"$J&FB]"4P[0%]DC8G9E/I- ^5
M5KEC6M*?;LW*)PD86%^<T5=I)X>AP;0^!7>WL#EI6G(ID"Y$G1GQQF>^&;+-
M$96PF$KH%/!]#DS["!C&"FTHV'EK+@]]&W4SJ45(S"GO@7RV4COKUXXC@4$Q
MUB;%$CK3+9]_Q+Y*0YD>[K,<PN"!M<M'#)>_+.MQJI./4KK^>KWJV?4S$C5I
MNI+3G8X![\NF:<2ZNUO2R:$5'%"*VLTKU8TR2:>M.%Z8B:9; M$S&N@D(@>V
MC<Y\Y9U/GB\ N._"5[S=X>;L"YT"&CJ7)9E(-X1QX'T48+E2RJ$.UG7J,M
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MG-C:/CK(F*W, 1RKYF9*=%R<CX 2K;9%)LU;-[;;2\S ^34M1/T\?([@^_@
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MTK9. TU[QHX+)1_(HYWG][>;F0AF"=.>@5BE1(I >Q'<@549I95"X,.AE9U
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M7H-$"J.5,;OFEMU)!(\IO')VO)XHOY<&UGH:R;.?9..R0"X)2H&!2CY!3,:
M#"%G)9E!UL<<Q$/I'%,$9@!H'B.M%XG(ZN]/4F!D\TH-G!=%;*V%GH8C9!:E
M",QFU[RYR7&4CLG2' J5!TOL)>*RQ@(F3/(B!9GM7B6DP\<#>&XSH(E.BY*-
MZ)9&V"<L*Z%CBMH,A,J#Y35TU&;'#G^\JD&"F]THSFM&OX=D=" ?LK: ,2C
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M'1"?=L3>WR@:]$R@!.<]W=]*&@BH$W@5?8K.*6?4J) \@-B^=,:QP#F6]#J
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M'3POO148<=A#VY:P8<!\T0&)*44Y-8SO35Z^&YO^@*M+LK_6>]-F;8A.\&P
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M-''\=T2[NKT\>@#7KI71]K1%#"[XVM E5-]52;0-)C4D[VUD+ AM6P]]O4=
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M+SIRW?F1NS]+0;J3V:&U#!@2X%4AX],9KD CXUEE&8,6QU\0$Q2D6U5DEEJ
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MVR'PNM!:QXP!R89(QFP,"7K":Z],4[!H9"PQ,]HU]@1=W2#M=" \!K)64ND
M:1^6JXUH+F\VMV>7N\I[QE3A,7'P2@10G)'ER@J')'0AF[8(FUJW0SB O$YP
MUPP;#P>8C22H#C!XG>_Z,7^E3>:T9=KCV^/&V^1XA.20V"CI-"/GJ2;[6QU#
M]M:U-A0/)'%:+(X&E1\RY\>36P>P_'E].?^"E_E]&<!'>CZ,C&BAV%C;>RD%
M/A4D#5EGES7#Z%JW^3Z$OFECH^<"Y&@2ZP"-=Q2;FR__.<\K(NKS][>U&'RC
MWW 7I3,I 6I51R5A!+21#II4UCDOR8IKG4,VC+)I$7A. Z25>'H"W5U?U8_[
MVZDW0C/FK"_@-:M)N,P#'20-@;B8F$I*Q]8!JH,([$1#;(B0QT#87%P]8?'7
MQ=>KR_6&8_SZT9#57ZTT(*OC4W6I^;[T!_)2F.:)N^99(4^0TPG.VH/@,;B=
M*)%.P25V6\E%A*02*0I)UP(5^B-X)P&+3R(QQY-K78'[!#F=O*.3@.L8B70
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M)D 4$3AWN:HJG.?64?]GB>K$)IT"@FT%U@$";Q6=72UUUI9>"2F 1:03%+T
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M$A:B%*Z:GA$PJP!8HDJ:15U4ZVJ4)PF:-A>WY>/4CN\]@&A+^^X\F1ALC"*
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M              "  0    !E>#$P,3 P,S,Q,C R,RYH=&U02P$"% ,4
M"  +@IQ6M!K7 K@Q   T5@$ $@              @ &V/0  97@Q,#$Q,#,S
M,3(P,C,N:'1M4$L! A0#%     @ "X*<5M5TT0_1,0  [U<! !(
M     ( !GF\  &5X,3 Q,C S,S$R,#(S+FAT;5!+ 0(4 Q0    (  N"G%9.
MT2ZD QP  *F?   2              "  9^A  !E>#$P,3,P,S,Q,C R,RYH
M=&U02P$"% ,4    "  +@IQ6F3MY2Y,8  "HC0  $@              @ '2
MO0  97@Q,#$T,#,S,3(P,C,N:'1M4$L! A0#%     @ "X*<5HL@[\*<;0
MUZ<" !(              ( !E=8  &5X,3 Q-3 S,S$R,#(S+FAT;5!+ 0(4
M Q0    (  N"G%8H4:H27WL  'KP @ 2              "  6%$ 0!E>#$P
M,38P,S,Q,C R,RYH=&U02P$"% ,4    "  +@IQ6&4EL!_TS  !W=P$ $0
M            @ 'POP$ 97@Q,#<P,S,Q,C R,RYH=&U02P$"% ,4    "  +
M@IQ6P[YDIXTZ   HJ@$ $0              @ $<] $ 97@Q,#@P,S,Q,C R
M,RYH=&U02P$"% ,4    "  +@IQ6 & FXNXU   ;B@$ $0
M@ '8+@( 97@Q,#DP,S,Q,C R,RYH=&U02P$"% ,4    "  +@IQ6='!+JDD#
M   Q"P  $0              @ 'U9 ( 97@R,C$P,S,Q,C R,RYH=&U02P$"
M% ,4    "  +@IQ6-H?8DE8(   )+0  $0              @ %M: ( 97@S
M,3$P,S,Q,C R,RYH=&U02P$"% ,4    "  +@IQ6T.@=44$(  #P+   $0
M            @ 'R< ( 97@S,3(P,S,Q,C R,RYH=&U02P$"% ,4    "  +
M@IQ6*KQ<6Z4%  "-&0  $0              @ %B>0( 97@S,C$P,S,Q,C R
M,RYH=&U02P$"% ,4    "  +@IQ6.IAB28L%  ![&0  $0
M@ $V?P( 97@S,C(P,S,Q,C R,RYH=&U02P$"% ,4    "  +@IQ62OZGGLX:
M P ;-"@ $0              @ 'PA ( <&5A:RTR,#(S,#,S,2YH=&U02P$"
M% ,4    "  +@IQ6C2I&7J(;  !$3@$ $0              @ 'MGP4 <&5A
M:RTR,#(S,#,S,2YX<V102P$"% ,4    "  +@IQ6C,_W9TLT  #<%P( %0
M            @ &^NP4 <&5A:RTR,#(S,#,S,5]C86PN>&UL4$L! A0#%
M  @ "X*<5KV7+FZIC0  :1@& !4              ( !// % '!E86LM,C R
M,S S,S%?9&5F+GAM;%!+ 0(4 Q0    (  N"G%;^/CI_#5,! -R=#0 5
M          "  1A^!@!P96%K+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4
M"  +@IQ6!#J\2WG7  "A@0D %0              @ %8T0< <&5A:RTR,#(S
B,#,S,5]P<F4N>&UL4$L%!@     5 !4 0@4   2I"     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
